Citrus Sinensis ID: 013201
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 447 | 2.2.26 [Sep-21-2011] | |||||||
| P28582 | 532 | Calcium-dependent protein | N/A | no | 0.955 | 0.802 | 0.743 | 0.0 | |
| Q9ZSA2 | 531 | Calcium-dependent protein | yes | no | 0.961 | 0.809 | 0.718 | 0.0 | |
| O49717 | 554 | Calcium-dependent protein | no | no | 0.973 | 0.785 | 0.676 | 0.0 | |
| P53683 | 533 | Calcium-dependent protein | yes | no | 0.961 | 0.806 | 0.703 | 0.0 | |
| P49101 | 513 | Calcium-dependent protein | N/A | no | 0.901 | 0.785 | 0.740 | 1e-179 | |
| Q38868 | 541 | Calcium-dependent protein | no | no | 0.885 | 0.731 | 0.718 | 1e-179 | |
| Q9C6P3 | 521 | Calcium-dependent protein | no | no | 0.888 | 0.761 | 0.722 | 1e-178 | |
| Q1PFH8 | 551 | Calcium-dependent protein | no | no | 0.984 | 0.798 | 0.654 | 1e-175 | |
| Q8RWL2 | 534 | Calcium-dependent protein | no | no | 0.812 | 0.679 | 0.722 | 1e-159 | |
| Q9M101 | 520 | Calcium-dependent protein | no | no | 0.937 | 0.805 | 0.644 | 1e-158 |
| >sp|P28582|CDPK_DAUCA Calcium-dependent protein kinase OS=Daucus carota PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/449 (74%), Positives = 376/449 (83%), Gaps = 22/449 (4%)
Query: 2 GCWGSKERVPPSDMNGYRSS-TAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQ 60
GC+ KE +D NGYRS+ TA+ H T Q+Y++ Q+ P+ Q
Sbjct: 3 GCFSKKEY--QADGNGYRSAPTAY--HTVTD-------QSYEKSSQRSQPQAQPQPQVQQ 51
Query: 61 PQPRQQPMKSSATSTRPVQKPE--TVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENST 118
P +P R V +PE T+LGKP EDIR YTLGKELGRGQFG Y CTENS+
Sbjct: 52 TGPSLKP--------RQVHRPESNTILGKPFEDIRGKYTLGKELGRGQFGCVYQCTENSS 103
Query: 119 GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178
G YACKSILKRKLV+K D+EDIKREIQI+QHLSGQ NIVEF+G +EDRQSVHLVMELC+
Sbjct: 104 GQLYACKSILKRKLVSKNDKEDIKREIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCA 163
Query: 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238
GGELFD+IIAQGHY+E+AAA +CR IVNVVH CHFMGVMHRDLKPENFLLS+KD AMLK
Sbjct: 164 GGELFDRIIAQGHYSERAAATICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLK 223
Query: 239 ATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWA 298
ATDFGLSVFI+EGKVYR+IVGSAYYVAPEVLRRSYGKEID+WSAGVILYILLSGVPPFWA
Sbjct: 224 ATDFGLSVFIEEGKVYRNIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWA 283
Query: 299 ETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358
E EKGIFDAIL+G +DFESEPW +S+SAKDLVRKML QDP++RITSA+VL+HPWMREGG
Sbjct: 284 ENEKGIFDAILEGVIDFESEPWPSVSNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGG 343
Query: 359 EASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTIT 418
EASDKPI SAVLSRMKQFRAMNKLK++ALKVIAE+LSEEEIKGLK+MFANMDTDKSGTIT
Sbjct: 344 EASDKPIDSAVLSRMKQFRAMNKLKQLALKVIAESLSEEEIKGLKSMFANMDTDKSGTIT 403
Query: 419 YEELKTGLARLGSKLSETEVKQLMDAVSI 447
YEELK+GLARLGSKLSE EV+QLMDA +
Sbjct: 404 YEELKSGLARLGSKLSEVEVQQLMDAADV 432
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Daucus carota (taxid: 4039) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZSA2|CDPKL_ARATH Calcium-dependent protein kinase 21 OS=Arabidopsis thaliana GN=CPK21 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/447 (71%), Positives = 375/447 (83%), Gaps = 17/447 (3%)
Query: 1 MGCWGSKERVPPSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQ 60
MGC+ SK R +D G +S + P QT+ + ++ PK P
Sbjct: 1 MGCFSSKHRKTQND-GGEKSIPIN------------PVQTHVVPEHRKPQTPTPK---PM 44
Query: 61 PQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGN 120
QP Q + + +++ V+ P+T+LGKP EDIR+FY+LGKELGRGQFGITY+C E TGN
Sbjct: 45 TQPIHQQISTPSSNPVSVRDPDTILGKPFEDIRKFYSLGKELGRGQFGITYMCKEIGTGN 104
Query: 121 SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGG 180
+YACKSILKRKL++KQD+ED+KREIQIMQ+LSGQ NIVE +GAYEDRQS+HLVMELC+GG
Sbjct: 105 TYACKSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQSIHLVMELCAGG 164
Query: 181 ELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240
ELFD+IIAQGHY+E+AAA + R+IVNVV CHFMGV+HRDLKPENFLLS+K+ AMLKAT
Sbjct: 165 ELFDRIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLLSSKEENAMLKAT 224
Query: 241 DFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAET 300
DFGLSVFI+EGKVYRDIVGSAYYVAPEVLRRSYGKEID+WSAGVILYILLSGVPPFWAE
Sbjct: 225 DFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAEN 284
Query: 301 EKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360
EKGIFD ++KG +DF SEPW IS+SAKDLVRKML +DPK+RIT+A+VLEHPW++ GGEA
Sbjct: 285 EKGIFDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQVLEHPWIK-GGEA 343
Query: 361 SDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYE 420
DKPI SAVLSRMKQFRAMNKLKK+ALKVIAE+LSEEEIKGLKTMFAN+DTDKSGTITYE
Sbjct: 344 PDKPIDSAVLSRMKQFRAMNKLKKLALKVIAESLSEEEIKGLKTMFANIDTDKSGTITYE 403
Query: 421 ELKTGLARLGSKLSETEVKQLMDAVSI 447
ELKTGL RLGS+LSETEVKQLM+A +
Sbjct: 404 ELKTGLTRLGSRLSETEVKQLMEAADV 430
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49717|CDPKF_ARATH Calcium-dependent protein kinase 15 OS=Arabidopsis thaliana GN=CPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 638 bits (1646), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/464 (67%), Positives = 370/464 (79%), Gaps = 29/464 (6%)
Query: 1 MGCWGSKERVPPSDM-NGYRSSTAHSSHQATGVAT-----------QTPYQTYQQQQQQQ 48
MGC+ SK R SD+ NG S+ ++ V+ Q P T QQ
Sbjct: 1 MGCFSSKHRNTESDIINGSVQSSIPTNQPENHVSRDVLKPQKPPSPQIPTTTQSNHHHQQ 60
Query: 49 LHVQPPKMSAPQPQPRQQPMKSSATSTRPVQ-----KPETVLGKPLEDIRQFYTLGKELG 103
+ +P Q ++ T+P++ + ET+LGKP E+IR+ YTLGKELG
Sbjct: 61 -----------ESKPVNQQIEKKHVLTQPLKPIVFRETETILGKPFEEIRKLYTLGKELG 109
Query: 104 RGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA 163
RGQFGITY C ENSTGN+YACKSILKRKL KQD +D+KREIQIMQ+LSGQ+NIVE +GA
Sbjct: 110 RGQFGITYTCKENSTGNTYACKSILKRKLTRKQDIDDVKREIQIMQYLSGQENIVEIKGA 169
Query: 164 YEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKP 223
YEDRQS+HLVMELC G ELFD+IIAQGHY+EKAAA + R+++NVV CHFMGV+HRDLKP
Sbjct: 170 YEDRQSIHLVMELCGGSELFDRIIAQGHYSEKAAAGVIRSVLNVVQICHFMGVIHRDLKP 229
Query: 224 ENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAG 283
ENFLL++ D AMLKATDFGLSVFI+EGKVYRDIVGSAYYVAPEVLRRSYGKEID+WSAG
Sbjct: 230 ENFLLASTDENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAG 289
Query: 284 VILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI 343
+ILYILL GVPPFW+ETEKGIF+ I+KG +DF+S+PW IS+SAKDLVRK+L +DPK+RI
Sbjct: 290 IILYILLCGVPPFWSETEKGIFNEIIKGEIDFDSQPWPSISESAKDLVRKLLTKDPKQRI 349
Query: 344 TSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLK 403
++A+ LEHPW+R GGEA DKPI SAVLSRMKQFRAMNKLKK+ALKVIAE+LSEEEIKGLK
Sbjct: 350 SAAQALEHPWIR-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKVIAESLSEEEIKGLK 408
Query: 404 TMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
TMFANMDTDKSGTITYEELK GLA+LGSKL+E EVKQLM+A +
Sbjct: 409 TMFANMDTDKSGTITYEELKNGLAKLGSKLTEAEVKQLMEAADV 452
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53683|CDPK2_ORYSJ Calcium-dependent protein kinase isoform 2 OS=Oryza sativa subsp. japonica GN=CPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 635 bits (1639), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/452 (70%), Positives = 361/452 (79%), Gaps = 22/452 (4%)
Query: 1 MGCWGSKERVPPSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQ 60
MG S+ P S G ++ SHQ T Y H QPP P
Sbjct: 1 MGSCCSRATSPDSGRGG--ANGYGYSHQTKPAQTTPSYN----------HPQPP----PP 44
Query: 61 PQPRQQP-----MKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTE 115
+ R P P P+T+LGKP +D+R Y+LGKELGRGQFG+TYLCTE
Sbjct: 45 AEVRYTPSAMNPPVVPPVVAPPKPTPDTILGKPYDDVRSVYSLGKELGRGQFGVTYLCTE 104
Query: 116 NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175
++G YACKSI KRKLV+K D+EDI+REIQIMQHLSGQQNIVEFRGAYED+ +VH+VME
Sbjct: 105 IASGKQYACKSISKRKLVSKADKEDIRREIQIMQHLSGQQNIVEFRGAYEDKSNVHVVME 164
Query: 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235
LC+GGELFD+IIA+GHY+E+AAA +CRA+VNVV+ CHFMGVMHRDLKPENFLL+ K+ A
Sbjct: 165 LCAGGELFDRIIAKGHYSERAAATICRAVVNVVNICHFMGVMHRDLKPENFLLATKEENA 224
Query: 236 MLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPP 295
MLKATDFGLSVFI+EGK+YRDIVGSAYYVAPEVLRR+YGKEIDVWSAGVILYILLSGVPP
Sbjct: 225 MLKATDFGLSVFIEEGKMYRDIVGSAYYVAPEVLRRNYGKEIDVWSAGVILYILLSGVPP 284
Query: 296 FWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
FWAETEKGIFDAIL+G +DFES+PW IS+SAKDLVRKML QDPKKRITSA+VL+HPW+R
Sbjct: 285 FWAETEKGIFDAILQGEIDFESQPWPSISESAKDLVRKMLTQDPKKRITSAQVLQHPWLR 344
Query: 356 EGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSG 415
+ GEASDKPI SAVLSRMKQFRAMNKLKKMALKVIA L+EEEIKGLK MF NMDTD SG
Sbjct: 345 D-GEASDKPIDSAVLSRMKQFRAMNKLKKMALKVIASNLNEEEIKGLKQMFTNMDTDNSG 403
Query: 416 TITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
TITYEELK GLA+LGSKLSE EVKQLM+A +
Sbjct: 404 TITYEELKAGLAKLGSKLSEAEVKQLMEAADV 435
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49101|CDPK2_MAIZE Calcium-dependent protein kinase 2 OS=Zea mays GN=CPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1622), Expect = e-179, Method: Compositional matrix adjust.
Identities = 305/412 (74%), Positives = 352/412 (85%), Gaps = 9/412 (2%)
Query: 42 QQQQQQQLHV-QPPKMSAPQPQPRQQPMKSSATSTRPVQK-----PETVLGKPLEDIRQF 95
+Q +++ L V PP+ +A + R P +++++ PV +T+LGK ED+R
Sbjct: 8 RQSRRKHLRVYNPPQQAA---EVRYTPSATNSSAVPPVAVPPKPTADTILGKQYEDVRSV 64
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y+ GKELGRGQFG+TYLCTE ++G YACKSI KRKLV+K DREDI+REIQIMQHLSGQ
Sbjct: 65 YSFGKELGRGQFGVTYLCTEIASGRQYACKSISKRKLVSKADREDIRREIQIMQHLSGQP 124
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
NIVEFRGAYED+ +VH+VMELC+GGELFD+IIA+GHYTE+AAA +CRA+VNVV+ CHFMG
Sbjct: 125 NIVEFRGAYEDKSNVHVVMELCAGGELFDRIIAKGHYTERAAATICRAVVNVVNICHFMG 184
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGK 275
VMHRDLKPENFLL+ + AMLKATDFGLSVFI+EGK+YRDIVGSAYYVAPEVLRRSYGK
Sbjct: 185 VMHRDLKPENFLLATMEENAMLKATDFGLSVFIEEGKMYRDIVGSAYYVAPEVLRRSYGK 244
Query: 276 EIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKML 335
EIDVWSAGVILYILLSGVPPFWAE EKGIFDAIL +DFES+PW IS+SAKDLVRKML
Sbjct: 245 EIDVWSAGVILYILLSGVPPFWAEIEKGIFDAILHEEIDFESQPWPSISESAKDLVRKML 304
Query: 336 IQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALS 395
+DPKKR+TSA+VL+H W+REGGEASDKPI SAVLSRMKQFRAMNKLKKMALKVIA L+
Sbjct: 305 TRDPKKRLTSAQVLQHQWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKMALKVIASNLN 364
Query: 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
EEEIKGLK MF NMDTD SGTITYEELK GLA+LGSKLSE EVKQLM+A +
Sbjct: 365 EEEIKGLKQMFMNMDTDNSGTITYEELKAGLAKLGSKLSEAEVKQLMEAADV 416
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q38868|CDPK9_ARATH Calcium-dependent protein kinase 9 OS=Arabidopsis thaliana GN=CPK9 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 627 bits (1617), Expect = e-179, Method: Compositional matrix adjust.
Identities = 296/412 (71%), Positives = 344/412 (83%), Gaps = 16/412 (3%)
Query: 52 QPPKMSAPQPQPRQQPMKSSAT----------------STRPVQKPETVLGKPLEDIRQF 95
Q P PQ + QQP K + S + K ++L ED++ F
Sbjct: 31 QDPPSYTPQARTTQQPEKPGSVNSQPPPWRAAAAAPGLSPKTTTKSNSILENAFEDVKLF 90
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
YTLGKELGRGQFG+TYLCTENSTG YACKSI K+KLV K D++D++REIQIMQHLSGQ
Sbjct: 91 YTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKLVTKADKDDMRREIQIMQHLSGQP 150
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
NIVEF+GAYED ++V+LVMELC+GGELFD+IIA+GHYTE+AAA++CR IVNVV CHFMG
Sbjct: 151 NIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHYTERAAASVCRQIVNVVKICHFMG 210
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGK 275
V+HRDLKPENFLLS+KD A++KATDFGLSVFI+EGKVYRDIVGSAYYVAPEVLRR YGK
Sbjct: 211 VLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGK 270
Query: 276 EIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKML 335
E+D+WSAG+ILYILLSGVPPFWAETEKGIFDAIL+G +DFES+PW IS SAKDLVR+ML
Sbjct: 271 EVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWPSISSSAKDLVRRML 330
Query: 336 IQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALS 395
DPK+RI++A+VL+HPW+REGGEASDKPI SAVLSRMKQFRAMNKLKK+ALKVIAE +
Sbjct: 331 TADPKRRISAADVLQHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENID 390
Query: 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
EEI+GLK MFAN+DTD SGTITYEELK GLA+LGSKL+E EVKQLMDA +
Sbjct: 391 TEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSKLTEAEVKQLMDAADV 442
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 625 bits (1612), Expect = e-178, Method: Compositional matrix adjust.
Identities = 294/407 (72%), Positives = 350/407 (85%), Gaps = 10/407 (2%)
Query: 43 QQQQQQLHVQPPKMSA--PQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGK 100
+ +++ H P K+S QP P + P K S + +L KP ED++ FYTL K
Sbjct: 26 ENRRRSTHQDPSKISTGTNQPPPWRNPAKHSGAAA--------ILEKPYEDVKLFYTLSK 77
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEF 160
ELGRGQFG+TYLCTE STG +ACKSI K+KLV K D+ED++REIQIMQHLSGQ NIVEF
Sbjct: 78 ELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQPNIVEF 137
Query: 161 RGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRD 220
+GAYED ++V+LVMELC+GGELFD+I+A+GHY+E+AAA++CR IVNVV+ CHFMGVMHRD
Sbjct: 138 KGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQIVNVVNICHFMGVMHRD 197
Query: 221 LKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVW 280
LKPENFLLS+KD A++KATDFGLSVFI+EG+VY+DIVGSAYYVAPEVL+R YGKEID+W
Sbjct: 198 LKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRYGKEIDIW 257
Query: 281 SAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPK 340
SAG+ILYILLSGVPPFWAETEKGIFDAIL+G +DFES+PW IS+SAKDLVR+ML QDPK
Sbjct: 258 SAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRRMLTQDPK 317
Query: 341 KRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIK 400
+RI++AEVL+HPW+REGGEASDKPI SAVLSRMKQFRAMNKLKK+ALKVIAE + EEI+
Sbjct: 318 RRISAAEVLKHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENIDTEEIQ 377
Query: 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
GLK MFAN+DTD SGTITYEELK GLA+LGS+L+E EVKQLMDA +
Sbjct: 378 GLKAMFANIDTDNSGTITYEELKEGLAKLGSRLTEAEVKQLMDAADV 424
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PFH8|CDPKJ_ARATH Calcium-dependent protein kinase 19 OS=Arabidopsis thaliana GN=CPK19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 615 bits (1586), Expect = e-175, Method: Compositional matrix adjust.
Identities = 299/457 (65%), Positives = 365/457 (79%), Gaps = 17/457 (3%)
Query: 1 MGCW----GSKERVPPSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQ-----QQQLHV 51
MGC K + P D++G +++ S TP + +Q+Q + Q+ V
Sbjct: 1 MGCLCINLKKKVKKPTPDISGEQNTEVKSREI-------TPKEQPRQRQPAPRAKFQIVV 53
Query: 52 QPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITY 111
QP K+ P PQP+++ + +Q+PE +LG+P EDI++ Y+LG+ELGRGQFGITY
Sbjct: 54 QPHKLPLPLPQPQEKQKLINHQKQSTLQQPEPILGRPFEDIKEKYSLGRELGRGQFGITY 113
Query: 112 LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171
+CTE S+G ++ACKSILKRKL+ +DRED++REIQIM +LSGQ NIVE +GAYEDRQSVH
Sbjct: 114 ICTEISSGKNFACKSILKRKLIRTKDREDVRREIQIMHYLSGQPNIVEIKGAYEDRQSVH 173
Query: 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK 231
LVMELC GGELFDKI +GHY+EKAAA + R++V VV CHFMGV+HRDLKPENFLLS+K
Sbjct: 174 LVMELCEGGELFDKITKRGHYSEKAAAEIIRSVVKVVQICHFMGVIHRDLKPENFLLSSK 233
Query: 232 D-GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILL 290
D +MLKATDFG+SVFI+EGKVY DIVGSAYYVAPEVL+R+YGK ID+WSAGVILYILL
Sbjct: 234 DEASSMLKATDFGVSVFIEEGKVYEDIVGSAYYVAPEVLKRNYGKAIDIWSAGVILYILL 293
Query: 291 SGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350
G PPFWAET+KGIF+ IL+G +DFESEPW IS+SAKDLVR ML DPKKR T+A+VLE
Sbjct: 294 CGNPPFWAETDKGIFEEILRGEIDFESEPWPSISESAKDLVRNMLKYDPKKRFTAAQVLE 353
Query: 351 HPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMD 410
HPW+REGGEASDKPI SAVLSRMKQ RAMNKLKK+A K IA+ L EEE+KGLKTMFANMD
Sbjct: 354 HPWIREGGEASDKPIDSAVLSRMKQLRAMNKLKKLAFKFIAQNLKEEELKGLKTMFANMD 413
Query: 411 TDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
TDKSGTITY+ELK+GL +LGS+L+ETEVKQL++ +
Sbjct: 414 TDKSGTITYDELKSGLEKLGSRLTETEVKQLLEDADV 450
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWL2|CDPKT_ARATH Calcium-dependent protein kinase 29 OS=Arabidopsis thaliana GN=CPK29 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 560 bits (1442), Expect = e-159, Method: Compositional matrix adjust.
Identities = 263/364 (72%), Positives = 311/364 (85%), Gaps = 1/364 (0%)
Query: 84 VLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKR 143
+L +P+ D+ Y L KELGRGQFGITY CT+ S G YACKSI KRKL+ ++D ED++R
Sbjct: 73 ILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKDIEDVRR 132
Query: 144 EIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRA 203
E+ I+QHL+GQ NIVEFRGAYED+ ++HLVMELCSGGELFD+II +G Y+EK AA + R
Sbjct: 133 EVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEAANIFRQ 192
Query: 204 IVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYY 263
IVNVVH CHFMGV+HRDLKPENFLL + + + +KATDFGLSVFI+EGKVYRDIVGSAYY
Sbjct: 193 IVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDIVGSAYY 252
Query: 264 VAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323
VAPEVL R+YGKEIDVWSAGV+LYILLSGVPPFW ETEK IF+AIL+G +D E+ PW I
Sbjct: 253 VAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLETSPWPTI 312
Query: 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLK 383
S+SAKDL+RKMLI+DPKKRIT+AE LEHPWM + + SDKPI SAVL RMKQFRAMNKLK
Sbjct: 313 SESAKDLIRKMLIRDPKKRITAAEALEHPWMTD-TKISDKPINSAVLVRMKQFRAMNKLK 371
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
K+ALKVIAE LSEEEIKGLK F NMDTD+SGTIT++EL+ GL RLGSKL+E+E+KQLM+
Sbjct: 372 KLALKVIAENLSEEEIKGLKQTFKNMDTDESGTITFDELRNGLHRLGSKLTESEIKQLME 431
Query: 444 AVSI 447
A +
Sbjct: 432 AADV 435
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M101|CDPKN_ARATH Calcium-dependent protein kinase 23 OS=Arabidopsis thaliana GN=CPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1437), Expect = e-158, Method: Compositional matrix adjust.
Identities = 288/447 (64%), Positives = 344/447 (76%), Gaps = 28/447 (6%)
Query: 1 MGCWGSKERVPPSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQ 60
MGC+ SK R +D G RS P QT+ Q P
Sbjct: 1 MGCFSSKHRKTQNDGGGERSIPI------------IPVQTHIVDQ------------VPD 36
Query: 61 PQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGN 120
+ Q P S S R PET+LGKP EDIR+FY+LG+ELGRG GITY+C E TGN
Sbjct: 37 HRKPQIPSPSIPISVR---DPETILGKPFEDIRKFYSLGRELGRGGLGITYMCKEIGTGN 93
Query: 121 SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGG 180
YACKSILKRKL+++ RED+K EIQIMQHLSGQ N+VE +G+YEDR SVHLVMELC+GG
Sbjct: 94 IYACKSILKRKLISELGREDVKTEIQIMQHLSGQPNVVEIKGSYEDRHSVHLVMELCAGG 153
Query: 181 ELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240
ELFD+IIAQGHY+E+AAA ++IV+VV CH GV+HRDLKPENFL S+K+ AMLK T
Sbjct: 154 ELFDRIIAQGHYSERAAAGTIKSIVDVVQICHLNGVIHRDLKPENFLFSSKEENAMLKVT 213
Query: 241 DFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAET 300
DFGLS FI+EGK+Y+D+VGS YYVAPEVLR+SYGKEID+WSAGVILYILL GVPPFWA+
Sbjct: 214 DFGLSAFIEEGKIYKDVVGSPYYVAPEVLRQSYGKEIDIWSAGVILYILLCGVPPFWADN 273
Query: 301 EKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360
E+G+F ILK +DF EPW ISDSAKDLV KML +DPK+RIT+A+VLEHPW++ GGEA
Sbjct: 274 EEGVFVEILKCKIDFVREPWPSISDSAKDLVEKMLTEDPKRRITAAQVLEHPWIK-GGEA 332
Query: 361 SDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYE 420
+KPI S VLSRMKQFRAMNKLKK+ALKV A +LSEEEIKGLKT+FANMDT++SGTITYE
Sbjct: 333 PEKPIDSTVLSRMKQFRAMNKLKKLALKVSAVSLSEEEIKGLKTLFANMDTNRSGTITYE 392
Query: 421 ELKTGLARLGSKLSETEVKQLMDAVSI 447
+L+TGL+RL S+LSETEV+QL++A +
Sbjct: 393 QLQTGLSRLRSRLSETEVQQLVEASDV 419
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Could act as a calcium sensor involved in drought- and salt stress-induced calcium signaling cascades. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 447 | ||||||
| 255554893 | 551 | calcium-dependent protein kinase, putati | 0.993 | 0.805 | 0.737 | 0.0 | |
| 59709746 | 556 | calcium-dependent calmodulin-independent | 0.984 | 0.791 | 0.748 | 0.0 | |
| 289413843 | 556 | calcium-dependent protein kinase 1 [Heve | 0.993 | 0.798 | 0.731 | 0.0 | |
| 449433950 | 552 | PREDICTED: calcium-dependent protein kin | 0.975 | 0.789 | 0.723 | 0.0 | |
| 84468312 | 558 | putative calcium dependent protein kinas | 0.982 | 0.786 | 0.718 | 0.0 | |
| 357480283 | 539 | Calcium-dependent protein kinase [Medica | 0.973 | 0.807 | 0.733 | 0.0 | |
| 356521991 | 529 | PREDICTED: calcium-dependent protein kin | 0.964 | 0.814 | 0.732 | 0.0 | |
| 224078616 | 532 | calcium dependent protein kinase 15 [Pop | 0.968 | 0.813 | 0.737 | 0.0 | |
| 267631890 | 549 | calcium-dependent protein kinase 1 [Pana | 1.0 | 0.814 | 0.745 | 0.0 | |
| 2827773 | 532 | RecName: Full=Calcium-dependent protein | 0.955 | 0.802 | 0.743 | 0.0 |
| >gi|255554893|ref|XP_002518484.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223542329|gb|EEF43871.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1785), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/457 (73%), Positives = 383/457 (83%), Gaps = 13/457 (2%)
Query: 1 MGCWGSKER-VPPSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAP 59
MGC GSKE+ P + NGYR + +S Q + QQQ + P++ A
Sbjct: 1 MGCCGSKEKPSKPKNDNGYRPANTGNSRPQQQQQQPQYPQQWDLQQQNLI---IPQIQAQ 57
Query: 60 QPQPRQQPMKSSATST---------RPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGIT 110
+PQ + + S +PVQKPET+LGKPL+DIRQFYTLGKELGRGQFGIT
Sbjct: 58 KPQAKPSQPQPSTPPPVKPAPAPIIKPVQKPETILGKPLDDIRQFYTLGKELGRGQFGIT 117
Query: 111 YLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170
YLCTENSTG++YACKSILKRKL++K DREDIK+E+QIMQHLSGQ NIVEFRGAYEDRQSV
Sbjct: 118 YLCTENSTGHTYACKSILKRKLISKSDREDIKKEVQIMQHLSGQPNIVEFRGAYEDRQSV 177
Query: 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSN 230
HLVMELC+GGELFD+IIA+GHY+E+ AA +C+ IVNVVH CHFMGV+HRDLKPENFLL++
Sbjct: 178 HLVMELCAGGELFDRIIAKGHYSERDAARICKDIVNVVHACHFMGVIHRDLKPENFLLAS 237
Query: 231 KDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILL 290
KD GA LKATDFGLSVFI+EGK YRD VGSAYYVAPEVL RSYGKEIDVWSAGVILYILL
Sbjct: 238 KDEGATLKATDFGLSVFIEEGKTYRDKVGSAYYVAPEVLSRSYGKEIDVWSAGVILYILL 297
Query: 291 SGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350
SGVPPFWAETE GIFDAIL+G +DFES+PW ISDSAKDL+R+ML QDPKKRITSA+VL+
Sbjct: 298 SGVPPFWAETENGIFDAILQGDIDFESKPWPSISDSAKDLIRRMLTQDPKKRITSAQVLD 357
Query: 351 HPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMD 410
HPW+++GG ASDKPI SAVLSRMKQFRAMNKLKK+ALKVIAE+LSEEEIKGLK MF NMD
Sbjct: 358 HPWIKDGGAASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAESLSEEEIKGLKVMFRNMD 417
Query: 411 TDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
TDKSGTITYEELKTGLARLGS+LSETEVKQLM+A +
Sbjct: 418 TDKSGTITYEELKTGLARLGSRLSETEVKQLMEAADV 454
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|59709746|gb|AAP72281.2| calcium-dependent calmodulin-independent protein kinase isoform 1 [Cicer arietinum] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1773), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/450 (74%), Positives = 381/450 (84%), Gaps = 10/450 (2%)
Query: 1 MGCWGSKERVPPS-DMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAP 59
MGC GSKE+ P+ D ++ ++ A+GVAT Y Q HVQ P
Sbjct: 1 MGCQGSKEKNKPTPDFTARHHGSSATAASASGVATNN--HQYHSVQPSSTHVQ-----TP 53
Query: 60 QPQPRQQPMKSSAT-STRPVQKPET-VLGKPLEDIRQFYTLGKELGRGQFGITYLCTENS 117
P+P P + T + + V K +T +LGKP +DI++ YTLG+ELGRGQFGITY CTENS
Sbjct: 54 PPKPDSNPKPTVTTQNVKTVHKTDTTILGKPFDDIKKHYTLGQELGRGQFGITYFCTENS 113
Query: 118 TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELC 177
TGN+YACKSILKRKLV+K DREDIKREIQI+QHLSGQ NIVEF+GAYEDR SVHLVMELC
Sbjct: 114 TGNTYACKSILKRKLVSKSDREDIKREIQILQHLSGQPNIVEFKGAYEDRFSVHLVMELC 173
Query: 178 SGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237
+GGELFD+IIAQGHY+E+AAA++CRA+VNVVH CHFMGV+HRDLKPENFLLS+KD GA L
Sbjct: 174 AGGELFDRIIAQGHYSERAAASICRAVVNVVHICHFMGVLHRDLKPENFLLSSKDEGATL 233
Query: 238 KATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFW 297
KATDFGLSVFI+EGKVYRD+VGSAYYVAPEVLRRSYGKEID+WSAG+ILYILLSGVPPFW
Sbjct: 234 KATDFGLSVFIEEGKVYRDMVGSAYYVAPEVLRRSYGKEIDIWSAGIILYILLSGVPPFW 293
Query: 298 AETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357
AETEKGIF+AIL+G +DF SEPW ISDSAKDLVRKML DPKKRITSA+VLEHPWMREG
Sbjct: 294 AETEKGIFNAILEGELDFASEPWPSISDSAKDLVRKMLNHDPKKRITSAQVLEHPWMREG 353
Query: 358 GEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTI 417
GEASDKPI SAVLSRMKQFRAMNKLKK+ALK+IAE LSEEEIKGLK MFANMDTD SGTI
Sbjct: 354 GEASDKPIDSAVLSRMKQFRAMNKLKKLALKIIAENLSEEEIKGLKAMFANMDTDNSGTI 413
Query: 418 TYEELKTGLARLGSKLSETEVKQLMDAVSI 447
TYEELKTGLAR+GS+LSETEVKQLM+ +
Sbjct: 414 TYEELKTGLARIGSRLSETEVKQLMELADV 443
|
Source: Cicer arietinum Species: Cicer arietinum Genus: Cicer Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|289413843|gb|ACB71246.2| calcium-dependent protein kinase 1 [Hevea brasiliensis] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/462 (73%), Positives = 379/462 (82%), Gaps = 18/462 (3%)
Query: 1 MGCWGSKERVPPSDMN-GYRSS-------------TAHSSHQATGVATQTPYQTYQQQQQ 46
MGC SKE+ S+ N GYRS A Q P T Q Q
Sbjct: 1 MGCCSSKEKPSKSEANKGYRSGGTGNLRQNQQQQSYYQQPEYQQQQAVQHPKMTVPQTQT 60
Query: 47 QQLHVQPPKMSAPQPQP-RQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRG 105
Q +P + A P P R P +A R VQ P+T+LGKPLEDI+Q+Y+LGKELGRG
Sbjct: 61 QTPQTRPQQPQASTPPPVRAAPTNLTA---RSVQTPQTILGKPLEDIKQYYSLGKELGRG 117
Query: 106 QFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165
QFG+TYLCTENSTG+ YACKSILKRKL+NK DREDIKRE+QIMQHLSGQ NIVEFRG+YE
Sbjct: 118 QFGVTYLCTENSTGHIYACKSILKRKLINKGDREDIKREVQIMQHLSGQPNIVEFRGSYE 177
Query: 166 DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPEN 225
DRQSVH+VMELC+GGELFD+IIA+GHY+E+ AA +C+ IVNVVH CHFMGVMHRDLKPEN
Sbjct: 178 DRQSVHVVMELCAGGELFDRIIAKGHYSERDAARICKDIVNVVHACHFMGVMHRDLKPEN 237
Query: 226 FLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVI 285
FLL++KD GAMLK TDFGLSVFI+EGK YR+IVGSAYYVAPEVLRRSYGKEID+WSAGVI
Sbjct: 238 FLLASKDEGAMLKTTDFGLSVFIEEGKTYRNIVGSAYYVAPEVLRRSYGKEIDIWSAGVI 297
Query: 286 LYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITS 345
LYILLSGVPPFWAETEKGIFDAIL+G +DFES PW ISDSAKDLVR+ML QDPK+RITS
Sbjct: 298 LYILLSGVPPFWAETEKGIFDAILEGYIDFESSPWPSISDSAKDLVRRMLTQDPKRRITS 357
Query: 346 AEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTM 405
A+VL+HPW+++GG ASDKPI SAVLSRMKQFRAMNKLKK+ALKVIAE LSEEEIKGLK M
Sbjct: 358 AQVLDHPWIKDGGAASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSEEEIKGLKAM 417
Query: 406 FANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
F NMDTDKSGTITYEELKTGLARLGS+LSETEVKQLM+A +
Sbjct: 418 FTNMDTDKSGTITYEELKTGLARLGSRLSETEVKQLMEAADV 459
|
Source: Hevea brasiliensis Species: Hevea brasiliensis Genus: Hevea Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433950|ref|XP_004134759.1| PREDICTED: calcium-dependent protein kinase 21-like [Cucumis sativus] gi|449479449|ref|XP_004155602.1| PREDICTED: calcium-dependent protein kinase 21-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/466 (72%), Positives = 379/466 (81%), Gaps = 30/466 (6%)
Query: 1 MGCWGSKERVPPSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQ 60
MGC S + P S +NG+ S ATG+AT+ PYQ YQ Q P K+SAPQ
Sbjct: 1 MGCCSSTQMPPSSGVNGFDS--------ATGIATRGPYQAYQPQSTVP---TPHKVSAPQ 49
Query: 61 ---PQPR---------QQPMKSSATSTRPVQKP-------ETVLGKPLEDIRQFYTLGKE 101
P R + P +SA S V P ET+LG+P +DI+++YTLGKE
Sbjct: 50 TQIPSSRNQPQPPPPAEHPTSASAFSKPAVSTPRTAQNYPETILGRPYDDIKKYYTLGKE 109
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LGRGQFGITYLCTENSTG +YACKSILKRKL++K D++D+KREI I+QHLSGQ NIVEF+
Sbjct: 110 LGRGQFGITYLCTENSTGQTYACKSILKRKLISKNDKDDMKREILILQHLSGQPNIVEFK 169
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
GAYEDR SVHLVMELC+GGELFD+IIA+G Y+EKAAA +CRAIVNVV CHFMGVMHRDL
Sbjct: 170 GAYEDRYSVHLVMELCAGGELFDRIIAKGQYSEKAAADICRAIVNVVQICHFMGVMHRDL 229
Query: 222 KPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWS 281
KPENFLL++K AMLKATDFGLSVFI+EGKVYRDIVGSAYYVAPEVLRR+YGKEIDVWS
Sbjct: 230 KPENFLLASKKEDAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRNYGKEIDVWS 289
Query: 282 AGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKK 341
AGVILYILLSGVPPFWAE EKGIFDAIL+G +DF S PW IS+SAKDLVRKML QDPKK
Sbjct: 290 AGVILYILLSGVPPFWAENEKGIFDAILQGDIDFASAPWPTISESAKDLVRKMLTQDPKK 349
Query: 342 RITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKG 401
RIT A+VLEH W+REGGEASDKPI +AVLSRMKQFRAMNKLKK+ALKVIAE LSEEEIKG
Sbjct: 350 RITPAQVLEHQWIREGGEASDKPIDNAVLSRMKQFRAMNKLKKLALKVIAENLSEEEIKG 409
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
LK MFAN+DTD SGTITYEELKTGLARLGS+LSE EVKQLM+A +
Sbjct: 410 LKAMFANIDTDNSGTITYEELKTGLARLGSRLSEAEVKQLMEAADV 455
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|84468312|dbj|BAE71239.1| putative calcium dependent protein kinase [Trifolium pratense] | Back alignment and taxonomy information |
|---|
Score = 674 bits (1740), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/469 (71%), Positives = 376/469 (80%), Gaps = 30/469 (6%)
Query: 1 MGCWGSKERVPPSDMNGYRSSTAHSSHQATGVATQTPYQT------YQQQQQQQLHVQPP 54
MGC GSKE +S+ HS H+ A T YQ Q HVQ
Sbjct: 1 MGCHGSKE--------AKKSAAEHSRHRHQSSAAAGGAATGGTNFQYQIVQPSSSHVQTS 52
Query: 55 KM---------------SAPQPQPRQQPMKSSATSTRPVQKPET-VLGKPLEDIRQFYTL 98
S P S++ + R VQKP+T +LGKP EDI++FYTL
Sbjct: 53 PPPKPKPESHSHSHSHASTVTTTTTSNPKPSASENVRTVQKPDTTILGKPFEDIKKFYTL 112
Query: 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIV 158
GKELGRGQFGITY CTENSTG +YACKSILKRKLV+K DREDIKREIQI+QHLSGQ NIV
Sbjct: 113 GKELGRGQFGITYFCTENSTGLNYACKSILKRKLVSKADREDIKREIQILQHLSGQPNIV 172
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMH 218
EF+GAYEDR SVHLVMELC+GGELFD+IIAQGHY+E+AAA++CRA+VNVVH CHFMGV+H
Sbjct: 173 EFKGAYEDRFSVHLVMELCAGGELFDRIIAQGHYSERAAASICRAVVNVVHICHFMGVLH 232
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEID 278
RDLKPENFLLS+KD GA LKATDFGLSVFI+EGKVYRD+VGSAYYVAPEVLRR+YGKEID
Sbjct: 233 RDLKPENFLLSSKDEGAALKATDFGLSVFIEEGKVYRDMVGSAYYVAPEVLRRNYGKEID 292
Query: 279 VWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338
+WSAG+ILYILLSGVPPFWAETEKGIF+AIL+G +DF SEPW ISDSAKDLVRKML QD
Sbjct: 293 IWSAGIILYILLSGVPPFWAETEKGIFNAILEGELDFVSEPWPSISDSAKDLVRKMLTQD 352
Query: 339 PKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEE 398
PKKRITS +VLEHPWMREGGEASDKPI SAVLSRMKQFRAMNK KK+ALKV+AE LSEEE
Sbjct: 353 PKKRITSTQVLEHPWMREGGEASDKPIDSAVLSRMKQFRAMNKFKKLALKVMAENLSEEE 412
Query: 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
IKGLK MFANMDTD SGTITYEELK+GLAR+GS+LSE EVKQLM+A +
Sbjct: 413 IKGLKAMFANMDTDGSGTITYEELKSGLARIGSRLSEPEVKQLMEAADV 461
|
Source: Trifolium pratense Species: Trifolium pratense Genus: Trifolium Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357480283|ref|XP_003610427.1| Calcium-dependent protein kinase [Medicago truncatula] gi|355511482|gb|AES92624.1| Calcium-dependent protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1727), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/454 (73%), Positives = 372/454 (81%), Gaps = 19/454 (4%)
Query: 1 MGCWGSKERVPPSD--MNGYRSSTAHSS---HQATGVATQTPYQTYQQQQQQQLHVQPPK 55
MGC GSKE+ D RSS A + + GV + Y Q QQ
Sbjct: 1 MGCHGSKEKKHAKDEFTARQRSSPARPTAPPSRPAGVDSNFRYINVPPQVQQS------- 53
Query: 56 MSAPQPQPRQQPMKSSATSTRPVQKP--ETVLGKPLEDIRQFYTLGKELGRGQFGITYLC 113
P P S+ T+ +PVQ+ T+LGKP EDI++FYTLGKELGRGQFGITY C
Sbjct: 54 -----STPSSNPKPSAITTQKPVQQKVDTTILGKPYEDIKKFYTLGKELGRGQFGITYFC 108
Query: 114 TENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173
TENSTG +YACKSILKRKLV+K DREDIKREIQI+QHLSGQ NIVEF+GA+EDR SVHLV
Sbjct: 109 TENSTGLNYACKSILKRKLVSKADREDIKREIQILQHLSGQPNIVEFKGAFEDRFSVHLV 168
Query: 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233
MELC+GGELFD+IIAQGHY+E+AAA++CR +V VVH CHFMGV+HRDLKPENFLLS+KD
Sbjct: 169 MELCAGGELFDRIIAQGHYSERAAASICRDVVKVVHICHFMGVLHRDLKPENFLLSSKDD 228
Query: 234 GAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGV 293
GA LKATDFGLSVFI+EGKVYRD+VGSAYYVAPEVLRR+YGKEID+WSAG+ILYILLSGV
Sbjct: 229 GAALKATDFGLSVFIEEGKVYRDMVGSAYYVAPEVLRRNYGKEIDIWSAGIILYILLSGV 288
Query: 294 PPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
PPFWAETEKGIF+AIL+G +DF SEPW ISDSAKDLVRKML DPKKRITS EVLEHPW
Sbjct: 289 PPFWAETEKGIFNAILEGELDFVSEPWPSISDSAKDLVRKMLTPDPKKRITSTEVLEHPW 348
Query: 354 MREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDK 413
MREGGEASDKPI SAVLSRMKQFRAMNK KK+ALKV+AE LSEEEIKGLK MFANMDTD
Sbjct: 349 MREGGEASDKPIDSAVLSRMKQFRAMNKFKKLALKVMAENLSEEEIKGLKAMFANMDTDS 408
Query: 414 SGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
SGTITYEELKTGLAR+GS+LSE EVKQLM+A +
Sbjct: 409 SGTITYEELKTGLARIGSRLSEAEVKQLMEAADV 442
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521991|ref|XP_003529633.1| PREDICTED: calcium-dependent protein kinase 21-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1727), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 328/448 (73%), Positives = 371/448 (82%), Gaps = 17/448 (3%)
Query: 1 MGCWGSKERVPPSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQ 60
MGC GSKE+ +S+T++ S + Y VQP + Q
Sbjct: 1 MGCHGSKEK---------KSNTSYGSAATGSGSGSGSGGGYNT-------VQPSPPTTDQ 44
Query: 61 PQPR-QQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTG 119
Q Q P A+ T + +++GKP +DI+++Y++GKELGRGQFGITYLCTENS+G
Sbjct: 45 VQASAQTPENRKASPTVQKKADTSIVGKPFDDIKKYYSIGKELGRGQFGITYLCTENSSG 104
Query: 120 NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179
+YACKSILKRKLV+K DRED+KREIQIMQHLSGQ NIVEF+GA+EDR SVHLVMELCSG
Sbjct: 105 GTYACKSILKRKLVSKADREDMKREIQIMQHLSGQPNIVEFKGAFEDRFSVHLVMELCSG 164
Query: 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239
GELFD+IIAQGHY+E+AAA+LCR+IVNVVH CHFMGVMHRDLKPENFLLS KD A LKA
Sbjct: 165 GELFDRIIAQGHYSERAAASLCRSIVNVVHICHFMGVMHRDLKPENFLLSTKDDHATLKA 224
Query: 240 TDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAE 299
TDFGLSVFI++GKVY D+VGSAYYVAPEVLRRSYGKEID+WSAG+ILYILLSGVPPFWAE
Sbjct: 225 TDFGLSVFIEQGKVYHDMVGSAYYVAPEVLRRSYGKEIDIWSAGIILYILLSGVPPFWAE 284
Query: 300 TEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359
TEKGIF+AIL+G +DF SEPW ISDSAKDLVRKML QDPKKRITSA+VLEHPWMREGG+
Sbjct: 285 TEKGIFNAILEGEIDFVSEPWPSISDSAKDLVRKMLTQDPKKRITSAQVLEHPWMREGGD 344
Query: 360 ASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITY 419
ASDKPI SAVLSRMKQFRAMNKLKK+ALKVIAE LSEEEIKGLK MFANMDTD SGTITY
Sbjct: 345 ASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENLSEEEIKGLKAMFANMDTDSSGTITY 404
Query: 420 EELKTGLARLGSKLSETEVKQLMDAVSI 447
EELKTGLAR+GS+LSE EVKQLMDA +
Sbjct: 405 EELKTGLARIGSRLSEAEVKQLMDAADV 432
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224078616|ref|XP_002305576.1| calcium dependent protein kinase 15 [Populus trichocarpa] gi|222848540|gb|EEE86087.1| calcium dependent protein kinase 15 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1723), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/449 (73%), Positives = 372/449 (82%), Gaps = 16/449 (3%)
Query: 1 MGCWGSKERVPPSDMNG--YRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSA 58
MGC+ SKE+ P D+NG YR ST S Q Q+ + Q Q Q PP+
Sbjct: 1 MGCFSSKEKAPRPDVNGCTYRPSTTGYSRQQQPQYHQSQQKAVAPQIQTQ---SPPR--- 54
Query: 59 PQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENST 118
+PQ QQ T TRPV K +T+LGKP EDI+Q YTL KELGRGQFGITYLCTEN+T
Sbjct: 55 -RPQQTQQ-----KTPTRPVPKVDTILGKPFEDIKQLYTLSKELGRGQFGITYLCTENAT 108
Query: 119 GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178
G+SYACKSIL+RKLVNK+D +DIKRE+ IMQHLSGQ N VEFRG YED QSVHLVMELC+
Sbjct: 109 GHSYACKSILRRKLVNKKDGDDIKREVNIMQHLSGQPNTVEFRGVYEDSQSVHLVMELCA 168
Query: 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238
GGELFD+IIA+GHY+E+ AA + R IVNVVH CHFMGVMHRDLKPENFLLS+KD GA LK
Sbjct: 169 GGELFDRIIAKGHYSERDAAKIFREIVNVVHACHFMGVMHRDLKPENFLLSSKDEGASLK 228
Query: 239 ATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWA 298
ATDFGLSVFI+EGKVYRDIVGSAYYVAPEVLRRSYGKEID+WSAGVILYILLSGVPPFWA
Sbjct: 229 ATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWA 288
Query: 299 ETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358
E E+GIFDAIL+G +DFES+PW I++SAKDLVR+ML QDP KRITSA+VLEHPW+++GG
Sbjct: 289 ENERGIFDAILQGDIDFESQPWPSITNSAKDLVRRMLTQDPNKRITSAQVLEHPWIKDGG 348
Query: 359 EASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTIT 418
+D+PI SAVLSRMKQFRAMNKL K+ALKVIAE LSEEEIKGLK MF NMDTDKSGTIT
Sbjct: 349 --ADRPIDSAVLSRMKQFRAMNKLMKLALKVIAENLSEEEIKGLKAMFTNMDTDKSGTIT 406
Query: 419 YEELKTGLARLGSKLSETEVKQLMDAVSI 447
YEELKTGLARLGSKLSE EVK LM+A +
Sbjct: 407 YEELKTGLARLGSKLSEAEVKNLMEAADV 435
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|267631890|gb|ACY78680.1| calcium-dependent protein kinase 1 [Panax ginseng] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/451 (74%), Positives = 379/451 (84%), Gaps = 4/451 (0%)
Query: 1 MGCWGSKERVPPSDMNGYRSS-TAHSSHQA-TGVATQTPYQTYQQQQQQQLHVQPPKMSA 58
MG SK++ +D+NGYRS + +Q +G + P Y Q Q+ H P+
Sbjct: 1 MGGCASKKQDYQADVNGYRSGRNGGTGYQTVSGQGYEKPSTQYNPTQPQRPHQTQPQPQP 60
Query: 59 PQPQPRQQPMKSSATSTRPVQKPE--TVLGKPLEDIRQFYTLGKELGRGQFGITYLCTEN 116
QP P + S RPV KPE T+LGK EDIR YTLGKELGRGQFG+TYLCTE
Sbjct: 61 KQPAPAPLKPAAHNPSPRPVHKPEPNTILGKKFEDIRAHYTLGKELGRGQFGVTYLCTEI 120
Query: 117 STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176
S+G+ YACKSILKRKLV+K D+ED+KREIQIMQHLSGQ +IVEF+GAYEDRQSVHLVMEL
Sbjct: 121 SSGHFYACKSILKRKLVSKNDKEDMKREIQIMQHLSGQPDIVEFKGAYEDRQSVHLVMEL 180
Query: 177 CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAM 236
C+GGELFD+IIAQGHY+E+AAA +CR IVNVVH CHFMGVMHRDLKPENFLLS+K+ GAM
Sbjct: 181 CAGGELFDRIIAQGHYSERAAATICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKNEGAM 240
Query: 237 LKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPF 296
LKATDFGLSVFI+EGKVYRDIVGSAYYVAPEVLRRSYGKEID+WSAGVILYILLSGVPPF
Sbjct: 241 LKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPF 300
Query: 297 WAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
WAE EKGIFDAIL+G +DFES+PW IS+SAKDLVRKML QDP++RITSA+VLEHPWMRE
Sbjct: 301 WAENEKGIFDAILEGVIDFESQPWPSISNSAKDLVRKMLTQDPRRRITSAQVLEHPWMRE 360
Query: 357 GGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGT 416
GGEASDKPI SAVLSRMKQFRAMNKLKK+ALK IAE+LSEEEIKGLK MF N+DTD SGT
Sbjct: 361 GGEASDKPIDSAVLSRMKQFRAMNKLKKLALKGIAESLSEEEIKGLKAMFTNIDTDNSGT 420
Query: 417 ITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
ITYEELK+GLARLGSKLSE EV+QLM+A +
Sbjct: 421 ITYEELKSGLARLGSKLSEAEVQQLMEAADV 451
|
Source: Panax ginseng Species: Panax ginseng Genus: Panax Family: Araliaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|2827773|sp|P28582.2|CDPK_DAUCA RecName: Full=Calcium-dependent protein kinase; Short=CDPK gi|1765912|emb|CAA39936.1| calcium- dependent protein kinase [Daucus carota] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/449 (74%), Positives = 376/449 (83%), Gaps = 22/449 (4%)
Query: 2 GCWGSKERVPPSDMNGYRSS-TAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQ 60
GC+ KE +D NGYRS+ TA+ H T Q+Y++ Q+ P+ Q
Sbjct: 3 GCFSKKEY--QADGNGYRSAPTAY--HTVTD-------QSYEKSSQRSQPQAQPQPQVQQ 51
Query: 61 PQPRQQPMKSSATSTRPVQKPE--TVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENST 118
P +P R V +PE T+LGKP EDIR YTLGKELGRGQFG Y CTENS+
Sbjct: 52 TGPSLKP--------RQVHRPESNTILGKPFEDIRGKYTLGKELGRGQFGCVYQCTENSS 103
Query: 119 GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178
G YACKSILKRKLV+K D+EDIKREIQI+QHLSGQ NIVEF+G +EDRQSVHLVMELC+
Sbjct: 104 GQLYACKSILKRKLVSKNDKEDIKREIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCA 163
Query: 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238
GGELFD+IIAQGHY+E+AAA +CR IVNVVH CHFMGVMHRDLKPENFLLS+KD AMLK
Sbjct: 164 GGELFDRIIAQGHYSERAAATICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLK 223
Query: 239 ATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWA 298
ATDFGLSVFI+EGKVYR+IVGSAYYVAPEVLRRSYGKEID+WSAGVILYILLSGVPPFWA
Sbjct: 224 ATDFGLSVFIEEGKVYRNIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWA 283
Query: 299 ETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358
E EKGIFDAIL+G +DFESEPW +S+SAKDLVRKML QDP++RITSA+VL+HPWMREGG
Sbjct: 284 ENEKGIFDAILEGVIDFESEPWPSVSNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGG 343
Query: 359 EASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTIT 418
EASDKPI SAVLSRMKQFRAMNKLK++ALKVIAE+LSEEEIKGLK+MFANMDTDKSGTIT
Sbjct: 344 EASDKPIDSAVLSRMKQFRAMNKLKQLALKVIAESLSEEEIKGLKSMFANMDTDKSGTIT 403
Query: 419 YEELKTGLARLGSKLSETEVKQLMDAVSI 447
YEELK+GLARLGSKLSE EV+QLMDA +
Sbjct: 404 YEELKSGLARLGSKLSEVEVQQLMDAADV 432
|
Source: Daucus carota Species: Daucus carota Genus: Daucus Family: Apiaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 447 | ||||||
| TAIR|locus:2138897 | 531 | CPK21 "calcium-dependent prote | 0.888 | 0.747 | 0.779 | 4.7e-172 | |
| TAIR|locus:2015846 | 521 | CPK33 "calcium-dependent prote | 0.872 | 0.748 | 0.735 | 1.1e-161 | |
| TAIR|locus:2092399 | 541 | CPK9 "calmodulin-domain protei | 0.885 | 0.731 | 0.738 | 2.5e-159 | |
| TAIR|locus:2036783 | 551 | CPK19 "calcium-dependent prote | 0.888 | 0.720 | 0.718 | 8e-156 | |
| TAIR|locus:2204340 | 561 | CPK29 "calcium-dependent prote | 0.868 | 0.691 | 0.695 | 9.6e-148 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.868 | 0.734 | 0.655 | 5.6e-139 | |
| TAIR|locus:2150225 | 523 | CPK34 "AT5G19360" [Arabidopsis | 0.827 | 0.707 | 0.678 | 6.5e-138 | |
| TAIR|locus:2128409 | 529 | CDPK6 "calcium-dependent prote | 0.836 | 0.706 | 0.671 | 2e-136 | |
| TAIR|locus:2827528 | 544 | CPK6 "calcium dependent protei | 0.814 | 0.669 | 0.651 | 8.4e-129 | |
| TAIR|locus:2075885 | 646 | CPK2 "calmodulin-domain protei | 0.883 | 0.611 | 0.596 | 3.6e-128 |
| TAIR|locus:2138897 CPK21 "calcium-dependent protein kinase 21" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1635 (580.6 bits), Expect = 4.7e-172, Sum P(2) = 4.7e-172
Identities = 315/404 (77%), Positives = 359/404 (88%)
Query: 50 HVQPP--KMSAPQPQPRQQPMKS--SATSTRPV--QKPETVLGKPLEDIRQFYTLGKELG 103
HV P K P P+P QP+ S S+ PV + P+T+LGKP EDIR+FY+LGKELG
Sbjct: 28 HVVPEHRKPQTPTPKPMTQPIHQQISTPSSNPVSVRDPDTILGKPFEDIRKFYSLGKELG 87
Query: 104 RGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA 163
RGQFGITY+C E TGN+YACKSILKRKL++KQD+ED+KREIQIMQ+LSGQ NIVE +GA
Sbjct: 88 RGQFGITYMCKEIGTGNTYACKSILKRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGA 147
Query: 164 YEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKP 223
YEDRQS+HLVMELC+GGELFD+IIAQGHY+E+AAA + R+IVNVV CHFMGV+HRDLKP
Sbjct: 148 YEDRQSIHLVMELCAGGELFDRIIAQGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKP 207
Query: 224 ENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAG 283
ENFLLS+K+ AMLKATDFGLSVFI+EGKVYRDIVGSAYYVAPEVLRRSYGKEID+WSAG
Sbjct: 208 ENFLLSSKEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAG 267
Query: 284 VILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI 343
VILYILLSGVPPFWAE EKGIFD ++KG +DF SEPW IS+SAKDLVRKML +DPK+RI
Sbjct: 268 VILYILLSGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRI 327
Query: 344 TSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLK 403
T+A+VLEHPW++ GGEA DKPI SAVLSRMKQFRAMNKLKK+ALKVIAE+LSEEEIKGLK
Sbjct: 328 TAAQVLEHPWIK-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKVIAESLSEEEIKGLK 386
Query: 404 TMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
TMFAN+DTDKSGTITYEELKTGL RLGS+LSETEVKQLM+A +
Sbjct: 387 TMFANIDTDKSGTITYEELKTGLTRLGSRLSETEVKQLMEAADV 430
|
|
| TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1541 (547.5 bits), Expect = 1.1e-161, Sum P(2) = 1.1e-161
Identities = 294/400 (73%), Positives = 346/400 (86%)
Query: 50 HVQPPKMSAP--QPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQF 107
H P K+S QP P + P K S + +L KP ED++ FYTL KELGRGQF
Sbjct: 33 HQDPSKISTGTNQPPPWRNPAKHSGAAA--------ILEKPYEDVKLFYTLSKELGRGQF 84
Query: 108 GITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167
G+TYLCTE STG +ACKSI K+KLV K D+ED++REIQIMQHLSGQ NIVEF+GAYED
Sbjct: 85 GVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDE 144
Query: 168 QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFL 227
++V+LVMELC+GGELFD+I+A+GHY+E+AAA++CR IVNVV+ CHFMGVMHRDLKPENFL
Sbjct: 145 KAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQIVNVVNICHFMGVMHRDLKPENFL 204
Query: 228 LSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILY 287
LS+KD A++KATDFGLSVFI+EG+VY+DIVGSAYYVAPEVL+R YGKEID+WSAG+ILY
Sbjct: 205 LSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILY 264
Query: 288 ILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAE 347
ILLSGVPPFWAETEKGIFDAIL+G +DFES+PW IS+SAKDLVR+ML QDPK+RI++AE
Sbjct: 265 ILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRRMLTQDPKRRISAAE 324
Query: 348 VLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFA 407
VL+HPW+REGGEASDKPI SAVLSRMKQFRAMNKLKK+ALKVIAE + EEI+GLK MFA
Sbjct: 325 VLKHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFA 384
Query: 408 NMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
N+DTD SGTITYEELK GLA+LGS+L+E EVKQLMDA +
Sbjct: 385 NIDTDNSGTITYEELKEGLAKLGSRLTEAEVKQLMDAADV 424
|
|
| TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1552 (551.4 bits), Expect = 2.5e-159, P = 2.5e-159
Identities = 294/398 (73%), Positives = 343/398 (86%)
Query: 52 QPPKMSA--PQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGI 109
QP K + QP P + + S + K ++L ED++ FYTLGKELGRGQFG+
Sbjct: 45 QPEKPGSVNSQPPPWRAAAAAPGLSPKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGV 104
Query: 110 TYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169
TYLCTENSTG YACKSI K+KLV K D++D++REIQIMQHLSGQ NIVEF+GAYED ++
Sbjct: 105 TYLCTENSTGKKYACKSISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKA 164
Query: 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229
V+LVMELC+GGELFD+IIA+GHYTE+AAA++CR IVNVV CHFMGV+HRDLKPENFLLS
Sbjct: 165 VNLVMELCAGGELFDRIIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLS 224
Query: 230 NKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYIL 289
+KD A++KATDFGLSVFI+EGKVYRDIVGSAYYVAPEVLRR YGKE+D+WSAG+ILYIL
Sbjct: 225 SKDEKALIKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYIL 284
Query: 290 LSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349
LSGVPPFWAETEKGIFDAIL+G +DFES+PW IS SAKDLVR+ML DPK+RI++A+VL
Sbjct: 285 LSGVPPFWAETEKGIFDAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVL 344
Query: 350 EHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANM 409
+HPW+REGGEASDKPI SAVLSRMKQFRAMNKLKK+ALKVIAE + EEI+GLK MFAN+
Sbjct: 345 QHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANI 404
Query: 410 DTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
DTD SGTITYEELK GLA+LGSKL+E EVKQLMDA +
Sbjct: 405 DTDNSGTITYEELKEGLAKLGSKLTEAEVKQLMDAADV 442
|
|
| TAIR|locus:2036783 CPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1519 (539.8 bits), Expect = 8.0e-156, P = 8.0e-156
Identities = 286/398 (71%), Positives = 341/398 (85%)
Query: 51 VQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGIT 110
VQP K+ P PQP+++ + +Q+PE +LG+P EDI++ Y+LG+ELGRGQFGIT
Sbjct: 53 VQPHKLPLPLPQPQEKQKLINHQKQSTLQQPEPILGRPFEDIKEKYSLGRELGRGQFGIT 112
Query: 111 YLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170
Y+CTE S+G ++ACKSILKRKL+ +DRED++REIQIM +LSGQ NIVE +GAYEDRQSV
Sbjct: 113 YICTEISSGKNFACKSILKRKLIRTKDREDVRREIQIMHYLSGQPNIVEIKGAYEDRQSV 172
Query: 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSN 230
HLVMELC GGELFDKI +GHY+EKAAA + R++V VV CHFMGV+HRDLKPENFLLS+
Sbjct: 173 HLVMELCEGGELFDKITKRGHYSEKAAAEIIRSVVKVVQICHFMGVIHRDLKPENFLLSS 232
Query: 231 KD-GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYIL 289
KD +MLKATDFG+SVFI+EGKVY DIVGSAYYVAPEVL+R+YGK ID+WSAGVILYIL
Sbjct: 233 KDEASSMLKATDFGVSVFIEEGKVYEDIVGSAYYVAPEVLKRNYGKAIDIWSAGVILYIL 292
Query: 290 LSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349
L G PPFWAET+KGIF+ IL+G +DFESEPW IS+SAKDLVR ML DPKKR T+A+VL
Sbjct: 293 LCGNPPFWAETDKGIFEEILRGEIDFESEPWPSISESAKDLVRNMLKYDPKKRFTAAQVL 352
Query: 350 EHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANM 409
EHPW+REGGEASDKPI SAVLSRMKQ RAMNKLKK+A K IA+ L EEE+KGLKTMFANM
Sbjct: 353 EHPWIREGGEASDKPIDSAVLSRMKQLRAMNKLKKLAFKFIAQNLKEEELKGLKTMFANM 412
Query: 410 DTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
DTDKSGTITY+ELK+GL +LGS+L+ETEVKQL++ +
Sbjct: 413 DTDKSGTITYDELKSGLEKLGSRLTETEVKQLLEDADV 450
|
|
| TAIR|locus:2204340 CPK29 "calcium-dependent protein kinase 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1415 (503.2 bits), Expect = 9.6e-148, Sum P(2) = 9.6e-148
Identities = 272/391 (69%), Positives = 324/391 (82%)
Query: 57 SAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTEN 116
S PQP+P+ P +TS+ P +L +P+ D+ Y L KELGRGQFGITY CT+
Sbjct: 75 SNPQPKPKPAPPPPPSTSSGSQIGP--ILNRPMIDLSALYDLHKELGRGQFGITYKCTDK 132
Query: 117 STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176
S G YACKSI KRKL+ ++D ED++RE+ I+QHL+GQ NIVEFRGAYED+ ++HLVMEL
Sbjct: 133 SNGREYACKSISKRKLIRRKDIEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMEL 192
Query: 177 CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAM 236
CSGGELFD+II +G Y+EK AA + R IVNVVH CHFMGV+HRDLKPENFLL + + +
Sbjct: 193 CSGGELFDRIIKKGSYSEKEAANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSP 252
Query: 237 LKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPF 296
+KATDFGLSVFI+EGKVYRDIVGSAYYVAPEVL R+YGKEIDVWSAGV+LYILLSGVPPF
Sbjct: 253 IKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPF 312
Query: 297 WAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
W ETEK IF+AIL+G +D E+ PW IS+SAKDL+RKMLI+DPKKRIT+AE LEHPWM +
Sbjct: 313 WGETEKTIFEAILEGKLDLETSPWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWMTD 372
Query: 357 GGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGT 416
+ SDKPI SAVL RMKQFRAMNKLKK+ALKVIAE LSEEEIKGLK F NMDTD+SGT
Sbjct: 373 T-KISDKPINSAVLVRMKQFRAMNKLKKLALKVIAENLSEEEIKGLKQTFKNMDTDESGT 431
Query: 417 ITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
IT++EL+ GL RLGSKL+E+E+KQLM+A +
Sbjct: 432 ITFDELRNGLHRLGSKLTESEIKQLMEAADV 462
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
Identities = 257/392 (65%), Positives = 318/392 (81%)
Query: 54 PKMSAPQPQPRQQPMKSS-ATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYL 112
P A PQ + P AT P+ P VLG+P+ED++ Y+LGKELGRGQFG+T+L
Sbjct: 33 PTAEASVPQSKHAPPSPPPATKQGPIG-P--VLGRPMEDVKASYSLGKELGRGQFGVTHL 89
Query: 113 CTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172
CT+ +TG+ +ACK+I KRKLVNK+D ED++RE+QIM HL+GQ NIVE +GAYED+ SVHL
Sbjct: 90 CTQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHL 149
Query: 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD 232
VMELC+GGELFD+IIA+GHY+E+AAA+L R IV +VH CH MGV+HRDLKPENFLL NKD
Sbjct: 150 VMELCAGGELFDRIIAKGHYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKD 209
Query: 233 GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSG 292
+ LKATDFGLSVF G+V++DIVGSAYY+APEVL+R YG E D+WS GV+LYILL G
Sbjct: 210 ENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCG 269
Query: 293 VPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
VPPFWAE+E GIF+AIL+G VDF S+PW IS AKDLV+KML DPK+R+T+A+VL HP
Sbjct: 270 VPPFWAESENGIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHP 329
Query: 353 WMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTD 412
W++E GEA D P+ +AV+SR+KQF+AMN KK+AL+VIA LSEEEI GLK MF MDTD
Sbjct: 330 WIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTD 389
Query: 413 KSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
SGTIT EEL+ GLA+ G++LSE EV+QLM+A
Sbjct: 390 SSGTITLEELRQGLAKQGTRLSEYEVQQLMEA 421
|
|
| TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1350 (480.3 bits), Expect = 6.5e-138, P = 6.5e-138
Identities = 253/373 (67%), Positives = 311/373 (83%)
Query: 72 ATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRK 131
AT P+ P VLG+P+ED++ YTLGKELGRGQFG+T+LCT+ +TG +ACK+I KRK
Sbjct: 47 ATKQGPIG-P--VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRK 103
Query: 132 LVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH 191
LVNK+D ED++RE+QIM HL+GQ NIVE +GAYED+ SVHLVMELC+GGELFD+IIA+GH
Sbjct: 104 LVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGH 163
Query: 192 YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251
Y+E+AAA+L R IV ++H CH MGV+HRDLKPENFLL +KD + LKATDFGLSVF G
Sbjct: 164 YSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPG 223
Query: 252 KVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG 311
+V++DIVGSAYY+APEVLRR YG E D+WS GV+LYILL GVPPFWAE+E GIF+AIL G
Sbjct: 224 EVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSG 283
Query: 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLS 371
VDF S+PW +IS AKDLVRKML DPK+R+T+A+VL HPW++E GEA D P+ +AV+S
Sbjct: 284 QVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMS 343
Query: 372 RMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS 431
R+KQF+AMN KK+AL+VIA LSEEEI GLK MF MDTD SGTIT EEL+ GLA+ G+
Sbjct: 344 RLKQFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGT 403
Query: 432 KLSETEVKQLMDA 444
+LSE EV+QLM+A
Sbjct: 404 RLSEYEVQQLMEA 416
|
|
| TAIR|locus:2128409 CDPK6 "calcium-dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1336 (475.4 bits), Expect = 2.0e-136, P = 2.0e-136
Identities = 251/374 (67%), Positives = 305/374 (81%)
Query: 74 STRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV 133
ST Q+ +LG+P+E++R+ Y G+ELGRGQFG+TYL T T ACKSI R+LV
Sbjct: 56 STTSTQQNGRILGRPMEEVRRTYEFGRELGRGQFGVTYLVTHKETKQQVACKSIPTRRLV 115
Query: 134 NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYT 193
+K D ED++RE+QIM HLSG +NIV+ +GAYEDR SV+L+MELC GGELFD+II++G Y+
Sbjct: 116 HKDDIEDVRREVQIMHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGLYS 175
Query: 194 EKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253
E+AAA LCR +V VVH CH MGVMHRDLKPENFL +KD + LKATDFGLSVF G
Sbjct: 176 ERAAADLCRQMVMVVHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDK 235
Query: 254 YRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV 313
++D+VGSAYYVAPEVL+R+YG E D+WSAGVILYILLSGVPPFW E E GIFDAIL+G +
Sbjct: 236 FKDLVGSAYYVAPEVLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQGQL 295
Query: 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRM 373
DF ++PW +SD AKDLVRKML DPK R+T+AEVL HPW+RE GEASDKP+ +AVLSRM
Sbjct: 296 DFSADPWPALSDGAKDLVRKMLKYDPKDRLTAAEVLNHPWIREDGEASDKPLDNAVLSRM 355
Query: 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKL 433
KQFRAMNKLKKMALKVIAE LSEEEI GLK MF ++DTD +G +T EEL+TGL +LGSK+
Sbjct: 356 KQFRAMNKLKKMALKVIAENLSEEEIIGLKEMFKSLDTDNNGIVTLEELRTGLPKLGSKI 415
Query: 434 SETEVKQLMDAVSI 447
SE E++QLM+A +
Sbjct: 416 SEAEIRQLMEAADM 429
|
|
| TAIR|locus:2827528 CPK6 "calcium dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1264 (450.0 bits), Expect = 8.4e-129, P = 8.4e-129
Identities = 237/364 (65%), Positives = 291/364 (79%)
Query: 84 VLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKR 143
VLG +IR YTL ++LG+GQFG TYLCT+ +TG YACKSI KRKL++K+D ED++R
Sbjct: 73 VLGHKTPNIRDLYTLSRKLGQGQFGTTYLCTDIATGVDYACKSISKRKLISKEDVEDVRR 132
Query: 144 EIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRA 203
EIQIM HL+G +NIV +GAYED VH+VMELC+GGELFD+II +GHY+E+ AA L +
Sbjct: 133 EIQIMHHLAGHKNIVTIKGAYEDPLYVHIVMELCAGGELFDRIIHRGHYSERKAAELTKI 192
Query: 204 IVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYY 263
IV VV CH +GVMHRDLKPENFLL NKD LKA DFGLSVF G++++D+VGS YY
Sbjct: 193 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFKDVVGSPYY 252
Query: 264 VAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323
VAPEVL + YG E DVW+AGVILYILLSGVPPFWAET++GIFDA+LKG +DF+++PW +I
Sbjct: 253 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGYIDFDTDPWPVI 312
Query: 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLK 383
SDSAKDL+RKML P +R+T+ EVL HPW+ E G A D+ + AVLSR+KQF AMNKLK
Sbjct: 313 SDSAKDLIRKMLCSSPSERLTAHEVLRHPWICENGVAPDRALDPAVLSRLKQFSAMNKLK 372
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
KMALKVIAE+LSEEEI GL+ MF MDTD SG IT++ELK GL R GS L +TE++ LM+
Sbjct: 373 KMALKVIAESLSEEEIAGLRAMFEAMDTDNSGAITFDELKAGLRRYGSTLKDTEIRDLME 432
Query: 444 AVSI 447
A +
Sbjct: 433 AADV 436
|
|
| TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
Identities = 238/399 (59%), Positives = 305/399 (76%)
Query: 52 QPPKMSAPQPQPRQQPMKSS---ATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFG 108
+P S +P+ + +P K S+ + + E+VL + E+ ++FY+LG++LG+GQFG
Sbjct: 140 KPETTSETKPETKAEPQKPKHMRRVSSAGL-RTESVLQRKTENFKEFYSLGRKLGQGQFG 198
Query: 109 ITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168
T+LC E TGN YACKSI KRKL+ +D ED++REIQIM HL+G N++ +GAYED
Sbjct: 199 TTFLCLEKGTGNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVV 258
Query: 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLL 228
+VHLVMELCSGGELFD+II +GHYTE+ AA L R IV V+ CH +GVMHRDLKPENFL
Sbjct: 259 AVHLVMELCSGGELFDRIIQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENFLF 318
Query: 229 SNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYI 288
+++ ++LK DFGLS+F +V+ D+VGS YYVAPEVLR+ YG E DVWSAGVI+YI
Sbjct: 319 VSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIVYI 378
Query: 289 LLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEV 348
LLSGVPPFWAETE+GIF+ +L G +DF S+PW IS+SAKDLVRKML++DPK+R+T+ +V
Sbjct: 379 LLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAHQV 438
Query: 349 LEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFAN 408
L HPW++ G A DKP+ SAVLSRMKQF AMNK KKMAL+VIAE+LSEEEI GLK MF
Sbjct: 439 LCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRVIAESLSEEEIAGLKQMFKM 498
Query: 409 MDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
+D D SG IT+EELK GL R+G+ L E+E+ LM A +
Sbjct: 499 IDADNSGQITFEELKAGLKRVGANLKESEILDLMQAADV 537
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P53683 | CDPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7035 | 0.9619 | 0.8067 | yes | no |
| P49101 | CDPK2_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.7402 | 0.9015 | 0.7855 | N/A | no |
| Q9ZSA2 | CDPKL_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7181 | 0.9619 | 0.8097 | yes | no |
| P28582 | CDPK_DAUCA | 2, ., 7, ., 1, 1, ., 1 | 0.7438 | 0.9552 | 0.8026 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 447 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-103 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-92 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-66 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-65 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-57 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-56 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-56 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-51 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-51 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-49 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-47 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-46 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-41 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-41 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-41 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-40 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-40 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-40 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-40 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-39 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-39 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-38 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-37 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-37 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-36 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-36 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-35 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-35 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-34 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-33 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-33 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-33 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-32 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-32 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-31 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-31 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-31 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-30 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-30 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-30 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-30 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-30 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-30 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-30 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-29 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-29 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-29 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-29 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-29 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-29 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-29 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-28 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-28 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-28 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-27 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-27 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-27 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-27 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-26 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-26 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-26 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-25 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-25 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-25 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-25 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-25 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-24 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-24 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-22 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-21 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-20 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-16 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd00051 | 63 | cd00051, EFh, EF-hand, calcium binding motif; A di | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-06 | |
| cd00051 | 63 | cd00051, EFh, EF-hand, calcium binding motif; A di | 6e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-05 | |
| pfam00036 | 29 | pfam00036, efhand, EF hand | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 5e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 9e-05 | |
| pfam13499 | 60 | pfam13499, EF_hand_5, EF-hand domain pair | 1e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-04 | |
| smart00054 | 29 | smart00054, EFh, EF-hand, calcium binding motif | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| PTZ00184 | 149 | PTZ00184, PTZ00184, calmodulin; Provisional | 2e-04 | |
| pfam13405 | 30 | pfam13405, EF_hand_4, EF-hand domain | 3e-04 | |
| PTZ00183 | 158 | PTZ00183, PTZ00183, centrin; Provisional | 3e-04 | |
| pfam13833 | 53 | pfam13833, EF_hand_6, EF-hand domain pair | 3e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.001 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.003 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.003 | |
| pfam13202 | 25 | pfam13202, EF_hand_3, EF hand | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 306 bits (786), Expect = e-103
Identities = 114/261 (43%), Positives = 160/261 (61%), Gaps = 9/261 (3%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + ++LG G FG YL + TG A K I K+K+ K+DRE I REI+I++ L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKL-KHP 57
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
NIV +ED ++LVME C GG+LFD + +G +E A R I++ + + H G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL-RRSYG 274
++HRDLKPEN LL ++DG +K DFGL+ +D G+ VG+ Y+APEVL + YG
Sbjct: 118 IVHRDLKPENILL-DEDG--HVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 275 KEIDVWSAGVILYILLSGVPPFWA-ETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333
K +D+WS GVILY LL+G PPF + +F I K F W IS AKDL+RK
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW-DISPEAKDLIRK 233
Query: 334 MLIQDPKKRITSAEVLEHPWM 354
+L++DP+KR+T+ E L+HP+
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 5e-92
Identities = 106/265 (40%), Positives = 150/265 (56%), Gaps = 11/265 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y L ++LG G FG Y TG A K + KR +K+D+ REI+I++ LS
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHP- 58
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
NIV A+ED+ ++LVME C GG+LFD + G +E A + I+ + + H G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIVGSAYYVAPEVLRRS-- 272
++HRDLKPEN LL ++K DFGL+ + + VG+ +Y+APEVL
Sbjct: 119 IIHRDLKPENILLDENG---VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 273 YGKEIDVWSAGVILYILLSGVPPFWAETEKG---IFDAILKGGVDFESEPWLLISDSAKD 329
YG ++DVWS GVILY LL+G PPF E + IL ++F+ W S+ AKD
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 330 LVRKMLIQDPKKRITSAEVLEHPWM 354
L++K L +DP KR T+ E+L+HPW
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 211 bits (541), Expect = 4e-66
Identities = 96/258 (37%), Positives = 146/258 (56%), Gaps = 13/258 (5%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG L + TG YA K + K+K++ +++ E E I+ ++ IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
A++ + ++LV+E GGELF + +G ++E+ A IV + + H +G+++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 222 KPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEIDV 279
KPEN LL + DG L TDFGL+ EG G+ Y+APEVL YGK +D
Sbjct: 120 KPENILL-DADGHIKL--TDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 280 WSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339
WS GV+LY +L+G PPF+AE K I++ ILK + F +S A+DL+ +L +DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF----LSPEARDLISGLLQKDP 232
Query: 340 KKRITSA---EVLEHPWM 354
KR+ S E+ HP+
Sbjct: 233 TKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 8e-65
Identities = 91/255 (35%), Positives = 128/255 (50%), Gaps = 44/255 (17%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG G FG YL + TG A K I K + E++ REI+I++ L+ NIV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHP-NIVKLY 57
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRD 220
G +ED ++LVME C GG L D + G +E + I+ + + H G++HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 221 LKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-VYRDIVGSAYYVAPEVLR--RSYGKEI 277
LKPEN LL + +G +K DFGLS + K + + IVG+ Y+APEVL Y ++
Sbjct: 118 LKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D+WS GVILY L KDL+RKML +
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200
Query: 338 DPKKRITSAEVLEHP 352
DP+KR ++ E+LEH
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 3e-60
Identities = 91/265 (34%), Positives = 144/265 (54%), Gaps = 19/265 (7%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
+ +G +G +L + STG+ YA K I K ++ K + + E I+ +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSP-YVVKLY 59
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
+++ +++++LVME GG+L + G E A IV + + H G++HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 222 KPENFLLSNKDGGAMLKATDFGLSVF---------IDEGKVYRDIVGSAYYVAPEV-LRR 271
KP+N L+ + +G LK TDFGLS D+ K + IVG+ Y+APEV L +
Sbjct: 120 KPDNILI-DSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
+ K +D WS G ILY L G+PPF ET + IF IL G +++ + +SD A DL+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLI 234
Query: 332 RKMLIQDPKKRITSA---EVLEHPW 353
K+L+ DP+KR+ + E+ HP+
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPF 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 7e-57
Identities = 88/267 (32%), Positives = 141/267 (52%), Gaps = 16/267 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+T G+ LGRG FG YL + TG A KS+ + ++++ E ++REI+I+ L
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQ-HP 59
Query: 156 NIVEFRGAYEDRQSVHL--VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
NIV + G+ D + L +E SGG L + G E R I+ + + H
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR 270
G++HRD+K N L+ D ++K DFG + + + + + G+ Y++APEV+R
Sbjct: 120 NGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 271 RS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL--LISDSA 327
YG+ D+WS G + + +G PP W+E A+ K G P + +S+ A
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP-WSELGNP-MAALYKIGSS-GEPPEIPEHLSEEA 233
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHPWM 354
KD +RK L +DPKKR T+ E+L+HP++
Sbjct: 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-56
Identities = 87/285 (30%), Positives = 132/285 (46%), Gaps = 35/285 (12%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED-IKREIQIMQHLSGQ 154
+ GK +G G F L E T YA K IL ++ + K+ + +K E +++ L+G
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIK-ILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
I++ ++D ++++ V+E GEL I G EK I+ + + H
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI----------------- 257
G++HRDLKPEN LL +KD + TDFG + +D
Sbjct: 122 GIIHRDLKPENILL-DKDMHIKI--TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 258 ----VGSAYYVAPEVLRRSY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG 312
VG+A YV+PE+L GK D+W+ G I+Y +L+G PPF E F ILK
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238
Query: 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITS----AEVLEHPW 353
F AKDL+ K+L+ DP+ R+ E+ HP+
Sbjct: 239 YSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 9e-56
Identities = 77/264 (29%), Positives = 140/264 (53%), Gaps = 16/264 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSI-LKRKLVNKQDREDIKREIQIMQHLSGQ 154
Y + K++G+G FG YL S G Y K I L +++++RED E++I++ L+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLN-H 58
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKI----IAQGHYTEKAAAALCRAIVNVVHH 210
NI+++ ++E++ + +VME GG+L KI + E+ + + +
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL 269
H ++HRD+KP+N L++ ++K DFG+S V + + +VG+ YY++PE+
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNG---LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 270 R-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328
+ + Y + D+WS G +LY L + PF E + ILKG + S +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQY---SSELR 232
Query: 329 DLVRKMLIQDPKKRITSAEVLEHP 352
+LV +L +DP++R + A++L+ P
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 178 bits (451), Expect = 1e-51
Identities = 91/284 (32%), Positives = 139/284 (48%), Gaps = 28/284 (9%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + ++LG G FG YL + A K + K+ ++ E REIQI+ L+
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFD---KIIAQGHYTEKAAAALCRAIVNVVHHCH 212
NIV+ ++D S++LVME GG L D KI +G +E A + I++ + + H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV-------YRDIVGSAYYVA 265
G++HRD+KPEN LL ++K DFGL+ + + VG+ Y+A
Sbjct: 119 SKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 266 PEVLR----RSYGKEIDVWSAGVILYILLSGVPPF----WAETEKGIFDAILKGGVDFES 317
PEVL D+WS G+ LY LL+G+PPF + IL+ +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 318 EPW-----LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
P LIS +A DL++K+L +DPK R++S+ L H +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280
|
Length = 384 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-51
Identities = 92/270 (34%), Positives = 143/270 (52%), Gaps = 22/270 (8%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ K LG G FG L +G YA K + K K+V + E + E +I+Q +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HP 61
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAA---AALCRAIVNVVHHCH 212
+V G+++D +++LVME GGELF + G + E A AA +V + + H
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA---QVVLALEYLH 118
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV-LRR 271
+ +++RDLKPEN LL + DG +K TDFG + + Y + G+ Y+APE+ L +
Sbjct: 119 SLDIVYRDLKPENLLL-DSDG--YIKITDFGFAKRVKGR-TY-TLCGTPEYLAPEIILSK 173
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
YGK +D W+ G+++Y +L+G PPF+ + I++ IL+G V F S S AKDL+
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF----FSPDAKDLI 229
Query: 332 RKMLIQDPKKRI-----TSAEVLEHPWMRE 356
R +L D KR+ ++ HPW
Sbjct: 230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-49
Identities = 83/260 (31%), Positives = 139/260 (53%), Gaps = 14/260 (5%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG G FG L S ++A K + KR +V +E I E +I++ + IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
++D++ ++++ME C GGEL+ + +G + E A +V + H G+++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 222 KPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV-LRRSYGKEIDVW 280
KPEN LL + +K DFG + + G+ G+ YVAPE+ L + Y +D W
Sbjct: 120 KPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 281 SAGVILYILLSGVPPFWAETEK--GIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338
S G++LY LL+G PPF + E I++ ILKG E I +AKDL++++L ++
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRN 234
Query: 339 PKKRITS-----AEVLEHPW 353
P++R+ + ++ +H W
Sbjct: 235 PEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 1e-49
Identities = 89/265 (33%), Positives = 143/265 (53%), Gaps = 20/265 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + +++G+G FG Y TG A K I KL +K+ +E I EIQI++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCK-HP 57
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCHFM 214
NIV++ G+Y + + +VME CSGG L D + + TE A +C+ ++ + + H
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SY 273
G++HRD+K N LL++ DG +K DFGLS + + K +VG+ Y++APEV+ Y
Sbjct: 118 GIIHRDIKAANILLTS-DGE--VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-GGVDF----ESEPWLLISDSAK 328
+ D+WS G+ L G PP+ +E A+ K E W SD K
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKW---SDEFK 228
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPW 353
D ++K L ++P+KR T+ ++L+HP+
Sbjct: 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 3e-47
Identities = 92/279 (32%), Positives = 151/279 (54%), Gaps = 18/279 (6%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
D R+ Y +++G G G Y T+ +TG A +K+ + KQ++E I EI IM+
Sbjct: 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVA----IKKMRLRKQNKELIINEILIMK 70
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY--TEKAAAALCRAIVNV 207
NIV++ +Y + +VME GG L D II Q E A +CR ++
Sbjct: 71 DCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQG 128
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAP 266
+ + H V+HRD+K +N LL +KDG +K DFG + + + K R+ +VG+ Y++AP
Sbjct: 129 LEYLHSQNVIHRDIKSDNILL-SKDGS--VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 267 EVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFDAILKGGVDF-ESEPWLLI 323
EV++R YG ++D+WS G++ + G PP+ E + +F KG E W
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW--- 242
Query: 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASD 362
S KD + K L++DP+KR ++ E+L+HP++++ +
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-46
Identities = 84/260 (32%), Positives = 128/260 (49%), Gaps = 10/260 (3%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K + +G FG YL + STG+ +A K + K ++ K ++K E IM + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++ + ++LVME +GG+ I G E A +V V H G++HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYG-KEID 278
D+KPEN L+ LK TDFGLS G + VG+ Y+APE + K D
Sbjct: 122 DIKPENLLIDQT---GHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 279 VWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338
WS G +++ L G PPF AET +FD IL +++ E S A DL+ ++L D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 339 PKKRITS---AEVLEHPWMR 355
P KR+ + E+ HP+ +
Sbjct: 236 PAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 87/292 (29%), Positives = 143/292 (48%), Gaps = 37/292 (12%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + K +GRG FG +L + TG YA K + K ++ + ++ E I+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
IV+ +++D + ++LVME GG+L + +I + + E+ A +V + H +G
Sbjct: 63 -IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK----------------------- 252
+HRD+KP+N L+ DG +K DFGL +++ K
Sbjct: 122 FIHRDIKPDNILID-ADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 253 ------VYRD-IVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGI 304
V + VG+ Y+APEVLR YG E D WS GVILY +L G PPF+++T +
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAE-VLEHPWMR 355
++ I+ P +S A DL+ + L+ DP+ R+ S E + HP+ +
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-41
Identities = 86/298 (28%), Positives = 135/298 (45%), Gaps = 57/298 (19%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED--IK----REIQIMQ 149
Y ++LG G +G+ Y + TG A K I + D E+ I REI +++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALREISLLK 53
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFD--KII--AQGHYTEKAAAALCRAIV 205
L NIV+ + ++LV E C D K + G + ++ ++
Sbjct: 54 ELK-HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYV 264
+ +CH ++HRDLKP+N L+ N+DG +LK DFGL+ F + Y V + +Y
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILI-NRDG--VLKLADFGLARAFGIPLRTYTHEVVTLWYR 165
Query: 265 APEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKG------- 311
APE+L + Y +D+WS G I +++G P F ++E IF IL G
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-IL-GTPTEESW 223
Query: 312 -GVD-----------FESEPWLLI----SDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
GV F + + DL+ KML +P KRI++ E L+HP+
Sbjct: 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 87/296 (29%), Positives = 133/296 (44%), Gaps = 45/296 (15%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK--REIQIMQHLSG 153
Y GK+LG G + + Y + TG A K I + +D + REI+++Q L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK- 60
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSG---GELFDKII--AQGHYTEKA-AAALCRAIVNV 207
NI+ + + +++LV E + DK I K+ R +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADI--KSYMLMTLRGL--- 115
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAP 266
+ H ++HRDLKP N LL DG +LK DFGL+ F + V + +Y AP
Sbjct: 116 -EYLHSNWILHRDLKPNN-LLIASDG--VLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171
Query: 267 EVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAI------------ 308
E+L R YG +D+WS G I LL VP +++ IF+A+
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231
Query: 309 -LKGGVDFESEP----WLLI---SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
L V+F+ P + SD A DL++++L +P KRIT+ + LEHP+
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-41
Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 37/289 (12%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + +G G GI + + TG + A K + R+L + + REI+ +Q
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQAL-REIKALQACQ-HP 59
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCHFM 214
+V+ + LVME +L + + + E + R ++ V + H
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSV--FIDEGKVYRDIVGSAYYVAPEVL--R 270
G+MHRDLKP N L+S +LK DFGL+ +E ++Y V + +Y APE+L
Sbjct: 119 GIMHRDLKPANLLISADG---VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 271 RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-------------------G 311
R Y +D+W+ G I LL+G P F E + + +
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 312 GVDF-ESEPWLL------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
+ F ES+P L S A DL++ +L+ DP KR+++AE L HP+
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-41
Identities = 98/267 (36%), Positives = 146/267 (54%), Gaps = 19/267 (7%)
Query: 100 KELGRGQFGITYLC---TENSTGNSYACKSILKRKLV-NKQDREDIKREIQIMQHLSGQQ 155
K LG+G +G + T TG +A K + K +V N++D K E I++ +
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
IV+ A++ ++L++E SGGELF + +G + E A I + H H G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLRRS-Y 273
+++RDLKPEN LL D +K TDFGL I EG V G+ Y+APE+L RS +
Sbjct: 121 IIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333
GK +D WS G ++Y +L+G PPF AE K D ILKG ++ P+L + A+DL++K
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL--PPYL--TPEARDLLKK 233
Query: 334 MLIQDPKKRITS-----AEVLEHPWMR 355
+L ++P R+ + AEV HP+ R
Sbjct: 234 LLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 6e-41
Identities = 70/255 (27%), Positives = 124/255 (48%), Gaps = 8/255 (3%)
Query: 103 GRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRG 162
G+G FG + + T +A K + K+K V K ++ E +I+Q L+ +V
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWY 67
Query: 163 AYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLK 222
+++D ++++LV++L GG+L + + ++E+ IV + + H G++HRD+K
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIK 127
Query: 223 PENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL-RRSYGKEIDVWS 281
P+N LL + + TDF ++ + + G+ Y+APEVL R+ Y +D WS
Sbjct: 128 PDNILLDEQ---GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWS 184
Query: 282 AGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKK 341
GV Y L G P+ + D I + S A D + K+L +DP+K
Sbjct: 185 LGVTAYECLRGKRPYRGHSRTIR-DQIRAKQETADVLYPATWSTEAIDAINKLLERDPQK 243
Query: 342 RI--TSAEVLEHPWM 354
R+ ++ HP+
Sbjct: 244 RLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 92/295 (31%), Positives = 151/295 (51%), Gaps = 25/295 (8%)
Query: 68 MKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSI 127
MK++ T KP+T K L D +G+ LG G FG + TG YA K +
Sbjct: 1 MKAAYMFT----KPDTSSWK-LSDFE----MGETLGTGSFGRVRIAKHKGTGEYYAIKCL 51
Query: 128 LKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKII 187
KR+++ + + + +E I+ LS IV +++D V+ ++E GGELF +
Sbjct: 52 KKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110
Query: 188 AQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247
G + A +V + H +++RDLKPEN LL D +K TDFG +
Sbjct: 111 KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKK 167
Query: 248 IDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFD 306
+ + + + + G+ Y+APEV++ + +GK +D W+ GV+LY ++G PPF+ +T I++
Sbjct: 168 VPD-RTF-TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE 225
Query: 307 AILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITS-----AEVLEHPWMRE 356
IL G + F + W A+DLV+ +L D KR+ + A+V HP+
Sbjct: 226 KILAGRLKFPN--W--FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 76/266 (28%), Positives = 140/266 (52%), Gaps = 24/266 (9%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +G G FG +L + + + YA K + +++ + + + E ++++ +S I+
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIR 65
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
D++ ++++ME GGELF + G ++ IV + + H +++R
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD----IVGSAYYVAPEVL-RRSYG 274
DLKPEN LL +K+G +K TDFG + K RD + G+ Y+APEV+ + +
Sbjct: 126 DLKPENILL-DKEG--HIKLTDFGFA------KKLRDRTWTLCGTPEYLAPEVIQSKGHN 176
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
K +D W+ G+++Y +L G PPF+ + GI++ IL G ++F + AKDL++K+
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH----LDLYAKDLIKKL 232
Query: 335 LIQDPKKRI-----TSAEVLEHPWMR 355
L+ D +R+ + +V H W +
Sbjct: 233 LVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 74/263 (28%), Positives = 126/263 (47%), Gaps = 14/263 (5%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHLSGQQNIV 158
K LG+G G+ Y TG YA K I + ++ R+ + RE++ + +V
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTL-RSCESPYVV 62
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH-FMGVM 217
+ GA+ + +V+E GG L D + G E A + R I+ + + H ++
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVLR-RSYGK 275
HRD+KP N L+ N G K DFG+S ++ + VG+ Y++PE ++ SY
Sbjct: 123 HRDIKPSNLLI-NSKGEV--KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 276 EIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW--LLISDSAKDLVRK 333
D+WS G+ L G PF + F+ +++ D S +D +
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFE-LMQAICDGPPPSLPAEEFSPEFRDFISA 238
Query: 334 MLIQDPKKRITSAEVLEHPWMRE 356
L +DPKKR ++AE+L+HP++++
Sbjct: 239 CLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 81/266 (30%), Positives = 133/266 (50%), Gaps = 20/266 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y LG +GRG FG+ Y TG+ A K I K+ ++ + I +EI ++++L
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HP 59
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
NIV++ G+ E S+++++E G L I G + E A ++ + + H G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSV-FIDEGKVYRDIVGSAYYVAPEVLRRSYG 274
V+HRD+K N L KDG ++K DFG++ D K +VG+ Y++APEV+
Sbjct: 120 VIHRDIKAANILT-TKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE---M 173
Query: 275 KEI----DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL--LISDSAK 328
D+WS G + LL+G PP++ I++ + P L IS K
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-----DDHPPLPEGISPELK 228
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPWM 354
D + + +DP R T+ ++L+HPW+
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-40
Identities = 86/276 (31%), Positives = 140/276 (50%), Gaps = 23/276 (8%)
Query: 96 YTLGKELGRGQFGITYLC---TENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHL 151
+ L + LG G +G +L + G YA K + K +V K E + E Q+++ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
+V A++ +HL+++ +GGELF + + H+TE IV + H
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR--DIVGSAYYVAPEVL 269
H +G+++RD+K EN LL + +G +L TDFGLS + R G+ Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILL-DSEGHVVL--TDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 270 RR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKGGVDFESEPWLL 322
R + K +D WS GV+ + LL+G PF + E+ I ILK F
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT---- 234
Query: 323 ISDSAKDLVRKMLIQDPKKRI---TSAEVLEHPWMR 355
+S A+D ++K+L +DPKKR+ + E+ HP+ +
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-39
Identities = 90/281 (32%), Positives = 142/281 (50%), Gaps = 21/281 (7%)
Query: 86 GKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREI 145
G P + F ++G G GI + T+ STG A K K L +Q RE + E+
Sbjct: 15 GDPRSYLDNF----VKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEV 67
Query: 146 QIM---QHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCR 202
IM QH NIVE +Y + +VME GG L D I+ E+ A +C
Sbjct: 68 VIMRDYQH----PNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCL 122
Query: 203 AIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIVGSA 261
A++ + H GV+HRD+K ++ LL+ DG +K +DFG + E + +VG+
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLT-SDG--RVKLSDFGFCAQVSKEVPRRKSLVGTP 179
Query: 262 YYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW 320
Y++APEV+ R YG E+D+WS G+++ ++ G PP++ E I
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL- 238
Query: 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361
+S + + +ML++DP +R T+AE+L HP++ + G S
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-39
Identities = 81/289 (28%), Positives = 127/289 (43%), Gaps = 38/289 (13%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y ++G G +G+ Y + TG A K I K + ++ + REI++++ L+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELN-HP 58
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKII--AQGHYTEKAAAALCRAIVNVVHHCHF 213
NI++ + + ++LV E K+I Q E + ++ + CH
Sbjct: 59 NIIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRRS 272
G++HRDLKPEN L+ N +G +LK DFGL+ F + Y V + +Y APE+L
Sbjct: 117 HGILHRDLKPENLLI-NTEG--VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 273 --YGKEIDVWSAGVILYILLSGVPPFWAETE-------------------KGIFDAILKG 311
Y +D+WS G I LLS P F ++E
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233
Query: 312 GVDFESE---PWLLI----SDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
F + P + S A DL+ +ML DP KRIT+ + L HP+
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 91/296 (30%), Positives = 141/296 (47%), Gaps = 49/296 (16%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKR---EIQIMQHLSGQQN 156
K LG+G G +L TG +A K + K++++ R +KR E +I+ L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK---RNKVKRVLTEQEILATLD-HPF 62
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFM 214
+ +++ + LVM+ C GGELF + Q +E+ A ++ + + H +
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDI---------------- 257
G+++RDLKPEN LL ++ G ML +DF LS D E
Sbjct: 123 GIVYRDLKPENILL-HESGHIML--SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 258 -------------VGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKG 303
VG+ Y+APEV+ +G +D W+ G++LY +L G PF
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239
Query: 304 IFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITS----AEVLEHPWMR 355
F ILK V F P +S SA+DL+RK+L++DP KR+ S AE+ +HP+ R
Sbjct: 240 TFSNILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 91/277 (32%), Positives = 148/277 (53%), Gaps = 24/277 (8%)
Query: 96 YTLGKELGRGQFGITYL---CTENSTGNSYACKSILKRKLVNK-QDREDIKREIQIMQHL 151
+ L K LG G +G +L T + TG YA K + K LV K + E + E +++H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
+V A++ +HL+++ SGGE+F + + +++E I+ + H
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV-FIDEGKVYR-DIVGSAYYVAPEVL 269
H +G+++RD+K EN LL + +G +L TDFGLS F+ E K G+ Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILL-DSEGHVVL--TDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 270 R--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKGGVDFESEPWLLI 323
R +GK +D WS G++++ LL+G PF E E+ + ILK F S I
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS----FI 234
Query: 324 SDSAKDLVRKMLIQDPKKRITSA-----EVLEHPWMR 355
A+DL+ K+L +DPKKR+ + E+ EHP+ +
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 87/295 (29%), Positives = 137/295 (46%), Gaps = 48/295 (16%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK-REIQIMQHLSGQ 154
Y + K+LG G FG YL TG A K +K+K + + E + RE++ ++ L+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKK-MKKKFYSWE--ECMNLREVKSLRKLNEH 57
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCH 212
NIV+ + + + ++ V E G L+ + + ++E ++ I+ + H H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRS 272
G HRDLKPEN L+S + ++K DFGL+ I Y D V + +Y APE+L RS
Sbjct: 117 KHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 273 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-----GGVDFESEPWL---- 321
Y +D+W+ G I+ L + P F +E D + K G + W
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSE---IDQLYKICSVLG--TPTKQDWPEGYK 228
Query: 322 -------------------LI---SDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
LI S A DL++ ML DPKKR T+++ L+HP+
Sbjct: 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 86/270 (31%), Positives = 130/270 (48%), Gaps = 16/270 (5%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
F L + +G+G +G +L + TG A K + K L + + E I+ +
Sbjct: 2 DFQILTQ-VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL--TTT 58
Query: 154 QQN-IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212
+ +V+ A++D + ++L ME GG+ + G +E A + V H
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-R 271
+G +HRDLKPENFL+ G +K TDFGLS I +VGS Y+APEVLR +
Sbjct: 119 ELGYIHRDLKPENFLID-ASG--HIKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRGK 173
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE----SEPWLLISDSA 327
Y +D WS G +LY L G PPF T ++ + + +P +SD A
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233
Query: 328 KDLVRKMLIQDPKKRITSAE-VLEHPWMRE 356
DL+ K+ I DP +R S E + HP+ +E
Sbjct: 234 WDLITKL-INDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 89/279 (31%), Positives = 150/279 (53%), Gaps = 25/279 (8%)
Query: 96 YTLGKELGRGQFGITYLCTENS---TGNSYACKSILKRKLVNK-QDREDIKREIQIMQHL 151
+ L K LG G +G +L + S +G YA K + K +V K + E + E Q+++H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
+V A++ +HL+++ +GGELF + + + E+ IV + H
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR--DIVGSAYYVAPEVL 269
H +G+++RD+K EN LL + +G +L TDFGLS E +V R G+ Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILL-DSNGHVVL--TDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 270 R---RSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKGGVDFESEPWLL 322
R + K +D WS GV++Y LL+G PF + EK I ILK + E
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE---- 234
Query: 323 ISDSAKDLVRKMLIQDPKKRITSA-----EVLEHPWMRE 356
+S AKD+++++L++DPKKR+ E+ +HP+ ++
Sbjct: 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 54/295 (18%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDI----KREIQIMQHLSGQQ 155
++G G +G Y TG A K K+ + ++E REI+++Q L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKLR-HP 58
Query: 156 NIVEFRGAYEDRQ--SVHLVMELCSGGELFD--KIIAQG--HYTEKAAAALCRAIVNVVH 209
NIV + + S+++V E D ++ +TE + ++ +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI--DEGKVYRDIVGSAYYVAPE 267
+ H G++HRD+K N L++N +LK DFGL+ Y + V + +Y PE
Sbjct: 115 YLHSNGILHRDIKGSNILINND---GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 268 VL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK--GGVDFESEPWL-- 321
+L YG E+D+WS G IL L G P F TE + I + G E+ P +
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 322 -----------------------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
LI SA DL+ K+L DPKKRI++ + L+H +
Sbjct: 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 82/263 (31%), Positives = 139/263 (52%), Gaps = 15/263 (5%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG+G FG L E +TG YA K + K ++ K + E +++Q+ + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+ +++ + VME +GGELF + + ++E A IV+ + + H V++R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEI 277
DLK EN +L +KDG +K TDFGL I +G + G+ Y+APEVL + YG+ +
Sbjct: 120 DLKLENLML-DKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D W GV++Y ++ G PF+ + + +F+ IL + F +S AK L+ +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232
Query: 338 DPKKRI-----TSAEVLEHPWMR 355
DPK+R+ + E++EH +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 15/264 (5%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN--IVE 159
+G+G FG Y + T YA K + K+++V K++ E I+ ++ IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+ +++ ++LV + SGGELF + +G ++E A +V + H H +++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL--RRSYGKE 276
DLKPEN LL D + DFGLS + + K G+ Y+APEVL + Y K
Sbjct: 121 DLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 277 IDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336
+D WS GV+++ + G PF+AE + ++ I G V F P ++SD + V+ +L
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKGLLN 234
Query: 337 QDPKKRITS----AEVLEHPWMRE 356
++P+ R+ + E+ EHP+ +
Sbjct: 235 RNPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 76/268 (28%), Positives = 139/268 (51%), Gaps = 21/268 (7%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
+ + + ++LG G +G Y TG A K + ++D ++I +EI I++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQ-CD 56
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI-IAQGHYTEKAAAALCRAIVNVVHHCH 212
IV++ G+Y + +VME C G + D + I TE+ AA+ + + + H
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVLRR 271
+HRD+K N LL N++G A K DFG+S + + R+ ++G+ +++APEV++
Sbjct: 117 SNKKIHRDIKAGNILL-NEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 272 S-YGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFDAILKGGVDFESEP--WLLISDS 326
Y + D+WS G+ + G PP+ ++ + IF K S+P W S
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPY-SDIHPMRAIFMIPNKPPPTL-SDPEKW---SPE 228
Query: 327 AKDLVRKMLIQDPKKRITSAEVLEHPWM 354
D V+K L++DP++R ++ ++L+HP++
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 91/324 (28%), Positives = 134/324 (41%), Gaps = 76/324 (23%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-QDREDIK---REIQIMQHL 151
Y L K +G G +G+ + TG A K K+ N D D K REI++++HL
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK-----KISNVFDDLIDAKRILREIKLLRHL 56
Query: 152 SGQQNIVEFR-----GAYEDRQSVHLVMELCSGGELFD----KIIAQGHY-TEKAAAA-- 199
+NI+ + ED V++V EL + K+I T+
Sbjct: 57 -RHENIIGLLDILRPPSPEDFNDVYIVTEL------METDLHKVIKSPQPLTDDHIQYFL 109
Query: 200 --LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI 257
+ R + + H V+HRDLKP N +L N + LK DFGL+ +D + +
Sbjct: 110 YQILRGL----KYLHSANVIHRDLKPSN-ILVNSN--CDLKICDFGLARGVDPDEDEKGF 162
Query: 258 ----VGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDA 307
V + +Y APE+L Y K ID+WS G I LL+ P F I +
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222
Query: 308 I------------------------LKGGVDFESEPWLL--ISDSAKDLVRKMLIQDPKK 341
+ K L S A DL+ KML+ DPKK
Sbjct: 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSK---LFPGASPEAIDLLEKMLVFDPKK 279
Query: 342 RITSAEVLEHPWMREGGEASDKPI 365
RIT+ E L HP++ + + D+P+
Sbjct: 280 RITADEALAHPYLAQLHDPEDEPV 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 89/267 (33%), Positives = 135/267 (50%), Gaps = 18/267 (6%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +GRG FG L S+ YA K + K +++ + D E IM H + + IV+
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIVQ 107
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
A++D + +++VME GG+L + +++ EK A +V + H MG +HR
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHR 166
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDI-VGSAYYVAPEVLRRS----- 272
D+KP+N LL D LK DFG + +D G V D VG+ Y++PEVL+
Sbjct: 167 DVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 273 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL--KGGVDFESEPWLLISDSAKDL 330
YG+E D WS GV LY +L G PF+A++ G + I+ K + F + IS AKDL
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI--EISKQAKDL 281
Query: 331 VRKMLIQDPKK--RITSAEVLEHPWMR 355
+ L + R E+ HP+ +
Sbjct: 282 ICAFLTDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 81/265 (30%), Positives = 136/265 (51%), Gaps = 19/265 (7%)
Query: 98 LGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKR---EIQIMQHLSGQ 154
GK LG+G FG YLC + TG A K + + + ++++ EIQ++++L
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPD-SPETKKEVNALECEIQLLKNLQ-H 63
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
+ IV++ G D +++ + ME GG + D++ A G TE R I+ V + H
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID----EGKVYRDIVGSAYYVAPEVLR 270
++HRD+K N L +D +K DFG S + G + + G+ Y+++PEV+
Sbjct: 124 MIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 271 -RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL--ISDSA 327
YG++ DVWS G + +L+ PP WAE E AI K + P L +S A
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP-WAEFEA--MAAIFKIATQ-PTNPQLPSHVSPDA 236
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHP 352
++ +R+ +++ KKR ++ E+L H
Sbjct: 237 RNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 79/275 (28%), Positives = 129/275 (46%), Gaps = 34/275 (12%)
Query: 98 LGKELGRGQFGITYLCTENSTGNSYACKSI----LKRKLVNKQDREDIKREIQIMQHLSG 153
G ++G G FG Y TG A K I K + ++I E+++++ L
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-----KEIADEMKVLELLK- 57
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFD----KIIAQGHYTEKAAAALCRAIVNVVH 209
N+V++ G R+ V++ ME CSGG L + I H L + +H
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEG-LAYLH 116
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-----GKVYRDIVGSAYYV 264
G++HRD+KP N L D ++K DFG +V + G+ + + G+ Y+
Sbjct: 117 SH---GIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170
Query: 265 APEVLRRS----YGKEIDVWSAGVILYILLSGVPPFWAE--TEKGIFDAILKGGVDFESE 318
APEV+ +G+ D+WS G ++ + +G P W+E E I + G +
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPPIPD 229
Query: 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
L +S KD + + L DPKKR T++E+L+HP+
Sbjct: 230 S-LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 81/277 (29%), Positives = 141/277 (50%), Gaps = 25/277 (9%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSI-LKRKLVNKQDREDIKREIQIMQHLS 152
+ +TL + +G+G FG Y + T A K I L+ + + EDI++EIQ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCR 57
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212
I ++ G++ + ++ME C GG D ++ G E A + R ++ + + H
Sbjct: 58 -SPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVLRR 271
G +HRD+K N LLS +G +K DFG+S + R+ VG+ +++APEV+++
Sbjct: 116 EEGKIHRDIKAANILLSE-EG--DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 272 S-YGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFDAILKGGVDFESEPWLL----IS 324
S Y ++ D+WS G+ L G PP ++ + +F I K + P L S
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPL-SDLHPMRVLF-LIPK------NNPPSLEGNKFS 224
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361
KD V L +DPK+R ++ E+L+H ++++ + S
Sbjct: 225 KPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTS 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 80/262 (30%), Positives = 129/262 (49%), Gaps = 18/262 (6%)
Query: 99 GKELGRGQFGITYLCTENSTGNSYACK--SILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
G+ LG G FG Y G+ +A K S+ ++ + +++EI ++ L N
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPN 63
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGV 216
IV++ G + ++++ +EL GG L + G + E R I+ + + H
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYG 274
+HRD+K N L+ ++K DFG++ + E + GS Y++APEV+ + YG
Sbjct: 124 VHRDIKGANILVDTN---GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLI----SDSAKDL 330
D+WS G + + +G PP W++ E A+ K G E P I SD AKD
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPP---IPDHLSDEAKDF 234
Query: 331 VRKMLIQDPKKRITSAEVLEHP 352
+ K L +DP R T+AE+LEHP
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-33
Identities = 85/271 (31%), Positives = 138/271 (50%), Gaps = 16/271 (5%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
RQ+ LGK G FG C +TG YACK + K+++ ++ E QI++ ++
Sbjct: 3 RQYRVLGK----GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN 58
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHH 210
Q +V AYE + ++ LV+ + +GG+L I G+ + E+ A I+ +
Sbjct: 59 -SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR 270
H ++RDLKPEN LL D ++ +D GL+V I EG+ R VG+ Y+APEVL
Sbjct: 118 LHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 271 -RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329
+ Y D W G ++Y ++ G PF EK + + + ++ E S+ AK
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234
Query: 330 LVRKMLIQDPKKRI-----TSAEVLEHPWMR 355
+ + +L +DPK+R+ + EV HP+ R
Sbjct: 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 41/280 (14%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + + +G+G FG S G K I + +++++ + E+ I++ L
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HP 59
Query: 156 NIVEFRGAYEDR--QSVHLVMELCSGGELFDKIIAQ-----GHYTEKAA----AALCRAI 204
NIV + DR Q++++VME C GG+L ++I + + E+ L A+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 205 VNVVHHCHF-----MGVMHRDLKPEN-FLLSNKDGGAMLKATDFGLSVFIDEG----KVY 254
+ CH V+HRDLKP N FL +N + +K DFGL+ + K Y
Sbjct: 119 ----YECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGHDSSFAKTY 170
Query: 255 RDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV 313
VG+ YY++PE L SY ++ D+WS G ++Y L + PPF A + + I +G
Sbjct: 171 ---VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF 227
Query: 314 DFESEPWLLI-SDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
S ++++ ML DP KR ++ E+L+ P
Sbjct: 228 R----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-33
Identities = 83/285 (29%), Positives = 128/285 (44%), Gaps = 45/285 (15%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ L + +G G +G Y TG A K I+ + + + E+IK E I++ S
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMD---IIEDEEEEIKEEYNILRKYSNHP 63
Query: 156 NIVEFRGAYEDRQSVH--------LVMELCSGG---ELFDKIIAQGH-YTEKAAAALCRA 203
NI F GA+ + LVMELC GG +L + +G E+ A + R
Sbjct: 64 NIATFYGAF--IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 204 IVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAY 262
+ + + H V+HRD+K +N LL K+ +K DFG+S +D R+ +G+ Y
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILL-TKNAE--VKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 263 YVAPEV------LRRSYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFDAI------ 308
++APEV SY DVWS G+ L G PP + + +F
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-CDMHPMRALFKIPRNPPPT 237
Query: 309 LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
LK E W S D + + LI++ ++R E+LEHP+
Sbjct: 238 LK-----SPENW---SKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 82/264 (31%), Positives = 148/264 (56%), Gaps = 19/264 (7%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEF 160
++G G GI + E +G A K + RK +Q RE + E+ IM+ QN+VE
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEM 83
Query: 161 RGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRD 220
+Y + + ++ME GG L D I++Q E+ A +C +++ + + H GV+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 221 LKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR-DIVGSAYYVAPEVLRRS-YGKEID 278
+K ++ LL+ DG +K +DFG I + R +VG+ Y++APEV+ R+ YG E+D
Sbjct: 143 IKSDSILLT-LDG--RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 279 VWSAGVILYILLSGVPPFWAETE----KGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
+WS G+++ ++ G PP+++++ K + D+ + IS +D + +M
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK-----ISPVLRDFLERM 254
Query: 335 LIQDPKKRITSAEVLEHPWMREGG 358
L ++P++R T+ E+L+HP++ + G
Sbjct: 255 LTREPQERATAQELLDHPFLLQTG 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 87/279 (31%), Positives = 152/279 (54%), Gaps = 17/279 (6%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEF 160
++G G GI + T S+G A K + RK +Q RE + E+ IM+ +N+VE
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEM 82
Query: 161 RGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRD 220
+Y + +VME GG L D I+ E+ AA+C A++ + H GV+HRD
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 221 LKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVAPEVLRR-SYGKEID 278
+K ++ LL++ DG +K +DFG + E + +VG+ Y++APE++ R YG E+D
Sbjct: 142 IKSDSILLTH-DG--RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 279 VWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338
+WS G+++ ++ G PP++ E I + + + + +S S K + ++L++D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 339 PKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFR 377
P +R T+AE+L+HP++ + G S ++ M+Q R
Sbjct: 258 PAQRATAAELLKHPFLAKAGPP------SCIVPLMRQNR 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 83/264 (31%), Positives = 136/264 (51%), Gaps = 21/264 (7%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
ELG G G+ TG A K+I R +N+ ++ I RE+ I+ IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHK-CNSPYIVG 63
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKII--AQGHYTEKAAAALCRAIVNVVHHCH-FMGV 216
F GA+ + + + ME GG L DKI+ QG E+ + A++ + + H +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLR-RSYG 274
+HRD+KP N L++++ +K DFG+S ++ + + VG++ Y+APE ++ Y
Sbjct: 123 IHRDVKPSNILVNSR---GQIKLCDFGVSGQLVNS--LAKTFVGTSSYMAPERIQGNDYS 177
Query: 275 KEIDVWSAGVILYILLSG-VP-PFWAETEKGIFDAILKGGVDFESEPWL---LISDSAKD 329
+ D+WS G+ L L +G P P + GIF+ +L+ V+ E P L S +D
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYIVN-EPPPRLPSGKFSPDFQD 235
Query: 330 LVRKMLIQDPKKRITSAEVLEHPW 353
V LI+DP++R + E+LEHP+
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPF 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 88/276 (31%), Positives = 135/276 (48%), Gaps = 26/276 (9%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
P ED Y L + +G G +G Y + +TG A K I KL D E I++EI +
Sbjct: 1 PQED----YELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISM 53
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI-IAQGHYTEKAAAALCRAIVN 206
++ NIV + G+Y R + +VME C GG L D + +G +E A +CR +
Sbjct: 54 LKECR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVA 265
+ + H G +HRD+K N LL +DG +K DFG+S + R +G+ Y++A
Sbjct: 113 GLAYLHETGKIHRDIKGANILL-TEDGD--VKLADFGVSAQLTATIAKRKSFIGTPYWMA 169
Query: 266 PEVL----RRSYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFDAILKGGVD----FE 316
PEV + Y + D+W+ G+ L PP + + +F I K +
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFPPPKLKD 228
Query: 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
E W S D ++K L +DPKKR T+ ++L+HP
Sbjct: 229 KEKW---SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 80/280 (28%), Positives = 138/280 (49%), Gaps = 31/280 (11%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN--I 157
K + G +G YL T +A K I K+ L+ + + + E I L+ +N +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI---LTFAENPFV 63
Query: 158 VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVM 217
V ++E ++ + +VME GG+ + G A V + + H G++
Sbjct: 64 VSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIV 123
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLS--------VFIDEGKVYRD--------IVGSA 261
HRDLKP+N L+++ +K TDFGLS + EG + +D + G+
Sbjct: 124 HRDLKPDNLLITSM---GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 262 YYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF-ESEP 319
Y+APEV LR+ YGK +D W+ G+ILY L G PF+ +T + +F ++ +++ E +
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240
Query: 320 WLLISDSAKDLVRKMLIQDPKKRI---TSAEVLEHPWMRE 356
L A+DL+ ++L Q+P +R+ + EV +H +
Sbjct: 241 AL--PADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 87/293 (29%), Positives = 154/293 (52%), Gaps = 25/293 (8%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
D R++ ++G G GI + TE TG A K + RK +Q RE + E+ IM+
Sbjct: 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRD 75
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
+N+V+ +Y + +VME GG L D I+ E+ A +C +++ + +
Sbjct: 76 YH-HENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSY 133
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVAPEVL 269
H GV+HRD+K ++ LL++ DG +K +DFG + E + +VG+ Y++APEV+
Sbjct: 134 LHNQGVIHRDIKSDSILLTS-DG--RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI 190
Query: 270 RR-SYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFDAILKGGVDFESEPWLLIS 324
R YG E+D+WS G+++ ++ G PP++ E + I D + D +S
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHK-----VS 245
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFR 377
+ + ML+++P +R T+ E+L+HP+++ G S ++ M+Q+R
Sbjct: 246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP------SCIVPLMRQYR 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-31
Identities = 84/259 (32%), Positives = 138/259 (53%), Gaps = 15/259 (5%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG+G FG L E +TG YA K + K ++ K + E +++Q+ + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+ A++ + VME +GGELF + + +TE+ A IV+ + + H V++R
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEI 277
D+K EN +L +KDG +K TDFGL I +G + G+ Y+APEVL YG+ +
Sbjct: 120 DIKLENLML-DKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D W GV++Y ++ G PF+ + + +F+ IL + F +S AK L+ +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232
Query: 338 DPKKRI-----TSAEVLEH 351
DPK+R+ + EV+EH
Sbjct: 233 DPKQRLGGGPSDAKEVMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 79/267 (29%), Positives = 127/267 (47%), Gaps = 20/267 (7%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG+G FG L T YA K + K ++ D E E +++ + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
++ + + VME +GG+L I G + E A IV + H G+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD----IVGSAYYVAPEVLR-RSYG 274
DLK +N LL D +K DFG+ EG + G+ Y+APE+L + YG
Sbjct: 121 DLKLDNVLL---DSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
+D W+ GV+LY +L+G PF + E +F +IL+ V + WL S AK +++
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WL--SKEAKSILKSF 230
Query: 335 LIQDPKKRITS-----AEVLEHPWMRE 356
L ++P+KR+ ++ HP+ RE
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 61/297 (20%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIMQHLSGQQN 156
+G G +G+ C +TG A K K +D ED+K RE+++++ L +N
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQLR-HEN 61
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIV--------NVV 208
IV + A+ + ++LV E L E + L V +
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLL--------ELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK--VYRDIVGSAYYVAP 266
+CH ++HRD+KPEN L+S +LK DFG + + D V + +Y AP
Sbjct: 114 AYCHSHNIIHRDIKPENILVSESG---VLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 267 EVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK--GGVD------FE 316
E+L +YGK +DVW+ G I+ LL G P F +++ I K G + F
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230
Query: 317 SEPWL--------------------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
S P +S A D ++ L DPK+R+T E+L+HP+
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 83/276 (30%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
+GRG FG + E +TG+ YA K + K L+ ++ + E I+ +S I + +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQ 67
Query: 162 GAYEDRQSVHLVMELCSGGEL----------FDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
A++D+ +++LVME GG+L FD+ +AQ + E +V +H
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE---------LVLAIHSV 118
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDI-VGSAYYVAPEVL 269
H MG +HRD+KPEN L+ D +K DFG + + V + VG+ Y+APEVL
Sbjct: 119 HQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 270 -------RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL--KGGVDFESEPW 320
+ +YG E D WS GVI Y ++ G PF T ++ I+ + + F +P
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP- 234
Query: 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
+S DL++ +L K+R+ + HP+ +
Sbjct: 235 -KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-31
Identities = 80/261 (30%), Positives = 127/261 (48%), Gaps = 12/261 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + LG+G FG L + K + +L K+ R D EI I+ L
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQ-HP 59
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHF 213
NI+ + + D ++ + ME +GG L+DKI+ Q + E+ IV+ V + H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLR-R 271
G++HRD+K N L K G ++K DFG+S + E + +VG+ YY++PE+ +
Sbjct: 120 AGILHRDIKTLNIFL-TKAG--LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
Y + D+W+ G +LY LL+ F A + I++G + S LV
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLV 233
Query: 332 RKMLIQDPKKRITSAEVLEHP 352
+L QDP+KR T+ EVL+ P
Sbjct: 234 HSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 86/292 (29%), Positives = 143/292 (48%), Gaps = 25/292 (8%)
Query: 69 KSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCT-ENSTGNSYACKSI 127
K S ++ P +K + ED + + LG G FG L T +N A K
Sbjct: 13 KDSDSTKEPKRKNKM----KYED----FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF 64
Query: 128 LKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKII 187
K K++ ++ + + E +I+ +++ V G+++D ++LV+E GGE F +
Sbjct: 65 EKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR 123
Query: 188 AQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247
+ IV + + + +++RDLKPEN LL +KDG +K TDFG +
Sbjct: 124 RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL-DKDG--FIKMTDFGFAKV 180
Query: 248 IDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFD 306
+D + Y + G+ Y+APE+L +GK D W+ G+ +Y +L G PPF+A I+
Sbjct: 181 VDT-RTY-TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ 238
Query: 307 AILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI-----TSAEVLEHPW 353
IL+G + F + ++ K L++K+L D KR + V EHPW
Sbjct: 239 KILEGIIYFPK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286
|
Length = 340 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 84/280 (30%), Positives = 146/280 (52%), Gaps = 18/280 (6%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
D ++ YT +++G+G G Y + +TG A K + L + +E I EI +M+
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRE 72
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
NIV + +Y + +VME +GG L D ++ + E AA+CR + +
Sbjct: 73 NK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVL 269
H V+HRD+K +N LL DG +K TDFG I + R +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLG-MDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 270 -RRSYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVDFESEPWLLISDSA 327
R++YG ++D+WS G++ ++ G PP+ E + ++ G + ++ L S
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL--SAIF 245
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGS 367
+D + + L D +KR ++ E+L+HP+++ KP+ S
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKIA-----KPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 70/262 (26%), Positives = 125/262 (47%), Gaps = 14/262 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + K+LG+G +G Y S YA K + +++++RED EI+I+ ++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVN-HP 59
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH----YTEKAAAALCRAIVNVVHHC 211
NI+ ++ A+ D + +VME G+L I + E+ + ++ +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR- 270
H ++HRDLK N LL D ++K D G+S + + I G+ +Y+APEV +
Sbjct: 120 HEQKILHRDLKSANILLVAND---LVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKG 175
Query: 271 RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330
R Y + D+WS G +LY + + PPF A + + + + +G + S ++
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIY---SQDLQNF 232
Query: 331 VRKMLIQDPKKRITSAEVLEHP 352
+R ML PK R ++L P
Sbjct: 233 IRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 81/272 (29%), Positives = 139/272 (51%), Gaps = 16/272 (5%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
RQ+ LGK G FG C +TG YACK + K+++ ++ E QI++ ++
Sbjct: 3 RQYRVLGK----GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN 58
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI--IAQGHYTEKAAAALCRAIVNVVHH 210
+ +V AYE + ++ LV+ L +GG+L I + + + E A I +
Sbjct: 59 -SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED 117
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR 270
H +++RDLKPEN LL D ++ +D GL+V + EG+ + VG+ Y+APEV++
Sbjct: 118 LHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 174
Query: 271 RS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329
Y D W+ G +LY +++G PF +K + + + + + E S A+
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARS 234
Query: 330 LVRKMLIQDPKKRI-----TSAEVLEHPWMRE 356
L + +L +DPK+R+ + EV EHP ++
Sbjct: 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 80/263 (30%), Positives = 124/263 (47%), Gaps = 15/263 (5%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG L +G YA K + K ++ D E E +I+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
++ + VME +GG+L I + E A I + + H G+++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 222 KPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEIDV 279
K +N LL D K DFG+ I GK G+ Y+APE+L+ YG +D
Sbjct: 123 KLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 280 WSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339
W+ GV+LY +L G PF AE E +F+AIL V + + WL S A D+++ + ++P
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WL--SQDAVDILKAFMTKNP 235
Query: 340 KKRITSAE------VLEHPWMRE 356
R+ S +L HP+ +E
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFKE 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 79/301 (26%), Positives = 142/301 (47%), Gaps = 52/301 (17%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +GRG FG L + TG+ YA K + K +++ K+ ++ E I+ + +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVK 65
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++D ++L+ME GG++ ++ + +TE+ + + H +G +HR
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGS---------------- 260
D+KP+N LL K +K +DFGL + + YR + +
Sbjct: 126 DIKPDNLLLDAK---GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 261 -------------AY-------YVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAE 299
AY Y+APEV L+ Y KE D WS GVI+Y +L G PPF ++
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242
Query: 300 TEKGIFDAIL--KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSA---EVLEHPWM 354
+ + I+ K + F E + +S AKDL++++ + ++R+ + E+ HP+
Sbjct: 243 NPQETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299
Query: 355 R 355
+
Sbjct: 300 K 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-30
Identities = 82/267 (30%), Positives = 137/267 (51%), Gaps = 11/267 (4%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
D ++ YT +++G+G G + + +TG A K I L + +E I EI +M+
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKE 72
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
L NIV F ++ + +VME +GG L D ++ + E AA+CR + +
Sbjct: 73 LK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVL 269
H V+HRD+K +N LL +K TDFG I + R +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 270 -RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328
R++YG ++D+WS G++ ++ G PP+ E I G P L S +
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL-SPIFR 246
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPWMR 355
D + + L D +KR ++ E+L+HP+++
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 89/311 (28%), Positives = 128/311 (41%), Gaps = 78/311 (25%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIMQHL 151
Y E+G G +G Y + +TG A K + E I REI +++ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP-----LSEEGIPLSTLREIALLKQL 55
Query: 152 SGQQ--NIVE----FRGAYEDRQ-SVHLVMELCSGGELFDKIIAQGHYTEKAAAA----- 199
+ NIV G DR+ + LV E D+ +A Y K
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV------DQDLAT--YLSKCPKPGLPPE 107
Query: 200 ----LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR 255
L R ++ V H ++HRDLKP+N +L DG +K DFGL+ ++Y
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQN-ILVTSDG--QVKIADFGLA------RIYS 158
Query: 256 D------IVGSAYYVAPEVL-RRSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGI 304
+V + +Y APEVL + SY +D+WS G I L P F +E I
Sbjct: 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218
Query: 305 FDAILKGGVDFESE-------PW---------------LLISDSAKDLVRKMLIQDPKKR 342
FD I G+ E E P I + DL++KML +P KR
Sbjct: 219 FDVI---GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKR 275
Query: 343 ITSAEVLEHPW 353
I++ E L+HP+
Sbjct: 276 ISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-30
Identities = 75/261 (28%), Positives = 130/261 (49%), Gaps = 17/261 (6%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR-EDIKREIQIMQHLSGQQ--NIV 158
+GRG +G Y TG A K I L D DI+RE+ ++ L Q NI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKII---NLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMH 218
++ G+Y + ++ME GG + + A G EK + + R ++ + + H +GV+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIH 124
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVLR--RSYGK 275
RD+K N L++N G L DFG++ +++ R VG+ Y++APEV+ + Y
Sbjct: 125 RDIKAANILVTN-TGNVKL--CDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181
Query: 276 EIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD-FESEPWLLISDSAKDLVRKM 334
+ D+WS G+ +Y + +G PP+ I K E + S ++ V
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGY---SKLLREFVAAC 238
Query: 335 LIQDPKKRITSAEVLEHPWMR 355
L ++PK+R+++ E+L+ W++
Sbjct: 239 LDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 32/276 (11%)
Query: 96 YTLGKELGRGQFGITY--LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
Y L + +G G + Y +C N A K I K + +++++E+Q M
Sbjct: 3 YELIEVIGVGATAVVYAAICLPN--NEKVAIKRIDLEKC--QTSVDELRKEVQAMS-QCN 57
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFD---KIIAQGHYTEKAAAALCRAIVNVVHH 210
N+V++ ++ + LVM SGG L D +G E A + + ++ + +
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-----KVYRDIVGSAYYVA 265
H G +HRD+K N LL +DG +K DFG+S + +G KV + VG+ ++A
Sbjct: 118 LHSNGQIHRDIKAGNILL-GEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 266 PEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG-------GVDFE 316
PEV+ Y + D+WS G+ L +G P+ + L+ G D++
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
S S + ++ L +DP KR T+ E+L+H
Sbjct: 235 K-----YSKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 87/271 (32%), Positives = 140/271 (51%), Gaps = 18/271 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + K +GRG FG L S+ YA K + K +++ + D E IM +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
+V+ A++D + +++VME GG+L + +++ EK A +V + H MG
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDI-VGSAYYVAPEVLRRS- 272
++HRD+KP+N LL D LK DFG + +DE G V D VG+ Y++PEVL+
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 273 ----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL--KGGVDFESEPWLLISDS 326
YG+E D WS GV L+ +L G PF+A++ G + I+ K ++F + + IS
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEISKH 277
Query: 327 AKDLVRKMLIQDPKK--RITSAEVLEHPWMR 355
AK+L+ L + R E+ +HP+ +
Sbjct: 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 84/266 (31%), Positives = 138/266 (51%), Gaps = 20/266 (7%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG C +TG YACK + K++L ++ + E +I++ +S + IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLA 59
Query: 162 GAYEDRQSVHLVMELCSGGELFDKI--IAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
A+E + + LVM L +GG+L I + + + E A I+ + H H +++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEID 278
DLKPEN LL + G ++ +D GL+V + GK + G+ Y+APEVL+ Y +D
Sbjct: 120 DLKPENVLLDD-HGN--VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 279 VWSAGVILYILLSGVPPFWAETEK----GIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
++ G LY +++G PF EK + L+ V++ + S AKDL +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK----FSPEAKDLCEAL 232
Query: 335 LIQDPKKRI-----TSAEVLEHPWMR 355
L +DP+KR+ ++ EV EHP +
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 79/262 (30%), Positives = 138/262 (52%), Gaps = 15/262 (5%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG+G FG L E ++G YA K + K ++ K + E +++++ + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+ +++ + + VME +GGELF + + ++E IV+ + + H +++R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEI 277
DLK EN +L +KDG +K TDFGL I + + G+ Y+APEVL YG+ +
Sbjct: 120 DLKLENLML-DKDG--HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D W GV++Y ++ G PF+ + + +F+ IL + F P L +D AK L+ +LI+
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF---PRTLSAD-AKSLLSGLLIK 232
Query: 338 DPKKRI-----TSAEVLEHPWM 354
DP KR+ + E++ H +
Sbjct: 233 DPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 79/262 (30%), Positives = 134/262 (51%), Gaps = 12/262 (4%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG C +TG YACK + K+++ ++ E QI++ ++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLA 66
Query: 162 GAYEDRQSVHLVMELCSGGELFDKI--IAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
AYE + ++ LV+ L +GG+L I + + E+ A I + H +++R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEID 278
DLKPEN LL D ++ +D GL+V I EG+ R VG+ Y+APEV++ Y D
Sbjct: 127 DLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 279 VWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338
W G ++Y ++ G PF EK + + + + + E S++A+ + R++L +D
Sbjct: 184 WWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKD 243
Query: 339 PKKRI-----TSAEVLEHPWMR 355
P R+ + EV HP+ R
Sbjct: 244 PGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-29
Identities = 76/262 (29%), Positives = 134/262 (51%), Gaps = 13/262 (4%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +G+G FG L + G YA K + K+ ++ K++++ I E ++ +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++ ++ V++ +GGELF + + + E A I + + + H + +++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEI 277
DLKPEN LL ++ G +L TDFGL I+ K G+ Y+APEVLR+ Y + +
Sbjct: 121 DLKPENILLDSQ-GHVVL--TDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D W G +LY +L G+PPF++ ++D IL + + IS SA+ L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN----ISVSARHLLEGLLQK 233
Query: 338 DPKKRITSA----EVLEHPWMR 355
D KR+ + E+ H +
Sbjct: 234 DRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-29
Identities = 75/261 (28%), Positives = 122/261 (46%), Gaps = 14/261 (5%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG L T YA K + K ++ D E E +++ + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
++ ++ VME +GG+L I G + E A I + H G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 222 KPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPE-VLRRSYGKEIDV 279
K +N +L D +K DFG+ I GK R G+ Y+APE + + YGK +D
Sbjct: 128 KLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 280 WSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339
W+ GV+LY +L+G PPF E E +F +I++ V + +S A + + +L + P
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLLTKHP 240
Query: 340 KKRITSA-----EVLEHPWMR 355
KR+ ++ EH + R
Sbjct: 241 AKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 75/263 (28%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG C +TG YACK + K+++ ++ E +I++ ++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLA 66
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHR 219
AYE + ++ LV+ + +GG+L I G+ + E+ A + + +++R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEID 278
DLKPEN LL D ++ +D GL+V I EG+ R VG+ Y+APEV+ Y D
Sbjct: 127 DLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPD 183
Query: 279 VWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338
W G ++Y ++ G PF E+ + + + + + E S+ AK + R +L ++
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKN 243
Query: 339 PKKRI-----TSAEVLEHPWMRE 356
PK+R+ +A V +HP +
Sbjct: 244 PKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 84/294 (28%), Positives = 140/294 (47%), Gaps = 45/294 (15%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +GRG FG L + TG+ YA K + K ++ K+ I+ E I+ G +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVK 65
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++D+++++L+ME GG++ ++ + +E+A V + H +G +HR
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEG---KVYRDI------------------- 257
D+KP+N LL D +K +DFGL + + + YR++
Sbjct: 126 DIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 258 --------------VGSAYYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETEK 302
VG+ Y+APEV ++ Y K D WS GVI+Y +L G PPF +ET +
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 303 GIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE---HPW 353
+ ++ P + IS+ AKDL+ + D + RI S V E HP+
Sbjct: 243 ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 83/260 (31%), Positives = 137/260 (52%), Gaps = 16/260 (6%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG+G FG L E +TG YA K + K +V K + E +++Q+ S +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMH 218
+ +++ + VME +GGELF + + ++E A IV+ + + H V++
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKE 276
RDLK EN +L +KDG +K TDFGL I +G + G+ Y+APEVL YG+
Sbjct: 120 RDLKLENLML-DKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 277 IDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336
+D W GV++Y ++ G PF+ + + +F+ IL + F +S AK L+ +L
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLSGLLK 232
Query: 337 QDPKKRI-----TSAEVLEH 351
+DPK+R+ + E+++H
Sbjct: 233 KDPKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 78/266 (29%), Positives = 134/266 (50%), Gaps = 23/266 (8%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN--IVE 159
LGRG FG L TG YA K++ K ++ + + E + E +I + + +++ +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
++ V VME +GG+L I ++E A +V + + H +++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD----IVGSAYYVAPEVL-RRSYG 274
DLK +N LL D +K DFGL EG + D G+ ++APEVL SY
Sbjct: 126 DLKLDNLLL---DTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
+ +D W GV++Y +L G PF + E+ +FD+I+ V + P L ++ ++R++
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY---PRFLSREAIS-IMRRL 235
Query: 335 LIQDPKKRITSAE-----VLEHPWMR 355
L ++P++R+ S E V + P+ R
Sbjct: 236 LRRNPERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 87/271 (32%), Positives = 135/271 (49%), Gaps = 18/271 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + K +GRG FG L ST YA K + K +++ + D E IM +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
+V+ A++D + +++VME GG+L + +++ EK A +V + H MG
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDI-VGSAYYVAPEVLRRS- 272
+HRD+KP+N LL D LK DFG + ++ EG V D VG+ Y++PEVL+
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 273 ----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL--KGGVDFESEPWLLISDS 326
YG+E D WS GV LY +L G PF+A++ G + I+ K + F + IS
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN--DISKE 277
Query: 327 AKDLVRKMLIQDPKK--RITSAEVLEHPWMR 355
AK+L+ L + R E+ H + +
Sbjct: 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 82/267 (30%), Positives = 138/267 (51%), Gaps = 11/267 (4%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
D ++ YT +++G+G G Y + +TG A K + L + +E I EI +M+
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRE 72
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
+ NIV + +Y + +VME +GG L D ++ + E AA+CR + +
Sbjct: 73 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVL 269
H V+HRD+K +N LL DG +K TDFG I + R +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLG-MDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 270 -RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328
R++YG ++D+WS G++ ++ G PP+ E I G P L S +
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL-SAVFR 246
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPWMR 355
D + + L D +R ++ E+L+HP+++
Sbjct: 247 DFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 82/293 (27%), Positives = 128/293 (43%), Gaps = 47/293 (16%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK-----REIQIMQH 150
Y + ++G G F TG YA K + K+ + ++ REIQ ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRR 53
Query: 151 LSGQQNIVEFRGAYEDRQ--SVHLVMELCSGGELFDKIIAQGHY-TEKAAAALCRAIVNV 207
LS NI+ DR+ + LV EL L++ I + EK + ++
Sbjct: 54 LSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPE 267
+ H H G+ HRD+KPEN L+ + +LK DFG I Y + + + +Y APE
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD----ILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168
Query: 268 VLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFD-------AILKG--- 311
L YG ++D+W+ G + + +LS P F E I D +LK
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228
Query: 312 ----GVDFESE-----PWLL--ISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
+F S+ LL S DL++K+L DP +RIT+ + L HP+
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 53/304 (17%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +G G FG L + T YA K++ K ++ + +K E I+ + + +V+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++D+ +++ VM+ GG++ +I G + E A + + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL---------SVFIDEGKVYR--------------- 255
D+KP+N L+ ++DG +K TDFGL S + +G +R
Sbjct: 126 DIKPDNILI-DRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 256 --------------------DIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVP 294
+VG+ Y+APEVL R+ Y + D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 295 PFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITS---AEVLEH 351
PF A+T ++ +S A DL+ + L + R+ E+ H
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAH 301
Query: 352 PWMR 355
P+ +
Sbjct: 302 PFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 83/295 (28%), Positives = 127/295 (43%), Gaps = 64/295 (21%)
Query: 105 GQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK------REIQIMQHLSGQQNIV 158
G +G+ Y + TG A K + K ++E REI I+ L NIV
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITSLREINILLKLQ-HPNIV 67
Query: 159 EFR----GAYEDRQSVHLVME-----LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
+ G+ D +++VME L S E + Q L +++ V
Sbjct: 68 TVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSE-----VKCLMLQLLSGVA 120
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEV 268
H H ++HRDLK N LL+N+ +LK DFGL+ + K Y +V + +Y APE+
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNR---GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177
Query: 269 L--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK---------------- 310
L + Y ID+WS G I LL+ P F ++E + I K
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237
Query: 311 ---GGVDFESEPW---------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
F P+ L +SD+ DL+ ++L DP KRI++ + L+HP+
Sbjct: 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 19/264 (7%)
Query: 100 KELGRGQFGITYLC---TENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
K LG+G FG +L T G YA K +LK+ + +DR K E I+ +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATLKVRDRVRTKMERDILAEV-NHPF 59
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGV 216
IV+ A++ ++L+++ GG+LF ++ + +TE+ + + H H +G+
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSV-FIDEGKVYRDIVGSAYYVAPEVL-RRSYG 274
++RDLKPEN LL D +K TDFGLS ID K G+ Y+APEV+ RR +
Sbjct: 120 IYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
+ D WS GV+++ +L+G PF + K ILK + P L S A+ L+R +
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---GMPQFL-SPEAQSLLRAL 232
Query: 335 LIQDPKKRITSA-----EVLEHPW 353
++P R+ + E+ HP+
Sbjct: 233 FKRNPANRLGAGPDGVEEIKRHPF 256
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 80/267 (29%), Positives = 134/267 (50%), Gaps = 20/267 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRE--DIKREIQIMQHLSG 153
+ LGK LG+G FG YLC + TG A K + + +E ++ EIQ++++L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL- 62
Query: 154 QQNIVEFRGAYEDRQ--SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
+ IV++ G D ++ + ME GG + D++ + G TE R I+ V +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFG----LSVFIDEGKVYRDIVGSAYYVAPE 267
H ++HRD+K N L +D +K DFG L G + + G+ Y+++PE
Sbjct: 123 HSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 268 VLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL--LIS 324
V+ YG++ D+WS G + +L+ PP WAE E AI K + P L +S
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEA--MAAIFKIATQ-PTNPVLPPHVS 235
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEH 351
D +D ++++ ++ K R ++ E+L H
Sbjct: 236 DHCRDFLKRIFVE-AKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 87/289 (30%), Positives = 132/289 (45%), Gaps = 28/289 (9%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+ + + ELG G FG Y TG A K I ++ ++++ ED EI I+
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILS 57
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVV 208
NIV AY + +++E C GG L ++ TE +CR ++ +
Sbjct: 58 ECK-HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEAL 116
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPE 267
+ H V+HRDLK N LL+ DG +K DFG+S RD +G+ Y++APE
Sbjct: 117 NFLHSHKVIHRDLKAGNILLT-LDGD--VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173
Query: 268 VL------RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321
V+ Y + D+WS G+ L L PP + ILK SEP
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK------SEPPT 227
Query: 322 LI-----SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
L S S D ++ L++DP R T+AE+L+HP++ + +K I
Sbjct: 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS--DNKAI 274
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 40/274 (14%)
Query: 97 TLGKELGRGQFGITYLCT-ENSTGNSY---ACKSILKRKLVNKQDREDIKREIQIMQHLS 152
TLGK+LG G FG Y + G A K++ + ++Q E+ RE +IM+ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAAL--------CRAI 204
N+V+ G + + +++VME GG+L Y K L I
Sbjct: 60 -HPNVVKLLGVCTEEEPLYIVMEYMEGGDL-------LSYLRKNRPKLSLSDLLSFALQI 111
Query: 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSA--Y 262
+ + +HRDL N L+ ++K +DFGLS + + YR G
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
Query: 263 YVAPEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPW 320
++APE L+ + + DVWS GV+L+ + + G P+ + + + + + G
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------- 221
Query: 321 LLISDSAKDLVRKMLIQ----DPKKRITSAEVLE 350
L + + +++Q DP+ R T +E++E
Sbjct: 222 LPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 75/265 (28%), Positives = 138/265 (52%), Gaps = 16/265 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y K++G G FG L G Y K I K+ K+ RE+ ++E+ ++ ++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE-REESRKEVAVLSNMK-HP 59
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHF 213
NIV+++ ++E+ ++++VM+ C GG+L+ KI AQ + E I + H H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLR-R 271
++HRD+K +N L+ KDG +K DFG++ V ++ R +G+ YY++PE+ R
Sbjct: 120 RKILHRDIKSQNIFLT-KDG--TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA--KD 329
Y + D+W+ G +LY + + F A K + I++G S P + S ++
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-----SYPPVSSHYSYDLRN 231
Query: 330 LVRKMLIQDPKKRITSAEVLEHPWM 354
LV ++ ++P+ R + +LE ++
Sbjct: 232 LVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 100/363 (27%), Positives = 142/363 (39%), Gaps = 104/363 (28%)
Query: 96 YTLGKELGRGQFGITYLC----TENSTGNSYACKSI---------LKRKLVNKQDREDIK 142
Y L KELG+G +GI +C E S + A K I KR L
Sbjct: 2 YELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKRAL---------- 49
Query: 143 REIQIMQHLSGQQNIVE-------FRGAYEDRQSVHLVMELCSGGELFDKIIAQG----- 190
RE+++++H G +NI F G + + ++L EL +II G
Sbjct: 50 RELKLLRHFRGHKNITCLYDMDIVFPGNFNE---LYLYEELMEAD--LHQIIRSGQPLTD 104
Query: 191 -HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249
H+ LC + + H V+HRDLKP N LL N D LK DFGL+
Sbjct: 105 AHFQSFIYQILCG-----LKYIHSANVLHRDLKPGN-LLVNADC--ELKICDFGLARGFS 156
Query: 250 EGKVYRD-----IVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAE--- 299
E V + +Y APE++ +SY K IDVWS G IL LL P F +
Sbjct: 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV 216
Query: 300 ----------------------TEKG---IFDAILKGGVDFESEPWLLI--SDSAKDLVR 332
+ K I F + + A DL+
Sbjct: 217 DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPF---ESIFPNANPLALDLLE 273
Query: 333 KMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFR-------AMNKLKKM 385
K+L DP KRI+ E LEHP++ + D+P+ K F +M +L+ M
Sbjct: 274 KLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQ------KPFDFSFESEDSMEELRDM 327
Query: 386 ALK 388
++
Sbjct: 328 IIE 330
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 81/267 (30%), Positives = 138/267 (51%), Gaps = 11/267 (4%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
D ++ YT +++G+G G Y + +TG A + + L + +E I EI +M+
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
+ NIV + +Y + +VME +GG L D ++ + E AA+CR + +
Sbjct: 74 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR-DIVGSAYYVAPEVL 269
H V+HRD+K +N LL DG +K TDFG I + R +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLG-MDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 270 -RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328
R++YG ++D+WS G++ ++ G PP+ E I G P L S +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL-SAIFR 247
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPWMR 355
D + + L D +KR ++ E+L+H +++
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 72/254 (28%), Positives = 134/254 (52%), Gaps = 10/254 (3%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +G+G FG L S G+ YA K + K+ ++ K+++ I E ++ +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++ + ++ V++ +GGELF + + + E A + + + + H + +++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEI 277
DLKPEN LL ++ G +L TDFGL ++ + G+ Y+APEVLR+ Y + +
Sbjct: 121 DLKPENILLDSQ-GHVVL--TDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D W G +LY +L G+PPF++ ++D IL + + +A DL+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK----TVAACDLLVGLLHK 233
Query: 338 DPKKRITS-AEVLE 350
D ++R+ + A+ LE
Sbjct: 234 DQRRRLGAKADFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 69/246 (28%), Positives = 124/246 (50%), Gaps = 9/246 (3%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +G+G FG L + YA K + K+ ++ K++ + I E ++ +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++ ++ V++ +GGELF + + + E A I + + + H + +++R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVL-RRSYGKEI 277
DLKPEN LL D + TDFGL I+ G+ Y+APEVL ++ Y + +
Sbjct: 121 DLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTV 177
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D W G +LY +L G+PPF++ ++D IL + + I++SA+ L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLLQK 233
Query: 338 DPKKRI 343
D KR+
Sbjct: 234 DRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-27
Identities = 83/268 (30%), Positives = 137/268 (51%), Gaps = 20/268 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRE--DIKREIQIMQHLSG 153
+ LGK LGRG FG YLC + TG A K + + +E ++ EIQ++++L
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR- 62
Query: 154 QQNIVEFRGAYED--RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
IV++ G D + + + +E GG + D++ A G TE R I+ V +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID----EGKVYRDIVGSAYYVAPE 267
H ++HRD+K N L +D +K DFG S I G + + G+ Y+++PE
Sbjct: 123 HSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 268 VLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL--IS 324
V+ YG++ DVWS + +L+ PP WAE E AI K ++P L +S
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEA--MAAIFKIATQ-PTKPMLPDGVS 235
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHP 352
D+ +D ++++ +++ K+R T+ +L HP
Sbjct: 236 DACRDFLKQIFVEE-KRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 73/266 (27%), Positives = 124/266 (46%), Gaps = 16/266 (6%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG+G FG L T YA K + K ++ D + E +I+ + +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
++ + + VME +GG+L +I + E + + + H GV++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEI 277
DLK +N LL D K DFG+ I G G+ Y+APE+L+ YG +
Sbjct: 121 DLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D W+ GV++Y +++G PPF A+ E +F++IL V + WL S A +++ + +
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--WL--SKEAVSILKAFMTK 233
Query: 338 DPKKRI-------TSAEVLEHPWMRE 356
+P KR+ + +HP+ +E
Sbjct: 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 70/268 (26%), Positives = 122/268 (45%), Gaps = 27/268 (10%)
Query: 97 TLGKELGRGQFGITYLCT-ENSTGNSY---ACKSILKRKLVNKQDREDIKREIQIMQHLS 152
TLGK+LG G FG Y T + A K++ + ++Q E+ RE +IM+ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY--TEKAAAALCRAIVNVVHH 210
NIV+ G + + + +VME GG+L D + + + I + +
Sbjct: 60 -HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSA--YYVAPEV 268
+HRDL N L+ ++K +DFGLS + + Y+ G ++APE
Sbjct: 119 LESKNFIHRDLAARNCLVGENL---VVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 269 LRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326
L+ + + DVWS GV+L+ + + G P+ + + + + KG L +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR-------LPKPPN 228
Query: 327 AKDLVRKMLIQ----DPKKRITSAEVLE 350
+ K+++Q DP+ R T +E++E
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 81/265 (30%), Positives = 133/265 (50%), Gaps = 18/265 (6%)
Query: 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRE--DIKREIQIMQHLSGQQN 156
GK LG+G FG YLC + TG A K + + +E ++ EIQ++++L +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HER 65
Query: 157 IVEFRGAYEDR--QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
IV++ G DR +++ + ME GG + D++ A G TE R I+ + + H
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFG----LSVFIDEGKVYRDIVGSAYYVAPEVLR 270
++HRD+K N L +D +K DFG L G R + G+ Y+++PEV+
Sbjct: 126 MIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 271 -RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW-LLISDSAK 328
YG++ DVWS G + +L+ PP WAE E AI K + IS+ A+
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTNPQLPSHISEHAR 239
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPW 353
D + + ++ + R ++ E+L HP+
Sbjct: 240 DFLGCIFVE-ARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 5e-27
Identities = 73/257 (28%), Positives = 128/257 (49%), Gaps = 13/257 (5%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
+G+G FG + T YA K+I K +V++ + E ++ ++ IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
+++ + ++LV+ +GGELF + +G + A ++ + + H V++RDL
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 222 KPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDV 279
KPEN LL D + DFGL + + + G+ Y+APE+L Y K +D
Sbjct: 120 KPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 280 WSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339
W+ GV+LY +L+G+PPF+ E ++ IL+ + F AKDL+ +L +DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRDP 232
Query: 340 KKRITSA---EVLEHPW 353
+R+ E+ HP+
Sbjct: 233 TRRLGYNGAQEIKNHPF 249
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 71/254 (27%), Positives = 122/254 (48%), Gaps = 10/254 (3%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
+GRG FGI +LC + K I ++ K +R + E Q+++ LS NI+E+
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYY 65
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+ + +++ +VME GG L + I + + E I+ +HH H ++HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEID 278
DLK +N LL ++K DFG+S + +VG+ Y++PE+ + Y ++ D
Sbjct: 126 DLKTQNILLDKHK--MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSD 183
Query: 279 VWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338
+W+ G +LY L S F A + I+ G S+ + S + L+ ML D
Sbjct: 184 IWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY---SPDLRQLILSMLNLD 240
Query: 339 PKKRITSAEVLEHP 352
P KR ++++ P
Sbjct: 241 PSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 69/276 (25%), Positives = 130/276 (47%), Gaps = 29/276 (10%)
Query: 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK-------REIQIMQHL 151
G+ +G+G +G YL +TG A K + + + K EI+ ++ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
NIV++ G + + + +E GG + + G + E+ ++ + +
Sbjct: 66 D-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-----IVGSAYYVAP 266
H G++HRDLK +N L+ D + K +DFG+S D+ +Y + + GS +++AP
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGISKKSDD--IYDNDQNMSMQGSVFWMAP 179
Query: 267 EVL---RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP---- 319
EV+ + Y ++D+WS G ++ + +G P W++ E A+ K G + P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEE--AIAAMFKLGNKRSAPPIPPD 236
Query: 320 -WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
+ +S A D + +P R T+ E+L+HP++
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 73/263 (27%), Positives = 131/263 (49%), Gaps = 19/263 (7%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +G+G FG L G YA K + K+ ++N+++++ I E ++ +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++ + ++ V++ +GGELF + + + E A I + + + H + +++R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV----GSAYYVAPEVLRRS-YG 274
DLKPEN LL D + TDFGL EG D G+ Y+APEV+R+ Y
Sbjct: 121 DLKPENILL---DSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
+D W G +LY +L G+PPF+ ++D IL + S +A ++ ++
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG----ASLTAWSILEEL 230
Query: 335 LIQDPKKRITSA----EVLEHPW 353
L +D ++R+ + E+ EHP+
Sbjct: 231 LEKDRQRRLGAKEDFLEIQEHPF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 41/269 (15%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +GRG FG L + TG+ YA K + K ++ K+ I+ E I+ +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW-VVK 65
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++D+ +++L+ME GG++ ++ + TE+ V + H +G +HR
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEG---KVYRDI------------------- 257
D+KP+N LL +K +K +DFGL + + + YR++
Sbjct: 126 DIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 258 --------------VGSAYYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETEK 302
VG+ Y+APEV ++ Y K D WS GVI+Y +L G PPF +ET +
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 303 GIFDAILKGGVDFESEPWLLISDSAKDLV 331
+ ++ P + IS+ AKDL+
Sbjct: 243 ETYKKVMNWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 82/270 (30%), Positives = 138/270 (51%), Gaps = 21/270 (7%)
Query: 99 GKELGRGQFGITYLCTENSTGNSYACKSI-LKRKLVNKQDR-----EDIKREIQIMQHLS 152
G +G G FG YL S+G A K + L + +DR + + REI +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212
+NIV++ G+ D +++ +E GG + + G + E R I+ +++ H
Sbjct: 65 -HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-------GKVYRDIVGSAYYVA 265
G++HRD+K N L+ NK G +K +DFG+S ++ + GS +++A
Sbjct: 124 NRGIIHRDIKGANILVDNKGG---IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 266 PEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324
PEV+++ SY ++ D+WS G ++ +L+G PF T+ AI K G + E IS
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENASPEIPSNIS 237
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
A D + K D KR T+AE+L+HP++
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 65/261 (24%), Positives = 127/261 (48%), Gaps = 12/261 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + ++G+G FG+ + + YA K I K+ N+++RE+ E +++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SS 59
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHF 213
I+ + ++ D+ +++VME G+L + Q E I+ + H H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY-RDIVGSAYYVAPEVLR-R 271
++HRD+K N L D +K D G++ + + + IVG+ YY++PE+ +
Sbjct: 120 KKILHRDIKSLNLFLDAYDN---VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
Y ++ DVW+ GV+LY +G PF A + + I++G S+ + S L+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLAQLI 233
Query: 332 RKMLIQDPKKRITSAEVLEHP 352
+ L +D ++R + ++L +P
Sbjct: 234 DQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 14/261 (5%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG L T YA K + K ++ D E E +++ + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
++ ++ VME +GG+L I G + E A I + H G+++RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 222 KPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDV 279
K +N +L D +K DFG+ + +G R G+ Y+APE++ + YGK +D
Sbjct: 128 KLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 280 WSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339
W+ GV+LY +L+G PPF E E +F +I++ V + +S A + + ++ + P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLMTKHP 240
Query: 340 KKRITSA-----EVLEHPWMR 355
KR+ ++ EH + R
Sbjct: 241 SKRLGCGPEGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 85/305 (27%), Positives = 133/305 (43%), Gaps = 53/305 (17%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQ 146
+ +F L + +G G +GI Y + ++G A K K+ +R+ I REI
Sbjct: 5 SVTEFEKLNR-IGEGTYGIVYRARDTTSGEIVALK-----KVRMDNERDGIPISSLREIT 58
Query: 147 IMQHLSGQQNIVEFRGAYEDRQ--SVHLVMELCSG--GELFDKIIAQGHYTEKAAAALCR 202
++ +L NIVE + + S+ LVME C L D + ++E L
Sbjct: 59 LLLNLR-HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLML 115
Query: 203 AIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSA 261
++ + + H ++HRDLK N LL++K LK DFGL+ + K V +
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAKPMTPKVVTL 172
Query: 262 YYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAI----------- 308
+Y APE+L +Y ID+W+ G IL LL+ P ++E D I
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232
Query: 309 --------LKGGVDFESEP---------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
L G +P WL S++ L+ +L+ DPKKR T+ E LE
Sbjct: 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWL--SEAGLRLLNFLLMYDPKKRATAEEALES 290
Query: 352 PWMRE 356
+ +E
Sbjct: 291 SYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 30/266 (11%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG +TG YACK + K++L K + E +I++ ++ IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLA 59
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQG----------HYTEKAAAALCRAIVNVVHHC 211
A+E + + LVM L +GG+L I G HY+ + + H
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGIL--------HL 111
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR- 270
H M +++RD+KPEN LL D + +D GL+V + +GK G+ Y+APE+L+
Sbjct: 112 HSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168
Query: 271 RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAI----LKGGVDFESEPWLLISDS 326
Y +D ++ G +Y +++G PF EK + + L+ V FE + + ++
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNF---TEE 225
Query: 327 AKDLVRKMLIQDPKKRITSAEVLEHP 352
+KD+ R L + P+ R+ S E + P
Sbjct: 226 SKDICRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 91/292 (31%), Positives = 139/292 (47%), Gaps = 31/292 (10%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEF 160
ELG+G +G Y TG + A K I R +++ I E+ I+ H + IV+F
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDIL-HKAVSPYIVDF 64
Query: 161 RGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN-VVHHCHFM----G 215
GA+ +V++ ME G L DK+ A G TE + R I VV F+
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR---- 271
++HRD+KP N L++ +K DFG+S + + + +G Y+APE ++
Sbjct: 124 IIHRDVKPTNVLVNGN---GQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 272 ---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF---DAILKGGVDFESEPWLL--I 323
+Y + DVWS G+ + + G P+ ET IF AI+ G P L
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-----DPPTLPSGY 234
Query: 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQ 375
SD A+D V K L + P +R T A++LEHPW+ + A D + V +K+
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA-DVDMAEWVTGALKR 285
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 86/313 (27%), Positives = 141/313 (45%), Gaps = 47/313 (15%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILK---RKLVNKQDREDIKREIQI 147
+I Y + +G G FG+ + TG + A K I+K ++ K+ RE+++
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR----TYRELKL 62
Query: 148 MQHLSGQQNIVEFRGAY-EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
++HL +NI+ + + ++ V EL G +++ ++ I+
Sbjct: 63 LKHLR-HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 207 VVHHCHFMGVMHRDLKPENFLLS-NKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
+ + H GV+HRDLKP N L++ N D LK DFGL+ D V + YY A
Sbjct: 120 GLKYVHSAGVVHRDLKPSNILINENCD----LKICDFGLARIQDPQMT--GYVSTRYYRA 173
Query: 266 PEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL-------------- 309
PE++ + Y E+D+WSAG I +L G P F + F I
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
Query: 310 --KGGVDF-----ESEPWLL------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
+ + F + EP SA DL+ KML+ DP+KRI++AE L HP++
Sbjct: 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293
Query: 357 GGEASDKPIGSAV 369
+ +D+P+
Sbjct: 294 YHDPTDEPVAEEK 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 79/266 (29%), Positives = 129/266 (48%), Gaps = 22/266 (8%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG+G FG L T +A K++ K ++ D E E +++ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
++ ++ + VME +GG+L I + G + E A I+ + H G+++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY-----YVAPEVLR-RSY 273
DLK +N LL +KDG +K DFG+ + + + S + Y+APE+L+ + Y
Sbjct: 121 DLKLDNVLL-DKDG--HIKIADFGMC----KENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL--LISDSAKDLV 331
+ +D WS GV+LY +L G PF E E +FD+IL P IS AKD +
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN------DRPHFPRWISKEAKDCL 227
Query: 332 RKMLIQDPKKRITSA-EVLEHPWMRE 356
K+ +DP KR+ ++ +HP+ R
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 86/313 (27%), Positives = 141/313 (45%), Gaps = 58/313 (18%)
Query: 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ 154
F+T+ K +G+G FG L + TG YA K++LK ++ K +K E ++ S
Sbjct: 3 FHTV-KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDS 60
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
+V +++D Q ++L+ME GG+L +I ++E V + H +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGL------------------------------ 244
G +HRD+KP+N L+ D G +K +DFGL
Sbjct: 121 GFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 245 SVFIDE-------------GKVYRDI-----VGSAYYVAPEV-LRRSYGKEIDVWSAGVI 285
SV +D K R + VG+ Y+APE+ L++ YG+E D WS G I
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 286 LYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI-- 343
++ L G PPF +E + I+ + +S A+DL+R+ LI + + R+
Sbjct: 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR-LITNAENRLGR 296
Query: 344 -TSAEVLEHPWMR 355
+ E+ HP+ R
Sbjct: 297 GGAHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 78/270 (28%), Positives = 133/270 (49%), Gaps = 23/270 (8%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG C +TG YACK + K++L ++ E E +I+ + + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLA 59
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGH----YTEKAAAALCRAIVNVVHHCHFMGVM 217
A++ + + LVM + +GG+L I + E A I++ + H H ++
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV-YRDIVGSAYYVAPEVLR-RSYGK 275
+RDLKPEN LL N DG ++ +D GL+V + +G+ + G+ ++APE+L+ Y
Sbjct: 120 YRDLKPENVLLDN-DGN--VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 276 EIDVWSAGVILYILLSGVPPFWAETE----KGIFDAILKGGVDFESEPWLLISDSAKDLV 331
+D ++ GV LY +++ PF A E K + IL V + + S ++K
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK----FSPASKSFC 232
Query: 332 RKMLIQDPKKRI-----TSAEVLEHPWMRE 356
+L +DP+KR+ + HP R+
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 87/292 (29%), Positives = 139/292 (47%), Gaps = 41/292 (14%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
+F LG +G G +G+ C T A K K N++ +E RE+++++ L
Sbjct: 2 KFEVLGV-VGEGAYGVVLKCRHKETKEIVAIKK-FKDSEENEEVKETTLRELKMLRTLK- 58
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGG--ELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
Q+NIVE + A+ R ++LV E EL +++ G EK + + + ++ +H C
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWC 116
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK--VYRDIVGSAYYVAPEVL 269
H ++HRD+KPEN L+S+ D +LK DFG + + EG Y + V + +Y +PE+L
Sbjct: 117 HKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 270 RRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK------------------ 310
+ YGK +D+WS G IL L G P F E+E I K
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233
Query: 311 -GGVDFES--EPWLL-------ISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
G+ F + P L +S DL++ +L +P R + + L HP
Sbjct: 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 81/272 (29%), Positives = 128/272 (47%), Gaps = 17/272 (6%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
P ED + L + +G G +G Y +TG A K I KL +D +++EI I
Sbjct: 7 PQED----FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEI-I 58
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNV 207
M NIV + G+Y R + + ME C GG L D G +E A + R +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR-DIVGSAYYVAP 266
+++ H G MHRD+K N LL++ +K DFG+S I R +G+ Y++AP
Sbjct: 119 LYYLHSKGKMHRDIKGANILLTDN---GHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 267 EVL----RRSYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFDAILKGGVDFESEPWL 321
EV + Y + D+W+ G+ L PP F + +F + + +
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
S+S V+ L ++PKKR T+ ++L+HP+
Sbjct: 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 96/345 (27%), Positives = 146/345 (42%), Gaps = 70/345 (20%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +GRG +GI + T A K I N+ D + REI++++HL +N++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLD-HENVIA 68
Query: 160 F--------RGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
R A+ D V++V EL +L I + ++ ++ + +
Sbjct: 69 IKDIMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 212 HFMGVMHRDLKPENFLL-SNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL 269
H V+HRDLKP N LL +N D LK DFGL+ ++G + V + +Y APE+L
Sbjct: 125 HSANVLHRDLKPSNLLLNANCD----LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 270 RRS--YGKEIDVWSAGVILYILLSGVPPF----WAETEKGIFDAILKGGVDFESEPWLLI 323
Y IDVWS G I LL P F + K I + + G E + +
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL---GSPSEEDLGFIR 237
Query: 324 SDSAK--------------------------DLVRKMLIQDPKKRITSAEVLEHPWMREG 357
++ A+ DL+ KML+ DP KRIT E L HP++
Sbjct: 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297
Query: 358 GEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGL 402
+ SD+P+ S +AL+EE+IK L
Sbjct: 298 HDPSDEPVCQTPFS---------------FDFEEDALTEEDIKEL 327
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 85/315 (26%), Positives = 139/315 (44%), Gaps = 57/315 (18%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG G FG L + T YA K++ K+ ++ + +K E I+ + + +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++D+ +++ VM+ GG++ +I G + E A + V H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSV---FIDEGKVYR--------------------- 255
D+KP+N L+ ++DG +K TDFGL + + K Y+
Sbjct: 126 DIKPDNILI-DRDG--HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 256 ------------------------DIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILL 290
+VG+ Y+APEVL R+ Y + D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 291 SGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI---TSAE 347
G PPF A+T ++ P +S A DL+ K L + P+ R+ + E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301
Query: 348 VLEHPWMREGGEASD 362
+ HP+ + +SD
Sbjct: 302 IKAHPFFKTIDFSSD 316
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 73/262 (27%), Positives = 127/262 (48%), Gaps = 16/262 (6%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN-IVEF 160
LG+G FG L T YA K + K ++ D E E +++ LSG+ + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKPPFLTQL 66
Query: 161 RGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRD 220
++ ++ VME +GG+L +I G + E A I + H G+++RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 221 LKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEID 278
LK +N +L D +K DFG+ + +G + G+ Y+APE++ + YGK +D
Sbjct: 127 LKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 279 VWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338
W+ GV+LY +L+G PF E E +F +I++ V + +S A + + ++ +
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKH 239
Query: 339 PKKRITSA-----EVLEHPWMR 355
P KR+ ++ EH + R
Sbjct: 240 PGKRLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 74/262 (28%), Positives = 131/262 (50%), Gaps = 14/262 (5%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG+G FG +L T +A K++ K ++ D E E +++ +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
++ ++++ VME +GG+L I + + A I+ + H G+++R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL--SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKE 276
DLK +N LL + DG +K DFG+ + + K G+ Y+APE+L + Y
Sbjct: 121 DLKLDNILL-DTDG--HIKIADFGMCKENMLGDAKT-CTFCGTPDYIAPEILLGQKYNTS 176
Query: 277 IDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP-WLLISDSAKDLVRKML 335
+D WS GV+LY +L G PF E+ +F +I +D P WL + AKD++ K+
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR---MDNPCYPRWL--TREAKDILVKLF 231
Query: 336 IQDPKKRI-TSAEVLEHPWMRE 356
+++P++R+ ++ +HP+ RE
Sbjct: 232 VREPERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 66/264 (25%), Positives = 130/264 (49%), Gaps = 16/264 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + K++G+GQF + Y G A K + ++++ + R+D +EI +++ L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HP 62
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKII----AQGH-YTEKAAAALCRAIVNVVHH 210
N++++ ++ + +++V+EL G+L ++I Q E+ + + + H
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL 269
H +MHRD+KP N ++ ++K D GL F + +VG+ YY++PE +
Sbjct: 122 MHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 270 RRS-YGKEIDVWSAGVILYILLSGVPPFWAETEK--GIFDAILKGGVDFESEPWLLISDS 326
+ Y + D+WS G +LY + + PF+ + + I K D+ P S+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADHYSEE 236
Query: 327 AKDLVRKMLIQDPKKRITSAEVLE 350
+DLV + + DP+KR + VL+
Sbjct: 237 LRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 79/269 (29%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG G G C +TG +A K+I N ++ I RE++I + IV++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYY 65
Query: 162 GAYEDRQS--VHLVMELCSGGEL---FDKIIAQGHYT-EKAAAALCRAIVNVVHHCHFMG 215
GA+ D S + + ME C GG L + K+ +G EK + +++ + + H
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLR-RSY 273
++HRD+KP N LL+ K +K DFG+S ++ + G+++Y+APE ++ + Y
Sbjct: 126 IIHRDIKPSNILLTRK---GQVKLCDFGVSGELVN--SLAGTFTGTSFYMAPERIQGKPY 180
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETEKG-----IFDAILKGGV-DFESEPWLLI--SD 325
DVWS G+ L + PF E E + I+ + + EP I S+
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
KD +++ L +DP +R T ++LEHPW+
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 100 KELGRGQFGITYLCT----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
K+LG G FG LC ++TG A KS L Q R D +REI+I++ L +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEE-QHRSDFEREIEILRTLD-HE 66
Query: 156 NIVEFRGAYED--RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCR---AIVNVVHH 210
NIV+++G E +S+ L+ME G L + Q H + L I + +
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY------RDIVGSAYYV 264
+HRDL N L+ ++D ++K +DFGL+ + E K Y + ++
Sbjct: 125 LGSQRYIHRDLAARNILVESED---LVKISDFGLAKVLPEDKDYYYVKEPGES--PIFWY 179
Query: 265 APEVLR-RSYGKEIDVWSAGVILYILLS 291
APE LR + DVWS GV LY L +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 81/314 (25%), Positives = 135/314 (42%), Gaps = 55/314 (17%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG G FG L + T YA K++ K+ ++N+ +K E I+ + + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
+++D+ +++ VM+ GG++ +I + E A + + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL---------SVFIDEGKVYR--------------- 255
D+KP+N L+ D +K TDFGL S + +G R
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 256 ------------------------DIVGSAYYVAPEVL-RRSYGKEIDVWSAGVILYILL 290
+VG+ Y+APEVL R+ Y + D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 291 SGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI--QDPKKRITSAEV 348
G PPF A T ++ P + +S A DL+ K+ ++ R + ++
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 349 LEHPWMREGGEASD 362
HP+ E +SD
Sbjct: 303 KAHPFFSEVDFSSD 316
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 76/271 (28%), Positives = 136/271 (50%), Gaps = 26/271 (9%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +GRG FG + +TG YA K + K +++ + + + E ++ + ++ I
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GDRRWITN 65
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCR----AIVNVVHHCHFMG 215
A++D +++LVM+ GG+L + + ++ + R +V + H +G
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDI-VGSAYYVAPEVLRR-- 271
+HRD+KP+N LL D ++ DFG + + G V ++ VG+ Y++PE+L+
Sbjct: 123 YVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 272 ----SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL--KGGVDFESEPWLLISD 325
YG E D WS GV +Y +L G PF+AE+ + I+ K F + +S+
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVSE 238
Query: 326 SAKDLVRKMLIQDPKKRITS---AEVLEHPW 353
AKDL+R+ LI P+ R+ + +HP+
Sbjct: 239 EAKDLIRR-LICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 1e-23
Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 34/273 (12%)
Query: 100 KELGRGQFGITYLCT---ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
K+LG G FG Y ++ A K++ + ++++R+D +E ++M+ L G N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKL-GHPN 57
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY---------TEKAAAALCRAIVNV 207
+V G + + ++LV+E GG+L D + + K + I
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV--- 264
+ + +HRDL N L+ +K +DFGLS + + YR G +
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 265 APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322
APE L+ + + DVWS GV+L+ + + G P+ + + + + + KG L
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-------LP 227
Query: 323 ISDSAKDLVRKMLIQ----DPKKRITSAEVLEH 351
+ D + ++++ DP+ R T +E++E
Sbjct: 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-23
Identities = 84/306 (27%), Positives = 137/306 (44%), Gaps = 59/306 (19%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK--REIQIMQHL-- 151
+ + ++G G +G Y + TG A K K +L N+++ I REI+I++ L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 152 ----------SGQQNIVEFRGAYEDRQSVHLVMELCSG---GELFDKIIAQGHYTEKAAA 198
+ +Q+ ++F+ +D+ + +LV E G L ++ H++E
Sbjct: 66 RNIVNLKEIVTDKQDALDFK---KDKGAFYLVFEYMDHDLMGLLESGLV---HFSEDHIK 119
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI--DEGKVYRD 256
+ + ++ +++CH +HRD+K N LL+NK +K DFGL+ +E + Y +
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK---GQIKLADFGLARLYNSEESRPYTN 176
Query: 257 IVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK--GG 312
V + +Y PE+L YG IDVWS G IL L + P F A E + I + G
Sbjct: 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236
Query: 313 VD------------FES------------EPWLLISDSAKDLVRKMLIQDPKKRITSAEV 348
F + E + I A DL+ ML DP KR T+ E
Sbjct: 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296
Query: 349 LEHPWM 354
L PW+
Sbjct: 297 LNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 13/258 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + + +G G FG L ++ YA K I R + ED ++E ++ +
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMK-HP 58
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHF 213
NIV F+ ++E +++VME C GG+L KI Q + E + V H H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR-DIVGSAYYVAPEVLRR- 271
V+HRD+K +N L+ +K DFG + + Y VG+ YYV PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQN---GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
Y + D+WS G ILY L + PF A + K + + +G + S + L+
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHY---SYELRSLI 232
Query: 332 RKMLIQDPKKRITSAEVL 349
++M ++P+ R ++ +L
Sbjct: 233 KQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 3e-23
Identities = 70/272 (25%), Positives = 129/272 (47%), Gaps = 21/272 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSIL---KRKLVNKQDREDIKREIQIMQHLS 152
+T G+ LG+G +G Y C + G A K + L +++ E ++ E+ +++ L
Sbjct: 2 WTKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212
NIV++ G D ++ + ME GG + + G E + I++ V + H
Sbjct: 61 -HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFG-------LSVFIDEGKVYRDIVGSAYYVA 265
V+HRD+K N +L ++K DFG + + + + + G+ Y++A
Sbjct: 120 NNCVVHRDIKGNNVMLMPN---GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 266 PEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL--L 322
PEV+ S YG++ D+WS G ++ + +G PP A ++ A+ G P L
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP-LASMDR--LAAMFYIGAHRGLMPRLPDS 233
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
S +A D V L +D +R ++ ++L H ++
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 86/293 (29%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIMQHLSGQQNI 157
+G G +G Y + +TG A K K + D E I REI ++Q LS I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 158 V-----EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH-----YTEKAAAALCRAIVNV 207
V E + S++LV E +L + + G K + ++
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAP 266
V HCH GVMHRDLKP+N L+ +K G +LK D GL F K Y + + +Y AP
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLV-DKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 267 EVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK--GGVDFESEPWLL 322
EVL Y +D+WS G I + P F ++E I K G + P +
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240
Query: 323 ----------------------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
+S DL++KML DP KRI++ L HP+
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 8e-23
Identities = 75/276 (27%), Positives = 123/276 (44%), Gaps = 25/276 (9%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRE---DIKREIQ 146
+D + +T +E+G G FG Y + T A K K KQ E DI +E++
Sbjct: 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVR 67
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELC--SGGELFDKIIAQGHYTEKAAAALCRAI 204
+Q L N +E++G Y + LVME C S ++ + + + E AA+C
Sbjct: 68 FLQQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGA 124
Query: 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV 264
+ + + H +HRD+K N LL+ +K DFG + + + VG+ Y++
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLTEP---GTVKLADFGSASLVSPANSF---VGTPYWM 178
Query: 265 APEVL----RRSYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFDAILKGGVDFESEP 319
APEV+ Y ++DVWS G+ L PP F ++ S
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND 238
Query: 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
W SD ++ V L + P+ R +S E+L+H ++
Sbjct: 239 W---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 8e-23
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 15/271 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSI-LKRKLVNKQDR--EDIKREIQIMQHLS 152
+ G++LG G F Y + TG A K + R ++Q+ E +++EI++M L+
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212
+I+ GA + +L +E +GG + + G + E ++ + + H
Sbjct: 62 -HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-----GKVYRDIVGSAYYVAPE 267
++HRD+K N L+ + G L+ DFG + + G+ ++G+ ++APE
Sbjct: 121 ENQIIHRDVKGANLLIDST--GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 268 VLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK--GGVDFESEPWLLIS 324
VLR YG+ DVWS G ++ + + PP+ AE I K S P L S
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL-S 237
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
+D+ + L P+ R S E+L+HP R
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 92/326 (28%), Positives = 136/326 (41%), Gaps = 68/326 (20%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSI--------LKRKLVNKQDREDI 141
D+ Y +G G +G+ T TG A K I +R L
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--------- 51
Query: 142 KREIQIMQHLSGQQNIVEFR-----GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKA 196
REI+I++ +NI+ ++E V++V EL +L+ K+I H +
Sbjct: 52 -REIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDH 107
Query: 197 AAALCRAIVNVVHHCHFMGVMHRDLKPENFLL-SNKDGGAMLKATDFGLSVFIDEGKVYR 255
I+ + + H V+HRDLKP N LL +N D LK DFGL+ D +
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD----LKICDFGLARIADPEHDHT 163
Query: 256 ----DIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL 309
+ V + +Y APE++ + Y K ID+WS G IL +LS P F + + IL
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL 223
Query: 310 KGGV-------DFES------------------EPWLLI----SDSAKDLVRKMLIQDPK 340
GV D PW + A DL+ KML +P
Sbjct: 224 --GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPH 281
Query: 341 KRITSAEVLEHPWMREGGEASDKPIG 366
KRIT E L HP++ + + SD+P+
Sbjct: 282 KRITVEEALAHPYLEQYHDPSDEPVA 307
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 77/282 (27%), Positives = 133/282 (47%), Gaps = 26/282 (9%)
Query: 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIM 148
L D + L + +G G +G Y TG A K + V + E+IK+EI ++
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINML 56
Query: 149 QHLSGQQNIVEFRGAYEDRQ------SVHLVMELCSGGELFDKIIAQGHYT--EKAAAAL 200
+ S +NI + GA+ + + LVME C G + D I T E+ A +
Sbjct: 57 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVG 259
CR I+ + H H V+HRD+K +N LL+ A +K DFG+S +D R+ +G
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIG 173
Query: 260 SAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFDAILKGG 312
+ Y++APEV+ +Y + D+WS G+ + G PP + +F
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 233
Query: 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
+S+ W S + + L+++ +R T+ ++++HP++
Sbjct: 234 PRLKSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 83/289 (28%), Positives = 138/289 (47%), Gaps = 30/289 (10%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
D + + + ELG G FG Y TG A K I + ++++ ED EI+I+
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILAT 65
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVV 208
+ IV+ GA+ + +++E C GG + D I+ + TE +CR ++ +
Sbjct: 66 CN-HPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEAL 123
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPE 267
+ H M ++HRDLK N LL+ DG +K DFG+S + RD +G+ Y++APE
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLT-LDGD--IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 268 VLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321
V+ Y + D+WS G+ L + PP + I K SEP
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK------SEPPT 234
Query: 322 LISDSA-----KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
L S +D ++ L + P+ R ++A++LEHP++ S++P+
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS--VTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 83/312 (26%), Positives = 136/312 (43%), Gaps = 59/312 (18%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK--REIQI 147
+++ ++ L K +G+G FG + T A K +L + N+++ I REI+I
Sbjct: 9 DEVSKYEKLAK-IGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKI 64
Query: 148 MQHLSGQQNIVEF--------RGAYEDRQSVHLVMELCS---GGELFDKIIAQGHYTEKA 196
+Q L +N+V + S +LV E C G L +K + +T
Sbjct: 65 LQLLK-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSE 120
Query: 197 AAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VF----IDEG 251
+ + ++N +++ H ++HRD+K N L++ KDG +LK DFGL+ F +
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILIT-KDG--ILKLADFGLARAFSLSKNSKP 177
Query: 252 KVYRDIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAI- 308
Y + V + +Y PE+L R YG ID+W AG I+ + + P TE+ I
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237
Query: 309 -LKGGVDFESEP-------------------------WLLISD-SAKDLVRKMLIQDPKK 341
L G + E P + D A DL+ K+L+ DP K
Sbjct: 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAK 297
Query: 342 RITSAEVLEHPW 353
RI + L H +
Sbjct: 298 RIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-22
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILK--RKLVNKQDREDIKREIQIMQHLSGQ 154
LGK+LG G FG Y T G K +K ++ ++++RE+ E IM+ LS
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS-H 60
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHF 213
NIV G + +++V E GG+L D + G T K + I + +
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV--------- 264
+HRDL N L++ ++K +DFGLS RDI YY
Sbjct: 121 KNFVHRDLAARNCLVTENL---VVKISDFGLS---------RDIYEDDYYRKRGGGKLPI 168
Query: 265 ---APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFW 297
APE L+ + + DVWS GV+L+ + + G P+
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 85/281 (30%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
D+ LG E+G G G Y TG+ A K + R+ NK++ + I ++ ++
Sbjct: 13 DLNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRILMDLDVVLK 69
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKII--AQGHYTEKAAAALCRAIVNVV 208
IV+ G + V + MEL S DK++ QG E + AIV +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKAL 127
Query: 209 HHC---HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
H+ H GV+HRD+KP N LL D +K DFG+S + + K G A Y+A
Sbjct: 128 HYLKEKH--GVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMA 182
Query: 266 PEVL-----RRSYGKEIDVWSAGVILYILLSGVPPF-WAETEKGIFDAILKGGVDFESEP 319
PE + Y DVWS G+ L L +G P+ +TE + IL + EP
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL------QEEP 236
Query: 320 WLL-----ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
L S V L +D +KR E+L+HP++R
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 3e-22
Identities = 72/263 (27%), Positives = 126/263 (47%), Gaps = 11/263 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + K++G G FG YL S K I K+ K+ +E K+E+ ++ +
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE-KEASKKEVILLAKMK-HP 59
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHF 213
NIV F ++++ + +VME C GG+L +I Q ++E + I + H H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLR-R 271
++HRD+K +N LS G + K DFG++ D ++ VG+ YY++PE+ + R
Sbjct: 120 RKILHRDIKSQNIFLSKN--GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
Y + D+WS G +LY L + PF + I +G S + S + L+
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF---SRDLRSLI 234
Query: 332 RKMLIQDPKKRITSAEVLEHPWM 354
++ P+ R + +L+ P++
Sbjct: 235 SQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 74/261 (28%), Positives = 124/261 (47%), Gaps = 14/261 (5%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K LG+G FG L G +A K++ K ++ D E E +++ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
++ ++ + VME +GG+L I +G + A IV + H G+++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 220 DLKPENFLLSNKDGGAMLKATDFGL---SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGK 275
DLK +N +L D +K DFG+ +VF D G+ Y+APE+L+ Y
Sbjct: 121 DLKLDNVML---DRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTF 175
Query: 276 EIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKML 335
+D WS GV+LY +L G PF + E +F++I VD P + +S KD++ K+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR---VDTPHYPRWITKES-KDILEKLF 231
Query: 336 IQDPKKRI-TSAEVLEHPWMR 355
+DP +R+ + HP+ +
Sbjct: 232 ERDPTRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 79/283 (27%), Positives = 130/283 (45%), Gaps = 28/283 (9%)
Query: 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIM 148
L D + L + +G G +G Y TG A K + V + + E+IK EI ++
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINML 66
Query: 149 QHLSGQQNIVEFRGAY-------EDRQSVHLVMELCSGGELFD--KIIAQGHYTEKAAAA 199
+ S +NI + GA+ D Q + LVME C G + D K E A
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 200 LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IV 258
+CR I+ + H H V+HRD+K +N LL+ A +K DFG+S +D R+ +
Sbjct: 126 ICREILRGLAHLHAHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 259 GSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFDAILKG 311
G+ Y++APEV+ +Y D+WS G+ + G PP + +F
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242
Query: 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
+S+ W S D + L+++ R ++ ++L+HP++
Sbjct: 243 PPKLKSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 7e-22
Identities = 80/309 (25%), Positives = 132/309 (42%), Gaps = 31/309 (10%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+D + + E+G G FG Y T + T A K + + +DI +E++ +Q
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
L N +E++G Y + LVME C G + + E AA+ + +
Sbjct: 77 QLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL 269
+ H ++HRD+K N LL+ +K DFG + + VG+ Y++APEV+
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASKSSPANSF---VGTPYWMAPEVI 189
Query: 270 ----RRSYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFDAILKGGVDFESEPWLLIS 324
Y ++DVWS G+ L PP F ++ +S W +
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---T 246
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAV--LSRMK-------- 374
DS + V L + P++R SAE+L H ++R D+P + + R K
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRR-----DRPARVLIDLIQRTKDAVRELDN 301
Query: 375 -QFRAMNKL 382
Q+R M K+
Sbjct: 302 LQYRKMKKI 310
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 9e-22
Identities = 66/261 (25%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSY-ACKSILKRKLVNKQDR-------EDIKREIQI 147
Y + + LG G FG Y + + G + A K I +D+ DI E+ I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRA 203
++ NIV + + + +++VM+L G L + + + +TE+ +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 204 IVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY 262
+V + + H ++HRDL P N +L D + TDFGL+ +VG+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDD---KVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 263 YVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321
Y PE+++ YG++ DVW+ G ILY + + PPF++ + I++ +E P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPLPEG 236
Query: 322 LISDSAKDLVRKMLIQDPKKR 342
+ S+ D++ L D + R
Sbjct: 237 MYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 81/271 (29%), Positives = 124/271 (45%), Gaps = 25/271 (9%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
+ Y L + +G G +G Y TG A K I KL D I++EI +++
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECK 64
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212
NIV + G+Y R+ + + ME C GG L D G +E A +CR + + + H
Sbjct: 65 -HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR-DIVGSAYYVAPEVL-- 269
G MHRD+K N LL+ D G +K DFG++ I R +G+ Y++APEV
Sbjct: 124 SKGKMHRDIKGANILLT--DNGD-VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 270 --RRSYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFDAILKGGVDF------ESEPW 320
Y + D+W+ G+ L PP F + +F L +F + W
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQPPKLKDKTKW 237
Query: 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
S + + V+ L ++PKKR T+ +L H
Sbjct: 238 ---SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 93/320 (29%), Positives = 138/320 (43%), Gaps = 79/320 (24%)
Query: 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHL 151
I + Y + ++LG+G +GI + + T A K I N D + REI +Q L
Sbjct: 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD-AFRNATDAQRTFREIMFLQEL 63
Query: 152 SGQQNIVEFRGAY--EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRA-IVNVV 208
NIV+ E+ + ++LV E Y E A+ RA I+ V
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFE----------------YMETDLHAVIRANILEDV 107
Query: 209 HHCHFM-------------GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR 255
H + M V+HRDLKP N LL++ +K DFGL+ + E +
Sbjct: 108 HKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENP 164
Query: 256 ------DIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAET-----EK 302
D V + +Y APE+L Y K +D+WS G IL +L G P F + EK
Sbjct: 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK 224
Query: 303 GIFDAILKGGV----DFES----EPWLLI------------------SDSAKDLVRKMLI 336
I + I G D ES ++ SD A DL++K+L+
Sbjct: 225 -IIEVI---GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLV 280
Query: 337 QDPKKRITSAEVLEHPWMRE 356
+P KR+T+ E LEHP++ +
Sbjct: 281 FNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-21
Identities = 78/269 (28%), Positives = 130/269 (48%), Gaps = 18/269 (6%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR-EDIKREIQIMQ 149
D + +T + +G+G FG Y +N T A K I L +D EDI++EI ++
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKII---DLEEAEDEIEDIQQEITVLS 57
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
I + G+Y + ++ME GG D ++ G E A + R I+ +
Sbjct: 58 QCDSPY-ITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLD 115
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEV 268
+ H +HRD+K N LLS + +K DFG++ + + ++ R+ VG+ +++APEV
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 269 LRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL--LISD 325
+++S Y + D+WS G+ L G PP + I K S P L S
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-----NSPPTLEGQYSK 227
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
K+ V L +DP+ R T+ E+L+H ++
Sbjct: 228 PFKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 77/290 (26%), Positives = 130/290 (44%), Gaps = 42/290 (14%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKR---KLVNKQDREDIKREIQIMQHLSG 153
LG +G G +G+ C TG A K L+ K+V K REI++++ L
Sbjct: 5 NLGL-VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKI----AMREIRMLKQLR- 58
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
+N+V + ++ ++LV E L D E I+ + CH
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIVGSAYYVAPEVL--R 270
++HRD+KPEN L+S ++K DFG + + G+VY D V + +Y APE+L
Sbjct: 119 HNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 271 RSYGKEIDVWSAGVILYILLSGVPPFWAETE------------------KGIFD-----A 307
YG+ +D+W+ G ++ +L+G P F +++ + IF A
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235
Query: 308 ILKGGVDFESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
++ E EP + +S DL ++ L DP R +S+++L H +
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 82/276 (29%), Positives = 134/276 (48%), Gaps = 36/276 (13%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
+G+G +G Y T G+ A K + V+ E+I+ E I+Q L N+V+F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYNILQSLPNHPNVVKFY 85
Query: 162 GA-YEDRQSVH----LVMELCSGG---ELFDKIIAQGHYTEKAAAA--LCRAIVNVVHHC 211
G Y+ + V LV+ELC+GG EL ++ G ++A + L A++ + H
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG-LQHL 144
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI-VGSAYYVAPEVLR 270
H ++HRD+K N LL+ + G +K DFG+S + ++ R+ VG+ +++APEV+
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 271 ------RSYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFDAILKGGVDFESEPWLLI 323
SY DVWS G+ L G PP F K +F + P LL
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK------IPRNPPPTLLH 255
Query: 324 SD----SAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
+ S + + LI+D + R + +LEHP+++
Sbjct: 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 70/247 (28%), Positives = 122/247 (49%), Gaps = 16/247 (6%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ-QNIV 158
K +GRG FG + T YA K + K +++ + + + E ++ ++G Q I
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL--VNGDCQWIT 64
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVM 217
A++D ++LVM+ GG+L + + E A +V +H H + +
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV 124
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLSV-FIDEGKVYRDI-VGSAYYVAPEVLRR---- 271
HRD+KP+N LL D ++ DFG + +G V + VG+ Y++PE+L+
Sbjct: 125 HRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 272 --SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL-ISDSAK 328
YG E D WS GV +Y +L G PF+AE+ + I+ F+ + +S+ AK
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAK 241
Query: 329 DLVRKML 335
DL+++++
Sbjct: 242 DLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 30/274 (10%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDI---KREIQIMQHLSGQQNIV 158
+GRG + L T YA K ++K++LVN D EDI + E + + S +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMK-VVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMH 218
++ + V+E +GG+L + Q E+ A I +++ H G+++
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKE 276
RDLK +N LL D +K TD+G+ + G G+ Y+APE+LR YG
Sbjct: 120 RDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 277 IDVWSAGVILYILLSGVPPF---------WAETEKGIFDAILKGGVDFESEPWLLISDSA 327
+D W+ GV+++ +++G PF TE +F IL+ + +S A
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKA 232
Query: 328 KDLVRKMLIQDPKKRITS------AEVLEHPWMR 355
+++ L +DPK+R+ A++ HP+ R
Sbjct: 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 20/269 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV---NKQDREDIKREIQIMQHLS 152
Y L + LG+G FG YL + K +LK V N + +E Q++ L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLK-VLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAA-----LCRAIVNV 207
IV+F ++ +R + ++ E C G +L K+ H + + + ++ V
Sbjct: 61 -HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIVGSAYYVAP 266
H+ H ++HRDLK +N L N +LK DFG+S + + G+ YY++P
Sbjct: 120 -HYMHQRRILHRDLKAKNIFLKNN----LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 267 EVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325
E L+ + Y + D+WS G ILY + F + + I++G E + S
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETY---SR 231
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
+++ ML +DP R ++AE+L +P++
Sbjct: 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-21
Identities = 88/318 (27%), Positives = 146/318 (45%), Gaps = 49/318 (15%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + K++G G+FG +L T + K+I R L ++++ + E+ +M+ L +
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HK 72
Query: 156 NIVEFRGAYEDR--QSVHLVMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVH 209
NIV + + ++ Q ++++ME C G+L I G E A + R +++ +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 210 HCHFMG-------VMHRDLKPENFLLS--------------NKDGGAMLKATDFGLSVFI 248
+CH + V+HRDLKP+N LS N +G + K DFGLS I
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 249 DEGKVYRDIVGSAYYVAPEVL---RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF 305
+ VG+ YY +PE+L +SY + D+W+ G I+Y L SG PF
Sbjct: 193 GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252
Query: 306 DAILKGGVDFESEPWLLISDSAKD---LVRKMLIQDPKKRITSAEVLEH--------PWM 354
+ LK G P L I +K+ L++ +L K+R ++ + L + P
Sbjct: 253 ISELKRG------PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPPVG 306
Query: 355 REGGEASDKPIGSAVLSR 372
GG A AV++R
Sbjct: 307 AAGGGAGVAAAPGAVVAR 324
|
Length = 1021 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 84/294 (28%), Positives = 144/294 (48%), Gaps = 34/294 (11%)
Query: 82 ETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDI 141
+T++ D + + + +G+G +G + G+ A K IL ++ D E+I
Sbjct: 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDP--IHDID-EEI 61
Query: 142 KREIQIMQHLSGQQNIVEFRGAYEDRQSVH-----LVMELCSGGELFDKI---IAQGHYT 193
+ E I++ LS N+V+F G Y + + LV+ELC+GG + D + + +G
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 194 EKAAAA--LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251
E+ A L A++ + H H +HRD+K N LL+ + G +K DFG+S +
Sbjct: 122 EEPIIAYILHEALMGL-QHLHVNKTIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTST 177
Query: 252 KVYRDI-VGSAYYVAPEV------LRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGI 304
++ R+ VG+ +++APEV L +Y DVWS G+ L G PP +
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHP 234
Query: 305 FDAILKGGVDFESEPWL----LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
A+ K + P L L S+ D +RK L +D +KR T +++L+H ++
Sbjct: 235 MRALFK--IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 85/320 (26%), Positives = 142/320 (44%), Gaps = 50/320 (15%)
Query: 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
L K + ++ Y +G G +G + TG A K L R + + RE
Sbjct: 6 LNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKK-LSRPFQSAIHAKRTYRE 64
Query: 145 IQIMQHLSGQQNIVEFRGAY------EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAA 198
+++++H+ +N++ + ED Q V+LV L G +L + I+ ++
Sbjct: 65 LRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHIQ 121
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258
L I+ + + H G++HRDLKP N + N+D LK DFGL+ D+ V
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSN-IAVNED--CELKILDFGLARHTDDEMT--GYV 176
Query: 259 GSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAILKGG 312
+ +Y APE++ Y + +D+WS G I+ LL+G F K I + +
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 313 VDFESEPWLLISDSAK--------------------------DLVRKMLIQDPKKRITSA 346
+ + + S+SA+ DL+ KML+ DP KRIT+A
Sbjct: 237 EELLQK---ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293
Query: 347 EVLEHPWMREGGEASDKPIG 366
E L HP++ E + D+P+
Sbjct: 294 EALAHPYLAEYHDPEDEPVA 313
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 8e-21
Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 43/292 (14%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIMQHL 151
YT +++G G +G+ Y TG A K I +L + + E + REI +++ L
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI---RLES--EEEGVPSTAIREISLLKEL 56
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELCSGG--ELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
NIV + ++L+ E S + D + + + + I+ +
Sbjct: 57 Q-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEV 268
CH V+HRDLKP+N L+ NK ++K DFGL+ F +VY V + +Y APEV
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 269 LRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAI------LKGGV--- 313
L S Y +D+WS G I + + P F ++E IF + + GV
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 314 -DFES------EPWLL-----ISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
D+++ + L + + DL+ KMLI DP KRI++ + L HP+
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 46/292 (15%)
Query: 98 LGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIMQHLSG 153
L K +G G +G+ + C TG A K K V +D IK REI++++ L
Sbjct: 6 LSK-IGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK- 58
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCH 212
N+V + ++ +HLV E C + +++ E + + V+ CH
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVAPEVL-- 269
+HRD+KPEN L+ K G +K DFG + + G Y D V + +Y APE+L
Sbjct: 118 KHNCIHRDVKPENILI-TKQG--QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 270 RRSYGKEIDVWSAGVILYILLSGVPPFWAETE------------------KGIF--DAIL 309
YG +DVW+ G + LL+G P + +++ + IF +
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234
Query: 310 KG---GVDFESEPWLL----ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
KG EP IS A ++ L DP +R++ E+LEHP+
Sbjct: 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 71/267 (26%), Positives = 118/267 (44%), Gaps = 15/267 (5%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
ED + +T +E+G G FG Y + T A K + + + +DI +E++ +Q
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
+ N +E++G Y + LVME C G + + E AA+ + +
Sbjct: 81 RIK-HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 139
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL 269
+ H ++HRD+K N LL+ +K DFG + + VG+ Y++APEV+
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASIASPANSF---VGTPYWMAPEVI 193
Query: 270 ----RRSYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFDAILKGGVDFESEPWLLIS 324
Y ++DVWS G+ L PP F ++ +S W S
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---S 250
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEH 351
D ++ V L + P+ R TS E+L+H
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 78/268 (29%), Positives = 124/268 (46%), Gaps = 22/268 (8%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN---IV 158
+GRG FG Y C + TG YA K + K+++ KQ E + +IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMH 218
A+ + +++L +GG+L + G ++E I+ + H H V++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKE 276
RDLKP N LL D ++ +D GL+ + K + VG+ Y+APEVL++ +Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSS 176
Query: 277 IDVWSAGVILYILLSGVPPFWAETEKG---IFDAILKGGVDFESEPWLLISDSAKDLVRK 333
D +S G +L+ LL G PF K I L V+ S + L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS----FSPELRSLLEG 232
Query: 334 MLIQDPKKRI-----TSAEVLEHPWMRE 356
+L +D +R+ + EV EHP+ R
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 73/269 (27%), Positives = 131/269 (48%), Gaps = 18/269 (6%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR-EDIKREIQIMQ 149
D + +T + +G+G FG + +N T A K I L +D EDI++EI ++
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII---DLEEAEDEIEDIQQEITVLS 57
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
+ ++ G+Y + ++ME GG D ++ G + E A + + I+ +
Sbjct: 58 QCDSPY-VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLD 115
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEV 268
+ H +HRD+K N LLS + +K DFG++ + + ++ R+ VG+ +++APEV
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 269 LRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL--ISD 325
+++S Y + D+WS G+ L G PP + I K + P L S
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-----NNPPTLTGEFSK 227
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
K+ + L +DP R T+ E+L+H ++
Sbjct: 228 PFKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 84/333 (25%), Positives = 122/333 (36%), Gaps = 92/333 (27%)
Query: 95 FYTLGKELGRGQFGITYLC--TENSTGNSYACKSILKRKLVNKQDREDIK-------REI 145
Y + +GRG +G Y G YA K K D+E REI
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-------KGDKEQYTGISQSACREI 53
Query: 146 QIMQHLSGQQNIVEFRGAYEDR--QSVHLVMELCSGGELFD--KIIAQGHYTEKAAAALC 201
+++ L +N+V + + +SV+L+ + D +II + + ++
Sbjct: 54 ALLRELK-HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIK--FHRQAKRVSIP 106
Query: 202 RAIV--------NVVHHCHFMGVMHRDLKPENFLL-SNKDGGAMLKATDFGLS------- 245
++V N VH+ H V+HRDLKP N L+ ++K D GL+
Sbjct: 107 PSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 246 -VFIDEGKVYRDIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEK 302
D V V + +Y APE+L R Y K ID+W+ G I LL+ P F K
Sbjct: 167 KPLADLDPV----VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222
Query: 303 -------------GIF------------------------DAILKGGVDFES-----EPW 320
IF S E
Sbjct: 223 IKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKH 282
Query: 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
DL+RK+L DP KRIT+ E LEHP+
Sbjct: 283 KKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 66/247 (26%), Positives = 123/247 (49%), Gaps = 16/247 (6%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN-IV 158
K +GRG FG + + +A K + K +++ + + + E ++ ++G I
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDNQWIT 64
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVM 217
A++D +++LVM+ GG+L + + E A +V + H + +
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLSV-FIDEGKVYRDI-VGSAYYVAPEVL------ 269
HRD+KP+N L+ D ++ DFG + +++G V + VG+ Y++PE+L
Sbjct: 125 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 270 RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL-ISDSAK 328
+ YG E D WS GV +Y +L G PF+AE+ + I+ F+ + +S+ AK
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK 241
Query: 329 DLVRKML 335
DL+R+++
Sbjct: 242 DLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 81/283 (28%), Positives = 135/283 (47%), Gaps = 25/283 (8%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
+F+ + ELG G FG Y TG A K I + ++++ ED EI I+
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD- 60
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHC 211
NIV+ A+ ++ +++E C+GG + D ++ + TE +C+ + +++
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVLR 270
H ++HRDLK N L + DG +K DFG+S RD +G+ Y++APEV+
Sbjct: 120 HENKIIHRDLKAGNILFT-LDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 271 ------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP--WLL 322
R Y + DVWS G+ L + PP + I K ++P W
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW-- 234
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
S KD ++K L ++ R T+ ++L+HP++ S+KPI
Sbjct: 235 -SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT---VNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 9e-20
Identities = 74/269 (27%), Positives = 130/269 (48%), Gaps = 18/269 (6%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR-EDIKREIQIMQ 149
D + +T +++G+G FG + +N T A K I L +D EDI++EI ++
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII---DLEEAEDEIEDIQQEITVLS 57
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
+ ++ G+Y + ++ME GG D ++ G E A + R I+ +
Sbjct: 58 QCDSPY-VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 115
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEV 268
+ H +HRD+K N LLS +K DFG++ + + ++ R+ VG+ +++APEV
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 269 LRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL--ISD 325
+++S Y + D+WS G+ L G PP + I K + P L S
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-----NNPPTLEGNYSK 227
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
K+ V L ++P R T+ E+L+H ++
Sbjct: 228 PLKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 30/274 (10%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDI---KREIQIMQHLSGQQNIV 158
+GRG + L T YA K ++K++LVN D EDI + E + + S +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMK-VIKKELVN--DDEDIDWVQTEKHVFETASNHPFLV 59
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMH 218
++ + V+E SGG+L + Q E+ A I ++ H G+++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKE 276
RDLK +N LL D +K TD+G+ I G G+ Y+APE+LR YG
Sbjct: 120 RDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 277 IDVWSAGVILYILLSGVPPF---------WAETEKGIFDAILKGGVDFESEPWLLISDSA 327
+D W+ GV+++ +++G PF TE +F IL+ + +S A
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKA 232
Query: 328 KDLVRKMLIQDPKKRITS------AEVLEHPWMR 355
+++ L +DPK+R+ ++ HP+ R
Sbjct: 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 79/311 (25%), Positives = 134/311 (43%), Gaps = 52/311 (16%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
+ LG G G+ + ++ A K I+ L + Q + REI+I++ L NIV+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIV---LTDPQSVKHALREIKIIRRLD-HDNIVK 66
Query: 160 -----FRGAYEDRQSVHLVMEL---CSGGELFD----KIIAQGHYTEKAAAALCRAIVNV 207
+ + V + EL E + ++ QG +E+ A ++
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRG 126
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-----EGKVYRDIVGSAY 262
+ + H V+HRDLKP N ++ +D +LK DFGL+ +D +G + +V + +
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTED--LVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKW 183
Query: 263 YVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG--GVDFESE 318
Y +P +L +Y K ID+W+AG I +L+G P F E IL+ V E
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243
Query: 319 PWLL------------------------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
LL ++ A D + ++L +P R+T+ E L HP+M
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303
Query: 355 REGGEASDKPI 365
D+P+
Sbjct: 304 SCYSCPFDEPV 314
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 69/261 (26%), Positives = 124/261 (47%), Gaps = 26/261 (9%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + K++GRGQF Y T G A K + L++ + R D +EI +++ L+
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 62
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTE-----------KAAAALCRAI 204
N++++ ++ + +++V+EL G+L I H+ + K LC A+
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIVGSAYY 263
H H VMHRD+KP N ++ ++K D GL F + +VG+ YY
Sbjct: 120 ----EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172
Query: 264 VAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-GGVDFESEPWL 321
++PE + + Y + D+WS G +LY + + PF+ + + ++ K D+ P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIEQCDYPPLPSD 231
Query: 322 LISDSAKDLVRKMLIQDPKKR 342
S+ + LV + DP+KR
Sbjct: 232 HYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 65/251 (25%), Positives = 116/251 (46%), Gaps = 16/251 (6%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
+GRG + L YA K + K + + +D + ++ E + + S +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
++ + LV+E +GG+L + Q E+ A I ++ H G+++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 222 KPENFLLSNKDGGAMLKATDFGL-SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDV 279
K +N LL D +K TD+G+ + G G+ Y+APE+LR YG +D
Sbjct: 123 KLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 280 WSAGVILYILLSGVPPF-------WAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332
W+ GV+++ +++G PF TE +F IL+ + +S A +++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHVLK 235
Query: 333 KMLIQDPKKRI 343
L +DPK+R+
Sbjct: 236 GFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 64/257 (24%), Positives = 125/257 (48%), Gaps = 18/257 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + K++GRGQF Y T A K + ++++ + R+D +EI +++ L+
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HP 62
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAI-------VNVV 208
N++++ ++ + +++V+EL G+L I ++ ++ R + + V
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIK---YFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIVGSAYYVAPE 267
H H VMHRD+KP N ++ ++K D GL F + +VG+ YY++PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 268 VLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-GGVDFESEPWLLISD 325
+ + Y + D+WS G +LY + + PF+ + + +F K D+ P S+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIEQCDYPPLPTEHYSE 235
Query: 326 SAKDLVRKMLIQDPKKR 342
++LV + DP +R
Sbjct: 236 KLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 71/262 (27%), Positives = 127/262 (48%), Gaps = 18/262 (6%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G +GI Y + ST A K I +R + + + + EI + +L +NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYL 71
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQG---HYTEKAAAALCRAIVNVVHHCHFMGVMH 218
G+ + + ME GG L + ++ E+ + I+ + + H ++H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIVGSAYYVAPEVL---RRSYG 274
RD+K +N L++ G ++K +DFG S + G+ Y+APEV+ R YG
Sbjct: 132 RDIKGDNVLVNTYSG--VVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL--LISDSAKDLVR 332
D+WS G + + +G PPF E A+ K G+ F+ P + +S AK+ +
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGM-FKIHPEIPESLSAEAKNFIL 246
Query: 333 KMLIQDPKKRITSAEVLEHPWM 354
+ DP KR ++ ++L+ P++
Sbjct: 247 RCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 78/264 (29%), Positives = 125/264 (47%), Gaps = 16/264 (6%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN---IV 158
+GRG FG Y C + TG YA K + K+++ KQ E + +IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMH 218
A+ + +++L +GG+L + G ++EK I+ + H H V++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKE 276
RDLKP N LL D ++ +D GL+ + K + VG+ Y+APEVL++ +Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 277 IDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336
D +S G +L+ LL G PF K + I + + E S K L+ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 337 QDPKKRI-----TSAEVLEHPWMR 355
+D KR+ + EV EH + +
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 19/272 (6%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+D + ++ +E+G G FG Y + A K + + + +DI +E++ +Q
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELC--SGGELFDKIIAQGHYTEKAAAALCRAIVNV 207
L N +++RG Y + LVME C S +L + + + E AA+ +
Sbjct: 71 KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQG 127
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPE 267
+ + H ++HRD+K N LLS ++K DFG + + + VG+ Y++APE
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAPANXF---VGTPYWMAPE 181
Query: 268 VL----RRSYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFDAILKGGVDFESEPWLL 322
V+ Y ++DVWS G+ L PP F ++ +S W
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-- 239
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
S+ ++ V L + P+ R TS +L+H ++
Sbjct: 240 -SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 78/319 (24%), Positives = 127/319 (39%), Gaps = 62/319 (19%)
Query: 90 EDIRQFYT-LGKELGRGQFGITYLCTENSTGNSYACKS--ILKRKLVNKQDREDIK---- 142
I + Y G LG G +G + TG A K I++ +DR+ +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 143 -----REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG--GELFDKIIAQGHYTEK 195
RE++IM + +NI+ Y + ++LVM++ + ++ D+ I TE
Sbjct: 64 HFTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTES 119
Query: 196 AAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-------VFI 248
+ I+N ++ H MHRDL P N +++K + K DFGL+
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK---GICKIADFGLARRYGYPPYSD 176
Query: 249 DEGKV--------YRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWA 298
K V + +Y APE+L + Y +D+WS G I LL+G P F
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236
Query: 299 ETEKGIFDAILKGGVDFESEPWLLI------------------------SDSAKDLVRKM 334
E E I + + W SD A DL++ +
Sbjct: 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296
Query: 335 LIQDPKKRITSAEVLEHPW 353
L +P +RI++ E L+H +
Sbjct: 297 LKLNPLERISAKEALKHEY 315
|
Length = 335 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 83/300 (27%), Positives = 122/300 (40%), Gaps = 57/300 (19%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED-----IKREIQIM 148
F L K LG G + Y +TG A K I D E+ REI +M
Sbjct: 1 NFKQLEK-LGEGTYATVYKGRNRTTGEIVALKEI-------HLDAEEGTPSTAIREISLM 52
Query: 149 QHLSGQQNIVEFRGAYEDRQSVHLVMELCSGG--ELFDKIIAQGHYTEKAAAALCRAIVN 206
+ L +NIV + LV E + D +G + ++
Sbjct: 53 KELK-HENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL--SVFIDEGKVYRDIVGSAYYV 264
+ CH V+HRDLKP+N L+ NK G LK DFGL + I ++V + +Y
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLI-NKRG--ELKLADFGLARAFGIPVNTFSNEVV-TLWYR 167
Query: 265 APEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAILKGGVDFESE 318
AP+VL R+Y ID+WS G I+ +++G P F IF + G ES
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM---GTPTEST 224
Query: 319 PWLLISDSAK-------------------------DLVRKMLIQDPKKRITSAEVLEHPW 353
W IS + DL+ ++L +P+ RI++ + L+HPW
Sbjct: 225 -WPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 66/199 (33%), Positives = 96/199 (48%), Gaps = 28/199 (14%)
Query: 172 LVMELCSGGELFDKIIAQG-----HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENF 226
L+ME SGG+L +K I Q + E L IV + H +MHRDLK N
Sbjct: 142 LIMEYGSGGDL-NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANI 200
Query: 227 LLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV---------GSAYYVAPEVL-RRSYGKE 276
L ++K DFG S K Y D V G+ YY+APE+ R+ Y K+
Sbjct: 201 FLMPT---GIIKLGDFGFS------KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251
Query: 277 IDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336
D+WS GVILY LL+ PF +++ I +L G D P +S K L+ +L
Sbjct: 252 ADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP---VSSGMKALLDPLLS 308
Query: 337 QDPKKRITSAEVLEHPWMR 355
++P R T+ ++L +++
Sbjct: 309 KNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 56/303 (18%)
Query: 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN---KQD-REDIKREIQIMQH 150
F LG ELG G G+ +G I+ RKL++ K R I RE++++ H
Sbjct: 3 FEKLG-ELGAGNGGVVTKVLHRPSG------LIMARKLIHLEIKPAIRNQIIRELKVL-H 54
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVN-VV 208
IV F GA+ + + ME GG L D+++ + G E + A++ +
Sbjct: 55 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLT 113
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPE 267
+ +MHRD+KP N L+ N G +K DFG+S ID + VG+ Y++PE
Sbjct: 114 YLREKHKIMHRDVKPSNILV-NSRGE--IKLCDFGVSGQLIDS--MANSFVGTRSYMSPE 168
Query: 268 VLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKG---IFDAILKGGVD--------- 314
L+ + Y + D+WS G+ L + G P K +F + G
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228
Query: 315 -----------FE-------SEPWLL----ISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
FE P L SD +D V K L ++PK+R E+ +HP
Sbjct: 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288
Query: 353 WMR 355
+++
Sbjct: 289 FIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 87/331 (26%), Positives = 137/331 (41%), Gaps = 84/331 (25%)
Query: 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSI---------LKRKLVNKQD 137
KP+E+I G G +G+ + +G A K I KR L
Sbjct: 8 KPIENI----------GSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----- 52
Query: 138 REDIKREIQIMQHLSGQQNIVE----FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYT 193
RE++I++H NI+ R D + V++VM+L +L I + T
Sbjct: 53 -----RELKILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLT 105
Query: 194 EKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL-----SVFI 248
E+ ++ + + H V+HRDLKP N LL N+D L+ DFG+ S
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSANVIHRDLKPSN-LLVNEDC--ELRIGDFGMARGLSSSPT 162
Query: 249 DEGKVYRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVI-------------------LY 287
+ + V + +Y APE+L Y ID+WS G I L
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222
Query: 288 ILLS--GVPPFWAETEKGIFDAILKGGV-----DFESE---PWLLI----SDSAKDLVRK 333
++LS G P + + + I V + + PW I S A DL+ +
Sbjct: 223 LILSVLGSPS------EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ 276
Query: 334 MLIQDPKKRITSAEVLEHPWMREGGEASDKP 364
ML DP++RIT + L+HP++ + + D+P
Sbjct: 277 MLQFDPEERITVEQALQHPFLAQYHDPDDEP 307
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-18
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 18/198 (9%)
Query: 165 EDRQSVHLVMELCSGGELFDKIIAQGH----YTEKAAAALCRAIVNVVHHCHFMGVMHRD 220
E+ + LV++ + G+L +I ++ + E A L ++ VHH H ++HRD
Sbjct: 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168
Query: 221 LKPENFLL-SNKDGGAMLKATDFGLSVFID---EGKVYRDIVGSAYYVAPEVLRRS-YGK 275
+K N LL SN ++K DFG S V R G+ YYVAPE+ RR Y K
Sbjct: 169 IKSANILLCSN----GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK 224
Query: 276 EIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD-FESEPWLLISDSAKDLVRKM 334
+ D++S GV+LY LL+ PF E + + L G D IS +++V +
Sbjct: 225 KADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS----ISPEMQEIVTAL 280
Query: 335 LIQDPKKRITSAEVLEHP 352
L DPK+R +S+++L P
Sbjct: 281 LSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 82/289 (28%), Positives = 124/289 (42%), Gaps = 48/289 (16%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSIL---KRKLVNKQDREDIKREIQIMQHLSGQQN 156
+LG G G TG A K + K + R+ I RE+QIM
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV-----RKQILRELQIMHECRSPY- 64
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVN------VVH 209
IV F GA+ + ++ + ME G L D+I + G + + A+V VH
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI----VGSAYYVA 265
+MHRD+KP N L+ + +K DFG+S G++ I VG++ Y++
Sbjct: 124 R-----IMHRDIKPSNILV---NSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMS 170
Query: 266 PEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK--------GIFDAILKGGVDFE 316
PE ++ Y + DVWS G+ + L G PF GI D +L+ V E
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQ-E 228
Query: 317 SEPWLLISD---SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASD 362
P L SD +D V L++DP +R T ++ P + AS+
Sbjct: 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 79/291 (27%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEF 160
E+GRG FG +G A K I R V++++++ + ++ ++ S IV+F
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 161 RGAYEDRQSVHLVMELCSGG-ELFDKII---AQGHYTEKAAAALCRAIVNVVHHC-HFMG 215
GA + MEL + F K + + E+ + A V +++ +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL----R 270
++HRD+KP N LL D +K DFG+S +D RD G Y+APE + R
Sbjct: 129 IIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSAR 184
Query: 271 RSYGKEIDVWSAGVILYILLSGVPPF--WAETEKGIFDA----------ILKGGVDFESE 318
Y DVWS G+ LY + +G P+ W +FD IL + E
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKW----NSVFDQLTQVVKGDPPILSNSEERE-- 238
Query: 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAV 369
S S + + LI+D KR E+LEHP++++ E + + + V
Sbjct: 239 ----FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD-YEERNVDVAAYV 284
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 68/298 (22%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIMQHLSGQQNI 157
+G G +G+ Y + TG A K I +L + + E + REI +++ L+ NI
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---RL--ETEDEGVPSTAIREISLLKELN-HPNI 60
Query: 158 VEFRGAYEDRQSVHLV-----------MELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
V ++LV M+ L +I Y L + I
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ------LLQGIA- 113
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVA 265
+CH V+HRDLKP+N LL +++G LK DFGL+ F + Y V + +Y A
Sbjct: 114 ---YCHSHRVLHRDLKPQN-LLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRA 167
Query: 266 PEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK------------- 310
PE+L R Y +D+WS G I +++ P F ++E D + +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIFRTLGTPDEDVW 224
Query: 311 GGV----DFES-------EPWLLI----SDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
GV D++ + + + DL+ KML+ DP KRI++ L+HP+
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 64/264 (24%), Positives = 129/264 (48%), Gaps = 13/264 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + +G+G +G L + G Y K L + ++++R+ ++E Q++ L
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKK-LNLRNASRRERKAAEQEAQLLSQLK-HP 59
Query: 156 NIVEFRGAYEDRQS-VHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCH 212
NIV +R ++E +++VM C GG+L+ K+ Q E I + + H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL-R 270
++HRDLK +N L+ + ++K D G++ V ++ + ++G+ YY++PE+
Sbjct: 120 EKHILHRDLKTQNVFLTRTN---IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 271 RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330
+ Y + DVW+ G +Y + + F A+ + I++G + + + S +L
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDY---SPELGEL 233
Query: 331 VRKMLIQDPKKRITSAEVLEHPWM 354
+ ML + P+KR + +L P++
Sbjct: 234 IATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 78/268 (29%), Positives = 126/268 (47%), Gaps = 21/268 (7%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEF 160
ELGRG +G+ TG A K I R VN Q+++ + ++ I V F
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 161 RGAYEDRQSVHLVMEL--CSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHF-MGV 216
GA V + ME+ S + + K+ +G E + +IV + + H + V
Sbjct: 66 YGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV 125
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL-----RR 271
+HRD+KP N L+ N++G +K DFG+S ++ + G Y+APE + ++
Sbjct: 126 IHRDVKPSNVLI-NRNG--QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL---LISDSAK 328
Y + DVWS G+ + L +G P+ ++ K F LK V+ E P L S +
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPY--DSWKTPFQQ-LKQVVE-EPSPQLPAEKFSPEFQ 238
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPWMRE 356
D V K L ++ K+R E+L+HP+
Sbjct: 239 DFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 84/301 (27%), Positives = 129/301 (42%), Gaps = 55/301 (18%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-QDREDIKREIQIMQHLS--GQQN 156
+ +G G FG+ + T+ G A K K+ N Q+ KR + ++ L N
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALK-----KMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 157 IVEFRGAYEDRQSVHL--------VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVV 208
++ A + Q H+ V EL +L I++ + I+ +
Sbjct: 61 VL---SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF--IDEGKVYRDIVGSAYYVAP 266
+ H G++HRD+KP N L+++ +LK DFGL+ DE K V + YY AP
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSN---CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 267 EVL--RRSYGKEIDVWSAGVILYILLS---------------------GVPPFWAETE-- 301
E+L R Y +D+WS G I LL G P A
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233
Query: 302 KGIFDAILKGGVDFESEP--WLLISDS---AKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
+G IL+G S P + L S + A L+ +ML+ DP KRI++A+ L HP++ E
Sbjct: 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293
Query: 357 G 357
G
Sbjct: 294 G 294
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 86/307 (28%), Positives = 133/307 (43%), Gaps = 59/307 (19%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y K +G G GI + G + A K L R N+ + RE+ +++ ++ +
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKK-LSRPFQNQTHAKRAYRELVLLKCVN-HK 80
Query: 156 NIVEFRGAY------EDRQSVHLVMELCSGGELFDKIIAQGHYTE---KAAAALCRAIVN 206
NI+ + E+ Q V+LVMEL D + Q + E + + L ++
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMEL------MDANLCQVIHMELDHERMSYLLYQMLC 134
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAP 266
+ H H G++HRDLKP N ++ + LK DFGL+ + V + YY AP
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
Query: 267 EV-LRRSYGKEIDVWSAGVILYILLSGVPPF--------WAE------TEKGIFDAILK- 310
EV L Y + +D+WS G I+ L+ G F W + T F L+
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 311 ------------GGVDFES--EPWLLISDS---------AKDLVRKMLIQDPKKRITSAE 347
G+ FE W+ S+S A+DL+ KML+ DP KRI+ E
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311
Query: 348 VLEHPWM 354
L HP++
Sbjct: 312 ALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 78/312 (25%), Positives = 131/312 (41%), Gaps = 42/312 (13%)
Query: 59 PQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENST 118
P P P SS++S LE + + +G G G Y T
Sbjct: 46 PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPT 98
Query: 119 GNSYACKSILKRKLVNKQD--REDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176
G YA K I N +D R I REI+I++ ++ N+V+ ++ + +++E
Sbjct: 99 GRLYALKVIYG----NHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEF 153
Query: 177 CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAM 236
GG L IA E+ A + R I++ + + H ++HRD+KP N L+ +
Sbjct: 154 MDGGSLEGTHIAD----EQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKN 206
Query: 237 LKATDFGLSVFIDEG-KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYIL 289
+K DFG+S + + VG+ Y++PE + G D+WS GV +
Sbjct: 207 VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266
Query: 290 LSGVPPF-------WAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKR 342
G PF WA + AI + E S + + L ++P KR
Sbjct: 267 YLGRFPFGVGRQGDWA----SLMCAIC---MSQPPEAPATASREFRHFISCCLQREPAKR 319
Query: 343 ITSAEVLEHPWM 354
++ ++L+HP++
Sbjct: 320 WSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 50/293 (17%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK--REIQIMQHLSG--QQN 156
E+G G +G Y + +G+ A KS+ ++ +D + RE+ +++ L N
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSV---RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 157 IVEFR----GAYEDRQS-VHLVMELCSGG--ELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
IV + DR++ V LV E DK+ G E L R + +
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD-LMRQFLRGLD 122
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL 269
H ++HRDLKPEN L+++ G +K DFGL+ +V + +Y APEVL
Sbjct: 123 FLHANCIVHRDLKPENILVTS---GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 270 RRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKGGVDFESEPWLL-- 322
+S Y +D+WS G I + P F +E IFD I G+ E + W
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI---GLPPEDD-WPRDV 235
Query: 323 ---------------------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
I +S L+ +ML +P KRI++ L+HP+
Sbjct: 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 46/288 (15%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIMQHLSGQQN 156
++G G +G + T A LKR ++ D E + REI +++ L +N
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVA----LKRVRLDDDD-EGVPSSALREICLLKELK-HKN 60
Query: 157 IVEFRGAYEDRQSVHLVMELCSGG--ELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
IV + + LV E C + FD G + + ++ + CH
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL--RR 271
V+HRDLKP+N LL NK+G LK DFGL+ F + Y V + +Y P+VL +
Sbjct: 119 NVLHRDLKPQN-LLINKNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETE-----KGIFDAI-------------LKGGV 313
Y ID+WSAG I L + P + + K IF + L
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 314 DFESEP----WLLI----SDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
+ P + + + + +DL++ +L+ +P +RI++ E L+HP+
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 79/316 (25%), Positives = 133/316 (42%), Gaps = 42/316 (13%)
Query: 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
L K + ++ + Y +G G +G + TG A K L R + + RE
Sbjct: 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQSIIHAKRTYRE 66
Query: 145 IQIMQHLS-----GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAA 199
+++++H+ G ++ + E+ V+LV L G + I+ T+
Sbjct: 67 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQF 124
Query: 200 LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVG 259
L I+ + + H ++HRDLKP N L N+D LK DFGL+ D+ V
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSN-LAVNED--CELKILDFGLARHTDDEMT--GYVA 179
Query: 260 SAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES 317
+ +Y APE++ Y + +D+WS G I+ LL+G F IL+ +
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 318 E--------------------PWLLISD-------SAKDLVRKMLIQDPKKRITSAEVLE 350
E P + ++ A DL+ KML+ D KRIT+A+ L
Sbjct: 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299
Query: 351 HPWMREGGEASDKPIG 366
H + + + D+P+
Sbjct: 300 HAYFAQYHDPDDEPVA 315
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 82/301 (27%), Positives = 135/301 (44%), Gaps = 55/301 (18%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQI---MQHLS 152
+++G G +G+ Y + T + A K I +L +Q+ E + REI + MQH
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI---RL--EQEDEGVPSTAIREISLLKEMQH-- 60
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTE--KAAAALCRAIVNVVHH 210
NIV + + ++LV E +L + + + + + I+ + +
Sbjct: 61 --GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL 269
CH V+HRDLKP+N L+ + LK DFGL+ F + + V + +Y APE+L
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNA--LKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 270 --RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-------------GGV- 313
R Y +D+WS G I +++ P F ++E D + K GV
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE---IDELFKIFRILGTPNEETWPGVT 232
Query: 314 ---DFESE--PWL---------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359
D++S W + + DL+ KML DP KRIT+ LEH + ++ G+
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292
Query: 360 A 360
A
Sbjct: 293 A 293
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 72/302 (23%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK---------REIQIMQH 150
+++G G +G+ Y TG A K I R D + REI +++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKI----------RLDTETEGVPSTAIREISLLKE 55
Query: 151 LSGQQNIVEFRGAYEDRQSVHLV-----------MELCSGGELFDKIIAQGHYTEKAAAA 199
L+ NIV+ ++LV M+ + +I Y +
Sbjct: 56 LN-HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS--YLFQ---- 108
Query: 200 LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIV 258
++ + CH V+HRDLKP+N LL N +G +K DFGL+ F + Y V
Sbjct: 109 ----LLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAFGVPVRTYTHEV 161
Query: 259 GSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETE----------KGIFD 306
+ +Y APE+L + Y +D+WS G I +++ F ++E G D
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 221
Query: 307 AILKGGV----DFESE--PWL---------LISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
++ GV D++ W + + +DL+ +ML DP KRI++ L H
Sbjct: 222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281
Query: 352 PW 353
P+
Sbjct: 282 PF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 53/300 (17%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +G G GI + + A K L R N+ + RE+ +M+ ++ +NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKK-LSRPFQNQTHAKRAYRELVLMKCVN-HKNIIS 80
Query: 160 FRGAY------EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
+ E+ Q V+LVMEL ++I E+ + L + + + H H
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI-KHLHS 137
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV-LRRS 272
G++HRDLKP N ++ + LK DFGL+ + V + YY APEV L
Sbjct: 138 AGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 273 YGKEIDVWSAGVIL------YILLSG-----------------VPPFWAETEKGIFDAIL 309
Y + +D+WS G I+ IL G P F + + + + +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 310 K----GGVDF-----------ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
G+ F +SE L + A+DL+ KML+ DP KRI+ E L+HP++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 80/313 (25%), Positives = 133/313 (42%), Gaps = 44/313 (14%)
Query: 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQ 146
K + ++ Y K++G G +G + TG A K L R ++ + RE++
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKK-LYRPFQSELFAKRAYRELR 66
Query: 147 IMQHLSGQQNIVEFRGAY------EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAAL 200
+++H+ +N++ + + +LVM G K++ +E L
Sbjct: 67 LLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
++ + + H G++HRDLKP N L N+D LK DFGL+ D V +
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGN-LAVNED--CELKILDFGLARQTDSEMT--GYVVT 178
Query: 261 AYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-GGVDFES 317
+Y APEV+ Y + +D+WS G I+ +L+G P F I+K G +
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238
Query: 318 EPWLLISDSAKDLVR--------------------------KMLIQDPKKRITSAEVLEH 351
L S+ AK+ V+ KML+ D + RIT+AE L H
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298
Query: 352 PWMREGGEASDKP 364
P+ E + D+
Sbjct: 299 PYFEEFHDPEDET 311
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 79/313 (25%), Positives = 129/313 (41%), Gaps = 67/313 (21%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK--REIQIMQHLSG 153
Y + +LG G FG Y + TG A K IL + N++D I REI+I++ L
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILKKLK- 65
Query: 154 QQNIVEF--------RGAYEDRQSVHLVM-----ELCSGGELFDKIIAQGHYTEKAAAAL 200
N+V + R SV++V +L G L + + TE
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIKCY 120
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV------- 253
++ +++ H ++HRD+K N L+ N+ +LK DFGL+ D
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQ---GILKIADFGLARPYDGPPPNPKGGGG 177
Query: 254 -----YRDIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE----K 302
Y ++V + +Y PE+L R Y +D+W G + + + P +++
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 303 GIFDAI----------------LKGGVDFESEPWLLISDSAK------DLVRKMLIQDPK 340
IF +G F + P L K DL+ K+L DP
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297
Query: 341 KRITSAEVLEHPW 353
KR+T+++ LEHP+
Sbjct: 298 KRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 80/314 (25%), Positives = 130/314 (41%), Gaps = 47/314 (14%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + + +G+G +G+ + TG A K I + D I REI++++ L
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLR-HP 59
Query: 156 NIVEFRG-----AYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
+IVE + + + + +++V EL +L I A T + ++ + +
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS--VFIDEGKV--YRDIVGSAYYVAP 266
H V HRDLKP+N +L+N D LK DFGL+ F D + D V + +Y AP
Sbjct: 119 IHTANVFHRDLKPKN-ILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 267 EVLRRSYGK---EIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL-------------- 309
E+ + K ID+WS G I +L+G P F + D I
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235
Query: 310 --------------KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
K V F S+ + A L+ ++L DPK R T+ E L P+ +
Sbjct: 236 RNEKARRYLSSMRKKQPVPF-SQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294
Query: 356 EGGEASDKPIGSAV 369
+ +P +
Sbjct: 295 GLAKVEREPSAQPI 308
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 85/316 (26%), Positives = 139/316 (43%), Gaps = 47/316 (14%)
Query: 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
+ K + ++ + YT K++G G +G + TG A K L R ++ + RE
Sbjct: 6 VNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK-LSRPFQSEIFAKRAYRE 64
Query: 145 IQIMQHLSGQQNIVEFRG------AYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAA 198
+ +++H+ +N++ + ++ Q +LVM KI+ +E
Sbjct: 65 LTLLKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQ 120
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDI 257
L ++ + + H G++HRDLKP N L N+D LK DFGL+ D E Y
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGN-LAVNED--CELKILDFGLARHADAEMTGY--- 174
Query: 258 VGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK----G 311
V + +Y APEV+ Y + +D+WS G I+ +L+G F + ILK
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234
Query: 312 GVDF-------------ESEP----------WLLISDSAKDLVRKMLIQDPKKRITSAEV 348
G +F +S P + S A DL+ KML D KR+T+ E
Sbjct: 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA 294
Query: 349 LEHPWMREGGEASDKP 364
LEHP+ +A ++
Sbjct: 295 LEHPYFDSFRDADEET 310
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 87/318 (27%), Positives = 130/318 (40%), Gaps = 86/318 (27%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +G G GI + TG + A K L R N + RE+ +M+ L +NI+
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKK-LSRPFQNVTHAKRAYRELVLMK-LVNHKNIIG 79
Query: 160 FRGAY------EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAI-VNVVH--- 209
+ E+ Q V+LVMEL A LC+ I +++ H
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMD-------------------ANLCQVIQMDLDHERM 120
Query: 210 ------------HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI 257
H H G++HRDLKP N ++ + LK DFGL+ +
Sbjct: 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPY 177
Query: 258 VGSAYYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPF--------WAE------TEK 302
V + YY APEV L Y + +D+WS G I+ ++ G F W + T
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237
Query: 303 GIFDAILKGGVD--FESEP-------------WLLISDS----------AKDLVRKMLIQ 337
F + L+ V E+ P L DS A+DL+ KML+
Sbjct: 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297
Query: 338 DPKKRITSAEVLEHPWMR 355
DP+KRI+ + L+HP++
Sbjct: 298 DPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 4/150 (2%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + K + RG FG YL + + YA K + K ++NK ++ E + LS
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSP 64
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
IV + + +V+LVME GG++ + G++ E+ A + + + H G
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG 124
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLS 245
++HRDLKP+N L+SN+ +K TDFGLS
Sbjct: 125 IIHRDLKPDNMLISNE---GHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 93 RQFYTLGKELGRGQFG-ITYLC---TENSTGNSYACKSILKRKLVNKQDREDIKREIQIM 148
+++ + LG G FG ++ C + TG A K+ LKR+ +Q+ K+EI I+
Sbjct: 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKT-LKRE-CGQQNTSGWKKEINIL 60
Query: 149 QHLSGQQNIVEFRGAYEDR--QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
+ L +NIV+++G ++ + + L+ME G L D Y K L + ++
Sbjct: 61 KTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLF 112
Query: 207 VVHHCHFMGVMH------RDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY----RD 256
C M +H RDL N LL N ++K DFGL+ + EG Y D
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVRED 169
Query: 257 IVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLS 291
++ A E L+ SY DVWS GV LY LL+
Sbjct: 170 GDSPVFWYAVECLKENKFSYAS--DVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 62/243 (25%), Positives = 97/243 (39%), Gaps = 15/243 (6%)
Query: 118 TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEF--RGAYEDRQSVHLVME 175
TG+ A K + + R +RE + L NIV G + V E
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGL-LFAVFE 59
Query: 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235
G L + + A G L +++ + H G++HRDLKP+N ++S
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 236 MLKATDFGLSVF------IDEGKVYR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVIL 286
K DFG+ D + R +++G+ Y APE LR D+++ G+I
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 287 YILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSA 346
L+G + I L VD PW+ ++RK L +DP++R SA
Sbjct: 180 LECLTGQRVVQGASVAEILYQQL-SPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASA 237
Query: 347 EVL 349
L
Sbjct: 238 PAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 75/315 (23%), Positives = 135/315 (42%), Gaps = 44/315 (13%)
Query: 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
L K + ++ + Y +G G +G + A K L R + RE
Sbjct: 6 LNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKK-LSRPFQSLIHARRTYRE 64
Query: 145 IQIMQHLSGQQNIVEFRGAY------EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAA 198
+++++H+ +N++ + E+ V+LV L G + I+ +++
Sbjct: 65 LRLLKHMK-HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQ 121
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258
L ++ + + H G++HRDLKP N + N+D L+ DFGL+ D+ V
Sbjct: 122 FLIYQLLRGLKYIHSAGIIHRDLKPSN-VAVNED--CELRILDFGLARQADDEMT--GYV 176
Query: 259 GSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPF----WAETEKGIFDAILKGG 312
+ +Y APE++ Y + +D+WS G I+ LL G F + + K I + +
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
Query: 313 VDF-------------ESEPWLLISDSAK----------DLVRKMLIQDPKKRITSAEVL 349
+ +S P + D K DL+ KML+ D KRI+++E L
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296
Query: 350 EHPWMREGGEASDKP 364
HP+ + + D+P
Sbjct: 297 AHPYFSQYHDPEDEP 311
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 78/302 (25%), Positives = 128/302 (42%), Gaps = 63/302 (20%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK-REIQIMQHLSGQQNIVE 159
+LG G + Y T N A K I +L +++ RE+ +++ L NIV
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK-HANIVT 68
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNV------------ 207
+S+ LV E DK + Q Y + C +N+
Sbjct: 69 LHDIIHTEKSLTLVFEY------LDKDLKQ--YLDD-----CGNSINMHNVKLFLFQLLR 115
Query: 208 -VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVA 265
+++CH V+HRDLKP+N L++ + LK DFGL+ K Y + V + +Y
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172
Query: 266 PEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK--GGVDFESEPWL 321
P++L S Y +ID+W G I Y + +G P F T + I + G E+ P +
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232
Query: 322 LISDSAK------------------------DLVRKMLIQDPKKRITSAEVLEHPWMREG 357
L ++ K +L+ K+L + +KRI++ E ++HP+
Sbjct: 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292
Query: 358 GE 359
GE
Sbjct: 293 GE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 6e-15
Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 50/288 (17%)
Query: 89 LEDIRQFY---TLGKELG--RGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKR 143
L ++ QF + K+L G+FG + T + K I K K N
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKII-KAKNFN--------- 55
Query: 144 EIQIMQH--LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALC 201
I+ M H + N ++ + + L+M+ G+LFD + +G +E +
Sbjct: 56 AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKII 115
Query: 202 RAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSA 261
R +V ++ H ++H D+K EN L L D+GL I Y G+
Sbjct: 116 RQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYL--CDYGLCKIIGTPSCYD---GTL 170
Query: 262 YYVAPE-VLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW 320
Y +PE + +Y D W+ GV+ Y LL+G PF K D E +
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF-------------KEDEDEELDLE 217
Query: 321 LL-------------ISDSAKDLVRKMLIQDPKKRITS-AEVLEHPWM 354
L +S +A D V+ ML + R+T+ E+++HP++
Sbjct: 218 SLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 78/299 (26%), Positives = 127/299 (42%), Gaps = 51/299 (17%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ-----HLSGQ 154
K +G G GI + + A K L R N+ + RE+ +M+ ++ G
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKK-LSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
N+ + + E+ Q V++VMEL ++I E+ + L + + + H H
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI-KHLHSA 145
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV-LRRSY 273
G++HRDLKP N ++ + LK DFGL+ + V + YY APEV L Y
Sbjct: 146 GIIHRDLKPSNIVVKSD---CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 274 GKEIDVWSAGVILYILLSG-----------------------VPPFWAETEKGIFDAILK 310
+ +D+WS G I+ ++ G P F + + + +
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 311 ----GGVDFE-----------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
G FE SE L + A+DL+ KML+ D KRI+ E L+HP++
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 20/223 (8%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK--QDREDIKREIQIMQHLSGQ 154
TL +E+G GQFG+ +L + K + K + + ED E Q+M LS
Sbjct: 7 TLVQEIGSGQFGLVWL-------GYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLS-H 58
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHF 213
+V+ G +R + LV E G L D + AQ G ++++ +C + + +
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---APEVLR 270
V+HRDL N L+ ++K +DFG++ F+ + + Y G+ + V +PEV
Sbjct: 119 SNVIHRDLAARNCLVGEN---QVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFS 174
Query: 271 RS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
S Y + DVWS GV+++ + S G P+ + + + I G
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG 217
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 38/232 (16%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGN---SYACKSILKRKLVNKQDREDIKREIQIMQ 149
R+ TLG+ +G GQFG Y S N + A K+ + + RE +E IM+
Sbjct: 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC--KNCTSPSVREKFLQEAYIMR 62
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKA------------A 197
+IV+ G + V +VMEL GEL Y + +
Sbjct: 63 QFD-HPHIVKLIGVITE-NPVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYS 113
Query: 198 AALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI 257
L A+ + +HRD+ N L+S+ D +K DFGLS ++++ Y+
Sbjct: 114 YQLSTALA----YLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKAS 166
Query: 258 VGS--AYYVAPEVLR-RSYGKEIDVWSAGVILY-ILLSGVPPF-WAETEKGI 304
G ++APE + R + DVW GV ++ IL+ GV PF + I
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI 218
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 75/279 (26%), Positives = 113/279 (40%), Gaps = 58/279 (20%)
Query: 102 LGRGQFGITYLCT-----ENSTGNS-YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
LG G FG Y T +G A K++ RK Q++++ +E +M + +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFN-HP 59
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAA-----------LCRAI 204
NIV+ G + +++MEL GG+L Y A L
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDIC 112
Query: 205 VNVVHHCHF---MGVMHRDLKPENFLLSNKDGGA--MLKATDFGLSVFIDEGKVYRDIVG 259
++V C + M +HRDL N L+S K A ++K DFGL+ RDI
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYK 163
Query: 260 SAYY------------VAPEVLRRS-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIF 305
S YY +APE L + + DVWS GV+++ IL G P+ A + +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
Query: 306 DAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRIT 344
+ GG + D L+ QDP +R T
Sbjct: 224 QHVTAGG---RLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 93 RQFYTLGKELGRGQFGITYLCT-----ENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
R TL + LG G FG Y ++ A K++ + ++QD D E I
Sbjct: 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALI 62
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRA 203
M + QNIV G +R +++EL +GG+L + + L
Sbjct: 63 MSKFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 204 IVNVVHHCHFM---GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
+V C ++ +HRD+ N LL+ K G + K DFG++ RDI +
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRA 172
Query: 261 AYY------------VAPEV-LRRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFD 306
+YY + PE L + + DVWS GV+L+ + S G P+ T + + +
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232
Query: 307 AILKGG 312
+ GG
Sbjct: 233 FVTGGG 238
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 100 KELGRGQFGITYLCT----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
++LG+G FG LC +++TG A K K + + D +REI+I++ L
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQ-HD 65
Query: 156 NIVEFRG-AYE-DRQSVHLVMELCSGGELFDKIIAQGHYTEKA-----AAALCRAIVNVV 208
NIV+++G Y R+++ LVME G L D + + A+ +C+ +
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM---- 121
Query: 209 HHCHFMGV---MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV----GSA 261
++G +HRDL N L+ ++ +K DFGL+ + + K Y +
Sbjct: 122 ---EYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 262 YYVAPEVLRRS-YGKEIDVWSAGVILYILLS 291
++ APE L S + DVWS GV+LY L +
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 57/181 (31%), Positives = 83/181 (45%), Gaps = 45/181 (24%)
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL----SVFIDEGKVYRDIVGSAYYVA 265
+CH V+HRDLKP+N L+S + LK DFGL SV K Y + V + +Y
Sbjct: 118 YCHQRRVLHRDLKPQNLLISER---GELKLADFGLARAKSV---PSKTYSNEVVTLWYRP 171
Query: 266 PEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK------------- 310
P+VL S Y +D+W G I Y + +G P F T+ + D + K
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETW 229
Query: 311 GGV----DFESE--------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
GV +F+ P L ++L K L +PKKRI++AE ++HP
Sbjct: 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289
Query: 353 W 353
+
Sbjct: 290 Y 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 47/265 (17%)
Query: 100 KELGRGQFGITY---LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
+ +GRG FG + L +N+ +C+ L L K +E +I++ S N
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYS-HPN 54
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG---------HYTEKAAAALCRAIVNV 207
IV G +Q +++VMEL GG+ + +G E AAA +
Sbjct: 55 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL---E 111
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVG----SAYY 263
HC +HRDL N L++ K+ +LK +DFG+S ++G VY G +
Sbjct: 112 SKHC-----IHRDLAARNCLVTEKN---VLKISDFGMSREEEDG-VYASTGGMKQIPVKW 162
Query: 264 VAPEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWL 321
APE L Y E DVWS G++L+ S G P+ + + +AI +G L
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-------L 215
Query: 322 LISDSAKDLVRKMLIQ----DPKKR 342
+ D V +++ + DP +R
Sbjct: 216 PCPELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 77/303 (25%), Positives = 122/303 (40%), Gaps = 60/303 (19%)
Query: 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK-REIQIMQH 150
+ + L K LG G + + T N A K I +L +++ RE+ ++++
Sbjct: 4 LETYVKLDK-LGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKN 59
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNV--- 207
L NIV + + LV E D + Q Y + + V +
Sbjct: 60 LK-HANIVTLHDIIHTERCLTLVFEY------LDSDLKQ--YLDNCGNLMSMHNVKIFMF 110
Query: 208 -----VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL----SVFIDEGKVYRDIV 258
+ +CH ++HRDLKP+N L++ K LK DFGL SV K Y + V
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEK---GELKLADFGLARAKSV---PTKTYSNEV 164
Query: 259 GSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK------ 310
+ +Y P+VL S Y ID+W G ILY + +G P F T K I +
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPT 224
Query: 311 ----GGVDFESE----------PWLLISDSAK------DLVRKMLIQDPKKRITSAEVLE 350
G+ E LI+ + + DL+ +L+ + K RI++ L
Sbjct: 225 EETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284
Query: 351 HPW 353
H +
Sbjct: 285 HSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 70/285 (24%), Positives = 123/285 (43%), Gaps = 23/285 (8%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG G G Y T A K I V Q + I E++I+ I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPY-IIGFY 65
Query: 162 GAYEDRQSVHLVMELCSGGEL--FDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
GA+ + + E GG L + KI E + A+V + + + ++HR
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKI------PEHVLGRIAVAVVKGLTYLWSLKILHR 119
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPE-VLRRSYGKEID 278
D+KP N L++ + +K DFG+S + + + VG+ Y+APE + YG D
Sbjct: 120 DVKPSNMLVNTR---GQVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 279 VWSAGVILYILLSGVPPF-WAETEKGIFDAI--LKGGVDFESEPWL---LISDSAKDLVR 332
VWS G+ L G P+ + +G + L+ VD E P L S+ +
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-EDPPVLPVGQFSEKFVHFIT 234
Query: 333 KMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFR 377
+ + + PK+R +++HP++ + + + + + V +++ R
Sbjct: 235 QCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRALEERR 279
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 93 RQFYTLGKELGRGQFGITYLC----TENSTGNSYACKSILKRKLVNKQDREDIKREIQIM 148
++F ++LG G FG LC ++TG A KS+ + D+K+EI+I+
Sbjct: 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEIL 60
Query: 149 QHLSGQQNIVEFRGAYEDR--QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
++L +NIV+++G + + L+ME G L + + K L + +
Sbjct: 61 RNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-----KNKINLKQQLKY 114
Query: 207 VVHHCHFMGVM------HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR----D 256
V C M + HRDL N L+ ++ +K DFGL+ I+ K Y D
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEH---QVKIGDFGLTKAIETDKEYYTVKDD 171
Query: 257 IVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLS 291
+ ++ APE L +S + DVWS GV LY LL+
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 72/273 (26%), Positives = 108/273 (39%), Gaps = 42/273 (15%)
Query: 100 KELGRGQFGITYLCTENSTGN---SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
K+LG G FG+ +++G A K + KL + D D +E IM L +N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSLD-HEN 57
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFD--KIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
++ G + +V EL G L D + A GH+ I N + +
Sbjct: 58 LIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---------- 264
+HRDL N LL++ D +K DFGL + + + +YV
Sbjct: 117 RFIHRDLAARNILLASDD---KVKIGDFGLMRALPQNE--------DHYVMEEHLKVPFA 165
Query: 265 --APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPW 320
APE LR R++ DVW GV L+ + + G P+ + I I K G E
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE- 224
Query: 321 LLISDSAKDLVRKML---IQDPKKRITSAEVLE 350
+D+ ML +P R T A + E
Sbjct: 225 ----ACPQDIYNVMLQCWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 22/221 (9%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD----REDIKREIQIMQHLSGQQN 156
ELG G G+ + + +G I+ RKL++ + R I RE+Q++ H
Sbjct: 12 ELGAGNGGVVFKVSHKPSG------LIMARKLIHLEIKPAIRNQIIRELQVL-HECNSPY 64
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC-HFMG 215
IV F GA+ + + ME GG L + G E+ + A++ + +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRRS-Y 273
+MHRD+KP N L++++ +K DFG+S ID + VG+ Y++PE L+ + Y
Sbjct: 125 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHY 179
Query: 274 GKEIDVWSAGVILYILLSG---VPPFWAETEKGIFDAILKG 311
+ D+WS G+ L + G +PP A+ + +F ++G
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 51/219 (23%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 97 TLGKELGRGQFGIT--YLCTENSTGNSYACKSILKRKLVNKQDREDIKR---EIQIMQHL 151
L +G+ + +L T A +K+ ++ +ED+K EI + L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVA----VKKINLDSCSKEDLKLLQQEIITSRQL 56
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYT----EKAAAALCRAIVNV 207
NI+ + ++ +++V L + G D + + H+ E A A + + ++N
Sbjct: 57 Q-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSA------ 261
+ + H G +HR +K + LLS DG +L + +S I GK R +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLS-GDGKVVLSGLRYSVS-MIKHGKRQRVVHDFPKSSVKN 171
Query: 262 -YYVAPEVLRRS---YGKEIDVWSAGVILYILLSGVPPF 296
+++PEVL+++ Y ++ D++S G+ L +G PF
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y LG +G G FG+ Y T A K +L QD + RE+ IM++L+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-------QDPQYKNRELLIMKNLN-HI 119
Query: 156 NIVEFRGAY--------EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAA--------- 198
NI+ + Y E +++VME + K + HY A
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMK--HYARNNHALPLFLVKLY 175
Query: 199 --ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD 256
LCRA+ + H F + HRDLKP+N L+ LK DFG + + G+
Sbjct: 176 SYQLCRALAYI--HSKF--ICHRDLKPQNLLIDPNT--HTLKLCDFGSAKNLLAGQRSVS 229
Query: 257 IVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPF 296
+ S +Y APE++ + Y ID+WS G I+ ++ G P F
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 54/245 (22%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL---VNKQDREDIKRE 144
PL +R +ELG G FG Y + S+ + L + +++ ++E
Sbjct: 3 PLSAVR----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 145 IQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAI 204
++M L NIV G Q ++ E + G+L + ++ +++ A + +
Sbjct: 59 AELMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 205 VNVVHHCHFMGV----------------MHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248
+ + F+ + +HRDL N L+ G +K +DFGLS
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE---GLTVKISDFGLS--- 171
Query: 249 DEGKVYRDIVGSAYY------------VAPEVLRRSYGK---EIDVWSAGVILYILLS-G 292
RDI + YY + PE + YGK E D+WS GV+L+ + S G
Sbjct: 172 ------RDIYSADYYRVQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEIFSYG 223
Query: 293 VPPFW 297
+ P++
Sbjct: 224 LQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 63/224 (28%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD---REDIKREIQIMQ 149
R + GK LG G FG T S A + + L RE + E++IM
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
HL +NIV GA + ++ E C G+L + + + L + V
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS-YQVAK 152
Query: 210 HCHFMG---VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV-- 264
F+ +HRDL N LL++ G ++K DFGL+ RDI+ + YV
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTH---GKIVKICDFGLA---------RDIMNDSNYVVK 200
Query: 265 ----------APE-VLRRSYGKEIDVWSAGVILYILLS-GVPPF 296
APE + Y E DVWS G++L+ + S G P+
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 70/275 (25%), Positives = 109/275 (39%), Gaps = 39/275 (14%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
+++ LG +G+G+FG L G A K LK Q E +
Sbjct: 4 NSKEL----KLGATIGKGEFGDVMLGD--YRGQKVAVKC-LKDDSTAAQAFLA---EASV 53
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIV 205
M L N+V+ G +++V E + G L D + ++G T +
Sbjct: 54 MTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL----SVFIDEGKVYRDIVGSA 261
+ + +HRDL N L+S D A K +DFGL S D GK+
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSE-DLVA--KVSDFGLAKEASQGQDSGKL------PV 163
Query: 262 YYVAPEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEP 319
+ APE LR + + DVWS G++L+ + S G P+ K + + KG + E
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEA 220
Query: 320 WLLISDSAKDLVRKMLIQ----DPKKRITSAEVLE 350
+ V K++ DP KR T ++ E
Sbjct: 221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 36/98 (36%), Positives = 58/98 (59%), Gaps = 4/98 (4%)
Query: 257 IVGSAYYVAPEVL-RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF 315
I+G+ Y+APE+L + +G +D W+ GV L+ L+G+PPF ET + +F IL + +
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599
Query: 316 -ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
E E L S +A++ + +L DP KR E+ +HP
Sbjct: 600 PEGEEKL--SVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 53/297 (17%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK-REIQIMQHLSGQQNIV 158
++LG G + + T N A K I +L +++ RE+ +++ L NIV
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLK-HANIV 67
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNV--------VHH 210
+S+ LV E DK + Q Y + + V + + +
Sbjct: 68 TLHDIVHTDKSLTLVFEY------LDKDLKQ--YMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVAPEVL 269
CH V+HRDLKP+N L++ + LK DFGL+ K Y + V + +Y P+VL
Sbjct: 120 CHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 270 RRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK----------GGVDFES 317
S Y +ID+W G I + + SG P F T + I + G+
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236
Query: 318 E----------PWLLISDSAK------DLVRKMLIQDPKKRITSAEVLEHPWMREGG 358
E P LI+ + + +L+ K L + KKRI++ E ++H + R G
Sbjct: 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 60/266 (22%), Positives = 113/266 (42%), Gaps = 31/266 (11%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
T KELG GQFG+ +L A K I + + +D E ++M LS N
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPN 60
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKA-----AAALCRAIVNVVHHC 211
+V+ G ++ + +V E + G L + + + + +C A+ + +
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI--DEGKVYRDIVGSAYYV---AP 266
+HRDL N L+ + ++K +DFGL+ ++ D+ Y G+ + V P
Sbjct: 121 ----FIHRDLAARNCLVGEDN---VVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPP 170
Query: 267 EVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324
EV S + + DVWS GV+++ + S G P+ + + +++ G + L
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG---YRLYRPKLAP 227
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLE 350
++ + P+ R ++L
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
T KELG GQFG+ +L + A K+I + + ED E ++M LS
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPK 60
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMG 215
+V+ G ++ +++V E G L + + QG ++ ++C+ + + +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI--DEGKVYRDIVGSAYYV---APEVLR 270
+HRDL N L+S+ ++K +DFG++ ++ DE Y G+ + V PEV
Sbjct: 121 FIHRDLAARNCLVSST---GVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFN 174
Query: 271 RS-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFDAILKG 311
S Y + DVWS GV+++ + G PF ++ + + I +G
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 33/213 (15%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
+++G+G FG Y A K+ R + + +E +I++ NIV+
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQYD-HPNIVK 56
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAAL--------CRAIVNVVHHC 211
G +Q +++VMEL GG L + K L + +
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLT-------FLRKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY----YVAPE 267
+HRDL N L+ + +LK +DFG+S +EG +Y G + APE
Sbjct: 110 ESKNCIHRDLAARNCLVGENN---VLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 268 VLRRSYGK---EIDVWSAGVILYILLS-GVPPF 296
L YG+ E DVWS G++L+ S G P+
Sbjct: 166 ALN--YGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD----REDIKREIQIMQHLSGQQN 156
ELG G G+ +G I+ RKL++ + R I RE+Q++ H
Sbjct: 12 ELGAGNGGVVTKVQHKPSG------LIMARKLIHLEIKPAIRNQIIRELQVL-HECNSPY 64
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTE-----KAAAALCRAIVNVVHHC 211
IV F GA+ + + ME GG L D+++ + K + A+ R + +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLR 270
+MHRD+KP N L++++ +K DFG+S ID + VG+ Y++PE L+
Sbjct: 124 Q---IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQ 175
Query: 271 RS-YGKEIDVWSAGVILYILLSG---VPPFWAETEKGIF 305
+ Y + D+WS G+ L L G +PP A+ + IF
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 9e-12
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 18/219 (8%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSI--LKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
+G G+FG G +I LK KQ R D E IM NI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFD-HPNIIH 69
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVM 217
G + V ++ E G L D + Q G +T + R I + + M +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK---VYRDIVGSAY---YVAPEVLR- 270
HRDL N L+++ + K +DFGLS F+++ Y +G + APE +
Sbjct: 129 HRDLAARNILVNSN---LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 271 RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAI 308
R + DVWS G++++ ++S G P+W + + + +AI
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
T KELG GQFG+ + A K I + + ++ E ++M LS +
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEK 60
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAA-AALCRAIVNVVHHCHFMG 215
+V+ G ++ +++V E S G L + + G + + +C+ + + +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI--DEGKVYRDIVGSAYYV---APEVLR 270
+HRDL N L+ + G +K +DFGLS ++ DE Y VGS + V PEVL
Sbjct: 121 FIHRDLAARNCLV-DDQG--CVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLL 174
Query: 271 RS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
S + + DVW+ GV+++ + S G P+ + + +G
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 44/181 (24%)
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVAP 266
+H H ++HRDLKP+N L+S LK DFGL+ + Y V + +Y P
Sbjct: 119 IHGQH---ILHRDLKPQNLLISYL---GELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172
Query: 267 EVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK----GGVDFESEPW 320
+VL + Y +D+W AG I +L G P F ++ +F+ + K GV E + W
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTE-DTW 229
Query: 321 LLISD----------------------------SAKDLVRKMLIQDPKKRITSAEVLEHP 352
+S A+DL +ML+ PK RI++ + L HP
Sbjct: 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP 289
Query: 353 W 353
+
Sbjct: 290 Y 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 28/231 (12%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSI--LKRKLVNKQDREDIKREIQIMQHLSGQ 154
+ K +G G+FG G +I LK KQ R D E IM
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFD-H 64
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCH 212
NI+ G + V +V E G L D + + G +T + R I + + +
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY---------- 262
MG +HRDL N L+++ + K +DFGLS +V D +AY
Sbjct: 124 DMGYVHRDLAARNILVNSN---LVCKVSDFGLS------RVLEDDPEAAYTTRGGKIPIR 174
Query: 263 YVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
+ APE + R + DVWS G++++ ++S G P+W + + + AI +G
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 78/296 (26%), Positives = 123/296 (41%), Gaps = 43/296 (14%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRE---DIKREIQIMQH 150
Q Y E+G G +G + + G + LKR V + RE+ +++H
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIREVAVLRH 57
Query: 151 LSG--QQNIVEFRG----AYEDRQS-VHLVMELCSGG--ELFDKIIAQGHYTEKAAAALC 201
L N+V + DR++ + LV E DK+ G TE +
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 202 RAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSA 261
+ ++ + H V+HRDLKP+N L+++ +K DFGL+ +V +
Sbjct: 118 Q-LLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 262 YYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAI-LKGGVDF 315
+Y APEV L+ SY +D+WS G I + P F ++ I D I L G D+
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
Query: 316 ESEPWLL------------------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
+ L I + KDL+ K L +P KRI++ L HP+
Sbjct: 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 16/222 (7%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSI--LKRKLVNKQDREDIKREIQIMQHLSGQQNI 157
K +G G+FG + G +I LK KQ R+D E IM S NI
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFS-HHNI 68
Query: 158 VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMG 215
+ G + ++ E G L DK + G ++ + R I + + M
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAY---YVAPEVLR- 270
+HRDL N L+++ K +DFGLS V D+ + G + APE +
Sbjct: 128 YVHRDLAARNILVNSN---LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 271 RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
R + DVWS G++++ ++S G P+W + + AI G
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 65/257 (25%), Positives = 105/257 (40%), Gaps = 53/257 (20%)
Query: 93 RQFYTLGKELGRGQFGITYL--CTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
R+ L +ELG G FG +L C S ++ K R+D +RE +++ +
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG-------------------- 190
L ++IV+F G D + +V E G+L + A G
Sbjct: 64 LQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 191 HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250
A+ + +V + HF+ HRDL N L+ ++K DFG+S
Sbjct: 123 SQMLHIASQIASGMVYLASQ-HFV---HRDLATRNCLVGA---NLLVKIGDFGMS----- 170
Query: 251 GKVYRDIVGSAYY------------VAPE-VLRRSYGKEIDVWSAGVILY-ILLSGVPPF 296
RD+ + YY + PE ++ R + E DVWS GVIL+ I G P+
Sbjct: 171 ----RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
Query: 297 WAETEKGIFDAILKGGV 313
+ + + + I +G V
Sbjct: 227 FQLSNTEVIECITQGRV 243
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 65/250 (26%), Positives = 105/250 (42%), Gaps = 44/250 (17%)
Query: 93 RQFYTLGKELGRGQFGITYL--CTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
R+ L ELG G FG +L C ++ K ++ R+D +RE +++
Sbjct: 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV 63
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFD---------KIIAQ------GHYTEK 195
L Q+IV F G + + + +V E G+L KI+A G T
Sbjct: 64 LQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 196 AAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR 255
A+ I + + + + +HRDL N L+ G ++K DFG+S R
Sbjct: 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ---GLVVKIGDFGMS---------R 170
Query: 256 DIVGSAYY------------VAPE-VLRRSYGKEIDVWSAGVILY-ILLSGVPPFWAETE 301
DI + YY + PE +L R + E D+WS GV+L+ I G P++ +
Sbjct: 171 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
Query: 302 KGIFDAILKG 311
+ I +G
Sbjct: 231 TEAIECITQG 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 17/225 (7%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSY---ACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
T+ K +G G+FG G A K+ LK +KQ R D E IM
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT-LKAGSSDKQ-RLDFLTEASIMGQFD- 63
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHC 211
NI+ G + V ++ E G L DK + + G +T + R I + + +
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVG---SAYYVAPEV 268
M +HRDL N L+++ + K +DFGLS +++ + G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSN---LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179
Query: 269 LR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
+ R + DVWS G++++ ++S G P+W + + + A+ G
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 66/271 (24%), Positives = 101/271 (37%), Gaps = 45/271 (16%)
Query: 100 KELGRGQFGIT---YLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
KELG G FG ++ A K++ + +++ RE +M L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--IAAGKKEFLREASVMAQLD-HPC 57
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAI---VNVVHHCHF 213
IV G + + + LVMEL G L + + L + + + HF
Sbjct: 58 IVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYY---------- 263
+ HRDL N LL N+ K +DFG+S + GS YY
Sbjct: 117 V---HRDLAARNVLLVNRH---QAKISDFGMS------RALG--AGSDYYRATTAGRWPL 162
Query: 264 --VAPEVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFES 317
APE + +YGK + DVWS GV L+ S G P+ + A+L+ G
Sbjct: 163 KWYAPECI--NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPR 219
Query: 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEV 348
++ P+ R T +E+
Sbjct: 220 PE--ECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 69/289 (23%), Positives = 111/289 (38%), Gaps = 40/289 (13%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
Q Y + + +G+G G YL + A K I + N ++ RE +I L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI- 60
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFD--------KIIAQGHYTEKAAAALCR--- 202
IV D V+ M G L + +++ + + A
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 203 AIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID------------- 249
I + + H GV+HRDLKP+N LL G ++ D+G ++F
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLG-LFGEVVI--LDWGAAIFKKLEEEDLLDIDVDE 177
Query: 250 EGKVYRD------IVGSAYYVAPEVLRRSYGKE-IDVWSAGVILYILLSGVPPFWAETEK 302
Y IVG+ Y+APE L E D+++ GVILY +L+ P+ + +
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237
Query: 303 GIFDAILKGGVDFESE--PWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349
I + + E P+ I + K L DP +R +S + L
Sbjct: 238 KI---SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 73/289 (25%), Positives = 117/289 (40%), Gaps = 52/289 (17%)
Query: 97 TLGKELGRGQFG----ITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
TLGK LG G FG + +N S +LK ++D D+ E+++M+ +
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIG 73
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212
+NI+ G +++V+E + G L D + A+ E A+ R +
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 213 FMG----------------VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD 256
+ +HRDL N L++ ++K DFGL+ RD
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE---DHVMKIADFGLA---------RD 181
Query: 257 IVGSAYY------------VAPEVL-RRSYGKEIDVWSAGVILY--ILLSGVPPFWAETE 301
I YY +APE L R Y + DVWS GV+L+ L G P E
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241
Query: 302 KGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350
+ +F +LK G + E + L+R + P +R T +++E
Sbjct: 242 E-LFK-LLKEG--YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 42/230 (18%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRK--LVNKQDREDIKREIQIMQHLSGQQ---- 155
LG+G FG + K LK K + K +ED+ +E++I + LS +
Sbjct: 3 LGKGNFGEVF-------------KGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQ 48
Query: 156 ----NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
NIV+ G RQ +++VMEL GG+ + + E L + ++
Sbjct: 49 YDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGM 106
Query: 212 HFM---GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY-----RDIVGSAYY 263
++ +HRDL N L+ + +LK +DFG+S D+G +Y + I +
Sbjct: 107 AYLESKNCIHRDLAARNCLVGENN---VLKISDFGMSRQEDDG-IYSSSGLKQI--PIKW 160
Query: 264 VAPEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
APE L Y E DVWS G++L+ S GV P+ T + + + KG
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 62/267 (23%), Positives = 109/267 (40%), Gaps = 28/267 (10%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
+G G FG G + ++ ++ D D E++++ L NI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 162 GAYEDRQSVHLVMELCSGGELFDKI-----------IAQGHYTEKAAAA--LCRAIVNVV 208
GA E+R +++ +E G L D + A+ H T + L + +V
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 209 HHCHFMG---VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS--AYY 263
++ +HRDL N L+ K DFGLS E + +G +
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGEN---LASKIADFGLSR--GEEVYVKKTMGRLPVRW 184
Query: 264 VAPEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWL 321
+A E L S Y + DVWS GV+L+ ++S G P+ T +++ + +G + E
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRMEKPR 241
Query: 322 LISDSAKDLVRKMLIQDPKKRITSAEV 348
D +L+R+ P +R A++
Sbjct: 242 NCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 42/250 (16%)
Query: 93 RQFYTLGKELGRGQFGITYL--CTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
R L +ELG G FG +L C ++ K + R+D RE +++ +
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN 63
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG-------------HYTEKAA 197
L ++IV+F G + + +V E G+L + A G T+
Sbjct: 64 LQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 198 AALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI 257
+ + I + + +HRDL N L+ ++K DFG+S RD+
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN---LLVKIGDFGMS---------RDV 170
Query: 258 VGSAYY------------VAPE-VLRRSYGKEIDVWSAGVILY-ILLSGVPPFWAETEKG 303
+ YY + PE ++ R + E DVWS GV+L+ I G P++ +
Sbjct: 171 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230
Query: 304 IFDAILKGGV 313
+ + I +G V
Sbjct: 231 VIECITQGRV 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 37/261 (14%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
Q TLG+ +G G+FG TG A K+I + V Q + + + H
Sbjct: 6 QKLTLGEIIGEGEFGAVL--QGEYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHH--- 58
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
+N+V G +++VMEL S G L + + +G +A ++ + + +
Sbjct: 59 -KNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEG 112
Query: 214 M------GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY----Y 263
M ++HRDL N L+S +DG A K +DFGL+ +V V ++ +
Sbjct: 113 MEYLESKKLVHRDLAARNILVS-EDGVA--KVSDFGLA------RVGSMGVDNSKLPVKW 163
Query: 264 VAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWL 321
APE L+ + + + DVWS GV+L+ + S G P+ + K + + + KG + EP
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPE 220
Query: 322 LISDSAKDLVRKMLIQDPKKR 342
L+ +PKKR
Sbjct: 221 GCPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 67/269 (24%), Positives = 112/269 (41%), Gaps = 30/269 (11%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
+G G FG G ++ +K D D E++++ L NI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 162 GAYEDRQSVHLVMELCSGGELFDKI-------------IAQGHYTEKAAAALCRAIVNVV 208
GA E R ++L +E G L D + IA + ++ L +V
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 209 HHCHFMG---VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY-RDIVGS--AY 262
++ +HRDL N L+ + K DFGLS +VY + +G
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLS---RGQEVYVKKTMGRLPVR 188
Query: 263 YVAPEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPW 320
++A E L S Y DVWS GV+L+ ++S G P+ T +++ + +G + E
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKP 245
Query: 321 LLISDSAKDLVRKMLIQDPKKRITSAEVL 349
L D DL+R+ + P +R + A++L
Sbjct: 246 LNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 197 AAALC--RAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254
AL + I+ + + H ++HRD+K EN +++ D + D G + F +
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCI---GDLGAAQFPVVAPAF 213
Query: 255 RDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLS 291
+ G+ APEVL R Y + D+WSAG++L+ +L+
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
P +R Y + L G G ++CT++ G+ K I+K K REI I
Sbjct: 86 PASVVRMQYNILSSLTPGSEGEVFVCTKH--GDEQRKKVIVKAVTGGK----TPGREIDI 139
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNV 207
++ +S + I+ AY + +V +VM +LF + G + A + R ++
Sbjct: 140 LKTIS-HRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEA 197
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG----LSVFIDEGKVYRDIVGSAYY 263
+ + H G++HRD+K EN L ++ A+L DFG L D + Y G+
Sbjct: 198 LAYLHGRGIIHRDVKTENIFL-DEPENAVLG--DFGAACKLDAHPDTPQCY-GWSGTLET 253
Query: 264 VAPEVLR-RSYGKEIDVWSAGVILY 287
+PE+L Y + D+WSAG++L+
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-08
Identities = 18/44 (40%), Positives = 25/44 (56%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
L+ F D D GTI+ +ELK L LG LSE E+ +++ V
Sbjct: 2 LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREV 45
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 31/231 (13%)
Query: 93 RQFYTLGKELGRGQFGITYLC------TENSTGNSYACKSILKRKLVNKQDREDIKREIQ 146
R TLGK LG G FG + + +LK +K D D+ E++
Sbjct: 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLVSEME 69
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGEL---------------FDKI-IAQG 190
+M+ + +NI+ GA +++++E S G L FD + +
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129
Query: 191 HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250
T K + + + + +HRDL N L++ + ++K DFGL+ +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN---VMKIADFGLARDVHN 186
Query: 251 GKVYRDIVGS---AYYVAPEVL-RRSYGKEIDVWSAGVILY-ILLSGVPPF 296
Y+ ++APE L R Y + DVWS GV+L+ I G P+
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 58/252 (23%), Positives = 96/252 (38%), Gaps = 42/252 (16%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYL-----CTENSTGNSYACKSILKRKLVNKQDREDIK 142
P E I TL +ELG+G FG+ Y + A K++ + + ++R +
Sbjct: 4 PREKI----TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFL 57
Query: 143 REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGEL----------------FDKI 186
E +M+ + ++V G Q +VMEL + G+L
Sbjct: 58 NEASVMKEFN-CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 187 IAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246
Q A A A + HRDL N +++ +K DFG++
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFV------HRDLAARNCMVAEDL---TVKIGDFGMTR 167
Query: 247 FIDEGKVYRDIVGSAYYV---APEVLRRS-YGKEIDVWSAGVILY-ILLSGVPPFWAETE 301
I E YR V APE L+ + + DVWS GV+L+ + P+ +
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
Query: 302 KGIFDAILKGGV 313
+ + ++ GG
Sbjct: 228 EEVLKFVIDGGH 239
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 49/228 (21%)
Query: 93 RQFYTLGKELGRGQFGITYL--CTENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQ 149
R L +ELG G FG +L C N ++ K D R+D +RE +++
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT 63
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG---HYTEKAAAALCRAIVN 206
+ +NIV+F G + +V E G+L + + G + + + + ++
Sbjct: 64 NF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 207 VVHHC--------------HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252
+ HF+ HRDL N L+ ++K DFG+S
Sbjct: 123 QLLQIAVQIASGMVYLASQHFV---HRDLATRNCLVGYD---LVVKIGDFGMS------- 169
Query: 253 VYRDIVGSAYY------------VAPE-VLRRSYGKEIDVWSAGVILY 287
RD+ + YY + PE ++ R + E DVWS GV+L+
Sbjct: 170 --RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 22/228 (9%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
R+ L K+LG GQFG ++ T N GN+ LK ++ E E QIM+ L
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLR 59
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKII-AQGHYTE-KAAAALCRAIVNVVHH 210
+V+ A + +++V E S G L D + +G + + + + +
Sbjct: 60 -HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY---YVAPE 267
M +HRDL+ N L+ + G + K DFGL+ I++ + Y G+ + + APE
Sbjct: 118 IERMNYIHRDLRSANILVGD---GLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPE 173
Query: 268 VLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
YG+ + DVWS G++L L++ G P+ + + + + +G
Sbjct: 174 AAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 50/206 (24%)
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG-AMLKATDFGLS-VFIDEGKVYRD 256
+L I++ +H+ H V+HRDLKP N L+ + +K D G + +F K D
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 257 ---IVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE---------- 301
+V + +Y APE+L R Y K ID+W+ G I LL+ P F E
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 231
Query: 302 ---KGIFDAI-LKGGVDFES-----EPWLLISDSAKD----------------------- 329
IF+ + D+E E L+ D ++
Sbjct: 232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 291
Query: 330 -LVRKMLIQDPKKRITSAEVLEHPWM 354
L++K+L DP KRITS + ++ P+
Sbjct: 292 HLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 51/230 (22%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 93 RQFYTLGKELGRGQFGITYLCT-----ENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
R TLGK LG G FG + ++ + + + ++D D+ E+++
Sbjct: 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI----------------IAQGH 191
M+ + +NI+ GA +++++E S G L + + +
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 192 YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251
T K + + + + +HRDL N L++ + ++K DFGL+ ++
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDVNNI 190
Query: 252 KVYRDIVGS---AYYVAPEVL-RRSYGKEIDVWSAGVILY-ILLSGVPPF 296
Y+ ++APE L R Y + DVWS GV+++ I G P+
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 36/229 (15%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENS-------TGNSYACKSILK-----RKLVNKQDRED 140
RQ L ++LG GQFG +LC + + +L R V K R D
Sbjct: 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND 63
Query: 141 IKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAA- 199
+EI+IM L NI+ G + ++ E G+L ++ ++Q A
Sbjct: 64 FLKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDL-NQFLSQREIESTFTHAN 121
Query: 200 --LCRAIVNVVH----------HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247
+I N+++ + + +HRDL N L+ N +K DFG+S
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH---YTIKIADFGMSRN 178
Query: 248 IDEGKVYRDIVGSAY----YVAPE-VLRRSYGKEIDVWSAGVILYILLS 291
+ G YR I G A ++A E +L + DVW+ GV L+ + +
Sbjct: 179 LYSGDYYR-IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 50/206 (24%)
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG-AMLKATDFGLS-VFIDEGKVYRD 256
+L I++ +H+ H V+HRDLKP N L+ + +K D G + +F K D
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171
Query: 257 ---IVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVP-------------PFWA 298
+V + +Y APE+L R Y K ID+W+ G I LL+ P PF
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH 231
Query: 299 ETEKGIFDAI-LKGGVDFE------SEPWL-------------LISDSAKD--------- 329
+ IF + D+E P L LI K
Sbjct: 232 DQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVF 291
Query: 330 -LVRKMLIQDPKKRITSAEVLEHPWM 354
L++K+L DP KRITS + L+ P+
Sbjct: 292 LLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 9e-08
Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 56/298 (18%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIMQHLSGQQ 155
++LG G + Y G S ++ K++ Q+ E RE +++ L
Sbjct: 11 EKLGEGSYATVY------KGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HA 63
Query: 156 NIVEFRGAYEDRQSVHLVME-----LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
NIV ++++ LV E LC + DK G + ++ + +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLC---QYMDK--HPGGLHPENVKLFLFQLLRGLSY 118
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVAPEVL 269
H ++HRDLKP+N L+S+ LK DFGL+ Y + V + +Y P+VL
Sbjct: 119 IHQRYILHRDLKPQNLLISDT---GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 270 RRS--YGKEIDVWSAGVILYILLSGVPPFWAETE-----KGIFDAILKGGVD-------- 314
S Y +D+W G I ++ GV F + + IF + D
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235
Query: 315 --FESEPWLLIS--------------DSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
F+ E + L S + A+DL K+L PK R+++ L H + +
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR---EDIKREIQIMQHLSG 153
T+ +LG GQ+G Y + A K++ K+D E+ +E +M+ +
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTMEVEEFLKEAAVMKEIK- 60
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRA--IVNVVHHC 211
N+V+ G +++ E + G L D + A L A I + + +
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY---YVAPEV 268
+HRDL N L+ ++K DFGLS + G Y G+ + + APE
Sbjct: 121 EKKNFIHRDLAARNCLVGENH---LVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 176
Query: 269 LR-RSYGKEIDVWSAGVILY-ILLSGVPPF 296
L + + DVW+ GV+L+ I G+ P+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF---IDEGKVYR 255
A+ R+++ + + H ++HRD+K EN + N G L DFG + F I+ K Y
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFI-NHPGDVCLG--DFGAACFPVDINANKYY- 241
Query: 256 DIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSG 292
G+ APE+L R YG +D+WSAG++L+ + +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 100 KELGRGQFGIT---YLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
ELG G FG + S + A K ILK + ++++ RE +MQ L
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSE-KTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPY- 57
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGV 216
IV G E +S LVMEL G L + H TEK L + + +
Sbjct: 58 IVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYY----VAPEVLR-R 271
+HRDL N LL + K +DFGLS + + Y + APE +
Sbjct: 117 VHRDLAARNVLLVTQH---YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 272 SYGKEIDVWSAGVILYILLS-GVPPF 296
+ + DVWS GV+++ S G P+
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 62/224 (27%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ---DREDIKREIQIMQ 149
R+ L ++LG GQFG ++ T N T A K++ K E +E QIM+
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTL-------KPGTMSPEAFLQEAQIMK 56
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI-------------------IAQG 190
L +V+ + + +++V E S G L D + IA+G
Sbjct: 57 KLR-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 191 -HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249
Y E +HRDL N L+ + K DFGL+ I
Sbjct: 116 MAYLES------------------RNYIHRDLAARNILVGE---NLVCKIADFGLARLI- 153
Query: 250 EGKVYRDIVGSAY---YVAPEVLRRSYGK---EIDVWSAGVILY 287
E Y G+ + + APE YG+ + DVWS G++L
Sbjct: 154 EDDEYTAREGAKFPIKWTAPEAAN--YGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 51/176 (28%), Positives = 78/176 (44%), Gaps = 26/176 (14%)
Query: 135 KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTE 194
K R+++ RE +IM L IV G E +++ LVME+ SGG L +
Sbjct: 36 KSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSG------ 87
Query: 195 KAAAALCRAIVNVVHHCHFMGV--------MHRDLKPENFLLSNKDGGAMLKATDFGLSV 246
K +V ++H MG+ +HRDL N LL N+ K +DFGLS
Sbjct: 88 KKDEITVSNVVELMHQVS-MGMKYLEGKNFVHRDLAARNVLLVNQH---YAKISDFGLSK 143
Query: 247 FID-EGKVYRDIVGSAY---YVAPE-VLRRSYGKEIDVWSAGVILYILLS-GVPPF 296
+ + Y+ + + APE + R + DVWS G+ ++ S G P+
Sbjct: 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 27/204 (13%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
L + +G+G+FG L + GN A K I N + E +M L N
Sbjct: 9 KLLQTIGKGEFGDVML--GDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQLR-HSN 60
Query: 157 IVEFRGA-YEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM- 214
+V+ G E++ +++V E + G L D + ++G + L + ++V ++
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE 119
Query: 215 --GVMHRDLKPENFLLSNKDGGAMLKATDFGL----SVFIDEGKVYRDIVGSAYYVAPEV 268
+HRDL N L+S + + K +DFGL S D GK+ + APE
Sbjct: 120 ANNFVHRDLAARNVLVSEDN---VAKVSDFGLTKEASSTQDTGKL------PVKWTAPEA 170
Query: 269 LR-RSYGKEIDVWSAGVILYILLS 291
LR + + + DVWS G++L+ + S
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 198 AALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID---EGKVY 254
A+ R +++ + + H G++HRD+K EN L++ + + DFG + F +
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICL---GDFGAACFARGSWSTPFH 319
Query: 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILY 287
I G+ APEVL Y +D+WSAG++++
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 46/182 (25%), Positives = 72/182 (39%), Gaps = 15/182 (8%)
Query: 112 LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171
L + T ++ K + K +++ I N+V SV
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRERLTIIPH---------CVPNMVCLHKYIVSEDSVF 61
Query: 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK 231
LV++ GG+L+ I + E+ +V + H G++ RDL P N LL
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL--- 118
Query: 232 DGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKE-IDVWSAGVILYILL 290
D ++ T F +++ + V Y APEV S E D WS G IL+ LL
Sbjct: 119 DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEETEACDWWSLGAILFELL 176
Query: 291 SG 292
+G
Sbjct: 177 TG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
R L ++LG GQFG + N+T A K+ LK D +D E QIM+ L
Sbjct: 5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKT-LK---PGTMDPKDFLAEAQIMKKLR 59
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFD--KIIAQGHYTEKAAAALCRAIVNVVHH 210
+++ + +++V EL G L + + A + + + + +
Sbjct: 60 -HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY---YVAPE 267
+HRDL N L+ + K DFGL+ I E +Y G+ + + APE
Sbjct: 119 LEAQNYIHRDLAARNVLVGE---NNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPE 174
Query: 268 VLRRS-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFDAILKG 311
+ + + DVWS G++L I+ G P+ T + + +G
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 5e-07
Identities = 64/267 (23%), Positives = 108/267 (40%), Gaps = 28/267 (10%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
+G G FG G ++ +K D D E++++ L NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 162 GAYEDRQSVHLVMELCSGGELFDKI-----------IAQGHYTEKAAAA--LCRAIVNVV 208
GA E R ++L +E G L D + A + T ++ L +V
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 209 HHCHFMG---VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS--AYY 263
++ +HRDL N L+ K DFGLS + + +G +
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSR--GQEVYVKKTMGRLPVRW 177
Query: 264 VAPEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWL 321
+A E L S Y DVWS GV+L+ ++S G P+ T +++ + +G + E L
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPL 234
Query: 322 LISDSAKDLVRKMLIQDPKKRITSAEV 348
D DL+R+ + P +R + A++
Sbjct: 235 NCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 31/231 (13%)
Query: 93 RQFYTLGKELGRGQFGITYLC------TENSTGNSYACKSILKRKLVNKQDREDIKREIQ 146
R LGK LG G FG + E + +LK K D D+ E++
Sbjct: 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLISEME 75
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-----------GHYTEK 195
+M+ + +NI+ GA +++++E S G L + + A+ E+
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 196 --AAAALCRAIVNVVHHCHFMG---VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250
+ L V ++ +HRDL N L++ + ++K DFGL+ I
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN---VMKIADFGLARDIHH 192
Query: 251 GKVYRDIVGS---AYYVAPEVL-RRSYGKEIDVWSAGVILY-ILLSGVPPF 296
Y+ ++APE L R Y + DVWS GV+L+ I G P+
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 73/301 (24%), Positives = 110/301 (36%), Gaps = 52/301 (17%)
Query: 19 RSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPV 78
S SH+ Q + V PP P K T P
Sbjct: 66 TDSGRTKSHEGAATTKQAT-----TTPTTNVEVAPP------------PKKKKVTYALPN 108
Query: 79 QKPE-----TVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV 133
Q E VLG+ ++ Q + + LG G FG + A K + + V
Sbjct: 109 QSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV---RNV 165
Query: 134 NKQDREDIKREIQIMQHLSGQQNIVEFR------GAYEDRQSVHLVMELCSGGE-LFDKI 186
K R D K EIQ M+ + +Q R Y ++ H+ + + G L D I
Sbjct: 166 PKYTR-DAKIEIQFMEKV--RQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWI 222
Query: 187 IAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGG----------- 234
+ G ++ + A + + + H + +MH DLKPEN L+ D
Sbjct: 223 MKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282
Query: 235 --AMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV-LRRSYGKEIDVWSAGVILYILLS 291
++ D G DE IV + +Y +PEV L + D+WS G I+Y L +
Sbjct: 283 DPCRVRICDLGGCC--DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340
Query: 292 G 292
G
Sbjct: 341 G 341
|
Length = 467 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 55/238 (23%), Positives = 92/238 (38%), Gaps = 45/238 (18%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENS--------------TGNSYACKSILKRKLVNKQDR 138
R ++LG GQFG +LC + G + R NK R
Sbjct: 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR 63
Query: 139 EDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAA- 197
D +E++I+ L NI+ G D + ++ E G+L ++ ++ H +K
Sbjct: 64 NDFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEEN 121
Query: 198 ----------------AALCRAIVNVVHHCHFMGVM---HRDLKPENFLLSNKDGGAMLK 238
++L + + ++ + HRDL N L+ +K
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTIK 178
Query: 239 ATDFGLSVFIDEGKVYRDIVGSAY----YVAPE-VLRRSYGKEIDVWSAGVILYILLS 291
DFG+S + G YR I G A ++A E +L + DVW+ GV L+ +L
Sbjct: 179 IADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 195 KAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254
K A+ + ++ V + H ++HRD+K EN L N DG +L DFG ++ ++ +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL-NCDGKIVLG--DFGTAMPFEKEREA 323
Query: 255 RDI--VGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLS 291
D VG+ +PE+L Y + D+WS G+IL +LS
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 25/230 (10%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
R+ +TL ++LG G FG + ILK + KQ D ++E+Q ++ L
Sbjct: 5 REEFTLERKLGSGYFGEVW--EGLWKNRVRVAIKILKSDDLLKQQ--DFQKEVQALKRLR 60
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELF-------DKIIAQGHYTEKAAAALCRAIV 205
+ I F V+++ EL G L +++ + A +
Sbjct: 61 HKHLISLFAVCSVGE-PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ-----VA 114
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY--RDIVGSAYY 263
+ + +HRDL N L+ + K DFGL+ I E VY D +
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKW 170
Query: 264 VAPEVL-RRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
APE ++ + DVWS G++LY + + G P+ ++D I G
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 51/231 (22%), Positives = 93/231 (40%), Gaps = 31/231 (13%)
Query: 93 RQFYTLGKELGRGQFGITY------LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQ 146
R LGK LG G FG + +LK +K D D+ E++
Sbjct: 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-DLADLISEME 69
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGEL---------------FDKI-IAQG 190
+M+ + +NI+ G +++++E + G L FD + +
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 191 HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250
+ K + + + + +HRDL N L++ + ++K DFGL+ + +
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN---VMKIADFGLARGVHD 186
Query: 251 GKVYRDIVGS---AYYVAPEVL-RRSYGKEIDVWSAGVILY-ILLSGVPPF 296
Y+ ++APE L R Y + DVWS G++++ I G P+
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 17/226 (7%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
R+ L K+LG GQFG ++ N++ A K+ LK ++ Q + ++ +QH
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGYYNNS-TKVAVKT-LKPGTMSVQAFLEEANLMKTLQH-- 60
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHH 210
+V + ++++ E + G L D + + G I + +
Sbjct: 61 --DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 118
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY---YVAPE 267
+HRDL+ N L+S M K DFGL+ I++ + Y G+ + + APE
Sbjct: 119 IERKNYIHRDLRAANVLVSES---LMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 174
Query: 268 VLRR-SYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFDAILKG 311
+ S+ + DVWS G++LY I+ G P+ + + A+ +G
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 24/232 (10%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
P E +R L +LG+G FG ++ T N T K +K E +E QI
Sbjct: 4 PRESLR----LDVKLGQGCFGEVWMGTWNGT-----TKVAIKTLKPGTMMPEAFLQEAQI 54
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG---HYTEKAAAALCRAI 204
M+ L + + + A + +++V E G L D + +G + + I
Sbjct: 55 MKKLRHDKLVPLY--AVVSEEPIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQI 111
Query: 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY-- 262
+ + + M +HRDL+ N L+ + + K DFGL+ I++ + Y G+ +
Sbjct: 112 ADGMAYIERMNYIHRDLRAANILVGDN---LVCKIADFGLARLIEDNE-YTARQGAKFPI 167
Query: 263 -YVAPE-VLRRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
+ APE L + + DVWS G++L L++ G P+ + + + + +G
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLS--VFIDEGKVYR-DIVGSAYYVAPE-VLRRS 272
+HRDL N LLS + ++K DFGL+ ++ D V + D ++APE + R
Sbjct: 201 IHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257
Query: 273 YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
Y + DVWS GV+L+ + S G P+ F LK G + + + ++
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY-----TTPEMY 312
Query: 332 RKMLI---QDPKKRITSAEVLEH 351
+ ML +P +R T +E++EH
Sbjct: 313 QTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 100 KELGRGQFGITYLC-----TENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ 154
LGRG+FG +L E K++ K K N Q + +RE+ + + LS
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFRKLS-H 67
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGEL--FDKIIAQGHYTEK-------AAAALCRAIV 205
+N+V G + + ++++E G+L F + K ALC I
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS--VFIDEGKVYRDIVGSAYY 263
+ H +HRDL N L+S++ +K + LS V+ E R+ + +
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQR---EVKVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 264 VAPEVLRRS-YGKEIDVWSAGVILY-ILLSGVPPF 296
+APE ++ + + DVWS GV+++ + G PF
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 66/266 (24%), Positives = 113/266 (42%), Gaps = 26/266 (9%)
Query: 96 YTLGKELGRGQFGI---TYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
+TLG+ LG+G+FG L +E+ + A K +LK + + D E+ RE M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFD 59
Query: 153 GQQNI----VEFRGAYEDRQSVHLV-MELCSGGELFDKIIAQGHYTEK---AAAALCRAI 204
I V R + R + +V + G+L ++ E L R +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 205 VNVVHHCHFMG---VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSA 261
+++ ++ +HRDL N +L + + DFGLS I G YR S
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 262 Y---YVAPEVLRRS-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFDAILKGGVDFE 316
++A E L + Y DVW+ GV ++ I+ G P+ I++ ++KG +
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLK 235
Query: 317 SEPWLLISDSAKDLVRKMLIQDPKKR 342
P L + +L+ + +PK R
Sbjct: 236 QPPDCL--EDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 26/233 (11%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
P E +R L +LG+G FG ++ T N T + +K E +E Q+
Sbjct: 4 PRESLR----LEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTMSPEAFLQEAQV 54
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTE----KAAAALCRA 203
M+ L ++ + + A + +++V E S G L D + +G + +
Sbjct: 55 MKKLRHEKLVQLY--AVVSEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQ 110
Query: 204 IVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY- 262
I + + + M +HRDL+ N L+ + K DFGL+ I++ + Y G+ +
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNE-YTARQGAKFP 166
Query: 263 --YVAPE-VLRRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
+ APE L + + DVWS G++L L + G P+ + + D + +G
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 6e-06
Identities = 19/44 (43%), Positives = 23/44 (52%), Gaps = 3/44 (6%)
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLA 427
K ALK + E LSEEEI M +D D G I +EE +A
Sbjct: 23 KAALKSLGEGLSEEEID---EMIREVDKDGDGKIDFEEFLELMA 63
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 43/141 (30%), Positives = 72/141 (51%), Gaps = 13/141 (9%)
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLS--VFIDEGKVYR--DIVGSAYYVAPEVL 269
M ++HRDL N L++ G +K +DFGLS V+ ++ V R + ++A E L
Sbjct: 146 MKLVHRDLAARNVLVAE---GRKMKISDFGLSRDVYEEDSYVKRSKGRI-PVKWMAIESL 201
Query: 270 -RRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327
Y + DVWS GV+L+ +++ G P+ + +F+ +LK G E S+
Sbjct: 202 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN-LLKTGYRMERPE--NCSEEM 258
Query: 328 KDLVRKMLIQDPKKRITSAEV 348
+L+ Q+P KR T A++
Sbjct: 259 YNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 55/247 (22%), Positives = 106/247 (42%), Gaps = 32/247 (12%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILK--RKLVNKQDREDIKREI 145
PL +R +ELG FG Y G +A +K + + N Q + ++E
Sbjct: 3 PLSAVR----FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 146 QIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIV 205
+M L NIV G Q V ++ E + G+L + +I + +++ ++ V
Sbjct: 59 SLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTV 117
Query: 206 -NVVHHCHFMGV----------------MHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248
+ + H F+ + +H+DL N L+ + +K +D GLS I
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ---LHVKISDLGLSREI 174
Query: 249 DEGKVYR---DIVGSAYYVAPE-VLRRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKG 303
YR + ++ PE ++ + + D+WS GV+L+ + S G+ P++ + +
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234
Query: 304 IFDAILK 310
+ + + K
Sbjct: 235 VIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 9e-06
Identities = 26/126 (20%), Positives = 52/126 (41%), Gaps = 11/126 (8%)
Query: 127 ILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEF-RGAYEDRQSVHLVMELCSGGELFDK 185
+LK +++ D +RE+ I+Q L+ + V + E +L+ME G L +
Sbjct: 25 VLKIN-PSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV 83
Query: 186 IIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244
+ E+ A L + +H + + H DL P N L+ + ++ D+
Sbjct: 84 SEEEKEDIAEQLAELLAK-----LHQLPLLVLCHGDLHPGNILVDDGKILGII---DWEY 135
Query: 245 SVFIDE 250
+ +
Sbjct: 136 AGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 9/149 (6%)
Query: 169 SVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFL 227
+V LV +L G L D + + + C I + + + ++HRDL N L
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141
Query: 228 LSNKDGGAMLKATDFGLSVF--IDEGKVYRD--IVGSAYYVAPEVLRRSYGKEIDVWSAG 283
+ + + +K TDFGL+ IDE + + D V + +L R + + DVWS G
Sbjct: 142 VKSPN---HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 284 VILYILLS-GVPPFWAETEKGIFDAILKG 311
V ++ L++ G P+ + I D + KG
Sbjct: 199 VTVWELMTFGAKPYDGIPAREIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 45/234 (19%)
Query: 93 RQFYTLGKELGRGQFGITYLC-------------TENSTGNS---YACKSILKRKLVNKQ 136
R+ T ++LG GQFG +LC + + +GN A K + R+ NK
Sbjct: 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML--REDANKN 61
Query: 137 DREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKA 196
R D +EI+IM L NI+ + ++ E G+L ++ +++ E A
Sbjct: 62 ARNDFLKEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAA 119
Query: 197 AAA------------LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244
A + I + + + + +HRDL N L+ +K DFG+
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN---YTIKIADFGM 176
Query: 245 SVFIDEGKVYRDIVGSAYYVAP-------EVLRRSYGKEIDVWSAGVILYILLS 291
S + G YR I G A V P +L + DVW+ GV L+ +L+
Sbjct: 177 SRNLYSGDYYR-IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 51/244 (20%), Positives = 103/244 (42%), Gaps = 50/244 (20%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD---REDIKREIQIMQHLSGQQN 156
+ELG +FG Y T +++ + L +K + RE+ K E + L N
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-HPN 69
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG- 215
IV G Q + ++ CS +L + ++ + +++ + + + + + F+
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 216 ---------------VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
V+H+DL N L+ +K L+V I + ++R++ +
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDK------------LNVKISDLGLFREVYAA 177
Query: 261 AYY------------VAPEVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGI 304
YY ++PE + YGK + D+WS GV+L+ + S G+ P+ + + +
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235
Query: 305 FDAI 308
+ I
Sbjct: 236 IEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 56/231 (24%), Positives = 89/231 (38%), Gaps = 39/231 (16%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENST---------GNSYACKSIL-----KRKLVNKQDR 138
RQ ++LG GQFG +LC + N A +L R + R
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 139 EDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGEL---------FDKIIAQ 189
ED +E++I+ LS NI G + ++ME G+L +A
Sbjct: 64 EDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 190 GHYTEKAAAAL--CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247
+ + L I + + + + +HRDL N L+ +K DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADFGMSRN 179
Query: 248 IDEGKVYRDIVGSAYYVAP-------EVLRRSYGKEIDVWSAGVILYILLS 291
+ YR + G A P VL + + DVW+ GV L+ +L+
Sbjct: 180 LYSSDYYR-VQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|200946 pfam00036, efhand, EF hand | Back alignment and domain information |
|---|
Score = 40.9 bits (97), Expect = 2e-05
Identities = 12/28 (42%), Positives = 15/28 (53%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARL 429
LK F D D G I++EE K L +L
Sbjct: 2 LKEAFKEFDKDGDGKISFEEFKELLKKL 29
|
The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 24/146 (16%)
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLS--VFIDEGKVYRDIVGSAY----YVAPE-VL 269
+HRDL N LLS + ++K DFGL+ ++ D V + GSA ++APE +
Sbjct: 196 IHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRK---GSARLPLKWMAPESIF 249
Query: 270 RRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328
+ Y + DVWS GV+L+ + S G P+ F LK G + ++A
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA------PENAT 303
Query: 329 DLVRKMLIQ----DPKKRITSAEVLE 350
+ ++++ DPK+R T + ++E
Sbjct: 304 PEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 32/94 (34%), Positives = 44/94 (46%), Gaps = 26/94 (27%)
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV------------ 264
+HRDL N LLS + ++K DFGL+ RDI YV
Sbjct: 195 IHRDLAARNILLSENN---VVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 242
Query: 265 APE-VLRRSYGKEIDVWSAGVILYILLS-GVPPF 296
APE + + Y + DVWS GV+L+ + S G P+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 20/54 (37%), Positives = 27/54 (50%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
L+EE+I+ LK F D D G I EL L LG SE E+ +L + +
Sbjct: 14 LTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA 67
|
Length = 160 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 60/280 (21%), Positives = 122/280 (43%), Gaps = 29/280 (10%)
Query: 90 EDIRQFYTLGKELGRGQFGITYL-----CTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
E R+ T+ +ELG+G FG+ Y ++ A K++ + + ++R + E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNE 59
Query: 145 IQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA----------QGHYTE 194
+M+ + ++V G Q ++MEL + G+L + + Q +
Sbjct: 60 ASVMKEFNC-HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 195 KAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254
K + I + + + + +HRDL N +++ +K DFG++ I E Y
Sbjct: 119 KKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYETDYY 175
Query: 255 R---DIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFDAIL 309
R + +++PE L+ + DVWS GV+L+ I P+ + + + ++
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235
Query: 310 KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349
+GG+ + + D +L+R +PK R + E++
Sbjct: 236 EGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 31/111 (27%), Positives = 48/111 (43%), Gaps = 26/111 (23%)
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPE--------- 267
+HRDL N L+ ++K DFGLS R+I + YY A E
Sbjct: 152 VHRDLATRNCLVG---ENMVVKIADFGLS---------RNIYSADYYKASENDAIPIRWM 199
Query: 268 ----VLRRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGV 313
+ Y E DVW+ GV+L+ + S G+ P++ + + + G V
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV 250
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 22/228 (9%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
R+ L K+LG GQFG ++ T N K +K E E +M+ L
Sbjct: 5 RESLKLEKKLGAGQFGEVWMATYNK-----HTKVAVKTMKPGSMSVEAFLAEANVMKTL- 58
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAAL--CRAIVNVVHH 210
Q + + A ++ ++++ E + G L D + + + + I +
Sbjct: 59 -QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAML--KATDFGLSVFIDEGKVYRDIVGSAY---YVA 265
+HRDL+ N L+S A L K DFGL+ I++ + Y G+ + + A
Sbjct: 118 IEQRNYIHRDLRAANILVS-----ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTA 171
Query: 266 PEVLRR-SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
PE + S+ + DVWS G++L +++ G P+ + + A+ +G
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 38/167 (22%), Positives = 64/167 (38%), Gaps = 24/167 (14%)
Query: 194 EKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253
E+ A+C + + H +L DG +LK G F +
Sbjct: 16 EEEIWAVCLQCLGALRELH-------RQAKSGNILLTWDG--LLKL--DGSVAFKTPEQ- 63
Query: 254 YRDIVGSAYYVAPEVL-RRSYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKG 311
Y++APEV+ +SY ++ D++S G+ LY L P+ E E I + +L G
Sbjct: 64 --SRPDP-YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120
Query: 312 ------GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
E + S +D +R + P++R + L H
Sbjct: 121 MPADDPRDRSNLEGVSA-ARSFEDFMRLCASRLPQRREAANHYLAHC 166
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 1e-04
Identities = 16/37 (43%), Positives = 24/37 (64%)
Query: 409 MDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+D D G I EEL+ L LG KL++ EV++L++A
Sbjct: 3 LDKDGDGYIDVEELRKLLKALGLKLTDEEVEELIEAD 39
|
Length = 60 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 21/226 (9%)
Query: 99 GKELGRGQFGITY--LCTENSTGNSY--ACKSILKRKLVNKQDREDIKREIQIMQHLSGQ 154
K LG G FG Y + A K + + + + ++I E +M +
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASV-DH 68
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAAL---CRAIVNVVHHC 211
++V G Q V L+ +L G L D + + H + L C I + +
Sbjct: 69 PHVVRLLGICLSSQ-VQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KVYRDIVGSA--YYVAPE- 267
++HRDL N L+ +K TDFGL+ +D K Y G ++A E
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 268 VLRRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
+L R Y + DVWS GV ++ L++ G P+ I D + KG
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif | Back alignment and domain information |
|---|
Score = 38.1 bits (90), Expect = 2e-04
Identities = 12/28 (42%), Positives = 13/28 (46%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARL 429
LK F D D G I +EE K L L
Sbjct: 2 LKEAFRLFDKDGDGKIDFEEFKDLLKAL 29
|
EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 28/148 (18%)
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV------------ 264
+HRDL N LL++ G + K DFGL+ RDI + YV
Sbjct: 236 IHRDLAARNILLTH---GRITKICDFGLA---------RDIRNDSNYVVKGNARLPVKWM 283
Query: 265 APE-VLRRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322
APE + Y E DVWS G++L+ + S G P+ F ++K G S P
Sbjct: 284 APESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS-PECA 342
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEVLE 350
S+ D+++ DP KR T ++++
Sbjct: 343 PSE-MYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 29/112 (25%), Positives = 48/112 (42%), Gaps = 8/112 (7%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL---VNKQDREDIKREIQIMQ 149
R LG+ LG G FG T + +S + + + L +++ + E++IM
Sbjct: 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMS 95
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH-----YTEKA 196
HL NIV GA ++++ E C G+L D + H Y +K
Sbjct: 96 HLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKN 147
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 21/56 (37%), Positives = 34/56 (60%)
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+A+ L+EE+I K F+ D D GTIT +EL T + LG +E E++ +++ V
Sbjct: 1 MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 56
|
Length = 149 |
| >gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 3e-04
Identities = 12/29 (41%), Positives = 15/29 (51%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLG 430
L+ F D D G I+ EEL+ L LG
Sbjct: 2 LREAFKLFDKDGDGYISAEELRKALRSLG 30
|
Length = 30 |
| >gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 19/49 (38%), Positives = 30/49 (61%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQL 441
L+E++ K ++ F DTD SGTI +ELK + LG + + E+KQ+
Sbjct: 10 GLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQM 58
|
Length = 158 |
| >gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 3e-04
Identities = 19/46 (41%), Positives = 26/46 (56%), Gaps = 3/46 (6%)
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL 429
K AL ++ +LSEEE+ +F DTD G I++EE L RL
Sbjct: 11 KRALALLGISLSEEEVD---ILFREFDTDGDGKISFEEFCVLLQRL 53
|
Length = 53 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 69/297 (23%), Positives = 126/297 (42%), Gaps = 49/297 (16%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKR--------KLVNK----QDRED 140
R+ TL +ELG+G FG+ Y GN+ + I+K K VN+ ++R +
Sbjct: 5 REKITLLRELGQGSFGMVY------EGNA---RDIIKGEAETRVAVKTVNESASLRERIE 55
Query: 141 IKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTE------ 194
E +M+ + ++V G Q +VMEL + G+L + + E
Sbjct: 56 FLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 195 ----KAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250
+ + I + + + + +HRDL N ++++ +K DFG++ I E
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF---TVKIGDFGMTRDIYE 171
Query: 251 GKVYRDI---VGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIF 305
YR + ++APE L+ + D+WS GV+L+ + S P+ + + +
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231
Query: 306 DAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE------HPWMRE 356
++ GG + + + DL+R +PK R T E++ HP E
Sbjct: 232 KFVMDGGYLDQPDN---CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 3/90 (3%)
Query: 98 LGKELGRGQFGITYLCTENSTGNSYACKSILKRKL---VNKQDREDIKREIQIMQHLSGQ 154
GK LG G FG T G + + L + +RE + E++I+ HL
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFD 184
+NIV GA V ++ E C G+L +
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLN 131
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI--DEGKVYRD--IVGSAYYVAPEVLRR 271
++HRDL N L+ +K TDFGL+ + DE + + + V + +L R
Sbjct: 130 LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 272 SYGKEIDVWSAGVILYILLS-GVPPF 296
Y + DVWS GV ++ L++ G P+
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 26/94 (27%)
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV------------ 264
+HRD+ N LL++ G + K DFGL+ RDI+ + YV
Sbjct: 234 IHRDVAARNVLLTD---GRVAKICDFGLA---------RDIMNDSNYVVKGNARLPVKWM 281
Query: 265 APE-VLRRSYGKEIDVWSAGVILYILLS-GVPPF 296
APE + Y + DVWS G++L+ + S G P+
Sbjct: 282 APESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 67/275 (24%), Positives = 110/275 (40%), Gaps = 28/275 (10%)
Query: 97 TLGKELGRGQFGITY---LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
LGK LG G+FG L ++ + A K++ K + + E+ E M+
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD- 59
Query: 154 QQNIVEFRGA---YEDRQSVH---LVMELCSGGELFDKIIAQ--GHYTEK-AAAALCRAI 204
N+++ G Q + +++ G+L ++ G EK L + +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 205 VNVVHHCHFMG---VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSA 261
V++ ++ +HRDL N +L + DFGLS I G YR +
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 262 Y---YVAPEVLR-RSYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFDAILKGGVDFE 316
++A E L R Y + DVW+ GV ++ I G P+ I+D L+ G +
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD-YLRHGNRLK 235
Query: 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
L D DL+ DPK R T ++ E
Sbjct: 236 QPEDCL--DELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 9/149 (6%)
Query: 169 SVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFL 227
S+ LV +L G L D + + + C I +++ ++HR+L N L
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141
Query: 228 LSNKDGGAMLKATDFGLSVFI---DEGKVYRDIVGSAYYVAPE-VLRRSYGKEIDVWSAG 283
L + ++++ DFG++ + D+ Y + ++A E +L Y + DVWS G
Sbjct: 142 LKSD---SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 284 VILYILLS-GVPPFWAETEKGIFDAILKG 311
V ++ ++S G P+ + D + KG
Sbjct: 199 VTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 28/96 (29%)
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYY------------- 263
+HRDL N +L D +K DFGL+ RDI YY
Sbjct: 120 VHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLPVK 167
Query: 264 -VAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPF 296
+A E L+ + + + DVWS GV+L+ L++ G PP+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 41/224 (18%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK--QDREDIKREIQIMQHLSGQQNI 157
KE+G G FG L NS + ++K V+ Q++ E Q + L N+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTP--AQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNL 57
Query: 158 VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRA---------IVNVV 208
++ G + LVME C G+L + + KA I +
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSC----RKAELMTPDPTTLQRMACEIALGL 113
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-------VFIDEGKVYRDIVGSA 261
H H +H DL N LL+ +K D+GLS ++ +++ +
Sbjct: 114 LHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL---- 166
Query: 262 YYVAPEVLRRSYG--------KEIDVWSAGVILYILLS-GVPPF 296
++APE++ +G KE +VWS GV ++ L G P+
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 28/236 (11%)
Query: 97 TLGKELGRGQFG--ITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ 154
LGK LG G+FG + ++ + A K+ +K + + + ED E M+
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKT-MKIAICTRSEMEDFLSEAVCMKEFD-H 59
Query: 155 QNIVEFRGA------YEDRQSVHLVMELCSGGEL-----FDKIIAQGHYTEKAAAALCRA 203
N++ G E S +++ G+L + ++ Y L +
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYL--PTQMLVKF 117
Query: 204 IVNVVHHCHFMG---VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
+ ++ ++ +HRDL N +L+ + DFGLS I G YR +
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNEN---MNVCVADFGLSKKIYNGDYYRQGRIA 174
Query: 261 AY---YVAPEVLR-RSYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFDAILKG 311
++A E L R Y + DVWS GV ++ I G P+ I+D + +G
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG 230
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|205383 pfam13202, EF_hand_3, EF hand | Back alignment and domain information |
|---|
Score = 34.2 bits (80), Expect = 0.004
Identities = 11/23 (47%), Positives = 14/23 (60%)
Query: 402 LKTMFANMDTDKSGTITYEELKT 424
LK +F DT+ G I+ EELK
Sbjct: 1 LKDLFRQFDTNGDGKISKEELKR 23
|
Length = 25 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 447 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.49 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.45 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.02 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.66 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.55 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.5 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 98.45 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.44 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.42 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.29 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.25 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.24 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.24 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 98.09 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.07 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 98.06 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.03 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.03 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 98.01 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 97.87 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.79 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 97.75 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.73 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.73 | |
| PF13405 | 31 | EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J | 97.7 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 97.68 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.67 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 97.66 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 97.65 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 97.63 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 97.6 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 97.57 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.51 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 97.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.46 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.43 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 97.42 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-66 Score=471.71 Aligned_cols=269 Identities=39% Similarity=0.679 Sum_probs=248.9
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChh----hHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ----DREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
.+.+.|.+.+.||.|+||.|.+|..+.||+.||||++.++...... ....+.+|+++|++|+ |||||+++++|+.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeeec
Confidence 4677899999999999999999999999999999999887665422 3344679999999998 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
....||||||++||+|++.+..++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+..+..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999988888999999999999
Q ss_pred eccCCCceeecCCcccccccccccc----cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCCCCCccc
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLRR----SYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFDAILKGGVDFESEPWL 321 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 321 (447)
...++....+.||||.|.|||++.. .+..++||||+||+||.+|+|.+||.+..... +.++|.+|.+.+..+.|.
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 9998888899999999999999863 25568999999999999999999999876655 889999999999999999
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
.+|+++.+||.+||..||++|||++|+|+||||+.....
T Consensus 408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL 446 (475)
T ss_pred hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence 999999999999999999999999999999999976543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-64 Score=428.36 Aligned_cols=299 Identities=37% Similarity=0.719 Sum_probs=278.7
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.+.|.+.+.||+|.|+.||++.+..+|+.+|+|+|....+.. .+.+++.+|+.|.+.|. |||||++.+.+.+.+..|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcC-CCcEeehhhhhcccceeE
Confidence 5667999999999999999999999999999999987665544 37789999999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||+|++.|++|..-|..+..++|..+-.+++||+++|.|||.+||||||+||+|+|+...+...-+||+|||+|..+.++
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999999999988888888999999999999999999999999999999999999988888888999999999999877
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......+|||.|||||+++ ..|+..+|||+.|||||-|+.|.+||++.+...+++.|+.+.++++.+.|..+++++++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 7777899999999999997 569999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHHHHHHhhhhHHHHHHHHh
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAE 392 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i~~ 392 (447)
|++||..||.+|+|+.|+|+|||+.+.......-....+.+.|++|.+.-++|-+++..+..
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s 308 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIA 308 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHh
Confidence 99999999999999999999999998766666666788999999999999999998887765
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-62 Score=465.35 Aligned_cols=261 Identities=35% Similarity=0.587 Sum_probs=245.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
.+|..++.||+|||+.||.+++..+|..||+|+|.+..+.....++.+.+||+|.+.|+ |||||+++++|+|.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence 56999999999999999999999999999999999988888888999999999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-C
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-K 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 252 (447)
+|+|..++|..++++++.++|.+++.+++||+.||.|||+++|+|||||..|+|+ +++.+|||+|||+|..+... +
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence 9999999999999999999999999999999999999999999999999999999 66678999999999988744 6
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
...+.||||.|+|||++. .+++..+||||+||+||.||+|++||...+..+++..|....+.++. .+|.++++||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 677899999999999986 56999999999999999999999999999999999999999888887 4899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWMREGGEASD 362 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~ 362 (447)
.+||+.||.+|||+++||.|+||+.+..+..
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 9999999999999999999999977655443
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-59 Score=448.47 Aligned_cols=322 Identities=60% Similarity=1.004 Sum_probs=298.1
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
...+...|++++.||+|.||.||+|+++.+|+.+|+|.+.+.........+.+.+|+.+|+++.+|||||.+.++|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 45667789999999999999999999999999999999999888777778899999999999998999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC-CCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG-GAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~-~~~vkl~Dfg~a~~ 247 (447)
.+++|||+|.||.|++.+.+. .+++..+..+++|++.++.|||+.||+||||||+|+|+..... ...+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999887 5999999999999999999999999999999999999977654 45899999999999
Q ss_pred ccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 248 IDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
...+......+||+.|+|||++. ..|+..+||||+|+++|.|++|.+||++.+..+....|..+.+.+..+.|..++..
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 88877888899999999999998 68999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHHHHHHhhhhHHHHHHHHhhhhHHHhhhhccee
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMF 406 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i~~~~~~~~~~~l~~~F 406 (447)
++++|++||..||.+|+|+.++|+|||++........+....+..+++++...+++++........... +..+++.|
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 345 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLKEMF 345 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHHHHH
Confidence 999999999999999999999999999998877777777777888888999999998887777777655 77788889
Q ss_pred eeecCCCC
Q 013201 407 ANMDTDKS 414 (447)
Q Consensus 407 ~~~D~~~~ 414 (447)
..+|.+.+
T Consensus 346 ~~~~~~~~ 353 (382)
T KOG0032|consen 346 KLMDTDNN 353 (382)
T ss_pred Hhhccccc
Confidence 99998877
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-59 Score=420.87 Aligned_cols=257 Identities=35% Similarity=0.656 Sum_probs=237.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||+||.++.+.+++.||+|++.|.........+...+|..||.+++ ||.||.++..|++.+.+|||
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEEE
Confidence 34999999999999999999999999999999999988887778889999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee-ccCCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF-IDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~-~~~~~ 252 (447)
+||+.||.|+.+|.+.+.|+|..++-++..|+.||.|||++|||||||||+|||+ |..++|+|+|||+++. ...+.
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCCC
Confidence 9999999999999999999999999999999999999999999999999999999 6666899999999985 44555
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
...++|||+.|||||++. ..|+..+|+||||+++|||++|.+||.+.+...+++.|.++....... .++.+++++|
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardll 257 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDLL 257 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHHH
Confidence 667789999999999986 569999999999999999999999999999999999999987444332 3799999999
Q ss_pred HHhcccCCCCCC----CHHHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRI----TSAEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~----t~~~~l~h~~~~~~ 357 (447)
+++|..||++|. ++.+|-+||||+..
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 999999999996 78999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-58 Score=415.07 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=227.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-eEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-SVHLV 173 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv 173 (447)
..+.++.||+|..|+||+|+|+.|++.+|+|+|. ...+....+++.+|+++++.+. ||+||.+++.|.+++ .++|+
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~--~~~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL--LNIDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec--ccCCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceEEee
Confidence 3667889999999999999999999999999993 2345667889999999999996 999999999999999 49999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||.||+|.+++...++++|.....++++++.||.|||+ ++||||||||+|||++.. +.|||||||.+..+...
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk---GeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK---GEVKICDFGVSGILVNS- 232 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC---CCEEeccccccHHhhhh-
Confidence 9999999999999999999999999999999999999995 999999999999999554 46999999999887665
Q ss_pred ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCC-----CHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAE-----TEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
...+++||..|||||.+.+ .|+.++||||||+.++|+++|+.||... ...+++..|..+..+-.. ...+|++
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP--~~~fS~e 310 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLP--EGEFSPE 310 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCC--cccCCHH
Confidence 5578899999999999985 6999999999999999999999999774 667888888876332211 1148999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+++||..||++||.+|+++.|+|+|||+++...
T Consensus 311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 999999999999999999999999999998644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-58 Score=419.93 Aligned_cols=263 Identities=36% Similarity=0.613 Sum_probs=240.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|.+.+.||+|+||+||+|+++.++..||||.|.+..+ .....+-+..|+.+|+.++ |||||.+++++++++.+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEEE
Confidence 459999999999999999999999999999999987665 4556788899999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCC---CceEEecCCCceeccC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG---AMLKATDFGLSVFIDE 250 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~---~~vkl~Dfg~a~~~~~ 250 (447)
||||.||+|.++|.+.+.++|..++.++.||+.||++||+++||||||||+||||+..... ..+||+|||+|+...+
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999876333 7899999999999998
Q ss_pred CCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
+....+.||+|.|||||++. ..|+.|+|+||+|+|||+|++|+.||...+..+++..+.++....+..+. .++....+
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~-~~s~~~~~ 246 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA-ELSNPLRE 246 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh-hccCchhh
Confidence 88888899999999999985 77999999999999999999999999999999999988887655554433 46777889
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
|+...|..+|.+|.+..+-+.|+++.....
T Consensus 247 Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 247 LLISLLQRNPKDRISFEDFFDHPFLAANPQ 276 (429)
T ss_pred hhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence 999999999999999999999999987653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-58 Score=431.09 Aligned_cols=257 Identities=35% Similarity=0.619 Sum_probs=238.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|.+++.||+|+|++|++|+++.+++.||||++.|+.+..+...+-+.+|-.+|.+|.+||.|++|+..|+|+..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 34999999999999999999999999999999999888777777788889999999998899999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
+||+++|+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+|||+ ++++.+||+|||.|+.+.+...
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhhc
Confidence 9999999999999999999999999999999999999999999999999999999 6667899999999987653211
Q ss_pred --------------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Q 013201 254 --------------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE 318 (447)
Q Consensus 254 --------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 318 (447)
..+++||..|.+||+|.. ..++.+|||+||||||.|+.|.+||.+.++.-++++|++-.+.++.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~- 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE- 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC-
Confidence 145899999999999974 5789999999999999999999999999999999999999888886
Q ss_pred ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 319 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.+++.++|||+++|..||.+|+|+.+|.+||||...
T Consensus 309 ---~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 309 ---GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred ---CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 478999999999999999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-58 Score=440.64 Aligned_cols=257 Identities=38% Similarity=0.636 Sum_probs=241.1
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++++.||.|+-|.|.+|++..||+.+|||+|.+...........+++||.||+.+. ||||++++++|++..++|+|+|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEEEE
Confidence 999999999999999999999999999999998875555556678999999999998 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCcee
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR 255 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~ 255 (447)
|++||.|++++.+.+++++.+++.+++||+.|+.|||..+|+||||||+|+|++.+ ..|||+|||+|..-.+++...
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~---~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK---NNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc---cCEeeeccceeecccCCcccc
Confidence 99999999999999999999999999999999999999999999999999999544 459999999999888888889
Q ss_pred ecCCccccccccccccc--CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 256 DIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 256 ~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
+.||+|.|.|||++.+. -+.++||||+|||||.||||+.||.+.+...++.++.+|.+.++. .+|+++++||++
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEAQDLLRR 245 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHHHHHHHH
Confidence 99999999999998753 488999999999999999999999999999999999999998885 589999999999
Q ss_pred hcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 334 MLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 334 ~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
||.+||++|+|.+||++|||+..+...
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred HhccCccccccHHHHhhCchhhcCCCC
Confidence 999999999999999999999987554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-57 Score=395.51 Aligned_cols=253 Identities=35% Similarity=0.640 Sum_probs=238.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||.|+||.|.+++++.+|..||+|++.+.........+...+|..+|+.+. ||.++++.+.+.+.+.+||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEEE
Confidence 4899999999999999999999999999999998888777777888999999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
||.+||.|+.+|++.++|++..++.++.||+.||+|||+++|++|||||+|||+ |.++.+||+|||+|+.+... +
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc--E
Confidence 999999999999999999999999999999999999999999999999999999 66678999999999987764 6
Q ss_pred eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
.+.||||.|+|||++. ++|+.++|+|||||++|||+.|.+||.+.+...++++|+.+.+.++. .++++++|||++
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLKK 274 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHHH
Confidence 7889999999999986 67999999999999999999999999999999999999999999887 479999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 334 MLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 334 ~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
+|++|-.+|. ...+|..||||+..
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCcccccc
Confidence 9999999993 56799999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=394.59 Aligned_cols=264 Identities=35% Similarity=0.646 Sum_probs=243.1
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN-----KQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+...|.-.+.||+|..++|.++.++.+|..+|+|+|....... ...++.-.+|+.||+++.+||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 45566888999999999999999999999999999986543211 1224555689999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
.+..+++|+|+|+.|.|+|+|...-.++|.+.+.|++|+++|+.|||.++||||||||+|||+ +++.+|||+|||++
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEecccee
Confidence 999999999999999999999999999999999999999999999999999999999999999 55667999999999
Q ss_pred eeccCCCceeecCCccccccccccc-------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR-------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE 318 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 318 (447)
..+.+++.....||||+|.|||.++ .+|+..+|+||+|+|+|.|+.|.+|||.....-++..|+.|.+.|..+
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9999999999999999999999874 348999999999999999999999999999999999999999999999
Q ss_pred ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 319 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.|..+|...+|||.+||++||.+|+|++|+|+||||...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 999999999999999999999999999999999999643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=422.69 Aligned_cols=259 Identities=42% Similarity=0.715 Sum_probs=234.3
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh--hhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK--QDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..+.|.+++.||+|+||+|++|.+..++..||+|++.+...... ...+.+.+|+.+++++.+||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 34569999999999999999999999999999997766433211 3456677999999999989999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec-
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI- 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~- 248 (447)
+|+|||||.||+|++++.+.+++.|.+++.+++||++|++|||++||+||||||+|||++.+. .++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~--~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE--GNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC--CCEEEeccccccccC
Confidence 999999999999999999999999999999999999999999999999999999999995542 57999999999988
Q ss_pred cCCCceeecCCcccccccccccc-c-C-CCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC-C
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLRR-S-Y-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLI-S 324 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-s 324 (447)
..+....+.+||+.|+|||++.+ . | +.++||||+||+||.|++|..||...+...++..|.++.+.++.. + |
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~~S 248 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----LLS 248 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----cCC
Confidence 46667788999999999999974 3 4 688999999999999999999999999999999999988777653 5 9
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
+++++||.+||..||.+|+|+.+++.||||+.
T Consensus 249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 249 PEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999999999999997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=394.78 Aligned_cols=257 Identities=27% Similarity=0.532 Sum_probs=221.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|+...++|+|+||+||+|+++.||+.||||++..+ ..+....+-..+|+++|++|+ |+|+|.++++|.....++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence 3588899999999999999999999999999988543 233444566789999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CC
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~ 251 (447)
+|||+. ++.+.|.+. ..+++..+..|+.|++.|+.|||+++++||||||+|||++.+ +.+||||||+|+.+. ++
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~---gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN---GVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC---CcEEeccchhhHhhcCCc
Confidence 999976 555666654 569999999999999999999999999999999999999554 479999999999887 77
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-----------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG----------------- 312 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~----------------- 312 (447)
..++.++.|.+|+|||.+-+ .|+..+||||+||++.||++|.+.|.+.++-+.+..|.+.-
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 88899999999999999865 59999999999999999999999999998877776664411
Q ss_pred --CCCCCC--------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 313 --VDFESE--------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 313 --~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
+.++.+ .++.++..+.||+++||..||.+|++.+++|.|+||..
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 112221 23457888999999999999999999999999999943
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-55 Score=413.76 Aligned_cols=260 Identities=32% Similarity=0.577 Sum_probs=234.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++++.||+|+||.||+|+.+.||..||+|++.|..+......+.+..|-.+|.... .|.||+++..|++..++|||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEecCCCeeEEE
Confidence 45999999999999999999999999999999999998888888899999999999865 89999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC---
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE--- 250 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~--- 250 (447)
|||++||++..+|.+.+.+++..++.++.+++.|+..+|+.|+|||||||+|+|| |..++|||+|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999 6667899999999753210
Q ss_pred -------------------C--Cc------------------------eeecCCccccccccccc-ccCCCCCcchhHHH
Q 013201 251 -------------------G--KV------------------------YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGV 284 (447)
Q Consensus 251 -------------------~--~~------------------------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~ 284 (447)
. .. ..+.+|||.|||||++. .+|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0 00 01258999999999986 56999999999999
Q ss_pred HHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCCC
Q 013201 285 ILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRIT---SAEVLEHPWMREGG 358 (447)
Q Consensus 285 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~h~~~~~~~ 358 (447)
|+||||.|.+||.+.+..+++.+|......+..+....++++++|||.+||. ||.+|.. ++||.+||||+...
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 9999999999999999999999999887666666666789999999999999 9999986 89999999999653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=402.80 Aligned_cols=262 Identities=29% Similarity=0.438 Sum_probs=225.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QSV 170 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~ 170 (447)
.+.|+..++||+|.||.||+|++..+|+.||+|.|...... ........+||.||++|. ||||++|.+...+. +.+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCceE
Confidence 34589999999999999999999999999999999765433 334556679999999998 99999999998776 799
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|||+|||+. +|.-++... -+|++.+++.|++||+.||+|||.+||+|||||.+|||| +.++.+||+|||+|+++.
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence 999999976 787777663 469999999999999999999999999999999999999 555679999999999776
Q ss_pred CCC--ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc-----
Q 013201 250 EGK--VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW----- 320 (447)
Q Consensus 250 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 320 (447)
... .++..+-|++|+|||.+.+ .|+.++|+||+||||.||++|++.|.+.++.+.+..|.+-.-......|
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 543 4677889999999999865 4999999999999999999999999999999999998774333222222
Q ss_pred --------------------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 321 --------------------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 321 --------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
..+++.+.+|+..||..||.+|.||.++|.|+||...+..
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP 409 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence 2368899999999999999999999999999999654443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-55 Score=405.64 Aligned_cols=262 Identities=29% Similarity=0.479 Sum_probs=226.2
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-e
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-S 169 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~ 169 (447)
.+.++|.+.++||.|.||.||+|+.+.+|..||||.+++. +...++.-. .+|++.|++|..||||+++.+++.+.. .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K-f~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK-FYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh-hccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 3557899999999999999999999999999999988553 333333222 489999999988999999999998887 9
Q ss_pred EEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+|+|||||+ .+|+++++.++ .|++..++.|+.||+.||+|+|.+|++||||||+|||+.. ...|||+|||+|+.+
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEeccccccccc
Confidence 999999995 69999998764 5999999999999999999999999999999999999953 447999999999999
Q ss_pred cCCCceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------------
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG-------------- 312 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-------------- 312 (447)
.....++.++.|.+|+|||++. +.|+.+.||||+|||++|+++-++.|.+.++.+.+.+|..--
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 9988999999999999999975 569999999999999999999999999999888877775421
Q ss_pred -----CCCCCCc-------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 313 -----VDFESEP-------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 313 -----~~~~~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+.++.-. ....+.++.+||.+||.+||.+||||.++|+||||+...
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1111110 123688999999999999999999999999999998653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-53 Score=409.38 Aligned_cols=256 Identities=30% Similarity=0.538 Sum_probs=236.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.++||+|+||+|++|..+.+++.||||++.|..+....+.+....|.+|+.....||.++.++..|+.+.++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 55999999999999999999999999999999999999988899999999999999998999999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~ 252 (447)
|||+.||++. .+...+.|++..++.|+..|+.||.|||++||||||||.+|||+ |..+.+||+|||+++..- .+.
T Consensus 448 mey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 448 MEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCCC
Confidence 9999999954 34455789999999999999999999999999999999999999 555689999999998643 566
Q ss_pred ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
.+.++||||.|||||++.+ .|+.++|+|||||+|||||.|..||.+.+..++++.|+...+.++. .+|.++.+++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~il 599 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAIM 599 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHHH
Confidence 7788999999999999975 5999999999999999999999999999999999999998877776 4899999999
Q ss_pred HHhcccCCCCCCCH-----HHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRITS-----AEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~t~-----~~~l~h~~~~~~ 357 (447)
+++|.+||++|..+ .+|.+||||+..
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999999875 789999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=407.28 Aligned_cols=256 Identities=32% Similarity=0.555 Sum_probs=234.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.|... .+.+...+.+|++|++.|+ ||||+.++++|+...++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence 358899999999999999999999999999999987653 4456778999999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK- 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 252 (447)
+|||.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.|||+ +..+.+|+||||+|+....+.
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence 999977 999999999999999999999999999999999999999999999999 666789999999999876554
Q ss_pred ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
..+..-|||.|||||.+.+ .|+..+|+||+|||+|||++|++||......++...|......++. ..|..+++|+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence 4566789999999999874 5999999999999999999999999999999999999998776665 5799999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
..+|.+||.+|+|..+++.|||.++...
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 9999999999999999999999986533
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-53 Score=372.74 Aligned_cols=268 Identities=37% Similarity=0.660 Sum_probs=240.5
Q ss_pred ccccceeec-ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe---
Q 013201 91 DIRQFYTLG-KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--- 166 (447)
Q Consensus 91 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 166 (447)
.+.+.|.+. ++||-|-.|.|..|.++.||+.+|+|++.. .....+|+++.-...+|||||.++++|+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 355667774 679999999999999999999999997732 35567899998888899999999999864
Q ss_pred -CCeEEEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 167 -RQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 167 -~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
...+.+|||.++||.|+..+..++. |+|.++..|++||..|+.|||+.+|.||||||+|+|......+..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 4678899999999999999998776 9999999999999999999999999999999999999988888999999999
Q ss_pred CceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH----HHHHHHHHhCCCCCCCC
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAILKGGVDFESE 318 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~ 318 (447)
+|+.........+.+-||+|.|||++. ..|+..+|+||+||++|.||+|.+||+.... .++..+|..+.+.|+.+
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 999877666677889999999999997 5699999999999999999999999987643 46778899999999999
Q ss_pred ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCccc
Q 013201 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIG 366 (447)
Q Consensus 319 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~ 366 (447)
.|..+|+.++|+|+++|..+|.+|.|+.+++.|||+.........++.
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~ 337 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS 337 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence 999999999999999999999999999999999999988766655554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-53 Score=365.44 Aligned_cols=262 Identities=30% Similarity=0.503 Sum_probs=224.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
.+|...+.||+|.||+||+|++..+|+.||||.|......+.... ...+||+.|+.++ |+||+.++++|-..+.+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~-talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINR-TALREIKLLQELK-HPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccH-HHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence 358889999999999999999999999999999987765544443 4569999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
+||++. +|...++.+. .++..++..++.+++.||+|||++.|+||||||.|+|++ .++.+||+|||+|+.+....
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCC
Confidence 999964 8988887654 589999999999999999999999999999999999994 44579999999999876543
Q ss_pred -ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc---------
Q 013201 253 -VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW--------- 320 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 320 (447)
.....+-|.+|+|||.+- +.|+..+||||.|||+.||+.|.+-|.+.++.+.+..|.+.--......|
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 333448899999999885 45999999999999999999999999999999988888764322222222
Q ss_pred ---------------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 321 ---------------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 321 ---------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
...+.++.||+.+||.+||.+|+|+.|+|+|+||+..+...
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 23577889999999999999999999999999999865543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=387.93 Aligned_cols=259 Identities=34% Similarity=0.604 Sum_probs=224.2
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh-----------hhHHHHHHHHHHHHhccCCCCeeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-----------QDREDIKREIQIMQHLSGQQNIVEF 160 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-----------~~~~~~~~E~~~l~~l~~h~~iv~~ 160 (447)
.-+.|++.+.||.|.||.|.+|++..+++.||+|++.+..+... ...+++.+||.||++|. |||||+|
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~L 173 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKL 173 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEE
Confidence 34569999999999999999999999999999999977654321 23468899999999998 9999999
Q ss_pred EEEEEeC--CeEEEEEeccCCCchHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCce
Q 013201 161 RGAYEDR--QSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 161 ~~~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
+++..+. +.+|||+|||..|.+.. .-..+. +++.+++.|++.++.||.|||.+||+||||||+|+|+ +.+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCcE
Confidence 9999764 67999999999988743 333344 8999999999999999999999999999999999999 445679
Q ss_pred EEecCCCceeccCC------CceeecCCcccccccccccc-----cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHH
Q 013201 238 KATDFGLSVFIDEG------KVYRDIVGSAYYVAPEVLRR-----SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFD 306 (447)
Q Consensus 238 kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 306 (447)
||+|||.+.....+ ..+...+|||.|+|||...+ ..+.+.||||+||+||.|+.|+.||.+....++++
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999866322 22334799999999998753 14778999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 307 AILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 307 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+|......++..+ .+.+.++|||.+||.+||++|++..+|..|||....
T Consensus 330 KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9999888777654 578999999999999999999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-53 Score=381.05 Aligned_cols=276 Identities=33% Similarity=0.540 Sum_probs=234.5
Q ss_pred CCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
.....+..+|...+.||+|+||.|+.|.++.+|..||+|.+.. .+......++..+|+++|++++ |+||+.+.+++..
T Consensus 15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p 92 (359)
T KOG0660|consen 15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRP 92 (359)
T ss_pred eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccc
Confidence 3445667778889999999999999999999999999998852 4566777888999999999998 9999999999865
Q ss_pred -----CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 167 -----RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 167 -----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
-+.+|+|+|+| +.+|...++.+..+++..+..++.||+.||.|+|+.+|+||||||+|+|++.+ ..+||||
T Consensus 93 ~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~---c~lKI~D 168 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD---CDLKICD 168 (359)
T ss_pred ccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC---CCEEecc
Confidence 46799999999 56899988888779999999999999999999999999999999999999544 4599999
Q ss_pred CCCceeccC---CCceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC----
Q 013201 242 FGLSVFIDE---GKVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG---- 312 (447)
Q Consensus 242 fg~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~---- 312 (447)
||+|+.... ....+.++.|.+|+|||++. ..|+.+.||||+|||+.||++|++.|.+.+....+..|+.--
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 999998764 44557789999999999874 459999999999999999999999999987766666554311
Q ss_pred -------------------CCCCCCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHH
Q 013201 313 -------------------VDFESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSA 368 (447)
Q Consensus 313 -------------------~~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~ 368 (447)
...+..+ +...++.+.||+.+||..||.+|+|++|+|+||||.......++|....
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~ 327 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQP 327 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCC
Confidence 1111112 2467899999999999999999999999999999999888877765433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=376.08 Aligned_cols=245 Identities=29% Similarity=0.540 Sum_probs=214.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEE-EEEe-CCeEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRG-AYED-RQSVH 171 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~-~~~~-~~~~~ 171 (447)
..|++.++||+|+||+||++.+..+|..+|.|.|.-. ..+...++.+..|+.+|++|+ |||||++++ .|.+ +..++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhH
Confidence 3499999999999999999999999999999999743 345667788999999999998 999999998 4444 44599
Q ss_pred EEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh--cC--cEeecCCCCceEeecCCCCCceEEecCC
Q 013201 172 LVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHF--MG--VMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~--~~--ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
||||||.+|+|...++. .+.++|..++.++.|++.||.+||. .+ |+||||||.||++ +.++.|||+|||
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfG 173 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFG 173 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccch
Confidence 99999999999988864 3569999999999999999999998 55 9999999999999 455579999999
Q ss_pred CceeccCCCce-eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 244 LSVFIDEGKVY-RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 244 ~a~~~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
+++.+...... .+.+|||+||+||.+. .+|+.++||||+||++|||+.-.+||.+.+-.++..+|..+.++. -+-.
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~--~p~~ 251 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP--LPDE 251 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC--CcHH
Confidence 99988765443 4689999999999987 569999999999999999999999999999999999999885542 2223
Q ss_pred cCChHHHHHHHHhcccCCCCCCCH
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITS 345 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~ 345 (447)
.+|..+..||..|+.+||..||+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 579999999999999999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-53 Score=401.96 Aligned_cols=257 Identities=33% Similarity=0.551 Sum_probs=225.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
....|....+||+|+.|.||.|+...+++.||||.+.... ...++-+.+|+.+|+.++ |+|||.+++.|...+.+|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhcc-chHHHHHHHHhcccceeE
Confidence 4567999999999999999999999999999999996543 345677899999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+||||++||+|.+.+... .++|.+++.|+++++.||+|||.+||+|||||.+|||++.++ .+||+|||++..+...
T Consensus 347 VVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g---~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG---SVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC---cEEEeeeeeeeccccc
Confidence 999999999998877654 599999999999999999999999999999999999995544 5999999999988765
Q ss_pred C-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 K-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
. ...+.+|||+|||||++. ..|++++||||||++++||+-|.+||...+....+..|..++.. .......+|++++|
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P-~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-KLKNPEKLSPELKD 501 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC-CcCCccccCHHHHH
Confidence 4 456789999999999986 56999999999999999999999999987776666666554432 22333478999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
|+.+||+.|+.+|++|.+||+||||+..
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999553
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-53 Score=385.91 Aligned_cols=257 Identities=37% Similarity=0.645 Sum_probs=242.2
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
-.+..+|++.+.||.|.||.|-+|+....|+.||||.|.+..+.++++.-.+.+||+||..|+ ||||+.++++|+..+.
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFENKDK 127 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcCCce
Confidence 345678999999999999999999999999999999999999999999999999999999998 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+.|||||..+|.|++|+.+++.+++.+++.+++||++|+.|||.++++|||||.+|||+ |.+.++||+|||++..+.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999 555579999999999999
Q ss_pred CCCceeecCCccccccccccccc--CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.++...++||+|-|.+||++++. -++.+|-|||||+||.|+.|..||.+.+...++.+|..|.+.-+.. +..+
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-----PSdA 279 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-----PSDA 279 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-----CchH
Confidence 99889999999999999999864 4889999999999999999999999999999999999998776654 5678
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
.-||+.||.+||++|.|+++|-.|=|+.
T Consensus 280 ~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 280 SGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHHHhcCcccchhHHHHhhhheee
Confidence 8999999999999999999999998886
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=372.27 Aligned_cols=263 Identities=30% Similarity=0.445 Sum_probs=222.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQSVH 171 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 171 (447)
+.|+....|++|+||.||+|+++.|+..||+|++........-.. .-.+||.+|.+++ |||||.+.++... -+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKAR-HPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcC-CCCeeeeEEEEeccccceee
Confidence 349999999999999999999999999999999966553322222 3468999999998 9999999998754 46799
Q ss_pred EEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||||+. +|...+...+ +|...+++.++.|++.|++|||.++|+|||||++|+|++.. +.+||+|||+|+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~---G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK---GILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC---CcEEecccchhhhhcC
Confidence 99999975 8988888765 79999999999999999999999999999999999999554 4699999999998765
Q ss_pred C-CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---------------
Q 013201 251 G-KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG--------------- 312 (447)
Q Consensus 251 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--------------- 312 (447)
. +.++..+-|.+|+|||.+.+ .|+.+.||||+|||+.||+++++.|.+....+.++.|.+.-
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 4 45677889999999999864 49999999999999999999999999999988888886521
Q ss_pred ----CCCCCCcc---------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 013201 313 ----VDFESEPW---------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASD 362 (447)
Q Consensus 313 ----~~~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~ 362 (447)
..++..++ ..+++...+|+..+|.+||.+|.||+|+|+|.||.+.+.+.+
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~ 372 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPID 372 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCC
Confidence 11111111 125688999999999999999999999999999999766544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-53 Score=360.80 Aligned_cols=255 Identities=33% Similarity=0.649 Sum_probs=235.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++++.||+|-||.||+|+.+.++..||+|++.|+.+.......++.+|++|-..|+ ||||++++++|-+....||+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence 44999999999999999999999999999999999988776777788999999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKII--AQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+||..+|+|+..|. ...++++..++.++.|++.||.|||.++|+||||||+|+|++ ....+||+|||-+.... .
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP-S 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecC-C
Confidence 99999999999998 567799999999999999999999999999999999999994 44469999999998765 4
Q ss_pred CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
....+.|||..|.+||+..+ .++..+|+|++|++.||++.|.+||......+++.+|.+..+.++. .++..++||
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~a~dl 252 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGGAADL 252 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChhHHHH
Confidence 44567899999999999874 5899999999999999999999999999999999999998877773 589999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
|.+||.++|.+|.+..|++.|||+...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=385.27 Aligned_cols=257 Identities=34% Similarity=0.548 Sum_probs=214.6
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--eEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ--SVHL 172 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~l 172 (447)
.|..++.||+|+||.||++.+..+|..+|||.+... +....+.+.+|+.+|++++ |||||++++...... .++|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEe
Confidence 488899999999999999999999999999988654 2222677999999999999 999999999754444 6999
Q ss_pred EEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-
Q 013201 173 VMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE- 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~- 250 (447)
+|||++||+|.+++.+.+ .+++..++.+.+||+.||.|||++|||||||||+|||++.. ++.+||+|||++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCccccccccc
Confidence 999999999999999987 79999999999999999999999999999999999999652 34699999999987663
Q ss_pred ---CCceeecCCcccccccccccccC--CCCCcchhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 251 ---GKVYRDIVGSAYYVAPEVLRRSY--GKEIDVWSAGVILYILLSGVPPFWA-ETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 251 ---~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
........||+.|||||++.... +.++|||||||++.||+||..||.. ......+-.+.........+ ..+|
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip--~~ls 249 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIP--DSLS 249 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCC--cccC
Confidence 12234578999999999988443 3499999999999999999999987 33333344444333222222 2489
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+++++||.+||..||++||||+++|.|||......
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999999987544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-51 Score=372.94 Aligned_cols=261 Identities=32% Similarity=0.549 Sum_probs=233.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||.|.-|+||+|....++..+|+|++.+..+.......+...|-+||+.+. ||.+++|+..|+.+...|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEEE
Confidence 45899999999999999999999999999999999988777777788889999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc--
Q 013201 174 MELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-- 249 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-- 249 (447)
||||+||+|...+.++ +.|++..++.|+.+++.||+|||-.|||+|||||+|||| .++++|.|+||.++....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999999999988774 459999999999999999999999999999999999999 455579999999754210
Q ss_pred --------------------------------CCC-----------------------ceeecCCcccccccccccc-cC
Q 013201 250 --------------------------------EGK-----------------------VYRDIVGSAYYVAPEVLRR-SY 273 (447)
Q Consensus 250 --------------------------------~~~-----------------------~~~~~~gt~~y~aPE~~~~-~~ 273 (447)
..+ ...+++||-.|.|||++.+ ++
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 0123689999999999985 58
Q ss_pred CCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCC----HHHHh
Q 013201 274 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRIT----SAEVL 349 (447)
Q Consensus 274 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t----~~~~l 349 (447)
+.++|+|+|||+||||+.|..||.+.+..+++.+|+.....++..+ .++..++|||+++|.+||++|.. |+||-
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 9999999999999999999999999999999999999888887765 67899999999999999999999 99999
Q ss_pred cCCCccCCCCC
Q 013201 350 EHPWMREGGEA 360 (447)
Q Consensus 350 ~h~~~~~~~~~ 360 (447)
+||||+....+
T Consensus 391 ~HpFF~gVnWa 401 (459)
T KOG0610|consen 391 RHPFFEGVNWA 401 (459)
T ss_pred cCccccCCChh
Confidence 99999976443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-51 Score=375.60 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=226.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++...||.|..++||+|++..++..||||++...+..+ +.+.+.+|+..|+.++ ||||++++..|..+..+|+|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLID-HPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcC-CCCcceEEEEEEecceeEEe
Confidence 45999999999999999999999999999999997665432 3788999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|.||.+|++.++++.. ..++|..++.|++++++||.|||.+|.||||||+.|||| +.++.|||+|||.+..+.+.
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeeccc
Confidence 9999999999999874 459999999999999999999999999999999999999 55567999999988655432
Q ss_pred -Cc----eeecCCccccccccccc---ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC------CCC
Q 013201 252 -KV----YRDIVGSAYYVAPEVLR---RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD------FES 317 (447)
Q Consensus 252 -~~----~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------~~~ 317 (447)
.. +...+||++|||||++. .+|+.|+|||||||+..||.+|..||......+++-.-+++... ++.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 21 14569999999999954 46999999999999999999999999998888777666666553 222
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
.....++..++.+|..||++||++|||++++|+|+||+....
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 333457889999999999999999999999999999997644
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=389.61 Aligned_cols=254 Identities=32% Similarity=0.612 Sum_probs=226.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++++. ||||+++++++.+++.+|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEE
Confidence 45999999999999999999999999999999987654444445677889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|||+.||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---NKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---CCCCEEEeeccCceEcCCCc-
Confidence 99999999999999988999999999999999999999999999999999999994 44569999999998765432
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+..+..+...++. .++..+++||.
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 247 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVK 247 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHHH
Confidence 3468999999999986 45889999999999999999999999998888888888877655443 37899999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
+||+.||.+|++ +++++.||||++.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 999999999997 7999999999863
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=388.09 Aligned_cols=250 Identities=31% Similarity=0.559 Sum_probs=220.8
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++++. ||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999987654444445567889999999997 99999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 258 (447)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.... ........+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC---CCCEEEeeCCCCcccccCCCccccee
Confidence 999999998889999999999999999999999999999999999999944 4569999999987532 223334568
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++. ..++.++|||||||++|||++|..||...+.......+..+...++. .+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 999999999986 45899999999999999999999999998888888888776655543 4799999999999999
Q ss_pred CCCCCC-----CHHHHhcCCCccCC
Q 013201 338 DPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 338 dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
||++|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=382.76 Aligned_cols=262 Identities=35% Similarity=0.608 Sum_probs=240.2
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+..-|.+.+.||+|-|++|.+|+|--+|..||||+|.|.++. ......+.+|++.|+.+. |||||+++++......+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTKL 92 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccceE
Confidence 4556699999999999999999999999999999999887763 445677889999999887 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|||+|+-.+|+|+++|.+. ..+.|..+++|+.||+.|+.|||...+|||||||+||.+...- +.|||.|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl--GlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL--GLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec--CceEeeeccccccCC
Confidence 9999999999999999875 4699999999999999999999999999999999999986543 479999999999999
Q ss_pred CCCceeecCCccccccccccccc-C-CCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRRS-Y-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
+++...+.||+..|-|||++.+. | .+++||||||||||.|++|++||...++.+.+-.|+...+..+. .+|.++
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~eC 246 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKEC 246 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHHH
Confidence 99999999999999999998653 5 56899999999999999999999999999999999999888776 489999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
+|||.+||..||++|.+.++|..|+|++.....
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 999999999999999999999999999876543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=383.28 Aligned_cols=253 Identities=28% Similarity=0.542 Sum_probs=224.7
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++++. ||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEEE
Confidence 5899999999999999999999999999999986544333344567889999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~---~~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK---EGHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC---CCCEEEEecCcchhccCC--c
Confidence 99999999999998889999999999999999999999999999999999999944 456999999999866443 2
Q ss_pred eecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++. .+++.+++||++
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 231 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKK 231 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHHH
Confidence 34579999999999864 4889999999999999999999999999888888888887665543 368899999999
Q ss_pred hcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 334 MLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 334 ~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
||+.||.+|++ +++++.||||...
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 99999999995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=364.26 Aligned_cols=266 Identities=35% Similarity=0.632 Sum_probs=238.3
Q ss_pred cccceee-cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 92 IRQFYTL-GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 92 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+.+.|++ .+.||+|+|+.|--|....+|..||||+|.|. ....+.++.+|++++.++.+|+||+.++++|+++..+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4556776 57899999999999999999999999999775 3456788999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||-+.||+|..+|.++..|+|.++..+++.|+.||.|||.+||.||||||+|||....+.-..||||||.+...+..
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999998777777899999998764432
Q ss_pred --------CCceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCC---------------H
Q 013201 251 --------GKVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAET---------------E 301 (447)
Q Consensus 251 --------~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~---------------~ 301 (447)
.....+.+|+..|||||+.. ..|+.++|+||||+|||.||+|.+||.+.- .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 12344578999999999853 248999999999999999999999996531 3
Q ss_pred HHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 302 KGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 302 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
+.+++.|.+|.+.|+...|..+|.+++|||..+|..|+.+|.++.++++|||+......
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 57889999999999999999999999999999999999999999999999999876443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=389.94 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=221.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++++. |+||+++++.+.+...+||||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEEE
Confidence 5899999999999999999999999999999987654444445567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
|||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~---~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS---KGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC---CCCEEEeeccCcccccccccc
Confidence 99999999999999889999999999999999999999999999999999999944 4579999999987543210
Q ss_pred ----------------------------------ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCC
Q 013201 253 ----------------------------------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFW 297 (447)
Q Consensus 253 ----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~ 297 (447)
.....+||+.|+|||++. ..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 012358999999999986 458999999999999999999999999
Q ss_pred CCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCC---CCCCHHHHhcCCCccCC
Q 013201 298 AETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPK---KRITSAEVLEHPWMREG 357 (447)
Q Consensus 298 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~---~R~t~~~~l~h~~~~~~ 357 (447)
+.+..+.+..+.........++...+++++++||.+|+. +|. .||+++|+++||||+..
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 988888888887654333333334578999999999775 444 46899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=376.30 Aligned_cols=258 Identities=28% Similarity=0.490 Sum_probs=215.8
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++++. |+||+++++++.+.+.+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEE
Confidence 788999999999999999999999999999987654433334456789999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 176 LCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++ .+..+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~---~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD---DRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeCCCcEEcCCCCe
Confidence 99999998887653 3589999999999999999999999999999999999994 445699999999987665555
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
.....||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+..............+++++.+||+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 55678999999999986 46899999999999999999999999876543322222221111111122347899999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
+||+.||.+||+ ++++++||||.+.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999999997 8999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=389.88 Aligned_cols=258 Identities=28% Similarity=0.536 Sum_probs=223.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+++.+||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEEE
Confidence 5899999999999999999999999999999997654444445567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
|||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD---AKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEeecccceeccccccc
Confidence 9999999999999888899999999999999999999999999999999999994 44579999999987543211
Q ss_pred -------------------------------------ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCC
Q 013201 253 -------------------------------------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVP 294 (447)
Q Consensus 253 -------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~ 294 (447)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 001246999999999986 458999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 013201 295 PFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRIT---SAEVLEHPWMREG 357 (447)
Q Consensus 295 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~h~~~~~~ 357 (447)
||...+..+....+......+..+....+++++++||.+||. +|.+|++ ++++++||||+..
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999988888887777655444444444679999999999997 9999998 9999999999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-50 Score=384.50 Aligned_cols=257 Identities=30% Similarity=0.499 Sum_probs=224.4
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+||||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEE
Confidence 5999999999999999999999999999999997654444445567889999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ....+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEEEeCcCCccccc--cc
Confidence 9999999999998888899999999999999999999999999999999999994 445699999999976544 23
Q ss_pred eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc----ccCChHHHH
Q 013201 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW----LLISDSAKD 329 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~ 329 (447)
....||+.|+|||++. ..++.++|||||||++|||++|..||...+..+.+..+......+..+.+ ..+++++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 4568999999999986 45899999999999999999999999998888777776654332222222 246899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
||.+||..+|.+||+++++++||||.+.
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-52 Score=382.34 Aligned_cols=273 Identities=27% Similarity=0.454 Sum_probs=232.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|...+.||+|+||.||+|.+..+++.||+|++.... .+...+++.+|+.+|.+++ ++||.++++.|..+..++++|
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHHH
Confidence 4888899999999999999999999999999996544 3455788999999999998 899999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
|||.||++.+.|.....+.+.++.-++++++.||.|||..+.+|||||+.|||+..+ +.+||+|||++.+.......
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~---g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES---GDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc---CcEEEEecceeeeeechhhc
Confidence 999999999999888778999999999999999999999999999999999999665 46999999999987765433
Q ss_pred -eecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 255 -RDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 255 -~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
.+++|||.|||||++.. .|+.++||||||++.|||++|.+|+........+..|-+...+... ..+|+.+++||.
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFKEFVE 244 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHHHHHH
Confidence 67899999999999985 6999999999999999999999999888775444444443322222 257999999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHHHHHH
Q 013201 333 KMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAM 379 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (447)
.||.+||+.||+|.++|+|+|++.. .........+.+.++++..
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~FIk~a---~k~s~L~~~i~r~~~~~~~ 288 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHKFIKRA---KKTSELKELIDRYKRWRVK 288 (467)
T ss_pred HHhhcCcccCcCHHHHhhhHHHHhc---CCchHHHHHHHHHHHHhhc
Confidence 9999999999999999999999983 2233335555555555543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=384.19 Aligned_cols=254 Identities=30% Similarity=0.555 Sum_probs=224.4
Q ss_pred cceeecceeccccCeEEEEEEECCCC-CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTG-NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
+.|.+.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEEE
Confidence 45999999999999999999876655 689999987655444445677889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||+.||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEecCCCCeecCCC-
Confidence 999999999999999988999999999999999999999999999999999999994 4457999999999876442
Q ss_pred ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..+...++. .+++.+.++|
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li 259 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLM 259 (340)
T ss_pred -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHH
Confidence 235689999999999864 4899999999999999999999999998888888888877655443 3689999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
++||+.||++|+ +++++++||||...
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999995 89999999999863
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=379.87 Aligned_cols=248 Identities=29% Similarity=0.543 Sum_probs=219.0
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGE 181 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 181 (447)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+..|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999987654444555677889999999997 9999999999999999999999999999
Q ss_pred hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCceeecCCc
Q 013201 182 LFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIVGS 260 (447)
Q Consensus 182 L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 260 (447)
|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++..... .......+||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD---YQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC---CCCcEEEEECcccccCccCCCccccccCC
Confidence 999999888999999999999999999999999999999999999994 445699999999875432 2233456899
Q ss_pred ccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCC
Q 013201 261 AYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339 (447)
Q Consensus 261 ~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 339 (447)
+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++. .+++++++||.+||..||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcCCCH
Confidence 99999999864 5899999999999999999999999998888888888877655543 478999999999999999
Q ss_pred CCCC---CHHHHhcCCCccCC
Q 013201 340 KKRI---TSAEVLEHPWMREG 357 (447)
Q Consensus 340 ~~R~---t~~~~l~h~~~~~~ 357 (447)
.+|| ++.++|.||||.+.
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 57999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=389.15 Aligned_cols=259 Identities=29% Similarity=0.486 Sum_probs=220.4
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++++++ |+||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence 4899999999999999999999999999999997765555555678899999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++ ....+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~---~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID---LDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC---CCCCEEEeeCcCCccccccccc
Confidence 9999999999999888899999999999999999999999999999999999994 44579999999975321000
Q ss_pred ----------------------------------------------ceeecCCccccccccccc-ccCCCCCcchhHHHH
Q 013201 253 ----------------------------------------------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVI 285 (447)
Q Consensus 253 ----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~i 285 (447)
.....+||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 012357999999999986 458999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcc--cCCCCCCCHHHHhcCCCccCC
Q 013201 286 LYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI--QDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 286 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~--~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+|||++|..||...+..+....+.........+....+++++.+||.+|+. .++..|++++++++||||.+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999999888777666666543334444444689999999999654 455569999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=380.80 Aligned_cols=250 Identities=29% Similarity=0.547 Sum_probs=219.7
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997655444555677889999999997 99999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 258 (447)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++..... .......+
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---CCCcEEEecCcCCccCCCccccccccc
Confidence 99999998888899999999999999999999999999999999999994 445699999999875332 22334568
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+......++. .+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----CCCHHHHHHHHHHcCC
Confidence 999999999986 45899999999999999999999999988888777777766555443 4789999999999999
Q ss_pred CCCCCC-----CHHHHhcCCCccCC
Q 013201 338 DPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 338 dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
||++|+ ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999997 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=376.36 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=213.0
Q ss_pred eeecceeccccCeEEEEEEECCCCCE-EEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-eEEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNS-YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-SVHLV 173 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~-~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv 173 (447)
..+.+.||+|+||+||+|.++ |.. ||+|++......... .+.|.+|+.+|.+++ |||||++++++.+.. .++||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEEE
Confidence 456677999999999999987 556 999998765544443 789999999999998 999999999999887 79999
Q ss_pred EeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC-cEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 174 MELCSGGELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMG-VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~-ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||+++|+|.+++.. .+.++...+..++.+|+.|+.|||+++ ||||||||+|||++.+. .++||+|||+++....
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREKVI 196 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceeecc
Confidence 999999999999988 578999999999999999999999999 99999999999994433 3899999999987665
Q ss_pred C-CceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 G-KVYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
. .......||+.|||||++.+ .|+.++|||||||+||||+||+.||.+....+....+..+......+. .+++.
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~~~~ 274 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--ECPPH 274 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHH
Confidence 4 23344789999999999984 399999999999999999999999999988766666665554444332 27899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+..||.+||..||.+||++.+++.
T Consensus 275 l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 275 LSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999999999863
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=379.85 Aligned_cols=250 Identities=32% Similarity=0.560 Sum_probs=220.1
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|++..+|..||+|++.+...........+.+|+.+++.++ ||||+++++++...+.+||||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46999999999999999999999999987654444445667788999999997 99999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 258 (447)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++.... .........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC---CCCEEecccHHhccccCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999954 4469999999987532 222334567
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++. +.++.++|||||||++|+|++|..||...+.......+......++. .+++++++||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 999999999986 45899999999999999999999999998888888887776655543 4789999999999999
Q ss_pred CCCCCC-----CHHHHhcCCCccCC
Q 013201 338 DPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 338 dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
||++|+ ++.++++|+||.+.
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999998 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=388.78 Aligned_cols=258 Identities=29% Similarity=0.528 Sum_probs=219.3
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|.+.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+...+||||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEEE
Confidence 5899999999999999999999999999999987654434445677889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
|||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++ .+..+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeeccccccccccccc
Confidence 9999999999999888899999999999999999999999999999999999994 44579999999985321100
Q ss_pred ----------------------------------------------ceeecCCccccccccccc-ccCCCCCcchhHHHH
Q 013201 253 ----------------------------------------------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVI 285 (447)
Q Consensus 253 ----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~i 285 (447)
.....+||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 001247999999999986 458999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCccCC
Q 013201 286 LYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKR---ITSAEVLEHPWMREG 357 (447)
Q Consensus 286 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---~t~~~~l~h~~~~~~ 357 (447)
+|||++|..||.+.+..+.+..+.........+....++.++++||.+||. +|.+| +++.+++.||||+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999999999999888877777776543333333334578999999999998 66665 599999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=377.93 Aligned_cols=255 Identities=29% Similarity=0.516 Sum_probs=224.6
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+..|+.++..+.+|++|+.+++++.+.+.+|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 88999999999999999999999999999998765444445567788999999999867789999999999999999999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCCce
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVY 254 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~ 254 (447)
|++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.... .....
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA---EGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC---CCCEEEeecCcceecCCCCCce
Confidence 9999999999988888999999999999999999999999999999999999954 4569999999987532 22334
Q ss_pred eecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......++. .+++++.++|.+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 234 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG 234 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 45689999999999864 5899999999999999999999999999888888888876655443 478999999999
Q ss_pred hcccCCCCCCCH-----HHHhcCCCccCC
Q 013201 334 MLIQDPKKRITS-----AEVLEHPWMREG 357 (447)
Q Consensus 334 ~L~~dp~~R~t~-----~~~l~h~~~~~~ 357 (447)
||..||.+|+++ +++++||||...
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999986 899999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=378.73 Aligned_cols=251 Identities=30% Similarity=0.534 Sum_probs=220.2
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987654434445567788999998886799999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 258 (447)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.... .........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~---~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeeCCCCeecCcCCCcccccc
Confidence 99999998888999999999999999999999999999999999999994 44569999999987543 223334568
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+++..+..+...++. .++.++.+||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccc
Confidence 999999999986 45899999999999999999999999999988888888876654433 4789999999999999
Q ss_pred CCCCCCCH------HHHhcCCCccCC
Q 013201 338 DPKKRITS------AEVLEHPWMREG 357 (447)
Q Consensus 338 dp~~R~t~------~~~l~h~~~~~~ 357 (447)
||++|+++ ++++.||||...
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99999998 899999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=388.09 Aligned_cols=258 Identities=30% Similarity=0.514 Sum_probs=221.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++++. |+||+++++.+.+++.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence 4899999999999999999999999999999987654434445667889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC---
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG--- 251 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~--- 251 (447)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~---~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEeECCCCccccccccc
Confidence 9999999999998888899999999999999999999999999999999999994 4457999999997532100
Q ss_pred ---------------------------------------------CceeecCCccccccccccc-ccCCCCCcchhHHHH
Q 013201 252 ---------------------------------------------KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVI 285 (447)
Q Consensus 252 ---------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~i 285 (447)
......+||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0012347999999999986 458999999999999
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 013201 286 LYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRIT---SAEVLEHPWMREG 357 (447)
Q Consensus 286 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~h~~~~~~ 357 (447)
+|||++|..||.+.+..+....+.........+....+++++.++|.+|+ .+|.+|++ +.++++||||+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999999988887777777665544444545568999999999986 59999997 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=384.20 Aligned_cols=259 Identities=32% Similarity=0.524 Sum_probs=224.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..++..||+|++.+...........+.+|+.+++.++ ||||+++++++.+++.+|+|
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEEE
Confidence 46999999999999999999999999999999987654434444566789999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 122 MEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc---CCCCEEEEeccceeeccCCCc
Confidence 999999999988765 4689999999999999999999999999999999999994 455799999999987644321
Q ss_pred --eeecCCcccccccccccc-----cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 254 --YRDIVGSAYYVAPEVLRR-----SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 254 --~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+....+..+.........+....+|.+
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 234679999999998753 3788999999999999999999999999888888888776544444444468999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 013201 327 AKDLVRKMLIQDPKK--RITSAEVLEHPWMREG 357 (447)
Q Consensus 327 ~~~li~~~L~~dp~~--R~t~~~~l~h~~~~~~ 357 (447)
+++||.+||..+|.+ |++++++++||||+..
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=388.10 Aligned_cols=258 Identities=28% Similarity=0.489 Sum_probs=220.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.+. |+||+++++.+.+++.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEEE
Confidence 5999999999999999999999999999999986654433344567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC---
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG--- 251 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~--- 251 (447)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ ....+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC---CCCCEEEEeCCCCccccccccc
Confidence 9999999999999888899999999999999999999999999999999999994 4457999999997432100
Q ss_pred -----------------------------------------CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHH
Q 013201 252 -----------------------------------------KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYIL 289 (447)
Q Consensus 252 -----------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~el 289 (447)
......+||+.|+|||++. ..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0011357999999999986 4589999999999999999
Q ss_pred hhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCC
Q 013201 290 LSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI---TSAEVLEHPWMREG 357 (447)
Q Consensus 290 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~~~l~h~~~~~~ 357 (447)
++|..||.+....+....+.........+....+++++.++|.+|+ .+|.+|+ ++.++++||||+..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999999988877777766655444444444568999999999977 5999999 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=376.90 Aligned_cols=251 Identities=27% Similarity=0.515 Sum_probs=220.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987655444455667788999998876799999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 258 (447)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD---AEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeecccceecccCCccccccc
Confidence 99999998888899999999999999999999999999999999999994 445799999999875432 22334567
Q ss_pred Ccccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+..+...++. .+++++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcc
Confidence 9999999999864 5899999999999999999999999999988888888877654443 3789999999999999
Q ss_pred CCCCCC-------CHHHHhcCCCccCC
Q 013201 338 DPKKRI-------TSAEVLEHPWMREG 357 (447)
Q Consensus 338 dp~~R~-------t~~~~l~h~~~~~~ 357 (447)
||++|+ +++++++||||...
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 999999 99999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=382.64 Aligned_cols=260 Identities=31% Similarity=0.513 Sum_probs=223.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..+++.+|+|++.+...........+.+|+.+++.++ ||||+++++++.+++.+|+
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEE
Confidence 456999999999999999999999999999999987654444445566889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ....+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEEecccceecccCC
Confidence 99999999999988654 689999999999999999999999999999999999994 44579999999998765432
Q ss_pred c--eeecCCcccccccccccc-----cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 253 V--YRDIVGSAYYVAPEVLRR-----SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 253 ~--~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
. ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+..+....++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 2 235679999999999853 278899999999999999999999999988888888877654444444446799
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 013201 326 SAKDLVRKMLIQDPKK--RITSAEVLEHPWMREG 357 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~--R~t~~~~l~h~~~~~~ 357 (447)
.++++|.+||..++.+ |++++++++||||+..
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999999999866654 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=361.69 Aligned_cols=257 Identities=29% Similarity=0.473 Sum_probs=218.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--C--
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--Q-- 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~-- 168 (447)
.-.|.-.+++|.|+||.||.|....++..||||.+..... ---+|+.+|+.+. |||||++..+|... .
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLD-HPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcC-CcCeeeEEEEEEecCCCch
Confidence 3458889999999999999999999999999998855432 2237999999997 99999999988542 2
Q ss_pred -eEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 169 -SVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 169 -~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
+..+||||++. +|.+.++. +.+++.-.++-+..||++||.|||+.||+||||||.|+|++.+. +.+||||||
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t--g~LKicDFG 171 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT--GVLKICDFG 171 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC--CeEEeccCC
Confidence 45689999964 89888874 56799999999999999999999999999999999999997654 479999999
Q ss_pred CceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---------
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG--------- 312 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--------- 312 (447)
.|+.+..++...++..|..|+|||.+-+ .|+.+.||||.||++.||+-|++.|.+.+....+..|.+--
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 9999998888889999999999998864 59999999999999999999999999998887777765411
Q ss_pred -----------CCCCCCcc-----ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 313 -----------VDFESEPW-----LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 313 -----------~~~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
..+....| ...++++.+|+.++|.++|.+|.++.|+|.||||.+....
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 01111112 2468999999999999999999999999999999876554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=357.44 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=219.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC-eeEEEEEEEeCC----
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN-IVEFRGAYEDRQ---- 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-iv~~~~~~~~~~---- 168 (447)
..|...++||+|+||+||+|+.+.+|+.||+|++.-.... +.......+|+.+|+.|+ |+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence 3478888999999999999999999999999998654321 223355679999999998 888 999999998877
Q ss_pred --eEEEEEeccCCCchHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecC
Q 013201 169 --SVHLVMELCSGGELFDKIIAQG----HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 169 --~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
.+++|+||+. .+|..++.... .++...++.+++||+.||+|||+++|+||||||+||||+. .+.+||+||
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~---~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS---SGVLKLADF 164 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC---CCcEeeecc
Confidence 8999999995 59999998755 5788899999999999999999999999999999999955 557999999
Q ss_pred CCceecc-CCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc
Q 013201 243 GLSVFID-EGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP 319 (447)
Q Consensus 243 g~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 319 (447)
|+|+... +...+..-++|.+|+|||++.+ .|+...||||+|||++||++++..|.+..+.+.+..|.+---......
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9999766 4455677899999999999864 499999999999999999999999999999888887765221111111
Q ss_pred c--------------------------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 320 W--------------------------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 320 ~--------------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
| ...++...+++.+||+++|.+|.|++.+|.||||......
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 1 1234589999999999999999999999999999986543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=384.04 Aligned_cols=258 Identities=32% Similarity=0.589 Sum_probs=224.6
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|.+.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..+. |+||+++++++.+++.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEEE
Confidence 5999999999999999999999999999999987655444455677889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEeecCCCCccCcccCcc
Confidence 9999999999999888899999999999999999999999999999999999994 44569999999997654432
Q ss_pred ----------------------------ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH
Q 013201 253 ----------------------------VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKG 303 (447)
Q Consensus 253 ----------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 303 (447)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2234579999999999864 58999999999999999999999999988887
Q ss_pred HHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCC-HHHHhcCCCccCC
Q 013201 304 IFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRIT-SAEVLEHPWMREG 357 (447)
Q Consensus 304 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t-~~~~l~h~~~~~~ 357 (447)
....+.........+....+++++.+||.+||. ||.+|++ ++++++||||+..
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 777777632222333333479999999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=378.10 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=206.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++ |+||+++++++.+.+.+|+|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEEE
Confidence 45888999999999999999999999999999885432 2344567899999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK- 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 252 (447)
|||+.+++|.+. ....+..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.......
T Consensus 151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS---AKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCEEEcccccceecccccc
Confidence 999999998643 34677888999999999999999999999999999999954 4569999999998765332
Q ss_pred ceeecCCcccccccccccc------cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 253 VYRDIVGSAYYVAPEVLRR------SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
......||..|+|||++.. ..+.++|||||||++|||++|+.||...........+..............++.+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2345689999999998742 2456899999999999999999999744332222211111111111122357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+++||.+||..||++||++.|+|+||||.+..
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 99999999999999999999999999998863
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=375.45 Aligned_cols=255 Identities=27% Similarity=0.491 Sum_probs=224.8
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+.+|++|+.+++++.+.+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 88999999999999999999999999999998765544444556677889999888779999999999999999999999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCce
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVY 254 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~ 254 (447)
|+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++..... ....
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---CCCcEEEccCCCceecCCCCCcc
Confidence 999999999998888899999999999999999999999999999999999994 445699999999975432 2233
Q ss_pred eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
...+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+...++..+......++. .+++++.+||.+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~ 234 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKG 234 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHHHH
Confidence 4568999999999986 45899999999999999999999999999888888888877665543 478999999999
Q ss_pred hcccCCCCCCCH-----HHHhcCCCccCC
Q 013201 334 MLIQDPKKRITS-----AEVLEHPWMREG 357 (447)
Q Consensus 334 ~L~~dp~~R~t~-----~~~l~h~~~~~~ 357 (447)
||+.||.+|+++ .++++||||+..
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999984 899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=378.14 Aligned_cols=250 Identities=31% Similarity=0.553 Sum_probs=219.5
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997655444455667788999999997 99999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCCceeec
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDI 257 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 257 (447)
|+|..++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++ .++.+||+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC---CCCCEEEecCCCCeecCCCCcccccc
Confidence 9999999888889999999999999999999997 7999999999999994 44569999999987543 22333456
Q ss_pred CCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcc
Q 013201 258 VGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336 (447)
Q Consensus 258 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 336 (447)
.||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++. .+++++.+||.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhh
Confidence 7999999999986 45899999999999999999999999998888888877766655543 478999999999999
Q ss_pred cCCCCCC-----CHHHHhcCCCccCC
Q 013201 337 QDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 337 ~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
.||++|+ ++.++++||||...
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 9999997 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=375.82 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=213.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997655444555667889999999997799999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec-cCCCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~ 258 (447)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA---EGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC---CCCEEECcCccccccccCCCcccccc
Confidence 999999988889999999999999999999999999999999999999944 456999999998753 2333344568
Q ss_pred Ccccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCC---------CHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 259 GSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAE---------TEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 259 gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+.......+. .++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~~~ 233 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC----CCCHHHH
Confidence 9999999999864 5899999999999999999999999632 112244455555444332 4789999
Q ss_pred HHHHHhcccCCCCCCC------HHHHhcCCCccC
Q 013201 329 DLVRKMLIQDPKKRIT------SAEVLEHPWMRE 356 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t------~~~~l~h~~~~~ 356 (447)
++|.+||+.||.+|++ ++++++||||..
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999997 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=378.17 Aligned_cols=258 Identities=29% Similarity=0.471 Sum_probs=223.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|.+.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+. |+||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEEE
Confidence 5899999999999999999999999999999997655444445667889999999887 999999999999999999999
Q ss_pred eccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 175 ELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||++||+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC---CCCCEEeccCCCCeECCCCCc
Confidence 999999999999876 6799999999999999999999999999999999999994 445699999999987654332
Q ss_pred e--eecCCccccccccccc-------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 254 Y--RDIVGSAYYVAPEVLR-------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 254 ~--~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
. ....||+.|+|||++. ..++.++|||||||++|+|++|..||...+....+..+.........+....++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 2 2357999999999874 347889999999999999999999999888877777777654333333333579
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+++.+||.+||. ||.+||+++++++||||...
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=372.41 Aligned_cols=251 Identities=27% Similarity=0.476 Sum_probs=216.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|+++.++..||+|.+.+...........+..|..++..+.+||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999987654333344566778888888775699999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 258 (447)
|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++..... .......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEeCccCCCeecccCCCceeccC
Confidence 99999998888899999999999999999999999999999999999994 445699999999875322 22334568
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++++||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHccC
Confidence 999999999986 45899999999999999999999999998888888777665443332 4789999999999999
Q ss_pred CCCCCCCH-HHHhcCCCccCC
Q 013201 338 DPKKRITS-AEVLEHPWMREG 357 (447)
Q Consensus 338 dp~~R~t~-~~~l~h~~~~~~ 357 (447)
||++|+++ +++++||||+..
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCC
Confidence 99999998 588999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=372.00 Aligned_cols=251 Identities=31% Similarity=0.525 Sum_probs=216.2
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|++..+++.||+|++.+.........+.+..|..++..+.+||||+++++++..+..+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987654433444556677888887766799999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-CceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~ 258 (447)
|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++...... ......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~---~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK---DGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC---CCCEEEccCcCCeECCCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999944 456999999999764332 2334568
Q ss_pred Ccccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+......++. .++.++.+||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR----WISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 9999999999864 5899999999999999999999999998888888877665433332 4789999999999999
Q ss_pred CCCCCCCHH-HHhcCCCccCC
Q 013201 338 DPKKRITSA-EVLEHPWMREG 357 (447)
Q Consensus 338 dp~~R~t~~-~~l~h~~~~~~ 357 (447)
||++||++. ++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHcCCChHHHHcCcccCCC
Confidence 999999864 88899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=381.26 Aligned_cols=258 Identities=30% Similarity=0.531 Sum_probs=221.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+. |+||+++++.+.+.+.+||||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEE
Confidence 4899999999999999999999999999999987654444445677889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
|||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~---~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEeeccCCccccccccc
Confidence 9999999999999888999999999999999999999999999999999999994 44579999999986542210
Q ss_pred ----------------------------------ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCC
Q 013201 253 ----------------------------------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFW 297 (447)
Q Consensus 253 ----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~ 297 (447)
.....+||+.|+|||++. ..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 011357999999999986 458999999999999999999999999
Q ss_pred CCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCC
Q 013201 298 AETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI---TSAEVLEHPWMREG 357 (447)
Q Consensus 298 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~~~l~h~~~~~~ 357 (447)
+.+....+..+.........++...+++++++||.+|+. ||.+|+ ++.++++||||...
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 988888888777643333333333478999999999874 999998 48999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=372.87 Aligned_cols=251 Identities=30% Similarity=0.545 Sum_probs=220.1
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997665444455667788999999887799999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 258 (447)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS---EGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC---CCcEEecccCCCeecCcCCCccccee
Confidence 999999988889999999999999999999999999999999999999944 4569999999987532 222334467
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++. .+++.+.+||.+||..
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHccC
Confidence 999999999986 45899999999999999999999999988888888877776554432 4789999999999999
Q ss_pred CCCCCCCH-----HHHhcCCCccCC
Q 013201 338 DPKKRITS-----AEVLEHPWMREG 357 (447)
Q Consensus 338 dp~~R~t~-----~~~l~h~~~~~~ 357 (447)
||++||++ .+++.||||+..
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=366.66 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=210.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||.|+||.||+|++..+++.||+|.+..... ......+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence 349999999999999999999999999999998854321 223356779999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+.+ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~---~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE---KGELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC---CCCEEECcCcceeeccCCC
Confidence 999975 8988887654 4789999999999999999999999999999999999944 446999999999765432
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD--------------- 314 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------------- 314 (447)
.......|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22334578999999998753 4889999999999999999999999988776666555432110
Q ss_pred ----CCC-------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 315 ----FES-------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 315 ----~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
++. .....+++++++||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000 0012467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=386.23 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=206.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc-----CCCCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS-----GQQNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~ 166 (447)
..++|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.+++.+. +|.+++.+++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4577999999999999999999999999999999885321 22344566888877765 24568999998876
Q ss_pred C-CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCC-----------
Q 013201 167 R-QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDG----------- 233 (447)
Q Consensus 167 ~-~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~----------- 233 (447)
+ ..+|||||++ |++|.+++.+.+.+++..+..|+.||+.||.|||+ .|||||||||+|||++.++.
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5789999998 77899999888899999999999999999999998 59999999999999965432
Q ss_pred --CCceEEecCCCceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 013201 234 --GAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK 310 (447)
Q Consensus 234 --~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 310 (447)
...+||+|||.+..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+.+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 12599999998764322 2345689999999999864 589999999999999999999999988776555444332
Q ss_pred CCCCCCC-------------------------Cc-------------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 013201 311 GGVDFES-------------------------EP-------------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352 (447)
Q Consensus 311 ~~~~~~~-------------------------~~-------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~ 352 (447)
....++. .+ ....++.+.|||.+||.+||++|||++|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 1110000 00 001245678999999999999999999999999
Q ss_pred CccCCCC
Q 013201 353 WMREGGE 359 (447)
Q Consensus 353 ~~~~~~~ 359 (447)
||.+...
T Consensus 440 ~~~~~~~ 446 (467)
T PTZ00284 440 YVLKYYP 446 (467)
T ss_pred cccccCC
Confidence 9987533
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=371.88 Aligned_cols=251 Identities=27% Similarity=0.484 Sum_probs=213.3
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++.++.+||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997765544555667889999998886799999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 258 (447)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~---~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCCEEEeeCCccccccCCCCcccccc
Confidence 99999998888999999999999999999999999999999999999994 44569999999987532 223334568
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC---------CHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE---------TEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
||+.|+|||++. ..++.++|||||||++|+|++|..||... ........+......++. .++..+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~ 233 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC----CCCHHHH
Confidence 999999999986 45899999999999999999999999521 122344455555444433 4789999
Q ss_pred HHHHHhcccCCCCCCC------HHHHhcCCCccCC
Q 013201 329 DLVRKMLIQDPKKRIT------SAEVLEHPWMREG 357 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t------~~~~l~h~~~~~~ 357 (447)
+||.+||+.||++|++ ++++++||||+..
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=376.58 Aligned_cols=260 Identities=31% Similarity=0.479 Sum_probs=222.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|+++.+++.+|+|++.+...........+.+|+.+++.++ ||||+++++++.+++.+|+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEE
Confidence 356999999999999999999999999999999987644444444566788999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 121 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCceeEcCcCC
Confidence 9999999999998765 4689999999999999999999999999999999999994 44569999999998765332
Q ss_pred --ceeecCCcccccccccccc-----cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 253 --VYRDIVGSAYYVAPEVLRR-----SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 253 --~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.........+....++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 2235679999999999853 278999999999999999999999999988888888877554444444446899
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 013201 326 SAKDLVRKMLIQDPKK--RITSAEVLEHPWMREG 357 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~--R~t~~~~l~h~~~~~~ 357 (447)
++++||.+||..++.+ |++++++++|+||++.
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999999854443 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=366.42 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=210.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++...+.+|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEEE
Confidence 59999999999999999999999999999998865432 2334567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++ .+..+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCcccccccccc
Confidence 9999877665544456799999999999999999999999999999999999994 44469999999998764322
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC------------------
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV------------------ 313 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------------------ 313 (447)
......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 223457999999999886 4589999999999999999999999988765544333322100
Q ss_pred -CCCCC---------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 314 -DFESE---------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 314 -~~~~~---------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.++.. ....+|.++.+||.+||++||++|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000 011368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=370.59 Aligned_cols=253 Identities=29% Similarity=0.528 Sum_probs=217.5
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHH---hccCCCCeeEEEEEEEeCCeEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ---HLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~---~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++. .+. ||||+++++++.+.+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCEEEE
Confidence 678899999999999999999999999999987654434444566777877664 444 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-C
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-G 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~ 251 (447)
||||++|++|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~---~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC---CCcEEeCcccCCccCCCCC
Confidence 9999999999887754 57999999999999999999999999999999999999954 44699999999875332 2
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+..+...++. .+++.+.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 2334568999999999986 45899999999999999999999999998888888888777655443 478999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 331 VRKMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 331 i~~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
|.+||+.||.+|| ++.++++||||++.
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999999999 79999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=374.69 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=214.3
Q ss_pred ceeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccC-ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 95 FYTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLV-NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.|++.+.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.+++++.+|+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 3889999999999999998864 47899999998654332 2233466789999999998899999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~---~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS---EGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC---CCCEEEeeCcCCccccc
Confidence 999999999999999998888999999999999999999999999999999999999954 44699999999976433
Q ss_pred C--CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCC----CHHHHHHHHHhCCCCCCCCcccc
Q 013201 251 G--KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 251 ~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+......++ ..
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF 233 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----CC
Confidence 2 22334689999999999864 3788999999999999999999999643 22334444444333222 24
Q ss_pred CChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
+++.+.++|.+||+.||++|| +++++++||||++.
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 789999999999999999999 88899999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=369.93 Aligned_cols=255 Identities=27% Similarity=0.504 Sum_probs=223.4
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|+.+++.+.+|++|+++++++.+.+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 77889999999999999999999999999998765443444556778899999988878899999999999999999999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-Cce
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KVY 254 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~ 254 (447)
|++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++...... ...
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~---~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeccccccccCCCCccc
Confidence 999999999998888999999999999999999999999999999999999995 4456999999998754322 223
Q ss_pred eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......++. .++.++.+++.+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~ 234 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG 234 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHH
Confidence 4567999999999986 45899999999999999999999999998888888888877655443 478999999999
Q ss_pred hcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 334 MLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 334 ~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
||+.||.+|++ .+++++||||...
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 235 LMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99999999997 4789999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=368.17 Aligned_cols=251 Identities=27% Similarity=0.478 Sum_probs=215.9
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||+||+|++..+++.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987654333334556677888888765699999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 258 (447)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT---DGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC---CCCEEEccCCcceECCCCCCceeeec
Confidence 999999988888999999999999999999999999999999999999954 44699999999875422 22334568
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+......++. .++.++++||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHhcc
Confidence 999999999986 45899999999999999999999999988888777777655433322 4789999999999999
Q ss_pred CCCCCCCHH-HHhcCCCccCC
Q 013201 338 DPKKRITSA-EVLEHPWMREG 357 (447)
Q Consensus 338 dp~~R~t~~-~~l~h~~~~~~ 357 (447)
||++|+++. ++++||||+..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHhhcCCChHHHHcCcccCCC
Confidence 999999996 89999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=369.18 Aligned_cols=250 Identities=36% Similarity=0.622 Sum_probs=216.7
Q ss_pred ceeccccCeEEEEEEEC---CCCCEEEEEEeeccccC-ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 100 KELGRGQFGITYLCTEN---STGNSYACKSILKRKLV-NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
+.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+++.+. ||||+++++++..++.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence 67999999999999864 46889999998764332 2233456788999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCce
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVY 254 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~ 254 (447)
|++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEeeCcCCeecccCCCcc
Confidence 999999999999888899999999999999999999999999999999999994 445799999999875432 2233
Q ss_pred eecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
....||+.|+|||++.+ .++.++|||||||++|||++|..||...+....+..+..+...++. .+++.+.+||.+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 44679999999999864 5889999999999999999999999998888888888877655443 478999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 334 MLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 334 ~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
||+.||++|| ++++++.||||...
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=369.82 Aligned_cols=250 Identities=30% Similarity=0.548 Sum_probs=214.4
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHH-HHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQ-IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
+.||+|+||+||+|++..+|+.||+|++.+...........+..|.. +++.++ ||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999999999999999987654433334455556655 456676 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCceeec
Q 013201 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDI 257 (447)
Q Consensus 179 g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 257 (447)
||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~---~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS---QGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC---CCcEEEeccCCCcccccCCCccccc
Confidence 9999999998888999999999999999999999999999999999999944 45699999999875432 2233456
Q ss_pred CCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcc
Q 013201 258 VGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336 (447)
Q Consensus 258 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 336 (447)
+||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+......... .+++.+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP----NISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhh
Confidence 7999999999986 45899999999999999999999999998888888888776554432 468999999999999
Q ss_pred cCCCCCCCH----HHHhcCCCccCC
Q 013201 337 QDPKKRITS----AEVLEHPWMREG 357 (447)
Q Consensus 337 ~dp~~R~t~----~~~l~h~~~~~~ 357 (447)
.||.+||++ .+++.||||...
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999999998 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=370.51 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=210.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-----Ce
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR-----QS 169 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~ 169 (447)
+|++.+.||+|+||.||+|++..++..||+|.+... .........+.+|+.++++++ ||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechh-hccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence 489999999999999999999999999999988542 222334457889999999997 99999999987543 35
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|+|||||. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEccCccccccc
Confidence 899999995 68999998888899999999999999999999999999999999999994 44579999999997543
Q ss_pred CCC----ceeecCCccccccccccc---ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------
Q 013201 250 EGK----VYRDIVGSAYYVAPEVLR---RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG----------- 311 (447)
Q Consensus 250 ~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----------- 311 (447)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 123467999999999875 35899999999999999999999999876654332222110
Q ss_pred ----------------CCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 312 ----------------GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 312 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
........+..+++.+.++|.+||..||++|||++++|+||||+.....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 0000011123467889999999999999999999999999999876553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=367.51 Aligned_cols=251 Identities=26% Similarity=0.483 Sum_probs=213.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++.++.+||||+.+++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997765544555677889999999997799999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec-cCCCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~ 258 (447)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++... .........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA---DGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC---CCCEEEeccccceeccCCCCceeccc
Confidence 999999988888999999999999999999999999999999999999954 446999999998753 2333345578
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC-------CHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE-------TEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
||+.|+|||++. ..++.++|||||||++|+|++|..||... ........+......++. .++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 999999999986 45899999999999999999999999632 222344444444333332 478999999
Q ss_pred HHHhcccCCCCCCC------HHHHhcCCCccCC
Q 013201 331 VRKMLIQDPKKRIT------SAEVLEHPWMREG 357 (447)
Q Consensus 331 i~~~L~~dp~~R~t------~~~~l~h~~~~~~ 357 (447)
|.+||..||++|++ +.++++||||+..
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999999999998 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=373.19 Aligned_cols=250 Identities=31% Similarity=0.553 Sum_probs=215.5
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc--CCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--GQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
||+|+||+||+|++..+++.||+|++.+...........+..|..++.++. +||||+.+++++.+...+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999987654433334445566777777654 699999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCceeecC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 258 (447)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++..... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA---TGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC---CCCEEEecCCcCcCCCCCCCCccCcc
Confidence 999999998889999999999999999999999999999999999999954 44699999999875432 22334568
Q ss_pred Ccccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcc
Q 013201 259 GSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336 (447)
Q Consensus 259 gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 336 (447)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++.. .+++++.+||.+||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc---cCCHHHHHHHHHHcC
Confidence 9999999999853 47899999999999999999999999988888888887776555432 478999999999999
Q ss_pred cCCCCCC----CHHHHhcCCCccCC
Q 013201 337 QDPKKRI----TSAEVLEHPWMREG 357 (447)
Q Consensus 337 ~dp~~R~----t~~~~l~h~~~~~~ 357 (447)
.||.+|| ++.++++||||++.
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCC
Confidence 9999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=361.02 Aligned_cols=258 Identities=30% Similarity=0.511 Sum_probs=215.6
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||+|+||+||++.+..+++.||+|.+.+...........+.+|+.++++++ ||||+++++.+..++.+++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEEe
Confidence 888999999999999999999999999999986644433334456778999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 176 LCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|+.+|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++ ++..++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC---CCCCEEEeeCCCceecCCCCc
Confidence 99999999888654 4589999999999999999999999999999999999994 445799999999987655444
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
.....|++.|+|||++. ..++.++||||+||++|+|++|..||.+.........+..............++..+.+||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 45568999999999986 45889999999999999999999999876654333333221111111112247899999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
+||..||++|| +++++++||||.+.
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 99999999999 89999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=368.09 Aligned_cols=262 Identities=35% Similarity=0.629 Sum_probs=238.1
Q ss_pred ccccceee--cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 91 DIRQFYTL--GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 91 ~~~~~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
++..-|++ .+.||.|-||+||-|+++.+|+.||||+|.|.++..+. ...+.+|+.||+.+. ||.||.+...|+..+
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~-HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLH-HPGIVNLECMFETPE 636 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcC-CCCeeEEEEeecCCc
Confidence 34455666 58899999999999999999999999999998876554 478999999999998 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 169 SVHLVMELCSGGELFDKII--AQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
.+++|||-+.| ++.+.|. +.+++++.....++.||+.||.|||.++|+|+||||+|||+...+.-..+||||||+|+
T Consensus 637 rvFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 637 RVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred eEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecccccee
Confidence 99999999965 6555554 35789999999999999999999999999999999999999888777889999999999
Q ss_pred eccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.+.+....++++|||.|.|||+++ ++|..+-||||.|||+|.-++|..||... +++-++|.+..+.++..+|..+++
T Consensus 716 iIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 716 IIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISP 793 (888)
T ss_pred ecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCH
Confidence 999988888999999999999986 66999999999999999999999999654 456788888999999999999999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
++.|||..+|++.-.+|.+....|.|||+++.
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999999999885
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=364.32 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=207.0
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+++.+. ||||+++++++.+....|+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEE
Confidence 459999999999999999999999999999998854322 222345678999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. ...+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD---TGELKLADFGLARAKSVPS 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEECCCCcceeccCCC
Confidence 99995 5787777664 56899999999999999999999999999999999999944 456999999998754322
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCC--------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVD-------------- 314 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~-------------- 314 (447)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+..+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22344678999999998753 478899999999999999999999987543 2233322211000
Q ss_pred CCCCc------------c--ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 315 FESEP------------W--LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 315 ~~~~~------------~--~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+.... + ...++.+.+||.+||+.||++|||+.|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00000 0 1245789999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=369.04 Aligned_cols=255 Identities=30% Similarity=0.523 Sum_probs=229.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe-EEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS-VHL 172 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-~~l 172 (447)
+.|..++.+|+|+||.+++++++.++..|++|.|....... ..+....+|+.+++++. |||||.+.+.|..++. ++|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence 45999999999999999999999999999999997665433 34457789999999998 9999999999988887 999
Q ss_pred EEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||+||+||+|.+.+.+.+ .|+++.+..++.|++.|+.|||+++|+|||||+.|||++.++ .|||+|||+|+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~---~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK---KVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC---ceeecchhhhhhcCC
Confidence 999999999999998754 499999999999999999999999999999999999996544 489999999999887
Q ss_pred CC-ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GK-VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ...+++|||.||+||++.+ .|+.|+|||||||++|||++-+++|.+.+..++..+|.++....... ..+.+++
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~---~ys~el~ 235 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS---MYSSELR 235 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc---cccHHHH
Confidence 66 5667899999999999975 59999999999999999999999999999999999999987443333 4689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.||+.||..+|..||++.++|.+|.+..
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999988763
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=366.17 Aligned_cols=259 Identities=27% Similarity=0.488 Sum_probs=217.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++ |+||+.+++++.+++.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEEE
Confidence 5999999999999999999999999999999987644434445566889999999986 999999999999999999999
Q ss_pred eccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 175 ELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||++||+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---CCCCEEEEECCceeecCCCCC
Confidence 99999999999976 45799999999999999999999999999999999999994 445699999999876544322
Q ss_pred e--eecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC-ccccCC
Q 013201 254 Y--RDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE-PWLLIS 324 (447)
Q Consensus 254 ~--~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s 324 (447)
. ...+||+.|+|||++. +.++.++|||||||++|+|++|..||.+....+.+..+......+..+ ....++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 237 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS 237 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCC
Confidence 2 2247999999999985 347889999999999999999999999888777777776543222211 123479
Q ss_pred hHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKK--RITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~--R~t~~~~l~h~~~~~~ 357 (447)
+.+++||.+||..++++ |+++.++++||||...
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 99999999999765544 8899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=371.05 Aligned_cols=258 Identities=29% Similarity=0.438 Sum_probs=217.2
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC-----CCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ-----QNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-----~~iv~~~~~~~~ 166 (447)
+.-+|.+.+.||+|+||.|-+|.+..|++.||||+|+.. .....+-..|+.+|.+|+.| -|+|+++++|..
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 344689999999999999999999999999999988543 34456677899999999833 489999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
.+++|||+|++ .-+|+++|+.+. .++...++.+++||+.||.+||+.||||+||||+||||...+.. .|||+|||.
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVIDFGS 337 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVIDFGS 337 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEEeccc
Confidence 99999999999 469999999864 48999999999999999999999999999999999999876554 799999999
Q ss_pred ceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-----------
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG----------- 312 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~----------- 312 (447)
+.+....-. .++-+..|+|||++. ..|+.+.||||||||++||++|.+.|.+.+..+.+..|..-.
T Consensus 338 Sc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 338 SCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 988765432 788999999999976 569999999999999999999999999998887777664310
Q ss_pred ----CCCCC-----------------------------------C----cc----c-cCChHHHHHHHHhcccCCCCCCC
Q 013201 313 ----VDFES-----------------------------------E----PW----L-LISDSAKDLVRKMLIQDPKKRIT 344 (447)
Q Consensus 313 ----~~~~~-----------------------------------~----~~----~-~~s~~~~~li~~~L~~dp~~R~t 344 (447)
.-+.. + .+ . .-...+.|||++||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00000 0 00 0 01246789999999999999999
Q ss_pred HHHHhcCCCccCC
Q 013201 345 SAEVLEHPWMREG 357 (447)
Q Consensus 345 ~~~~l~h~~~~~~ 357 (447)
+.++|+||||...
T Consensus 496 p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 496 PAQALNHPFLTGT 508 (586)
T ss_pred HHHHhcCcccccc
Confidence 9999999999954
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=364.47 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=215.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..++..+|+|.+.... .......+.+|+.++++++ ||||+++++++.+++.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence 356999999999999999999999999999999885432 2334567899999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||++|++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++. +..+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC---CCcEEEccCccccccccc
Confidence 999999999999998888899999999999999999999986 6999999999999954 446999999998765432
Q ss_pred CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV----------------- 313 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~----------------- 313 (447)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..++...+.....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2344679999999999864 589999999999999999999999977665443322211000
Q ss_pred ---------------------------CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 314 ---------------------------DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 314 ---------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
..+..+...+++++++||.+||+.||++|||+.++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 000011123678999999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=367.15 Aligned_cols=250 Identities=28% Similarity=0.532 Sum_probs=213.9
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHH-HHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI-MQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~-l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
+.||+|+||+||+|++..+|+.||+|++.+...........+..|..+ ++.++ ||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999999999999999876544334444556666654 56666 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCCceeec
Q 013201 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDI 257 (447)
Q Consensus 179 g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 257 (447)
||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.... ........
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~---~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS---QGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC---CCCEEEeecCCcccCCCCCCCcccc
Confidence 9999999988889999999999999999999999999999999999999944 4569999999987532 22233456
Q ss_pred CCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcc
Q 013201 258 VGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336 (447)
Q Consensus 258 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 336 (447)
+||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+++..+......... .++..+.++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP----GASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCC----CCCHHHHHHHHHHhc
Confidence 8999999999986 45899999999999999999999999998888888887776543332 468899999999999
Q ss_pred cCCCCCCCH----HHHhcCCCccCC
Q 013201 337 QDPKKRITS----AEVLEHPWMREG 357 (447)
Q Consensus 337 ~dp~~R~t~----~~~l~h~~~~~~ 357 (447)
.||.+||++ .++++||||...
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 999999987 589999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=358.43 Aligned_cols=248 Identities=30% Similarity=0.531 Sum_probs=207.1
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGE 181 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 181 (447)
||+|+||+||+|.+..+++.||+|.+.+.........+.+..|+.+++.++ |+||+++.+++..+..+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999999999999999987654443444567788999999997 9999999999999999999999999999
Q ss_pred hHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-ceee
Q 013201 182 LFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-VYRD 256 (447)
Q Consensus 182 L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~ 256 (447)
|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++ .+..+||+|||++....... ....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCCCccccc
Confidence 9887743 34689999999999999999999999999999999999994 44569999999997665432 2334
Q ss_pred cCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH----HHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 257 IVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 257 ~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
..||+.|+|||++. ..++.++|||||||++|+|++|+.||...... .....+......+ ...+++.+.+++
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li 232 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY----PDKFSPASKSFC 232 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCC----cccCCHHHHHHH
Confidence 67999999999986 45889999999999999999999999765432 2223333222222 124789999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
.+||+.||++|| +++++++||||+..
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=358.09 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=207.5
Q ss_pred ceeecceeccccCeEEEEEEECC-CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc--CCCCeeEEEEEEE-----e
Q 013201 95 FYTLGKELGRGQFGITYLCTENS-TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--GQQNIVEFRGAYE-----D 166 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~-----~ 166 (447)
+|++.+.||+|+||.||+|++.. +++.||+|.+..... .......+.+|+.+++.+. .||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 59999999999999999999854 468899998864332 2223345667888887764 4999999999885 3
Q ss_pred CCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
...+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~---~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC---CCCEEEccccc
Confidence 456899999996 5898888764 34899999999999999999999999999999999999954 44699999999
Q ss_pred ceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC-----
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE----- 318 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~----- 318 (447)
+.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+....+.+..+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 98765544445568999999999985 558999999999999999999999999988877776665432110000
Q ss_pred ------------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 319 ------------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 319 ------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
....+++.+++||.+||+.||++|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=344.70 Aligned_cols=256 Identities=31% Similarity=0.572 Sum_probs=238.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|...++||+|.||.|-+|+.+.+++.||+|++.|..+........-..|-++|+..+ ||.+..+-..|+..+++|+|
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEEE
Confidence 45889999999999999999999999999999999988888877788889999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee-ccCCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF-IDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~-~~~~~ 252 (447)
|||..||.|+-+|.+.+.|++..++.+...|+.||.|||+++||+||||.+|+|+ +.+++|||+|||+++. +..+.
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcccccc
Confidence 9999999999999999999999999999999999999999999999999999999 5566899999999974 55666
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
...++||||.|.|||++. ..|+.++|+|.+||++|||++|+.||+..+...++..|+.+...++.. ++++++.|+
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~----ls~eAktLL 399 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT----LSPEAKTLL 399 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc----CCHHHHHHH
Confidence 778899999999999997 569999999999999999999999999999999999999998888874 899999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
..+|.+||++|.. +.||.+|+||...
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999974 7899999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=380.82 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=207.4
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-----
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR----- 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~----- 167 (447)
.+.|++++.||+|+||.||+|++..+++.||+|.+.... ....+|+.+|+.++ ||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeecccccC
Confidence 356999999999999999999999999999999875421 23457999999997 99999999887432
Q ss_pred ---CeEEEEEeccCCCchHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 168 ---QSVHLVMELCSGGELFDKII----AQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
..+++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~--~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT--HTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC--Cceeee
Confidence 257799999975 6766664 345699999999999999999999999999999999999995433 369999
Q ss_pred cCCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------
Q 013201 241 DFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG------ 312 (447)
Q Consensus 241 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~------ 312 (447)
|||++.............||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+.+..+.+..+....
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9999987765555556789999999998753 58999999999999999999999999887665555544311
Q ss_pred -----------CCCCCCc--------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 313 -----------VDFESEP--------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 313 -----------~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
..++... ....++++++||.+||.+||.+|||+.|+|+||||....
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0111100 013578999999999999999999999999999998643
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=365.73 Aligned_cols=249 Identities=31% Similarity=0.542 Sum_probs=216.4
Q ss_pred ceeccccCeEEEEEEE---CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 013201 100 KELGRGQFGITYLCTE---NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~---~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 176 (447)
+.||+|+||.||++++ ..+|+.||+|++.+... .......+.+|+.++++++ ||||+++++++.+++.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999886 35789999999876433 2233456778999999997 99999999999999999999999
Q ss_pred cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-Ccee
Q 013201 177 CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KVYR 255 (447)
Q Consensus 177 ~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~~ 255 (447)
+++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE---EGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC---CCcEEEeeccCCcccCCCCCcee
Confidence 999999999988888999999999999999999999999999999999999944 446999999998765443 2334
Q ss_pred ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHh
Q 013201 256 DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334 (447)
Q Consensus 256 ~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 334 (447)
...||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+......++. .+++.+.+||.+|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHH
Confidence 568999999999986 45889999999999999999999999998888888888776655443 3789999999999
Q ss_pred cccCCCCCCC-----HHHHhcCCCccCC
Q 013201 335 LIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 335 L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
|+.||++||+ +.+++.||||...
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 9999999999 7789999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=368.83 Aligned_cols=257 Identities=19% Similarity=0.361 Sum_probs=208.4
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
...|++.+.||+|+||.||+|++..+++.||+|... ...+.+|+.++++++ ||||+++++++..+...++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEE
Confidence 356999999999999999999999999999999642 234678999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++. ...+||+|||++......
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~---~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH---PGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC---CCCEEEEeCCccccccccc
Confidence 999995 689999988888999999999999999999999999999999999999954 446999999999754322
Q ss_pred -CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHhCC----------
Q 013201 252 -KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAET-------EKGIFDAILKGG---------- 312 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~---------- 312 (447)
......+||+.|+|||++. ..++.++|||||||++|+|++|..||.... ....+..+....
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 2233468999999999986 458999999999999999999998876432 111111111100
Q ss_pred ----------------CC--CCCCcc---ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 013201 313 ----------------VD--FESEPW---LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDK 363 (447)
Q Consensus 313 ----------------~~--~~~~~~---~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~ 363 (447)
.. ...+.| ..++.++.+||.+||+.||.+|||++|+|+||||+......+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~ 388 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPN 388 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCC
Confidence 00 001111 1346789999999999999999999999999999886554443
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=363.19 Aligned_cols=259 Identities=25% Similarity=0.460 Sum_probs=218.5
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+++++.+++.+|+|++.+...........+.+|+.++..+. |+||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999986543333334456788999999886 999999999999999999999
Q ss_pred eccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 175 ELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~---~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEeecchheecccCCc
Confidence 99999999999987 46789999999999999999999999999999999999994 445699999999876543322
Q ss_pred --eeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc-cccCC
Q 013201 254 --YRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP-WLLIS 324 (447)
Q Consensus 254 --~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s 324 (447)
....+||+.|+|||++. +.++.++|||||||++|||++|+.||...+..+.+..+.........+. ...++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 22357999999999874 3478999999999999999999999999888888888876543332221 23579
Q ss_pred hHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKK--RITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~--R~t~~~~l~h~~~~~~ 357 (447)
+++++||.+||..++.+ |++++++++||||...
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 99999999999765555 7899999999999763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=364.39 Aligned_cols=249 Identities=28% Similarity=0.537 Sum_probs=211.9
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHH-HHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQ-IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
+.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.+. ||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999987654333333344555554 456676 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCceeec
Q 013201 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDI 257 (447)
Q Consensus 179 g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 257 (447)
|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++..... .......
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~---~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS---QGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC---CCCEEEccCCCCcccccCCCCcccc
Confidence 9999999998888999999999999999999999999999999999999954 44699999999875432 2233456
Q ss_pred CCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcc
Q 013201 258 VGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336 (447)
Q Consensus 258 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 336 (447)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+. ..+++.+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcc
Confidence 89999999999864 589999999999999999999999999888888888776644433 2478999999999999
Q ss_pred cCCCCCCCHH----HHhcCCCccC
Q 013201 337 QDPKKRITSA----EVLEHPWMRE 356 (447)
Q Consensus 337 ~dp~~R~t~~----~~l~h~~~~~ 356 (447)
.||.+|+++. ++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCC
Confidence 9999999876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=363.44 Aligned_cols=249 Identities=29% Similarity=0.537 Sum_probs=212.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHH-HHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQ-IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++ ||||+++++++.+.+.+|+|||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999987654433334455666655 567776 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CCceeec
Q 013201 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDI 257 (447)
Q Consensus 179 g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 257 (447)
|++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS---QGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC---CCCEEEccCCCCccCCCCCCccccc
Confidence 9999999988888999999999999999999999999999999999999944 44699999999875322 2233456
Q ss_pred CCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcc
Q 013201 258 VGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336 (447)
Q Consensus 258 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 336 (447)
+||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......++. ..+..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG----GKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHcc
Confidence 8999999999986 45899999999999999999999999998888888888776544432 368899999999999
Q ss_pred cCCCCCCCH----HHHhcCCCccC
Q 013201 337 QDPKKRITS----AEVLEHPWMRE 356 (447)
Q Consensus 337 ~dp~~R~t~----~~~l~h~~~~~ 356 (447)
.||.+|+++ .++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCC
Confidence 999999976 49999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=362.69 Aligned_cols=259 Identities=26% Similarity=0.455 Sum_probs=219.0
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..+. |+||+.+++++.+.+..|+||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEE
Confidence 5999999999999999999999999999999986643333344556788999999887 999999999999999999999
Q ss_pred eccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 175 ELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||++||+|.+++.+ ...+++..+..++.|++.||.|||++||+||||||+|||++ ....+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD---MNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---CCCCEEEEeccceeeccCCCc
Confidence 99999999999987 46799999999999999999999999999999999999995 444699999999976654332
Q ss_pred e--eecCCcccccccccccc------cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC-ccccCC
Q 013201 254 Y--RDIVGSAYYVAPEVLRR------SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE-PWLLIS 324 (447)
Q Consensus 254 ~--~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s 324 (447)
. ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+..+......++.+ ....++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 237 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVS 237 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCC
Confidence 2 23579999999998853 47889999999999999999999999888887777777654333222 223578
Q ss_pred hHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKK--RITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~--R~t~~~~l~h~~~~~~ 357 (447)
++++++|.+||..++++ |++++++++|+||...
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 99999999999976655 5799999999999763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=372.91 Aligned_cols=259 Identities=26% Similarity=0.458 Sum_probs=224.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|.++..||.|+||.||+|..+.++-..|.|+|. .......+++.-||.||..+. ||+||++++.|..++.+|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceE
Confidence 3567999999999999999999999999888999883 345677889999999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+.|||.||-+..++..- ..+++.++..+++|++.||.|||+++|+|||||..|||++.++. |+|+|||.+.....
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKNKS 182 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---Eeeecccccccchh
Confidence 999999999988877764 45999999999999999999999999999999999999976654 99999999865432
Q ss_pred -CCceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 251 -GKVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 251 -~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
.....+++|||+|||||++. ..|+.++|||||||+|.||..+.+|....+...++-.|.+...+....+. ..
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS-~W 261 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPS-HW 261 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcc-hh
Confidence 23445789999999999862 45999999999999999999999999988888877777765443333322 35
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+..+.||+.+||.+||..||+++++|+||||....
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 88999999999999999999999999999998653
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=353.40 Aligned_cols=254 Identities=31% Similarity=0.537 Sum_probs=212.2
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.++++++ |+||+.+++.+.+.+.+|+|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEEE
Confidence 778899999999999999999999999999987654443434456778999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 176 LCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++. ...++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~---~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD---HGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC---CCCEEEeeccceeecCCCcc
Confidence 99999999888654 35899999999999999999999999999999999999944 44699999999977655444
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH---HHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK---GIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.....|++.|+|||++. ..++.++||||||+++|+|++|..||...... +....+..... ......+++++.+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 234 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---EEYSEKFSPDARS 234 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---hhcCccCCHHHHH
Confidence 44568999999999986 45899999999999999999999999865432 22222222111 1112347889999
Q ss_pred HHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 013201 330 LVRKMLIQDPKKRIT-----SAEVLEHPWMRE 356 (447)
Q Consensus 330 li~~~L~~dp~~R~t-----~~~~l~h~~~~~ 356 (447)
||.+||+.||++||| ++++++||||++
T Consensus 235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999999999999 999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=350.72 Aligned_cols=249 Identities=29% Similarity=0.504 Sum_probs=207.2
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGE 181 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 181 (447)
||+|+||.||+++++.+|+.||+|.+.+...........+..|+.++++++ ||||+++++++.++..+|+||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999986544433333445667999999997 9999999999999999999999999999
Q ss_pred hHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCC
Q 013201 182 LFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVG 259 (447)
Q Consensus 182 L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 259 (447)
|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++. +..++|+|||++.............|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD---QGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC---CCCEEEeeceeeeecCCCceeeccCC
Confidence 998886543 4889999999999999999999999999999999999954 45699999999987765554455689
Q ss_pred ccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH----HHHHHHHHhCCCCCCCCccccCChHHHHHHHHh
Q 013201 260 SAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334 (447)
Q Consensus 260 t~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 334 (447)
++.|+|||++. ..++.++|||||||++|+|++|..||..... ......+........ ...+++++++||.+|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 233 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF 233 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence 99999999985 4589999999999999999999999976533 223333333322222 225789999999999
Q ss_pred cccCCCCCCCH----HHHhcCCCccCC
Q 013201 335 LIQDPKKRITS----AEVLEHPWMREG 357 (447)
Q Consensus 335 L~~dp~~R~t~----~~~l~h~~~~~~ 357 (447)
|+.||++||++ ++++.|+||+..
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999 678899999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=351.73 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=206.0
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc--CCCCeeEEEEEEEe-----C
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--GQQNIVEFRGAYED-----R 167 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~-----~ 167 (447)
+|++.+.||+|+||+||+|++..+++.||+|.+..... .......+.+|+.+++.+. +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48999999999999999999999999999998865322 2222334567888877764 49999999998864 3
Q ss_pred CeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
..+++||||+.+ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++. +..+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~---~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEECccCcc
Confidence 468999999975 888888764 34899999999999999999999999999999999999954 446999999999
Q ss_pred eeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC----------
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD---------- 314 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---------- 314 (447)
.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 8765544444567899999999885 45899999999999999999999999887766655554431100
Q ss_pred ------CC-------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 315 ------FE-------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 315 ------~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+. ......++..+.+||.+||++||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 00112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=350.12 Aligned_cols=258 Identities=31% Similarity=0.521 Sum_probs=216.3
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|+..+.||.|+||+||+|.+..+++.+|+|.+.+...........+.+|+.++++++ |+||+.+.+.+..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEEE
Confidence 778899999999999999999999999999986654443444556788999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 176 LCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++ .+..+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcceecCCCCc
Confidence 99999998888654 3599999999999999999999999999999999999994 445699999999976654444
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
.....|++.|+|||++. ..++.++|+|||||++|+|++|..||.+.........+..............++.++.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 44568999999999985 45899999999999999999999999877655443333322211111222347889999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
+||+.||++||+ +.+++.|+||+..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 999999999999 8899999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=357.04 Aligned_cols=244 Identities=27% Similarity=0.434 Sum_probs=211.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
++.+++++.||+|-||.||+|.++. ...||+|.+....+ ..+.|.+|+.+|++|+ |+|||++++++..++.+||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEE
Confidence 4457889999999999999999873 44899998865433 3467789999999998 9999999999999889999
Q ss_pred EEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||++.|+|.++|.. ...+...+.+.++.||++|++||+++++|||||-..|||+ +++..+||+|||+|+.+.+
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCC
Confidence 9999999999999997 4568999999999999999999999999999999999999 6666899999999996555
Q ss_pred CCceeecCC---ccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 251 GKVYRDIVG---SAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 251 ~~~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
+.. ....| ...|.|||++. +.++.++|||||||+||||+| |+.||.+.+..++++.+.+|. .++.+. .+|+
T Consensus 356 ~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy-Rlp~P~--~CP~ 431 (468)
T KOG0197|consen 356 DEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY-RLPRPE--GCPD 431 (468)
T ss_pred Cce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC-cCCCCC--CCCH
Confidence 433 33333 34699999987 679999999999999999999 999999999999999988774 444443 6999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHh
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
++.+++..||..+|++|||++.+.
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999999999999999664
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=362.39 Aligned_cols=259 Identities=38% Similarity=0.612 Sum_probs=238.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
...|.+.+.||.|.|+.|.+|++..++..||+|.|.+... +...+..+.+|+++|+.|. |||||+++.+.+....+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcC-CcceeeeeeeeeecceeEE
Confidence 3459999999999999999999999999999999987655 3444556899999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||+.+|.+++++.+.+++.+..++.++.|++.|++|||+++|||||||.+|||| +.+.++||+|||++.++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecccc
Confidence 99999999999999999999999999999999999999999999999999999999 666679999999999999888
Q ss_pred ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
...+.+|++.|.|||++.+ .-++++|+||+|++||.|+.|..||.+.+..++-...+.+.+..+.. ++.++.+|
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~----ms~dce~l 285 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY----MSCDCEDL 285 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce----eechhHHH
Confidence 8899999999999999874 36899999999999999999999999999999888888888776653 78899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
|+++|..+|.+|++.++++.|.|.......
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999999765443
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=362.07 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=207.9
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--- 167 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--- 167 (447)
.+.++|++.+.||+|+||.||+|.+..+|..||+|.+.+.. ........+.+|+.+++.++ ||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCc
Confidence 34567999999999999999999999999999999885432 23344567789999999997 99999999998654
Q ss_pred ---CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 168 ---QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
..+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~---~~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC---CCCEEEecCCC
Confidence 357999999965 5666553 35889999999999999999999999999999999999954 45699999999
Q ss_pred ceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG------------ 311 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------ 311 (447)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.+.
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 976554444445689999999999864 5899999999999999999999999877654433322211
Q ss_pred ----------CCCCCC----------------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 312 ----------GVDFES----------------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 312 ----------~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
....+. ......++++++||.+||..||++|||+.|+|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000000 001124678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=390.72 Aligned_cols=258 Identities=31% Similarity=0.518 Sum_probs=229.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|.+.+.||+|+||.|.+++++.+++.||+|++.|-.+....+..-|..|-.+|..-. .+=|+.++..|+|+.++|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence 456999999999999999999999999999999998755555556677888999998665 7889999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||++||+|..++.+.+++++..++.|+..|+.||+.||+.|+|||||||+|||| |..++|||+|||.+..+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCC
Confidence 99999999999999998899999999999999999999999999999999999999 666789999999998776443
Q ss_pred ce--eecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--CCCCCCCcccc
Q 013201 253 VY--RDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG--GVDFESEPWLL 322 (447)
Q Consensus 253 ~~--~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 322 (447)
.. ...+|||.|++||++. +.|+..+|+||+||++|||+.|..||+..+.-+++.+|+.. .+.|| .-..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~ 307 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETD 307 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccc
Confidence 32 3468999999999984 35999999999999999999999999999999999999887 45555 3345
Q ss_pred CChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRIT---SAEVLEHPWMREG 357 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t---~~~~l~h~~~~~~ 357 (447)
+|+++++||.+++. +|+.|.. ++++..||||.+.
T Consensus 308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 99999999999987 6888888 9999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=357.30 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=213.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|++++++++ |+||+++++++.+++.+|+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence 456999999999999999999999999999999875432 2334567899999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||+.|++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++. +..+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~---~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC---CCCEEEeeCCcchhhhhh
Confidence 999999999999999888899999999999999999999975 7999999999999954 446999999998765332
Q ss_pred CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHH---------------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL--------------------- 309 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--------------------- 309 (447)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2234579999999999864 58899999999999999999999997655433322110
Q ss_pred -----------------------hCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 310 -----------------------KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 310 -----------------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.... +......++.++++||.+||++||++|||++|++.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000 0000113578899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=373.10 Aligned_cols=253 Identities=27% Similarity=0.452 Sum_probs=217.9
Q ss_pred cceeecceeccccCeEEEEEEECCC-CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENST-GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
..|.+.+.||+|+||.||+|.+..+ +..||+|.+.. ........+.+|+.+++.++ ||||+++++++..++.+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~---~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML---NDERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc---CCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEEE
Confidence 3499999999999999999998887 78888887632 23344566788999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 173 VMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ....+||+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCceec
Confidence 9999999999987754 34689999999999999999999999999999999999995 4456999999999876
Q ss_pred cCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 249 DEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 249 ~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+++..+..+...... ..++
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~s 296 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP---CPVS 296 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---ccCC
Confidence 5432 233467999999999986 45899999999999999999999999998888888888776543221 2478
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.++++||.+||..||++||++++++.|+|++.
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999999975
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=354.63 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=212.0
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|.+.+.||+|+||.||+|++..++..||+|.+..... ......+.+|+.++++++ ||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence 459999999999999999999999999999998864432 223345778999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+.+ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||++......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE---RGELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEECccccceecCCCc
Confidence 999975 8888877654 4899999999999999999999999999999999999954 446999999998764332
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC----------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV---------------- 313 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------------- 313 (447)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22234578999999998753 478999999999999999999999988776655554433110
Q ss_pred ---CCCC-------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 314 ---DFES-------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 314 ---~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.++. .....+++++++||.+||..||.+|||++|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0000 01124688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=372.76 Aligned_cols=258 Identities=29% Similarity=0.480 Sum_probs=219.5
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC---
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ--- 168 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--- 168 (447)
..++|.+.+.||+|+||+||+|++..+++.||+|++..... .......+.+|+.++..+. |+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccC
Confidence 34679999999999999999999999999999999865433 3445667889999999997 999999988775332
Q ss_pred -----eEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEE
Q 013201 169 -----SVHLVMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 169 -----~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. +..+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~---~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC---CCCEEE
Confidence 478999999999999988653 45899999999999999999999999999999999999954 456999
Q ss_pred ecCCCceeccCC---CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC
Q 013201 240 TDFGLSVFIDEG---KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF 315 (447)
Q Consensus 240 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 315 (447)
+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+.+..+..+....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999999765432 22335689999999999874 58999999999999999999999999988888888877765432
Q ss_pred CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 316 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.. ..+++++.+||.+||..||.+||++.++++|||++..
T Consensus 265 ~~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 265 LP---PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CC---CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 22 2478999999999999999999999999999998753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=347.84 Aligned_cols=254 Identities=36% Similarity=0.641 Sum_probs=212.1
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++++.||+|+||+||+|++..+++.||+|++...... ........+|+.++++++ ||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhcccccc-cccccccccccccccccccccc
Confidence 78999999999999999999999999999998665322 222233456999999996 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec-cCCCce
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVY 254 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~-~~~~~~ 254 (447)
|+.+++|.+++.....+++..+..++.||+.||.+||++||+|+||||+||+++ .+..++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~---~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD---ENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---TTSEEEESSGTTTEESTSTTSEB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 999999999999888999999999999999999999999999999999999995 4456999999999863 333444
Q ss_pred eecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 255 RDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
....+++.|+|||++. ..++.++||||||+++|+|++|..||.... .......................++.+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5678999999999987 458999999999999999999999999873 33333333332222111111122479999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+|.+||+.||++||++.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=383.69 Aligned_cols=263 Identities=30% Similarity=0.521 Sum_probs=217.4
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--C
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--R 167 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 167 (447)
+...+.|++.+.||+|+||+||+|++..++..+|+|++..... .......+..|+.++++|. ||||++++++|.+ .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKAN 86 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCC
Confidence 3445679999999999999999999999999999998865433 3345677889999999998 9999999998854 4
Q ss_pred CeEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc-------CcEeecCCCCceEeecC-----
Q 013201 168 QSVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFM-------GVMHRDLKPENFLLSNK----- 231 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~-------~ivH~Dlkp~Nill~~~----- 231 (447)
..+|||||||++++|.++|.. ...+++..++.|+.||+.||.|||+. +||||||||+||||...
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 679999999999999998875 25699999999999999999999985 49999999999999642
Q ss_pred ---------CCCCceEEecCCCceeccCCCceeecCCccccccccccc---ccCCCCCcchhHHHHHHHHhhCCCCCCCC
Q 013201 232 ---------DGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR---RSYGKEIDVWSAGVILYILLSGVPPFWAE 299 (447)
Q Consensus 232 ---------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~elltg~~pf~~~ 299 (447)
+....+||+|||++............+||+.|+|||++. ..++.++||||||||||+|++|..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 223459999999998765544445568999999999874 34889999999999999999999999866
Q ss_pred CHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 300 TEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 300 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.....+...+.....++ ....+.++.+||..||..+|.+||++.++|.|+||+..
T Consensus 247 ~~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 247 NNFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 55443333333322222 23468999999999999999999999999999999854
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=324.00 Aligned_cols=258 Identities=28% Similarity=0.376 Sum_probs=221.4
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
.+....||.|+.|.|++++.+.+|...|||.+.+. .+....+++...+.++....++|+||+.+++|..+..++|.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 45567899999999999999999999999988654 4566778889999998888779999999999999999999999
Q ss_pred ccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 176 LCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
.|. ..+..++++ .++++|..+-.+...++.||.||.+ +||+|||+||+|||+ |..++|||||||++..+.+...
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc
Confidence 984 345555544 4679999999999999999999975 689999999999999 5556799999999998888777
Q ss_pred eeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 254 YRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.....|.+.|||||.+. ..|+.++||||||++|+||.||..||.+. ++.+++..++.... ...+.-..+|+.++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDFQ 326 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHHH
Confidence 77779999999999984 34999999999999999999999999875 56778888877543 22233335899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
+|+..||.+|+.+||...++|+|||++.+...
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 99999999999999999999999999987544
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=347.07 Aligned_cols=253 Identities=34% Similarity=0.642 Sum_probs=223.4
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.+..+++.+|+|.+.+.........+.+.+|+++++++. ||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEE
Confidence 5899999999999999999999999999999987655444445677889999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
||+++++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|+||+++. +..+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~---~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS---DGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC---CCCEEEeeCCCccccCCC--C
Confidence 99999999999998889999999999999999999999999999999999999944 456999999999876554 2
Q ss_pred eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
....|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+..+...++. .++..++++|.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~ 231 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRN 231 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHHH
Confidence 3457899999999875 45788999999999999999999999888877777777766544433 358999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 334 MLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 334 ~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
||..||.+|+ +++++++||||...
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccccC
Confidence 9999999999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=343.63 Aligned_cols=257 Identities=25% Similarity=0.443 Sum_probs=218.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|.++.+||+|+||.||+|.|+.+|+.+|+|.+.. ..+.+++..|+.||+++. .|+||++++.|-....+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEee
Confidence 348899999999999999999999999999998743 456788999999999998 89999999999999999999
Q ss_pred EeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||..|++.++++. ++.+++.++..+++..+.||+|||...-+|||||..|||++. ++..||+|||.|..+.+..
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT---~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT---DGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc---cchhhhhhccccchhhhhH
Confidence 999999999999875 567999999999999999999999999999999999999954 4579999999998876643
Q ss_pred -ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 -VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
..++++|||.|||||++.. +|+.++||||||++..||..|++||.+......+..|-.. ...........|.++-|+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~-PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK-PPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC-CCCCCCChHhhhhHHHHH
Confidence 3456899999999999974 5999999999999999999999999776553322222111 111111112458899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
|++||.+.|++|.|+-++++|||++..+..
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 999999999999999999999999976543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=358.00 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=210.2
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--- 167 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--- 167 (447)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.+.. ........+.+|+.+++.++ ||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeecccccc
Confidence 34567999999999999999999999999999999885432 23344567789999999997 99999999987543
Q ss_pred ---CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 168 ---QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++. +..+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC---CCcEEEEeCCC
Confidence 467999999965 67776643 5889999999999999999999999999999999999944 45699999999
Q ss_pred ceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---------
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD--------- 314 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------- 314 (447)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 987655444455689999999999864 5899999999999999999999999888776665555431100
Q ss_pred -------------CC----------------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 315 -------------FE----------------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 315 -------------~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
+. .......+..+++||.+||+.||.+|||+.++|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 0001123567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=362.63 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=212.1
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----eE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-----SV 170 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~~ 170 (447)
|++.+.||+|+||.||+|.+..+++.||+|.+... .........+.+|+.+++.++ |+||+++++++.... ..
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceE
Confidence 78899999999999999999999999999987542 223334567889999999997 999999999998776 88
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN---SNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC---CCCCEEeccccceeeccc
Confidence 99999996 58888888888899999999999999999999999999999999999994 445799999999986543
Q ss_pred CC--ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC---------------
Q 013201 251 GK--VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG--------------- 311 (447)
Q Consensus 251 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--------------- 311 (447)
.. ......+|+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 22 2234578999999999864 4789999999999999999999999887766555544321
Q ss_pred --------CCCCCC-----CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 312 --------GVDFES-----EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 312 --------~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
....+. ......++++.+||.+||+.||++|||+.++|+||||.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111100 0012357899999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=359.18 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=205.5
Q ss_pred ccccceeecceeccccCeEEEEEEECC--CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENS--TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
.+...|.+.+.||+|+||.||+|.... ++..||+|.+... ....+|+.+|++++ ||||+++++++....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS 159 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence 345679999999999999999997643 4678999977432 23468999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+|+|||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||++...
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~---~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE---PENAVLGDFGAACKL 235 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC---CCCEEEccCcccccc
Confidence 9999999995 688899877788999999999999999999999999999999999999954 446999999999765
Q ss_pred cCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH---HHHHHHHHhC----CCCCC-
Q 013201 249 DEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE---KGIFDAILKG----GVDFE- 316 (447)
Q Consensus 249 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~----~~~~~- 316 (447)
..... .....||+.|+|||++. ..++.++|||||||++|||++|..||.+... ...+..+.+. ...++
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 44321 23467999999999986 4589999999999999999999999976532 1222222211 00000
Q ss_pred ----------------------CCc---cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 317 ----------------------SEP---WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 317 ----------------------~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.+. ...++.+++++|.+||..||++|||+.++|.||||++.+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 000 013467889999999999999999999999999998753
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=340.00 Aligned_cols=254 Identities=28% Similarity=0.490 Sum_probs=214.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC--hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN--KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.|.+.+.||+|++|.||.|.+..+++.+|+|.+....... ......+.+|+.++++++ ||||+++++++.+...+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLSI 81 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEEE
Confidence 4899999999999999999999999999999886543222 123457889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|+||++|++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++. +..++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~---~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEeecccceeccccc
Confidence 9999999999999988888999999999999999999999999999999999999954 4469999999987654321
Q ss_pred ce----eecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 253 VY----RDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 253 ~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.. ....|+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+.........+ ..++..+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 236 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP--SHVSPDA 236 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC--ccCCHHH
Confidence 11 23568899999999864 48899999999999999999999998776655555444332222211 2478999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.++|.+||..+|.+|||+.++++|+||
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=358.90 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=208.7
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--- 167 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--- 167 (447)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+++.++ ||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccc
Confidence 35567999999999999999999999999999999885432 23344567789999999997 99999999988643
Q ss_pred ---CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 168 ---QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++. +..+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~---~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC---CCCEEEeeCcc
Confidence 357999999965 66666643 5889999999999999999999999999999999999944 45699999999
Q ss_pred ceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-----------
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG----------- 312 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~----------- 312 (447)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.+..
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987655444455689999999999864 58999999999999999999999998776544433322210
Q ss_pred -----------CCC----------------CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 313 -----------VDF----------------ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 313 -----------~~~----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
... ........+.++++||.+||..||++|||+.|+|+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 000011245678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=350.40 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=193.3
Q ss_pred cceeccccCeEEEEEEEC--CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeEEEEE
Q 013201 99 GKELGRGQFGITYLCTEN--STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQSVHLVM 174 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~ 174 (447)
+++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.++++++ ||||+++++++.. ...+|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence 568999999999999976 467899999875432 2345678999999997 9999999998854 46789999
Q ss_pred eccCCCchHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC-CCCCceEEecCCC
Q 013201 175 ELCSGGELFDKIIAQ---------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK-DGGAMLKATDFGL 244 (447)
Q Consensus 175 e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~~~vkl~Dfg~ 244 (447)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +....+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9995 5888877532 248999999999999999999999999999999999999643 3445799999999
Q ss_pred ceeccCCC----ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCH---------HHHHHHHH
Q 013201 245 SVFIDEGK----VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETE---------KGIFDAIL 309 (447)
Q Consensus 245 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~ 309 (447)
+....... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||..... ...+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98654321 2334688999999998854 489999999999999999999999965332 11122221
Q ss_pred hCCC-C-------------------------CC--------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 310 KGGV-D-------------------------FE--------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 310 ~~~~-~-------------------------~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.... . .. .......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1000 0 00 00001235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=345.23 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=205.4
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
...|++.+.||+||.+.||++... +.+.||+|.+.. ...+......+.+|+.+|.+|.+|.+|++|++|-..++.+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345999999999999999999854 456677766533 234566778899999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||- ..+|..+|.+... ++...++.|..|+|.|+.++|.+||||.||||.|+|+.. +.+||+|||+|..+..+
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk----G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK----GRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe----eeEEeeeechhcccCcc
Confidence 99975 5689999988765 444688999999999999999999999999999999954 35999999999887665
Q ss_pred Cc---eeecCCcccccccccccc------------cCCCCCcchhHHHHHHHHhhCCCCCCCCC-HHHHHHHHHhCCC--
Q 013201 252 KV---YRDIVGSAYYVAPEVLRR------------SYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFDAILKGGV-- 313 (447)
Q Consensus 252 ~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~-- 313 (447)
.. ..+.+||+.||+||.+.. ..+.++||||||||||+|+.|+.||..-. ...-+..|.....
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 32 245799999999998731 15789999999999999999999995432 2233344444333
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.|+.-+ -..++.++++.||..||++||++.++|+|||+.-
T Consensus 593 efp~~~---~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 593 EFPDIP---ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cccCCC---CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 222211 1234899999999999999999999999999975
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=355.58 Aligned_cols=261 Identities=24% Similarity=0.406 Sum_probs=210.7
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR-- 167 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 167 (447)
..+.++|++.+.||.|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.++++++ ||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccc
Confidence 445678999999999999999999999999999999885432 22233456779999999998 99999999887543
Q ss_pred ----CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 168 ----QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 168 ----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
..+|+++|++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~---~~~~kl~Dfg 163 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE---DCELRILDFG 163 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC---CCCEEEcCCc
Confidence 4579999998 778877664 457999999999999999999999999999999999999944 4569999999
Q ss_pred CceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-------
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD------- 314 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------- 314 (447)
++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+......
T Consensus 164 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 164 LARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred cceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876542 234679999999999864 4889999999999999999999999877655444443321100
Q ss_pred ----------------CCCC----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 315 ----------------FESE----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 315 ----------------~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
.+.. .+...++.+.+||.+||..||.+|||+.++|+||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0000 01235677899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=345.06 Aligned_cols=259 Identities=26% Similarity=0.409 Sum_probs=212.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|.+.+.||.|+||.||+|++..+++.||+|.+..... ......+.+|+.+++.++ ||||+++++++...+.+++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence 459999999999999999999999999999998854332 223446778999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE---RGELKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC---CCcEEECcCcchhccCCCC
Confidence 99997 5888888764 46899999999999999999999999999999999999954 446999999998754322
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD--------------- 314 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------------- 314 (447)
.......+++.|+|||++.+ .++.++|||||||++|+|++|.+||...+..+....+......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22234567899999998753 4788999999999999999999999887766555444321100
Q ss_pred ----CCC-------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 315 ----FES-------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 315 ----~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
.+. .....+++.+++||.+||+.||.+|||++++|+||||+...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 000 001246889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=338.94 Aligned_cols=254 Identities=29% Similarity=0.470 Sum_probs=212.4
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|.+.+.||+|+||.||+|++..+++.||+|.+... .......+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence 35699999999999999999999999999999987543 2233456788999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++ ....+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeEccCcc
Confidence 999999999999998888999999999999999999999999999999999999994 44469999999987654321
Q ss_pred -ceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC-CccccCChH
Q 013201 253 -VYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES-EPWLLISDS 326 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~ 326 (447)
......|++.|+|||++. +.++.++|+|||||++|+|++|..||...........+.......+. .....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457999999999873 34888999999999999999999999766554444333333322211 111246788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPW 353 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~ 353 (447)
+.++|.+||..||++||+++++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=352.46 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=200.1
Q ss_pred ccceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++.+||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 356999999999999999999752 345789999875332 2334567889999999996699999999988754
Q ss_pred -CeEEEEEeccCCCchHHHHHHc---------------------------------------------------------
Q 013201 168 -QSVHLVMELCSGGELFDKIIAQ--------------------------------------------------------- 189 (447)
Q Consensus 168 -~~~~lv~e~~~g~~L~~~l~~~--------------------------------------------------------- 189 (447)
+.+++|||||++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999998753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc---eeecCCcc
Q 013201 190 -----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSA 261 (447)
Q Consensus 190 -----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~ 261 (447)
..+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++........ .....+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE---NNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC---CCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23677888999999999999999999999999999999954 45699999999976543221 12345678
Q ss_pred ccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCC
Q 013201 262 YYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339 (447)
Q Consensus 262 ~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 339 (447)
.|+|||++. ..++.++|||||||++|||++ |..||.+....+.+............+ ..+++.+.+||.+||+.||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHccCCh
Confidence 899999875 558999999999999999997 999998765444333333332222211 2578899999999999999
Q ss_pred CCCCCHHHHhc
Q 013201 340 KKRITSAEVLE 350 (447)
Q Consensus 340 ~~R~t~~~~l~ 350 (447)
++|||+.++++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=346.23 Aligned_cols=256 Identities=34% Similarity=0.562 Sum_probs=225.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|+.-+.||+||||.||.++.+.||+-||+|.+.|..+..........+|-.||++++ .+.||.+-..|+..+.++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence 44778899999999999999999999999999998877665555666789999999998 89999999999999999999
Q ss_pred EeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|..|.||+|.-+|-+.+ .|++..++.++.+|+.||.+||+.+||+|||||+|||+ |+.++|+|+|+|+|..+.++
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence 99999999988887766 69999999999999999999999999999999999999 56667999999999999999
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH----HHHHHHHhCCCCCCCCccccCChH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
+.....+||.+|||||++. +.|+.+.|+|||||+||||+.|+.||...... ++-..++.....++ ..+|++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kFS~e 416 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKFSEE 416 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cccCHH
Confidence 8888889999999999987 45999999999999999999999999765433 33333444333333 468999
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 327 AKDLVRKMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
+++|.+.+|++||++|.. ++++.+||||+..
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 999999999999999975 5689999999974
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=351.54 Aligned_cols=255 Identities=26% Similarity=0.467 Sum_probs=218.6
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|.-.+.||.|+||.||-|++..+...||||.+....-.....-.++..|+.+|+++. |||++.+.++|..+...|
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHH
Confidence 3455777899999999999999999999999999886554444445678899999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||||-| +-.|++.- .+++-+-+++.|+.+.+.||.|||+++.||||||..|||+ .+.+.|||+|||.|....+
T Consensus 103 LVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 103 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCc
Confidence 99999965 66676654 4679999999999999999999999999999999999999 4555799999999987765
Q ss_pred CCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHh-CCCCCCCCccccCCh
Q 013201 251 GKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-GGVDFESEPWLLISD 325 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~ 325 (447)
. .+++|||+|||||++. |.|+-++|||||||+..||...++|+++.+....+.-|.. ....+.... .|.
T Consensus 179 A---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~e---WS~ 252 (948)
T KOG0577|consen 179 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE---WSD 252 (948)
T ss_pred h---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCch---hHH
Confidence 4 4679999999999863 6799999999999999999999999888766554444443 444444443 488
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.++.||..||++-|.+|||.+++|.|+|+...
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 99999999999999999999999999999764
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=337.57 Aligned_cols=254 Identities=28% Similarity=0.485 Sum_probs=210.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR---- 167 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---- 167 (447)
..+.|++.+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.+++++.+|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 456699999999999999999999999999999988543 223467889999999996699999999998653
Q ss_pred --CeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 168 --QSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 168 --~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
..+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++. +..+||+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~---~~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE---NAEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC---CCCEEEccCC
Confidence 4689999999999999998864 35899999999999999999999999999999999999954 4469999999
Q ss_pred CceeccCC-CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 013201 244 LSVFIDEG-KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316 (447)
Q Consensus 244 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 316 (447)
++...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-- 234 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP-- 234 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC--
Confidence 99765432 2223467999999999874 24788999999999999999999999876655544444332221
Q ss_pred CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 317 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
......++.++.+||.+||..||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 11223478899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.75 Aligned_cols=258 Identities=32% Similarity=0.572 Sum_probs=220.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++++. |+||+++++.+.+....|+||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEE
Confidence 5899999999999999999999999999999987665443345677889999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 175 ELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. +..++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE---SGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC---CCCEEEeecchhhcccccc
Confidence 999999999998764 46899999999999999999999999999999999999954 4469999999986543211
Q ss_pred ------------------------------ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCH
Q 013201 253 ------------------------------VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETE 301 (447)
Q Consensus 253 ------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~ 301 (447)
......||..|+|||++.+ .++.++||||||+++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1113468999999999864 488899999999999999999999998887
Q ss_pred HHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCC----HHHHhcCCCccCCC
Q 013201 302 KGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRIT----SAEVLEHPWMREGG 358 (447)
Q Consensus 302 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t----~~~~l~h~~~~~~~ 358 (447)
...+..+......++.. ..+++.+.++|.+||..||++||+ ++++|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 238 DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 77777766554443332 236899999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=337.37 Aligned_cols=255 Identities=28% Similarity=0.466 Sum_probs=217.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||.|+||.||+|++..++..+|+|.+.... .......+.+|+.+++.+. |+||+++++++.++..+|+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEEE
Confidence 5889999999999999999999999999999885432 2334567889999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-Cc
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~ 253 (447)
||+++++|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||+++. +..++|+|||++...... ..
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~---~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE---EGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC---CCCEEEcccccceeecccccc
Confidence 999999999988765 8899999999999999999999999999999999999954 456999999999876543 22
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
.....|++.|+|||.+. ..++.++||||||+++|+|++|..||...+.......+......... ...++..+.++|.
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 232 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFVS 232 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHHH
Confidence 33457899999999886 45899999999999999999999999877666555555544222111 1127889999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 333 KMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+||..||++|||++++++||||.+..
T Consensus 233 ~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 233 LCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHhhCChhhCcCHHHHhhChhhcCCC
Confidence 99999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=341.89 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=220.6
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||.|+||.||++.+..+++.|++|.+.+...........+.+|+.+++.++ ||||+++++.+..++.+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEEE
Confidence 4899999999999999999999999999999886654333344567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++ ....+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCccccCcCccc
Confidence 9999999999998888899999999999999999999999999999999999994 44569999999886311000
Q ss_pred --------------ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC
Q 013201 253 --------------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES 317 (447)
Q Consensus 253 --------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 317 (447)
......|+..|+|||.+. ..++.++|+||||+++|+|++|..||.+....+....+..+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 011246788999999875 55899999999999999999999999988888888877776554444
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRIT---SAEVLEHPWMREG 357 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~h~~~~~~ 357 (447)
... .++.++.++|.+||+.||++||+ +.++|+||||...
T Consensus 238 ~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 238 GDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 332 57899999999999999999998 7899999999763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=342.77 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=211.6
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|++++++++ ||||+++++++.+++.+|+||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEEe
Confidence 4899999999999999999999999999999875321 2334567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||++|++|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+|||++. +..+||+|||++...... .
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~~-~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLIDS-M 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec---CCcEEEccCCCccccccc-c
Confidence 999999999999988889999999999999999999997 69999999999999954 446999999998765332 2
Q ss_pred eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-----------------
Q 013201 254 YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF----------------- 315 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~----------------- 315 (447)
.....|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 234678999999999864 47889999999999999999999997655433322221110000
Q ss_pred -----------------CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 316 -----------------ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 316 -----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+..+...++.++++||.+||..||++|||+.++++||||.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 001112367889999999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=353.73 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=201.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|.+.+.||+|+||.||+|++..+++.||+|... ...+.+|+.+|++++ |+||+++++++...+..++|
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence 46999999999999999999999999999999532 123568999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ...+||+|||++.......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~---~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG---PEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC---CCCEEEcccCCceeccccc
Confidence 99995 6888888764 46999999999999999999999999999999999999954 4469999999998654322
Q ss_pred ---ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCC---C--
Q 013201 253 ---VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAET--------EKGIFDAILKGGVD---F-- 315 (447)
Q Consensus 253 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~~---~-- 315 (447)
......||+.|+|||++.+ .++.++|||||||+||||++|..|+.... ...+...+...... +
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1224579999999999864 58999999999999999999886654321 22333333322211 0
Q ss_pred ----------------------CCCcc---ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 316 ----------------------ESEPW---LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 316 ----------------------~~~~~---~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
....| ..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11112 135678999999999999999999999999999975
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=335.05 Aligned_cols=252 Identities=33% Similarity=0.533 Sum_probs=213.4
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||.|+||.||+|++..+++.||+|.+.+...........+..|..++....+|+||+++++++..++.+|+|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999886544332333344556666665554699999999999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCC
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVG 259 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 259 (447)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++. ...+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ---TGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCcEEEeecccceeccc---cccCCC
Confidence 999999988888999999999999999999999999999999999999954 44699999999876443 224578
Q ss_pred cccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccC
Q 013201 260 SAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338 (447)
Q Consensus 260 t~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 338 (447)
++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+..+...++......+++++.++|.+||+.|
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 899999999864 4789999999999999999999999988888777777766555544444467999999999999999
Q ss_pred CCCCCC---HHHHhcCCCccCC
Q 013201 339 PKKRIT---SAEVLEHPWMREG 357 (447)
Q Consensus 339 p~~R~t---~~~~l~h~~~~~~ 357 (447)
|++||+ ++|+|.||||++.
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcC
Confidence 999994 5799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=348.38 Aligned_cols=248 Identities=23% Similarity=0.377 Sum_probs=209.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+...++..||+|.||+||+|++-. .||||++..... .....+.|++|+.++++-+ |.||+-+.|++..... .||
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-AII 465 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-eee
Confidence 346778999999999999999875 499998865443 4457889999999999998 9999999999988877 899
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec---c
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI---D 249 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~---~ 249 (447)
+-+|+|.+|+.+|.-. .+|.....+.|++||+.|+.|||.++|||||||..||++ .++..|||+|||++... .
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeeec
Confidence 9999999999999753 468899999999999999999999999999999999999 44467999999998642 2
Q ss_pred CCCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC-CccccCC
Q 013201 250 EGKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES-EPWLLIS 324 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s 324 (447)
....+....|...|||||+++ ..|++.+|||||||++|||+||..||.......++..+-+|...... .....++
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence 333445567889999999985 35999999999999999999999999977777777766666332221 2233578
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+++++|+..||.+++++||.+.+||.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 89999999999999999999999986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=338.55 Aligned_cols=256 Identities=27% Similarity=0.496 Sum_probs=211.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++.+.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.+++++. |+||+++++++.....+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence 359999999999999999999999999999998864422 2223456789999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK- 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 252 (447)
|||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||+++. +..+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK---QGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC---CCcEEECccccceecCCCcc
Confidence 999999888877777677999999999999999999999999999999999999954 4469999999998765433
Q ss_pred ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----------------
Q 013201 253 VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV----------------- 313 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~----------------- 313 (447)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||.+....+....+.....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 3334578899999998753 478899999999999999999999987765544433322100
Q ss_pred --CCCCC--------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 314 --DFESE--------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 314 --~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
..+.+ .+..++..+.+||.+||+.||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00000 012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=336.72 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=216.0
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||.|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.+. ||||+++++++...+..|+|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence 4488999999999999999999999999999987432 2344567889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+++++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++. +..+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~---~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc---CCCEEEccccccccccccc
Confidence 999999999887765 456999999999999999999999999999999999999954 446999999998754332
Q ss_pred CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 252 KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.......|++.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+......... ....++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-CccccCH
Confidence 2223457899999999873 23678999999999999999999999887776666666554322111 1124788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
++.+||.+||+.||.+||+++++++||||+...
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=334.42 Aligned_cols=250 Identities=32% Similarity=0.599 Sum_probs=215.9
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGE 181 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 181 (447)
||.|+||.||+|++..+++.+|+|++.+.........+.+.+|+.+++.++ ||||+++++++.++..+|+||||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999999999999999987665544455678999999999997 9999999999999999999999999999
Q ss_pred hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCCcc
Q 013201 182 LFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSA 261 (447)
Q Consensus 182 L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~ 261 (447)
|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++. +..++|+|||++.............|++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS---NGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC---CCCEEEeeCCcccccCcccccccccCCc
Confidence 9999988888999999999999999999999999999999999999954 4469999999998776543334467899
Q ss_pred ccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccC
Q 013201 262 YYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAET--EKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338 (447)
Q Consensus 262 ~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 338 (447)
.|+|||.+. ..++.++|+||||+++|+|++|..||.... .......+..+......+. ..+++++++|.+||..|
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCC
Confidence 999999875 458899999999999999999999998776 5566666664332222222 24889999999999999
Q ss_pred CCCCCC-----HHHHhcCCCccCC
Q 013201 339 PKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 339 p~~R~t-----~~~~l~h~~~~~~ 357 (447)
|++||+ ++|+++||||++.
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCC
Confidence 999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=337.98 Aligned_cols=241 Identities=20% Similarity=0.217 Sum_probs=206.4
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CCeEEEEEe
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----RQSVHLVME 175 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~~lv~e 175 (447)
..||+|++|.||+|.. +|+.||+|.+.+.........+.+.+|+.+|++++ ||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence 5799999999999987 58899999986544333333577889999999998 9999999999876 457899999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
||+||+|.+++.+...+++.....++.|++.||.|||+ .+++||||||+|||++ .++.+||+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHhhhcccc--
Confidence 99999999999988889999999999999999999998 4999999999999994 44579999999987654322
Q ss_pred eecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
....|++.|+|||++.+ .++.++|||||||++|||++|..||.+.+..++...+......+..+ ..+++++++||
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence 23478999999999863 58999999999999999999999999988888888876655444332 24789999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 013201 332 RKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~ 350 (447)
.+||+.||++|||++++++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999985
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=337.94 Aligned_cols=260 Identities=29% Similarity=0.492 Sum_probs=216.3
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+...+|++.+.||+|+||.||+|++..+++.+++|.+..... ...+.+.+|+.+++.+. |+||+++++.+......
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL 92 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEE
Confidence 345679999999999999999999999999999998865332 23467889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+||||++|++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||+++. +..+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~---~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITP 168 (296)
T ss_pred EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC---CCCEEECccccchhccc
Confidence 999999999999998754 46899999999999999999999999999999999999944 44699999999876543
Q ss_pred CC-ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GK-VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+...... .......++..+.
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 247 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFR 247 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCCccccCHHHH
Confidence 32 2233578999999998864 4789999999999999999999999877665444333332221 1111235788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
++|.+||..||++||++.++++||||.....
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 9999999999999999999999999987533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=335.85 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=210.4
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++ ||||+++++++..++.+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEE
Confidence 356999999999999999999999999999999885432 233456789999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++. ...+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~---~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD---NGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC---CCCEEECcCccceeecccc
Confidence 9999999999999988888999999999999999999999999999999999999944 4469999999998654322
Q ss_pred -ceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC-ccccCChH
Q 013201 253 -VYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE-PWLLISDS 326 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~ 326 (447)
......|++.|+|||.+. ..++.++|+|||||++|+|++|..||...........+.......+.. ....++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 223457899999999873 337889999999999999999999997655443333222222221111 11246889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPW 353 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~ 353 (447)
+.+||.+||..||++||+++++|+|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=337.07 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=234.7
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|..+.+||.|+||.|.+|..+.+...||||++.+.......+.+--..|-++|......|.++.++..|+.-+++|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 38899999999999999999999999999999988877777777777788888887777899999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee-ccCCCc
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF-IDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~-~~~~~~ 253 (447)
||+.||+|--.+..-+++.|..+..++..|+-||-+||++||++||||.+|||+ +..++|||+|||+++. +.++..
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCCcc
Confidence 999999999999999999999999999999999999999999999999999999 5566799999999974 445566
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
+.+++|||.|+|||++. ..|+.++|+||+||+||||+.|.+||.+.+..+++..|......++.. +|.++.++.+
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs----lSkEAv~ick 582 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS----LSKEAVAICK 582 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc----ccHHHHHHHH
Confidence 78899999999999986 779999999999999999999999999999999999999998888764 7999999999
Q ss_pred HhcccCCCCCCCH-----HHHhcCCCccCC
Q 013201 333 KMLIQDPKKRITS-----AEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~t~-----~~~l~h~~~~~~ 357 (447)
.+|.+.|.+|... .+|-.||||+..
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhc
Confidence 9999999999865 589999999854
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=330.05 Aligned_cols=251 Identities=25% Similarity=0.492 Sum_probs=217.5
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|.+.+.||+|++|.||+|++..++..|++|.+..... .......+.+|+.++++++ ||||+++++++.+.+.+|+|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEEE
Confidence 7888999999999999999999999999998865433 3445677889999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 176 LCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. +..+||+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~---~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA---YDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC---CCCEEEcccccceeccCccc
Confidence 99999999998774 56899999999999999999999999999999999999954 34699999999887654322
Q ss_pred -eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 254 -YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 254 -~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
.....|++.|+|||++. +.++.++|+||||+++|+|++|..||...+.......+..+....... .++..+.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i 233 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ---MYSQQLAQLI 233 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc---ccCHHHHHHH
Confidence 23457899999999876 457899999999999999999999998888777777776654432221 4788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCc
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.+||+.+|++||++.++++|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=333.30 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=212.6
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh------hhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK------QDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+|.+++.||.|+||.||+|.+..+++.+|+|.+........ ...+.+.+|+.++++++ ||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence 37889999999999999999998999999998865433221 12356889999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++ .+..+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~---~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---CCCCEEecccCCCccc
Confidence 9999999999999999998888899999999999999999999999999999999999994 4456999999998766
Q ss_pred cCCC-------ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Q 013201 249 DEGK-------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 249 ~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 320 (447)
.... ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||........+..+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc---CC
Confidence 4211 112346889999999886 457889999999999999999999998876655555444432211 11
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
..++..+.++|.+||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 2468999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=333.28 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=214.7
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||.|+||+||+|.+..++..+++|++...... .....+.+|+.+++.++ |+||+++++.+...+.+|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEEE
Confidence 589999999999999999999989999999988543322 25677899999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 175 ELCSGGELFDKIIAQ---GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 175 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|+++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++. +..++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~---~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE---DGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC---CCCEEEcccchHHHhccC
Confidence 999999999999764 45899999999999999999999999999999999999954 446999999998765443
Q ss_pred Cc-----eeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC--cccc
Q 013201 252 KV-----YRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE--PWLL 322 (447)
Q Consensus 252 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~ 322 (447)
.. .....|+..|+|||++.. .++.++|+||||+++|+|++|..||........+..+.......... .+..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 22 133578999999998763 48899999999999999999999998877666565555543221111 1235
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+++.+.++|.+||..||++||++++++.||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 78899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=338.06 Aligned_cols=252 Identities=33% Similarity=0.539 Sum_probs=209.3
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGE 181 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 181 (447)
||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.++++++ ||||+++++++...+.+|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999999999999999987654433444556778999999998 9999999999999999999999999999
Q ss_pred hHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCC
Q 013201 182 LFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVG 259 (447)
Q Consensus 182 L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 259 (447)
|.+++.+.. .+++..+..++.|++.||.|||++|++||||+|+||+++. +..+||+|||++.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD---HGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC---CCCEEEccCcchhhhccCCccccccC
Confidence 999998766 6999999999999999999999999999999999999954 44699999999876654444445678
Q ss_pred ccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccC
Q 013201 260 SAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQD 338 (447)
Q Consensus 260 t~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 338 (447)
+..|+|||++. +.++.++||||||+++|+|++|..||...........+..............+++.+.++|.+||+.|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999875 44888999999999999999999999765442222222222222222222346899999999999999
Q ss_pred CCCCC-----CHHHHhcCCCccCC
Q 013201 339 PKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 339 p~~R~-----t~~~~l~h~~~~~~ 357 (447)
|.+|| ++.+++.||||++.
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcC
Confidence 99999 88899999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=351.60 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=199.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|++.+.||+|+||.||+|++..++..||+|+..+. ....|+.++++++ |+||+++++++......++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence 3599999999999999999999999999999975322 2346999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND---VDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEEecCccccccccCc
Confidence 99995 588888865 456999999999999999999999999999999999999944 4469999999997654444
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH-----------HHHHHHHHhCCC---CCC-
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE-----------KGIFDAILKGGV---DFE- 316 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------~~~~~~i~~~~~---~~~- 316 (447)
......||+.|+|||++. ..++.++|||||||++|||+++..|+..... ..+...+..... .++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 444568999999999986 4589999999999999999986555433211 111111111000 000
Q ss_pred -------------------------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 317 -------------------------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 317 -------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
......++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0001245778889999999999999999999999999975
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=336.78 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=217.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+.++++++ |+||+++++++..+..+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence 35599999999999999999999989999999987432 3445567889999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.||+|+||||+||+++. +..++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~---~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC---CCCEEEccCccchhhccc
Confidence 99999999999988764 46999999999999999999999999999999999999944 456999999988654332
Q ss_pred -CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 252 -KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.......|++.|+|||.+. ..++.++|+||||+++|+|++|..||........+..+..+...... ....++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 235 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPSKWS 235 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-CcccCC
Confidence 2223457899999999873 23678999999999999999999999888776666666554322111 112468
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.++.++|.+||..||.+||++.++++||||.+.
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 899999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=337.15 Aligned_cols=254 Identities=29% Similarity=0.442 Sum_probs=206.5
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|++|.||+|++..++..||+|.+.... ........+.+|+.+++++. ||||+++++++.+++.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence 3889999999999999999999999999999885432 22333467789999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 175 ELCSGGELFDKIIAQ---GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 175 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN---KGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC---CCcEEECcccceeecCCC
Confidence 9997 5888887653 45899999999999999999999999999999999999954 456999999998765432
Q ss_pred -CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Q 013201 252 -KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF------------- 315 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~------------- 315 (447)
.......+++.|+|||++.+ .++.++|||||||++|+|+||..||.+.........+.......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 22233467899999998753 36889999999999999999999998766543333222110000
Q ss_pred ------------CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 316 ------------ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 316 ------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.......+++++.++|.+||..||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001122478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.69 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=215.7
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||.|+||.||+|++..++..+++|.+... .......+.+|+.+++.+. |+||+++++.+..++.+|+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEEE
Confidence 45699999999999999999999999999999987542 3445677889999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||++|++|..++.+ ...+++..+..++.|++.+|.|||+.||+||||||+||+++. +..+||+|||++......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL---DGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC---CCCEEEccCccceecccc
Confidence 9999999999887765 456899999999999999999999999999999999999954 446999999998754332
Q ss_pred -CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 252 -KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.......+++.|+|||.+. ..++.++|+|||||++|+|++|..||...+....+..+........ .....++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-SQPSKWS 242 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC-CCCcccC
Confidence 2223457899999999873 2367899999999999999999999988776665555544322111 1122467
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.++.++|.+||..||++||+++++++||||....
T Consensus 243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 8999999999999999999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=363.47 Aligned_cols=250 Identities=32% Similarity=0.476 Sum_probs=209.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEE-EE---eC-
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA-YE---DR- 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~-~~---~~- 167 (447)
..++++.+.|.+|||+.||+|.+...|..||+|++... ++...+.+.+||.+|++|.+|+|||.+++. .. .+
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 45688999999999999999999988899999988543 677888999999999999999999999993 22 11
Q ss_pred --CeEEEEEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCCCCceEEec
Q 013201 168 --QSVHLVMELCSGGELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 --~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
-.++|.||||.||.|.+++.. ..+|+|.++++|+.++++|+.+||... |||||||-+||||+.+ +..||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~---g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD---GNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC---CCEEeCc
Confidence 357899999999999999985 356999999999999999999999988 9999999999999554 4699999
Q ss_pred CCCceeccCCC-ce---------eecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHH
Q 013201 242 FGLSVFIDEGK-VY---------RDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDA 307 (447)
Q Consensus 242 fg~a~~~~~~~-~~---------~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 307 (447)
||.+....... .. -...-|+.|+|||++. ...++|+|||+|||+||-||....||..... ..
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----la 265 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LA 265 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----ee
Confidence 99986432211 00 0135689999999974 3489999999999999999999999987644 35
Q ss_pred HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 308 ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 308 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
|+.+.+.++.. ..++..+.+||+.||+.||.+||++.+++.+-+-
T Consensus 266 Ilng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 266 ILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred EEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 67777777654 3689999999999999999999999999876443
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=328.92 Aligned_cols=252 Identities=25% Similarity=0.502 Sum_probs=212.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-CCeEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED-RQSVHLV 173 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv 173 (447)
.|++.+.||.|++|.||++.+..+++.+|+|.+..... .....+.+.+|+.++++++ |+|++++++.+.. +..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence 38999999999999999999999999999999854332 2334567889999999997 9999999998764 4568999
Q ss_pred EeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||+++++|.+++... ..+++..+..++.|++.||.+||+.||+||||||+||+++. ...++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~---~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR---TNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec---CCcEEEecccceEEeccc
Confidence 9999999999998763 35899999999999999999999999999999999999944 456999999999766432
Q ss_pred -CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 -KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.......|++.|+|||++. ..++.++||||||+++|+|++|..||...+.......+..+..... ...+++++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM---PKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHHH
Confidence 2223457899999999876 4588899999999999999999999988777666666665543221 1247899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+|.+||+.||++||++.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.34 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=218.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++ ||||+++++.+..++.+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence 489999999999999999999999999999998765432 334678899999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 175 ELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||++|++|.+++... ..+++..+..++.|++.+|.|||++||+|+||+|+||+++.++ ..+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK--MVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEccCCCceecCCCc
Confidence 999999999999764 3489999999999999999999999999999999999995433 368999999998776554
Q ss_pred ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
......|+..|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+..+...... ..+++.+.++|
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS---DRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC---CCcCHHHHHHH
Confidence 4445678999999999864 4788999999999999999999999888777666666654332211 24788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCc
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.+||..||.+|||+.++++||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=355.90 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=211.6
Q ss_pred eeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCC
Q 013201 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGG 180 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 180 (447)
+||+|.||+||.|++..+...+|||.|..+ +....+-+..||.+.++|+ |.|||+++|.+..++.+-|.||-.+||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 699999999999999999999999998543 3445667889999999999 999999999999999999999999999
Q ss_pred chHHHHHH-cCCC--CHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-Cceee
Q 013201 181 ELFDKIIA-QGHY--TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KVYRD 256 (447)
Q Consensus 181 ~L~~~l~~-~~~~--~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~ 256 (447)
+|.++|.. .+++ .|..+..+.+||++||.|||++.|||||||-+|||++.-. +.+||+|||-++.+... ..+.+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS--GvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS--GVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc--ceEEecccccchhhccCCccccc
Confidence 99999976 4677 7889999999999999999999999999999999997543 47999999999876543 34456
Q ss_pred cCCccccccccccc---ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 257 IVGSAYYVAPEVLR---RSYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 257 ~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
+.||..|||||++. ++|+.++|||||||++.||.||++||...... ..+-+ -|.+....+-...+|.+++.+|.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk--VGmyKvHP~iPeelsaeak~Fil 813 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK--VGMYKVHPPIPEELSAEAKNFIL 813 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh--hcceecCCCCcHHHHHHHHHHHH
Confidence 89999999999996 45999999999999999999999999765332 22211 23232222222357899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+|+.+||.+||+|.++|..||++..
T Consensus 814 rcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 814 RCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHcCCCcccCccHHHhccCcccccC
Confidence 9999999999999999999999876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=350.18 Aligned_cols=248 Identities=35% Similarity=0.542 Sum_probs=215.7
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.+.|.+...+|.|+|+.|..+.+..+++.+++|++.+.. .+..+|+.++....+||||+++.+.+.++.+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCcee
Confidence 35677999999999999999999999999999999997652 22346888888888899999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+|||++.|+.|.+.+.....+. .++..|+.+|+.|+.|||++|||||||||+|||+. +..++++|+|||.+.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence 99999999999998888776666 88889999999999999999999999999999995 3445799999999987765
Q ss_pred CCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
. +.+.+-|..|.|||++. ..|++++||||||++||+||+|..||...... ++...+..+.+. ..+|++++
T Consensus 469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AK 540 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAK 540 (612)
T ss_pred h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHH
Confidence 4 44557788999999987 45999999999999999999999999876555 666666555443 36899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
|||.+||++||.+|+++.+++.||||.+
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcchhc
Confidence 9999999999999999999999999943
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=334.91 Aligned_cols=252 Identities=28% Similarity=0.484 Sum_probs=216.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||.|+||.||+|++..++..||+|.+.+.........+.+.+|+.++++++ ||||+++++.+.+....|+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence 3899999999999999999999999999999997655544455678999999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
||+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++. +..++|+|||++.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE---QGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC---CCCEEEeecccccccCCCccc
Confidence 99999999999988878999999999999999999999999999999999999954 446999999998876554444
Q ss_pred eecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 255 RDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETE---KGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
....|+..|+|||.+.. .++.++|+||||+++|+|++|..||..... ..............+ ..++..+.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP----ATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc----ccCcHHHHHH
Confidence 55678999999999864 479999999999999999999999987763 333333222211111 2468999999
Q ss_pred HHHhcccCCCCCCCH--HHHhcCCCc
Q 013201 331 VRKMLIQDPKKRITS--AEVLEHPWM 354 (447)
Q Consensus 331 i~~~L~~dp~~R~t~--~~~l~h~~~ 354 (447)
|.+||..||.+||++ .|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=333.64 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=206.7
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|++..+++.||+|.+.+.. .......+.+|+.+++++. ||||+++++++...+..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEEE
Confidence 4788899999999999999999999999999885432 2334467889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++. +..+||+|||++...... ..
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~---~~~~~l~dfg~~~~~~~~-~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT---RGQVKLCDFGVSTQLVNS-IA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC---CCCEEEeeCCcceecccc-cc
Confidence 99999988654 35789999999999999999999999999999999999954 456999999999765433 22
Q ss_pred eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCCCCCCCCccccCChH
Q 013201 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE-------KGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
....||..|+|||++. ..++.++|+||||+++|+|++|..||..... .+....+..... ...+....+++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 228 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEK 228 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCHH
Confidence 3468999999999886 4589999999999999999999999965322 122222222211 11112346889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+.++|.+||+.||.+||++++++.||||...
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=336.41 Aligned_cols=258 Identities=30% Similarity=0.508 Sum_probs=217.7
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
..+|++.+.||.|+||.||+|++..+++.|++|.+.... ....+.+.+|+.+++.++ ||||+++++++.....+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEE
Confidence 456999999999999999999999999999999885432 234567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|+||+++++|..++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++. +..+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~---~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEccCccchhccccc
Confidence 9999999999988765 46899999999999999999999999999999999999944 4469999999987654432
Q ss_pred c-eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 V-YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 ~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
. .....|++.|+|||.+. ..++.++|+|||||++|+|++|..||...+.......+....... ......+++.+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-cCCcccCCHHHHHH
Confidence 2 23357899999999886 458899999999999999999999998877665555544432221 11223578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
|.+||..||.+||++.++++||||+....
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 99999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=352.86 Aligned_cols=258 Identities=21% Similarity=0.442 Sum_probs=221.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeecccc-CChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe--EE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL-VNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS--VH 171 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--~~ 171 (447)
..+....||+|+|-+||+|.|..+|..||.-.+.-..+ ......++|..|+.+|+.|. ||||++++++|.+... +.
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceee
Confidence 34667899999999999999999999999765543332 33455789999999999998 9999999999987654 88
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|+|++..|+|..|+++.++++...++.|++||+.||.|||++. |+|||||.+||+|+.+ .+.|||+|+|+|....
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~--~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN--LGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC--cCceeecchhHHHHhh
Confidence 99999999999999999999999999999999999999999874 9999999999999744 4579999999998765
Q ss_pred CCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
... ...++|||.|||||++...|+..+||||||++++||+|+..||... +..++++++..|..+-.... .-.++++
T Consensus 198 ~s~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr 274 (632)
T KOG0584|consen 198 KSH-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVR 274 (632)
T ss_pred ccc-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHH
Confidence 543 3458999999999999999999999999999999999999999876 45567788877754322111 2368999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+||.+||.. .+.|+|+.|+|+||||.....
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence 999999999 999999999999999998643
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=340.37 Aligned_cols=254 Identities=25% Similarity=0.454 Sum_probs=205.3
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||.|+||.||+|++..+|..+|+|.+..... .......+.+|+.++++++ |+||+++++++.+.+.+|+|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence 48899999999999999999999999999998865322 2223356778999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-C
Q 013201 175 ELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-K 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 252 (447)
||+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++. +..+||+|||++...... .
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~---~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC---CCcEEECccchhhccCCCCC
Confidence 99964 78887765 567999999999999999999999999999999999999954 446999999998765432 2
Q ss_pred ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCC-CCCHHHHHHHHHhCCCC---------------
Q 013201 253 VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFDAILKGGVD--------------- 314 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~--------------- 314 (447)
......+++.|+|||++.+ .++.++|||||||++|+|++|..||. +.+..+.+..+.+....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234567899999998754 37899999999999999999988864 34444444433221000
Q ss_pred --CCC--------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 315 --FES--------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 315 --~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
++. .....+++++++||.+||..||.+|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 0112468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=338.10 Aligned_cols=263 Identities=29% Similarity=0.500 Sum_probs=217.6
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+..++|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++ |+||+++++++...+.+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL 91 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCEE
Confidence 44567999999999999999999999999999999885432 233466889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++. +..++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~---~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEECcCccceEccC
Confidence 999999999999998765 46899999999999999999999999999999999999944 44699999999876544
Q ss_pred CCc-eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GKV-YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
... .....|++.|+|||.+. ..++.++|+|||||++|+|++|..||...+.......+...... .......++..++
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPERLSAVFR 246 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC-CCCCccccCHHHH
Confidence 322 23457899999999886 45789999999999999999999999876654433333322211 1112234688899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGEASD 362 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~ 362 (447)
+||.+||..||++||+++++++||||+.......
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 9999999999999999999999999987655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=339.21 Aligned_cols=262 Identities=28% Similarity=0.438 Sum_probs=215.4
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC--hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN--KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
+|.+.+.||+|+||.||+|.+..+++.||+|.+....... ......+.+|+.++++++ |+||+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence 3888999999999999999999999999999986554321 222355678999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++. +..+||+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~---~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS---DGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC---CCCEEEccceeeeeccCC
Confidence 99999 889999998766 7999999999999999999999999999999999999954 446999999999876543
Q ss_pred -CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC-----------
Q 013201 252 -KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES----------- 317 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~----------- 317 (447)
.......+++.|+|||.+.+ .++.++|||||||++|+|++|.+||.+....+.+..+.........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 22334467889999998753 4788999999999999999998888877665555554332100000
Q ss_pred -------------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 318 -------------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 318 -------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
..+...+..+.++|.+||..||++|||+.++|.|+||.+.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 00123578899999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=343.45 Aligned_cols=255 Identities=20% Similarity=0.301 Sum_probs=203.8
Q ss_pred ecceeccc--cCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 98 LGKELGRG--QFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 98 ~~~~lg~G--~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
+.++||+| +|++||+++++.+|+.||+|.+..... .....+.+.+|+.+++.++ ||||+++++++..++..|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence 56789999 788999999999999999998854332 2334567788999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-C
Q 013201 176 LCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-K 252 (447)
Q Consensus 176 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 252 (447)
|+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+ ..++++|||........ .
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~---~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC---CcEEEcccchhhccccccc
Confidence 99999999998653 458999999999999999999999999999999999999544 46999999865433211 1
Q ss_pred -------ceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC------
Q 013201 253 -------VYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE------ 316 (447)
Q Consensus 253 -------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------ 316 (447)
......++..|+|||++.+ .++.++|||||||++|+|++|..||..............+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0112356788999999863 488999999999999999999999987655443333332211100
Q ss_pred ------------------------------------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 317 ------------------------------------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 317 ------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.+....+++++.+||.+||+.||++|||++++++||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00011346789999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=336.03 Aligned_cols=259 Identities=28% Similarity=0.396 Sum_probs=212.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.+..++..||+|.+... ........+.+|+.+++++. |+||+++++.+...+.+|+||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEEE
Confidence 488999999999999999999999999999988542 13334567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 175 ELCSGGELFDKIIAQ---GHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 175 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||++|++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++. +..+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC---CCCEEEeecCCcccccC
Confidence 999999998888763 368999999999999999999996 59999999999999954 44699999999876543
Q ss_pred CCceeecCCcccccccccccc-------cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR-------SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
. ......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+..............+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 2 2234578899999998742 2578999999999999999999999766554444332221111111111247
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
++++.++|.+||..+|++||++++++.||||......
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 8999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=347.90 Aligned_cols=236 Identities=25% Similarity=0.448 Sum_probs=208.8
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
++-||.|+.|.||+|+.. ++.||||++.. .-+.+|+-|++|+ ||||+.+.++|...-.+|||||||.
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence 456999999999999976 78999997732 2246889999998 9999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecC
Q 013201 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258 (447)
Q Consensus 179 g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 258 (447)
.|.|...|+....++......+..+|+.|+.|||.+.|||||||.-||||..++ .|||+|||-++...+....-.++
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d---~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD---VVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc---eEEeccccchHhhhhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999998776 49999999998887766666789
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||..|||||+++ ...+.|+|||||||+|||||||..||.+-+...++.-+-.+...++.+. .+++-++-||+.||+-
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPs--tcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPS--TCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcc--cCchHHHHHHHHHHhc
Confidence 999999999997 4589999999999999999999999988777666555544444444442 5789999999999999
Q ss_pred CCCCCCCHHHHhcCC
Q 013201 338 DPKKRITSAEVLEHP 352 (447)
Q Consensus 338 dp~~R~t~~~~l~h~ 352 (447)
.|..||++.+||.|-
T Consensus 351 KpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHL 365 (904)
T ss_pred CCCCCccHHHHHHHH
Confidence 999999999999984
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=334.52 Aligned_cols=250 Identities=30% Similarity=0.440 Sum_probs=200.9
Q ss_pred eeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhc--cCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHL--SGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l--~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++.+ .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999988765443333233344555544443 248999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecC
Q 013201 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258 (447)
Q Consensus 179 g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 258 (447)
|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++ .+..++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~---~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---CCCCEEEccCCcceeccccC-ccCcC
Confidence 999999998888899999999999999999999999999999999999994 44569999999987654332 23357
Q ss_pred Cccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH--HHHHHHHhCCCCCCCCccccCChHHHHHHHHh
Q 013201 259 GSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEK--GIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334 (447)
Q Consensus 259 gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 334 (447)
|++.|+|||.+. ..++.++|||||||++|+|++|..||...... ....... ..........++.++.++|.+|
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hcCCcCCccccCHHHHHHHHHH
Confidence 999999999875 34789999999999999999999999754321 1122111 1111111234789999999999
Q ss_pred cccCCCCCC-----CHHHHhcCCCccCC
Q 013201 335 LIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 335 L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
|..||++|+ +++++++||||+..
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 999999999 69999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=325.82 Aligned_cols=252 Identities=30% Similarity=0.512 Sum_probs=218.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||.|+||.||.+++..+++.+++|.+..... .......+.+|+.++++++ |+||+++++++.+.+.+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence 48999999999999999999999999999998865433 2344567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 175 ELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||++++|.+++.+. ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++. +..+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~---~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK---AGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC---CCCEEECcCcceEEccccc
Confidence 999999999999775 45899999999999999999999999999999999999954 3469999999998664433
Q ss_pred -ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 -VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+....+..+...... ..++.++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2334678999999998764 4788999999999999999999999988888888887766544322 3578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCc
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
|.+||..+|.+||++.++|+|+|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=328.28 Aligned_cols=254 Identities=30% Similarity=0.491 Sum_probs=215.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||.|+||.||+|.+..++..+++|.+.... ......+.+|+.++++++ ||||+++++++.+.+.+|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence 356999999999999999999999999999999886432 235678899999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++. +..+||+|||++......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~---~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE---DGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC---CCCEEECccccchhhhhh
Confidence 99999999999988776 78999999999999999999999999999999999999954 446999999998765432
Q ss_pred C-ceeecCCccccccccccc-c---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC-CccccCCh
Q 013201 252 K-VYRDIVGSAYYVAPEVLR-R---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES-EPWLLISD 325 (447)
Q Consensus 252 ~-~~~~~~gt~~y~aPE~~~-~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~ 325 (447)
. ......|+..|+|||.+. . .++.++|+||||+++|+|++|..||...+.......+....+.... .....++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 2 223457899999999875 3 5788999999999999999999999887766655555444322211 11123578
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPW 353 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~ 353 (447)
++.++|.+||..||.+|||+.+++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=333.35 Aligned_cols=270 Identities=26% Similarity=0.439 Sum_probs=220.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|+..+.||.|+||.||+|.+..++..+|+|.+.... .......+.+|+.+++++. |+||+++++++.++..+|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEE
Confidence 45888999999999999999999999999999886432 2334567889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|||++|++|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||+++. +..++|+|||++........
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~---~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE---QGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC---CCCEEEcccccceeccCCcc
Confidence 999999999998864 57899999999999999999999999999999999999954 44699999999976644332
Q ss_pred -eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 254 -YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 254 -~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
.....++..|+|||++. ..++.++|+||||+++|+|++|..||...........+..+... .....++..+.++|
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li 233 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---TLTGEFSKPFKEFI 233 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---CCchhhhHHHHHHH
Confidence 23356889999999886 45789999999999999999999999887766555544333221 11124678899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHH
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQ 375 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 375 (447)
.+||..+|++||++.++++|+||...... .......+.++++
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~--~~~~~~~~~~~~~ 275 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKNAKK--TSYLTELIDRFKR 275 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhcchh--hhHHHHHHHHHHh
Confidence 99999999999999999999999775332 2233444444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=328.89 Aligned_cols=254 Identities=28% Similarity=0.491 Sum_probs=208.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC--hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN--KQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQSV 170 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~ 170 (447)
.|...+.||+|+||.||+|.+..++..|++|.+....... ......+.+|+.++++++ ||||+++++++.+ ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence 4889999999999999999999999999999886543222 223456889999999997 9999999998875 4678
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
++++||+++++|.+++.....+++..+..++.|++.||.|||+.+|+||||||+||+++ .+..+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEccCCCcccccc
Confidence 99999999999999998888899999999999999999999999999999999999994 444699999999875432
Q ss_pred C----CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 251 G----KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 251 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
. .......|+..|+|||.+.+ .++.++|||||||++|+|++|..||...........+.........+ ..+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP--SHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc--hhcCH
Confidence 1 12233568899999999864 47899999999999999999999998776555444443322211111 24678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
.++++| +||..+|++||++++++.||||+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=333.28 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=208.6
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE------e
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE------D 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~------~ 166 (447)
.+.|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.+++++.+|+||+++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 45699999999999999999999999999999987542 2334668899999999977999999999985 3
Q ss_pred CCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++. ...++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~---~~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE---NAEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEeeCcc
Confidence 56789999999999999988763 34888899999999999999999999999999999999954 44699999999
Q ss_pred ceeccCC-CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC
Q 013201 245 SVFIDEG-KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES 317 (447)
Q Consensus 245 a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 317 (447)
+...... .......|++.|+|||.+. ..++.++|+|||||++|+|++|..||...........+...... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~ 245 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP--K 245 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC--C
Confidence 8755322 2223467899999999874 34788999999999999999999999876655444443333211 1
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.....++.++.+||.+||..||.+||++.++|+||||
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1122478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=335.44 Aligned_cols=257 Identities=29% Similarity=0.412 Sum_probs=207.6
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe-----
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS----- 169 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----- 169 (447)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+.+|+||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5899999999999999999999999999999875432 2223345678899999999878999999999887665
Q ss_pred EEEEEeccCCCchHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 170 VHLVMELCSGGELFDKIIAQ-----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+ +..+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~--~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ--KGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC--CCeEEEeeccc
Confidence 8999999986 788887653 347999999999999999999999999999999999999652 34699999999
Q ss_pred ceeccCC-CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC----
Q 013201 245 SVFIDEG-KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES---- 317 (447)
Q Consensus 245 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~---- 317 (447)
+...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8765322 22233467889999998753 4789999999999999999999999887665554444331100000
Q ss_pred --------------------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 318 --------------------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 318 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
.....+++++.+||.+||.+||.+||++.++|.||||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00124688999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=329.03 Aligned_cols=253 Identities=25% Similarity=0.441 Sum_probs=209.5
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC---ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV---NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
|++++.||.|+||.||+|.+. +++.+|+|.+...... .......+.+|+.++++++ |+||+++++++.+.+.+++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred ccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEEE
Confidence 788999999999999999864 7889999987543221 1223456889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC--
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-- 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-- 250 (447)
|+||++|++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++ ....++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---CCCeEEeccchhhHhhhhcc
Confidence 999999999999998888899999999999999999999999999999999999995 445699999999875421
Q ss_pred -----CCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 251 -----GKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 251 -----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
........|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+.......+. ....++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 235 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR-LPDSFS 235 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC-CCCCCC
Confidence 111234578999999999864 4789999999999999999999999876655444333332111111 122478
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.++.++|.+||..+|.+||++.+++.||||
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=326.28 Aligned_cols=252 Identities=27% Similarity=0.552 Sum_probs=217.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||.|+||.||++++..+++.||+|.+..... .......+.+|+.++++++ ||||+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence 48999999999999999999999999999998865433 2334567899999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 175 ELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||+.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++. +..++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~---~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK---DGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC---CCCEEEeeccceeecCcch
Confidence 9999999999887643 5789999999999999999999999999999999999954 4469999999997664432
Q ss_pred c-eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 V-YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 ~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
. .....|++.|+|||++. ..++.++|+|||||++|+|++|..||......+....+..+...... ..++.++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS---SHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCc---ccCCHHHHHH
Confidence 2 22356889999999976 45788999999999999999999999988888887777766543221 2468899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCc
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
|.+||+.+|.+||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.19 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=201.1
Q ss_pred cceeeccee--ccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 94 QFYTLGKEL--GRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 94 ~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.|.+.+.+ |.|+||.||+++++.++..+|+|.+.+..... .|+.....+.+|+||+++++.+...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666666 99999999999999999999999886543211 13333333335999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. .++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD--RIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC--eEEEecCccceecCCC
Confidence 99999999999999988888999999999999999999999999999999999999965442 6999999998765433
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
....|+..|+|||++. ..++.++||||||+++|+|++|..||..........................+++.+.++
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF 240 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHH
Confidence 2346899999999986 458899999999999999999999998654433211111111112222233589999999
Q ss_pred HHHhcccCCCCCCC-HHHHhcCCCccC
Q 013201 331 VRKMLIQDPKKRIT-SAEVLEHPWMRE 356 (447)
Q Consensus 331 i~~~L~~dp~~R~t-~~~~l~h~~~~~ 356 (447)
|.+||+.||.+|++ ++++|+||||+.
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999996 599999999973
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=331.42 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=211.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC---hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN---KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
.|+.++.||+|+||.||+|.+..+++.+|+|++....... ......+.+|+.++++++ |+||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence 3788999999999999999999999999999886433211 123567889999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+|+||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ ..+||+|||++......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~--~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG--QRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEcccccccccccc
Confidence 9999999999999998888899999999999999999999999999999999999995433 35999999998765432
Q ss_pred C-----ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHH---hCCCCCCCCcccc
Q 013201 252 K-----VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL---KGGVDFESEPWLL 322 (447)
Q Consensus 252 ~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~ 322 (447)
. ......|+..|+|||.+. ..++.++|+||+|+++|+|++|..||...........+. ....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 235 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS--IPEH 235 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC--Cchh
Confidence 1 112346889999999876 458899999999999999999999997544332222222 2211111 1124
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
+++++.+++.+||..||.+||++.++++||||+
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 688999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.29 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=191.5
Q ss_pred cceeccccCeEEEEEEECC--CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE--eCCeEEEEE
Q 013201 99 GKELGRGQFGITYLCTENS--TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE--DRQSVHLVM 174 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~ 174 (447)
+.+||+|+||.||+|++.. ++..||+|.+.... ....+.+|+.++++++ ||||+++++++. .+..+|+||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence 4689999999999999764 56889999875432 2345778999999998 999999999885 456789999
Q ss_pred eccCCCchHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC-CCCCceEEecCCC
Q 013201 175 ELCSGGELFDKIIAQ---------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK-DGGAMLKATDFGL 244 (447)
Q Consensus 175 e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~~~vkl~Dfg~ 244 (447)
||+.+ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+..+ +....+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99964 777776531 247899999999999999999999999999999999999543 3445799999999
Q ss_pred ceeccCCC----ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH---------HHHHHHH
Q 013201 245 SVFIDEGK----VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEK---------GIFDAIL 309 (447)
Q Consensus 245 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~~~i~ 309 (447)
+....... ......||+.|+|||++.+ .++.++|||||||++|||+||.+||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 98664322 2234578999999998854 4789999999999999999999999654321 1111111
Q ss_pred hCCC--------------C------------CC--------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 310 KGGV--------------D------------FE--------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 310 ~~~~--------------~------------~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.... . .. .......+..+.+||.+||..||.+|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1000 0 00 00001235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=336.15 Aligned_cols=262 Identities=28% Similarity=0.420 Sum_probs=212.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QSVH 171 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~ 171 (447)
+.|++.+.||+|+||.||+|.+..+|..||+|.+...... ......+.+|+.++++++ |+||+++++++.+. +.++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeEE
Confidence 4599999999999999999999999999999988643321 122234568999999998 99999999998755 5789
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++. ...+||+|||++.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD---KGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEECccceeeecCC
Confidence 99999964 78888775 356899999999999999999999999999999999999954 44699999999987654
Q ss_pred C-CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--------------
Q 013201 251 G-KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV-------------- 313 (447)
Q Consensus 251 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-------------- 313 (447)
. .......+++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 3 22233456888999998753 478999999999999999999999998888777666554211
Q ss_pred -----CCCCCc-------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 314 -----DFESEP-------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 314 -----~~~~~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
...... ....++++.+||.+||..||++|||+.+++.||||++.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 111111 123588899999999999999999999999999999765553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=333.22 Aligned_cols=255 Identities=30% Similarity=0.503 Sum_probs=212.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||.|+||.||+|++..+|..||+|++...... ......+.+|+.++++++ ||||+++++++.+...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence 389999999999999999999999999999988654322 233567889999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-
Q 013201 175 ELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 252 (447)
||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++. ...++|+|||++.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~---~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA---DGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC---CCcEEEeeeeecccccCCCC
Confidence 999 9999998865 356899999999999999999999999999999999999954 4569999999988665432
Q ss_pred -ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---------------
Q 013201 253 -VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD--------------- 314 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------------- 314 (447)
......|+..|+|||++.+ .++.++||||+|+++|+|++|.+||.+......+..+......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2344578999999998753 4689999999999999999998888877766555554432110
Q ss_pred ----CCCC-------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 315 ----FESE-------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 315 ----~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
++.. .....+..+.+||.+||..||.+||+++++|.||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 0124578999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=331.08 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=211.2
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR-- 167 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 167 (447)
....+.|.+.+.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++.+||||+++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 344677999999999999999999999999999999875421 23456788999999996699999999998643
Q ss_pred ---CeEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 168 ---QSVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
+.+|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++. +..+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~---~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC---CCCEEEe
Confidence 468999999999999988753 356899999999999999999999999999999999999954 3469999
Q ss_pred cCCCceeccCCC-ceeecCCcccccccccccc------cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Q 013201 241 DFGLSVFIDEGK-VYRDIVGSAYYVAPEVLRR------SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 241 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 313 (447)
|||++....... ......|+..|+|||.+.. .++.++|||||||++|+|++|+.||........+..+.+...
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 999987654322 2234578999999998742 268899999999999999999999988776555555544422
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
.... ....++..+.+||.+||+.||++||++.++++||||+
T Consensus 251 ~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1111 1123567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=333.92 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=214.8
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+..+.|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++ ||||+++++++.+.+..
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTA 90 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeE
Confidence 34566999999999999999999999999999999886544444445567889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|+||||+. |+|.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++. +..+||+|||++....
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~---~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE---PGTVKLADFGSASLVS 166 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC---CCCEEEeecCcceecC
Confidence 99999997 467676654 456899999999999999999999999999999999999944 4569999999987654
Q ss_pred CCCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.. ....|++.|+|||++. +.++.++||||||+++|+|++|..||...........+...... ......++.
T Consensus 167 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 241 (307)
T cd06607 167 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDWSD 241 (307)
T ss_pred CC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhhCH
Confidence 33 2457889999999873 45888999999999999999999999887766655544433211 111123678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.+.++|.+||..||++||++.+++.||||....
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.60 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=203.0
Q ss_pred ccceeecceeccccCeEEEEEEE-----CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTE-----NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.++|++++.||+|+||.||+|++ ..++..||+|++.... .....+.+.+|+.+++.+.+||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45699999999999999999974 3456789999875332 2334567889999999996699999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC---------------------------------------------------------
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG--------------------------------------------------------- 190 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~--------------------------------------------------------- 190 (447)
+..++|||||+||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886532
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 191 ------------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 191 ------------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
.+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~---~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH---GRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC---CCcEEEecCccceeccCcc
Confidence 3677889999999999999999999999999999999954 4469999999998664432
Q ss_pred ce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 253 VY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 253 ~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.. ....++..|+|||++. ..++.++|||||||++|+|++ |..||.....................+ ...+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP--ECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC--CCCCHHH
Confidence 21 1234566799999986 458999999999999999998 899998765443333333433322222 2467899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++||.+||+.||++||++.++++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=331.56 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=209.1
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE--
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE-- 165 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 165 (447)
......+.|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+.+|+||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34456677999999999999999999999999999999864321 223567889999999966999999999873
Q ss_pred ---eCCeEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceE
Q 013201 166 ---DRQSVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238 (447)
Q Consensus 166 ---~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vk 238 (447)
....+++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++.+ ..+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC---CCEE
Confidence 45679999999999999988753 3468899999999999999999999999999999999999543 4599
Q ss_pred EecCCCceeccCCC-ceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Q 013201 239 ATDFGLSVFIDEGK-VYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG 311 (447)
Q Consensus 239 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 311 (447)
|+|||++....... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+..+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 99999987654322 223457999999999874 33788999999999999999999999877654444333222
Q ss_pred CCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 312 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
... .......++..+.+||.+||+.||++|||+.++++|+||
T Consensus 245 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 111 111112357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=328.94 Aligned_cols=256 Identities=24% Similarity=0.460 Sum_probs=211.3
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC-------hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN-------KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+....... ....+.+.+|+.++++++ |+||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence 4889999999999999999999999999999875322111 112356788999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 168 QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
...++||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++ .+..++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~---~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD---ADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---CCCeEEEeecccccc
Confidence 99999999999999999998888899999999999999999999999999999999999995 445799999999876
Q ss_pred ccCCC---ceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CCCCCc
Q 013201 248 IDEGK---VYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV--DFESEP 319 (447)
Q Consensus 248 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~--~~~~~~ 319 (447)
..... ......|+..|+|||.+.. .++.++|+||||+++|++++|..||......+....+..... .++...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 43321 1223568899999998753 378899999999999999999999976655544443332221 222222
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
...++.++.++|.+||.+||.+||+++++|+||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 23568999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=347.65 Aligned_cols=257 Identities=30% Similarity=0.533 Sum_probs=237.7
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.+++...||-||||.|=++..+.....+|+|++.|....+....+.+..|-.||..++ .|.||+++..|.+..++|++|
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhH
Confidence 3667788999999999999877666679999999988888888899999999999998 899999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
|-|-||.|+..|.+++.|.+..++.++..+++|++|||++|||+|||||+|.++ +.++.+||.|||+|+.+..+..+
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCce
Confidence 999999999999999999999999999999999999999999999999999999 66678999999999999999999
Q ss_pred eecCCcccccccccc-cccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVL-RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
.++||||.|.|||++ +++++.++|.||||+++|||++|.+||.+.+...+++.|++|.-.+..+ ..++..+.+||++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKK 654 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHH
Confidence 999999999999975 5779999999999999999999999999999999999999985444443 2589999999999
Q ss_pred hcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 334 MLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 334 ~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
+...+|.+|.. +.+|-+|.||...
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 99999999987 7899999999764
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=358.53 Aligned_cols=263 Identities=21% Similarity=0.297 Sum_probs=195.4
Q ss_pred cccccceeecceeccccCeEEEEEEECCCC-CEEEEE--------------EeeccccCChhhHHHHHHHHHHHHhccCC
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTG-NSYACK--------------SILKRKLVNKQDREDIKREIQIMQHLSGQ 154 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~avK--------------~i~~~~~~~~~~~~~~~~E~~~l~~l~~h 154 (447)
..+.+.|++.+.||+|+||+||+|..+... ...+.| .+.+...........+.+|+.+|++++ |
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence 445678999999999999999998765332 222222 111111122234456889999999997 9
Q ss_pred CCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 155 ~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
|||+++++++.+.+..|+|+|++. ++|.+++... .......++.++.||+.||.|||++||+||||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999999999995 5777776542 2244677889999999999999999999999999999994
Q ss_pred cCCCCCceEEecCCCceeccCCCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC---CHHH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE---TEKG 303 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~ 303 (447)
. ++.+||+|||++..+..... ....+||+.|+|||++. ..++.++|||||||++|||++|..+++.. ....
T Consensus 302 ~---~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 302 C---DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred C---CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 4 45699999999987654322 22468999999999986 45899999999999999999988654332 1112
Q ss_pred HHHHHHhCC----CCCCCC------------------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 304 IFDAILKGG----VDFESE------------------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 304 ~~~~i~~~~----~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
.+..+.... ..++.. ....++..+.++|.+||++||.+|||+.|+|.||||.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 222221110 000000 0113567788999999999999999999999999998
Q ss_pred CC
Q 013201 356 EG 357 (447)
Q Consensus 356 ~~ 357 (447)
..
T Consensus 459 ~~ 460 (501)
T PHA03210 459 AE 460 (501)
T ss_pred cC
Confidence 75
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=326.34 Aligned_cols=255 Identities=27% Similarity=0.494 Sum_probs=209.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC--ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV--NKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~ 169 (447)
..|++++.||+|+||.||+|.+..++..||+|.+...... .....+.+.+|+.+++++. ||||+++++++.+ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence 3589999999999999999999999999999987543211 1233567889999999997 9999999998876 357
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+++||||++|++|.+++.+...+++..+..++.|++.||.|||+.||+|+||||+||+++. +..++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS---VGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecC---CCCEEECcCccccccc
Confidence 8899999999999999988888999999999999999999999999999999999999954 4469999999987543
Q ss_pred CC----CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 250 EG----KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 250 ~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.. .......|+..|+|||++. ..++.++||||||+++|+|++|..||...........+.........+ ..++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 235 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLP--PHVS 235 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCc--hhhC
Confidence 21 1123356899999999875 458899999999999999999999998766555444443332211111 2467
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
..+.++|.+||. +|++||+++++++|||+.
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 889999999995 999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=346.23 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=204.3
Q ss_pred ccceeecceeccccCeEEEEEEECCCC-----CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTG-----NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.+.|++++.||+|+||.||+|++..++ ..||+|.+.... .....+.+.+|+.+++.+.+|+||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 456999999999999999999865443 579999885432 2334567889999999995599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHc----------------------------------------------------------
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ---------------------------------------------------------- 189 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~---------------------------------------------------------- 189 (447)
+.+|+|||||++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce---
Q 013201 190 ------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY--- 254 (447)
Q Consensus 190 ------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~--- 254 (447)
..+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++.........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~---~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD---GRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC---CCeEEEeeceeeeeccCCcceeec
Confidence 13678889999999999999999999999999999999953 457999999999765433221
Q ss_pred eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
....+++.|+|||++. ..++.++|||||||++|+|++ |..||........+..+.........+. .+++++.++|.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPD--FAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCC--CCCHHHHHHHH
Confidence 1233566899999875 568999999999999999997 9999987665554445444443333222 36899999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 013201 333 KMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~ 350 (447)
+||+.||++|||+.++++
T Consensus 350 ~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 350 MCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=325.32 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=214.7
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC--ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV--NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
+|+..+.||+|+||.||+|.+..++..|++|.+...... .....+.+.+|+.+++.++ |+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence 378889999999999999999989999999988653321 2334567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|+||+++++|.+++.+...+++..+..++.||+.||.|||+.||+|+||+|+||+++. +..+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~---~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT---NGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEccCccceeccccc
Confidence 9999999999999988888999999999999999999999999999999999999954 4569999999988765544
Q ss_pred ceeecCCccccccccccc-cc-CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......|++.|+|||.+. .. ++.++|+||||+++|+|++|..||...........+........ ....+++.+.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP--IPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCC--cCCCcCHHHHHH
Confidence 344567899999999875 33 78999999999999999999999987765554444443211111 112468999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCc
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+.+||..+|.+||++.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=335.86 Aligned_cols=255 Identities=27% Similarity=0.478 Sum_probs=210.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.++++++ ||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEEE
Confidence 58999999999999999999998999999998765432 2234567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-Cc
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~ 253 (447)
||+++++|..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++. +..++|+|||++...... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~---~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ---SGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC---CCcEEEEeeeeeeeccCCccc
Confidence 99999888887766667999999999999999999999999999999999999944 457999999998765433 22
Q ss_pred eeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC------------------
Q 013201 254 YRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV------------------ 313 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------------------ 313 (447)
.....|+..|+|||++.+ .++.++||||||+++|+|++|.+||......+....+.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 334578999999998753 378899999999999999999999977665443333221100
Q ss_pred -CCCC--------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 314 -DFES--------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 314 -~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
..+. .....++..+.+|+.+||..||.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 0122468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=336.47 Aligned_cols=262 Identities=29% Similarity=0.562 Sum_probs=217.7
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
...+.|.....||.|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.++ |+||+++++.+...+..
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDEL 94 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeE
Confidence 3455677778899999999999999999999999987432 2344567889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCEEEccCcchhhccc
Confidence 999999999999887744 56899999999999999999999999999999999999954 44699999999875432
Q ss_pred C-CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 G-KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
. .......|++.|+|||.+.+ .++.++||||||+++|||++|..||........+..+.... .........++..+.
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 249 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLR 249 (292)
T ss_pred ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccCHHHH
Confidence 2 22234578999999998864 58899999999999999999999998877766555544332 111122224688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
++|.+||..||.+|||++++++||||......+
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 999999999999999999999999999765554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=329.67 Aligned_cols=250 Identities=29% Similarity=0.462 Sum_probs=201.5
Q ss_pred eeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhc--cCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHL--SGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l--~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
.||+|+||.||+|.+..+++.||+|.+.+...........+..|..+++.+ .+||+|+.+++++.+...+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998765433222222334444443332 248999999999999999999999999
Q ss_pred CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecC
Q 013201 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258 (447)
Q Consensus 179 g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 258 (447)
|++|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+||+++ .+..+||+|||++....... .....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~~-~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK-PHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCccC-CcCcC
Confidence 999999998888899999999999999999999999999999999999994 44569999999987654322 23457
Q ss_pred Ccccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 259 GSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 259 gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
|+..|+|||++.+ .++.++||||+|+++|+|++|..||.... .......+......++ ..++.++.++|.+
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~ 232 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEG 232 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC----CcCCHHHHHHHHH
Confidence 9999999999863 47899999999999999999999998763 2222222222222222 2368999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCCCccCCC
Q 013201 334 MLIQDPKKRI-----TSAEVLEHPWMREGG 358 (447)
Q Consensus 334 ~L~~dp~~R~-----t~~~~l~h~~~~~~~ 358 (447)
||..||.+|+ ++.++++||||++..
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 9999999999 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=326.30 Aligned_cols=251 Identities=26% Similarity=0.465 Sum_probs=211.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||.|+||.||+|++..+++.+++|.+.... ..+.+.+|+.++++++ |+||+++++++.+...+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEE
Confidence 45999999999999999999999889999999875431 2678899999999996 99999999999999999999
Q ss_pred EeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++. +..+||+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~---~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE---EGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC---CCcEEEcccccchhcccCc
Confidence 999999999999876 456899999999999999999999999999999999999954 4469999999998765433
Q ss_pred -ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 -VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......|+..|+|||++.+ .++.++||||||+++|+|++|..||...........+....... ......++.++.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDF 232 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHHHHH
Confidence 2234568899999999864 58889999999999999999999998766554443332221111 11112467899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCc
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
|.+||+.||++|||+.++|+||||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=328.76 Aligned_cols=254 Identities=30% Similarity=0.470 Sum_probs=210.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC----
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ---- 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 168 (447)
.++|++.+.||.|++|.||+|.+..+++.+++|++.... ...+.+.+|+.+++++.+|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 467999999999999999999999999999999875432 234678899999999966999999999997644
Q ss_pred --eEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecC
Q 013201 169 --SVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 169 --~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. +..+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~---~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK---NAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc---CCeEEECCC
Confidence 58999999999999988865 347899999999999999999999999999999999999954 446999999
Q ss_pred CCceeccCC-CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC
Q 013201 243 GLSVFIDEG-KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF 315 (447)
Q Consensus 243 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 315 (447)
|++...... .......|++.|+|||++. ..++.++||||||+++|+|++|..||...........+.+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 998765432 2223457899999999874 236789999999999999999999998766655555555543221
Q ss_pred CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 316 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
. .....+++++++||.+||..||++|||+.++++|||+
T Consensus 238 ~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1 1112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=325.48 Aligned_cols=255 Identities=27% Similarity=0.483 Sum_probs=213.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|.+.+.||+|+||.||+|.+..+++.|++|.+..... .......+.+|+.++++++ |+||+++++.+...+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence 48899999999999999999999999999999865433 2346678999999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc-
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV- 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~- 253 (447)
||+++++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++. ...+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH---NGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEcccccccccCCCCCc
Confidence 99999999999988777999999999999999999999999999999999999954 45699999999876644322
Q ss_pred ----eeecCCcccccccccccc-c---CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 254 ----YRDIVGSAYYVAPEVLRR-S---YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 254 ----~~~~~gt~~y~aPE~~~~-~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.....+++.|+|||++.+ . ++.++||||||+++|++++|..||.....................+.+..+++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 123568899999999863 2 78899999999999999999999976543332222222222233334445689
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.+.++|.+||+.||.+||++.+++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=326.02 Aligned_cols=265 Identities=29% Similarity=0.432 Sum_probs=213.6
Q ss_pred CCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC-C----CeeEEE
Q 013201 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ-Q----NIVEFR 161 (447)
Q Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~----~iv~~~ 161 (447)
...+.+..+|.+...+|+|.||.|-.+.+..++..||+|++..- ..-++...-|+++|+++..+ | -++.+.
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 34456688999999999999999999999999999999987421 23345667799999999532 2 378899
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC-------
Q 013201 162 GAYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD------- 232 (447)
Q Consensus 162 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~------- 232 (447)
+||+..++.+||+|.+ |-+++++|.+++ +++...++.+++||+.++.|||+.+++|.||||+|||+...+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence 9999999999999998 679999998865 489999999999999999999999999999999999995322
Q ss_pred ----------CCCceEEecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH
Q 013201 233 ----------GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE 301 (447)
Q Consensus 233 ----------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 301 (447)
....|||+|||.|....+.. ...+.|..|+|||++. -+|+..+||||+||||+|++||...|+..++
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 13458999999998766544 5678999999999876 4799999999999999999999999998876
Q ss_pred HH---HHHHHHh------------------CCCCCCCCccc---------------------cCChHHHHHHHHhcccCC
Q 013201 302 KG---IFDAILK------------------GGVDFESEPWL---------------------LISDSAKDLVRKMLIQDP 339 (447)
Q Consensus 302 ~~---~~~~i~~------------------~~~~~~~~~~~---------------------~~s~~~~~li~~~L~~dp 339 (447)
.+ +++.|+. +..+++..... .-..++.|||++||.+||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 65 3333321 11111110000 012357799999999999
Q ss_pred CCCCCHHHHhcCCCccCCC
Q 013201 340 KKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 340 ~~R~t~~~~l~h~~~~~~~ 358 (447)
.+|+|+.|+|.||||+...
T Consensus 395 ~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 395 ARRITLREALSHPFFARLT 413 (415)
T ss_pred cccccHHHHhcCHHhhcCC
Confidence 9999999999999998753
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=331.00 Aligned_cols=252 Identities=31% Similarity=0.493 Sum_probs=206.7
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeEEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QSVHLV 173 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv 173 (447)
|++.+.||+|+||.||+|.+..++..||+|.+.+.. ... ......+|+.+++++.+|+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~-~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc-CCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 678899999999999999999999999999875432 122 2233457999999997799999999999987 899999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||+.+ +|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||+++. ..+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----CCeEEEecccccccccCC
Confidence 999974 888887764 56899999999999999999999999999999999999955 579999999998765544
Q ss_pred ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------------------
Q 013201 253 VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG------------------ 312 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~------------------ 312 (447)
......+++.|+|||.+. +.++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 444567899999999764 347889999999999999999999998877665554443211
Q ss_pred CCCCCC-------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 313 VDFESE-------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 313 ~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
..++.. ....++.++.+||.+||.+||++||+++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 001000 012468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=292.48 Aligned_cols=257 Identities=26% Similarity=0.466 Sum_probs=216.0
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|...++||+|.||+||+|++..++..||+|.+..... ++.......+|+-+|+.|+ |.|||+++++...++.+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence 47778999999999999999999999999999864332 2333456789999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-C
Q 013201 175 ELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-K 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 252 (447)
|||. .+|..+... ++.+..+.++.++.|++.||.|||+++++||||||.|.||+. ++.+||+|||+++.+.-. .
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~---ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR---NGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc---CCcEEecccchhhhcCCceE
Confidence 9995 578877765 577999999999999999999999999999999999999954 456999999999876543 2
Q ss_pred ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccc--------
Q 013201 253 VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWL-------- 321 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------- 321 (447)
-+..-+-|.+|++|.++-+ -|+.+.|+||.|||+.|+.. |++.|.+.+..+.+..|.+---....+.|+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 3444577999999999864 39999999999999999986 888899999888888887632222222221
Q ss_pred -----------------cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 322 -----------------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 322 -----------------~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.++...+||+.++|.-+|.+|++++++|+||||.+.
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 245667899999999999999999999999999864
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=329.87 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=212.7
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||.|+||.||+|.++.+++.+|+|.+.... .......+.+|+.+++++. ||||+++++.+...+.+++|+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEE
Confidence 4788899999999999999999999999999886543 2345567889999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 175 ELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++. ...++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~---~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS---RGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC---CCCEEEeecccchhhHHHH
Confidence 999999999999876 779999999999999999999999 99999999999999954 4469999999987654322
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHhCCCCCCCCccccCChH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAET-----EKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
. ....|+..|+|||.+. ..++.++||||||+++|+|++|..||.... .......+...... ..+...++.+
T Consensus 156 ~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (265)
T cd06605 156 A-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGKFSPD 232 (265)
T ss_pred h-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhhcCHH
Confidence 2 1267899999999876 458899999999999999999999997642 22333333333211 1111127889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+.++|.+||..||++|||+.+++.||||+..
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=332.78 Aligned_cols=255 Identities=30% Similarity=0.455 Sum_probs=208.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QSVH 171 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~ 171 (447)
+.|++.+.||.|+||.||+|.+..+++.+++|.+...... ......+.+|+.+++++. ||||+++++++... ...|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence 3599999999999999999999999999999988654322 223345678999999998 99999999998877 8999
Q ss_pred EEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++. +..+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~---~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN---RGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC---CCcEEEeecCceeeccC
Confidence 99999974 8988887644 4899999999999999999999999999999999999954 45699999999987654
Q ss_pred C-CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-------------
Q 013201 251 G-KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD------------- 314 (447)
Q Consensus 251 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------------- 314 (447)
. .......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+..+......
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 23344568899999998754 3688999999999999999999999887766555544321100
Q ss_pred ------CC-------CCcccc--CChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 315 ------FE-------SEPWLL--ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 315 ------~~-------~~~~~~--~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.. ...+.. +++.+.++|.+||+.||++|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00 001111 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=328.70 Aligned_cols=256 Identities=25% Similarity=0.327 Sum_probs=205.6
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|++..+|..||+|.+..... ......+..|+.++.+..+||||+++++++..++..|+||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 48999999999999999999999999999998865422 2233456667776555556999999999999999999999
Q ss_pred eccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 175 ELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 175 e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
||++ ++|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+||+++. +..+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~---~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR---NGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC---CCCEEEeecccccccc
Confidence 9996 578777654 24589999999999999999999997 9999999999999944 4569999999998765
Q ss_pred CCCceeecCCcccccccccccc-----cCCCCCcchhHHHHHHHHhhCCCCCCCCC-HHHHHHHHHhCCCCCCCCccccC
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRR-----SYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
.........|+..|+|||.+.+ .++.++|+|||||++|+|++|..||.... ..+.+..+..+... ..+...+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 233 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP--QLPAEKF 233 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC--CCCcccc
Confidence 4333334578999999998742 36889999999999999999999996532 22333333333211 1111247
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
|.++.++|.+||..+|.+||++.++++||||....
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 89999999999999999999999999999998854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=319.55 Aligned_cols=265 Identities=29% Similarity=0.430 Sum_probs=208.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCC----EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-C
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGN----SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED-R 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~ 167 (447)
...|++...||+|.||.||+|..+.++. .+|+|.+..++... ......-+|+.+++.|+ ||||+.+..+|.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELK-HPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence 3459999999999999999997665543 68999875543222 22345568999999998 9999999998876 8
Q ss_pred CeEEEEEeccCCCchHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC-CCCceEEec
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ-----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD-GGAMLKATD 241 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~~~vkl~D 241 (447)
..+++++||.+. +|..+|+-. +.++...++.|+.||++|++|||++.|+||||||.|||+..++ +.+.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999976 888887532 3489999999999999999999999999999999999996553 247899999
Q ss_pred CCCceeccCC----CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCH---------HHHHH
Q 013201 242 FGLSVFIDEG----KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETE---------KGIFD 306 (447)
Q Consensus 242 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~ 306 (447)
||+++.+.+. .....++-|.+|+|||.+.+ .|+++.||||+|||+.||+|-.+.|.+... ...++
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999876542 12234678999999999864 599999999999999999999988865321 23444
Q ss_pred HHHhCCCCCCCCcc---------------------------------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 013201 307 AILKGGVDFESEPW---------------------------------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353 (447)
Q Consensus 307 ~i~~~~~~~~~~~~---------------------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~ 353 (447)
.|++---......| ..-++.+.+|+.+||++||.+|+|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 44432111111111 112566889999999999999999999999999
Q ss_pred ccCCCCC
Q 013201 354 MREGGEA 360 (447)
Q Consensus 354 ~~~~~~~ 360 (447)
|.+...+
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9987554
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=331.53 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=210.4
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++++. |+||+++++++.+++..++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEE
Confidence 5999999999999999999999999999999875432 23344578899999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
||++++.+..++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++ .+..+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccccCCCccc
Confidence 9999877766666666799999999999999999999999999999999999994 45579999999988765443
Q ss_pred ceeecCCccccccccccc-c-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----------------
Q 013201 253 VYRDIVGSAYYVAPEVLR-R-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV----------------- 313 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~----------------- 313 (447)
......++..|+|||++. . .++.++||||||+++|+|++|..||.+....+.+..+.....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 334567899999999875 3 578999999999999999999999987655443333221100
Q ss_pred --CCCCC---------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 314 --DFESE---------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 314 --~~~~~---------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.+... ....++.++.+||.+||..||++||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000 001248889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=323.66 Aligned_cols=252 Identities=29% Similarity=0.513 Sum_probs=214.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQSVHL 172 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~l 172 (447)
.|++.+.||.|+||.||+|.+..++..+|+|.+..... .....+.+.+|+.++++++ |+||+++++++.. ....|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence 38899999999999999999999999999998865433 3445677889999999998 9999999997753 467899
Q ss_pred EEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 173 VMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCH-----FMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH-----~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
+|||+++++|.+++.. ...+++..++.++.||+.||.||| +.+++|+||||+||+++. ...+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~---~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA---NNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec---CCCEEEeccc
Confidence 9999999999999876 356899999999999999999999 999999999999999954 4469999999
Q ss_pred CceeccCCCc-eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 244 LSVFIDEGKV-YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 244 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
++........ .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||...+.......+..+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP---Y 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCc---c
Confidence 9987655433 34567899999999986 44788999999999999999999999988776666666655432211 2
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.++..+.+++.+||..+|++||++.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=338.66 Aligned_cols=266 Identities=30% Similarity=0.448 Sum_probs=210.0
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR---- 167 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---- 167 (447)
+.++|++.+.||+|+||.||+|++..+|+.||+|.+... ........+.+|+.++++++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence 456799999999999999999999999999999988532 22234466788999999998 99999999887544
Q ss_pred -CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 168 -QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 168 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
...|+|+||+.+ +|.+++. ...+++..+..++.|++.||.|||+.||+||||||+||+++ ....+||+|||++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TNCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEECccccee
Confidence 358999999964 7877664 45799999999999999999999999999999999999994 44569999999987
Q ss_pred eccCCC----ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-------
Q 013201 247 FIDEGK----VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV------- 313 (447)
Q Consensus 247 ~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------- 313 (447)
...... ......||+.|+|||.+. ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 654322 112357899999999864 3588999999999999999999999987654433322211000
Q ss_pred ---------------CC-CCC----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcc
Q 013201 314 ---------------DF-ESE----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365 (447)
Q Consensus 314 ---------------~~-~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~ 365 (447)
.. ... ....+++++.++|.+||+.||++|||+.++++||||+........+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~ 306 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPV 306 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCccc
Confidence 00 000 01235788999999999999999999999999999998765544433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=340.40 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=208.3
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--- 167 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--- 167 (447)
.+.++|++.+.||+|+||.||+|++..+++.||+|.+.+.. ........+.+|+.+++++. |+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCc
Confidence 35677999999999999999999999999999999875432 23344566788999999997 99999999988644
Q ss_pred ---CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 168 ---QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
...|+||||+. ++|.+.+... +++..+..++.|++.||.|||++||+||||||+||+++. +..+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~---~~~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC---CCCEEEccCcc
Confidence 35799999996 4888877654 899999999999999999999999999999999999944 45699999999
Q ss_pred ceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-----------
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG----------- 312 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~----------- 312 (447)
+.............|++.|+|||++. ..++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 98765544444557899999999876 458999999999999999999999998776544444332210
Q ss_pred -----------CCCCCC-----------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 313 -----------VDFESE-----------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 313 -----------~~~~~~-----------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
...... .....++.++++|.+||+.||++|||+.|+|.||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000000 01124567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.74 Aligned_cols=256 Identities=31% Similarity=0.573 Sum_probs=215.5
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|...+.||.|++|.||++.+..+++.+++|.+... .....+.+.+|+.+++.+. ||||+++++++...+..++|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEEE
Confidence 455667999999999999999999999999987432 2334566889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-c
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-V 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~ 253 (447)
||+.|++|.+++.. .++++..+..++.|++.||.|||++||+||||+|+||+++. +..++|+|||++....... .
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC---CCcEEEcccccchhhccCCcc
Confidence 99999999998877 67999999999999999999999999999999999999944 4569999999887544321 2
Q ss_pred eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+......... ....++..+.++|.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~ 250 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLRSFLD 250 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHHHHHH
Confidence 234578999999999864 5889999999999999999999999887776666666554222211 11236889999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 333 KMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+||..+|++||++.++++||||++...
T Consensus 251 ~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 251 RMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHcccChhhCcCHHHHccCcccccCCC
Confidence 999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=330.49 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=206.3
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||.|++|.||+|++..+++.||+|.+.... ........+.+|++++++++ ||||+++++++.+.+..++|||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEee
Confidence 889999999999999999999999999999875432 22233457889999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-C
Q 013201 176 LCSGGELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-K 252 (447)
Q Consensus 176 ~~~g~~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 252 (447)
|+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++. +..+||+|||++...... .
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~---~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEEeeccchhhcccCcc
Confidence 996 588888865 346899999999999999999999999999999999999954 446999999998765432 2
Q ss_pred ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC---------------
Q 013201 253 VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF--------------- 315 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--------------- 315 (447)
......+++.|+|||++.+ .++.++||||||+++|+|+||..||...+.......+.+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 2233467889999998754 36889999999999999999999998776654443333211100
Q ss_pred ---CC-------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 316 ---ES-------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 316 ---~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+. .....++++++++|.+||+.||++|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00 0012367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=327.05 Aligned_cols=256 Identities=28% Similarity=0.501 Sum_probs=213.4
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc--CCCCeeEEEEEEEeCCeEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--GQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~~~~l 172 (447)
.|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. .|||++++++++.++..+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999875432 2334567889999999996 59999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++. ...++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~---~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC---CCCEEEccCCceeecCCCc
Confidence 9999999999998765 47899999999999999999999999999999999999954 4569999999998765432
Q ss_pred -ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 253 -VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
......|+..|+|||.+.+ .++.++|+||||+++|+|++|..||.+.........+.... .+......++.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccCCHHHHH
Confidence 2234578999999998753 36889999999999999999999998776554443332221 111111236889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
++.+||..||++||++.+++.|+||++..
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=331.34 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=200.5
Q ss_pred ccceeecceeccccCeEEEEEEECC----------------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS----------------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 156 (447)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++++++ |||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence 4569999999999999999998643 34479999875432 2344567899999999997 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCcE
Q 013201 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG-------------------HYTEKAAAALCRAIVNVVHHCHFMGVM 217 (447)
Q Consensus 157 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~i~~qil~~l~~lH~~~iv 217 (447)
|+++++++.+.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886532 357788999999999999999999999
Q ss_pred eecCCCCceEeecCCCCCceEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh--
Q 013201 218 HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-- 291 (447)
Q Consensus 218 H~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-- 291 (447)
||||||+|||++. +..+||+|||++......... ....++..|+|||++. +.++.++||||||+++|+|++
T Consensus 161 H~dlkp~Nill~~---~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLVGE---NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEEcC---CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999954 456999999999866443221 2235678899999875 568999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHHHhC---C-CCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 013201 292 GVPPFWAETEKGIFDAILKG---G-VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 292 g~~pf~~~~~~~~~~~i~~~---~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
+..||...+..+.+..+... . ..........+++.+.+||.+||..||++|||+.+|.
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 66788877666555443221 1 1111111124688999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=338.79 Aligned_cols=264 Identities=30% Similarity=0.429 Sum_probs=212.7
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR---- 167 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---- 167 (447)
+.++|.+.+.||+|+||+||+|++..++..||+|.+.... ........+.+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence 4567999999999999999999999999999999886432 22333456778999999997 99999999987654
Q ss_pred -CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 168 -QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 168 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
..+|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++. +..+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~---~~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC---CCCEEECcCcccc
Confidence 35899999995 689999988888999999999999999999999999999999999999954 4469999999998
Q ss_pred eccCC-CceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-----------
Q 013201 247 FIDEG-KVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG----------- 312 (447)
Q Consensus 247 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~----------- 312 (447)
..... .......|+..|+|||.+. ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 66443 2233457899999999875 358899999999999999999999997765433332221100
Q ss_pred ------------CCCC----CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 313 ------------VDFE----SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 313 ------------~~~~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
.... ......+++++.+||.+||+.||++|||++++++||||.......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 0000 001235788999999999999999999999999999998754443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.67 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=210.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|++|.||+|.++.+++.||+|.+..... .......+.+|+.++++++ |+||+++++++.+...+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence 359999999999999999999999999999998754322 2233466789999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||++ ++|.+++..... +++..+..++.||+.||.|||++|++||||+|+||+++.++ ..+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~--~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC--CEEEEcccccccccCCC
Confidence 99996 588888766443 57888999999999999999999999999999999996433 35999999999765332
Q ss_pred -CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Q 013201 252 -KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF------------- 315 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~------------- 315 (447)
.......|++.|+|||.+.+ .++.++||||||+++|+|+||..||...+..+.+..+.......
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 22234567899999998754 47889999999999999999999998877665555443211000
Q ss_pred --------CCC----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 316 --------ESE----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 316 --------~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
... ....+++++.++|.+||+.||++||++.++++||||.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 000 0124688899999999999999999999999999998754
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=328.48 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=209.2
Q ss_pred ceeecceeccccCeEEEEEEECCCC-----CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTG-----NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.|++.+.||+|+||.||+|.+...+ ..+|+|.+... ........+.+|+.++++++ ||||+++++++.+.+.
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQP 82 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCCc
Confidence 4899999999999999999976655 67999987532 22344567899999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC
Q 013201 170 VHLVMELCSGGELFDKIIAQ----------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~ 233 (447)
.|++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~--- 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE--- 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC---
Confidence 99999999999999999764 45788899999999999999999999999999999999954
Q ss_pred CCceEEecCCCceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 013201 234 GAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAI 308 (447)
Q Consensus 234 ~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 308 (447)
+..+||+|||++....... ......+++.|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 4569999999997654322 122346788999999875 568999999999999999998 99999998888877777
Q ss_pred HhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 309 LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 309 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..+..... ...+++++.+|+.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66543322 13578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=328.41 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=202.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||.|++|.||+|.++.+++.||+|.+..... ......+.+|+.++++++ |+||+++++++.++...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence 459999999999999999999999999999998865322 112244678999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++. +..+||+|||++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE---RGELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC---CCCEEECccccccccCCCC
Confidence 999975 899888764 46899999999999999999999999999999999999954 446999999998754321
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCC-HHHHHHHHHhCCCC--------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFDAILKGGVD-------------- 314 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~-------------- 314 (447)
.......++..|+|||++.+ .++.++||||+|+++|+|++|..||.+.. ..+.+..+.+....
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 11223457889999998753 47889999999999999999999997665 22333222211000
Q ss_pred -------CC--C---CccccCC--hHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 315 -------FE--S---EPWLLIS--DSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 315 -------~~--~---~~~~~~s--~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.. . .....++ ..+.++|.+||+.||++|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0 0001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.05 Aligned_cols=259 Identities=26% Similarity=0.358 Sum_probs=214.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.++ ||||+++++++.....+|+|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence 45899999999999999999999999999999875432 2334577899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||+++++|.+++.+.+.+++..+..++.+++.+|.|||+ .+++||||||+||+++. ...++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~---~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS---RGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC---CCcEEEccCCcccchhhh-
Confidence 9999999999998888889999999999999999999997 69999999999999944 456999999998654322
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-----------HHHHHHHhCCCCCCCCcc
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK-----------GIFDAILKGGVDFESEPW 320 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~ 320 (447)
......|+..|+|||++. +.++.++|||||||++|+|++|..||...... +....+..... +....
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRLPS 235 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCCCc
Confidence 123457899999999875 56889999999999999999999999765431 22233332211 11111
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
..++.++.+||.+||..||.+|||+.++++|+||.+.....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 23678999999999999999999999999999998765444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=324.32 Aligned_cols=248 Identities=17% Similarity=0.286 Sum_probs=206.2
Q ss_pred cceeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
..|++.+.||+|+||.||+|.++ ..+..||+|.+.... .......+.+|+.++++++ ||||+++++++..++..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCc
Confidence 45999999999999999999875 346789999875432 2334467889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++ .+..+||+|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~---~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc---CCCcEEECCCccccccc
Confidence 9999999999999998774 5689999999999999999999999999999999999994 44579999999876543
Q ss_pred CCCcee--ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKVYR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
...... ...++..|+|||.+. +.++.++|||||||++||+++ |..||+.....+....+..+.. .+. ...++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~ 235 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LPA--PRNCPN 235 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CCC--CCCCCH
Confidence 222111 234567899999875 568999999999999999775 9999999888877777765532 222 235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+.+++.+||+.+|.+||++.+|++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=329.77 Aligned_cols=253 Identities=34% Similarity=0.611 Sum_probs=219.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++.+|+||+++++++.+.+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 58999999999999999999999999999999876544444455778899999999977999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++. +..++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~---~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK---DMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC---CCCEEecCCccccccCCcccc
Confidence 99999999999998888999999999999999999999999999999999999954 4469999999987654322
Q ss_pred -------------------ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Q 013201 253 -------------------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG 312 (447)
Q Consensus 253 -------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 312 (447)
......|+..|+|||++. ..++.++|+||||+++|++++|..||........+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 112346789999999876 457889999999999999999999999887776666666554
Q ss_pred CCCCCCccccCChHHHHHHHHhcccCCCCCCCH----HHHhcCCCc
Q 013201 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITS----AEVLEHPWM 354 (447)
Q Consensus 313 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~----~~~l~h~~~ 354 (447)
..++. .+++.+.++|.+||+.||.+||++ +++++||||
T Consensus 239 ~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 44332 468899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=330.75 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=206.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|...+.||+|+||.||++.+..+++.+|+|.+.+... ......+.+|+.++.++.+|+||+++++++..++..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 46778899999999999999999999999998865332 2345678899999999977999999999999999999999
Q ss_pred eccCCCchHHHH---H--HcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 175 ELCSGGELFDKI---I--AQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 175 e~~~g~~L~~~l---~--~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
||+.+ ++.++. . ....+++..+..++.|++.||+|||+ .+|+||||||+||+++. ...+||+|||++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR---NGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc---CCcEEEeecchhHHh
Confidence 99864 554432 2 23569999999999999999999997 49999999999999954 446999999999765
Q ss_pred cCCCceeecCCcccccccccccc----cCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCC-CCCCCcccc
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLRR----SYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGV-DFESEPWLL 322 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~-~~~~~~~~~ 322 (447)
..........|++.|+|||++.+ .++.++|||||||++|+|++|..||..... .+.+..+..+.. .........
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 54433344578999999999863 488999999999999999999999976542 122222222211 111222234
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
++.++.+||.+||+.||++|||++++++||||...
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 78999999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=322.34 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=217.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||.|++|.||+|++..+++.|++|.+..... ......+.+|+.+++++. |+||+++++++...+.+++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence 48899999999999999999999999999998865432 144678899999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++. +..++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~---~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS---KGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC---CCCEEEccCccceecccCCC
Confidence 999999999999888889999999999999999999999 99999999999999954 45699999999987654332
Q ss_pred e-eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC---CHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 254 Y-RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE---TEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 254 ~-~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
. ....++..|+|||.+. ..++.++|+||||+++|+|++|..||... ...+....+....... .....++..+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 233 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS--LPAEEFSPEFR 233 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC--CCcccCCHHHH
Confidence 2 2457889999999886 45788999999999999999999999776 4445555555432211 11112688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
++|.+||..+|++||++.++++||||+..
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.61 Aligned_cols=252 Identities=25% Similarity=0.461 Sum_probs=209.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence 35999999999999999999999999999999886544444555667889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 174 MELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++. +..++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~---~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC---CCCEEECccccceecc
Confidence 999999999888753 344899999999999999999999999999999999999954 4469999999988765
Q ss_pred CCCc-eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKV-YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.... .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||..... ......+..... +......++.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--PPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--CCCChhhcCH
Confidence 4322 22457889999999876 4588899999999999999999999976532 344444433322 2222234678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+.++|.+||..+|++||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=325.65 Aligned_cols=250 Identities=35% Similarity=0.620 Sum_probs=216.1
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGE 181 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 181 (447)
||.|+||.||+|++..+++.+++|.+.............+.+|+.+++++. |+||+++++.+..+...|+||||+.+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999999999999999886654434455678899999999998 9999999999999999999999999999
Q ss_pred hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC---------
Q 013201 182 LFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK--------- 252 (447)
Q Consensus 182 L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~--------- 252 (447)
|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++. +..++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS---NGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcC---CCCEEEEecccchhcccCcccccccccc
Confidence 9999988788999999999999999999999999999999999999954 4469999999987543321
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
......++..|+|||.+. ..++.++|+||||+++|+|++|..||......+....+..+...++.. ..++..+.++|
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence 223456888999999875 447889999999999999999999999888888887777655444332 23589999999
Q ss_pred HHhcccCCCCCCCH---HHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRITS---AEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~t~---~~~l~h~~~~~~ 357 (447)
.+||+.+|++|||+ .++|+||||++.
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 99999999999999 999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=331.10 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=202.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEE--EEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSY--ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.|++.+.||+|+||.||+|.+..++..+ ++|.+. ..........+.+|+.++.++.+|+||+++++++...+.+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~--~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEec--ccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 34899999999999999999998777654 666543 22233445678899999999966999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCC
Q 013201 172 LVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
+||||+++++|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++. +.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~---~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE---NY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC---CC
Confidence 9999999999999997543 4788999999999999999999999999999999999954 44
Q ss_pred ceEEecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCC
Q 013201 236 MLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 313 (447)
.+||+|||++.............++..|+|||.+. ..++.++|||||||++|+|+| |..||...+..+....+..+ .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~ 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-Y 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-C
Confidence 69999999986432211111223466799999876 447899999999999999998 99999887777666665433 1
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
... ....+++++.+||.+||+.+|++||++++++.+
T Consensus 241 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 112468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=324.95 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=210.4
Q ss_pred ccceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.+.|.+.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.++++++ |+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 3569999999999999999999987 6788999977432 22334466889999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG-------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
+..++||||+.|++|.+++...+ .+++..+..++.||+.||.|||+++++||||||+||+++.++....+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999987653 48899999999999999999999999999999999999876655679999
Q ss_pred cCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCC
Q 013201 241 DFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDF 315 (447)
Q Consensus 241 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 315 (447)
|||++......... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~- 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL- 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence 99999866432211 1223456899999975 558999999999999999997 99999988877777666554221
Q ss_pred CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 316 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.. ...++..+.+++.+||+.||++||++.++++|
T Consensus 241 ~~--~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DP--PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11 12468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.37 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=213.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+-|++.+.||.|+||.||+|.+..++..+|+|.+..... ......+.+|+.++++++ ||||+++++++.++..+|+|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence 458889999999999999999998999999998754322 234567889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK- 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 252 (447)
|||+++++|.+++.. ..+++..+..++.|++.++.|||+.|++|+||+|+||+++. +..++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~---~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE---HGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC---CCCEEEeecccceecccchh
Confidence 999999999988764 56899999999999999999999999999999999999954 4469999999987654432
Q ss_pred ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
......|+..|+|||.+.. .++.++|+|||||++|+|++|..||...........+........ ...++.++.++|
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i 233 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSKPLKEFV 233 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCC---CcccCHHHHHHH
Confidence 1233578899999998863 478899999999999999999999987766655555544322211 124688999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.+||..+|.+||++.++++||||.+.
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=330.76 Aligned_cols=259 Identities=29% Similarity=0.555 Sum_probs=216.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
+..|.....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.+. ||||+++++++..++.+|+
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEE
Confidence 344666778999999999999999999999999885432 234567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||+++++|..++.. ..+++..++.++.|++.||.|||++||+||||||+||+++. +..+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~---~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 96 LMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc---CCcEEEeechhHhhccccc
Confidence 9999999999886644 57899999999999999999999999999999999999944 4569999999987544322
Q ss_pred -ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 -VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......|+..|+|||++. ..++.++|||||||++|+|++|..||......+.+..+...... .......++..+.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHH
Confidence 223467899999999986 45889999999999999999999999887766666555443222 112233578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
|.+||+.+|.+||+++++++||||.+....
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.93 Aligned_cols=253 Identities=27% Similarity=0.514 Sum_probs=215.4
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|.+.+.||.|+||.||+|.++.+|..+|+|.+..... .....+.+.+|+.++++++ |+||+++++.+.+...+|+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence 48899999999999999999999999999998865433 2234567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 175 ELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+++|+||||+||+++.++ ..+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG--MVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC--CeEEecccccchhccCCc
Confidence 9999999999987654 478999999999999999999999999999999999995443 357999999987664432
Q ss_pred -ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 -VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......|++.|+|||++. ..++.++|+||||+++|+|++|..||...+.......+..+...... ..++.++.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS---PNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCC---CCCCHHHHHH
Confidence 223356899999999876 45889999999999999999999999887777666666655433222 2468899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCc
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
|.+||..+|++|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.98 Aligned_cols=257 Identities=32% Similarity=0.576 Sum_probs=212.8
Q ss_pred ceeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccCC-hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 95 FYTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLVN-KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.|++.+.||.|+||.||+|.+. .+|..||+|++....... ....+.+.+|+.+++++.+|+||+.+++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 3889999999999999999875 478999999886543222 223467789999999998799999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++. +..+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC---CCCEEEeeCccceeccc
Confidence 999999999999999998888999999999999999999999999999999999999954 45799999999976544
Q ss_pred CC--ceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCH----HHHHHHHHhCCCCCCCCccc
Q 013201 251 GK--VYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 251 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 321 (447)
.. ......|+..|+|||.+.. .++.++||||||+++|+|++|..||..... ..+...+......++ .
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~ 233 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----Q 233 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----c
Confidence 32 2234578999999998753 467899999999999999999999964322 333333333332222 2
Q ss_pred cCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCCC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRI-----TSAEVLEHPWMREGG 358 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~-----t~~~~l~h~~~~~~~ 358 (447)
.+++.+.+++.+||..||++|+ ++.+++.||||....
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 4688999999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=331.04 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=212.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|+..+.||.|+||.||+|.+..++..||+|.+.... .....+.+.+|+.++++++ ||||+++++++..+..+|+
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEE
Confidence 345888999999999999999999999999999875432 2234567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++. +..++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~---~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE---QGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC---CCCEEEccccccccccCcc
Confidence 9999999999988754 57899999999999999999999999999999999999954 3469999999987655432
Q ss_pred c-eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 V-YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
. .....|+..|+|||++.+ .++.++|+|||||++|+|++|..||...........+..+.... ....++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 232 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---LEGQYSKPFKEF 232 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---CCcccCHHHHHH
Confidence 2 223468899999999864 47889999999999999999999997766555444443332111 112467889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
|.+||..+|.+||++.++++||||...
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=319.31 Aligned_cols=248 Identities=29% Similarity=0.499 Sum_probs=212.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... .....+.+.+|+.+++.++ |+||+++++.+.+++.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence 3889999999999999999999999999999885432 2334567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 175 ELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 175 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++. ...++|+|||++.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ---NGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC---CCcEEEcccCcceeecccc
Confidence 999999999988653 35899999999999999999999999999999999999944 4469999999987664332
Q ss_pred -ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 -VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+..+...... ..++..+.+|
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence 2234678999999999864 5889999999999999999999999988877777777665543222 2468899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 013201 331 VRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h 351 (447)
|.+||+.||++||++.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=329.77 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=202.6
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC----
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ---- 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 168 (447)
-+.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccccc
Confidence 3459999999999999999999999999999998854322 2222345678999999997 999999999886543
Q ss_pred ----eEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 169 ----SVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 169 ----~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
..++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++ .+..+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg 164 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFG 164 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCcEEECcCC
Confidence 46999999964 7877776543 689999999999999999999999999999999999994 44579999999
Q ss_pred CceeccCCC-----ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-
Q 013201 244 LSVFIDEGK-----VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF- 315 (447)
Q Consensus 244 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~- 315 (447)
++....... ......++..|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.......+..-....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 997654321 1223467889999998754 36889999999999999999999998776654443332211000
Q ss_pred ------------------CCCc---------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 316 ------------------ESEP---------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 316 ------------------~~~~---------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+... ....+..+.+||.+||..||.+|||++++|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0000 01135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.41 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=207.6
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||.|++|.||+|++..+|..||+|.+..... ......+.+|+.++++++ |+||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence 38899999999999999999999999999998864322 223456778999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 175 ELCSGGELFDKIIAQ---GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 175 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++. +..+||+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~---~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC---CCcEEEeecchhhhhcCC
Confidence 99975 888887654 35899999999999999999999999999999999999954 446999999998755332
Q ss_pred -CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC----------
Q 013201 252 -KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE---------- 318 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 318 (447)
.......+++.|++||++.+ .++.++||||||+++|+|++|..||.+.+..+....+..........
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 12234567899999998754 46889999999999999999999998877666555543321100000
Q ss_pred ---------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 319 ---------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 319 ---------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
....+++.+.++|.+||+.||.+||+++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=339.84 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=203.1
Q ss_pred ccceeecceeccccCeEEEEEEECCC-----CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENST-----GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
++.|++++.||+|+||.||+|++... +..||+|++.... .....+.+.+|+.+++++..||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 56799999999999999999987543 3469999885432 2344567899999999997799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHc----------------------------------------------------------
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ---------------------------------------------------------- 189 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~---------------------------------------------------------- 189 (447)
+.+|||||||++|+|.++|..+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988653
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC
Q 013201 190 --------------------------------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK 231 (447)
Q Consensus 190 --------------------------------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~ 231 (447)
..+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~- 272 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ- 272 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC-
Confidence 13677888999999999999999999999999999999954
Q ss_pred CCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHH
Q 013201 232 DGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFD 306 (447)
Q Consensus 232 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 306 (447)
+..+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||........+.
T Consensus 273 --~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 273 --GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred --CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 44699999999986543221 12345778899999875 458999999999999999997 999998765444333
Q ss_pred HHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 307 AILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 307 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
...........+ ..++.++.++|.+||+.||++||++.++.+
T Consensus 351 ~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMAKP--DHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCCCC--ccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333333333222 257889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.87 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=204.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++.+.||+|+||.||+|++..+++.||+|++...........+++.+|+.+++++. ||||+++++++.+++..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence 45999999999999999999999999999999986544333445677899999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecC
Q 013201 174 MELCSGGELFDKIIAQ-----------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
|||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++. .+.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~---dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC---CCCEEEEec
Confidence 9999999999988642 23456678899999999999999999999999999999954 446999999
Q ss_pred CCceeccCCC-------------------ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH
Q 013201 243 GLSVFIDEGK-------------------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK 302 (447)
Q Consensus 243 g~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 302 (447)
|++....... .....+||+.|+|||++. ..++.++|||||||++|||+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997652110 011257999999999886 45899999999999999999999999876544
Q ss_pred HHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 303 GIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 303 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
......... ......++..+++.+.+++.+||..||++|++..+.+.+
T Consensus 238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333221111 111112234578999999999999999999887766543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=336.85 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=212.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE----eCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE----DRQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----~~~ 168 (447)
.+.|++.+.||.|+||.||+|++..++..||+|++.... ........+.+|+.++++++ ||||+++++++. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCc
Confidence 467999999999999999999999999999999886432 22334567788999999998 999999998875 345
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEecccccceee
Confidence 7899999995 58999988778899999999999999999999999999999999999995 4456999999998765
Q ss_pred cCCC-----ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC----------
Q 013201 249 DEGK-----VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG---------- 311 (447)
Q Consensus 249 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~---------- 311 (447)
.... ......|+..|+|||.+.+ .++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 4321 1124578999999998753 4889999999999999999999999876554333322210
Q ss_pred -------------CCCCCCCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 013201 312 -------------GVDFESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASD 362 (447)
Q Consensus 312 -------------~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~ 362 (447)
........ ...+++++.++|.+||+.||.+||++++++.||||.+......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 00000111 1246889999999999999999999999999999987655543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.53 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=216.2
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+....|...+.||+|+||.||+|++..++..+|+|.+.............+.+|+.+++++. |+|++++++++.++...
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTA 100 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeE
Confidence 34455889999999999999999999999999999886544434444567889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|+||||+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++. +..+||+|||++....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~---~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE---PGQVKLADFGSASIAS 176 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC---CCCEEEecCCCccccC
Confidence 999999975 77777654 456899999999999999999999999999999999999944 4469999999987544
Q ss_pred CCCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.. ....|++.|+|||.+. +.++.++|||||||++|+|++|..||...........+......... ...+++
T Consensus 177 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 251 (317)
T cd06635 177 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSD 251 (317)
T ss_pred Cc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--CccccH
Confidence 32 2457899999999863 45888999999999999999999999887776666666555432221 124678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.++++|.+||+.+|.+||++.++++|+|+....
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 899999999999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=326.14 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=214.1
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|...+.||+|+||.||+|++..++..|++|.+.............+.+|+.+++.++ |||++++++++.+....|
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence 3445788889999999999999999999999999986554444444567889999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+||||+. ++|.+++.. ...+++..+..++.||+.+|.|||++||+|+||+|+||++.. +..+||+|||++.....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~---~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE---PGQVKLADFGSASKSSP 173 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC---CCCEEEeecCCCcccCC
Confidence 9999996 577777765 456899999999999999999999999999999999999944 44699999999865332
Q ss_pred CCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.....|+..|+|||++. +.++.++|||||||++|+|++|..||...........+...... ......++..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 248 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQSNEWTDS 248 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCHH
Confidence 23457899999999873 44788999999999999999999999887766655555443222 1122346788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+++||.+||+.+|.+||++.+++.||||....
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.64 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=207.5
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.++++++ ||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence 6778899999999999999999999999998865432 2223456788999999998 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-C
Q 013201 176 LCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-K 252 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 252 (447)
|++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++. +..++|+|||++...... .
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC---CCcEEEeecccccccCCCcc
Confidence 995 68999887765 6899999999999999999999999999999999999955 456999999998755322 2
Q ss_pred ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC----------------
Q 013201 253 VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD---------------- 314 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---------------- 314 (447)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||...+....+..+.+....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233467889999998753 3688999999999999999999999877665444433321100
Q ss_pred ---------CCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 315 ---------FESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 315 ---------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
........++..+.++|.+||+.||.+|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0001123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=333.33 Aligned_cols=264 Identities=27% Similarity=0.395 Sum_probs=213.0
Q ss_pred ccccee-ecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChh-----------hHHHHHHHHHHHHhccCCCCeeE
Q 013201 92 IRQFYT-LGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ-----------DREDIKREIQIMQHLSGQQNIVE 159 (447)
Q Consensus 92 ~~~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~~iv~ 159 (447)
+.++|. +.+.||.|+||+||+|.+..+++.||+|.+......... ....+.+|+.+++++. |+||++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 84 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG 84 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence 445675 567899999999999999999999999988654322110 1124678999999997 999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEE
Q 013201 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
+++++..++..++||||+. ++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++. ...+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~---~~~~kl 160 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINS---KGICKI 160 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECC---CCCEEE
Confidence 9999999999999999996 589999988888999999999999999999999999999999999999954 446999
Q ss_pred ecCCCceeccCC---------------CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH
Q 013201 240 TDFGLSVFIDEG---------------KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEK 302 (447)
Q Consensus 240 ~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~ 302 (447)
+|||++...... .......+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+.+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998765411 11123457889999998864 3688999999999999999999999988777
Q ss_pred HHHHHHHhCCCCCCCC------------------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 303 GIFDAILKGGVDFESE------------------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 303 ~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+.+..+.......... .....+.++.++|.+||+.||++||+++++|.||||+...
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 6665554311100000 0123578899999999999999999999999999998764
Q ss_pred CC
Q 013201 359 EA 360 (447)
Q Consensus 359 ~~ 360 (447)
..
T Consensus 321 ~~ 322 (335)
T PTZ00024 321 LP 322 (335)
T ss_pred CC
Confidence 43
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=350.94 Aligned_cols=246 Identities=24% Similarity=0.423 Sum_probs=215.3
Q ss_pred cceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 94 QFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
..-++.+.||+|+||+||+|.... +...||||.++.. .+.+...+|.+|++++..|+ |||||+|+|+|..++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQ-HPNIVRLLGVCREGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCC
Confidence 346678899999999999998543 3467999987543 23456789999999999998 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQG--------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG 234 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~ 234 (447)
-+|+|+|||..|+|.++|.... .++..+.+.|+.||+.|+.||-++.+|||||-.+|+|+ +++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccc
Confidence 9999999999999999997542 27788999999999999999999999999999999999 778
Q ss_pred CceEEecCCCceeccCCCceee---cCCcccccccccc-cccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 013201 235 AMLKATDFGLSVFIDEGKVYRD---IVGSAYYVAPEVL-RRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAIL 309 (447)
Q Consensus 235 ~~vkl~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 309 (447)
..|||+|||+++.+...+.++. ..-..+|||||.| .+.|+.++|||||||+|||+++ |+.||++.+..+.++.|.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 8999999999998765554442 2345689999976 4889999999999999999998 999999999999999999
Q ss_pred hCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHH
Q 013201 310 KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEV 348 (447)
Q Consensus 310 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~ 348 (447)
.+.. ++.+. .+|.++++|+..||+.+|++||+++||
T Consensus 720 ~g~l-L~~Pe--~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 720 AGQL-LSCPE--NCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cCCc-ccCCC--CCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 9887 55543 689999999999999999999999997
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=327.17 Aligned_cols=258 Identities=29% Similarity=0.505 Sum_probs=214.3
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.++|.+.+.||+|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.++ ||||+++++++...+..|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEE
Confidence 45699999999999999999999989999999987432 2234567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++. +..+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~---~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC---CCCEEEccCcceecccccc
Confidence 9999999999998865 36889999999999999999999999999999999999954 4469999999887654332
Q ss_pred -ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 -VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......|++.|+|||.+. +.++.++|+||||+++|++++|..||...+....+..+...... .......++..++++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCC-CCCCccccCHHHHHH
Confidence 223457899999999875 45889999999999999999999999877654443333322211 111223467889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
|.+||..+|.+||++.+++.|+||+....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 99999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=313.06 Aligned_cols=256 Identities=27% Similarity=0.500 Sum_probs=229.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|.+.+.||+|+|++|.+++++.|.+.||+|+++++...+..+.+=+..|-.++.+..+||.+|.++.+|+.+.++++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 45999999999999999999999999999999999888877777777888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee-ccCCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF-IDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~-~~~~~ 252 (447)
.||.+||+|--++.+.++++++.++.+...|..||.|||++||++||||.+|||+ +..+.|||.|+|+++. +.++.
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCCc
Confidence 9999999998888889999999999999999999999999999999999999999 5555799999999975 56677
Q ss_pred ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCC--------CCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFW--------AETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~--------~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
.+.+++|||.|+|||++++ .|+.++|+|+||++++||+.|+.||. ..+...++.-|++..+..+.. +
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs----l 482 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS----L 482 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce----e
Confidence 7788999999999999986 49999999999999999999999995 234455677777777766653 6
Q ss_pred ChHHHHHHHHhcccCCCCCCC------HHHHhcCCCccC
Q 013201 324 SDSAKDLVRKMLIQDPKKRIT------SAEVLEHPWMRE 356 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t------~~~~l~h~~~~~ 356 (447)
|-.+..+++..|.+||++|.. ++++-.|+||+.
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 778889999999999999964 579999999984
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.50 Aligned_cols=266 Identities=28% Similarity=0.432 Sum_probs=211.7
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR---- 167 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---- 167 (447)
+..+|.+.+.||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++ ||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence 4567999999999999999999999999999999885443 234567889999999997 99999999776543
Q ss_pred ----------CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCce
Q 013201 168 ----------QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 168 ----------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++.++ ..+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~--~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED--LVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--ceE
Confidence 36899999996 588877654 5799999999999999999999999999999999999996433 468
Q ss_pred EEecCCCceeccCCC----ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Q 013201 238 KATDFGLSVFIDEGK----VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG 311 (447)
Q Consensus 238 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 311 (447)
||+|||++....... ......|+..|+|||.+. ..++.++|||||||++|+|++|..||.+....+....+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999997654321 112246788999999864 34788999999999999999999999877765555444332
Q ss_pred CCC----------------------CCCCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcc
Q 013201 312 GVD----------------------FESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365 (447)
Q Consensus 312 ~~~----------------------~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~ 365 (447)
... ....+ ...++.++.+||.+||..||.+|||+.++|.||||+....+.+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~ 314 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPV 314 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccC
Confidence 100 00000 1246788999999999999999999999999999987655444433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=319.62 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=202.5
Q ss_pred eecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 013201 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176 (447)
Q Consensus 97 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 176 (447)
.....||+|+||.||+|++..++..|++|.+... .....+.+.+|+.++++++ |+||+++++++..++.+++|+||
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEec
Confidence 3346899999999999999999999999987543 2344567889999999997 99999999999999999999999
Q ss_pred cCCCchHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-
Q 013201 177 CSGGELFDKIIAQ-GHY--TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK- 252 (447)
Q Consensus 177 ~~g~~L~~~l~~~-~~~--~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 252 (447)
+++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++.++ ..+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CeEEEecchhheecccCCC
Confidence 9999999998764 445 8888999999999999999999999999999999995432 369999999987654322
Q ss_pred ceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCCCCCccccCChHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||....... ....+....... .....+++++.
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 242 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP--EIPESLSAEAK 242 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC--CCCcccCHHHH
Confidence 2233468999999998753 37889999999999999999999997643321 111111101111 11124688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+++.+||..+|.+|||+.+++.||||
T Consensus 243 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=322.48 Aligned_cols=257 Identities=29% Similarity=0.473 Sum_probs=207.4
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQSVHL 172 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~l 172 (447)
.|+..+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|++++++++ ||||+++++++.+ .+.+|+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEE
Confidence 4889999999999999999999999999999886432 2244577899999999997 9999999998864 447899
Q ss_pred EEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 173 VMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++. ...++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~---~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR---KGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec---CCeEEEeeccccccc
Confidence 9999999999887653 345899999999999999999999999999999999999954 346999999998755
Q ss_pred cCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC-----CHHHHHHHHHhCCCC-CCCCcc-
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE-----TEKGIFDAILKGGVD-FESEPW- 320 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~-~~~~~~- 320 (447)
.... .....++..|+|||.+. ..++.++||||||+++|+|++|..||... ...+....+...... ......
T Consensus 156 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 156 VNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred cccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 4322 12456788999999876 45889999999999999999999999765 223344443332111 111110
Q ss_pred -ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 321 -LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 321 -~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
...++.+.++|.+||..||.+|||+.|++.||||++..
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 12467899999999999999999999999999996643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=323.39 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=209.0
Q ss_pred cceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 94 QFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+.|.+.+.||+|+||.||+|++.. ++..||+|.+.... .....+.+.+|+++++++. |+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence 458999999999999999998753 46789999875432 2334578899999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQG--------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG 234 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~ 234 (447)
..++||||++|++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++. +
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~---~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY---D 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC---C
Confidence 9999999999999999997643 3788899999999999999999999999999999999944 4
Q ss_pred CceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 013201 235 AMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAIL 309 (447)
Q Consensus 235 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 309 (447)
..+||+|||++........ .....+++.|+|||++. +.++.++|||||||++|+|++ |..||......+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 5799999999976533221 12335678899999886 458999999999999999998 999999888888888877
Q ss_pred hCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 310 KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 310 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+...... ..++..+.++|.+||..||++||++.|+++
T Consensus 239 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66543322 247899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.41 Aligned_cols=258 Identities=30% Similarity=0.454 Sum_probs=203.3
Q ss_pred ceeecceeccccCeEEEEEEECC--CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeE
Q 013201 95 FYTLGKELGRGQFGITYLCTENS--TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QSV 170 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~ 170 (447)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+...........+.+.+|+.++++++ ||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence 38899999999999999999988 89999999987643223334467789999999997 99999999999988 889
Q ss_pred EEEEeccCCCchHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC-CCCCceEEecCCC
Q 013201 171 HLVMELCSGGELFDKIIAQ-----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK-DGGAMLKATDFGL 244 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~~~vkl~Dfg~ 244 (447)
|+||||+++ +|.+.+... ..+++..+..++.||+.||.|||+.+|+||||||+||+++.+ +....+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999965 676666432 258999999999999999999999999999999999999651 1256799999999
Q ss_pred ceeccCCCc----eeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH---------HHHHHH
Q 013201 245 SVFIDEGKV----YRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKG---------IFDAIL 309 (447)
Q Consensus 245 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------~~~~i~ 309 (447)
+........ .....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886543221 233578899999998753 47899999999999999999999997654321 111111
Q ss_pred h------------------------CC--CCCCCC-------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 310 K------------------------GG--VDFESE-------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 310 ~------------------------~~--~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
. .. ..++.. .+...+.++.++|.+||+.||++|||+.++++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 00 000000 001457789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=324.28 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=201.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++ |+||+++++++.++...|+|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence 459999999999999999999999999999998854322 222345678999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+. ++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||||+|||++. +..+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~---~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY---LGELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC---CCcEEEeccccccccCCCC
Confidence 99996 577776655 356788999999999999999999999999999999999954 446999999998754322
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCC--------------C
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGV--------------D 314 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~--------------~ 314 (447)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.... +.+..+..... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 12233467899999999854 4788999999999999999999999765432 22222211000 0
Q ss_pred C-------CCC-----cc--ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 315 F-------ESE-----PW--LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 315 ~-------~~~-----~~--~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+ ... .+ ...+..+.++|.+||..||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 000 00 0125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.05 Aligned_cols=254 Identities=28% Similarity=0.483 Sum_probs=210.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeecccc--CChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--Ce
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL--VNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~ 169 (447)
..|++.+.||+|+||.||+|++..++..||+|.+..... ........+.+|+.++++++ |+||+++++++.+. +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence 359999999999999999999999999999998754321 12334567889999999997 99999999998764 56
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+++|+||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++. +..++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~---~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC---CCCEEECccccccccc
Confidence 8999999999999999988888999999999999999999999999999999999999954 4469999999997653
Q ss_pred CC----CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 250 EG----KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 250 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.. .......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+......... ...++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML--PDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCC--CcccC
Confidence 21 12234578999999998864 4788999999999999999999999877665555544432221111 12478
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+.+.++|.+||. +|.+||++.+++.|||.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=324.04 Aligned_cols=253 Identities=30% Similarity=0.472 Sum_probs=209.6
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeEEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QSVHLV 173 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv 173 (447)
|++.+.||.|+||.||+|++..+++.+|+|.+.... ........+.+|+.+++++. |+|++++++++.+. +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999999999999999987543 22334466889999999998 99999999999888 899999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||+++ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. +..+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~---~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN---DGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC---CCCEEEccccceeeccCCC
Confidence 999975 888888765 57999999999999999999999999999999999999954 4569999999998765432
Q ss_pred --ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc---------
Q 013201 253 --VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP--------- 319 (447)
Q Consensus 253 --~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 319 (447)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||...+....+..+.+.........
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2334567889999997753 478999999999999999999999988777666555544211111000
Q ss_pred -----------------ccc-CChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 320 -----------------WLL-ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 320 -----------------~~~-~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
... +++.+.++|.+||..||.+||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011 38889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=325.70 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=203.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCC--EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGN--SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.|++.+.||.|+||.||+|++..++. .+++|.+.. .......+.+.+|+.+++++.+||||+++++++.+.+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 458999999999999999999887765 467776532 2233445678899999999966999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCC
Q 013201 172 LVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
+||||+++++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+|||++. +.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE---NL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC---CC
Confidence 9999999999999997642 4788999999999999999999999999999999999944 45
Q ss_pred ceEEecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCC
Q 013201 236 MLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 313 (447)
.+||+|||++..............+..|+|||++. ..++.++|||||||++|+|++ |..||...........+..+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 69999999986432211111123345799999876 458999999999999999997 9999998888777777655422
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
... ...++..+.+||.+||..||.+||+++++++.
T Consensus 237 -~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 -MEK--PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred -CCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 12478999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=323.18 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=207.0
Q ss_pred cceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+.|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+++++. ||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence 46999999999999999999863 34567889977432 2344567899999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQG-------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~-------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
.+++||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+|||++ ...
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~---~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cCC
Confidence 9999999999999999987543 389999999999999999999999999999999999994 445
Q ss_pred ceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHh
Q 013201 236 MLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILK 310 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 310 (447)
.+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......+....+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 699999999976543321 12234577899999886 458999999999999999998 9999988888888888777
Q ss_pred CCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 311 GGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 311 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+...... ..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6533221 246889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=332.74 Aligned_cols=264 Identities=26% Similarity=0.413 Sum_probs=214.0
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
..+.+.++|++.+.||+|+||.||+|.+..++..||+|.+.+.. ........+.+|+.++++++ ||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPD 86 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCC
Confidence 34567788999999999999999999999999999999885432 23334466889999999997 99999999998765
Q ss_pred C------eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 168 Q------SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 ~------~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
. .+++||||+ |++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||+++. +..+||+|
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~---~~~~kl~d 161 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE---DCELKILD 161 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEee
Confidence 3 468999999 778877765 457999999999999999999999999999999999999954 44699999
Q ss_pred CCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC---
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE--- 316 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--- 316 (447)
||++...... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.+....+..+.+.....+
T Consensus 162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 162 FGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9999765432 234578999999998764 478899999999999999999999987766554444433211100
Q ss_pred --------------------C----CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 317 --------------------S----EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 317 --------------------~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
. ..+..+++.+.++|.+||..||++|||+.+++.||||+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 0 0112468889999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.40 Aligned_cols=252 Identities=30% Similarity=0.566 Sum_probs=217.6
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|.+.+.||.|+||.||++.+..++..+++|++..... .......+.+|+++++.++ |+|++++.+.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence 48899999999999999999999999999998855332 3355677889999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 175 ELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 175 e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||+++++|.+++... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++. +..++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~---~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS---NGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC---CCcEEECCccceeeccc
Confidence 999999999998774 67999999999999999999999999999999999999954 44699999999987654
Q ss_pred CC-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GK-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||...........+......... ..++..+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 43 233457899999999875 45888999999999999999999999888777777776655432221 14789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
++|.+||..+|++|||+.++|+||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=321.84 Aligned_cols=250 Identities=26% Similarity=0.482 Sum_probs=208.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.+..++..+|+|.+.............+.+|+.+++.+. |+||+++++++.+++.+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEEE
Confidence 4889999999999999999999999999999886654444555678889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 175 ELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 175 e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||++|++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++. +..++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCCEEECcchhhhcccc
Confidence 99999999998864 345899999999999999999999999999999999999954 44699999999876544
Q ss_pred CC-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GK-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.. ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||.+... ......+.... .+..+...+++.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEE 236 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccHH
Confidence 32 223457899999999986 4588899999999999999999999976543 23333333322 222223357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++++|.+||..||.+|||+.+|++
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=321.38 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=206.1
Q ss_pred cccceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++ ||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 35679999999999999999998653 35679999874321 2234566889999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCc
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG----------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAM 236 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~ 236 (447)
+...++||||+++++|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+||+++ .+..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCC
Confidence 999999999999999999987632 256788899999999999999999999999999999995 4456
Q ss_pred eEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhC
Q 013201 237 LKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311 (447)
Q Consensus 237 vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 311 (447)
+||+|||++......... ....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.........+..+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998765433221 1235578899999986 458999999999999999999 78999888877777766665
Q ss_pred CCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 312 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
...... ..++..+.++|.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 432221 2468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=333.46 Aligned_cols=263 Identities=32% Similarity=0.463 Sum_probs=218.5
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----e
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-----S 169 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~ 169 (447)
+|++.+.||.|++|.||+|++..++..||+|.+.+. .......+.+.+|+.+++.++ |+||+++++++.+.. .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccc-cccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence 489999999999999999999999999999988643 222344567889999999997 999999999988775 7
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|+||||+. ++|.+++.+...+++..++.++.||+.||.|||+.||+||||||+|||++. +..++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~---~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS---NCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEcccCceEeec
Confidence 899999997 589998888778999999999999999999999999999999999999954 4579999999998765
Q ss_pred CCC----ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC-----
Q 013201 250 EGK----VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE----- 318 (447)
Q Consensus 250 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~----- 318 (447)
... ......+++.|+|||++.+ .++.++|+||||+++|+|++|..||.+.+..+.+..+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 543 2345678999999999863 57899999999999999999999998887766665554421111100
Q ss_pred ----------------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 013201 319 ----------------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDK 363 (447)
Q Consensus 319 ----------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~ 363 (447)
....++.++.++|.+||+.||.+||++++++.||||+........
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 012367889999999999999999999999999999876655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=334.61 Aligned_cols=268 Identities=28% Similarity=0.459 Sum_probs=217.4
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
....+.++|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++++. |+||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA 86 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence 34456778999999999999999999999999999999875432 22334466778999999997 99999999887665
Q ss_pred Ce------EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 168 QS------VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 ~~------~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
.. .++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++. +..+||+|
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~---~~~~kL~d 161 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILD 161 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCCEEEcc
Confidence 54 89999999 6699887765 57999999999999999999999999999999999999954 45699999
Q ss_pred CCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC---
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE--- 316 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--- 316 (447)
||++...... .....++..|+|||.+.+ .++.++|||||||++|+|++|..||.+....+.+..+.......+
T Consensus 162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 162 FGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9999865433 334578899999998753 478899999999999999999999988776665555443211000
Q ss_pred --------------------C----CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCc
Q 013201 317 --------------------S----EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364 (447)
Q Consensus 317 --------------------~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~ 364 (447)
. ..+..+++.+.++|.+||..||++|||+.++++||||.+.....+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~ 311 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEP 311 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccc
Confidence 0 00123588999999999999999999999999999999876554443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=313.75 Aligned_cols=252 Identities=29% Similarity=0.516 Sum_probs=216.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||+|++|.||+|++..+++.|++|.+..... .....+.+.+|+++++++. |+|++++++++.+.+.+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence 38899999999999999999999999999999866533 2345678999999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc-
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV- 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~- 253 (447)
||+++++|.+++.....+++..+..++.|++.+|.|||+.||+||||+|+||+++. ...++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~---~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC---CCCEEEeccccceecCCCccc
Confidence 99999999999988888999999999999999999999999999999999999954 45699999999987654432
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
.....|+..|+|||.+. ..++.++||||+|+++|+|++|..||...........+....... ....+++.+.++|.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP---LPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC---CCCCCCHHHHHHHH
Confidence 23457899999999875 347889999999999999999999998776655454444332211 11246899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCc
Q 013201 333 KMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+||..+|++||++.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=316.88 Aligned_cols=245 Identities=38% Similarity=0.686 Sum_probs=214.6
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGE 181 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 181 (447)
||+|+||.||++.+..+++.+|+|.+.+...........+.+|+.+++++. |+||+++++.++.+..+|+||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999999899999999987765555556678899999999998 9999999999999999999999999999
Q ss_pred hHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-CceeecCCc
Q 013201 182 LFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KVYRDIVGS 260 (447)
Q Consensus 182 L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt 260 (447)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++. ...++|+|||++...... .......|+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA---DGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC---CCcEEEeecCcceecccCCCcccCCcCC
Confidence 9999988888999999999999999999999999999999999999954 446999999999876543 233456789
Q ss_pred ccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCC
Q 013201 261 AYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339 (447)
Q Consensus 261 ~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp 339 (447)
..|+|||.+.+ ..+.++|+||||+++|+|++|..||...........+......++. .++..+.++|.+||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhcCCH
Confidence 99999998864 4788999999999999999999999888776667776664443333 358899999999999999
Q ss_pred CCCCCH---HHHhcCCCc
Q 013201 340 KKRITS---AEVLEHPWM 354 (447)
Q Consensus 340 ~~R~t~---~~~l~h~~~ 354 (447)
++||++ +++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=356.09 Aligned_cols=149 Identities=30% Similarity=0.469 Sum_probs=136.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++ |+||+++++++.....+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence 45999999999999999999999999999999987655555555678899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
|||+.|++|.+++...+.+++..++.|+.||+.||.|||.+||+||||||+|||++. ...+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~---~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN---EGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC---CCCEEEEeCCCCc
Confidence 999999999999988888999999999999999999999999999999999999954 4569999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.85 Aligned_cols=258 Identities=32% Similarity=0.554 Sum_probs=218.2
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+..+.|++.+.||.|+||.||+|.+..++..+++|++..... ..+.+.+|+.+++.++ |+||+++++.+......
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence 455669999999999999999999998999999998854321 4567889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++. +..++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~---~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK---DGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC---CCCEEECccchhhhhc
Confidence 99999999999999998876 8999999999999999999999999999999999999954 4469999999886544
Q ss_pred CCC-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 250 EGK-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 250 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
... ......+++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+....... ......++..+
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 246 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEF 246 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCCHHH
Confidence 321 223346889999999876 448899999999999999999999998877665555554433221 11222378899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+++|.+||+.+|.+||++.+++.|+||++.
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 999999999999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.41 Aligned_cols=244 Identities=25% Similarity=0.414 Sum_probs=205.3
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.++ ++..+|+|.+.... .....+.+|+.++++++ ||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----MSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----ccHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEEE
Confidence 4888999999999999999876 45679999875332 23467889999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 175 ELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++ .+..+||+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccCCCce
Confidence 999999999998753 4689999999999999999999999999999999999994 445699999999876543322
Q ss_pred ee--ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 254 YR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 254 ~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.. ...++..|+|||++. ..++.++||||||+++|+|++ |+.||...+..+.+..+..+...... ...+..+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~ 232 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVYE 232 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHHH
Confidence 21 234566899999986 458899999999999999999 99999988888888887765432221 235788999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013201 330 LVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.+||..||++||+++++++
T Consensus 233 li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.69 Aligned_cols=250 Identities=32% Similarity=0.566 Sum_probs=212.6
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|.+.+.||+|++|.||++.+..++..+++|++..... .....+.+|+.+++++. |+||+++++++......++++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEe
Confidence 7889999999999999999998999999998855332 35678899999999998 9999999999999999999999
Q ss_pred ccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 176 LCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 176 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
|++|++|.+++... ..+++..+..++.|++.+|.+||..|++||||+|+||+++. +..++|+|||.+.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~---~~~~~l~d~~~~~~~~~~~~~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKAR 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc---CCeEEEeeccccccccccccc
Confidence 99999999998776 67999999999999999999999999999999999999954 446999999999877654333
Q ss_pred eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
....|+..|+|||.+. ..++.++|+||||+++|+|++|..||...+.......+........ .....++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-CcccccCHHHHHHHHH
Confidence 4567899999999886 4478899999999999999999999988755554444443222111 1112248899999999
Q ss_pred hcccCCCCCCCHHHHhcCCC
Q 013201 334 MLIQDPKKRITSAEVLEHPW 353 (447)
Q Consensus 334 ~L~~dp~~R~t~~~~l~h~~ 353 (447)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=369.49 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=219.7
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.-+|..+..||.|.||.||-|.+..+|...|+|.|.-.... ....+.+.+|..+|..+. |||+|+++++-.+.+..
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecHHHH
Confidence 3455688889999999999999999999999999988554332 445567889999999998 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+|.||||.||+|.+.+...+..+|.....+..|++.|+.|||++|||||||||.||+++. ++.||++|||.|..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~---~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF---NGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec---CCcEEeecccceeEecC
Confidence 999999999999999888777888888999999999999999999999999999999954 44799999999988765
Q ss_pred CC-----ceeecCCcccccccccccc----cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCCCCCcc
Q 013201 251 GK-----VYRDIVGSAYYVAPEVLRR----SYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPW 320 (447)
Q Consensus 251 ~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 320 (447)
.. .....+||+.|||||++.+ +...++|||||||++.||+||+.||...+.+ .++..+-.|..+ ..+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P-q~P~- 1464 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP-QIPE- 1464 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC-CCch-
Confidence 32 2346799999999999853 4677999999999999999999999766544 333333334322 2222
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.+|++.+|||..||..||++|.++.|+|+|.|-+...
T Consensus 1465 -~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1465 -RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred -hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 3899999999999999999999999999999877653
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.69 Aligned_cols=254 Identities=29% Similarity=0.429 Sum_probs=207.9
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc--CCCCeeEEEEEEEeCCe----
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--GQQNIVEFRGAYEDRQS---- 169 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~~---- 169 (447)
|++.+.||+|+||.||+|.++.++..||+|.+..... .......+.+|+.+++++. .|+||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999998899999998864332 2223455678888887775 49999999999988776
Q ss_pred -EEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 170 -VHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 170 -~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
++++|||+.+ +|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ ..+||+|||++.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~---~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD---GQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC---CCEEEeccCcce
Confidence 9999999975 8888887643 48999999999999999999999999999999999999544 579999999998
Q ss_pred eccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----CC----
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD-----FE---- 316 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-----~~---- 316 (447)
............++..|+|||++. ..++.++|+|||||++|+|++|.+||.+....+.+..+...... ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 765544444556889999999886 45889999999999999999999999888777666665442110 00
Q ss_pred -------C---C----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 317 -------S---E----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 317 -------~---~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
. . ....+++.+.++|.+||+.||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 0 011346788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.79 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=211.6
Q ss_pred eeecceeccccCeEEEEEEECCCCC---E-EEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGN---S-YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~---~-~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
-.+.++||+|+||.||+|+.+..+. . ||+|..............++.+|+++|++++ |||||+++|+..+..-+|
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCccE
Confidence 4457899999999999998776432 3 8999775434445667788999999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||+|.||+|.++|.+.+. ++..+...++.+.+.||+|||+++++||||-.+|+|++. +..+||+|||+++.-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~---~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK---KGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC---CCeEEeCccccccCCcc
Confidence 99999999999999999874 999999999999999999999999999999999999944 44589999999876432
Q ss_pred CCcee-ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 251 GKVYR-DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 251 ~~~~~-~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
..... ..--...|+|||.+. +.|++++|||||||++||+++ |..||.+....++...|....+..+.+. ..+.++
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--~~p~~~ 392 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--KTPKEL 392 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--CCHHHH
Confidence 11111 112346899999997 569999999999999999998 8899999999999999977666655544 568899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
..++.+||..||++||++.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999854
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=331.32 Aligned_cols=264 Identities=31% Similarity=0.470 Sum_probs=211.7
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--C
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--Q 168 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~ 168 (447)
.+.++|++.+.||+|+||.||+|.+..++..+|+|.+.+. .........+.+|+.+++++.+|+||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc-cCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 4567799999999999999999999989999999988543 223334456778999999994499999999988643 4
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+|+||||+. ++|..++... .+++..+..++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccchhcc
Confidence 6899999997 5898887665 788999999999999999999999999999999999994 4557999999998765
Q ss_pred cCCC------ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-------
Q 013201 249 DEGK------VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV------- 313 (447)
Q Consensus 249 ~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------- 313 (447)
.... ......|++.|+|||.+. ..++.++||||||+++|+|++|+.||.+.........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 4321 223457899999999874 3478899999999999999999999987665544433322110
Q ss_pred --------------------CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 314 --------------------DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 314 --------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
.........++.++.++|.+||+.||++|||+.++++||||.+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 00011112368899999999999999999999999999999876444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=322.36 Aligned_cols=256 Identities=30% Similarity=0.561 Sum_probs=213.1
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|.....||+|+||.||++.+..++..+|+|.+... .......+.+|+.+++.++ |+||+++++.+...+..|+||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEE
Confidence 355567899999999999999999999999987432 2334567889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-c
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-V 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~ 253 (447)
||+++++|.+++. ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++. +..++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~---~~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 97 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEEcccccceeccccccc
Confidence 9999999988764 457899999999999999999999999999999999999954 4469999999987654322 2
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
.....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+.........+..... ........++..+.++|.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHH
Confidence 23457899999999875 4578899999999999999999999988776655555443321 111122346889999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 333 KMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+||..||.+||++.+++.||||.+...
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=313.07 Aligned_cols=253 Identities=33% Similarity=0.548 Sum_probs=213.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QSVHL 172 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~l 172 (447)
+|.+.+.||+|++|.||+|.+..++..+++|++..... .....+.+.+|+.+++++. |+||+++++.+.+. ..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence 37888999999999999999999999999998865432 2345678899999999998 99999999999988 89999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|+||+++++|.+++.....+++..+..++.|++.+|.|||+.|++|+||+|+||+++. +..++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~---~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC---CCCEEEcccccEEeccccc
Confidence 9999999999999988889999999999999999999999999999999999999955 4469999999998776554
Q ss_pred c---eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC-HHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 253 V---YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 253 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
. .....++..|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+........ ....++..+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE--IPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcC--CCcccCHHH
Confidence 3 345678999999999864 48899999999999999999999998765 2222333222111111 112458999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.++|.+||..||.+||++.++++||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.19 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=208.0
Q ss_pred ccceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++ ||||+++++++.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKG 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence 4569999999999999999997652 35579999774322 2233456788999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCce
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG----------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
...|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+||+++. +..+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~---~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC---CCcE
Confidence 99999999999999999997532 2456788999999999999999999999999999999954 4569
Q ss_pred EEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCC
Q 013201 238 KATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312 (447)
Q Consensus 238 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 312 (447)
||+|||++........ .....++..|+|||.+. +.++.++|+|||||++|||++ |..||.+....+....+..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876543221 11234567899999876 558999999999999999998 789998888777777766554
Q ss_pred CCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCccC
Q 013201 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE------HPWMRE 356 (447)
Q Consensus 313 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~------h~~~~~ 356 (447)
..... ..+++.+.++|.+||+.||++|||+.++++ ||||..
T Consensus 239 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 239 YLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 32211 246789999999999999999999999986 898875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=330.47 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=201.0
Q ss_pred ccceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED- 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 166 (447)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... .....+.+.+|+.+++++.+|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3569999999999999999997543 45789999875322 223345678899999999669999999998764
Q ss_pred CCeEEEEEeccCCCchHHHHHHc---------------------------------------------------------
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQ--------------------------------------------------------- 189 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~--------------------------------------------------------- 189 (447)
+..+++||||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46788999999999999988642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc---eeecCCccc
Q 013201 190 ----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAY 262 (447)
Q Consensus 190 ----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~ 262 (447)
..+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++..+..... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~---~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE---NNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC---CCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 25788899999999999999999999999999999999954 44699999999986543221 123456778
Q ss_pred cccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCC
Q 013201 263 YVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPK 340 (447)
Q Consensus 263 y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 340 (447)
|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+............+ ...++++.+++.+||+.+|+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCC--ccCCHHHHHHHHHHccCChh
Confidence 99999875 568999999999999999998 999998755444443333333222222 24688999999999999999
Q ss_pred CCCCHHHHhcC
Q 013201 341 KRITSAEVLEH 351 (447)
Q Consensus 341 ~R~t~~~~l~h 351 (447)
+||++.++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.99 Aligned_cols=261 Identities=31% Similarity=0.425 Sum_probs=208.6
Q ss_pred ceeecceeccccCeEEEEEEECCC--CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CC
Q 013201 95 FYTLGKELGRGQFGITYLCTENST--GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----RQ 168 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~ 168 (447)
+|++.+.||+|+||.||+|++..+ +..||+|.+... .........+.+|+.+++++.+||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV-FSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc-cccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 388999999999999999999988 899999987532 22233356678899999999779999999987532 25
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+|+++||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~---~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC---CCCEEeCcCCCceec
Confidence 6789999985 689999988888999999999999999999999999999999999999954 446999999999765
Q ss_pred cCCC-----ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--------
Q 013201 249 DEGK-----VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV-------- 313 (447)
Q Consensus 249 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-------- 313 (447)
.... ......||+.|+|||.+.+ .++.++||||||+++|+|++|.+||...+....+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 4321 1233578999999998753 478999999999999999999999987665444433322100
Q ss_pred ---------------CCCC----CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 314 ---------------DFES----EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 314 ---------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
..+. ..+..++..+.+||.+||+.||++|||+.+++.||||.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 0000 0112357899999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=315.51 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=206.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|.+.+.||+|+||.||+|.+..++..+|+|.+... ......+.+|+.+++++. |+||+++++++.....+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEE
Confidence 3488999999999999999999999999999987532 233567889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++ .+..+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCccccccccc
Confidence 99999999999987643 588999999999999999999999999999999999994 4456999999999776543
Q ss_pred Ccee--ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 252 KVYR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 252 ~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.... ...++..|+|||.+. ..++.++|||||||++|+|++ |..||.+.+..+....+..+. .... ...++.++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~ 234 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-RMER--PEGCPPKV 234 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCC--CCCCCHHH
Confidence 2211 123456799999876 458899999999999999998 999998887777766665542 2221 23578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.++|.+||..||++||++.++++
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=319.35 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=205.3
Q ss_pred cceeecceeccccCeEEEEEEEC----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..|++.+.||+|+||.||+|... .++..+++|.+... ........+.+|+.++++++ ||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 34889999999999999999853 45678999987532 22334567889999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC
Q 013201 170 VHLVMELCSGGELFDKIIAQ-----------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD 232 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~ 232 (447)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~-- 159 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE-- 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC--
Confidence 99999999999999998643 23788889999999999999999999999999999999954
Q ss_pred CCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 013201 233 GGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDA 307 (447)
Q Consensus 233 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 307 (447)
...+||+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+.........
T Consensus 160 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 160 -QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred -CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 45699999999976543221 22345677899999876 558999999999999999998 9999988877666666
Q ss_pred HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 308 ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 308 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+...... + ....+++.+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLL-P--CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcC-C--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6554322 1 123578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.32 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=212.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
....|...+.||+|+||.||+|++..++..+|+|.+............++.+|+.+++.++ |+|++++++++......|
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence 3445888899999999999999999999999999886543333344567889999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+||||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++. +..+||+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC---CCcEEECCcccceeecC
Confidence 9999996 577777654 456899999999999999999999999999999999999954 45699999999876544
Q ss_pred CCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
. ....|++.|+|||.+. +.++.++|||||||++|+|++|..||...........+..+..... ....++..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 242 (308)
T cd06634 168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEY 242 (308)
T ss_pred c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHH
Confidence 3 2357889999999873 3578899999999999999999999987765555554444332211 11246889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+.+||.+||..+|.+||++.++++|||+...
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.95 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=199.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|++..+++.+|+|.+... ........+.+|+.++++++ ||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence 4699999999999999999999999987432 23344567899999999997 99999999999999999999999999
Q ss_pred CchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCcee---
Q 013201 180 GELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR--- 255 (447)
Q Consensus 180 ~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~--- 255 (447)
++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++. +..+||+|||++..........
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE---KNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC---CCcEEECccccCcccccccccccCC
Confidence 99999987654 5899999999999999999999999999999999999954 4469999999987544321111
Q ss_pred ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 256 DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 256 ~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
...++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+...... .. ...++..+.+|+.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-PC--PELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-CC--cccCCHHHHHHHHH
Confidence 112345699999876 458899999999999999998 89999877766665555543221 11 22468999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 013201 334 MLIQDPKKRITSAEVLE 350 (447)
Q Consensus 334 ~L~~dp~~R~t~~~~l~ 350 (447)
||+.||++|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=314.71 Aligned_cols=251 Identities=25% Similarity=0.488 Sum_probs=209.0
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++++. |+||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence 46999999999999999999999999999999886554444555678899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 174 MELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++. +..++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~---~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC---CCcEEEeccceeeecc
Confidence 999999999998864 244899999999999999999999999999999999999954 4469999999987654
Q ss_pred CCC-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGK-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAET--EKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
... ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||.... .....+.+..+... ..+...++.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCChhhcCH
Confidence 322 223457899999999876 458899999999999999999999996543 23344444443221 122225688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=314.25 Aligned_cols=241 Identities=27% Similarity=0.329 Sum_probs=200.3
Q ss_pred eeccccCeEEEEEEE--CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 101 ELGRGQFGITYLCTE--NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~--~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
.||+|+||.||+|.+ ..++..+|+|++... .......+.+.+|+.+++.+. ||||+++++++. ...+++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC-CCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecCC
Confidence 689999999999965 456789999987533 233445677899999999997 999999999885 456789999999
Q ss_pred CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce----
Q 013201 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY---- 254 (447)
Q Consensus 179 g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~---- 254 (447)
+++|.+++.....+++..+..++.|++.||.|||++||+||||||.||+++. +..+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT---QHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC---CCeEEECCCccccccCCCCCeeeec
Confidence 9999999988888999999999999999999999999999999999999954 457999999999765433221
Q ss_pred eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 255 RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
....++..|+|||.+. ..++.++|||||||++|||++ |..||......+....+.++.. .+.+ ..++++++++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~--~~~~~~l~~li~ 232 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-MECP--QRCPPEMYDLMK 232 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CCCC--CCCCHHHHHHHH
Confidence 1223457899999886 457889999999999999998 9999988888777777766543 2211 247899999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 013201 333 KMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~ 350 (447)
+||+.||++||++++|..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.92 Aligned_cols=259 Identities=28% Similarity=0.361 Sum_probs=209.7
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||.|+||.||+|.+..+++.||+|.+.+... ......+..|+.++.++.+|+||+++++++.+....|+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3558999999999999999999999999999999865422 22345667788877777779999999999999999999
Q ss_pred EEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||+. ++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++ .+..+||+|||++.....
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~---~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc---CCCCEEECccccchhccC
Confidence 999985 477666655 4568999999999999999999997 6999999999999994 445799999999977654
Q ss_pred CCceeecCCcccccccccccc-----cCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCCCCCCccccCC
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR-----SYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
........+++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .+.+..+....... .+....++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 246 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-LPPNEGFS 246 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-CCCCCCCC
Confidence 433344568889999999853 278899999999999999999999976432 34444444443211 11112468
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.++.+||.+||..||.+||++++++.||||....
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 8999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=329.41 Aligned_cols=255 Identities=18% Similarity=0.278 Sum_probs=201.4
Q ss_pred ceeccc--cCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 013201 100 KELGRG--QFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELC 177 (447)
Q Consensus 100 ~~lg~G--~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 177 (447)
..||+| +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++ ||||+++++++..++..++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence 456666 999999999999999999998764432 2334577889999999997 999999999999999999999999
Q ss_pred CCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-ce
Q 013201 178 SGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-VY 254 (447)
Q Consensus 178 ~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~~ 254 (447)
.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+|++||+.+....... ..
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~---~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD---GLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---CcEEEechHHHhhhhccCccc
Confidence 999999988764 348999999999999999999999999999999999999543 469999998653322110 00
Q ss_pred -------eecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC---------
Q 013201 255 -------RDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF--------- 315 (447)
Q Consensus 255 -------~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--------- 315 (447)
....++..|+|||++.+ .++.++|||||||++|+|++|..||...........+.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 01235667999999864 37899999999999999999999998776554443333221100
Q ss_pred ----------------------------------CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 316 ----------------------------------ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 316 ----------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
..+....+++.+.+||++||..||++|||++++|+||||.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00111235678999999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=309.71 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=212.6
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE------
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE------ 165 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~------ 165 (447)
....|....+||+|.||.||+|+.+.+|+.||+|++....... .......+|+++|..|. |+|++.+++.|.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lk-Henv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKATPT 92 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCc
Confidence 3456888999999999999999999999999998775433222 22344568999999998 999999988764
Q ss_pred --eCCeEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecC
Q 013201 166 --DRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 166 --~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
+...+|+||.+|+. +|..+|... -+++..++..++.++++||.|+|+..|+|||+|+.|+|| +.++++||+||
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADF 168 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADF 168 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeecc
Confidence 33569999999975 888888765 579999999999999999999999999999999999999 55568999999
Q ss_pred CCceeccCC-----CceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC
Q 013201 243 GLSVFIDEG-----KVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF 315 (447)
Q Consensus 243 g~a~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 315 (447)
|+++.+... ..++..+-|.+|++||.+. +.|+++.|||..|||+.||.||.+.+.+.+....+..|..-.-..
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 999765422 2344567799999999876 459999999999999999999999999998887776664322111
Q ss_pred CCCccc-------------------------------cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 316 ESEPWL-------------------------------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 316 ~~~~~~-------------------------------~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
..+.|+ .-.+++.||+.+||..||.+|+++.++|+|.||.+.+.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 111111 11457889999999999999999999999999988543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=325.09 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=202.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCE----EEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNS----YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..|++.+.||+|+||.||+|++..++.. ||+|.+... ........+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence 3499999999999999999998766654 888877432 22344567889999999997 99999999998764 5
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.++|+||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~---~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT---PQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC---CCcEEEccccccccc
Confidence 67999999999999999874 45889999999999999999999999999999999999944 446999999999876
Q ss_pred cCCCcee---ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 249 DEGKVYR---DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 249 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
....... ...++..|+|||.+. ..++.++||||||+++|||++ |..||.+....+....+.. ...++.+ ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQP--PIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC-CCCCCCC--CCC
Confidence 5433211 223467899999876 568999999999999999997 9999988776665544433 3333322 246
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+.++.+++.+||..||.+||++.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=321.20 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=206.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCC----------------CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTG----------------NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 156 (447)
.++|++.+.||+|+||.||+|++...+ ..||+|.+.... .....+.+.+|+.++++++ |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence 356999999999999999999876544 457899875432 2345678889999999997 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCc
Q 013201 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG-----------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPEN 225 (447)
Q Consensus 157 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~N 225 (447)
|+++++++..++.+++||||+.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred eEeecCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh--CCCCCCCC
Q 013201 226 FLLSNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS--GVPPFWAE 299 (447)
Q Consensus 226 ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt--g~~pf~~~ 299 (447)
|+++. ...++|+|||++........ .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||...
T Consensus 161 ili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLVGK---NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eeecC---CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99954 45799999999876543321 22345678899999876 468999999999999999998 77899877
Q ss_pred CHHHHHHHHHhC----CCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 300 TEKGIFDAILKG----GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 300 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.....+..+... ......+....++.++.++|.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 766666555432 111111112246789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=313.61 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=205.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|.+.. +..+|+|.+.... ...+.+.+|+.++++++ ||||+++++++.+...+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS----MSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc----ccHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence 348999999999999999998764 4569999875432 22467889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++. +..+||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~---~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD---QGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC---CCCEEECCCccceecCCCc
Confidence 9999999999998764 46899999999999999999999999999999999999954 4469999999987654433
Q ss_pred cee--ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 253 VYR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 253 ~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+...... ...++.++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 221 123556899999986 458899999999999999998 99999888777777777665433222 23588999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+++.+||..||.+||++.+++.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.70 Aligned_cols=253 Identities=31% Similarity=0.494 Sum_probs=208.3
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|.+.+.||+|++|+||+|+...+++.|++|.+..... . .......+|+..++++.+|+||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999998999999998754322 1 2223456799999999779999999999999999999999
Q ss_pred ccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 176 LCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|+ +++|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++. ...++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~---~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG---PEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC---CCCEEEeecccceeccCCCC
Confidence 99 789999888765 7899999999999999999999999999999999999944 45699999999987765544
Q ss_pred eeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC--------------
Q 013201 254 YRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES-------------- 317 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------- 317 (447)
.....|+..|+|||++. ..++.++|+||||+++|+|++|..||......+.+..+.........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 45567899999999874 34789999999999999999999999877665544433321100000
Q ss_pred ------------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 318 ------------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 318 ------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
......+..+.++|.+||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.23 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=203.3
Q ss_pred cccCCCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEE
Q 013201 83 TVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRG 162 (447)
Q Consensus 83 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 162 (447)
.+...+....++.|.-...||+|+||.||+|.... +..||||++...... . ..+|.+|+.++.+++ |||+|+|+|
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~-H~Nlv~LlG 138 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ--G-EREFLNEVEILSRLR-HPNLVKLLG 138 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCc--c-hhHHHHHHHHHhcCC-CcCcccEEE
Confidence 34445556667889999999999999999999764 489999976443211 1 345999999999998 999999999
Q ss_pred EEEeCC-eEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC---cEeecCCCCceEeecCCCCCc
Q 013201 163 AYEDRQ-SVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMG---VMHRDLKPENFLLSNKDGGAM 236 (447)
Q Consensus 163 ~~~~~~-~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~~~ 236 (447)
||.+.+ ..+||+||+++|+|.++|.... .++|....+|+.+++.||+|||... |+|||||++|||+ |.+..
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCC
Confidence 999988 5999999999999999998765 8999999999999999999999854 9999999999999 67778
Q ss_pred eEEecCCCceeccC-CCceeec-CCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCC---HHHHHH----
Q 013201 237 LKATDFGLSVFIDE-GKVYRDI-VGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFD---- 306 (447)
Q Consensus 237 vkl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~---- 306 (447)
.||+|||+|+.... ....... .||.+|+|||.+. +..+.++||||||++|.||+||+.+..... ...+..
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 99999999976554 3333333 8999999999986 678999999999999999999998876432 111111
Q ss_pred HHHhCCCCCCCCcc---ccCC-----hHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 307 AILKGGVDFESEPW---LLIS-----DSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 307 ~i~~~~~~~~~~~~---~~~s-----~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+.++......++. ...+ ..+..+..+|++.+|.+||++.++++
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 22222111111111 1122 22556778999999999999999754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=314.76 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=208.0
Q ss_pred cceeecceeccccCeEEEEEEECCC---CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENST---GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+.|++.+.||+|+||.||+|++..+ ...||+|.+.... .......+.+|+.++++++ ||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence 4589999999999999999998654 4579999875432 3344567889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++ .+..+||+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccchhhccc
Confidence 9999999999999998764 4689999999999999999999999999999999999994 44569999999998764
Q ss_pred C-CCcee--ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 250 E-GKVYR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 250 ~-~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
. ..... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+... +. ...++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-PP--PMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-CC--CCCCC
Confidence 2 11111 234567899999886 458999999999999999998 99999888877777777654322 11 23578
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+.+.+|+.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=320.83 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=205.3
Q ss_pred ccceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... .....+.+.+|+.+++++.+|+||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 456999999999999999999853 345689999875432 2334567889999999995599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
+..|+||||+.+++|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+|||++ .+..+||+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECCCccc
Confidence 99999999999999999987643 389999999999999999999999999999999999994 4457999999999
Q ss_pred eeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Q 013201 246 VFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 246 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 320 (447)
........ .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.....................+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 266 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP-- 266 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC--
Confidence 76543321 11234677899999875 458999999999999999998 999998776655554444443332222
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
...++++.+++.+||..+|++|||+.++++
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 246889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=313.61 Aligned_cols=243 Identities=25% Similarity=0.403 Sum_probs=208.1
Q ss_pred ceeccccCeEEEEEEECCC---CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 013201 100 KELGRGQFGITYLCTENST---GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 176 (447)
+.||+|+||.||+|.+... +..+++|.+..... ......+.+|+.+++.++ |+||+++++++.+...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 4699999999999999866 89999998854432 224678899999999998 99999999999999999999999
Q ss_pred cCCCchHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 177 CSGGELFDKIIAQ---------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 177 ~~g~~L~~~l~~~---------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++. +..+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~---~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE---DLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECC---CCcEEEcccccccc
Confidence 9999999999875 67999999999999999999999999999999999999954 45699999999987
Q ss_pred ccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 248 IDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 248 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
..... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+... ..+ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL-PKP--EY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCC--cc
Confidence 65432 223456788999999886 468999999999999999999 69999988887777777664322 212 24
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++.++.+++.+||..||++|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 68999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=328.35 Aligned_cols=268 Identities=26% Similarity=0.432 Sum_probs=213.5
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
....+.++|.+.+.||+|+||.||+|.+..+++.||+|++.+.. ......+.+.+|+.++++++ ||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~ 88 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 88 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeec
Confidence 34556788999999999999999999999999999999886432 22233456788999999997 99999999988643
Q ss_pred ------CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 168 ------QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 ------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
...|++++++ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++. +..+||+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~---~~~~kl~d 163 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILD 163 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC---CCCEEEec
Confidence 3478899987 7788776654 46999999999999999999999999999999999999954 44699999
Q ss_pred CCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC------
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV------ 313 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------ 313 (447)
||++...... .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||........+..+.....
T Consensus 164 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 164 FGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred cccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998765432 234578999999998754 478899999999999999999999987665554444322110
Q ss_pred -----------------CCCCC----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCc
Q 013201 314 -----------------DFESE----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364 (447)
Q Consensus 314 -----------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~ 364 (447)
..+.. .+...++++.++|.+||+.||.+||++.+++.||||++.......+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~ 313 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 313 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccc
Confidence 00000 0113578899999999999999999999999999999865554433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=322.14 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=205.3
Q ss_pred ccceeecceeccccCeEEEEEEECC-------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+.|.+++.||+|+||.||+|.+.. +...+|+|.+.... .......+.+|+.+++++.+|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 4569999999999999999998643 23569999875432 23345678899999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
..+..|+||||+++++|.+++.... .++...+..++.|++.||.|||++|++||||||+||+++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 9999999999999999999997642 378889999999999999999999999999999999995
Q ss_pred cCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 304 (447)
. +..+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 175 ~---~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 175 E---DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred C---CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 4 44699999999876543221 11223457899999876 458999999999999999998 8899988777766
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
...+..+.. ... ...++.++.+||.+||..+|.+||++.+++++
T Consensus 252 ~~~~~~~~~-~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGHR-MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCCC-CCC--CCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 666655432 111 12468999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=322.68 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=207.7
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC---
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ--- 168 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--- 168 (447)
..+.|++.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.++++++ ||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhh
Confidence 34569999999999999999999999999999998864322 2233456778999999997 999999999987654
Q ss_pred -------eEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 169 -------SVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 169 -------~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
.+++|+||+++ +|...+... ..+++..+..++.||+.||.|||+.||+|+||||+||+++ .+..+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCcEEeC
Confidence 89999999976 677766654 4689999999999999999999999999999999999994 44579999
Q ss_pred cCCCceeccCCC--ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 013201 241 DFGLSVFIDEGK--VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316 (447)
Q Consensus 241 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 316 (447)
|||++....... ......++..|+|||.+.+ .++.++|||||||++|+|++|++||......+.+..+.+......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999997654332 2223456788999998753 478899999999999999999999987766655544443211000
Q ss_pred --------------------------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 317 --------------------------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 317 --------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
...+..++..+.++|.+||..||.+||++++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 00122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=301.89 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=204.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----C
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED-----R 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~ 167 (447)
.++|++.+.||+|||+.||++....++..||+|+|... ...+.+...+|++..++++ ||||++++++... .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCc
Confidence 56799999999999999999999999999999998543 3566788899999999998 8999999887643 3
Q ss_pred CeEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCCCCceEEec
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
...||+++|...|+|.+.+... ..++|.++..|+.+|++||.+||+.. ..||||||.|||+.. ...++|.|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~---~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD---SGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC---CCceEEEe
Confidence 4599999999999999988753 35999999999999999999999999 999999999999954 45699999
Q ss_pred CCCceeccCC---C-------ceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH--HH
Q 013201 242 FGLSVFIDEG---K-------VYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKG--IF 305 (447)
Q Consensus 242 fg~a~~~~~~---~-------~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~ 305 (447)
||.+....-. . ....-..|..|+|||.+. ...+.++|||||||+||+|+.|..||...-..+ +.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9998754211 0 111235789999999985 237899999999999999999999995322111 11
Q ss_pred HHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 306 DAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 306 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
-.+..+.+.++... .+|+.+.+||+.||++||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22334455555443 489999999999999999999999999864
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=321.77 Aligned_cols=255 Identities=32% Similarity=0.553 Sum_probs=208.8
Q ss_pred eeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccCC-hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 96 YTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLVN-KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
|++.+.||.|+||.||+|++. .++..||+|.+.+..... ......+.+|+.+++++.+||||+++++.+..+..+|
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 888999999999999999864 467899999886543221 2234567899999999987999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+||||+.+++|.+++.....+++..+..++.|++.+|.|||+.|++||||+|+||+++. +..++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS---EGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC---CCCEEEEECccccccccc
Confidence 99999999999999988888999999999999999999999999999999999999944 456999999998765433
Q ss_pred Cc--eeecCCccccccccccccc---CCCCCcchhHHHHHHHHhhCCCCCCCCC----HHHHHHHHHhCCCCCCCCcccc
Q 013201 252 KV--YRDIVGSAYYVAPEVLRRS---YGKEIDVWSAGVILYILLSGVPPFWAET----EKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 252 ~~--~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
.. .....|+..|+|||.+.+. .+.++|+||||+++|+|++|..||.... ..+....+.......+ ..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 234 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP----KT 234 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC----cc
Confidence 22 1235689999999987532 6889999999999999999999996432 2233333333322221 24
Q ss_pred CChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRIT---SAEVLEHPWMREG 357 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t---~~~~l~h~~~~~~ 357 (447)
++..+.++|.+||+.||++||| +.++|+||||+..
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 6889999999999999999998 5677999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=319.76 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=207.1
Q ss_pred ccceeecceeccccCeEEEEEEECCC-----CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENST-----GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++.+|+||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 45699999999999999999987643 3689999875432 2334566889999999995599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ----------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK 231 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~ 231 (447)
+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~- 167 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE- 167 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC-
Confidence 9999999999999999998642 35889999999999999999999999999999999999954
Q ss_pred CCCCceEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHH
Q 013201 232 DGGAMLKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFD 306 (447)
Q Consensus 232 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 306 (447)
+..+||+|||++......... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+...
T Consensus 168 --~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 168 --DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred --CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 457999999999876543221 1223567899999875 558999999999999999997 999998887777777
Q ss_pred HHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 307 AILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 307 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+..+.. ... ...++..+.+|+.+||..||++|||+.+++++
T Consensus 246 ~~~~~~~-~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYR-MEK--PQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCc-CCC--CCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6655432 111 12468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.62 Aligned_cols=245 Identities=30% Similarity=0.455 Sum_probs=200.4
Q ss_pred eecceeccccCeEEEEEEEC----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 97 TLGKELGRGQFGITYLCTEN----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 97 ~~~~~lg~G~~g~Vy~~~~~----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.+.||.|+||.||+|... ..+..|+||.+.. .......+.+.+|++++++++ ||||+++++++...+.+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccc-ccccccccccccccccccc
Confidence 46789999999999999988 4567899998833 233445788999999999996 9999999999998888999
Q ss_pred EEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||++|+|.++|... ..+++..+..++.||+.||.|||+++++|+||+++||+++. +..+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~---~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS---NGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET---TTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc
Confidence 99999999999999987 67999999999999999999999999999999999999954 44799999999987743
Q ss_pred CCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 251 GKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 251 ~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.... ....+...|+|||.+. ..++.++||||||+++|||++ |..||...+..+....+.++..... ...++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhH
Confidence 3222 2235677899999986 448999999999999999999 7899998888888888865543222 124789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+.++|.+||..||++||++.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=313.06 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=205.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.++||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.++++++ |+||+++++.+.+.+..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC----chhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEE
Confidence 45999999999999999999865 5677999987532 223567889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++ ....+||+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCccceecCCC
Confidence 9999999999998763 4588899999999999999999999999999999999994 4457999999999876543
Q ss_pred Cce--eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 252 KVY--RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 252 ~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
... ....++..|+|||.+. +.++.++|||||||++|+|++ |..||...........+..+. ..+ ....++.++
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~ 233 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RMP--RMENCPDEL 233 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCCCHHH
Confidence 221 2234567899999876 458889999999999999998 999998887777777765542 222 223578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.++|.+||..+|++||+++++++
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=314.50 Aligned_cols=243 Identities=25% Similarity=0.354 Sum_probs=197.2
Q ss_pred ceeccccCeEEEEEEECCCCCE--EEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 013201 100 KELGRGQFGITYLCTENSTGNS--YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELC 177 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~--~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 177 (447)
+.||+|+||.||+|++..++.. +++|.+.. .......+.+.+|+.+++++.+||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc--cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3689999999999999887764 57776642 2233445678899999999966999999999999999999999999
Q ss_pred CCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 178 SGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 178 ~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++ .+..+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc---CCCeEEECC
Confidence 9999999987643 378899999999999999999999999999999999994 445799999
Q ss_pred CCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCc
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEP 319 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 319 (447)
||++..............+..|+|||++. ..++.++||||||+++|+|++ |..||.+.+..+....+..+. ... .
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~--~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLE--K 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CCC--C
Confidence 99985332211111123456799999875 458899999999999999997 999998877777666665432 111 1
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
...++.++.+|+.+||..||.+|||+.++++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 1246889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=312.60 Aligned_cols=251 Identities=27% Similarity=0.468 Sum_probs=215.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+|++.+.||+|+||.||++.+..++..+++|.+..... .......+.+|+.+++++. |+||+++++++.+....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence 38899999999999999999999999999998865443 2344567789999999998 999999999999999999999
Q ss_pred eccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 175 ELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 175 e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||+++++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ...+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~---~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA---NDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec---CCcEEEeeccchhhhcc
Confidence 99999999998876 356899999999999999999999999999999999999965 34699999999977655
Q ss_pred CCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
. ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+..+....... .++.++++
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP---IYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCch---hhCHHHHH
Confidence 4 3334578999999999864 47889999999999999999999999888777666666554332221 46889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+|.+||..+|.+||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=314.52 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=203.2
Q ss_pred eeecceeccccCeEEEEEEECCC---CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe---
Q 013201 96 YTLGKELGRGQFGITYLCTENST---GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS--- 169 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--- 169 (447)
|.+++.||+|+||.||+|.+..+ +..||+|.+... .........+.+|+.+++.++ |+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC-cCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 56889999999999999997654 478999987543 223444567899999999997 9999999998865544
Q ss_pred ---EEEEEeccCCCchHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 170 ---VHLVMELCSGGELFDKIIAQ------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 170 ---~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
.++||||+++++|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++ .+..+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC---CCCeEEEC
Confidence 79999999999999888543 3589999999999999999999999999999999999994 44569999
Q ss_pred cCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCC
Q 013201 241 DFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDF 315 (447)
Q Consensus 241 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 315 (447)
|||++......... ....++..|+|||.+. ..++.++|||||||++|||++ |..||.+....+.++.+..+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999866443221 1224567899999886 458999999999999999999 999998888777777776653221
Q ss_pred CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 316 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+ ..++.++.+++.+||+.||++||++.+++++
T Consensus 236 -~~--~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 -QP--EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -CC--cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 2478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=317.90 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=205.0
Q ss_pred cceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 94 QFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+.|.+.+.||+|+||.||+|.+.. ++..+++|.+... .......+.+|+.++++++ |+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence 348999999999999999998643 4556888876322 2334467889999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD 232 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~ 232 (447)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~--- 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG--- 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---
Confidence 9999999999999999997642 378999999999999999999999999999999999995
Q ss_pred CCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 013201 233 GGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDA 307 (447)
Q Consensus 233 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 307 (447)
.+..+||+|||++........ .....|+..|+|||.+. ..++.++||||||+++|+|+| |..||......+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 445799999999976543321 12345678899999876 558899999999999999999 9999988888777777
Q ss_pred HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 308 ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 308 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+..+...... ..++..+.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6655433221 246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=324.04 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=204.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-----
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR----- 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~----- 167 (447)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++ |+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence 456999999999999999999999999999999886543222 22345678999999997 99999999887443
Q ss_pred ---CeEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 168 ---QSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
..+|+||||+.+ +|...+.. ...+++..+..++.||+.||.|||++||+|+||||+||+++ .+..+||+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECcCc
Confidence 357999999965 67676654 34799999999999999999999999999999999999994 44579999999
Q ss_pred CceeccCCC------------ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 013201 244 LSVFIDEGK------------VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL 309 (447)
Q Consensus 244 ~a~~~~~~~------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 309 (447)
++....... ......|++.|+|||.+.+ .++.++|||||||++|+|++|.+||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 987553321 1123467889999998753 47899999999999999999999998877766555544
Q ss_pred hCCCCCCC--------------------------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 310 KGGVDFES--------------------------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 310 ~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
........ ..+..+++.+.++|.+||..||++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 32111000 0012345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=312.12 Aligned_cols=245 Identities=23% Similarity=0.398 Sum_probs=203.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.++ ++..+|+|.+.+... ....+.+|+.+++++. |+||+++++++...+..|+||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEE
Confidence 3889999999999999999886 467899998754322 2356788999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 175 ELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||++|++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++. +..+||+|||++....+...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~---~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE---DNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC---CCcEEECCcccceecccccc
Confidence 999999999998764 46899999999999999999999999999999999999954 45699999999876543321
Q ss_pred ee--ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 254 YR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 254 ~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.. ...++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+....+..+. ....+ ..++.++.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~ 232 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RLYRP--KLAPTEVYT 232 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHH
Confidence 11 122345799999876 568999999999999999999 899998887777777665542 22222 247899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h 351 (447)
++.+||..+|++|||+.++++.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=317.84 Aligned_cols=248 Identities=20% Similarity=0.300 Sum_probs=206.8
Q ss_pred ceeecceeccccCeEEEEEEECCC-----CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 95 FYTLGKELGRGQFGITYLCTENST-----GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.|++.+.||.|+||.||+|++..+ +..||+|.+.... .....+.+.+|+.+++.+. ||||+++++++.....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCc
Confidence 488899999999999999987543 5789999875322 2334567889999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC
Q 013201 170 VHLVMELCSGGELFDKIIAQ----------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~ 233 (447)
.++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~--- 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD--- 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC---
Confidence 99999999999999988532 24788889999999999999999999999999999999954
Q ss_pred CCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 013201 234 GAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAI 308 (447)
Q Consensus 234 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 308 (447)
+..+||+|||++........ .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 44699999999876543322 12345678999999875 568999999999999999998 88999888888888887
Q ss_pred HhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 309 LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 309 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..+...... ..++..+.+|+.+||+.+|.+||++++++..
T Consensus 240 ~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 776543221 2478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=328.10 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=210.0
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR- 167 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 167 (447)
...+.++|.+.+.||+|+||.||+|++..+++.||+|.+.+.. ........+.+|+.+++.+. ||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 87 (342)
T cd07879 10 VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAV 87 (342)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcC-CCCccchhheecccc
Confidence 3455678999999999999999999999999999999886532 22333456789999999997 99999999998654
Q ss_pred -----CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecC
Q 013201 168 -----QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 168 -----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
..+|+|+||+.+ +|..++ ...+++..+..++.|++.||.|||+.||+||||||+||+++. ++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~---~~~~kL~df 161 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE---DCELKILDF 161 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEeeC
Confidence 356999999964 676554 346899999999999999999999999999999999999954 456999999
Q ss_pred CCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-------
Q 013201 243 GLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV------- 313 (447)
Q Consensus 243 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------- 313 (447)
|++...... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 162 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 162 GLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998765332 234578899999998754 478899999999999999999999988776555544433110
Q ss_pred ----------------CCCCCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 314 ----------------DFESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 314 ----------------~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
..+... +...++.+.+||.+||+.||++||++++++.||||......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000010 12467889999999999999999999999999999886544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=314.78 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=201.5
Q ss_pred eeecceeccccCeEEEEEEECCCCC--EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC------
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGN--SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR------ 167 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~--~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~------ 167 (447)
|.+++.||+|+||.||+|.+..++. .+|+|.+... .......+.+.+|+.+++.++ |+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence 3578899999999999999887765 5899977543 233445678889999999997 99999999976432
Q ss_pred CeEEEEEeccCCCchHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
...++||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++ .+..+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc---CCCCEEECC
Confidence 3578999999999999887532 3478999999999999999999999999999999999994 445699999
Q ss_pred CCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCC
Q 013201 242 FGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFE 316 (447)
Q Consensus 242 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 316 (447)
||++......... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+..+.....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999876443221 1234667899999986 458999999999999999999 8999988877777777766543211
Q ss_pred CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 317 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
...++..+.++|.+||+.||++|||+.+++++
T Consensus 236 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 236 ---PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=320.04 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=204.9
Q ss_pred ccceeecceeccccCeEEEEEEECC-------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.++|.+++.||+|+||.||+|++.. ....+|+|.+.... .......+.+|+.+++++.+||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 4569999999999999999998642 34578999875322 23345678899999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQ----------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 999999999999999999999763 2478889999999999999999999999999999999995
Q ss_pred cCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 304 (447)
. +..+||+|||++........ .....++..|+|||++. +.++.++||||||+++|+|++ |..||.+....+.
T Consensus 169 ~---~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 169 E---DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred C---CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 4 44699999999976543221 11223456799999876 458999999999999999999 8999988887777
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+..+..+... .. ...++.+++++|.+||..||++||++.++++
T Consensus 246 ~~~~~~~~~~-~~--~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHRM-DK--PSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCCC-CC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7776654321 11 1246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=308.15 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=216.6
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
.+-...||.|+||+|++-.++.+|+..|||.|.... ......++..|.....+-.++||||++++..-.++..||.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 444678999999999999999999999999996543 345567888999988888889999999999999999999999
Q ss_pred ccCCCchHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHH-hcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 176 LCSGGELFDKI-----IAQGHYTEKAAAALCRAIVNVVHHCH-FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 176 ~~~g~~L~~~l-----~~~~~~~~~~~~~i~~qil~~l~~lH-~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|. -+|..+- ..+..++|+.+..|....+.||.||. ...|+|||+||+|||+ +..+.|||||||++..+.
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHH
Confidence 995 3553322 23567999999999999999999997 4689999999999999 555569999999998876
Q ss_pred CCCceeecCCccccccccccc---ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCCCCCCcc--ccC
Q 013201 250 EGKVYRDIVGSAYYVAPEVLR---RSYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVDFESEPW--LLI 323 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~--~~~ 323 (447)
+.-..+.-+|...|||||.+. .+|+-++|+||||++|||+.||..||.+.+. .+.+..+..+..+...... ..+
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 654445568999999999985 3599999999999999999999999977543 4556666666544333222 247
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDK 363 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~ 363 (447)
+..+..+|..||.+|-.+||...+++++||++.+......
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence 8899999999999999999999999999999987665443
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=318.87 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=206.8
Q ss_pred ccceeecceeccccCeEEEEEEEC-------CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN-------STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+.|.+.+.||+|+||.||+|++. .++..+|+|.+... ........+.+|+.+++.+.+||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 456999999999999999999753 23457899977432 123445678999999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
..+..|+||||+++++|.+++.... .++...+..++.||+.||.|||++||+||||||+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 9999999999999999999997642 367788999999999999999999999999999999995
Q ss_pred cCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 304 (447)
. +..+||+|||++........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+.+..++
T Consensus 172 ~---~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 172 E---NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred C---CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 4 44699999999987644221 12234667899999876 458999999999999999998 8899988888887
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
...+..+.... . ...++.++.+||.+||..+|.+||++.++++.
T Consensus 249 ~~~~~~~~~~~-~--~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHRMD-K--PANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCcCC-C--CCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 77776553221 1 12578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.27 Aligned_cols=246 Identities=22% Similarity=0.302 Sum_probs=204.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
++.|++.+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|+.+++++. |+||+++++++...+..|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeee
Confidence 456999999999999999999975 45789999875432 23467889999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. +..+||+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE---NNICKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC---CCCEEECCcceEEEccC
Confidence 999999999999997754 6899999999999999999999999999999999999954 44699999999987653
Q ss_pred CCcee--ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKVYR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
..... ...++..|+|||.+. ..++.++||||||+++|+|++ |+.||.+.+.......+.... ..+.+ ..++..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~ 232 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RMPCP--PGCPKE 232 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCC--CcCCHH
Confidence 32111 112345799999876 458899999999999999999 999998888777777665542 22211 246899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.76 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=215.7
Q ss_pred ccceeecceeccccCeEEEEEEECCCCC-----EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGN-----SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
+..-++.+.||+|+||.||.|....... .||+|.+. ...+.+...+|.+|..+|++++ |||||+++|++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence 3456788999999999999998765433 38888774 3456778899999999999998 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ-------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
+..+|++|||+||+|..+|++. ..++......++.+|+.|+.||+++++|||||-.+|+|+ +...+|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 9999999999999999999886 238899999999999999999999999999999999999 555789999
Q ss_pred cCCCceeccCCCceeec---CCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCC
Q 013201 241 DFGLSVFIDEGKVYRDI---VGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDF 315 (447)
Q Consensus 241 Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 315 (447)
|||+|+.+...+.+... .-...|||||.+. +.++.++|||||||+|||++| |..||.+.+..+++...++++ .+
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 99999966554443321 2235799999987 679999999999999999999 999999999999998888887 44
Q ss_pred CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 316 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.+. .++..+.++|..||+.+|++||++..|++
T Consensus 924 ~~P~--~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPPS--YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCC--CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 4443 58999999999999999999999999987
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=310.11 Aligned_cols=241 Identities=24% Similarity=0.320 Sum_probs=199.4
Q ss_pred ceeccccCeEEEEEEECCCC---CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 013201 100 KELGRGQFGITYLCTENSTG---NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 176 (447)
+.||+|+||.||+|+...++ ..+|+|.+...... ...+.+.+|+.+++.+. |+||+++++++. ...+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence 47999999999999876554 78999988654332 34567889999999997 999999999876 4567999999
Q ss_pred cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce-e
Q 013201 177 CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY-R 255 (447)
Q Consensus 177 ~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~-~ 255 (447)
+++++|.+++.....+++..+..++.|++.||.|||+.+++||||||+|||++. +..+||+|||++......... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~---~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN---RHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcC---CCcEEeccccccceeecCCcccc
Confidence 999999999998888999999999999999999999999999999999999954 446999999999866443221 1
Q ss_pred ---ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 256 ---DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 256 ---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
...++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+....+...... . ....++..++++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-P--RPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-C--CCCCCCHHHHHH
Confidence 122346799999876 458999999999999999998 99999888777776666554322 1 123578999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 013201 331 VRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~ 350 (447)
|.+||..||++||++.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=320.77 Aligned_cols=265 Identities=31% Similarity=0.477 Sum_probs=211.1
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-CC
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED-RQ 168 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~ 168 (447)
..+.++|++.+.||.|+||.||+|.+..++..||+|.+.+.. ........+.+|+.+++.+. ||||+++++++.. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 83 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLE 83 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCC
Confidence 346778999999999999999999999999999999886532 22334567889999999998 9999999999865 56
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+|+|+||+ +++|..++. ...+++..+..++.||+.||.|||+.||+||||+|+||+++ ....+||+|||++...
T Consensus 84 ~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLARIQ 158 (328)
T ss_pred cEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---CCCCEEeCcccccccc
Confidence 789999999 568877665 35688999999999999999999999999999999999994 4456999999998755
Q ss_pred cCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC---------------
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG--------------- 311 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--------------- 311 (447)
... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.+.
T Consensus 159 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 159 DPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred CCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 332 234578899999998753 5889999999999999999999999776543222211110
Q ss_pred ---------C--CCCCC-CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 013201 312 ---------G--VDFES-EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDK 363 (447)
Q Consensus 312 ---------~--~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~ 363 (447)
. ...+. .....+++.+.++|.+||+.+|++||++++++.||||.........
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 0 00000 0112467899999999999999999999999999999876554333
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=314.25 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=206.3
Q ss_pred ccceeecceeccccCeEEEEEEECCC-----CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENST-----GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.+.|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+. |+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCC
Confidence 45699999999999999999998644 3789999874332 2234567889999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCce
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG----------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
...|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++. +..+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~---~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE---DLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC---CCCE
Confidence 99999999999999999986532 3677889999999999999999999999999999999954 4569
Q ss_pred EEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCC
Q 013201 238 KATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312 (447)
Q Consensus 238 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 312 (447)
||+|||++........ .....++..|+|||.+. +.++.++|||||||++|++++ |..||.+.+.......+..+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 9999999876543321 12345678999999875 558999999999999999998 999998888877777766443
Q ss_pred CCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 313 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.. ..+ ..++.++.++|.+||+.+|++|||+.++++
T Consensus 239 ~~-~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 HL-DLP--ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CC-CCC--CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22 111 236899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=293.80 Aligned_cols=254 Identities=28% Similarity=0.515 Sum_probs=211.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QSV 170 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~ 170 (447)
.+.|++.+++|+|.|+.||.|.+..++..++||++.+ ...+.+.+|++||+.|.++|||++++++..+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4569999999999999999999999999999998743 33578999999999999999999999998765 467
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
.||+||..+.+...+ -..++.-.++.++.+++.||.|||+.||+|||+||.|++|+.... .++|+|||+|.+..+
T Consensus 111 aLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r--kLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc--eeeeeecchHhhcCC
Confidence 899999988665443 245788899999999999999999999999999999999976544 599999999999999
Q ss_pred CCceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCC-CHHHHHHHHHh-------------CCCC
Q 013201 251 GKVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFDAILK-------------GGVD 314 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~-------------~~~~ 314 (447)
+..++..+.+.+|-.||.+- ..|+.+-|+|||||+|..|+..+.||... +..+.+-+|.+ -...
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 98888889999999999985 45999999999999999999999998643 33333322211 0111
Q ss_pred C-----------CCCcc---------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 315 F-----------ESEPW---------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 315 ~-----------~~~~~---------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+ ...+| ..+++++.||+.++|.+|-.+|+|+.|++.||||...
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 1 11111 2357999999999999999999999999999999754
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=329.66 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=203.8
Q ss_pred ccceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.+.|.+++.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+|.++..||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 355889999999999999999964 345689999985432 2233457889999999997799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC---------------------------------------------------------
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG--------------------------------------------------------- 190 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~--------------------------------------------------------- 190 (447)
+..++|||||.+|+|.+++.+.+
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986532
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 191 -----------------------------------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 191 -----------------------------------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
.+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 256677888999999999999999999999999999995
Q ss_pred cCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 304 (447)
. ...+||+|||++........ .....+++.|+|||.+. ..++.++||||||+++|||++ |..||......+.
T Consensus 274 ~---~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 274 E---GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred C---CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 4 45799999999976533211 12346788899999886 458899999999999999998 8999987665555
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.............+ ..++.++.+||.+||..+|.+||++++|+..
T Consensus 351 ~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKRGYRMAKP--AHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44444443332222 2468999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=311.27 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=202.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.++|++.+.||+|+||.||+|++..+ ..||+|.+.+.. ...+.+.+|+.++++++ |+||+++++.+. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~----~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc----cCHHHHHHHHHHHHhCC-CCCcceEEEEEC-CCCcEE
Confidence 35699999999999999999998755 469999875432 23457889999999997 999999999875 456889
Q ss_pred EEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+|+||||||+||+++. +..+||+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~---~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE---NLVCKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC---CCcEEeccCCceeeccc
Confidence 99999999999999763 35889999999999999999999999999999999999954 45699999999976654
Q ss_pred CCce--eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKVY--RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.... ....++..|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..+.. .+. ...++..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~ 231 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPC--PPECPES 231 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CCC--ccccCHH
Confidence 3221 1234667899999875 558999999999999999999 8889988877777776655422 211 1247899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.++|.+||+.||++||+++++++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=314.54 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=204.9
Q ss_pred cceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+.|++.++||+|+||.||+|... .++..+|+|.+... .......+.+|+.+++.+. |+||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence 45888999999999999999743 34668888876432 3445678899999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQG---------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~---------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~ 233 (447)
..++||||+++++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---Q 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---C
Confidence 9999999999999999987643 478899999999999999999999999999999999995 4
Q ss_pred CCceEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 013201 234 GAMLKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAI 308 (447)
Q Consensus 234 ~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 308 (447)
+..+||+|||++......... ....+++.|+|||.+. ..++.++|||||||++|+|++ |..||......+....+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 457999999998765433221 1234567899999876 558999999999999999998 99999888777777776
Q ss_pred HhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 309 LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 309 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
..+.... . ...+++.+.+||.+||+.||.+||++++++.
T Consensus 238 ~~~~~~~-~--~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELE-R--PRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCC-C--CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6553221 1 1247899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=325.74 Aligned_cols=252 Identities=26% Similarity=0.381 Sum_probs=199.0
Q ss_pred ccceeecceeccccCeEEEEEEE-----CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-
Q 013201 93 RQFYTLGKELGRGQFGITYLCTE-----NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED- 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 166 (447)
.++|++++.||+|+||.||+|.+ ..+++.||||.+.... .......+.+|+.++.++.+||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 35699999999999999999985 3467899999885432 223346788999999999779999999998754
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC--------------------------------------------------------
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG-------------------------------------------------------- 190 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~-------------------------------------------------------- 190 (447)
+..+++|||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 456899999999999999886531
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc---eee
Q 013201 191 -----------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV---YRD 256 (447)
Q Consensus 191 -----------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~ 256 (447)
.++...+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcchhhcCC
Confidence 257778889999999999999999999999999999995 445799999999876533211 112
Q ss_pred cCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHh
Q 013201 257 IVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334 (447)
Q Consensus 257 ~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 334 (447)
..++..|+|||.+. ..++.++||||||+++|+|++ |..||.....................+. .+++++.+++.+|
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~c 318 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDC 318 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCC--CCCHHHHHHHHHH
Confidence 34567899999875 558999999999999999997 9999977544333333333322222222 3678999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 013201 335 LIQDPKKRITSAEVLEH 351 (447)
Q Consensus 335 L~~dp~~R~t~~~~l~h 351 (447)
|+.||++|||+.++++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=317.24 Aligned_cols=253 Identities=31% Similarity=0.504 Sum_probs=208.8
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.++++++ |+||+++++++.++..+++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence 5677899999999999999999999999998755432 2234567889999999998 9999999999999999999999
Q ss_pred ccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-c
Q 013201 176 LCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-V 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~ 253 (447)
|+++ +|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++. +..+||+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~---~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC---CCcEEEeeeeeeEecCCCccc
Confidence 9975 88887766 357899999999999999999999999999999999999954 4469999999997765543 3
Q ss_pred eeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Q 013201 254 YRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD----------------- 314 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~----------------- 314 (447)
.....++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 334578899999998753 5789999999999999999999999887765554444321100
Q ss_pred --CCC-------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 315 --FES-------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 315 --~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
++. ..+..++.++.++|.+||.+||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000 0112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=312.63 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=202.0
Q ss_pred cceeecceeccccCeEEEEEEECCCCC----EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGN----SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+.|++.+.||+|+||+||+|++..++. .||+|.+... ........+.+|+.+++.+. |+||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-ST 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-CC
Confidence 458999999999999999999877776 4788877533 23344567889999999997 9999999999865 45
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.++++||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++. +..+||+|||++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~---~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS---PNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC---CCcEEECCCCceeec
Confidence 77999999999999998774 56999999999999999999999999999999999999954 346999999999876
Q ss_pred cCCCcee---ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 249 DEGKVYR---DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 249 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
....... ...+++.|+|||.+. ..++.++|||||||++|||++ |..||...........+..+.. .+. ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~ 236 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-LPQ--PPIC 236 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CCC--CccC
Confidence 5332211 224567899999875 458999999999999999998 8999987776666655544332 222 2347
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.++.++|.+||..||++||++.+++.
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=312.46 Aligned_cols=246 Identities=20% Similarity=0.329 Sum_probs=208.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|++.+.||.|+||.||+|.+.. +..+++|.+.... ......+.+|+.+++.++ |+||+++++++.+...+++|
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEEE
Confidence 459999999999999999999987 8899999875432 334567889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+|+||||+||+++. +..+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~---~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE---DLVCKVADFGLARLIKED 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC---CceEEEccccchhhcCCc
Confidence 9999999999999763 45899999999999999999999999999999999999944 456999999999765433
Q ss_pred Cc-eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 252 KV-YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 252 ~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. .....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+.+..+..+. ..+. ...+++.+.
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~ 234 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-RMPC--PAKCPQEIY 234 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-cCCC--CCCCCHHHH
Confidence 21 12334567899999875 458899999999999999998 899998888777777776542 2222 235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013201 329 DLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++|.+||..||.+|||++++++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=320.85 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=199.8
Q ss_pred eecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 013201 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176 (447)
Q Consensus 97 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 176 (447)
.+++.+|.| |.||.+++..+++.||+|++.... ........+.+|+.+++.++ |+||+++++++.+.+..|++|||
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEec
Confidence 344444444 556666677789999999986542 23445678999999999998 99999999999999999999999
Q ss_pred cCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 177 CSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 177 ~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.+ ..+||+|||.+.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~---~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD---GKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---CceEEecCccceeecccccc
Confidence 9999999998764 458999999999999999999999999999999999999543 469999999886543221
Q ss_pred ------ceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--------
Q 013201 253 ------VYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF-------- 315 (447)
Q Consensus 253 ------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-------- 315 (447)
......++..|+|||++.. .++.++|||||||++|+|++|..||..............+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 1123467888999999854 47899999999999999999999998765544332222211100
Q ss_pred ----------------------CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 316 ----------------------ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 316 ----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.......++.++.+||.+||..||++|||++++|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000012356789999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=316.46 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=209.3
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|++.+.||+|+||.||+|++..+++.+|+|.+.... ......+.+.+|+.+++++. |+||+++++++.+.+.+++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence 567889999999999999999999999999886543 22334467788999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-c
Q 013201 176 LCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-V 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~ 253 (447)
|+. ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++. +..+||+|||++....... .
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~---~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR---DGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC---CCCEEEecCCcccccCCCccc
Confidence 997 5899999876 57999999999999999999999999999999999999954 4569999999987654432 2
Q ss_pred eeecCCccccccccccc-c-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC------------------
Q 013201 254 YRDIVGSAYYVAPEVLR-R-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV------------------ 313 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------------------ 313 (447)
.....++..|+|||.+. . .++.++||||||+++|+|++|..||...+..+.+..+.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 33446678899999875 3 588999999999999999999999988776655554432110
Q ss_pred CCCC-------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 314 DFES-------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 314 ~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.++. .....++..+.++|.+||..||++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 1112347789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=310.54 Aligned_cols=248 Identities=24% Similarity=0.406 Sum_probs=205.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCC---EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGN---SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+|++.+.||+|+||.||+|++..++. .+|+|.+.... .......+.+|+.++++++ ||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence 458999999999999999999865543 78999875422 2334567899999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++ .+..++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCcccccc
Confidence 9999999999999999775 4589999999999999999999999999999999999994 44579999999998765
Q ss_pred CCCce----eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 250 EGKVY----RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 250 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
..... ....++..|+|||.+. +.++.++|+||||+++|++++ |..||......+....+.++. ..+. ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLPA--PMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCCC--CCCC
Confidence 43211 1123356899999986 468999999999999999886 999999887777777766542 2222 2346
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.65 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=199.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCE----EEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNS----YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+.|++.+.||+|+||+||+|.+..++.. +++|.+... ........+..|+.+++++. ||||+++++++. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GAS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CCc
Confidence 3588999999999999999999877775 555554221 12233456778888999997 999999999875 456
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.++|+||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++ .+..+||+|||++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEEcCCccceec
Confidence 78999999999999999764 5689999999999999999999999999999999999994 4457999999999865
Q ss_pred cCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 249 DEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 249 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
..... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+.......+.+.++... ..+ ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL-AQP--QIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-CCC--CCC
Confidence 43321 22345777899999885 568999999999999999998 99999887776655555444322 211 236
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+..+.+++.+||..||.+|||+.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.25 Aligned_cols=240 Identities=27% Similarity=0.355 Sum_probs=196.2
Q ss_pred eeccccCeEEEEEEEC--CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 101 ELGRGQFGITYLCTEN--STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
.||+|+||.||+|.+. .++..||+|++... ......+.+.+|+.++++++ |+||+++++++. ....++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 4899999999999775 44567999987543 22344567899999999997 999999999885 457899999999
Q ss_pred CCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce-e-
Q 013201 179 GGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY-R- 255 (447)
Q Consensus 179 g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~-~- 255 (447)
+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++. +..+||+|||++......... .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN---QHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC---CCcEEeccCCccccccCCccceec
Confidence 9999999875 456899999999999999999999999999999999999944 456999999999765433221 1
Q ss_pred --ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 256 --DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 256 --~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
...+++.|+|||++. ..++.++||||||+++|++++ |..||......+....+..+... ..+ ..+++++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL-DCP--AECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-CCC--CCCCHHHHHHH
Confidence 123357899999876 458899999999999999996 99999988877777666655322 211 24689999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 013201 332 RKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~ 350 (447)
.+||..||++||++.++.+
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=312.66 Aligned_cols=252 Identities=27% Similarity=0.468 Sum_probs=208.7
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC--ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV--NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
+|.+.+.||+|+||.||++++..++..+++|++...... .......+.+|+.++++++ ||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence 488999999999999999999888777777766432221 1223445678999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 173 VMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ..+||+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeec
Confidence 9999999999888764 346899999999999999999999999999999999999953 24999999998765
Q ss_pred cCCC-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 249 DEGK-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 249 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.... ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+..+..... ...++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence 4432 233457899999999875 4578899999999999999999999987776666666655432221 1246889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
+.++|.+||..||++||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.28 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=200.2
Q ss_pred cceeecceeccccCeEEEEEEECCCC--------------CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTG--------------NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--------------~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 159 (447)
++|++.+.||+|+||.||+|++..++ ..||+|.+... ........+.+|++++++++ |+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLK-NPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence 56999999999999999999875432 35899987543 22344567899999999998 999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCchHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceE
Q 013201 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQG------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFL 227 (447)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nil 227 (447)
+++++...+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886532 3678889999999999999999999999999999999
Q ss_pred eecCCCCCceEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh--CCCCCCCCCH
Q 013201 228 LSNKDGGAMLKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS--GVPPFWAETE 301 (447)
Q Consensus 228 l~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt--g~~pf~~~~~ 301 (447)
++. +..+||+|||++......... ....++..|+|||++. +.++.++|||||||++|+|++ |..||...+.
T Consensus 162 l~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 VGN---HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EcC---CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 954 446999999998765433221 2234567899999875 568999999999999999988 6788887766
Q ss_pred HHHHHHHHh---C-CCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 302 KGIFDAILK---G-GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 302 ~~~~~~i~~---~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+....+.. . ...........+++.+.+||.+||+.||++||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 655544322 1 111111112246889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=307.36 Aligned_cols=242 Identities=25% Similarity=0.357 Sum_probs=205.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||.|+||.||+|... |+.||+|.+.... ....++.+|+.+++.+. |+||+++++++.+....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccch----hHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence 45899999999999999999865 7899999885432 14577899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++. +..+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~---~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE---DLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC---CCCEEEcccccccccccc
Confidence 99999999999998765 6999999999999999999999999999999999999954 446999999999876432
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.. ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.......+...+..+.. ... ...+++.+.+
T Consensus 156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~ 230 (256)
T cd05039 156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-MEA--PEGCPPEVYK 230 (256)
T ss_pred cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCC--ccCCCHHHHH
Confidence 22 334566799999876 558889999999999999997 9999988887777666655422 111 1246899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013201 330 LVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~ 350 (447)
+|.+||..+|++||++.++++
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.97 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=205.2
Q ss_pred ccceeecceeccccCeEEEEEEECCC-------CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENST-------GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
..+|++++.||+|+||.||+|++... +..+|+|.+... ........+.+|+.+++++.+||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 35699999999999999999986432 236899976432 223345678899999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
..+..++||||+++|+|.+++.+.. .++...+..++.|++.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 9999999999999999999987632 367788899999999999999999999999999999995
Q ss_pred cCCCCCceEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 304 (447)
. +..+||+|||++......... ....++..|+|||++. ..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus 169 ~---~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 169 E---DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred C---CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 4 446999999999765443211 1233456799999885 458899999999999999998 8999998888777
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
...+..+... .. ...++.++.+||.+||+.+|.+||++.+++++
T Consensus 246 ~~~~~~~~~~-~~--~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHRM-DK--PANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCCC-CC--CCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7776654322 11 12468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=309.79 Aligned_cols=247 Identities=22% Similarity=0.404 Sum_probs=205.0
Q ss_pred ceeecceeccccCeEEEEEEECCCCC---EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGN---SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
.|++.+.||+|+||.||+|.+..++. .||+|.+.+. ........+..|+.+++++. ||||+++++++.++..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCceE
Confidence 48999999999999999999887665 5999987542 23445678999999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+||||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++ .+..+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~---~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---CCCcEEECCCcccccccc
Confidence 999999999999988764 5589999999999999999999999999999999999994 445799999999876543
Q ss_pred CCce---eecC---Cccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 251 GKVY---RDIV---GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 251 ~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
.... .... ++..|+|||.+. ..++.++|||||||++|||++ |..||+..........+... ...+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~--~~~ 235 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPP--PMD 235 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCC--ccc
Confidence 2211 1111 245799999986 458999999999999999886 99999988877777766543 22222 235
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++..+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=308.61 Aligned_cols=248 Identities=23% Similarity=0.399 Sum_probs=205.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCC---EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGN---SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+.|+..+.||+|+||.||+|++..++. .+|+|.+.... .......+.+|+.+++++. |+||+++.+++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence 458889999999999999999876655 68999774321 2334567889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|+||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++ .+..+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCccceecc
Confidence 9999999999999998764 5689999999999999999999999999999999999995 44569999999987654
Q ss_pred CCCc--ee--ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 250 EGKV--YR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 250 ~~~~--~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
.... .. ...++..|+|||++. +.++.++|||||||++|+|++ |..||+..+..+....+..+.. . +....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~-~--~~~~~~ 235 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-L--PAPMDC 235 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC-C--CCCCCC
Confidence 3221 11 122345799999876 458899999999999999997 9999998888777777765432 1 122246
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.++.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.70 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=201.6
Q ss_pred ceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 95 FYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+|++.+.||+|+||.||+|++.. ....+++|.+.... .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 37889999999999999998753 23568888775332 2334567889999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCc
Q 013201 170 VHLVMELCSGGELFDKIIAQ------------------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPEN 225 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~N 225 (447)
.++|+||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999988642 247788999999999999999999999999999999
Q ss_pred eEeecCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCC
Q 013201 226 FLLSNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAET 300 (447)
Q Consensus 226 ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 300 (447)
||++. +..+||+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+..
T Consensus 158 ill~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAE---GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcC---CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99944 45799999999876533221 12234567899999875 458999999999999999998 999998887
Q ss_pred HHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 301 EKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 301 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
...+...+..+ ..... ...++.++.++|.+||+.||++||+++++++
T Consensus 235 ~~~~~~~~~~~-~~~~~--~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTG-YRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCC-CCCCC--CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 77766665543 22222 2357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=306.51 Aligned_cols=246 Identities=27% Similarity=0.428 Sum_probs=207.9
Q ss_pred eeecceeccccCeEEEEEEECCCC----CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTG----NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~----~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+++.+.||.|+||.||+|++..++ ..+|+|.+.... .......+.+|+.+++.+. |+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeE
Confidence 356789999999999999998766 899999884432 2225678899999999995 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+||||+++++|.+++..... +++..+..++.|++.||.|||+.|++|+||||+||+++. ...++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~---~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE---NLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc---CCeEEEcccCCceecc
Confidence 99999999999999977554 999999999999999999999999999999999999954 4479999999998765
Q ss_pred CCCceee--cCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKVYRD--IVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~~~~--~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
....... ..+++.|+|||.+. ..++.++||||||+++|+|++ |..||...+.......+..+...... ..++.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCH
Confidence 5432221 34778999999885 458999999999999999998 88999888777777777665433222 23789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.+++.+||..||++|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.46 Aligned_cols=254 Identities=29% Similarity=0.453 Sum_probs=200.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-------
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED------- 166 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------- 166 (447)
..|+..+.||+||||.||+++++-+|+.||||+|.... .......+.+|+.+|.+|+ |||||+++..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCcccc
Confidence 44788899999999999999999999999999996543 4455677899999999998 9999998754300
Q ss_pred -----------------------------------------------------------------------C--------
Q 013201 167 -----------------------------------------------------------------------R-------- 167 (447)
Q Consensus 167 -----------------------------------------------------------------------~-------- 167 (447)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeEEEEEeccCCCchHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 013201 168 ---------------------------------QSVHLVMELCSGGELFDKIIAQGHY-TEKAAAALCRAIVNVVHHCHF 213 (447)
Q Consensus 168 ---------------------------------~~~~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~i~~qil~~l~~lH~ 213 (447)
..+||-||||+..+|.+++.++... ....++.++++|++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 1368999999886666666555443 477899999999999999999
Q ss_pred cCcEeecCCCCceEeecCCCCCceEEecCCCceecc-------------------CCCceeecCCcccccccccccc---
Q 013201 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-------------------EGKVYRDIVGSAYYVAPEVLRR--- 271 (447)
Q Consensus 214 ~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~--- 271 (447)
.|||||||||.||+++. ...|||+|||+|.... +....++.+||--|+|||++.+
T Consensus 716 ~giIHRDLKP~NIFLd~---~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDS---RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred CceeeccCCcceeEEcC---CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99999999999999954 4469999999998621 0113445799999999999852
Q ss_pred -cCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 013201 272 -SYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 272 -~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
.|+.|+|||||||||+||+. ||...-+ ..++..+.++.++.+..-+..--+.-..+|++||+.||.+||||.|+|
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 59999999999999999996 5754433 345566666665555222222334567899999999999999999999
Q ss_pred cCCCccC
Q 013201 350 EHPWMRE 356 (447)
Q Consensus 350 ~h~~~~~ 356 (447)
++.||--
T Consensus 870 ~s~llpp 876 (1351)
T KOG1035|consen 870 NSELLPP 876 (1351)
T ss_pred hccCCCc
Confidence 9999853
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=312.20 Aligned_cols=240 Identities=18% Similarity=0.249 Sum_probs=192.8
Q ss_pred ceeccccCeEEEEEEECCCCCE-------EEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 100 KELGRGQFGITYLCTENSTGNS-------YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~-------~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
+.||.|+||.||+|.+..++.. +++|.+... .....+.+.+|+.+++.+. ||||+++++++..+...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 4699999999999998665443 777766332 1233467888999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC-----CCceEEecCCCce
Q 013201 173 VMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG-----GAMLKATDFGLSV 246 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~-----~~~vkl~Dfg~a~ 246 (447)
||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++. ...++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999997754 5899999999999999999999999999999999999976542 2348999999987
Q ss_pred eccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCC-CCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGV-PPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
..... ....+++.|+|||++.+ .++.++||||||+++|+|++|. .||.......... +......++. ..
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPA----PK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCC----CC
Confidence 55432 23568899999999864 4788999999999999999985 6665554443332 3333333332 24
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+.++.+||.+||+.||++|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=313.00 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=205.5
Q ss_pred ccceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.+.|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++++. ||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence 3569999999999999999998753 67889999875332 2334567889999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCc
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG----------------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPEN 225 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~----------------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~N 225 (447)
...++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999987532 36788899999999999999999999999999999
Q ss_pred eEeecCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCC
Q 013201 226 FLLSNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAET 300 (447)
Q Consensus 226 ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 300 (447)
|+++ .+..+||+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEec---CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9994 445699999999876543321 11234567799999875 568999999999999999997 889998888
Q ss_pred HHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 301 EKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 301 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
..+....+..+.... .+ ..++.++.+||.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~-~~--~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLS-CP--DNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCC-CC--CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 777777766554321 11 246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=325.77 Aligned_cols=257 Identities=30% Similarity=0.503 Sum_probs=217.5
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|..++.||-|+||+|.+++...|...||+|.+.|...........++.|-.||.... ++-||+|+..|+|++.+|+|||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEEEe
Confidence 778899999999999999999999999999998876666666778889999999887 7899999999999999999999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec-------
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI------- 248 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~------- 248 (447)
|++||++-.+|.+.+-|.|..++.|+..+..|+++.|..|+|||||||+|||| |.+++|||.|||++.-+
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccccc
Confidence 99999999999999999999999999999999999999999999999999999 56668999999997532
Q ss_pred --cCCC----------------------------------ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh
Q 013201 249 --DEGK----------------------------------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS 291 (447)
Q Consensus 249 --~~~~----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt 291 (447)
.++. .-...+||+.|+|||++. .+|+..+|+||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 1100 001257999999999986 569999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCC---HHHHhcCCCccCC
Q 013201 292 GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRIT---SAEVLEHPWMREG 357 (447)
Q Consensus 292 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~h~~~~~~ 357 (447)
|++||-..+..+...++..-...+..+.-..+|+++.+||.++.. +++.|.. ++++-.||||+..
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 999998887766555544332223333344689999999988654 6777764 5679999999864
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=306.50 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=202.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.++++++ |+||+++++++. ....|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCCcEE
Confidence 456999999999999999999876 566799998754322 3457889999999997 999999999875 456889
Q ss_pred EEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. +..++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~---~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD---GLVCKIADFGLARLIED 154 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC---CceEEeCCceeeeeccC
Confidence 99999999999998763 35899999999999999999999999999999999999954 45699999999976544
Q ss_pred CCce--eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKVY--RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.+..+....+..+. ..+. ....+..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~ 231 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RMPC--PQDCPIS 231 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCC--CCcCCHH
Confidence 3211 1234566899999875 458899999999999999999 899998888777777765542 2221 2246889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.+|+.+||.+||++|||++++.+
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=305.76 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=200.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEE-EeCCeEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAY-EDRQSVHL 172 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~~~~~~l 172 (447)
+.|++.+.||+|+||.||++... +..+|+|.+... ...+.+.+|+.++++++ |+|++++++++ ..++..|+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence 35899999999999999999765 778999987432 23467889999999997 99999999875 45667899
Q ss_pred EEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||+++++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+||+++. +..+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC---CCcEEecCCccceeccc
Confidence 999999999999987654 3789999999999999999999999999999999999954 44699999999876543
Q ss_pred CCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ....++..|+|||++.+ .++.++|||||||++|+|++ |..||...........+..+... .....+++.+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHHHH
Confidence 22 23345678999998864 58899999999999999997 99999888777777666554221 11235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013201 329 DLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++|.+||..||++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=306.35 Aligned_cols=242 Identities=26% Similarity=0.400 Sum_probs=201.8
Q ss_pred ceeccccCeEEEEEEECC-CCC--EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 013201 100 KELGRGQFGITYLCTENS-TGN--SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~-~~~--~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 176 (447)
+.||+|++|.||+|.+.. .+. .+|+|.+...... ...+.+.+|+.++++++ ||||+++++++.+ ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999865 333 6899988654332 45678899999999998 9999999999988 899999999
Q ss_pred cCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc-
Q 013201 177 CSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV- 253 (447)
Q Consensus 177 ~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~- 253 (447)
+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.+ ..+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD---DKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC---CEEEeccccccccccccccc
Confidence 99999999998764 68999999999999999999999999999999999999544 5799999999987644211
Q ss_pred ---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 254 ---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 254 ---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.....++..|+|||.+. ..++.++|||||||++|+|++ |..||...+..+....+.........+ ..++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERP--EACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCC--ccCCHHHH
Confidence 11245778899999886 458999999999999999998 999998887777777666533322222 24688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 013201 329 DLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+++.+||..+|++||++.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=305.42 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=200.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++...||+|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++++. |+|++++++++. .+..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCCcEEE
Confidence 5699999999999999999987654 468999775432 23467889999999997 999999999875 4568899
Q ss_pred EeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++ .+..++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~---~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCeEEECCCccceEccCC
Confidence 99999999999997643 478999999999999999999999999999999999994 4456999999999766443
Q ss_pred Cce--eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 252 KVY--RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 252 ~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
... ....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+....+..+. ..+. ...++..+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~ 232 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RMPC--PQGCPESL 232 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CcccCHHH
Confidence 211 2234667899999875 458899999999999999999 999999888777777665542 2221 22478899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+++.+||..||.+||+++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.02 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=218.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----- 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----- 166 (447)
..+.|++.+.||.|.+|.||+++++.+++..|+|+... +....++++.|.++|+.+.+|||++.++++|..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~----~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP----TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC----CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34569999999999999999999999999999997643 234457788999999999999999999999853
Q ss_pred CCeEEEEEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
++.+|||||||.||+.-|+++. ..++.|..++.|++.++.||.+||.+.++|||||=.|||++.++ .|||+|||+
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~---~VKLvDFGv 169 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA---EVKLVDFGV 169 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC---cEEEeeeee
Confidence 5789999999999999998876 35699999999999999999999999999999999999996655 499999999
Q ss_pred ceeccCCC-ceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC
Q 013201 245 SVFIDEGK-VYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES 317 (447)
Q Consensus 245 a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 317 (447)
+.++..+. ...+.+|||+|||||++. ..|+..+|+||||++..||.-|.+|+-+......+-.|-++. +...
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkL 248 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKL 248 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Cccc
Confidence 98876542 345679999999999984 237889999999999999999999998877655554443331 1112
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
..+...++++.++|..||.+|..+||+..++|+|||+++.
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 2234568999999999999999999999999999999954
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=305.58 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=203.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.++||+|+||.||+|... +++.||+|.+.... .....+.+|+.++++++ |+||+++++++. .+.+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcEE
Confidence 466999999999999999999865 57889999875432 23467889999999997 999999999874 457899
Q ss_pred EEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++ .+..++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCcceeecCC
Confidence 99999999999988763 3589999999999999999999999999999999999994 445699999999976653
Q ss_pred CCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
... .....++..|+|||++. ..++.++||||||+++|+|++ |+.||.+.+..+....+..+. ..+ ....++.+
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~ 231 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-RMP--RPDNCPEE 231 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-CCC--CCCCCCHH
Confidence 221 12335667899999886 458899999999999999999 999999888777776665442 222 12346889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.++|.+||..+|++||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=309.22 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=193.4
Q ss_pred eeecceeccccCeEEEEEE----ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCe
Q 013201 96 YTLGKELGRGQFGITYLCT----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQS 169 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~ 169 (447)
|++.+.||+|+||+||++. ...++..||+|.+.... .......+.+|+.++++++ ||||+++++++.. ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCce
Confidence 4999999999999998765 34568899999875432 2234567889999999997 9999999998765 346
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++. +..+||+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN---DRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC---CCcEEEeecccccccC
Confidence 89999999999999988764 6999999999999999999999999999999999999954 4569999999998665
Q ss_pred CCCc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH--HH------------HHHHHh
Q 013201 250 EGKV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK--GI------------FDAILK 310 (447)
Q Consensus 250 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~------------~~~i~~ 310 (447)
.... .....++..|+|||++. ..++.++||||||+++|+|++|..||...... +. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 4322 11234567799999886 55899999999999999999999998643221 00 001111
Q ss_pred CCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 311 GGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 311 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.....+. ...++.++.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPC--PKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCC--CCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111111 1246889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=307.24 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=204.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCC----EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGN----SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..|++.+.||+|+||.||+|.++.++. .+|+|.+.+.. .......+.+|+.+++++. ||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cc
Confidence 458999999999999999999877665 58888765432 2344567889999999997 9999999999887 78
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||++...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~---~~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT---PQHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcC---CCeEEECCCcccccc
Confidence 89999999999999998874 46899999999999999999999999999999999999954 446999999999876
Q ss_pred cCCCceee---cCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 249 DEGKVYRD---IVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 249 ~~~~~~~~---~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
........ ..++..|+|||.+. ..++.++|+||||+++||+++ |..||.+....++...+..+.. .+.+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~ 236 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQP--PIC 236 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCCC--CCC
Confidence 54322111 22356799999875 568899999999999999998 9999998887777776665432 2222 236
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+..+.+++.+||..||.+||++.++++
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=304.39 Aligned_cols=246 Identities=23% Similarity=0.355 Sum_probs=206.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|.+. +++.+|+|.+.... .....+.+|+.+++++. |+||+++++++......++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceEE
Confidence 466999999999999999999976 45789999875432 23567889999999998 9999999999999899999
Q ss_pred EEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++. +..+||+|||++.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~---~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE---NLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC---CCCEEECccccceeccc
Confidence 999999999999997653 6899999999999999999999999999999999999944 45699999999876643
Q ss_pred CCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
... .....++..|+|||.+. ..++.++||||||+++|+|++ |+.||.+......+..+..+.. .+.+ ...+.+
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~ 232 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-MPRP--PNCPEE 232 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC--CCCCHH
Confidence 211 11223456899999886 458889999999999999998 9999988887777777765422 1111 235889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.+++.+||..+|++||+++++++
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=311.43 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=199.3
Q ss_pred ccceeecceeccccCeEEEEEEECC----------------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS----------------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 156 (447)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+... ........+.+|+.+++.++ |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCC
Confidence 4569999999999999999986442 3446899987533 22344578899999999997 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCc
Q 013201 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG-----------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPEN 225 (447)
Q Consensus 157 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~N 225 (447)
|+++++++...+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999987643 36677899999999999999999999999999999
Q ss_pred eEeecCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh--CCCCCCCC
Q 013201 226 FLLSNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS--GVPPFWAE 299 (447)
Q Consensus 226 ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt--g~~pf~~~ 299 (447)
||++. +..++|+|||++........ .....+++.|++||... +.++.++|||||||++|||++ |..||...
T Consensus 161 ili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGK---NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcC---CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99954 44699999999876543321 11234467899999754 568999999999999999998 77999877
Q ss_pred CHHHHHHHHHh---C-CCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 300 TEKGIFDAILK---G-GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 300 ~~~~~~~~i~~---~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+..+....... . ......+....+++.+.+|+.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555443211 1 011111111246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=303.27 Aligned_cols=245 Identities=27% Similarity=0.453 Sum_probs=205.3
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
.|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++++. ||||+++++++......++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEEE
Confidence 4889999999999999999876 467899998754322 2456889999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 175 ELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 175 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||+.+++|.+++... +.+++..+..++.|++.+|.|||+.+++||||||+||+++ .+..+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecccCcc
Confidence 999999999998764 4589999999999999999999999999999999999994 444699999999876543321
Q ss_pred --eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 254 --YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 254 --~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+.++...... ...+..+.+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYE 232 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHH
Confidence 11234567899999876 568889999999999999998 99999888877777777655332221 236889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h 351 (447)
|+.+||+.+|++|||+.+++++
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=305.35 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=191.7
Q ss_pred ceeccccCeEEEEEEECC--CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 013201 100 KELGRGQFGITYLCTENS--TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELC 177 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 177 (447)
+.||+|+||.||+|.... ++..+|+|.+.... .......+.+|+.++++++ ||||+++++++.+...+++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence 368999999999998653 45678999774432 2233457888999999997 999999999999999999999999
Q ss_pred CCCchHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 178 SGGELFDKIIAQG-----HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 178 ~g~~L~~~l~~~~-----~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
++|+|.+++.... ..++..+..++.|++.||.|||+.|++||||||+||+++. ...+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~---~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC---CCcEEECCccccccccCcc
Confidence 9999999987532 3567788899999999999999999999999999999954 4579999999987543322
Q ss_pred ce---eecCCcccccccccccc--------cCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCc
Q 013201 253 VY---RDIVGSAYYVAPEVLRR--------SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG-GVDFESEP 319 (447)
Q Consensus 253 ~~---~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~ 319 (447)
.. ....|++.|+|||++.+ .++.++||||||+++|||++ |..||......+.......+ ......+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 11 23467888999998753 25789999999999999996 99999877665544433322 22222222
Q ss_pred c-ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 320 W-LLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 320 ~-~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
. ...++.+.+++.+|| .+|++|||+++|+.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1 235788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.79 Aligned_cols=242 Identities=25% Similarity=0.346 Sum_probs=199.2
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++++. ||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence 46899999999999865 68899999875432 2333456889999999997 99999999999999999999999999
Q ss_pred CchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce--ee
Q 013201 180 GELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY--RD 256 (447)
Q Consensus 180 ~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~--~~ 256 (447)
++|.+++... ..+++..+..++.|++.+|.|+|++|++||||||+||+++ .+..+||+|||++......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceeccccccccCCC
Confidence 9999988764 4588999999999999999999999999999999999994 4456999999998765433211 12
Q ss_pred cCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHh
Q 013201 257 IVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334 (447)
Q Consensus 257 ~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 334 (447)
..++..|+|||++. +.++.++||||||+++|++++ |..||...........+..+... . ....++..+.+++.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-S--CPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCCCHHHHHHHHHH
Confidence 24456799999886 458889999999999999998 99999888777666666554221 1 1224789999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 013201 335 LIQDPKKRITSAEVLEH 351 (447)
Q Consensus 335 L~~dp~~R~t~~~~l~h 351 (447)
|..+|++||++.++++.
T Consensus 231 l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 231 WDYKPENRPKFSELQKE 247 (250)
T ss_pred cccCcccCCCHHHHHHH
Confidence 99999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=308.58 Aligned_cols=239 Identities=16% Similarity=0.178 Sum_probs=190.6
Q ss_pred eeccccCeEEEEEEECCC------------------------CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC
Q 013201 101 ELGRGQFGITYLCTENST------------------------GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~~~------------------------~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~ 156 (447)
.||+|+||.||+|+...+ ...|++|.+... .......+.+|+.+++.+. |||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCC-CCC
Confidence 699999999999975322 235778876432 1223456788999999997 999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC---
Q 013201 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD--- 232 (447)
Q Consensus 157 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~--- 232 (447)
|+++++++.+....++||||+++|+|..++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999988876 45689999999999999999999999999999999999996432
Q ss_pred -CCCceEEecCCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHh-hCCCCCCCCCHHHHHHHH
Q 013201 233 -GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILL-SGVPPFWAETEKGIFDAI 308 (447)
Q Consensus 233 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i 308 (447)
....+||+|||++...... ....++..|+|||.+.+ .++.++||||||+++|||+ +|..||......+....+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 2335899999988654322 23467889999998853 4789999999999999985 699999877655443322
Q ss_pred HhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 309 LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 309 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
......+. ..++.+.++|.+||+.+|++|||+.++|++
T Consensus 235 -~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 -EKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222222 245789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=308.53 Aligned_cols=250 Identities=22% Similarity=0.395 Sum_probs=207.3
Q ss_pred cceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 94 QFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+.|++.+.||+|+||.||+|+.+. +.+.+++|.+.... .......+.+|+.++++++ |+||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 458999999999999999999754 34678888764321 2224567899999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEE
Q 013201 169 SVHLVMELCSGGELFDKIIAQG---------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
..|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++. ...++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~---~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS---QREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC---CCcEEE
Confidence 9999999999999999998765 6899999999999999999999999999999999999954 346999
Q ss_pred ecCCCceeccCCC--ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCC
Q 013201 240 TDFGLSVFIDEGK--VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDF 315 (447)
Q Consensus 240 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 315 (447)
+|||++....... ......++..|+|||.+. ..++.++||||||+++|+|++ |..||........+..+..+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999986543221 223346678899999875 457889999999999999998 889998877777777666554433
Q ss_pred CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 316 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
... ..++..+.++|.+||..||.+||++.+++.+
T Consensus 239 ~~~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PVP--EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 322 2478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=306.95 Aligned_cols=249 Identities=19% Similarity=0.219 Sum_probs=204.2
Q ss_pred ccceeecceeccccCeEEEEEEECC----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-C
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED-R 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~ 167 (447)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+++++. |+||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 4569999999999999999999876 3578888876432 23445677889999999996 9999999998765 5
Q ss_pred CeEEEEEeccCCCchHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEE
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ--------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
...++++||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++ ....+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEE
Confidence 7789999999999999998763 3588999999999999999999999999999999999994 4457999
Q ss_pred ecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCC
Q 013201 240 TDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVD 314 (447)
Q Consensus 240 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 314 (447)
+|||+++.+...... ....++..|+|||++. ..++.++||||||+++|++++ |..||...+..++...+..+ ..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CC
Confidence 999999765433211 1234567899999876 458999999999999999999 99999887776666555543 22
Q ss_pred CCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 315 FESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 315 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.. ...+++++.+++.+||..||++|||+.++++
T Consensus 238 ~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222 2346899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.88 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=207.9
Q ss_pred eeecceeccccCeEEEEEEECC-CCCEEEEEEeecccc-------CChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 96 YTLGKELGRGQFGITYLCTENS-TGNSYACKSILKRKL-------VNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
|++.+.||+|+||.||+|.+.. +++.+|+|.+..... .......++.+|+.++.+.-+||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 8889999999999999999987 688999998754321 12233456778999887644599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecC
Q 013201 168 QSVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
+..++||||++|++|.+++.. ...+++..++.++.|++.+|.|||+ .|++|+||+|+||+++ ....+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCCcEEEecc
Confidence 999999999999999888743 3458999999999999999999996 7899999999999994 4456999999
Q ss_pred CCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 243 GLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 243 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
|++.............|+..|+|||.+. +.++.++|+||||+++|+|++|..||...........+..+..... ...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 236 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--PEG 236 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--Ccc
Confidence 9998766554445567899999999886 4488999999999999999999999988777666666655543321 122
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+++.+.++|.+||+.||++||++.|+.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 468999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.32 Aligned_cols=199 Identities=34% Similarity=0.567 Sum_probs=179.6
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC------e
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ------S 169 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~------~ 169 (447)
|...+.||+||||.||+++++.+|+.||||.+.+.. ....++..-+|+++|++|+ |+|||+++++-+... .
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccccc
Confidence 677889999999999999999999999999886543 4566788899999999998 999999998866543 4
Q ss_pred EEEEEeccCCCchHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC-CCCceEEecCCCc
Q 013201 170 VHLVMELCSGGELFDKIIAQ---GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD-GGAMLKATDFGLS 245 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~~~vkl~Dfg~a 245 (447)
..+|||||.||+|...|.+. ..+++.+++.++..+..||.|||++||+||||||.||++.... +...-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 67999999999999999763 4599999999999999999999999999999999999996543 5667899999999
Q ss_pred eeccCCCceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCC
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFW 297 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~ 297 (447)
+.+.++..+.+.+||+.|.+||++. +.|+.-+|.|||||++|+++||..||.
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9999999999999999999999987 568999999999999999999999984
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.33 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=203.0
Q ss_pred cceeecceeccccCeEEEEEEECCC---CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENST---GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+.|.+.+.||+|+||.||+|.+... ...+++|..... ......+.+.+|+.+++++. ||||+++++++.+ ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CCc
Confidence 4589999999999999999987644 456888976432 12345578899999999997 9999999999876 456
Q ss_pred EEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++. ...+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~---~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS---PDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec---CCCeEEccCceeeecc
Confidence 79999999999999997744 5899999999999999999999999999999999999954 4469999999987665
Q ss_pred CCCcee--ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKVYR--DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
...... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+....+..+... . ....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 235 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-P--MPPNCPP 235 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-C--CCCCCCH
Confidence 432222 223456799999875 458899999999999999986 99999888877777666554322 1 1235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++.++|.+||..+|.+|||+.+++..
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.90 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=199.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.||.|+||.||+|.+.. ++.||+|.+..... ......+.+|+.+++++. |+||+++++++.+....++||||+.|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999887 99999998754322 235577899999999997 99999999999999999999999999
Q ss_pred CchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce---e
Q 013201 180 GELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY---R 255 (447)
Q Consensus 180 ~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~---~ 255 (447)
++|.+++... ..+++..+..++.+++.+|.|||+++++||||||+||+++. +..+||+|||++......... .
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~---~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE---NNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC---CCcEEEeeccccccccCCcceeccc
Confidence 9999998764 46899999999999999999999999999999999999954 446999999998765432211 1
Q ss_pred ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHH
Q 013201 256 DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333 (447)
Q Consensus 256 ~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 333 (447)
...++..|+|||.+. +.++.++|+||||+++|+|++ |..||...........+.... .... ...++.++.++|.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMPA--PQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCCC--CccCCHHHHHHHHH
Confidence 123456799999876 458999999999999999999 889998877666666554432 2211 23468899999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 013201 334 MLIQDPKKRITSAEVLE 350 (447)
Q Consensus 334 ~L~~dp~~R~t~~~~l~ 350 (447)
||..+|.+|||+.++++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=311.62 Aligned_cols=263 Identities=29% Similarity=0.447 Sum_probs=217.7
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChh----hHHHHHHHHHHHHhccCCCCeeEEEEEEE-
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ----DREDIKREIQIMQHLSGQQNIVEFRGAYE- 165 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 165 (447)
.+.++|-++.+||+|||+.||+|.+...++.||||+-...+..... -.+...+|..|.+.|. ||.||+++++|.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfsl 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFSL 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeeee
Confidence 3456799999999999999999999999999999975433221111 1234568999999998 999999999996
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM--GVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~--~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
+.+.+|-|+|||+|.+|.-+|+..+-+++.+++.|+.||+.||.||.+. .|+|-||||.|||+.+....+.|||.|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 5678899999999999999999999999999999999999999999975 59999999999999887778899999999
Q ss_pred CceeccCCCc--------eeecCCccccccccccc-c----cCCCCCcchhHHHHHHHHhhCCCCCCCCC-HHHHHH--H
Q 013201 244 LSVFIDEGKV--------YRDIVGSAYYVAPEVLR-R----SYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFD--A 307 (447)
Q Consensus 244 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~--~ 307 (447)
+++.+.+... +....||-+|.+||++- + ..+.++||||+|||+|.++.|+.||.... ...++. .
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9998765422 23468999999999873 2 37889999999999999999999997543 233332 2
Q ss_pred HHh-CCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 308 ILK-GGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 308 i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
|++ ..+.|+.. +.++.++++||++||++--++|....++..||||.-
T Consensus 699 IlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 ILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 333 23444443 368999999999999999999999999999999975
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.33 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=197.5
Q ss_pred cceeecceeccccCeEEEEEEE----CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--
Q 013201 94 QFYTLGKELGRGQFGITYLCTE----NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR-- 167 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 167 (447)
+.|++.+.||+|+||.||+|.. ..++..||+|.+... ........+.+|+.+++++. ||||+++.+++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence 4578999999999999999974 456889999987533 22344567899999999997 99999999998775
Q ss_pred CeEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
..+++||||++|++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+||+++. +..+||+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~---~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES---EHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC---CCCEEECCCcccc
Confidence 67899999999999999987653 5899999999999999999999999999999999999954 4469999999998
Q ss_pred eccCCCc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCC---------------HHHHHH
Q 013201 247 FIDEGKV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAET---------------EKGIFD 306 (447)
Q Consensus 247 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~---------------~~~~~~ 306 (447)
....... .....|+..|+|||++. ..++.++||||||+++|+|+++..|+.... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 6543321 12345677899999875 458899999999999999999876653211 011111
Q ss_pred HHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 307 AILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 307 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+..+ ...+ ....++..+.+||.+||+.||++||++.+++++
T Consensus 238 ~~~~~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEG-KRLP--RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcC-ccCC--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 22222 1121 123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=302.34 Aligned_cols=228 Identities=23% Similarity=0.359 Sum_probs=187.1
Q ss_pred ccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCchHH
Q 013201 105 GQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFD 184 (447)
Q Consensus 105 G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~ 184 (447)
|.+|.||+|++..+++.||+|.+.+.. ...+|...+.... ||||+++++++.+...+|+||||++||+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999986532 1223444444444 8999999999999999999999999999999
Q ss_pred HHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCCccccc
Q 013201 185 KIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV 264 (447)
Q Consensus 185 ~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~ 264 (447)
++.+...+++..+..++.|++.||.|||++||+||||||+||+++. +..++|+|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD---RGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC---CCCEEEecccchhccccc--cccCCcCcccc
Confidence 9988888999999999999999999999999999999999999954 446999999987655432 23345678899
Q ss_pred cccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCC
Q 013201 265 APEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI 343 (447)
Q Consensus 265 aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~ 343 (447)
|||.+. ..++.++|+||+|+++|+|++|..||...... .........+ ..+++.++++|.+||+.||++|+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIP--EWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCc--ccCCHHHHHHHHHHccCCHHHhc
Confidence 999886 45889999999999999999999887643221 0111111112 24788999999999999999999
Q ss_pred CH-----HHHhcCCCc
Q 013201 344 TS-----AEVLEHPWM 354 (447)
Q Consensus 344 t~-----~~~l~h~~~ 354 (447)
++ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 96 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.03 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=191.5
Q ss_pred ceeccccCeEEEEEEECC--CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 013201 100 KELGRGQFGITYLCTENS--TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELC 177 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 177 (447)
+.||+|+||.||+|.... ....+++|.+... ........+.+|+.+++.++ |+||+++++.+.....+|+||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeC
Confidence 368999999999996543 3456788866432 22334466789999999997 999999999999999999999999
Q ss_pred CCCchHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 178 SGGELFDKIIAQGH-----YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 178 ~g~~L~~~l~~~~~-----~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
++|+|.+++..... .++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC---CCcEEEeccccccccccch
Confidence 99999999876432 467788999999999999999999999999999999944 4569999999986543322
Q ss_pred c---eeecCCccccccccccc--------ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCc
Q 013201 253 V---YRDIVGSAYYVAPEVLR--------RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG-VDFESEP 319 (447)
Q Consensus 253 ~---~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 319 (447)
. .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......+.+..+.... ..++.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 12235677899999864 236789999999999999999 788998877666665554433 2222221
Q ss_pred -cccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 320 -WLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 320 -~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
...+++.+.+++..|| .||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 1246888999999999 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.04 Aligned_cols=240 Identities=18% Similarity=0.222 Sum_probs=190.6
Q ss_pred ceeccccCeEEEEEEECCC------------CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 100 KELGRGQFGITYLCTENST------------GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~------------~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
+.||+|+||.||+|+.... ...+++|.+... .......+.+|+.+++.+. ||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 4689999999999985422 235777865332 2334457788999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC----CCceEEecC
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG----GAMLKATDF 242 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~----~~~vkl~Df 242 (447)
...++||||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+|++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998888754 56899999999999999999999999999999999999965332 124899999
Q ss_pred CCceeccCCCceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHh-hCCCCCCCCCHHHHHHHHHhCCCCCCCCc
Q 013201 243 GLSVFIDEGKVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILL-SGVPPFWAETEKGIFDAILKGGVDFESEP 319 (447)
Q Consensus 243 g~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 319 (447)
|++...... ....|+..|+|||.+. ..++.++|||||||++|+|+ +|..||......+.. .+.........
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~-- 230 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT-- 230 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC--
Confidence 998654322 2356888999999875 45889999999999999998 588888766544332 23333222222
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..++++.+||.+||+.||.+||++.+|+.+
T Consensus 231 --~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 --PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.30 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=202.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|.+. .+..+|+|.+... ......+.+|+.+++++. |+||+++++.+.+ ..+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeEE
Confidence 466999999999999999999865 4567999977532 223567889999999997 9999999999887 78899
Q ss_pred EEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+||+++ ....+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceeeccC
Confidence 99999999999999763 3578889999999999999999999999999999999994 445799999999876543
Q ss_pred CCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
... .....++..|+|||.+. +.++.++|+|||||++|++++ |..||.+.+.......+..+. ..+ .....+.+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~ 231 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMP--RPENCPEE 231 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCC--CcccCCHH
Confidence 321 11234567799999886 458889999999999999999 999998887777666655442 222 22357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.+++.+||..+|++||++.++++
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=305.42 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=194.8
Q ss_pred cceeecceeccccCeEEEEEE----ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--C
Q 013201 94 QFYTLGKELGRGQFGITYLCT----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--R 167 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 167 (447)
+.|++.+.||+|+||.||+|. +..++..||+|.+... .......+.+|+.+++++. ||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 468999999999999999997 4457889999987432 2344567889999999997 9999999998643 4
Q ss_pred CeEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
..+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||+++ .+..+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---SENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---CCCeEEECCCcccc
Confidence 5689999999999999998764 4589999999999999999999999999999999999994 44569999999998
Q ss_pred eccCCCce----eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH---------------HHH
Q 013201 247 FIDEGKVY----RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKG---------------IFD 306 (447)
Q Consensus 247 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------------~~~ 306 (447)
........ ....++..|+|||++. ..++.++||||||+++|||++|..++....... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76443221 1123445699999886 458899999999999999999877654332110 011
Q ss_pred HHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 307 AILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 307 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+......++. ...++.++.+||.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLPA--PPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12222222221 2346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.68 Aligned_cols=237 Identities=19% Similarity=0.221 Sum_probs=190.5
Q ss_pred ceeccccCeEEEEEEECCCC----------CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 100 KELGRGQFGITYLCTENSTG----------NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~----------~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.++++++ ||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46999999999999998776 346777553221 12577889999999997 9999999999887 77
Q ss_pred EEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC----CCCceEEecCCC
Q 013201 170 VHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD----GGAMLKATDFGL 244 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~----~~~~vkl~Dfg~ 244 (447)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998766 789999999999999999999999999999999999996544 223699999999
Q ss_pred ceeccCCCceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 320 (447)
+...... ....++..|+|||++.+ .++.++||||||+++|+|++ |..||...+........... ...+.+
T Consensus 155 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~-- 228 (259)
T cd05037 155 PITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPMP-- 228 (259)
T ss_pred ccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCCC--
Confidence 8865442 23467788999999864 48899999999999999999 57888766543333322221 111111
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 --~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 --DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred --CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.81 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=199.4
Q ss_pred ceeccccCeEEEEEEECCCC------CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 100 KELGRGQFGITYLCTENSTG------NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~------~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.||.|+||.||+|++.... ..+|+|.+.+.. .......+.+|+.+++.+. ||||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 36899999999999986543 679999875431 1234567889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC--CCCceEEecCCC
Q 013201 174 MELCSGGELFDKIIAQ-------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD--GGAMLKATDFGL 244 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~~~vkl~Dfg~ 244 (447)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ ....+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998752 2378899999999999999999999999999999999997644 234799999999
Q ss_pred ceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCc
Q 013201 245 SVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEP 319 (447)
Q Consensus 245 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 319 (447)
+........ .....++..|+|||.+. +.++.++|||||||++|+|++ |..||...+..+....+..+.. +. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~--~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR-LQ--K 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc-cC--C
Confidence 876543221 12235678899999886 558999999999999999998 9999988777666665544321 11 1
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
...++..+.++|.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2247889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=301.22 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=193.5
Q ss_pred ceeccccCeEEEEEEECC---CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE-eCCeEEEEEe
Q 013201 100 KELGRGQFGITYLCTENS---TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE-DRQSVHLVME 175 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~~~lv~e 175 (447)
+.||+|+||.||+|.+.. ....+|+|.+... ......+.+.+|+.+++.++ ||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 468999999999998653 3457899976432 22344567889999999997 999999999765 5667899999
Q ss_pred ccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc-
Q 013201 176 LCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV- 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~- 253 (447)
|+.+++|.+++.+. ...++..+..++.||+.||.|||+.+++||||||+|||++. ...+||+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~---~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE---SFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC---CCcEEECCccccccccCCcce
Confidence 99999999998764 34677888999999999999999999999999999999944 45699999999875543211
Q ss_pred ----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 254 ----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 254 ----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.....++..|+|||.+. ..++.++|||||||++|||++ |.+||...........+..+.... .+ ..+++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL-QP--EYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC-CC--CcCCHHH
Confidence 12335677899999875 558899999999999999999 566777766666666665543221 11 2468899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+++.+||..+|++||++.++++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=299.11 Aligned_cols=240 Identities=27% Similarity=0.382 Sum_probs=199.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||++. .+++.+|+|.+... .....+.+|+.++++++ ||||+++++++..+ ..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-CcEEE
Confidence 459999999999999999986 46888999987432 23467889999999997 99999999998765 47899
Q ss_pred EeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++. +..+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~---~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE---DGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC---CCcEEECCCccceecccc
Confidence 99999999999997653 4789999999999999999999999999999999999944 446999999998764432
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
. .....+..|+|||.+. +.++.++|+||||+++|+|++ |..||...+..+....+.++.. .. ....++..+.+
T Consensus 154 ~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~ 228 (254)
T cd05083 154 V--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-ME--PPEGCPADVYV 228 (254)
T ss_pred C--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-CC--CCCcCCHHHHH
Confidence 1 2234467899999876 568899999999999999997 9999988887777776655422 22 12357899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 013201 330 LVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.+||+.+|.+||++++++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.91 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=215.6
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccC-----CCCeeEEEEE
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG-----QQNIVEFRGA 163 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~iv~~~~~ 163 (447)
.+.+..+|.+....|.|-||+|..|.+...|+.||||+|... +...+.=..|+.||++|.. --++++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 455678899999999999999999999999999999999653 3333445689999999973 3479999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 164 YEDRQSVHLVMELCSGGELFDKIIAQGH---YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 164 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
|...+++|||+|-+. .+|.+.|++.+. +....++.|+.|++.||..|-.+||+|.||||+|||++.. ..++|||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~--k~iLKLC 579 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES--KNILKLC 579 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC--cceeeec
Confidence 999999999999884 589999988654 8889999999999999999999999999999999999643 3579999
Q ss_pred cCCCceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC-
Q 013201 241 DFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE- 318 (447)
Q Consensus 241 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~- 318 (447)
|||.|....+... +.+.-+..|+|||++.+ .|+...|+||.||+||||+||+..|.+.+.+.++...+...-.++..
T Consensus 580 DfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 580 DFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 9999988876543 44556778999998765 69999999999999999999999999999988887655422211110
Q ss_pred ---------cc----------------------------------------------ccCChHHHHHHHHhcccCCCCCC
Q 013201 319 ---------PW----------------------------------------------LLISDSAKDLVRKMLIQDPKKRI 343 (447)
Q Consensus 319 ---------~~----------------------------------------------~~~s~~~~~li~~~L~~dp~~R~ 343 (447)
.+ ..+-..+++|+.+||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 00 00124688999999999999999
Q ss_pred CHHHHhcCCCccC
Q 013201 344 TSAEVLEHPWMRE 356 (447)
Q Consensus 344 t~~~~l~h~~~~~ 356 (447)
|..++|+||||..
T Consensus 739 t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 739 TVNQALKHPFITE 751 (752)
T ss_pred CHHHHhcCCcccC
Confidence 9999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=326.80 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=176.3
Q ss_pred ccceeecceeccccCeEEEEEEECCC----CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEE-----
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENST----GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA----- 163 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~----- 163 (447)
.+.|.+.+.||+|+||.||+|++..+ +..||+|.+.... ..+....| . +++.. +.++..++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e-~-l~~~~-~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE-R-VRRAC-PNSCADFVYGFLEPV 202 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH-H-HHhhc-hhhHHHHHHhhhccc
Confidence 45699999999999999999999988 9999999874321 11111111 1 11111 2222222111
Q ss_pred -EEeCCeEEEEEeccCCCchHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCcEeecCC
Q 013201 164 -YEDRQSVHLVMELCSGGELFDKIIAQGH--------------------YTEKAAAALCRAIVNVVHHCHFMGVMHRDLK 222 (447)
Q Consensus 164 -~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------------------~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlk 222 (447)
......++||+||+.+++|.+++..... ..+..+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456789999999999999998865421 1234567899999999999999999999999
Q ss_pred CCceEeecCCCCCceEEecCCCceeccCCC--ceeecCCcccccccccccc-----------------------cCCCCC
Q 013201 223 PENFLLSNKDGGAMLKATDFGLSVFIDEGK--VYRDIVGSAYYVAPEVLRR-----------------------SYGKEI 277 (447)
Q Consensus 223 p~Nill~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------------------~~~~~~ 277 (447)
|+|||++.+ ...+||+|||++.....+. .....+||+.|+|||.+.. .++.++
T Consensus 283 P~NILl~~~--~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFSEG--SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEeCC--CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999643 2469999999998654322 2345689999999996521 134467
Q ss_pred cchhHHHHHHHHhhCCCCCCCCCHHHHHHHH-HhCCCCC----------CCC-------ccccCChHHHHHHHHhcccCC
Q 013201 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAI-LKGGVDF----------ESE-------PWLLISDSAKDLVRKMLIQDP 339 (447)
Q Consensus 278 DiwslG~il~elltg~~pf~~~~~~~~~~~i-~~~~~~~----------~~~-------~~~~~s~~~~~li~~~L~~dp 339 (447)
|||||||+||||+++..++... ...+..+ ......+ ..+ ........+++||.+||++||
T Consensus 361 DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 9999999999999977665322 1112211 1111100 000 001123456699999999999
Q ss_pred CCCCCHHHHhcCCCccCCCC
Q 013201 340 KKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 340 ~~R~t~~~~l~h~~~~~~~~ 359 (447)
++|||+.++|+||||.....
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999987544
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=306.07 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=199.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCC----EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGN----SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+.|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence 348889999999999999999887776 46777664321 2233446889999999997 99999999998654 4
Q ss_pred EEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.++|+||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. +..+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~---~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS---PNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC---CCceEEccccccccc
Confidence 679999999999999987754 5899999999999999999999999999999999999954 346999999999865
Q ss_pred cCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 249 DEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 249 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
..... .....++..|+|||.+. ..++.++||||||+++|||++ |..||.+.........+..+ ..++.+ ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-ERLPQP--PIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCC--CCC
Confidence 43321 12234577899999876 458899999999999999997 99999877665555544433 222222 246
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+..+.+++.+||..+|++||+++++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=304.08 Aligned_cols=249 Identities=14% Similarity=0.146 Sum_probs=185.1
Q ss_pred cccceeecceeccccCeEEEEEEECCC---CCEEEEEEeeccccCChhh--------HHHHHHHHHHHHhccCCCCeeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENST---GNSYACKSILKRKLVNKQD--------REDIKREIQIMQHLSGQQNIVEF 160 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~--------~~~~~~E~~~l~~l~~h~~iv~~ 160 (447)
..+.|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..+. |+||+++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~ 88 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPKY 88 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCcE
Confidence 346799999999999999999998877 6677777542221100000 011122333445555 9999999
Q ss_pred EEEEEeCC----eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCc
Q 013201 161 RGAYEDRQ----SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAM 236 (447)
Q Consensus 161 ~~~~~~~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~ 236 (447)
++.+.... ..++++|++. .++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++ ....
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---GNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCc
Confidence 98765443 4578888874 46767776665678999999999999999999999999999999999994 4456
Q ss_pred eEEecCCCceeccCCC--------ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-H---
Q 013201 237 LKATDFGLSVFIDEGK--------VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEK-G--- 303 (447)
Q Consensus 237 vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~-~--- 303 (447)
++|+|||++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+.... .
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999997653211 1123479999999998864 5899999999999999999999999876322 1
Q ss_pred -----HHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 304 -----IFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 304 -----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+..+..+.... ..+++++.+++..||..+|++||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222333322222 245789999999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=305.56 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=209.6
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
..++...++++||+|-||.|.+|.-. .+..||||.+.... ....+.+|.+|+++|.+|+ ||||+.++++|..++.+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPL 610 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCch
Confidence 34667889999999999999999855 36899999885433 3445688999999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 171 HLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
++|+||+++|+|.+++.+... +.......|+.||+.|++||.+.++|||||.+.|+|+ |+++++||+|||+++.+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccccccc
Confidence 999999999999999988743 3455667899999999999999999999999999999 77889999999999977
Q ss_pred cCCCceee---cCCcccccccccc-cccCCCCCcchhHHHHHHHHhh--CCCCCCCCCHHHHHHHHHhCCC------CCC
Q 013201 249 DEGKVYRD---IVGSAYYVAPEVL-RRSYGKEIDVWSAGVILYILLS--GVPPFWAETEKGIFDAILKGGV------DFE 316 (447)
Q Consensus 249 ~~~~~~~~---~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~~~~i~~~~~------~~~ 316 (447)
..++.+.. .+-...|||||.+ .+.++.++|+|+||+++||+++ ...||...++.+..++...--. -+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 66654432 3556899999975 5889999999999999999865 7899999888877766432111 111
Q ss_pred CCccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 013201 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 317 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
.+ ..++..+.++|.+||..|-++||+++++-
T Consensus 768 ~P--~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 768 RP--PACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred CC--CcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 11 24789999999999999999999999984
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.66 Aligned_cols=243 Identities=21% Similarity=0.313 Sum_probs=189.8
Q ss_pred eeccccCeEEEEEEECCC--CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 101 ELGRGQFGITYLCTENST--GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~~~--~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
.||+|+||.||+|..... ...+++|.+.... .....+.+.+|+.+++.++ ||||+++++.+.+....|+||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCC
Confidence 699999999999975433 2345566553321 2334577899999999997 9999999999999999999999999
Q ss_pred CCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 179 GGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 179 g~~L~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
+|+|.+++.+. ..+++..+..++.||+.||.|||+.+++||||||+|||++ .+..+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc---CCccEEecccccccccCcchhh
Confidence 99999998764 2356777889999999999999999999999999999994 44569999999986432211
Q ss_pred -ceeecCCcccccccccccc--------cCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCC-CCCCCCc-c
Q 013201 253 -VYRDIVGSAYYVAPEVLRR--------SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG-VDFESEP-W 320 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~-~ 320 (447)
......|+..|+|||++.. .++.++||||||+++|||++ |..||......+.+..+.++. .....+. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 1224578899999998742 25778999999999999997 577888777777666655442 2222221 1
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
..+++.+.+++..|| .+|++||+++++++
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 246888999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=298.60 Aligned_cols=144 Identities=23% Similarity=0.358 Sum_probs=121.6
Q ss_pred CccccCCCccccc-cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC-----
Q 013201 81 PETVLGKPLEDIR-QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ----- 154 (447)
Q Consensus 81 ~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h----- 154 (447)
.++..-+..+.+. .+|.+.++||+|-|++||+|.|..+.+.||+|+++. ...-.+....||++|++++.+
T Consensus 64 GGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~ 139 (590)
T KOG1290|consen 64 GGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDP 139 (590)
T ss_pred CCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 4444445556666 789999999999999999999999999999998743 233456678999999998732
Q ss_pred --CCeeEEEEEEEe----CCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCc
Q 013201 155 --QNIVEFRGAYED----RQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPEN 225 (447)
Q Consensus 155 --~~iv~~~~~~~~----~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~N 225 (447)
..||+|++.|.. +.+++||+|++ |.+|..+|... +.++...++.|++|||.||.|||. .||+|.||||+|
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence 369999999964 56899999999 78999999875 459999999999999999999995 699999999999
Q ss_pred eEee
Q 013201 226 FLLS 229 (447)
Q Consensus 226 ill~ 229 (447)
||+.
T Consensus 219 vLl~ 222 (590)
T KOG1290|consen 219 VLLC 222 (590)
T ss_pred eeee
Confidence 9985
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=299.72 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=199.4
Q ss_pred eeecceeccccCeEEEEEEECC---CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC----
Q 013201 96 YTLGKELGRGQFGITYLCTENS---TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ---- 168 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 168 (447)
|.+.+.||+|+||.||+|.+.. +++.+|+|.+.... ......+.+.+|+.+++++. ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 6778899999999999998653 57899999885432 33445677889999999997 999999999886532
Q ss_pred --eEEEEEeccCCCchHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 169 --SVHLVMELCSGGELFDKIIAQ------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 169 --~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
..++++||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ .+..+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCCCEEEC
Confidence 347899999999998887532 2478899999999999999999999999999999999994 44569999
Q ss_pred cCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCC
Q 013201 241 DFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDF 315 (447)
Q Consensus 241 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 315 (447)
|||++........ .....+++.|++||.+. +.++.++||||||+++|+|++ |..||.+.+..+....+..+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999886543221 12234567899999886 457889999999999999999 899998877777666665543221
Q ss_pred CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 316 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.. ..++..+.+++.+||..+|++||++.+++++
T Consensus 236 -~~--~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 -QP--PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -CC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 2467899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=311.52 Aligned_cols=245 Identities=27% Similarity=0.440 Sum_probs=207.4
Q ss_pred ceeecceeccccCeEEEEEEECCC----CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 95 FYTLGKELGRGQFGITYLCTENST----GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
...+.++||.|-||.||.|....- .-.||||.-+.. ....+.+.|..|..+|+.++ ||||++++|++.+ .-.
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVE-QPM 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCC-Ccchhheeeeeec-cce
Confidence 345678899999999999985432 345788865432 34556889999999999998 9999999999865 578
Q ss_pred EEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|||||+++.|.|..+|..++ .++......++.||..||.|||+.++|||||-..|||+...+ .|||+|||+++.+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~---CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ---CVKLADFGLSRYLE 542 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc---eeeecccchhhhcc
Confidence 99999999999999998764 589999999999999999999999999999999999996544 69999999999998
Q ss_pred CCCceeecCCc--cccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKVYRDIVGS--AYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~~~~~~gt--~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
+...+....|. .-|||||.++ +.++.++|||.|||++||++. |..||.+-...+.+-.+.+|.. ++.++ .+++
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-lP~P~--nCPp 619 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-LPCPP--NCPP 619 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-CCCCC--CCCh
Confidence 87766655554 4699999998 679999999999999999987 9999999888877777766644 33333 6899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHh
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
.+..|+.+||++||.+||.+.++.
T Consensus 620 ~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 620 ALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHHHhccCcccCCcHHHHH
Confidence 999999999999999999998764
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=301.18 Aligned_cols=249 Identities=29% Similarity=0.440 Sum_probs=199.1
Q ss_pred cceeecceeccccCeEEEEEEEC----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--C
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--R 167 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 167 (447)
+.|++.+.||+|+||.||+|+.. .++..+|+|.+...... .....+.+|+.+++.+. |+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 45888899999999999999864 34789999988543221 34578899999999997 9999999999877 5
Q ss_pred CeEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
...++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++. +..++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES---EDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC---CCCEEEccccccc
Confidence 68999999999999999997754 5899999999999999999999999999999999999954 4579999999998
Q ss_pred eccCCCce----eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH--------------HHHH
Q 013201 247 FIDEGKVY----RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKG--------------IFDA 307 (447)
Q Consensus 247 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------------~~~~ 307 (447)
........ ....++..|+|||.+. ..++.++||||||+++|+|++|..||....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 1234556799999875 458889999999999999999999986542211 1122
Q ss_pred HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 308 ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 308 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
........+. ...++.++.+|+.+||..+|++|||+.++++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222222 2246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.41 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=212.5
Q ss_pred eeecceeccccCeEEEEEEECCCC---CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTG---NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
..+.++||+|+||.|++|.+...+ -.||||.+...... ....+|.+|+.+|.+|. |+|+++||++..+ .-..+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chhhH
Confidence 567899999999999999987543 36899988654432 25688999999999998 9999999999987 77889
Q ss_pred EEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||++++|+|.+.|.+ ...|.......|+.||+.|+.||..+++|||||-..|+|+.. ...|||||||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceeccCC
Confidence 9999999999999987 345888899999999999999999999999999999999954 44799999999998876
Q ss_pred CCceeecCC----ccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 251 GKVYRDIVG----SAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 251 ~~~~~~~~g----t~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
++..-.+.+ ...|+|||.++ +.++.++|+|+|||+||||+| |..||.+.....+++.|-++ -.++.+. .++
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-erLpRPk--~cs 341 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-ERLPRPK--YCS 341 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-ccCCCCC--CCh
Confidence 654333322 34699999997 679999999999999999998 89999999999999988744 3344333 589
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
+.++++++.||..+|.+|||+.+|.+.-+..+
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 99999999999999999999999976555443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=305.85 Aligned_cols=241 Identities=22% Similarity=0.389 Sum_probs=211.4
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
.....+||-|-||.||.|.++...-.||||.+.. +.-..++|..|+.+|+.++ |||+|+|+++|..+--+|||+|
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEEEe
Confidence 4556789999999999999999999999997743 3345789999999999998 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 176 LCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||..|+|.+||.+..+ ++.-..++++.||.+|+.||..+++|||||-..|+|+ +++..||++|||+++.+..+.
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDT- 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDT- 419 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCc-
Confidence 9999999999998654 6777788999999999999999999999999999999 777789999999999887653
Q ss_pred eeecCCc---cccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 254 YRDIVGS---AYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 254 ~~~~~gt---~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
++...|. .-|.|||-+. +.++.++|||+|||+|||+.| |..||.+.+...++..+.++ +.+..+ ..|++.+.
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~~P--eGCPpkVY 496 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMDGP--EGCPPKVY 496 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-ccccCC--CCCCHHHH
Confidence 3444554 4699999886 668999999999999999998 99999999988888776655 444433 37999999
Q ss_pred HHHHHhcccCCCCCCCHHHH
Q 013201 329 DLVRKMLIQDPKKRITSAEV 348 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~ 348 (447)
.|++.||+.+|.+||+++|+
T Consensus 497 eLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 497 ELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHHHhcCCcccCccHHHH
Confidence 99999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.56 Aligned_cols=248 Identities=24% Similarity=0.433 Sum_probs=215.8
Q ss_pred ceeecceeccccCeEEEEEEECCCC---CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTG---NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
...+.+.||.|.||.||+|+.+..| ..||||.++.. ..+..+.+|..|+.||-++. ||||++|.++.....-++
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeE
Confidence 3568899999999999999988766 46999987543 23556788999999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||+|||++|+|..+|+.+ +.|+..++..+++.|+.|+.||.+.+.|||||-..|||+ +.+..+|++|||+++.+.+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeeccc
Confidence 999999999999999875 569999999999999999999999999999999999999 7778999999999998765
Q ss_pred CC--ceeecCC--ccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 251 GK--VYRDIVG--SAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 251 ~~--~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
+. .+.+.-| ...|.|||.+. +.++.++||||+||+|||.++ |..|||+.+..+.++.|..+.. ++.+ ..++
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR-LPpP--mDCP 860 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR-LPPP--MDCP 860 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC-CCCC--CCCc
Confidence 43 2222223 35799999986 779999999999999999886 9999999999999999988743 3322 3689
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..+..|+..||++|-.+||++.+|+.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999998754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=288.21 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=208.9
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-----CeE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR-----QSV 170 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~ 170 (447)
.+-.+.||.|+||.||.+++..+|+.||+|++.. .+.+....+++.+|+++|.-.+ |.|++..+++.... ..+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHH
Confidence 3456789999999999999999999999998742 3334445678899999999998 99999998887654 357
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+|+|++. .+|..++.....++...++-++.||+.||+|||+.+|+||||||.|.|+ +.+..+||||||+++....
T Consensus 133 YV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccch
Confidence 89999995 5899999988899999999999999999999999999999999999999 6667899999999987654
Q ss_pred CCc--eeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHh----------------
Q 013201 251 GKV--YRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK---------------- 310 (447)
Q Consensus 251 ~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~---------------- 310 (447)
+.. .+.-+-|-+|+|||++.+ .|+.+.||||.|||+.||+.++..|......+.++.|..
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 432 233466889999999874 599999999999999999999999988877666655532
Q ss_pred -------CCCCCCCCc-cc------cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 311 -------GGVDFESEP-WL------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 311 -------~~~~~~~~~-~~------~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+....+.-+ .. .-..+..+++.++|.+||.+|.+.++++.|++..++
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111111111 00 123467889999999999999999999999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=307.95 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=185.1
Q ss_pred ccceeecceeccccCeEEEEEEEC----------------CCCCEEEEEEeeccccCC-----------hhhHHHHHHHH
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN----------------STGNSYACKSILKRKLVN-----------KQDREDIKREI 145 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~~avK~i~~~~~~~-----------~~~~~~~~~E~ 145 (447)
.+.|++.++||+|+||+||+|.+. ..++.||||.+....... ....+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 567999999999999999999752 245679999874321100 00112234577
Q ss_pred HHHHhccCCC----CeeEEEEEEEe--------CCeEEEEEeccCCCchHHHHHHcC-----------------------
Q 013201 146 QIMQHLSGQQ----NIVEFRGAYED--------RQSVHLVMELCSGGELFDKIIAQG----------------------- 190 (447)
Q Consensus 146 ~~l~~l~~h~----~iv~~~~~~~~--------~~~~~lv~e~~~g~~L~~~l~~~~----------------------- 190 (447)
.++.++.+++ ++++++++|.. .+..||||||+++++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 7777776332 24667776643 356899999999999999886421
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceee--cCCcccccccc
Q 013201 191 -HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--IVGSAYYVAPE 267 (447)
Q Consensus 191 -~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE 267 (447)
.+++..++.++.|++.+|.|||+.+|+||||||+|||++. +..+||+|||++........... ..+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC---CCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2345678899999999999999999999999999999954 44699999999976544332222 34589999999
Q ss_pred ccccc---------------------CC--CCCcchhHHHHHHHHhhCCC-CCCCCCHH-----------HHHHHHHhCC
Q 013201 268 VLRRS---------------------YG--KEIDVWSAGVILYILLSGVP-PFWAETEK-----------GIFDAILKGG 312 (447)
Q Consensus 268 ~~~~~---------------------~~--~~~DiwslG~il~elltg~~-pf~~~~~~-----------~~~~~i~~~~ 312 (447)
.+... |+ .+.||||+||++|+|++|.. ||...... ..+..+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 87421 11 34799999999999999875 66532111 1111111222
Q ss_pred CCCCCCccccCChHHHHHHHHhcccCC---CCCCCHHHHhcCCCccC
Q 013201 313 VDFESEPWLLISDSAKDLVRKMLIQDP---KKRITSAEVLEHPWMRE 356 (447)
Q Consensus 313 ~~~~~~~~~~~s~~~~~li~~~L~~dp---~~R~t~~~~l~h~~~~~ 356 (447)
+.+ ..+..+++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 461 ~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 222 3455679999999999999876 68999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=283.59 Aligned_cols=242 Identities=45% Similarity=0.749 Sum_probs=205.4
Q ss_pred cCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHH
Q 013201 106 QFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDK 185 (447)
Q Consensus 106 ~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~ 185 (447)
+||.||+|.+..+++.+|+|++........ .+.+.+|+..+++++ |+||+++++++......++++||+.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 589999999998899999998865432211 578899999999996 99999999999999999999999999999999
Q ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCCcccccc
Q 013201 186 IIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265 (447)
Q Consensus 186 l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~a 265 (447)
+.....++...+..++.+++.++.|||+.+++|+||+|+||+++.+ ..++|+|||.+.............++..|++
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED---GHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC---CcEEEccccceeeeccccccccccCCcCCCC
Confidence 8887669999999999999999999999999999999999999544 5699999999988766544556688999999
Q ss_pred ccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCC
Q 013201 266 PEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWA-ETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI 343 (447)
Q Consensus 266 PE~~~-~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~ 343 (447)
||.+. ..++.++||||||+++|+|++|..||.. .........+........ .....++.++.+++.+||..+|++||
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhcc
Confidence 99886 5588899999999999999999999987 444445555444433322 22222788999999999999999999
Q ss_pred CHHHHhcCCCc
Q 013201 344 TSAEVLEHPWM 354 (447)
Q Consensus 344 t~~~~l~h~~~ 354 (447)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=312.26 Aligned_cols=250 Identities=31% Similarity=0.484 Sum_probs=201.1
Q ss_pred eeecceeccccCeE-EEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 96 YTLGKELGRGQFGI-TYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 96 y~~~~~lg~G~~g~-Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
|.-.+.+|.|+-|+ ||+|... |+.||||++... ......+||..|+..+.|||||++++.-.+.+..||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 55567899999885 7999864 889999987533 23456799999999999999999999999999999999
Q ss_pred eccCCCchHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC--CCCCceEEecCCCceec
Q 013201 175 ELCSGGELFDKIIAQGH----YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK--DGGAMLKATDFGLSVFI 248 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~----~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~--~~~~~vkl~Dfg~a~~~ 248 (447)
|+|. .+|.+++...+. ......+.++.|++.||++||+.+||||||||.||||... +....++|+|||+++.+
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9995 699999977411 1113457899999999999999999999999999999764 33467999999999987
Q ss_pred cCCC----ceeecCCccccccccccccc-CCCCCcchhHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 249 DEGK----VYRDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 249 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
..+. ...+..||-+|+|||++... -..++||||+||++|+.++| .+||...... -.+|+++.+....-...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~- 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPL- 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccC-
Confidence 6553 23457899999999999744 56689999999999999985 8999765433 34566665544321110
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
...++.|||.+||.+||..||+|.++|.||||...
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 11289999999999999999999999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.25 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=208.4
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR---- 167 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---- 167 (447)
+..+|.-.+.+|.|+- .|-.|.|.-++++||+|.+... +.+....++..+|..++..+. |+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHH
Confidence 3456888899999998 7888999999999999988655 445555677789999999998 99999999999644
Q ss_pred --CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 168 --QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 168 --~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
...|+||||+. .+|...+. -.+....+..|+.|++.|+.|||+.||+||||||+||++ .....+||.|||+|
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLA 165 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhh
Confidence 46899999995 48877766 357788999999999999999999999999999999999 44557999999999
Q ss_pred eeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------------
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG------------ 312 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~------------ 312 (447)
+.....-..+.++.|..|+|||++.+ .|...+||||+||++.||++|...|.+.+..+.+.++..--
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 87666545567899999999998753 49999999999999999999999998877665554443210
Q ss_pred ---------------C----CCCCCccc-------cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 313 ---------------V----DFESEPWL-------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 313 ---------------~----~~~~~~~~-------~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
+ .++...|. .-+..+++++.+||..||++|.++.++|.||||+
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 01111111 1245689999999999999999999999999997
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=253.70 Aligned_cols=212 Identities=25% Similarity=0.363 Sum_probs=178.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+....+..||+|+||.|-+-++..+|...|+|.+.... +.+...++.+|+.+..+...+|.+|.+++.+.+.+.+||.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 34556788999999999999999999999999986432 3455677889999988888899999999999999999999
Q ss_pred EeccCCCchHHH----HHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 174 MELCSGGELFDK----IIAQGHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 174 ~e~~~g~~L~~~----l~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
||.|.. +|..+ +.+.+.++|..+-+|+..++.||.|||++ .++|||+||+||||+.+ +.||+||||++..+
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~---GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD---GQVKICDFGISGYL 199 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC---CcEEEcccccceee
Confidence 999953 65433 34456799999999999999999999975 89999999999999554 46999999999887
Q ss_pred cCCCceeecCCccccccccccc-----ccCCCCCcchhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHhC
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLR-----RSYGKEIDVWSAGVILYILLSGVPPFWA-ETEKGIFDAILKG 311 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~ 311 (447)
.+.-..+-..|...|||||.+. ..|+-++||||||+++.||.+++.||.. .+..+.+.++.+.
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 6654434457889999999885 3589999999999999999999999965 4667777777665
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=303.05 Aligned_cols=260 Identities=28% Similarity=0.478 Sum_probs=225.4
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+..+.|.+...+|.|.||.||+|+++.++...|+|+|... ...+..-+.+|+-+++.++ |||||.+++.|.....+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence 3456699999999999999999999999999999998543 3455677789999999998 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|++||||.||+|.+.-.-.+.+++.++...++..+.+|+|||+.|-+|||||-.|||++..+ .+||+|||.+..+..
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g---DvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG---DVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC---ceeecccCchhhhhh
Confidence 99999999999999888888999999999999999999999999999999999999996555 499999999887654
Q ss_pred C-CceeecCCcccccccccc----cccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC-ccccCC
Q 013201 251 G-KVYRDIVGSAYYVAPEVL----RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE-PWLLIS 324 (447)
Q Consensus 251 ~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s 324 (447)
. ....++.|||+|||||+- ++.|...+|||++|+...|+-.-.+|.+.......+....+..+..+.- .....+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 3 233568999999999974 4679999999999999999999899988777776666666665554432 122468
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+.+-+|++.+|.++|++||+++-+|.|||....
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 899999999999999999999999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.39 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=207.7
Q ss_pred ccceeecceeccccCeEEEEEEECC-------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
++...+.+.||+|+||.|++|.... ....||||.+.... .....+.+..|+++|+.+..|+||+.+++++.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 3445677799999999999987431 14578999775433 23667889999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
..+.+++|+|||..|+|.++|+.++ .++......++.||+.|+.||++.++|||||-.+|||+
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi- 451 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI- 451 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe-
Confidence 9999999999999999999998876 38888999999999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCceeccCCCceee--cCCc--ccccccccccc-cCCCCCcchhHHHHHHHHhh-CCCCCCCCC-HH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKVYRD--IVGS--AYYVAPEVLRR-SYGKEIDVWSAGVILYILLS-GVPPFWAET-EK 302 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~gt--~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~pf~~~~-~~ 302 (447)
..+..+||+|||+++.......+.. ..|+ ..|||||.+.. .|+.++|||||||+|||++| |..||.+.. ..
T Consensus 452 --~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 452 --TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred --cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 4556899999999997665544432 2332 35999999874 69999999999999999998 899998865 55
Q ss_pred HHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 303 GIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 303 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++++.+..| .....+. .+++++.++++.||+.+|++||++.++.+
T Consensus 530 ~l~~~l~~G-~r~~~P~--~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 ELLEFLKEG-NRMEQPE--HCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHhcC-CCCCCCC--CCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 665544444 4444443 57999999999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.61 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=203.3
Q ss_pred cccccceeecceeccccCeEEEEEEECC---CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENS---TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..+...|.++++||+|.|++||+|.+.. .++.||+|.+... ....++.+|+++|..+.++.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3456679999999999999999999887 7889999988543 3346789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
++...+||||++.....++.. .++..++..+++.++.||.++|.+|||||||||+|+|.+..... -.|+|||+|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~r--g~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQR--GVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCC--ceEEechhHH
Confidence 999999999999877777653 46788999999999999999999999999999999999877664 4569999986
Q ss_pred ecc-----------------C--C---------------Cc-----------eeecCCccccccccccc--ccCCCCCcc
Q 013201 247 FID-----------------E--G---------------KV-----------YRDIVGSAYYVAPEVLR--RSYGKEIDV 279 (447)
Q Consensus 247 ~~~-----------------~--~---------------~~-----------~~~~~gt~~y~aPE~~~--~~~~~~~Di 279 (447)
... . + .. .....||++|+|||++. ..-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 210 0 0 00 01247999999999985 346889999
Q ss_pred hhHHHHHHHHhhCCCCCCCCCHH-HHHHHH--------------HhCC-------------------CCC----------
Q 013201 280 WSAGVILYILLSGVPPFWAETEK-GIFDAI--------------LKGG-------------------VDF---------- 315 (447)
Q Consensus 280 wslG~il~elltg~~pf~~~~~~-~~~~~i--------------~~~~-------------------~~~---------- 315 (447)
||.|+|+.-++++..||....+. ..+..| ..+. ...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999999654221 111111 0011 000
Q ss_pred ---CCCc-cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 316 ---ESEP-WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 316 ---~~~~-~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.... ....+..+.||+.+||+.||.+|+|++++|+||||.+.
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0000 11245689999999999999999999999999999853
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.91 Aligned_cols=240 Identities=22% Similarity=0.256 Sum_probs=182.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|...+.||+|+||.||+|++..++..||+|.+..... ....|++++++++ ||||+++++++.+.+..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEE
Confidence 346677899999999999999999999999998753221 1235688899997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH---FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||+++|+|.+++. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ ..++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~---~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD---EPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC---ceEEE-ecccccccc
Confidence 99999999999985 4889999999999999999999 67999999999999995433 35554 555443322
Q ss_pred CCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH--HHHHH---HHHhCC-----CCCCC--
Q 013201 251 GKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFD---AILKGG-----VDFES-- 317 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~---~i~~~~-----~~~~~-- 317 (447)
. ....||+.|+|||++. ..++.++|||||||++|||+||+.||..... ..... ...... .+...
T Consensus 835 ~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 D---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred C---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1 2337899999999986 4589999999999999999999999853211 11111 111000 00000
Q ss_pred --CccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 318 --EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 318 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
........++.+++.+||+.||++|||++|+++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000112356789999999999999999999865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=284.55 Aligned_cols=199 Identities=30% Similarity=0.547 Sum_probs=177.1
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhcc--CCCCeeEEEEEEEeCC
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-----QDREDIKREIQIMQHLS--GQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~ 168 (447)
|...+.+|+|+||.|++|.++.+...|++|.|.|++..-. ...-.+-.||.||..|+ .|+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 8999999999999999999999999999999988765332 22334567999999986 4899999999999999
Q ss_pred eEEEEEecc-CCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 SVHLVMELC-SGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~-~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
++||+||-. +|-+|+++|.....++|.++..|++|++.|+++||+.||||||||-+||.+ +.++.+||+|||.+..
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccchhh
Confidence 999999965 467999999999999999999999999999999999999999999999999 6666899999999987
Q ss_pred ccCCCceeecCCccccccccccccc--CCCCCcchhHHHHHHHHhhCCCCCCC
Q 013201 248 IDEGKVYRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWA 298 (447)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~pf~~ 298 (447)
...+ .+..++||..|.|||++.+. .+..-|||++|++||.++....||++
T Consensus 720 ~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 7665 45778999999999999854 58889999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=269.77 Aligned_cols=239 Identities=25% Similarity=0.382 Sum_probs=187.2
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc-CCCCeeEEEEEEEeCC----eE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS-GQQNIVEFRGAYEDRQ----SV 170 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~~----~~ 170 (447)
..+.++||+|.||.||+|... ++.||||++. ....+.+.+|-+|.+... .|+||++++++-+... .+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred hhhHHHhhcCccceeehhhcc--CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 677899999999999999865 6899999873 456678888988887543 4999999998876544 89
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---------cCcEeecCCCCceEeecCCCCCceEEec
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF---------MGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~---------~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
+||+||.+.|+|.++|+.+ .+++....+++.-+++||+|||+ ..|+|||||..|||+ ..+.+.-|+|
T Consensus 284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaD 359 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIAD 359 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeec
Confidence 9999999999999999876 68999999999999999999996 359999999999999 4455799999
Q ss_pred CCCceeccCCCc---eeecCCcccccccccccccCCC-------CCcchhHHHHHHHHhhCC------------CCCCC-
Q 013201 242 FGLSVFIDEGKV---YRDIVGSAYYVAPEVLRRSYGK-------EIDVWSAGVILYILLSGV------------PPFWA- 298 (447)
Q Consensus 242 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-------~~DiwslG~il~elltg~------------~pf~~- 298 (447)
||+|..+..+.. ....+||.+|||||++.+.... +.||||+|.+||||+++- .||..
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999998765532 2347999999999999765332 489999999999999853 23321
Q ss_pred ----CCHHHHHHHHHhCCCC-CCCCcccc--CChHHHHHHHHhcccCCCCCCCHH
Q 013201 299 ----ETEKGIFDAILKGGVD-FESEPWLL--ISDSAKDLVRKMLIQDPKKRITSA 346 (447)
Q Consensus 299 ----~~~~~~~~~i~~~~~~-~~~~~~~~--~s~~~~~li~~~L~~dp~~R~t~~ 346 (447)
.+..++...+...+.. .....|.. -...+++.+.-||..|++-|.|+.
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 1233444444333222 22223332 235678999999999999999985
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=266.04 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=188.0
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHh--ccCCCCeeEEEEEEEeC-
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH--LSGQQNIVEFRGAYEDR- 167 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~--l~~h~~iv~~~~~~~~~- 167 (447)
.+.+...+.+.||+|.||.||+|+++ |..||||++.. .+...+.+|.+|.+. |+ |+||+.+++.-..+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s------rdE~SWfrEtEIYqTvmLR-HENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS------RDERSWFRETEIYQTVMLR-HENILGFIAADNKDN 278 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc--CCceEEEEecc------cchhhhhhHHHHHHHHHhc-cchhhhhhhccccCC
Confidence 45666889999999999999999987 88999998843 234677888888775 55 99999999875433
Q ss_pred ---CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--------cCcEeecCCCCceEeecCCCCCc
Q 013201 168 ---QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF--------MGVMHRDLKPENFLLSNKDGGAM 236 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~--------~~ivH~Dlkp~Nill~~~~~~~~ 236 (447)
..+|||++|.+.|+|+|+|.+ ..++.+.+.+++..++.||++||. -.|.|||||..|||+. .++.
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK---kn~~ 354 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGT 354 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc---cCCc
Confidence 368999999999999999988 579999999999999999999994 2599999999999994 4456
Q ss_pred eEEecCCCceeccCCC-----ceeecCCcccccccccccccCC-------CCCcchhHHHHHHHHhhC----------CC
Q 013201 237 LKATDFGLSVFIDEGK-----VYRDIVGSAYYVAPEVLRRSYG-------KEIDVWSAGVILYILLSG----------VP 294 (447)
Q Consensus 237 vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~DiwslG~il~elltg----------~~ 294 (447)
+-|+|+|+|....... ..+..+||.+|||||++..... ..+||||||.++||++.+ .+
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 9999999998655431 2345799999999999864322 358999999999999873 47
Q ss_pred CCCCCCH-----HHHHHHHHhCCCCCC-CCccccCC--hHHHHHHHHhcccCCCCCCCHHHH
Q 013201 295 PFWAETE-----KGIFDAILKGGVDFE-SEPWLLIS--DSAKDLVRKMLIQDPKKRITSAEV 348 (447)
Q Consensus 295 pf~~~~~-----~~~~~~i~~~~~~~~-~~~~~~~s--~~~~~li~~~L~~dp~~R~t~~~~ 348 (447)
||++..+ .++.+-+.-...... ...|...+ ..+..+++-||..+|.-|.|+--+
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 8865432 233333222222222 22333211 245678999999999999988655
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=280.99 Aligned_cols=245 Identities=25% Similarity=0.356 Sum_probs=205.2
Q ss_pred eeecceeccccCeEEEEEEECCCCC----EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGN----SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
.+..++||.|+||+||+|.+--.|. +||+|++... .......++..|+-+|.+++ |||++++++++.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HH
Confidence 4557899999999999998865554 6788876543 23344578899999999998 999999999997665 88
Q ss_pred EEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||++|+++|+|.++++.+ +.+-....+.|..||++|+.|||++++|||||-.+|||+... ..+||.|||+++....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP---~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP---NHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC---CeEEEEecchhhccCc
Confidence 999999999999999874 568899999999999999999999999999999999999544 4699999999987765
Q ss_pred CC-ceeecC--Cccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 251 GK-VYRDIV--GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 251 ~~-~~~~~~--gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.. .+.... -.+.|||=|.+. ..|+.++|||||||++||++| |..|+.+....++-+.+.++.. +..++ .++-
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqPp--iCti 927 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQPP--ICTI 927 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCCC--CccH
Confidence 43 222222 245799999876 669999999999999999998 9999999998888887777755 55554 5788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.-++.+||..|+..||+++++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=249.45 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=200.9
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEE-EEEeCC
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRG-AYEDRQ 168 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~-~~~~~~ 168 (447)
-++.+.|.+.+.||+|.||.+.+|.|+.++..+++|.+.+.. ....+|.+|...--.|..|.||+.-++ .|+..+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 345677999999999999999999999999999999886543 345788999988888888999998766 477888
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+++++||++.|+|.+-+.. ..+-|.....++.|+++|+.|+|++++||||||.+||||-..+- ..|||||||+....
T Consensus 96 ~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df-~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF-YRVKLCDFGLTRKV 173 (378)
T ss_pred eEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc-cEEEeeeccccccc
Confidence 99999999999999876655 45888999999999999999999999999999999999976554 37999999998754
Q ss_pred cCCCceeecCCccccccccccc----cc--CCCCCcchhHHHHHHHHhhCCCCCCCCCH---HH-HHHHHHhCCCCCCCC
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLR----RS--YGKEIDVWSAGVILYILLSGVPPFWAETE---KG-IFDAILKGGVDFESE 318 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~~DiwslG~il~elltg~~pf~~~~~---~~-~~~~i~~~~~~~~~~ 318 (447)
+..- ...--+..|.+||... +. ..+.+|+|.|||++|.++||.+||..... .. .+.+-..+...-...
T Consensus 174 g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 GTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred Ccee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 4321 1122345689999753 22 57889999999999999999999974322 11 122222222222223
Q ss_pred ccccCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCcc
Q 013201 319 PWLLISDSAKDLVRKMLIQDPKKR---ITSAEVLEHPWMR 355 (447)
Q Consensus 319 ~~~~~s~~~~~li~~~L~~dp~~R---~t~~~~l~h~~~~ 355 (447)
.+..+++.+..+.++-|..++++| .+++......|..
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 345689999999999999999999 4555555666654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-31 Score=238.50 Aligned_cols=211 Identities=43% Similarity=0.706 Sum_probs=183.8
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGE 181 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 181 (447)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.+. |++|+++++++......++++|++.|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999998889999999885433211 3567899999999998 8999999999999999999999999899
Q ss_pred hHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-ceeecCC
Q 013201 182 LFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-VYRDIVG 259 (447)
Q Consensus 182 L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~g 259 (447)
|.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++.. ...++|+|||.+....... ......+
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence 99998776 578999999999999999999999999999999999999652 3469999999998765432 1234568
Q ss_pred cccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 260 SAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 260 t~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
...|++||.+.. .++.+.|+|++|+++++| ..+.+++.+||..
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence 889999999865 678899999999999999 5678999999999
Q ss_pred CCCCCCCHHHHhcCC
Q 013201 338 DPKKRITSAEVLEHP 352 (447)
Q Consensus 338 dp~~R~t~~~~l~h~ 352 (447)
||++||+++++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=237.40 Aligned_cols=210 Identities=42% Similarity=0.744 Sum_probs=179.8
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|.+.+.||.|++|.||++.+..+++.+++|.+...... ...+.+.+|+..++++. |+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence 56788999999999999999988999999988654322 24678899999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC--
Q 013201 176 LCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-- 252 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~-~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 252 (447)
|+++++|.+++..... +++..+..++.+++.++.+||+.+++|+||+|.||+++.+ ..++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~---~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD---GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeeCceeeEecCcccc
Confidence 9999999999988766 8999999999999999999999999999999999999554 569999999998765542
Q ss_pred ceeecCCcccccccccc-c-ccCCCCCcchhHHHHHHHHhhCCCCCCC-CCHH-HHHHHHHhC
Q 013201 253 VYRDIVGSAYYVAPEVL-R-RSYGKEIDVWSAGVILYILLSGVPPFWA-ETEK-GIFDAILKG 311 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~elltg~~pf~~-~~~~-~~~~~i~~~ 311 (447)
......++..|++||.+ . ..++.++|+|+||+++|+|++|+.||.. .... .+.+.+..+
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 33456788899999987 3 3477799999999999999999999977 3443 556666555
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=293.74 Aligned_cols=197 Identities=19% Similarity=0.220 Sum_probs=147.5
Q ss_pred CCeeEEEEEE-------EeCCeEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCce
Q 013201 155 QNIVEFRGAY-------EDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENF 226 (447)
Q Consensus 155 ~~iv~~~~~~-------~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Ni 226 (447)
+||+.++++| .....+++++||+ +++|.++|... ..+++.+++.+++||+.||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777777766 2234677888987 56999999763 4599999999999999999999999999999999999
Q ss_pred EeecC----------------CCCCceEEecCCCceeccCCC-----------------ceeecCCccccccccccc-cc
Q 013201 227 LLSNK----------------DGGAMLKATDFGLSVFIDEGK-----------------VYRDIVGSAYYVAPEVLR-RS 272 (447)
Q Consensus 227 ll~~~----------------~~~~~vkl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 272 (447)
||+.. +....+||+|||+++...... .....+||++|||||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 99531 234468888888876432100 011246899999999876 55
Q ss_pred CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 013201 273 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352 (447)
Q Consensus 273 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~ 352 (447)
|+.++|||||||+||||++|..|+.... ..+..+..... + +......+...+++.+||.+||.+||++.|+|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--P-PQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--C-hhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 8999999999999999999998875422 22222222211 1 11111245677899999999999999999999999
Q ss_pred CccCC
Q 013201 353 WMREG 357 (447)
Q Consensus 353 ~~~~~ 357 (447)
||.+.
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=238.97 Aligned_cols=249 Identities=19% Similarity=0.220 Sum_probs=200.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCC-----CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE-e
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTG-----NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE-D 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~ 166 (447)
+.++++...+-+|.||.||.|.++... +.+-+|.+.. ..+......+..|..++..+. |||+..+.++.. +
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--HASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIED 359 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--cccHHHHHHHHHHHHHHhcCc-CCCccceeEEEeec
Confidence 566888999999999999999776433 3344454421 123445677888999999887 999999999875 4
Q ss_pred CCeEEEEEeccCCCchHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceE
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQ--------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vk 238 (447)
....++++.++.-|+|..+|... ..++..+...++.|+..|++|||++||||.||-..|.+| ++...||
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVk 436 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVK 436 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEE
Confidence 56788899999889999998732 236677888999999999999999999999999999999 6668899
Q ss_pred EecCCCceeccCCCcee---ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCC
Q 013201 239 ATDFGLSVFIDEGKVYR---DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 239 l~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 313 (447)
|+|=.+++.+.+.+... .---...||+||.+. ..|+.++|+||||++||||+| |+.|+...+..++...+.+|..
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR 516 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence 99999998776554321 112245799999986 569999999999999999998 9999999999988887777643
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
...+ .++++++..++..||..+|++||+++|+..
T Consensus 517 -laQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 -LAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -ecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 3322 268999999999999999999999999853
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=216.56 Aligned_cols=162 Identities=25% Similarity=0.335 Sum_probs=127.6
Q ss_pred CchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecC
Q 013201 180 GELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258 (447)
Q Consensus 180 ~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 258 (447)
|+|.+++... ..+++..++.++.||+.||.|||+.+ ||+|||++ .+..+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeecccc----CC
Confidence 6899999874 45999999999999999999999998 99999994 4456888 99988765432 26
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCCCCC---CccccCCh--HHHHHH
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVDFES---EPWLLISD--SAKDLV 331 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 331 (447)
||+.|+|||++. ..++.++|||||||++|||++|..||..... ...+..+......... .....++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999986 4589999999999999999999999976543 2333343333222111 11112333 699999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccC
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.+||..||.+||++.++++|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=214.11 Aligned_cols=247 Identities=20% Similarity=0.297 Sum_probs=192.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.-.|+++++||+|+||+++.|++.-++++||||.-.. +....++..|....+.|.+.++|+.++.+...+.+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 3459999999999999999999999999999995422 34457889999999999999999999999988889999
Q ss_pred EEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC--CCCceEEecCCCceecc
Q 013201 173 VMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD--GGAMLKATDFGLSVFID 249 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~~~vkl~Dfg~a~~~~ 249 (447)
|+|++ |-+|.|+..-+ ++|+...++.++.|++.-++|+|++.+|+|||||+|+||...+ ....|-|+|||+|+...
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99999 77998887654 4699999999999999999999999999999999999996432 23468899999999775
Q ss_pred CCCc--------eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC---CHHHHHHHHHhCCCCCCC
Q 013201 250 EGKV--------YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE---TEKGIFDAILKGGVDFES 317 (447)
Q Consensus 250 ~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~ 317 (447)
+.+. ..+..||..||+-.... +.-+.+.|+-|||-+++++|.|..||.+. +..+-+++|-..+...+.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 5432 23568999999987643 44688999999999999999999999875 344555555433322221
Q ss_pred Ccc-ccCChHHHHHHHHhcccCCCCCCCH
Q 013201 318 EPW-LLISDSAKDLVRKMLIQDPKKRITS 345 (447)
Q Consensus 318 ~~~-~~~s~~~~~li~~~L~~dp~~R~t~ 345 (447)
... ..++.++...++-.-..+-.+-|..
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 111 1345555555554444444444444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-27 Score=226.04 Aligned_cols=253 Identities=24% Similarity=0.284 Sum_probs=193.2
Q ss_pred ceeecceeccccCeEEEEEEECCCC-CEEEEEEeeccccCChhhHHHHHHHHHHHHhcc---CCCCeeEEEEEE-EeCCe
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTG-NSYACKSILKRKLVNKQDREDIKREIQIMQHLS---GQQNIVEFRGAY-EDRQS 169 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~---~h~~iv~~~~~~-~~~~~ 169 (447)
.|.+.+.||+|+||.||+|.+..++ ..+|+|........ ....+..|+.++..+. +.++++.+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~---~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS---KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC---CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 6999999999999999999988775 57888876543211 1126778999998887 346899999999 58889
Q ss_pred EEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC--CCceEEecCCCc
Q 013201 170 VHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG--GAMLKATDFGLS 245 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~~~vkl~Dfg~a 245 (447)
.||||+.+ |.+|.++.... +.++...+..++.|++.+|.++|+.|++||||||+|+++...+. ...+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 78999977554 57999999999999999999999999999999999999976542 257999999999
Q ss_pred e--ecc-CCC-------c-eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Q 013201 246 V--FID-EGK-------V-YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 246 ~--~~~-~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 313 (447)
+ ... ... . .....||..|+++.+..+ ..+.+.|+||++.++.+++.|..||.+.........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 321 111 1 123469999999998764 489999999999999999999999977654322333222211
Q ss_pred CCCCC-ccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 314 DFESE-PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 314 ~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..... .....+.++.++...+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 11111 122345677888887777888888888877543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=258.25 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=199.6
Q ss_pred cce-eecceeccccCeEEEEEEECCCCCEEEEEEeecc--ccCChhh-HHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFY-TLGKELGRGQFGITYLCTENSTGNSYACKSILKR--KLVNKQD-REDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~--~~~~~~~-~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+.| .....+|.|++|.|+.+........++.|..... ....... ...+..|+-+-..+. |+|++..+..+.+...
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDG 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhccc
Confidence 334 5678999999999998888877777777754321 1111111 122566777778887 9999887777766666
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
.+-+||||++ +|+..+...+.++..++..+++||+.|+.|+|+.||.|||||++|+++... +.+||+|||.+....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~---g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN---GILKIIDFGAASVFR 471 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC---CceEEeecCcceeec
Confidence 6666999999 999999998899999999999999999999999999999999999999544 479999999987653
Q ss_pred CC-----CceeecCCcccccccccccc-cCCC-CCcchhHHHHHHHHhhCCCCCCCCCHHHHH--HHHHhCCCCCCC---
Q 013201 250 EG-----KVYRDIVGSAYYVAPEVLRR-SYGK-EIDVWSAGVILYILLSGVPPFWAETEKGIF--DAILKGGVDFES--- 317 (447)
Q Consensus 250 ~~-----~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~--~~i~~~~~~~~~--- 317 (447)
-. ......+|+..|+|||++.+ .|++ ..||||.|++++.|.+|+.||......+.. .......+....
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 22 22345789999999999864 4655 589999999999999999999755433221 111111122222
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
..+..++.+.+.+|.+||++||.+|.|+++|++.+||+....
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 223457889999999999999999999999999999987543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=222.28 Aligned_cols=257 Identities=34% Similarity=0.533 Sum_probs=208.9
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.++++|+++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999987 78899988765543333567889999999999844489999999988888899999
Q ss_pred ccCCCchHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 176 LCSGGELFDKIIAQG---HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~---~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
++.++++.+++.... .+.+..+..++.|++.++.|+|+.+++|||+||+||+++..+. .++++|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDPG 156 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCCC
Confidence 999999997777664 7999999999999999999999999999999999999954432 59999999998654432
Q ss_pred -------ceeecCCcccccccccccc----cCCCCCcchhHHHHHHHHhhCCCCCCCCCH----HHHHHHHHhCCCC-CC
Q 013201 253 -------VYRDIVGSAYYVAPEVLRR----SYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAILKGGVD-FE 316 (447)
Q Consensus 253 -------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~-~~ 316 (447)
......||..|++||.+.+ .++...|+||+|++++++++|..||..... ......+...... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 2356789999999998864 578899999999999999999999877663 4555555544433 22
Q ss_pred CCccccC----ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 317 SEPWLLI----SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 317 ~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
....... ...+.+++.+++..+|..|.+..+...++|....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 2211111 2578999999999999999999999988776654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=205.31 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=198.3
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
...+|+++++||.|+||.+|+|....+|..||+|+-.. .....++..|.++.+.|.+...|+.+..++.+..+-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-----~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-----KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-----cCCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 45679999999999999999999999999999996422 2233567889999999998899999999999999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+|||++ |.+|.+++.- .+.|+...++.++-|++.-++|+|.++++||||||+|+|+.-......+-|+|||+|+...+
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999998 7799887753 56799999999999999999999999999999999999997655556789999999987654
Q ss_pred CCc--------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCCCC
Q 013201 251 GKV--------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFDAILKGGVDFESE 318 (447)
Q Consensus 251 ~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~ 318 (447)
... -....||..|.+-....+ .-+.+.|+-|+|.+|.++..|..||.+.. ..+-++.|.+.....+..
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 321 234689999998776543 35778999999999999999999998754 345566666554443332
Q ss_pred cc-ccCChHHHHHHHHhcccCCCCCCCHH
Q 013201 319 PW-LLISDSAKDLVRKMLIQDPKKRITSA 346 (447)
Q Consensus 319 ~~-~~~s~~~~~li~~~L~~dp~~R~t~~ 346 (447)
.. ..+|.++.-.+.-|-..--++-|...
T Consensus 247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 22 24677888888887666555555543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=227.42 Aligned_cols=166 Identities=19% Similarity=0.211 Sum_probs=128.3
Q ss_pred cccccceeecceeccccCeEEEEEEECC-CCCEEEEEEeecccc--CChhhHHHHHHHHHHHHhccCCCCeeE-EEEEEE
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENS-TGNSYACKSILKRKL--VNKQDREDIKREIQIMQHLSGQQNIVE-FRGAYE 165 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~-~~~~~~ 165 (447)
..+...|.+.+.||+|+||+||+|++.. +++.+|||.+..... ........+.+|+.+|+++. |+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~-- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT-- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc--
Confidence 3445669999999999999999999876 677889998653211 12334567899999999998 888874 5432
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecC-CCCceEeecCCCCCceEEecCCC
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL-KPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dl-kp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
+..|||||||+|++|.. +. ... ...++.|++.+|.|||++||+|||| ||+|||++. +..+||+|||+
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~---~~~ikLiDFGl 158 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGP---DGEAAVIDFQL 158 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcC---CCCEEEEECcc
Confidence 46899999999999863 21 111 2568899999999999999999999 999999943 34699999999
Q ss_pred ceeccCCC---------ceeecCCccccccccccc
Q 013201 245 SVFIDEGK---------VYRDIVGSAYYVAPEVLR 270 (447)
Q Consensus 245 a~~~~~~~---------~~~~~~gt~~y~aPE~~~ 270 (447)
+..+.... ......+++.|+|||.+.
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 98664432 123467889999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=241.14 Aligned_cols=240 Identities=28% Similarity=0.485 Sum_probs=208.1
Q ss_pred eeccccCeEEEEEE---ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc
Q 013201 101 ELGRGQFGITYLCT---ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELC 177 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~---~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 177 (447)
.+|.|+||.|++++ -...+..||+|+..+......... ....|..++..+++||.++++...++.+...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 37999999998754 234577899998877655444333 55678888998888999999999999999999999999
Q ss_pred CCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeec
Q 013201 178 SGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI 257 (447)
Q Consensus 178 ~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 257 (447)
.||.|+..+.+...+.+.....+...++-+++++|+.+|+|||+|++||++ +..+++++.|||+++...+.+..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---
Confidence 999999999998889999999999999999999999999999999999999 55567999999999876654433
Q ss_pred CCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 258 VGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 258 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
|||.-|||||+++ .+..++|.||||+++++|+||..||.. ++...|.+....++.. ++..+++++..++..
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~----l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE----LSAEARSLFRQLFKR 224 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh----hhHHHHHHHHHHHhh
Confidence 9999999999998 678899999999999999999999987 6778888876666654 688999999999999
Q ss_pred CCCCCCCH-----HHHhcCCCccC
Q 013201 338 DPKKRITS-----AEVLEHPWMRE 356 (447)
Q Consensus 338 dp~~R~t~-----~~~l~h~~~~~ 356 (447)
+|.+|.-. .++++|+||..
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred CHHHHhccCcchhHHHhccchhee
Confidence 99999865 68999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-26 Score=228.93 Aligned_cols=220 Identities=31% Similarity=0.551 Sum_probs=171.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|..++.|..|+||.||.++|+.+.+++|+| +.+..+. .+- ++... ++|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--------lRn--ilt~a-~npfvv--------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------LRN--ILTFA-GNPFVV--------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--------hhc--ccccc-CCccee---------------
Confidence 34889999999999999999999999999995 5443221 110 22222 244444
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC---
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE--- 250 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~--- 250 (447)
|+=...++.-+.++... +.+++|+|+.||+|||+||+|.+| ..-+.+|+.|||+++..-.
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhcc
Confidence 33334455555555544 679999999999999999999999 4455799999999764311
Q ss_pred -----CC------c--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 013201 251 -----GK------V--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316 (447)
Q Consensus 251 -----~~------~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 316 (447)
+. . -..++|||.|+|||++. .+|+..+|+|++|+|+||.+.|..||++.+.++++..++...+.++
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 10 0 12369999999999864 6799999999999999999999999999999999999998888887
Q ss_pred CCccccCChHHHHHHHHhcccCCCCCC---CHHHHhcCCCccCCC
Q 013201 317 SEPWLLISDSAKDLVRKMLIQDPKKRI---TSAEVLEHPWMREGG 358 (447)
Q Consensus 317 ~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~~~l~h~~~~~~~ 358 (447)
...+ .++++++++|.++|..+|..|. .+-++.+|+||+...
T Consensus 279 E~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 279 EEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred ccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 7643 4789999999999999999996 456788999998653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=190.62 Aligned_cols=143 Identities=22% Similarity=0.197 Sum_probs=110.3
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhh-----------------------HHHHHHHHHHHHhccCCC
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD-----------------------REDIKREIQIMQHLSGQQ 155 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~~h~ 155 (447)
...||+|+||.||+|.+. +|+.||+|++.......... .....+|+.++.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 468999999999999987 89999999986543211110 122345999999997 66
Q ss_pred CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeecCCCCceEeecCCCC
Q 013201 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC-HFMGVMHRDLKPENFLLSNKDGG 234 (447)
Q Consensus 156 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~l-H~~~ivH~Dlkp~Nill~~~~~~ 234 (447)
++.....+... ..+|||||++|+++...+.....+++..+..++.|++.+|.++ |+.||+||||||+|||++.
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---- 153 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---- 153 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC----
Confidence 65433322222 2379999999887766555567899999999999999999999 7999999999999999963
Q ss_pred CceEEecCCCceecc
Q 013201 235 AMLKATDFGLSVFID 249 (447)
Q Consensus 235 ~~vkl~Dfg~a~~~~ 249 (447)
..++|+|||++....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 259999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=191.94 Aligned_cols=174 Identities=17% Similarity=0.148 Sum_probs=132.9
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHH------HHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED------IKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~------~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
+..+|++.+.||.|+||.||++.. ++..+|+|++............. +.+|+..+.++. |++|..+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~ 105 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFYL 105 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEeee
Confidence 567899999999999999999755 47789999886544333333233 679999999997 999999998876
Q ss_pred eC--------CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCce
Q 013201 166 DR--------QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 166 ~~--------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
+. +..+|||||++|.+|.++. .+++ ....+++.+|..||+.|++|||+||+||+++.+ + +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~---g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN---G-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC---C-E
Confidence 43 3588999999999997763 2333 346699999999999999999999999999543 3 9
Q ss_pred EEecCCCceeccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHh
Q 013201 238 KATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILL 290 (447)
Q Consensus 238 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~ell 290 (447)
+|+|||............. =++...|+.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 9999998865533221110 023355778999999999887554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=198.08 Aligned_cols=234 Identities=25% Similarity=0.374 Sum_probs=150.7
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccC---------CCCeeEEEEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG---------QQNIVEFRGAYE 165 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~~iv~~~~~~~ 165 (447)
.+..++.||.|+++.||.+++..|++.+|+|+..-.........+.+.+|.-....+.+ |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46788999999999999999999999999998876554344456777776654444331 212333233221
Q ss_pred ---------eC---C-----eEEEEEeccCCCchHHHHH---HcCCC----CHHHHHHHHHHHHHHHHHHHhcCcEeecC
Q 013201 166 ---------DR---Q-----SVHLVMELCSGGELFDKII---AQGHY----TEKAAAALCRAIVNVVHHCHFMGVMHRDL 221 (447)
Q Consensus 166 ---------~~---~-----~~~lv~e~~~g~~L~~~l~---~~~~~----~~~~~~~i~~qil~~l~~lH~~~ivH~Dl 221 (447)
.. . +.+++|+-+. ++|.+.+. ..... .......+..|++..+++||..|+||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 2367777774 57766653 22222 12223456689999999999999999999
Q ss_pred CCCceEeecCCCCCceEEecCCCceeccCCCceeecCCcccccccccccc---------cCCCCCcchhHHHHHHHHhhC
Q 013201 222 KPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR---------SYGKEIDVWSAGVILYILLSG 292 (447)
Q Consensus 222 kp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~elltg 292 (447)
+|+|++++. ++.+.|+||+.....+. .......+..|.+||.... .++.+.|.|+||+++|.|.+|
T Consensus 172 ~~~nfll~~---~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQ---DGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-T---TS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcC---CCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999955 45699999987765443 2222455678999997532 268889999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCC
Q 013201 293 VPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKR 342 (447)
Q Consensus 293 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 342 (447)
..||........... .+. ... .+++.+++||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999976543321111 111 111 478999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=184.09 Aligned_cols=188 Identities=18% Similarity=0.220 Sum_probs=139.6
Q ss_pred eecceeccccCeEEEEEEECCCCCEEEEEEeeccccC-ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 97 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
.+...|++|+||+||.+.. .+.+++.+.+...... .......+.+|+++|++|.++++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999998765 5777776655332221 111223578999999999878999999886 34689999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecC-CCCceEeecCCCCCceEEecCCCceeccCCCce
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL-KPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dl-kp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 254 (447)
|+.|.+|...+.. ....++.|++.+|.++|++||+|||| ||+|||++. +..++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~---~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE---DGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC---CCCEEEEECCCceecCCcchH
Confidence 9999888654321 12457889999999999999999999 799999954 346999999999865543210
Q ss_pred ------e--------ecCCccccccccccc---ccCCCCCcchhHHHHHHHHhhCCCCCCCCC
Q 013201 255 ------R--------DIVGSAYYVAPEVLR---RSYGKEIDVWSAGVILYILLSGVPPFWAET 300 (447)
Q Consensus 255 ------~--------~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~ 300 (447)
. -...++.|++|+... ...-...++++.|+-+|.++|+..++++..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 123577788887532 222256799999999999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=192.03 Aligned_cols=190 Identities=27% Similarity=0.390 Sum_probs=141.2
Q ss_pred cCCCCeeEEEEEEEe---------------------------CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHH
Q 013201 152 SGQQNIVEFRGAYED---------------------------RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAI 204 (447)
Q Consensus 152 ~~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi 204 (447)
..|||||++..+|.+ +..+|+||...+ .+|..++..+ ..+....+-++.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHH
Confidence 369999999988743 236899998774 5898888765 45777788899999
Q ss_pred HHHHHHHHhcCcEeecCCCCceEeecCCC-CCceEEecCCCceeccC-------CCceeecCCccccccccccccc----
Q 013201 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDG-GAMLKATDFGLSVFIDE-------GKVYRDIVGSAYYVAPEVLRRS---- 272 (447)
Q Consensus 205 l~~l~~lH~~~ivH~Dlkp~Nill~~~~~-~~~vkl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~---- 272 (447)
++|+.|||.+||.|||+|.+|||+..+++ ...+.|+|||.+-.-.. .......-|.-.-||||+....
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 99999999999999999999999975543 45688899998753222 1122334678889999997522
Q ss_pred ---CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHH-HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHH
Q 013201 273 ---YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDA-ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSA 346 (447)
Q Consensus 273 ---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ 346 (447)
--.++|.|+.|.+.||+++...||++.....+-.. ..+...+.. ...+++.+++||..+|+.||++|++..
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPal---p~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPAL---PSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCC---cccCChHHHHHHHHHhcCCccccCCcc
Confidence 13479999999999999999999988433211111 111111111 125789999999999999999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=220.75 Aligned_cols=245 Identities=21% Similarity=0.312 Sum_probs=178.3
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccc-cCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRK-LVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
.|...+.||.+.|=+|.+|++.+ | .|+||++.+.. ........+...|++ .... .+||++.+..+-+.+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence 47888999999999999998763 4 49999987754 222333344445555 3333 499999998888888888999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec--cCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI--DEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~--~~~ 251 (447)
-+|.. .+|+|.|.-+..+..-+.+.|+.||+.||.-||..||+|||||.+|||| ..-..+-|+||...+.. .++
T Consensus 100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCC
Confidence 99995 4999999887778888999999999999999999999999999999999 55557899999866432 111
Q ss_pred C--ce----eecCCcccccccccccc-----------c-CCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCC
Q 013201 252 K--VY----RDIVGSAYYVAPEVLRR-----------S-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312 (447)
Q Consensus 252 ~--~~----~~~~gt~~y~aPE~~~~-----------~-~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 312 (447)
. .+ .+..--.+|+|||.+.. . .+++.||||+||++.||++ |++||.- .++ -....+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL-~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQL-LAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHH-HhHhccC
Confidence 1 11 11223357999997631 1 4678999999999999998 7888831 111 1111221
Q ss_pred CCCCCCccc-cCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 313 VDFESEPWL-LISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 313 ~~~~~~~~~-~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
...+..... .-+..++.||..|++.||++|.+|++.|+.
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 100000000 114468999999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=181.19 Aligned_cols=144 Identities=18% Similarity=0.157 Sum_probs=112.2
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChh-----------------------hHHHHHHHHHHHHhccCCC
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ-----------------------DREDIKREIQIMQHLSGQQ 155 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~~h~ 155 (447)
...||+|++|.||+|++. +|+.||||++......... ....+.+|...+.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence 568999999999999987 8999999998764211000 0123467899999997 78
Q ss_pred CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCC
Q 013201 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGG 234 (447)
Q Consensus 156 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~ 234 (447)
+|.....+.... .||||||++|+++.........+++..+..++.|++.++.++|. .||+||||||+|||++ +
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----~ 153 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----D 153 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----C
Confidence 775444433332 47999999988665443445678899999999999999999999 9999999999999996 2
Q ss_pred CceEEecCCCceeccC
Q 013201 235 AMLKATDFGLSVFIDE 250 (447)
Q Consensus 235 ~~vkl~Dfg~a~~~~~ 250 (447)
..++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 3599999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=177.31 Aligned_cols=138 Identities=20% Similarity=0.239 Sum_probs=109.0
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc----CCCCeeEEEEEEEeCC---eEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS----GQQNIVEFRGAYEDRQ---SVH 171 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~---~~~ 171 (447)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+. .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 56899999999995 7777666 689875532 224567899999999994 3899999999998873 434
Q ss_pred -EEEec--cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHhcCcEeecCCCCceEeecCC-CCCceEEecCCCc
Q 013201 172 -LVMEL--CSGGELFDKIIAQGHYTEKAAAALCRAIVNVV-HHCHFMGVMHRDLKPENFLLSNKD-GGAMLKATDFGLS 245 (447)
Q Consensus 172 -lv~e~--~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l-~~lH~~~ivH~Dlkp~Nill~~~~-~~~~vkl~Dfg~a 245 (447)
+|+|| +.+++|.+++.+ ..+++. ..++.|++.++ .|||+++|+||||||+|||++..+ +...++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 557999999966 356666 36678888877 899999999999999999997544 3457999995433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-23 Score=178.85 Aligned_cols=239 Identities=19% Similarity=0.242 Sum_probs=186.1
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
..+..+|.+.-.|..|+|++. |..+++|++..+.. ......+|..|.-.|+-+. ||||+.+++.|....++.+|..
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeee
Confidence 456778999999999999987 55677787654433 2333456788888888887 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCCCCceEE--ecCCCceecc
Q 013201 176 LCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKA--TDFGLSVFID 249 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~~~vkl--~Dfg~a~~~~ 249 (447)
|++.|+|+..|..... .+..++.+++..++.|+.|||+.. |.---|....+++ +++.+.+| +|--++-+.
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfqe- 343 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQE- 343 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeeec-
Confidence 9999999999987654 677889999999999999999875 4445678888999 44444443 443322211
Q ss_pred CCCceeecCCccccccccccccc----CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRRS----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
....-.|.||+||.+.+. .-.++|+|||++++|||.|...||.+....+.-.+|.-.+.....++ .++.
T Consensus 344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp--gis~ 416 (448)
T KOG0195|consen 344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP--GISR 416 (448)
T ss_pred -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC--CccH
Confidence 122446899999998643 34579999999999999999999998888776666555444444443 6899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHh
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
.+..|+.-|+..||.+||.+..++
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999988764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=205.24 Aligned_cols=195 Identities=24% Similarity=0.370 Sum_probs=157.6
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc--CCCCeeEEEEEEEeCCeE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--GQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~~~~~ 170 (447)
...|.|.+.||+|+||.||+|.+.. |+.||+|+=..... -+|.--.+++.+|+ --+-|..+...+...+..
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~------WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP------WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc------eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 4568899999999999999999887 99999996543321 12222233333333 124566666666777888
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeec----CCCCCceEEecCCCce
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSN----KDGGAMLKATDFGLSV 246 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~----~~~~~~vkl~Dfg~a~ 246 (447)
+||+||.+.|+|.+++...+.+++..+..++.|++..+++||..+|||+||||+|+||.. +.+..-++|+|||.+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 899999999999999998888999999999999999999999999999999999999942 2234569999999986
Q ss_pred ec---cCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCC
Q 013201 247 FI---DEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVP 294 (447)
Q Consensus 247 ~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~ 294 (447)
.+ .++..+...++|-.+-.+|+..| .|+..+|.|.|+.+++.||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 43 45557778899999999999875 59999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=173.41 Aligned_cols=148 Identities=21% Similarity=0.182 Sum_probs=114.4
Q ss_pred ceeecceeccccCeEEEEEE-ECCCCCEEEEEEeeccccCCh---------------------hhHHHHHHHHHHHHhcc
Q 013201 95 FYTLGKELGRGQFGITYLCT-ENSTGNSYACKSILKRKLVNK---------------------QDREDIKREIQIMQHLS 152 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~avK~i~~~~~~~~---------------------~~~~~~~~E~~~l~~l~ 152 (447)
.|.+.+.||.|+||.||+|. +..+|+.||+|.+........ .....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 777899999998865421100 01134578999999997
Q ss_pred C-CCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC-cEeecCCCCceEeec
Q 013201 153 G-QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG-VMHRDLKPENFLLSN 230 (447)
Q Consensus 153 ~-h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~-ivH~Dlkp~Nill~~ 230 (447)
+ ...+++++++ ...+|||||++|++|.........+....+..++.||+.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 2 1234455443 235899999999888766544556677778899999999999999999 99999999999996
Q ss_pred CCCCCceEEecCCCceeccC
Q 013201 231 KDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 231 ~~~~~~vkl~Dfg~a~~~~~ 250 (447)
...++|+|||.+.....
T Consensus 184 ---~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 ---DGKVVIIDVSQSVELDH 200 (237)
T ss_pred ---CCCEEEEEChhhhccCC
Confidence 23599999999875443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=187.06 Aligned_cols=176 Identities=27% Similarity=0.425 Sum_probs=136.7
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGH---YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
..++||.|++|.-.+|.++|..+.. .+...++.++.|+..++.| +|.+|+|+||.||++..++ .+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~---q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD---QLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch---hhhhhhhh
Confidence 3468999999999999999976543 5677889999999999999 9999999999999996554 69999999
Q ss_pred CceeccCCC-------ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCC
Q 013201 244 LSVFIDEGK-------VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVD 314 (447)
Q Consensus 244 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 314 (447)
+........ .....+||..||+||.+. ..|+.++||||||+||+|+++ -..+| .....+..+..+.++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIP 478 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCC
Confidence 988765544 345578999999999998 569999999999999999998 22222 122334444444433
Q ss_pred CCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 315 FESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 315 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
. .-+.. -++-.+|+.+||...|.+||++.+.--|+|.
T Consensus 479 ~--~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 P--EFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred h--HHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1 11112 2445789999999999999988887777775
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=178.27 Aligned_cols=198 Identities=26% Similarity=0.352 Sum_probs=155.9
Q ss_pred HhccCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCc-EeecCCCCce
Q 013201 149 QHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGV-MHRDLKPENF 226 (447)
Q Consensus 149 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~i-vH~Dlkp~Ni 226 (447)
+.+. |.|+.++++.+.+....++|.+||.-|+|.+.+.. .-.++..-...+++.|+.||.|+|.-.| +|+.+++.|.
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4566 99999999999999999999999999999999987 4457788888999999999999998876 9999999999
Q ss_pred EeecCCCCCceEEecCCCceeccCC---CceeecCCccccccccccccc--------CCCCCcchhHHHHHHHHhhCCCC
Q 013201 227 LLSNKDGGAMLKATDFGLSVFIDEG---KVYRDIVGSAYYVAPEVLRRS--------YGKEIDVWSAGVILYILLSGVPP 295 (447)
Q Consensus 227 ll~~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~elltg~~p 295 (447)
++ +....+||.|||+....... .......-..-|.|||.++.. .+.+.||||||++++|+++...|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 77788999999998766421 111111234569999998642 46779999999999999999999
Q ss_pred CCCC----CHHHHHHHHHhCCCCCCCCc---cccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 296 FWAE----TEKGIFDAILKGGVDFESEP---WLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 296 f~~~----~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
|... ...+++..+.++......+. ...+.+++..++..||..+|..||+++++-.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9753 23356666555222222221 1145667999999999999999999999753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-22 Score=202.50 Aligned_cols=258 Identities=30% Similarity=0.468 Sum_probs=207.1
Q ss_pred eeecceeccccCeEEEEEEECC-CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENS-TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
|.+.+.||+|+|+.|-++.... ....+|+|.+.... ........+..|..+-+.+..|+|++.+++...+.+..++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 7778889999999998877643 34456666553322 233344556668888888877999999999999999999999
Q ss_pred eccCCCchHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-hcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-
Q 013201 175 ELCSGGELFDKI-IAQG-HYTEKAAAALCRAIVNVVHHCH-FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE- 250 (447)
Q Consensus 175 e~~~g~~L~~~l-~~~~-~~~~~~~~~i~~qil~~l~~lH-~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~- 250 (447)
+|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+. .+|++|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYRNK 178 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhcccccc
Confidence 999999999988 5544 6788889999999999999999 999999999999999965442 699999999987654
Q ss_pred C---CceeecCC-cccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHH-HHHHhCCCCCCCCccccC
Q 013201 251 G---KVYRDIVG-SAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF-DAILKGGVDFESEPWLLI 323 (447)
Q Consensus 251 ~---~~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~ 323 (447)
. ......+| ++.|+|||...+ ...+..|+||+|+++.-+++|..|+......... .........+...+|..+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 2 22344688 999999998765 4688999999999999999999999765443321 222222233445677788
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
+....+++.++|..+|..|.+.+++..++|+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 999999999999999999999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=161.57 Aligned_cols=137 Identities=29% Similarity=0.382 Sum_probs=112.2
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-----QDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
+.||+|++|.||+|.+ .|..+++|+......... .....+.+|+.++..+. |++|+....++.+....++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999987 577899997643322211 12346788999999997 788877777777778889999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ...++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999998865432 7889999999999999999999999999999996 23599999998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.7e-19 Score=156.35 Aligned_cols=134 Identities=24% Similarity=0.299 Sum_probs=104.9
Q ss_pred eeccccCeEEEEEEECCCCCEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-----QDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
.||+|+||.||+|.. ++..+++|.......... ....++.+|+.+++.+. ++++.....++.+....++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999984 578899998654322211 12366789999999998 6655444444556667789999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
|++|++|.+.+..... .++.+++.+|.++|+.|++|+|++|.||+++ ...++++|||++...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 9999999887754321 8899999999999999999999999999996 235999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=176.51 Aligned_cols=141 Identities=19% Similarity=0.245 Sum_probs=112.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN-----KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
...|...+.||+|+||+||++.+.. ..+++|+........ ....+++.+|+.+++.+. |++++....++.+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~ 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDP 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeC
Confidence 4456778999999999999998653 345555433222211 122456889999999998 89998887777777
Q ss_pred CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 168 QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
...++||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||++ + ..++|+|||++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~---~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D---DRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C---CcEEEEeCccccc
Confidence 78899999999999998875 3567899999999999999999999999999993 2 2599999999875
Q ss_pred c
Q 013201 248 I 248 (447)
Q Consensus 248 ~ 248 (447)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=172.69 Aligned_cols=263 Identities=21% Similarity=0.247 Sum_probs=204.8
Q ss_pred Cccccccceeecceecc--ccCeEEEEEEE--CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEE
Q 013201 88 PLEDIRQFYTLGKELGR--GQFGITYLCTE--NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA 163 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 163 (447)
..+.+.+.+.+...+|. |.+|.||.+.. ..++..+|+|.-. ..........+-.+|+...++++.|+|.++.+..
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~-~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSK-IPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCccccccccc-CCCCCccccccccchhhcccccCccccccccCcc
Confidence 34455677888999999 99999999998 8889999999632 2222233344446788888888889999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHhcCcEeecCCCCceEeecCCCCCceE
Q 013201 164 YEDRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVN----VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238 (447)
Q Consensus 164 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qil~----~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vk 238 (447)
++..+..|+-+|+| +.+|..+...... +++..++.++.+... ||.++|..+++|-|+||.||++..+. ..++
T Consensus 187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~ 263 (524)
T KOG0601|consen 187 WEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCK 263 (524)
T ss_pred cccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceee
Confidence 99999999999999 5788888877555 899999999999999 99999999999999999999995442 4689
Q ss_pred EecCCCceeccCCCce------eecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Q 013201 239 ATDFGLSVFIDEGKVY------RDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG 312 (447)
Q Consensus 239 l~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 312 (447)
++|||+...+.+.... ....|..-|++||.+++-++...|+|++|.++.+..++..++....... ... .+..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~-~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQ-LRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-ccc-cccc
Confidence 9999999887765421 1236778899999999999999999999999999998876654331110 001 1111
Q ss_pred CCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 313 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+ .+.+.-...+.++...+..|++.+|..|++++.+++|+++...
T Consensus 342 ~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 342 Y-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred c-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 1 1111112346677779999999999999999999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-19 Score=155.54 Aligned_cols=141 Identities=21% Similarity=0.267 Sum_probs=107.5
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh-------------------hhHHHHHHHHHHHHhccCCC
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-------------------QDREDIKREIQIMQHLSGQQ 155 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-------------------~~~~~~~~E~~~l~~l~~h~ 155 (447)
.|.+.+.||.|+||.||+|.+. +|+.+|||++........ .......+|+.++..+. ++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-Hc
Confidence 3888999999999999999875 799999998754321000 01123678899999986 55
Q ss_pred --CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC
Q 013201 156 --NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233 (447)
Q Consensus 156 --~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~ 233 (447)
.++..++ ....++||||++|++|..... ......++.+++.++.++|..||+||||||+||+++.
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~--- 160 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD--- 160 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC---
Confidence 4455543 245589999999998865432 1346778899999999999999999999999999954
Q ss_pred CCceEEecCCCceeccC
Q 013201 234 GAMLKATDFGLSVFIDE 250 (447)
Q Consensus 234 ~~~vkl~Dfg~a~~~~~ 250 (447)
+..++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 45699999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=150.10 Aligned_cols=142 Identities=20% Similarity=0.250 Sum_probs=100.2
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHH---------------------HHHHHHHHHhccCC-CC
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED---------------------IKREIQIMQHLSGQ-QN 156 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~---------------------~~~E~~~l~~l~~h-~~ 156 (447)
++.||+|+||.||+|.+. +++.||+|++............. ...|...+.++.++ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999987 89999999886533211111111 14567777777522 23
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCC
Q 013201 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 157 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
+++.++. ...++||||++|+.+........... ..+..++.+++.++.++|. .||+||||||+||+++ +.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----CC
Confidence 5555543 24589999999854322111111111 6788999999999999999 9999999999999996 34
Q ss_pred ceEEecCCCceeccC
Q 013201 236 MLKATDFGLSVFIDE 250 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~~ 250 (447)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 699999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-16 Score=145.48 Aligned_cols=139 Identities=19% Similarity=0.288 Sum_probs=102.7
Q ss_pred cceec-cccCeEEEEEEECCCCCEEEEEEeeccccC----------ChhhHHHHHHHHHHHHhccCCCCe--eEEEEEEE
Q 013201 99 GKELG-RGQFGITYLCTENSTGNSYACKSILKRKLV----------NKQDREDIKREIQIMQHLSGQQNI--VEFRGAYE 165 (447)
Q Consensus 99 ~~~lg-~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~----------~~~~~~~~~~E~~~l~~l~~h~~i--v~~~~~~~ 165 (447)
...|| .||.|+||.+... +..+++|.+...... .......+.+|+.++.+|. |++| +..+++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~ 112 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARV 112 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeee
Confidence 34677 7888888888754 778999987543221 1123456789999999997 6664 67776643
Q ss_pred eC-C---eEEEEEeccCC-CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 166 DR-Q---SVHLVMELCSG-GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 166 ~~-~---~~~lv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
.. . ..++|||+++| .+|.+++.. ..+++.. +.+|+.+|.+||++||+||||||.|||++.++ .++|+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---~v~LI 184 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG---KFWLI 184 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC---CEEEE
Confidence 32 2 23599999997 688877654 4566543 57899999999999999999999999996543 59999
Q ss_pred cCCCceec
Q 013201 241 DFGLSVFI 248 (447)
Q Consensus 241 Dfg~a~~~ 248 (447)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-16 Score=133.33 Aligned_cols=133 Identities=23% Similarity=0.316 Sum_probs=110.1
Q ss_pred ecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC-CCeeEEEEEEEeCCeEEEEEec
Q 013201 98 LGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ-QNIVEFRGAYEDRQSVHLVMEL 176 (447)
Q Consensus 98 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~~~~~~lv~e~ 176 (447)
+.+.||.|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.++ .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35789999999999999754 7899998744321 46788999999999844 6899999998888899999999
Q ss_pred cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc---CcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 177 CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM---GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 177 ~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
+.|+.+..+ +......++.+++.+|.++|.. +++|+|++|+||+++. ...++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~---~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD---GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC---CcEEEEEecccccC
Confidence 998877543 5566778899999999999985 7999999999999965 34699999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.7e-18 Score=171.96 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=202.8
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
+.+.+-+.+|+++.++.+.-..+|...+.|+..+.......+.+....+-.++-... +|-++.....+......+||++
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcchhhH
Confidence 667778899999999998888888777777654433333333344444444433222 5666665555556678899999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-----
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE----- 250 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~----- 250 (447)
|..|++|...|...+..+++.++.++..+..+++|||...+.|+|++|.|+++.. .+..++.|||.......
T Consensus 885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~---~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY---DGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcc---cCCcccCccccccccccccCcC
Confidence 9999999999999888888899999999999999999999999999999999944 44688999984321100
Q ss_pred -------------------------C--CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH
Q 013201 251 -------------------------G--KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK 302 (447)
Q Consensus 251 -------------------------~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 302 (447)
+ .......||+.|.+||.+. ...+..+|+|++|++++|.++|.+||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 0112357999999999876 45788999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHH---HHhcCCCccCCCC
Q 013201 303 GIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSA---EVLEHPWMREGGE 359 (447)
Q Consensus 303 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~---~~l~h~~~~~~~~ 359 (447)
.+++.|..+...++..+- ..+.++++++.++|..+|.+|..+. ++-.|+||+....
T Consensus 1042 ~~f~ni~~~~~~~p~g~~-~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPE-EGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhccccCCCCCCCCcc-ccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 999999888777665443 4689999999999999999999988 8899999987543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.8e-15 Score=147.08 Aligned_cols=157 Identities=19% Similarity=0.288 Sum_probs=102.2
Q ss_pred CCCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC--------------------------C-h---
Q 013201 86 GKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV--------------------------N-K--- 135 (447)
Q Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~--------------------------~-~--- 135 (447)
+.+.+++-..|.. +.||.|++|.||+|+.+.+|+.||||++.+.... + .
T Consensus 112 G~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v 190 (537)
T PRK04750 112 GGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV 190 (537)
T ss_pred CCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH
Confidence 4444555555776 7899999999999999988999999998654210 0 0
Q ss_pred -hhHHH------HHHHHHHHHhcc---CCCCeeEEEEEE-EeCCeEEEEEeccCCCchHHH--HHHcC----CCCHHHHH
Q 013201 136 -QDRED------IKREIQIMQHLS---GQQNIVEFRGAY-EDRQSVHLVMELCSGGELFDK--IIAQG----HYTEKAAA 198 (447)
Q Consensus 136 -~~~~~------~~~E~~~l~~l~---~h~~iv~~~~~~-~~~~~~~lv~e~~~g~~L~~~--l~~~~----~~~~~~~~ 198 (447)
...+. +.+|+..+.++. .+.+.+.+-.++ +.....+|||||+.|+.+.+. +...+ .+.+..+.
T Consensus 191 ~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~ 270 (537)
T PRK04750 191 AEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE 270 (537)
T ss_pred HHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence 01112 334554454443 122333333333 235567899999999999764 33332 23444445
Q ss_pred HHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC-CCCceEEecCCCceeccC
Q 013201 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD-GGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 199 ~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~~~vkl~Dfg~a~~~~~ 250 (447)
.++.|++ ..|++|+|+||.||+++.++ ....++++|||++..+.+
T Consensus 271 ~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5555554 58999999999999996543 223699999999987654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.4e-16 Score=140.96 Aligned_cols=238 Identities=16% Similarity=0.205 Sum_probs=156.8
Q ss_pred EEEEEEECCCCCEEEEEEeeccccCChhh-HHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----eEEEEEeccCCCch
Q 013201 109 ITYLCTENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-----SVHLVMELCSGGEL 182 (447)
Q Consensus 109 ~Vy~~~~~~~~~~~avK~i~~~~~~~~~~-~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~~~lv~e~~~g~~L 182 (447)
.||++.+...|..|+.-.+......+... .+....-...|-++. |.|||+++.|+.+.. +..++.||+..|+|
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 47888888888777655443222111111 111222233344455 889999999986644 47899999999999
Q ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhc--CcEeecCCCCceEeecCCCCCceEEecCCCcee---ccCC--
Q 013201 183 FDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFM--GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF---IDEG-- 251 (447)
Q Consensus 183 ~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~--~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~---~~~~-- 251 (447)
..+|++. ..+......+++.||++||.|||+. -|+|+++..+-|++.. ++.||+.--..... +...
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~---ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQH---NGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecC---CceEEecccCccccchhhhhhhH
Confidence 9999864 3488888999999999999999987 4999999999999953 34566542111000 0000
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWA-ETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.....-.|-++|.+||.=. ...+.++|||+||....+|..+..--.. ...-..-..+.+..+... ...-++
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~ 309 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG 309 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence 0011235678899999743 3456789999999999999988754322 222122222222211111 122367
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+|.+||+..|..||++.++|.||.+-+.
T Consensus 310 ~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred cCcccccCCCCCCcchhhhhcCceeeec
Confidence 8999999999999999999999987653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.1e-14 Score=139.92 Aligned_cols=145 Identities=19% Similarity=0.203 Sum_probs=97.4
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh-h----------------------h--------H------HHH
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-Q----------------------D--------R------EDI 141 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~----------------------~--------~------~~~ 141 (447)
.+.||.|++|.||+|+.+ +|+.||||+..+.....- . + . -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999975 799999998754311000 0 0 0 024
Q ss_pred HHHHHHHHhcc----CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 013201 142 KREIQIMQHLS----GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVN-VVHHCHFMG 215 (447)
Q Consensus 142 ~~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~-~l~~lH~~~ 215 (447)
.+|+..+.++. ++++|.-..-+.......+|||||++|++|.+..... .... ...++..++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 45666555553 3444332222233345578999999999998876432 1222 3445566655 477899999
Q ss_pred cEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 216 ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
++|+|+||.||++.. ++.++|+|||++..+.+
T Consensus 278 ~~H~D~hPgNilv~~---~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLK---DGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECC---CCcEEEEeCCCeeECCH
Confidence 999999999999944 34699999999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.4e-13 Score=119.93 Aligned_cols=144 Identities=13% Similarity=0.130 Sum_probs=104.0
Q ss_pred cceeccccCeEEEEEEECC------CCCEEEEEEeecccc--C--------C---------hhhHHHHH----HHHHHHH
Q 013201 99 GKELGRGQFGITYLCTENS------TGNSYACKSILKRKL--V--------N---------KQDREDIK----REIQIMQ 149 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~------~~~~~avK~i~~~~~--~--------~---------~~~~~~~~----~E~~~l~ 149 (447)
...||.|--+.||.|.... .+..+|+|+..-... . + ...+..+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 357999997642211 0 0 11122333 8999999
Q ss_pred hccCC-CCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeecCCCCceE
Q 013201 150 HLSGQ-QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC-HFMGVMHRDLKPENFL 227 (447)
Q Consensus 150 ~l~~h-~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~l-H~~~ivH~Dlkp~Nil 227 (447)
++... -+++.++++ ..-+|||||+.++.+.....+...+++..+..+..+++.+|..+ |..||||+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 98732 467777765 45679999997654433223333566667788899999999998 8999999999999999
Q ss_pred eecCCCCCceEEecCCCceeccC
Q 013201 228 LSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 228 l~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+.. ..+.|+|||.+.....
T Consensus 158 ~~~----~~v~iIDF~qav~~~h 176 (197)
T cd05146 158 WHD----GKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEC----CcEEEEECCCceeCCC
Confidence 953 2489999999876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5e-15 Score=144.41 Aligned_cols=250 Identities=19% Similarity=0.194 Sum_probs=183.9
Q ss_pred cceeecceeccccCeEEEEEEEC-CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN-STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
..|.++..||.|.|+.|+.+..+ .++..|++|.+.+.......+. .-..|+-+...+..|.+++.+...|......|+
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 34778899999999999987755 6788899998766544333222 224677777777778999998888887788889
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
-.|||.++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..++ +..++.|||....+.-.
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhcccccccccccee-
Confidence 999999998876665555688889999999999999999999999999999999997654 67899999988642111
Q ss_pred ceeecCCccccc-cccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 253 VYRDIVGSAYYV-APEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 253 ~~~~~~gt~~y~-aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.....+.-+++ ..|++. ..+..+.|++|||..+++.++|...-+.... ...|..+...... ....++..
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~----~~~~~~q~ 492 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNLP----GLKLQLQV 492 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCCC----chHHhhhh
Confidence 01122333444 355554 3478899999999999999998754333222 1223333222111 23477889
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
+.+.++..++..|+.+.++..|.-|.
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999999999998886554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.5e-13 Score=112.53 Aligned_cols=147 Identities=21% Similarity=0.242 Sum_probs=112.9
Q ss_pred ecceeccccCeEEEEEEECCCCCEEEEEEeeccccC-----ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 98 LGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-----NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 98 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
....|-+|+-+.|+++.+. |+.++||.=....+. ....+.+..+|+++|.++. --.|.--.-++.|...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence 4567889999999998865 888888853322222 2234567789999999987 3455554556667777789
Q ss_pred EEeccCC-CchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 173 VMELCSG-GELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 173 v~e~~~g-~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
+|||++| .++.+++.... .........+++.|-..+.-||.++|+|+||..+||++..++....+-|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999987 46777776532 233344478999999999999999999999999999999988888889999999854
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.9e-13 Score=130.85 Aligned_cols=183 Identities=16% Similarity=0.195 Sum_probs=134.9
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|.+ ...+-++.+..-.|..+.++.+|.|.+..... ....+...+.++-|+.++ ||||+++++.++.++..|||+|
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEee
Confidence 555 44444555532246777889999998775433 233456778899999998 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc-
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH-FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV- 253 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH-~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~- 253 (447)
.+. .|..++.+.+ ...+..-+.||+.||.||| +.+++|++|..+.|+++..+ ..||++|.++........
T Consensus 90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G---eWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG---EWKLGGLELVSKASGFNAP 161 (690)
T ss_pred ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC---cEEEeeeEEEeccccCCcc
Confidence 985 5666776644 7778888999999999997 77899999999999995544 599999988765433221
Q ss_pred eeecCCcccccccccccccCCCCCcchhHHHHHHHHhhC
Q 013201 254 YRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSG 292 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg 292 (447)
.....---.|..|+.+... .-..|.|-|||++++++.|
T Consensus 162 ~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 AKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 1111122235566654321 1357999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=117.74 Aligned_cols=128 Identities=17% Similarity=0.147 Sum_probs=94.7
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
+.|+.|.++.||+++.. +..|++|....... ....+.+|+.+++.+.+...+++++.+.. ...++||||++|
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 56889999999999865 77899997643211 12345789999999874434556665543 345799999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCc-----EeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGV-----MHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~i-----vH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++ .++++|||.+..
T Consensus 76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~---~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG---RLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC---eEEEEecccccC
Confidence 887543 11123467889999999999985 9999999999996 22 489999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-12 Score=109.46 Aligned_cols=136 Identities=26% Similarity=0.324 Sum_probs=101.9
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChh-----hHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ-----DREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
..+++|+-+.+|.+.+. |..+++|.=.+.....+. ...+-.+|+.++.++. --.|..-+-+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence 45789999999998653 556777754443333322 2355678999999887 345555455556677778999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
||++|..|.+.+... ...+++.+-..+.-||..||+|+||.++||++...+ +-++|||++....
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~----i~~IDfGLg~~s~ 142 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEFSD 142 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc----EEEEECCcccccc
Confidence 999998888888765 256777788888899999999999999999996543 8899999997543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3e-10 Score=109.07 Aligned_cols=287 Identities=17% Similarity=0.223 Sum_probs=186.7
Q ss_pred CeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE----eCCeEEEEEeccCC-Cc
Q 013201 107 FGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE----DRQSVHLVMELCSG-GE 181 (447)
Q Consensus 107 ~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----~~~~~~lv~e~~~g-~~ 181 (447)
-.+.|+|....+|..|++|++.-.+... ......-+++++++. |+|||.+.++|. .+..+++|++|.++ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 3578999999999999999983222211 112234578899998 999999999886 35678999999986 46
Q ss_pred hHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 182 LFDKIIA---------------QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 182 L~~~l~~---------------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
|.++-.. ....+|+.+|.|+.||..||.++|+.|+.-+-|.|.+||+ .++..|+|...|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEeccccee
Confidence 7665432 2236789999999999999999999999999999999999 444469999888877
Q ss_pred eccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCC-HHHH-HHHHHhCCCCCCCCccccCC
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAET-EKGI-FDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~-~~~i~~~~~~~~~~~~~~~s 324 (447)
.+..+.. |.+. --.+-|.=.||.+++.|.||..--+..+ .... +..|.. .++
T Consensus 442 vl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~-----------~yS 495 (655)
T KOG3741|consen 442 VLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT-----------TYS 495 (655)
T ss_pred eecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh-----------hhh
Confidence 6655430 1111 1235789999999999999965432222 2222 333322 368
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC---CCccCCCCCCC-CcccHHHHHHHHHHHHHhhhhHHHHHH--HHhhhh---
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEH---PWMREGGEASD-KPIGSAVLSRMKQFRAMNKLKKMALKV--IAEALS--- 395 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~k~~~~~~--i~~~~~--- 395 (447)
.+++++|.-+...++.+ -++.++|.| .||........ ....+..+ -+-....+|.+..... |.++..
T Consensus 496 ~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~~d~mE~~L---s~emENGRLfRll~Kln~I~dR~e~~~ 571 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLKTDVMETEL---SREMENGRLFRLLLKLNFIDDRPEYVD 571 (655)
T ss_pred HHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHHHHHHHHHH---HHHHhcchHHHHHHHHhhhccCccccc
Confidence 89999999999998887 788888865 23322111100 00011111 1111112222221111 111100
Q ss_pred ---HHH------hhhhc-ceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 396 ---EEE------IKGLK-TMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 396 ---~~~------~~~l~-~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
..+ +.-++ -+|...|.||..-+++..+.+.|.+|.
T Consensus 572 D~~WSesG~~fmi~LFRDYlFHqvtedg~p~lDlaHvl~CLNKLD 616 (655)
T KOG3741|consen 572 DPDWSESGDRFMIKLFRDYLFHQVTEDGKPWLDLAHVLQCLNKLD 616 (655)
T ss_pred CCcchhccceehHHHHHHhhheEeccCCChhhhHHHHHHHhhhcc
Confidence 000 11122 468899999999999999999888874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.5e-11 Score=108.78 Aligned_cols=143 Identities=24% Similarity=0.386 Sum_probs=103.5
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC-CCeeEEEEEEEeC---CeEEEEEe
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ-QNIVEFRGAYEDR---QSVHLVME 175 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~~---~~~~lv~e 175 (447)
+.||.|..+.||++.... |..+++|........ .....+.+|+.+++.+.++ .++++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998753 678999976443211 1345678999999999742 3467777776654 36789999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF------------------------------------------ 213 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~------------------------------------------ 213 (447)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999887664422 346666666777777777777763
Q ss_pred --------------cCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 214 --------------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 214 --------------~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
..++|+|++|.||+++.+ ....+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999653 134588999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.2e-09 Score=100.71 Aligned_cols=137 Identities=18% Similarity=0.130 Sum_probs=95.0
Q ss_pred eEEEEEEECCCCCEEEEEEeeccccC----C----hhhHHHHHHHHHHHHhccCCCC--eeEEEEEEEe-----CCeEEE
Q 013201 108 GITYLCTENSTGNSYACKSILKRKLV----N----KQDREDIKREIQIMQHLSGQQN--IVEFRGAYED-----RQSVHL 172 (447)
Q Consensus 108 g~Vy~~~~~~~~~~~avK~i~~~~~~----~----~~~~~~~~~E~~~l~~l~~h~~--iv~~~~~~~~-----~~~~~l 172 (447)
..|+++.. .|+.|.||........ . ........+|...+.+|. .-+ ++.++.+++. ...-+|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEE
Confidence 34555543 4677888865322210 0 011124678988888885 223 3444555543 235789
Q ss_pred EEeccCCC-chHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC----CCCCceEEecCCCc
Q 013201 173 VMELCSGG-ELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK----DGGAMLKATDFGLS 245 (447)
Q Consensus 173 v~e~~~g~-~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~----~~~~~vkl~Dfg~a 245 (447)
|||++++. +|.+++.. ....++.....++.+++..+.-||..||+|+|+++.|||+..+ ++...+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999875 78888754 3456677788999999999999999999999999999999752 33567999999987
Q ss_pred ee
Q 013201 246 VF 247 (447)
Q Consensus 246 ~~ 247 (447)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.1e-09 Score=99.04 Aligned_cols=239 Identities=16% Similarity=0.166 Sum_probs=156.1
Q ss_pred eecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEE------EEe-CCe
Q 013201 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA------YED-RQS 169 (447)
Q Consensus 97 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~------~~~-~~~ 169 (447)
.+++.||+|+-+.+|-.-.- + ..+.|+..+..-. .-.+-+..|.....||-+-.-+.| .-+ ...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa------~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPA------AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh--h-chhheeecCCCch------HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 35678999999999954321 2 2344766443211 111233444444445543321111 112 223
Q ss_pred EEEEEeccCCCc-hHHHHH---HcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecC
Q 013201 170 VHLVMELCSGGE-LFDKII---AQG---HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 170 ~~lv~e~~~g~~-L~~~l~---~~~---~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
..++|..++|.. +..++. ++. ...+.-+.+.++.|+.+...||+.|.+-+|+.++|+|++++ ..|.|+|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~---~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD---SKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC---ceEEEEcc
Confidence 778888887752 222221 122 25677889999999999999999999999999999999544 45888886
Q ss_pred CCceeccCCCceeecCCccccccccccc-c-----cCCCCCcchhHHHHHHHHhhC-CCCCCCCCHH----HHHH-HHHh
Q 013201 243 GLSVFIDEGKVYRDIVGSAYYVAPEVLR-R-----SYGKEIDVWSAGVILYILLSG-VPPFWAETEK----GIFD-AILK 310 (447)
Q Consensus 243 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DiwslG~il~elltg-~~pf~~~~~~----~~~~-~i~~ 310 (447)
........+..+...+|.+.|.+||.-. + .-+...|.|.||+++++++.| ++||.+.... .-++ .|-.
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 6555445666677889999999999754 2 246679999999999999986 9999753210 0111 2222
Q ss_pred CCC------------CCCCCccccCChHHHHHHHHhcccC--CCCCCCHHH
Q 013201 311 GGV------------DFESEPWLLISDSAKDLVRKMLIQD--PKKRITSAE 347 (447)
Q Consensus 311 ~~~------------~~~~~~~~~~s~~~~~li~~~L~~d--p~~R~t~~~ 347 (447)
+.+ .....+|..+++.++.|..+|+... +.-|||++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 211 2223456678999999999999853 568999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-09 Score=95.01 Aligned_cols=131 Identities=21% Similarity=0.201 Sum_probs=82.6
Q ss_pred EEEEEEECCCCCEEEEEEeeccccCC-----------------------hhhHHHHHHHHHHHHhccCC-CCeeEEEEEE
Q 013201 109 ITYLCTENSTGNSYACKSILKRKLVN-----------------------KQDREDIKREIQIMQHLSGQ-QNIVEFRGAY 164 (447)
Q Consensus 109 ~Vy~~~~~~~~~~~avK~i~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~ 164 (447)
.||.|... +|..+|+|+.......- ........+|.+.|.++... -++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48998864 57799999764321110 01124467899999999843 2577777553
Q ss_pred EeCCeEEEEEeccC--CCchHHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 165 EDRQSVHLVMELCS--GGELFDKIIAQGHYTEKAAAALCRAIVNVVHH-CHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 165 ~~~~~~~lv~e~~~--g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~-lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
..+|||||++ |..+.. |... .++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iID 149 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYIID 149 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE--
T ss_pred ----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEEe
Confidence 2359999998 655543 3332 12244567788888885555 689999999999999999654 499999
Q ss_pred CCCceeccC
Q 013201 242 FGLSVFIDE 250 (447)
Q Consensus 242 fg~a~~~~~ 250 (447)
||.+.....
T Consensus 150 f~qav~~~~ 158 (188)
T PF01163_consen 150 FGQAVDSSH 158 (188)
T ss_dssp GTTEEETTS
T ss_pred cCcceecCC
Confidence 999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-10 Score=114.09 Aligned_cols=152 Identities=19% Similarity=0.255 Sum_probs=108.0
Q ss_pred HHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCce-----e-----ecCCcccccccccccc-
Q 013201 204 IVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY-----R-----DIVGSAYYVAPEVLRR- 271 (447)
Q Consensus 204 il~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~-----~-----~~~gt~~y~aPE~~~~- 271 (447)
+.+|+.|+|. .++||++|.|++|.++ ..+..||+.|+++........+ . ...-...|.|||++.+
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~n---a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVN---ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred ccchhhhhccCcceeecccchhheeec---cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4499999995 5899999999999994 4456999999988765542111 1 1133457999999864
Q ss_pred cCCCCCcchhHHHHHHHHh-hCCCCCCCCCHHHHHHHHHhCCCCCCCCc-cccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 013201 272 SYGKEIDVWSAGVILYILL-SGVPPFWAETEKGIFDAILKGGVDFESEP-WLLISDSAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 272 ~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
..+.++|+||+|+++|.+. .|+.-+........ ..+..+........ ...+++++++-+.++|..++..||++..++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 4688999999999999998 56555544322111 11111111111110 135889999999999999999999999999
Q ss_pred cCCCccCCCC
Q 013201 350 EHPWMREGGE 359 (447)
Q Consensus 350 ~h~~~~~~~~ 359 (447)
.-+||.+...
T Consensus 264 ~~~ff~D~~~ 273 (700)
T KOG2137|consen 264 SIPFFSDPGL 273 (700)
T ss_pred cccccCCchh
Confidence 9999987543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.2e-09 Score=93.30 Aligned_cols=112 Identities=26% Similarity=0.290 Sum_probs=87.8
Q ss_pred hHHHHHHHHHHHHhccC-CCCeeEEEEEEEeC----CeEEEEEeccCCC-chHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Q 013201 137 DREDIKREIQIMQHLSG-QQNIVEFRGAYEDR----QSVHLVMELCSGG-ELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210 (447)
Q Consensus 137 ~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~----~~~~lv~e~~~g~-~L~~~l~~~~~~~~~~~~~i~~qil~~l~~ 210 (447)
...+..+|...+..|.. .=.++..+.+.+.. ...+||+|+++|. +|.+++......+......++.+++..+.-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 34567788888777752 12245566665542 2458999999874 788888775557788889999999999999
Q ss_pred HHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 211 lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
||+.||+|+|+++.|||+..+++...+.|+||+-+...
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999988776677999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.9e-08 Score=85.36 Aligned_cols=141 Identities=16% Similarity=0.126 Sum_probs=100.7
Q ss_pred eccccCeEEEEEEECCCCCEEEEEEeeccc---cCChhhHHHHHHHHHHHHhccC--CCCeeEEEEEEE-e----CCeEE
Q 013201 102 LGRGQFGITYLCTENSTGNSYACKSILKRK---LVNKQDREDIKREIQIMQHLSG--QQNIVEFRGAYE-D----RQSVH 171 (447)
Q Consensus 102 lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~---~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~~~-~----~~~~~ 171 (447)
-|+||.+-|+..... |..+-+|.-.... +.-......|.+|+..+.+|.. -| ++++. ++. . ...-+
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEE
Confidence 466888889886644 4467777643111 1113356789999999998872 23 55555 332 1 22467
Q ss_pred EEEeccCC-CchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 172 LVMELCSG-GELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 172 lv~e~~~g-~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
||+|-+.| .+|.+++... .+.++.....++.+++..+.-||+.|+.|+|+.+.||+++.++ ...|+++||.-++.
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence 99997754 5788877653 3467777889999999999999999999999999999997544 45699999986643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.4e-08 Score=90.86 Aligned_cols=141 Identities=21% Similarity=0.260 Sum_probs=101.9
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC-----------------C--hhhHHHHHHHHHHHHhccCC-C
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-----------------N--KQDREDIKREIQIMQHLSGQ-Q 155 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-----------------~--~~~~~~~~~E~~~l~~l~~h-~ 155 (447)
+.++..||-|--|.||.|.+. .|.++|+|.=...... + ...+....+|.++|.+|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567899999999999999976 6899999953221110 0 01233457899999999733 2
Q ss_pred CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCC
Q 013201 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 156 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
.|++.+++ +.-.+||||++|-.|... ++..+....++..|+.-+..+-..||||+|+.+-||+++.++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg--- 239 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG--- 239 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC---
Confidence 57776544 566799999998766542 223555666777777777766689999999999999996543
Q ss_pred ceEEecCCCceecc
Q 013201 236 MLKATDFGLSVFID 249 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~ 249 (447)
.+.++||-.+....
T Consensus 240 ~~~vIDwPQ~v~~~ 253 (304)
T COG0478 240 DIVVIDWPQAVPIS 253 (304)
T ss_pred CEEEEeCcccccCC
Confidence 49999997665543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.5e-10 Score=112.17 Aligned_cols=247 Identities=16% Similarity=0.174 Sum_probs=172.1
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC-eeEEEEEEEeCCe
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN-IVEFRGAYEDRQS 169 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-iv~~~~~~~~~~~ 169 (447)
+-.+.|....-+++|+++.+++.+...+.... .+.+... ....-++++|.+++ ||| .+..++-++.+..
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDY 308 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccc
Confidence 33455777888999999999998866554333 5544221 34456899999998 899 7777777788889
Q ss_pred EEEEEeccCCC-ch-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 170 VHLVMELCSGG-EL-FDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 170 ~~lv~e~~~g~-~L-~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.++++++|.++ +. .......-.+.+-+...+.+.-+.+|+++|+.--+|+| ||+... ...|+.||+....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~----~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE----EEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc----cccccccccCCcc
Confidence 99999999877 22 11111122344556677788888899999998778998 888744 3489999999988
Q ss_pred ccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCC-CccccC
Q 013201 248 IDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG--VDFES-EPWLLI 323 (447)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~-~~~~~~ 323 (447)
+......+...+|+.++|||+.. +.+....|.|++|+-..++.-|.+|-..... ....+-.+. ..+.. ..|.
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~-- 456 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWS-- 456 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcC--
Confidence 87766667789999999999765 5688899999999877778878777533100 000000000 00000 1111
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+..-.++...|+..-|..|+....++.|.+|...+.
T Consensus 457 ~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 457 PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred cccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 111225778899999999999999999999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.6e-07 Score=81.18 Aligned_cols=141 Identities=23% Similarity=0.251 Sum_probs=85.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhH------HHHHHHHHHHHhcc--CCCCeeEEEEE-
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR------EDIKREIQIMQHLS--GQQNIVEFRGA- 163 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~------~~~~~E~~~l~~l~--~h~~iv~~~~~- 163 (447)
...|...+.+-.....-|.+.. .+|..+++|.-........... +...+++..+.++. +-.....++-+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3456666777666665555543 4578888886533221111111 11234444444443 12222222222
Q ss_pred ----EEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEE
Q 013201 164 ----YEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 164 ----~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
+......+|||||++|..|.+.. .+++ .+...+..++.-+|+.|++|+|.+|.|+++..++ +++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~----i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG----IRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc----EEE
Confidence 22234567999999998886543 1333 2445677788999999999999999999996433 999
Q ss_pred ecCCCcee
Q 013201 240 TDFGLSVF 247 (447)
Q Consensus 240 ~Dfg~a~~ 247 (447)
+||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.6e-07 Score=97.22 Aligned_cols=207 Identities=19% Similarity=0.230 Sum_probs=147.2
Q ss_pred HHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE----EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 013201 138 REDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH----LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213 (447)
Q Consensus 138 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~----lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~ 213 (447)
....+-|+..+.++. |+|++.++.|........ +..|+|...++...+..-+.++...++.+..+++.||.|+|+
T Consensus 226 i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344556777888887 999999998876544333 345889999999999888899999999999999999999999
Q ss_pred cCcEeecCCCCceEeecCCCCCceEEe--cCCCceeccCCCceeecCCccccccccccccc-C--CCCCcchhHHHHHHH
Q 013201 214 MGVMHRDLKPENFLLSNKDGGAMLKAT--DFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRS-Y--GKEIDVWSAGVILYI 288 (447)
Q Consensus 214 ~~ivH~Dlkp~Nill~~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~--~~~~DiwslG~il~e 288 (447)
....|.-|..+-..-...++...+.+. ||+......+.........+.-|.++|..... + ....|+|.+|..+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 966666555553332223444556655 88888776655444444556678888887643 2 334699999999999
Q ss_pred HhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 289 LLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 289 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+..|..+-... .....++.. ....+..+.+.+|+.-++++|+++.+++.|+|.+...
T Consensus 385 ~~~~~~i~~~~---~~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 385 LSQGEDISEKS---AVPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhcCcccccc---cchhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 99876543111 111111111 0112678899999999999999999999999987543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.4e-07 Score=81.39 Aligned_cols=73 Identities=23% Similarity=0.244 Sum_probs=55.1
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCC-CeeEEEEEEEeCCeEEEEEeccC
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ-NIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
..||.|..+.||+. .+..+++|..... .....+.+|.++++.+.... .+++.+++.++.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 2556788865321 13456789999999987432 26788888888888899999999
Q ss_pred CCc
Q 013201 179 GGE 181 (447)
Q Consensus 179 g~~ 181 (447)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.8e-07 Score=92.14 Aligned_cols=145 Identities=18% Similarity=0.173 Sum_probs=94.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCC--------------------h-------hh----HH------HHH
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVN--------------------K-------QD----RE------DIK 142 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~--------------------~-------~~----~~------~~~ 142 (447)
+.|+.++-|.||+|+.++ |+.||||+..+.-... . .. .+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999999874 9999999875432100 0 00 01 133
Q ss_pred HHHHHHHhcc----CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHH--HHcCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 013201 143 REIQIMQHLS----GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI--IAQGHYTEKAAAALCRAIVNVVHHCHFMGV 216 (447)
Q Consensus 143 ~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l--~~~~~~~~~~~~~i~~qil~~l~~lH~~~i 216 (447)
+|...+.+++ +.++|.--.-+++..+.-.|+|||+.|-.+.+.. .. ..++...+.....++ .+..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 4555555543 3455443333445566778999999998887764 33 445544433322222 1233345899
Q ss_pred EeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 217 vH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+|.|.+|.||++..+ +.+-+.|||+...+.+.
T Consensus 287 fHaDpHpGNi~v~~~---g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSD---GRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecC---CcEEEEcCcceecCCHH
Confidence 999999999999554 46889999998877653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.6e-06 Score=78.73 Aligned_cols=79 Identities=20% Similarity=0.201 Sum_probs=56.8
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCC-CeeEEEEEEE---eCCeEEEEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ-NIVEFRGAYE---DRQSVHLVM 174 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~---~~~~~~lv~ 174 (447)
.+.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+..+- .+++++.+.. .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 3578999999999998764 58999975322 34577889999999887432 2667776443 345679999
Q ss_pred eccCCCchHH
Q 013201 175 ELCSGGELFD 184 (447)
Q Consensus 175 e~~~g~~L~~ 184 (447)
++++|..+..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999887766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.2e-06 Score=80.31 Aligned_cols=76 Identities=16% Similarity=0.145 Sum_probs=54.8
Q ss_pred eeccccC-eEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 101 ELGRGQF-GITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 101 ~lg~G~~-g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
.|-.|.+ +.||++... +..+.+|...... ...+.+|+.+++.+..+--+++++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444555 789998643 4678888653221 345678999999997665677888888777788999999998
Q ss_pred CchHH
Q 013201 180 GELFD 184 (447)
Q Consensus 180 ~~L~~ 184 (447)
.+|..
T Consensus 77 ~~l~~ 81 (244)
T cd05150 77 VPAAA 81 (244)
T ss_pred ccHhH
Confidence 76653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.2e-07 Score=74.71 Aligned_cols=55 Identities=29% Similarity=0.473 Sum_probs=51.6
Q ss_pred HhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 391 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
-..+.+.++++++++|..+|.|+||.|..++|+..|..||...+++||+.||+++
T Consensus 23 Famf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea 77 (171)
T KOG0031|consen 23 FAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEA 77 (171)
T ss_pred HHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhC
Confidence 3456889999999999999999999999999999999999999999999999986
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.7e-06 Score=71.13 Aligned_cols=138 Identities=23% Similarity=0.269 Sum_probs=96.0
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeecccc-------------CChhhHHHHHHHHHHHHhcc-----CCCCeeEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKL-------------VNKQDREDIKREIQIMQHLS-----GQQNIVEF 160 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-------------~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~ 160 (447)
...||+|+.-.||. |. ......||+...... .......+..+|+.....+. .+..|.++
T Consensus 6 ~~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35799999999995 33 344567888765540 01122355667777665554 36789999
Q ss_pred EEEEEeCCeEEEEEeccCC------CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCC
Q 013201 161 RGAYEDRQSVHLVMELCSG------GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG 234 (447)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~g------~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~ 234 (447)
+|+.+.+....+|+|.+.. .+|.+++.+ +.+++ .. ...+-.-..||-+++|+.+||+|.||++...++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998732 357777743 45665 33 3334445567789999999999999999876655
Q ss_pred C-ceEEec-CCC
Q 013201 235 A-MLKATD-FGL 244 (447)
Q Consensus 235 ~-~vkl~D-fg~ 244 (447)
. .+.|+| ||.
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 5 677777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.3e-05 Score=69.69 Aligned_cols=129 Identities=19% Similarity=0.242 Sum_probs=90.6
Q ss_pred cceeecceeccccC-eEEEEEEECCCCCEEEEEEeeccccCCh------------------hhHHHHHHHHHHHHhccC-
Q 013201 94 QFYTLGKELGRGQF-GITYLCTENSTGNSYACKSILKRKLVNK------------------QDREDIKREIQIMQHLSG- 153 (447)
Q Consensus 94 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~avK~i~~~~~~~~------------------~~~~~~~~E~~~l~~l~~- 153 (447)
..++..+.||.|.- |.||++... |+.||+|....-..... .....|..|.+...+|..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 45899999999999 999999865 78999998321111000 112357788888877763
Q ss_pred -CCCe--eEEEEEEEeC------------------CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 013201 154 -QQNI--VEFRGAYEDR------------------QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212 (447)
Q Consensus 154 -h~~i--v~~~~~~~~~------------------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH 212 (447)
+.++ |++++|..-. ....||.||.+... .+. ..=+.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 4455 8999987322 12457888776543 122 233566777888899
Q ss_pred hcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 213 ~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
..||+-+|+++.|.. + -||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~----~----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR----G----GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc----C----CEEEecccC
Confidence 999999999999986 2 578999965
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.6e-06 Score=74.86 Aligned_cols=140 Identities=20% Similarity=0.202 Sum_probs=92.4
Q ss_pred eeccccCeEEEEEEECCCCCEEEEEEeeccccCChh----------------hHHH-----HHHHHHHHHhccC-CCCee
Q 013201 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ----------------DRED-----IKREIQIMQHLSG-QQNIV 158 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~----------------~~~~-----~~~E~~~l~~l~~-h~~iv 158 (447)
.|+.|--+.||+|.. .++..+|+|+.......... .+.+ ...|+..|+++.. +=.++
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 566777789999885 46889999987543221110 1111 2468888887762 23455
Q ss_pred EEEEEEEeCCeEEEEEeccCCCch-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCc
Q 013201 159 EFRGAYEDRQSVHLVMELCSGGEL-FDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAM 236 (447)
Q Consensus 159 ~~~~~~~~~~~~~lv~e~~~g~~L-~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~ 236 (447)
+-+.+. .-.|||||+..... .-.|.. -.+...++..+..+++..+.-|-. .|+||+||..=|||+. + ..
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~---~~ 204 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D---GE 204 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C---Ce
Confidence 665554 34599999954311 111221 123344778888889998887765 9999999999999996 2 24
Q ss_pred eEEecCCCceeccC
Q 013201 237 LKATDFGLSVFIDE 250 (447)
Q Consensus 237 vkl~Dfg~a~~~~~ 250 (447)
+.++|||.|.....
T Consensus 205 p~iID~~QaV~~~h 218 (268)
T COG1718 205 PYIIDVSQAVTIDH 218 (268)
T ss_pred EEEEECccccccCC
Confidence 88999999876553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.1e-06 Score=90.15 Aligned_cols=81 Identities=22% Similarity=0.334 Sum_probs=57.3
Q ss_pred cceeccccCeEEEEEEECCCC--CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCe--eEEEEEEEeC---CeEE
Q 013201 99 GKELGRGQFGITYLCTENSTG--NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNI--VEFRGAYEDR---QSVH 171 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~--~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i--v~~~~~~~~~---~~~~ 171 (447)
.+.|+.|.++.+|+......+ ..+++|+...... ......+.+|+.+|+.+..|.+| ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 467899999999998765432 4677776533221 12345788999999999645554 8888887664 5688
Q ss_pred EEEeccCCCc
Q 013201 172 LVMELCSGGE 181 (447)
Q Consensus 172 lv~e~~~g~~ 181 (447)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999998864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.1e-06 Score=83.59 Aligned_cols=146 Identities=14% Similarity=0.128 Sum_probs=90.9
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCC----------------------------hhhHHH------HHHH
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN----------------------------KQDRED------IKRE 144 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~----------------------------~~~~~~------~~~E 144 (447)
.+.||.-+.|.||+|+.+. |+.||||+-.+..... ....+. |.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3679999999999999876 9999999754321100 000111 2334
Q ss_pred HHHHHhcc---CCCC------eeEEEEEEEeCCeEEEEEeccCCCchHH--HHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Q 013201 145 IQIMQHLS---GQQN------IVEFRGAYEDRQSVHLVMELCSGGELFD--KIIAQGHYTEKAAAALCRAIVNVVHHCHF 213 (447)
Q Consensus 145 ~~~l~~l~---~h~~------iv~~~~~~~~~~~~~lv~e~~~g~~L~~--~l~~~~~~~~~~~~~i~~qil~~l~~lH~ 213 (447)
++...+.. .|-+ |++++. .......|+||||+|..+.+ .|.+. .++...+...+.+... .-+-.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHh
Confidence 44333322 1333 444433 23456679999999986654 33343 4555544443333322 22335
Q ss_pred cCcEeecCCCCceEeecC-CCCCceEEecCCCceeccC
Q 013201 214 MGVMHRDLKPENFLLSNK-DGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 214 ~~ivH~Dlkp~Nill~~~-~~~~~vkl~Dfg~a~~~~~ 250 (447)
.|++|+|-+|.||++..+ ..+..+.+-|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 789999999999999754 2456799999999877654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.8e-06 Score=70.02 Aligned_cols=130 Identities=24% Similarity=0.298 Sum_probs=91.0
Q ss_pred eecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEec
Q 013201 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176 (447)
Q Consensus 97 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 176 (447)
+..+.||+|.+|.||++.+. |..+|+|+-. ....+..+..|+++|..+.+--.-++++.|.++. +.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-----~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRR-----RDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEec-----CCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhh
Confidence 45678999999999999876 6689999542 2445778999999999998655556777665433 55999
Q ss_pred cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCC-CC-ceEeecCCCCCceEEecCCCceec
Q 013201 177 CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLK-PE-NFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 177 ~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlk-p~-Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+.|-.|.+.-... + ..-+..+++.-.-|-..||-|+.|. |. ||+++.. .+-|+||..|...
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~----~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR----DVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC----cEEEEEccchhhc
Confidence 9987876543211 2 2233445555555778899999995 43 5555332 3889999988743
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.4e-06 Score=70.66 Aligned_cols=50 Identities=26% Similarity=0.458 Sum_probs=47.4
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++++.+|+.+|.|++|.|+..+|+.+.++||++++++|+++||+++|.
T Consensus 104 t~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~ 153 (172)
T KOG0028|consen 104 TKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADR 153 (172)
T ss_pred cHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcc
Confidence 56788999999999999999999999999999999999999999999973
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.9e-05 Score=75.56 Aligned_cols=80 Identities=18% Similarity=0.222 Sum_probs=56.1
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccC--C--hhhHHHHHHHHHHHHhccC--CCCeeEEEEEEEeCCeEEEE
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLV--N--KQDREDIKREIQIMQHLSG--QQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~--~--~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~~~~~~~~~lv 173 (447)
+.||.|.+..||++.....++.++||.-...... . ....++...|.+.|+.+.. ..++++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998643368999975321111 1 2245677788888888653 2467888776 44667899
Q ss_pred EeccCCCc
Q 013201 174 MELCSGGE 181 (447)
Q Consensus 174 ~e~~~g~~ 181 (447)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-06 Score=72.72 Aligned_cols=61 Identities=31% Similarity=0.495 Sum_probs=52.2
Q ss_pred HHHHHHhhh-hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 386 ALKVIAEAL-SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 386 ~~~~i~~~~-~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
++.+|.... .....++++.+|+.||.|++|+|+..||+.+++.+|.+++++||++|++++|
T Consensus 77 Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d 138 (160)
T COG5126 77 FLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYD 138 (160)
T ss_pred HHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcC
Confidence 344444444 3344678999999999999999999999999999999999999999999987
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.5e-06 Score=64.24 Aligned_cols=51 Identities=18% Similarity=0.289 Sum_probs=46.5
Q ss_pred HHhhhhcceeeeecC-CCCcccCHHHHHHHHHH-hCCCCCH-HHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDT-DKSGTITYEELKTGLAR-LGSKLSE-TEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~-~~~g~i~~~el~~~l~~-l~~~~~~-~e~~~~~~~~d~ 447 (447)
..+..++++|+.||. +++|+|+.+||+.+|+. +|..++. +++++||+.+|.
T Consensus 5 ~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~ 58 (89)
T cd05022 5 KAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDV 58 (89)
T ss_pred HHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCC
Confidence 345678999999999 99999999999999999 9988888 999999999884
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.6e-06 Score=69.95 Aligned_cols=55 Identities=36% Similarity=0.532 Sum_probs=52.3
Q ss_pred hhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 392 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..+.++++++++++|..||.|++|.|+..||..+|+.+|..+++.++.+|+.++|
T Consensus 12 ~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d 66 (160)
T COG5126 12 TQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEID 66 (160)
T ss_pred ccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhcc
Confidence 4568899999999999999999999999999999999999999999999999987
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.2e-06 Score=71.30 Aligned_cols=50 Identities=36% Similarity=0.550 Sum_probs=47.1
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++++++|+.||.|++|+|+.+||+.+|..+|.+.+.+++++|++++|.
T Consensus 83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~ 132 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDV 132 (151)
T ss_pred cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCC
Confidence 45689999999999999999999999999999999999999999999884
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.3e-05 Score=70.45 Aligned_cols=73 Identities=14% Similarity=0.122 Sum_probs=46.2
Q ss_pred ceeccccCe-EEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC--CCeeEEEEEEEeC---CeEEEE
Q 013201 100 KELGRGQFG-ITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ--QNIVEFRGAYEDR---QSVHLV 173 (447)
Q Consensus 100 ~~lg~G~~g-~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~---~~~~lv 173 (447)
+.|+.|+.. .||+. +..+++|.... ......+.+|.++++.+..+ --++++++..... ...++|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~-----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSA-----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCc-----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457777766 48875 23577775322 11245788999999988743 1355555544332 245889
Q ss_pred EeccCCCch
Q 013201 174 MELCSGGEL 182 (447)
Q Consensus 174 ~e~~~g~~L 182 (447)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999998766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.03 E-value=6e-06 Score=62.24 Aligned_cols=50 Identities=16% Similarity=0.251 Sum_probs=45.4
Q ss_pred Hhhhhcceeeeec-CCCCc-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMD-TDKSG-TITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
.+..++++|+.|| .|++| .|+.+||+.+|+. +|...++++++++++++|.
T Consensus 6 ~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~ 62 (88)
T cd05027 6 AMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDS 62 (88)
T ss_pred HHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCC
Confidence 4567889999998 79999 5999999999999 8988999999999999874
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.8e-06 Score=49.92 Aligned_cols=29 Identities=38% Similarity=0.657 Sum_probs=26.4
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
+++++|+.+|.|+||+|+.+|+..+|+.|
T Consensus 1 E~~~~F~~~D~d~dG~I~~~Ef~~~~~~L 29 (29)
T PF00036_consen 1 ELKEAFREFDKDGDGKIDFEEFKEMMKKL 29 (29)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHT
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHhC
Confidence 46789999999999999999999999875
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.9e-05 Score=69.28 Aligned_cols=134 Identities=19% Similarity=0.142 Sum_probs=75.4
Q ss_pred eeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCC
Q 013201 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGG 180 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 180 (447)
.+..|-.+.+|+.. .++..+++|...... ....-...+|..+++.+..+.-.++++... . -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 34567778899886 356788888643221 110012467999999987443345555443 2 26899999986
Q ss_pred chHH--------------HHHH---cC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------cCcEeecC
Q 013201 181 ELFD--------------KIIA---QG----HYTE-KAAAALCRAI---------VNVVHHCHF--------MGVMHRDL 221 (447)
Q Consensus 181 ~L~~--------------~l~~---~~----~~~~-~~~~~i~~qi---------l~~l~~lH~--------~~ivH~Dl 221 (447)
.+.. .+.+ .. .++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5431 1111 00 1111 1122222111 111222211 25899999
Q ss_pred CCCceEeecCCCCCceEEecCCCcee
Q 013201 222 KPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 222 kp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.|.||+++.++ +.|+||+.+..
T Consensus 154 ~~~Nil~~~~~----~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG----LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC----CEEEeccccCc
Confidence 99999996532 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.90 E-value=4.6e-05 Score=66.55 Aligned_cols=99 Identities=17% Similarity=0.234 Sum_probs=77.8
Q ss_pred HHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCCCchHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHh---cCc
Q 013201 143 REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFD---KIIAQGHYTEKAAAALCRAIVNVVHHCHF---MGV 216 (447)
Q Consensus 143 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~---~l~~~~~~~~~~~~~i~~qil~~l~~lH~---~~i 216 (447)
.|.-+++.+.+.+++++++|+| +. ++|.||...+++.. .+..-...++....+|+.++++.+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 5888999998768999999998 23 46889998766542 12222346889999999999999999987 458
Q ss_pred EeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 217 vH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.-.|++++|+-++.+ +.+|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~---~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDD---GRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCC---CcEEEEechhcchh
Confidence 899999999999643 45999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00016 Score=65.76 Aligned_cols=75 Identities=16% Similarity=0.180 Sum_probs=48.9
Q ss_pred ceeccccCeEEEEEEECC-CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 100 KELGRGQFGITYLCTENS-TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
+.|..|-...+|++.... .+..|++|+...... ..-...+|+.+++.+..+...++++..+. + .+||||++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~ 75 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP 75 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC
Confidence 467778888999987543 356888886532211 11223579999998864545666665443 2 37999998
Q ss_pred CCch
Q 013201 179 GGEL 182 (447)
Q Consensus 179 g~~L 182 (447)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=1.5e-05 Score=67.27 Aligned_cols=53 Identities=38% Similarity=0.575 Sum_probs=49.3
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...+..+++++|+.||.+++|+|+.+||..+++.+|..+++.|+..+++++|.
T Consensus 3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~ 55 (151)
T KOG0027|consen 3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDL 55 (151)
T ss_pred CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999999883
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=5.1e-06 Score=89.83 Aligned_cols=205 Identities=16% Similarity=0.063 Sum_probs=133.7
Q ss_pred HHHHHHHHHHhccCCCCeeEEEEEEE--eCCeEEEEEeccCCCchHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh
Q 013201 140 DIKREIQIMQHLSGQQNIVEFRGAYE--DRQSVHLVMELCSGGELFDKIIAQG----HYTEKAAAALCRAIVNVVHHCHF 213 (447)
Q Consensus 140 ~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~qil~~l~~lH~ 213 (447)
....|..-++.+. |+++.....-.. .....|.+++||.+|.+++.|.+.- .+.+..+.....+.+.+..-+|.
T Consensus 1275 mll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1275 MLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 3444555555565 777766544332 2345689999999999999987642 23344444444444667777665
Q ss_pred c-----CcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCCceeecCCcccccccccccc-cCCCCCcchhHHHHH
Q 013201 214 M-----GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVIL 286 (447)
Q Consensus 214 ~-----~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il 286 (447)
. -.+|++||+-|.+| ..+..+|++++|+.+... ........++++.|++|++.+. .++.++|+|..|+.+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred cccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 4 27899999999999 555569999999998333 3333445688999999999875 467779999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHhCCCC----CCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 287 YILLSGVPPFWAETEKGIFDAILKGGVD----FESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 287 ~elltg~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
|+...|..+|- .....++++..+ +..+. ..|.++-.....+|-..-..||.-...+.-+.|-
T Consensus 1431 y~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI-----FFLQPALKGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHhcccHHHH-----HHHHHHHcCcccccccccccc--cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999988873 233334443221 11111 1133333444444555556678777777666554
|
|
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=97.75 E-value=2.9e-05 Score=59.84 Aligned_cols=51 Identities=24% Similarity=0.407 Sum_probs=45.9
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+++++...++++|..+|.+++|.|+.+|++.+|+.+| ++++++++|++.+|
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d 54 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLAD 54 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhc
Confidence 3566788999999999999999999999999999976 68999999999876
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00043 Score=66.00 Aligned_cols=84 Identities=14% Similarity=0.088 Sum_probs=53.6
Q ss_pred eeccccCeEEEEEEECCCCCEEEEEEeeccccC----ChhhHHHHHHHHHHHHhccC-CC-CeeEEEEEEEeCCeEEEEE
Q 013201 101 ELGRGQFGITYLCTENSTGNSYACKSILKRKLV----NKQDREDIKREIQIMQHLSG-QQ-NIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 101 ~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~----~~~~~~~~~~E~~~l~~l~~-h~-~iv~~~~~~~~~~~~~lv~ 174 (447)
.||.|....||++.....++.++||.-..-... -+...++..-|...|+.... .| .+++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997644468999965432111 13345566678888877653 23 46666443 556667999
Q ss_pred eccCCCc-hHHHH
Q 013201 175 ELCSGGE-LFDKI 186 (447)
Q Consensus 175 e~~~g~~-L~~~l 186 (447)
|+++... |...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 9986432 33444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00029 Score=66.58 Aligned_cols=137 Identities=16% Similarity=0.191 Sum_probs=80.5
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCC-CeeEEEEE------EEeCCeEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ-NIVEFRGA------YEDRQSVH 171 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~------~~~~~~~~ 171 (447)
.+.|..|....+|+... ++..+++|+... .....+..|+.++..|..+- .+++++.. ...++..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 45677787789998764 345788887632 23456778888888886321 25555442 23456678
Q ss_pred EEEeccCCCchHH----HH----------HHc-CCCCH--------H----HH--------HHHHHHHHHHHHHHHh---
Q 013201 172 LVMELCSGGELFD----KI----------IAQ-GHYTE--------K----AA--------AALCRAIVNVVHHCHF--- 213 (447)
Q Consensus 172 lv~e~~~g~~L~~----~l----------~~~-~~~~~--------~----~~--------~~i~~qil~~l~~lH~--- 213 (447)
+|++|++|..+.. .+ +.. ..+.. . .. ......+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998865421 01 100 00000 0 00 0011112233444443
Q ss_pred ----cCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 214 ----MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 214 ----~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
.+++|+|+.|.||+++. +..+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~---~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDG---DELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeC---CceEEEeehhhhc
Confidence 47999999999999954 3346799998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13405 EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J_B 1OE9_B 1W7I_B 1KFU_S 1KFX_S 2BL0_B 1Y1X_B 3MSE_B | Back alignment and domain information |
|---|
Probab=97.70 E-value=1.3e-05 Score=47.49 Aligned_cols=30 Identities=40% Similarity=0.635 Sum_probs=26.3
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHH-HhC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLA-RLG 430 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~-~l~ 430 (447)
+++++|..+|.|++|+|+.+||..+|+ .+|
T Consensus 1 ~l~~~F~~~D~d~dG~I~~~el~~~l~~~lG 31 (31)
T PF13405_consen 1 RLREAFKMFDKDGDGFIDFEELRAILRKSLG 31 (31)
T ss_dssp HHHHHHHHH-TTSSSEEEHHHHHHHHHHHTT
T ss_pred CHHHHHHHHCCCCCCcCcHHHHHHHHHHhcC
Confidence 367899999999999999999999999 576
|
... |
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=97.68 E-value=2.9e-05 Score=55.24 Aligned_cols=46 Identities=33% Similarity=0.567 Sum_probs=38.5
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHH----HHhhCC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQL----MDAVSI 447 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~----~~~~d~ 447 (447)
++++|+.+|.|++|+|+.+||..++..++....+++++++ ++.+|.
T Consensus 2 l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 51 (66)
T PF13499_consen 2 LKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDT 51 (66)
T ss_dssp HHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCC
Confidence 6789999999999999999999999999976666555555 777763
|
... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00015 Score=70.87 Aligned_cols=166 Identities=24% Similarity=0.264 Sum_probs=108.6
Q ss_pred HHHHHHHHHHHHhccCCCCeeEEEEEEEeC-CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 013201 138 REDIKREIQIMQHLSGQQNIVEFRGAYEDR-QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGV 216 (447)
Q Consensus 138 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~i 216 (447)
..++.-...+++.+. |+|...++++-... .+..+|||++ +.+|.+++.... +-..... .+|+
T Consensus 26 s~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~ 88 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGV 88 (725)
T ss_pred HHHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccc
Confidence 345566778888887 99999999887643 3578999999 669999887653 2111111 2223
Q ss_pred EeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCC
Q 013201 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPF 296 (447)
Q Consensus 217 vH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf 296 (447)
.|- || ++.+| -++ ... |-. .++++||||+|.++.++.-|...+
T Consensus 89 ~~~-----~~----------~~~td-~~~---t~~--------------~~~----~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 89 LHL-----NI----------IYITD-HFL---TKY--------------PSP----IGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred cee-----hh----------hhccc-ccc---ccC--------------CCC----CCcchhhhhHHHHHHHHHHhhHHH
Confidence 222 22 22233 000 000 111 124999999999999999998888
Q ss_pred CCCCHHHHHHHHHhCCCCCCCC--------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 297 WAETEKGIFDAILKGGVDFESE--------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 297 ~~~~~~~~~~~i~~~~~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
......+....+.+-....... -...++....++..+|+-..|..||...++++++-|.+.
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 7666666665555432211100 011356777899999999999999999999999999875
|
|
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=97.66 E-value=5.2e-05 Score=57.15 Aligned_cols=51 Identities=27% Similarity=0.472 Sum_probs=44.4
Q ss_pred HHhhhhcceeeeecC-CC-CcccCHHHHHHHHHH---hCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDT-DK-SGTITYEELKTGLAR---LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~-~~-~g~i~~~el~~~l~~---l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..+.++|.++|. ++ +|+|+.+||+++|+. +|.+++++|+++|++.+|.
T Consensus 7 ~~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~ 62 (88)
T cd05029 7 QAIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDR 62 (88)
T ss_pred HHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcC
Confidence 345667889999998 78 899999999999973 7999999999999999874
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.65 E-value=2.8e-05 Score=61.74 Aligned_cols=52 Identities=19% Similarity=0.340 Sum_probs=47.3
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..++..+++++|..||..+||+|+..++..+|+.+|.++++.||.+.+.+.+
T Consensus 6 ~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~ 57 (152)
T KOG0030|consen 6 TPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPK 57 (152)
T ss_pred CcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcc
Confidence 4566789999999999999999999999999999999999999998877654
|
|
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=97.63 E-value=5.4e-05 Score=58.09 Aligned_cols=49 Identities=20% Similarity=0.321 Sum_probs=43.1
Q ss_pred hhhhcceeeeecC-CC-CcccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDT-DK-SGTITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~-~~-~g~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
...++++|..||. |+ +|+|+.+||+.+|+. +|..+++++++++++++|.
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~ 62 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQ 62 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCC
Confidence 4568899999997 98 699999999999986 5678899999999999873
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=97.60 E-value=7.2e-05 Score=57.16 Aligned_cols=50 Identities=18% Similarity=0.293 Sum_probs=42.6
Q ss_pred Hhhhhcceeeeec-CCCCc-ccCHHHHHHHHHH-hCC----CCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMD-TDKSG-TITYEELKTGLAR-LGS----KLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-l~~----~~~~~e~~~~~~~~d~ 447 (447)
.++.++++|..|| .+++| .|+.+||+.+|+. +|. .+++++++++++++|.
T Consensus 7 ~~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~ 63 (92)
T cd05025 7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDE 63 (92)
T ss_pred HHHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCC
Confidence 3467899999997 99999 5999999999986 553 5689999999999873
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00011 Score=59.49 Aligned_cols=61 Identities=21% Similarity=0.408 Sum_probs=51.2
Q ss_pred HHHHHHHhhhh-HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 385 MALKVIAEALS-EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 385 ~~~~~i~~~~~-~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
..+..+.+.+. .+..+.+..+|+.||.++.|.|..+.|+++|...|.+++++||++|++..
T Consensus 85 ~FLTmfGekL~gtdpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~ 146 (171)
T KOG0031|consen 85 VFLTMFGEKLNGTDPEEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREA 146 (171)
T ss_pred HHHHHHHHHhcCCCHHHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhC
Confidence 34555555552 33456788999999999999999999999999999999999999999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=6.2e-05 Score=69.47 Aligned_cols=140 Identities=20% Similarity=0.265 Sum_probs=95.4
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC-----Ch------------h--hHHHHHHHHHHHHhccCCC
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-----NK------------Q--DREDIKREIQIMQHLSGQQ 155 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-----~~------------~--~~~~~~~E~~~l~~l~~h~ 155 (447)
.+.+++.||-|.-+.||.+.+. .|++.++|.-...... .. . .+-...+|...|+.|..|-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3678899999999999998865 5888888843211110 00 0 1122357999999887432
Q ss_pred -CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCC
Q 013201 156 -NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG 234 (447)
Q Consensus 156 -~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~ 234 (447)
-|++.++ -++.++|||++.|-.|...-. ...+..+...++.-+--|-.+|+||+|..-=||++..++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-- 239 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-- 239 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC--
Confidence 2555543 356789999999887754321 122344555666667778899999999999999996533
Q ss_pred CceEEecCCCceec
Q 013201 235 AMLKATDFGLSVFI 248 (447)
Q Consensus 235 ~~vkl~Dfg~a~~~ 248 (447)
.++++||-.....
T Consensus 240 -~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 240 -KIVVIDFPQMVST 252 (465)
T ss_pred -CEEEeechHhhcc
Confidence 5999999765544
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00071 Score=64.16 Aligned_cols=76 Identities=13% Similarity=0.124 Sum_probs=48.6
Q ss_pred ceeccccCeEEEEEEECC------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 100 KELGRGQFGITYLCTENS------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|..|-...||++.... .++.+++|+..... .......+|..+++.+..+--.++++.++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 345566677899887543 25788899753321 1223457899899888754445566666542 368
Q ss_pred EeccCCCchH
Q 013201 174 MELCSGGELF 183 (447)
Q Consensus 174 ~e~~~g~~L~ 183 (447)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=97.51 E-value=8.4e-05 Score=56.26 Aligned_cols=52 Identities=23% Similarity=0.362 Sum_probs=44.5
Q ss_pred HHHhhhhcceeeeecC--CCCcccCHHHHHHHHHH-hCCCC----CHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDT--DKSGTITYEELKTGLAR-LGSKL----SETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~--~~~g~i~~~el~~~l~~-l~~~~----~~~e~~~~~~~~d~ 447 (447)
+++++.++++|..||. +++|.|+.+||+.+++. +|..+ +++++++|+..+|.
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~ 62 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDV 62 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhcc
Confidence 4567789999999999 89999999999999986 56444 59999999998863
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0015 Score=63.44 Aligned_cols=77 Identities=16% Similarity=0.182 Sum_probs=51.5
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccC-Ch---hhHHHHHHHHHHHHhccC--CCCeeEEEEEEEeCCeEEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-NK---QDREDIKREIQIMQHLSG--QQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~---~~~~~~~~E~~~l~~l~~--h~~iv~~~~~~~~~~~~~l 172 (447)
.+.||.|....||+..+. +..++||.-...... .. ....+-..|...|+.+.. ...+++++.++. ...++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 467899999999998863 457889975422211 11 134445556777776642 247888888776 44568
Q ss_pred EEeccCC
Q 013201 173 VMELCSG 179 (447)
Q Consensus 173 v~e~~~g 179 (447)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00087 Score=63.17 Aligned_cols=145 Identities=21% Similarity=0.233 Sum_probs=93.2
Q ss_pred eecceeccccCeEEEEEEECCCCCEEEEEEeeccccC-------------------ChhhHHH----HHHHHHHHHhccC
Q 013201 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-------------------NKQDRED----IKREIQIMQHLSG 153 (447)
Q Consensus 97 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-------------------~~~~~~~----~~~E~~~l~~l~~ 153 (447)
.+-.+|..|--+.||.|+. .+|..+|||++.-.-+. ....++. .+.|++-|+++.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~- 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN- 224 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-
Confidence 3456788888899999884 57888999976432111 0111111 246888888886
Q ss_pred CCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhcCcEeecCCCCceEeecCC
Q 013201 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC-HFMGVMHRDLKPENFLLSNKD 232 (447)
Q Consensus 154 h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~l-H~~~ivH~Dlkp~Nill~~~~ 232 (447)
.-.|+----+. - ....|||+|+.......-..+.-.++...+..+-.|++..+.-| |.+++||.||.--|+|+..
T Consensus 225 ~aGIP~PePIl-L-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-- 300 (520)
T KOG2270|consen 225 NAGIPCPEPIL-L-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-- 300 (520)
T ss_pred hcCCCCCCcee-e-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC--
Confidence 33332211111 1 23359999996433322223344677778888878887777655 6789999999999999943
Q ss_pred CCCceEEecCCCceecc
Q 013201 233 GGAMLKATDFGLSVFID 249 (447)
Q Consensus 233 ~~~~vkl~Dfg~a~~~~ 249 (447)
+.+-|+|-+.+....
T Consensus 301 --G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 --GKLYIIDVSQSVEHD 315 (520)
T ss_pred --CEEEEEEccccccCC
Confidence 358899988776443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0015 Score=62.04 Aligned_cols=138 Identities=19% Similarity=0.203 Sum_probs=78.5
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC-CCeeEEEEE------EEeCCeEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ-QNIVEFRGA------YEDRQSVH 171 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~------~~~~~~~~ 171 (447)
.+.++.|....+|++... +..+++|+.... .....+..|+.++..|..+ -.+++++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~-----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKR-----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEeC--CCcEEEEEecCC-----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 456777777889987642 446788865331 1134566778888887522 124555442 12356788
Q ss_pred EEEeccCCCchH----H-------H---HHH-cCCCC--------HHH----HH-----------HHHHHHHHHHHHHH-
Q 013201 172 LVMELCSGGELF----D-------K---IIA-QGHYT--------EKA----AA-----------ALCRAIVNVVHHCH- 212 (447)
Q Consensus 172 lv~e~~~g~~L~----~-------~---l~~-~~~~~--------~~~----~~-----------~i~~qil~~l~~lH- 212 (447)
+|+||++|..+. . . ++. ...++ ... .. .....+...+.++.
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 1 1 111 00110 000 00 00111233444443
Q ss_pred ------hcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 213 ------FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 213 ------~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
..+++|+|+++.||+++.+ ..+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~---~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGD---SVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECC---ceEEEeeccccc
Confidence 2689999999999999653 346799998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00016 Score=55.19 Aligned_cols=51 Identities=24% Similarity=0.332 Sum_probs=42.2
Q ss_pred HHhhhhcceeeeec-CCCCc-ccCHHHHHHHHHH-h----CCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMD-TDKSG-TITYEELKTGLAR-L----GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-l----~~~~~~~e~~~~~~~~d~ 447 (447)
..+..++++|..|| .|++| +|+.+||+.+|+. + +...++.+|++|++++|.
T Consensus 7 ~a~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~ 64 (93)
T cd05026 7 GAMDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDS 64 (93)
T ss_pred HHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCC
Confidence 34567889999999 78998 5999999999977 3 334578899999999984
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 447 | ||||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-65 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-65 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-65 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-65 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-63 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-61 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-61 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-61 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-59 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-59 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-59 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-58 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-58 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-58 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-57 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-57 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-57 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-56 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-56 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-56 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-56 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-55 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-55 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-55 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-54 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-54 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-54 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-53 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-52 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-52 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-52 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-52 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-52 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-52 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-52 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-52 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-52 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-52 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-52 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-52 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-52 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-52 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-52 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-52 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-52 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-51 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-51 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-51 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-50 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-50 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-50 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-50 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-50 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-50 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-50 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-48 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-48 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-46 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-46 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-46 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-46 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-46 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-45 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-45 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-45 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-45 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-45 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-45 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-44 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-43 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-41 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-41 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-41 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-41 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-40 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-39 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-39 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-39 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-39 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-39 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-39 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-39 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-38 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-38 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-38 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-38 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-38 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-37 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-37 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-37 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-37 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-37 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-37 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-37 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-37 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-37 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-37 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-37 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-37 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-37 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-37 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-37 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-37 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-37 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-37 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-37 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-37 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-37 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-36 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-36 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-36 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-36 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-36 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-36 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-36 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-36 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-36 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-36 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-36 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-35 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-35 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-35 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-35 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-35 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-35 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-35 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-35 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-35 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-35 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-35 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-35 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-35 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-35 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-35 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-35 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-35 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-35 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-35 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-35 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-35 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-35 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-35 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-34 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-34 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-34 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-34 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-34 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-34 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-34 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-34 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-33 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-33 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-33 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-33 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-32 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-32 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-32 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-32 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-32 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-32 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-32 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-32 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-32 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-32 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-32 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-32 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-32 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-32 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-32 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-32 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-32 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-32 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-32 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-32 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-32 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-32 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-32 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-32 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-32 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-32 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-32 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-32 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-32 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-32 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-32 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-32 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-32 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-32 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-32 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-32 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-32 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-32 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-32 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-32 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-32 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-32 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-32 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-32 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-32 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-32 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-32 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-32 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-32 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-31 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-31 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-31 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-31 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-31 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-31 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-31 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-31 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-31 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-31 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-31 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-31 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-31 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-31 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-31 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-31 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-31 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-31 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-31 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-31 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-31 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-31 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-31 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-31 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-31 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-31 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-31 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-31 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-31 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-31 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-31 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-31 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-31 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-31 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-30 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-30 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-30 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-30 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-30 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-30 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-30 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-30 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-30 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-30 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-30 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-29 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-29 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-29 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-29 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-29 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-29 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-29 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-29 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-29 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-29 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-29 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-29 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-29 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-29 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-29 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-29 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-29 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-29 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-29 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-29 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-29 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-28 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-28 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-28 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-28 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-28 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-28 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-28 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-28 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-28 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-28 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-28 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-28 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-27 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-27 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-26 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-26 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-26 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-26 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-26 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-26 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-26 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-26 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-26 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-26 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-25 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-25 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-25 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-25 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-25 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-25 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-25 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-25 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-25 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-25 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-25 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-25 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-25 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-25 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-25 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-25 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-25 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-25 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-25 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-25 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-24 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-24 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-24 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-24 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-24 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-24 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-24 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-24 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-24 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-24 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-24 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-23 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-23 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-23 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-22 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-21 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-21 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-21 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-21 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-21 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-21 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-21 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-21 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-21 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-21 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-20 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-20 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-18 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-18 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-18 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-18 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-18 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-18 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-18 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-18 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-18 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-18 | ||
| 2aao_A | 166 | Regulatory Apparatus Of Calcium Dependent Protein K | 5e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-18 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-17 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-17 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-17 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-16 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-15 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-15 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-14 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-14 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-14 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-14 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-14 | ||
| 1s6j_A | 87 | N-Terminal Region Of The Ca2+-Saturated Calcium Reg | 3e-14 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-14 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-14 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-14 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-14 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-14 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-14 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 1s6i_A | 188 | Ca2+-Regulatory Region (Cld) From Soybean Calcium-D | 4e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-14 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-14 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-14 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-13 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-13 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-13 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-13 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-13 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-13 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-13 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-09 | ||
| 3pm8_A | 197 | Cad Domain Of Pff0520w, Calcium Dependent Protein K | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 7e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 8e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-06 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 4e-06 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 5e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 3k21_A | 191 | Crystal Structure Of Carboxy-Terminus Of Pfc0420w L | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-05 | ||
| 3e7e_A | 365 | Structure And Substrate Recruitment Of The Human Sp | 5e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-04 | ||
| 4ds7_A | 147 | Crystal Structure Of Yeast Calmodulin Bound To The | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-04 | ||
| 1exr_A | 148 | The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Ca | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-04 | ||
| 1f54_A | 77 | Solution Structure Of The Apo N-Terminal Domain Of | 4e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-04 | ||
| 1clm_A | 148 | Structure Of Paramecium Tetraurelia Calmodulin At 1 | 5e-04 | ||
| 1lkj_A | 146 | Nmr Structure Of Apo Calmodulin From Yeast Saccharo | 5e-04 | ||
| 2lhh_A | 128 | Solution Structure Of Ca2+-Bound Ycam Length = 128 | 5e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-04 | ||
| 3o4y_A | 196 | Crystal Structure Of Cad Domain Of The Plasmodium V | 7e-04 | ||
| 2joj_A | 77 | Nmr Solution Structure Of N-Terminal Domain Of Eupl | 8e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-04 |
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1S6J|A Chain A, N-Terminal Region Of The Ca2+-Saturated Calcium Regulatory Domain (Cld) From Soybean Calcium-Dependent Protein Kinase- Alpha (Cdpk) Length = 87 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1S6I|A Chain A, Ca2+-Regulatory Region (Cld) From Soybean Calcium-Dependent Protein Kinase-Alpha (Cdpk) In The Presence Of Ca2+ And The Junction Domain (Jd) Length = 188 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PM8|A Chain A, Cad Domain Of Pff0520w, Calcium Dependent Protein Kinase Length = 197 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3K21|A Chain A, Crystal Structure Of Carboxy-Terminus Of Pfc0420w Length = 191 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3E7E|A Chain A, Structure And Substrate Recruitment Of The Human Spindle Checkpoint Kinase Bub Length = 365 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DS7|A Chain A, Crystal Structure Of Yeast Calmodulin Bound To The C-Terminal Fragment Of Spindle Pole Body Protein Spc110 Length = 147 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1EXR|A Chain A, The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Calmodulin Length = 148 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1F54|A Chain A, Solution Structure Of The Apo N-Terminal Domain Of Yeast Calmodulin Length = 77 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1CLM|A Chain A, Structure Of Paramecium Tetraurelia Calmodulin At 1.8 Angstroms Resolution Length = 148 | Back alignment and structure |
|
| >pdb|1LKJ|A Chain A, Nmr Structure Of Apo Calmodulin From Yeast Saccharomyces Cerevisiae Length = 146 | Back alignment and structure |
|
| >pdb|2LHH|A Chain A, Solution Structure Of Ca2+-Bound Ycam Length = 128 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3O4Y|A Chain A, Crystal Structure Of Cad Domain Of The Plasmodium Vivax Cdpk, Pvx_11610 Length = 196 | Back alignment and structure |
|
| >pdb|2JOJ|A Chain A, Nmr Solution Structure Of N-Terminal Domain Of Euplotes Octocarinatus Centrin Length = 77 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 593 bits (1531), Expect = 0.0
Identities = 140/381 (36%), Positives = 209/381 (54%), Gaps = 16/381 (4%)
Query: 80 KPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRE 139
P + Y + LG+G FG LC + TG A K I KR++ K D+E
Sbjct: 12 TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 140 DIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAA 199
+ RE+Q+++ L NI++ +ED+ +LV E+ +GGELFD+II++ ++E AA
Sbjct: 72 SLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 130
Query: 200 LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVG 259
+ R +++ + + H ++HRDLKPEN LL +K A ++ DFGLS + K +D +G
Sbjct: 131 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190
Query: 260 SAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP 319
+AYY+APEVL +Y ++ DVWS GVILYILLSG PPF E I + KG FE
Sbjct: 191 TAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 250
Query: 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR---EGGEASDKPIGSAVLSRMKQF 376
W +S+SAKDL+RKML P RI++ + L+H W++ + + D P + ++QF
Sbjct: 251 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQF 310
Query: 377 RAMNKLKKMALKVIAEAL-SEEEIKGLKTMFANMDTDKSGTITYEELKTGLAR------- 428
+ KL + AL + L S++E K L +F MD + G + EL G
Sbjct: 311 QGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQ 370
Query: 429 ----LGSKLSETEVKQLMDAV 445
L + E EV Q++DAV
Sbjct: 371 DASMLDASAVEHEVDQVLDAV 391
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 593 bits (1530), Expect = 0.0
Identities = 133/416 (31%), Positives = 207/416 (49%), Gaps = 32/416 (7%)
Query: 52 QPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITY 111
S+ + Q + + P + K I + Y ++LG G +G
Sbjct: 3 HHHHHSSGRENLYFQGIAIN---------PGMYVRKKEGKIGESYFKVRKLGSGAYGEVL 53
Query: 112 LCTENSTGNSYACKSILKRKLVN----------KQDREDIKREIQIMQHLSGQQNIVEFR 161
LC E + + A K I K + ++ E+I EI +++ L NI++
Sbjct: 54 LCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLF 112
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
+ED++ +LV E GGELF++II + + E AA + + I++ + + H ++HRD+
Sbjct: 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDI 172
Query: 222 KPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWS 281
KPEN LL NK+ +K DFGLS F + RD +G+AYY+APEVL++ Y ++ DVWS
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWS 232
Query: 282 AGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKK 341
GVI+YILL G PPF + ++ I + KG F+ W ISD AK+L++ ML D K
Sbjct: 233 CGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNK 292
Query: 342 RITSAEVLEHPWMREG---GEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSE-E 397
R T+ E L W+++ SD+ LS M++F KL + A+ I L+ E
Sbjct: 293 RCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLE 352
Query: 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGS--------KLSETEVKQLMDAV 445
E K L +F +D + G + +EL G L + K E EV ++ V
Sbjct: 353 ERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEV 408
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 586 bits (1513), Expect = 0.0
Identities = 138/375 (36%), Positives = 202/375 (53%), Gaps = 21/375 (5%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+ Y + LG+G FG C + T YA K I K NK D I RE+++++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
L NI++ ED S ++V EL +GGELFD+II + ++E AA + + + + +
Sbjct: 77 KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL 269
+ H ++HRDLKPEN LL +K+ +K DFGLS + +D +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 270 RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329
R +Y ++ DVWSAGVILYILLSG PPF+ + E I + G F+ W ISD AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 330 LVRKMLIQDPKKRITSAEVLEHPWMR----EGGEASDKPIGSAVLSRMKQFRAMNKLKKM 385
L+RKML P RIT+ + LEHPW++ E SD P + ++ ++QF+A KL +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQA 315
Query: 386 ALKVIAEALSE-EEIKGLKTMFANMDTDKSGTITYEELKTGLARL--------------G 430
AL +A L+ +E K L +F +DT+ G + +EL G
Sbjct: 316 ALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNE 375
Query: 431 SKLSETEVKQLMDAV 445
E ++ LM +
Sbjct: 376 GSTIEDQIDSLMPLL 390
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 14/59 (23%), Positives = 28/59 (47%), Gaps = 3/59 (5%)
Query: 390 IAEALSEEEIKG---LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
IA A+ + ++ F D D SG I+ +EL ++ S + E++ +++ V
Sbjct: 404 IASAIDRTILLSRERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQV 462
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 585 bits (1510), Expect = 0.0
Identities = 133/410 (32%), Positives = 223/410 (54%), Gaps = 24/410 (5%)
Query: 49 LHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFG 108
+H S + Q ++++ P + + + Y K+LG G +G
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQAT---------PGMFITSKKGHLSEMYQRVKKLGSGAYG 51
Query: 109 ITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168
LC + T A K I K + + + E+ +++ L NI++ +ED++
Sbjct: 52 EVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKR 109
Query: 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLL 228
+ +LVME GGELFD+II + + E AA + + +++ V + H ++HRDLKPEN LL
Sbjct: 110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLL 169
Query: 229 SNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYI 288
+K+ A++K DFGLS + K ++ +G+AYY+APEVLR+ Y ++ DVWS GVIL+I
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFI 229
Query: 289 LLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEV 348
LL+G PPF +T++ I + KG F+S W +S+ AKDL+++ML D ++RI++ +
Sbjct: 230 LLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
Query: 349 LEHPWMREGGEAS----DKPIGSAVLSRMKQFRAMNKLKKMALKVIAEAL-SEEEIKGLK 403
LEHPW++E + P + + M++F+ KL + AL +A L S+EE K L
Sbjct: 290 LEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELT 349
Query: 404 TMFANMDTDKSGTITYEELKTGLARLGSK--------LSETEVKQLMDAV 445
+F ++D + G + +EL G ++L + E+EV ++ A
Sbjct: 350 DIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAA 399
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 564 bits (1456), Expect = 0.0
Identities = 112/355 (31%), Positives = 187/355 (52%), Gaps = 6/355 (1%)
Query: 67 PMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKS 126
P +S T + + + + Y + +ELG+G F + C +TG +A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 127 ILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI 186
I +KL + +D + ++RE +I + L NIV + ++ +LV +L +GGELF+ I
Sbjct: 62 INTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119
Query: 187 IAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246
+A+ Y+E A+ + I+ + +CH G++HR+LKPEN LL++K GA +K DFGL++
Sbjct: 120 VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 247 FIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIF 305
+++ + + G+ Y++PEVL++ Y K +D+W+ GVILYILL G PPFW E + ++
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 239
Query: 306 DAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
I G D+ S W ++ AK L+ ML +PKKRIT+ + L+ PW+ +
Sbjct: 240 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIH 299
Query: 366 GSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYE 420
+ +K+F A KLK L + + + L N + E
Sbjct: 300 RQDTVDCLKKFNARRKLKGAILTTMI---ATRNLSNLGRNLLNKKEQGPPSTIKE 351
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 563 bits (1453), Expect = 0.0
Identities = 123/360 (34%), Positives = 194/360 (53%), Gaps = 8/360 (2%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+ Y L +ELG+G F + C + G YA I +KL + +D + ++RE +I +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICR 65
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
L NIV + + +L+ +L +GGELF+ I+A+ +Y+E A+ + I+ V
Sbjct: 66 LLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVAPEV 268
HCH MGV+HR+LKPEN LL++K GA +K DFGL++ ++ E + + G+ Y++PEV
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 269 LRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327
LR+ YGK +D+W+ GVILYILL G PPFW E + ++ I G DF S W ++ A
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMAL 387
KDL+ KML +P KRIT+AE L+HPW+ + + +K+F A KLK L
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAIL 304
Query: 388 KVIA--EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
V+ S + + +K ++ +G E + + L++ +
Sbjct: 305 TVMLATRNFSVRKQEIIKVTEQLIEAISNGDF--ESYTKMCDPGMTAFEPEALGNLVEGL 362
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 539 bits (1390), Expect = 0.0
Identities = 110/345 (31%), Positives = 173/345 (50%), Gaps = 12/345 (3%)
Query: 80 KPETVLGKPLED--IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ- 136
+L +D Y L + +G+G F + C TG +A K + K +
Sbjct: 8 GGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG 67
Query: 137 -DREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH---- 191
ED+KRE I L +IVE Y +++V E G +L +I+ +
Sbjct: 68 LSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV 126
Query: 192 YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV-FIDE 250
Y+E A+ R I+ + +CH ++HRD+KP LL++K+ A +K FG+++ +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 251 GKVYRDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL 309
G V VG+ +++APEV++R YGK +DVW GVIL+ILLSG PF+ E+ +F+ I+
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGII 245
Query: 310 KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAV 369
KG W IS+SAKDLVR+ML+ DP +RIT E L HPW++E + K
Sbjct: 246 KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPET 305
Query: 370 LSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKS 414
+ ++++F A KLK L ++ + D +
Sbjct: 306 VEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPT 350
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 532 bits (1374), Expect = 0.0
Identities = 117/329 (35%), Positives = 180/329 (54%), Gaps = 16/329 (4%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ---DREDIKREIQ 146
E++ +Y G+ELG GQF + C E STG YA K I KR+ + + REDI+RE+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
I++ + N++ YE++ V L++EL +GGELFD + + TE+ A + I+N
Sbjct: 67 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDG-GAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
V++ H + + H DLKPEN +L +++ +K DFGL+ ID G +++I G+ +VA
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 266 PEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324
PE++ G E D+WS GVI YILLSG PF +T++ + +FE E + S
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKK 384
AKD +R++L++DPKKR+T + L+HPW++ LSR M K KK
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT-------QQALSRKASAVNMEKFKK 298
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDK 413
A + + S GL +F +
Sbjct: 299 FAARKKSNNGSGG---GLNDIFEAQKIEW 324
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 530 bits (1367), Expect = 0.0
Identities = 120/343 (34%), Positives = 187/343 (54%), Gaps = 10/343 (2%)
Query: 52 QPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITY 111
Q S+A T + + G + + F+ + ELGRG I Y
Sbjct: 11 VDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVY 70
Query: 112 LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171
C + T YA K + K D++ ++ EI ++ LS NI++ + +E +
Sbjct: 71 RCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEIS 124
Query: 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK 231
LV+EL +GGELFD+I+ +G+Y+E+ AA + I+ V + H G++HRDLKPEN L +
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP 184
Query: 232 DGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILL 290
A LK DFGLS ++ + + + G+ Y APE+LR +YG E+D+WS G+I YILL
Sbjct: 185 APDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
Query: 291 SGVPPFWAET-EKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349
G PF+ E ++ +F IL F S W +S +AKDLVRK+++ DPKKR+T+ + L
Sbjct: 245 CGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 350 EHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAE 392
+HPW+ G+A++ ++++F A KLK V+A
Sbjct: 305 QHPWVT--GKAANFVHMDTAQKKLQEFNARRKLKAAVKAVVAS 345
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 513 bits (1324), Expect = 0.0
Identities = 90/312 (28%), Positives = 157/312 (50%), Gaps = 6/312 (1%)
Query: 80 KPETVLGKPLEDIRQFYTL-GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR 138
E + + +E+ FY L KELGRG+F + C STG YA K + KR+ + R
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCR 72
Query: 139 EDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKA 196
+I EI +++ ++ YE+ + L++E +GGE+F + + +E
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132
Query: 197 AAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD 256
L + I+ V++ H ++H DLKP+N LLS+ +K DFG+S I R+
Sbjct: 133 VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE 192
Query: 257 IVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF 315
I+G+ Y+APE+L D+W+ G+I Y+LL+ PF E + + I + VD+
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252
Query: 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG-EASDKPIGSAVLSRMK 374
E + +S A D ++ +L+++P+KR T+ L H W+++ E P ++ S+ +
Sbjct: 253 SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQ 312
Query: 375 QFRAMNKLKKMA 386
+ K +
Sbjct: 313 DHSVRSSEDKTS 324
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 510 bits (1316), Expect = 0.0
Identities = 82/321 (25%), Positives = 162/321 (50%), Gaps = 12/321 (3%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+++ + Y + ++LGRG+FGI + C E S+ +Y K + + D+ +K+EI I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVV 208
+NI+ ++E + + ++ E SG ++F++I E+ + + +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV 268
H + H D++PEN + + + +K +FG + + G +R + + Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRS-STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 269 LRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327
+ D+WS G ++Y+LLSG+ PF AET + I + I+ F+ E + IS A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMAL 387
D V ++L+++ K R+T++E L+HPW+++ + + + V+ +K R + L K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ----KIERVSTKVIRTLKHRRYYHTLIKKDL 290
Query: 388 KVIAEALSEEEIKGLKTMFAN 408
++ A +++
Sbjct: 291 NMVVSAARISCGGAIRSQKGV 311
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 501 bits (1293), Expect = e-179
Identities = 111/280 (39%), Positives = 165/280 (58%), Gaps = 4/280 (1%)
Query: 86 GKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREI 145
G DI Q+YTL +GRG +G + + T A K I K + +D + K+EI
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57
Query: 146 QIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIV 205
+IM+ L NI+ +ED ++LVMELC+GGELF++++ + + E AA + + ++
Sbjct: 58 EIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
+ V +CH + V HRDLKPENFL + LK DFGL+ GK+ R VG+ YYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 266 PEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325
P+VL YG E D WSAGV++Y+LL G PPF A T+ + I +G F + WL +S
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
A+ L+R++L + PK+RITS + LEH W + +S + +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 504 bits (1300), Expect = e-179
Identities = 115/348 (33%), Positives = 184/348 (52%), Gaps = 10/348 (2%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK---QDREDIKREIQ 146
+ + FY +G+ELG GQF I C E STG YA K I KR+ RE+I+RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
I++ + NI+ YE+R V L++EL SGGELFD + + +E+ A + + I++
Sbjct: 68 ILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDG-GAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
V++ H + H DLKPEN +L +K+ +K DFGL+ I++G +++I G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 266 PEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324
PE++ G E D+WS GVI YILLSG PF +T++ I DF+ E + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG--EASDKPIGSAVLSRMKQFRAMNKL 382
+ AKD +RK+L+++ +KR+T E L HPW+ +A + L K+ +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRW 306
Query: 383 KK-MALKVIAEALSEEEIKGLKT-MFANMDTDKSGTITYEELKTGLAR 428
K ++ + L+ +K + ++ +S T + L
Sbjct: 307 KLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHP 354
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 505 bits (1302), Expect = e-179
Identities = 105/375 (28%), Positives = 169/375 (45%), Gaps = 24/375 (6%)
Query: 53 PPKMSAPQ-PQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITY 111
PP+ P P P QP + K I + + LG G G
Sbjct: 20 PPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79
Query: 112 LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----R 167
T +A K + QD +RE+++ S +IV YE+ R
Sbjct: 80 QIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGR 131
Query: 168 QSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPEN 225
+ + +VME GGELF +I +G +TE+ A+ + ++I + + H + + HRD+KPEN
Sbjct: 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 191
Query: 226 FLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL-RRSYGKEIDVWSAGV 284
L ++K A+LK TDFG + + YYVAPEVL Y K D+WS GV
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251
Query: 285 ILYILLSGVPPFWAE----TEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPK 340
I+YILL G PPF++ G+ I G +F + W +S+ K L+R +L +P
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
Query: 341 KRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIK 400
+R+T E + HPW+ + + P+ ++ + + + R + ++M + + E+IK
Sbjct: 312 QRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIK 371
Query: 401 GLKTMFANMDTDKSG 415
+ D
Sbjct: 372 ----IKKIEDASNPL 382
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 494 bits (1275), Expect = e-176
Identities = 103/344 (29%), Positives = 165/344 (47%), Gaps = 20/344 (5%)
Query: 77 PVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ 136
V L + Y + +++G G + + C +T +A K I K K
Sbjct: 5 GVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----- 59
Query: 137 DREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKA 196
D EI+I+ NI+ + Y+D + V++V EL GGEL DKI+ Q ++E+
Sbjct: 60 --RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE 117
Query: 197 AAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA-MLKATDFGLSVFI-DEGKVY 254
A+A+ I V + H GV+HRDLKP N L ++ G ++ DFG + + E +
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 255 RDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWA---ETEKGIFDAILK 310
+A +VAPEVL R Y D+WS GV+LY +L+G PF +T + I I
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237
Query: 311 GGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVL 370
G W +SD+AKDLV KML DP +R+T+A VL HPW+ + +
Sbjct: 238 GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDA 297
Query: 371 SRMKQ------FRAMNKLKKMALKVIAEALSEEEIKGLKTMFAN 408
+ + + A+N+ + L+ + + + +G+K + +
Sbjct: 298 PHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQR-RGIKKITST 340
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 494 bits (1273), Expect = e-176
Identities = 108/309 (34%), Positives = 174/309 (56%), Gaps = 9/309 (2%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ---DREDIKREIQ 146
+ + FY +G+ELG GQF I C E STG YA K I KR+ + RE+I+RE+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
I++ + N++ YE+R V L++EL SGGELFD + + +E+ A + + I++
Sbjct: 68 ILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGG-AMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
V++ H + H DLKPEN +L +K+ +K DFGL+ I++G +++I G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 266 PEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324
PE++ G E D+WS GVI YILLSG PF +T++ I DF+ E + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG--GEASDKPIGSAVLSRMKQFRAMNKL 382
+ AKD +RK+L+++ +KR+T E L HPW+ +A + L ++ +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRW 306
Query: 383 KKMALKVIA 391
K + +++
Sbjct: 307 KL-SFSIVS 314
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 492 bits (1270), Expect = e-175
Identities = 104/324 (32%), Positives = 163/324 (50%), Gaps = 25/324 (7%)
Query: 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQ 146
P K LG G F I C + ++A K I KR + ++EI
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEIT 57
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
++ G NIV+ + D+ LVMEL +GGELF++I + H++E A+ + R +V+
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIVGSAYYVA 265
V H H +GV+HRDLKPEN L ++++ +K DFG + + + + + +Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 266 PEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEK-------GIFDAILKGGVDFES 317
PE+L ++ Y + D+WS GVILY +LSG PF + I I KG FE
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI---------GSA 368
E W +S AKDL++ +L DP KR+ + + + W+++G + S P+ G+A
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
Query: 369 VLSRMK-QFRAMNKLKKMALKVIA 391
V + +K F A NK K+ +
Sbjct: 298 VHTCVKATFHAFNKYKREGFCLQN 321
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 487 bits (1257), Expect = e-174
Identities = 112/267 (41%), Positives = 159/267 (59%), Gaps = 2/267 (0%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+ Y + LG+G FG C + T YA K I K NK D I RE+++++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
L NI++ ED S ++V EL +GGELFD+II + ++E AA + + + + +
Sbjct: 77 KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL 269
+ H ++HRDLKPEN LL +K+ +K DFGLS + +D +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 270 RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329
R +Y ++ DVWSAGVILYILLSG PPF+ + E I + G F+ W ISD AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 330 LVRKMLIQDPKKRITSAEVLEHPWMRE 356
L+RKML P RIT+ + LEHPW+++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 487 bits (1256), Expect = e-174
Identities = 106/283 (37%), Positives = 164/283 (57%), Gaps = 6/283 (2%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ---DREDIKREIQI 147
+ Y +G+ELG GQF I C + TG YA K I KR+L + + RE+I+RE+ I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNV 207
++ + NI+ +E++ V L++EL SGGELFD + + TE A + I++
Sbjct: 62 LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDG-GAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAP 266
VH+ H + H DLKPEN +L +K+ +K DFG++ I+ G +++I G+ +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 267 EVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325
E++ G E D+WS GVI YILLSG PF ET++ I DF+ E + S+
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSA 368
AKD +R++L++DPK+R+T A+ LEH W++ + + S
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 487 bits (1255), Expect = e-173
Identities = 99/275 (36%), Positives = 162/275 (58%), Gaps = 3/275 (1%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
Y + +ELG+G F + C +TG +A K I +KL + +D + ++RE +I +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR 60
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
L NIV + ++ +LV +L +GGELF+ I+A+ Y+E A+ + I+ +
Sbjct: 61 KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL 269
+CH G++HR+LKPEN LL++K GA +K DFGL++ +++ + + G+ Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 270 RRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328
++ Y K +D+W+ GVILYILL G PPFW E + ++ I G D+ S W ++ AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDK 363
L+ ML +PKKRIT+ + L+ PW+ +
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-172
Identities = 95/363 (26%), Positives = 167/363 (46%), Gaps = 25/363 (6%)
Query: 4 WGSKERVPPSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQPQP 63
+KER + ++ + Q ++ QP
Sbjct: 14 KFNKERRRAR-------REIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 64 RQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYA 123
+ + + P+ ++ Q Y +GRG + C +TG+ +A
Sbjct: 67 KGTENLYFQSMGPEDELPDW---AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123
Query: 124 CKSILKRKLVNKQD-----REDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178
K + + RE +RE I++ ++G +I+ +YE + LV +L
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 179 GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238
GELFD + + +EK ++ R+++ V H ++HRDLKPEN LL + ++
Sbjct: 184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN---MQIR 240
Query: 239 ATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-------RSYGKEIDVWSAGVILYILLS 291
+DFG S ++ G+ R++ G+ Y+APE+L+ YGKE+D+W+ GVIL+ LL+
Sbjct: 241 LSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 292 GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
G PPFW + + I++G F S W S + KDL+ ++L DP+ R+T+ + L+H
Sbjct: 301 GSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360
Query: 352 PWM 354
P+
Sbjct: 361 PFF 363
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 486 bits (1253), Expect = e-172
Identities = 95/377 (25%), Positives = 169/377 (44%), Gaps = 29/377 (7%)
Query: 46 QQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRG 105
H K+ P+ P+ V K + +Y + +ELG G
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSG 62
Query: 106 QFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165
FG+ + C E +TG + K I + D+ +K EI IM L ++ A+E
Sbjct: 63 AFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLH-HPKLINLHDAFE 118
Query: 166 DRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPE 224
D+ + L++E SGGELFD+I A+ + +E R + H H ++H D+KPE
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 178
Query: 225 NFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAG 283
N + K + +K DFGL+ ++ ++ + +A + APE++ R G D+W+ G
Sbjct: 179 NIMCETKKA-SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG 237
Query: 284 VILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI 343
V+ Y+LLSG+ PF E + + + +F+ + + +S AKD ++ +L ++P+KR+
Sbjct: 238 VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 297
Query: 344 TSAEVLEHPWMREGGEASDKPIGSAVLS---------------------RMKQFRAMNKL 382
T + LEHPW++ I S+ + R+ F ++ K
Sbjct: 298 TVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKH 357
Query: 383 KKMALKVIAEALSEEEI 399
+ ++ +E
Sbjct: 358 RPQEYQIYDSYFDRKEA 374
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-171
Identities = 114/429 (26%), Positives = 183/429 (42%), Gaps = 14/429 (3%)
Query: 19 RSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPV 78
+ H + ++++++ V +
Sbjct: 83 IAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQ 142
Query: 79 QKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR 138
P+ V K + + Y + +ELG G FG+ + TE +TGN++A K ++ D+
Sbjct: 143 YYPQPVEIKH-DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDK 198
Query: 139 EDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAA 197
E +++EIQ M L +V A+ED + ++ E SGGELF+K+ + +E A
Sbjct: 199 ETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 257
Query: 198 AALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI 257
R + + H H +H DLKPEN + + K LK DFGL+ +D + +
Sbjct: 258 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVT 316
Query: 258 VGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316
G+A + APEV + G D+WS GV+ YILLSG+ PF E + + + +
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG-GEASDKPIGSAVLSRMKQ 375
+ IS+ KD +RK+L+ DP R+T + LEHPW+ G D I S SR +
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS---SRYTK 433
Query: 376 FRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSE 435
R K K A L I ++ + + S + + R K
Sbjct: 434 IRDSIKTKYDAWPEPLPPLG--RISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYG 491
Query: 436 TEVKQLMDA 444
TEV + A
Sbjct: 492 TEVGEGQSA 500
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-170
Identities = 84/272 (30%), Positives = 148/272 (54%), Gaps = 8/272 (2%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
I + ++LG G FG +L E S+G K+I K + + E I+ EI++++
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLK 75
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIV 205
L NI++ +ED ++++VME C GGEL ++I++ +E A L + ++
Sbjct: 76 SLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
N + + H V+H+DLKPEN L + + +K DFGL+ + + G+A Y+A
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194
Query: 266 PEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325
PEV +R + D+WSAGV++Y LL+G PF + + + ++ E ++
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR-PLTP 253
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357
A DL+++ML +DP++R ++A+VL H W ++
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-169
Identities = 97/288 (33%), Positives = 148/288 (51%), Gaps = 16/288 (5%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN------KQDREDIKR 143
+ Y + LGRG + C T YA K I + ++ RE +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 144 EIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRA 203
E+ I++ +SG NI++ + YE LV +L GELFD + + +EK + RA
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 204 IVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYY 263
++ V+ H + ++HRDLKPEN LL + +K TDFG S +D G+ R++ G+ Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDD---MNIKLTDFGFSCQLDPGEKLREVCGTPSY 189
Query: 264 VAPEVLR-------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316
+APE++ YGKE+D+WS GVI+Y LL+G PPFW + + I+ G F
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249
Query: 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364
S W SD+ KDLV + L+ P+KR T+ E L HP+ ++ +
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 472 bits (1217), Expect = e-167
Identities = 103/319 (32%), Positives = 159/319 (49%), Gaps = 18/319 (5%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-----NKQDREDIKRE 144
+ +R Y + K LG G G L E T A K I KRK +++ E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 145 IQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAI 204
I+I++ L+ I++ + ++ ++V+EL GGELFDK++ E +
Sbjct: 66 IEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV 264
+ V + H G++HRDLKPEN LLS+++ ++K TDFG S + E + R + G+ Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 265 APEVL----RRSYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFDAILKGGVDFESEP 319
APEVL Y + +D WS GVIL+I LSG PPF T+ + D I G +F E
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAM 379
W +S+ A DLV+K+L+ DPK R T+ E L HPW++ D+ + + +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ------DEDMKRKFQDLLSEENES 297
Query: 380 NKLKKMALKVIAEALSEEE 398
L ++ + E
Sbjct: 298 TALPQVLAQPSTSRKRPRE 316
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 462 bits (1190), Expect = e-163
Identities = 98/313 (31%), Positives = 152/313 (48%), Gaps = 36/313 (11%)
Query: 91 DIRQFYTLGKE-LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
Y L ++ LG G C T YA K I K+ R + RE++++
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLY 65
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
G +N++E +E+ +LV E GG + I + H+ E A+ + + + + +
Sbjct: 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI--------VGSA 261
H G+ HRDLKPEN L + + + +K DF L I I GSA
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 262 YYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAE---------------T 300
Y+APEV+ Y K D+WS GVILYILLSG PPF
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 301 EKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360
+ +F++I +G +F + W IS +AKDL+ K+L++D K+R+++A+VL+HPW++ G A
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ--GCA 303
Query: 361 SDKPIGSA-VLSR 372
+ + + VL R
Sbjct: 304 PENTLPTPMVLQR 316
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 463 bits (1194), Expect = e-163
Identities = 109/375 (29%), Positives = 178/375 (47%), Gaps = 16/375 (4%)
Query: 16 NGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATST 75
+G T + Q+ + ++ + ++ P R + +
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 76 RPVQKPETVLGKPLEDIRQFYTLGK--ELGRGQFGITYLCTENSTGNSYACKSILKRKLV 133
V K + FYT+ K LG G+FG + C E +TG A K I R +
Sbjct: 70 PAPFDHRIVTAKQ-GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM- 127
Query: 134 NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH-Y 192
+D+E++K EI +M L N+++ A+E + + LVME GGELFD+II + +
Sbjct: 128 --KDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL 184
Query: 193 TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252
TE + I + H H M ++H DLKPEN L N+D +K DFGL+ +
Sbjct: 185 TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ-IKIIDFGLARRYKPRE 243
Query: 253 VYRDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG 311
+ G+ ++APEV+ D+WS GVI Y+LLSG+ PF + + + IL
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303
Query: 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLS 371
D E E + IS+ AK+ + K+LI++ RI+++E L+HPW+ SD + S + +
Sbjct: 304 RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL------SDHKLHSRLSA 357
Query: 372 RMKQFRAMNKLKKMA 386
+ K+ R + +
Sbjct: 358 QKKKNRGSDAQDFVT 372
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 460 bits (1186), Expect = e-162
Identities = 101/324 (31%), Positives = 158/324 (48%), Gaps = 25/324 (7%)
Query: 90 EDIRQFYTLGKE-LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIM 148
+ Y L K+ LG G G C TG A K + ++E+
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHH 75
Query: 149 QHLSGQQNIVEFRGAYED----RQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCR 202
SG +IV YE+ ++ + ++ME GGELF +I +G +TE+ AA + R
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 203 AIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY 262
I + H + HRD+KPEN L ++K+ A+LK TDFG + + + + Y
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCYTPY 194
Query: 263 YVAPEVL-RRSYGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFDAILKGGVDFES 317
YVAPEVL Y K D+WS GVI+YILL G PPF++ T + G+ I G F +
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254
Query: 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSA-VLSRMKQF 376
W +S+ AK L+R +L DP +R+T + + HPW+ + P+ +A VL K
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH 314
Query: 377 RAMNKLKKMALKVIAEA-LSEEEI 399
+++K+ +A + +++
Sbjct: 315 --WDEVKEEMTSALATMRVDYDQV 336
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-158
Identities = 89/315 (28%), Positives = 145/315 (46%), Gaps = 39/315 (12%)
Query: 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQ 146
K I + + LG G G T +A K + QD +RE++
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 147 IMQHLSGQQNIVEFRGAYED----RQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAAL 200
+ S +IV YE+ R+ + +VME GGELF +I +G +TE+ A+ +
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
++I + + H + + HRD+KPEN L ++K A+LK TDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 261 AYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFDAILKGGVDFE 316
A E Y K D+WS GVI+YILL G PPF++ G+ I G +F
Sbjct: 167 ----AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQF 376
+ W +S+ K L+R +L +P +R+T E + HPW+ + + P+ ++ + + +
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 282
Query: 377 RAMNKLKKMALKVIA 391
R +K+ +A
Sbjct: 283 R-WEDVKEEMTSALA 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 436 bits (1122), Expect = e-151
Identities = 101/279 (36%), Positives = 152/279 (54%), Gaps = 12/279 (4%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRE-----DIKRE 144
+ +R Y + K LG G G L E T A + I KRK RE +++ E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 145 IQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAI 204
I+I++ L+ I++ + ++ ++V+EL GGELFDK++ E +
Sbjct: 191 IEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV 264
+ V + H G++HRDLKPEN LLS+++ ++K TDFG S + E + R + G+ Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 265 APEVL----RRSYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFDAILKGGVDFESEP 319
APEVL Y + +D WS GVIL+I LSG PPF T+ + D I G +F E
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358
W +S+ A DLV+K+L+ DPK R T+ E L HPW+++
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 432 bits (1113), Expect = e-151
Identities = 100/340 (29%), Positives = 153/340 (45%), Gaps = 52/340 (15%)
Query: 74 STRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL- 132
++ G L ++++ Y L +G+G +G+ + EN T A K + K K+
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 133 -VNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH 191
+N +D E IK E+++M+ L NI YED Q + LVMELC GG L DK+
Sbjct: 66 QINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFID 124
Query: 192 ----------------------------------------YTEKAAAALCRAIVNVVHHC 211
EK + + R I + +H+
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-----EGKVYRDIVGSAYYVAP 266
H G+ HRD+KPENFL S +K DFGLS E G+ Y+VAP
Sbjct: 185 HNQGICHRDIKPENFLFSTNKS-FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 267 EVLR---RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323
EVL SYG + D WSAGV+L++LL G PF + +L + FE+ + ++
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL 303
Query: 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDK 363
S A+DL+ +L ++ +R + L+HPW+ + + K
Sbjct: 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 322 bits (826), Expect = e-106
Identities = 79/366 (21%), Positives = 144/366 (39%), Gaps = 28/366 (7%)
Query: 71 SATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKR 130
S+ S E + I + LG G G T + A K IL
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKIS--FCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPE 59
Query: 131 KLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG 190
RE+Q+++ N++ + +DRQ ++ +ELC L + + +
Sbjct: 60 CF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112
Query: 191 H-YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA--TDFGLSVF 247
+ L + + + H H + ++HRDLKP N L+S + +KA +DFGL
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 248 IDEGKVY----RDIVGSAYYVAPEVLRRS----YGKEIDVWSAGVILYILLS-GVPPFWA 298
+ G+ + G+ ++APE+L +D++SAG + Y ++S G PF
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232
Query: 299 ETEKGIFDAILKGGVDFES-EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357
++ IL G + P A++L+ KM+ DP+KR ++ VL+HP+
Sbjct: 233 SLQRQAN--ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW-- 288
Query: 358 GEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTI 417
V R+++ + K + + + + + D K T
Sbjct: 289 SLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQT-DLRKFRTY 347
Query: 418 TYEELK 423
++
Sbjct: 348 KGGSVR 353
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-102
Identities = 76/342 (22%), Positives = 135/342 (39%), Gaps = 54/342 (15%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+ ++ K LG G G + G A K +L + EI+++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLT 63
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY-------TEKAAAALCR 202
N++ + + + +++ +ELC L D + ++ E +L R
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 203 AIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAM----------LKATDFGLSVFIDEGK 252
I + V H H + ++HRDLKP+N L+S + +DFGL +D G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 253 VY-----RDIVGSAYYVAPEVLR--------RSYGKEIDVWSAGVILYILLS-GVPPFWA 298
+ G++ + APE+L R + ID++S G + Y +LS G PF
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 299 ETEKGIFDAILKGGVDF---ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
+ + I++G + + A DL+ +M+ DP KR T+ +VL HP
Sbjct: 243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
Query: 356 EGG-------EASDKPIGSAVLSRMKQFRAMNKLKKMALKVI 390
+ SD+ + +R + K + VI
Sbjct: 301 PKSKKLEFLLKVSDR---LEIENRDPPSALLMKFDAGSDFVI 339
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 1e-95
Identities = 94/306 (30%), Positives = 140/306 (45%), Gaps = 11/306 (3%)
Query: 54 PKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLC 113
P + P A + P K + R+ Y G+ LG+G F +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRR-YVRGRFLGKGGFAKCFEI 60
Query: 114 TENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173
++ T +A K + K L+ RE + EI I + L+ Q++V F G +ED V +V
Sbjct: 61 SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVV 119
Query: 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233
+ELC L + + TE A R IV + H V+HRDLK N L N+D
Sbjct: 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL-NEDL 178
Query: 234 GAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVL-RRSYGKEIDVWSAGVILYILLS 291
+K DFGL+ ++ + + G+ Y+APEVL ++ + E+DVWS G I+Y LL
Sbjct: 179 --EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236
Query: 292 GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
G PPF K + I K ++ I+ A L++KML DP R T E+L
Sbjct: 237 GKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQKMLQTDPTARPTINELLND 292
Query: 352 PWMREG 357
+ G
Sbjct: 293 EFFTSG 298
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 1e-92
Identities = 88/264 (33%), Positives = 130/264 (49%), Gaps = 10/264 (3%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y G+ LG+G F + ++ T +A K + K L+ RE + EI I + L+ Q
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQ 75
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
++V F G +ED V +V+ELC L + + TE A R IV + H
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVL-RRSY 273
V+HRDLK N L N+D +K DFGL+ ++ + + G+ Y+APEVL ++ +
Sbjct: 136 VIHRDLKLGNLFL-NEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333
E+DVWS G I+Y LL G PPF K + I K ++ I+ A L++K
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQK 248
Query: 334 MLIQDPKKRITSAEVLEHPWMREG 357
ML DP R T E+L + G
Sbjct: 249 MLQTDPTARPTINELLNDEFFTSG 272
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 2e-90
Identities = 63/303 (20%), Positives = 118/303 (38%), Gaps = 43/303 (14%)
Query: 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHL 151
+ L LG+G + TG+ +A K + D RE ++++ L
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKL 64
Query: 152 SGQQNIVEFRGAYEDRQSVH--LVMELCSGGELFDKIIAQGH---YTEKAAAALCRAIVN 206
+ +NIV+ E+ + H L+ME C G L+ + + E + R +V
Sbjct: 65 N-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 207 VVHHCHFMGVMHRDLKPENFLLS-NKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
++H G++HR++KP N + +DG ++ K TDFG + +++ + + + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 266 PEVLRRS---------YGKEIDVWSAGVILYILLSGVPPFWA----ETEKGIFDAILKGG 312
P++ R+ YG +D+WS GV Y +G PF K + I+ G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 313 V-----------------DFESEPWLLISDSAKDLV----RKMLIQDPKKRITSAEVLEH 351
+ +S + L+ +L D +K +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 352 PWM 354
Sbjct: 304 TSD 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 3e-89
Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 11/274 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ +G LG+G F Y TG A K I K+ + + ++ E++I L
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HP 71
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFM 214
+I+E +ED V+LV+E+C GE+ + + ++E A I+ + + H
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVL-RRS 272
G++HRDL N LL +K DFGL+ + + G+ Y++PE+ R +
Sbjct: 132 GILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 273 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332
+G E DVWS G + Y LL G PPF +T K + ++ D+E + +S AKDL+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF--LSIEAKDLIH 244
Query: 333 KMLIQDPKKRITSAEVLEHPWMREGGEASDKPIG 366
++L ++P R++ + VL+HP+M K G
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 2e-88
Identities = 82/264 (31%), Positives = 138/264 (52%), Gaps = 12/264 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ +G+ LG+G+FG YL E + A K + K +L ++RE++I HL
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
NI+ G + D V+L++E G ++ ++ + E+ A + N + +CH
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVL-RRSY 273
V+HRD+KPEN LL + LK DFG SV + R + G+ Y+ PE++ R +
Sbjct: 130 VIHRDIKPENLLLGSAG---ELKIADFGWSVHAPSSR--RTDLCGTLDYLPPEMIEGRMH 184
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333
+++D+WS GV+ Y L G PPF A T + + I + +F + +++ A+DL+ +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF--VTEGARDLISR 240
Query: 334 MLIQDPKKRITSAEVLEHPWMREG 357
+L +P +R EVLEHPW+
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-87
Identities = 88/302 (29%), Positives = 154/302 (50%), Gaps = 20/302 (6%)
Query: 73 TSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL 132
T+ + K + + + +G+ LG+G+FG YL E A K + K +L
Sbjct: 1 TALAEMPKRKFTIDD--------FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 52
Query: 133 VNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY 192
+ ++REI+I HL NI+ + DR+ ++L++E GEL+ ++ G +
Sbjct: 53 EKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF 111
Query: 193 TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252
E+ +A + + +H+CH V+HRD+KPEN L+ LK DFG SV +
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSLR 168
Query: 253 VYRDIV-GSAYYVAPEVL-RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK 310
R + G+ Y+ PE++ +++ +++D+W AGV+ Y L G+PPF + + I+
Sbjct: 169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 226
Query: 311 GGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVL 370
D + P+L SD +KDL+ K+L P +R+ V+EHPW++ P+ +
Sbjct: 227 V--DLKFPPFL--SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQ 282
Query: 371 SR 372
S+
Sbjct: 283 SK 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 3e-87
Identities = 65/295 (22%), Positives = 118/295 (40%), Gaps = 41/295 (13%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ LG+G FG YA K I ++ I E+ ++ L+ Q
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQ 62
Query: 156 NIVEFRGAYEDRQSVH-------------LVMELCSGGELFDKIIAQGHYTEKAAAA-LC 201
+V + A+ +R++ + ME C G L+D I ++ ++ L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 202 RAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI---- 257
R I+ + + H G++HRDLKP N + +K DFGL+ + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 258 -----------VGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGI 304
+G+A YVA EVL + Y ++ID++S G+I + ++ P I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI 237
Query: 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359
+ ++F + K ++R ++ DP KR + +L W+ +
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 4e-86
Identities = 79/382 (20%), Positives = 143/382 (37%), Gaps = 35/382 (9%)
Query: 42 QQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIR---QFYTL 98
+ P + + + + + E I + Y++
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60
Query: 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ-QNI 157
K++G G + N YA K + + + Q + + EI + L I
Sbjct: 61 LKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 158 VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVM 217
+ Q +++VME C +L + + + + ++ VH H G++
Sbjct: 119 IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLSVFI--DEGKVYRD-IVGSAYYVAPEVLRRS-- 272
H DLKP NFL+ + MLK DFG++ + D V +D VG+ Y+ PE ++
Sbjct: 178 HSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 273 ----------YGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPWL 321
+ DVWS G ILY + G PF + AI+ + E
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI- 292
Query: 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSA------VLSRMKQ 375
+D+++ L +DPK+RI+ E+L HP+++ ++ VL ++
Sbjct: 293 -PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVG 351
Query: 376 FRAMNKLKKMALKVIAEALSEE 397
+ N + K A + E
Sbjct: 352 LNSPNSILKAAKTLYEHYSGGE 373
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 5e-86
Identities = 75/326 (23%), Positives = 132/326 (40%), Gaps = 32/326 (9%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ- 154
Y++ K++G G + N YA K + + + Q + + EI + L
Sbjct: 11 YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 68
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
I+ Q +++VME C +L + + + + ++ VH H
Sbjct: 69 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK--VYRD-IVGSAYYVAPEVLRR 271
G++H DLKP NFL+ + MLK DFG++ + V +D VG+ Y+ PE ++
Sbjct: 128 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 272 S------------YGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESE 318
+ DVWS G ILY + G PF + AI+ + E
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
Query: 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSA------VLSR 372
+D+++ L +DPK+RI+ E+L HP+++ ++ VL +
Sbjct: 244 DI--PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ 301
Query: 373 MKQFRAMNKLKKMALKVIAEALSEEE 398
+ + N + K A + E
Sbjct: 302 LVGLNSPNSILKAAKTLYEHYSGGES 327
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 7e-86
Identities = 72/323 (22%), Positives = 128/323 (39%), Gaps = 33/323 (10%)
Query: 64 RQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYA 123
+ + +V G+ Y++ K++G G + N YA
Sbjct: 5 HHHSSGVDLGTENLYFQSMSVKGRI-------YSILKQIGSGGSSKVFQVL-NEKKQIYA 56
Query: 124 CKSILKRKLVNKQDREDIKREIQIMQHLSGQ-QNIVEFRGAYEDRQSVHLVMELCSGGEL 182
K + + + Q + + EI + L I+ Q +++VME C +L
Sbjct: 57 IKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDL 114
Query: 183 FDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242
+ + + + ++ VH H G++H DLKP NFL+ + MLK DF
Sbjct: 115 NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDF 170
Query: 243 GLSVFI--DEGKVYRD-IVGSAYYVAPEVLRRS------------YGKEIDVWSAGVILY 287
G++ + D V +D VG+ Y+ PE ++ + DVWS G ILY
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230
Query: 288 ILLSGVPPFWAETEK-GIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSA 346
+ G PF + AI+ + E +D+++ L +DPK+RI+
Sbjct: 231 YMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIP 288
Query: 347 EVLEHPWMREGGEASDKPIGSAV 369
E+L HP+++ ++
Sbjct: 289 ELLAHPYVQIQTHPVNQMAKGTT 311
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 2e-85
Identities = 100/308 (32%), Positives = 160/308 (51%), Gaps = 13/308 (4%)
Query: 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ 154
Y L K +G+G F L TG A K I K +L N + + RE++IM+ L+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-H 73
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
NIV+ E ++++L+ME SGGE+FD ++A G EK A + R IV+ V +CH
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSY 273
++HRDLK EN LL D +K DFG S G G+ Y APE+ + + Y
Sbjct: 134 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 274 -GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332
G E+DVWS GVILY L+SG PF + K + + +L+G + ++ S ++L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFYM--STDCENLLK 246
Query: 333 KMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMAL--KVI 390
+ L+ +P KR T ++++ W+ G E + + + ++ + M + I
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEI 306
Query: 391 AEALSEEE 398
E+LS+ +
Sbjct: 307 QESLSKMK 314
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 2e-85
Identities = 49/371 (13%), Positives = 102/371 (27%), Gaps = 45/371 (12%)
Query: 37 PYQTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFY 96
++ + ++ + +++ + P TV + R+
Sbjct: 6 AGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERK-L 64
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHL----- 151
L + L G + +L + +A K ++ + E + L
Sbjct: 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124
Query: 152 ------------------SGQQNIVEFRGAYEDR--QSVHLVMELCSG------GELFDK 185
Q + +D + L+M S L
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184
Query: 186 IIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245
+ +G A L ++ + + G++H P+N + DG L D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM-PDG--RLMLGDVSAL 241
Query: 246 VFIDEGKVYRDIVGSAYYVAPEVLRRS---YGKEIDVWSAGVILYILLSGVPPFWAETEK 302
G Y E L S + ++ W G+ +Y + PF T
Sbjct: 242 W--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 303 GIFDAILKGGVDFESEPWLL-----ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357
++ + D K L+ + L D ++R+ E +E P +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359
Query: 358 GEASDKPIGSA 368
+ +
Sbjct: 360 QNEISSSLSTG 370
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 1e-84
Identities = 81/312 (25%), Positives = 126/312 (40%), Gaps = 28/312 (8%)
Query: 62 QPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNS 121
+P Q P T T P GK E Y LG LG+G FG + +
Sbjct: 5 KPLQGPPAPPGTPTPPPG------GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQ 58
Query: 122 YACKSILKRKLVNKQDRED---IKREIQIMQHLSGQQ---NIVEFRGAYEDRQSVHLVME 175
A K I + +++ D E+ ++ + ++ +E ++ LV+E
Sbjct: 59 VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118
Query: 176 L-CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG 234
+LFD I +G E + +V + HCH GV+HRD+K EN L+ + G
Sbjct: 119 RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG- 177
Query: 235 AMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSY-GKEIDVWSAGVILYILLSG 292
K DFG + + Y D G+ Y PE + Y VWS G++LY ++ G
Sbjct: 178 -CAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
Query: 293 VPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
PF E ++ I +A + + S L+R+ L P R + E+L P
Sbjct: 236 DIPF--ERDQEILEA------ELHFPAHV--SPDCCALIRRCLAPKPSSRPSLEEILLDP 285
Query: 353 WMREGGEASDKP 364
WM+ E
Sbjct: 286 WMQTPAEDVPLN 297
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 2e-84
Identities = 84/325 (25%), Positives = 135/325 (41%), Gaps = 28/325 (8%)
Query: 47 QQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQ 106
H P+ AT P ++ E + + Y +G LG G
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQ--------YQVGPLLGSGG 55
Query: 107 FGITYLCTENSTGNSYACKSILKRKLVNKQDRED---IKREIQIMQHLS-GQQNIVEFRG 162
FG Y S A K + K ++ + + + + E+ +++ +S G ++
Sbjct: 56 FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115
Query: 163 AYEDRQSVHLVMELCSG-GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
+E S L++E +LFD I +G E+ A + ++ V HCH GV+HRD+
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDI 175
Query: 222 KPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSY-GKEIDV 279
K EN L+ G LK DFG + + Y D G+ Y PE +R Y G+ V
Sbjct: 176 KDENILIDLNRG--ELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 280 WSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339
WS G++LY ++ G PF + E I++G + S + L+R L P
Sbjct: 233 WSLGILLYDMVCGDIPFEHDEE------IIRG--QVFFRQRV--SSECQHLIRWCLALRP 282
Query: 340 KKRITSAEVLEHPWMREGGEASDKP 364
R T E+ HPWM++ +
Sbjct: 283 SDRPTFEEIQNHPWMQDVLLPQETA 307
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 2e-84
Identities = 64/302 (21%), Positives = 121/302 (40%), Gaps = 43/302 (14%)
Query: 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHL 151
+ L LG+G + TG+ +A K + D RE ++++ L
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKL 64
Query: 152 SGQQNIVEFRGAYEDRQSVH--LVMELCSGGELFDKIIAQGH---YTEKAAAALCRAIVN 206
+ +NIV+ E+ + H L+ME C G L+ + + E + R +V
Sbjct: 65 N-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 207 VVHHCHFMGVMHRDLKPENFLLS-NKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
++H G++HR++KP N + +DG ++ K TDFG + +++ + + + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 266 PEVLRRS---------YGKEIDVWSAGVILYILLSGVPPFWA----ETEKGIFDAILKG- 311
P++ R+ YG +D+WS GV Y +G PF K + I+ G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 312 --------------GVDFESE--PWLLISDSAKDLV----RKMLIQDPKKRITSAEVLEH 351
+D+ + +S + L+ +L D +K +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 352 PW 353
Sbjct: 304 TS 305
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 5e-84
Identities = 101/265 (38%), Positives = 133/265 (50%), Gaps = 10/265 (3%)
Query: 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ 154
Y LG LG G FG + TG+ A K + ++K+ + IKREIQ ++
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-H 70
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
+I++ +VME SGGELFD I G E A L + I++ V +CH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSY 273
V+HRDLKPEN LL D K DFGLS + +G+ R GS Y APEV+ R Y
Sbjct: 131 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 274 -GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332
G E+D+WS GVILY LL G PF E +F I G F +L + S L+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYL--NRSVATLLM 243
Query: 333 KMLIQDPKKRITSAEVLEHPWMREG 357
ML DP KR T ++ EH W ++
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQD 268
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 7e-84
Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 14/275 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ L + LG G +G L T + A K + ++ V+ + IK+EI I + L+ +
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN-HE 65
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
N+V+F G + +L +E CSGGELFD+I E A ++ V + H +G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI---VGSAYYVAPEVL-RR 271
+ HRD+KPEN LL D LK +DFGL+ R + G+ YVAPE+L RR
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 272 SY-GKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPWLLISDSAKD 329
+ + +DVWS G++L +L+G P+ ++ + + PW I +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLA 240
Query: 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364
L+ K+L+++P RIT ++ + W + + K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 2e-83
Identities = 57/379 (15%), Positives = 109/379 (28%), Gaps = 61/379 (16%)
Query: 24 HSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTR--PVQKP 81
H H + +Q ++L + P+ + Q S ST +P
Sbjct: 2 HHHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQP 61
Query: 82 ETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDI 141
V + E R G LG+ T+ TG S+ + + +
Sbjct: 62 FRVESELGERPRT-LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120
Query: 142 KREIQIMQHL------------------------SGQQNIVEFRGAYEDRQ--SVHLVME 175
K E+ ++ L ++ ++ R D S +
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180
Query: 176 LCS------GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229
G L A L ++ ++ H G++H L+P + +L
Sbjct: 181 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD 240
Query: 230 NKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL------------RRSYGKEI 277
+ G + T F V S + PE+ R
Sbjct: 241 -QRG--GVFLTGFEHLVRDGA---RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D W+ G+++Y + P + G + I + + I + L+ L
Sbjct: 295 DAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRY 346
Query: 338 DPKKRITSAEVLEHPWMRE 356
+ R+ + +E P +
Sbjct: 347 PKEDRLLPLQAMETPEYEQ 365
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 4e-83
Identities = 96/336 (28%), Positives = 150/336 (44%), Gaps = 24/336 (7%)
Query: 68 MKSSATSTRPVQKPETV-LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKS 126
M + +T P+ P + Y K++G G FG+ L + T A K
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDR--------YDFVKDIGSGNFGVARLMRDKLTKELVAVKY 52
Query: 127 ILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI 186
I + +++ ++REI + L NIV F+ + ++ME SGGEL+++I
Sbjct: 53 IERGAAIDEN----VQREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGGELYERI 107
Query: 187 IAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246
G ++E A + +++ V +CH M + HRDLK EN LL LK DFG S
Sbjct: 108 CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAP-RLKICDFGYSK 166
Query: 247 FIDEGKVYRDIVGSAYYVAPEVL-RRSY-GKEIDVWSAGVILYILLSGVPPFWAETEKGI 304
+ VG+ Y+APEVL R+ Y GK DVWS GV LY++L G PF E
Sbjct: 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226
Query: 305 F----DAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360
+ IL + + IS L+ ++ + DP RI+ E+ H W + A
Sbjct: 227 YRKTIQRILSV--KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA 284
Query: 361 SDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSE 396
+ + + M L + +++I+EA
Sbjct: 285 DLMNESNTGSQFQEPEQPMQSLDTI-MQIISEATIP 319
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 3e-82
Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 14/275 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ L + LG G +G L T + A K + ++ V+ + IK+EI I + L+ +
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN-HE 65
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
N+V+F G + +L +E CSGGELFD+I E A ++ V + H +G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI---VGSAYYVAPEVL-RR 271
+ HRD+KPEN LL D LK +DFGL+ R + G+ YVAPE+L RR
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 272 SY-GKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPWLLISDSAKD 329
+ + +DVWS G++L +L+G P+ ++ + + PW I +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLA 240
Query: 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364
L+ K+L+++P RIT ++ + W + + K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 4e-82
Identities = 69/358 (19%), Positives = 142/358 (39%), Gaps = 53/358 (14%)
Query: 61 PQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGN 120
P + + S+ ++ + K K + D Y + + L +G+F LC +
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYIND----YRIIRTLNQGKFNKIILCEK--DNK 55
Query: 121 SYACKSILKRKLVNKQDR--------------EDIKREIQIMQHLSGQQNIVEFRGAYED 166
YA K K L K+D +D K E+QI+ + + + G +
Sbjct: 56 FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITN 114
Query: 167 RQSVHLVMELCSGGELFDKIIAQGH--------YTEKAAAALCRAIVNVVHHCH-FMGVM 217
V+++ E + + + ++++N + H +
Sbjct: 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC 174
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRS---YG 274
HRD+KP N L+ D +K +DFG S ++ + K+ + G+ ++ PE G
Sbjct: 175 HRDVKPSNILM---DKNGRVKLSDFGESEYMVDKKI-KGSRGTYEFMPPEFFSNESSYNG 230
Query: 275 KEIDVWSAGVILYILLSGVPPFWAE-TEKGIFDAILKGGVDF---------------ESE 318
++D+WS G+ LY++ V PF + + +F+ I +++ +
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290
Query: 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQF 376
+S+ D ++ L ++P +RITS + L+H W+ + + + + K+
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 7e-81
Identities = 94/308 (30%), Positives = 145/308 (47%), Gaps = 13/308 (4%)
Query: 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ 154
Y + + LG G FG L T T A K I ++ L ++REI ++ L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-H 68
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
+I++ + +V+E GGELFD I+ + TE + I+ + +CH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSY 273
++HRDLKPEN LL D +K DFGLS + +G + GS Y APEV+ + Y
Sbjct: 128 KIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 274 -GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332
G E+DVWS G++LY++L G PF E +F + + +L S A+ L+R
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDFL--SPGAQSLIR 240
Query: 333 KMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSR--MKQFRAMNKLKKMALKVI 390
+M++ DP +RIT E+ PW +P+ S + + + + I
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYI 300
Query: 391 AEALSEEE 398
EAL +E
Sbjct: 301 VEALRSDE 308
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 9e-81
Identities = 78/315 (24%), Positives = 131/315 (41%), Gaps = 37/315 (11%)
Query: 56 MSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTE 115
M+ +P + +A QK Y+ LG G FG + +
Sbjct: 1 MALEEPPKAVELEGLAACEGEYSQK---------------YSTMSPLGSGAFGFVWTAVD 45
Query: 116 NSTGNSYACKSILKRKLVNKQDRED-----IKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170
K I K K++ ED + EI I+ + NI++ +E++
Sbjct: 46 KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFF 104
Query: 171 HLVMEL-CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229
LVME SG +LF I E A+ + R +V+ V + ++HRD+K EN ++
Sbjct: 105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI- 163
Query: 230 NKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSY-GKEIDVWSAGVILY 287
+K DFG + +++ GK++ G+ Y APEVL Y G E+++WS GV LY
Sbjct: 164 --AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLY 221
Query: 288 ILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAE 347
L+ PF + ++ + S LV +L P++R T +
Sbjct: 222 TLVFEENPFCE------LEETVEA--AIHPPYLV--SKELMSLVSGLLQPVPERRTTLEK 271
Query: 348 VLEHPWMREGGEASD 362
++ PW+ + +D
Sbjct: 272 LVTDPWVTQPVNLAD 286
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 2e-80
Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 37/290 (12%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR----------------- 138
YTL E+G+G +G+ L + YA K + K+KL+ +
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 139 ------EDIKREIQIMQHLSGQQNIVEFRGAYED--RQSVHLVMELCSGGELFDKIIAQG 190
E + +EI I++ L N+V+ +D +++V EL + G + + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 191 HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFID 249
+E A + ++ + + H+ ++HRD+KP N L+ +K DFG+S F
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG---HIKIADFGVSNEFKG 189
Query: 250 EGKVYRDIVGSAYYVAPEVL---RRSY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIF 305
+ + VG+ ++APE L R+ + GK +DVW+ GV LY + G PF E +
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 306 DAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
I ++F +P I++ KDL+ +ML ++P+ RI E+ HPW+
Sbjct: 250 SKIKSQALEFPDQPD--IAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 2e-80
Identities = 100/286 (34%), Positives = 142/286 (49%), Gaps = 18/286 (6%)
Query: 74 STRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV 133
+ + +G Y LG LG G FG + TG+ A K + ++K+
Sbjct: 4 AEKQKHDGRVKIGH--------YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR 55
Query: 134 NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYT 193
+ I+REIQ ++ +I++ + +VME SGGELFD I G
Sbjct: 56 SLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLD 114
Query: 194 EKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253
EK + L + I++ V +CH V+HRDLKPEN LL D K DFGLS + +G+
Sbjct: 115 EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEF 171
Query: 254 YRDIVGSAYYVAPEVLR-RSY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG 311
R GS Y APEV+ R Y G E+D+WS+GVILY LL G PF + +F I G
Sbjct: 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG 231
Query: 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357
F + +L + S L++ ML DP KR T ++ EH W ++
Sbjct: 232 --IFYTPQYL--NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 5e-79
Identities = 78/302 (25%), Positives = 119/302 (39%), Gaps = 15/302 (4%)
Query: 57 SAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTEN 116
S Q QPR+ + A+ +Q P +P +Q + LG G +G +
Sbjct: 22 SMHQLQPRRVSFRGEASE--TLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79
Query: 117 STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMEL 176
G YA K +DR E+ + + V A+E+ ++L EL
Sbjct: 80 EDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138
Query: 177 CSGGELFDKIIAQGHY-TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235
C G L A G E R + + H H G++H D+KP N L G
Sbjct: 139 C-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG-PRG-- 194
Query: 236 MLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVP- 294
K DFGL V + G Y+APE+L+ SYG DV+S G+ + + +
Sbjct: 195 RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL 254
Query: 295 PFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
P E + + L E +S + ++ ML DPK R T+ +L P +
Sbjct: 255 PHGGEGWQQLRQGYLPP------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
Query: 355 RE 356
R+
Sbjct: 309 RQ 310
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 252 bits (644), Expect = 4e-77
Identities = 71/352 (20%), Positives = 133/352 (37%), Gaps = 41/352 (11%)
Query: 76 RPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK 135
R P G + + + LG G FG TG A K + +
Sbjct: 4 RSPSLPTQTCGP--------WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SP 53
Query: 136 QDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH------LVMELCSGGELFDKIIAQ 189
++RE EIQIM+ L+ N+V R + Q + L ME C GG+L +
Sbjct: 54 KNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF 112
Query: 190 GH---YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246
+ E L I + + + H ++HRDLKPEN +L + K D G +
Sbjct: 113 ENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172
Query: 247 FIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF 305
+D+G++ + VG+ Y+APE+L + Y +D WS G + + ++G PF + +
Sbjct: 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232
Query: 306 DAILKGGVDFESEPWLLISDS--------------------AKDLVRKMLIQDPKKRITS 345
++ + + ++ + + ++ ML+ ++R T
Sbjct: 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD 292
Query: 346 AEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEE 397
+ + + S + + + L+ + L ++
Sbjct: 293 PQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQD 344
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-76
Identities = 74/281 (26%), Positives = 137/281 (48%), Gaps = 20/281 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED-IKREIQIMQHLSGQ 154
Y +G LG G +G ++ T A K + K+KL + E +K+EIQ+++ L
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-H 65
Query: 155 QNIVEFRG--AYEDRQSVHLVMELCSGG--ELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
+N+++ E++Q +++VME C G E+ D + + + A +++ + +
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEY 124
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID---EGKVYRDIVGSAYYVAPE 267
H G++H+D+KP N LL G LK + G++ + R GS + PE
Sbjct: 125 LHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 268 VLR--RSY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324
+ ++ G ++D+WSAGV LY + +G+ PF + +F+ I KG +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDC--G 237
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
DL++ ML +P KR + ++ +H W R+ ++ P+
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-73
Identities = 72/274 (26%), Positives = 127/274 (46%), Gaps = 21/274 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + +G G +G S G K + + + +++ + E+ +++ L
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HP 65
Query: 156 NIVEFRGAYEDRQS--VHLVMELCSGGELFDKIIAQG----HYTEKAAAALCRAIVNVVH 209
NIV + DR + +++VME C GG+L I + E+ + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 210 HCH-----FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY-RDIVGSAYY 263
CH V+HRDLKP N L K +K DFGL+ ++ + + VG+ YY
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ---NVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 264 VAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL 322
++PE + SY ++ D+WS G +LY L + +PPF A ++K + I +G +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY-- 240
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
SD +++ +ML R + E+LE+P + E
Sbjct: 241 -SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-70
Identities = 72/265 (27%), Positives = 136/265 (51%), Gaps = 12/265 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y +++G G FG L G Y K I ++ + ++RE+ +RE+ ++ ++
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HP 83
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHF 213
NIV++R ++E+ S+++VM+ C GG+LF +I AQ + E I + H H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVLR-R 271
++HRD+K +N L+ KDG ++ DFG++ ++ +G+ YY++PE+ +
Sbjct: 144 RKILHRDIKSQNIFLT-KDG--TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
Y + D+W+ G +LY L + F A + K + I+ G F L S + LV
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--SFPPVS-LHYSYDLRSLV 257
Query: 332 RKMLIQDPKKRITSAEVLEHPWMRE 356
++ ++P+ R + +LE ++ +
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 6e-70
Identities = 71/307 (23%), Positives = 130/307 (42%), Gaps = 20/307 (6%)
Query: 58 APQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENS 117
Q Q Q P + ++ L + + + K++GRGQF Y
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMG--YNTLAN----FRIEKKIGRGQFSEVYRAACLL 55
Query: 118 TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELC 177
G A K + L++ + R D +EI +++ L+ N++++ ++ + +++V+EL
Sbjct: 56 DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELA 114
Query: 178 SGGELFDKIIAQG----HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233
G+L I E+ + + + H H VMHRD+KP N ++ G
Sbjct: 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-ATG 173
Query: 234 GAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS 291
++K D GL F + +VG+ YY++PE + Y + D+WS G +LY + +
Sbjct: 174 --VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 292 GVPPFWAETE--KGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349
PF+ + + I + D+ P S+ + LV + DP+KR V
Sbjct: 232 LQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVY 289
Query: 350 EHPWMRE 356
+
Sbjct: 290 DVAKRMH 296
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 8e-65
Identities = 63/280 (22%), Positives = 110/280 (39%), Gaps = 38/280 (13%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + +G G FG + G +Y K + K + E +RE++ + L
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLD-HV 64
Query: 156 NIVEFRGAYEDR----------------QSVHLVMELCSGGELFDKIIAQ--GHYTEKAA 197
NIV + G ++ + + + ME C G L I + + A
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 198 AALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI 257
L I V + H +++RDLKP N L +K DFGL +
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLV-DTK--QVKIGDFGLVTSLKNDGKRTRS 181
Query: 258 VGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316
G+ Y++PE + + YGKE+D+++ G+IL LL F + G
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDG----- 234
Query: 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
+ K L++K+L + P+ R ++E+L + +
Sbjct: 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-64
Identities = 64/282 (22%), Positives = 98/282 (34%), Gaps = 32/282 (11%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y ++LG G F L G+ YA K IL +QDRE+ +RE + +
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHP 86
Query: 156 NIVEFRGAYEDRQS----VHLVMELCSGGELFDKI----IAQGHYTEKAAAALCRAIVNV 207
NI+ + L++ G L+++I TE L I
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD----------I 257
+ H G HRDLKP N LL ++ D G
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEG---QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 258 VGSAYYVAPEVL----RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFDAILKGG 312
+ Y APE+ + DVWS G +LY ++ G P+ +KG ++
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263
Query: 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
+ P S + L+ M+ DP +R +L
Sbjct: 264 LSIPQSPRH--SSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-64
Identities = 98/314 (31%), Positives = 143/314 (45%), Gaps = 33/314 (10%)
Query: 56 MSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTE 115
M +PR P S +P +P ED + GK LG G F L E
Sbjct: 1 MDGTAAEPR--PGAGSLQHAQPPPQPRKK---RPED----FKFGKILGEGSFSTVVLARE 51
Query: 116 NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175
+T YA K + KR ++ + + RE +M L V+ ++D + ++ +
Sbjct: 52 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLS 110
Query: 176 LCSGGELFDKIIAQGHYTEKAA---AALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD 232
GEL I G + E A IV+ + + H G++HRDLKPEN LL N+D
Sbjct: 111 YAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILL-NED 166
Query: 233 GGAMLKATDFGLS-VFIDEGKVYRD--IVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYI 288
++ TDFG + V E K R VG+A YV+PE+L K D+W+ G I+Y
Sbjct: 167 M--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224
Query: 289 LLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITS--- 345
L++G+PPF A E IF I+K DF + A+DLV K+L+ D KR+
Sbjct: 225 LVAGLPPFRAGNEYLIFQKIIKLEYDFPEK----FFPKARDLVEKLLVLDATKRLGCEEM 280
Query: 346 ---AEVLEHPWMRE 356
+ HP+
Sbjct: 281 EGYGPLKAHPFFES 294
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 1e-63
Identities = 56/379 (14%), Positives = 106/379 (27%), Gaps = 57/379 (15%)
Query: 24 HSSHQATGVATQTPYQTYQQQQQ-----QQLHVQPPKMSAPQPQPRQQPMKSSATSTRPV 78
H H + +Q ++ ++L + P+ + Q S ST
Sbjct: 2 HHHHHHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLW 61
Query: 79 QKPETVLGKPLEDIRQF-YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD 137
+ + R G LG+ T+ TG S+ +
Sbjct: 62 NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 121
Query: 138 REDIKREIQIMQHLSGQQN------------------------IVEFRGAYEDR--QSVH 171
+ +K E+ ++ L G +N ++ R D S
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 181
Query: 172 LVMELCSG------GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPEN 225
+ L A L ++ ++ H G++H L+P +
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 241
Query: 226 FLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--IVGSAYYVAPEVLRRS------YGKEI 277
+L + GG L T F V V A +L
Sbjct: 242 IVLD-QRGGVFL--TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337
D W+ G+ +Y + P + G + I + + I + L+ L
Sbjct: 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRY 350
Query: 338 DPKKRITSAEVLEHPWMRE 356
+ R+ + +E P +
Sbjct: 351 PKEDRLLPLQAMETPEYEQ 369
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-61
Identities = 76/315 (24%), Positives = 123/315 (39%), Gaps = 43/315 (13%)
Query: 70 SSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILK 129
+ + +G+ +E + + L G F Y + +G YA K +L
Sbjct: 4 PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS 63
Query: 130 RKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS--------VHLVMELCSGGE 181
++ I +E+ M+ LSG NIV+F A + L+ ELC G+
Sbjct: 64 N---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQ 119
Query: 182 LFDKII---AQGHYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAM 236
L + + ++G + + V H H ++HRDLK EN LLSN+
Sbjct: 120 LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG---T 176
Query: 237 LKATDFGLSVFIDEGKVYRDI-------------VGSAYYVAPEVL----RRSYGKEIDV 279
+K DFG + I Y + Y PE++ G++ D+
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236
Query: 280 WSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339
W+ G ILY+L PF E G I+ G + P L+R ML +P
Sbjct: 237 WALGCILYLLCFRQHPF----EDGAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNP 290
Query: 340 KKRITSAEVLEHPWM 354
++R++ AEV+
Sbjct: 291 EERLSIAEVVHQLQE 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-60
Identities = 70/302 (23%), Positives = 122/302 (40%), Gaps = 46/302 (15%)
Query: 86 GKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREI 145
G+ L D + + LGRG FG+ + +YA K I R + RE + RE+
Sbjct: 1 GRYLTD----FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREV 54
Query: 146 QIMQHLSGQQNIVEFRGAYEDRQS------------VHLVMELCSGGELFDKIIAQGHYT 193
+ + L IV + A+ ++ + +++ M+LC L D + +
Sbjct: 55 KALAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 194 ---EKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250
+ I V H G+MHRDLKP N D ++K DFGL +D+
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF-TMDD--VVKVGDFGLVTAMDQ 170
Query: 251 GKVYRDI-------------VGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPF 296
+ + + VG+ Y++PE + SY ++D++S G+IL+ LL PF
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF 227
Query: 297 WAETEKG-IFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
+ E+ + F +V+ ML P +R + ++E+
Sbjct: 228 STQMERVRTLTDVRNL--KFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
Query: 356 EG 357
+
Sbjct: 285 DL 286
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-60
Identities = 58/286 (20%), Positives = 115/286 (40%), Gaps = 32/286 (11%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ +++G G+FG + C + G YA K K+ L D ++ RE+ L
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHC 211
++V + A+ + + + E C+GG L D I ++ E L + + +
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 212 HFMGVMHRDLKPENFLLSNK----------------DGGAMLKATDFGLSVFIDEGKVYR 255
H M ++H D+KP N +S M K D G I +V
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE- 190
Query: 256 DIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV 313
G + ++A EVL+ ++ + D+++ + + P + + I +G
Sbjct: 191 --EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG-- 243
Query: 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359
P +L S +L++ M+ DP++R ++ +++H +
Sbjct: 244 RLPRIPQVL-SQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-56
Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 30/271 (11%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ K LG G FG L +GN YA K + K+K+V + E E +I+Q ++
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FP 101
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAA---AALCRAIVNVVHHCH 212
+V+ +++D ++++VME +GGE+F + G ++E A AA IV + H
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA---QIVLTFEYLH 158
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV----GSAYYVAPEV 268
+ +++RDLKPEN L+ ++ G ++ TDFG + K + G+ +APE+
Sbjct: 159 SLDLIYRDLKPENLLI-DQQG--YIQVTDFGFA------KRVKGRTWTLCGTPEALAPEI 209
Query: 269 LRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327
+ Y K +D W+ GV++Y + +G PPF+A+ I++ I+ G V F S S
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDL 265
Query: 328 KDLVRKMLIQDPKKRITS-----AEVLEHPW 353
KDL+R +L D KR + ++ H W
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 9e-56
Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 29/291 (9%)
Query: 80 KPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRE 139
P + F L + +G+G FG + +N T YA K + K+K V + +
Sbjct: 2 MPPVFDENEDVNFDHFEIL-RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 140 DIKREIQIMQHLSGQQN--IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAA 197
++ +E+QIMQ L + +V +++D + + +V++L GG+L + H+ E+
Sbjct: 61 NVFKELQIMQGLE---HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV 117
Query: 198 ----AALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253
L A+ + ++HRD+KP+N LL ++ G + TDF ++ +
Sbjct: 118 KLFICELVMAL----DYLQNQRIIHRDMKPDNILL-DEHGHVHI--TDFNIAAMLPRETQ 170
Query: 254 YRDIVGSAYYVAPEVLRRS----YGKEIDVWSAGVILYILLSGVPPFW---AETEKGIFD 306
+ G+ Y+APE+ Y +D WS GV Y LL G P+ + + K I
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
Query: 307 AILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSA-EVLEHPWMRE 356
V + S S L++K+L +P +R + +V P+M +
Sbjct: 231 TFETTVVTYPSA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-55
Identities = 81/267 (30%), Positives = 130/267 (48%), Gaps = 16/267 (5%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +GRG FG L ST YA K + K +++ + D E IM + +V+
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQ 133
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
A++D + +++VME GG+L +++ EK A +V + H MG +HR
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 192
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--IVGSAYYVAPEVLRR-----S 272
D+KP+N LL +K G L DFG + +++ + R VG+ Y++PEVL+
Sbjct: 193 DVKPDNMLL-DKSGHLKL--ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 273 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332
YG+E D WS GV LY +L G PF+A++ G + I+ IS AK+L+
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 333 KMLIQDPKKRITS---AEVLEHPWMRE 356
+ D + R+ E+ H + +
Sbjct: 310 A-FLTDREVRLGRNGVEEIKRHLFFKN 335
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 9e-55
Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 34/276 (12%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + + LG G FG +L G YA K + K +V + E E ++ ++
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--- 64
Query: 156 N--IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAA---AALCRAIVNVVHH 210
+ I+ G ++D Q + ++M+ GGELF + + A AA + + +
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EVCLALEY 121
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV----GSAYYVAP 266
H +++RDLKPEN LL +K+G +K TDFG + K D+ G+ Y+AP
Sbjct: 122 LHSKDIIYRDLKPENILL-DKNG--HIKITDFGFA------KYVPDVTYTLCGTPDYIAP 172
Query: 267 EVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325
EV+ Y K ID WS G+++Y +L+G PF+ ++ IL + F ++
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----FNE 228
Query: 326 SAKDLVRKMLIQDPKKRI-----TSAEVLEHPWMRE 356
KDL+ +++ +D +R+ + +V HPW +E
Sbjct: 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-54
Identities = 81/296 (27%), Positives = 129/296 (43%), Gaps = 22/296 (7%)
Query: 70 SSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILK 129
S TR Q L L + F + +GRG FG Y C + TG YA K + K
Sbjct: 167 ESDKFTRFCQWKNVELNIHL-TMNDFSVH-RIIGRGGFGEVYGCRKADTGKMYAMKCLDK 224
Query: 130 RKLVNKQDREDIKREIQIMQHLSGQQN--IVEFRGAYEDRQSVHLVMELCSGGELFDKII 187
+++ KQ E ++ +S IV A+ + +++L +GG+L +
Sbjct: 225 KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284
Query: 188 AQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247
G ++E I+ + H H V++RDLKP N LL D ++ +D GL+
Sbjct: 285 QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACD 341
Query: 248 IDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKG-- 303
+ K + VG+ Y+APEVL++ +Y D +S G +L+ LL G PF K
Sbjct: 342 FSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
Query: 304 -IFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRI-----TSAEVLEHPW 353
I L V+ S + L+ +L +D +R+ + EV E P+
Sbjct: 401 EIDRMTLTMAVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-54
Identities = 52/319 (16%), Positives = 101/319 (31%), Gaps = 40/319 (12%)
Query: 60 QPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCT----- 114
P P KP+ + + + LG G F Y T
Sbjct: 35 SKPVSSYPNTFEWQCKLPAIKPK----TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 115 ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174
+ + K + ++ ++F A+ + LV
Sbjct: 91 DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ----HMFMKFYSAHLFQNGSVLVG 146
Query: 175 ELCSGGELFDKIIAQGHYTEKA-----AAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229
EL S G L + I + EK + ++ ++ H ++H D+KP+NF+L
Sbjct: 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206
Query: 230 NK--------DGGAMLKATDFGLSV---FIDEGKVYRDIVGSAYYVAPEVL-RRSYGKEI 277
N D A L D G S+ +G ++ ++ + E+L + + +I
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266
Query: 278 DVWSAGVILYILLSGVPPFWA-ETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLI 336
D + +Y +L G E + + + + + W + ML
Sbjct: 267 DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL--PHLDMW-------NEFFHVMLN 317
Query: 337 QDPKKRITSAEVLEHPWMR 355
+ S ++L +
Sbjct: 318 IPDCHHLPSLDLLRQKLKK 336
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-53
Identities = 70/267 (26%), Positives = 132/267 (49%), Gaps = 18/267 (6%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +GRG FG + + +A K + K +++ + + + E ++ + + I
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITT 138
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKII-AQGHYTEKAAAALCRAIVNVVHHCHFMGVMH 218
A++D +++LVM+ GG+L + + E+ A +V + H + +H
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRD-IVGSAYYVAPEVL------R 270
RD+KP+N L+ + +G ++ DFG +++G V VG+ Y++PE+L +
Sbjct: 199 RDIKPDNILM-DMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 271 RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL-LISDSAKD 329
YG E D WS GV +Y +L G PF+AE+ + I+ F+ + +S++AKD
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 330 LVRKMLIQDPKKRITS---AEVLEHPW 353
L+R+ LI + R+ + +HP+
Sbjct: 316 LIRR-LICSREHRLGQNGIEDFKKHPF 341
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-53
Identities = 85/316 (26%), Positives = 154/316 (48%), Gaps = 14/316 (4%)
Query: 49 LHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFG 108
+H S +S + + ++ D R ++G G G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQ-GDPRLLLDSYVKIGEGSTG 59
Query: 109 ITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168
I L E +G A K + L +Q RE + E+ IM+ N+VE +Y +
Sbjct: 60 IVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGE 115
Query: 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLL 228
+ ++ME GG L D I++Q E+ A +C A++ + + H GV+HRD+K ++ LL
Sbjct: 116 ELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174
Query: 229 SNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVLRRS-YGKEIDVWSAGVIL 286
+ DG K +DFG I + R +VG+ Y++APEV+ RS Y E+D+WS G+++
Sbjct: 175 TL-DGRV--KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231
Query: 287 YILLSGVPPFWAETE-KGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITS 345
++ G PP+++++ + + + + S +D + +ML++DP++R T+
Sbjct: 232 IEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKV-SPVLRDFLERMLVRDPQERATA 289
Query: 346 AEVLEHPWMREGGEAS 361
E+L+HP++ + G
Sbjct: 290 QELLDHPFLLQTGLPE 305
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-52
Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 20/269 (7%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
K +GRG F + TG YA K + K ++ + + + E ++ + ++ I +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQ 125
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMH 218
A++D ++LVME GG+L + G + A IV + H +G +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--IVGSAYYVAPEVLRR----- 271
RD+KP+N LL ++ G L DFG + + R VG+ Y++PE+L+
Sbjct: 186 RDIKPDNILL-DRCGHIRL--ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 272 ---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL-ISDSA 327
SYG E D W+ GV Y + G PF+A++ + I+ + + A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 328 KDLVRKMLIQDPKKRITS---AEVLEHPW 353
+D +++ L+ P+ R+ + HP+
Sbjct: 303 RDFIQR-LLCPPETRLGRGGAGDFRTHPF 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-51
Identities = 62/271 (22%), Positives = 122/271 (45%), Gaps = 16/271 (5%)
Query: 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
+F E+GRG F Y + T A + RKL K +R+ K E ++++ L
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ- 83
Query: 154 QQNIVEFRGAYED----RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
NIV F ++E ++ + LV EL + G L + K + CR I+ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 210 --HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPE 267
H ++HRDLK +N ++ G +K D GL+ + ++G+ ++APE
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRASFA-KAVIGTPEFMAPE 200
Query: 268 VLRRSYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFDAILKGGVDFESEPWLLISD 325
+ Y + +DV++ G+ + + + P ++E + I+ + G + +
Sbjct: 201 MYEEKYDESVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVTSG--VKPASFDKVAIP 257
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
K+++ + Q+ +R + ++L H + +E
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 8e-51
Identities = 74/290 (25%), Positives = 130/290 (44%), Gaps = 15/290 (5%)
Query: 74 STRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV 133
+T V K + + + F L LG+G FG L T YA K + K ++
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFL-MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI 59
Query: 134 NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYT 193
D E E +++ + + ++ ++ VME +GG+L I G +
Sbjct: 60 QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK 119
Query: 194 EKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGK 252
E A I + G+++RDLK +N +L + +G + DFG+ I +G
Sbjct: 120 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML-DSEGHIKI--ADFGMCKENIWDGV 176
Query: 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG 311
+ G+ Y+APE++ YGK +D W+ GV+LY +L+G PF E E +F +I++
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
Query: 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITS-----AEVLEHPWMRE 356
V + + S A + + ++ + P KR+ ++ EH + R
Sbjct: 237 NVAY--PKSM--SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 62/309 (20%), Positives = 113/309 (36%), Gaps = 22/309 (7%)
Query: 54 PKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLC 113
SA + + + KP + + T +GRG FG +
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDY---EYREEVHWMTHQPRVGRGSFGEVHRM 77
Query: 114 TENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173
+ TG A K + + E+ LS IV GA + V++
Sbjct: 78 KDKQTGFQCAVKKV--------RLEVFRVEELVACAGLS-SPRIVPLYGAVREGPWVNIF 128
Query: 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233
MEL GG L I G E A + + + H ++H D+K +N LLS+
Sbjct: 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD-- 186
Query: 234 GAMLKATDFGLSVFIDEGKVYR------DIVGSAYYVAPEVLRRS-YGKEIDVWSAGVIL 286
G+ DFG ++ + + + I G+ ++APEV+ ++D+WS+ ++
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 287 YILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSA 346
+L+G P+ + I P + +++ L ++P R ++
Sbjct: 247 LHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPLTAQAIQEGLRKEPVHRASAM 305
Query: 347 EVLEHPWMR 355
E+
Sbjct: 306 ELRRKVGKA 314
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 81/298 (27%), Positives = 136/298 (45%), Gaps = 21/298 (7%)
Query: 67 PMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKS 126
P +SS LG +++ + + LG+G FG L TG+ YA K
Sbjct: 2 PKESSKEGNGIGVNSSNRLG--IDN----FEFIRVLGKGSFGKVMLARVKETGDLYAVKV 55
Query: 127 ILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI 186
+ K ++ D E E +I+ + + ++ + VME +GG+L I
Sbjct: 56 LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115
Query: 187 IAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS- 245
+ E A I++ + H G+++RDLK +N LL + +G L DFG+
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL-DHEGHCKL--ADFGMCK 172
Query: 246 VFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGI 304
I G G+ Y+APE+L+ YG +D W+ GV+LY +L G PF AE E +
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITS------AEVLEHPWMRE 356
F+AIL V + + + + A +++ + ++P R+ S +L HP+ +E
Sbjct: 233 FEAILNDEVVYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-50
Identities = 75/329 (22%), Positives = 138/329 (41%), Gaps = 15/329 (4%)
Query: 35 QTPYQTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQ 94
+ Y + + + + + Q + + K + + +
Sbjct: 283 EGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD 342
Query: 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ 154
F L LG+G FG L T YA K + K ++ D E E +++
Sbjct: 343 FNFL-MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
+ + ++ ++ VME +GG+L I G + E A I +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRR-S 272
G+++RDLK +N +L + +G +K DFG+ I +G + G+ Y+APE++
Sbjct: 462 GIIYRDLKLDNVML-DSEG--HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 518
Query: 273 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332
YGK +D W+ GV+LY +L+G PF E E +F +I++ V + +S A + +
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICK 574
Query: 333 KMLIQDPKKRITS-----AEVLEHPWMRE 356
++ + P KR+ ++ EH + R
Sbjct: 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-50
Identities = 82/275 (29%), Positives = 138/275 (50%), Gaps = 13/275 (4%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
D ++ YT +++G+G G Y + +TG A + + L + +E I EI +M+
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMR 72
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
NIV + +Y + +VME +GG L D ++ + E AA+CR + +
Sbjct: 73 ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEV 268
H V+HRD+K +N LL DG K TDFG I + R +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLGM-DGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 269 LRRS-YGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVDFESEPWLLISDS 326
+ R YG ++D+WS G++ ++ G PP+ E + ++ I G P L S
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKL-SAI 245
Query: 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361
+D + + L D +KR ++ E+L+H +++ S
Sbjct: 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-50
Identities = 82/312 (26%), Positives = 143/312 (45%), Gaps = 29/312 (9%)
Query: 52 QPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITY 111
QP + P P S + P P F+ L K +G+G FG
Sbjct: 4 QPQEPELMNANPAPPPAPSQQINLGPSSNPHA-------KPSDFHFL-KVIGKGSFGKVL 55
Query: 112 LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171
L + YA K + K+ ++ K++ + I E ++ +V +++ ++
Sbjct: 56 LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115
Query: 172 LVMELCSGGELFDKIIAQGHYTEKAA----AALCRAIVNVVHHCHFMGVMHRDLKPENFL 227
V++ +GGELF + + + E A A + A+ + H + +++RDLKPEN L
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL----GYLHSLNIVYRDLKPENIL 171
Query: 228 LSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVI 285
L + G +L TDFGL I+ G+ Y+APEVL + Y + +D W G +
Sbjct: 172 L-DSQGHIVL--TDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAV 228
Query: 286 LYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITS 345
LY +L G+PPF++ ++D IL + + I++SA+ L+ +L +D KR+ +
Sbjct: 229 LYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLLQKDRTKRLGA 284
Query: 346 ----AEVLEHPW 353
E+ H +
Sbjct: 285 KDDFMEIKSHVF 296
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-50
Identities = 71/258 (27%), Positives = 124/258 (48%), Gaps = 10/258 (3%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG +L T +A K++ K ++ D E E +++ +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
++ ++++ VME +GG+L I + + A I+ + H G+++RDL
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 222 KPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDV 279
K +N LL +KDG +K DFG+ + G+ Y+APE+L Y +D
Sbjct: 145 KLDNILL-DKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 280 WSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339
WS GV+LY +L G PF + E+ +F +I + + AKDL+ K+ +++P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLVKLFVREP 257
Query: 340 KKRITSA-EVLEHPWMRE 356
+KR+ ++ +HP RE
Sbjct: 258 EKRLGVRGDIRQHPLFRE 275
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 82/271 (30%), Positives = 136/271 (50%), Gaps = 33/271 (12%)
Query: 100 KELGRGQFGITYLC---TENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
K LG+G FG +L + + YA K +LK+ + +DR K E I+ + N
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMK-VLKKATLKVRDRVRTKMERDILVEV----N 84
Query: 157 ---IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAA----AALCRAIVNVVH 209
IV+ A++ ++L+++ GG+LF ++ + +TE+ A L A+
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL----D 140
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEV 268
H H +G+++RDLKPEN LL +++G L TDFGLS ID K G+ Y+APEV
Sbjct: 141 HLHSLGIIYRDLKPENILL-DEEGHIKL--TDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 269 LRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327
+ R + + D WS GV+++ +L+G PF + K ILK + +S A
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LSPEA 253
Query: 328 KDLVRKMLIQDPKKRITS-----AEVLEHPW 353
+ L+R + ++P R+ + E+ H +
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 88/274 (32%), Positives = 141/274 (51%), Gaps = 31/274 (11%)
Query: 100 KELGRGQFGITYLC---TENSTGNSYACKSILKRKLVNKQ-DREDIKREIQIMQHLSGQQ 155
+ LG+G +G + T +TG +A K + K +V D K E I++ +
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK--- 79
Query: 156 N--IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAA----AALCRAIVNVVH 209
+ IV+ A++ ++L++E SGGELF ++ +G + E A A + A+
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL----G 135
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEV 268
H H G+++RDLKPEN +L N G L TDFGL I +G V G+ Y+APE+
Sbjct: 136 HLHQKGIIYRDLKPENIML-NHQGHVKL--TDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 269 LRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327
L RS + + +D WS G ++Y +L+G PPF E K D ILK ++ ++ A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY----LTQEA 248
Query: 328 KDLVRKMLIQDPKKRITS-----AEVLEHPWMRE 356
+DL++K+L ++ R+ + EV HP+ R
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 5e-49
Identities = 73/334 (21%), Positives = 141/334 (42%), Gaps = 28/334 (8%)
Query: 40 TYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLG 99
+Y + P + ++ + + + L+D + L
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQD----FDLL 57
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
+ +GRG + L T YA + + K + + +D + ++ E + + S +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
++ + V+E +GG+L + Q E+ A I +++ H G+++R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEI 277
DLK +N LL + +G L TD+G+ + G G+ Y+APE+LR YG +
Sbjct: 178 DLKLDNVLL-DSEGHIKL--TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 234
Query: 278 DVWSAGVILYILLSGVPPFW---------AETEKGIFDAILKGGVDFESEPWLLISDSAK 328
D W+ GV+++ +++G PF TE +F IL+ + +S A
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAA 290
Query: 329 DLVRKMLIQDPKKRITS------AEVLEHPWMRE 356
+++ L +DPK+R+ A++ HP+ R
Sbjct: 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-49
Identities = 77/264 (29%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LG+G FG C +TG YACK + K+++ ++ E QI++ ++ + +V
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLA 250
Query: 162 GAYEDRQSVHLVMELCSGGELFDKI--IAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
AYE + ++ LV+ L +GG+L I + Q + E A I + H +++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEID 278
DLKPEN LL + G + +D GL+V + EG+ + VG+ Y+APEV++ Y D
Sbjct: 311 DLKPENILL-DDHGHIRI--SDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 279 VWSAGVILYILLSGVPPFWAETEKG----IFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
W+ G +LY +++G PF +K + + + ++ S A+ L ++
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER----FSPQARSLCSQL 423
Query: 335 LIQDPKKRITS-----AEVLEHPW 353
L +DP +R+ EV EHP
Sbjct: 424 LCKDPAERLGCRGGSAREVKEHPL 447
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 7e-49
Identities = 70/272 (25%), Positives = 128/272 (47%), Gaps = 22/272 (8%)
Query: 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIV 158
LG+G +GI Y + S A K I + + + + EI + +HL +NIV
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK-HKNIV 82
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY-----TEKAAAALCRAIVNVVHHCHF 213
++ G++ + + + ME GG L + + + E+ + I+ + + H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSA--LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVLR-- 270
++HRD+K +N L++ G +LK +DFG S + + G+ Y+APE++
Sbjct: 141 NQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 271 -RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL--LISDSA 327
R YGK D+WS G + + +G PP + E + A+ K G+ F+ P + +S A
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP-FYELGEPQ-AAMFKVGM-FKVHPEIPESMSAEA 255
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359
K + K DP KR + ++L +++ +
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 8e-49
Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 19/266 (7%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN--I 157
K LG+G FG L E +TG YA K + K ++ K + E +++Q+ ++ +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT---RHPFL 67
Query: 158 VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVM 217
+ A++ + VME +GGELF + + +TE+ A IV+ + + H V+
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRR-SYGK 275
+RD+K EN +L +KDG + TDFGL I +G + G+ Y+APEVL YG+
Sbjct: 128 YRDIKLENLML-DKDGHIKI--TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 276 EIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKML 335
+D W GV++Y ++ G PF+ + + +F+ IL + F +S AK L+ +L
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLL 240
Query: 336 IQDPKKRITS-----AEVLEHPWMRE 356
+DPK+R+ EV+EH +
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 9e-49
Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 23/267 (8%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161
LGRG FG + C +TG YACK + K++L ++ + E +I+ + + IV
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLA 251
Query: 162 GAYEDRQSVHLVMELCSGGELF----DKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVM 217
A+E + + LVM + +GG++ + + E A IV+ + H H ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLSV-FIDEGKVYRDIVGSAYYVAPEVLRR-SYGK 275
+RDLKPEN LL + DG + +D GL+V + G+ ++APE+L Y
Sbjct: 312 YRDLKPENVLL-DDDGNVRI--SDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 276 EIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKGGVDFESEPWLLISDSAKDLV 331
+D ++ GV LY +++ PF A EK + +L+ V + + S ++KD
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSPASKDFC 424
Query: 332 RKMLIQDPKKRITS-----AEVLEHPW 353
+L +DP+KR+ + HP
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 95/337 (28%), Positives = 158/337 (46%), Gaps = 40/337 (11%)
Query: 42 QQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKE 101
+++ + +K + E V I F L K
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKV------GIENFELL-KV 61
Query: 102 LGRGQFGITYLC---TENSTGNSYACKSILKRKLVNKQ-DREDIKREIQIMQHLSGQQNI 157
LG G +G +L + + TG YA K + K +V K E + E Q+++H+ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 158 VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAA----AALCRAIVNVVHHCHF 213
V A++ +HL+++ +GGELF + + +TE + A+ H H
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL----EHLHK 177
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLS--VFIDEGKVYRDIVGSAYYVAPEVLRR 271
+G+++RD+K EN LL + +G +L TDFGLS DE + D G+ Y+AP+++R
Sbjct: 178 LGIIYRDIKLENILL-DSNGHVVL--TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 272 S---YGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKGGVDFESEPWLLIS 324
+ K +D WS GV++Y LL+G PF + EK I ILK + E +S
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE----MS 290
Query: 325 DSAKDLVRKMLIQDPKKRITS-----AEVLEHPWMRE 356
AKDL++++L++DPKKR+ E+ EH + ++
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-48
Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 1/100 (1%)
Query: 347 EVLEHPWMRE-GGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTM 405
H RE + S +L +K F+ N+LKK+AL +IA+ L + EI L+ +
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62
Query: 406 FANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
F +D D SGT++ +E+ GL ++G + ++ Q++ +
Sbjct: 63 FIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDI 102
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 82/327 (25%), Positives = 147/327 (44%), Gaps = 31/327 (9%)
Query: 71 SATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKR 130
S S P + + + L D + L + +G G +G Y TG A K +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-- 58
Query: 131 KLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH------LVMELCSGGELFD 184
V + E+IK+EI +++ S +NI + GA+ + LVME C G + D
Sbjct: 59 --VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 185 --KIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242
K E+ A +CR I+ + H H V+HRD+K +N LL+ ++ L DF
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKL--VDF 173
Query: 243 GLSVFIDEGKVYRD-IVGSAYYVAPEVLRR------SYGKEIDVWSAGVILYILLSGVPP 295
G+S +D R+ +G+ Y++APEV+ +Y + D+WS G+ + G PP
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 296 FWAETE--KGIFDAILKGGV-DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
+ + +F I + +S+ W S + + L+++ +R + ++++HP
Sbjct: 234 L-CDMHPMRALF-LIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHP 288
Query: 353 WMREGGEASD-KPIGSAVLSRMKQFRA 378
++R+ + + R K+ R
Sbjct: 289 FIRDQPNERQVRIQLKDHIDRTKKKRG 315
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-47
Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
+ +GRG + L T YA K + K + + +D + ++ E + + S +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219
++ + V+E +GG+L + Q E+ A I +++ H G+++R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEI 277
DLK +N LL + +G L TD+G+ + G G+ Y+APE+LR YG +
Sbjct: 135 DLKLDNVLL-DSEGHIKL--TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 191
Query: 278 DVWSAGVILYILLSGVPPFW---------AETEKGIFDAILKGGVDFESEPWLLISDSAK 328
D W+ GV+++ +++G PF TE +F IL+ + +S A
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAA 247
Query: 329 DLVRKMLIQDPKKRITS------AEVLEHPWMRE 356
+++ L +DPK+R+ A++ HP+ R
Sbjct: 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 82/312 (26%), Positives = 145/312 (46%), Gaps = 18/312 (5%)
Query: 74 STRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV 133
+ PVQ + D + +T +++G+G FG + +N T A K I L
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII---DLE 58
Query: 134 NKQDR-EDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY 192
+D EDI++EI ++ + ++ G+Y + ++ME GG D ++ G
Sbjct: 59 EAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPL 116
Query: 193 TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252
E A + R I+ + + H +HRD+K N LLS G L DFG++ + + +
Sbjct: 117 DETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE-HGEVKL--ADFGVAGQLTDTQ 173
Query: 253 VYRD-IVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAIL 309
+ R+ VG+ +++APEV+++S Y + D+WS G+ L G PP K +F I
Sbjct: 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-LIP 232
Query: 310 KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAV 369
K + S K+ V L ++P R T+ E+L+H ++ A + +
Sbjct: 233 KNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILR--NAKKTSYLTEL 287
Query: 370 LSRMKQFRAMNK 381
+ R K+++A
Sbjct: 288 IDRYKRWKAEQS 299
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-47
Identities = 88/321 (27%), Positives = 148/321 (46%), Gaps = 23/321 (7%)
Query: 43 QQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKEL 102
Q L Q + + + V + +F L K L
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRV------TMNEFEYL-KLL 156
Query: 103 GRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRG 162
G+G FG L E +TG YA K + K +V K + E +++Q+ S + +
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKY 215
Query: 163 AYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH-FMGVMHRDL 221
+++ + VME +GGELF + + ++E A IV+ + + H V++RDL
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 222 KPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEIDV 279
K EN +L +KDG +K TDFGL I +G + G+ Y+APEVL + YG+ +D
Sbjct: 276 KLENLML-DKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332
Query: 280 WSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDP 339
W GV++Y ++ G PF+ + + +F+ IL + F + AK L+ +L +DP
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKDP 388
Query: 340 KKRITS-----AEVLEHPWMR 355
K+R+ E+++H +
Sbjct: 389 KQRLGGGSEDAKEIMQHRFFA 409
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 74/329 (22%), Positives = 131/329 (39%), Gaps = 20/329 (6%)
Query: 39 QTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTL 98
Y P Q PM + + ++ P+ +D + ++
Sbjct: 2 SYYHHHHHHD--YDIPTTENLYFQGAMDPMPAGGRA-GSLKDPDVAELFFKDDPEKLFSD 58
Query: 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIV 158
+E+G G FG Y + A K + + + +DI +E++ +Q L N +
Sbjct: 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTI 117
Query: 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMH 218
++RG Y + LVME C G + + E AA+ + + + H ++H
Sbjct: 118 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEVL----RRSY 273
RD+K N LLS G K DFG + + + VG+ Y++APEV+ Y
Sbjct: 178 RDVKAGNILLSE-PGLV--KLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQY 230
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVDFESEPWLLISDSAKDLVR 332
++DVWS G+ L PP + ++ +S W S+ ++ V
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVD 287
Query: 333 KMLIQDPKKRITSAEVLEHPWMREGGEAS 361
L + P+ R TS +L+H ++ +
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFVLRERPPT 316
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 40/308 (12%)
Query: 66 QPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACK 125
K + T Q+ + + D+ E+G G G + TG+ A K
Sbjct: 5 SSGKQTGYLTIGGQRYQA----EINDLENL----GEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 126 SILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDK 185
+ R+ NK++ + I ++ ++ IV+ G + V + MEL K
Sbjct: 57 QM--RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLK 114
Query: 186 IIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244
QG E+ + AIV +++ GV+HRD+KP N LL ++ G K DFG+
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL-DERGQI--KLCDFGI 171
Query: 245 SVFIDEGKVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWA 298
S + + K G A Y+APE + Y DVWS G+ L L +G P+
Sbjct: 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY-- 229
Query: 299 ETEKGIFDAI----------LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEV 348
+ K F+ + L G + F S + V+ L +D +KR ++
Sbjct: 230 KNCKTDFEVLTKVLQEEPPLLPGHMGF--------SGDFQSFVKDCLTKDHRKRPKYNKL 281
Query: 349 LEHPWMRE 356
LEH +++
Sbjct: 282 LEHSFIKR 289
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-46
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 1/97 (1%)
Query: 349 LEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFAN 408
+ H G + G VL K + + K +K+A+ +IA+ ++ +++ LK+ F
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 409 MDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+D D G IT E+LK GL + G KL L+D +
Sbjct: 61 LDEDGKGYITKEQLKKGLEKDGLKLPY-NFDLLLDQI 96
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 7e-04
Identities = 17/66 (25%), Positives = 27/66 (40%), Gaps = 8/66 (12%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLS-----ETEVK 439
+A + + LS++ I +F D D G IT EL L K + VK
Sbjct: 110 IAAALDRKQLSKKLIYCAFRVF---DVDNDGEITTAELAHILYNGNKKGNITQRDVNRVK 166
Query: 440 QLMDAV 445
+++ V
Sbjct: 167 RMIRDV 172
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-46
Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 22/283 (7%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
D + + + ELG G FG Y TG A K I + ++++ ED EI+I+
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILA 71
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI-IAQGHYTEKAAAALCRAIVNVV 208
IV+ GAY + +++E C GG + + TE +CR ++ +
Sbjct: 72 TCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPE 267
+ H ++HRDLK N L++ +G + DFG+S + RD +G+ Y++APE
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTL-EGDI--RLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 268 VLRR------SYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGG--VDFESE 318
V+ Y + D+WS G+ L + PP + + I K
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPS 246
Query: 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361
W S +D ++ L ++P+ R ++A++LEHP++
Sbjct: 247 KW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 77/278 (27%), Positives = 141/278 (50%), Gaps = 19/278 (6%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+ + + + ++LG G +G Y TG A K + + + D ++I +EI IMQ
Sbjct: 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PV--ESDLQEIIKEISIMQ 79
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI-IAQGHYTEKAAAALCRAIVNVV 208
++V++ G+Y + +VME C G + D I + TE A + ++ + +
Sbjct: 80 QCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPE 267
+ HFM +HRD+K N LL+ +G A K DFG++ + + R+ ++G+ +++APE
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNT-EGHA--KLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195
Query: 268 VLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGG--VDFESEPWLLI 323
V++ Y D+WS G+ + G PP+ + IF I + E W
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELW--- 251
Query: 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361
SD+ D V++ L++ P++R T+ ++L+HP++R S
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-45
Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 27/272 (9%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE 159
ELGRG +G+ +G A K I R VN Q+++ + ++ I V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 160 FRGAYEDRQSVHLVMELCSGGELFDKIIA-----QGHYTEKAAAALCRAIVNVVHHCHF- 213
F GA V + MEL DK E + +IV + H H
Sbjct: 71 FYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR--- 270
+ V+HRD+KP N L+ N G K DFG+S ++ + G Y+APE +
Sbjct: 129 LSVIHRDVKPSNVLI-NALGQV--KMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 271 --RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFD---AILKGGV-DFESEPWLLIS 324
+ Y + D+WS G+ + L P+ ++ F +++ ++ + S
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKF---S 240
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
D + L ++ K+R T E+++HP+
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 78/305 (25%), Positives = 129/305 (42%), Gaps = 32/305 (10%)
Query: 68 MKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSI 127
++SS ++ + L+D+ E+GRG +G +G A K I
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDL-------GEIGRGAYGSVNKMVHKPSGQIMAVKRI 55
Query: 128 LKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKII 187
R V++++++ + ++ ++ S IV+F GA + MEL S FDK
Sbjct: 56 --RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFY 111
Query: 188 ------AQGHYTEKAAAALCRAIVNVVHHCHFMG-VMHRDLKPENFLLSNKDGGAMLKAT 240
E+ + A V ++H ++HRD+KP N LL ++ G K
Sbjct: 112 KYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL-DRSGNI--KLC 168
Query: 241 DFGLSVFIDEGKVYRDIVGSAYYVAPEVL-----RRSYGKEIDVWSAGVILYILLSGVPP 295
DFG+S + + G Y+APE + R+ Y DVWS G+ LY L +G P
Sbjct: 169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
Query: 296 FWAETEKGIFDA---ILKGGV-DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
+ +FD ++KG + S S + V L +D KR E+L+H
Sbjct: 229 Y--PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286
Query: 352 PWMRE 356
P++
Sbjct: 287 PFILM 291
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-43
Identities = 76/317 (23%), Positives = 123/317 (38%), Gaps = 71/317 (22%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIMQHL 151
Y ++G G +G+ + C TG A K K + +D IK REI++++ L
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQL 59
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELC---------SGGELFD-----KIIAQGHYTEKAA 197
N+V + ++ +HLV E C I Q
Sbjct: 60 K-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ-------- 110
Query: 198 AALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRD 256
+A+ + CH +HRD+KPEN +L K ++K DFG + + Y D
Sbjct: 111 --TLQAV----NFCHKHNCIHRDVKPEN-ILITKHS--VIKLCDFGFARLLTGPSDYYDD 161
Query: 257 IVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAI-- 308
V + +Y +PE+L YG +DVW+ G + LLSGVP + +++ I +
Sbjct: 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD 221
Query: 309 -----------LKGGVDFESEPWL----------LISDSAKDLVRKMLIQDPKKRITSAE 347
+ + IS A L++ L DP +R+T +
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281
Query: 348 VLEHPWMREGGEASDKP 364
+L HP+ E D
Sbjct: 282 LLHHPYFENIREIEDLA 298
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-43
Identities = 72/283 (25%), Positives = 118/283 (41%), Gaps = 30/283 (10%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR-EDIKREIQIMQHLSGQ 154
Y L + +G G + A K I L Q +++ +EIQ M
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRI---NLEKCQTSMDELLKEIQAMSQCH-H 72
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFD--------KIIAQGHYTEKAAAALCRAIVN 206
NIV + ++ + + LVM+L SGG + D G E A + R ++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD------IVGS 260
+ + H G +HRD+K N LL DG + DFG+S F+ G VG+
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGE-DGSV--QIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 261 AYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG------G 312
++APEV+ + Y + D+WS G+ L +G P+ + L+
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
+ E S + ++ L +DP+KR T+AE+L H + +
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-42
Identities = 86/357 (24%), Positives = 134/357 (37%), Gaps = 58/357 (16%)
Query: 50 HVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGI 109
+ K + ++ T P YT K +G G FG+
Sbjct: 10 FAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGV 69
Query: 110 TYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR------GA 163
Y +G A K +L QD+ RE+QIM+ L NIV R G
Sbjct: 70 VYQAKLCDSGELVAIKKVL-------QDKRFKNRELQIMRKLD-HCNIVRLRYFFYSSGE 121
Query: 164 YEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAA---------LCRAIVNVVHHCHFM 214
+D ++LV++ E ++ ++ L R++ + H
Sbjct: 122 KKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL----AYIHSF 175
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRS-- 272
G+ HRD+KP+N LL + D +LK DFG + + G+ + S YY APE++ +
Sbjct: 176 GICHRDIKPQN-LLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 233
Query: 273 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-----------------GGVDF 315
Y IDVWSAG +L LL G P F ++ I+K F
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 293
Query: 316 ---ESEPWLLI-----SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364
++ PW + A L ++L P R+T E H + E + + K
Sbjct: 294 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-42
Identities = 85/351 (24%), Positives = 133/351 (37%), Gaps = 83/351 (23%)
Query: 60 QPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTG 119
T Q E ++ LG +G G +G+ C TG
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSME-----------KYENLGL-VGEGSYGMVMKCRNKDTG 50
Query: 120 NSYACKSILKRKLVNKQDREDIK----REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175
A K K + D + +K REI++++ L +N+V + ++ +LV E
Sbjct: 51 RIVAIK-----KFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYLVFE 104
Query: 176 LC---------SGGELFD-----KIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221
D K + Q + I CH ++HRD+
Sbjct: 105 FVDHTILDDLELFPNGLDYQVVQKYLFQ----------IINGI----GFCHSHNIIHRDI 150
Query: 222 KPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL--RRSYGKEID 278
KPEN +L ++ G ++K DFG + G+VY D V + +Y APE+L YGK +D
Sbjct: 151 KPEN-ILVSQSG--VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVD 207
Query: 279 VWSAGVILYILLSGVPPFWAETE----KGIF-------DAILKG--------GVDF---- 315
VW+ G ++ + G P F +++ I + GV
Sbjct: 208 VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267
Query: 316 ESEPWLL----ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASD 362
E EP +S+ DL +K L DP KR AE+L H + + G A
Sbjct: 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER 318
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 76/334 (22%), Positives = 127/334 (38%), Gaps = 57/334 (17%)
Query: 65 QQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYAC 124
QQ + A T+ + E +D + ELG G G+ + + +G A
Sbjct: 12 QQRKRLEAFLTQKQKVGEL----KDDD----FEKISELGAGNGGVVFKVSHKPSGLVMAR 63
Query: 125 KSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFD 184
K I + R I RE+Q++ H IV F GA+ + + ME GG L
Sbjct: 64 KLI--HLEIKPAIRNQIIRELQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 185 KIIAQGHYTEKAAAALCRAIVNVVHHCHFMG-VMHRDLKPENFLLSNKDGGAMLKATDFG 243
+ G E+ + A++ + + +MHRD+KP N L+ N G K DFG
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV-NSRGEI--KLCDFG 177
Query: 244 LSVFIDEGKVYRDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEK 302
+S + + VG+ Y++PE L+ + Y + D+WS G+ L + G P K
Sbjct: 178 VSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 303 GIFDAIL--------------------KGGVDFESEPWLLI------------------- 323
+ +S P + I
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
Query: 324 -SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
S +D V K LI++P +R +++ H +++
Sbjct: 297 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 85/344 (24%), Positives = 138/344 (40%), Gaps = 67/344 (19%)
Query: 57 SAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTEN 116
+AP + P+ + + GK E YT K +G G FG+ +
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVL----ASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62
Query: 117 STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR------GAYEDRQSV 170
+ A K +L QD+ RE+QIM+ + N+V+ + G +D +
Sbjct: 63 ESD-EVAIKKVL-------QDKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFL 113
Query: 171 HLVMELCSGGELFDKIIAQGHYTEKAAAA-----------LCRAIVNVVHHCHFMGVMHR 219
+LV+E E + HY + L R++ + H +G+ HR
Sbjct: 114 NLVLEYV--PETVYRASR--HYAKLKQTMPMLLIKLYMYQLLRSL----AYIHSIGICHR 165
Query: 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRS--YGKEI 277
D+KP+N LL + G +LK DFG + + G+ + S YY APE++ + Y I
Sbjct: 166 DIKPQN-LLLDPPSG-VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNI 223
Query: 278 DVWSAGVILYILLSGVPPFWAETEKGIFDAILK-----------------GGVDF---ES 317
D+WS G ++ L+ G P F E+ I+K F
Sbjct: 224 DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRP 283
Query: 318 EPWLLI-----SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
P+ + A DL+ ++L P R+T+ E L HP+ E
Sbjct: 284 HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-41
Identities = 84/347 (24%), Positives = 136/347 (39%), Gaps = 68/347 (19%)
Query: 50 HVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGI 109
H + A P + S+A S + + Y +LG G +G
Sbjct: 6 HHHMGTLEAQTQGPGSMSV-SAAPSATSIDR---------------YRRITKLGEGTYGE 49
Query: 110 TYLCTENSTGNSYACKSILKRKLVNKQDRED-------IKREIQIMQHLSGQQNIVEFRG 162
Y + T + A K I + + E+ I RE+ +++ L +NI+E +
Sbjct: 50 VYKAIDTVTNETVAIKRI-------RLEHEEEGVPGTAI-REVSLLKELQ-HRNIIELKS 100
Query: 163 AYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLK 222
+HL+ E +L + + + + ++N V+ CH +HRDLK
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 223 PENFLLSNKDGGA--MLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVL--RRSYGKEI 277
P+N LLS D +LK DFGL+ F + + + + +Y PE+L R Y +
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSV 219
Query: 278 DVWSAGVILYILLSGVPPFWAETEKG----IFDAILKG--------GV------------ 313
D+WS I +L P F ++E IF+ + G GV
Sbjct: 220 DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL--GLPDDTTWPGVTALPDWKQSFPK 277
Query: 314 ----DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
+ L+ D DL+ ML DP KRI++ LEHP+
Sbjct: 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 6e-41
Identities = 52/261 (19%), Positives = 95/261 (36%), Gaps = 28/261 (10%)
Query: 113 CTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172
+ + L + + +I+ M S +N V + +++
Sbjct: 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYI 138
Query: 173 VMELCSGGELFDKIIAQGHYT---EKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229
M+LC L D + + + I V H G+MHRDLKP N +
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT 198
Query: 230 NKDGGAMLKATDFGLS-------------VFIDEGKVYRDIVGSAYYVAPEVLR-RSYGK 275
D ++K DFGL + + VG+ Y++PE + +Y
Sbjct: 199 MDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 276 EIDVWSAGVILYILLSGVPPFWAETEKG-IFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
++D++S G+IL+ LL F + E+ I + F +V+ M
Sbjct: 256 KVDIFSLGLILFELLY---SFSTQMERVRIITDVRNL--KFPLLFT-QKYPQEHMMVQDM 309
Query: 335 LIQDPKKRITSAEVLEHPWMR 355
L P +R + +++E+
Sbjct: 310 LSPSPTERPEATDIIENAIFE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 18/72 (25%), Positives = 32/72 (44%), Gaps = 3/72 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + +GRG FG+ + +YA K I R + RE + RE++ + L
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLE-HP 64
Query: 156 NIVEFRGAYEDR 167
IV + A+ +
Sbjct: 65 GIVRYFNAWLET 76
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-40
Identities = 76/315 (24%), Positives = 120/315 (38%), Gaps = 60/315 (19%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED------IKREIQIMQ 149
+ ++LG G + Y +TG A K + K D E+ I REI +M+
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAI-REISLMK 58
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGG-----ELFDKIIAQGHYTEKAAAALCRAI 204
L +NIV + LV E + +
Sbjct: 59 ELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYY 263
+ + CH ++HRDLKP+N LL NK G LK DFGL+ F + V + +Y
Sbjct: 118 LQGLAFCHENKILHRDLKPQN-LLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 264 VAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAI--------- 308
AP+VL R+Y ID+WS G IL +++G P F ++ IFD +
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 309 -------------------LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349
L+ + ++ L + D + +L +P R+++ + L
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL--DGNLMDFLHGLLQLNPDMRLSAKQAL 292
Query: 350 EHPWMREGGEASDKP 364
HPW E +
Sbjct: 293 HHPWFAEYYHHASMG 307
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 58/403 (14%), Positives = 130/403 (32%), Gaps = 78/403 (19%)
Query: 56 MSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQ--FGITYLC 113
M+ + +S P Y L +G+G L
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLP----------EGGC----YELLTVIGKGFEDLMTVNLA 46
Query: 114 TENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173
TG + + + + + ++ E+ + + + NIV +R + + +V
Sbjct: 47 RYKPTGEYVTVR-RINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVV 104
Query: 174 MELCSGGELFD--KIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK 231
+ G D E A A + + ++ + + H MG +HR +K + L+S
Sbjct: 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV- 163
Query: 232 DGGAMLKATDFGLSVFIDEGKVYR--------DIVGSAYYVAPEVLRRS---YGKEIDVW 280
DG L + ++ + + V +++PEVL+++ Y + D++
Sbjct: 164 DGKVYL--SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221
Query: 281 SAGVILYILLSGVPPF------------------------------------WAETEKGI 304
S G+ L +G PF + G+
Sbjct: 222 SVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGL 281
Query: 305 FDAILKGGVDFESEPWLLI------SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358
D++ + S V + L ++P R +++ +L H + ++
Sbjct: 282 SDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341
Query: 359 EASDKPIGSAV--LSRMKQFRAMNKLKKMALKVIAEALSEEEI 399
+ + + + ++ + F + + L E E+
Sbjct: 342 RRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEELEV 384
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 77/308 (25%), Positives = 128/308 (41%), Gaps = 69/308 (22%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED------IKREIQIMQ 149
Y LG GQF Y + +T A K I KL ++ + +D + REI+++Q
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTAL-REIKLLQ 67
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELC---------SGGELFD-----KIIAQGHYTEK 195
LS NI+ A+ + ++ LV + + +
Sbjct: 68 ELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM------ 120
Query: 196 AAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVY 254
+ + + H ++HRDLKP N LL +++G +LK DFGL+ F + Y
Sbjct: 121 ----TLQG----LEYLHQHWILHRDLKPNNLLL-DENG--VLKLADFGLAKSFGSPNRAY 169
Query: 255 RDIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAI 308
V + +Y APE+L R YG +D+W+ G IL LL VP +++ IF+ +
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 309 -------------LKGGVDFESEPWL-------LISDSAKDLVRKMLIQDPKKRITSAEV 348
L V F+S P + D DL++ + + +P RIT+ +
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 349 LEHPWMRE 356
L+ +
Sbjct: 290 LKMKYFSN 297
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 81/321 (25%), Positives = 126/321 (39%), Gaps = 83/321 (25%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED------IKREIQIMQ 149
Y +LG G + Y T N A K I + + E+ I RE+ +++
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAI-REVSLLK 55
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELC---------SGGELFD-----KIIAQGHYTEK 195
L NIV +S+ LV E G + + + Q
Sbjct: 56 DLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ------ 108
Query: 196 AAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVY 254
L R + +CH V+HRDLKP+N LL N+ G LK DFGL+ K Y
Sbjct: 109 ----LLRGL----AYCHRQKVLHRDLKPQN-LLINERG--ELKLADFGLARAKSIPTKTY 157
Query: 255 RDIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAI 308
+ V + +Y P++L Y +ID+W G I Y + +G P F T + IF +
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217
Query: 309 LKG--------GV----DFESE--------------PWLLISDSAKDLVRKMLIQDPKKR 342
G G+ +F++ P L DL+ K+L + + R
Sbjct: 218 --GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRL--DSDGADLLTKLLQFEGRNR 273
Query: 343 ITSAEVLEHPWMREGGEASDK 363
I++ + ++HP+ GE K
Sbjct: 274 ISAEDAMKHPFFLSLGERIHK 294
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 87/302 (28%), Positives = 137/302 (45%), Gaps = 60/302 (19%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED-------IKREIQIM 148
Y +++G G +G+ Y N+ G ++A K I + ++ED I REI I+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKI-------RLEKEDEGIPSTTI-REISIL 54
Query: 149 QHLSGQQNIVEFRGAYEDRQSVHLVMELCSG--GELFDKIIAQGHYTEKAAAALCRAIVN 206
+ L NIV+ ++ + LV E +L D +G A + ++N
Sbjct: 55 KELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLN 111
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVA 265
+ +CH V+HRDLKP+N LL N++G LK DFGL+ F + Y + + +Y A
Sbjct: 112 GIAYCHDRRVLHRDLKPQN-LLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 266 PEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKG-------- 311
P+VL + Y ID+WS G I +++G P F +E IF + G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL--GTPNSKNWP 226
Query: 312 GV----DFESE-------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
V ++ L +S DL+ KML DP +RIT+ + LEH +
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGL--DESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
Query: 355 RE 356
+E
Sbjct: 285 KE 286
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 76/301 (25%), Positives = 128/301 (42%), Gaps = 56/301 (18%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED-------IKREIQIM 148
Y +++G G +G + T A K + + D +D + REI ++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSAL-REICLL 55
Query: 149 QHLSGQQNIVEFRGAYEDRQSVHLVMELCSG--GELFDKIIAQGHYTEKAAAALCRAIVN 206
+ L +NIV + + LV E C + FD G + + ++
Sbjct: 56 KELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLK 112
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVA 265
+ CH V+HRDLKP+N LL N++G LK +FGL+ F + Y V + +Y
Sbjct: 113 GLGFCHSRNVLHRDLKPQN-LLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 266 PEVL--RRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKG----IFDAILKG------- 311
P+VL + Y ID+WSAG I L + G P F IF + G
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL--GTPTEEQW 227
Query: 312 -GV----DFESEP-----------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
+ D++ P ++ + +DL++ +L +P +RI++ E L+HP+
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 356 E 356
+
Sbjct: 288 D 288
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 81/304 (26%), Positives = 132/304 (43%), Gaps = 63/304 (20%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y L ++LGRG++ + + K + K V K+ IKREI+I+++L G
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKK---IKREIKILENLRGGP 91
Query: 156 NIVEFRGAYEDRQSVH--LVMELCSGGELFDKIIAQG-------HYTEKAAAALCRAIVN 206
NI+ +D S LV E + + K + Q Y + + +A+
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYE----ILKAL-- 143
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAP 266
+CH MG+MHRD+KP N ++ ++ L+ D+GL+ F G+ Y V S Y+ P
Sbjct: 144 --DYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 267 EVL--RRSYGKEIDVWSAGVILYILLSGVPPFWA-----------------ETEKGI--- 304
E+L + Y +D+WS G +L ++ PF+ E
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259
Query: 305 --------FDAIL--KGGVDFE----SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350
F+ IL +E SE L+S A D + K+L D + R+T+ E +E
Sbjct: 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319
Query: 351 HPWM 354
HP+
Sbjct: 320 HPYF 323
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 81/303 (26%), Positives = 126/303 (41%), Gaps = 61/303 (20%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED-------IKREIQIM 148
Y +++G G +G+ Y +S G A K I + D ED I REI ++
Sbjct: 23 YQKLEKVGEGTYGVVYKAK-DSQGRIVALKRI-------RLDAEDEGIPSTAI-REISLL 73
Query: 149 QHLSGQQNIVEFRGAYEDRQSVHLVMELCSG--GELFDKIIAQGHYTEKAAAALCRAIVN 206
+ L NIV + + LV E ++ D+ + + ++
Sbjct: 74 KELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLR 130
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVA 265
V HCH ++HRDLKP+N LL N DG LK DFGL+ F + Y V + +Y A
Sbjct: 131 GVAHCHQHRILHRDLKPQN-LLINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 266 PEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKG-------- 311
P+VL + Y +D+WS G I +++G P F T+ IF + G
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL--GTPNPREWP 245
Query: 312 GV----DFESE--------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
V ++ P DL+ ML DP KRI++ + + HP+
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGF--CQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
Query: 354 MRE 356
++
Sbjct: 304 FKD 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-36
Identities = 71/276 (25%), Positives = 121/276 (43%), Gaps = 36/276 (13%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
++I + + +GRG FG+ A K ++ ++ +R+ E++
Sbjct: 6 DYKEI----EVEEVVGRGAFGVVCKAKWR--AKDVAIK-----QIESESERKAFIVELRQ 54
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG---HYTEKAAAALCRAI 204
+ ++ NIV+ GA V LVME GG L++ + +YT A + C
Sbjct: 55 LSRVN-HPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 205 ---VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSA 261
V +H ++HRDLKP N LL GG +LK DFG + I GSA
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQTHMTNN--KGSA 167
Query: 262 YYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFW--AETEKGIFDAILKGG---VDF 315
++APEV S Y ++ DV+S G+IL+ +++ PF I A+ G +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK 227
Query: 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
+ + L+ + +DP +R + E+++
Sbjct: 228 NLPKPI------ESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 70/295 (23%), Positives = 113/295 (38%), Gaps = 49/295 (16%)
Query: 102 LGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK-----REIQIMQHLSGQQ- 155
+G G +G Y + +G+ A KS+ ++ N RE+ +++ L +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 156 -NIVEFR-----GAYEDRQSVHLVMELCSG--GELFDKIIAQGHYTEKAAAALCRAIVNV 207
N+V + V LV E DK + L R +
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAETIKDLMRQFLRG 132
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPE 267
+ H ++HRDLKPEN +L G +K DFGL+ +V + +Y APE
Sbjct: 133 LDFLHANCIVHRDLKPEN-ILVTSGG--TVKLADFGLARIYSYQMALTPVVVTLWYRAPE 189
Query: 268 VL-RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKG--------GV- 313
VL + +Y +D+WS G I + P F +E IFD I G
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI--GLPPEDDWPRDV 247
Query: 314 ---DFESEPWL---------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
P + +S L+ +ML +P KRI++ L+H ++ +
Sbjct: 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 82/340 (24%), Positives = 135/340 (39%), Gaps = 65/340 (19%)
Query: 77 PVQKPETVLGKPLEDIRQF----YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL 132
P ++ + + + + G+G FG L E STG S A K ++
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---- 57
Query: 133 VNKQDREDIKREIQIMQHLSGQQ--NIVEFR-----GAYEDRQSV--HLVMELCSGGELF 183
QD RE+QIMQ L+ NIV+ + DR+ + ++VME +
Sbjct: 58 ---QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTL 112
Query: 184 DKIIAQGHYTEKAAAA---------LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG 234
+ + + A L R+I + H + V HRD+KP N L++ DG
Sbjct: 113 HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCL--HLPSVNVCHRDIKPHNVLVNEADG- 169
Query: 235 AMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSG 292
LK DFG + + + + S YY APE++ + Y +D+WS G I ++ G
Sbjct: 170 -TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
Query: 293 VPPFWAETEKGIFDAILK-------------------------GGVDFE---SEPWLLIS 324
P F + G I++ G+ + S+ L +
Sbjct: 229 EPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDA 288
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364
A DL+ +L P++R+ E L HP+ E + + K
Sbjct: 289 KEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKL 328
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-34
Identities = 66/298 (22%), Positives = 121/298 (40%), Gaps = 32/298 (10%)
Query: 70 SSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILK 129
+ S P + T+ +I K++G+G FG+ + + A KS++
Sbjct: 2 AMGGSEFPKSRLPTL---ADNEI----EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54
Query: 130 RKLVNKQD----REDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDK 185
+ + ++ +RE+ IM +L+ NIV+ G +VME G+L+ +
Sbjct: 55 GDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHR 111
Query: 186 IIAQGH-YTEKAAAALCRAIVNVVH--HCHFMGVMHRDLKPENFLLSNKDGGA--MLKAT 240
++ + H L I + ++HRDL+ N L + D A K
Sbjct: 112 LLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 241 DFGLSVFIDEGKVYRDIVGSAYYVAPEVLR---RSYGKEIDVWSAGVILYILLSGVPPFW 297
DFGLS ++G+ ++APE + SY ++ D +S +ILY +L+G PF
Sbjct: 172 DFGLSQQSVHSV--SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF- 228
Query: 298 AETEKGIFDAILKGGVDFESEPWLLISDSA----KDLVRKMLIQDPKKRITSAEVLEH 351
E + E I + ++++ DPKKR + +++
Sbjct: 229 --DEYSYGKIKFINMIREEGLR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 88/361 (24%), Positives = 137/361 (37%), Gaps = 90/361 (24%)
Query: 62 QPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNS 121
M ++A + PE V G+ + + YT +G G +G+ +N
Sbjct: 1 HHHHHHMAAAAAAG-----PEMVRGQVFD-VGPRYTNLSYIGEGAYGMVCSAYDNLNKVR 54
Query: 122 YACKSILKRKLVNKQDREDIK---REIQIMQHLSGQQNIVEFR-----GAYEDRQSVHLV 173
A K K+ + + + REI+I+ +NI+ E + V++V
Sbjct: 55 VAIK-----KISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIV 108
Query: 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM-------------GVMHRD 220
+L +L K++ H + H C+F+ V+HRD
Sbjct: 109 QDLM-ETDL-YKLLKTQHLSND-------------HICYFLYQILRGLKYIHSANVLHRD 153
Query: 221 LKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI----VGSAYYVAPEVL--RRSYG 274
LKP N LL N LK DFGL+ D + V + +Y APE++ + Y
Sbjct: 154 LKPSN-LLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAI---------------------- 308
K ID+WS G IL +LS P F + I +
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 309 --LKGGVDFESEPWLL--ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364
K V + L A DL+ KML +P KRI + L HP++ + + SD+P
Sbjct: 271 LPHKNKVPWNR---LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 327
Query: 365 I 365
I
Sbjct: 328 I 328
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-34
Identities = 77/331 (23%), Positives = 137/331 (41%), Gaps = 69/331 (20%)
Query: 79 QKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDR 138
++ ++V +++ ++ L K +G+G FG + TG A K + + N ++
Sbjct: 3 KQYDSVECPFCDEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKV---LMEN--EK 56
Query: 139 EDIK----REIQIMQHLSGQQNIV--------EFRGAYEDRQSVHLVMELC----SGGEL 182
E REI+I+Q L +N+V + + S++LV + C +G L
Sbjct: 57 EGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--L 113
Query: 183 FDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242
+ +T + + ++N +++ H ++HRD+K N L++ +LK DF
Sbjct: 114 LSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADF 168
Query: 243 GLSVFID-----EGKVYRDIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPP 295
GL+ + Y + V + +Y PE+L R YG ID+W AG I+ + + P
Sbjct: 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 228
Query: 296 FWAETEKG----IFDAILKG--------GV----DFESE--------------PWLLISD 325
TE+ I L G V +E +
Sbjct: 229 MQGNTEQHQLALISQ--LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDP 286
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
A DL+ K+L+ DP +RI S + L H +
Sbjct: 287 YALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 48/72 (66%), Positives = 56/72 (77%)
Query: 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKL 433
KQF AMNK KKMAL+VIAE+LSEEEI GLK MF +D DKSG IT+EELK GL R+G+ L
Sbjct: 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANL 60
Query: 434 SETEVKQLMDAV 445
E+E+ LM A
Sbjct: 61 KESEILDLMQAA 72
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 1e-04
Identities = 16/61 (26%), Positives = 27/61 (44%), Gaps = 6/61 (9%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
L + + E+ + T F D D SG IT +EL+ G + + +++LM
Sbjct: 88 ATLH-LNKIEREDHLFAAFTYF---DKDGSGYITPDELQQACEEFG--VEDVRIEELMRD 141
Query: 445 V 445
V
Sbjct: 142 V 142
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-33
Identities = 69/305 (22%), Positives = 118/305 (38%), Gaps = 59/305 (19%)
Query: 96 YTLGKELGRGQFGITYLCTE-NSTGNSYACKSILKRKLVNKQDRED-------IKREIQI 147
Y E+G G +G + + + G A K + + + I RE+ +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTI-REVAV 64
Query: 148 MQHLSGQQ--NIVEFR-----GAYEDRQSVHLVMELCSG--GELFDKIIAQGHYTEKAAA 198
++HL + N+V + + LV E DK+ + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIK 123
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258
+ ++ + H V+HRDLKP+N L+++ +K DFGL+ +V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQMALTSVV 180
Query: 259 GSAYYVAPEVL-RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKGGV 313
+ +Y APEVL + SY +D+WS G I + P F ++ I D I G+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI---GL 237
Query: 314 -------DFESEPWL---------------LISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
+ P I + KDL+ K L +P KRI++ L H
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 352 PWMRE 356
P+ ++
Sbjct: 298 PYFQD 302
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 79/354 (22%), Positives = 131/354 (37%), Gaps = 92/354 (25%)
Query: 86 GKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREI 145
G + Y+LGK LG G FGI + +G +A K +L QD RE+
Sbjct: 1 GLETSSKK--YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-------QDPRYKNREL 51
Query: 146 QIMQHLSGQQNIVEFR--------------------------------------GAYEDR 167
IM+ L NI++
Sbjct: 52 DIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 168 QSVHLVMELCSGGELFDKIIAQGHYTEKAAAA---------LCRAIVNVVHHCHFMGVMH 218
+ ++++ME + K++ + ++ L RA V H +G+ H
Sbjct: 111 KYLNVIMEYV--PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA----VGFIHSLGICH 164
Query: 219 RDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL--RRSYGKE 276
RD+KP+N L+++KD LK DFG + + + + S +Y APE++ Y
Sbjct: 165 RDIKPQNLLVNSKDN--TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPS 222
Query: 277 IDVWSAGVILYILLSGVPPFWAETEKGIFDAILK-----------------GGVDF---E 316
ID+WS G + L+ G P F ET I++ V F +
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282
Query: 317 SEPWLLI-----SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
++ W I A DL+ ++L +P RI E + HP+ + + +
Sbjct: 283 AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEV 336
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 82/351 (23%), Positives = 134/351 (38%), Gaps = 64/351 (18%)
Query: 55 KMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCT 114
K + M S + +G + + Y K +G G GI
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYS---VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAY 82
Query: 115 ENSTGNSYACKSILKRKLVNK-QDREDIK---REIQIMQHLSGQQNIVEFR------GAY 164
+ + A K KL Q++ K RE+ +M+ + +NI+
Sbjct: 83 DAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL 136
Query: 165 EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPE 224
E+ Q V+LVMEL ++I + + L ++ + H H G++HRDLKP
Sbjct: 137 EEFQDVYLVMEL--MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 193
Query: 225 NFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV-LRRSYGKEIDVWSAG 283
N ++ D LK DFGL+ + V + YY APEV L Y + +D+WS G
Sbjct: 194 N-IVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250
Query: 284 VILYILLSGVPPFWAETEKGIFDAIL---------------------------KGGVDFE 316
I+ ++ F ++ ++ G+ F
Sbjct: 251 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 310
Query: 317 -----------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
SE L + A+DL+ KML+ DP KRI+ + L+HP++
Sbjct: 311 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD-REDIKREIQ 146
++ TL + +G G FG Y G+ A K+ + E++++E +
Sbjct: 5 DFAEL----TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAI-- 204
+ L NI+ RG ++ LVME GG L +++ I
Sbjct: 59 LFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIAR 116
Query: 205 -VNVVHHCHFMGVMHRDLKPENFLLSNKDGGA-----MLKATDFGLSVFIDEGKVYRDIV 258
+N +H + ++HRDLK N L+ K +LK TDFGL+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAA 175
Query: 259 GSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPF 296
G+ ++APEV+R S + K DVWS GV+L+ LL+G PF
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-32
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 12/95 (12%)
Query: 363 KPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSE-EEIKGLKTMFANMDTDKSGTITYEE 421
K + L MK+F++ KL + A+ + L+ EE K L +F +D + G + +E
Sbjct: 2 KHALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKE 61
Query: 422 LKTGLAR-----------LGSKLSETEVKQLMDAV 445
L G + L S E EV ++ +V
Sbjct: 62 LIEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSV 96
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-32
Identities = 70/320 (21%), Positives = 130/320 (40%), Gaps = 47/320 (14%)
Query: 54 PKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLC 113
P+M+ R P K+S TS +Q+ + P E + +G+ +G+G+FG Y
Sbjct: 2 PEMNLSLLSARSFPRKASQTSI-FLQEWDI----PFEQL----EIGELIGKGRFGQVYHG 52
Query: 114 TENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173
+ A + ++ + N+ + KRE+ + +N+V F GA + ++
Sbjct: 53 RWHGE---VAIR-LIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAII 107
Query: 174 MELCSGGELFDKI-IAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD 232
LC G L+ + A+ + + IV + + H G++H+DLK +N N
Sbjct: 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK 167
Query: 233 GGAMLKATDFGLS------VFIDEGKVYRDIVGSAYYVAPEVLRRS----------YGKE 276
+ TDFGL R G ++APE++R+ + K
Sbjct: 168 ----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223
Query: 277 IDVWSAGVILYILLSGVPPFWAETEKGI-FDAILKGGVDFESEPWLLISDSA----KDLV 331
DV++ G I Y L + PF K +AI+ + +P L D++
Sbjct: 224 SDVFALGTIWYELHAREWPF-----KTQPAEAII-WQMGTGMKP-NLSQIGMGKEISDIL 276
Query: 332 RKMLIQDPKKRITSAEVLEH 351
+ ++R T ++++
Sbjct: 277 LFCWAFEQEERPTFTKLMDM 296
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 72/342 (21%), Positives = 128/342 (37%), Gaps = 82/342 (23%)
Query: 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
G+P +D R Y L ++LG G F +L + A K I++ K E + E
Sbjct: 12 KGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGD---KVYTEAAEDE 65
Query: 145 IQIMQHLS----------GQQNIVEFRGA--YEDRQSVH--LVMELCSGGELFDKIIAQG 190
I+++Q ++ G +I++ ++ VH +V E+ G L I
Sbjct: 66 IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE 124
Query: 191 H--YTEKAAAALCRAIVNVVHHCH-FMGVMHRDLKPENFLLSNKD---GGAMLKATDFGL 244
H + + ++ + + H G++H D+KPEN L+ D +K D G
Sbjct: 125 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 245 SVFIDEGKVYRDIVGSAYYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG 303
+ + DE I + Y +PEV L +G D+WS +++ L++G F +
Sbjct: 185 ACWYDE-HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 304 -------------------------------IFDA-----------------ILKGGVDF 315
F++ +L F
Sbjct: 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302
Query: 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357
+ ISD + ML DP+KR + ++ HPW+++
Sbjct: 303 SKDEAKEISD----FLSPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 80/315 (25%), Positives = 129/315 (40%), Gaps = 61/315 (19%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-QDREDIK---REIQ 146
+ + Y K +G G GI + + A K KL Q++ K RE+
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELV 76
Query: 147 IMQHLSGQQNIVEFR------GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAAL 200
+M+ + +NI+ + E+ Q V++VMEL L ++I + + L
Sbjct: 77 LMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYL 132
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
++ + H H G++HRDLKP N ++ D LK DFGL+ + V +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSN-IVVKSD--CTLKILDFGLARTAGTSFMMTPYVVT 189
Query: 261 AYYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL---------- 309
YY APEV L Y + +D+WS G I+ ++ G F ++ ++
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249
Query: 310 -----------------KGGVDFE-----------SEPWLLISDSAKDLVRKMLIQDPKK 341
G FE SE L + A+DL+ KML+ D K
Sbjct: 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309
Query: 342 RITSAEVLEHPWMRE 356
RI+ E L+HP++
Sbjct: 310 RISVDEALQHPYINV 324
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 20/83 (24%), Positives = 48/83 (57%), Gaps = 4/83 (4%)
Query: 365 IGSAVLSRMKQFRAMNKLKKMALKVIAEALS--EEEIKGLKTMFANMDTDKSGTITYEEL 422
I VL+ MK + + ++ + + ++A LS IK + +F +DT+ +G++++ E+
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 423 KTGLARLGSKLSETEVKQLMDAV 445
T LA +G + + ++ +++ A+
Sbjct: 62 YTVLASVG--IKKWDINRILQAL 82
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
G+ LG+G FG T TG K +++ +++ + +E+++M+ L N
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMG 215
+++F G + ++ + E GG L I + Y + + I + + + H M
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD---------------IVGS 260
++HRDL N L+ + DFGL+ + + K + +VG+
Sbjct: 129 IIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 261 AYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPF 296
Y++APE++ RSY +++DV+S G++L ++ V
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 84/332 (25%), Positives = 136/332 (40%), Gaps = 76/332 (22%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK---REIQI 147
D+ Y K LG G G+ + +N A K K+V D + +K REI+I
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVL-TDPQSVKHALREIKI 61
Query: 148 MQHLSGQQNIVE--------------FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYT 193
++ L NIV+ G+ + SV++V E +L ++ QG
Sbjct: 62 IRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLL 118
Query: 194 EKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253
E+ A ++ + + H V+HRDLKP N ++ +D +LK DFGL+ +D
Sbjct: 119 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED--LVLKIGDFGLARIMDPHYS 176
Query: 254 YRDI----VGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG---- 303
++ + + +Y +P +L +Y K ID+W+AG I +L+G F G
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF-----AGAHEL 231
Query: 304 -----IFDAI-----------------------LKGGVDFESEPWLL--ISDSAKDLVRK 333
I ++I + LL IS A D + +
Sbjct: 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ---LLPGISREAVDFLEQ 288
Query: 334 MLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
+L P R+T+ E L HP+M D+PI
Sbjct: 289 ILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 75/343 (21%), Positives = 121/343 (35%), Gaps = 74/343 (21%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHL--- 151
Y + LG G FG C +++ G S I++ N RE + EI +++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEK 76
Query: 152 --SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY---TEKAAAALCRAIVN 206
+ V + + + EL G F+ + + ++ + + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCH 134
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKD----------------GGAMLKATDFGLSVFIDE 250
+ H + H DLKPEN L N + ++ DFG + F E
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194
Query: 251 GKVYRDIVGSAYYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETE-------- 301
IV + +Y PEV L + + DVWS G IL+ G F
Sbjct: 195 -HHTT-IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252
Query: 302 --KGIFDAIL-----------KGGVDFESEP--------------WLLISDSAK-----D 329
G + + KGG+ ++ ++ DS + D
Sbjct: 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312
Query: 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSR 372
L+R+ML DP +RIT AE L HP+ S SR
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
P D+ + +++G G FG + + G+ A K IL + + + + RE+ I
Sbjct: 35 PWCDL----NIKEKIGAGSFGTVHRAEWH--GSDVAVK-ILMEQDFHAERVNEFLREVAI 87
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG---HYTEKAAAALCRAI 204
M+ L NIV F GA ++ +V E S G L+ + G E+ ++ +
Sbjct: 88 MKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 205 VNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR-DIVGSA 261
+++ H ++HR+LK N L+ K +K DFGLS + G+
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKY---TVKVCDFGLSRLKASTFLSSKSAAGTP 203
Query: 262 YYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPF 296
++APEVLR ++ DV+S GVIL+ L + P+
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 74/310 (23%), Positives = 131/310 (42%), Gaps = 44/310 (14%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
++ + Y +G G +G + TG A K + R + + RE+++++H
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 84
Query: 151 LSGQQNIVEFR------GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAI 204
+ +N++ + E+ V+LV L G +L + I+ T+ L I
Sbjct: 85 MK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQI 141
Query: 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV 264
+ + + H ++HRDLKP N L N+D LK DFGL+ + V + +Y
Sbjct: 142 LRGLKYIHSADIIHRDLKPSN-LAVNEDC--ELKILDFGLARHTADEMT--GYVATRWYR 196
Query: 265 APEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAI---------- 308
APE++ Y + +D+WS G I+ LL+G F K I +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 309 ---------LKGGVDFESEPWLLI----SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355
++ + + + A DL+ KML+ D KRIT+A+ L H +
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
Query: 356 EGGEASDKPI 365
+ + D+P+
Sbjct: 317 QYHDPDDEPV 326
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 63/337 (18%), Positives = 114/337 (33%), Gaps = 86/337 (25%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-----QDREDIK--- 142
++ YT+ + + G +G +S G A K + + D K
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 143 REIQIMQHLSGQQNIVEFR-----GAYEDRQSVHLVMEL----------CSGGELFDK-- 185
REI+++ H NI+ R ++LV EL + +
Sbjct: 78 REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 186 --IIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243
+ + + H H GV+HRDL P N +L + + DF
Sbjct: 137 QYFMYH----------ILLGL----HVLHEAGVVHRDLHPGN-ILLADNN--DITICDFN 179
Query: 244 LSVFIDEGKVYRDIVGSAYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETE 301
L+ V +Y APE++ + + K +D+WSAG ++ + + F
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF----- 234
Query: 302 KG---------IFDA--------------------ILKGGVDFESEPWLLI----SDSAK 328
+G I + + + + W + A
Sbjct: 235 RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL 294
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
DL+ KML +P++RI++ + L HP+ + D
Sbjct: 295 DLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTE 331
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 76/310 (24%), Positives = 125/310 (40%), Gaps = 63/310 (20%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-QDREDIK---REIQ 146
++ + Y +G G +G + +G A K KL Q K RE+
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYRELL 75
Query: 147 IMQHLSGQQNIVEFR------GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAAL 200
+++H+ +N++ + + +LVM +L KI+ ++E+ L
Sbjct: 76 LLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGL-KFSEEKIQYL 131
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
++ + + H GV+HRDLKP N L N+D LK DFGL+ D V +
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGN-LAVNEDC--ELKILDFGLARHADAEMT--GYVVT 186
Query: 261 AYYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG---------IFDAI- 308
+Y APEV+ Y + +D+WS G I+ +L+G F KG I
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-----KGKDYLDQLTQILKVTG 241
Query: 309 ------------------LKGGVDFESEPWLLI----SDSAKDLVRKMLIQDPKKRITSA 346
++ + + + S A DL+ KML D KR+T+A
Sbjct: 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301
Query: 347 EVLEHPWMRE 356
+ L HP+
Sbjct: 302 QALTHPFFEP 311
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 67/263 (25%), Positives = 117/263 (44%), Gaps = 18/263 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHLSGQ 154
Y + +LG G YL + A K + K++ + +RE+ LS
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLS-H 70
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
QNIV E+ +LVME G L + I + G + A I++ + H H M
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--IVGSAYYVAPEVLRRS 272
++HRD+KP+N L+ + K DFG++ + E + + ++G+ Y +PE +
Sbjct: 131 RIVHRDIKPQNILID-SNKTL--KIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 273 Y-GKEIDVWSAGVILYILLSGVPPFWAETE-----KGIFDAILKGGVDFESEPWLLISDS 326
+ D++S G++LY +L G PPF ET K I D++ D + I S
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD----IPQS 243
Query: 327 AKDLVRKMLIQDPKKRITSAEVL 349
+++ + +D R + + +
Sbjct: 244 LSNVILRATEKDKANRYKTIQEM 266
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 87/349 (24%), Positives = 140/349 (40%), Gaps = 66/349 (18%)
Query: 56 MSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTE 115
MS+P P R + V E +R Y + +G G +G +
Sbjct: 1 MSSPPP-------------ARSGFYRQEVTKTAWE-VRAVYRDLQPVGSGAYGAVCSAVD 46
Query: 116 NSTGNSYACKSILKRKLVNK-QDREDIK---REIQIMQHLSGQQNIVEFR------GAYE 165
TG A K KL Q K RE+++++H+ +N++ +
Sbjct: 47 GRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLD 100
Query: 166 DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPEN 225
D +LVM G +L K++ E L ++ + + H G++HRDLKP N
Sbjct: 101 DFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 158
Query: 226 FLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL--RRSYGKEIDVWSAG 283
L N+D LK DFGL+ D V + +Y APEV+ Y + +D+WS G
Sbjct: 159 -LAVNEDC--ELKILDFGLARQADSEMT--GYVVTRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 284 VILYILLSGVPPFWAETE----KGIFDAI-------------------LKGGVDFESEPW 320
I+ +++G F K I +KG + E + +
Sbjct: 214 CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF 273
Query: 321 LLI----SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
I S A +L+ KML+ D ++R+T+ E L HP+ + D+P
Sbjct: 274 ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 322
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 94/380 (24%), Positives = 145/380 (38%), Gaps = 109/380 (28%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK---REIQI 147
+I + L LG G +G+ T TG A K K+ REI+I
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKI 62
Query: 148 MQHLSGQQNIVEFR-----GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCR 202
++H +NI+ ++E+ V+++ EL +L ++I+ ++
Sbjct: 63 LKHFK-HENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSD-------- 111
Query: 203 AIVNVVHHCHFM-------------GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249
H +F+ V+HRDLKP N LL N + LK DFGL+ ID
Sbjct: 112 -----DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN-LLINSNC--DLKVCDFGLARIID 163
Query: 250 EGKVYRDIVGSA-----------YYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPF 296
E +Y APEV+ Y + +DVWS G IL L P F
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
Query: 297 WAETEKG---------IFDAILKGGVDFESEPWLLISDSAK------------------- 328
G IF I G +++ + S A+
Sbjct: 224 -----PGRDYRHQLLLIFGII--GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP 276
Query: 329 -------DLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRA--- 378
DL+++ML+ DP KRIT+ E LEHP+++ + +D+P G + +F
Sbjct: 277 RVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKE 336
Query: 379 ---MNKLKKMALKVIAEALS 395
LKK+ + E S
Sbjct: 337 ALTTKDLKKL---IWNEIFS 353
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-30
Identities = 27/130 (20%), Positives = 49/130 (37%), Gaps = 9/130 (6%)
Query: 320 WLLISDSAKDLVRKMLIQDPK--KRITSAEVLEHPW--MREGGEASDKPIGSAVLSRMKQ 375
I+ ++ K+ D K + E E R A + + S +
Sbjct: 43 EAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLKDLEDD 102
Query: 376 FRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSE 435
N+L+ LSEE+ L+ +F + SG ++++LK LA+ + E
Sbjct: 103 ASGYNRLR-----PSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPE 157
Query: 436 TEVKQLMDAV 445
+K+L V
Sbjct: 158 GPLKKLFVMV 167
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 11/45 (24%), Positives = 22/45 (48%), Gaps = 1/45 (2%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLG-SKLSETEVKQLMDAV 445
L+ ++A D DKSG ++ EE++ L + + + + V
Sbjct: 255 LRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVV 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 33/220 (15%), Positives = 77/220 (35%), Gaps = 27/220 (12%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
+ + +L G + GN K +LK + + + D E
Sbjct: 8 DFKQL----NFLTKLNENHSGELWKGRWQ--GNDIVVK-VLKVRDWSTRKSRDFNEECPR 60
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHL--VMELCSGGELFDKIIAQGHYTEKAAAALCRAI- 204
++ S N++ GA + + H + G L++ + ++ + A+ A+
Sbjct: 61 LRIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 205 ----VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
+ +H + + L + ++ + + + + +
Sbjct: 120 MARGMAFLHTLEPL-IPRHALNSRSVMIDEDM---TARISMADVKFSFQSPGR----MYA 171
Query: 261 AYYVAPEVLRRS----YGKEIDVWSAGVILYILLSGVPPF 296
+VAPE L++ + D+WS V+L+ L++ PF
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 61/252 (24%), Positives = 102/252 (40%), Gaps = 20/252 (7%)
Query: 56 MSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTE 115
M + + E+ G Y L + +GRG G Y +
Sbjct: 1 MGSSHHHHHH-SSGLVPRGSHMDGTAESREGTQFGP----YRLRRLVGRGGMGDVYEAED 55
Query: 116 NSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174
A K ++ L + R ++RE + L + ++V E +++ M
Sbjct: 56 TVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYVDM 113
Query: 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG 234
L +G +L + QG A A+ R I + + H G HRD+KPEN L+S D
Sbjct: 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS-ADDF 172
Query: 235 AMLKATDFGLSVFIDEGKVYR--DIVGSAYYVAPEVLRRSYGKEI----DVWSAGVILYI 288
A L DFG++ + K+ + + VG+ YY+APE D+++ +LY
Sbjct: 173 AYL--VDFGIASATTDEKLTQLGNTVGTLYYMAPERFS---ESHATYRADIYALTCVLYE 227
Query: 289 LLSGVPPFWAET 300
L+G PP+ +
Sbjct: 228 CLTGSPPYQGDQ 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 83/366 (22%), Positives = 134/366 (36%), Gaps = 109/366 (29%)
Query: 86 GKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-QDREDIK-- 142
G+ + + Y L K+LG+G +GI + + TG A K K+ + Q+ D +
Sbjct: 1 GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRT 55
Query: 143 -REIQIMQHLSGQQNIVEFRGAY--EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAA 199
REI I+ LSG +NIV ++ + V+LV + +L +I
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEP----- 108
Query: 200 LCRAIVNVVHHCHFM-------------GVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246
VH + + G++HRD+KP N LL N + +K DFGLS
Sbjct: 109 --------VHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL-NAEC--HVKVADFGLSR 157
Query: 247 FIDEGKVYRDIVGSA----------------------YYVAPEVL--RRSYGKEIDVWSA 282
+ + + + +Y APE+L Y K ID+WS
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217
Query: 283 GVILYILLSGVPPF------------------------------------------WAET 300
G IL +L G P F
Sbjct: 218 GCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIR 277
Query: 301 EKGIFDAILKGGVDFES-EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359
+ D K P ++ A DL+ K+L +P KRI++ + L+HP++
Sbjct: 278 QSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337
Query: 360 ASDKPI 365
+++P
Sbjct: 338 PNEEPN 343
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 16/95 (16%), Positives = 36/95 (37%)
Query: 351 HPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMD 410
P + + +PI + + ++ ++ + + ++ + F +D
Sbjct: 2 QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVD 61
Query: 411 TDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
D+SGT+ EL G G +LS ++M
Sbjct: 62 RDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIF 96
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 9/48 (18%), Positives = 20/48 (41%)
Query: 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
+ ++ +F +SGT+ E+ L +LG +++ L
Sbjct: 114 KFMELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRL 161
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 74/332 (22%), Positives = 119/332 (35%), Gaps = 84/332 (25%)
Query: 95 FYTLGKELGRGQFGITY--LCTENSTGNSYACKSILKRKLVNKQDREDIK----REIQIM 148
F G ++GRG +G Y + YA K I + I REI ++
Sbjct: 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI---------EGTGISMSACREIALL 72
Query: 149 QHLSGQQNIVEFRGAYEDRQ--SVHLVMELCSGGELFD--KIIAQGHYTEKAAAA----- 199
+ L N++ + + V L+ + D II ++
Sbjct: 73 RELK-HPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPR 127
Query: 200 -----LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK-DGGAMLKATDFGLS-VFIDEGK 252
L I++ +H+ H V+HRDLKP N L+ + +K D G + +F K
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 253 VYRDIVGSA---YYVAPEVL--RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG---- 303
D+ +Y APE+L R Y K ID+W+ G I LL+ P F E
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 304 ---------IFDAI------------------------------LKGGVDFESEPWLLIS 324
IF+ + + + + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
A L++K+L DP KRITS + ++ P+ E
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 78/323 (24%), Positives = 115/323 (35%), Gaps = 72/323 (22%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHL--- 151
Y + LG G FG C ++ G + I+K N E + EIQ+++HL
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTT 71
Query: 152 --SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNV 207
+ V+ +E + +V EL G +D I G + + I
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAM----------------LKATDFGLSVFIDEG 251
V+ H + H DLKPEN L D +K DFG + + DE
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE- 189
Query: 252 KVYRDIVGSAYYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETE--------- 301
+V + +Y APEV L + + DVWS G IL G F
Sbjct: 190 HHST-LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 302 -KGIFDA-ILKGG-----VDFESEPWLLISDSAK------------------------DL 330
G +++ + W S + + DL
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 331 VRKMLIQDPKKRITSAEVLEHPW 353
++KML DP KRIT E L+HP+
Sbjct: 309 IQKMLEYDPAKRITLREALKHPF 331
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--- 152
Y + K +G+G FG ++ A K +++ + K+ EI+I++HL
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALK-MVRNE---KRFHRQAAEEIRILEHLRKQD 154
Query: 153 --GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY---TEKAAAALCRAIVNV 207
N++ + R + + EL S L++ +I + + + +I+
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYE-LIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPE 267
+ H ++H DLKPEN LL + + +K DFG S + + +VY I S +Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSSCYEHQ-RVYTYIQ-SRFYRAPE 269
Query: 268 V-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETE 301
V L YG ID+WS G IL LL+G P E E
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 11/30 (36%), Positives = 17/30 (56%)
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREG 357
D +++ L DP R+T + L HPW+R
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 24/88 (27%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 358 GEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTI 417
G P+GS + M KL+ L A I+GL F +D D S ++
Sbjct: 3 GLVPRGPLGSHMD---AVDATMEKLRAQCLSRGAS-----GIQGLARFFRQLDRDGSRSL 54
Query: 418 TYEELKTGLARLGSKLSETEVKQLMDAV 445
+E + GLA+LG L + E + +
Sbjct: 55 DADEFRQGLAKLGLVLDQAEAEGVCRKW 82
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 64/331 (19%), Positives = 111/331 (33%), Gaps = 80/331 (24%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHLS-- 152
+ + +++G G FG LC YA K +++ N + K E I++ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-VVR----NIKKYTRSAKIEADILKKIQND 91
Query: 153 --GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVV 208
NIV++ G + + L+ E G L++ I + + + C I+ +
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAM----------------------LKATDFGLSV 246
++ M + H DLKPEN LL + +K DFG +
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 247 FIDEGKVYRDIVGSAYYVAPEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETE---- 301
F + I + Y APEV L + D+WS G +L L +G F
Sbjct: 211 FKSD-YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 302 ------KGIFD--------------------------------AILKGGVDFESEPWLLI 323
+K ++
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328
Query: 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354
+ D + +L DP R + AE+L+H ++
Sbjct: 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 64/261 (24%), Positives = 103/261 (39%), Gaps = 34/261 (13%)
Query: 96 YTLGKELGRGQFGITYLCT-ENSTGNSYACKSILKRKLVNKQDREDIKR---EIQIMQHL 151
Y + + G G YL N G K LV+ D E E Q + +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAERQFLAEV 136
Query: 152 SGQQNIVEFR--GAYEDRQSVH---LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
+IV+ + DR +VME G L A A I+
Sbjct: 137 V-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILP 193
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAP 266
+ + H +G+++ DLKPEN +L+ ++ LK D G I+ + + G+ + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLT-EEQ---LKLIDLGAVSRINS---FGYLYGTPGFQAP 246
Query: 267 EVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326
E++R D+++ G L L +P G+ E +P L DS
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDS 296
Query: 327 AKDLVRKMLIQDPKKRITSAE 347
L+R+ + DP++R T+AE
Sbjct: 297 YGRLLRRAIDPDPRQRFTTAE 317
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-27
Identities = 69/266 (25%), Positives = 111/266 (41%), Gaps = 19/266 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHLSGQ 154
Y LG+ LG G +L + A K +L+ L +RE Q L+
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN-H 71
Query: 155 QNIVEF--RGAYEDRQSVH--LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
IV G E +VME G L D + +G T K A + ++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY----RDIVGSAYYVAP 266
H G++HRD+KP N ++S K DFG++ I + ++G+A Y++P
Sbjct: 132 SHQNGIIHRDVKPANIMIS-ATNAV--KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 267 EVLRRSY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAI--LKGGVDFESEPWLLI 323
E R DV+S G +LY +L+G PPF ++ + A ++ S +
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPIPPSARHEGL 246
Query: 324 SDSAKDLVRKMLIQDPKKRITSAEVL 349
S +V K L ++P+ R +A +
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEM 272
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD-REDIKREIQIMQHLS-- 152
Y + +G+G FG + A K I+K NK+ + E+++++ ++
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIK----NKKAFLNQAQIEVRLLELMNKH 110
Query: 153 ---GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNV 207
+ IV + + R + LV E+ S L+D + + + +
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 208 VHHCHF--MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
+ + ++H DLKPEN LL N + +K DFG S + + ++Y+ I S +Y +
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQ-RIYQYIQ-SRFYRS 226
Query: 266 PEV-LRRSYGKEIDVWSAGVILYILLSGVPPFWAETE 301
PEV L Y ID+WS G IL + +G P F E
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 12/29 (41%), Positives = 18/29 (62%)
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
KDL+ +ML DPK RI L+H + ++
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
P I T+G+ +G G FG Y + A K +L Q + K E+ +
Sbjct: 22 PDGQI----TVGQRIGSGSFGTVYKGKWHGD---VAVK-MLNVTAPTPQQLQAFKNEVGV 73
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI-IAQGHYTEKAAAALCRAIVN 206
++ NI+ F G + +V + C G L+ + ++ + K + R
Sbjct: 74 LRKTR-HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS---VFIDEGKVYRDIVGSAYY 263
+ + H ++HRDLK N L +K DFGL+ + + GS +
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 264 VAPEVLRRS----YGKEIDVWSAGVILYILLSGVPPF 296
+APEV+R Y + DV++ G++LY L++G P+
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 61/301 (20%), Positives = 116/301 (38%), Gaps = 63/301 (20%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ-----HL 151
TL + +G+G++G + + G + A K + +D + RE ++ H
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIF------SSRDEKSWFRETELYNTVMLRH- 61
Query: 152 SGQQNIVEFRGAYEDRQSVH----LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNV 207
+NI+ F + + L+ G L+D + + + +I +
Sbjct: 62 ---ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASG 117
Query: 208 VHHCHF--------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI-- 257
+ H H + HRDLK +N L+ K+G D GL+V + D+
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV-KKNG--QCCIADLGLAVMHSQSTNQLDVGN 174
Query: 258 ---VGSAYYVAPEVLR-------RSYGKEIDVWSAGVILYILLSGV----------PPFW 297
VG+ Y+APEVL K +D+W+ G++L+ + + PPF+
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 298 AETEKGIFDAILKGGVDFESE----PWLLISDSA----KDLVRKMLIQDPKKRITSAEVL 349
++ V + + P SD L+++ Q+P R+T+ +
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
Query: 350 E 350
+
Sbjct: 295 K 295
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 78/436 (17%), Positives = 135/436 (30%), Gaps = 141/436 (32%)
Query: 43 QQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKEL 102
+ ++ + S++P I Y + +
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMP--RPHSDWQIPDRYEIRHLI 61
Query: 103 GRGQFGITYLCTENSTGNSYACKSILKRKLVNK-QDREDIK---REIQIMQHLSGQQNIV 158
G G +G + A K K++ +D D K REI I+ L+ ++V
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILNRLN-HDHVV 115
Query: 159 EFR-----GAYEDRQSVHLVMELC---------SGGELFDK----IIAQGHYTEKAAAAL 200
+ E +++V+E+ + L + ++ L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN----------L 165
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
+ + H G++HRDLKP N L N+D +K DFGL+ +D + +
Sbjct: 166 LVGV----KYVHSAGILHRDLKPAN-CLVNQDC--SVKVCDFGLARTVDYPENGNSQLPI 218
Query: 261 A----------------------------YYVAPEVL--RRSYGKEIDVWSAGVILYILL 290
+ +Y APE++ + +Y + IDVWS G I LL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 291 SGVPPFWAETEKG-----------------------------------IFDAILKGGVDF 315
+ + A IF+ + G
Sbjct: 279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL---GTPS 335
Query: 316 ESEPWLLISDSAKDLVR--------------------------KMLIQDPKKRITSAEVL 349
E + L + AK +R +ML+ +P KRIT E L
Sbjct: 336 EEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECL 395
Query: 350 EHPWMREGGEASDKPI 365
HP+ +E A +
Sbjct: 396 AHPFFKEVRIAEVETN 411
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/296 (21%), Positives = 106/296 (35%), Gaps = 53/296 (17%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
L + +G+G+FG + G A K I + RE EI L +N
Sbjct: 45 VLQESIGKGRFGEVWRGKWR--GEEVAVK-IFSSREERSWFRE---AEIYQTVMLR-HEN 97
Query: 157 IVEFRGAYEDRQSVH----LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212
I+ F A LV + G LFD + + T + L + + + H H
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLH 156
Query: 213 F--------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI-----VG 259
+ HRDLK +N +L K+G D GL+V D DI VG
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKN-ILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 260 SAYYVAPEVLRRS-------YGKEIDVWSAGVILYILLSGV----------PPFWAETEK 302
+ Y+APEVL S K D+++ G++ + + P++
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273
Query: 303 GIFDAILKGGVDFESE----PWLLISDSA----KDLVRKMLIQDPKKRITSAEVLE 350
++ V + P S A ++R+ + R+T+ + +
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 69/338 (20%), Positives = 117/338 (34%), Gaps = 58/338 (17%)
Query: 56 MSAPQPQPRQQPM-KSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCT 114
M+ P + + + S +S P V + I + K++G+G++G ++
Sbjct: 2 MTYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQI----QMVKQIGKGRYGEVWMGK 57
Query: 115 ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH--- 171
G A K + RE EI + +NI+ F A
Sbjct: 58 WR--GEKVAVK-VFFTTEEASWFRE---TEIYQTVLMR-HENILGFIAADIKGTGSWTQL 110
Query: 172 -LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF--------MGVMHRDLK 222
L+ + G L+D + K+ L + V+ + H H + HRDLK
Sbjct: 111 YLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169
Query: 223 PENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI-----VGSAYYVAPEVLRRS----- 272
+N +L K+G D GL+V DI VG+ Y+ PEVL S
Sbjct: 170 SKN-ILVKKNG--TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNH 226
Query: 273 --YGKEIDVWSAGVILYILLSGV----------PPFWAETEKGIFDAILKGGVDFESE-- 318
D++S G+IL+ + P+ ++ V +
Sbjct: 227 FQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP 286
Query: 319 --PWLLISDSA----KDLVRKMLIQDPKKRITSAEVLE 350
P SD L+ + +P R+T+ V +
Sbjct: 287 SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-24
Identities = 39/281 (13%), Positives = 75/281 (26%), Gaps = 36/281 (12%)
Query: 71 SATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKR 130
S+ P + V G + + R Y L G + + + A + +
Sbjct: 10 DRESSAPPDDVQLVPGARIANGR--YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQ 67
Query: 131 KLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG 190
++ ++ + + + + R +V E GG L + +A
Sbjct: 68 GVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADT 124
Query: 191 HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250
+ A +++ H GV P +S DG +L
Sbjct: 125 SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI-DGDVVL--AYPA------- 174
Query: 251 GKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK 310
P+ + D+ G LY LL P + +
Sbjct: 175 -------------TMPDANPQD-----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 311 GGVDFESEPWLL---ISDSAKDLVRKMLIQDPKKRITSAEV 348
EP + I + + + D R S +
Sbjct: 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 71/377 (18%), Positives = 124/377 (32%), Gaps = 125/377 (33%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-QDREDIK---REIQ 146
+ Y + +GRG +G YL + +T + A K K+ +D D K REI
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREIT 77
Query: 147 IMQHLSGQQNIVEFR-----GAYEDRQSVHLVMELC---------SGGELFDK----IIA 188
I+ L I+ +++V+E+ + L ++ I+
Sbjct: 78 ILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY 136
Query: 189 QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248
L + H G++HRDLKP N LL N+D +K DFGL+ I
Sbjct: 137 N----------LLLGE----NFIHESGIIHRDLKPANCLL-NQDC--SVKVCDFGLARTI 179
Query: 249 DEGKVYRDIVGSA-----------------------YYVAPEVL--RRSYGKEIDVWSAG 283
+ K + +Y APE++ + +Y K ID+WS G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
Query: 284 VILYILLSGVPPFWAETE--KGIF------------DAILKGGVDF-------------- 315
I LL+ + + +F ++
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 316 -ESEPWLLISDSAKDLVR--------------------------KMLIQDPKKRITSAEV 348
E + + ++ ML +P KRIT +
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359
Query: 349 LEHPWMREGGEASDKPI 365
L+HP++++ + +
Sbjct: 360 LDHPYLKDVRKKKLENF 376
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-23
Identities = 37/58 (63%), Positives = 46/58 (79%)
Query: 388 KVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
K +AE LSEEEI GLK +F +DTD SGTIT++ELK GL R+GS+L E+E+K LMDA
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-23
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 4/88 (4%)
Query: 361 SDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYE 420
+D + + F A + + L ++ +K +F +D DKSG I +
Sbjct: 3 TDLLSAEDIKKAIGAFTAADSFDHKKFFQMV-GLKKKSADDVKKVFHILDKDKSGFIEED 61
Query: 421 ELKTGLARL---GSKLSETEVKQLMDAV 445
EL + L LS E K LM A
Sbjct: 62 ELGSILKGFSSDARDLSAKETKTLMAAG 89
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-22
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 4/82 (4%)
Query: 367 SAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGL 426
S + + ++ +A + I+ +S++ LK +F +D D+SG I +ELK L
Sbjct: 9 SDIAAALRDCQAPDSFSPKKFFQISG-MSKKSSSQLKEIFRILDNDQSGFIEEDELKYFL 67
Query: 427 ARLGS---KLSETEVKQLMDAV 445
R S L+ +E K + A
Sbjct: 68 QRFESGARVLTASETKTFLAAA 89
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 61/365 (16%), Positives = 116/365 (31%), Gaps = 112/365 (30%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--- 152
Y + ++LG G F +L + A K ++K + E EI++++ +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKS---AEHYTETALDEIRLLKSVRNSD 94
Query: 153 ----GQQNIVEFRGAYEDR--QSVH--LVMELCSGGELFDKIIAQGH--YTEKAAAALCR 202
++ +V+ ++ H +V E+ G L II + + +
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 203 AIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAM------------------------- 236
++ + + H ++H D+KPEN LLS +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 237 ---------------------LKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV-LRRSYG 274
+K D G + ++ + + + + + Y + EV + Y
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYN 271
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFD---------AIL------------KGGV 313
D+WS + + L +G F + + +L
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331
Query: 314 DFESE----------PWLLIS-------------DSAKDLVRKMLIQDPKKRITSAEVLE 350
F + PW L D + ML P+KR T+AE L
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
Query: 351 HPWMR 355
HPW+
Sbjct: 392 HPWLN 396
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 64/327 (19%), Positives = 111/327 (33%), Gaps = 59/327 (18%)
Query: 66 QPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACK 125
+S + L + RG+FG + A K
Sbjct: 2 GHHHHHHSSGVDLGTENLYF-----QSMPL-QLLEVKARGRFGCVWKAQLL--NEYVAVK 53
Query: 126 SILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH----LVMELCSGGE 181
I + E E+ + + +NI++F GA + SV L+ G
Sbjct: 54 -IFPIQDKQSWQNE---YEVYSLPGMK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGS 108
Query: 182 LFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM----------GVMHRDLKPENFLLSNK 231
L D + + + + + + H + HRD+K +N LL
Sbjct: 109 LSD-FLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-KN 166
Query: 232 DGGAMLKATDFGLSVFIDEGKVYRDI---VGSAYYVAPEVLR------RSYGKEIDVWSA 282
+ A DFGL++ + GK D VG+ Y+APEVL R ID+++
Sbjct: 167 NLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 283 GVILYILLSG-----------VPPFWAET-EKGIFDAILKGGVDFESEPWLLISDSAKDL 330
G++L+ L S + PF E + + + + V + P L
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284
Query: 331 VRKM--LI-----QDPKKRITSAEVLE 350
+ + I D + R+++ V E
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 69/258 (26%), Positives = 108/258 (41%), Gaps = 34/258 (13%)
Query: 69 KSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSIL 128
KS R V K + VL ED+ LG+++GRG FG + + A KS
Sbjct: 95 KSGVVLHRAVPKDKWVL--NHEDL----VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC- 147
Query: 129 KRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFD---- 184
R+ + + +E +I++ S NIV G +Q +++VMEL GG+
Sbjct: 148 -RETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT 205
Query: 185 -----KIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239
++ AAA + + +HRDL N L++ K+ +LK
Sbjct: 206 EGARLRVKTLLQMVGDAAAGME--------YLESKCCIHRDLAARNCLVTEKN---VLKI 254
Query: 240 TDFGLSVFIDEGKVYRDIVGSAYYV---APEVLR-RSYGKEIDVWSAGVILY-ILLSGVP 294
+DFG+S +G V APE L Y E DVWS G++L+ G
Sbjct: 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314
Query: 295 PFWAETEKGIFDAILKGG 312
P+ + + + + KGG
Sbjct: 315 PYPNLSNQQTREFVEKGG 332
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-21
Identities = 36/55 (65%), Positives = 44/55 (80%)
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
AE LSEEEI GLK +F +DTD SGTIT++ELK GL R+GS+L E+E+K LMDA
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 55
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 13/68 (19%)
Query: 378 AMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE 437
A L K+ EE L + F+ D D SG IT +E++ G L +
Sbjct: 71 ATVHLNKL--------EREEN---LVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIH 117
Query: 438 VKQLMDAV 445
+ ++ +
Sbjct: 118 IDDMIKEI 125
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 66/318 (20%), Positives = 112/318 (35%), Gaps = 75/318 (23%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQI--- 147
D+ L + +GRG++G Y + + A K + +R++ E I
Sbjct: 11 DLDNL-KLLELIGRGRYGAVYKGSLD--ERPVAVK-VFS-----FANRQNFINEKNIYRV 61
Query: 148 --MQHLSGQQNIVEFRGAYEDRQSVH-----LVMELCSGGELFDKIIAQGHYTEKAAAAL 200
M+H NI F E + LVME G L ++ ++ L
Sbjct: 62 PLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRL 116
Query: 201 CRAIVNVVHHCHFM---------GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251
++ + + H + HRDL N +L DG +DFGLS+ +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRN-VLVKNDGTC--VISDFGLSMRLTGN 173
Query: 252 KVYRD---------IVGSAYYVAPEVLR--------RSYGKEIDVWSAGVILYILLSGV- 293
++ R VG+ Y+APEVL S K++D+++ G+I + +
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 294 ------------PPFWAETEKGIFDAILKGGVDFE------SEPWLLISDSAKDLVRKML 335
F E ++ V E E W S + + L +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 336 I---QDPKKRITSAEVLE 350
QD + R+T+ E
Sbjct: 294 DCWDQDAEARLTAQXAEE 311
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-20
Identities = 17/68 (25%), Positives = 31/68 (45%), Gaps = 5/68 (7%)
Query: 383 KKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEEL-----KTGLARLGSKLSETE 437
K A+K+ + + IK K MF +D + +G IT +E+ A+L + +T+
Sbjct: 3 SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62
Query: 438 VKQLMDAV 445
Q+
Sbjct: 63 RHQVCVEA 70
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-07
Identities = 16/68 (23%), Positives = 23/68 (33%)
Query: 378 AMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE 437
+L LK A + +F D D SGTIT +E K G S+ +
Sbjct: 91 GWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQED 150
Query: 438 VKQLMDAV 445
+
Sbjct: 151 CEATFRHC 158
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 66/303 (21%), Positives = 116/303 (38%), Gaps = 47/303 (15%)
Query: 38 YQTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQ-KPETVLGKPLEDIRQFY 96
+Q + Q + K+ P A T + E P ++I
Sbjct: 22 FQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEV----PRKNI---- 73
Query: 97 TLGKELGRGQFGITYLCTENSTGNSY-----ACKSILKRKLVNKQDREDIKREIQIMQHL 151
TL + LG G FG Y + N A K++ ++ ++QD D E I+
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF 131
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH- 210
+ QNIV G +++EL +GG+L + + ++ +++V
Sbjct: 132 N-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 211 ---CHFMGVM---HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV 264
C ++ HRD+ N LL+ G + K DFG++ RDI + YY
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRAGYYR 241
Query: 265 ------------APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILK 310
PE + + D WS GV+L+ + S G P+ +++ + + + +
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
Query: 311 GGV 313
GG
Sbjct: 302 GGR 304
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-19
Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 1/68 (1%)
Query: 379 MNKLKK-MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE 437
M+K + + + L EE+ + + F+ D + G + Y ELK + LG +L + E
Sbjct: 1 MSKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE 60
Query: 438 VKQLMDAV 445
+ L+D
Sbjct: 61 ILDLIDEY 68
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-05
Identities = 14/61 (22%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
+ + I + +EIK F D D +G I+ + L+ LG L++ E++ +++
Sbjct: 84 VMGEKILKRDPLDEIK---RAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEE 140
Query: 445 V 445
Sbjct: 141 F 141
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-19
Identities = 21/80 (26%), Positives = 40/80 (50%), Gaps = 4/80 (5%)
Query: 369 VLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLAR 428
+ + +++ + + + LS+ +K +F +D D+SG + +ELK L +
Sbjct: 11 IAAALQECQDPDTFEPQKF-FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQK 69
Query: 429 LGS---KLSETEVKQLMDAV 445
S +L+E+E K LMDA
Sbjct: 70 FQSDARELTESETKSLMDAA 89
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 43/240 (17%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y LG+++G G FG YL T+ + G A K + K + Q + E +I + + G
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQ----LHIESKIYKMMQGGV 65
Query: 156 NIVEFRGAYEDRQSVHLVMELC--SGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
I R + +VMEL S +LF+ ++ K L +++ + + H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--------------IVG 259
+HRD+KP+NFL+ G ++ DFGL+ K YRD + G
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA------KKYRDARTHQHIPYRENKNLTG 177
Query: 260 SAYYVAPEVLRRSYGKEI----DVWSAG-VILYILLSGVPPFW----AETEKGIFDAILK 310
+A Y + + G E D+ S G V++Y L +P W A T++ ++ I +
Sbjct: 178 TARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYERISE 232
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-19
Identities = 17/68 (25%), Positives = 32/68 (47%), Gaps = 5/68 (7%)
Query: 379 MNKLKKMALKVIAEALSEEEIKGLKTMFANMDTD-KSGTITYEELKTGLARLGSKLSETE 437
M+ + K E L+EE+ K F + G+I+ +EL + LG + E
Sbjct: 1 MDDIYK----AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE 56
Query: 438 VKQLMDAV 445
+++++D V
Sbjct: 57 LQEMIDEV 64
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 19/63 (30%), Positives = 29/63 (46%), Gaps = 5/63 (7%)
Query: 385 MALKVIAE--ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
M + + SEEE L +F D + G I EELK L G ++E ++++LM
Sbjct: 81 MVRSMKDDSKGKSEEE---LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELM 137
Query: 443 DAV 445
Sbjct: 138 KDG 140
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 17/225 (7%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSY----ACKSILKRKLVNKQDREDIKREIQIMQHLS 152
K LG G FG Y G A K + R+ + + ++I E +M +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHC 211
++ G +V L+ +L G L D + + + + C I +++
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---APEV 268
++HRDL N L+ +K TDFGL+ + + G + A E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 269 LR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
+ R Y + DVWS GV ++ L++ G P+ I + KG
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 6e-19
Identities = 65/309 (21%), Positives = 112/309 (36%), Gaps = 40/309 (12%)
Query: 21 STAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQK 80
+T + + + ++ V+ +S + + + T T P +
Sbjct: 324 ATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTR 383
Query: 81 PETVLGKPLEDIRQFYTLGKELGRGQFGITY---LCTENSTGNSYACKSILKRKLVNKQD 137
+ E I LG+ +G GQFG + + + + A K+ + +
Sbjct: 384 DYEI---QRERI----ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSV 434
Query: 138 REDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKA 196
RE +E M+ +IV+ G V ++MELC+ GEL + + +
Sbjct: 435 REKFLQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 197 AAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD 256
+ + + +HRD+ N L+S+ D +K DFGLS R
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS---------RY 540
Query: 257 IVGSAYYV-----------APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKG 303
+ S YY APE + R + DVW GV ++ +L GV PF
Sbjct: 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600
Query: 304 IFDAILKGG 312
+ I G
Sbjct: 601 VIGRIENGE 609
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 53/249 (21%), Positives = 90/249 (36%), Gaps = 43/249 (17%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSY---ACKSILKRKLVNKQDREDIKREIQIMQ 149
Q +TLG+ LG+G+FG S+ A K LK ++ D E+ RE M+
Sbjct: 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKM-LKADIIASSDIEEFLREAACMK 80
Query: 150 HLSGQQNIVEFRGA------YEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRA 203
++ + G +++ G+L ++A L
Sbjct: 81 EFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 204 I---VNVVHHCHF---MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI 257
+ V++ + +HRDL N +L+ + DFGLS R I
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM---TVCVADFGLS---------RKI 187
Query: 258 VGSAYYV------------APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKG 303
YY A E L Y DVW+ GV ++ +++ G P+
Sbjct: 188 YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 304 IFDAILKGG 312
I++ ++ G
Sbjct: 248 IYNYLIGGN 256
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 40/237 (16%), Positives = 72/237 (30%), Gaps = 33/237 (13%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSI---LKR-KLVNKQDREDIKREIQIMQHLS 152
+ LG+G F + G+ LK ++ E +M LS
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH 212
+++V G LV E G L + + + + H
Sbjct: 71 -HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMH 127
Query: 213 F---MGVMHRDLKPENFLLSNKDGGA-----MLKATDFGLSVFIDEGKVYRDIVGSAYY- 263
F ++H ++ +N LL ++ +K +D G+S ++
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---------ITVLPKDILQ 178
Query: 264 -----VAPEVL--RRSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
V PE + ++ D WS G L+ + S G P A +
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 46/220 (20%), Positives = 83/220 (37%), Gaps = 34/220 (15%)
Query: 56 MSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDI-RQFYTLGKELGRGQFGITYLCT 114
M + + + + PE GK L+D+ + LGK++G G FG+ YL
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMPFPE---GKVLDDMEGNQWVLGKKIGSGGFGLIYLAF 57
Query: 115 ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR------------- 161
+ A + K V Q+ + E++ Q ++ + I ++
Sbjct: 58 PTNKPEKDARHVV---K-VEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113
Query: 162 ---GAYEDRQSVH--LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGV 216
G E + + +VME G +L G + + L +++V+ + H
Sbjct: 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEY 172
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD 256
+H D+K N LL K+ + D+GLS Y
Sbjct: 173 VHGDIKAANLLLGYKNPD-QVYLADYGLS------YRYCP 205
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 64/239 (26%), Positives = 94/239 (39%), Gaps = 41/239 (17%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ LG+++G G FG YL T T A K K + E +I + L G
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRILQGGT 63
Query: 156 NIVEFRGAYEDRQSVHLVMELC--SGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
I R + LVM+L S +LF+ + K L ++N V H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS 121
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--------------IVG 259
+HRD+KP+NFL+ + DFGL+ K YRD + G
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA------KKYRDTSTHQHIPYRENKNLTG 175
Query: 260 SAYYVAPEVLRRSYGKEI----DVWSAGVILYILLSGVPPFW----AETEKGIFDAILK 310
+A Y + + G E D+ S G +L L G P W A T+K ++ I +
Sbjct: 176 TARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISE 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 77/316 (24%), Positives = 118/316 (37%), Gaps = 22/316 (6%)
Query: 9 RVPPSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQPQPRQQPM 68
+ + + +S A + +T T Q + P +PR PM
Sbjct: 251 KEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPM 310
Query: 69 KSSATSTRPVQKPETVLGKPLEDIRQFYTLGK-ELGRGQFGITYLCTENSTGNSY--ACK 125
+S + P PE + K L R + ELG G FG A K
Sbjct: 311 DTSVFES-PFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK 369
Query: 126 SILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDK 185
+ ++ K D E++ RE QIM L IV G + +++ LVME+ GG L
Sbjct: 370 VL--KQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKF 425
Query: 186 IIAQGHYTEKAAAALCRAIVNVVHHCHF---MGVMHRDLKPENFLLSNKDGGAMLKATDF 242
+ G E + + + V + +HR+L N LL N+ K +DF
Sbjct: 426 L--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH---YAKISDF 480
Query: 243 GLSVFIDEGK-VYRDIVGSAYYV---APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPF 296
GLS + Y + + APE + R + DVWS GV ++ LS G P+
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 297 WAETEKGIFDAILKGG 312
+ I +G
Sbjct: 541 KKMKGPEVMAFIEQGK 556
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 54/241 (22%), Positives = 96/241 (39%), Gaps = 43/241 (17%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y +G+ +G G FG+ + T A K + D ++ E + + L+G
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 156 NIVEFRGAYEDRQSVHLVMELC--SGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
I ++ LV++L S +L D ++ K A + ++ V H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 214 MGVMHRDLKPENFLLSNKDG--GAMLKATDFGLSVFIDEGKVYRD--------------I 257
+++RD+KP+NFL+ + M+ DFG+ K YRD +
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV------KFYRDPVTKQHIPYREKKNL 178
Query: 258 VGSAYYVAPEVLRRSYGKEI----DVWSAGVILYILLSGVPPFW----AETEKGIFDAIL 309
G+A Y++ + G+E D+ + G + L G P W A T K ++ I
Sbjct: 179 SGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-WQGLKAATNKQKYERIG 234
Query: 310 K 310
+
Sbjct: 235 E 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 61/254 (24%), Positives = 105/254 (41%), Gaps = 46/254 (18%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSY-----ACKSILKRKLVNKQDREDIK 142
P ++I TL + LG G FG Y + N A K++ ++ ++QD D
Sbjct: 28 PRKNI----TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFL 81
Query: 143 REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCR 202
E I+ + QNIV G ++MEL +GG+L + + ++
Sbjct: 82 MEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 203 AIVNVVHH----CHFMGVM---HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR 255
+++V C ++ HRD+ N LL+ G + K DFG++ R
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------R 191
Query: 256 DIVGSAYYV------------APEVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAE 299
DI ++YY PE G + D WS GV+L+ + S G P+ ++
Sbjct: 192 DIYRASYYRKGGCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 300 TEKGIFDAILKGGV 313
+ + + + + GG
Sbjct: 250 SNQEVLEFVTSGGR 263
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 16/227 (7%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
R T+ +LG GQ+G Y + A K+ LK + + E+ +E +M+ +
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKE---DTMEVEEFLKEAAVMKEIK 274
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAAL--CRAIVNVVHH 210
N+V+ G +++ E + G L D + A L I + + +
Sbjct: 275 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---APE 267
+HR+L N L+ ++K DFGLS + G Y G+ + + APE
Sbjct: 334 LEKKNFIHRNLAARNCLVGENH---LVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 389
Query: 268 VLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
L + + DVW+ GV+L+ + + G+ P+ +++ + K
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 40/234 (17%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
T +E+G GQFG+ +L + + A K+ ++ ED E ++M LS
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNK-DKVAIKT-IR---EGAMSEEDFIEEAEVMMKLS-HPK 64
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF--- 213
+V+ G ++ + LV E G L D + + AA L ++V +
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV--------- 264
V+HRDL N L+ ++K +DFG++ R ++ Y
Sbjct: 123 ACVIHRDLAARNCLVGENQ---VIKVSDFGMT---------RFVLDDQYTSSTGTKFPVK 170
Query: 265 --APEVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
+PEV + + + DVWS GV+++ + S G P+ + + + I G
Sbjct: 171 WASPEVFS--FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSY----ACKSILKRKLVNKQDREDIKR 143
P ++F ++LG G FG LC + G++ A KS LK + D+K+
Sbjct: 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPE-SGGNHIADLKK 72
Query: 144 EIQIMQHLSGQQNIVEFRGA--YEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAAL 200
EI+I+++L +NIV+++G + + L+ME G L + + + K
Sbjct: 73 EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
I + + +HRDL N L+ ++ +K DFGL+ I+ K Y
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEH---QVKIGDFGLTKAIETDKEY------ 182
Query: 261 AYYV-----------APEVLR-RSYGKEIDVWSAGVILYILLS 291
Y V APE L + DVWS GV L+ LL+
Sbjct: 183 -YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 69/308 (22%), Positives = 115/308 (37%), Gaps = 54/308 (17%)
Query: 45 QQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDI----RQFYTLGK 100
Q M++ P R SS T+ P+ + P + R TLGK
Sbjct: 29 QVTVSAESSSSMNSNTPLVRITTRLSS-TADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 101 ELGRGQFGITYLCTENSTGNSYACKSI------LKRKLVNKQDREDIKREIQIMQHLSGQ 154
LG G FG + +++ LK ++D D+ E+++M+ +
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKH 146
Query: 155 QNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
+NI+ GA +++++E S G L + + A+ + + + R + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 215 GVM----------------HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258
HRDL N L++ + M K DFGL+ RDI
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLA---------RDIN 254
Query: 259 GSAYYV------------APEVLR-RSYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGI 304
YY APE L R Y + DVWS GV+++ I G P+ + +
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314
Query: 305 FDAILKGG 312
F + +G
Sbjct: 315 FKLLKEGH 322
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 2e-18
Identities = 23/56 (41%), Positives = 33/56 (58%)
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+++ L+EE+I K FA D D SG+I+ EL T + LG SE EV LM+ +
Sbjct: 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEI 56
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 46.7 bits (112), Expect = 2e-06
Identities = 18/62 (29%), Positives = 33/62 (53%), Gaps = 5/62 (8%)
Query: 385 MALKVIAEALSEEEI-KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+ + + SE+E+ + K +F D + G I+ ELK L +G KL++ EV +++
Sbjct: 72 LMSRQLKCNDSEQELLEAFK-VF---DKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLR 127
Query: 444 AV 445
V
Sbjct: 128 EV 129
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-18
Identities = 16/56 (28%), Positives = 27/56 (48%)
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ +L EEI+ L+ F D DK G I +L + +G +E E+ +L +
Sbjct: 1 MDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQI 56
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 15/64 (23%), Positives = 33/64 (51%), Gaps = 5/64 (7%)
Query: 383 KKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGL-ARLGSKLSETEVKQL 441
K+ + A+ + +E L+ F DT+ G I+ EL+ + A LG ++ +++++
Sbjct: 75 PKLLAET-ADMIGVKE---LRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEI 130
Query: 442 MDAV 445
+ V
Sbjct: 131 IRDV 134
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-18
Identities = 12/70 (17%), Positives = 27/70 (38%), Gaps = 2/70 (2%)
Query: 376 FRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSE 435
+ + L EE+ L+++FA D ++SG + EE + L +
Sbjct: 3 HHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRP 60
Query: 436 TEVKQLMDAV 445
+ + + +
Sbjct: 61 ADAEAVFQRL 70
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-18
Identities = 20/75 (26%), Positives = 38/75 (50%), Gaps = 4/75 (5%)
Query: 371 SRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLG 430
+ K + + +K L+EE+ + ++ F DTD SGTI +ELK + LG
Sbjct: 3 YKAKTVVSARRDQKKG----RVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALG 58
Query: 431 SKLSETEVKQLMDAV 445
+ + E+K+++ +
Sbjct: 59 FEPKKEEIKKMISEI 73
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 8e-06
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
M K + E S EEI F D D SGTIT ++L+ LG L+E E+++++
Sbjct: 90 MTAK-MGERDSREEIL---KAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAE 145
Query: 445 V 445
Sbjct: 146 A 146
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 59/273 (21%), Positives = 101/273 (36%), Gaps = 45/273 (16%)
Query: 71 SATSTRPVQKPETVLGKPLEDI---RQFYTLGKELGRGQFGITYLCTENSTGNSY---AC 124
S+ V + L LED+ R LGK LG G+FG + A
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 125 KSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH-----LVMELCSG 179
K+ +K ++++ E+ E M+ S N++ G + S +++
Sbjct: 68 KT-MKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125
Query: 180 GELFDKIIAQGHYTEKAAAALCRAI---VNVVHHCHF---MGVMHRDLKPENFLLSNKDG 233
G+L ++ T L + V++ + +HRDL N +L +
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD--- 182
Query: 234 GAMLKATDFGLSVFIDEGKVYRDIVGSAYYV------------APEVLR-RSYGKEIDVW 280
+ DFGLS + I YY A E L R Y + DVW
Sbjct: 183 DMTVCVADFGLS---------KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 233
Query: 281 SAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
+ GV ++ + + G+ P+ ++D +L G
Sbjct: 234 AFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 37/253 (14%)
Query: 62 QPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFY----TLGKELGRGQFGITYLCTENS 117
T+ + D QF ++LG+G FG +C +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 118 TGNSY----ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA--YEDRQSVH 171
++ A K + + ++ D +REI+I++ L NIV+++G R+++
Sbjct: 65 LQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLK 120
Query: 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSN 230
L+ME G L D + + I + + +HRDL N L+ N
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 180
Query: 231 KDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV-----------APEVLR-RSYGKEID 278
++ +K DFGL+ + + K Y Y V APE L + D
Sbjct: 181 EN---RVKIGDFGLTKVLPQDKEY-------YKVKEPGESPIFWYAPESLTESKFSVASD 230
Query: 279 VWSAGVILYILLS 291
VWS GV+LY L +
Sbjct: 231 VWSFGVVLYELFT 243
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 58/241 (24%), Positives = 91/241 (37%), Gaps = 36/241 (14%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSY---ACKSILKRKLVNKQDREDIKREIQIMQ 149
+ +GRG FG Y T A KS L ++ + + E IM+
Sbjct: 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LN-RITDIGEVSQFLTEGIIMK 81
Query: 150 HLSGQQNIVEFRGA-YEDRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNV 207
S N++ G S +V+ G+L + I + H T K +
Sbjct: 82 DFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV--- 264
+ + +HRDL N +L K +K DFGL+ RD+ YY
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKF---TVKVADFGLA---------RDMYDKEYYSVHN 188
Query: 265 -----------APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
A E L+ + + + DVWS GV+L+ L++ G PP+ I +L+G
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 312 G 312
Sbjct: 249 R 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 55/237 (23%), Positives = 92/237 (38%), Gaps = 41/237 (17%)
Query: 97 TLGKELGRGQFGITY---LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
L + LG G FG Y + A K+ +K ++E E IM++L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLD- 71
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
+IV+ G E + ++MEL GEL + + + L + + +
Sbjct: 72 HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 214 ---MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV------ 264
+ +HRD+ N L+++ + +K DFGLS R I YY
Sbjct: 129 LESINCVHRDIAVRNILVASPE---CVKLGDFGLS---------RYIEDEDYYKASVTRL 176
Query: 265 -----APEVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
+PE + + + DVW V ++ +LS G PF+ K + + KG
Sbjct: 177 PIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD 231
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 59/326 (18%), Positives = 102/326 (31%), Gaps = 40/326 (12%)
Query: 12 PSDMNGYRSSTAHSSHQATGVATQTPYQTYQQQQQQQLHVQPPKMSAPQPQPRQQPMKSS 71
P D G+ + P + + + ++
Sbjct: 3 PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62
Query: 72 ATSTRPVQKPETVLGKP----LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSY---AC 124
++ + + +GRG FG Y T A
Sbjct: 63 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 125 KSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA-YEDRQSVHLVMELCSGGELF 183
KS L ++ + + E IM+ S N++ G S +V+ G+L
Sbjct: 123 KS-LN-RITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 184 DKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242
+ I + T K + + +HRDL N +L K +K DF
Sbjct: 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF---TVKVADF 236
Query: 243 GLSVFIDEGKVYRDIVGSAYYV--------------APEVLR-RSYGKEIDVWSAGVILY 287
GL+ RD+ + A E L+ + + + DVWS GV+L+
Sbjct: 237 GLA---------RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 287
Query: 288 ILLS-GVPPFWAETEKGIFDAILKGG 312
L++ G PP+ I +L+G
Sbjct: 288 ELMTRGAPPYPDVNTFDITVYLLQGR 313
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 44/222 (19%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSI----LKRKLVNKQDREDIKREIQIMQHLS 152
GK LG G FG T G A + LK + ++E + E++IM HL
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMSHLG 107
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFD------KIIAQGHYTEKAAAAL------ 200
+NIV GA V ++ E C G+L + +++ A +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 201 --CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258
+ + +HRD+ N LL+N G + K DFGL+ RDI+
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTN---GHVAKIGDFGLA---------RDIM 215
Query: 259 GSAYYV------------APEVLR-RSYGKEIDVWSAGVILY 287
+ Y+ APE + Y + DVWS G++L+
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 49/223 (21%), Positives = 95/223 (42%), Gaps = 16/223 (7%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
T+ +LG GQ+G Y + A K+ LK + + E+ +E +M+ + N
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LK---EDTMEVEEFLKEAAVMKEIK-HPN 70
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFD--KIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
+V+ G +++ E + G L D + + + + I + + +
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---APEVLR- 270
+HRDL N L+ ++K DFGLS + Y G+ + + APE L
Sbjct: 131 NFIHRDLAARNCLVGENH---LVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAY 186
Query: 271 RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
+ + DVW+ GV+L+ + + G+ P+ +++ + K
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 61/241 (25%), Positives = 93/241 (38%), Gaps = 34/241 (14%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSY----ACKSILKRKLVNKQDREDIKREIQIM 148
+ +LG+G FG LC + G++ A K + + + D +REIQI+
Sbjct: 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQIL 78
Query: 149 QHLSGQQNIVEFRG--AYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIV 205
+ L IV++RG RQS+ LVME G L D + + I
Sbjct: 79 KALH-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV- 264
+ + +HRDL N L+ ++ +K DFGL+ + K Y Y V
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEA---HVKIADFGLAKLLPLDKDY-------YVVR 187
Query: 265 ----------APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
APE L + ++ DVWS GV+LY L + E +
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 313 V 313
Sbjct: 248 P 248
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 5e-18
Identities = 20/68 (29%), Positives = 31/68 (45%), Gaps = 4/68 (5%)
Query: 378 AMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE 437
+M + A LSEE I K F D D G I+ +EL T + LG ++ E
Sbjct: 2 SMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEE 57
Query: 438 VKQLMDAV 445
+ +++ V
Sbjct: 58 LDAIIEEV 65
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 15/61 (24%), Positives = 26/61 (42%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
M ++ + E + + L F D + G I EEL L G ++E +++ LM
Sbjct: 81 MMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKD 140
Query: 445 V 445
Sbjct: 141 S 141
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 6e-18
Identities = 20/52 (38%), Positives = 32/52 (61%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
LSEE+ + +K F DT+K+G+I Y ELK + LG + + E+ +LM+
Sbjct: 1 LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEY 52
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 52/257 (20%), Positives = 97/257 (37%), Gaps = 52/257 (20%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSY-----ACKSILKRKLVNKQDREDIK 142
E I T+ +ELG+G FG+ Y A K++ + + ++R +
Sbjct: 23 AREKI----TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFL 76
Query: 143 REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCR 202
E +M+ ++V G Q ++MEL + G+L + +
Sbjct: 77 NEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 203 AIVNVVHHCH----------FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252
++ ++ +HRDL N +++ +K DFG++
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE---DFTVKIGDFGMT------- 185
Query: 253 VYRDIVGSAYYV------------APEVLRRSYGK---EIDVWSAGVILY-ILLSGVPPF 296
RDI + YY +PE L+ G DVWS GV+L+ I P+
Sbjct: 186 --RDIYETDYYRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 297 WAETEKGIFDAILKGGV 313
+ + + +++GG+
Sbjct: 242 QGLSNEQVLRFVMEGGL 258
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 63/220 (28%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSY----ACKSILKRKLVNKQDREDIKREIQIM 148
+++ ++LG G FG L + T + A K+ LK Q R K+EI I+
Sbjct: 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKAD-AGPQHRSGWKQEIDIL 87
Query: 149 QHLSGQQNIVEFRGA--YEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
+ L ++I++++G S+ LVME G L D + H A L
Sbjct: 88 RTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRH--SIGLAQLLLFAQQ 142
Query: 207 VVHHCHFMGVM---HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYY 263
+ ++ HRDL N LL N ++K DFGL+ + EG Y Y
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEY-------YR 192
Query: 264 V-----------APEVLR-RSYGKEIDVWSAGVILYILLS 291
V APE L+ + DVWS GV LY LL+
Sbjct: 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 40/234 (17%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
T KELG GQFG+ A K +K ++ E ++M +LS +
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQ-YDVAIKM-IK---EGSMSEDEFIEEAKVMMNLS-HEK 80
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF--- 213
+V+ G ++ + ++ E + G L + + + L +V +
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV--------- 264
+HRDL N L++++ ++K +DFGLS R ++ Y
Sbjct: 139 KQFLHRDLAARNCLVNDQG---VVKVSDFGLS---------RYVLDDEYTSSVGSKFPVR 186
Query: 265 --APEVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
PEVL Y K + D+W+ GV+++ + S G P+ T + I +G
Sbjct: 187 WSPPEVLM--YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 8e-18
Identities = 21/56 (37%), Positives = 34/56 (60%)
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+A+ L+EE+I K F+ D D GTIT +EL T + LG +E E++ +++ V
Sbjct: 1 MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 56
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 6e-06
Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
M + + + SEEEI+ +F D D +G I+ EL+ + LG KL++ EV +++
Sbjct: 72 MMARKMKDTDSEEEIREAFRVF---DKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 128
Query: 445 V 445
Sbjct: 129 A 129
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 53/261 (20%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSI------LKRKLVNKQDREDI 141
P + + TLGK LG G FG + +++ LK ++D D+
Sbjct: 33 PRDKL----TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDL 87
Query: 142 KREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALC 201
E+++M+ + +NI+ GA +++++E S G L + + A+ + + +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 202 RAIVNVVHHCHF----------------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245
R + +HRDL N L++ ++K DFGL+
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE---NNVMKIADFGLA 204
Query: 246 VFIDEGKVYRDIVGSAYYV------------APEVLR-RSYGKEIDVWSAGVILY-ILLS 291
RDI YY APE L R Y + DVWS GV+++ I
Sbjct: 205 ---------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 292 GVPPFWAETEKGIFDAILKGG 312
G P+ + +F + +G
Sbjct: 256 GGSPYPGIPVEELFKLLKEGH 276
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 17/225 (7%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSY----ACKSILKRKLVNKQDREDIKREIQIMQHLS 152
K LG G FG Y G A K + R+ + + ++I E +M +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHC 211
++ G +V L+ +L G L D + + + + C I +++
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---APEV 268
++HRDL N L+ +K TDFGL+ + + G + A E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 269 LR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
+ R Y + DVWS GV ++ L++ G P+ I + KG
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 55/236 (23%), Positives = 85/236 (36%), Gaps = 54/236 (22%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSY-----ACKSILKRKLVNKQDREDIK 142
P + + GK LG G FG T S A K + + + +RE +
Sbjct: 21 PRNRL----SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALM 74
Query: 143 REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGEL-----------FDKIIAQGH 191
E++++ +L NIV GA ++ E C G+L +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 192 YTEKAAAALCRAIVNVVH-------HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244
+ A +++ + +HRDL N LL++ G + K DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH---GRITKICDFGL 191
Query: 245 SVFIDEGKVYRDIVGSAYYV------------APEVLR-RSYGKEIDVWSAGVILY 287
+ RDI + YV APE + Y E DVWS G+ L+
Sbjct: 192 A---------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-18
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSY----ACKSILKRKLVNKQDREDIKREIQIM 148
+ ++LG+G FG +C + ++ A K + + ++ D +REI+I+
Sbjct: 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEIL 65
Query: 149 QHLSGQQNIVEFRGA--YEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIV 205
+ L NIV+++G R+++ L+ME G L D + + I
Sbjct: 66 KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV- 264
+ + +HRDL N L+ N++ +K DFGL+ + + K + + V
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDKEF-------FKVK 174
Query: 265 ----------APEVLR-RSYGKEIDVWSAGVILYILLS 291
APE L + DVWS GV+LY L +
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 48/225 (21%), Positives = 83/225 (36%), Gaps = 17/225 (7%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSY----ACKSILKRKLVNKQDREDIKREIQIMQHLS 152
K LG G FG + G S K I +Q + + + + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLD 73
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHC 211
+IV G S+ LV + G L D + +G + I +++
Sbjct: 74 -HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---APEV 268
G++HR+L N LL + ++ DFG++ + + + A E
Sbjct: 132 EEHGMVHRNLAARNVLLKSPS---QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 269 LR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311
+ Y + DVWS GV ++ L++ G P+ + D + KG
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 43/241 (17%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ +GK++G G FG L T A K + K Q + E + + L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQLGSGD 65
Query: 156 NIVEFRGAYEDRQSVHLVMELC--SGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
I + + +V+EL S +LFD ++ K + +++ + + H
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 214 MGVMHRDLKPENFLLSNKDGGA--MLKATDFGLSVFIDEGKVYRD--------------I 257
+++RD+KPENFL+ ++ DF L+ K Y D +
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA------KEYIDPETKKHIPYREHKSL 177
Query: 258 VGSAYYVAPEVLRRSYGKEI----DVWSAGVILYILLSGVPPFW----AETEKGIFDAIL 309
G+A Y++ + GKE D+ + G + L G P W A+T K + I
Sbjct: 178 TGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIG 233
Query: 310 K 310
Sbjct: 234 D 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 58/239 (24%), Positives = 92/239 (38%), Gaps = 50/239 (20%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
TL KELG GQFG+ L A K +K ++ +E Q M LS
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQ-YDVAVKM-IK---EGSMSEDEFFQEAQTMMKLS-HPK 64
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKA-----AAALCRAIVNVVHHC 211
+V+F G +++V E S G L + + + G E + +C
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG-------M 117
Query: 212 HF---MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---- 264
F +HRDL N L+ +K +DFG++ R ++ Y
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDL---CVKVSDFGMT---------RYVLDDQYVSSVGT 165
Query: 265 -------APEVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
APEV Y K + DVW+ G++++ + S G P+ T + + +G
Sbjct: 166 KFPVKWSAPEVFH--YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 59/286 (20%), Positives = 101/286 (35%), Gaps = 31/286 (10%)
Query: 41 YQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGK 100
+ + P+PQ +P T P + E + K
Sbjct: 3 HHHHHSSGRENLYFQGKLPEPQFYAEP----HTYEEPGR---AGRSFTREIEASRIHIEK 55
Query: 101 ELGRGQFGITYLCTENSTGNSY---ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNI 157
+G G G G A K++ + ++ R D E IM NI
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFD-HPNI 112
Query: 158 VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF---M 214
+ G + +V E G L + + H + L + V + +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIVGSAYYV---APEVLR 270
G +HRDL N L+ + + K +DFGLS + D+ G + APE +
Sbjct: 171 GYVHRDLAARNVLVDSNL---VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 271 RSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
+ DVWS GV+++ +L+ G P+W T + + ++ +G
Sbjct: 228 --FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 60/225 (26%), Positives = 89/225 (39%), Gaps = 18/225 (8%)
Query: 98 LGKELGRGQFGITYLCTENSTGNSY--ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
KELG G FG A K LK + + ++++ E +MQ L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI-LKNEANDPALKDELLAEANVMQQLD-NP 78
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
IV G E +S LVME+ G L + H +K L + + +
Sbjct: 79 YIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIVGSAYYV---APEVLRR 271
+HRDL N LL + K +DFGLS + + Y+ + V APE +
Sbjct: 138 FVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN- 193
Query: 272 SYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
Y K + DVWS GV+++ S G P+ + + KG
Sbjct: 194 -YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 237
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 77.1 bits (191), Expect = 4e-17
Identities = 15/51 (29%), Positives = 30/51 (58%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+EE+ + ++ F D D +GTI +ELK + LG + + E+K+++ +
Sbjct: 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEI 51
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 5e-06
Identities = 18/61 (29%), Positives = 35/61 (57%), Gaps = 4/61 (6%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
M K ++E ++EEI +F D D++G I+++ LK LG L++ E+++++D
Sbjct: 68 MTQK-MSEKDTKEEILKAFKLF---DDDETGKISFKNLKRVAKELGENLTDEELQEMIDE 123
Query: 445 V 445
Sbjct: 124 A 124
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 4e-17
Identities = 17/93 (18%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 358 GEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKG----LKTMFANMDTDK 413
G K S + K +K A + I +A+ E+ +F D ++
Sbjct: 2 GACGSKGSTSDKGLASDKDGKKAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNE 61
Query: 414 SGTITYEELKTGLAR-LGSKLSETEVKQLMDAV 445
+G + Y+E+ +G L + V+ +
Sbjct: 62 TGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRA 94
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 10/53 (18%), Positives = 18/53 (33%), Gaps = 4/53 (7%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSK-LSETEVKQLMDAV 445
E L MF +D + + EE K + +L + + L +
Sbjct: 127 YDFFE---LTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKEL 176
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 58/252 (23%), Positives = 94/252 (37%), Gaps = 49/252 (19%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSI------LKRKLVNKQDREDIKREIQIMQH 150
LGK LG G FG L + LK ++D D+ E+++M+
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKM 130
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
+ +NI+ GA +++++E S G L + + A+ + + +
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 211 CHF----------------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254
+HRDL N L++ ++K DFGL+
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE---DNVMKIADFGLA--------- 238
Query: 255 RDIVGSAYYV------------APEVLR-RSYGKEIDVWSAGVILY-ILLSGVPPFWAET 300
RDI YY APE L R Y + DVWS GV+L+ I G P+
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298
Query: 301 EKGIFDAILKGG 312
+ +F + +G
Sbjct: 299 VEELFKLLKEGH 310
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-17
Identities = 18/77 (23%), Positives = 37/77 (48%), Gaps = 3/77 (3%)
Query: 372 RMKQFRAMNKLKKMAL---KVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLAR 428
+ +Q ++++ K L K ++ +++G K + D + +G I LK L +
Sbjct: 1 KAQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60
Query: 429 LGSKLSETEVKQLMDAV 445
LG + E+K+L+ V
Sbjct: 61 LGVPKTHLELKKLIGEV 77
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 15/226 (6%)
Query: 97 TLGKELGRGQFGITY---LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
L ++LG G FG+ + S A K + L + +D RE+ M L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCH 212
+N++ G + +V EL G L D++ QGH+ + + + +
Sbjct: 80 HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KVYRDIVGSAYYV---APEV 268
+HRDL N LL+ +D ++K DFGL + + Y APE
Sbjct: 139 SKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 269 LR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
L+ R++ D W GV L+ + + G P+ I I K G
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 46/291 (15%)
Query: 41 YQQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGK 100
Y + + Q P ++ T + + T K
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEI---------HPSCV----TRQK 50
Query: 101 ELGRGQFGITYLCTENSTGNSY----ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
+G G+FG Y ++ A K++ + ++ R D E IM S N
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFS-HHN 107
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMG 215
I+ G + + ++ E G L + G ++ + R I + + M
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV----------A 265
+HRDL N L+++ + K +DFGLS + D + Y A
Sbjct: 168 YVHRDLAARNILVNSNL---VCKVSDFGLSRVL------EDDPEATYTTSGGKIPIRWTA 218
Query: 266 PEVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
PE + SY K DVWS G++++ +++ G P+W + + AI G
Sbjct: 219 PEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF 267
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 6e-17
Identities = 15/56 (26%), Positives = 33/56 (58%), Gaps = 1/56 (1%)
Query: 391 AEALSEEEIKGLKTMFANMDT-DKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
LS ++K L+T F + +T + SG ++ +++ L LG + +++ ++QL+D
Sbjct: 4 VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEF 59
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-06
Identities = 14/61 (22%), Positives = 29/61 (47%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
A + E E+ + L+ F D + +G I+ + ++ LA L LS ++ ++D
Sbjct: 76 GARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDE 135
Query: 445 V 445
+
Sbjct: 136 I 136
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 60/267 (22%), Positives = 103/267 (38%), Gaps = 40/267 (14%)
Query: 61 PQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGN 120
+S T+ + K + P E + L +LG+G FG ++ T N T
Sbjct: 157 CHRLTTVCPTSKPQTQGLAKDAWEI--PRESL----RLEVKLGQGCFGEVWMGTWNGTTR 210
Query: 121 SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGG 180
A K+ LK E +E Q+M+ L + +V+ + +++V E S G
Sbjct: 211 V-AIKT-LKP---GTMSPEAFLQEAQVMKKLR-HEKLVQLYAVV-SEEPIYIVTEYMSKG 263
Query: 181 ELFDKIIAQGHYTEKAAAAL--CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238
L D + + + + I + + + M +HRDL+ N L+ + K
Sbjct: 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL---VCK 320
Query: 239 ATDFGLSVFIDEGKVYRDIVGSAYYV-----------APEVLR-RSYGKEIDVWSAGVIL 286
DFGL+ R I + Y APE + + DVWS G++L
Sbjct: 321 VADFGLA---------RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 287 YILLS-GVPPFWAETEKGIFDAILKGG 312
L + G P+ + + D + +G
Sbjct: 372 TELTTKGRVPYPGMVNREVLDQVERGY 398
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 8e-17
Identities = 11/50 (22%), Positives = 26/50 (52%)
Query: 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
++++ K F D++++G IT E L+T L + G ++ ++ +
Sbjct: 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEA 51
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 6e-06
Identities = 13/61 (21%), Positives = 25/61 (40%), Gaps = 3/61 (4%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
M + + + SE+ ++ F D + +G I L+ L LG +L E + +
Sbjct: 67 MMGRRMKQTTSEDILR---QAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGI 123
Query: 445 V 445
Sbjct: 124 T 124
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 58/262 (22%), Positives = 103/262 (39%), Gaps = 33/262 (12%)
Query: 73 TSTRPVQKPETVLGKPLEDIRQFY--------TLGKELGRGQFGITYLCTENSTGNSY-- 122
R P T P + + +F ++ K +G G+FG
Sbjct: 17 PGLRTFVDPHTF-EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 123 -ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGE 181
A K++ + ++ R D E IM NI+ G + V +V E G
Sbjct: 76 VAIKTL--KVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGS 132
Query: 182 LFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF---MGVMHRDLKPENFLLSNKDGGAMLK 238
L + + H + L + + + MG +HRDL N L+++ + K
Sbjct: 133 LDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL---VCK 187
Query: 239 ATDFGLSVFI-DEGKVYRDIVGSAYYV---APEVLRRSYGK---EIDVWSAGVILYILLS 291
+DFGL + D+ + G + +PE + +Y K DVWS G++L+ ++S
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMS 245
Query: 292 -GVPPFWAETEKGIFDAILKGG 312
G P+W + + + A+ +G
Sbjct: 246 YGERPYWEMSNQDVIKAVDEGY 267
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 54/263 (20%), Positives = 101/263 (38%), Gaps = 58/263 (22%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSY-----ACKSILKRKLVNKQDREDIK 142
L + +ELG +FG Y A K++ + RE+ +
Sbjct: 7 SLSAV----RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFR 60
Query: 143 REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCR 202
E + L N+V G Q + ++ CS G+L + ++ + +++ + R
Sbjct: 61 HEAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 203 AIVNVVHHCHFMGV-------M---------HRDLKPENFLLSNKDGGAMLKATDFGLSV 246
+ + + F+ + M H+DL N L+ +K +K +D GL
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL---NVKISDLGLF- 175
Query: 247 FIDEGKVYRDIVGSAYYV------------APEVLRRSYGK---EIDVWSAGVILYILLS 291
R++ + YY APE + YGK + D+WS GV+L+ + S
Sbjct: 176 --------REVYAADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFS 225
Query: 292 -GVPPFWAETEKGIFDAILKGGV 313
G+ P+ + + + + I V
Sbjct: 226 YGLQPYCGYSNQDVVEMIRNRQV 248
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 54/237 (22%), Positives = 91/237 (38%), Gaps = 36/237 (15%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSY---ACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
+ +G+G FG+ Y + A KS L ++ Q E RE +M+ L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LS-RITEMQQVEAFLREGLLMRGLN- 80
Query: 154 QQNIVEFRGAYEDRQSVHL-VMELCSGGELFDKIIAQGHY-TEKAAAALCRAIVNVVHHC 211
N++ G + + ++ G+L I + T K + + + +
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV------- 264
+HRDL N +L +K DFGL+ RDI+ YY
Sbjct: 141 AEQKFVHRDLAARNCMLDESF---TVKVADFGLA---------RDILDREYYSVQQHRHA 188
Query: 265 -------APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
A E L+ + + DVWS GV+L+ LL+ G PP+ + + +G
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 60/235 (25%), Positives = 92/235 (39%), Gaps = 37/235 (15%)
Query: 97 TLGKELGRGQFGITY---LCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
LG+ +G GQFG + + + + A K+ + + RE +E M+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFD- 74
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
+IV+ G V ++MELC+ GEL + Q A+L + +
Sbjct: 75 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 214 ---MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV------ 264
+HRD+ N L+S+ D +K DFGLS R + S YY
Sbjct: 132 LESKRFVHRDIAARNVLVSSND---CVKLGDFGLS---------RYMEDSTYYKASKGKL 179
Query: 265 -----APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
APE + R + DVW GV ++ +L GV PF + I G
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 54/226 (23%), Positives = 84/226 (37%), Gaps = 49/226 (21%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSY-----ACKSILKRKLVNKQDREDIKREIQIMQHL 151
LGK LGRG FG + A K + ++ + + E++I+ H+
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 87
Query: 152 SGQQNIVEFRGA-YEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
N+V GA + + +++E C G L + ++ + A + +
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 211 CHF----------------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY 254
H +HRDL N LLS ++K DFGL+
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE---KNVVKICDFGLA--------- 195
Query: 255 RDIVGSAYYV------------APEVLR-RSYGKEIDVWSAGVILY 287
RDI YV APE + R Y + DVWS GV+L+
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 59/263 (22%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSY-----ACKSILKRKLVNKQDREDIK 142
DI L +ELG G FG +L + + A K++ K R+D +
Sbjct: 13 KRRDI----VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQ 65
Query: 143 REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCR 202
RE +++ +L ++IV+F G D + +V E G+L + A G R
Sbjct: 66 REAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 203 AIVNVVHHCHFMGVM----------------HRDLKPENFLLSNKDGGAMLKATDFGLSV 246
+ + + HRDL N L+ ++K DFG+S
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS- 180
Query: 247 FIDEGKVYRDIVGSAYYV------------APEVLRRSYGK---EIDVWSAGVILYILLS 291
RD+ + YY PE + Y K E DVWS GVIL+ + +
Sbjct: 181 --------RDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFT 230
Query: 292 -GVPPFWAETEKGIFDAILKGGV 313
G P++ + + + I +G V
Sbjct: 231 YGKQPWFQLSNTEVIECITQGRV 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 61/230 (26%), Positives = 91/230 (39%), Gaps = 25/230 (10%)
Query: 97 TLGK-ELGRGQFGITYLCTENSTGNSY--ACKSILKRKLVNKQDREDIKREIQIMQHLSG 153
+ ELG G FG A K + ++ K D E++ RE QIM L
Sbjct: 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD- 68
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
IV G + +++ LVME+ GG L + G E + + + V +
Sbjct: 69 NPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKY 125
Query: 214 ---MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-VYRDIVGSAYYV---AP 266
+HRDL N LL N+ K +DFGLS + Y + + AP
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 267 EVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
E + ++ K DVWS GV ++ LS G P+ + I +G
Sbjct: 183 ECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 57/231 (24%), Positives = 87/231 (37%), Gaps = 53/231 (22%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSI----LKRKLVNKQDREDIKREIQIMQHLS 152
GK LG G FG T + + LK + + +RE + E+++M L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLG 106
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFD-------KIIAQGHYTEKAAAALCRAIV 205
+NIV GA ++L+ E C G+L + K E +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 206 NVVHHCHF----------------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249
NV+ +HRDL N L+++ G ++K DFGL+
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH---GKVVKICDFGLA---- 219
Query: 250 EGKVYRDIVGSAYYV------------APEVLR-RSYGKEIDVWSAGVILY 287
RDI+ + YV APE L Y + DVWS G++L+
Sbjct: 220 -----RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 74.4 bits (184), Expect = 3e-16
Identities = 23/55 (41%), Positives = 33/55 (60%)
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
AE L+EE+I K FA D D GTIT +EL T + LG +E E++ +++ V
Sbjct: 1 AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 55
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 45.9 bits (110), Expect = 3e-06
Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 6/62 (9%)
Query: 385 MALKVIAEALSEEEI-KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
MA K + E SEEE+ + K +F D D +G I+ EL+ + LG KL++ EV +++
Sbjct: 72 MARK-MKEQDSEEELIEAFK-VF---DRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIR 126
Query: 444 AV 445
Sbjct: 127 EA 128
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 60/262 (22%), Positives = 103/262 (39%), Gaps = 40/262 (15%)
Query: 66 QPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACK 125
+S T+ + K + P E + L +LG+G FG ++ T N T A K
Sbjct: 245 TVCPTSKPQTQGLAKDAWEI--PRESL----RLEVKLGQGCFGEVWMGTWNGTTRV-AIK 297
Query: 126 SILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDK 185
+ LK E +E Q+M+ L + +V+ + +++V E S G L D
Sbjct: 298 T-LKP---GTMSPEAFLQEAQVMKKLR-HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDF 351
Query: 186 IIAQGHYTEKAAAAL--CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243
+ + + + I + + + M +HRDL+ N L+ + K DFG
Sbjct: 352 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL---VCKVADFG 408
Query: 244 LSVFIDEGKVYRDIVGSAYYV-----------APEVLR-RSYGKEIDVWSAGVILYILLS 291
L+ R I + Y APE + + DVWS G++L L +
Sbjct: 409 LA---------RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
Query: 292 -GVPPFWAETEKGIFDAILKGG 312
G P+ + + D + +G
Sbjct: 460 KGRVPYPGMVNREVLDQVERGY 481
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 58/248 (23%), Positives = 88/248 (35%), Gaps = 35/248 (14%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSY--ACKSILKRKLVNKQDREDIKREI 145
DI +G G FG G A K +K + +K D D E+
Sbjct: 23 DWNDI----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MK-EYASKDDHRDFAGEL 76
Query: 146 QIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIV 205
+++ L NI+ GA E R ++L +E G L D + A A+ +
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 206 NVVHHCHF----------------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249
+ + +HRDL N L+ + K DFGLS +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE---NYVAKIADFGLSRGQE 193
Query: 250 EGKVYRDIVGSAYYV---APEVLR-RSYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGI 304
Y V A E L Y DVWS GV+L+ I+ G P+ T +
Sbjct: 194 V---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
Query: 305 FDAILKGG 312
++ + +G
Sbjct: 251 YEKLPQGY 258
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 34/231 (14%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
L K+LG GQFG ++ T N A K+ +K E E +M+ L
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKV-AVKT-MKP---GSMSVEAFLAEANVMKTLQ-HDK 244
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFD--KIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
+V+ ++ ++++ E + G L D K I +
Sbjct: 245 LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---------- 264
+HRDL+ N L+S + K DFGL+ R I + Y
Sbjct: 304 NYIHRDLRAANILVSASL---VCKIADFGLA---------RVIEDNEYTAREGAKFPIKW 351
Query: 265 -APEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
APE + S+ + DVWS G++L +++ G P+ + + A+ +G
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 7e-16
Identities = 13/61 (21%), Positives = 31/61 (50%)
Query: 386 ALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
A + L +++I+ +K F+ +D D+ G ++ E++K +LG + E+ ++
Sbjct: 4 AASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEA 63
Query: 446 S 446
Sbjct: 64 P 64
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 7e-06
Identities = 21/122 (17%), Positives = 45/122 (36%), Gaps = 27/122 (22%)
Query: 326 SAKDL--VRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLK 383
S +D+ + + L + P E+ ++E P+ F ++
Sbjct: 36 SKEDIKAISEQLGRAPDD----KELTAM--LKEA----PGPLN------FTMFLSI---- 75
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+ K ++ SEE I+ MF D ++ + E +K L +G ++ E++
Sbjct: 76 -FSDK-LSGTDSEETIRNAFAMF---DEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFK 130
Query: 444 AV 445
Sbjct: 131 EA 132
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 58/259 (22%), Positives = 105/259 (40%), Gaps = 42/259 (16%)
Query: 67 PMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKS 126
M+ + + + L ++++ L + +G+G+FG L GN A K
Sbjct: 172 VMEGTVAAQDEFYRSGWAL--NMKEL----KLLQTIGKGEFGDVMLGDYR--GNKVAVKC 223
Query: 127 ILKRKLVNKQD--REDIKREIQIMQHLSGQQNIVEFRGA-YEDRQSVHLVMELCSGGELF 183
I K D + E +M L N+V+ G E++ +++V E + G L
Sbjct: 224 I-------KNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 184 DKIIAQGHYTEKAAAAL--CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241
D + ++G L + + + +HRDL N L+S + + K +D
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSD 332
Query: 242 FGLSVFIDEGKVYRDIVGSAYYV-------APEVLR-RSYGKEIDVWSAGVILYILLS-G 292
FGL+ ++ + APE LR + + + DVWS G++L+ + S G
Sbjct: 333 FGLT---------KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 383
Query: 293 VPPFWAETEKGIFDAILKG 311
P+ K + + KG
Sbjct: 384 RVPYPRIPLKDVVPRVEKG 402
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 56/317 (17%), Positives = 104/317 (32%), Gaps = 70/317 (22%)
Query: 42 QQQQQQQLHVQPPKMSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKE 101
+ L P ++ + P + + E P +I ++
Sbjct: 3 MESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEY----PRNNI----EYVRD 54
Query: 102 LGRGQFGITYLCT-ENSTGNSY----ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
+G G FG + A K + ++ + + D +RE +M N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFD-NPN 111
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGEL--------FDKIIAQGHYTEKAAAALCRAIVNVV 208
IV+ G + + L+ E + G+L + + H A + +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 209 HHCHFMGVM----------------HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252
+ + HRDL N L+ ++K DFGLS
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE---NMVVKIADFGLS------- 221
Query: 253 VYRDIVGSAYYV------------APEVLRRSYGK---EIDVWSAGVILYILLS-GVPPF 296
R+I + YY PE + Y + E DVW+ GV+L+ + S G+ P+
Sbjct: 222 --RNIYSADYYKADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 297 WAETEKGIFDAILKGGV 313
+ + + + G +
Sbjct: 278 YGMAHEEVIYYVRDGNI 294
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 66/289 (22%), Positives = 113/289 (39%), Gaps = 57/289 (19%)
Query: 64 RQQPMKSSATSTRP--VQKPETVLGKPLEDI-RQFYTLGKELGRGQFGITYLCTENSTGN 120
P + + + ++ P+ + I R+ L ELG G FG +L ++
Sbjct: 8 SLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLP 67
Query: 121 SY-----ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175
A K++ K ++ R+D +RE +++ L Q+IV F G + + + +V E
Sbjct: 68 EQDKMLVAVKAL---KEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRPLLMVFE 123
Query: 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH------------CHF---MGVMHRD 220
G+L + + G + A A + + + +HRD
Sbjct: 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD 183
Query: 221 LKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV------------APEV 268
L N L+ G ++K DFG+S RDI + YY PE
Sbjct: 184 LATRNCLVGQ---GLVVKIGDFGMS---------RDIYSTDYYRVGGRTMLPIRWMPPES 231
Query: 269 LRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGV 313
+ Y K E DVWS GV+L+ + + G P++ + D I +G
Sbjct: 232 IL--YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 278
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 55/233 (23%), Positives = 88/233 (37%), Gaps = 38/233 (16%)
Query: 97 TLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN 156
L + LG GQFG ++ N A KS LK + E +M+ L Q
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHT-KVAVKS-LK---QGSMSPDAFLAEANLMKQLQ-HQR 69
Query: 157 IVEFRGAYEDRQSVHLVMELCSGGELFD--KIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
+V ++ ++++ E G L D K + T + I +
Sbjct: 70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV---------- 264
+HRDL+ N L+S+ K DFGL+ R I + Y
Sbjct: 129 NYIHRDLRAANILVSDTL---SCKIADFGLA---------RLIEDNEYTAREGAKFPIKW 176
Query: 265 -APEVLRRSYGK---EIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGG 312
APE + YG + DVWS G++L +++ G P+ T + + +G
Sbjct: 177 TAPEAIN--YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 58/260 (22%), Positives = 100/260 (38%), Gaps = 46/260 (17%)
Query: 68 MKSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSI 127
M S + + L ++++ L + +G+G+FG L GN A K I
Sbjct: 1 MGGSVAAQDEFYRSGWAL--NMKEL----KLLQTIGKGEFGDVMLGDYR--GNKVAVKCI 52
Query: 128 LKRKLVNKQD--REDIKREIQIMQHLSGQQNIVEFRGA-YEDRQSVHLVMELCSGGELFD 184
K D + E +M L N+V+ G E++ +++V E + G L D
Sbjct: 53 -------KNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 104
Query: 185 --KIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242
+ + + + + +HRDL N L+S + + K +DF
Sbjct: 105 YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN---VAKVSDF 161
Query: 243 GLSVFIDEGKVYRDIVGSAYYV-------APEVLRRSYGK---EIDVWSAGVILYILLS- 291
GL+ ++ + APE LR K + DVWS G++L+ + S
Sbjct: 162 GLT---------KEASSTQDTGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYSF 210
Query: 292 GVPPFWAETEKGIFDAILKG 311
G P+ K + + KG
Sbjct: 211 GRVPYPRIPLKDVVPRVEKG 230
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 40/223 (17%), Positives = 85/223 (38%), Gaps = 40/223 (17%)
Query: 56 MSAPQPQPRQQPMKSSATSTRPVQKPETVLGKPLEDI-RQFYTLGKELGRGQFGITYLCT 114
M Q + +SSA Q G+ + D+ + +G +G+G FG YL
Sbjct: 2 MRVKAAQAGR---QSSAKRHLAEQFAV---GEIITDMAAAAWKVGLPIGQGGFGCIYLAD 55
Query: 115 ENSTGNSYA-CKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR------------ 161
NS+ + + ++K V D + E++ Q + + I ++
Sbjct: 56 MNSSESVGSDAPCVVK---VEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112
Query: 162 ----GAYEDRQSVH--LVMEL--CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
G ++ + ++M+ ++++ ++ K L I++++ + H
Sbjct: 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHE 170
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD 256
+H D+K N LL+ K+ + D+GL+ Y
Sbjct: 171 HEYVHGDIKASNLLLNYKN-PDQVYLVDYGLA------YRYCP 206
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 4e-15
Identities = 8/44 (18%), Positives = 25/44 (56%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ +F +D + G ++YEE+K +++ + +E ++ + ++
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 38.7 bits (91), Expect = 6e-04
Identities = 10/61 (16%), Positives = 21/61 (34%), Gaps = 3/61 (4%)
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
K + +E+ L+ +F ++D D +G I E + + + L
Sbjct: 23 KAFVSKKRAIKNEQL---LQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKV 79
Query: 444 A 444
Sbjct: 80 L 80
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 6e-15
Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 5/86 (5%)
Query: 363 KPIGSAVLS--RMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTD--KSGTIT 418
K + ++VL + ++ L L S EI+ L +F + + G I
Sbjct: 9 KHLCTSVLGCFDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLIN 68
Query: 419 YEELKTGLARLGSKLSETEVKQLMDA 444
EE + L + K S ++ D
Sbjct: 69 KEEFQLALFKTNKKESL-FADRVFDL 93
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-15
Identities = 8/44 (18%), Positives = 25/44 (56%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ +F +D + G ++YEE+K +++ + +E ++ + ++
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 8e-06
Identities = 8/46 (17%), Positives = 18/46 (39%), Gaps = 3/46 (6%)
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL 429
K + +E+ ++ +F ++D D +G I E +
Sbjct: 23 KAFVSKKRAIKNEQLLQ---LIFKSIDADGNGEIDQNEFAKFYGSI 65
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 57/269 (21%), Positives = 101/269 (37%), Gaps = 62/269 (23%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCT-ENSTGNSY----ACKSILKRKLVNKQDREDIK 142
P +++ LGK LG G+FG T + G + A K + ++ + + D+
Sbjct: 21 PRKNL----VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLL 74
Query: 143 REIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGEL-----------FDKIIAQGH 191
E +++ + ++++ GA + L++E G L + + G
Sbjct: 75 SEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 192 YTEKAAAALCRAIVNVVHHCHF-------------MGVMHRDLKPENFLLSNKDGGAMLK 238
+ + + F M ++HRDL N L++ G +K
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE---GRKMK 190
Query: 239 ATDFGLSVFIDEGKVYRDIVGSAYYV------------APEVLR-RSYGKEIDVWSAGVI 285
+DFGLS RD+ YV A E L Y + DVWS GV+
Sbjct: 191 ISDFGLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 286 LY-ILLSGVPPFWAETEKGIFDAILKGGV 313
L+ I+ G P+ + +F+ + G
Sbjct: 242 LWEIVTLGGNPYPGIPPERLFNLLKTGHR 270
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 14/60 (23%), Positives = 27/60 (45%), Gaps = 2/60 (3%)
Query: 388 KVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSET--EVKQLMDAV 445
+ E L + + L F D D G + +E+ R+ ++ T +V+++ DAV
Sbjct: 24 QFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAV 83
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 9/68 (13%), Positives = 20/68 (29%), Gaps = 2/68 (2%)
Query: 378 AMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE 437
A + + + + +D D GT+ +ELKT + + +
Sbjct: 106 ANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEA 163
Query: 438 VKQLMDAV 445
+
Sbjct: 164 AYTFFEKA 171
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-14
Identities = 16/83 (19%), Positives = 33/83 (39%), Gaps = 5/83 (6%)
Query: 368 AVLSRMKQFRAMNKLKKMALKVIAEA--LSEEEIKGLKTMFANMDTD--KSGTITYEELK 423
+S+ K+ AM +++A + EE++ L +F + + G I EE +
Sbjct: 3 CSVSKKKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQ 62
Query: 424 TGLARLGSKLSETEVKQLMDAVS 446
L R ++ ++ D
Sbjct: 63 LALFRNRNR-RNLFADRIFDVFD 84
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-14
Identities = 15/56 (26%), Positives = 29/56 (51%), Gaps = 1/56 (1%)
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+A + ++I + +F DT+ G I+ EL L LG ++ EV+++M +
Sbjct: 1 MAAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEI 55
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 13/100 (13%), Positives = 36/100 (36%), Gaps = 3/100 (3%)
Query: 343 ITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGL 402
+ VL + + G + + +V ++ ++ + + L +++E++ L
Sbjct: 11 VLIVIVLFVKLLEQFG-LIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQIL 69
Query: 403 KTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
F + SG + E K ++ + T +
Sbjct: 70 YRGF--KNECPSGVVNEETFKEIYSQFFPQGDSTTYAHFL 107
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 1/64 (1%)
Query: 366 GSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGL-KTMFANMDTDKSGTITYEELKT 424
+++ + M + M K L E+ + +T F MD +K G +T +E
Sbjct: 151 KDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIE 210
Query: 425 GLAR 428
+
Sbjct: 211 SCQK 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 30/211 (14%), Positives = 65/211 (30%), Gaps = 31/211 (14%)
Query: 65 QQPMKSSATSTRPVQKPETVLGKPLEDIR-QFYTLGKELGRGQFGITYLCTENSTGNSYA 123
+ + + +T P G L D + + L R GI Y ST +
Sbjct: 15 TENLYFQSMTTSLEALPT---GTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDS 71
Query: 124 CKS----ILKRKLVNKQ--------DREDIKREIQIMQHLSGQQNI----VEFRGAYEDR 167
LK + + R ++ + L + G ++D+
Sbjct: 72 GPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK 131
Query: 168 QSVHLVMEL--CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPEN 225
LV+ S D + +E++ + +++ + H +H ++ EN
Sbjct: 132 YRF-LVLPSLGRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189
Query: 226 FLLSNKDGGAMLKATDFGLSVFIDEGKVYRD 256
+ +D + + +G + Y
Sbjct: 190 IFVDPED-QSQVTLAGYGFA------FRYCP 213
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-13
Identities = 20/68 (29%), Positives = 31/68 (45%), Gaps = 4/68 (5%)
Query: 378 AMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE 437
+M + A LSEE I K F D D G I+ +EL T + LG ++ E
Sbjct: 2 SMTDQQAEARAF----LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEE 57
Query: 438 VKQLMDAV 445
+ +++ V
Sbjct: 58 LDAIIEEV 65
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-13
Identities = 15/66 (22%), Positives = 27/66 (40%), Gaps = 3/66 (4%)
Query: 383 KKMALKVIAEALSE---EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVK 439
A + I L + + F N DT K+ TI+ EE + R L++ +
Sbjct: 4 MATADRDILARLHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFD 63
Query: 440 QLMDAV 445
+L + +
Sbjct: 64 RLWNEM 69
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105 | Back alignment and structure |
|---|
Score = 38.2 bits (89), Expect = 6e-04
Identities = 10/92 (10%), Positives = 29/92 (31%), Gaps = 21/92 (22%)
Query: 339 PKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLK---------KMALKV 389
P ++L + + + I ++F + +K +
Sbjct: 2 PHMATADRDILAR--LHKAVTSHYHAI-------TQEFENFDTMKTNTISREEFRAICNR 52
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEE 421
+ L++E+ ++ M + G + Y +
Sbjct: 53 RVQILTDEQFD---RLWNEMPVNAKGRLKYPD 81
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-13
Identities = 15/53 (28%), Positives = 23/53 (43%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
A + + L F +DTD SG I+ EL L+ G S ++L+
Sbjct: 20 ARHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMY 72
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 11/48 (22%), Positives = 20/48 (41%)
Query: 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446
I ++ F D+ G + E++ L G ++SE + LM
Sbjct: 92 ILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFD 139
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 9e-13
Identities = 13/55 (23%), Positives = 22/55 (40%)
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
+ E EI+ K F +D + G I ++L+ A +G + E M
Sbjct: 15 VFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIK 69
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 15/61 (24%), Positives = 24/61 (39%), Gaps = 4/61 (6%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
K + A E+ I F +D D G+I L+ L G + + E+K + A
Sbjct: 84 FGEK-LKGADPEDVIM---GAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAA 139
Query: 445 V 445
Sbjct: 140 F 140
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-12
Identities = 16/74 (21%), Positives = 32/74 (43%)
Query: 372 RMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS 431
+ ++ +NK K + +++ K + D + +G I LK L +LG
Sbjct: 20 QEERLEGINKQFLDDPKYSNDEDLPSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGV 79
Query: 432 KLSETEVKQLMDAV 445
+ E+K+L+ V
Sbjct: 80 PKTHLELKRLIREV 93
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 16/53 (30%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLG--SKLSETEVKQLMDAV 445
S+ ++ +KT F +D DK G IT + ++ R S++ K LMD++
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSL 53
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 13/62 (20%), Positives = 27/62 (43%), Gaps = 3/62 (4%)
Query: 385 MALKVIAEALSEEEIKG-LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+++ ++ ++G L F +DT++ I+ +E LG L +T D
Sbjct: 78 SMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFD 135
Query: 444 AV 445
A+
Sbjct: 136 AI 137
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-12
Identities = 11/65 (16%), Positives = 26/65 (40%), Gaps = 5/65 (7%)
Query: 386 ALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEEL-----KTGLARLGSKLSETEVKQ 440
K+ ++ + I K MF +D + +G I+ +E+ + LG+ + + +
Sbjct: 2 NSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHK 61
Query: 441 LMDAV 445
Sbjct: 62 DAVEA 66
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 14/68 (20%), Positives = 24/68 (35%)
Query: 378 AMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE 437
KL L+ A+ +F +D D++G IT +E K G S +
Sbjct: 87 GWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSED 146
Query: 438 VKQLMDAV 445
++
Sbjct: 147 CEETFRVC 154
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-12
Identities = 16/83 (19%), Positives = 30/83 (36%), Gaps = 11/83 (13%)
Query: 374 KQFRAMNKLKKMALKVIAEA-----------LSEEEIKGLKTMFANMDTDKSGTITYEEL 422
K F + ++ L I E++ K + D + G I L
Sbjct: 13 KAFGILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSL 72
Query: 423 KTGLARLGSKLSETEVKQLMDAV 445
K + +LG + E+K+++ V
Sbjct: 73 KRMMEKLGVPKTHLEMKKMISEV 95
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 2e-12
Identities = 12/53 (22%), Positives = 25/53 (47%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446
+ +I+ K F +D ++ G I E+L LA +G ++ ++ +M
Sbjct: 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSEAP 53
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 6e-06
Identities = 13/61 (21%), Positives = 25/61 (40%), Gaps = 4/61 (6%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
K + E+ I+ F D + SG I + L+ L +G + ++ EV ++
Sbjct: 65 FGEK-LNGTDPEDVIRNAFACF---DEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYRE 120
Query: 445 V 445
Sbjct: 121 A 121
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-11
Identities = 14/50 (28%), Positives = 24/50 (48%), Gaps = 4/50 (8%)
Query: 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+EIK L F +D D SG+++ EE + L V++++D
Sbjct: 2 ADEIKRLGKRFKKLDLDNSGSLSVEEFMS----LPELQQNPLVQRVIDIF 47
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 5e-11
Identities = 6/44 (13%), Positives = 19/44 (43%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
K +F D +K G ++ +E + ++ ++ + + +
Sbjct: 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67 | Back alignment and structure |
|---|
Score = 37.1 bits (87), Expect = 6e-04
Identities = 7/38 (18%), Positives = 16/38 (42%), Gaps = 3/38 (7%)
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEE 421
+ + ++E+I F +D D +G + +E
Sbjct: 24 REVALAFSPYFTQEDIV---KFFEEIDVDGNGELNADE 58
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-11
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 16/95 (16%)
Query: 360 ASDKPIGSAVLSRMKQFRAMNK------LKKMALKVIAEALSEEEIKGLKTMFANMDTDK 413
A D + + +A + LK A+S + +K +F +D D
Sbjct: 3 AKDLLKADDIKKALDAVKAEGSFNHKKFFALVGLK----AMSAND---VKKVFKAIDADA 55
Query: 414 SGTITYEELKTGLARL---GSKLSETEVKQLMDAV 445
SG I EELK L G L++ E K + A
Sbjct: 56 SGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAA 90
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 10/46 (21%), Positives = 19/46 (41%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEV 438
A + + G ++ + D D +G I +EL + KL +
Sbjct: 4 AFANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDK 49
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-10
Identities = 8/53 (15%), Positives = 18/53 (33%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446
EE++ + G I+ + +LG S + K++ +
Sbjct: 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYG 61
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-06
Identities = 14/51 (27%), Positives = 26/51 (50%), Gaps = 3/51 (5%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ EE+ MFA+ D + +G +T ++K L G L++ E ++A
Sbjct: 82 NVEELI---KMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF 129
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-10
Identities = 11/50 (22%), Positives = 23/50 (46%), Gaps = 1/50 (2%)
Query: 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLG-SKLSETEVKQLMDAV 445
+ L +F +D D+SG I+ EL+ L+ + + V+ ++
Sbjct: 4 PDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMF 53
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 15/45 (33%), Positives = 21/45 (46%)
Query: 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
I + +F D D SG I ELK L+ G +LS+ L+
Sbjct: 73 ITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIR 117
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-10
Identities = 9/67 (13%), Positives = 23/67 (34%), Gaps = 2/67 (2%)
Query: 380 NKLKKMALKVIAEALSEEEIKGLKTMFAN-MDTDKSGTITYEELKTGLARLGSKLSETEV 438
+ + A+ + L+ + ++ SGT+ E K ++ + V
Sbjct: 3 QQFSWEEAEEN-GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYV 61
Query: 439 KQLMDAV 445
+ + A
Sbjct: 62 EAMFRAF 68
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-10
Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 3/64 (4%)
Query: 383 KKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLG-SKLSETEVKQL 441
++ +A+ +E F M SG T E KT L G ++ + + Q+
Sbjct: 5 NGKSIAGDQKAVPTQETHVWYRTF--MMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQV 62
Query: 442 MDAV 445
+
Sbjct: 63 YNTF 66
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-10
Identities = 12/58 (20%), Positives = 24/58 (41%), Gaps = 2/58 (3%)
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS--KLSETEVKQLMDAV 445
I E+ ++ +KT +D G I+ E+ + R+ KLS + ++
Sbjct: 4 ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEF 61
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 12/63 (19%), Positives = 26/63 (41%), Gaps = 2/63 (3%)
Query: 385 MALKVIAEALSEEEIKG--LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
++ E+ + M+ +DTDK G ++ E K L +G L++ +
Sbjct: 85 ATDSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCF 144
Query: 443 DAV 445
+ +
Sbjct: 145 NTL 147
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 10/46 (21%), Positives = 22/46 (47%), Gaps = 3/46 (6%)
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL 429
K L+ + L++++ T F +D +K+G I+ +E +
Sbjct: 125 KAFLQAVGPDLTDDK---AITCFNTLDFNKNGQISRDEFLVTVNDF 167
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 7e-10
Identities = 15/72 (20%), Positives = 34/72 (47%), Gaps = 6/72 (8%)
Query: 377 RAMNKLKKMALKVIAEA--LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLS 434
RA L+ L+ I + S +I L + F ++D ++GT++ E+ + + L
Sbjct: 4 RASTLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIPELAINPLG 63
Query: 435 ETEVKQLMDAVS 446
+ ++++A
Sbjct: 64 D----RIINAFF 71
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 7e-04
Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 2/74 (2%)
Query: 373 MKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGL-ARLGS 431
+ FR + +K E L+ K L F D DK I+ +EL L +G
Sbjct: 87 LAHFRPIEDNEKSKDVNGPEPLNSRSNK-LHFAFRLYDLDKDDKISRDELLQVLRMMVGV 145
Query: 432 KLSETEVKQLMDAV 445
+S+ ++ + D
Sbjct: 146 NISDEQLGSIADRT 159
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 29/143 (20%), Positives = 54/143 (37%), Gaps = 12/143 (8%)
Query: 97 TLGKELGRGQFGITYLCT-----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHL 151
LGK LGRG FG + +T + A K LK + + E++I+ H+
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGA-THSEHRALMSELKILIHI 82
Query: 152 SGQQNIVEFRGAY-EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
N+V GA + + +++E C G L + ++ +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP----YKTKGARFRQG 138
Query: 211 CHFMGVMHRDLKPENFLLSNKDG 233
++G + DLK +++
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQS 161
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 7e-06
Identities = 33/96 (34%), Positives = 41/96 (42%), Gaps = 26/96 (27%)
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYV--------- 264
+HRDL N LLS ++K DFGL+ RDI YV
Sbjct: 212 RKCIHRDLAARNILLSE---KNVVKICDFGLA---------RDIYKDPDYVRKGDARLPL 259
Query: 265 ---APEVLR-RSYGKEIDVWSAGVILY-ILLSGVPP 295
APE + R Y + DVWS GV+L+ I G P
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 11/54 (20%), Positives = 19/54 (35%), Gaps = 4/54 (7%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL----GSKLSETEVKQLMDA 444
+ LK F D D +G + + + + G EV+ L +A
Sbjct: 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNA 55
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-06
Identities = 11/54 (20%), Positives = 21/54 (38%), Gaps = 2/54 (3%)
Query: 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ + +K + D + G I +E L LG +S+ E + + V
Sbjct: 94 ASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQV 145
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-09
Identities = 9/71 (12%), Positives = 26/71 (36%), Gaps = 4/71 (5%)
Query: 377 RAMNKLKKMALKVIAEA--LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLS 434
++ +KL + L+ + + ++E++ F SG + E + +
Sbjct: 3 KSQSKLSQDQLQDLVRSTRFDKKELQQWYKGF--FKDCPSGHLNKSEFQKIYKQFFPFGD 60
Query: 435 ETEVKQLMDAV 445
+ + + V
Sbjct: 61 PSAFAEYVFNV 71
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 9e-04
Identities = 15/64 (23%), Positives = 29/64 (45%), Gaps = 1/64 (1%)
Query: 366 GSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGL-KTMFANMDTDKSGTITYEELKT 424
+ ++S + R ++ + KM ++ E+ + +F MD +K G +T EE
Sbjct: 112 NNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFCE 171
Query: 425 GLAR 428
G R
Sbjct: 172 GSKR 175
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 17/107 (15%), Positives = 42/107 (39%), Gaps = 8/107 (7%)
Query: 336 IQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALS 395
+ D +K+ + + G + P + + R+ + + M +
Sbjct: 1 MGDDEKKEKKKKSKKKAEEEGGDAPAAPPAPKPPSQKRRAQRSGSNVFAM--------FT 52
Query: 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
+ +++ K F +D DK G I+ +++ LG +E E+ ++
Sbjct: 53 QHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMV 99
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 9e-04
Identities = 18/63 (28%), Positives = 23/63 (36%), Gaps = 5/63 (7%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
+ IA E+ I F D + G E LK L G K S+ EV Q +
Sbjct: 115 FGDR-IAGTDEEDVIVN---AFNLFD-EGDGKCKEETLKRSLTTWGEKFSQDEVDQALSE 169
Query: 445 VSI 447
I
Sbjct: 170 API 172
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-08
Identities = 14/51 (27%), Positives = 25/51 (49%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ ++ L+ F D D G IT +EL+ +A LG L + E+ ++
Sbjct: 1 ARAGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREA 51
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-08
Identities = 10/52 (19%), Positives = 22/52 (42%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
++++++ K F D G I Y + + LG + EV +++
Sbjct: 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNP 55
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-06
Identities = 14/67 (20%), Positives = 28/67 (41%), Gaps = 8/67 (11%)
Query: 379 MNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEV 438
+ + K + E+ +F D + +G + EL+ L LG K++E EV
Sbjct: 74 LQAVAKNR-----GQGTYEDYLEGFRVF---DKEGNGKVMGAELRHVLTTLGEKMTEEEV 125
Query: 439 KQLMDAV 445
+ ++
Sbjct: 126 ETVLAGH 132
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 11/58 (18%), Positives = 21/58 (36%), Gaps = 6/58 (10%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSET------EVKQLMDAV 445
S ++ + D D SG + +EL+ + L + E+K +D
Sbjct: 10 SSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQY 67
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 25/113 (22%), Positives = 41/113 (36%), Gaps = 11/113 (9%)
Query: 333 KMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAM--NKLKKMALKVI 390
+ L+Q KK ++ + G+ D I + + + + + L
Sbjct: 43 QELLQARKKAGLELSPEMKTFVDQYGQRDDGKI------GIVELAHVLPTEENFLLLFRC 96
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+ S EE + DTD SG I EELK L L K ++T +
Sbjct: 97 QQLKSCEE---FMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLA 146
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 14/67 (20%), Positives = 21/67 (31%), Gaps = 3/67 (4%)
Query: 377 RAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSET 436
R + + LK + +E F D D +G I EL L L K +
Sbjct: 171 RLLPVQENFLLKFQGIKMCGKE---FNKAFELYDQDGNGYIDENELDALLKDLCEKNKQE 227
Query: 437 EVKQLMD 443
+
Sbjct: 228 LDINNIS 234
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 20/54 (37%), Positives = 32/54 (59%)
Query: 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ L+EE+I K F+ D D GTIT +EL T + LG +E E++ +++ V
Sbjct: 304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 357
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
MA K + + SEEEI+ +F D D +G I+ EL+ + LG KL++ EV +++
Sbjct: 374 MARK-MKDTDSEEEIREAFRVF---DKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 429
Query: 445 V 445
Sbjct: 430 A 430
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 7/61 (11%), Positives = 22/61 (36%), Gaps = 5/61 (8%)
Query: 389 VIAEALSEEEIKGLKTMFANM-DTDKSGTITYEELKTGLARL----GSKLSETEVKQLMD 443
+ A LS+ + + +F D + G I +++ + + ++ + +
Sbjct: 1 MAAHQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARA 60
Query: 444 A 444
Sbjct: 61 T 61
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 4e-06
Identities = 14/71 (19%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 375 QFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLS 434
++ M + + E+L E K + MF DT I E T G +
Sbjct: 85 EWLKMWA-ECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IP 141
Query: 435 ETEVKQLMDAV 445
+++ D +
Sbjct: 142 KSDCDAAFDTL 152
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 3e-08
Identities = 61/413 (14%), Positives = 123/413 (29%), Gaps = 120/413 (29%)
Query: 81 PETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRK---LVNKQD 137
P+++L K E+I + L ++ + +L+ L++
Sbjct: 42 PKSILSK--EEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK 99
Query: 138 REDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI-IAQGHYTEKA 196
E + + ++ DR L + ++F K +++ K
Sbjct: 100 TEQRQPSMMTRMYIE-----------QRDR--------LYNDNQVFAKYNVSRLQPYLKL 140
Query: 197 AAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD 256
AL L+P +L + G G + + V
Sbjct: 141 RQALLE------------------LRPAKNVLIDGVLG-------SGKTWVALD--VCLS 173
Query: 257 IVGSAYYVAPEVLRRSYGKEIDV-W-------SAGVILYILLSGVPPFWAETEKGIFDAI 308
+V + K + W S +L +L + D
Sbjct: 174 Y---------KVQCKMDFK---IFWLNLKNCNSPETVLEMLQK----LLYQ-----IDPN 212
Query: 309 LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSA 368
D S L I S + +R++L P + VL + + A + +
Sbjct: 213 WTSRSDHSSNIKLRI-HSIQAELRRLLKSKPYEN--CLLVLLNVQNAKAWNAFN--LSCK 267
Query: 369 VL--SRMKQ---FRAMNKLKKMALKVIAEALSEEEIKGL--K------------------ 403
+L +R KQ F + ++L + L+ +E+K L K
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 404 ---TMFANMDTDKSGTITY------EELKTGLARLGSKLSETEVKQLMDAVSI 447
++ A D T ++L T + + L E +++ D +S+
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-08
Identities = 20/75 (26%), Positives = 30/75 (40%), Gaps = 15/75 (20%)
Query: 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSK- 432
K F + L + ++ +K +F +D DKSG I EEL+ L S
Sbjct: 28 KSFFSTVGLSSK---------TPDQ---IKKVFGILDQDKSGFIEEEELQLFLKNFSSSA 75
Query: 433 --LSETEVKQLMDAV 445
L+ E K + A
Sbjct: 76 RVLTSAETKAFLAAG 90
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-08
Identities = 8/57 (14%), Positives = 23/57 (40%), Gaps = 9/57 (15%)
Query: 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSK--------LSETEVKQLMDAV 445
EE++ + +FA + D ++ EL L ++ ++ + ++ +
Sbjct: 1 EEVRQFRRLFAQLAGD-DMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVM 56
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-07
Identities = 13/48 (27%), Positives = 20/48 (41%)
Query: 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
IK + ++ D D+SGTI EL G L+E ++
Sbjct: 74 NNIKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRR 121
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 12/63 (19%), Positives = 26/63 (41%), Gaps = 4/63 (6%)
Query: 380 NKLKKMALKVIAEA--LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE 437
+KL+ ++ + E+ +E EI+ F + SG ++ EE K ++
Sbjct: 6 SKLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASK 63
Query: 438 VKQ 440
+
Sbjct: 64 FAE 66
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-08
Identities = 9/52 (17%), Positives = 17/52 (32%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
S+ K F D IT ++ LG + E+ +++
Sbjct: 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNP 53
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 31/123 (25%), Positives = 60/123 (48%), Gaps = 21/123 (17%)
Query: 326 SAKDL--VRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLK 383
+A + + + L Q+P AE+ + G S + + +A ++ ++F M +
Sbjct: 26 TASQVGDIARALGQNPTN----AEINKI-----LGNPSKEEMNAAAIT-FEEFLPMLQ-A 74
Query: 384 KMALKVIAEALSEEEI-KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
K + + E+ +GL+ +F D + +GT+ EL+ LA LG K++E EV++LM
Sbjct: 75 AANNK---DQGTFEDFVEGLR-VF---DKEGNGTVMGAELRHVLATLGEKMTEEEVEELM 127
Query: 443 DAV 445
Sbjct: 128 KGQ 130
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 6e-08
Identities = 16/52 (30%), Positives = 29/52 (55%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ + + LK F D D++G I+ EL+ + LG KL++ EV+Q++
Sbjct: 3 MDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEA 54
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-08
Identities = 7/49 (14%), Positives = 15/49 (30%)
Query: 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
E + + F D D +G I + + ++ A+
Sbjct: 1 EYERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQAL 49
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 15/71 (21%), Positives = 25/71 (35%), Gaps = 5/71 (7%)
Query: 375 QFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLS 434
+F K++ K + +E L DTD G +T + L G +
Sbjct: 76 EFVTGAV-KRLRDK--PDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFG--VP 130
Query: 435 ETEVKQLMDAV 445
E +Q A+
Sbjct: 131 EDLARQAAAAL 141
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 22/152 (14%), Positives = 43/152 (28%), Gaps = 41/152 (26%)
Query: 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE---HPWMREGGEASDKPIGSAVLSR 372
S+ LL L ++ I+ + R T ++ W+ + L
Sbjct: 10 ASDGNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCLIKWILSSAAPQGSDSSDSELEL 69
Query: 373 MKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANM----------------------- 409
L ++ + +++E++ L F N
Sbjct: 70 STVRHQPEGLDQLQAQ---TKFTKKELQSLYRGFKNECPTGLVDEDTFKLIYSQFFPQGD 126
Query: 410 ------------DTDKSGTITYEELKTGLARL 429
D D +G I +E+ GL+ L
Sbjct: 127 ATTYAHFLFNAFDADGNGAIHFEDFVVGLSIL 158
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-07
Identities = 21/75 (28%), Positives = 29/75 (38%), Gaps = 15/75 (20%)
Query: 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL---G 430
K F A L S ++ +K F +D DKSG I +ELK L
Sbjct: 28 KAFFAKVGLTAK---------SADD---IKKAFFVIDQDKSGFIEEDELKLFLQVFSAGA 75
Query: 431 SKLSETEVKQLMDAV 445
L++ E K + A
Sbjct: 76 RALTDAETKAFLKAG 90
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 110 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-07
Identities = 12/55 (21%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
++EE+ + F ++ D S I+ K + SKLS E+ + +
Sbjct: 15 RITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTK--SKLSIPELSYIWELSDA 67
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 1e-07
Identities = 20/75 (26%), Positives = 29/75 (38%), Gaps = 15/75 (20%)
Query: 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL---G 430
K+F A L S ++ +K F +D DKSG I +ELK L
Sbjct: 27 KEFFAKVGLASK---------SLDD---VKKAFYVIDQDKSGFIEEDELKLFLQNFSPSA 74
Query: 431 SKLSETEVKQLMDAV 445
L++ E K +
Sbjct: 75 RALTDAETKAFLADG 89
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 2e-07
Identities = 33/221 (14%), Positives = 59/221 (26%), Gaps = 53/221 (23%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSI-----LKRKLVNKQDREDIKREIQIMQH 150
+++G G FG + + A K I +++ E+I EI I +
Sbjct: 22 LQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 151 LSGQQ--------NIVEFRGAY------------------------------EDRQSVHL 172
LS + + + +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSN-- 230
V+E GG +++ + A + L + ++ + HRDL N LL
Sbjct: 140 VLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTS 199
Query: 231 ------KDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
G GL V I + + R
Sbjct: 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFC 240
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-07
Identities = 14/56 (25%), Positives = 19/56 (33%), Gaps = 3/56 (5%)
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE-VKQLMDAV 445
E LS E F M SG +T E K S + V+Q+ +
Sbjct: 8 VEELSATECHQWYKKF--MTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETF 61
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-07
Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 5/62 (8%)
Query: 385 MALKVIAEALSEEEIK-GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+ +E+ + D + +GTI EL+ L LG L+ +EV++LM
Sbjct: 64 YRKPIKTPTEQSKEMLDAFR-AL---DKEGNGTIQEAELRQLLLNLGDALTSSEVEELMK 119
Query: 444 AV 445
V
Sbjct: 120 EV 121
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 3e-07
Identities = 11/49 (22%), Positives = 20/49 (40%)
Query: 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
++ F D D G ++ EEL + L LG + E+ + +
Sbjct: 2 ASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQL 50
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-07
Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 5/62 (8%)
Query: 385 MALKVIAEALSEEEI-KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+ E + + + K F D + G I+ EL+ L LG +LS+ +V +++
Sbjct: 72 YEGLMDCEQGTFADYMEAFK-TF---DREGQGFISGAELRHVLTALGERLSDEDVDEIIK 127
Query: 444 AV 445
Sbjct: 128 LT 129
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-06
Identities = 13/52 (25%), Positives = 21/52 (40%), Gaps = 2/52 (3%)
Query: 394 LSEEEIKGLKTMFANMD--TDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
LS++EI LK +F D + G + +L LG +V +
Sbjct: 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG 54
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-07
Identities = 17/61 (27%), Positives = 31/61 (50%), Gaps = 3/61 (4%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
++ + SEEEI+ + D D +G I+ EL+ + LG KL++ EV +++
Sbjct: 17 YFQSLMKDTDSEEEIREAFRVE---DKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 73
Query: 445 V 445
Sbjct: 74 A 74
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 4e-07
Identities = 11/53 (20%), Positives = 28/53 (52%), Gaps = 1/53 (1%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSK-LSETEVKQLMDAV 445
+ +++ + + F D + G I ++E K + ++G + L++ EV++ M
Sbjct: 2 VRQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEA 54
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 95 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-07
Identities = 9/55 (16%), Positives = 19/55 (34%), Gaps = 2/55 (3%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
+S E +F D D G ++ E++ + + L T + +
Sbjct: 3 VVSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLK--TGLPSTLLAHIWSLCDT 55
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 8/51 (15%), Positives = 19/51 (37%), Gaps = 1/51 (1%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
S+ + L F +D +K G ++ +L+ + L + +
Sbjct: 23 FSQASLLRLHHRFRALDRNKKGYLSRMDLQQ-IGALAVNPLGDRIIESFFP 72
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 12/79 (15%), Positives = 31/79 (39%), Gaps = 4/79 (5%)
Query: 368 AVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLA 427
VL+ + + + K ++ ++ D D+ G I+ E+ L
Sbjct: 85 RVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLY---DLDRDGKISRHEMLQVLR 141
Query: 428 RL-GSKLSETEVKQLMDAV 445
+ G +++E +++ + D
Sbjct: 142 LMVGVQVTEEQLENIADRT 160
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 7/48 (14%), Positives = 22/48 (45%), Gaps = 1/48 (2%)
Query: 382 LKKMALKVIAEALSEEEIKGL-KTMFANMDTDKSGTITYEELKTGLAR 428
+ ++ ++ ++EE+++ + D D G +++ E L +
Sbjct: 136 MLQVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSLEK 183
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 9e-07
Identities = 14/50 (28%), Positives = 27/50 (54%), Gaps = 4/50 (8%)
Query: 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
++ ++ +F DT+ G I+ EL L LGS ++ EV+++M +
Sbjct: 2 ADD---MERIFKRFDTNGDGKISLSELTDALRTLGSTSAD-EVQRMMAEI 47
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 Length = 92 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-06
Identities = 10/55 (18%), Positives = 21/55 (38%), Gaps = 2/55 (3%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
+++E+ + F + D +G I K + SKL E+ + +
Sbjct: 2 KITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK--SKLPILELSHIWELSDF 54
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 21/67 (31%), Positives = 33/67 (49%), Gaps = 10/67 (14%)
Query: 382 LKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELK---TGLARLGSKLSETEV 438
+ LK ++ + +K +F +D D+SG I EELK G + G L++TE
Sbjct: 30 FHLVGLK----GKTDAQ---VKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTET 82
Query: 439 KQLMDAV 445
K L+ A
Sbjct: 83 KALLAAG 89
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-06
Identities = 14/64 (21%), Positives = 27/64 (42%), Gaps = 5/64 (7%)
Query: 383 KKMALKVIAEALSEEEIK-GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQL 441
E+ + +F D + +G ++ +L+ L LG KL++ EV +L
Sbjct: 69 VNEKELDATTKAKTEDFVKAFQ-VF---DKESTGKVSVGDLRYMLTGLGEKLTDAEVDEL 124
Query: 442 MDAV 445
+ V
Sbjct: 125 LKGV 128
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-06
Identities = 10/47 (21%), Positives = 19/47 (40%)
Query: 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
+ K +F D G I + L L +G + V+ +++A
Sbjct: 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINA 48
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 35/137 (25%), Positives = 54/137 (39%), Gaps = 36/137 (26%)
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGK--VYRDIVGSAYYVA 265
H+ H ++HRD+K N LL D + K TDFG+S + + + + G+ Y+
Sbjct: 153 HYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYID 209
Query: 266 PEVLRR------SYGKEIDVWSAGVILYILLSGVPPF-------------WAET--EKGI 304
PE + S DV+S GV+L+ +L WA G
Sbjct: 210 PEYFIKGRLTEKS-----DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 305 FDAI----LKGGVDFES 317
+ I L + ES
Sbjct: 265 LEQIVDPNLADKIRPES 281
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-06
Identities = 10/58 (17%), Positives = 25/58 (43%), Gaps = 5/58 (8%)
Query: 393 ALSEEEIKGLKTMFANM-DTDKSGTITYEELKTGLARL----GSKLSETEVKQLMDAV 445
L++ + + +K F D + G+I + + + R LS+ + K + ++
Sbjct: 1 GLNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASL 58
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 13/71 (18%), Positives = 25/71 (35%), Gaps = 3/71 (4%)
Query: 375 QFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLS 434
++ AM + K +A L + +F MD G + EE + L
Sbjct: 81 EYLAMWE-KTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQ 137
Query: 435 ETEVKQLMDAV 445
+V + + +
Sbjct: 138 CADVPAVYNVI 148
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} Length = 111 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-06
Identities = 11/55 (20%), Positives = 25/55 (45%), Gaps = 2/55 (3%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
A+ + + +F + D SG +T + +T L + S L + ++ + + I
Sbjct: 7 AVPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQ--SSLPQAQLASIWNLSDI 59
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 3e-06
Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 22/112 (19%)
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-R 271
+HRD+K N LL D K +DFGL+ ++ + IVG+ Y+APE LR
Sbjct: 154 HIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE 210
Query: 272 SYGKEIDVWSAGVILYILLSGVPPF-----------WAE---TEKGIFDAIL 309
K D++S GV+L +++G+P E E+ + +
Sbjct: 211 ITPKS-DIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI 261
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-06
Identities = 20/64 (31%), Positives = 28/64 (43%), Gaps = 8/64 (12%)
Query: 383 KKMALKVIAEALSEEEI-KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQL 441
+ EE KG + +F D D +G I EL+ L LG KLS E+ +L
Sbjct: 65 RPNGFD---MPGDPEEFVKGFQ-VF---DKDATGMIGVGELRYVLTSLGEKLSNEEMDEL 117
Query: 442 MDAV 445
+ V
Sbjct: 118 LKGV 121
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 7e-05
Identities = 8/46 (17%), Positives = 16/46 (34%)
Query: 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
+ K F+ D +G I + L G + E+ ++
Sbjct: 2 TDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIE 47
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 6e-06
Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK--VYRDIVGSAYYVAPEVLRRSY 273
++HRD+K N LL D DFGL+ +D V + G+ ++APE L
Sbjct: 155 IIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211
Query: 274 GKE-IDVWSAGVILYILLSGVPPF 296
E DV+ GV+L L++G F
Sbjct: 212 SSEKTDVFGYGVMLLELITGQRAF 235
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 12/45 (26%), Positives = 23/45 (51%)
Query: 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+ K F +D D SGT+ + EL+ + +G +LS + ++
Sbjct: 69 LNAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVK 113
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-05
Identities = 9/49 (18%), Positives = 20/49 (40%), Gaps = 6/49 (12%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLGSK-----LSETEVKQLMDAV 445
L FA++ + G I +EL+ L + G + + ++ +
Sbjct: 4 LYGYFASV-AGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSML 51
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 9e-05
Identities = 14/48 (29%), Positives = 26/48 (54%)
Query: 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446
+ G + F + D+D+SGT+ +EL+ L +G +L+ V + S
Sbjct: 71 LNGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRYS 118
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 15/45 (33%), Positives = 25/45 (55%)
Query: 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+ G + F + DTD+SGT+ +EL+ L +G +LS V +
Sbjct: 102 LNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAK 146
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 9/60 (15%), Positives = 19/60 (31%), Gaps = 6/60 (10%)
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSK-----LSETEVKQLMDAV 445
A + L F + G I +EL+ L + G + + ++ +
Sbjct: 24 GPAFPGQTQDPLYGYF-AAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSML 82
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-05
Identities = 10/58 (17%), Positives = 24/58 (41%), Gaps = 6/58 (10%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLS------ETEVKQLMDAV 445
++ + L+ F +D + G +T EL+T + L + + + +L+
Sbjct: 1 MACKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMA 58
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A Length = 76 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 1e-04
Identities = 17/53 (32%), Positives = 27/53 (50%), Gaps = 3/53 (5%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSET--EVKQLMDAV 445
S EEIKG +FA + I+ EELK + LG L + + ++++ V
Sbjct: 3 SPEEIKGAFEVFAAKE-GDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEV 54
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* Length = 183 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 12/48 (25%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 382 LKKMALKVIAEALSEEEIKGL-KTMFANMDTDKSGTITYEELKTGLAR 428
+ + + LS E+K L + D D+ GTI E + ++R
Sbjct: 124 VNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISR 171
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A Length = 214 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 12/48 (25%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 382 LKKMALKVIAEALSEEEIKGL-KTMFANMDTDKSGTITYEELKTGLAR 428
+ + + LS E+K L + D D+ GTI E + ++R
Sbjct: 155 VNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISR 202
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 4e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 5/62 (8%)
Query: 385 MALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS-KLSETEVKQLMD 443
MA K+ E E L F+ + + IT E L+ LG +S+ + + ++
Sbjct: 29 MAEKMDVEEFVSE----LCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVR 84
Query: 444 AV 445
Sbjct: 85 EG 86
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 Length = 224 | Back alignment and structure |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 1/64 (1%)
Query: 366 GSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGL-KTMFANMDTDKSGTITYEELKT 424
+++ + + + M K L E+ + F MD +K G +T +E
Sbjct: 138 KDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLE 197
Query: 425 GLAR 428
Sbjct: 198 SCQE 201
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A Length = 121 | Back alignment and structure |
|---|
Score = 38.3 bits (89), Expect = 8e-04
Identities = 11/55 (20%), Positives = 23/55 (41%), Gaps = 3/55 (5%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447
A++ EE F ++ SG IT ++ + + S L + + Q+ +
Sbjct: 26 AITVEERAKHDQQFHSLK-PISGFITGDQARNFFFQ--SGLPQPVLAQIWALADM 77
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 447 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 98.93 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 98.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.57 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 98.33 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 98.33 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 98.31 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 98.27 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 98.25 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 98.25 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 98.23 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 98.21 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.16 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 98.14 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.13 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 98.13 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 98.11 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 98.11 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.11 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.11 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.1 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 98.09 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 98.07 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.07 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 98.07 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 98.07 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 98.03 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.99 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 97.99 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 97.95 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 97.95 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 97.95 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 97.94 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 97.94 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 97.92 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 97.92 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 97.91 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 97.91 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 97.9 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 97.9 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 97.89 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 97.88 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 97.88 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 97.87 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 97.86 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 97.85 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 97.83 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 97.82 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 97.8 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 97.8 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 97.79 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 97.79 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 97.79 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 97.74 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 97.73 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.72 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 97.72 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 97.72 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 97.72 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 97.72 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 97.72 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 97.71 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 97.7 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 97.69 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 97.68 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 97.67 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.67 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.66 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 97.66 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 97.66 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 97.65 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 97.65 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 97.64 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.63 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 97.63 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 97.62 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 97.61 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.61 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 97.6 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 97.59 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 97.59 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 97.57 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 97.55 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.55 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.55 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 97.55 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 97.55 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 97.55 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 97.55 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 97.54 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.52 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 97.5 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 97.5 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 97.5 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 97.5 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 97.49 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.48 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 97.47 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 97.47 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 97.46 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 97.44 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.43 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 97.42 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.42 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 97.42 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 97.41 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 97.39 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 97.39 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 97.39 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 97.39 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 97.38 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.38 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 97.38 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 97.37 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 97.34 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.34 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 97.33 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 97.33 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 97.32 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 97.31 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 97.29 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 97.28 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 97.27 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 97.27 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.24 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 97.24 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 97.24 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 97.22 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 97.17 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 97.14 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 97.13 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 97.13 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 97.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.1 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 97.08 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 97.08 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 97.08 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 97.07 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 97.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.06 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.05 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 97.03 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 97.02 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 96.98 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 96.97 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 96.96 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 96.93 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 96.89 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 96.89 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 96.88 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 96.87 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 96.87 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.86 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 96.86 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 96.86 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 96.84 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 96.84 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 96.84 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 96.83 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 96.83 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 96.83 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 96.79 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 96.78 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 96.78 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 96.77 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 96.74 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 96.74 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 96.65 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 96.64 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 96.63 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 96.62 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 96.58 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 96.54 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 96.52 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 96.51 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 96.5 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 96.48 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 96.42 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 96.39 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.34 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 96.3 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 96.29 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 96.24 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 96.24 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 96.2 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 96.1 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 96.09 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 96.08 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 96.06 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 96.03 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 95.99 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 95.99 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 95.96 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 95.94 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 95.91 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 95.91 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 95.9 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 95.8 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 95.76 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 95.73 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 95.72 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 95.69 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 95.67 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 95.66 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 95.64 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 95.61 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 95.59 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.51 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 95.4 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 95.4 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 95.39 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 95.34 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 95.26 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 95.25 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 95.24 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 95.23 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 95.22 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 95.21 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 95.19 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 95.12 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 95.03 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 95.01 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 94.94 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 94.84 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 94.83 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 94.83 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 93.88 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 93.47 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 93.46 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-67 Score=494.75 Aligned_cols=256 Identities=33% Similarity=0.547 Sum_probs=233.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|++|+ |||||+++++|++++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence 34999999999999999999999999999999998766555556788999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC--
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-- 251 (447)
||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~---~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc---CCCCEEEEEcCCceecCCCCC
Confidence 99999999999999999999999999999999999999999999999999999994 4457999999999987533
Q ss_pred -CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 -KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
....+.+||+.|||||++. ..|+.++|||||||+||+|+||..||.+.+..+++..|.++.+.++. .+|+++++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHH
Confidence 2345679999999999987 45999999999999999999999999999999999999998877654 48999999
Q ss_pred HHHHhcccCCCCCCCHHH------HhcCCCccCC
Q 013201 330 LVRKMLIQDPKKRITSAE------VLEHPWMREG 357 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~------~l~h~~~~~~ 357 (447)
||.+||++||++|||++| |++||||++.
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999999999987 6899999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-67 Score=500.32 Aligned_cols=259 Identities=31% Similarity=0.550 Sum_probs=230.4
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|++.+.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|++++ |||||+++++|.+++.+|
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 45679999999999999999999999999999999976543 23456889999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||||+||+|.+++.+ +.+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---CCCCEEEecCcCceecCCC
Confidence 99999999999998865 5799999999999999999999999999999999999994 4457999999999877543
Q ss_pred -CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 -KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
....+.+||+.|||||++. ..|+.++|||||||++|||++|.+||.+.+..+++..+..+.. .....+..+|+++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHH
Confidence 3456789999999999987 4599999999999999999999999999999888888877532 333445678999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
||.+||++||++|||++|+|+||||++...
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 999999999999999999999999987543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-66 Score=479.37 Aligned_cols=255 Identities=35% Similarity=0.608 Sum_probs=214.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|++++ |||||++++++++++.+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence 35999999999999999999999999999999998776665666788999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|||| +|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...+...
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---CCCCEEEeecCCCeecCCCCc
Confidence 9999 679999999999999999999999999999999999999999999999994 445699999999988776666
Q ss_pred eeecCCccccccccccccc--CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
..+.+||+.|||||++.+. ++.++|||||||++|+|+||+.||.+.+..+++..+.++...++. .+|+++++||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 243 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLI 243 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 6678999999999998743 468999999999999999999999999999999999988766553 4799999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.+||+.||++|||++|+|+||||+..
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHccCChhHCcCHHHHHcCcccccC
Confidence 99999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-66 Score=504.06 Aligned_cols=259 Identities=31% Similarity=0.560 Sum_probs=230.2
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+..+.|++.+.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+|++|+ |||||+++++|.+++.+
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL 223 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEE
Confidence 34577999999999999999999999999999999996543 234467889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||||+||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+||||+ .++.|||+|||+|+.+..
T Consensus 224 ~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~---~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---TTCCEEECCCTTCEECCS
T ss_pred EEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEecCccceECCC
Confidence 999999999999998865 5799999999999999999999999999999999999994 445699999999987754
Q ss_pred C-CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 G-KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
. ....+.+||+.|||||++. ..|+.++|||||||++|||++|..||.+.+..+.+..|..+.. .....+..+|++++
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~ 378 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLK 378 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHH
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHH
Confidence 3 3456789999999999987 4599999999999999999999999999999988888877632 22334456899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+||.+||+.||++|||++|+|+||||++..
T Consensus 379 dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-65 Score=516.38 Aligned_cols=364 Identities=35% Similarity=0.584 Sum_probs=320.8
Q ss_pred cccCCCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh----------hhHHHHHHHHHHHHhcc
Q 013201 83 TVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK----------QDREDIKREIQIMQHLS 152 (447)
Q Consensus 83 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~----------~~~~~~~~E~~~l~~l~ 152 (447)
.........+.+.|++++.||+|+||+||+|++..+++.||+|++.+...... ...+.+.+|+.++++++
T Consensus 25 ~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred heeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 33334445677889999999999999999999999999999999976543221 34577899999999997
Q ss_pred CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC
Q 013201 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD 232 (447)
Q Consensus 153 ~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~ 232 (447)
||||+++++++.+.+.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 105 -hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 105 -HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183 (504)
T ss_dssp -CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT
T ss_pred -CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC
Confidence 9999999999999999999999999999999999989999999999999999999999999999999999999997766
Q ss_pred CCCceEEecCCCceeccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Q 013201 233 GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG 312 (447)
Q Consensus 233 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 312 (447)
....+||+|||++............+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+++..+..+.
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 65679999999999887766666788999999999998889999999999999999999999999999999999999998
Q ss_pred CCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC---CcccHHHHHHHHHHHHHhhhhHHHHHH
Q 013201 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASD---KPIGSAVLSRMKQFRAMNKLKKMALKV 389 (447)
Q Consensus 313 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~k~~~~~~ 389 (447)
..++.+.|..+++++++||.+||+.||.+|||++|+|+||||++...... .......+.++++|...+++++.+..+
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~ 343 (504)
T 3q5i_A 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF 343 (504)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHH
T ss_pred CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 88777777789999999999999999999999999999999987654422 122345677888899999999999999
Q ss_pred HHhhh-hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHh--------CCCCCHHHHHHHHHhhCC
Q 013201 390 IAEAL-SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL--------GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 390 i~~~~-~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l--------~~~~~~~e~~~~~~~~d~ 447 (447)
+...+ ++++..+++++|..||.|++|.|+.+||..+++.+ |...++++++++++.+|.
T Consensus 344 i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 410 (504)
T 3q5i_A 344 IGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDF 410 (504)
T ss_dssp HHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCT
T ss_pred hhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCC
Confidence 98877 78889999999999999999999999999999988 567889999999999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-65 Score=514.84 Aligned_cols=359 Identities=39% Similarity=0.648 Sum_probs=321.1
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
....+.++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++++++ ||||+++++++.+.
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDK 98 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 33456788999999999999999999999999999999997766555566788999999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 168 QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
+.+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999999999989999999999999999999999999999999999999997655667899999999988
Q ss_pred ccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 248 IDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
..........+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+.+..+..+...+..+.|..+++++
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 77666666678999999999998889999999999999999999999999999999999999999888888888999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC---CCCcccHHHHHHHHHHHHHhhhhHHHHHHHHhhh-hHHHhhhhc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA---SDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEAL-SEEEIKGLK 403 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i~~~~-~~~~~~~l~ 403 (447)
++||.+||+.||.+|||+.++|+||||+..... ...+.....+.++++|...+++++.++..|...+ ++++.++++
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~ 338 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELT 338 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHH
Confidence 999999999999999999999999999865432 2345567788899999999999999999998876 778889999
Q ss_pred ceeeeecCCCCcccCHHHHH----HHHHHhCCCCC-------HHHHHHHHHhhCC
Q 013201 404 TMFANMDTDKSGTITYEELK----TGLARLGSKLS-------ETEVKQLMDAVSI 447 (447)
Q Consensus 404 ~~F~~~D~~~~g~i~~~el~----~~l~~l~~~~~-------~~e~~~~~~~~d~ 447 (447)
++|..+|.|++|.|+.+||. .+++.+|..++ +++++++++.+|.
T Consensus 339 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~ 393 (484)
T 3nyv_A 339 AIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDF 393 (484)
T ss_dssp HHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTC
T ss_pred HHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCC
Confidence 99999999999999999995 44455677777 8999999999873
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=489.16 Aligned_cols=257 Identities=27% Similarity=0.534 Sum_probs=224.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++|+ |||||++++++++++.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence 469999999999999999999999999999999976544 3456788999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||+||+|.++|...+ .+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC---TTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCCEEEcccccceeecCC
Confidence 99999999999997653 479999999999999999999999999999999999994 4456999999999876543
Q ss_pred C-ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 K-VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+..+++..+..+.+... +..+|+++++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---SLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---CccCCHHHHH
Confidence 2 2345789999999999874 599999999999999999999999999999999999998865432 2358999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
||.+||++||++|||++|+|+||||++..
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 99999999999999999999999998643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-64 Score=510.25 Aligned_cols=355 Identities=38% Similarity=0.654 Sum_probs=315.6
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.++|++.+.||+|+||+||+|++..+++.||+|++.+.... ......+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCEE
Confidence 4667899999999999999999999999999999998664332 234678899999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+|||||.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999999989999999999999999999999999999999999999997766667899999999987766
Q ss_pred CCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
.......+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.+..+.+..+..+...+..+.|..+|+++++|
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66666778999999999999889999999999999999999999999999999999999998888888888999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC----cccHHHHHHHHHHHHHhhhhHHHHHHHHhhh-hHHHhhhhcce
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREGGEASDK----PIGSAVLSRMKQFRAMNKLKKMALKVIAEAL-SEEEIKGLKTM 405 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~k~~~~~~i~~~~-~~~~~~~l~~~ 405 (447)
|.+||+.||.+|||+.++|+||||++....... +.....+.++++|....++++.++.+|...+ ..+++++++++
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~ 336 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEI 336 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHH
Confidence 999999999999999999999999876544321 2335567788999999999999999999877 77889999999
Q ss_pred eeeecCCCCcccCHHHHHHHH----HHhCCCCC----------HHHHHHHHHhhCC
Q 013201 406 FANMDTDKSGTITYEELKTGL----ARLGSKLS----------ETEVKQLMDAVSI 447 (447)
Q Consensus 406 F~~~D~~~~g~i~~~el~~~l----~~l~~~~~----------~~e~~~~~~~~d~ 447 (447)
|..+|.|+||.|+.+||..++ +.+|..++ +++++++++.+|.
T Consensus 337 F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~ 392 (486)
T 3mwu_A 337 FRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDM 392 (486)
T ss_dssp HHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCT
T ss_pred HHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcC
Confidence 999999999999999995554 44576655 8999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-65 Score=515.42 Aligned_cols=364 Identities=35% Similarity=0.632 Sum_probs=320.4
Q ss_pred ccccCCCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEE
Q 013201 82 ETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFR 161 (447)
Q Consensus 82 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 161 (447)
..........+.+.|++.+.||+|+||+||+|++..++..||+|++.+.... ......+.+|+.+++.++ ||||++++
T Consensus 25 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~ 102 (494)
T 3lij_A 25 GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLD-HPNIMKLY 102 (494)
T ss_dssp GGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEE
T ss_pred hheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCC-CCCCCeEE
Confidence 3344445566778899999999999999999999999999999998765432 233567889999999997 99999999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 162 GAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 162 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
+++.+.+.+|+|||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|
T Consensus 103 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEE
Confidence 99999999999999999999999999988999999999999999999999999999999999999997766667899999
Q ss_pred CCCceeccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.+..+++..+..+...+..+.|.
T Consensus 183 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (494)
T 3lij_A 183 FGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262 (494)
T ss_dssp CTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred CCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence 99999887766666788999999999998889999999999999999999999999999999999999999888888888
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC----CCCcccHHHHHHHHHHHHHhhhhHHHHHHHHhhh-hH
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA----SDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEAL-SE 396 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i~~~~-~~ 396 (447)
.+++.+++||.+||+.||.+|||+.++|+||||++.... ...+.....+.++++|...+++++.++..+...+ ++
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~ 342 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQ 342 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCH
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccH
Confidence 899999999999999999999999999999999864221 2334456778899999999999999999998877 78
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCC--------CCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS--------KLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~--------~~~~~e~~~~~~~~d~ 447 (447)
++.++++++|+.||.|++|.|+.+||..+|+.+|. ..++++++++++.+|.
T Consensus 343 ~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 401 (494)
T 3lij_A 343 EETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADF 401 (494)
T ss_dssp HHHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCC
Confidence 88999999999999999999999999999999864 4568999999998873
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-64 Score=470.70 Aligned_cols=256 Identities=23% Similarity=0.426 Sum_probs=220.2
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CCeE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----RQSV 170 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~ 170 (447)
.|++.+.||+|+||+||+|++..++..||+|++.+... .....+.+.+|+.+|++|+ |||||+++++|++ ++.+
T Consensus 27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEE
T ss_pred eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEE
Confidence 35888999999999999999999999999999976543 4456778999999999998 9999999999875 3568
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
|||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.. ++.+||+|||+|+..
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~--~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST--TSCEEECCTTGGGGC
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC--CCCEEEEeCcCCEeC
Confidence 999999999999999999999999999999999999999999999 9999999999999532 346999999999754
Q ss_pred cCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCCCCCccccCChHH
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.. ....+.+||+.|||||++.+.|+.++|||||||+||||+||+.||.+.... .++..+..+... ......+++++
T Consensus 183 ~~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 259 (290)
T 3fpq_A 183 RA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEV 259 (290)
T ss_dssp CT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHHH
T ss_pred CC-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC--CCCCccCCHHH
Confidence 43 345678999999999999988999999999999999999999999876544 445555444322 12233578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
++||.+||+.||++|||++|+|+||||++.
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-64 Score=473.57 Aligned_cols=255 Identities=30% Similarity=0.504 Sum_probs=220.8
Q ss_pred cceeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+.|++.+.||+|+||+||+|++. .+++.||+|++.+.... ......+.+|+.+|++++ |||||++++++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 45999999999999999999984 46889999999765432 223346789999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---CCCCEEecccccceeccC
Confidence 99999999999999999999999999999999999999999999999999999999994 445799999999986543
Q ss_pred -CCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 -GKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.....+.+||+.|||||++. ..|+.++|||||||++|||+||..||.+.+..+++..|.++...++. .+|++++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 254 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ 254 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHHH
Confidence 33445679999999999986 56999999999999999999999999999999999999998766543 4899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 329 DLVRKMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
+||.+||++||++||| ++|+++||||+..
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999999998 5799999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-63 Score=468.48 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=221.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.++||+|+||+||+|+++.+|+.||||++.+... ..+|+.+|++|+ |||||++++++.+++.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~-HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLS-SPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence 469999999999999999999999999999999975432 146999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.++. .+||+|||+|+.+.....
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS--RAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC--CEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC--EEEEeeCCCCeEccCCCc
Confidence 999999999999999999999999999999999999999999999999999999954432 599999999987654321
Q ss_pred ------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 254 ------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 254 ------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
....+||+.|||||++.+ .|+.++|||||||+||||+||..||.+.+..+++..|..+...+.. .+..+|++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE-IPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGG-SCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchh-cCccCCHH
Confidence 223589999999999874 5999999999999999999999999988887788888876543321 22358999
Q ss_pred HHHHHHHhcccCCCCCCCHHHH-------------hcCCCccCCCCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEV-------------LEHPWMREGGEA 360 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~-------------l~h~~~~~~~~~ 360 (447)
+++||.+||++||++|||+.|+ |+|||+.+...+
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 9999999999999999999997 579999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-62 Score=477.54 Aligned_cols=264 Identities=25% Similarity=0.380 Sum_probs=224.6
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED---- 166 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---- 166 (447)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.+|++|+ |||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence 35567999999999999999999999999999999986543 33445677889999999997 9999999998754
Q ss_pred --CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 167 --RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 167 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
.+.+|||||||. |+|.+++.+.+.+++..++.|++||+.||.|||++|||||||||+|||++ .++.+||+|||+
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~---~~~~~Ki~DFGl 204 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGDFGM 204 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC---CCCCEEEeecce
Confidence 468999999995 68999999889999999999999999999999999999999999999994 445699999999
Q ss_pred ceeccCC-----CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC
Q 013201 245 SVFIDEG-----KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES 317 (447)
Q Consensus 245 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 317 (447)
|+.+... ....+.+||+.|||||++.+ .|+.++||||+||++|||++|.+||.+.+..+.+..|......++.
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9865432 23446799999999999764 4799999999999999999999999999998888887653222111
Q ss_pred C-----------------------c----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 318 E-----------------------P----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 318 ~-----------------------~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
. + +..++++++|||.+||.+||++|||++|+|+||||++....
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 1 1 12468999999999999999999999999999999986544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=452.76 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=211.6
Q ss_pred ccccceeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.+.++|++.+.||+|+||+||+|+++ .+++.||+|.+.+. ....++.+|+++|+.+.+||||++++++|.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 46678999999999999999999875 46789999988543 23457889999999997799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 168 QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
+.+|||||||+||+|.+++ +.+++.+++.+++||+.||.|||++||+||||||+|||++.+. ..+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~--~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL--KKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC--CeEEECcCCCCcc
Confidence 9999999999999999988 4699999999999999999999999999999999999996542 3699999999976
Q ss_pred ccCCC-----------------------------ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCC
Q 013201 248 IDEGK-----------------------------VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPF 296 (447)
Q Consensus 248 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf 296 (447)
..+.. .....+||+.|||||++.+ .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 54321 1234689999999999864 4899999999999999999999999
Q ss_pred CCC-CHHHHHHHHHhC--------------------------------------C------------CCCCCCccccCCh
Q 013201 297 WAE-TEKGIFDAILKG--------------------------------------G------------VDFESEPWLLISD 325 (447)
Q Consensus 297 ~~~-~~~~~~~~i~~~--------------------------------------~------------~~~~~~~~~~~s~ 325 (447)
... +..+.+..|... . .......|..+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 654 343444433210 0 0011123456899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+++|||.+||++||++|+|++|+|+||||++.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-59 Score=478.41 Aligned_cols=265 Identities=34% Similarity=0.638 Sum_probs=242.2
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.++|++++.||+|+||+||+|+++.+|+.||+|++.+. .....+.+.+|+.+|+.|+ |||||+++++|++++.+
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 3456799999999999999999999999999999998654 3445678899999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|||||||+||+|.++|.. .+.+++.+++.|++||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+.+.
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEcc
Confidence 999999999999999865 4679999999999999999999999999999999999999653 23479999999999988
Q ss_pred CCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
........+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..|......++...+..+|++++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 8777788899999999999874 589999999999999999999999999999999999999988888887888999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
+||.+||+.||.+|||+.|+|+||||+.....
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 99999999999999999999999999976544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-59 Score=439.93 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=200.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-----
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ----- 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----- 168 (447)
+.|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++|+ |||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence 34999999999999999999999999999999986542 3445678999999999997 999999999987544
Q ss_pred -------eEEEEEeccCCCchHHHHHHcCCC---CHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceE
Q 013201 169 -------SVHLVMELCSGGELFDKIIAQGHY---TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238 (447)
Q Consensus 169 -------~~~lv~e~~~g~~L~~~l~~~~~~---~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vk 238 (447)
.+|||||||+||+|.+++.....+ .+..++.|+.||+.||+|||++||+||||||+|||++. ++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~---~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC---CCcEE
Confidence 479999999999999999876653 45668899999999999999999999999999999954 44699
Q ss_pred EecCCCceeccCCCc-------------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-H
Q 013201 239 ATDFGLSVFIDEGKV-------------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEK-G 303 (447)
Q Consensus 239 l~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~-~ 303 (447)
|+|||+|+....... ..+.+||+.|||||++.+ .|+.++|||||||++|||++ ||...... .
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999987654321 234689999999999874 59999999999999999996 88654322 2
Q ss_pred HHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 304 IFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 304 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.+..+....+ + +.+...++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus 236 ~~~~~~~~~~--p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 236 TLTDVRNLKF--P-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHTTCC--C-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHhcCCC--C-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 3333333322 1 22334577889999999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=470.52 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=221.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHH---HHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE---IQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E---~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+.|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+| +.+++.++ |||||+++++|++.+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEECCEE
Confidence 459999999999999999999999999999999987654433334444444 55555665 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.|||+|||+|.....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecCC
Confidence 9999999999999999999999999999999999999999999999999999999999 4455799999999987765
Q ss_pred CCceeecCCccccccccccc-c-cCCCCCcchhHHHHHHHHhhCCCCCCCC---CHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 251 GKVYRDIVGSAYYVAPEVLR-R-SYGKEIDVWSAGVILYILLSGVPPFWAE---TEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.. ..+.+||+.|||||++. + .|+.++|||||||+||||++|.+||.+. +..++...+......++. .+|+
T Consensus 345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~----~~S~ 419 (689)
T 3v5w_A 345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSP 419 (689)
T ss_dssp CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT----TSCH
T ss_pred CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc----cCCH
Confidence 43 35679999999999985 3 5999999999999999999999999764 344566677776665543 4899
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 326 SAKDLVRKMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
++++||.+||+.||.+|++ ++||++||||+..
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999999998 7999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-59 Score=435.65 Aligned_cols=252 Identities=24% Similarity=0.412 Sum_probs=215.6
Q ss_pred ccceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
++.|.+.+.||+|+||+||+|++. .++..||||++... .....+.|.+|+.+|++|+ |||||++++++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence 356999999999999999999875 35788999998542 3455678999999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCC
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ-------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG 234 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~-------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~ 234 (447)
+.+|||||||+||+|.++|... ..+++..+..|+.||+.||.|||+++|+||||||+|||++ .+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~---~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---EN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC---CC
Confidence 9999999999999999999764 3599999999999999999999999999999999999994 45
Q ss_pred CceEEecCCCceeccCCCcee---ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 013201 235 AMLKATDFGLSVFIDEGKVYR---DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAIL 309 (447)
Q Consensus 235 ~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 309 (447)
..+||+|||+|+......... ...||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 579999999998765433222 246999999999986 569999999999999999998 899999999999999998
Q ss_pred hCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 310 KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 310 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.+...... ..+|+++.+||.+||+.||++|||++++ |+|+++
T Consensus 245 ~~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 245 QGRVLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred cCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 87643221 2589999999999999999999999998 445543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-58 Score=435.57 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=208.6
Q ss_pred cceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+.|.+.++||+|+||+||+|+++ .++..||||++... .....+.|.+|+.+|++|+ |||||++++++.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 45899999999999999999875 36889999998532 4556788999999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQ---------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~---------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~ 233 (447)
.+|||||||+||+|.++|... +.+++.++..|+.||+.||.|||+++||||||||+|||++ .
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---Q 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---T
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---C
Confidence 999999999999999999753 3589999999999999999999999999999999999994 4
Q ss_pred CCceEEecCCCceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHH
Q 013201 234 GAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAI 308 (447)
Q Consensus 234 ~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 308 (447)
+..+||+|||+++...... .....+||+.|||||++. ..|+.++|||||||+||||+| |+.||.+.+..+++..+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 5579999999998764432 223468999999999986 459999999999999999999 99999999999999888
Q ss_pred HhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 309 LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 309 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..+... +.+ ..+++++.+||.+||+.||++|||++||+++
T Consensus 274 ~~g~~~-~~p--~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 274 TQGREL-ERP--RACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHTCCC-CCC--TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HcCCCC-CCc--ccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 887432 222 2589999999999999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=441.15 Aligned_cols=302 Identities=35% Similarity=0.682 Sum_probs=269.4
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
...+.+.|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES 101 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence 34567789999999999999999999999999999999876543 3445678899999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
..|+|||||.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999999999988888999999999999999999999999999999999999977666667999999999887
Q ss_pred cCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...++..+..+...++.+.|..+++++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 76655566799999999999875 58999999999999999999999999999999999999998888888888899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHHHHHHhhhhHHHHHHHHh
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAE 392 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i~~ 392 (447)
++||.+||..||++|||+.++|+||||..................+++|....+++..++..+..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 326 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIA 326 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999986543333444567788899999999998887766543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=431.14 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=204.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.++++++||+|+||+||+|++. ..||||++... .......+.|.+|+.+|++++ |||||++++++.+ +.+|||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~-~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVV-DPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCS-SCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEec-CCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEEE
Confidence 45889999999999999999864 35999987543 234556788999999999998 9999999998754 568999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
||||+||+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+|||++ .++.+||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceecccCC
Confidence 9999999999999764 5799999999999999999999999999999999999994 4567999999999875432
Q ss_pred --CceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--CCccccC
Q 013201 252 --KVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE--SEPWLLI 323 (447)
Q Consensus 252 --~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 323 (447)
......+||+.|||||++. +.|+.++|||||||+||||+||+.||.+.+....+..+.......+ ...+..+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 2334578999999999985 2489999999999999999999999988766555555444433322 1223468
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++++.+||.+||+.||++|||+.|++++
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987644
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=453.09 Aligned_cols=299 Identities=39% Similarity=0.720 Sum_probs=264.8
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..+.+.|++.+.||+|+||.||+|.+..+|+.+|+|++.+... .....+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGH 84 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCE
Confidence 3456789999999999999999999999999999999876543 3345677899999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
.|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+..+..+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999999999999999999999999999999999999999999999999766566789999999998765
Q ss_pred CCC-ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 250 EGK-VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 250 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+..+...++.+.|..+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 432 3345789999999999875 58999999999999999999999999999999999999999988888888899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHHHHHHhhhhHHHHHHH
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVI 390 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i 390 (447)
++||.+||+.||++|||++|+|+||||+..............+..+++|....+++..++..|
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~ 307 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVM 307 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEE
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999875444444445677889999999999988776655
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=429.21 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=214.1
Q ss_pred cceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
..+++.+.||+|+||+||+|+.. .+++.||||++.... .....+.|.+|+.+|++++ |||||++++++.+++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECC
Confidence 44889999999999999999864 467899999985432 3445678999999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQ----------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD 232 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~ 232 (447)
.+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+|||++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~--- 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--- 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC---
Confidence 999999999999999999753 3589999999999999999999999999999999999994
Q ss_pred CCCceEEecCCCceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 013201 233 GGAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDA 307 (447)
Q Consensus 233 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 307 (447)
.+..+||+|||+++...... .....+||+.|||||++. +.|+.++|||||||+||||+| |..||.+.+..+++..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 45579999999998764332 234568999999999986 569999999999999999998 8999999999999988
Q ss_pred HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 308 ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 308 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+..+.... .+ ..+++++.+||.+||+.||++|||+.||+++
T Consensus 260 i~~~~~~~-~p--~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLP-CP--DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCC-CC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCC-Cc--ccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88765432 22 3589999999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-57 Score=433.97 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=210.6
Q ss_pred ccceeecceeccccCeEEEEEEECCCC-----CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTG-----NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED- 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 166 (447)
+++|++++.||+|+||+||+|++..++ +.||||.+.... .....+.+.+|+.+|+++.+|||||+++++|..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 567999999999999999999986543 579999885432 344567799999999999878999999999865
Q ss_pred CCeEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeec
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQ----------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSN 230 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~ 230 (447)
++.+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+|||++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~- 219 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 219 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC-
Confidence 45789999999999999999763 2389999999999999999999999999999999999994
Q ss_pred CCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHH-H
Q 013201 231 KDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKG-I 304 (447)
Q Consensus 231 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~-~ 304 (447)
.+..+||+|||+|+.+..... ....+||+.|||||++. +.|+.++|||||||+||||+| |..||.+....+ +
T Consensus 220 --~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 220 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp --GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred --CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 445799999999987654332 23467999999999986 569999999999999999998 999998876544 4
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
...+..+ ..++.+ ..+++++.+||.+||+.||++|||+.+|++|
T Consensus 298 ~~~i~~g-~~~~~p--~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEG-TRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcC-CCCCCC--ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4444444 333333 2579999999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=424.89 Aligned_cols=267 Identities=40% Similarity=0.691 Sum_probs=241.2
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh---hhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK---QDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..+.+.|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+++. ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe
Confidence 4567789999999999999999999999999999999976543221 24678999999999998 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC-CCceEEecCCCc
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG-GAMLKATDFGLS 245 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~-~~~vkl~Dfg~a 245 (447)
.+.+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999988888999999999999999999999999999999999999965432 236999999999
Q ss_pred eeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++...+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 98777666667889999999999874 68999999999999999999999999999999999999988877766677899
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+++++||.+||..||.+|||+.|+|+||||+..
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999999999853
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=427.65 Aligned_cols=301 Identities=35% Similarity=0.625 Sum_probs=247.4
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC--hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN--KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
..+.+.|++.+.||+|+||.||+|+++.+++.||+|++.+..... ....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 345678999999999999999999999999999999986543221 224678999999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
+.+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999998887653 248999999999999999999999999999999999999776666679999999
Q ss_pred CceeccCCCc-eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 244 LSVFIDEGKV-YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 244 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
++........ ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+. ....+..+..+...+....+.
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence 9987765432 34568999999999986 45899999999999999999999999875 456777777877766655566
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHHHHHHhhhhHHHHHHHHh
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAE 392 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i~~ 392 (447)
.+++++++||.+||..||++|||+.++|+||||++.............+..+++|....+++..++..+..
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 328 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSS 328 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC-----------
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999999999999999987543233333456677888888888888777666543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-55 Score=420.49 Aligned_cols=296 Identities=38% Similarity=0.680 Sum_probs=238.8
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
....+.+.|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.+++++. ||||+++++++.+.
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETP 120 (349)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECS
T ss_pred ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecC
Confidence 34556788999999999999999999999999999999886432 3456789999999998 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 168 QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++..
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999999999998888899999999999999999999999999999999999997645567899999999987
Q ss_pred ccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCCCCCccccCCh
Q 013201 248 IDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+..+......+..+.+..++.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 765555556789999999999874 58999999999999999999999998765544 6777777776666666667899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHHHHHHhhhhHHHHHHHH
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIA 391 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i~ 391 (447)
++.+||.+||..||++|||+.++|+||||....... ........+++.|....+++......++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF--VHMDTAQKKLQEFNARRKLKAAVKAVVA 344 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCC--SCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccch--hhhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998754332 2345667788888888888877766554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=415.07 Aligned_cols=258 Identities=36% Similarity=0.604 Sum_probs=233.4
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..+|+.||+|++.+... .....+.+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEE
Confidence 4569999999999999999999999999999999876543 4455678899999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc---CCCCEEEeeccCceecCCCC
Confidence 999999999999999989999999999999999999999999999999999999994 44569999999998777666
Q ss_pred ceeecCCccccccccccccc-C-CCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRRS-Y-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..++...+..+....+. .+++++.+|
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 244 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENL 244 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 66678999999999998643 4 57899999999999999999999999999999999988776554 379999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
|.+||..||.+|||++|+|+||||+....
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 99999999999999999999999987543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=428.24 Aligned_cols=262 Identities=34% Similarity=0.601 Sum_probs=218.6
Q ss_pred cccceeec-ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 013201 92 IRQFYTLG-KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED---- 166 (447)
Q Consensus 92 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---- 166 (447)
+.+.|.+. +.||+|+||+||+|++..+++.||||++... ..+.+|+.++.++.+||||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 34456665 7999999999999999999999999988532 4567899998777679999999999876
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
.+.+|||||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 667999999999999999998754 599999999999999999999999999999999999997655567899999999
Q ss_pred ceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH----HHHHHHHhCCCCCCCCc
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK----GIFDAILKGGVDFESEP 319 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~ 319 (447)
+............+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.... .....+..+.+.++.+.
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 98776655556778999999999986 56899999999999999999999999876432 25566777777777777
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
|..+++++++||.+||..||++|||+.++|+||||.+.....
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~ 332 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSC
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCC
Confidence 778999999999999999999999999999999998765443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-55 Score=416.32 Aligned_cols=263 Identities=29% Similarity=0.594 Sum_probs=238.0
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
++.++|++.+.||+|+||.||+|++..+++.||+|.+... ......+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence 3567899999999999999999999999999999988532 334567889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|+|||||+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+..+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence 99999999999999997654 69999999999999999999999999999999999999653 24579999999999887
Q ss_pred CCCceeecCCccccccccccccc-CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+..+...++...+..+++++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 77666778899999999998754 79999999999999999999999999999999999999888877766778999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+||.+||..||.+|||+.|+|+||||++...
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 9999999999999999999999999987643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=419.61 Aligned_cols=257 Identities=29% Similarity=0.517 Sum_probs=227.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.+.+||||+++++++.+.+.+|||
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 45999999999999999999999999999999997654444556677889999999987799999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~ 252 (447)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... ...
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSCC---
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC---CCCCEEEccccceeecccCCc
Confidence 99999999999999989999999999999999999999999999999999999994 44579999999998643 333
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
.....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+++..+..+...++. .+++++.+||
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li 255 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGIL 255 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 445678999999999986 45999999999999999999999999999999999999998776654 3799999999
Q ss_pred HHhcccCCCCCCCH------HHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRITS------AEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~t~------~~~l~h~~~~~~ 357 (447)
.+||..||.+||++ +++++||||++.
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 99999999999999 899999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-54 Score=411.58 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=230.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence 46999999999999999999999999999999997654434445678889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~ 252 (447)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC---CCCCEEEeeccchhhcccCCC
Confidence 99999999999999988999999999999999999999999999999999999994 44579999999998643 333
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
.....+||+.|+|||++. ..++.++|||||||++|||++|..||.+.+...+...+......++. .+++++++||
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 236 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 455678999999999986 45899999999999999999999999999999999998887766554 4799999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
.+||+.||++|| +++++++||||+..
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999999 99999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=410.84 Aligned_cols=267 Identities=39% Similarity=0.713 Sum_probs=238.4
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh---hhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK---QDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..+.+.|++.+.||+|+||.||+|++..+++.||+|++.+...... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 4566789999999999999999999999999999999876543221 24678999999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC-CCCceEEecCCCc
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD-GGAMLKATDFGLS 245 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~~~vkl~Dfg~a 245 (447)
.+.+|+|||||+|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999996544 2336999999999
Q ss_pred eeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......++...+..++
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 8876655556678999999999986 458999999999999999999999999999888888888877766655556789
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 999999999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=414.93 Aligned_cols=257 Identities=33% Similarity=0.535 Sum_probs=209.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.++|++.+.||+|+||+||+|++..+++.||+|++.+... ..+.+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEEE
Confidence 4569999999999999999999999999999999865432 2356889999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~-~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-SCCEEECCCCCC-------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CceEEEeecCccccccccC
Confidence 999999999999999888999999999999999999999999999999999999995432 2359999999998655444
Q ss_pred ceeecCCcccccccccccc-cCCC-CCcchhHHHHHHHHhhCCCCCCCCCH----HHHHHHHHhCCCCCCCCccccCChH
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGK-EIDVWSAGVILYILLSGVPPFWAETE----KGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.....+||+.|+|||++.+ .++. ++|||||||++|+|++|..||.+... ...+..+......++. ...++++
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~ 250 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRISPE 250 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCCHH
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCCHH
Confidence 4456789999999999854 4544 48999999999999999999987543 4555566655544433 2357999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+++||.+||+.||.+|||+.|+++||||.+.
T Consensus 251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 9999999999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=399.17 Aligned_cols=267 Identities=41% Similarity=0.743 Sum_probs=242.6
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..+.++|++.+.||+|+||.||+|++..++..+|+|.+.+... ...+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTD 80 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCe
Confidence 4567789999999999999999999999999999999865432 34578899999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
.|+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+..++.+..+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999998899999999999999999999999999999999999999665566679999999998877
Q ss_pred CCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+..+...++...+..+++.+.+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 66666677899999999999888999999999999999999999999999999999999888777776666678999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
||.+||+.||.+|||+.++|+||||++....
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence 9999999999999999999999999875443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=416.43 Aligned_cols=257 Identities=27% Similarity=0.495 Sum_probs=224.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+++++.+||||+++++++.+.+.+|||
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 45999999999999999999999999999999998766555555567889999999886699999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee-ccCCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF-IDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~-~~~~~ 252 (447)
||||+||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.. .....
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCTTC
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC---CCCCEEEeecceeeecccCCC
Confidence 99999999999999989999999999999999999999999999999999999994 445799999999986 33444
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC---------CHHHHHHHHHhCCCCCCCCcccc
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE---------TEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
.....+||+.|+|||++. ..|+.++|||||||++|||++|..||... ....+...+......++. .
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~ 284 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----S 284 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT----T
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC----c
Confidence 556789999999999987 45899999999999999999999999632 334466777777666554 4
Q ss_pred CChHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITS------AEVLEHPWMREG 357 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~------~~~l~h~~~~~~ 357 (447)
+++++++||.+||+.||.+||++ +|+++||||+..
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 79999999999999999999985 899999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=408.70 Aligned_cols=262 Identities=36% Similarity=0.605 Sum_probs=231.6
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..+.+.|++.+.||+|+||.||+|+++.+++.||+|++.+... ...+|+.++.++.+||||+++++++.+.+.
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 4567789999999999999999999999999999999865432 234788899888679999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC-CCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD-GGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~~~vkl~Dfg~a~~~ 248 (447)
+|+|||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..++ ....+||+|||++...
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999999999988999999999999999999999999999999999999985543 3356999999999876
Q ss_pred cCC-CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCC---CCHHHHHHHHHhCCCCCCCCccccC
Q 013201 249 DEG-KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWA---ETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 249 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+.+.+....|..+
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 543 33456789999999999874 488999999999999999999999986 4567788888888888877777789
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
++++++||.+||..||++|||++++|+||||.+..
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 99999999999999999999999999999997643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-53 Score=395.43 Aligned_cols=268 Identities=37% Similarity=0.741 Sum_probs=243.9
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence 356779999999999999999999999999999999866543 4455678889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
++||||+.|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++....+||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999999999999988999999999999999999999999999999999999997766666799999999988776
Q ss_pred CCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++.+.+..+++++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 665566789999999999864 4899999999999999999999999999999999999998888887777788999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
||.+||+.||++|||++|+|+||||++....
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 9999999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=405.84 Aligned_cols=269 Identities=36% Similarity=0.657 Sum_probs=216.9
Q ss_pred cccceeec---ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 92 IRQFYTLG---KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 92 ~~~~y~~~---~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+.++|++. +.||+|+||.||+|++..+++.||+|++.+. ....+.+|+.+++.+.+||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34557775 7899999999999999999999999998543 34677899999999988999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
..|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999999999989999999999999999999999999999999999999987666668999999999865
Q ss_pred cCC-CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCc
Q 013201 249 DEG-KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAET-------EKGIFDAILKGGVDFESEP 319 (447)
Q Consensus 249 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~ 319 (447)
... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.... ..+.+..+..+...+....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 543 2334568999999999986 458999999999999999999999997643 3567778888877777777
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCccc
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIG 366 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~ 366 (447)
|..+++++++||.+||..||.+|||++++++||||++.......++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~ 286 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLM 286 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCS
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCC
Confidence 77899999999999999999999999999999999987666555443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=403.12 Aligned_cols=254 Identities=28% Similarity=0.577 Sum_probs=229.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEEE
Confidence 45999999999999999999999999999999997654433345677889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc---CCCCEEEeecCcceecCCc--
Confidence 99999999999999988999999999999999999999999999999999999994 4457999999999876543
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+....+..+..+...++. .+++++.+||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 235 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLS 235 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHH
Confidence 34568999999999986 45899999999999999999999999999999999999888766553 47999999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
+||..||++|| +++++++||||++.
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999999999 99999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=410.25 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=229.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+++.+.+||||+++++++.+.+.+|+|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 45999999999999999999999999999999997654333445677889999999885699999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~ 252 (447)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..... ..
T Consensus 97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---CCCCEEEeEChhhhhcccCCC
Confidence 99999999999999888999999999999999999999999999999999999994 445799999999986432 23
Q ss_pred ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+..+...++. .+++++++||
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 249 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLL 249 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHHHHHH
Confidence 3456789999999999864 5899999999999999999999999999999999999887665543 4799999999
Q ss_pred HHhcccCCCCCCCHH-HHhcCCCccCC
Q 013201 332 RKMLIQDPKKRITSA-EVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~-~~l~h~~~~~~ 357 (447)
.+||..||++||++. ++++||||+..
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcCCHhHcCCChHHHHcCccccCC
Confidence 999999999999998 99999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-53 Score=411.69 Aligned_cols=264 Identities=31% Similarity=0.619 Sum_probs=236.3
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.+.|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+|+.+. ||||+++++++.+...+|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCEEE
Confidence 456799999999999999999999999999999988543 2334567899999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+|||||.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ ....+||+|||++.....
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceecCC
Confidence 9999999999999887654 69999999999999999999999999999999999999542 235699999999998876
Q ss_pred CCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
........||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+......++...+..+++++.+
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 66666778999999999986 45899999999999999999999999999998889998888777776666778999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
||.+||..||.+|||+.++|+||||+.....
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred HHHHHcCCChhHCcCHHHHhhCccccCCccc
Confidence 9999999999999999999999999876443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=405.85 Aligned_cols=257 Identities=27% Similarity=0.485 Sum_probs=226.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++++.+||||+++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 45999999999999999999999999999999998776666666778899999999986699999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~ 252 (447)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... ...
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCGGGCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEEeccccccccCCCC
Confidence 99999999999999888999999999999999999999999999999999999994 44579999999998633 333
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCC---------CCHHHHHHHHHhCCCCCCCCcccc
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWA---------ETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
.....+||+.|+|||++. ..++.++|||||||++|||++|..||.. .....+...+......++. .
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~ 241 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----S 241 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT----T
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC----C
Confidence 455679999999999986 4589999999999999999999999975 3344566677777665543 4
Q ss_pred CChHHHHHHHHhcccCCCCCCCH------HHHhcCCCccCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITS------AEVLEHPWMREG 357 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~------~~~l~h~~~~~~ 357 (447)
+++++++||.+||+.||.+||++ +++++||||+..
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 79999999999999999999995 899999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=412.32 Aligned_cols=256 Identities=27% Similarity=0.506 Sum_probs=218.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHH-HhccCCCCeeEEEEEEEeCCeEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIM-QHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l-~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
+.|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|..++ +.+. ||||+++++++.+.+.+|+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEEEE
Confidence 4599999999999999999999999999999999877665555556677788774 5565 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~ 251 (447)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... ..
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEeeCccccccccCC
Confidence 999999999999999988999999999999999999999999999999999999994 44579999999998643 33
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......+||+.|+|||++. ..++.++|||||||++|||++|..||.+.+..+++..+......++. .+++++++|
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~l 269 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHL 269 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----SSCHHHHHH
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHHHHH
Confidence 3455679999999999986 45899999999999999999999999999999999999887665543 479999999
Q ss_pred HHHhcccCCCCCCCH----HHHhcCCCccCC
Q 013201 331 VRKMLIQDPKKRITS----AEVLEHPWMREG 357 (447)
Q Consensus 331 i~~~L~~dp~~R~t~----~~~l~h~~~~~~ 357 (447)
|.+||+.||.+||++ .++++||||+..
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 999999999999997 699999999853
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=409.38 Aligned_cols=256 Identities=27% Similarity=0.491 Sum_probs=230.0
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..++..+.+||||+++++++.+.+.+|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 45999999999999999999999999999999997754434445677889999999886799999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CCC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~ 252 (447)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... ...
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---CCCcEEEEeCCcccccccCCc
Confidence 99999999999999888999999999999999999999999999999999999994 44579999999998643 333
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
.....+||+.|+|||++. ..++.++|||||||++|||++|..||.+.+..+++..+......++. .+++++++||
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 252 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAIC 252 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHH
Confidence 445678999999999986 45899999999999999999999999999999999999988776654 4799999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCCccC
Q 013201 332 RKMLIQDPKKRIT-----SAEVLEHPWMRE 356 (447)
Q Consensus 332 ~~~L~~dp~~R~t-----~~~~l~h~~~~~ 356 (447)
.+||..||.+||+ ++++++||||+.
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999994 699999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=401.40 Aligned_cols=247 Identities=21% Similarity=0.267 Sum_probs=192.3
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC----
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ---- 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 168 (447)
.+.|.+.+.||+|+||+||+|++ +|+.||||++.... ......+.|+..+.+++ |||||++++++.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence 45699999999999999999997 48899999885421 11223345666667787 999999999997654
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeecCCCCceEeecCCCCCceEEe
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM--------GVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~--------~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
.+|||||||+||+|.++|.. ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence 68999999999999999976 4689999999999999999999987 99999999999999 555679999
Q ss_pred cCCCceeccCCCce-----eecCCcccccccccccc-------cCCCCCcchhHHHHHHHHhhCCCCCCCC---------
Q 013201 241 DFGLSVFIDEGKVY-----RDIVGSAYYVAPEVLRR-------SYGKEIDVWSAGVILYILLSGVPPFWAE--------- 299 (447)
Q Consensus 241 Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~elltg~~pf~~~--------- 299 (447)
|||+|+........ ...+||+.|||||++.+ .|+.++|||||||+||||+||..||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 99999876544322 24589999999999864 3677899999999999999997765321
Q ss_pred ------CHHHHHHHHHhCCCCCCCCccc---cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 300 ------TEKGIFDAILKGGVDFESEPWL---LISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 300 ------~~~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
....+...+.........+... ..++.+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 2233444444444433322211 12357889999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=418.23 Aligned_cols=260 Identities=31% Similarity=0.492 Sum_probs=226.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+||
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEE
Confidence 456999999999999999999999999999999987643322333455789999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTS
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccCC
Confidence 9999999999998865 579999999999999999999999999999999999999 445579999999998776543
Q ss_pred c--eeecCCccccccccccccc-----CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 253 V--YRDIVGSAYYVAPEVLRRS-----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 253 ~--~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
. ....+||+.|+|||++.+. |+.++|||||||++|||++|..||.+.+..+.+..+..+...+..+.+..+++
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 302 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence 2 2357899999999998532 78899999999999999999999999999999999887643333344446899
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 013201 326 SAKDLVRKMLIQDPKK--RITSAEVLEHPWMREG 357 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~--R~t~~~~l~h~~~~~~ 357 (447)
++++||.+||..+|.+ |++++||++||||+..
T Consensus 303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 9999999999999998 9999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=393.31 Aligned_cols=262 Identities=32% Similarity=0.593 Sum_probs=225.3
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.+.|.+.+.||+|+||.||+|.+..++..+|+|++.+.. .....+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeE
Confidence 45677999999999999999999999999999999987643 2344678899999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 171 HLVMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999999988643 679999999999999999999999999999999999999766666789999999998
Q ss_pred eccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
............||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+......+.... ..++++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 254 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPLTPQ 254 (285)
T ss_dssp C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-CcCCHH
Confidence 7766555566789999999999988899999999999999999999999999888887777766554443322 237899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
+.+||.+||+.||++|||++|+|+||||++
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=405.69 Aligned_cols=254 Identities=31% Similarity=0.561 Sum_probs=229.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEEE
Confidence 45999999999999999999999999999999997655444445678889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECSSC--
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC---CCCCEEEcccccceeccCC--
Confidence 99999999999999988999999999999999999999999999999999999994 4457999999999876543
Q ss_pred eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+++..+..+...++. .+++++.+||.
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 270 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHH
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence 24568999999999986 45899999999999999999999999999999999999988766553 47999999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
+||+.||.+||+ ++++++||||+..
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 999999999998 9999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=407.88 Aligned_cols=257 Identities=26% Similarity=0.492 Sum_probs=228.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++ ||||+++++++.+.+.+|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEE
Confidence 356999999999999999999999999999999997665444455678899999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---CCCCEEEeccceeeeccCCC
Confidence 999999999999999888999999999999999999999999999999999999994 44579999999999877666
Q ss_pred ceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCC---CHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 253 VYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAE---TEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|..||... ........+......++. .+++
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~----~~s~ 245 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQ 245 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT----TSCH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC----cCCH
Confidence 667789999999999985 24899999999999999999999999743 445566666666555443 4799
Q ss_pred HHHHHHHHhcccCCCCCCC-HHHHhcCCCccCC
Q 013201 326 SAKDLVRKMLIQDPKKRIT-SAEVLEHPWMREG 357 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t-~~~~l~h~~~~~~ 357 (447)
++.+||.+||+.||.+||+ ++++++||||+..
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 9999999999999999998 8999999999853
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-54 Score=411.27 Aligned_cols=256 Identities=33% Similarity=0.575 Sum_probs=221.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
-+.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEE
Confidence 356999999999999999999999999999999987654333334467899999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---TTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---CCCCEEEEEeccceeccCCc
Confidence 99999 789999999989999999999999999999999999999999999999994 44569999999998877766
Q ss_pred ceeecCCccccccccccccc--CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
.....+||+.|+|||++.+. .+.++|||||||++|+|++|..||.+.........+..+...++ ..+++++.+|
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 238 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQSL 238 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHHHH
Confidence 66677999999999998754 37899999999999999999999987655444333333322222 2479999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
|.+||..||.+|||++|+++||||+..
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=408.47 Aligned_cols=261 Identities=36% Similarity=0.643 Sum_probs=227.5
Q ss_pred cccceee--cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 92 IRQFYTL--GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 92 ~~~~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+...|.+ .+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND 160 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence 3444655 678999999999999999999999999986532 345678899999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+|||||||+|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+..+ ....+||+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET-TTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC-CCCcEEEEeCCCceec
Confidence 99999999999999988764 469999999999999999999999999999999999999643 2357999999999987
Q ss_pred cCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.........+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+......++...+..+++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 7666566678999999999986 458899999999999999999999999999999999999887777766677889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
++||.+||+.||.+|||+.|+|+||||++.
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=392.72 Aligned_cols=259 Identities=29% Similarity=0.489 Sum_probs=224.1
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+..++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEE
Confidence 34567999999999999999999999999999999986543 234567889999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+|||||.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TCCEEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC---CCCEEEeeCCCceecCC
Confidence 9999999999999988764 6999999999999999999999999999999999999954 44699999999987654
Q ss_pred CC-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GK-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+........ .....+++.+.
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFR 247 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSCHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCHHHH
Confidence 33 334568999999999986 4589999999999999999999999998887776666554433221 22245899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+||.+||+.||++|||++|+|+||||+...
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 999999999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=397.81 Aligned_cols=265 Identities=35% Similarity=0.607 Sum_probs=223.4
Q ss_pred ccccceeec-ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 91 DIRQFYTLG-KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 91 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.+.+.|++. +.||+|+||.||+|++..+++.||+|++.+.. ......+.+|+.+++++.+||||+++++++.+.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 355679984 78999999999999999999999999986542 33467889999999997669999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999999998899999999999999999999999999999999999999766655569999999987653
Q ss_pred CC--------CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCC---------------
Q 013201 250 EG--------KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAET--------------- 300 (447)
Q Consensus 250 ~~--------~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~--------------- 300 (447)
.. ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 21 1123457999999999985 348999999999999999999999997754
Q ss_pred HHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 301 EKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 301 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
...+...+..+...++...+..+++++++||.+||..||.+|||++|+|+||||+...
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 2446677777777666555567899999999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=417.25 Aligned_cols=261 Identities=26% Similarity=0.468 Sum_probs=225.4
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++ ||||+++++++.+.+.+||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEEEE
Confidence 467999999999999999999999999999999987643322333345789999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcccC
Confidence 9999999999999987 5779999999999999999999999999999999999999 44557999999999876554
Q ss_pred Cce--eecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc-ccc
Q 013201 252 KVY--RDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP-WLL 322 (447)
Q Consensus 252 ~~~--~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~ 322 (447)
... ...+||+.|+|||++. +.|+.++|||||||++|||++|..||.+.+..+.+..+......+..+. +..
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 308 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence 332 3368999999999985 3589999999999999999999999999999888888876432222222 235
Q ss_pred CChHHHHHHHHhcccCCCC--CCCHHHHhcCCCccCC
Q 013201 323 ISDSAKDLVRKMLIQDPKK--RITSAEVLEHPWMREG 357 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~--R~t~~~~l~h~~~~~~ 357 (447)
+++++++||++||..+|++ |++++|+++||||+..
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 8999999999999999988 9999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=396.62 Aligned_cols=267 Identities=39% Similarity=0.699 Sum_probs=236.5
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh---hhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK---QDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..+.+.|++.+.||+|+||.||+|++..+|+.||+|++.+...... ...+.+.+|+.+++++. ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence 3466789999999999999999999999999999999876543221 24678999999999998 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC-CCceEEecCCCc
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG-GAMLKATDFGLS 245 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~-~~~vkl~Dfg~a 245 (447)
.+.+|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999998888999999999999999999999999999999999999965432 126999999999
Q ss_pred eeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+.+..+......++...+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 8877665556678999999999986 458999999999999999999999999999988888888876665544445689
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+.+.+||.+||..||++|||+.++|+||||+..
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=417.59 Aligned_cols=257 Identities=37% Similarity=0.591 Sum_probs=231.6
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|.+++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence 456999999999999999999999999999999997654433345678899999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.......
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~---~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---TTCCEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---cCCCeEEEeccchhhccccc
Confidence 999999999999998888899999999999999999999999999999999999994 44569999999999877666
Q ss_pred ceeecCCccccccccccccc--CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
.....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....+...+..+....+. .+++++.+|
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~L 246 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVISL 246 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT----TCCHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc----cCCHHHHHH
Confidence 66677999999999998754 478999999999999999999999999888888888887655443 478999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
|.+||..||.+|||++++++||||++.
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=403.13 Aligned_cols=263 Identities=33% Similarity=0.660 Sum_probs=234.6
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN-----KQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+.+.|++.+.||+|+||.||+|++..+|+.||||++....... ....+.+.+|+.+++++.+||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 45577999999999999999999999999999999886543211 1224567899999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
..+..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQIRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEEecCcc
Confidence 9999999999999999999999888999999999999999999999999999999999999994 4456999999999
Q ss_pred eeccCCCceeecCCcccccccccccc-------cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLRR-------SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE 318 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 318 (447)
............+||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+..+...+..+
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 88877666667899999999998752 47889999999999999999999999998888888888887777666
Q ss_pred ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 319 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.+..+++.+.+||.+||+.||++|||++++|+||||++
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 66778999999999999999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=396.97 Aligned_cols=273 Identities=31% Similarity=0.564 Sum_probs=236.4
Q ss_pred CCCccccccceeec-ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 013201 86 GKPLEDIRQFYTLG-KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAY 164 (447)
Q Consensus 86 ~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 164 (447)
....+.+.++|.+. +.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.+.+||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34456778889987 899999999999999999999999999865432 3445678899999999998789999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecC
Q 013201 165 EDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 165 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
.+.+.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.......+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999999988553 56999999999999999999999999999999999999966444567999999
Q ss_pred CCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 243 GLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 243 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
|++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+......+....+.
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred ccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 9998876665556678999999999986 458999999999999999999999999999988888888887777777667
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
.+++.+.+||.+||+.||.+|||++++|+||||++...
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 78999999999999999999999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=415.08 Aligned_cols=257 Identities=30% Similarity=0.532 Sum_probs=219.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEEE
Confidence 456999999999999999999999999999999997655445555667889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceecc-C
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-E 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~ 250 (447)
|||||+||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.... .
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~---~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS---SSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC---CCCEEEccCCCceeccCC
Confidence 99999999999999998899999999999999999999998 99999999999999944 4579999999997643 3
Q ss_pred CCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+...+...+......++. .+++++.+
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ 378 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKS 378 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHH
Confidence 33445678999999999986 55899999999999999999999999999999999998888766554 47999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 330 LVRKMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 330 li~~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
||.+||+.||.+|| +++|+++||||...
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999999 99999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=410.36 Aligned_cols=261 Identities=26% Similarity=0.456 Sum_probs=223.7
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..+. ||||+++++++.+.+.+||
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEEE
Confidence 467999999999999999999999999999999997644333333455789999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccCC
Confidence 999999999999998754 79999999999999999999999999999999999999 44557999999999877654
Q ss_pred Cce--eecCCccccccccccc--------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc-c
Q 013201 252 KVY--RDIVGSAYYVAPEVLR--------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP-W 320 (447)
Q Consensus 252 ~~~--~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~ 320 (447)
... ...+||+.|+|||++. +.|+.++|||||||++|||++|..||.+.+..+.+..+......+..+. .
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 332 2468999999999985 3589999999999999999999999999999888888876432221111 2
Q ss_pred ccCChHHHHHHHHhcccCCCCC---CCHHHHhcCCCccCCC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKR---ITSAEVLEHPWMREGG 358 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R---~t~~~~l~h~~~~~~~ 358 (447)
..+|+++++||.+||. +|.+| ++++|+++||||+...
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 3589999999999999 99998 5999999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=387.36 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=214.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++.+.||+|+||+||+|++..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+++.+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence 459999999999999999999999999999999865442 3445577889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
||||.+ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~---~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEeecccceecCCcc
Confidence 999976 55555554 678999999999999999999999999999999999999954 456999999999876533
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCC-CCCCCHHHHHHHHHhCCCCCCCC----------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPP-FWAETEKGIFDAILKGGVDFESE---------- 318 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~---------- 318 (447)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..| |.+.+..+.+..+.+........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 33345689999999999864 379999999999999999988777 45556666666654421111100
Q ss_pred ---------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 319 ---------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 319 ---------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
....+++++++||.+||+.||++|||++|+|+||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 112468899999999999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=389.93 Aligned_cols=265 Identities=40% Similarity=0.702 Sum_probs=233.4
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..+.+.|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIK-HENIVTLEDIYESTTH 80 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCC-CCCeeehhhhcccCCE
Confidence 346678999999999999999999999999999999986532 223457889999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++...+.+..+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999988899999999999999999999999999999999999999655556679999999997654
Q ss_pred CCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+...++.+.+..+++++.
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 32 2334579999999999864 589999999999999999999999999999999999988887777666667899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+||.+||..||.+|||++++|+||||.....
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 9999999999999999999999999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=394.45 Aligned_cols=261 Identities=33% Similarity=0.502 Sum_probs=232.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..++|.+++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence 3567999999999999999999999999999999997766556667788999999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE---DLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcC---CCCEEEeeccCceecccC
Confidence 99999999999999988889999999999999999999999999999999999999954 456999999999876532
Q ss_pred -CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 -KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+.+..+......++. .+++++.+
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 270 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAAS 270 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHH
Confidence 33345689999999999864 5889999999999999999999999998888888888777655443 47899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
||.+||+.||++|||++++|+||||......
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 9999999999999999999999999876543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=389.12 Aligned_cols=266 Identities=41% Similarity=0.721 Sum_probs=241.1
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..+.++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++++++ ||||+++++++.+.+.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCe
Confidence 4566789999999999999999999999999999999865443 2345678899999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999999888899999999999999999999999999999999999999776666689999999998766
Q ss_pred CCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.........+..+...+..+.+..+++++.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 55555556799999999999888999999999999999999999999999998888888888877776666778999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
||.+||..||.+|||+.++|+||||++.
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=390.28 Aligned_cols=260 Identities=26% Similarity=0.363 Sum_probs=214.0
Q ss_pred CCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
.+.+.+.++|++.+.||+|+||+||+|++..+++.||||++.... ...........|+..+.++.+||||+++++++.+
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF-RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC-CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc-cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 344556678999999999999999999999999999999875432 2344455666777777777569999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
.+.+|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~---~~~~kl~DFG~a 204 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP---RGRCKLGDFGLL 204 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECG---GGCEEECCCTTC
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC---CCCEEEccceee
Confidence 99999999999 668988887654 5999999999999999999999999999999999999954 446999999999
Q ss_pred eeccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.............||+.|+|||++.+.++.++|||||||++|||++|..||.+... ...+..+.. +......+++
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~ 279 (311)
T 3p1a_A 205 VELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYL--PPEFTAGLSS 279 (311)
T ss_dssp EECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCC--CHHHHTTSCH
T ss_pred eecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCC--CcccccCCCH
Confidence 88766555556789999999999988899999999999999999999877765422 333333321 1112235799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
++.+||.+||+.||++|||++++|+||||++
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=405.69 Aligned_cols=265 Identities=31% Similarity=0.473 Sum_probs=211.7
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ- 168 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 168 (447)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+. .........+.+|+.+++++.+||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 34567799999999999999999999999999999988543 3445566788899999999988999999999997544
Q ss_pred -eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 -SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 -~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.+|+|||||. ++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+++.
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGLSRS 158 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc---CCCCEEecCCccccc
Confidence 7999999997 589888766 5799999999999999999999999999999999999994 445799999999986
Q ss_pred ccC----------------------CCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH
Q 013201 248 IDE----------------------GKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKG 303 (447)
Q Consensus 248 ~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 303 (447)
... .......+||+.|+|||++.+ .++.++|||||||++|||++|.+||.+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 532 112344689999999999864 58999999999999999999999999998887
Q ss_pred HHHHHHhCCCCCC------------------------------C-------------CccccCChHHHHHHHHhcccCCC
Q 013201 304 IFDAILKGGVDFE------------------------------S-------------EPWLLISDSAKDLVRKMLIQDPK 340 (447)
Q Consensus 304 ~~~~i~~~~~~~~------------------------------~-------------~~~~~~s~~~~~li~~~L~~dp~ 340 (447)
.+..+........ . .+...+++++.+||.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 7777653210000 0 00115688999999999999999
Q ss_pred CCCCHHHHhcCCCccCCCCC
Q 013201 341 KRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 341 ~R~t~~~~l~h~~~~~~~~~ 360 (447)
+|||++|+|+||||+.....
T Consensus 319 ~R~t~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 319 KRISANDALKHPFVSIFHNP 338 (388)
T ss_dssp GSCCHHHHTTSTTTTTTCCG
T ss_pred cCCCHHHHhCCHHHHHhcCC
Confidence 99999999999999865443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=385.77 Aligned_cols=265 Identities=37% Similarity=0.664 Sum_probs=236.4
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC------hhhHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN------KQDREDIKREIQIMQHLSGQQNIVEFRGAY 164 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 164 (447)
.+.++|++.+.||+|+||.||+|++..+++.||+|++....... ....+.+.+|+.+++++.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34567999999999999999999999999999999986543111 123466889999999997799999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 165 EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 165 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
.+.+..|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD---DMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC---CCcEEEecccc
Confidence 999999999999999999999998889999999999999999999999999999999999999944 45699999999
Q ss_pred ceeccCCCceeecCCccccccccccc-------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLR-------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES 317 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 317 (447)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..+...+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 98877666666778999999999874 24788999999999999999999999999988888888888887777
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+.+..+++.+.+||.+||+.||.+|||++++|+||||++..
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 77778899999999999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=392.39 Aligned_cols=257 Identities=32% Similarity=0.562 Sum_probs=216.1
Q ss_pred ccceeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccC-ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLV-NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
.+.|++.+.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+++.++ ||||+++++++.+.+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence 456999999999999999999985 68999999998765332 2234566789999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+|+|||||+|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKES 171 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTSCEEECCCSCC---
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---CCCcEEEEeCCccccc
Confidence 9999999999999999999888999999999999999999999999999999999999994 4457999999999764
Q ss_pred cC-CCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 249 DE-GKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 249 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.. .......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+....+..+......++. .++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~ 247 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQE 247 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSCHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence 33 23344568999999999986 45899999999999999999999999999998899998887665543 47999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 327 AKDLVRKMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
+++||.+||..||.+|| +++++++||||+..
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 99999999999999999 89999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=390.72 Aligned_cols=263 Identities=26% Similarity=0.452 Sum_probs=215.2
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
.+.+.++|++.+.||+|+||+||+|++. +++.||+|++.... ........+.+|+.++++++ ||||+++++++.+.+
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSER 92 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSS
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCC
Confidence 3456778999999999999999999986 58999999885432 23334567889999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.+++|||||++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~---~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS---DGALKLADFGLARA 168 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTCEE
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC---CCCEEEccCcCcee
Confidence 99999999975 788887765 45999999999999999999999999999999999999954 44699999999987
Q ss_pred ccCC-CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC-------
Q 013201 248 IDEG-KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES------- 317 (447)
Q Consensus 248 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------- 317 (447)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.........
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 6533 33445689999999999854 5899999999999999999999999887776666655431111100
Q ss_pred ---------------Cc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 318 ---------------EP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 318 ---------------~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.. ...+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 00 123678999999999999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=389.69 Aligned_cols=264 Identities=25% Similarity=0.369 Sum_probs=216.1
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC--hhhHHHHHHHHHHHHhcc--CCCCeeEEEEEEEe
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN--KQDREDIKREIQIMQHLS--GQQNIVEFRGAYED 166 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~--~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~ 166 (447)
.+.++|++.+.||+|+||+||+|++..+++.||+|++....... ......+.+|+.+++++. +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34567999999999999999999999999999999986543211 122345677888887775 49999999999987
Q ss_pred CC-----eEEEEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEE
Q 013201 167 RQ-----SVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 167 ~~-----~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
.. .+++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ .+..+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---TTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEE
Confidence 65 5899999996 599999987654 99999999999999999999999999999999999994 4456999
Q ss_pred ecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Q 013201 240 TDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE 318 (447)
Q Consensus 240 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 318 (447)
+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+....+..+.......+..
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9999998776655556678999999999985 568999999999999999999999999998888777776532111111
Q ss_pred c-----------------------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 319 P-----------------------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 319 ~-----------------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
. ...+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1 124788999999999999999999999999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=396.26 Aligned_cols=264 Identities=27% Similarity=0.446 Sum_probs=213.6
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..++|++.+.||+|+||+||+|++..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+++.+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEE
Confidence 34569999999999999999999999999999999865432 2333456789999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC--CCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD--GGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~~~vkl~Dfg~a~~~~ 249 (447)
|||||+.| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++....
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999974 9999999988999999999999999999999999999999999999996443 34569999999998664
Q ss_pred CC-CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc------
Q 013201 250 EG-KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW------ 320 (447)
Q Consensus 250 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------ 320 (447)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........+
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 32 23345688999999999864 4899999999999999999999999998887777766542111111100
Q ss_pred --------------------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 321 --------------------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 321 --------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
..+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 12688999999999999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=411.58 Aligned_cols=264 Identities=37% Similarity=0.660 Sum_probs=220.0
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-----QDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+.+.|.+.+.||+|+||.||+|.+..+++.||+|++.+...... .....+.+|+.+|++++ ||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 456789999999999999999999999999999999976543221 12235789999999997 999999999985
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
.+.+|+|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4568999999999999999988889999999999999999999999999999999999999987666678999999999
Q ss_pred eeccCCCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCCCCCCcc
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~ 320 (447)
............+||+.|+|||++. ..++.++|||||||++|+|++|..||..... ......+..+...+....+
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 8877665566778999999999974 3578899999999999999999999976543 3445566666666555555
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
..+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 678999999999999999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=415.06 Aligned_cols=256 Identities=29% Similarity=0.540 Sum_probs=226.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|++++ ||||+++++++.+.+.+||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEEE
Confidence 456999999999999999999999999999999997655444445677889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld---~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe---CCCCeEEEecccceeccc
Confidence 9999999999999987544 99999999999999999999999999999999999994 445799999999998877
Q ss_pred CCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC----HHHHHHHHHhCCCCCCCCccccCCh
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAET----EKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.. ...+...+......++ ..+++
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s~ 414 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSP 414 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCCH
Confidence 666667799999999999864 58999999999999999999999998753 3455666666544443 25799
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHhcCCCccC
Q 013201 326 SAKDLVRKMLIQDPKKRI-----TSAEVLEHPWMRE 356 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~-----t~~~~l~h~~~~~ 356 (447)
++++||.+||+.||.+|| +++|+++||||+.
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999999999999999999 8999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=392.84 Aligned_cols=259 Identities=31% Similarity=0.525 Sum_probs=217.1
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++ ||||+++++++.+.+..|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence 34669999999999999999999999999999999864432 223466889999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+|||||+|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE---RDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeC---CCCEEEEEeeccceeccC
Confidence 99999999999999988888999999999999999999999999999999999999954 446999999999865432
Q ss_pred C---ceeecCCccccccccccccc--CCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCCCCCccccCCh
Q 013201 252 K---VYRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 252 ~---~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
. .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||...... ..+........ ....+..+++
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS 236 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCCH
Confidence 2 23456899999999998643 477899999999999999999999876554 22333333322 2233557899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.+.+||.+||..||++|||++|+++||||++..
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999999999998653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=387.19 Aligned_cols=257 Identities=29% Similarity=0.554 Sum_probs=216.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh-----------------------hhHHHHHHHHHHHH
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-----------------------QDREDIKREIQIMQ 149 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-----------------------~~~~~~~~E~~~l~ 149 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|++.+...... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3569999999999999999999999999999999876543211 12356889999999
Q ss_pred hccCCCCeeEEEEEEEe--CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceE
Q 013201 150 HLSGQQNIVEFRGAYED--RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFL 227 (447)
Q Consensus 150 ~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nil 227 (447)
+++ ||||+++++++.+ .+.+|+||||+++++|.+++ ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 92 ~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 997 9999999999987 67899999999999998754 3457999999999999999999999999999999999999
Q ss_pred eecCCCCCceEEecCCCceeccCCC-ceeecCCccccccccccccc----CCCCCcchhHHHHHHHHhhCCCCCCCCCHH
Q 013201 228 LSNKDGGAMLKATDFGLSVFIDEGK-VYRDIVGSAYYVAPEVLRRS----YGKEIDVWSAGVILYILLSGVPPFWAETEK 302 (447)
Q Consensus 228 l~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~ 302 (447)
++ .+..+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus 170 ~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 170 VG---EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EC---TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EC---CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 94 44569999999998765433 33456899999999998643 377899999999999999999999998888
Q ss_pred HHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 303 GIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 303 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.....+......++.. ..+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 247 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQ--PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHCCCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHhcccCCCCCc--cccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 8877777765554432 357999999999999999999999999999999963
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=413.44 Aligned_cols=263 Identities=28% Similarity=0.406 Sum_probs=199.8
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED---- 166 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---- 166 (447)
.+.++|++.+.||+|+||+||+|++..+++.||||++.+. .......+.+.+|+.+|++++ ||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcc
Confidence 3456799999999999999999999999999999988543 334556678999999999997 9999999999843
Q ss_pred -CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 167 -RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 167 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
...+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~~~~kl~DFGla 203 (458)
T 3rp9_A 128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN---QDCSVKVCDFGLA 203 (458)
T ss_dssp TCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECCCTTC
T ss_pred cCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC---CCCCEeecccccc
Confidence 36799999998 569999998888899999999999999999999999999999999999994 4457999999999
Q ss_pred eeccCC----------------------------CceeecCCcccccccccc-c-ccCCCCCcchhHHHHHHHHhh----
Q 013201 246 VFIDEG----------------------------KVYRDIVGSAYYVAPEVL-R-RSYGKEIDVWSAGVILYILLS---- 291 (447)
Q Consensus 246 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~ellt---- 291 (447)
+..... ......+||+.|+|||++ . ..|+.++||||||||||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 875422 123456899999999976 3 459999999999999999999
Q ss_pred -------CCCCCCCCCH--------------------HHHHHHHHhC--C--------------------C-C----CCC
Q 013201 292 -------GVPPFWAETE--------------------KGIFDAILKG--G--------------------V-D----FES 317 (447)
Q Consensus 292 -------g~~pf~~~~~--------------------~~~~~~i~~~--~--------------------~-~----~~~ 317 (447)
|.++|.+... ...+..+... . . . ...
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 6777765431 1222222110 0 0 0 001
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
..+..+++++.+||.+||..||++|||++|+|+||||++...
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 112346899999999999999999999999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=398.83 Aligned_cols=270 Identities=36% Similarity=0.598 Sum_probs=231.5
Q ss_pred CCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC--ChhhHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 013201 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV--NKQDREDIKREIQIMQHLSGQQNIVEFRGAY 164 (447)
Q Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 164 (447)
.....+.++|++.+.||+|+||.||+|++..++..||+|++.+.... .....+.+.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 97 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY 97 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence 34456778899999999999999999999999999999998765332 2345678999999999997 99999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHH----------------------------------------cCCCCHHHHHHHHHHH
Q 013201 165 EDRQSVHLVMELCSGGELFDKIIA----------------------------------------QGHYTEKAAAALCRAI 204 (447)
Q Consensus 165 ~~~~~~~lv~e~~~g~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi 204 (447)
.+.+..++|||||+||+|.+++.. ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 999999999999999999998742 1113677889999999
Q ss_pred HHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-----ceeecCCccccccccccc---ccCCCC
Q 013201 205 VNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-----VYRDIVGSAYYVAPEVLR---RSYGKE 276 (447)
Q Consensus 205 l~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~ 276 (447)
+.||.|||++||+||||||+|||++.++ ...+||+|||++....... ......||+.|+|||++. ..++.+
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSS-SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCC-CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999999999999999999996432 3469999999998654321 234568999999999985 458999
Q ss_pred CcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 277 IDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 277 ~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
+|||||||++|+|++|..||.+....+....+......+..+.+..+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 99999999999999999999999999999999998888777777778999999999999999999999999999999987
Q ss_pred CC
Q 013201 357 GG 358 (447)
Q Consensus 357 ~~ 358 (447)
..
T Consensus 337 ~~ 338 (345)
T 3hko_A 337 FS 338 (345)
T ss_dssp TS
T ss_pred Ch
Confidence 54
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=382.39 Aligned_cols=259 Identities=31% Similarity=0.604 Sum_probs=226.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++++. ||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEE
Confidence 456999999999999999999999999999999987654433444677899999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---TTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---CCCCEEEEeccccccCCcc-
Confidence 999999999999999888999999999999999999999999999999999999994 4456999999998654433
Q ss_pred ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++. .+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li 238 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLI 238 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHHHHH
Confidence 2345689999999999864 5789999999999999999999999999988888888877655543 4789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
.+||+.||.+|||+.|+|+||||+.....
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HHHhccChhhCCCHHHHhhCccccCCccC
Confidence 99999999999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=427.46 Aligned_cols=258 Identities=26% Similarity=0.478 Sum_probs=232.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|+++.+++.||||++.+.........+.+..|..++..+.+||+|+.+++++.+.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 35699999999999999999999999999999999765443444567788999999998779999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc-CC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~ 251 (447)
||||++||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++.... ..
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~---~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC---SSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc---CCCcEEEeecceeeccccCC
Confidence 999999999999999989999999999999999999999999999999999999994 44579999999998643 33
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......+||+.|+|||++. ..|+.++|||||||+||||++|..||.+.+..+++..|......++. .+++++++|
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 572 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI 572 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHH
Confidence 4455679999999999986 56899999999999999999999999999999999999998776664 479999999
Q ss_pred HHHhcccCCCCCCCH-----HHHhcCCCccCC
Q 013201 331 VRKMLIQDPKKRITS-----AEVLEHPWMREG 357 (447)
Q Consensus 331 i~~~L~~dp~~R~t~-----~~~l~h~~~~~~ 357 (447)
|.+||+.||++|+++ +||++||||+..
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 999999999999997 999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=389.28 Aligned_cols=260 Identities=24% Similarity=0.405 Sum_probs=206.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.++++++ ||||+++++++.+++.+|+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEE
Confidence 45999999999999999999999999999999986543 2333467889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 174 MELCSGGELFDKIIAQ------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
|||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~---~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK---RGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC---CCCEEECcCcccee
Confidence 99997 5999988764 35899999999999999999999999999999999999954 44699999999987
Q ss_pred ccCC-CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC------
Q 013201 248 IDEG-KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE------ 318 (447)
Q Consensus 248 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 318 (447)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+........
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 6532 23345689999999999864 58999999999999999999999999988887777765421100000
Q ss_pred ------------------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 319 ------------------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 319 ------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
....+++++.+||.+||+.||++|||++|+|+||||++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 011468899999999999999999999999999999986544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=382.30 Aligned_cols=265 Identities=40% Similarity=0.720 Sum_probs=230.2
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh---hhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK---QDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+.+.|++.+.||+|+||.||+|++..+++.||+|++........ ...+.+.+|+.+++++. ||||+++++++.+.+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence 45679999999999999999999999999999999876543322 24678999999999998 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC-CCCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD-GGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~~~vkl~Dfg~a~~ 247 (447)
..++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999999888999999999999999999999999999999999999996543 234699999999988
Q ss_pred ccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 248 IDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
...........||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+......+....+..+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 76655556678999999999986 45899999999999999999999999999888888888777666554444568999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+.+||.+||..||++|||+.++|+||||+..
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=398.19 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=216.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccC-CCCeeEEEEEEEeCCeEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG-QQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~~~~~ 171 (447)
.+.|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+++.+ ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 4569999999999999999999865 99999999865432 44566789999999999974 799999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+|||++......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~----~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS----SCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC----CeEEEEecCccccccCC
Confidence 9999 568899999999889999999999999999999999999999999999999932 36999999999876543
Q ss_pred C---ceeecCCcccccccccccc------------cCCCCCcchhHHHHHHHHhhCCCCCCCCC-HHHHHHHHHhCCCCC
Q 013201 252 K---VYRDIVGSAYYVAPEVLRR------------SYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFDAILKGGVDF 315 (447)
Q Consensus 252 ~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~ 315 (447)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+..+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 2 2245689999999999853 58889999999999999999999998754 335566666655444
Q ss_pred CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 316 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
..+. ..++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 288 ~~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 EFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCCc--cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 3332 3578999999999999999999999999999998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=384.51 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=211.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++.+.||+|+||.||+|++ .+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+.+.+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence 4599999999999999999998 5789999999865432 2233467889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEeECccccccCccc
Confidence 999975 898888764 6799999999999999999999999999999999999994 4456999999999765432
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE------------- 316 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------------- 316 (447)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+......
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 23345689999999999853 489999999999999999999999999888777666654210000
Q ss_pred --------CCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 317 --------SEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 317 --------~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
..+ ...+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000 12478999999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=393.14 Aligned_cols=264 Identities=38% Similarity=0.669 Sum_probs=222.9
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC-----ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-----NKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+.+.|++.+.||+|+||.||+|++..+++.||||++.+.... .......+.+|+.+++++. ||||+++++++.
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEc
Confidence 4567799999999999999999999999999999998654321 1122345789999999997 999999999997
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
.+. +|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 665 8999999999999999988888999999999999999999999999999999999999977666667999999999
Q ss_pred eeccCCCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCCCCCcc
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPW 320 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 320 (447)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .+...+..+...+....+
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 8876655445668999999999873 45889999999999999999999999765433 345555666555444444
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
..+++.+.+||.+||..||++|||++++|+||||++
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 568999999999999999999999999999999976
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=397.81 Aligned_cols=262 Identities=19% Similarity=0.296 Sum_probs=215.9
Q ss_pred ccceeecceeccc--cCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 93 RQFYTLGKELGRG--QFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 93 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.++|++.+.||+| +||.||+|++..+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEE
Confidence 3569999999999 999999999999999999999876533 3455678889999999998 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 171 HLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~---~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccccceee
Confidence 9999999999999999876 6799999999999999999999999999999999999994 4447999999998654
Q ss_pred cCCC--------ceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--
Q 013201 249 DEGK--------VYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF-- 315 (447)
Q Consensus 249 ~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-- 315 (447)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+..+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 3211 1122479999999999864 58999999999999999999999998766555444433222110
Q ss_pred ----------------------------------------CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 316 ----------------------------------------ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 316 ----------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
..+....+++++.+||.+||+.||++|||++|+|+||||+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 0011234789999999999999999999999999999998
Q ss_pred CCCC
Q 013201 356 EGGE 359 (447)
Q Consensus 356 ~~~~ 359 (447)
+...
T Consensus 339 ~~~~ 342 (389)
T 3gni_B 339 QIKR 342 (389)
T ss_dssp GC--
T ss_pred HHhh
Confidence 7643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=379.48 Aligned_cols=262 Identities=33% Similarity=0.500 Sum_probs=232.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..++|.+.+.||+|+||.||+|.+..+++.+|+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEEE
Confidence 3467999999999999999999999999999999997766555666788999999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc---CCCCEEEEeccCceecccC
Confidence 9999999999999998888999999999999999999999999999999999999994 4456999999999876532
Q ss_pred -CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 -KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+. .+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 244 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAAS 244 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCHHHHH
Confidence 33345689999999999864 4889999999999999999999999998888888887776554443 47899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
||.+||+.||++|||++++++||||.......
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 99999999999999999999999998865544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=379.23 Aligned_cols=258 Identities=32% Similarity=0.641 Sum_probs=228.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+.+|+|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEEE
Confidence 56999999999999999999999999999999987654333334577899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY---KGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT---TCCEEECCCTTCEECSSSC-
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcC---CCCEEEecccccccCcccc-
Confidence 999999999999998889999999999999999999999999999999999999954 4469999999997654432
Q ss_pred eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++. .++..+++||.
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~ 244 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLIS 244 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHH
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC----cCCHHHHHHHH
Confidence 345689999999999864 5899999999999999999999999998888888888776555442 47899999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 333 KMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
+||..||.+|||++++++||||+.....
T Consensus 245 ~~l~~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 245 KLLRYHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp HHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred HHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence 9999999999999999999999875443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=409.06 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=210.5
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC---
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--- 167 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--- 167 (447)
.+.++|++.+.||+|+||+||+|++..+++.||||++.+. .........+.+|+.+|+.++ ||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence 4567899999999999999999999999999999998654 334555678899999999997 99999999999654
Q ss_pred ---CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 168 ---QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
..+||||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---~~~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---CCCCEEEEEEEe
Confidence 468999999976 5666653 3599999999999999999999999999999999999994 445799999999
Q ss_pred ceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---------
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD--------- 314 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------- 314 (447)
+............+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+....
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 98877665566789999999999986 46999999999999999999999999998887777666542110
Q ss_pred -------------CCCCccc----------------cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 315 -------------FESEPWL----------------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 315 -------------~~~~~~~----------------~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.....+. ..++++++||.+||..||++|||++|+|+||||+..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0000000 015679999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=394.65 Aligned_cols=264 Identities=25% Similarity=0.426 Sum_probs=215.7
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
....+.+.|++.+.||+|+||.||+|++..+|+.||+|++... .........+.+|+.++++++ ||||+++++++...
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD 96 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecC
Confidence 3445677899999999999999999999999999999988543 334455678899999999998 99999999999765
Q ss_pred ------CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 168 ------QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 ------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~D 171 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---DCELKILD 171 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECC
T ss_pred CccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC---CCCEEEEe
Confidence 3569999999 7899988876 67999999999999999999999999999999999999944 45699999
Q ss_pred CCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD----- 314 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~----- 314 (447)
||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+.+....
T Consensus 172 fg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 172 FGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9999876542 345689999999998864 5899999999999999999999999998887777666542111
Q ss_pred ------------------CCCCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 315 ------------------FESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 315 ------------------~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
..... +..+++++.+||.+||..||.+|||++++|+||||++....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 01111 12468999999999999999999999999999999876443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=391.99 Aligned_cols=264 Identities=24% Similarity=0.374 Sum_probs=221.4
Q ss_pred cCCCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc----CCCCeeEE
Q 013201 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS----GQQNIVEF 160 (447)
Q Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~ 160 (447)
...+...+.++|++.+.||+|+||.||+|++..+++.||+|++.. .......+..|+.+++.+. +||||+++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 345556677889999999999999999999999999999998853 2344566788999999986 49999999
Q ss_pred EEEEEeCCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC-------
Q 013201 161 RGAYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK------- 231 (447)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~------- 231 (447)
++++...+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999999 889999998764 49999999999999999999999999999999999999641
Q ss_pred ---------------CCCCceEEecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCC
Q 013201 232 ---------------DGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPP 295 (447)
Q Consensus 232 ---------------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~p 295 (447)
.....+||+|||++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 12457999999999875443 24568999999999986 4589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCCCCCCCc------------------------------------------cccCChHHHHHHHH
Q 013201 296 FWAETEKGIFDAILKGGVDFESEP------------------------------------------WLLISDSAKDLVRK 333 (447)
Q Consensus 296 f~~~~~~~~~~~i~~~~~~~~~~~------------------------------------------~~~~s~~~~~li~~ 333 (447)
|......+.+..+......++... ....++.+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 998888777666554322211000 00124778899999
Q ss_pred hcccCCCCCCCHHHHhcCCCcc
Q 013201 334 MLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 334 ~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
||+.||++|||++|+|+||||+
T Consensus 339 ~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HCCSSGGGSCCHHHHTTSGGGC
T ss_pred HhcCChhhCCCHHHHhcCcccC
Confidence 9999999999999999999995
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=377.64 Aligned_cols=259 Identities=37% Similarity=0.587 Sum_probs=219.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEE
Confidence 3466999999999999999999999999999999986654333345678899999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ .+..+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---TTSCEEECCCCGGGCCCC-
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---CCCCEEEeecccccccCCC
Confidence 9999999999999999888999999999999999999999999999999999999994 4456999999999877665
Q ss_pred CceeecCCccccccccccccc-C-CCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLRRS-Y-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
.......||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+..+....+. .++..+.+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~ 240 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVAT 240 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch----hcCHHHHH
Confidence 555567899999999998754 3 67999999999999999999999998888888888776554432 46899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+|.+||+.||.+|||++++++||||++..
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=383.08 Aligned_cols=261 Identities=28% Similarity=0.507 Sum_probs=215.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEEE
Confidence 56999999999999999999999999999999885542 23444577889999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-C
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-K 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 252 (447)
||||++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++ .+..+||+|||++...... .
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---CCCCEEEeeCCCchhccCccc
Confidence 99999999999888888899999999999999999999999999999999999994 4457999999999876533 2
Q ss_pred ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------------------
Q 013201 253 VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG------------------ 312 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~------------------ 312 (447)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+.+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3345689999999999853 58999999999999999999999999888776665543310
Q ss_pred -CCCCCC--------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 313 -VDFESE--------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 313 -~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
...+.+ .+..+++++.+||.+||+.||.+|||++|+|+||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 011111 01357889999999999999999999999999999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=407.94 Aligned_cols=256 Identities=29% Similarity=0.530 Sum_probs=224.7
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+.+|+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEEE
Confidence 356999999999999999999999999999999997655444445677889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 173 VMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~---~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe---CCCCEEEeecceeeec
Confidence 99999999999998764 3699999999999999999999999999999999999994 4457999999999877
Q ss_pred cCCCc-eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCC----CHHHHHHHHHhCCCCCCCCcccc
Q 013201 249 DEGKV-YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 249 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
..... ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+. ...++...+......++. .
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~----~ 415 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD----K 415 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT----T
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc----c
Confidence 65433 344689999999999874 5899999999999999999999999875 346677777777655543 4
Q ss_pred CChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCccC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRIT-----SAEVLEHPWMRE 356 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t-----~~~~l~h~~~~~ 356 (447)
+++++++||.+||+.||.+||+ ++++++||||+.
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 7999999999999999999996 589999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=402.28 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=211.3
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
..+.....|++.+.||+|+||+||+|++..++. +|+|++..... ...+|+.+++.++ ||||+++++++...
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~-h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVK-HPNVVDLKAFFYSN 104 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCC-CCCcceEEEEEEec
Confidence 334456679999999999999999999987665 88887754322 1237999999997 99999999998544
Q ss_pred C------eEEEEEeccCCCchHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCce
Q 013201 168 Q------SVHLVMELCSGGELFDKII----AQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 168 ~------~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
+ .+++|||||+++ +...+. ....+++..++.++.||+.||.|||++||+||||||+|||++. .+..+
T Consensus 105 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEE
T ss_pred CCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CCCcE
Confidence 3 388999999764 434333 2567999999999999999999999999999999999999963 23479
Q ss_pred EEecCCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---
Q 013201 238 KATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG--- 312 (447)
Q Consensus 238 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--- 312 (447)
||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+..
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999998766666667789999999999854 48999999999999999999999999988777666665421
Q ss_pred --------------CCCC---CCc-----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 313 --------------VDFE---SEP-----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 313 --------------~~~~---~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
..++ ..+ ...+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0010 001 1137889999999999999999999999999999987544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=384.49 Aligned_cols=255 Identities=28% Similarity=0.489 Sum_probs=213.7
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQSV 170 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~ 170 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|++.. ...+.+.+|+.+++++.+||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc------cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 4679999999999999999999999999999998853 2346789999999999889999999999988 6789
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++.....
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCCTTCEECCT
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC--CEEEEEeCCCceEcCC
Confidence 99999999999988763 489999999999999999999999999999999999996543 2699999999988776
Q ss_pred CCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCC-HHHHHHHH-------------HhCCCC
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAET-EKGIFDAI-------------LKGGVD 314 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i-------------~~~~~~ 314 (447)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ..+.+..+ ......
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 666667789999999999864 58999999999999999999999996543 22222221 111111
Q ss_pred CC--------------------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 315 FE--------------------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 315 ~~--------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.. ......+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11 111223799999999999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=379.90 Aligned_cols=256 Identities=29% Similarity=0.544 Sum_probs=222.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..|+|
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEE
Confidence 34888889999999999999999999999999986432 334677889999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-C
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-K 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 252 (447)
|||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++...... .
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TCCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCcEEEeeeeeeeecccCcc
Confidence 999999999998754 57999999999999999999999999999999999999954 446999999999876543 2
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+....... ......+++.+.+||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHH
Confidence 334568999999999986 458999999999999999999999999988888777776654322 122345799999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.+||+.||++|||+.++|+||||.+..
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=377.30 Aligned_cols=257 Identities=30% Similarity=0.529 Sum_probs=197.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++++++ ||||+++++++.+.+..|+|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEEE
Confidence 45999999999999999999999999999999986554333334578899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. +..+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR---NMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT---TCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCCEEEEeecceeeccCCC
Confidence 9999999999999875 56999999999999999999999999999999999999944 456999999999876532
Q ss_pred CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.......+ ..++.++.+|
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l 242 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEAKDL 242 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCHHHHHH
Confidence 2233467999999999986 4588999999999999999999999987766555544433332222 2478999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 331 VRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 331 i~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
|.+||..||++|||++++++||||.+..
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=389.98 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=218.5
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK-----QDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.+...... .....+.+|+.++++++ ||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 456789999999999999999999999999999999976543221 13345678999999997 999999999999
Q ss_pred eCCeEEEEEeccCCC-chHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 166 DRQSVHLVMELCSGG-ELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~-~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
+.+.+++||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcEEEeeccc
Confidence 999999999999766 9999999888999999999999999999999999999999999999994 445799999999
Q ss_pred ceeccCCCceeecCCccccccccccccc--CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
+............+||+.|+|||++.+. ++.++|||||||++|+|++|..||..... ...... .....
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~----~~~~~ 246 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI----HPPYL 246 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC----CCSSC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc----CCCcc
Confidence 9988776666678899999999998643 37889999999999999999999976322 111111 11224
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+++++.+||.+||+.||++|||++++++||||++..
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 799999999999999999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=373.84 Aligned_cols=258 Identities=23% Similarity=0.424 Sum_probs=218.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----RQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~ 168 (447)
.+.|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+.+|+.++++++ ||||+++++++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCc
Confidence 3459999999999999999999999999999998865443 4556778999999999997 9999999999875 46
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
.+++||||+++++|.+++.....+++..++.++.||+.||.|||+.| |+||||||+|||++. .+..+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeCCCcc
Confidence 68999999999999999998889999999999999999999999999 999999999999952 33469999999997
Q ss_pred eccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCCCCCccccCCh
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
..... ......||+.|+|||++.+.++.++||||||+++|+|++|..||....... ....+..+... .......++
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIP 257 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCH
T ss_pred ccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--cccCCCCCH
Confidence 54443 344568999999999998889999999999999999999999998855444 44444333221 112234678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
++.+||.+||+.||.+|||++++|+||||++.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 99999999999999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=386.54 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=222.4
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
...+.|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA 129 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeE
Confidence 34567999999999999999999999999999999987654434445577899999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|+||||+. |+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++. +..+||+|||++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET---TTEEEECCCTTCBSSS
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC---CCCEEEeeccCceecC
Confidence 99999997 578787754 567999999999999999999999999999999999999954 4479999999997664
Q ss_pred CCCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.. ....||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+....+..+..+...... ...+++
T Consensus 206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 280 (348)
T 1u5q_A 206 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSE 280 (348)
T ss_dssp SB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC--CTTSCH
T ss_pred CC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCH
Confidence 42 3468999999999873 45899999999999999999999999988887777777665433222 235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.+.+||.+||+.||++|||++++++||||....
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 999999999999999999999999999998643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=396.58 Aligned_cols=265 Identities=28% Similarity=0.442 Sum_probs=211.5
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR-- 167 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 167 (447)
..+.++|++.+.||+|+||.||+|++..+++.||||++.+. .........+.+|+.+|++++ ||||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCC
Confidence 34567799999999999999999999999999999998543 334556678999999999998 99999999999766
Q ss_pred ---CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 168 ---QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~~kL~DFGl 175 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVCDFGL 175 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC---CCCCEEEccCCC
Confidence 67999999996 59999998888899999999999999999999999999999999999994 445799999999
Q ss_pred ceeccCCC-----------------------ceeecCCcccccccccc-c-ccCCCCCcchhHHHHHHHHhhC-------
Q 013201 245 SVFIDEGK-----------------------VYRDIVGSAYYVAPEVL-R-RSYGKEIDVWSAGVILYILLSG------- 292 (447)
Q Consensus 245 a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~elltg------- 292 (447)
+....... .....+||+.|+|||++ . ..|+.++|||||||++|||++|
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 98765432 23567899999999986 3 4599999999999999999984
Q ss_pred ----CCCCCCCC-----------------HHHHHHHHHh------------------------CCCCCCCC---ccccCC
Q 013201 293 ----VPPFWAET-----------------EKGIFDAILK------------------------GGVDFESE---PWLLIS 324 (447)
Q Consensus 293 ----~~pf~~~~-----------------~~~~~~~i~~------------------------~~~~~~~~---~~~~~s 324 (447)
.++|.+.+ ....+..+.. .....+.. .+..++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 34443332 1122222211 00000000 123579
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
+++.+||.+||..||++|||++|+|+||||++....
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 999999999999999999999999999999976544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=389.70 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=221.6
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ- 168 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 168 (447)
..+.++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.++++++ ||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCC
Confidence 345677999999999999999999999999999999987655555556678899999999997 999999999987654
Q ss_pred ---eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 169 ---SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 169 ---~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
..|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a 163 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIA 163 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT---SCEEECCCSCC
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC---CCEEEeeccCc
Confidence 359999999999999999988899999999999999999999999999999999999999554 46999999999
Q ss_pred eeccCCC----ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Q 013201 246 VFIDEGK----VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 246 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 320 (447)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 8664432 2234579999999999864 5899999999999999999999999999888877777776544433334
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
..+++++.+||.+||+.||.+||++.++|.|+|++..
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 4589999999999999999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=387.40 Aligned_cols=263 Identities=27% Similarity=0.420 Sum_probs=217.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe------
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED------ 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------ 166 (447)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence 4569999999999999999999999999999998865433 2333456789999999998 9999999999987
Q ss_pred --CCeEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 167 --RQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 167 --~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
.+.+|+|||||.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCCEEEccch
Confidence 4578999999975 777777654 5699999999999999999999999999999999999994 44579999999
Q ss_pred CceeccCC-----CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 013201 244 LSVFIDEG-----KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316 (447)
Q Consensus 244 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 316 (447)
++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99876422 22345689999999998853 489999999999999999999999999888877777655322222
Q ss_pred CCcccc----------------------------CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 317 SEPWLL----------------------------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 317 ~~~~~~----------------------------~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
...+.. .++.+.+||.+||+.||++|||++|+|+||||+......
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 221111 267899999999999999999999999999998765443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=387.49 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=210.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+++.||+|++..... ......+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence 459999999999999999999999999999998854321 111123457999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 174 MELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||+. |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~---~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE---RGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT---TCCEEECSSSEEECC----
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC---CCCEEEccCcccccccCCc
Confidence 99997 58988888754 4999999999999999999999999999999999999954 446999999999765432
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc----------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP---------- 319 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~---------- 319 (447)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+.........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23345688999999999864 589999999999999999999999999988877777655211111111
Q ss_pred ----------------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 320 ----------------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 320 ----------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
...+++++.+||.+||+.||++|||++|+|+||||.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 12468899999999999999999999999999999876544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=381.84 Aligned_cols=259 Identities=25% Similarity=0.425 Sum_probs=212.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC-CCeeEEEEEEEeCCeE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ-QNIVEFRGAYEDRQSV 170 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~~~~~ 170 (447)
..+.|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+.+|+.+|+++.+| +||+++++++.+.+.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 4567999999999999999999875 68999999986543 3445567889999999999843 9999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||+ .+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ..+||+|||++.....
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~----~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCCC--
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC----CcEEEeecccccccCc
Confidence 999995 57899999999999999999999999999999999999999999999999952 3599999999987654
Q ss_pred CCc---eeecCCccccccccccc------------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCC
Q 013201 251 GKV---YRDIVGSAYYVAPEVLR------------RSYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVD 314 (447)
Q Consensus 251 ~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~ 314 (447)
... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+..+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 322 23568999999999974 3578899999999999999999999987533 3444555544333
Q ss_pred CCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 315 FESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 315 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
...+ ...++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 240 ~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 240 IEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred cCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 3222 235789999999999999999999999999999986543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=370.47 Aligned_cols=256 Identities=21% Similarity=0.346 Sum_probs=214.3
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.+.|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.++..+.+||||+++++++.+.+.++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 45679999999999999999999999999999999865432 33456778899999999955999999999999999999
Q ss_pred EEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC---------------
Q 013201 172 LVMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD--------------- 232 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~--------------- 232 (447)
+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999999765 6799999999999999999999999999999999999997543
Q ss_pred -CCCceEEecCCCceeccCCCceeecCCccccccccccccc--CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 013201 233 -GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL 309 (447)
Q Consensus 233 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 309 (447)
....+||+|||++....... ...||+.|+|||++.+. ++.++|||||||++|+|++|.+++.... ....+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~ 241 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIR 241 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHH
T ss_pred CCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHH
Confidence 45579999999998765532 34699999999998754 5579999999999999999998875543 344445
Q ss_pred hCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 310 KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 310 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.+...... ..+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 242 ~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 242 QGRLPRIP---QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TTCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred cCCCCCCC---cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 54332221 2579999999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=374.19 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=219.3
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..+.++|++.+.||+|+||.||+|++..++..||+|.+...........+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSSE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCCe
Confidence 345678999999999999999999999999999999987665555666788999999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~---~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS---NKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TSCEEECCCSSSTTC-
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEEeCCCccccc
Confidence 9999999999999999999889999999999999999999999999999999999999944 4569999999998665
Q ss_pred CCC--ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCCh
Q 013201 250 EGK--VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE-SEPWLLISD 325 (447)
Q Consensus 250 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~ 325 (447)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+................ ......+++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 432 2234679999999999864 588999999999999999999999999888776666655533221 111235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999999999766666666654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=385.97 Aligned_cols=264 Identities=27% Similarity=0.377 Sum_probs=214.1
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh--hhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK--QDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..++|++.+.||+|+||.||+|++..+|+.||+|++........ .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCc
Confidence 34679999999999999999999999999999999865332211 11246789999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+++||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE---NGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC---CCCEEEEecccceec
Confidence 9999999976 888887764 35899999999999999999999999999999999999944 456999999999876
Q ss_pred cCC-CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc------
Q 013201 249 DEG-KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP------ 319 (447)
Q Consensus 249 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~------ 319 (447)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+...........
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 432 33445689999999999853 488999999999999999999999999988887777765311111110
Q ss_pred ------------------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 320 ------------------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 320 ------------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
+..+++++++||.+||..||.+|||++|+|+||||++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 13457899999999999999999999999999999876544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=370.69 Aligned_cols=275 Identities=25% Similarity=0.429 Sum_probs=230.6
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
...+.|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++++. ||||+++++++.+...+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeE
Confidence 345669999999999999999999999999999999865432 345678999999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++ .+..+||+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---CCCCEEEeecccceecCc
Confidence 999999999999998754 5799999999999999999999999999999999999994 445699999999987655
Q ss_pred CC-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GK-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..+..... ...++..+.
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 248 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL---EGNYSKPLK 248 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CSSCCHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC---ccccCHHHH
Confidence 43 234568999999999986 4588999999999999999999999998888777777666543222 225789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHHHH
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFR 377 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (447)
+||.+||..||.+|||+.++++||||....... ......+.+++++.
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~--~~~~~~~~~~~~~~ 295 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKT--SYLTELIDRYKRWK 295 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCG--GGGHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhhChhhhcCCCcc--HHHHHHHHHHHHhh
Confidence 999999999999999999999999998754321 22244444444443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=375.69 Aligned_cols=261 Identities=28% Similarity=0.478 Sum_probs=216.2
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED-- 166 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 166 (447)
.....+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++++.+||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3445677999999999999999999999999999999885432 2346788999999999669999999999987
Q ss_pred ----CCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 167 ----RQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 167 ----~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
.+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~---~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc---CCCCEEEe
Confidence 56899999999999999999874 5699999999999999999999999999999999999994 44569999
Q ss_pred cCCCceeccCC-CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Q 013201 241 DFGLSVFIDEG-KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 241 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 313 (447)
|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.....
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 99999866432 2234568999999999984 3488999999999999999999999998887777666665533
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
... ....+++.+.+||.+||..||.+||+++++++||||++..
T Consensus 252 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 252 PRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 221 1235789999999999999999999999999999998753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=389.83 Aligned_cols=266 Identities=25% Similarity=0.420 Sum_probs=205.2
Q ss_pred CCCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 86 GKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+....+.++|++.+.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++.++ ||||+++++++.
T Consensus 21 ~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 98 (367)
T 2fst_X 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFT 98 (367)
T ss_dssp TTEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEEC
T ss_pred cCcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc-ccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEe
Confidence 344556778899999999999999999999999999999988543 234455678889999999998 999999999996
Q ss_pred eC------CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEE
Q 013201 166 DR------QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 166 ~~------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
.. ..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kL 173 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKI 173 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC---CCCCEEE
Confidence 54 6689999999 7899888765 6799999999999999999999999999999999999994 4456999
Q ss_pred ecCCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---
Q 013201 240 TDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD--- 314 (447)
Q Consensus 240 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--- 314 (447)
+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.+....
T Consensus 174 ~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 174 LDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp CC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred eecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999999875432 345689999999999864 5899999999999999999999999998887776666542100
Q ss_pred --------------------CCCCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 315 --------------------FESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 315 --------------------~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
.+... +..+++.+.+||.+||..||++|||++++|+||||.+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 01111 12468899999999999999999999999999999976544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=381.00 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=207.0
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC---
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ--- 168 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--- 168 (447)
+.+.|++.+.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence 3456999999999999999999999999999999986543 3445678999999999997 999999999986543
Q ss_pred ------------------------------------------------------eEEEEEeccCCCchHHHHHHcCC---
Q 013201 169 ------------------------------------------------------SVHLVMELCSGGELFDKIIAQGH--- 191 (447)
Q Consensus 169 ------------------------------------------------------~~~lv~e~~~g~~L~~~l~~~~~--- 191 (447)
.+++|||||+|++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987644
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-------------ceeecC
Q 013201 192 YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-------------VYRDIV 258 (447)
Q Consensus 192 ~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~ 258 (447)
.++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++....... ......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeC---CCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 566678999999999999999999999999999999954 4479999999998765532 223457
Q ss_pred Cccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 259 GSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 259 gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
||+.|+|||++. ..++.++|||||||++|+|++|..|+.. .......+...... ..+...++++.+||.+||+.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFP---LLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHHCS
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCC---cccccCChhHHHHHHHHccC
Confidence 999999999986 4589999999999999999998776522 12233333333211 12234578899999999999
Q ss_pred CCCCCCCHHHHhcCCCccC
Q 013201 338 DPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 338 dp~~R~t~~~~l~h~~~~~ 356 (447)
||++|||++|+|+||||++
T Consensus 313 ~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 313 SPTERPEATDIIENAIFEN 331 (332)
T ss_dssp SGGGSCCHHHHHHSTTCCC
T ss_pred CCCcCCCHHHHhhchhhhc
Confidence 9999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=388.43 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=211.7
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----- 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----- 166 (447)
..++|++++.||+|+||+||+|++..+|+.||+|++..... ...+|+.+++.++ ||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCccc
Confidence 45679999999999999999999999999999998864321 2237999999997 9999999999843
Q ss_pred ---------------------------------CCeEEEEEeccCCCchHHHHH----HcCCCCHHHHHHHHHHHHHHHH
Q 013201 167 ---------------------------------RQSVHLVMELCSGGELFDKII----AQGHYTEKAAAALCRAIVNVVH 209 (447)
Q Consensus 167 ---------------------------------~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~qil~~l~ 209 (447)
...+++||||+++ +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 4458999999975 7766654 3567999999999999999999
Q ss_pred HHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHH
Q 013201 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILY 287 (447)
Q Consensus 210 ~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~ 287 (447)
|||++||+||||||+|||++.+ +..+||+|||++.............||+.|+|||++.+ .++.++|||||||++|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSK--DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETT--TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCC--CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999999633 34799999999998776666667789999999998764 4899999999999999
Q ss_pred HHhhCCCCCCCCCHHHHHHHHHhCC-----------------CCCC---CCcc-----ccCChHHHHHHHHhcccCCCCC
Q 013201 288 ILLSGVPPFWAETEKGIFDAILKGG-----------------VDFE---SEPW-----LLISDSAKDLVRKMLIQDPKKR 342 (447)
Q Consensus 288 elltg~~pf~~~~~~~~~~~i~~~~-----------------~~~~---~~~~-----~~~s~~~~~li~~~L~~dp~~R 342 (447)
+|++|..||.+.+..+.+..+.+.. ..++ ...| ..+++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999988877776665410 0111 0111 1368899999999999999999
Q ss_pred CCHHHHhcCCCccCC
Q 013201 343 ITSAEVLEHPWMREG 357 (447)
Q Consensus 343 ~t~~~~l~h~~~~~~ 357 (447)
||+.|+|+||||++.
T Consensus 314 ~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 314 INPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHHTSGGGHHH
T ss_pred CCHHHHhcCHHHHHH
Confidence 999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=390.38 Aligned_cols=256 Identities=30% Similarity=0.446 Sum_probs=210.9
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR---- 167 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---- 167 (447)
....|++.+.||+|+||.||+|++..+++.||||++..... ...+|+.+|++++ ||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence 34569999999999999999999999999999998864321 2347999999997 99999999988532
Q ss_pred --CeEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 168 --QSVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 --~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
..+++||||+++ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--~~~kl~D 200 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCD 200 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT--TEEEECC
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC--CeEEecc
Confidence 247799999975 66655542 46799999999999999999999999999999999999996433 3689999
Q ss_pred CCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--------
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG-------- 311 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-------- 311 (447)
||+++...........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+.+.
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999998766555566789999999999853 5899999999999999999999999998877666655431
Q ss_pred ---------CCCCC---CCcc-----ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 312 ---------GVDFE---SEPW-----LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 312 ---------~~~~~---~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.+.++ ..+| ..+++++.+||.+||.+||.+|||+.|+|+||||.+..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 01111 1111 23588999999999999999999999999999998653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=390.92 Aligned_cols=263 Identities=27% Similarity=0.441 Sum_probs=217.0
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc-----CCCCeeEEEE
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS-----GQQNIVEFRG 162 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~ 162 (447)
+.+.+..+|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+. +|+||+++++
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 3455677899999999999999999999999999999988542 344567788999998885 4779999999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 163 AYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 163 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
++...+.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+
T Consensus 167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~ 244 (429)
T 3kvw_A 167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVI 244 (429)
T ss_dssp EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEEC
T ss_pred ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEe
Confidence 9999999999999996 58999988764 4999999999999999999999999999999999999955332 249999
Q ss_pred cCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC---
Q 013201 241 DFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE--- 316 (447)
Q Consensus 241 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--- 316 (447)
|||++...... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 245 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 245 DFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99999765442 34568999999999986 4599999999999999999999999999888777666543200000
Q ss_pred -----------------------------------------------CCcc-----ccCChHHHHHHHHhcccCCCCCCC
Q 013201 317 -----------------------------------------------SEPW-----LLISDSAKDLVRKMLIQDPKKRIT 344 (447)
Q Consensus 317 -----------------------------------------------~~~~-----~~~s~~~~~li~~~L~~dp~~R~t 344 (447)
...| ...++++.+||.+||+.||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 0000 023788999999999999999999
Q ss_pred HHHHhcCCCccCCC
Q 013201 345 SAEVLEHPWMREGG 358 (447)
Q Consensus 345 ~~~~l~h~~~~~~~ 358 (447)
++|+|+||||++..
T Consensus 403 a~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 403 PGQALRHPWLRRRL 416 (429)
T ss_dssp HHHHHTSTTTC---
T ss_pred HHHHhCChhhccCC
Confidence 99999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=382.41 Aligned_cols=260 Identities=28% Similarity=0.452 Sum_probs=215.6
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+.+.+|+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEE
Confidence 456999999999999999999999999999999886543 33445567889999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++......
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---CCCcEEEEeCCCceeecCCc
Confidence 999999999988877778899999999999999999999999999999999999994 4457999999999765442
Q ss_pred CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC----------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV---------------- 313 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------------- 313 (447)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 33445689999999999864 589999999999999999999999998887766655432100
Q ss_pred ---CCCC--------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 314 ---DFES--------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 314 ---~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
..+. ..+..+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0000 0112468999999999999999999999999999999763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=381.27 Aligned_cols=266 Identities=36% Similarity=0.636 Sum_probs=194.2
Q ss_pred ccccceeecc-eeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe---
Q 013201 91 DIRQFYTLGK-ELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--- 166 (447)
Q Consensus 91 ~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 166 (447)
.+.++|.+.+ .||+|+||.||+|++..+++.||+|++... ....+|+..+.++.+||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 4566799854 699999999999999999999999988542 1233444443334459999999999976
Q ss_pred -CCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 167 -RQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 167 -~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
...+++|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 556899999999999999998764 59999999999999999999999999999999999999876666789999999
Q ss_pred CceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHhCCCCCCCC
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGI----FDAILKGGVDFESE 318 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~ 318 (447)
++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+..+...++.+
T Consensus 177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 99876543 234568899999999985 4588899999999999999999999977655433 23333444455555
Q ss_pred ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcc
Q 013201 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365 (447)
Q Consensus 319 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~ 365 (447)
.+..+++++++||.+||+.||.+|||++++|+||||++.......+.
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 302 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBC
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCcc
Confidence 56678999999999999999999999999999999998655444433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=367.51 Aligned_cols=259 Identities=31% Similarity=0.526 Sum_probs=219.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.+. ||||+++++++.+.+..|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEEE
Confidence 4569999999999999999999999999999999865432 334578899999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE---RDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTCEECEETT
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc---CCCEEEeeCCCccccCCCc
Confidence 9999999999999887778999999999999999999999999999999999999954 4469999999998654322
Q ss_pred ---ceeecCCcccccccccccc-c-CCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCCCCCccccCChH
Q 013201 253 ---VYRDIVGSAYYVAPEVLRR-S-YGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 253 ---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
......||+.|+|||++.+ . ++.++||||||+++|+|++|..||...... ..+..+...... ...+..+++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 237 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDSA 237 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCHH
Confidence 2345689999999999864 3 477899999999999999999999876543 233333333222 2334568999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+.+||.+||+.||.+|||++++++||||++...
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 999999999999999999999999999987543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=386.44 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=206.5
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-- 168 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 168 (447)
.+.++|++.+.||+|+||.||+|++..+++.||+|++... .........+.+|+.+++.+. ||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc-cCChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence 4567899999999999999999999999999999998653 234455677889999999997 999999999997665
Q ss_pred ----eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 169 ----SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 169 ----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
.+|+|||||.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCCCC
T ss_pred ccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEEEeec
Confidence 78999999975 7888775 4699999999999999999999999999999999999994 445699999999
Q ss_pred ceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE------- 316 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------- 316 (447)
+............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+......
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 987665544556789999999999864 589999999999999999999999999888877777665321110
Q ss_pred ---------------CCc----------------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 317 ---------------SEP----------------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 317 ---------------~~~----------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
... ....++++++||.+||..||++|||++|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 000 00125678999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=388.98 Aligned_cols=257 Identities=32% Similarity=0.572 Sum_probs=216.6
Q ss_pred cceeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccC-ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLV-NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+.|++.+.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.+++++.+||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 56999999999999999999984 58999999998654321 122345567899999999779999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|||||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++....
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCcEEEeeCCCCeecc
Confidence 999999999999999999888999999999999999999999999999999999999994 44579999999998654
Q ss_pred CC--CceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCC----CHHHHHHHHHhCCCCCCCCcc
Q 013201 250 EG--KVYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 250 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~~~~~~~~~~~ 320 (447)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||... ....+...+......++.
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 287 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--- 287 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT---
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc---
Confidence 32 22334689999999999863 3788999999999999999999999753 334455555555443332
Q ss_pred ccCChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
.+++.+.+||.+||..||.+|| +++++++||||++.
T Consensus 288 -~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 288 -EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 4789999999999999999999 99999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=376.91 Aligned_cols=259 Identities=22% Similarity=0.402 Sum_probs=215.2
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-- 168 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 168 (447)
.+.++|++.+.||+|+||+||+|++..+++.||+|++..... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR 82 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCc
Confidence 345779999999999999999999999999999999865432 234567889999999998 999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee-cCCCCCceEEecCCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQGH---YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS-NKDGGAMLKATDFGL 244 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~-~~~~~~~vkl~Dfg~ 244 (447)
.+|+||||++|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+. .++....+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 78999999999999999986543 99999999999999999999999999999999999973 334456799999999
Q ss_pred ceeccCCCceeecCCccccccccccc---------ccCCCCCcchhHHHHHHHHhhCCCCCCCCC----HHHHHHHHHhC
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLR---------RSYGKEIDVWSAGVILYILLSGVPPFWAET----EKGIFDAILKG 311 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~ 311 (447)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.... ..+.+..+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 99877766666778999999999874 458899999999999999999999997432 24455555543
Q ss_pred CCCC-------------------C--CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 013201 312 GVDF-------------------E--SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352 (447)
Q Consensus 312 ~~~~-------------------~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~ 352 (447)
.... + ......+++.+.+||.+||+.||++|||++|+|+||
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 2210 0 011123456889999999999999999999999996
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=382.19 Aligned_cols=263 Identities=28% Similarity=0.410 Sum_probs=218.0
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR-- 167 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 167 (447)
..+.++|++.+.||+|+||.||+|++..+++.||+|++... ........+.+|+.+++++. ||||+++++++...
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTI 99 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSST
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCc
Confidence 34557899999999999999999999999999999988542 23445578899999999997 99999999999654
Q ss_pred ---CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 168 ---QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||+
T Consensus 100 ~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 100 EQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGL 174 (364)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred cccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---CCCCEEEEeCcc
Confidence 47899999996 589888765 5799999999999999999999999999999999999994 445699999999
Q ss_pred ceeccCCCc----eeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC---
Q 013201 245 SVFIDEGKV----YRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF--- 315 (447)
Q Consensus 245 a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--- 315 (447)
+........ ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 987653321 23468999999999864 348999999999999999999999999887776666654311000
Q ss_pred --------------------CCCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 316 --------------------ESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 316 --------------------~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
...+ ...+++++.+||.+||+.||++|||++|+|+||||++....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 0000 12468899999999999999999999999999999986443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=390.97 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=198.6
Q ss_pred cccccceee-cceeccccCeEEEEEEEC--CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 90 EDIRQFYTL-GKELGRGQFGITYLCTEN--STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 90 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..+.+.|.+ +++||+|+||+||+|+++ .+++.||+|++.... ....+.+|+.+|++++ ||||+++++++..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHCC-CTTBCCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhcC-CCCeeeEeeEEec
Confidence 345667887 668999999999999976 568899999885432 2246789999999998 9999999999954
Q ss_pred --CCeEEEEEeccCCCchHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC-CCC
Q 013201 167 --RQSVHLVMELCSGGELFDKIIAQ---------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK-DGG 234 (447)
Q Consensus 167 --~~~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~ 234 (447)
...+||||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ +..
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 778999999996 5888877532 249999999999999999999999999999999999999544 345
Q ss_pred CceEEecCCCceeccCC----CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCH-------
Q 013201 235 AMLKATDFGLSVFIDEG----KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETE------- 301 (447)
Q Consensus 235 ~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~------- 301 (447)
..+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 67999999999876532 22345689999999999864 489999999999999999999999976543
Q ss_pred --HHHHHHHHhCCCCCCCCccc----------------------------------cCChHHHHHHHHhcccCCCCCCCH
Q 013201 302 --KGIFDAILKGGVDFESEPWL----------------------------------LISDSAKDLVRKMLIQDPKKRITS 345 (447)
Q Consensus 302 --~~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~li~~~L~~dp~~R~t~ 345 (447)
.+.+..+...........|. ..++.+.+||.+||..||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 23444443321111111111 127789999999999999999999
Q ss_pred HHHhcCCCccCCCCC
Q 013201 346 AEVLEHPWMREGGEA 360 (447)
Q Consensus 346 ~~~l~h~~~~~~~~~ 360 (447)
+|+|+||||++....
T Consensus 329 ~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 329 EQAMQDPYFLEDPLP 343 (405)
T ss_dssp HHHHTSGGGTSSSCC
T ss_pred HHHhcChhhccCCCC
Confidence 999999999876543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=396.25 Aligned_cols=250 Identities=17% Similarity=0.197 Sum_probs=204.3
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc--CCCCeeEEE-------E
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--GQQNIVEFR-------G 162 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~-------~ 162 (447)
..+.|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++.+. .||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3567999999999999999999999999999999997665555566788999996555554 499999988 7
Q ss_pred EEEeCCe-----------------EEEEEeccCCCchHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHhcCcEe
Q 013201 163 AYEDRQS-----------------VHLVMELCSGGELFDKIIAQGHYTE-------KAAAALCRAIVNVVHHCHFMGVMH 218 (447)
Q Consensus 163 ~~~~~~~-----------------~~lv~e~~~g~~L~~~l~~~~~~~~-------~~~~~i~~qil~~l~~lH~~~ivH 218 (447)
++++.+. .||||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 7776643 89999999 6799999987665665 778889999999999999999999
Q ss_pred ecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCCcccccccccccc------------cCCCCCcchhHHHHH
Q 013201 219 RDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR------------SYGKEIDVWSAGVIL 286 (447)
Q Consensus 219 ~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il 286 (447)
|||||+|||++. +..+||+|||++..... .....+| +.|+|||++.+ .++.++|||||||++
T Consensus 230 rDikp~NIll~~---~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQ---RGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECT---TCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcC---CCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999954 44799999999986433 4456678 99999999863 589999999999999
Q ss_pred HHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 287 YILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 287 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
|+|++|..||.+.........+.. .+..+++++.+||.+||+.||.+|||+.++|+||||++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999976654333322222 12357999999999999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=381.11 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=217.2
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|++.+.||+|+||.||+|++..++..||+|++... ......+.+.+|+.++++++ ||||+++++++.+.+.+|
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCEEE
Confidence 456799999999999999999999999999999998654 23455678899999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++. +..+||+|||++.....
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT---TCCEEECCCCCCHHHHH
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECC---CCCEEEEECCCCccccc
Confidence 9999999999999999988999999999999999999999996 9999999999999954 44699999999875533
Q ss_pred CCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHH----------------------
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDA---------------------- 307 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---------------------- 307 (447)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......
T Consensus 185 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 185 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp H-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred c-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2 2335689999999999864 589999999999999999999999987665443222
Q ss_pred --------------------HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 308 --------------------ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 308 --------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+..... +..+...++.++.+||.+||+.||++|||++++|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 122111 1111224688999999999999999999999999999998753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=381.21 Aligned_cols=263 Identities=26% Similarity=0.377 Sum_probs=217.1
Q ss_pred CCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC-----eeEEE
Q 013201 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN-----IVEFR 161 (447)
Q Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-----iv~~~ 161 (447)
...+.+.++|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.+.+|++ |+.++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 34455677899999999999999999999999999999988532 3345677889999998875664 99999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hcCcEeecCCCCceEeecCCCCCce
Q 013201 162 GAYEDRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCH--FMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 162 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
+++...+.+||||||+. ++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++.+ ....+
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~-~~~~~ 200 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP-KRSAI 200 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-TSCCE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-CCCcE
Confidence 99999999999999996 5999999875 45999999999999999999999 5799999999999999542 24569
Q ss_pred EEecCCCceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 013201 238 KATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316 (447)
Q Consensus 238 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 316 (447)
||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 201 kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp EECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999999876543 345689999999999864 589999999999999999999999999888877776654211000
Q ss_pred ------------------CCccc------------------------------------------cCChHHHHHHHHhcc
Q 013201 317 ------------------SEPWL------------------------------------------LISDSAKDLVRKMLI 336 (447)
Q Consensus 317 ------------------~~~~~------------------------------------------~~s~~~~~li~~~L~ 336 (447)
...|. ..++++++||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 00000 001378999999999
Q ss_pred cCCCCCCCHHHHhcCCCccCC
Q 013201 337 QDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 337 ~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.||++|||++|+|+||||++.
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC-
T ss_pred CChhhCCCHHHHhcCcccccC
Confidence 999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=369.71 Aligned_cols=259 Identities=27% Similarity=0.492 Sum_probs=218.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC-hhhHHHHHHHHHHHHhccCCCCeeEEEEEE--EeCC
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN-KQDREDIKREIQIMQHLSGQQNIVEFRGAY--EDRQ 168 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--~~~~ 168 (447)
+.++|++++.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|+.++++++ ||||+++++++ .+.+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence 3466999999999999999999999999999999986543221 234577899999999997 99999999998 4556
Q ss_pred eEEEEEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 169 SVHLVMELCSGGELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
.+|+||||+.++ |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~---~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT---GGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcC---CCcEEeecccccc
Confidence 899999999876 7777765 456999999999999999999999999999999999999954 4469999999998
Q ss_pred eccCC---CceeecCCccccccccccccc---CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Q 013201 247 FIDEG---KVYRDIVGSAYYVAPEVLRRS---YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 247 ~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 320 (447)
..... .......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+..+...++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 234 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--- 234 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS---
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC---
Confidence 76432 233456799999999998642 477999999999999999999999999888888888887655443
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
.+++.+.+||.+||..||.+|||++++++||||++...
T Consensus 235 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 235 -DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 47899999999999999999999999999999987544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=378.61 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=214.2
Q ss_pred cccceeecceeccccCeEEEEEEEC-------CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTEN-------STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAY 164 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 164 (447)
..+.|++++.||+|+||.||+|++. .++..||+|++... ......+.+.+|+.+++++.+||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3567999999999999999999874 34567999988543 23445678999999999995599999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEe
Q 013201 165 EDRQSVHLVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLL 228 (447)
Q Consensus 165 ~~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill 228 (447)
.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999998753 47899999999999999999999999999999999999
Q ss_pred ecCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHH
Q 013201 229 SNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKG 303 (447)
Q Consensus 229 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 303 (447)
+ .++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|||++ |..||.+....+
T Consensus 237 ~---~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 237 T---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp C---TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred C---CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 4 445799999999987654322 23356788999999886 458999999999999999999 999999988888
Q ss_pred HHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 304 IFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 304 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+...+..+..... ...+++++.+||.+||+.||.+|||+.|++++
T Consensus 314 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8777766543211 12578999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=366.38 Aligned_cols=258 Identities=24% Similarity=0.299 Sum_probs=197.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|++..... .......+..+...++.+. ||||+++++++.+.+..|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCCEEE
Confidence 4679999999999999999999999999999998854321 1222333444444566665 9999999999999999999
Q ss_pred EEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 173 VMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
||||++| +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++. ...+||+|||++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA---LGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT---TCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC---CCCEEEeecCCccc
Confidence 9999975 87776654 46799999999999999999999998 9999999999999944 44699999999987
Q ss_pred ccCCCceeecCCccccccccccc-----ccCCCCCcchhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCCCCCCCccc
Q 013201 248 IDEGKVYRDIVGSAYYVAPEVLR-----RSYGKEIDVWSAGVILYILLSGVPPFWA-ETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
...........||+.|+|||++. ..++.++||||||+++|+|++|..||.. ......+.......... .+..
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 237 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ--LPAD 237 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--CCTT
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC--cccc
Confidence 76655555568999999999962 3488899999999999999999999986 34444444444443222 1223
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.+++++.+||.+||+.||++|||++++++||||+...
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 5799999999999999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=367.56 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=218.2
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.+..+.|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-C
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCe
Confidence 34567899999999999999999999999999999988543 2345678899999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||++...
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT---TSCEEECCCHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECC---CCCEEEEECCCCccc
Confidence 9999999999999998876 466999999999999999999999999999999999999954 446999999987543
Q ss_pred cCC-CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 249 DEG-KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 249 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
... .......||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+........ ....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 246 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPS 246 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGG
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCcc
Confidence 211 1223457999999999872 4578899999999999999999999999888777777766543322 1223
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.++..+.+||.+||..||.+|||++++++||||+...
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 5789999999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=367.60 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=210.3
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
..+...+.|++.+.||+|+||+||+|++ +++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQP 106 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECST
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEC
Confidence 3344467799999999999999999987 488999998865432 3445677899999999998 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCCCCceEEecC
Q 013201 168 QSVHLVMELCSGGELFDKIIAQGH---YTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
+.+++||||+++|+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|||++ .+..+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~---~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC---TTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe---CCCcEEECCC
Confidence 999999999999999999987654 999999999999999999999999 99999999999994 4457999999
Q ss_pred CCceeccCCC-ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Q 013201 243 GLSVFIDEGK-VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 243 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 320 (447)
|++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.........+
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 261 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP-- 261 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC--
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--
Confidence 9997654332 2345689999999999864 58999999999999999999999999988888777765444333322
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc--CCCccC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLE--HPWMRE 356 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--h~~~~~ 356 (447)
..+++++.+||.+||+.||.+|||++++++ +++++.
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 257999999999999999999999999987 455544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=382.50 Aligned_cols=259 Identities=24% Similarity=0.469 Sum_probs=221.6
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhh--------------HHHHHHHHHHHHhccCCCCe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD--------------REDIKREIQIMQHLSGQQNI 157 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~--------------~~~~~~E~~~l~~l~~h~~i 157 (447)
..++|++.+.||+|+||.||+|++ +++.||+|++.......... .+.+.+|+.++++++ ||||
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i 105 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYC 105 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTTB
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCCc
Confidence 446799999999999999999998 89999999987654332211 278899999999997 9999
Q ss_pred eEEEEEEEeCCeEEEEEeccCCCchHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEe
Q 013201 158 VEFRGAYEDRQSVHLVMELCSGGELFDK------IIA--QGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLL 228 (447)
Q Consensus 158 v~~~~~~~~~~~~~lv~e~~~g~~L~~~------l~~--~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill 228 (447)
+++++++.+.+.+|+||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999988 655 5679999999999999999999999 999999999999999
Q ss_pred ecCCCCCceEEecCCCceeccCCCceeecCCccccccccccccc--CCC-CCcchhHHHHHHHHhhCCCCCCCCCH-HHH
Q 013201 229 SNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRS--YGK-EIDVWSAGVILYILLSGVPPFWAETE-KGI 304 (447)
Q Consensus 229 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiwslG~il~elltg~~pf~~~~~-~~~ 304 (447)
+ .+..+||+|||++...... ......||+.|+|||++.+. ++. ++||||||+++|+|++|..||..... .+.
T Consensus 186 ~---~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 D---KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp C---TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred c---CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 4 4456999999999876554 34557899999999998743 455 89999999999999999999988776 677
Q ss_pred HHHHHhCCCCCCCCc---------------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 305 FDAILKGGVDFESEP---------------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
...+..+...++... ...+++++.+||.+||+.||.+|||++++|+||||++.
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 777776655544211 13578999999999999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=364.80 Aligned_cols=257 Identities=27% Similarity=0.487 Sum_probs=215.6
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+.+|+.+++++. ||||+++++++...+.+|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence 4567999999999999999999999999999999886432 3467889999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++. +..+||+|||++.....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT---EGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TCCEEECCCTTCEECBT
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC---CCCEEEeecccchhhhh
Confidence 99999999999999874 567999999999999999999999999999999999999954 44699999999987654
Q ss_pred CC-ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GK-VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+....... ......+++.+.
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 256 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT-FRKPELWSDNFT 256 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGSCHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc-cCCcccCCHHHH
Confidence 32 2345689999999999864 58999999999999999999999999887766665555543221 122235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+||.+||..||.+|||+.++|+||||+...
T Consensus 257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 999999999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=386.72 Aligned_cols=258 Identities=16% Similarity=0.188 Sum_probs=196.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc-CCCCeeEEE-------EEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS-GQQNIVEFR-------GAYE 165 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~-------~~~~ 165 (447)
..|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.|. .||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 44999999999999999999999999999999997765444556677888866555554 499988865 5554
Q ss_pred eC-----------------CeEEEEEeccCCCchHHHHHHcC-CCCHHHH------HHHHHHHHHHHHHHHhcCcEeecC
Q 013201 166 DR-----------------QSVHLVMELCSGGELFDKIIAQG-HYTEKAA------AALCRAIVNVVHHCHFMGVMHRDL 221 (447)
Q Consensus 166 ~~-----------------~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~------~~i~~qil~~l~~lH~~~ivH~Dl 221 (447)
.. ..+|||||||+ |+|.+++...+ .+.+... ..++.||+.||.|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 43 34899999998 79999998743 3444444 577799999999999999999999
Q ss_pred CCCceEeecCCCCCceEEecCCCceeccCCCceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCC
Q 013201 222 KPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWA 298 (447)
Q Consensus 222 kp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~ 298 (447)
||+|||++ .++.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 221 kp~NIll~---~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 221 TPDNLFIM---PDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp SGGGEEEC---TTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CHHHEEEC---CCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999995 4456999999999876432 225577899999999864 589999999999999999999999987
Q ss_pred CCHHHH--HHH---HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 299 ETEKGI--FDA---ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 299 ~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
...... +.. .......+..+.+..+++.+.+||.+||+.||++|||+.++|+||||++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 643210 000 01111122223334689999999999999999999999999999999763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=379.77 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=221.0
Q ss_pred ccccceeecceeccccCeEEEEEE-----ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCT-----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
...+.|++.+.||+|+||.||+|+ +..+++.||||++... ........+.+|+.++++++ ||||+++++++.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 144 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSL 144 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence 345779999999999999999999 4457789999988532 23455667889999999997 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceE
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQG-------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vk 238 (447)
+....|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999998753 489999999999999999999999999999999999997666667799
Q ss_pred EecCCCceeccC---CCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCC
Q 013201 239 ATDFGLSVFIDE---GKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 239 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 313 (447)
|+|||++..... ........||+.|+|||++. ..++.++|||||||++|||++ |..||......+....+..+..
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999975432 12233467899999999885 568999999999999999998 9999999999888888877653
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
.... ..+++.+.+||.+||+.||.+|||++++++|.|+.
T Consensus 305 ~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 MDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3222 25789999999999999999999999999987764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=371.80 Aligned_cols=264 Identities=29% Similarity=0.434 Sum_probs=216.6
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR- 167 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 167 (447)
...+.+.|++.+.||+|+||.||+|++..+|+.||+|++... ........+.+|+.++++++ ||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRPDS 82 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccc
Confidence 345667899999999999999999999999999999988532 23445667889999999997 99999999988654
Q ss_pred ----CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 168 ----QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 168 ----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
...|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg 157 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVCDFG 157 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCT
T ss_pred cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---CCCcEEEEecc
Confidence 67999999996 589888766 5799999999999999999999999999999999999994 44569999999
Q ss_pred CceeccCCC-----------ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHh
Q 013201 244 LSVFIDEGK-----------VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILK 310 (447)
Q Consensus 244 ~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 310 (447)
++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 998764321 122357899999999874 4589999999999999999999999998887665554432
Q ss_pred C--CC----------------------CCCCC----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 311 G--GV----------------------DFESE----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 311 ~--~~----------------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
. .. ..+.. .+..+++++.+||.+||..||++|||++++|+||||+.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 1 00 00000 013578999999999999999999999999999999876544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=378.63 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=214.6
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
....+.+.|.+.+.||+|+||.||+|++..+|+.||+|++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 36 ~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 113 (371)
T 4exu_A 36 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA 113 (371)
T ss_dssp EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred ceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheecc
Confidence 34556788999999999999999999999999999999886432 34445678889999999998 99999999999877
Q ss_pred CeE------EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 168 QSV------HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 ~~~------~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
+.. |+||||+. ++|.+.+ ...+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~D 187 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILD 187 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECS
T ss_pred CCcccceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC---CCCCEEEEe
Confidence 654 99999997 5887766 34599999999999999999999999999999999999994 445699999
Q ss_pred CCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD----- 314 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~----- 314 (447)
||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+....
T Consensus 188 fg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 188 FGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp TTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 9999865442 345689999999999864 5899999999999999999999999998877776666441110
Q ss_pred ------------------CCCC----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 315 ------------------FESE----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 315 ------------------~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.... .+..+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0000 0124689999999999999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=369.61 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=217.2
Q ss_pred cccceeecceeccccCeEEEEEEEC-CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc--CCCCeeEEEEEEE---
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTEN-STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--GQQNIVEFRGAYE--- 165 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~--- 165 (447)
..+.|++.+.||+|+||.||+|++. .+++.||+|++...... ......+.+|+.+++.+. +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567999999999999999999995 67899999988654322 222335667888888774 4999999999987
Q ss_pred --eCCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 166 --DRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 166 --~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
....+++||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~---~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcC---CCCEEEec
Confidence 5678999999997 59999998754 4999999999999999999999999999999999999944 44699999
Q ss_pred CCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-----
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF----- 315 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~----- 315 (447)
||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+......+..+.......
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 99998765544455678999999999986 458999999999999999999999999988887777765421100
Q ss_pred C------------------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 316 E------------------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 316 ~------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
+ ......+++.+++||.+||..||.+|||+.++|+||||++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0 0011347899999999999999999999999999999987644
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=371.58 Aligned_cols=263 Identities=28% Similarity=0.401 Sum_probs=216.1
Q ss_pred CccccccceeecceeccccCeEEEEEEE-CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccC-----CCCeeEEE
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTE-NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG-----QQNIVEFR 161 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-----h~~iv~~~ 161 (447)
..+.+.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.+.+ |++|++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3455677899999999999999999998 567899999988532 3445778899999998871 33599999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC------
Q 013201 162 GAYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG------ 233 (447)
Q Consensus 162 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~------ 233 (447)
+++.+.+.+|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++..+.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 889999998765 5899999999999999999999999999999999999965321
Q ss_pred ----------CCceEEecCCCceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH
Q 013201 234 ----------GAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEK 302 (447)
Q Consensus 234 ----------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 302 (447)
+..+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 456999999999875443 345689999999999864 5899999999999999999999999988776
Q ss_pred HHHHHHHhCCCCCCCC----------------------------------------ccccCChHHHHHHHHhcccCCCCC
Q 013201 303 GIFDAILKGGVDFESE----------------------------------------PWLLISDSAKDLVRKMLIQDPKKR 342 (447)
Q Consensus 303 ~~~~~i~~~~~~~~~~----------------------------------------~~~~~s~~~~~li~~~L~~dp~~R 342 (447)
+....+.......+.. .....++++.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 6555443221111100 001124678999999999999999
Q ss_pred CCHHHHhcCCCccCC
Q 013201 343 ITSAEVLEHPWMREG 357 (447)
Q Consensus 343 ~t~~~~l~h~~~~~~ 357 (447)
||++|+|+||||+..
T Consensus 321 pt~~ell~hp~f~~~ 335 (339)
T 1z57_A 321 ITLREALKHPFFDLL 335 (339)
T ss_dssp CCHHHHTTSGGGGGG
T ss_pred cCHHHHhcCHHHHHH
Confidence 999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=362.32 Aligned_cols=258 Identities=28% Similarity=0.494 Sum_probs=220.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQSV 170 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~ 170 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|.+..... .....+.+.+|+.++++++ ||||+++++++.+ ...+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence 3569999999999999999999999999999999865433 3455678999999999997 9999999998754 6789
Q ss_pred EEEEeccCCCchHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----cEeecCCCCceEeecCCCCCceEEec
Q 013201 171 HLVMELCSGGELFDKIIAQ----GHYTEKAAAALCRAIVNVVHHCHFMG-----VMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qil~~l~~lH~~~-----ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
|+||||++|++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++ .+..+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~---~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---SSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---CCCCEEEec
Confidence 9999999999999998763 34999999999999999999999999 99999999999994 445699999
Q ss_pred CCCceeccCCCc-eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc
Q 013201 242 FGLSVFIDEGKV-YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP 319 (447)
Q Consensus 242 fg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 319 (447)
||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.......+...+..+......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-- 237 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-- 237 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC--
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC--
Confidence 999976654322 234579999999999864 5889999999999999999999999998888888888777553222
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
..+++++.++|.+||+.||.+|||+.++++|+|+.+..
T Consensus 238 -~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 238 -YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred -cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 24789999999999999999999999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=371.05 Aligned_cols=263 Identities=29% Similarity=0.411 Sum_probs=212.7
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE----
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE---- 165 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---- 165 (447)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGS 82 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccccc
Confidence 45677899999999999999999999999999999988543 3455678899999999997 999999999873
Q ss_pred ----------eCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCC
Q 013201 166 ----------DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 166 ----------~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
+...+|+||||+. |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~ 158 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED--L 158 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--T
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--C
Confidence 4578999999997 59988875 46799999999999999999999999999999999999996433 4
Q ss_pred ceEEecCCCceeccCC----CceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Q 013201 236 MLKATDFGLSVFIDEG----KVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL 309 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 309 (447)
.+||+|||++...... .......||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+.+..+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6999999999866432 1223457899999999875 458999999999999999999999999988877766665
Q ss_pred hCCCCC----------------------CCC----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 310 KGGVDF----------------------ESE----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 310 ~~~~~~----------------------~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
...... +.. ....+++++++||.+||+.||.+|||++++|+||||+....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 432111 000 012478999999999999999999999999999999876444
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=367.57 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=212.4
Q ss_pred cccceeecceeccccCeEEEEEEECCCCC---EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGN---SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
..++|++.+.||+|+||.||+|++..++. .||||++... ......+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 34679999999999999999999986655 4999988543 23455678999999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.+|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++..
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRV 200 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCSSCEE
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC---CCCCEEECCCCcccc
Confidence 999999999999999999764 5799999999999999999999999999999999999994 445799999999987
Q ss_pred ccCCCc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 248 IDEGKV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 248 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+..... ..
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 277 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA---PM 277 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CT
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC---CC
Confidence 654321 12345678899999986 568999999999999999999 9999999999888888877633221 23
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+++.+.+||.+||..||.+|||+.++++
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 57999999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=378.78 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=203.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe---
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS--- 169 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--- 169 (447)
.++|++.+.||+|+||.||+|++..+++.||||++.... .......+|+..++.+. ||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcC-CCCcccHHHhhhccccccc
Confidence 456999999999999999999999999999999885432 22345567888888887 9999999999865433
Q ss_pred ----EEEEEeccCCCchHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH--hcCcEeecCCCCceEeecCCCCCceEE
Q 013201 170 ----VHLVMELCSGGELFDKII----AQGHYTEKAAAALCRAIVNVVHHCH--FMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 170 ----~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~qil~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
+++||||+.+ +|...+. ....+++..+..++.||+.||.||| ++||+||||||+|||++.. +..+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT--TTEEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC--CCcEEE
Confidence 8899999986 5444443 4567899999999999999999999 9999999999999999642 347999
Q ss_pred ecCCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--
Q 013201 240 TDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF-- 315 (447)
Q Consensus 240 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-- 315 (447)
+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.+.....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 99999988776666667789999999998853 38999999999999999999999999988877777665421100
Q ss_pred ------------------CCCcc--------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 316 ------------------ESEPW--------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 316 ------------------~~~~~--------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
...+| ...++++.+||.+||+.||.+|||+.|+|+||||++....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 00000 1246789999999999999999999999999999976543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=383.53 Aligned_cols=261 Identities=22% Similarity=0.372 Sum_probs=208.8
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccC-------CCCeeEEE
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG-------QQNIVEFR 161 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-------h~~iv~~~ 161 (447)
.+.+.++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.+.+ |+||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 345567899999999999999999999999999999988532 3456778899999999862 78899999
Q ss_pred EEEE----eCCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCC--
Q 013201 162 GAYE----DRQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKD-- 232 (447)
Q Consensus 162 ~~~~----~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~-- 232 (447)
+++. +...+||||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9987 556899999999 56777777654 4699999999999999999999998 999999999999996443
Q ss_pred --------------------------------------------CCCceEEecCCCceeccCCCceeecCCccccccccc
Q 013201 233 --------------------------------------------GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV 268 (447)
Q Consensus 233 --------------------------------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 268 (447)
....+||+|||++...... ....+||+.|+|||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChh
Confidence 1136999999999876543 345689999999999
Q ss_pred ccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC------HHHHHHHHHh--CC----------CC---CC----------
Q 013201 269 LRR-SYGKEIDVWSAGVILYILLSGVPPFWAET------EKGIFDAILK--GG----------VD---FE---------- 316 (447)
Q Consensus 269 ~~~-~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~--~~----------~~---~~---------- 316 (447)
+.+ .++.++|||||||++|+|++|..||...+ ....+..+.. +. .. +.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 864 58999999999999999999999997654 2222222221 10 00 00
Q ss_pred CC-------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 317 SE-------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 317 ~~-------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.. .....++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00 00123467889999999999999999999999999973
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=369.90 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=215.9
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh---hhHHHHHHHHHHHHhccC-CCCeeEEEEEE
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK---QDREDIKREIQIMQHLSG-QQNIVEFRGAY 164 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~ 164 (447)
.+.+.++|++.+.||+|+||.||+|++..+++.||+|++........ .....+.+|+.+++++.+ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34556779999999999999999999999999999999876543321 122456789999999973 79999999999
Q ss_pred EeCCeEEEEEeccCC-CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 165 EDRQSVHLVMELCSG-GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 165 ~~~~~~~lv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
...+.+++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~--~~~~kL~Dfg 195 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFG 195 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TTEEEECCCT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC--CCCEEEeeCc
Confidence 999999999999976 8999999998899999999999999999999999999999999999999632 3469999999
Q ss_pred CceeccCCCceeecCCcccccccccccc-c-CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLRR-S-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
++...... ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||.... .+..+...+. .
T Consensus 196 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~----~ 264 (320)
T 3a99_A 196 SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----Q 264 (320)
T ss_dssp TCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----S
T ss_pred cccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc----c
Confidence 99876543 3345689999999998863 3 4678999999999999999999996532 2333433332 2
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.+++++.+||.+||+.||++|||++++++||||++.
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 479999999999999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=370.53 Aligned_cols=264 Identities=26% Similarity=0.378 Sum_probs=215.4
Q ss_pred CCCccccccceeecceeccccCeEEEEEEECCCC-CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC------ee
Q 013201 86 GKPLEDIRQFYTLGKELGRGQFGITYLCTENSTG-NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN------IV 158 (447)
Q Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~------iv 158 (447)
......+.++|++.+.||+|+||.||+|++..++ ..||+|++... ....+.+.+|+.+++++. |++ ++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~ 85 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCV 85 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEE
Confidence 3445567788999999999999999999998877 68999988532 344577889999999987 444 99
Q ss_pred EEEEEEEeCCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC-----
Q 013201 159 EFRGAYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK----- 231 (447)
Q Consensus 159 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~----- 231 (447)
.+++++...+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 667778777654 69999999999999999999999999999999999999543
Q ss_pred -----------CCCCceEEecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC
Q 013201 232 -----------DGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE 299 (447)
Q Consensus 232 -----------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~ 299 (447)
+....+||+|||++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 23457999999999875443 34568999999999986 46899999999999999999999999988
Q ss_pred CHHHHHHHHHhCCCCCCCC----------------------------------------ccccCChHHHHHHHHhcccCC
Q 013201 300 TEKGIFDAILKGGVDFESE----------------------------------------PWLLISDSAKDLVRKMLIQDP 339 (447)
Q Consensus 300 ~~~~~~~~i~~~~~~~~~~----------------------------------------~~~~~s~~~~~li~~~L~~dp 339 (447)
...+.+..+.+.....+.. .....+.++.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 7766555443321111100 000124578899999999999
Q ss_pred CCCCCHHHHhcCCCccCC
Q 013201 340 KKRITSAEVLEHPWMREG 357 (447)
Q Consensus 340 ~~R~t~~~~l~h~~~~~~ 357 (447)
++|||++|+|+||||++.
T Consensus 323 ~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTSCCHHHHTTSGGGGGC
T ss_pred hhCcCHHHHhcChhhcCC
Confidence 999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=367.70 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=196.4
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++++. ||||+++++++...+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSCEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCcEE
Confidence 4569999999999999999999998999999998754321 234567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 173 VMELCSGGELFDKIIA--------QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~--------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE---DGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT---TCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC---CCCEEEEeccc
Confidence 9999999999999874 355999999999999999999999999999999999999944 45699999999
Q ss_pred ceeccCCC------ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Q 013201 245 SVFIDEGK------VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316 (447)
Q Consensus 245 a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 316 (447)
+....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||....................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 87654321 123457999999999986 3589999999999999999999999988777666555554432211
Q ss_pred C------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 317 S------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 317 ~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
. .....+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 1 11235789999999999999999999999999999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=376.10 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=207.3
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC--------ChhhHHHHHHHHHHHHhccCCCCeeEEE
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV--------NKQDREDIKREIQIMQHLSGQQNIVEFR 161 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 161 (447)
..+.+.|++.+.||+|+||.||+|.+.. +..||+|++...... .....+.+.+|+.++++++ ||||++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~ 95 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLR 95 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCS
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCcccee
Confidence 4566789999999999999999999865 999999988654321 2223478899999999997 99999999
Q ss_pred EEEEe-----CCeEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCC
Q 013201 162 GAYED-----RQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 162 ~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
+++.. ...+|+||||+. |+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++. +.
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~---~~ 171 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD---NN 171 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TC
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcC---CC
Confidence 99854 347899999997 5888887754 36999999999999999999999999999999999999944 44
Q ss_pred ceEEecCCCceeccCCCceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Q 013201 236 MLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 313 (447)
.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 172 DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 69999999998665555555678999999999886 4589999999999999999999999999887777666543111
Q ss_pred ------------------------CCCCCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 314 ------------------------DFESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 314 ------------------------~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
..+... ...+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 111111 124588899999999999999999999999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=369.72 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=212.6
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..+.+.|.+.+.||+|+||.||+|++..+|+.||+|++... .........+.+|+.++++++ ||||+++++++...+.
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASS 97 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc-ccchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccc
Confidence 44567899999999999999999999999999999988543 234445678889999999997 9999999999987654
Q ss_pred ------EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 170 ------VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 170 ------~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg 171 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFG 171 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTCCEEECSTT
T ss_pred cccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC---CCCcEEEeecc
Confidence 599999997 58887763 3599999999999999999999999999999999999994 44569999999
Q ss_pred CceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--------
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV-------- 313 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-------- 313 (447)
++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+...
T Consensus 172 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 172 LARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp CTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred cccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99765432 345689999999998864 589999999999999999999999999887766665543100
Q ss_pred ---------------CC----CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 314 ---------------DF----ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 314 ---------------~~----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.. ....+..+++++.+||.+||..||++|||++++|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00 0111235789999999999999999999999999999998643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=361.15 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=208.1
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----- 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----- 166 (447)
+.+.|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence 456799999999999999999999999999999988542 345577899999999997 9999999998865
Q ss_pred --------CCeEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCce
Q 013201 167 --------RQSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 167 --------~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
.+.+|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .+..+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~---~~~~~ 155 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNV 155 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc---CCCCE
Confidence 457899999999999999998654 578899999999999999999999999999999999994 44569
Q ss_pred EEecCCCceeccCC---------------CceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCC-
Q 013201 238 KATDFGLSVFIDEG---------------KVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAE- 299 (447)
Q Consensus 238 kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~- 299 (447)
||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++ ||...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999999765421 12234679999999999863 58999999999999999998 66533
Q ss_pred CHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 300 TEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 300 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
........+......++.......++.+++||.+||+.||.+|||++++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 3344555555555555444344567889999999999999999999999999999763
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=360.93 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=212.9
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccC-CCCeeEEEEEEEeCC
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG-QQNIVEFRGAYEDRQ 168 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~~ 168 (447)
....+.|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+.+|+.+++++.+ |+||+++++++.+.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 334567999999999999999999986 58999999986543 234556788999999999984 699999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+|+||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+|||++...
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCC-
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC----CeEEEeeccccccc
Confidence 9999999 558899999999889999999999999999999999999999999999999943 46999999999876
Q ss_pred cCCCc---eeecCCcccccccccccc------------cCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCC
Q 013201 249 DEGKV---YRDIVGSAYYVAPEVLRR------------SYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGG 312 (447)
Q Consensus 249 ~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~ 312 (447)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ...+..+....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 54321 234579999999999853 578899999999999999999999987543 34445555443
Q ss_pred CCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 313 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
.....+ ...++++.+||.+||..||.+||+++++|+||||+...
T Consensus 257 ~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 257 HEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp SCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred cccCCc--ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 333222 23588999999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=372.97 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=209.8
Q ss_pred cccceeecceeccccCeEEEEEE-----ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCT-----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..++|++++.||+|+||.||+|+ +..+++.||||++... ......+.+.+|+.+++++.+||||+++++++.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 45779999999999999999999 5566789999998543 2344557789999999999779999999999987
Q ss_pred CC-eEEEEEeccCCCchHHHHHHcCC------------------------------------------------------
Q 013201 167 RQ-SVHLVMELCSGGELFDKIIAQGH------------------------------------------------------ 191 (447)
Q Consensus 167 ~~-~~~lv~e~~~g~~L~~~l~~~~~------------------------------------------------------ 191 (447)
.+ .+++|||||+||+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 55 48999999999999999986543
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC---ceee
Q 013201 192 ------------YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK---VYRD 256 (447)
Q Consensus 192 ------------~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~ 256 (447)
+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++....... ....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE---KNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG---GGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC---CCcEEEEeccceeeecccccchhccc
Confidence 899999999999999999999999999999999999954 4469999999998664332 2234
Q ss_pred cCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHh
Q 013201 257 IVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334 (447)
Q Consensus 257 ~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 334 (447)
..||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+............+ ..+++++.++|.+|
T Consensus 255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDC 332 (359)
T ss_dssp CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHH
T ss_pred cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHH
Confidence 57899999999886 558999999999999999998 999998876554444443333222222 24789999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 013201 335 LIQDPKKRITSAEVLEH 351 (447)
Q Consensus 335 L~~dp~~R~t~~~~l~h 351 (447)
|+.||.+|||++++++|
T Consensus 333 l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEH 349 (359)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCCCHHHHHHH
Confidence 99999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=367.35 Aligned_cols=258 Identities=29% Similarity=0.521 Sum_probs=204.7
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh---hhHHHHHHHHHHHHhcc---CCCCeeEEEE
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK---QDREDIKREIQIMQHLS---GQQNIVEFRG 162 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~~iv~~~~ 162 (447)
.+.+.++|++.+.||+|+||.||+|++..+++.||+|++........ .....+.+|+.+++++. +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34566779999999999999999999999999999999865433221 12334567999999983 4999999999
Q ss_pred EEEeCCeEEEEEec-cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 163 AYEDRQSVHLVMEL-CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 163 ~~~~~~~~~lv~e~-~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
++.+.+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++. .+..+||+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl~d 183 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLID 183 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEECC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEEEE
Confidence 99999999999999 789999999999889999999999999999999999999999999999999963 234699999
Q ss_pred CCCceeccCCCceeecCCcccccccccccc-cC-CCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SY-GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP 319 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 319 (447)
||++...... ......||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.... .+......++
T Consensus 184 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~--- 253 (312)
T 2iwi_A 184 FGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP--- 253 (312)
T ss_dssp CSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC---
T ss_pred cchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc---
Confidence 9999876553 3345689999999998863 33 458999999999999999999996532 2333333333
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
..+++.+.+||.+||+.||++|||++++++||||+....
T Consensus 254 -~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 254 -AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred -ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 247899999999999999999999999999999987544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=369.40 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=216.1
Q ss_pred ccccceeecceeccccCeEEEEEEECCC-------CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENST-------GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA 163 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 163 (447)
...++|++++.||+|+||.||+|++..+ +..||+|++... ........+.+|+.+++++.+||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3456799999999999999999997543 357999988543 2345567889999999999559999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceE
Q 013201 164 YEDRQSVHLVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFL 227 (447)
Q Consensus 164 ~~~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nil 227 (447)
+.+.+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 999999999999999999999998754 4899999999999999999999999999999999999
Q ss_pred eecCCCCCceEEecCCCceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHH
Q 013201 228 LSNKDGGAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEK 302 (447)
Q Consensus 228 l~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 302 (447)
++. +..+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....
T Consensus 224 l~~---~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 224 VTE---DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp ECT---TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EcC---CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 944 4569999999998765432 223456789999999886 458999999999999999999 99999999888
Q ss_pred HHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 303 GIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 303 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++...+..+...... ..+++++.+||.+||+.||++|||+++++++
T Consensus 301 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 301 ELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 888877766432221 3579999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=364.70 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=197.6
Q ss_pred cccceeecceeccccCeEEEEEEECCCCC---EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGN---SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
..++|++++.||+|+||.||+|++..++. .||+|++..... .....+.+.+|+.++++++ ||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceeeccc
Confidence 45679999999999999999999887765 899998865432 3445678999999999997 999999999998776
Q ss_pred eE------EEEEeccCCCchHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCc
Q 013201 169 SV------HLVMELCSGGELFDKIIAQG------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAM 236 (447)
Q Consensus 169 ~~------~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~ 236 (447)
.. ++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---CCCC
Confidence 65 99999999999999987543 599999999999999999999999999999999999994 4457
Q ss_pred eEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhC
Q 013201 237 LKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKG 311 (447)
Q Consensus 237 vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 311 (447)
+||+|||++......... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..+
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 999999999876543322 2346788999999986 458999999999999999999 99999998888888887776
Q ss_pred CCCCCCCccccCChHHHHHHHHhcccCCCCCCC-------HHHHhcCCCccCCCC
Q 013201 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRIT-------SAEVLEHPWMREGGE 359 (447)
Q Consensus 312 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t-------~~~~l~h~~~~~~~~ 359 (447)
...... ..+++++.+||.+||+.||.+||| +++++.|+|+.....
T Consensus 256 ~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 256 NRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp CCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred CCCCCC---CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 432222 257899999999999999999999 777889999987543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=358.37 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=205.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++++. ||||+++++++.+++.+|+|
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEEE
Confidence 45999999999999999999999999999999987655444555678999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK- 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 252 (447)
|||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~---~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA---DDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcC---CCCEEEecCccCcccccccc
Confidence 999999999999998889999999999999999999999999999999999999954 4469999999997665432
Q ss_pred -ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHH
Q 013201 253 -VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 330 (447)
......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+ .............+++++.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHHHHH
Confidence 233567999999999986 45899999999999999999999999887665444433 333322222234689999999
Q ss_pred HHHhcccCCCCCC-CHHHHhc
Q 013201 331 VRKMLIQDPKKRI-TSAEVLE 350 (447)
Q Consensus 331 i~~~L~~dp~~R~-t~~~~l~ 350 (447)
|.+||+.||++|| +++++++
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999 7887764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=365.53 Aligned_cols=253 Identities=18% Similarity=0.186 Sum_probs=207.1
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.+.|++.+.||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++++.+||||+++++++.+.+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 45679999999999999999999999999999998864322 2357899999999966999999999999999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC--CCceEEecCCCceec
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG--GAMLKATDFGLSVFI 248 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~~~vkl~Dfg~a~~~ 248 (447)
+||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 8999999987 467999999999999999999999999999999999999954432 123999999999876
Q ss_pred cCCCc--------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCC
Q 013201 249 DEGKV--------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFDAILKGGVDFE 316 (447)
Q Consensus 249 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~ 316 (447)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 44322 245689999999999874 58999999999999999999999998743 3444444443322222
Q ss_pred CCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 317 SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 317 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
........+++.++|.+||..||.+||+++++++
T Consensus 241 ~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111112339999999999999999999998865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=357.25 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=204.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++++.||+|+||+||+|++..+++.||+|.+.. ......+.+.+|+.++++++ ||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEEE
Confidence 569999999999999999999999999999998743 24556788999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---TTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---CCCCEEEeecccceeccccc
Confidence 999999999999987 56799999999999999999999999999999999999994 44569999999998764332
Q ss_pred ce---------------eecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH-----HHHHHHhC
Q 013201 253 VY---------------RDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKG-----IFDAILKG 311 (447)
Q Consensus 253 ~~---------------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~i~~~ 311 (447)
.. ...+||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 11 14579999999999874 58999999999999999999999986532210 01111111
Q ss_pred CCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 312 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.. ...+++.+.+||.+||+.||++|||++++++
T Consensus 243 ~~------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 243 YC------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TC------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 10 1246889999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=357.45 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=206.3
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
|.....||+|+||.||+|++..+++.||+|.+... .....+.+.+|+.+++.+. ||||+++++++.+.+.+++|||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence 33445899999999999999999999999988653 2344577899999999997 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 176 LCSGGELFDKIIAQG---HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~---~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.. +..+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC--CCCEEEeecccccccCCCC
Confidence 999999999998752 46789999999999999999999999999999999999652 3369999999998765432
Q ss_pred -ceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH-HH-HHHHhCCCCCCCCccccCChH
Q 013201 253 -VYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IF-DAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~-~~i~~~~~~~~~~~~~~~s~~ 326 (447)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... .. ....... . ......++++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~ 254 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-H--PEIPESMSAE 254 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-C--CCCCTTSCHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-c--ccccccCCHH
Confidence 2345689999999999863 37899999999999999999999997643322 12 2111111 1 1112357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+.+||.+||+.||++||+++++|+||||+...
T Consensus 255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=349.49 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=213.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++++. ||||+++++++.+.+..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS----MSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT----BCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC----CcHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceEE
Confidence 467999999999999999999876 57789999885432 23467899999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++ .+..+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---TTCCEEECCTTCEEECCTT
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---CCCCEEEccCccceecchh
Confidence 999999999999998754 499999999999999999999999999999999999994 4456999999999876554
Q ss_pred Cce--eecCCcccccccccccc-cCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 252 KVY--RDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 252 ~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
... ....||+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+...... ..+++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l 234 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTI 234 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHHH
Confidence 322 23456778999999864 58999999999999999999 99999998888888877766543332 2468999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.++|.+||+.||.+|||+.+++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=359.42 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=195.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|++.+.||+|+||.||+|++..+++.||+|++..... .......+..+..+++.+. ||||+++++++.+.+.+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEE
Confidence 34669999999999999999999999999999999865432 1222233444445666665 999999999999999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+||||+ ++.+..+... ...+++..+..++.||+.||.|||+. ||+||||||+|||++ .+..+||+|||++....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC---TTSCEEECCCTTC----
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC---CCCCEEEEECCCchhcc
Confidence 999999 5555555443 46799999999999999999999995 999999999999994 44569999999998766
Q ss_pred CCCceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhCCCCCCCCcccc
Q 013201 250 EGKVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
.........||+.|+|||++. ..++.++||||||+++|+|++|..||... ...+.+..+..+..... +....
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 255 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHMG 255 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSSC
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccCC
Confidence 555555668999999999983 34888999999999999999999999873 45566666666543322 22235
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+++++.+||.+||+.||.+||+++++++||||++.
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 79999999999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=359.44 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=214.4
Q ss_pred cccceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..+.|++.+.||+|+||.||+|++. .++..||+|++... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence 3567999999999999999999983 45689999988543 23455678899999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCcEeecCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGH------------------------YTEKAAAALCRAIVNVVHHCHFMGVMHRDLK 222 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~------------------------~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlk 222 (447)
.+.+|+||||++|++|.+++..... +++..++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 9999999999999999999987543 8999999999999999999999999999999
Q ss_pred CCceEeecCCCCCceEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCC
Q 013201 223 PENFLLSNKDGGAMLKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFW 297 (447)
Q Consensus 223 p~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~ 297 (447)
|+|||++. +..+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++ |..||.
T Consensus 178 p~NIli~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 178 ARNILVAE---GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGGEEEET---TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hheEEEcC---CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999954 346999999999876543322 2346788999999886 458999999999999999999 999999
Q ss_pred CCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 298 AETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 298 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+.........+..+..... ...+++++.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9888777777766542221 23579999999999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.72 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=212.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++++++ ||||+++++++.+.+..|+|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc----cCHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEE
Confidence 56999999999999999999987 57789999886432 23467899999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. +..+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE---NQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG---GGCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC---CCCEEeccccccccccccc
Confidence 9999999999999764 45899999999999999999999999999999999999954 3469999999998654432
Q ss_pred --ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 253 --VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 253 --~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
......||+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+...... ..+++.+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 237 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVY 237 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHHH
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCHHHH
Confidence 122346788899999986 568999999999999999999 99999999988888888776333222 24689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++|.+||+.||.+|||++++++|
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.92 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=202.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCC-hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN-KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
.+.|++.+.||+|+||.||+|++. +..||+|++....... ....+.+.+|+.+++.++ ||||+++++++.+.+..|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceE
Confidence 356999999999999999999975 8899999886543222 233577889999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---cEeecCCCCceEeecCC-----CCCceEEecCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG---VMHRDLKPENFLLSNKD-----GGAMLKATDFG 243 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivH~Dlkp~Nill~~~~-----~~~~vkl~Dfg 243 (447)
+||||++|++|.+++. ...+++..++.++.|++.||.|||++| |+||||||+|||++... ....+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999988774 567999999999999999999999999 89999999999996532 24579999999
Q ss_pred CceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
++........ ....||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+.......+.+ ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 238 (271)
T 3dtc_A 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP--ST 238 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC--TT
T ss_pred cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC--cc
Confidence 9986654332 3458999999999986 458999999999999999999999999988887777777665544333 35
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+++.+.++|.+||+.||.+|||+.++++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 78999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=370.66 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=212.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|++..+++.||+|.+... ........+.+|+.+|++++ ||||+++++++.+.+.+|+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcEE
Confidence 45799999999999999999999999999999987543 23344567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++......
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~---~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---CCCcEEECcCCCceecCCC
Confidence 999999999999998754 599999999999999999999999999999999999994 4457999999999865443
Q ss_pred Ccee---ecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 252 KVYR---DIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 252 ~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.... ...+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+.. .+.+ ..++++
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~ 343 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-LPCP--ELCPDA 343 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-CCCC--TTCCHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC--CCCCHH
Confidence 2111 123567899999986 568999999999999999998 9999999888877777766532 2222 247899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.+||.+||+.||++|||++++++
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=364.21 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=215.4
Q ss_pred ccccceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
...+.|++.+.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 120 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCA 120 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEc
Confidence 34567999999999999999999987 345899999886432 3445678899999999997 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecC
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQ------------------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dl 221 (447)
+.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999874 56899999999999999999999999999999
Q ss_pred CCCceEeecCCCCCceEEecCCCceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCC
Q 013201 222 KPENFLLSNKDGGAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPF 296 (447)
Q Consensus 222 kp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf 296 (447)
||+|||++. +..+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||
T Consensus 201 kp~NIl~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 201 ATRNCLVGE---NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SGGGEEECG---GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CcceEEECC---CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999954 4469999999997654322 223457899999999886 568999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 297 WAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 297 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+....+....+..+...... ..+++++.+||.+||+.||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTSCHHHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCChHHHHHHHhCCCcCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999988888888776543222 2578999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=364.91 Aligned_cols=259 Identities=23% Similarity=0.298 Sum_probs=216.9
Q ss_pred cccceeecceeccccCeEEEEEE-----ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCT-----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..++|++.+.||+|+||.||+|+ +..++..||+|.+... ........+.+|+.+++++. ||||+++++++.+
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcC
Confidence 45679999999999999999999 5667889999988532 23455677899999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEE
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG-------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
....|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++....+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999998763 4899999999999999999999999999999999999976666678999
Q ss_pred ecCCCceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCC
Q 013201 240 TDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVD 314 (447)
Q Consensus 240 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 314 (447)
+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 9999987554322 123457899999999885 568999999999999999998 99999998888888877776433
Q ss_pred CCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 315 FESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 315 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
... ..+++.+.+||.+||+.||.+||++.++++|.|+..
T Consensus 265 ~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 265 DPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 222 357899999999999999999999999999987653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=355.73 Aligned_cols=253 Identities=25% Similarity=0.460 Sum_probs=201.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++ ||||+++++++.+.+.+++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEEE
Confidence 356999999999999999999999999999999987655555666788999999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 173 VMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++ .+..+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~---~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc---CCCCEEEEeccceeee
Confidence 9999999999998865 45699999999999999999999999999999999999995 4456999999999765
Q ss_pred cCCC-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHhCCCCCCCCccccCC
Q 013201 249 DEGK-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAET--EKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 249 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.. .......+...... ......++
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 264 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHYS 264 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCCTTTSC
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCcccccC
Confidence 4432 233467999999999886 458999999999999999999999997643 33445555554332 22223578
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+++.+||.+||..||.+|||+.+++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=354.29 Aligned_cols=255 Identities=19% Similarity=0.267 Sum_probs=211.5
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
..+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+.+|+|++++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 345677999999999999999999999999999999885432 224578899999999779999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC--CCCceEEecCCCce
Q 013201 170 VHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD--GGAMLKATDFGLSV 246 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~~~vkl~Dfg~a~ 246 (447)
.++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 999999998754 599999999999999999999999999999999999996543 23459999999998
Q ss_pred eccCCCc--------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCC---CHHHHHHHHHhCCCC
Q 013201 247 FIDEGKV--------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAE---TEKGIFDAILKGGVD 314 (447)
Q Consensus 247 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~ 314 (447)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+. .....+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7654321 245679999999999864 5899999999999999999999999874 344444444333221
Q ss_pred CCCC-ccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 315 FESE-PWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 315 ~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+.. ....+++++.+||.+||+.||++||+++++++
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1111 11247899999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=351.75 Aligned_cols=247 Identities=21% Similarity=0.366 Sum_probs=210.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++++. ||||+++++++.+.+.+|+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC----CCHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEE
Confidence 456999999999999999999887 67789999886432 23467889999999998 9999999999999999999
Q ss_pred EEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTSCEEECSTTGGGGBCCH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---CCCCEEEcccccccccccc
Confidence 9999999999999987 56799999999999999999999999999999999999994 4456999999999865443
Q ss_pred Cc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 252 KV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 252 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.. .....||+.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+...... ..+++.+
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l 250 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKV 250 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCHHH
Confidence 21 12345788899999986 568999999999999999998 99999999888888888776433322 2468999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+||.+||+.||.+|||++++++|
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=362.35 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=190.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHH-HHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQ-IMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.... .......+..|+. +++.+. ||||+++++++.+.+..|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~-h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSD-CPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCC-CTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCC-CCcEeeeeeEEEeCCceE
Confidence 456999999999999999999999999999999986532 2334456667776 555554 999999999999999999
Q ss_pred EEEeccCCCchHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 172 LVMELCSGGELFDKIIA-----QGHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++. +..+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR---SGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEET---TTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcC---CCCEEEccCCCc
Confidence 99999975 78777763 56799999999999999999999999 9999999999999954 446999999999
Q ss_pred eeccCCCceeecCCccccccccccc-----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCC-CCCCC
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR-----RSYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILKGGV-DFESE 318 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~-~~~~~ 318 (447)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... +.+..+..+.. .+...
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence 8776554444558999999999983 34899999999999999999999999765321 22222222211 12222
Q ss_pred ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 319 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
....+++.+.+||.+||..||.+|||+.++++||||....
T Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 2335799999999999999999999999999999998654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=363.81 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=211.0
Q ss_pred cccceeecceeccccCeEEEEEEE-----CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTE-----NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..+.|++.+.||+|+||.||+|++ ..++..||+|++.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 356799999999999999999997 3456789999886432 233457789999999999559999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG-----------------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKP 223 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp 223 (447)
.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 999999999999999999998653 278999999999999999999999999999999
Q ss_pred CceEeecCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCC
Q 013201 224 ENFLLSNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWA 298 (447)
Q Consensus 224 ~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~ 298 (447)
+|||++. +..+||+|||++........ .....||+.|+|||++. +.++.++||||||+++|+|+| |..||.+
T Consensus 201 ~NIll~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLVTH---GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEEET---TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEEcC---CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999954 44799999999986644322 22346788999999885 568999999999999999998 9999988
Q ss_pred CCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 013201 299 ETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352 (447)
Q Consensus 299 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~ 352 (447)
......+..+.........+ ..+++++.+||.+||..||.+|||+.++++|.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 77666555555554443333 24799999999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=369.41 Aligned_cols=260 Identities=23% Similarity=0.404 Sum_probs=208.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccC----------CCCeeEEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG----------QQNIVEFRG 162 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~----------h~~iv~~~~ 162 (447)
.++|++.+.||+|+||.||+|++..+++.||+|++.. .....+.+.+|+.+++++.+ |+||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 3569999999999999999999999999999998853 23345678899999998862 789999999
Q ss_pred EEEeCC----eEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc-CcEeecCCCCceEeecCC---
Q 013201 163 AYEDRQ----SVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFM-GVMHRDLKPENFLLSNKD--- 232 (447)
Q Consensus 163 ~~~~~~----~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~-~ivH~Dlkp~Nill~~~~--- 232 (447)
++...+ .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 997654 789999999 88999999874 4599999999999999999999998 999999999999996432
Q ss_pred CCCceEEecCCCceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC------HHHHH
Q 013201 233 GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAET------EKGIF 305 (447)
Q Consensus 233 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~ 305 (447)
....+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 3457999999999876543 344589999999999864 58999999999999999999999997654 22222
Q ss_pred HHHHhCCCCCCC--------------------------------------CccccCChHHHHHHHHhcccCCCCCCCHHH
Q 013201 306 DAILKGGVDFES--------------------------------------EPWLLISDSAKDLVRKMLIQDPKKRITSAE 347 (447)
Q Consensus 306 ~~i~~~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~ 347 (447)
..+.......+. .....+++++.+||.+||+.||.+|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 222211000000 000124678899999999999999999999
Q ss_pred HhcCCCccCCCC
Q 013201 348 VLEHPWMREGGE 359 (447)
Q Consensus 348 ~l~h~~~~~~~~ 359 (447)
+|+||||++...
T Consensus 331 ll~hp~f~~~~~ 342 (373)
T 1q8y_A 331 LVNHPWLKDTLG 342 (373)
T ss_dssp HHTCGGGTTCTT
T ss_pred HhhChhhhcccC
Confidence 999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=351.17 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=202.0
Q ss_pred cccccceeecceeccccCeEEEEEEECCC---CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENST---GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
+...++|++.+.||+|+||.||+|++..+ +..||+|.+... ......+.+.+|+.++++++ ||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~- 86 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT- 86 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-
Confidence 34456799999999999999999998754 456999977432 23455678899999999997 999999999984
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
++..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLS 163 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECC----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC---CCEEECccccc
Confidence 567889999999999999998754 69999999999999999999999999999999999999654 46999999999
Q ss_pred eeccCCCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 246 VFIDEGKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 246 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+..... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~---~~ 240 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PP 240 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CT
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC---CC
Confidence 87654332 22346788999999986 568999999999999999996 9999999888888888776643221 23
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+++.+.++|.+||..||++|||+.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 579999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=372.00 Aligned_cols=257 Identities=23% Similarity=0.411 Sum_probs=212.4
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-- 168 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 168 (447)
...++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR 82 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCC
Confidence 446779999999999999999999999999999999865432 234567789999999997 999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee-cCCCCCceEEecCCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQGH---YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS-NKDGGAMLKATDFGL 244 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~-~~~~~~~vkl~Dfg~ 244 (447)
..|+|||||+||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+. .++....+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 78999999999999999876433 99999999999999999999999999999999999983 234456799999999
Q ss_pred ceeccCCCceeecCCccccccccccc---------ccCCCCCcchhHHHHHHHHhhCCCCCCC----CCHHHHHHHHHhC
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLR---------RSYGKEIDVWSAGVILYILLSGVPPFWA----ETEKGIFDAILKG 311 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~elltg~~pf~~----~~~~~~~~~i~~~ 311 (447)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.. ....+.+..+..+
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 98877666666778999999999875 3478899999999999999999999964 2334556666655
Q ss_pred CCCCC---------------------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 312 GVDFE---------------------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 312 ~~~~~---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
..... ......+++.+.++|.+||+.||++||++.++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 32110 0001224567889999999999999999999854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=350.35 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=207.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhh----HHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD----REDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
.++|++.+.||+|+||.||+|++..+++.||+|++.......... .+.+.+|+.++++++ ||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNPP 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTTT
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCCC
Confidence 456999999999999999999999999999999986544322221 167889999999997 999999999997665
Q ss_pred eEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCC--CCceEEecCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDG--GAMLKATDFG 243 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~--~~~vkl~Dfg 243 (447)
++||||+++++|.+.+... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++. ...+||+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 6999999999999888765 46999999999999999999999999 999999999999965432 2349999999
Q ss_pred CceeccCCCceeecCCccccccccccc---ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH--HHHHHHhCCCCCCCC
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLR---RSYGKEIDVWSAGVILYILLSGVPPFWAETEKG--IFDAILKGGVDFESE 318 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~~ 318 (447)
++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... ....+.........+
T Consensus 175 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 4f0f_A 175 LSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252 (287)
T ss_dssp TCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC
T ss_pred ccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC
Confidence 9975443 345578999999999983 347889999999999999999999998765433 344444444333222
Q ss_pred ccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 319 PWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 319 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
..+++++.+||.+||+.||.+|||++++++
T Consensus 253 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 253 --EDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 357999999999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=372.09 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=201.6
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++++.+||||+++++++.+.+.+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 456678889999999999998754 457999999988542 2356789999999885699999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC----------CC
Q 013201 171 HLVMELCSGGELFDKIIAQGHY-------TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK----------DG 233 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~-------~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~----------~~ 233 (447)
|||||||. |+|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 99999995 6999999775433 233457899999999999999999999999999999754 24
Q ss_pred CCceEEecCCCceeccCCCc-----eeecCCcccccccccccc--------cCCCCCcchhHHHHHHHHhh-CCCCCCCC
Q 013201 234 GAMLKATDFGLSVFIDEGKV-----YRDIVGSAYYVAPEVLRR--------SYGKEIDVWSAGVILYILLS-GVPPFWAE 299 (447)
Q Consensus 234 ~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~ellt-g~~pf~~~ 299 (447)
...+||+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|||++ |..||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 56799999999987655321 234689999999999853 48899999999999999999 99999766
Q ss_pred CHHHHHHHHHhCCCCCCCCc---cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 300 TEKGIFDAILKGGVDFESEP---WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 300 ~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.... ..+..+....+... ...+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 5443 34455544433221 1234688999999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=356.77 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=213.4
Q ss_pred ccceeecceeccccCeEEEEEEEC-------CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN-------STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+.|++++.||+|+||.||+|++. .++..||+|++... ........+.+|+.+++++.+||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 467999999999999999999986 45778999988543 234556788999999999955999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
+.+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 9999999999999999999998654 389999999999999999999999999999999999994
Q ss_pred cCCCCCceEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 304 (447)
.+..+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+....++
T Consensus 192 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 192 ---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp ---TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ---CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 4456999999999876554322 2346788999999886 458999999999999999999 9999999888888
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
...+..+..... ...+++++.++|.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 269 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 877776643222 12578999999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=355.03 Aligned_cols=248 Identities=16% Similarity=0.219 Sum_probs=206.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCC-------CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTG-------NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+.|++.+.||+|+||.||+|++..++ ..||+|++.+. .....+.+.+|+.++++++ ||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLS-HKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE
Confidence 467999999999999999999998877 47999988543 2345678999999999998 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCC-----CceEE
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG-----AMLKA 239 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~-----~~vkl 239 (447)
+.+..++||||+.|++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.. ..+||
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999999987655 9999999999999999999999999999999999999765432 22999
Q ss_pred ecCCCceeccCCCceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC
Q 013201 240 TDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES 317 (447)
Q Consensus 240 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 317 (447)
+|||++...... ....||+.|+|||++. ..++.++||||||+++|+|++|..|++..........+.......+.
T Consensus 163 ~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (289)
T 4fvq_A 163 SDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239 (289)
T ss_dssp CCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred ccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC
Confidence 999998755432 2346889999999986 45899999999999999999965554444333333344444333332
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..++++.+||.+||+.||.+|||+.++++|
T Consensus 240 ----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 240 ----PKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 357889999999999999999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=356.07 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=212.2
Q ss_pred cccceeecceeccccCeEEEEEEE-----CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTE-----NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..++|++++.||+|+||.||+|++ ..+++.||+|++.... .....+.+.+|+.+++++.+||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 356799999999999999999985 4567899999885432 334567899999999999559999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEe
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG------------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLL 228 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill 228 (447)
.+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999998754 38999999999999999999999999999999999999
Q ss_pred ecCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHH
Q 013201 229 SNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKG 303 (447)
Q Consensus 229 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 303 (447)
+. +..+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+.....
T Consensus 179 ~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 TH---GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ET---TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cC---CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 54 44699999999987654432 22345788999999875 568999999999999999999 999998876555
Q ss_pred HHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 304 IFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 304 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
....+.........+ ..+++.+.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCCc--ccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 454444433332222 3578999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=374.65 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=198.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|.+.+.||+|+||+||. ....+++.||||++.+... ..+.+|+.+|+.+.+||||+++++++.+.+.+|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 4599999999999999764 3446799999999854322 23468999999996699999999999999999999
Q ss_pred EeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecC--CCCCceEEecCCCceeccC
Q 013201 174 MELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNK--DGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~--~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||. |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++.+ ++...+||+|||++.....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99996 59999987654 46666778999999999999999999999999999999643 2345688999999987654
Q ss_pred CC----ceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCC-CCcc
Q 013201 251 GK----VYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFE-SEPW 320 (447)
Q Consensus 251 ~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~ 320 (447)
.. .....+||+.|+|||++. ..++.++|||||||++|+|++ |..||........... .+..... ..+.
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~ 253 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--LGACSLDCLHPE 253 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--TTCCCCTTSCTT
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--hccCCccccCcc
Confidence 32 234568999999999985 346789999999999999999 9999976554433222 2222111 1111
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
...+..+.+||.+||+.||.+|||++++++||||..
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 234567899999999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=353.03 Aligned_cols=245 Identities=33% Similarity=0.602 Sum_probs=198.1
Q ss_pred cccceeec-ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 013201 92 IRQFYTLG-KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED---- 166 (447)
Q Consensus 92 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---- 166 (447)
+.+.|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++.++.+||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 44456666 889999999999999999999999998843 24567899998666669999999999987
Q ss_pred CCeEEEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
...+|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 778999999999999999998864 599999999999999999999999999999999999997655467899999999
Q ss_pred ceeccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHH----HhCCCCCCCCcc
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAI----LKGGVDFESEPW 320 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i----~~~~~~~~~~~~ 320 (447)
+..... ..++.++|||||||++|+|++|..||...........+ ..+...++...+
T Consensus 167 a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (299)
T 3m2w_A 167 AKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226 (299)
T ss_dssp CEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred cccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence 865432 33677899999999999999999999776544322111 111222222223
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCc
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~ 364 (447)
..+++++.+||.+||+.||.+|||++|+|+||||++.......+
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~ 270 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence 46899999999999999999999999999999998876554433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=367.19 Aligned_cols=256 Identities=16% Similarity=0.171 Sum_probs=193.9
Q ss_pred cccceeecceeccccCeEEEEEEECCC-----CCEEEEEEeeccccCCh--------hhHHHHHHHHHHHHhccCCCCee
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENST-----GNSYACKSILKRKLVNK--------QDREDIKREIQIMQHLSGQQNIV 158 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~iv 158 (447)
..+.|++++.||+|+||.||+|.+..+ ++.||+|++........ .....+..|+..++.+. ||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCCC
Confidence 345799999999999999999998765 58899998854321000 00012233444555555 99999
Q ss_pred EEEEEEEeC----CeEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC
Q 013201 159 EFRGAYEDR----QSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233 (447)
Q Consensus 159 ~~~~~~~~~----~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~ 233 (447)
++++++... ...||||||| |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-N 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-C
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-C
Confidence 999998764 5689999999 99999999876 679999999999999999999999999999999999999632 3
Q ss_pred CCceEEecCCCceeccCCCc--------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHH
Q 013201 234 GAMLKATDFGLSVFIDEGKV--------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGI 304 (447)
Q Consensus 234 ~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 304 (447)
...+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 45799999999987543221 133569999999999874 489999999999999999999999986432221
Q ss_pred HHHHHhCCCCCCCC-------ccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 305 FDAILKGGVDFESE-------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 305 ~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.............. ....+++++.+||..||..||.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11111100000000 00246899999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=359.32 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=208.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEE--EEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSY--ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.|++.+.||+|+||.||+|++..++..+ |+|.+... ......+.+.+|+.+++++.+||||+++++++.+.+.+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 45999999999999999999999888865 88887532 233445678899999999955999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCC
Q 013201 172 LVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. +.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE---NY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG---GG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC---CC
Confidence 9999999999999998754 6999999999999999999999999999999999999954 44
Q ss_pred ceEEecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCC
Q 013201 236 MLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 313 (447)
.+||+|||++.............+++.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 69999999987543322233456788999999986 458999999999999999998 9999999988887777765532
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
. . ....+++.+.+||.+||..||.+|||+++++++
T Consensus 260 ~-~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 L-E--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp C-C--CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-C--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 1 122578999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=358.88 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=202.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEE----EEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSY----ACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~----avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
.+.|++.+.||+|+||+||+|++..+++.+ |+|.+... ........+.+|+.++++++ ||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 356999999999999999999998888766 55554322 22345678899999999997 999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.++|+||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++..
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP---QHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET---TEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC---CCEEEccCcceeE
Confidence 77899999999999999874 569999999999999999999999999999999999999654 4699999999987
Q ss_pred ccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 248 IDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 248 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
...... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.....+...+..+.... .+ ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~--~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-QP--PI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-CC--TT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-CC--cc
Confidence 654322 22346788999999886 558999999999999999999 999999888877777666554322 22 24
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++.++.++|.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=354.68 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=215.7
Q ss_pred cccccceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEE
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAY 164 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 164 (447)
+...++|++.+.||+|+||.||+|++. .+++.||+|.+... ........+.+|+.+++++. ||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEE
Confidence 445678999999999999999999876 35788999988543 23445567889999999997 99999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCC
Q 013201 165 EDRQSVHLVMELCSGGELFDKIIAQ----------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGG 234 (447)
Q Consensus 165 ~~~~~~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~ 234 (447)
.+.+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---ED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CC
Confidence 9999999999999999999998753 3579999999999999999999999999999999999995 44
Q ss_pred CceEEecCCCceeccCCCce---eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHH
Q 013201 235 AMLKATDFGLSVFIDEGKVY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAIL 309 (447)
Q Consensus 235 ~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 309 (447)
+.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 56999999999865443222 2345788999999986 458999999999999999999 899999988888888877
Q ss_pred hCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 310 KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 310 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+...... ..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 255 ~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 76543222 2578999999999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=352.51 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=201.6
Q ss_pred ccccceeecceeccccCeEEEEEE----ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCT----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
...++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++ ||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS 82 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 345679999999999999999998 5678999999988532 3455678899999999997 9999999999854
Q ss_pred --CCeEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 167 --RQSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 167 --~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
...+++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~---~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE---NRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC---CeEEEccCc
Confidence 456899999999999999998754 49999999999999999999999999999999999999654 469999999
Q ss_pred CceeccCCC----ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH----------------
Q 013201 244 LSVFIDEGK----VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK---------------- 302 (447)
Q Consensus 244 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------------- 302 (447)
++....... ......|++.|+|||++. ..++.++||||||+++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 998765432 122346788899999986 55899999999999999999999998643211
Q ss_pred HHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 303 GIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 303 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.....+..+ ...+. ...+++++.+||.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 240 HLIELLKNN-GRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHTT-CCCCC--CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcc-CcCCC--CcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 122222222 22222 2357999999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=382.75 Aligned_cols=247 Identities=26% Similarity=0.334 Sum_probs=204.0
Q ss_pred ccceeecc-eeccccCeEEEEEEEC--CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 93 RQFYTLGK-ELGRGQFGITYLCTEN--STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 93 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.+.+.+.+ .||+|+||.||+|.+. .++..||||++... ......+.+.+|+.+|++++ ||||+++++++.+ +.
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC--CSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SS
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--CChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CC
Confidence 34455555 8999999999999875 35667999988653 23345688999999999997 9999999999976 56
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+|||||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~---~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR---HYAKISDFGLSKAL 486 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCCSTTTTC
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC---CcEEEeeccCcccc
Confidence 89999999999999998754 459999999999999999999999999999999999999654 47999999999876
Q ss_pred cCCCc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 249 DEGKV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 249 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
..... .....+++.|+|||++. +.++.++|||||||++|||++ |..||.+.+..++...+..+... ..+ ..
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-~~p--~~ 563 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-ECP--PE 563 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC-CCC--TT
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CCC--Cc
Confidence 43321 12234668999999986 569999999999999999998 99999998888888888776432 222 25
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHh
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
+++++.+||.+||..||++||++.+++
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 799999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=364.80 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=201.1
Q ss_pred ccceeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.+.|.+.+.||+|+||.||+|++. .++..||+|.+... ......+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence 456999999999999999999877 46778999988543 23455678999999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++...
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc---CCCCEEECcCcccccc
Confidence 999999999999999998754 699999999999999999999999999999999999994 4457999999999876
Q ss_pred cCCCc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 249 DEGKV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 249 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
..... .....+++.|+|||++. ..++.++|||||||++|||++ |..||......+....+..+... +. ...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-~~--~~~ 274 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-PP--PMD 274 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-CC--CTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CC--Ccc
Confidence 54321 12234578899999986 568999999999999999998 99999999888888777665322 21 225
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++..+.+||.+||+.||.+||++.++++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 7899999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.39 Aligned_cols=247 Identities=25% Similarity=0.295 Sum_probs=206.4
Q ss_pred ceee-cceeccccCeEEEEEEE--CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 95 FYTL-GKELGRGQFGITYLCTE--NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 95 ~y~~-~~~lg~G~~g~Vy~~~~--~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
.+.+ .+.||+|+||.||+|.+ ..+++.||||++... .......+.+.+|+.+|++++ ||||+++++++.. +.++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGG-GGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccc-cCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEE
Confidence 3444 35899999999999954 456789999988553 334455688999999999997 9999999999965 4588
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||||.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++......
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~---~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCTTHHHHTTC-
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC---CCEEEEEcCCccccccC
Confidence 999999999999999988899999999999999999999999999999999999999654 46999999999876543
Q ss_pred Cc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 252 KV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 252 ~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.. .....||+.|+|||++. ..++.++|||||||++|||++ |..||.+....++...+..+...... ..+++
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~ 599 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---AGCPR 599 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCH
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCH
Confidence 21 22345788999999986 469999999999999999998 99999999998888888776432221 25799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.+||.+||+.||++||+++++++
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=349.18 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=206.5
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++.+.+|+++..+..++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 356779999999999999999999999999999998754332 245889999999999666677776677888999
Q ss_pred EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+..+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 8999999974 4579999999999999999999999999999999999999643445579999999998765
Q ss_pred CCCc--------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCCC
Q 013201 250 EGKV--------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFDAILKGGVDFES 317 (447)
Q Consensus 250 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~ 317 (447)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....+..+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 4322 245689999999999864 58999999999999999999999998643 22233333332222211
Q ss_pred C-ccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 318 E-PWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 318 ~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
. ....+++++.+||.+||+.||.+|||++++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0 11247899999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=347.76 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=214.1
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|++.+.||+|+||.||+|.+..++..||+|.+... ....+.+.+|+.++++++ ||||+++++++.+.+.+|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCEE
Confidence 456799999999999999999999999999999988542 335678899999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE---NHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECG---GGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcC---CCCEEEccCccceecc
Confidence 999999999999999874 34999999999999999999999999999999999999954 4469999999998765
Q ss_pred CCCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||...........+...... . ....+++
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 239 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-E--RPEGCPE 239 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-C--CCTTCCH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC-C--CCCCCCH
Confidence 4332 22345788999999986 568999999999999999999 99999988877777776655322 1 1235799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+.+||.+||..||.+|||++++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=355.37 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=211.7
Q ss_pred cccceeecceeccccCeEEEEEEECCCCC-----EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGN-----SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..+.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++++.+||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 35679999999999999999999987665 79999885432 344567889999999999559999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQ--------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD 232 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~--------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~ 232 (447)
.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~- 200 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG- 200 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG-
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC-
Confidence 99999999999999999998753 357999999999999999999999999999999999999544
Q ss_pred CCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHH
Q 013201 233 GGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDA 307 (447)
Q Consensus 233 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 307 (447)
..+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........
T Consensus 201 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 201 --HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp --GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred --CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 4699999999986543322 12345788999999876 568999999999999999998 9999988766555555
Q ss_pred HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 308 ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 308 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+.........+ ..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 279 LVKDGYQMAQP--AFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 55544433322 2468999999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=359.14 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=205.3
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCE----EEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNS----YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
.+.|++.+.||+|+||.||+|++..++.. ||+|.+.... .......+.+|+.++++++ ||||+++++++. .+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CC
Confidence 35699999999999999999999988887 5555543221 1222345678999999997 999999999986 45
Q ss_pred eEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
..++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES---SSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC---CCCeEEECCCCcccc
Confidence 688999999999999999874 5799999999999999999999999999999999999994 445699999999987
Q ss_pred ccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 248 IDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 248 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
..... ......||+.|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+..+...... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence 65432 234457888999999986 568999999999999999999 99999988887777777665432222 13
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++.++.+||.+||..||.+|||+.++++|
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 68889999999999999999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=346.24 Aligned_cols=249 Identities=25% Similarity=0.301 Sum_probs=209.5
Q ss_pred ccceeecc-eeccccCeEEEEEEE--CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 93 RQFYTLGK-ELGRGQFGITYLCTE--NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 93 ~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.+.|.+.+ .||+|+||.||+|.+ ..+++.||+|++.... ......+.+.+|+.+++.++ ||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCC
Confidence 45699988 999999999999954 5668899999886542 23344678999999999997 99999999999 5677
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEECC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC---CcEEEccCCcceeec
Confidence 89999999999999999998889999999999999999999999999999999999999654 469999999998765
Q ss_pred CCCce----eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 250 EGKVY----RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 250 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
..... ....|++.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+..... ...+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 245 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGC 245 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCCC
Confidence 44322 2245678999999986 458889999999999999999 9999999888887777766543221 1257
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.+.++|.+||+.||.+||++.++++
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=355.21 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=208.6
Q ss_pred cccceeecceeccccCeEEEEEEE-----CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTE-----NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
..++|++.+.||+|+||.||+|++ ..+++.||+|++.... .......+.+|+.+++++.+||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 356799999999999999999985 3567899999885432 344556789999999999779999999999876
Q ss_pred CC-eEEEEEeccCCCchHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 167 RQ-SVHLVMELCSGGELFDKIIAQGH----------------YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 167 ~~-~~~lv~e~~~g~~L~~~l~~~~~----------------~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
.+ .+++||||++|++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 58999999999999999987654 89999999999999999999999999999999999995
Q ss_pred cCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHH-
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKG- 303 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~- 303 (447)
. +..+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+.....
T Consensus 183 ~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 183 E---KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp G---GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred C---CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 4 44699999999987644322 22356789999999886 558999999999999999998 999998766444
Q ss_pred HHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 304 IFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 304 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
....+..+. ....+ ..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGT-RMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCc-cCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 334444432 22222 2478999999999999999999999999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=354.26 Aligned_cols=247 Identities=20% Similarity=0.246 Sum_probs=197.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC----
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ---- 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 168 (447)
.++|++.+.||+|+||+||+|++. ++.||+|++... ........+|+.++++++ ||||+++++++.+..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCc
Confidence 456999999999999999999876 789999988543 233455667999999997 999999999998743
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc----------CcEeecCCCCceEeecCCCCCceE
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM----------GVMHRDLKPENFLLSNKDGGAMLK 238 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~----------~ivH~Dlkp~Nill~~~~~~~~vk 238 (447)
.+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++ ....+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---~~~~~k 171 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTAC 171 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---TTCCEE
T ss_pred eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---CCCeEE
Confidence 47999999999999999876 4699999999999999999999999 999999999999994 445799
Q ss_pred EecCCCceeccCCCc---eeecCCcccccccccccc------cCCCCCcchhHHHHHHHHhhCCCCCCCCC---------
Q 013201 239 ATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLRR------SYGKEIDVWSAGVILYILLSGVPPFWAET--------- 300 (447)
Q Consensus 239 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~pf~~~~--------- 300 (447)
|+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999987654332 233579999999999864 35678899999999999999999997542
Q ss_pred -------HHHHHHHHHhCCCCCCCCcc-c--cCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 301 -------EKGIFDAILKGGVDFESEPW-L--LISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 301 -------~~~~~~~i~~~~~~~~~~~~-~--~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.......+............ . ..++++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22223333333222221111 1 12456999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.32 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=206.3
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
.....++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTT
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCC
Confidence 3445677999999999999999999964 6899999987543 3345678899999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 169 SVHLVMELCSGGELFDKIIAQG----HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC---TTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC---CCCCEEEeeccc
Confidence 9999999999999999886543 489999999999999999999999999999999999994 445799999999
Q ss_pred ceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHhCCC
Q 013201 245 SVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIF-------DAILKGGV 313 (447)
Q Consensus 245 a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~i~~~~~ 313 (447)
+....... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||......+.. .....+..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98654321 223456899999999885 56899999999999999999999999765432111 11111111
Q ss_pred C------CCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 013201 314 D------FESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352 (447)
Q Consensus 314 ~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~ 352 (447)
. ........++..+.++|.+||+.||++|||+.++++|.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 00111123456789999999999999999999998763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=348.37 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=211.1
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED---- 166 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---- 166 (447)
.+...|++.+.||+|+||.||+|++..+++.||+|.+.... +.+.+|+.+++++. ||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEeccccC
Confidence 45567999999999999999999999999999999885432 35678999999997 9999999998864
Q ss_pred ------------CCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC
Q 013201 167 ------------RQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD 232 (447)
Q Consensus 167 ------------~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~ 232 (447)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~- 158 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT- 158 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-
Confidence 45689999999999999999764 579999999999999999999999999999999999999654
Q ss_pred CCCceEEecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Q 013201 233 GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG 311 (447)
Q Consensus 233 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 311 (447)
..+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||... ......+..+
T Consensus 159 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~ 234 (284)
T 2a19_B 159 --KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG 234 (284)
T ss_dssp --TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT
T ss_pred --CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc
Confidence 469999999998876655555678999999999986 45899999999999999999999988532 2333444443
Q ss_pred CCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 312 GVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 312 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
... ..+++.+.+||.+||..||.+|||+.++++|.|....
T Consensus 235 ~~~------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 235 IIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ccc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 221 2468999999999999999999999999999887654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=354.34 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=203.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccc--cCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRK--LVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~--~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.|++.+.||+|+||.||+|++..+++.+++|+..+.. .........+.+|+.++++++ ||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC-c
Confidence 356999999999999999999999888876555443321 123345678899999999997 999999999998765 7
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
++|+||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTC-----
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC---CEEEccCcceeEcc
Confidence 8999999999999999874 5699999999999999999999999999999999999996543 69999999998764
Q ss_pred CCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 250 EGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 250 ~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..+..... + ..++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-~--~~~~ 245 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-P--PICT 245 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-C--TTBC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-C--ccCC
Confidence 4322 22346788999999986 458999999999999999999 9999999888877777666543222 2 2478
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.++.+||.+||..||.+||++.++++
T Consensus 246 ~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 246 IDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=356.06 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=190.0
Q ss_pred CCccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE-
Q 013201 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE- 165 (447)
Q Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 165 (447)
...+....+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++++.+||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 33344456799999999999999999999999999999988543 34456778999999999977999999999984
Q ss_pred -------eCCeEEEEEeccCCCchHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCC
Q 013201 166 -------DRQSVHLVMELCSGGELFDKIIA---QGHYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDG 233 (447)
Q Consensus 166 -------~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~ 233 (447)
....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~--- 173 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN--- 173 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT---
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC---
Confidence 3456899999995 689888865 456999999999999999999999999 999999999999954
Q ss_pred CCceEEecCCCceeccCCCce-------------eecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCC
Q 013201 234 GAMLKATDFGLSVFIDEGKVY-------------RDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPF 296 (447)
Q Consensus 234 ~~~vkl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf 296 (447)
+..+||+|||++......... ....||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 446999999999876543221 1456999999999973 34788999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 013201 297 WAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353 (447)
Q Consensus 297 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~ 353 (447)
......... ......+ .....+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 254 ~~~~~~~~~----~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 254 EDGAKLRIV----NGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----------------CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cchhHHHhh----cCcccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 765543322 2222222 22346788999999999999999999999998743
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=370.75 Aligned_cols=247 Identities=21% Similarity=0.336 Sum_probs=213.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
...|++.+.||+|+||.||+|+++.++..||||.+.... ...+.+.+|+.+|++++ ||||+++++++.+...+||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcEEE
Confidence 456999999999999999999999999999999885432 34678999999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE---NHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG---GGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECC---CCcEEEeecccceeccC
Confidence 99999999999999874 35899999999999999999999999999999999999944 45799999999987654
Q ss_pred CCce--eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKVY--RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.... ....+++.|+|||++. +.++.++|||||||++|||++ |..||.+.+..++...+..+. .... ...+++.
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~ 447 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RMER--PEGCPEK 447 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCC--CTTCCHH
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCHH
Confidence 3221 2235678899999986 558999999999999999999 999999888877777665543 2222 2357999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.+||.+||+.||.+|||+.++++
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=351.86 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=205.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCC----CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTG----NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
...|++.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|+.+++++. ||||+++++++.+.+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCC
Confidence 456999999999999999999987653 359999885432 3445667899999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---CCCcEEECCCCcchh
Confidence 999999999999999999875 5699999999999999999999999999999999999994 445799999999987
Q ss_pred ccCCCc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 248 IDEGKV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 248 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+... +. ..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-~~--~~ 273 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-PT--PM 273 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-CC--CT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-CC--cc
Confidence 654321 12345688999999986 558999999999999999999 99999998888888877765322 21 22
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+++.+.+||.+||+.||.+||++.+++++
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 578999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.07 Aligned_cols=245 Identities=16% Similarity=0.218 Sum_probs=208.6
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC--CeE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR--QSV 170 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~ 170 (447)
.+.|++.+.||+|+||.||+|++. ++.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+. +.+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCe
Confidence 356999999999999999999985 8899999886543 23445677999999999997 99999999999877 788
Q ss_pred EEEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 171 HLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
++||||++||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++ .+..++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKF 161 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC---TTSCEEEEGGGSCC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc---CCcceeEEecccee
Confidence 99999999999999998765 4899999999999999999999999 99999999999994 44468888888765
Q ss_pred eccCCCceeecCCccccccccccccc-C---CCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLRRS-Y---GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
.... ....||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.........+.........+ ..
T Consensus 162 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 235 (271)
T 3kmu_A 162 SFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP--PG 235 (271)
T ss_dssp TTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC--TT
T ss_pred eecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC--CC
Confidence 4332 234789999999998643 3 347999999999999999999999988888777777665443332 35
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+++++.++|.+||+.||++|||++++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7999999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=348.30 Aligned_cols=254 Identities=20% Similarity=0.276 Sum_probs=201.8
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+.++++|..+..++.+....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 345779999999999999999999999999999998654322 235788999999999666677777777889999
Q ss_pred EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..+....+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 8999999885 4579999999999999999999999999999999999999544445579999999998765
Q ss_pred CCCc--------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH---HHHHHHHhCCCCCCC
Q 013201 250 EGKV--------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEK---GIFDAILKGGVDFES 317 (447)
Q Consensus 250 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~ 317 (447)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..+..+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 4322 235689999999999864 5899999999999999999999999764321 222222222111111
Q ss_pred C-ccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 318 E-PWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 318 ~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
. ....+++++.+||.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1 11246899999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=365.93 Aligned_cols=242 Identities=24% Similarity=0.347 Sum_probs=206.3
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-eEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-SVH 171 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~ 171 (447)
.+.|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.+|++++ ||||+++++++.... .+|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCceE
Confidence 467999999999999999999976 7799999885432 4567899999999997 999999999987655 799
Q ss_pred EEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
||||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---CCCCEEEeeCCCccccc
Confidence 99999999999999987654 79999999999999999999999999999999999994 44579999999998654
Q ss_pred CCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
... ....+++.|+|||++. ..++.++|||||||++|||++ |..||.+....+....+..+.. ...+ ..+++++
T Consensus 341 ~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~p--~~~~~~l 415 (450)
T 1k9a_A 341 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MDAP--DGCPPAV 415 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-CCCC--TTCCHHH
T ss_pred ccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC--CcCCHHH
Confidence 322 2346789999999986 558999999999999999998 9999998887777777766532 2222 3579999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+||.+||..||.+|||+.++++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=342.11 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=212.0
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|+.++++++ ||||+++++++.+.+.+|+|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT----BCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEEE
Confidence 56999999999999999999987 57889999886533 23467899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. +..+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE---NQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG---GGCEEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC---CCCEEEccccccccccccc
Confidence 9999999999999875 45899999999999999999999999999999999999954 4469999999997654321
Q ss_pred --ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 253 --VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 253 --~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
......|++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+...... ..+++.+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l~ 235 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVY 235 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHHH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC---ccCcHHHH
Confidence 112346788999999986 568999999999999999999 89999998888888887776432222 24689999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++|.+||+.||.+|||+.+++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=346.03 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=202.7
Q ss_pred ccceeecceeccccCeEEEEEE----ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC-
Q 013201 93 RQFYTLGKELGRGQFGITYLCT----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR- 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 167 (447)
.+.|++.+.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.++++++ ||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence 4569999999999999999999 56789999999986443 3345678899999999997 99999999999876
Q ss_pred -CeEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 168 -QSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 168 -~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
..+++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLT 173 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC---CCEEECccccc
Confidence 678999999999999999955 4569999999999999999999999999999999999999654 36999999999
Q ss_pred eeccCCCc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC--------------CHH-HHH
Q 013201 246 VFIDEGKV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE--------------TEK-GIF 305 (447)
Q Consensus 246 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~--------------~~~-~~~ 305 (447)
........ .....||+.|+|||++. ..++.++||||||+++|+|++|..|+... ... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87765432 23457888999999886 45888999999999999999999876322 111 222
Q ss_pred HHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 306 DAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 306 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
..+..+ ...+.+ ..+++++.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEG-KRLPCP--PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhcc-CCCCCC--CCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 233322 222222 357899999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=343.55 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=210.4
Q ss_pred ccceeecc-eeccccCeEEEEEEEC--CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 93 RQFYTLGK-ELGRGQFGITYLCTEN--STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 93 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.+.|.+.+ .||+|+||.||+|.+. .++..||+|++... ......+.+.+|+.++++++ ||||+++++++ ..+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCCC
Confidence 45566665 9999999999999864 46788999988643 23456778999999999997 99999999999 5567
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+ ..+||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR---HYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET---TEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC---CCEEECcccceeee
Confidence 89999999999999998654 459999999999999999999999999999999999999654 46999999999876
Q ss_pred cCCCce----eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 249 DEGKVY----RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 249 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
...... ....||+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+..... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~ 237 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPE 237 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC---CCC
Confidence 543322 2345789999999986 558999999999999999998 9999999888888877776543221 125
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h~ 352 (447)
+++++.++|.+||..||.+||++.++++|.
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 799999999999999999999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=342.95 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=207.4
Q ss_pred cccceeecceeccccCeEEEEEEECCC---CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENST---GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
..+.|++.+.||+|+||.||+|++... +..||+|.+.+.. .....+.+.+|+.++++++ ||||+++++++.++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS-
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC-
Confidence 346799999999999999999986543 3469999885432 3445678999999999997 99999999998654
Q ss_pred eEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
..|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT---EEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC---cEEeCccCCCcc
Confidence 5689999999999999997754 599999999999999999999999999999999999996543 699999999987
Q ss_pred ccCCCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 248 IDEGKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 248 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
...... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+...... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 239 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP---DLC 239 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC---TTC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC---CCC
Confidence 654322 23356788999999986 558999999999999999998 99999888777777777665432221 247
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++.+.++|.+||..||++|||+.+++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 8999999999999999999999999865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=346.58 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=196.4
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+-..++|++.+.||+|+||.||+|++. ..+|+|++... .......+.+.+|+.++++++ ||||++++++. ....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAPQ 93 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCS-SCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSSS
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEecc-CCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCCc
Confidence 334566999999999999999999854 35999988543 234556678999999999998 99999999965 5567
Q ss_pred EEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.++|||||.|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED---NTVKIGDFGLATEK 170 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---TEEEECCCC-----
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC---CCEEEccceecccc
Confidence 8999999999999999864 3569999999999999999999999999999999999999554 46999999999765
Q ss_pred cC---CCceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCCCCC-c
Q 013201 249 DE---GKVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKG-IFDAILKGGVDFESE-P 319 (447)
Q Consensus 249 ~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~-~ 319 (447)
.. ........||+.|+|||++. ..++.++||||||+++|+|++|..||.+..... ....+..+....... .
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 43 22234567999999999884 347889999999999999999999998865544 444444444332221 2
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
...+++.+.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2357899999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=360.42 Aligned_cols=256 Identities=18% Similarity=0.169 Sum_probs=196.9
Q ss_pred ccceeecceeccccCeEEEEEEECC---CCCEEEEEEeeccccCCh--------hhHHHHHHHHHHHHhccCCCCeeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS---TGNSYACKSILKRKLVNK--------QDREDIKREIQIMQHLSGQQNIVEFR 161 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~iv~~~ 161 (447)
.++|++.+.||+|+||.||+|++.. ++..+|+|++........ .....+.+|+.+++.+. ||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcceee
Confidence 4569999999999999999999987 788999998865421100 11234567888888887 99999999
Q ss_pred EEEEe----CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCce
Q 013201 162 GAYED----RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 162 ~~~~~----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
+++.. ...+|+||||| |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~ 192 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP-DQV 192 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST-TSE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC-CcE
Confidence 99988 78899999999 9999999988778999999999999999999999999999999999999976432 379
Q ss_pred EEecCCCceeccCCC--------ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCC--CHHHHHH
Q 013201 238 KATDFGLSVFIDEGK--------VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAE--TEKGIFD 306 (447)
Q Consensus 238 kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~ 306 (447)
||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. .......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999998764321 1134589999999999875 4899999999999999999999999653 2222211
Q ss_pred HHHhCCCCCCCC-----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 307 AILKGGVDFESE-----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 307 ~i~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.........+.. +...+++++.+||.+||..||++||+++++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 111100011100 001578999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=364.07 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=210.3
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|++.+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|+.+|++++ ||||+++++++. .+.+|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCccE
Confidence 4567999999999999999999986 46789999886432 34678999999999997 999999999986 56789
Q ss_pred EEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
||||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++....
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIE 335 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTCCEEECSTTGGGGBC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC---CCCcEEEeeCCCceEcC
Confidence 999999999999999754 3689999999999999999999999999999999999994 44579999999998764
Q ss_pred CCCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.... .....+|+.|+|||++. +.++.++|||||||++|||++ |..||.+.+..++...+..+.. .+.+ ..+++
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~~--~~~~~ 412 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MPRP--ENCPE 412 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-CCCC--TTSCH
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC--CCCCH
Confidence 4221 12345678999999986 568999999999999999999 9999999988888888776633 2222 35799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.+||.+||..||++|||+++++.
T Consensus 413 ~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=346.15 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=204.0
Q ss_pred ccceeecceeccccCeEEEEEEECC-CCC--EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-TGN--SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.+.|++.+.||+|+||.||+|++.. ++. .||+|++...........+.+.+|+.++++++ ||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence 4569999999999999999998643 333 68999886654444556788999999999997 999999999998765
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~---~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC---CEEEccccccccc
Confidence 88999999999999999874 5699999999999999999999999999999999999996543 6999999999876
Q ss_pred cCCCc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 249 DEGKV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 249 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
..... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+.......+.. ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--ED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC--TT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC--cC
Confidence 54332 12346788999999986 457899999999999999999 999999999888888887765544433 35
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+++++.++|.+||..||.+|||+.+++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 79999999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=365.83 Aligned_cols=253 Identities=22% Similarity=0.261 Sum_probs=208.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.|.++++|+.+..++......+
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 45779999999999999999999999999999998754332 2347889999999997788888888889999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+..+....+||+|||++.....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 8999999986 56799999999999999999999999999999999999996444556799999999987654
Q ss_pred CCc--------eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCCCC
Q 013201 251 GKV--------YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETE---KGIFDAILKGGVDFESE 318 (447)
Q Consensus 251 ~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~ 318 (447)
... .....||+.|+|||++.+ .++.++|||||||+||+|++|..||.+... ...+..+..........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 322 125689999999999864 589999999999999999999999987533 33343333322111111
Q ss_pred -ccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 319 -PWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 319 -~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
....+++++.+||.+||..||++||++.+|++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11247899999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=351.08 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=205.7
Q ss_pred ccceeecceeccccCeEEEEEE----ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE--e
Q 013201 93 RQFYTLGKELGRGQFGITYLCT----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE--D 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~ 166 (447)
.++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++ ||||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence 3579999999999999999999 4678999999988543 3455677899999999997 999999999886 5
Q ss_pred CCeEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 167 RQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
.+.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE---AHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC---CCEEEcccccc
Confidence 6779999999999999999987 4569999999999999999999999999999999999999654 46999999999
Q ss_pred eeccCCCce----eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH---------------HHH
Q 013201 246 VFIDEGKVY----RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK---------------GIF 305 (447)
Q Consensus 246 ~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------------~~~ 305 (447)
......... ....||+.|+|||++. ..++.++||||||+++|+|++|..||...... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 876543321 2346888999999986 45789999999999999999999998654321 222
Q ss_pred HHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 306 DAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 306 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..+..+ ...+. ...+++++.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEG-QRLPA--PPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcc-cCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222 22222 23579999999999999999999999999654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=348.63 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=201.9
Q ss_pred ccceeecceeccccCeEEEEEEECC---CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC-
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS---TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ- 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 168 (447)
.+.|.+++.||+|+||.||+|++.. ++..||+|.+.... ......+.+.+|+.++++++ ||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSS 110 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC---
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccc
Confidence 4679999999999999999998765 45689999885432 23445677899999999997 999999999997755
Q ss_pred ----eEEEEEeccCCCchHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceE
Q 013201 169 ----SVHLVMELCSGGELFDKIIA------QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLK 238 (447)
Q Consensus 169 ----~~~lv~e~~~g~~L~~~l~~------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vk 238 (447)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .+..+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC---TTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEE
Confidence 35999999999999999853 34699999999999999999999999999999999999994 445699
Q ss_pred EecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCC
Q 013201 239 ATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 239 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 313 (447)
|+|||++........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 999999987654321 22346788999999986 458999999999999999999 9999998888888887777643
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
... ...+++.+.+||.+||..||.+|||+.+++++
T Consensus 268 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 LKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221 23578999999999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=345.70 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=195.1
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHh--ccCCCCeeEEEEEEEe--
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH--LSGQQNIVEFRGAYED-- 166 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~--l~~h~~iv~~~~~~~~-- 166 (447)
.+.+.|++.+.||+|+||+||+|++ +++.||+|++... ....+.+|.+++.. ++ ||||+++++++.+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASDMTSR 75 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEeecccc
Confidence 4567799999999999999999987 5889999987432 34556677777776 55 9999999998654
Q ss_pred --CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcEeecCCCCceEeecCCCCCc
Q 013201 167 --RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH--------FMGVMHRDLKPENFLLSNKDGGAM 236 (447)
Q Consensus 167 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH--------~~~ivH~Dlkp~Nill~~~~~~~~ 236 (447)
...+|+||||+++|+|.+++. ...+++..+..++.||+.||.||| ++||+||||||+|||++ .+..
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~---~~~~ 151 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK---KNGQ 151 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC---TTSC
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc---CCCC
Confidence 356899999999999999984 457999999999999999999999 99999999999999994 4457
Q ss_pred eEEecCCCceeccCCCce-----eecCCccccccccccccc-------CCCCCcchhHHHHHHHHhhC----------CC
Q 013201 237 LKATDFGLSVFIDEGKVY-----RDIVGSAYYVAPEVLRRS-------YGKEIDVWSAGVILYILLSG----------VP 294 (447)
Q Consensus 237 vkl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~elltg----------~~ 294 (447)
+||+|||++......... ....||+.|+|||++.+. ++.++|||||||++|||++| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 999999999876544322 234899999999998643 44689999999999999999 88
Q ss_pred CCCCCC----HHHHHHHHHhC-CCCCCCCc---cccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 295 PFWAET----EKGIFDAILKG-GVDFESEP---WLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 295 pf~~~~----~~~~~~~i~~~-~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
||.... ........... ......+. ...+++++.+||.+||+.||++|||+.++++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 886532 22223333222 21111111 0124578999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=385.14 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=212.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe------C
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED------R 167 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------~ 167 (447)
++|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+.+|+.++++++ ||||+++++++.. .
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCC
Confidence 4599999999999999999999999999999987543 24555678999999999997 9999999998765 6
Q ss_pred CeEEEEEeccCCCchHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG---HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
+..|+|||||+||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++....+||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 77899999999999999998754 589999999999999999999999999999999999998777777799999999
Q ss_pred ceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHH--------------HH
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDA--------------IL 309 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--------------i~ 309 (447)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||........+.. ..
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 99877666666778999999999986 5689999999999999999999999976533221100 00
Q ss_pred hCCCCCC------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 310 KGGVDFE------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 310 ~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
.+...+. ......+++.+.+||.+||..||++|||++++++||||+.
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 1111111 1112235788999999999999999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=338.06 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=209.0
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++++. ||||+++++++.+ +..+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEcC-CCcE
Confidence 4567999999999999999999976 56789999885432 24578899999999997 9999999999864 5688
Q ss_pred EEEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++ .+..+||+|||++....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---CCCCEEECCCccccccc
Confidence 9999999999999986543 699999999999999999999999999999999999994 44579999999998765
Q ss_pred CCCce--eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKVY--RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
..... ....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..+..... ...+++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 237 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCPE 237 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC---cccccH
Confidence 54322 2345788999999986 558999999999999999999 9999999888888887766533222 135789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.+||.+||..||++|||+.++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=348.88 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=202.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE----eCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE----DRQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----~~~ 168 (447)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.+. ||||+++++++. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCc
Confidence 46799999999999999999999999999999988542 3456678899999999997 999999999986 345
Q ss_pred eEEEEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 169 SVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
..|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~---~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD---EGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---CCCEEEEecCc
Confidence 78999999999999999876 466999999999999999999999999999999999999944 45699999999
Q ss_pred ceeccCCC----------ceeecCCcccccccccccc----cCCCCCcchhHHHHHHHHhhCCCCCCCCCH--HHHHHHH
Q 013201 245 SVFIDEGK----------VYRDIVGSAYYVAPEVLRR----SYGKEIDVWSAGVILYILLSGVPPFWAETE--KGIFDAI 308 (447)
Q Consensus 245 a~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i 308 (447)
+....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ......
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~- 259 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA- 259 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH-
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH-
Confidence 87643211 1123468999999999853 268999999999999999999999953211 111222
Q ss_pred HhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 013201 309 LKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352 (447)
Q Consensus 309 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~ 352 (447)
.......+. ...+++++.+||.+||+.||.+|||+.+++++-
T Consensus 260 ~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 260 VQNQLSIPQ--SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHCC--CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhccCCCCc--cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 222222222 235789999999999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=357.64 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=196.6
Q ss_pred ccccceeecceeccccCeEEEEE-----EECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccC--CCCeeEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLC-----TENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG--QQNIVEFRGA 163 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~-----~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~ 163 (447)
...+.|.+.+.||+|+||+||+| .+..+++.||+|++... ....+.+|+.+++.+.. |+||+.++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34567999999999999999999 46778999999988532 34567788888888763 7999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeec--------
Q 013201 164 YEDRQSVHLVMELCSGGELFDKIIA-----QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSN-------- 230 (447)
Q Consensus 164 ~~~~~~~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~-------- 230 (447)
+...+..|||||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999974 456999999999999999999999999999999999999965
Q ss_pred CCCCCceEEecCCCceecc---CCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHH
Q 013201 231 KDGGAMLKATDFGLSVFID---EGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFD 306 (447)
Q Consensus 231 ~~~~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 306 (447)
++....+||+|||++.... ........+||+.|+|||++.+ .++.++|||||||++|||+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 2225679999999997643 3334456789999999999874 48999999999999999999999996543210
Q ss_pred HHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 307 AILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 307 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
......+.. ...++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 293 --~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 --CKPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp --EEECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred --eeechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 000001111 1246789999999999999999765554443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=342.18 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=204.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCC---CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEE-EeCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTG---NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAY-EDRQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~~~ 168 (447)
...|++.+.||+|+||.||+|++..++ ..+|+|.+.. .......+.+.+|+.++++++ ||||+++++++ ..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~--~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc--CCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence 345999999999999999999976443 3588887753 234455678899999999997 99999999985 5567
Q ss_pred eEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC---CCCCEEECccccccc
Confidence 889999999999999999764 4589999999999999999999999999999999999994 445799999999986
Q ss_pred ccCCC-----ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Q 013201 248 IDEGK-----VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 248 ~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 320 (447)
..... ......||+.|+|||++. ..++.++||||||+++|+|++ |.+||......+....+..+......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence 64432 123456788999999986 458999999999999999999 66777777776777777666543332
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
..+++.+.++|.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 247899999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=360.30 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=207.7
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|++++ ||||+++++++.+ +.+|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-CceE
Confidence 35679999999999999999999875 4679999886432 23567899999999997 9999999999876 6789
Q ss_pred EEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++....
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE---NLVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG---GGCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC---CCCEEECCCccceecC
Confidence 999999999999999753 56999999999999999999999999999999999999944 4569999999998765
Q ss_pred CCCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCCh
Q 013201 250 EGKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325 (447)
Q Consensus 250 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 325 (447)
.... .....+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+.. .+.+ ..+++
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~~--~~~~~ 408 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCP--PECPE 408 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CCCC--TTSCH
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC--CCCCH
Confidence 4321 22345788999999886 568999999999999999999 9999999988888888776532 2222 25799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc--CCCccC
Q 013201 326 SAKDLVRKMLIQDPKKRITSAEVLE--HPWMRE 356 (447)
Q Consensus 326 ~~~~li~~~L~~dp~~R~t~~~~l~--h~~~~~ 356 (447)
.+.+||.+||+.||++|||++++++ ..++..
T Consensus 409 ~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 9999999999999999999999876 355544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=340.44 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=203.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCC---EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE-
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGN---SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV- 170 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~- 170 (447)
.|.+++.||+|+||.||+|++..++. .+|+|.+.. .......+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~--~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc--cccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCCc
Confidence 47888999999999999999766554 799998743 234455678899999999997 99999999999766555
Q ss_pred EEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDIL 175 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECCTTSSCTTT
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEeCcCCCccccc
Confidence 999999999999999987 45689999999999999999999999999999999999994 44579999999997654
Q ss_pred CCC-----ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 250 EGK-----VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 250 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
... ......||+.|+|||.+.+ .++.++||||||+++|+|++| .+||...+.......+..+..... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 252 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---PEY 252 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---CTT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---Ccc
Confidence 321 2234578999999999864 589999999999999999995 555555666666666655543222 224
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+++.+.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7899999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.66 Aligned_cols=247 Identities=27% Similarity=0.381 Sum_probs=200.5
Q ss_pred ceeecceeccccCeEEEEEEE----CCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CC
Q 013201 95 FYTLGKELGRGQFGITYLCTE----NSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQ 168 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~ 168 (447)
.|++.+.||+|+||+||+|.. ..+++.||+|++... ........+.+|+.++++++ ||||+++++++.+ ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTTT
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecCCCc
Confidence 359999999999999987753 457899999998643 23455678999999999998 9999999999987 46
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+++||||+++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++ .+..+||+|||++...
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCEEC
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---CCCCEEECCccccccc
Confidence 899999999999999988654 599999999999999999999999999999999999994 4456999999999877
Q ss_pred cCCCc----eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH--------------HHHHHHH
Q 013201 249 DEGKV----YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEK--------------GIFDAIL 309 (447)
Q Consensus 249 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~--------------~~~~~i~ 309 (447)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ..+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 65432 234568889999999864 5889999999999999999999999654221 0112222
Q ss_pred hCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 310 KGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 310 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
......+. ...+++++.+||.+||+.||.+|||+.++++
T Consensus 265 ~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ERGERLPR--PDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccCCCC--CccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22222222 2357999999999999999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=350.06 Aligned_cols=260 Identities=20% Similarity=0.226 Sum_probs=204.4
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
......+.|++.+.||+|+||.||+|++. +++.||+|++...... .....+.+|+.+++.+. ||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAV-HRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhcc-CCCccceEEEEecC
Confidence 34455678999999999999999999854 6899999998654321 22236889999999998 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc---CcEeecCCCCceEeecCCCCCceEEe
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG----HYTEKAAAALCRAIVNVVHHCHFM---GVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~qil~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
+..++||||+.+|+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++ .+..+||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~ 176 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVG 176 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC---TTCCEEEC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC---CCCCEEec
Confidence 99999999999999999998643 399999999999999999999999 999999999999994 44569999
Q ss_pred cCCCceeccCC--CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC----CHHHHHHHHHhCCC
Q 013201 241 DFGLSVFIDEG--KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE----TEKGIFDAILKGGV 313 (447)
Q Consensus 241 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~~~~ 313 (447)
|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||... ..............
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999876533 2234456999999999985 55899999999999999999999999521 11111111111111
Q ss_pred CC-----------CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 314 DF-----------ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 314 ~~-----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
.. ........++.+.++|.+||+.||.+|||+.++++|-.-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00 001111234679999999999999999999999988543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=338.78 Aligned_cols=242 Identities=23% Similarity=0.334 Sum_probs=198.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-CCeEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED-RQSVH 171 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~ 171 (447)
.+.|++.+.||+|+||.||+|.+. ++.||+|++... ...+.+.+|+.++++++ ||||+++++++.+ .+.+|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCceE
Confidence 456999999999999999999875 889999987532 24577899999999997 9999999998754 45789
Q ss_pred EEEeccCCCchHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 172 LVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+||+++ .+..+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC-----
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe---CCCcEEEeecccccccc
Confidence 99999999999999987544 89999999999999999999999999999999999995 44569999999987654
Q ss_pred CCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
... ....+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+.. . .....+++.+
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l 243 (278)
T 1byg_A 169 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-M--DAPDGCPPAV 243 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-C--CCCTTCCHHH
T ss_pred ccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-C--CCcccCCHHH
Confidence 432 2346889999999986 458999999999999999998 9999998887777777655422 1 1123579999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.++|.+||..||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=353.00 Aligned_cols=247 Identities=15% Similarity=0.186 Sum_probs=199.9
Q ss_pred ccceeecceeccccCeEEEEEEECCC--------CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeE-----
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENST--------GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVE----- 159 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~----- 159 (447)
.++|++.+.||+|+||.||+|++..+ ++.||+|++.+. +.+.+|+.+++++. ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 35699999999999999999999874 889999988543 35789999999997 888876
Q ss_pred ----------EEEEEEe-CCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCce
Q 013201 160 ----------FRGAYED-RQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENF 226 (447)
Q Consensus 160 ----------~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Ni 226 (447)
+++++.. ++.+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777766 78899999999 99999999886 7799999999999999999999999999999999999
Q ss_pred EeecCCCCCceEEecCCCceeccCCC--------ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCC
Q 013201 227 LLSNKDGGAMLKATDFGLSVFIDEGK--------VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFW 297 (447)
Q Consensus 227 ll~~~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~ 297 (447)
|++.++ ...+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 191 l~~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPED-QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTE-EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCC-CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 996432 1269999999997654321 1133589999999999875 58999999999999999999999998
Q ss_pred CCC--HHHHHHHH---HhCCCCC--CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 298 AET--EKGIFDAI---LKGGVDF--ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 298 ~~~--~~~~~~~i---~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
... ...+.... ......+ ....+..+++++.+||.+||..||++|||++++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 753 22222222 2222111 12223457999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=355.45 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=197.9
Q ss_pred cceeecceeccccCeEEEEEEECCCC---CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE-eCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTG---NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE-DRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~ 169 (447)
..|.+.+.||+|+||.||+|++..++ ..||+|.+.. .......+.+.+|+.++++++ ||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS--CSCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC--CCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence 34889999999999999999976443 4688897743 234456678999999999997 999999999864 4568
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++...
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC---CCCCEEEeeccccccc
Confidence 89999999999999999765 3589999999999999999999999999999999999994 4457999999999865
Q ss_pred cCCC-----ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 249 DEGK-----VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 249 ~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
.... ......||+.|+|||++. ..++.++|||||||++|||++ |.+||......+....+..+...... .
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p---~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---E 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---T
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---C
Confidence 4322 122346788999999986 568999999999999999999 78888877766666666665433222 2
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+++.+.++|.+||..||++|||+.+++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 578999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=345.29 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=202.8
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeecccc-CChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL-VNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 174 (447)
|..++.||+|+||.||+|++ +++.||+|++..... ......+.+.+|+.++++++ ||||+++++++.+.+..++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEE
Confidence 55669999999999999985 588999998865432 23345678999999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 175 ELCSGGELFDKIIA---QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 175 e~~~g~~L~~~l~~---~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++ .+..+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---CCCcEEEeecccccccccc
Confidence 99999999999874 34599999999999999999999999999999999999994 4457999999999876543
Q ss_pred Cc---eeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHH----HHHHHHhCCCCC-------CC
Q 013201 252 KV---YRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKG----IFDAILKGGVDF-------ES 317 (447)
Q Consensus 252 ~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~-------~~ 317 (447)
.. .....||+.|+|||++.+.++.++||||||+++|+|++|..||....... +...+......+ ..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 21 23457999999999998889999999999999999999999997654322 222222211100 01
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
......++.+.++|.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1112345778999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=340.31 Aligned_cols=240 Identities=28% Similarity=0.431 Sum_probs=193.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++. ++.||+|.+.. ....+.+.+|+.++++++ ||||+++++++. +..|+|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVN-HPNIVKLYGACL--NPVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCT--TTTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--CCcEEE
Confidence 46999999999999999999975 78899998742 334678899999999997 999999999886 347899
Q ss_pred EeccCCCchHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHh---cCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 174 MELCSGGELFDKIIAQGH---YTEKAAAALCRAIVNVVHHCHF---MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qil~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
|||++|++|.+++..... +++..+..++.|++.||.|||+ +||+||||||+|||++.++ ..+||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG--TVLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT--TEEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC--CEEEEcccccccc
Confidence 999999999999987653 7899999999999999999999 8999999999999996543 2489999999976
Q ss_pred ccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHhCCCCCCCCccccCC
Q 013201 248 IDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAET--EKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+..+... .....++
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 230 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP---PLIKNLP 230 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC---CCBTTCC
T ss_pred cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC---CcccccC
Confidence 5432 234579999999999874 58999999999999999999999997543 23333444443222 1223579
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+.+.+||.+||+.||++|||++++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=353.12 Aligned_cols=251 Identities=17% Similarity=0.206 Sum_probs=201.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC-----ChhhHHHHHHHHHHHHhcc--------CCCCeeE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-----NKQDREDIKREIQIMQHLS--------GQQNIVE 159 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~~iv~ 159 (447)
.++|++.+.||+|+||+||+|++ +|+.||+|++.+.... .....+.+.+|+.+++.++ .||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35699999999999999999998 6899999999765432 2334578899999999886 5899999
Q ss_pred EEEEEE------------------------------eCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHH
Q 013201 160 FRGAYE------------------------------DRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209 (447)
Q Consensus 160 ~~~~~~------------------------------~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~ 209 (447)
+.+++. +.+.+|||||||++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 888753 26889999999999987776644 57899999999999999999
Q ss_pred HHH-hcCcEeecCCCCceEeecCC-----------------CCCceEEecCCCceeccCCCceeecCCcccccccccccc
Q 013201 210 HCH-FMGVMHRDLKPENFLLSNKD-----------------GGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR 271 (447)
Q Consensus 210 ~lH-~~~ivH~Dlkp~Nill~~~~-----------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 271 (447)
||| ++||+||||||+|||++.++ ....+||+|||+++..... ..+||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 99999999999999997654 1237999999999877653 3489999999999987
Q ss_pred cCCCCCcchhHHHH-HHHHhhCCCCCCCCCH-HHHHHHHHhCC-CC--CCCCccccCChHHHHHHHHhcccCCCCCCCHH
Q 013201 272 SYGKEIDVWSAGVI-LYILLSGVPPFWAETE-KGIFDAILKGG-VD--FESEPWLLISDSAKDLVRKMLIQDPKKRITSA 346 (447)
Q Consensus 272 ~~~~~~DiwslG~i-l~elltg~~pf~~~~~-~~~~~~i~~~~-~~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ 346 (447)
..+.++||||||++ .+++++|..||.+... ......+.... .. .....+..+++++++||.+||+.| |++
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 77889999998777 7788999999954221 22333444221 11 111223457899999999999977 999
Q ss_pred HHh-cCCCcc
Q 013201 347 EVL-EHPWMR 355 (447)
Q Consensus 347 ~~l-~h~~~~ 355 (447)
|+| +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=365.83 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=210.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||.||+|++.. +..||||++.... ...+.+.+|+.+|++++ ||||+++++++.+ +.+|||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEE
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEee-ccceEe
Confidence 458899999999999999999875 4679999886432 23567899999999997 9999999999876 678999
Q ss_pred EeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE---NLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG---GGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC---CCcEEEcccccceecCCC
Confidence 9999999999999753 56999999999999999999999999999999999999944 456999999999866432
Q ss_pred Cc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 252 KV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 252 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.. .....++..|+|||++. +.++.++|||||||+||||++ |..||.+....+++..+..+.. .+.+ ..+++.+
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~~~--~~~~~~l 493 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCP--PECPESL 493 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-CCCC--TTCCHHH
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC--CCCCHHH
Confidence 11 12345778999999886 568999999999999999999 9999999988888888776532 2222 2579999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC--CCccC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEH--PWMRE 356 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h--~~~~~ 356 (447)
.+||.+||+.||++|||+++|++. .+|..
T Consensus 494 ~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999999999998763 45543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=340.74 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=194.2
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc-CCCCeeEEEEEEEeC-
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS-GQQNIVEFRGAYEDR- 167 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~- 167 (447)
..+.+.|++.+.||+|+||.||+|++. ++.||+|++... ......+|.+++..+. +||||+++++++.+.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 345677999999999999999999976 889999988532 2344556666665542 499999999999887
Q ss_pred ---CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcEeecCCCCceEeecCCCCCc
Q 013201 168 ---QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM--------GVMHRDLKPENFLLSNKDGGAM 236 (447)
Q Consensus 168 ---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~--------~ivH~Dlkp~Nill~~~~~~~~ 236 (447)
..+|+|||||++|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++ .+..
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~---~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK---KNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC---TTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC---CCCC
Confidence 7899999999999999998654 799999999999999999999998 999999999999994 4457
Q ss_pred eEEecCCCceeccCCCce-----eecCCccccccccccccc-CCCC------CcchhHHHHHHHHhhC----------CC
Q 013201 237 LKATDFGLSVFIDEGKVY-----RDIVGSAYYVAPEVLRRS-YGKE------IDVWSAGVILYILLSG----------VP 294 (447)
Q Consensus 237 vkl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~------~DiwslG~il~elltg----------~~ 294 (447)
+||+|||++......... ....||+.|+|||++.+. ++.. +|||||||++|||++| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 999999999766443221 245899999999998654 4443 8999999999999999 77
Q ss_pred CCCCCC-----HHHHHHHHHhCCCCCCCCc---cccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 295 PFWAET-----EKGIFDAILKGGVDFESEP---WLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 295 pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
||.... .......+.........+. ...+++++.+||.+||+.||.+|||+.++++|
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 775432 1222222222222222111 11356779999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=344.90 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=206.5
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||.||+|.+.. .+|+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+.+++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSCEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCceEE
Confidence 4569999999999999999999864 499998865432 2233456778999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-
Q 013201 173 VMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE- 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~- 250 (447)
||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ +..+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC-----
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccccccc
Confidence 999999999999987754 699999999999999999999999999999999999995 23699999999875432
Q ss_pred -----CCceeecCCcccccccccccc----------cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC
Q 013201 251 -----GKVYRDIVGSAYYVAPEVLRR----------SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDF 315 (447)
Q Consensus 251 -----~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 315 (447)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 122234569999999999853 36889999999999999999999999988888887777664432
Q ss_pred CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 316 ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 316 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.. ...++.++.++|.+||..||.+|||+.++++.
T Consensus 263 ~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 LS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 22 22578999999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.51 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=201.9
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHh--ccCCCCeeEEEEEEEeC
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH--LSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~--l~~h~~iv~~~~~~~~~ 167 (447)
..+.+.|++.+.||+|+||.||+|++ +++.||+|++... ....+.+|+++++. ++ ||||+++++++...
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCC-CTTBCCEEEEEECC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcC-CCcEEEEEeeeccc
Confidence 34567899999999999999999997 4899999988432 34667889999987 55 99999999999887
Q ss_pred C----eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcEeecCCCCceEeecCCCCC
Q 013201 168 Q----SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH--------FMGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 168 ~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH--------~~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
. .+|+||||+++|+|.+++.+ ..+++..++.++.||+.||.||| +.||+||||||+|||++. +.
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~---~~ 184 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NG 184 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT---TS
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC---CC
Confidence 6 89999999999999999876 47999999999999999999999 899999999999999944 45
Q ss_pred ceEEecCCCceeccCCCc-----eeecCCccccccccccccc-------CCCCCcchhHHHHHHHHhhC----------C
Q 013201 236 MLKATDFGLSVFIDEGKV-----YRDIVGSAYYVAPEVLRRS-------YGKEIDVWSAGVILYILLSG----------V 293 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~elltg----------~ 293 (447)
.+||+|||++........ .....||+.|+|||++.+. ++.++|||||||++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 699999999987655432 2345799999999998653 23689999999999999999 7
Q ss_pred CCCCCCC-----HHHHHHHHHhCCCCCCCCcc---ccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 294 PPFWAET-----EKGIFDAILKGGVDFESEPW---LLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 294 ~pf~~~~-----~~~~~~~i~~~~~~~~~~~~---~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.||.... .......+.........+.. ..+++.+.+||.+||+.||++|||+.++++|
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 8987642 33444444443333222211 1234678999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=339.23 Aligned_cols=248 Identities=23% Similarity=0.365 Sum_probs=202.2
Q ss_pred ccceeecceeccccCeEEEEEE----ECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 93 RQFYTLGKELGRGQFGITYLCT----ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
.+.|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++ ||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecC
Confidence 4569999999999999999998 4668999999988542 3445678999999999997 999999999986544
Q ss_pred --eEEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 169 --SVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 169 --~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~---~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE---NRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET---TEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC---CcEEEecCcch
Confidence 789999999999999999876 459999999999999999999999999999999999999654 46999999999
Q ss_pred eeccCCCce----eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH----------------HH
Q 013201 246 VFIDEGKVY----RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK----------------GI 304 (447)
Q Consensus 246 ~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~----------------~~ 304 (447)
......... ....+++.|+|||++. ..++.++||||||+++|+|++|..||...... .+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 876554321 2346788899999986 45889999999999999999999998643110 11
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
...+..+ ...+. ...+++++.+||.+||..||++|||+.++++
T Consensus 273 ~~~~~~~-~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELLKNN-GRLPR--PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTT-CCCCC--CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhcC-CCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1222222 22222 2357899999999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=358.81 Aligned_cols=249 Identities=17% Similarity=0.199 Sum_probs=192.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC----------------
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN---------------- 156 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~---------------- 156 (447)
.+.|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.+.+.+|
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458899999999999999999999999999998864443334446788999999999873232
Q ss_pred -----eeEEEEEEEe-----CCeEEEEEeccCCCchHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhcCcEee
Q 013201 157 -----IVEFRGAYED-----RQSVHLVMELCSGGELFDKIIA-------QGHYTEKAAAALCRAIVNVVHHCHFMGVMHR 219 (447)
Q Consensus 157 -----iv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~-------~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~ 219 (447)
...+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1112122222 23467888877 6799888742 2337788899999999999999999999999
Q ss_pred cCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCCcccccccccc----------cc-cCCCCCcchhHHHHHHH
Q 013201 220 DLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL----------RR-SYGKEIDVWSAGVILYI 288 (447)
Q Consensus 220 Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~DiwslG~il~e 288 (447)
||||+|||++. +..+||+|||++...... ....+| +.|+|||++ .+ .++.++|||||||++|+
T Consensus 236 DiKp~NILl~~---~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQ---RGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECT---TCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEec---CCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999954 445999999998865432 455688 999999988 32 37789999999999999
Q ss_pred HhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 289 LLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 289 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
|++|+.||......+....+.. .+..+++++.+||.+||+.||++||++.++++||||++
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999987665443333322 12257899999999999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.14 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=188.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHH--HhccCCCCeeEEEEEEEe-----
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIM--QHLSGQQNIVEFRGAYED----- 166 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l--~~l~~h~~iv~~~~~~~~----- 166 (447)
+.|++.+.||+|+||.||+|++ +++.||+|++... ....+..|..++ ..+. ||||+++++.+..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA------NRQNFINEKNIYRVPLME-HDNIARFIVGDERVTADG 83 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECTTS
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc------chhhHHHHHHHHHHHhcc-CcchhhheecccccccCC
Confidence 4599999999999999999986 5889999988543 233444455544 3465 9999999986542
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc---------CcEeecCCCCceEeecCCCCCce
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM---------GVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~---------~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
...+|+|||||++|+|.+++... ..++..+..++.||+.||.|||+. ||+||||||+|||++ .+..+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---~~~~~ 159 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---NDGTC 159 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---TTSCE
T ss_pred CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---CCCcE
Confidence 34679999999999999998665 458999999999999999999999 999999999999994 44579
Q ss_pred EEecCCCceeccCCC---------ceeecCCcccccccccccc--------cCCCCCcchhHHHHHHHHhhCCCCCCCCC
Q 013201 238 KATDFGLSVFIDEGK---------VYRDIVGSAYYVAPEVLRR--------SYGKEIDVWSAGVILYILLSGVPPFWAET 300 (447)
Q Consensus 238 kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~elltg~~pf~~~~ 300 (447)
||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999998764321 1224579999999999864 35678999999999999999977764321
Q ss_pred H-----------------HHHHHHHHh-CCCCCCCC----ccccCChHHHHHHHHhcccCCCCCCCHHHH------hcCC
Q 013201 301 E-----------------KGIFDAILK-GGVDFESE----PWLLISDSAKDLVRKMLIQDPKKRITSAEV------LEHP 352 (447)
Q Consensus 301 ~-----------------~~~~~~i~~-~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~------l~h~ 352 (447)
. ......... .......+ ....+++++.+||.+||+.||++|||++|+ +.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1 111111111 11111111 111245579999999999999999999999 4577
Q ss_pred CccCCCC
Q 013201 353 WMREGGE 359 (447)
Q Consensus 353 ~~~~~~~ 359 (447)
|-++...
T Consensus 320 ~~~~~~~ 326 (336)
T 3g2f_A 320 WERNKSV 326 (336)
T ss_dssp CCC----
T ss_pred HHhcccC
Confidence 8776543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=335.38 Aligned_cols=229 Identities=12% Similarity=0.030 Sum_probs=187.2
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++++. ||||+++++++.+.+.+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcE
Confidence 34567999999999999999999999999999999997665555556688999999999997 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|+||||++|++|.+++.. .....++..++.||+.||.|||++||+||||||+|||++.+ +.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~---g~~kl~~~~------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID---GDVVLAYPA------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT---SCEEECSCC-------
T ss_pred EEEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC---CCEEEEecc-------
Confidence 999999999999999843 34667889999999999999999999999999999999654 458887543
Q ss_pred CCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHH---HHHhCCCCCCCCccccCChHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFD---AILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~~ 327 (447)
|++| ++.++|||||||++|+|++|+.||.+.+....+. ....+...........+++++
T Consensus 175 ------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 3333 6889999999999999999999998765432110 001111111111123579999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.+||.+||+.||++| |+.++++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999999 99999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=363.69 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=208.1
Q ss_pred cccceeecceeccccCeEEEEEEECCC---CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENST---GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
..+.|++++.||+|+||.||+|++..+ +..||+|.+... ......+.+.+|+.++++++ ||||+++++++. ++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-EN 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-cC
Confidence 456799999999999999999998654 456899976432 23445678999999999997 999999999985 45
Q ss_pred eEEEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 169 SVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
..|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++..
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~---~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC---CCEEEEecCCCee
Confidence 6899999999999999998654 68999999999999999999999999999999999999654 4699999999987
Q ss_pred ccCCCce--eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 248 IDEGKVY--RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 248 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
....... ....||+.|+|||++. ..++.++|||||||++|||++ |..||.+....+....+..+...... ..+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~ 617 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---PNC 617 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC---TTC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC---ccc
Confidence 6543322 2346788999999986 568999999999999999997 99999999888888888776432221 257
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
++.+.+||.+||..||.+|||+.++++
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 899999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=370.88 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=203.5
Q ss_pred cccccceeecceeccccCeEEEEEEECC-CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENS-TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
+.+.++|++.+.||+|+||.||+|++.. +++.||||++... ........+.+|+.++++++ ||||+++++++...+
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTD 152 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEEC
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecC
Confidence 4556789999999999999999999976 7899999987543 23445667889999999997 999999999998766
Q ss_pred e-----EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 169 S-----VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 169 ~-----~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
. .||||||++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~DFG 226 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLIDLG 226 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEECCCT
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEEecc
Confidence 5 7999999999999887654 79999999999999999999999999999999999999542 59999999
Q ss_pred CceeccCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
++...... ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+.... ... ...+...+
T Consensus 227 ~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~-~~~~~~~~ 293 (681)
T 2pzi_A 227 AVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP-EDDPVLKT 293 (681)
T ss_dssp TCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC-TTCHHHHH
T ss_pred cchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc---------ccc-cccccccc
Confidence 99876553 456799999999999877789999999999999999999988653211 000 11222235
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
++.+.+||.+||+.||.+||+..+++.|+|+.
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 78899999999999999999999999888874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=316.42 Aligned_cols=232 Identities=16% Similarity=0.138 Sum_probs=158.8
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCC-------hhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVN-------KQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
...+.|+.|.+..++....|+.|++|++.+..... ....+++.+|+++|+++.+|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 45678888888888888889999999997653322 23456799999999999889999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG- 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 251 (447)
|||||+|++|.++|.+.+.+++. .|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~---dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDA---RQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECT---TSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECC---CCCEEEeecccCeeCCCCC
Confidence 99999999999999998888875 47899999999999999999999999999954 456999999999876543
Q ss_pred CceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 252 KVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
....+.+||+.|||||++.+.+..++|+||+|++++++.++..++ ...+... +.. ...+.+++
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-----~~~~~~l~ 456 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-----RWNFVLLL 456 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHTS----CGG-----GCSHHHHH
T ss_pred ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhcC----CCC-----CCcHHHHH
Confidence 334567899999999999988889999999999998887764443 1111111 000 11245566
Q ss_pred HHhcccCCCCCCCHHHHhcCCCc
Q 013201 332 RKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
..++..+|..|+.......|+|.
T Consensus 457 ~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 457 ALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHHHTGGGSCCGGGSSCCHHHHH
T ss_pred HHHhCCCCCCCCChhhhccchhH
Confidence 66667777777666555555554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=262.74 Aligned_cols=185 Identities=17% Similarity=0.161 Sum_probs=144.3
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChh-----hHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ-----DREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+...+.||+|+||.||+|. ..+..+++|........... ..+++.+|+.++++++ ||||+++..++.+.+..
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~ 414 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNK 414 (540)
T ss_dssp ----------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTT
T ss_pred CCCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCcc
Confidence 3456799999999999994 45788999987554333221 2456899999999997 99999655555577778
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||||+|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++....
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCC
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCC
Confidence 999999999999998865 6789999999999999999999999999999954 699999999998765
Q ss_pred CCc--------eeecCCccccccccccc---ccCCCCCcchhHHHHHHHHhhCCCCC
Q 013201 251 GKV--------YRDIVGSAYYVAPEVLR---RSYGKEIDVWSAGVILYILLSGVPPF 296 (447)
Q Consensus 251 ~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~elltg~~pf 296 (447)
... ....+||+.|||||++. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 322 13568999999999986 35888899999998888888777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=214.61 Aligned_cols=159 Identities=23% Similarity=0.261 Sum_probs=123.0
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh---------------hhHHHHHHHHHHHHhccCCCCeeE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK---------------QDREDIKREIQIMQHLSGQQNIVE 159 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~~iv~ 159 (447)
.|.+++.||+|+||.||+|.+ .+|+.||+|.+........ .....+.+|+.+++++. |.+++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~~ 168 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPK 168 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCC
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcCe
Confidence 466779999999999999999 7899999998854321111 13567889999999998 455555
Q ss_pred EEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEE
Q 013201 160 FRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239 (447)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl 239 (447)
+ +.. +..|+|||||+|++|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.+||
T Consensus 169 ~---~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vkl 233 (282)
T 1zar_A 169 V---YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWI 233 (282)
T ss_dssp E---EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEE
T ss_pred E---Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEEE
Confidence 4 333 45689999999999987 31 134567999999999999999999999999999996 346999
Q ss_pred ecCCCceeccCCCceeecCCcccccccccccc-----------cCCCCCcchhH
Q 013201 240 TDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-----------SYGKEIDVWSA 282 (447)
Q Consensus 240 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~Diwsl 282 (447)
+|||++.. +..|+|||.+.+ .|+..+|+|.+
T Consensus 234 ~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 234 IDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999864 345789998742 35666777654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-22 Score=184.98 Aligned_cols=142 Identities=14% Similarity=0.120 Sum_probs=107.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCE--EEEEEeeccccCC---------------------hhhHHHHHHHHHHHHhc
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNS--YACKSILKRKLVN---------------------KQDREDIKREIQIMQHL 151 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~avK~i~~~~~~~---------------------~~~~~~~~~E~~~l~~l 151 (447)
.|.+.+.||+|+||.||+|.+..+|+. ||||++....... ......+.+|+.+|+++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778989 9999864331110 01123678999999999
Q ss_pred cCCCC--eeEEEEEEEeCCeEEEEEeccCC-C----chHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hcCcEeecCCC
Q 013201 152 SGQQN--IVEFRGAYEDRQSVHLVMELCSG-G----ELFDKIIAQGHYTEKAAAALCRAIVNVVHHCH-FMGVMHRDLKP 223 (447)
Q Consensus 152 ~~h~~--iv~~~~~~~~~~~~~lv~e~~~g-~----~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH-~~~ivH~Dlkp 223 (447)
. |++ ++.++++ +..+|||||+.+ | +|.+.... .++..+..++.||+.+|.||| +.||+||||||
T Consensus 128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 7 554 4444443 356899999942 3 56554322 235578899999999999999 99999999999
Q ss_pred CceEeecCCCCCceEEecCCCceecc
Q 013201 224 ENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 224 ~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+|||++. .++|+|||+|....
T Consensus 200 ~NILl~~-----~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID-----KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS-----SEEECCCTTCEETT
T ss_pred HHEEEcC-----cEEEEECcccccCC
Confidence 9999943 59999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=5.7e-19 Score=169.01 Aligned_cols=143 Identities=17% Similarity=0.242 Sum_probs=102.3
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC-----------ChhhH--------HHHHHHHHHHHhccCCC
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-----------NKQDR--------EDIKREIQIMQHLSGQQ 155 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-----------~~~~~--------~~~~~E~~~l~~l~~h~ 155 (447)
.|.++..||.|++|.||+|.+. +|+.||||++...... ..... -...+|...|.++. +.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~ 173 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE 173 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence 3899999999999999999975 6999999987532211 00001 11235778888885 44
Q ss_pred Ce--eEEEEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC
Q 013201 156 NI--VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG 233 (447)
Q Consensus 156 ~i--v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~ 233 (447)
++ +..++. .. .+|||||++|++|..+. ....+..++.||+.+|.+||++|||||||||.|||++.++.
T Consensus 174 gv~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 174 GFPVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TCSCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 43 333322 22 36999999998886532 22345678999999999999999999999999999976542
Q ss_pred C-------CceEEecCCCceecc
Q 013201 234 G-------AMLKATDFGLSVFID 249 (447)
Q Consensus 234 ~-------~~vkl~Dfg~a~~~~ 249 (447)
. ..+.|+||+.+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 1 137899999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.2e-13 Score=125.33 Aligned_cols=141 Identities=17% Similarity=0.142 Sum_probs=111.4
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|++...++.|+.+.||++... ++.+++|+...... .....+.+|+.+++.+.++..++++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34888899999999999998743 68999998754211 12245889999999997677899999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF---------------------------------------- 213 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~---------------------------------------- 213 (447)
|||++|.+|.+.+ .+......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999887652 1223345788899999999998
Q ss_pred -------------------cCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 214 -------------------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 214 -------------------~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
..++|+|++|.|||++. ...+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~---~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD---GKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET---TEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC---CcEEEEEEchhccc
Confidence 45899999999999953 33567999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=2.7e-12 Score=117.62 Aligned_cols=134 Identities=14% Similarity=0.153 Sum_probs=97.2
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC-eeEEEEEEEeCCeEEEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN-IVEFRGAYEDRQSVHLVM 174 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~-iv~~~~~~~~~~~~~lv~ 174 (447)
|.+....+.|..+.||++.. .+|..+++|..... ....+.+|+.+++.+.++.- +++++.+..+.+..++||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 55544445666799999864 46778999976432 12457789999999975522 677899888888899999
Q ss_pred eccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 013201 175 ELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG--------------------------------------- 215 (447)
Q Consensus 175 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~--------------------------------------- 215 (447)
||++|.+|. . .... ...++.++...|..||+..
T Consensus 95 e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999998883 1 1122 2356677777777777643
Q ss_pred -------------------cEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 216 -------------------VMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 216 -------------------ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
++|+|++|.|||++. +..+.|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~---~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVEN---GRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET---TEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC---CcEEEEEcchhccc
Confidence 999999999999953 33567999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.9e-11 Score=117.78 Aligned_cols=142 Identities=23% Similarity=0.374 Sum_probs=105.0
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEee--ccccCChhhHHHHHHHHHHHHhccC-CCCeeEEEEEEEeC---CeEEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSIL--KRKLVNKQDREDIKREIQIMQHLSG-QQNIVEFRGAYEDR---QSVHL 172 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~---~~~~l 172 (447)
.+.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.|.. +..+++++.++.+. +..|+
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 567899999999998754 4688888654 2211 1123567889999999974 34588899888776 45899
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF--------------------------------------- 213 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~--------------------------------------- 213 (447)
||||++|..+.+.. ...+++.....++.+++..|..||.
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998774311 2346788888999999999999997
Q ss_pred -------------------cCcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 214 -------------------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 214 -------------------~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.+++|+|+++.|||++.++. ..+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence 36899999999999965432 3468999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-11 Score=115.56 Aligned_cols=186 Identities=14% Similarity=0.208 Sum_probs=124.0
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCC--eeEEEEEEEeCC---eEEEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQN--IVEFRGAYEDRQ---SVHLV 173 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~--iv~~~~~~~~~~---~~~lv 173 (447)
.+.++.|....||++. ..+++|+... ......+.+|+.+|+.+..+.. +++++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999853 4688886421 2345678999999998853333 455655544333 34899
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF---------------------------------------- 213 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~---------------------------------------- 213 (447)
||+++|.+|.+... ..++..+...++.++...|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865433 347778888888888888888885
Q ss_pred ------------------cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeecCCccccccccccc---cc
Q 013201 214 ------------------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR---RS 272 (447)
Q Consensus 214 ------------------~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~ 272 (447)
..++|+|++|.||+++.++ ...+.|+||+.+..-..............-..|+... ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1379999999999996531 3468899999987543321111111000002333221 12
Q ss_pred CCC------------CCcchhHHHHHHHHhhCCCCCC
Q 013201 273 YGK------------EIDVWSAGVILYILLSGVPPFW 297 (447)
Q Consensus 273 ~~~------------~~DiwslG~il~elltg~~pf~ 297 (447)
|.. ..+.|++|.++|.+.+|..+|.
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 222 2589999999999999988773
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=98.93 E-value=5e-10 Score=98.02 Aligned_cols=96 Identities=28% Similarity=0.481 Sum_probs=77.0
Q ss_pred cCCCccCCCCCCCCcccHHHHHHHHHHHHHhhhhHHHHHHHHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 350 EHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 350 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.|||.+... ....++...++.++++|...+++++.++..+...+..+++..++++|..+|.|++|.|+.+||..+|+.+
T Consensus 8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~ 86 (197)
T 3pm8_A 8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKI 86 (197)
T ss_dssp ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence 589998764 4567788999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhhC
Q 013201 430 GSKLSETEVKQLMDAVS 446 (447)
Q Consensus 430 ~~~~~~~e~~~~~~~~d 446 (447)
|..+++.+++.+++.+|
T Consensus 87 g~~~~~~~~~~l~~~~D 103 (197)
T 3pm8_A 87 GYQKIPPDIHQVLRDID 103 (197)
T ss_dssp C----CHHHHHHHHC--
T ss_pred CCCCCHHHHHHHHHHhC
Confidence 99999999999999887
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.2e-09 Score=95.17 Aligned_cols=96 Identities=30% Similarity=0.453 Sum_probs=79.8
Q ss_pred cCCCccCCCCCCCCcccHHHHHHHHHHHHHhhhhHHHHHHHHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 350 EHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 350 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.|||+-.. .....++...++.+|++|...+++++.++..+...+..+++.+++++|..+|.|++|.|+.+||..+++.+
T Consensus 3 ~~~~~~~~-~~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~ 81 (191)
T 3k21_A 3 HHHHHSSG-RENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD 81 (191)
T ss_dssp ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred CCccccCC-ccccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence 47777654 33455778899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhhCC
Q 013201 430 GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 430 ~~~~~~~e~~~~~~~~d~ 447 (447)
|..++ .+++.+++.+|.
T Consensus 82 g~~~~-~~~~~l~~~~D~ 98 (191)
T 3k21_A 82 GLKLP-YNFDLLLDQIDS 98 (191)
T ss_dssp TCCCC-TTHHHHHHHHCT
T ss_pred CCCcH-HHHHHHHHHhCC
Confidence 99888 899999998873
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=3.2e-08 Score=90.96 Aligned_cols=134 Identities=15% Similarity=0.200 Sum_probs=97.0
Q ss_pred eeccccCe-EEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 013201 101 ELGRGQFG-ITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 101 ~lg~G~~g-~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~g 179 (447)
.+..|..| .||+......+..+++|+-.. .....+.+|..+|+.|..+--|++++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445554 699988777788899997532 23467889999999997655578899999999999999999999
Q ss_pred CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 013201 180 GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM--------------------------------------------- 214 (447)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~--------------------------------------------- 214 (447)
.++.+..... ......+..++...|..||..
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8876654331 122334555666666666631
Q ss_pred -------------CcEeecCCCCceEeecCCCCCceEEecCCCcee
Q 013201 215 -------------GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVF 247 (447)
Q Consensus 215 -------------~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~ 247 (447)
.++|+|+.+.|||++. ...+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~---~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDE---GKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEET---TEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEEC---CeEEEEEECccccc
Confidence 2689999999999953 33567899998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=9e-08 Score=89.72 Aligned_cols=136 Identities=19% Similarity=0.295 Sum_probs=93.5
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCC--CeeEEEEEEE-eCCeEEEEEec
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ--NIVEFRGAYE-DRQSVHLVMEL 176 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~--~iv~~~~~~~-~~~~~~lv~e~ 176 (447)
+.++.|....||+. +..+++|+- . .......+.+|+.+|+.|.++- .|++++.+.. ..+..|+|||+
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~-~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFP-K----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEE-S----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE-----CCEEEEEec-C----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45788888899987 567888863 1 2234567899999999997532 3667777764 45668899999
Q ss_pred cCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 013201 177 CSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM------------------------------------------ 214 (447)
Q Consensus 177 ~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~------------------------------------------ 214 (447)
++|.+|.+... ..++......++.++...|..||+.
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99988865321 2344555555555555555555532
Q ss_pred ------------------CcEeecCCCCceEeecCCC-CCceEEecCCCcee
Q 013201 215 ------------------GVMHRDLKPENFLLSNKDG-GAMLKATDFGLSVF 247 (447)
Q Consensus 215 ------------------~ivH~Dlkp~Nill~~~~~-~~~vkl~Dfg~a~~ 247 (447)
.++|+|+++.|||++.++. ...+.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999965222 23458999998764
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.63 E-value=1e-08 Score=78.79 Aligned_cols=54 Identities=26% Similarity=0.507 Sum_probs=50.5
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.+++.++++++|+.||.|++|+|+.+||+.+|+.+|..++++|++++++++|.
T Consensus 30 l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~ 83 (100)
T 2lv7_A 30 IPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDM 83 (100)
T ss_dssp CCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCS
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCC
Confidence 456778889999999999999999999999999999999999999999999984
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=1.4e-07 Score=91.91 Aligned_cols=81 Identities=14% Similarity=0.102 Sum_probs=51.6
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeecccc-CC---hhhHHHHHHHHHHHHhccCC-C-CeeEEEEEEEeCCeEEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKL-VN---KQDREDIKREIQIMQHLSGQ-Q-NIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~---~~~~~~~~~E~~~l~~l~~h-~-~iv~~~~~~~~~~~~~l 172 (447)
.+.||.|.++.||++....+++.+++|....... .. ....+++..|..+++.+... + .+++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4578999999999997666678999997643211 00 11234567899999887632 2 35566544 3445679
Q ss_pred EEeccCCCc
Q 013201 173 VMELCSGGE 181 (447)
Q Consensus 173 v~e~~~g~~ 181 (447)
|||+++|..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=98.41 E-value=3.8e-07 Score=78.22 Aligned_cols=80 Identities=25% Similarity=0.523 Sum_probs=73.3
Q ss_pred cHHHHHHHHHHHHHhhhhHHHHHHHHhhhh--HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHH
Q 013201 366 GSAVLSRMKQFRAMNKLKKMALKVIAEALS--EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443 (447)
Q Consensus 366 ~~~~~~~~~~~~~~~~~k~~~~~~i~~~~~--~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~ 443 (447)
...++.+|++|...+++++.++..+...+. +++..+++++|..+|.|++|.|+.+||..+++.+|. +..++..+++
T Consensus 3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~--~~~~~~~~~~ 80 (180)
T 3mse_B 3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGI--KKWDINRILQ 80 (180)
T ss_dssp CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC--CHHHHHHHHH
Confidence 467889999999999999999999999887 888999999999999999999999999999999986 4789999999
Q ss_pred hhCC
Q 013201 444 AVSI 447 (447)
Q Consensus 444 ~~d~ 447 (447)
.+|.
T Consensus 81 ~~D~ 84 (180)
T 3mse_B 81 ALDI 84 (180)
T ss_dssp HHCT
T ss_pred HhCC
Confidence 8873
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.9e-07 Score=88.11 Aligned_cols=84 Identities=8% Similarity=0.056 Sum_probs=55.6
Q ss_pred ccee-ccccCeEEEEEEEC--C----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC--CCeeEEEEEEEeC--
Q 013201 99 GKEL-GRGQFGITYLCTEN--S----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ--QNIVEFRGAYEDR-- 167 (447)
Q Consensus 99 ~~~l-g~G~~g~Vy~~~~~--~----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~-- 167 (447)
.+.| +.|....+|+.... . ++..+++|...............+.+|+.+++.|..+ -.+++++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88888999987643 1 1567888865332100000124567899999888744 3577888877655
Q ss_pred -CeEEEEEeccCCCch
Q 013201 168 -QSVHLVMELCSGGEL 182 (447)
Q Consensus 168 -~~~~lv~e~~~g~~L 182 (447)
+..|+||||++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 457899999988654
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=98.33 E-value=2.4e-08 Score=94.15 Aligned_cols=121 Identities=20% Similarity=0.308 Sum_probs=82.1
Q ss_pred ccCChHHHHHHHHhc---ccCCCCCCCHHHHhcC------CCccCCCCCC-----------------------CCcccHH
Q 013201 321 LLISDSAKDLVRKML---IQDPKKRITSAEVLEH------PWMREGGEAS-----------------------DKPIGSA 368 (447)
Q Consensus 321 ~~~s~~~~~li~~~L---~~dp~~R~t~~~~l~h------~~~~~~~~~~-----------------------~~~~~~~ 368 (447)
..++.++.+|.++++ ..+|.+|.+.++.+.| +|+....+.. .......
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~ 94 (323)
T 1ij5_A 15 KKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLAS 94 (323)
T ss_dssp HHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHH
Confidence 346778899999999 8899999999999888 8887652211 0111123
Q ss_pred HHHHHH-HHHHHhhhhHHHHHHHHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 369 VLSRMK-QFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 369 ~~~~~~-~~~~~~~~k~~~~~~i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
++.+++ +|...+.+++ +...++.+++..++.+|..||.|++|.|+.+||..+|+.+|..+++.++..++..+|
T Consensus 95 vl~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D 168 (323)
T 1ij5_A 95 LLKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVE 168 (323)
T ss_dssp HHHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence 344444 4555555544 334567788899999999999999999999999999999999999999999998775
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=98.33 E-value=4.5e-07 Score=68.03 Aligned_cols=58 Identities=31% Similarity=0.434 Sum_probs=52.7
Q ss_pred HHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 390 i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
|...+.+++..+++++|..+|.|++|+|+.+||+.+++.+|..+++++++++++.+|.
T Consensus 10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~ 67 (90)
T 1avs_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDE 67 (90)
T ss_dssp HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4445677788899999999999999999999999999999999999999999999873
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=98.31 E-value=3.2e-07 Score=68.10 Aligned_cols=56 Identities=27% Similarity=0.486 Sum_probs=48.9
Q ss_pred HhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 391 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...+++++.++++++|..+|.|++|+|+.+|++.+++.+| .+++++++++++.+|.
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~ 57 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDT 57 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCT
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCC
Confidence 4456677788999999999999999999999999999999 9999999999999873
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.27 E-value=6.8e-07 Score=75.21 Aligned_cols=74 Identities=65% Similarity=0.955 Sum_probs=65.1
Q ss_pred HHHHHHhhhhHHHHHHHHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 374 ~~~~~~~~~k~~~~~~i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++|...+.+++.++..+...+.+++...++++|..+|.|++|.|+.+|+..++..+|..+++.++..+++.+|.
T Consensus 1 ~~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~ 74 (166)
T 2aao_A 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADV 74 (166)
T ss_dssp -----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCT
T ss_pred CchhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 35777888999999999999989999999999999999999999999999999999999999999999998873
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.25 E-value=1.8e-07 Score=80.75 Aligned_cols=84 Identities=29% Similarity=0.470 Sum_probs=76.1
Q ss_pred cccHHHHHHHHHHHHHhhhhHHHHHHHHhhh-hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHh-----------CC
Q 013201 364 PIGSAVLSRMKQFRAMNKLKKMALKVIAEAL-SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL-----------GS 431 (447)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~k~~~~~~i~~~~-~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-----------~~ 431 (447)
++...++.++++|...+.+++.++..+...+ .+++..+++++|..+|.|++|.|+.+|+..++..+ |.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~ 82 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS 82 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence 4557788999999999999999999999988 78889999999999999999999999999999988 66
Q ss_pred CCCHHHHHHHHHhhCC
Q 013201 432 KLSETEVKQLMDAVSI 447 (447)
Q Consensus 432 ~~~~~e~~~~~~~~d~ 447 (447)
.++++++..+++.+|.
T Consensus 83 ~~~~~~~~~~~~~~D~ 98 (191)
T 3khe_A 83 SQIEAEVDHILQSVDF 98 (191)
T ss_dssp HHHHHHHHHHHHHTCT
T ss_pred hhhHHHHHHHHHHhCC
Confidence 7789999999998873
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=98.23 E-value=3.4e-07 Score=67.98 Aligned_cols=55 Identities=18% Similarity=0.217 Sum_probs=50.0
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHH---HHHHHHhhCC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE---VKQLMDAVSI 447 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e---~~~~~~~~d~ 447 (447)
.+++++..+++++|..||.+++|+|+.+||+.+|+.+|..+++.+ +.++++++|.
T Consensus 7 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~ 64 (86)
T 1j7q_A 7 ALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKG 64 (86)
T ss_dssp CCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSC
T ss_pred cCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCC
Confidence 345667788999999999999999999999999999999999999 9999998873
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=98.21 E-value=6.2e-07 Score=64.89 Aligned_cols=53 Identities=36% Similarity=0.584 Sum_probs=48.6
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++..+++++|..+|.+++|.|+.+|++.+++.+|..+++++++++++.+|.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 54 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDR 54 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCC
Confidence 34567789999999999999999999999999999999999999999999873
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=98.18 E-value=8.1e-07 Score=67.95 Aligned_cols=50 Identities=14% Similarity=0.238 Sum_probs=44.6
Q ss_pred HHhhhhcceeeeec-CCCC-cccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhC
Q 013201 397 EEIKGLKTMFANMD-TDKS-GTITYEELKTGLAR-----LGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 397 ~~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d 446 (447)
..+.+++++|+.|| .||+ |+|+.+||+.+|+. +|..+++++|++||+++|
T Consensus 7 ~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D 63 (101)
T 3nso_A 7 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLD 63 (101)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhC
Confidence 45678999999998 8998 99999999999996 467889999999999987
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.5e-05 Score=75.41 Aligned_cols=74 Identities=11% Similarity=0.125 Sum_probs=43.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC-CCeeEEEE------EEEeCCeEEE
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ-QNIVEFRG------AYEDRQSVHL 172 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~~~~------~~~~~~~~~l 172 (447)
+.|+.|..+.||++... +..+++|+.... ...+..|+.+++.|..+ -.+++++. +....+..++
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 45666778999998754 345889977431 23445666766666521 12344443 2235778899
Q ss_pred EEeccCCCch
Q 013201 173 VMELCSGGEL 182 (447)
Q Consensus 173 v~e~~~g~~L 182 (447)
||||++|..+
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998644
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.1e-05 Score=78.95 Aligned_cols=77 Identities=14% Similarity=0.152 Sum_probs=47.0
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeecccc-CCh-----hhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKL-VNK-----QDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.||.|..+.||++.. +++.+++|....... ... .....++.|+..+..-.....+++++.+. .+..++
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 45789999999999863 467899995432111 111 13334444544433222234567777665 566789
Q ss_pred EEecc-CC
Q 013201 173 VMELC-SG 179 (447)
Q Consensus 173 v~e~~-~g 179 (447)
||||+ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 77
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.14 E-value=1.5e-06 Score=65.76 Aligned_cols=51 Identities=27% Similarity=0.498 Sum_probs=46.8
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++++++|..||.|++|+|+.+||+.+++.+|..+++++++++++++|.
T Consensus 26 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~ 76 (94)
T 2kz2_A 26 DSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 76 (94)
T ss_dssp SCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred CHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 345678899999999999999999999999999999999999999999873
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.13 E-value=6.3e-07 Score=66.63 Aligned_cols=56 Identities=64% Similarity=0.955 Sum_probs=50.1
Q ss_pred hhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 392 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..++..+++++|..+|.+++|+|+.+||+.+++.+|..+++++++++++.+|.
T Consensus 15 ~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~ 70 (87)
T 1s6j_A 15 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70 (87)
T ss_dssp SSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCT
T ss_pred HHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 34455567789999999999999999999999999999999999999999999873
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.13 E-value=1.4e-06 Score=65.68 Aligned_cols=51 Identities=16% Similarity=0.204 Sum_probs=46.0
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.++..+++++|+.||.|++|+|+.+|++.+++.+| +++++++++++++|.
T Consensus 4 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~ 54 (92)
T 1fi6_A 4 TDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDF 54 (92)
T ss_dssp CHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCT
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCC
Confidence 456778899999999999999999999999999997 689999999999874
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=98.11 E-value=1.6e-06 Score=67.81 Aligned_cols=52 Identities=23% Similarity=0.394 Sum_probs=46.5
Q ss_pred HHHhhhhcceeeeec-CCCCc-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMD-TDKSG-TITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
..++++++++|+.|| .|++| +|+.+||+.+|+. +|..++++++++||+++|.
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~ 76 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDS 76 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCS
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCC
Confidence 456778999999999 89997 9999999999987 7778899999999999884
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.11 E-value=1.6e-06 Score=72.18 Aligned_cols=54 Identities=28% Similarity=0.505 Sum_probs=50.2
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++++++++++++|..||.|++|.|+.+||+.+|+.+|..+++.++..++...+
T Consensus 9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~~ 62 (153)
T 3i5g_B 9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLKECP 62 (153)
T ss_dssp TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHHTSS
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHHhcc
Confidence 467889999999999999999999999999999999999999999999987654
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.9e-06 Score=64.74 Aligned_cols=54 Identities=20% Similarity=0.388 Sum_probs=48.7
Q ss_pred hhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 392 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+.+++.+.++++|..+|.|++|.|+.+||+.+++.+| +++++++++++.+|.
T Consensus 19 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g--~~~~~~~~~~~~~D~ 72 (91)
T 2pmy_A 19 ADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRPADAEAVFQRLDA 72 (91)
T ss_dssp CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCHHHHHHHHHHHCT
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC--cCHHHHHHHHHHhCC
Confidence 455677788899999999999999999999999999998 689999999999873
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.10 E-value=1.5e-06 Score=72.79 Aligned_cols=49 Identities=20% Similarity=0.424 Sum_probs=45.9
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++++++|+.||.|++|+|+.+||+.+|..+|..++++|+++|++++|+
T Consensus 84 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~ 132 (159)
T 3i5g_C 84 ADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDI 132 (159)
T ss_dssp HHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCc
Confidence 4568899999999999999999999999999999999999999999873
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.09 E-value=1.5e-06 Score=65.96 Aligned_cols=51 Identities=20% Similarity=0.273 Sum_probs=45.9
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.++.++++++|..||.|++|+|+.+|++.+++.+| +++++++++++.+|.
T Consensus 5 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~ 55 (95)
T 1c07_A 5 SPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDT 55 (95)
T ss_dssp CSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCT
T ss_pred CHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC--CCHHHHHHHHHHHCC
Confidence 456678899999999999999999999999999987 689999999999874
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.7e-06 Score=82.47 Aligned_cols=58 Identities=34% Similarity=0.544 Sum_probs=53.9
Q ss_pred HHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 390 i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
-.+.++++++++++++|+.||.|++|+|+.+||+.+|+.+|..++++|++++++.+|.
T Consensus 292 s~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~ 349 (440)
T 3u0k_A 292 TRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 349 (440)
T ss_dssp BCBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred hHhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 3456788999999999999999999999999999999999999999999999999874
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.07 E-value=1.3e-06 Score=72.79 Aligned_cols=48 Identities=27% Similarity=0.430 Sum_probs=45.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.+.++++|+.||.|++|+|+.+||+.+|..+|..++++|+++|++++|
T Consensus 84 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D 131 (153)
T 3i5g_B 84 EDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAP 131 (153)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCC
T ss_pred HHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhC
Confidence 357899999999999999999999999999999999999999999887
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=98.07 E-value=2.3e-06 Score=64.33 Aligned_cols=52 Identities=31% Similarity=0.539 Sum_probs=47.7
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+..++++++|..+|.+++|+|+.+||+.+++.+|..+++++++++++.+|.
T Consensus 5 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~ 56 (92)
T 2kn2_A 5 TDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADL 56 (92)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred ccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4556788999999999999999999999999999999999999999999873
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.07 E-value=2.1e-06 Score=60.00 Aligned_cols=47 Identities=13% Similarity=0.454 Sum_probs=44.0
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+++++|..+|.|++|.|+.+|++.+++.+|..+++++++++++.+|.
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~ 48 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDV 48 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCC
Confidence 56789999999999999999999999999999999999999999873
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.1e-06 Score=60.88 Aligned_cols=49 Identities=29% Similarity=0.580 Sum_probs=45.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++++++|..+|.+++|+|+.+||+.+++.+|..+++++++++++.+|.
T Consensus 5 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~ 53 (71)
T 2b1u_A 5 LEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADV 53 (71)
T ss_dssp HHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4568889999999999999999999999999999999999999999873
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=98.02 E-value=3.4e-06 Score=64.38 Aligned_cols=51 Identities=24% Similarity=0.307 Sum_probs=45.5
Q ss_pred HHhhhhcceeeeec-CCCCc-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMD-TDKSG-TITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
.++.+++++|+.|| .|++| +|+.+||+.+|+. +|..++++++++|++++|.
T Consensus 7 ~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~ 64 (99)
T 2y5i_A 7 GAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDS 64 (99)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCC
Confidence 45678999999997 89998 9999999999987 6778899999999999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.99 E-value=4.5e-05 Score=71.20 Aligned_cols=76 Identities=14% Similarity=0.132 Sum_probs=60.5
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC--CCeeEEEEEEEeCCeEEEEEec
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ--QNIVEFRGAYEDRQSVHLVMEL 176 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~~~~~lv~e~ 176 (447)
.+.|+.|.+..+|+... ++..+++|+.... ....+..|...|+.|... ..+++++.+....+..|+||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 46789999999999874 4678899975432 356788999999988643 5688899888888899999999
Q ss_pred cCCCch
Q 013201 177 CSGGEL 182 (447)
Q Consensus 177 ~~g~~L 182 (447)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.99 E-value=5.4e-06 Score=64.26 Aligned_cols=52 Identities=29% Similarity=0.474 Sum_probs=48.5
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+++..+++++|..+|.|++|+|+.+|++.+++.+|..+++++++++++.+|.
T Consensus 28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~D~ 79 (107)
T 2d58_A 28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKKLIGEVSS 79 (107)
T ss_dssp HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 5667889999999999999999999999999999999999999999999873
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.95 E-value=5.6e-06 Score=63.69 Aligned_cols=52 Identities=21% Similarity=0.315 Sum_probs=44.2
Q ss_pred HHHhhhhcceeeeec-CCCC-cccCHHHHHHHHHH-hC----CCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMD-TDKS-GTITYEELKTGLAR-LG----SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-l~----~~~~~~e~~~~~~~~d~ 447 (447)
+..+.+++++|..|| .|++ |+|+.+||+.+|+. +| ..++++++++||+++|.
T Consensus 9 e~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~ 67 (104)
T 3zwh_A 9 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDS 67 (104)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcC
Confidence 345678999999998 6786 89999999999996 65 45689999999999984
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=97.95 E-value=7.3e-06 Score=63.18 Aligned_cols=49 Identities=24% Similarity=0.356 Sum_probs=45.7
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
...+++++|..||.|++|+|+.+||+.+|+.+|..+++++++++++.+|
T Consensus 22 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d 70 (105)
T 1wlz_A 22 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMP 70 (105)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSC
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcC
Confidence 3467889999999999999999999999999999999999999999887
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.95 E-value=5e-06 Score=64.98 Aligned_cols=51 Identities=20% Similarity=0.286 Sum_probs=45.7
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++.++++++|+.||.|++|+|+.+||+.+++ +..+++++++++++.+|.
T Consensus 9 s~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~~~~~~~~~~i~~~~D~ 59 (111)
T 2kgr_A 9 PQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QSSLPQAQLASIWNLSDI 59 (111)
T ss_dssp CHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TTCCCHHHHHHHHHHHCS
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hCCCCHHHHHHHHHHHCC
Confidence 456677899999999999999999999999998 677899999999999874
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=97.94 E-value=3.3e-06 Score=63.98 Aligned_cols=51 Identities=20% Similarity=0.307 Sum_probs=39.7
Q ss_pred HHhhhhcceeeeec-CCC-CcccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMD-TDK-SGTITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D-~~~-~g~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
+++.+++++|+.|| .|+ +|+|+.+||+.+|+. +|..++++++++|++++|.
T Consensus 6 ~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~ 63 (95)
T 1j55_A 6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDA 63 (95)
T ss_dssp HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCC
Confidence 45678999999999 798 589999999999987 5667899999999999874
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=97.94 E-value=1.2e-05 Score=66.29 Aligned_cols=52 Identities=27% Similarity=0.433 Sum_probs=48.5
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++..+++++|..||.|++|.|+.+||+.+|+.+|..+++++++++++.+|.
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~ 95 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVSS 95 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4677889999999999999999999999999999999999999999999873
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=97.92 E-value=2.2e-06 Score=70.83 Aligned_cols=53 Identities=32% Similarity=0.533 Sum_probs=49.9
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
++++++++++++|..||.|++|.|+.+||..+++.+|..+++.++..++..+|
T Consensus 4 lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d 56 (148)
T 2lmt_A 4 LTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAE 56 (148)
T ss_dssp CCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcc
Confidence 56788999999999999999999999999999999999999999999998876
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=97.92 E-value=2.5e-06 Score=64.69 Aligned_cols=52 Identities=17% Similarity=0.337 Sum_probs=45.7
Q ss_pred HHHhhhhcceeeeec-CCCCc-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMD-TDKSG-TITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
++++.+++++|+.|| .|++| +|+.+||+.+|+. +|..+++++++++++++|.
T Consensus 8 e~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~ 66 (95)
T 2wcb_A 8 EEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDA 66 (95)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSS
T ss_pred HHHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcC
Confidence 345678999999999 89998 9999999999987 6778899999999999873
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=97.91 E-value=7.6e-06 Score=61.53 Aligned_cols=50 Identities=18% Similarity=0.321 Sum_probs=44.9
Q ss_pred HHhhhhcceeeeecCCCCc---ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSG---TITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g---~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
..+.+++++|..|| +++| +|+.+||+.+|+. +|..+++++++++++++|.
T Consensus 6 ~~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~ 63 (92)
T 3rm1_A 6 KAVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDS 63 (92)
T ss_dssp HHHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcC
Confidence 45678899999999 7766 9999999999999 8999999999999999884
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=6.5e-06 Score=62.01 Aligned_cols=52 Identities=21% Similarity=0.315 Sum_probs=42.9
Q ss_pred HHHhhhhcceeeeec-CCCC-cccCHHHHHHHHHH-hC----CCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMD-TDKS-GTITYEELKTGLAR-LG----SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-l~----~~~~~~e~~~~~~~~d~ 447 (447)
+..+.+++++|+.|| .||+ |+|+.+||+.+|+. +| ...+++++++|++++|.
T Consensus 6 e~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~ 64 (93)
T 4eto_A 6 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDS 64 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCC
Confidence 345678999999998 6885 89999999999996 65 35689999999999984
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=97.90 E-value=4.5e-06 Score=68.37 Aligned_cols=52 Identities=29% Similarity=0.517 Sum_probs=48.1
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+++..+++++|..||.|++|.|+.+||..+|+.+|..+++.+++++++.+|.
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 53 (143)
T 2obh_A 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDK 53 (143)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 4567789999999999999999999999999999999999999999998873
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=97.90 E-value=3.6e-06 Score=64.29 Aligned_cols=49 Identities=10% Similarity=0.188 Sum_probs=44.3
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++.++++++|+.||.|++|+|+.+|++.+|+.+| ++++++++|++.+|.
T Consensus 8 ~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~--l~~~~l~~i~~~~D~ 56 (99)
T 1qjt_A 8 SGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADT 56 (99)
T ss_dssp TTCTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCC
T ss_pred hhHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHHCC
Confidence 4567889999999999999999999999999986 589999999999874
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=97.89 E-value=5.4e-06 Score=60.01 Aligned_cols=47 Identities=30% Similarity=0.564 Sum_probs=43.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++++|..+|.|++|+|+.+|++.+++.+| .+++++++++++.+|.
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~ 49 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLG-STSADEVQRMMAEIDT 49 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH-TCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC-CCCHHHHHHHHHHhCC
Confidence 4578899999999999999999999999999 9999999999999873
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=97.88 E-value=1.7e-05 Score=64.94 Aligned_cols=49 Identities=24% Similarity=0.505 Sum_probs=45.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+++.+|+.||.|++|+|+.+||+.++..+|..+++++++++++++|.
T Consensus 78 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~ 126 (143)
T 2obh_A 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADR 126 (143)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4568899999999999999999999999999999999999999999874
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=97.88 E-value=8.2e-06 Score=63.00 Aligned_cols=50 Identities=14% Similarity=0.230 Sum_probs=45.4
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.++..+++++|+.||. ++|+|+.+|++.+|+.+| +++++++++++.+|.
T Consensus 10 s~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~ 59 (106)
T 1eh2_A 10 KPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDI 59 (106)
T ss_dssp CHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT--CCHHHHHHHHHHHCS
T ss_pred CHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcC
Confidence 45677889999999999 999999999999999987 689999999999884
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=97.87 E-value=7e-06 Score=67.71 Aligned_cols=48 Identities=23% Similarity=0.476 Sum_probs=45.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.++++|+.||.|++|+|+.+||+.++..+|..+++++++++++++|.
T Consensus 83 ~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~ 130 (148)
T 2lmt_A 83 EEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADF 130 (148)
T ss_dssp HHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCC
Confidence 468889999999999999999999999999999999999999999884
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=97.86 E-value=3.5e-06 Score=61.54 Aligned_cols=50 Identities=26% Similarity=0.489 Sum_probs=45.5
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHhC-CCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLG-SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~-~~~~~~e~~~~~~~~d~ 447 (447)
...++++ +|..+|.|++|+|+.+||..+++.+| ..+++++++++++.+|.
T Consensus 6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~ 56 (81)
T 1c7v_A 6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADE 56 (81)
T ss_dssp -CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCS
T ss_pred cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCC
Confidence 3456788 99999999999999999999999999 99999999999999873
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=97.85 E-value=2.6e-06 Score=59.42 Aligned_cols=46 Identities=17% Similarity=0.425 Sum_probs=42.2
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++|..+|.|++|.|+.+|++.+++.+|..+++++++++++.+|.
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~ 47 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDA 47 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCC
Confidence 5678999999999999999999999999988899999999998873
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=97.83 E-value=8.7e-06 Score=69.41 Aligned_cols=48 Identities=33% Similarity=0.505 Sum_probs=45.0
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++++++|+.||.|++|+|+.+||+.+|..+|..++++|+++|++++|
T Consensus 83 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d 130 (176)
T 2lhi_A 83 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS 130 (176)
T ss_dssp HHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc
Confidence 457889999999999999999999999999999999999999999875
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=97.82 E-value=8.2e-06 Score=61.32 Aligned_cols=50 Identities=18% Similarity=0.298 Sum_probs=45.9
Q ss_pred HHhhhhcceeeeec-CCCCc-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhC
Q 013201 397 EEIKGLKTMFANMD-TDKSG-TITYEELKTGLAR-----LGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 397 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d 446 (447)
.+..+++++|..|| .|++| +|+.+||+.+++. +|..+++++++++++.+|
T Consensus 6 ~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D 62 (93)
T 1k2h_A 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELD 62 (93)
T ss_dssp HHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Confidence 45677899999999 79999 9999999999998 999999999999999876
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=97.80 E-value=1.5e-05 Score=65.87 Aligned_cols=52 Identities=23% Similarity=0.425 Sum_probs=47.9
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++..+++++|..||.|++|+|+.+||+.+|+.+|..+++++++++++.+|.
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D~ 97 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTG 97 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHCC
Confidence 4566789999999999999999999999999999999999999999998873
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=97.80 E-value=2.8e-06 Score=62.41 Aligned_cols=51 Identities=27% Similarity=0.381 Sum_probs=45.6
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHhC--CCCCHHHHHH----HHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLG--SKLSETEVKQ----LMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~--~~~~~~e~~~----~~~~~d~ 447 (447)
+..++++++|..+|.|++|+|+.+|+..++..+| ..++++++++ +++.+|.
T Consensus 4 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D~ 60 (83)
T 1yx7_A 4 KVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADK 60 (83)
T ss_dssp CSCTHHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTCS
T ss_pred cHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhCC
Confidence 3456788999999999999999999999999999 8889999999 9888773
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.79 E-value=8.6e-06 Score=64.30 Aligned_cols=50 Identities=18% Similarity=0.341 Sum_probs=45.3
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
..++.++.+|..||.| +|+|+.+||+.+|+. +|...+++++++||+++|.
T Consensus 12 ~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~ 66 (121)
T 4drw_A 12 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQ 66 (121)
T ss_dssp HHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcC
Confidence 4567899999999988 899999999999987 7889999999999999984
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=97.79 E-value=1.4e-06 Score=68.01 Aligned_cols=51 Identities=20% Similarity=0.180 Sum_probs=44.9
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++..+++++|+.||.|++|+|+.+|++.+|+.+| ++++++++|++++|.
T Consensus 17 s~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~ 67 (110)
T 1iq3_A 17 TEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDA 67 (110)
T ss_dssp SSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCS
T ss_pred CHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcC
Confidence 445677899999999999999999999999998886 578899999999874
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=97.79 E-value=1.2e-05 Score=66.03 Aligned_cols=54 Identities=39% Similarity=0.584 Sum_probs=49.5
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++++.+++++|..+|.|++|.|+.+||..+++.+|..+++.+++.+++.+|.
T Consensus 4 l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~ 57 (148)
T 1exr_A 4 LTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 57 (148)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCC
Confidence 456677889999999999999999999999999999999999999999998873
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=97.74 E-value=3.3e-06 Score=70.73 Aligned_cols=50 Identities=24% Similarity=0.383 Sum_probs=45.7
Q ss_pred hhHHHhhhhcceeeeecC--CCCcccCHHHHHHHHHHhCCCCCHHHHHHHHH
Q 013201 394 LSEEEIKGLKTMFANMDT--DKSGTITYEELKTGLARLGSKLSETEVKQLMD 443 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~--~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~ 443 (447)
++++++++++++|..||. |++|+|+.+||+.+|+.||.+++++||++|+.
T Consensus 3 Lt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~ 54 (159)
T 3i5g_C 3 LTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGG 54 (159)
T ss_dssp CCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTC
T ss_pred CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHc
Confidence 567889999999999995 89999999999999999999999999998764
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=97.73 E-value=1.7e-05 Score=64.76 Aligned_cols=57 Identities=40% Similarity=0.594 Sum_probs=50.7
Q ss_pred HHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 390 i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
|+..+++++...++++|..+|.+++|.|+.+|+..+++.+|..+++.++..+++.+|
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d 57 (147)
T 4ds7_A 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEID 57 (147)
T ss_dssp ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHC
T ss_pred CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhc
Confidence 345567788899999999999999999999999999999999999999999999886
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.72 E-value=8.6e-05 Score=69.01 Aligned_cols=72 Identities=8% Similarity=-0.070 Sum_probs=45.5
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEecc-
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELC- 177 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~- 177 (447)
.+.|+.|....+|++ ..+++|+...... .. -...+|+.+++.+..+.-.++++.+. ...-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~---~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EY---INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----C---CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-ce---eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 577888999999998 4688886543211 01 12346888888776443335666543 43446899999
Q ss_pred CCCch
Q 013201 178 SGGEL 182 (447)
Q Consensus 178 ~g~~L 182 (447)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66554
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=97.72 E-value=1.8e-05 Score=63.99 Aligned_cols=48 Identities=15% Similarity=0.257 Sum_probs=43.4
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++..+++++|+.|| |++|+|+.+|++.+|+.+| ++++++++|++.+|.
T Consensus 48 ~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~g--l~~~el~~I~~~~D~ 95 (139)
T 2jq6_A 48 KDKPTYDEIFYTLS-PVNGKITGANAKKEMVKSK--LPNTVLGKIWKLADV 95 (139)
T ss_dssp GTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHhC-CCCCeECHHHHHHHHHHhC--cCHHHHHHHHHHhCC
Confidence 45677899999999 9999999999999999977 789999999999884
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=97.72 E-value=1.4e-05 Score=61.95 Aligned_cols=50 Identities=32% Similarity=0.401 Sum_probs=45.6
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.||.|++|+|+.+||+.+++.+ |..+++++++++++.+|.
T Consensus 40 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 92 (109)
T 1bu3_A 40 SADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDS 92 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHHHHHHCT
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHHHHHhCC
Confidence 34568889999999999999999999999999 788999999999999873
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=2.1e-05 Score=61.61 Aligned_cols=51 Identities=16% Similarity=0.215 Sum_probs=44.6
Q ss_pred HHhhhhcceeeeecC-CCCc-ccCHHHHHHHHH-HhCCC-----CCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDT-DKSG-TITYEELKTGLA-RLGSK-----LSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~-~~~g-~i~~~el~~~l~-~l~~~-----~~~~e~~~~~~~~d~ 447 (447)
+++.+++++|..||. |++| +|+.+||+.+|+ .+|.. +++.++++||+++|.
T Consensus 9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~ 67 (113)
T 1xk4_C 9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDT 67 (113)
T ss_dssp HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCC
Confidence 446788999999995 9999 999999999999 78853 589999999999874
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=97.72 E-value=1.5e-05 Score=61.70 Aligned_cols=50 Identities=36% Similarity=0.425 Sum_probs=45.6
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.+|.|++|+|+.+||+.+++.+ |..+++++++++++.+|.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (109)
T 1rwy_A 39 SADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDK 91 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCT
T ss_pred hHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHHHHHHCC
Confidence 44678889999999999999999999999999 788999999999999873
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=97.72 E-value=9.2e-06 Score=61.07 Aligned_cols=50 Identities=24% Similarity=0.448 Sum_probs=43.8
Q ss_pred HHhhhhcceeeeec-CCCCc-ccCHHHHHHHHHH---hCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMD-TDKSG-TITYEELKTGLAR---LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~---l~~~~~~~e~~~~~~~~d~ 447 (447)
+++.+++++|..|| .|++| +|+.+||+.+|+. +|. +++.+++++++++|.
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~ 61 (92)
T 2kax_A 7 KALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDK 61 (92)
T ss_dssp HHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCC
Confidence 45678999999999 99999 9999999999997 334 889999999999874
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=97.71 E-value=1.8e-05 Score=61.29 Aligned_cols=49 Identities=39% Similarity=0.474 Sum_probs=45.1
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
.++++.+|+.+|.|++|+|+.+||+.+++.+ |..+++++++++++.+|.
T Consensus 40 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (109)
T 5pal_A 40 DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDS 91 (109)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 3567889999999999999999999999999 999999999999999873
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=97.70 E-value=1e-05 Score=62.42 Aligned_cols=52 Identities=19% Similarity=0.324 Sum_probs=43.4
Q ss_pred HHHhhhhcceeeeec-CCCC-cccCHHHHHHHHHH-hCCCC-CHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMD-TDKS-GTITYEELKTGLAR-LGSKL-SETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-l~~~~-~~~e~~~~~~~~d~ 447 (447)
++++++++++|+.|| .|++ |+|+.+||+.+|+. +|... +++++++||+++|.
T Consensus 18 e~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~ 73 (106)
T 2h2k_A 18 EESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDV 73 (106)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCC
Confidence 345678999999999 7997 79999999999986 77554 45899999999874
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=97.69 E-value=5.3e-06 Score=59.64 Aligned_cols=49 Identities=22% Similarity=0.375 Sum_probs=44.9
Q ss_pred hhhhcceeeee-cCCCC-cccCHHHHHHHHHHhCCCC--CHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANM-DTDKS-GTITYEELKTGLARLGSKL--SETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~-D~~~~-g~i~~~el~~~l~~l~~~~--~~~e~~~~~~~~d~ 447 (447)
.++++++|..| |.+++ |+|+.+||+.+++.+|..+ ++++++++++.+|.
T Consensus 4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~ 56 (76)
T 1qx2_A 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDK 56 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCT
T ss_pred HHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCC
Confidence 45688899999 99999 9999999999999999988 99999999998873
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=97.68 E-value=1.2e-05 Score=62.24 Aligned_cols=50 Identities=30% Similarity=0.409 Sum_probs=45.6
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.||.|++|+|+.+||+.+++.+ |..+++++++++++.+|.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (108)
T 2pvb_A 39 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDK 91 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHHHHHhCC
Confidence 34568889999999999999999999999999 788999999999999873
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.67 E-value=2.3e-05 Score=63.47 Aligned_cols=50 Identities=18% Similarity=0.240 Sum_probs=45.6
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhC-CCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLG-SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~-~~~~~~e~~~~~~~~d~ 447 (447)
...+++.+|+.||.|++|+|+.+||+.+++.+| ..+++++++++++.+|.
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~~D~ 88 (135)
T 3h4s_E 38 FVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGDL 88 (135)
T ss_dssp HHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCC
Confidence 345688899999999999999999999999999 59999999999999873
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=0.0001 Score=70.66 Aligned_cols=140 Identities=13% Similarity=0.126 Sum_probs=82.3
Q ss_pred ceeccccCeEEEEEEECC-------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 100 KELGRGQFGITYLCTENS-------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
+.|..|-...+|++.... +++.+++|+.-. . ......+.+|..+++.|..+.-.+++++++.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-I---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-c---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 467678888899987642 357888886421 1 12345667999999988755555777766643 28
Q ss_pred EEeccCCCchHH--------------HHH---Hc----C-CC--CHHHHHHHHHHHHH-------------------HHH
Q 013201 173 VMELCSGGELFD--------------KII---AQ----G-HY--TEKAAAALCRAIVN-------------------VVH 209 (447)
Q Consensus 173 v~e~~~g~~L~~--------------~l~---~~----~-~~--~~~~~~~i~~qil~-------------------~l~ 209 (447)
||||++|.+|.. .|. .. + .. ....+..+..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998865421 111 11 0 11 13455555544422 123
Q ss_pred HHH----h----cCcEeecCCCCceEeecCC-CCCceEEecCCCcee
Q 013201 210 HCH----F----MGVMHRDLKPENFLLSNKD-GGAMLKATDFGLSVF 247 (447)
Q Consensus 210 ~lH----~----~~ivH~Dlkp~Nill~~~~-~~~~vkl~Dfg~a~~ 247 (447)
.|. . ..++|+|+.+.|||+..++ ....+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 2 3589999999999997641 124589999988753
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=97.66 E-value=2.3e-05 Score=65.66 Aligned_cols=54 Identities=24% Similarity=0.511 Sum_probs=49.2
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCC-CCCHHHHHHHHHhhC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS-KLSETEVKQLMDAVS 446 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~-~~~~~e~~~~~~~~d 446 (447)
.+.+++..+++++|..+|.|++|.|+.+||..+|+.+|. .++..++..+++..|
T Consensus 18 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~d 72 (166)
T 2mys_B 18 MFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEAS 72 (166)
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHCC
Confidence 556778889999999999999999999999999999999 999999999987643
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=97.66 E-value=2.8e-05 Score=64.64 Aligned_cols=57 Identities=26% Similarity=0.405 Sum_probs=51.4
Q ss_pred HhhhhHHHhhhhcceeeeecCCC-CcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 391 AEALSEEEIKGLKTMFANMDTDK-SGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 391 ~~~~~~~~~~~l~~~F~~~D~~~-~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...+++++..+++++|..+|.|+ +|.|+.+|+..+++.+|..+++.+++.+++.+|.
T Consensus 9 ~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~ 66 (161)
T 1dtl_A 9 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDE 66 (161)
T ss_dssp GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred HhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 34566778889999999999999 9999999999999999999999999999998873
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.66 E-value=2.4e-05 Score=63.56 Aligned_cols=52 Identities=21% Similarity=0.484 Sum_probs=46.7
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+++..+++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|.
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~ 53 (142)
T 2bl0_C 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADA 53 (142)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCc
Confidence 3567788999999999999999999999999999999999999999998873
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=97.65 E-value=6.1e-05 Score=61.76 Aligned_cols=49 Identities=31% Similarity=0.503 Sum_probs=45.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++++|+.+|.|++|+|+.+||+.++..+|..+++++++++++++|.
T Consensus 82 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 130 (148)
T 1exr_A 82 EEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADI 130 (148)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4567889999999999999999999999999999999999999999873
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=97.65 E-value=1.7e-05 Score=70.28 Aligned_cols=74 Identities=18% Similarity=0.251 Sum_probs=63.7
Q ss_pred HHHHHHhhhhHHHHHHHHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 374 ~~~~~~~~~k~~~~~~i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+.....++......+...++.++.++++++|..+|.|++|.|+.+||..+++.+|..+++++++.+++.+|.
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~ 98 (220)
T 3sjs_A 25 CIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDT 98 (220)
T ss_dssp HHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCT
T ss_pred hccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 34555556666666666778888999999999999999999999999999999999999999999999998873
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=97.64 E-value=4.5e-05 Score=58.16 Aligned_cols=51 Identities=14% Similarity=0.176 Sum_probs=42.3
Q ss_pred HHhhhhcceeeeecCCC---CcccCHHHHHHHHHHh-CCCCC----HHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDK---SGTITYEELKTGLARL-GSKLS----ETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~---~g~i~~~el~~~l~~l-~~~~~----~~e~~~~~~~~d~ 447 (447)
..+.+++++|..||.++ +|+|+.+||+.+|+.+ +..++ +++|++||+++|.
T Consensus 8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~ 66 (100)
T 3nxa_A 8 KAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDA 66 (100)
T ss_dssp HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCC
Confidence 45678999999999964 7999999999999874 44443 7899999999984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=8.1e-05 Score=69.83 Aligned_cols=138 Identities=17% Similarity=0.145 Sum_probs=76.6
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCC-CeeEEEEE------EEeCCeEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ-NIVEFRGA------YEDRQSVH 171 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~------~~~~~~~~ 171 (447)
.+.|+.|....+|++... +..+++|..... ...+.+..|+.+++.|..+. .+++++.. ....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 356777888999998754 336888977432 12235667888888876321 13333321 23356789
Q ss_pred EEEeccCCCchHH--------------HHHHc-CCC--------CHHHHHH---------------HHHHHHHHHHHHHh
Q 013201 172 LVMELCSGGELFD--------------KIIAQ-GHY--------TEKAAAA---------------LCRAIVNVVHHCHF 213 (447)
Q Consensus 172 lv~e~~~g~~L~~--------------~l~~~-~~~--------~~~~~~~---------------i~~qil~~l~~lH~ 213 (447)
+||+|++|..+.. .+... ..+ ....... +...+...+..+..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999998864310 11111 011 1000000 00113334455542
Q ss_pred -------cCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 214 -------MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 214 -------~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
.+++|+|+++.|||++.+ ..+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~---~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGD---ELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETT---EEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCC---ceEEEecchhcc
Confidence 469999999999999542 345799998775
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=97.63 E-value=1.9e-05 Score=61.34 Aligned_cols=50 Identities=34% Similarity=0.507 Sum_probs=45.4
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.+|.|++|+|+.+||+.+++.+ |..+++++++++++.+|.
T Consensus 40 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~d~ 92 (110)
T 1pva_A 40 SANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADK 92 (110)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCT
T ss_pred hHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999 788999999999999873
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=97.62 E-value=1.4e-05 Score=59.61 Aligned_cols=50 Identities=28% Similarity=0.496 Sum_probs=45.1
Q ss_pred HHhhhhcceeeeec-CCCCc-ccCHHHHHHHHHH---hCCCCCHHHHHHHHHhhC
Q 013201 397 EEIKGLKTMFANMD-TDKSG-TITYEELKTGLAR---LGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 397 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~---l~~~~~~~e~~~~~~~~d 446 (447)
+...+++.+|..+| .|++| .|+.+||+.+++. +|..+++++++++++.+|
T Consensus 7 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D 61 (90)
T 1k8u_A 7 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLD 61 (90)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhC
Confidence 34567889999999 59999 9999999999998 998899999999999876
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=97.61 E-value=2e-05 Score=61.10 Aligned_cols=49 Identities=33% Similarity=0.407 Sum_probs=45.0
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
.++++.+|+.||.|++|+|+.+||+.+++.+ |..+++++++++++.+|.
T Consensus 41 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~D~ 92 (109)
T 3fs7_A 41 PDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDT 92 (109)
T ss_dssp HHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHHhCC
Confidence 4567889999999999999999999999999 889999999999999874
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=97.61 E-value=4.1e-05 Score=62.64 Aligned_cols=52 Identities=17% Similarity=0.280 Sum_probs=48.3
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
++++++.+++++|..+|.+++|.|+.+|+..+++.+|..++++++..+++.+
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~ 53 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNP 53 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence 3566788899999999999999999999999999999999999999999887
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=97.60 E-value=3.8e-05 Score=73.23 Aligned_cols=49 Identities=29% Similarity=0.523 Sum_probs=46.0
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++++++|+.||.|++|+|+.+||+.+|..+|..++++|+++||+++|.
T Consensus 374 eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~ 422 (440)
T 3u0k_A 374 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 422 (440)
T ss_dssp CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4578899999999999999999999999999999999999999999984
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00014 Score=68.48 Aligned_cols=139 Identities=14% Similarity=0.095 Sum_probs=71.1
Q ss_pred ceeccccCeE-EEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCC-CeeEEEEEEEeCCeEEEEEecc
Q 013201 100 KELGRGQFGI-TYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ-NIVEFRGAYEDRQSVHLVMELC 177 (447)
Q Consensus 100 ~~lg~G~~g~-Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~~~~~~lv~e~~ 177 (447)
+.|+.|+... +|+... .++..+++|...... ...+..|+.+++.+..+. .+++++.+..+.+ ++|||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 3455554444 666652 236677777543211 023456788888776432 3566766643333 6899999
Q ss_pred CCCchHHHHHHc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 013201 178 SGGELFDKIIAQ--------------------------GHYTEKAAA-------A-LC------------RAIVNVVHHC 211 (447)
Q Consensus 178 ~g~~L~~~l~~~--------------------------~~~~~~~~~-------~-i~------------~qil~~l~~l 211 (447)
.+..+.+.+... ..+...... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776665433211 012221110 0 00 0111122222
Q ss_pred ------HhcCcEeecCCCCceEeecCCC-CCceEEecCCCcee
Q 013201 212 ------HFMGVMHRDLKPENFLLSNKDG-GAMLKATDFGLSVF 247 (447)
Q Consensus 212 ------H~~~ivH~Dlkp~Nill~~~~~-~~~vkl~Dfg~a~~ 247 (447)
+...++|+|+.+.|||++.+.. ...+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 2346999999999999964311 14689999998764
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=97.59 E-value=7.7e-06 Score=61.60 Aligned_cols=51 Identities=8% Similarity=0.161 Sum_probs=44.1
Q ss_pred HHhhhhcceeeeecC-CCCc-ccCHHHHHHHH-HHhCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDT-DKSG-TITYEELKTGL-ARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~-~~~g-~i~~~el~~~l-~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+...+++++|..||. |++| +|+.+||+.++ +.+|..++..+++++++.+|.
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~~~~~~~~~l~~~~D~ 60 (93)
T 1xk4_A 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDI 60 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHHCcccCCHHHHHHHHHHhCC
Confidence 345678899999999 9999 99999999999 788876777888999998873
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=97.59 E-value=1.3e-05 Score=66.05 Aligned_cols=55 Identities=29% Similarity=0.487 Sum_probs=50.5
Q ss_pred hhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 392 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..+.+++...++++|..+|.|++|.|+.+|+..+++.+|..+++.++..+++.+|
T Consensus 3 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d 57 (153)
T 3ox6_A 3 RSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQIN 57 (153)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 3456778889999999999999999999999999999999999999999998876
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=97.57 E-value=4.6e-05 Score=63.17 Aligned_cols=55 Identities=25% Similarity=0.467 Sum_probs=50.2
Q ss_pred hhhHHHhhhhcceeeeec-CCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 393 ALSEEEIKGLKTMFANMD-TDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D-~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.++++..++++|..+| .+++|.|+.+|+..+++.+|..+++.++..+++.+|.
T Consensus 6 ~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~ 61 (158)
T 2jnf_A 6 KLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDP 61 (158)
T ss_dssp TSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCT
T ss_pred hCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 345677889999999999 9999999999999999999999999999999998873
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=97.55 E-value=5.2e-05 Score=63.01 Aligned_cols=58 Identities=31% Similarity=0.434 Sum_probs=53.0
Q ss_pred HHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 390 i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+...++++++.+++++|..+|.|++|.|+.+|+..++..+|..++++++..+++.+|.
T Consensus 10 ~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~ 67 (162)
T 1top_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDE 67 (162)
T ss_dssp HHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred hhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcC
Confidence 4456778889999999999999999999999999999999999999999999998873
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00061 Score=62.72 Aligned_cols=78 Identities=14% Similarity=0.058 Sum_probs=54.3
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCC--CCeeEEEEEEEeCCeEEEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ--QNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~~~~~lv 173 (447)
..-.+.+|.|..+.||+++. .+|+.|++|+-.... ......+..|+..|+.|... --+++++.+. . -++|
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv 88 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence 45567899999999999885 478999999653322 12234578899999988633 2355665542 2 3689
Q ss_pred EeccCCCc
Q 013201 174 MELCSGGE 181 (447)
Q Consensus 174 ~e~~~g~~ 181 (447)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00084 Score=58.11 Aligned_cols=122 Identities=15% Similarity=0.044 Sum_probs=76.1
Q ss_pred CchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCceeec
Q 013201 180 GELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDI 257 (447)
Q Consensus 180 ~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 257 (447)
.+|.++|.. ..+++|++++.++.|.+.+|.-+-. ..-..+=+.|..|++..++ .|.+.+ +.+ .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG---~V~f~~-~~s-----------~ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG---AVTLAP-AAD-----------D 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS---CEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC---ceeccc-ccc-----------c
Confidence 478898876 4579999999999999999887622 1112233456778885544 343332 110 0
Q ss_pred CCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhccc
Q 013201 258 VGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQ 337 (447)
Q Consensus 258 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 337 (447)
.....+.|||......+.+.=|||||++||.-+--..| ...-..+|+.+.+||..|..-
T Consensus 98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 12335678888754556778899999999988852222 222235899999999999866
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=97.55 E-value=5.1e-05 Score=63.66 Aligned_cols=55 Identities=33% Similarity=0.535 Sum_probs=50.4
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.+++..+++++|..+|.|++|.|+.+||..+++.+|..+++.++..+++.+|.
T Consensus 21 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~ 75 (169)
T 3qrx_A 21 GLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDK 75 (169)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCS
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcC
Confidence 3466778899999999999999999999999999999999999999999998873
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=97.55 E-value=1.8e-05 Score=61.24 Aligned_cols=50 Identities=36% Similarity=0.508 Sum_probs=45.0
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
...+++.+|+.||.|++|+|+.+||+.+++.+ |..+++++++++++.+|.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (108)
T 1rro_A 39 SASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADN 91 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCC
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999 678999999999999873
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=97.55 E-value=5.2e-05 Score=62.96 Aligned_cols=55 Identities=29% Similarity=0.491 Sum_probs=50.5
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+++++...++++|..+|.+++|.|+.+||..+++.+|..+++.+++.+++.+|.
T Consensus 16 ~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~ 70 (161)
T 3fwb_A 16 ELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDS 70 (161)
T ss_dssp TSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCc
Confidence 4567788899999999999999999999999999999999999999999998863
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=97.54 E-value=8e-06 Score=62.47 Aligned_cols=51 Identities=20% Similarity=0.259 Sum_probs=43.9
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHH-----hCC--CCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLAR-----LGS--KLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-----l~~--~~~~~e~~~~~~~~d~ 447 (447)
++++.+++++|+.||.+ +|+|+.+||+.+|+. +|. .++++++++||+++|.
T Consensus 6 ~~~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~ 63 (100)
T 1psr_A 6 ERSIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDK 63 (100)
T ss_dssp HHHHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCT
T ss_pred HHHHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCC
Confidence 35677899999999976 799999999999987 565 6788999999999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00029 Score=68.87 Aligned_cols=75 Identities=15% Similarity=0.182 Sum_probs=51.2
Q ss_pred cceeccccCeEEEEEEECC-------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 99 GKELGRGQFGITYLCTENS-------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
.+.|+.|....||++.... ++..+++|+.... ...+.+.+|..+++.|..+.-.+++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 4568888889999998653 3578888876221 112455689999998875544567776653 2 2
Q ss_pred EEEeccCCCch
Q 013201 172 LVMELCSGGEL 182 (447)
Q Consensus 172 lv~e~~~g~~L 182 (447)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00033 Score=65.80 Aligned_cols=77 Identities=12% Similarity=0.112 Sum_probs=49.6
Q ss_pred ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCC-CeeEEEEE-----EEeCCeEEEE
Q 013201 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ-NIVEFRGA-----YEDRQSVHLV 173 (447)
Q Consensus 100 ~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~-----~~~~~~~~lv 173 (447)
..|+ |....||++.. .+|+.+++|...... .....+..|..+++.|..+. .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3466 78889998764 346679999874321 13456778999888886321 14444432 2335677899
Q ss_pred EeccCCCch
Q 013201 174 MELCSGGEL 182 (447)
Q Consensus 174 ~e~~~g~~L 182 (447)
|++++|..+
T Consensus 106 ~~~i~G~~~ 114 (328)
T 1zyl_A 106 FPSVGGRQF 114 (328)
T ss_dssp EECCCCEEC
T ss_pred EEecCCCCC
Confidence 999987543
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=97.50 E-value=9.3e-06 Score=58.65 Aligned_cols=50 Identities=20% Similarity=0.296 Sum_probs=44.3
Q ss_pred HhhhhcceeeeecC-CCCc-ccCHHHHHHHHHH-hCCCC-CHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDT-DKSG-TITYEELKTGLAR-LGSKL-SETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~-~~~g-~i~~~el~~~l~~-l~~~~-~~~e~~~~~~~~d~ 447 (447)
+..+++++|..+|. |++| .|+.+||+.+++. +|..+ ++++++++++.+|.
T Consensus 5 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~ 58 (78)
T 1cb1_A 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDK 58 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCC
T ss_pred HHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcC
Confidence 45678899999999 9999 9999999999986 88877 89999999998873
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.50 E-value=5.2e-05 Score=61.42 Aligned_cols=49 Identities=33% Similarity=0.485 Sum_probs=45.3
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.|++|+|+.+||+.+++.+|..+++++++++++.+|.
T Consensus 75 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 123 (140)
T 1ggw_A 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV 123 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC
Confidence 3567889999999999999999999999999999999999999999873
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=97.50 E-value=1.8e-05 Score=59.91 Aligned_cols=50 Identities=16% Similarity=0.313 Sum_probs=43.1
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
+++.+++++|+.||. ++|+|+.+||+.+|+. +|..++++++++|++++|.
T Consensus 6 ~~~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~ 60 (96)
T 1a4p_A 6 HAMETMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQ 60 (96)
T ss_dssp HHHHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCC
Confidence 456789999999994 5679999999999987 6667899999999999874
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=97.49 E-value=3.3e-05 Score=63.24 Aligned_cols=49 Identities=22% Similarity=0.347 Sum_probs=44.7
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh-C
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV-S 446 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~-d 446 (447)
++.+++++|..+|.|++|.|+.+||..+|+.+|..+++.++..+++.+ |
T Consensus 2 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D 51 (148)
T 1m45_A 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSS 51 (148)
T ss_dssp -CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--C
T ss_pred hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhC
Confidence 456789999999999999999999999999999999999999999987 6
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=97.48 E-value=5.4e-05 Score=62.63 Aligned_cols=54 Identities=22% Similarity=0.466 Sum_probs=47.3
Q ss_pred HhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHh
Q 013201 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444 (447)
Q Consensus 391 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~ 444 (447)
...+.+++..+++++|..+|.|++|.|+.+||..+|+.+|..+++.++..+++.
T Consensus 9 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~ 62 (156)
T 1wdc_B 9 LTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKE 62 (156)
T ss_dssp ---CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHTT
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHh
Confidence 345567788899999999999999999999999999999999999999998864
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=97.47 E-value=5.8e-05 Score=61.77 Aligned_cols=50 Identities=26% Similarity=0.537 Sum_probs=45.9
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.+|.|++|.|+.+||+.++..+|..+++++++++++.+|.
T Consensus 81 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 130 (148)
T 1m45_A 81 KTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEV 130 (148)
T ss_dssp CTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCC
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 34568889999999999999999999999999999999999999998873
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=97.47 E-value=4.6e-05 Score=65.03 Aligned_cols=51 Identities=24% Similarity=0.335 Sum_probs=45.7
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHH-HhCCC-C------CHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLA-RLGSK-L------SETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~-~l~~~-~------~~~e~~~~~~~~d~ 447 (447)
....+++.+|+.||.|++|+|+.+||+.+++ .+|.+ + ++++++++++++|.
T Consensus 95 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~ 153 (179)
T 3a8r_A 95 GFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDP 153 (179)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHST
T ss_pred CHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCC
Confidence 3456789999999999999999999999999 88877 6 89999999999874
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.46 E-value=4.3e-05 Score=62.16 Aligned_cols=49 Identities=24% Similarity=0.463 Sum_probs=45.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.|++|+|+.+||+.++..+|..+++++++++++.+|.
T Consensus 75 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 123 (143)
T 3j04_B 75 EDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPI 123 (143)
T ss_dssp HHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCC
Confidence 3567889999999999999999999999999999999999999999874
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.44 E-value=3.9e-05 Score=62.39 Aligned_cols=49 Identities=24% Similarity=0.472 Sum_probs=44.9
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHH
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~ 443 (447)
+++++.+++++|..+|.|++|.|+.+||..+|+.+|..++.+++..++.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~ 50 (143)
T 3j04_B 2 DQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMS 50 (143)
T ss_dssp CHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTT
T ss_pred CHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999988764
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=97.43 E-value=7.4e-05 Score=61.80 Aligned_cols=48 Identities=17% Similarity=0.356 Sum_probs=44.9
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
...++.+|+.+|.|++|+|+.+||+.++..+|..+++++++++++.+|
T Consensus 86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d 133 (156)
T 1wdc_B 86 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAP 133 (156)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcC
Confidence 356788999999999999999999999999999999999999999987
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=97.42 E-value=2.2e-05 Score=64.64 Aligned_cols=53 Identities=19% Similarity=0.372 Sum_probs=43.9
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
++++++.+++++|..+|.|++|.|+.+||..+++.+|..++..++..+++.+|
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d 56 (151)
T 1w7j_B 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPK 56 (151)
T ss_dssp -------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 45677889999999999999999999999999999999999999999998765
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=97.42 E-value=8.1e-05 Score=62.29 Aligned_cols=49 Identities=22% Similarity=0.287 Sum_probs=45.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.|++|+|+.+||+.++..+|..+++++++++++.+|.
T Consensus 94 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~ 142 (166)
T 2mys_B 94 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPP 142 (166)
T ss_pred HHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCC
Confidence 3567889999999999999999999999999999999999999999873
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=97.39 E-value=5.9e-05 Score=61.95 Aligned_cols=49 Identities=24% Similarity=0.390 Sum_probs=43.7
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
....++++|+.+|.|++|+|+.+||+.++..+|..+++++++++++.+|
T Consensus 85 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d 133 (151)
T 1w7j_B 85 TYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE 133 (151)
T ss_dssp ---CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc
Confidence 3457788999999999999999999999999999999999999998875
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.39 E-value=8.7e-05 Score=60.18 Aligned_cols=48 Identities=23% Similarity=0.403 Sum_probs=44.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
...++.+|+.+|.|++|.|+.+|++.++..+|..+++++++++++.+|
T Consensus 78 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d 125 (142)
T 2bl0_C 78 EDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE 125 (142)
T ss_dssp HHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 456788999999999999999999999999999999999999999876
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00017 Score=59.80 Aligned_cols=49 Identities=22% Similarity=0.534 Sum_probs=45.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.+++|+|+.+||+.++..+|..+++++++++++.+|.
T Consensus 95 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~ 143 (161)
T 3fwb_A 95 LDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDL 143 (161)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCS
T ss_pred HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4567889999999999999999999999999999999999999999873
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.38 E-value=7.8e-05 Score=60.62 Aligned_cols=50 Identities=36% Similarity=0.555 Sum_probs=45.7
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.+|.|++|+|+.+|++.++..+|..+++++++++++.+|.
T Consensus 74 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~ 123 (145)
T 2bl0_B 74 QSKEMLDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSV 123 (145)
T ss_dssp GHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCC
T ss_pred cHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCC
Confidence 34567889999999999999999999999999999999999999998873
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00011 Score=60.65 Aligned_cols=49 Identities=24% Similarity=0.440 Sum_probs=45.3
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHh--hCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA--VSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~--~d~ 447 (447)
...++.+|+.+|.|++|+|+.+||+.++..+|..+++++++++++. +|.
T Consensus 83 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~ 133 (156)
T 1wdc_C 83 FADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQE 133 (156)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCC
Confidence 4567889999999999999999999999999999999999999998 763
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00029 Score=58.39 Aligned_cols=50 Identities=26% Similarity=0.375 Sum_probs=45.8
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.+|.|++|.|+.+|++.++..+|..+++++++++++.+|.
T Consensus 94 ~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~ 143 (162)
T 1top_A 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDK 143 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCT
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999873
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00028 Score=59.02 Aligned_cols=49 Identities=29% Similarity=0.468 Sum_probs=45.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...+..+|+.+|.|++|.|+.+||+.++..+|..+++++++++++.+|.
T Consensus 100 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~ 148 (169)
T 3qrx_A 100 REEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADR 148 (169)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 4567789999999999999999999999999999999999999999874
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.34 E-value=5.9e-05 Score=64.01 Aligned_cols=46 Identities=13% Similarity=0.182 Sum_probs=42.8
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh----CCCCCHHHHHHHHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL----GSKLSETEVKQLMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~~~~~~~e~~~~~~~~d 446 (447)
.+++++|+.|| |++|+|+.+||+.+++.+ |..++++++++|++++|
T Consensus 76 ~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d 125 (174)
T 2i7a_A 76 VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS 125 (174)
T ss_dssp HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS
T ss_pred HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc
Confidence 35788999999 999999999999999999 99999999999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00042 Score=66.30 Aligned_cols=76 Identities=11% Similarity=0.062 Sum_probs=45.2
Q ss_pred cceeccccCeEEEEEEECC--------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 99 GKELGRGQFGITYLCTENS--------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~--------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.+.|+.|....+|++.... .+..+++|+..... ........|..+++.|..+.-++++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4567888888999988653 13678888653211 11112367888888887443355776554 33
Q ss_pred EEEEeccCCCch
Q 013201 171 HLVMELCSGGEL 182 (447)
Q Consensus 171 ~lv~e~~~g~~L 182 (447)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987543
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=97.33 E-value=6.9e-05 Score=61.22 Aligned_cols=51 Identities=16% Similarity=0.182 Sum_probs=47.4
Q ss_pred HHHhhhhcceeeeecCCC-CcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 396 EEEIKGLKTMFANMDTDK-SGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~-~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++..+++++|..+|.|+ +|.|+.+|+..+++.+|..++..++..+++.+|
T Consensus 10 ~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d 61 (146)
T 2qac_A 10 LEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYG 61 (146)
T ss_dssp HHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Confidence 456678999999999999 999999999999999999999999999999877
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0003 Score=57.12 Aligned_cols=48 Identities=33% Similarity=0.511 Sum_probs=44.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
...++.+|+.+|.+++|.|+.+|++.++..+|..+++++++++++.+|
T Consensus 83 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d 130 (147)
T 4ds7_A 83 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS 130 (147)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS
T ss_pred HHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence 356778999999999999999999999999999999999999999876
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=97.32 E-value=1.8e-05 Score=61.25 Aligned_cols=50 Identities=34% Similarity=0.450 Sum_probs=45.5
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
...+++.+|+.+|.|++|+|+.+||+.++..+ |..+++++++++++.+|.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (108)
T 2kyc_A 39 SSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVLTASETKTFLAAADH 91 (108)
T ss_dssp CSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCCCTTTTHHHHTTTCC
T ss_pred cHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCC
Confidence 45678899999999999999999999999999 788999999999998873
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00012 Score=60.64 Aligned_cols=50 Identities=22% Similarity=0.390 Sum_probs=46.1
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.+|.|++|+|+.+||+.++..+|..+++++++++++.+|.
T Consensus 89 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~ 138 (158)
T 2jnf_A 89 MQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDA 138 (158)
T ss_dssp TSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCC
Confidence 34578899999999999999999999999999999999999999999873
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00016 Score=59.20 Aligned_cols=49 Identities=24% Similarity=0.587 Sum_probs=45.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHH-hCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLAR-LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.+++|.|+.+||+.++.. +|..+++++++++++.+|.
T Consensus 87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~ 136 (153)
T 3ox6_A 87 VKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDL 136 (153)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCC
Confidence 456788999999999999999999999999 8999999999999999873
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00025 Score=60.86 Aligned_cols=44 Identities=27% Similarity=0.324 Sum_probs=38.2
Q ss_pred ceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 404 TMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 404 ~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+|+.+|.|++|+|+.+||+.++..+|..+++++++++++.+|.
T Consensus 117 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 160 (195)
T 1qv0_A 117 AVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDL 160 (195)
T ss_dssp HHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCC
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 89999999999999999999999999999999999999999873
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00014 Score=59.38 Aligned_cols=47 Identities=28% Similarity=0.478 Sum_probs=43.6
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
...++.+|+.+|.|++|+|+.+||+.++..+|..+++++++++++.+
T Consensus 83 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~ 129 (146)
T 2qac_A 83 VEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF 129 (146)
T ss_dssp HHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc
Confidence 45688899999999999999999999999999999999999999875
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00015 Score=62.84 Aligned_cols=52 Identities=29% Similarity=0.499 Sum_probs=43.1
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++.+++++|..+|.|++|.|+.+|+..+++.+|..+++++++.+++.+|.
T Consensus 33 ~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~ 84 (204)
T 3e3r_A 33 ASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDR 84 (204)
T ss_dssp -------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCT
T ss_pred chhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhcc
Confidence 4567889999999999999999999999999999999999999999998873
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00018 Score=58.61 Aligned_cols=48 Identities=31% Similarity=0.478 Sum_probs=44.3
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
....++.+|..+|.+++|.|+.+|++.++..+|..+++++++++++. |
T Consensus 83 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d 130 (149)
T 2mys_C 83 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-Q 130 (149)
T ss_pred hHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-C
Confidence 34567889999999999999999999999999999999999999987 6
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=97.24 E-value=7.8e-05 Score=56.55 Aligned_cols=51 Identities=16% Similarity=0.267 Sum_probs=44.0
Q ss_pred HHhhhhcceeeeec-CCCCc-ccCHHHHHHHHH-HhC----CCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMD-TDKSG-TITYEELKTGLA-RLG----SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~-~l~----~~~~~~e~~~~~~~~d~ 447 (447)
....+++.+|..+| .|++| +|+.+||+.+++ .+| ..+++.+++++++.+|.
T Consensus 10 ~~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D~ 67 (99)
T 1qls_A 10 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDL 67 (99)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhCC
Confidence 34567889999998 99999 999999999998 454 67899999999999873
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00036 Score=59.62 Aligned_cols=44 Identities=25% Similarity=0.380 Sum_probs=42.2
Q ss_pred ceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 404 TMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 404 ~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+|+.+|.|++|+|+.+||+.+++.+|..+++++++++++.+|.
T Consensus 113 ~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 156 (191)
T 1uhk_A 113 ALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDI 156 (191)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCC
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 89999999999999999999999999999999999999999873
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00011 Score=63.52 Aligned_cols=53 Identities=21% Similarity=0.468 Sum_probs=47.7
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
.++.+++..++++|..||.|++|.|+.+||..+|+.+|..++..++..++..+
T Consensus 50 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~ 102 (196)
T 3dtp_E 50 MFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA 102 (196)
T ss_dssp SSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc
Confidence 34566778899999999999999999999999999999999999999998654
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00016 Score=62.46 Aligned_cols=47 Identities=17% Similarity=0.152 Sum_probs=43.9
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
...++.+|..||.|++|+|+.+||+.+| .+|..+++++++++|+.+|
T Consensus 125 ~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D 171 (196)
T 3dtp_E 125 EDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAP 171 (196)
T ss_dssp HHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcC
Confidence 3567889999999999999999999999 9999999999999999887
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00056 Score=57.76 Aligned_cols=49 Identities=29% Similarity=0.523 Sum_probs=43.3
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|..+|.|++|.|+.+|++.++..+|..+++++++++++.+|.
T Consensus 83 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~ 131 (179)
T 2f2o_A 83 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 131 (179)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCC
Confidence 3567889999999999999999999999999999999999999999873
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=7.3e-05 Score=64.32 Aligned_cols=56 Identities=25% Similarity=0.306 Sum_probs=48.6
Q ss_pred hhhhHHHhhhhcceeeeecCCCCcccCHHHHH-----HHHHHhCCCCCHH-----HHHHHHHhhCC
Q 013201 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELK-----TGLARLGSKLSET-----EVKQLMDAVSI 447 (447)
Q Consensus 392 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~-----~~l~~l~~~~~~~-----e~~~~~~~~d~ 447 (447)
..+++++..+++++|..+|.|++|.|+.+||. .+++.+|..++.. +++.+++.+|.
T Consensus 12 ~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~ 77 (195)
T 1qv0_A 12 DFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGM 77 (195)
T ss_dssp CTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTC
T ss_pred ccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCC
Confidence 34577888999999999999999999999999 7889999888776 68889988763
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00024 Score=62.66 Aligned_cols=47 Identities=19% Similarity=0.224 Sum_probs=44.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..++.+|+.+|.|++|+|+.+||+.+++.+|..+++++++++++.+|
T Consensus 117 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d 163 (220)
T 3sjs_A 117 ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA 163 (220)
T ss_dssp HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc
Confidence 55788999999999999999999999999999999999999999876
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00013 Score=63.65 Aligned_cols=55 Identities=18% Similarity=0.275 Sum_probs=44.6
Q ss_pred hhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCC--CCCHHHHHHHH-------HhhC
Q 013201 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS--KLSETEVKQLM-------DAVS 446 (447)
Q Consensus 392 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~--~~~~~e~~~~~-------~~~d 446 (447)
..+.++++.+++++|..+|.|++|.|+.+||..+++.+|. .++++++..++ +.+|
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D 91 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKG 91 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTT
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhC
Confidence 3456677889999999999999999999999999999998 89999999999 8776
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0026 Score=59.97 Aligned_cols=69 Identities=12% Similarity=0.068 Sum_probs=43.7
Q ss_pred ccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccC--CCCeeEEEEE------EEeCCeEEEEE
Q 013201 103 GRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSG--QQNIVEFRGA------YEDRQSVHLVM 174 (447)
Q Consensus 103 g~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~--h~~iv~~~~~------~~~~~~~~lv~ 174 (447)
|.|....||++... +| .+++|+..... ...|+.+++.|.. -|.+++.+.. ....+..++||
T Consensus 32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~---------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~ 100 (339)
T 3i1a_A 32 GADTNAFAYQADSE-SK-SYFIKLKYGYH---------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY 100 (339)
T ss_dssp TSCSSCEEEEEECS-SC-EEEEEEEECSS---------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred cCccccceEEEEeC-CC-CEEEEEecCcc---------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence 33446789998743 34 89999764432 1356777776652 2334555432 23467889999
Q ss_pred eccCCCch
Q 013201 175 ELCSGGEL 182 (447)
Q Consensus 175 e~~~g~~L 182 (447)
+|++|..+
T Consensus 101 ~~i~G~~~ 108 (339)
T 3i1a_A 101 PFIHAPNG 108 (339)
T ss_dssp ECCCCCBT
T ss_pred eccCCCcC
Confidence 99998755
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0003 Score=60.47 Aligned_cols=48 Identities=21% Similarity=0.353 Sum_probs=44.0
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++++|+.+|.|++|.|+.+|++.++..+|..+++++++++++.+|.
T Consensus 93 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~ 140 (191)
T 1y1x_A 93 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDR 140 (191)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 356789999999999999999999999999999999999999999873
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00034 Score=60.64 Aligned_cols=47 Identities=23% Similarity=0.398 Sum_probs=43.6
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh-CCCCCHHHHHHHHHh
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL-GSKLSETEVKQLMDA 444 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-~~~~~~~e~~~~~~~ 444 (447)
....++.+|+.+|.|++|+|+.+||+.++..+ |..+++++++++++.
T Consensus 112 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~ 159 (202)
T 2bec_A 112 RRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADR 159 (202)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 44568889999999999999999999999999 999999999999988
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00034 Score=61.00 Aligned_cols=49 Identities=22% Similarity=0.353 Sum_probs=44.2
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh-CCCCCHHHHHHH----HHhhC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL-GSKLSETEVKQL----MDAVS 446 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-~~~~~~~e~~~~----~~~~d 446 (447)
....++.+|+.+|.|++|+|+.+||+.++..+ |..+++++++++ ++.+|
T Consensus 111 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D 164 (208)
T 2ct9_A 111 RSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEAD 164 (208)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhC
Confidence 34567889999999999999999999999997 999999999988 88876
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00021 Score=57.72 Aligned_cols=46 Identities=17% Similarity=0.244 Sum_probs=42.2
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHH
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~ 443 (447)
+.++++++|..+|.|++|.|+.+||..+++.+|..++.+++.++++
T Consensus 3 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~ 48 (140)
T 1ggw_A 3 DDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES 48 (140)
T ss_dssp CCTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh
Confidence 3567889999999999999999999999999999999999998875
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00035 Score=58.72 Aligned_cols=48 Identities=29% Similarity=0.426 Sum_probs=44.6
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++.+|+.+|.|++|+|+.+|++.++..+|..+++++++++++.+|.
T Consensus 74 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 121 (172)
T 2znd_A 74 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDR 121 (172)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 467889999999999999999999999999999999999999998873
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0053 Score=60.29 Aligned_cols=76 Identities=14% Similarity=0.063 Sum_probs=49.0
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEeccC
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
.+.|+.|-...+|++.....+..+++|+.... .....+ ..+|..+++.|..+.-.+++++.+. +. +||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~-~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPK-TDEIIN---REREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC--CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCC-hhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence 45688888899999987644578888865322 111111 2589999999985444567777762 32 5999998
Q ss_pred CCch
Q 013201 179 GGEL 182 (447)
Q Consensus 179 g~~L 182 (447)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7544
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=97.05 E-value=8.8e-05 Score=61.28 Aligned_cols=51 Identities=24% Similarity=0.318 Sum_probs=36.2
Q ss_pred hHHHhhhhcceeeeecC--CCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 395 SEEEIKGLKTMFANMDT--DKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~--~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+++++.+++++|..+|. |++|.|+.+||..+|+.+|..++..++..+ +.+|
T Consensus 4 s~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D 56 (156)
T 1wdc_C 4 SQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTH 56 (156)
T ss_dssp CHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCS
T ss_pred CHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhC
Confidence 44566667777777777 777777777777777777777777777766 5544
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00024 Score=56.56 Aligned_cols=45 Identities=18% Similarity=0.440 Sum_probs=33.4
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
++++|..+|.+++|.|+.+|+..++..+|..+++++++.+++.+|
T Consensus 2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D 46 (134)
T 1jfj_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSID 46 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHC
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHc
Confidence 456777777777777777777777777777777777777777665
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00023 Score=60.82 Aligned_cols=53 Identities=21% Similarity=0.382 Sum_probs=47.2
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHH-----HHHHHhCCCCCHH-----HHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELK-----TGLARLGSKLSET-----EVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~-----~~l~~l~~~~~~~-----e~~~~~~~~d~ 447 (447)
++++..+++++|..+|.|++|.|+.+||. .+++.+|..+++. +++.+++.+|.
T Consensus 11 ~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~ 73 (191)
T 1uhk_A 11 NPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGM 73 (191)
T ss_dssp CHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCc
Confidence 56678889999999999999999999999 8899999988877 68889988873
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00047 Score=57.50 Aligned_cols=46 Identities=26% Similarity=0.461 Sum_probs=42.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
..++.+|+.+|.|++|+|+.+|++.+++.+|..+++++++++++.+
T Consensus 70 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~ 115 (165)
T 1k94_A 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY 115 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence 4577899999999999999999999999999999999999999875
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00024 Score=58.84 Aligned_cols=50 Identities=28% Similarity=0.439 Sum_probs=43.7
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.+|.|++|.|+.+|++.++..+|..+++++++++++.+|.
T Consensus 93 ~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 142 (161)
T 1dtl_A 93 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDK 142 (161)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999873
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0011 Score=54.92 Aligned_cols=47 Identities=23% Similarity=0.308 Sum_probs=42.9
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.|++|.|+.+|++.++..+| +++++++++++.+|.
T Consensus 97 ~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~~~~~~~~~~~~D~ 143 (166)
T 3akb_A 97 RPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDT 143 (166)
T ss_dssp HHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CCHHHHHHHHHHhCC
Confidence 34578899999999999999999999999998 899999999999873
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00011 Score=62.74 Aligned_cols=51 Identities=18% Similarity=0.298 Sum_probs=45.1
Q ss_pred hhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHh------CCCCCHHHHHHHH
Q 013201 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL------GSKLSETEVKQLM 442 (447)
Q Consensus 392 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l------~~~~~~~e~~~~~ 442 (447)
..+++++..+++++|..+|.|++|.|+.+||..+++.+ |..++++++.+++
T Consensus 6 ~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~ 62 (186)
T 2hps_A 6 ESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFL 62 (186)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHH
Confidence 34567778899999999999999999999999999877 8888899999885
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00053 Score=66.72 Aligned_cols=55 Identities=36% Similarity=0.564 Sum_probs=48.4
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.+++.++++++|+.+|.|++|.|+.+||+.+|+.+|..+++++++++++.+|.
T Consensus 305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~ 359 (450)
T 3sg6_A 305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 359 (450)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCT
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhcc
Confidence 3455667888999999999999999999999999999999999999999998873
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00034 Score=55.47 Aligned_cols=46 Identities=13% Similarity=0.399 Sum_probs=38.8
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++..+++++|+.|| |+|+.+||+.+|+.+|. +++|+++|++++|.
T Consensus 46 ~~~~~~l~~aF~~fD----G~I~~~El~~~l~~lG~--t~~ei~~~~~~~D~ 91 (123)
T 2kld_A 46 KNTVDDISESLRQGG----GKLNFDELRQDLKGKGH--TDAEIEAIFTKYDQ 91 (123)
T ss_dssp -----CCSCSSTTTT----TCEEHHHHHHHTTTCCS--SHHHHHHHHHHHSS
T ss_pred hhHHHHHHHHHHHhC----CCCCHHHHHHHHHHhCC--CHHHHHHHHHHHcC
Confidence 345578999999999 99999999999999998 99999999999874
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00031 Score=60.74 Aligned_cols=52 Identities=13% Similarity=0.206 Sum_probs=46.5
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCC-----CCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS-----KLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~-----~~~~~e~~~~~~~~d~ 447 (447)
...+.+++++ |..+|.|++|.|+.+||..+++.+|. .+++++++.+++.+|.
T Consensus 28 ~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~ 84 (198)
T 1juo_A 28 PGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDR 84 (198)
T ss_dssp TTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCT
T ss_pred CccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCC
Confidence 4456788999 99999999999999999999999986 6799999999998873
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00023 Score=58.13 Aligned_cols=47 Identities=19% Similarity=0.189 Sum_probs=37.1
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhC--------CCCCHHHHHHHH----HhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLG--------SKLSETEVKQLM----DAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~--------~~~~~~e~~~~~----~~~d 446 (447)
++++.+|+.||.|++|+|+.+||+.++..++ ..++++++++++ +++|
T Consensus 68 ~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D 126 (143)
T 3a4u_B 68 ELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDD 126 (143)
T ss_dssp HHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCCHHHHHHHHHHHHHHcC
Confidence 4567789999999999999999999999884 578999998777 7666
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0003 Score=61.95 Aligned_cols=49 Identities=18% Similarity=0.279 Sum_probs=44.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCC-CCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGS-KLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~-~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.||.|++|+|+.+||+.++..+|. .+++++++++|+.+|.
T Consensus 129 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~ 178 (219)
T 3cs1_A 129 FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDK 178 (219)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCC
Confidence 356889999999999999999999999999997 7899999999999873
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.00038 Score=59.80 Aligned_cols=49 Identities=29% Similarity=0.394 Sum_probs=41.3
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++++++|..+|.|++|.|+.+||..++..+|..+++++++.+++.+|.
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~ 74 (191)
T 1y1x_A 26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDK 74 (191)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 3567888999999999999999999998777788888999988888763
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=96.86 E-value=0.00039 Score=58.53 Aligned_cols=47 Identities=28% Similarity=0.409 Sum_probs=43.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..++.+|+.+|.|++|.|+.+|++.+++.+|..+++++++++++.+|
T Consensus 77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d 123 (173)
T 1alv_A 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS 123 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence 46788999999999999999999999999999999999999998765
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00037 Score=56.46 Aligned_cols=43 Identities=26% Similarity=0.507 Sum_probs=40.8
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHh
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~ 444 (447)
++++|..+|.|++|.|+.+|+..+++.+|..++.+++..+++.
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~ 49 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ 49 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh
Confidence 8899999999999999999999999999999999999998874
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00024 Score=61.54 Aligned_cols=49 Identities=27% Similarity=0.339 Sum_probs=42.6
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh--CCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL--GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l--~~~~~~~e~~~~~~~~d~ 447 (447)
.+.++.+|+.+|.|++|+|+.+||+.++..+ |..+++++++++++++|.
T Consensus 128 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~l~~~~D~ 178 (197)
T 3pm8_A 128 KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDL 178 (197)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCHHHHHHHHHHHcC
Confidence 3467889999999999999999999999998 778899999999999873
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00054 Score=56.22 Aligned_cols=47 Identities=32% Similarity=0.464 Sum_probs=43.2
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHH-hCCCCCHHHHHHHHHh
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLAR-LGSKLSETEVKQLMDA 444 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-l~~~~~~~e~~~~~~~ 444 (447)
....++.+|+.+|.|++|.|+.+|++.++.. +|..+++++++++++.
T Consensus 73 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~ 120 (155)
T 3ll8_B 73 KEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDK 120 (155)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHH
Confidence 3467889999999999999999999999999 6999999999999988
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00062 Score=56.92 Aligned_cols=46 Identities=28% Similarity=0.554 Sum_probs=42.8
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
..++.+|+.+|.|++|.|+.+|++.++..+|..+++++++++++.+
T Consensus 72 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~ 117 (167)
T 1gjy_A 72 NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY 117 (167)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh
Confidence 4677899999999999999999999999999999999999999875
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00031 Score=61.86 Aligned_cols=52 Identities=17% Similarity=0.352 Sum_probs=45.1
Q ss_pred hhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHH-hCCCCCHHHHHHHHH
Q 013201 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLAR-LGSKLSETEVKQLMD 443 (447)
Q Consensus 392 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-l~~~~~~~e~~~~~~ 443 (447)
..+..+++.+++++|..+|.|++|.|+.+||..+|.. +|..++.+++.++++
T Consensus 40 ~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~ 92 (219)
T 3cs1_A 40 REKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITK 92 (219)
T ss_dssp CSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHH
Confidence 3456788899999999999999999999999999998 898888777777654
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00072 Score=58.34 Aligned_cols=46 Identities=33% Similarity=0.572 Sum_probs=43.0
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
..++++|+.+|.|++|.|+.+||+.+++.+|..+++++++++++.+
T Consensus 103 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~ 148 (198)
T 1juo_A 103 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY 148 (198)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence 4678899999999999999999999999999999999999999875
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00091 Score=56.06 Aligned_cols=47 Identities=26% Similarity=0.339 Sum_probs=42.6
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.|++|+|+.+|++.++..+| +++++++++++.+|.
T Consensus 93 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~~~~~~~~~~~~D~ 139 (174)
T 1q80_A 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAIDT 139 (174)
T ss_dssp HTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CCGGGHHHHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CCHHHHHHHHHHhCC
Confidence 46788999999999999999999999999997 688999999999873
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00067 Score=53.05 Aligned_cols=50 Identities=20% Similarity=0.246 Sum_probs=41.5
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.++..+++++|+.+|. ++|+|+.+|++.++...| ++++++.++++.+|.
T Consensus 28 t~ee~~~y~~iF~~lD~-~dG~Isg~elr~~~~~sg--Lp~~~L~~Iw~laD~ 77 (121)
T 3fia_A 28 TVEERAKHDQQFHSLKP-ISGFITGDQARNFFFQSG--LPQPVLAQIWALADM 77 (121)
T ss_dssp CHHHHHHHHHHHHHTCC-BTTBEEHHHHHHHHGGGC--CCHHHHHHHHHHHCT
T ss_pred CHHHHHHHHHHHHHhCC-CCCeECHHHHHHHHHHcC--CCHHHHHHHHHHHcC
Confidence 45677788889999988 899999999999998764 578889999888874
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00071 Score=56.83 Aligned_cols=46 Identities=24% Similarity=0.382 Sum_probs=42.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++.+|+.+|.|++|.|+.+|++.++..+| +++++++.+++.+|.
T Consensus 102 ~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~~~~~~~~~~~~D~ 147 (176)
T 1nya_A 102 PVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDT 147 (176)
T ss_dssp HHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CCHHHHHHHHHHhCC
Confidence 4578899999999999999999999999998 899999999999873
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.00054 Score=59.63 Aligned_cols=44 Identities=18% Similarity=0.376 Sum_probs=41.3
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++.+|+.+|.|++|+|+.+||+.++..+| +++++++++++.+|.
T Consensus 130 ~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~ 173 (208)
T 2hpk_A 130 SNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEAAYTFFEKADT 173 (208)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SCTTHHHHHHHHHCT
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cCHHHHHHHHHHhCC
Confidence 78899999999999999999999999999 899999999999873
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.00094 Score=57.05 Aligned_cols=46 Identities=24% Similarity=0.290 Sum_probs=42.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++.+|+.+|.|++|+|+.+|+..++..+| +++++++++++.+|.
T Consensus 109 ~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~~~~~~~~~~~~D~ 154 (191)
T 2ccm_A 109 KYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPKSDCDAAFDTLSD 154 (191)
T ss_dssp HHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CCHHHHHHHHHHhCC
Confidence 4678899999999999999999999999998 799999999999873
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.00065 Score=51.86 Aligned_cols=47 Identities=23% Similarity=0.322 Sum_probs=38.6
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHH-----hCCCCCH-----------HHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLAR-----LGSKLSE-----------TEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~-----l~~~~~~-----------~e~~~~~~~~d~ 447 (447)
.++.+|..||.|++|+|+.+||..++.. +|...++ ..+.++++.+|.
T Consensus 21 ~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D~ 83 (103)
T 1snl_A 21 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDT 83 (103)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCS
T ss_pred CHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcCC
Confidence 5778999999999999999999999996 5765443 348889988873
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=96.65 E-value=0.001 Score=64.70 Aligned_cols=49 Identities=29% Similarity=0.523 Sum_probs=45.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.++.+|+.+|.|++|+|+.+||+.+|..+|..+++++++++++.+|.
T Consensus 384 ~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~ 432 (450)
T 3sg6_A 384 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 432 (450)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred hhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 3467889999999999999999999999999999999999999999873
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.00064 Score=57.72 Aligned_cols=46 Identities=20% Similarity=0.341 Sum_probs=41.8
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++.+|+.+|.|++|+|+.+||+.++. +..+++++++++++.+|.
T Consensus 108 ~~~~~~F~~~D~d~~G~I~~~El~~~l~--~~~~~~~~~~~~~~~~d~ 153 (180)
T 3mse_B 108 TFLKAAFNKIDKDEDGYISKSDIVSLVH--DKVLDNNDIDNFFLSVHS 153 (180)
T ss_dssp CHHHHHHHHHCTTCSSCBCHHHHHHHTT--TSSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHc--CCCCCHHHHHHHHHHhhh
Confidence 5678899999999999999999999998 677899999999998873
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00085 Score=57.26 Aligned_cols=46 Identities=26% Similarity=0.376 Sum_probs=42.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.++.+|+.+|.|++|.|+.+|++.++. |..+++++++++++.+|.
T Consensus 123 ~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~~~~~~~~~~~~~~~D~ 168 (191)
T 3khe_A 123 ERLLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQVLQECDK 168 (191)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHTT--SSCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHCCCCcCcCCHHHHHHHHc--cCCCCHHHHHHHHHHhCC
Confidence 5678899999999999999999999999 888999999999999873
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0014 Score=55.60 Aligned_cols=48 Identities=21% Similarity=0.425 Sum_probs=42.1
Q ss_pred hhhccee--eeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMF--ANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F--~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++..+| ..||.|++|+|+.+||+.++..+|..+++++++++++.+|.
T Consensus 100 ~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~ 149 (186)
T 2hps_A 100 AVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDF 149 (186)
T ss_dssp TTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcC
Confidence 4455555 67799999999999999999999999999999999999873
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=96.58 E-value=0.00056 Score=60.01 Aligned_cols=49 Identities=29% Similarity=0.373 Sum_probs=42.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCC-----CCCHHHHHH----HHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGS-----KLSETEVKQ----LMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~-----~~~~~e~~~----~~~~~d~ 447 (447)
.+.++.+|+.||.|++|+|+.+||+.++..+|. .++++++++ +++++|.
T Consensus 128 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~ 185 (214)
T 2l4h_A 128 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDI 185 (214)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCC
Confidence 357888999999999999999999999999875 788888876 8888763
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0016 Score=55.90 Aligned_cols=49 Identities=27% Similarity=0.327 Sum_probs=41.6
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHH--hCCCCCH---HHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLAR--LGSKLSE---TEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~--l~~~~~~---~e~~~~~~~~d~ 447 (447)
.+.++.+|+.+|.|++|+|+.+||+.++.. .|..+++ ++++++++.+|.
T Consensus 121 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~~~~~~~~D~ 174 (191)
T 3k21_A 121 KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDK 174 (191)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHHHHHHHHhcC
Confidence 356788999999999999999999999998 5566776 468999998873
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.00038 Score=61.64 Aligned_cols=54 Identities=15% Similarity=0.219 Sum_probs=46.2
Q ss_pred hhhhHHHhhhhcceeeeecCCCCcccCHHHHHH-HHHHhCCCCCHHHHHHHHHhh
Q 013201 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKT-GLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 392 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~-~l~~l~~~~~~~e~~~~~~~~ 445 (447)
..+++++..+++++|..+|.|++|.|+.+||.. +++.+|..++..++.++++.+
T Consensus 43 ~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~ 97 (226)
T 2lvv_A 43 RDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRA 97 (226)
T ss_dssp SSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHH
T ss_pred hhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHH
Confidence 345678889999999999999999999999998 666688888888888888765
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.00054 Score=58.24 Aligned_cols=48 Identities=29% Similarity=0.407 Sum_probs=42.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCC-----CCCHHHHHH----HHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGS-----KLSETEVKQ----LMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~-----~~~~~e~~~----~~~~~d~ 447 (447)
..++.+|+.||.|++|+|+.+||+.++..+|. .++++++++ +++.+|.
T Consensus 98 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 154 (183)
T 1dgu_A 98 IKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDI 154 (183)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCC
Confidence 46889999999999999999999999999986 678899886 8888763
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0013 Score=58.34 Aligned_cols=48 Identities=21% Similarity=0.277 Sum_probs=40.1
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh------------CCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL------------GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l------------~~~~~~~e~~~~~~~~d~ 447 (447)
+.++.+|+.+|.|++|+|+.+|+..++..+ +...++++++++++.+|.
T Consensus 138 ~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~ 197 (229)
T 3dd4_A 138 EKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDK 197 (229)
T ss_dssp HHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCS
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcC
Confidence 467889999999999999999999999987 566788999999999873
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0012 Score=57.19 Aligned_cols=47 Identities=21% Similarity=0.246 Sum_probs=37.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..+..+|..+|.|++|.|+.+|+..++..++...+++++..+++.+|
T Consensus 59 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D 105 (204)
T 1jba_A 59 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYD 105 (204)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHHHHHHhC
Confidence 45667788888888888888888888888777777788888888776
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.42 E-value=0.00054 Score=58.74 Aligned_cols=46 Identities=24% Similarity=0.517 Sum_probs=41.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..++.+|+.+|.|++|+|+.+||+.++..+| +++++++++++.+|.
T Consensus 82 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~ 127 (188)
T 1s6i_A 82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQ 127 (188)
T ss_dssp CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCS
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCC
Confidence 4678899999999999999999999999988 678899999999873
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0028 Score=55.23 Aligned_cols=49 Identities=24% Similarity=0.301 Sum_probs=41.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhC-----CCCCHH-HHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLG-----SKLSET-EVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~-----~~~~~~-e~~~~~~~~d~ 447 (447)
.++++.+|+.+|.|++|+|+.+||+.++..++ ...+.+ +++++|+.+|.
T Consensus 92 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~ 146 (211)
T 2ggz_A 92 EQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDI 146 (211)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCC
Confidence 34678899999999999999999999999987 556654 58999999873
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0067 Score=58.87 Aligned_cols=76 Identities=14% Similarity=0.091 Sum_probs=49.2
Q ss_pred cceeccccCeEEEEEEECCC-------CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 99 GKELGRGQFGITYLCTENST-------GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~-------~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
.+.|..|-...+|++..... +..+++++..... ... -...+|..+++.|..+.-.+++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~---idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKF---YDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CC---CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chh---cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 35677788889999886521 5788888753211 111 12357888888887554456776543 33 6
Q ss_pred EEEeccCCCch
Q 013201 172 LVMELCSGGEL 182 (447)
Q Consensus 172 lv~e~~~g~~L 182 (447)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998653
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0027 Score=53.66 Aligned_cols=49 Identities=22% Similarity=0.306 Sum_probs=39.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh----CCC----CC----HHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL----GSK----LS----ETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~~~----~~----~~e~~~~~~~~d~ 447 (447)
..+++.+|+.+|.|++|+|+.+|+..++..+ |.. ++ +++++++++.+|.
T Consensus 91 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 151 (183)
T 1s6c_A 91 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDK 151 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCC
Confidence 3567889999999999999999999999887 643 34 4899999999873
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0012 Score=57.12 Aligned_cols=50 Identities=18% Similarity=0.355 Sum_probs=43.4
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHH-------HhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLA-------RLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~-------~l~~~~~~~e~~~~~~~~d~ 447 (447)
....++.+|+.+|.|++|+|+.+||..++. .+|...++++++++++.+|.
T Consensus 107 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 163 (204)
T 3e3r_A 107 REAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDS 163 (204)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhc
Confidence 345678899999999999999999999998 45677889999999999873
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=96.24 E-value=0.00058 Score=61.60 Aligned_cols=55 Identities=20% Similarity=0.216 Sum_probs=46.4
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCH------HHHHHHHHhhCC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSE------TEVKQLMDAVSI 447 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~------~e~~~~~~~~d~ 447 (447)
.+.+.+.++++++|..+|.|++|.|+.+||..+++.+|..++. .+++.+++.+|.
T Consensus 9 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~~~~~~~~~~~~~~~l~~~~D~ 69 (263)
T 2f33_A 9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQ 69 (263)
T ss_dssp TTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHTT
T ss_pred hcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhhcCCCccchHHHHHHHHHHhCC
Confidence 3455667789999999999999999999999999999865554 788899988763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0039 Score=61.88 Aligned_cols=48 Identities=27% Similarity=0.353 Sum_probs=42.8
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+.++++|+.||.|++|+|+.+||+.++.. ..+++++++++|+++|.
T Consensus 416 ~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~--~~~~~~~~~~~~~~~D~ 463 (484)
T 3nyv_A 416 SRERLERAFRMFDSDNSGKISSTELATIFGV--SDVDSETWKSVLSEVDK 463 (484)
T ss_dssp HHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH--TTCCHHHHHHHHHHHCT
T ss_pred cHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhcC
Confidence 3457889999999999999999999999987 56799999999999884
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=96.20 E-value=0.0036 Score=53.74 Aligned_cols=48 Identities=23% Similarity=0.358 Sum_probs=40.8
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhC------CCCCHHH-HHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLG------SKLSETE-VKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~------~~~~~~e-~~~~~~~~d~ 447 (447)
..++.+|+.+|.|++|+|+.+||..++..++ ...+.++ ++++|+.+|.
T Consensus 88 ~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~ 142 (198)
T 2r2i_A 88 QKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDI 142 (198)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCC
Confidence 4677899999999999999999999999986 4556544 8999999873
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.10 E-value=0.00078 Score=57.01 Aligned_cols=45 Identities=18% Similarity=0.370 Sum_probs=40.2
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..++.+|+.+|.|++|.|+.+|+..+++.+| ++++++.++++.+|
T Consensus 105 ~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g--~~~~~~~~~~~~~D 149 (185)
T 2sas_A 105 NRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVIT 149 (185)
T ss_dssp HHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC--CCHHHHHHHHHHhc
Confidence 5678899999999999999999999999887 57888999998876
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=96.09 E-value=0.0043 Score=55.76 Aligned_cols=48 Identities=27% Similarity=0.411 Sum_probs=43.3
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh----CCCCCHHHHHH----HHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL----GSKLSETEVKQ----LMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~~~~~~~e~~~----~~~~~d 446 (447)
..+++.+|..+|.|++|+|+.+||..++..+ |..++++++.+ +++.+|
T Consensus 102 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d 157 (263)
T 2f33_A 102 CEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFD 157 (263)
T ss_dssp HHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcC
Confidence 4568899999999999999999999999998 99999999987 888776
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0039 Score=55.02 Aligned_cols=46 Identities=26% Similarity=0.488 Sum_probs=39.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
..++.+|+.||.|++|+|+.+||+.+|..+ |...+ +++++|+.+|.
T Consensus 133 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~--e~~~~~~~~D~ 181 (226)
T 2lvv_A 133 FELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDIT--DATTVFNEIDT 181 (226)
T ss_dssp HHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCC--SCHHHHHHHCC
T ss_pred HHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHH--HHHHHHHHhCC
Confidence 568889999999999999999999999988 65544 58999998874
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0034 Score=53.41 Aligned_cols=49 Identities=22% Similarity=0.308 Sum_probs=41.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh----C--------CCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL----G--------SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~--------~~~~~~e~~~~~~~~d~ 447 (447)
..+++.+|+.+|.|++|.|+.+|+..++..+ | ...++++++++++.+|.
T Consensus 98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 158 (190)
T 1g8i_A 98 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDK 158 (190)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcC
Confidence 3467789999999999999999999999883 3 35678999999999873
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0037 Score=55.09 Aligned_cols=48 Identities=21% Similarity=0.330 Sum_probs=41.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHH----HhCCCCCHHHHHHHHH----hhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLA----RLGSKLSETEVKQLMD----AVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~----~l~~~~~~~e~~~~~~----~~d 446 (447)
.+.++.+|+.+|.|++|+|+.+||+.++. .+|..+++++++++++ .+|
T Consensus 121 ~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D 176 (226)
T 2zfd_A 121 DDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEAD 176 (226)
T ss_dssp HHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhC
Confidence 45678899999999999999999999996 6788999999887775 665
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0012 Score=54.90 Aligned_cols=47 Identities=30% Similarity=0.456 Sum_probs=34.8
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.+++|.|+.+|++.++..+| +++++++++++.+|.
T Consensus 98 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~--~~~~~~~~~~~~~d~ 144 (166)
T 2aao_A 98 EDHLFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRDVDQ 144 (166)
T ss_dssp THHHHHHHHHHCTTCSSSBCHHHHHHHTCC----------CCHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHhCC
Confidence 35678899999999999999999999999887 568889999988873
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0051 Score=55.37 Aligned_cols=49 Identities=24% Similarity=0.327 Sum_probs=42.1
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh----C--------CCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL----G--------SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~--------~~~~~~e~~~~~~~~d~ 447 (447)
.++++.+|+.+|.|++|+|+.+|+..++..+ | ...++++++++|+.+|.
T Consensus 164 ~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 224 (256)
T 2jul_A 164 HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDR 224 (256)
T ss_dssp HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCC
Confidence 3467789999999999999999999999887 5 34578999999999874
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0048 Score=54.37 Aligned_cols=49 Identities=22% Similarity=0.308 Sum_probs=40.9
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh----CCC----C----CHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL----GSK----L----SETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~~~----~----~~~e~~~~~~~~d~ 447 (447)
.++++.+|+.+|.|++|+|+.+|+..++..+ |.. + .+++++++|+.+|.
T Consensus 124 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 184 (224)
T 1s1e_A 124 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDK 184 (224)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCC
Confidence 3467889999999999999999999999886 643 2 35889999999873
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0045 Score=52.63 Aligned_cols=47 Identities=21% Similarity=0.299 Sum_probs=41.6
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+..+|..+|.|++|.|+.+|+..++..++...+++++..+++.+|.
T Consensus 64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~ 110 (190)
T 1fpw_A 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDL 110 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCS
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHHHhcC
Confidence 46778999999999999999999999999888888999999988873
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0016 Score=56.25 Aligned_cols=50 Identities=16% Similarity=0.279 Sum_probs=42.2
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++.+++.+++++|..+|.|++|.|+.+||..+ ..+|..++ ++.+++.+|
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D 71 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFF 71 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTS
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhC
Confidence 346778889999999999999999999999998 77876655 777887776
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0022 Score=68.61 Aligned_cols=54 Identities=24% Similarity=0.537 Sum_probs=49.5
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+..++...++++|..||.|++|+|+.+||+.+|+.+|..+++++++.+++.+|.
T Consensus 719 l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 772 (863)
T 1sjj_A 719 ISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDP 772 (863)
T ss_dssp SSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCT
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 345677889999999999999999999999999999999999999999999873
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0048 Score=53.36 Aligned_cols=48 Identities=27% Similarity=0.297 Sum_probs=40.9
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHH----HhCCCCCHHHHHHHHH----hhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLA----RLGSKLSETEVKQLMD----AVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~----~l~~~~~~~e~~~~~~----~~d 446 (447)
.+.++.+|+.+|.|++|+|+.+|+..++. .+|..+++++++++++ .+|
T Consensus 110 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D 165 (207)
T 2ehb_A 110 HEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQAD 165 (207)
T ss_dssp HHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhC
Confidence 35678899999999999999999999996 5688999999877764 665
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=95.80 E-value=0.00052 Score=68.30 Aligned_cols=48 Identities=23% Similarity=0.375 Sum_probs=25.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.++++|+.||.|++|+|+.+||+.++..+|..+++++++++|+++|.
T Consensus 417 ~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 464 (486)
T 3mwu_A 417 ERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDN 464 (486)
T ss_dssp HHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCS
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 567889999999999999999999999999999999999999998873
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=95.76 E-value=0.0041 Score=53.79 Aligned_cols=49 Identities=20% Similarity=0.239 Sum_probs=41.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh----C----CCCC------HHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL----G----SKLS------ETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~----~~~~------~~e~~~~~~~~d~ 447 (447)
.++++.+|+.+|.|++|+|+.+||..++..+ | ..++ +++++++|+.+|.
T Consensus 106 ~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~ 168 (207)
T 2d8n_A 106 NQKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGK 168 (207)
T ss_dssp STTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCC
Confidence 3567889999999999999999999999987 7 4444 4779999999873
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=95.73 E-value=0.002 Score=60.38 Aligned_cols=47 Identities=23% Similarity=0.335 Sum_probs=43.7
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHH-HHhCCCCCHHHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGL-ARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l-~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+..+|..||.|++|+|+.+||..++ ..+|..+++++++.+|..+|.
T Consensus 254 ~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D~ 301 (323)
T 1ij5_A 254 VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDV 301 (323)
T ss_dssp HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTT
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHCC
Confidence 57789999999999999999999999 999998999999999999873
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=95.72 E-value=0.0073 Score=51.32 Aligned_cols=48 Identities=23% Similarity=0.398 Sum_probs=41.2
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh----C--------CCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL----G--------SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~--------~~~~~~e~~~~~~~~d~ 447 (447)
++++.+|+.+|.|++|+|+.+|+..++..+ | ...++++++++++.+|.
T Consensus 99 ~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 158 (190)
T 2l2e_A 99 DKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDK 158 (190)
T ss_dssp HHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTC
T ss_pred HHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCC
Confidence 467789999999999999999999999873 2 35689999999999874
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=95.69 E-value=0.0031 Score=57.02 Aligned_cols=48 Identities=15% Similarity=0.367 Sum_probs=42.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCC----CCCHHHHHH----HHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGS----KLSETEVKQ----LMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~----~~~~~e~~~----~~~~~d~ 447 (447)
..++.+|+.+|.|++|+|+.+||+.+++.++. .++++++++ +++.+|.
T Consensus 196 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~ 251 (272)
T 2be4_A 196 RDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDM 251 (272)
T ss_dssp HHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCC
Confidence 45778999999999999999999999998876 789999987 8888873
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=95.67 E-value=0.0065 Score=52.13 Aligned_cols=49 Identities=18% Similarity=0.283 Sum_probs=44.1
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...+..+|..+|.|++|.|+.+|+..++..++...+++++..+|+.+|.
T Consensus 51 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~ 99 (198)
T 2r2i_A 51 NKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDV 99 (198)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhcC
Confidence 3457789999999999999999999999999988889999999998874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.0041 Score=62.12 Aligned_cols=47 Identities=32% Similarity=0.405 Sum_probs=41.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.++++|+.||.|++|+|+.+||+.++.. ..+++++++++|+++|.
T Consensus 434 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~--~~~~~~~~~~~~~~~D~ 480 (504)
T 3q5i_A 434 EERLRRAFNLFDTDKSGKITKEELANLFGL--TSISEKTWNDVLGEADQ 480 (504)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHTTC--SCCCHHHHHHHHHTTCS
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHhh--CCCCHHHHHHHHHHhCC
Confidence 357889999999999999999999999876 35799999999999884
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=95.64 E-value=0.0042 Score=64.67 Aligned_cols=47 Identities=21% Similarity=0.394 Sum_probs=44.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
++++++|+.||.|++|+|+.+||+.+|+.+|..+++++++++++.+|
T Consensus 605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D 651 (714)
T 3bow_A 605 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA 651 (714)
T ss_dssp HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 56889999999999999999999999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=95.61 E-value=0.0034 Score=62.47 Aligned_cols=47 Identities=21% Similarity=0.406 Sum_probs=41.0
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.++.+|+.||.|++|+|+.+||+.++.. ..++++++++||+++|.
T Consensus 425 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~--~~~~~~~~~~~~~~~D~ 471 (494)
T 3lij_A 425 KDKLESAFQKFDQDGNGKISVDELASVFGL--DHLESKTWKEMISGIDS 471 (494)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHC-C--CSCCCHHHHHHHHTTCS
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhCC
Confidence 456889999999999999999999999876 56789999999999884
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=95.59 E-value=0.0053 Score=52.21 Aligned_cols=48 Identities=17% Similarity=0.212 Sum_probs=43.6
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..+|..+|.|++|.|+.+|+..++..++...+++++..+++.+|.
T Consensus 63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~ 110 (190)
T 2l2e_A 63 AFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDL 110 (190)
T ss_dssp HHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccC
Confidence 356789999999999999999999999999988899999999998873
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.51 E-value=0.05 Score=52.41 Aligned_cols=32 Identities=28% Similarity=0.360 Sum_probs=25.2
Q ss_pred cEeecCCCCceEeecC---CCCCceEEecCCCcee
Q 013201 216 VMHRDLKPENFLLSNK---DGGAMLKATDFGLSVF 247 (447)
Q Consensus 216 ivH~Dlkp~Nill~~~---~~~~~vkl~Dfg~a~~ 247 (447)
++|+|+.+.|||+..+ +....+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999542 3345699999988753
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=95.40 E-value=0.0065 Score=63.69 Aligned_cols=48 Identities=15% Similarity=0.201 Sum_probs=30.9
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh-CCC---------CCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL-GSK---------LSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-~~~---------~~~~e~~~~~~~~d~ 447 (447)
++++++|+.||.+++|+|+.+||+.+|+.+ |+. ++++|+++||+++|.
T Consensus 219 ~el~~aF~~fD~d~~g~Is~~eL~~fL~~~Qge~~~~~~~~~~~t~ee~~~iI~~~d~ 276 (799)
T 2zkm_X 219 PEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEP 276 (799)
T ss_dssp HHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCC
T ss_pred HHHHHHHHHhccCCCCeEcHHHHHHHHHHhcCCcccccccccCCCHHHHHHHHHHhhc
Confidence 568999999999999999999999999998 665 789999999999873
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=95.40 E-value=0.0072 Score=51.31 Aligned_cols=48 Identities=29% Similarity=0.420 Sum_probs=41.0
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh----CC--------CCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL----GS--------KLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~~--------~~~~~e~~~~~~~~d~ 447 (447)
++++.+|+.+|.|++|.|+.+|+..++..+ |. ..++++++++|+.+|.
T Consensus 99 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 158 (190)
T 1fpw_A 99 EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDK 158 (190)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCC
Confidence 456789999999999999999999999883 42 3678999999999873
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=95.39 E-value=0.0049 Score=53.29 Aligned_cols=48 Identities=13% Similarity=0.252 Sum_probs=43.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..+|+.+|.|++|.|+.+|+..++..++...+++++..+|+.+|.
T Consensus 71 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~ 118 (207)
T 2d8n_A 71 AYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDV 118 (207)
T ss_dssp HHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcC
Confidence 457889999999999999999999999999988889999999998873
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=95.34 E-value=0.0082 Score=51.84 Aligned_cols=44 Identities=18% Similarity=0.316 Sum_probs=25.7
Q ss_pred cceeeeecCCCCcccCHHHHHHHHHHhCCC-CCHHHHHHHHHhhC
Q 013201 403 KTMFANMDTDKSGTITYEELKTGLARLGSK-LSETEVKQLMDAVS 446 (447)
Q Consensus 403 ~~~F~~~D~~~~g~i~~~el~~~l~~l~~~-~~~~e~~~~~~~~d 446 (447)
.++|..+|.|++|.|+.+|+..++..++.. ..++++..+++.+|
T Consensus 77 ~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D 121 (207)
T 2ehb_A 77 DRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYD 121 (207)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhC
Confidence 345666666666666666666666655432 34555666666555
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=95.26 E-value=0.0084 Score=50.57 Aligned_cols=49 Identities=18% Similarity=0.311 Sum_probs=43.2
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...+..+|+.+|.|++|.|+.+|+..++..++...+++++..+++.+|.
T Consensus 55 ~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~ 103 (183)
T 1s6c_A 55 STYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDI 103 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHHHHHHHHHHHhCC
Confidence 4567789999999999999999999999998877789999999998873
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.25 E-value=0.0085 Score=50.98 Aligned_cols=45 Identities=20% Similarity=0.313 Sum_probs=25.3
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+..+|..+|.|++|.|+.+|+..++..++...+++++..+|+.+|
T Consensus 65 ~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D 109 (193)
T 1bjf_A 65 AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYD 109 (193)
T ss_dssp HHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHC
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHHhhcC
Confidence 344555555566666666666555555555555555555555554
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=95.24 E-value=0.0066 Score=63.21 Aligned_cols=53 Identities=26% Similarity=0.386 Sum_probs=47.5
Q ss_pred hhHHH-hhhhcceeeeecCCCCcccCHHHHHHHHHHh--------CCCCCHHHHHHHHHhhCC
Q 013201 394 LSEEE-IKGLKTMFANMDTDKSGTITYEELKTGLARL--------GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 394 ~~~~~-~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l--------~~~~~~~e~~~~~~~~d~ 447 (447)
+.+++ .++++++|..+| |++|.|+.+||..+|+.+ |..+++++++.|+..+|.
T Consensus 525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~ 586 (714)
T 3bow_A 525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDE 586 (714)
T ss_dssp CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCC
T ss_pred CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCC
Confidence 44556 778999999999 999999999999999997 788999999999999873
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.23 E-value=0.011 Score=51.46 Aligned_cols=49 Identities=16% Similarity=0.283 Sum_probs=43.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...+.++|..+|.|++|.|+.+|+..++..++...+++++..+|+.+|.
T Consensus 56 ~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F~~~D~ 104 (211)
T 2ggz_A 56 NKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDA 104 (211)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHHHHHhcC
Confidence 3457789999999999999999999999999888889999999998873
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=95.22 E-value=0.0084 Score=50.72 Aligned_cols=55 Identities=13% Similarity=0.296 Sum_probs=41.4
Q ss_pred HHHHHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 387 LKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 387 ~~~i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+.+++......++.++++.|..|| ++|.|+.+||..+ +|..+++.+++++++.+|
T Consensus 15 l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~---lg~~~~~~~~~~i~~~~d 69 (179)
T 3a8r_A 15 LQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKC---IGMDGSDEFAVQMFDSLA 69 (179)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHH---HTCCSCHHHHHHHHHHHH
T ss_pred HHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHH---HCCCCcHHHHHHHHHHHH
Confidence 444555444456678888999999 8999999999985 477778888888887654
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.21 E-value=0.01 Score=51.20 Aligned_cols=31 Identities=29% Similarity=0.345 Sum_probs=26.1
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.+.++.+|+.+|.|++|+|+.+||..++..+
T Consensus 94 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~ 124 (204)
T 1jba_A 94 EHKLKWTFKIYDKDRNGCIDRQELLDIVESI 124 (204)
T ss_dssp THHHHHHHHHHCSSCSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 3567888999999999999999999888765
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=95.19 E-value=0.0087 Score=52.68 Aligned_cols=44 Identities=16% Similarity=0.316 Sum_probs=24.7
Q ss_pred cceeeeecCCCCcccCHHHHHHHHHHhCC-CCCHHHHHHHHHhhC
Q 013201 403 KTMFANMDTDKSGTITYEELKTGLARLGS-KLSETEVKQLMDAVS 446 (447)
Q Consensus 403 ~~~F~~~D~~~~g~i~~~el~~~l~~l~~-~~~~~e~~~~~~~~d 446 (447)
.++|..+|.|++|.|+.+|+..++..++. ...++++..+|+.+|
T Consensus 88 ~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D 132 (226)
T 2zfd_A 88 DRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYD 132 (226)
T ss_dssp HHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHC
T ss_pred HHHHHHHcCCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHHHhC
Confidence 34566666666666666666666655542 234555666665555
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=95.12 E-value=0.0079 Score=54.27 Aligned_cols=48 Identities=25% Similarity=0.378 Sum_probs=42.3
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh----CCCCCHHHHHH----HHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL----GSKLSETEVKQ----LMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~~~~~~~e~~~----~~~~~d 446 (447)
..+++.+|..+|.|++|.|+.+|+..++..+ |..++++++.+ +++.+|
T Consensus 103 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D 158 (272)
T 2be4_A 103 SVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFD 158 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhc
Confidence 4568899999999999999999999999998 88999998865 777766
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=95.03 E-value=0.011 Score=63.41 Aligned_cols=48 Identities=25% Similarity=0.403 Sum_probs=44.8
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++++++|+.||.|++|+|+.+||+.+|+.+|..+++++++++++.+|
T Consensus 606 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d 653 (900)
T 1qxp_A 606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA 653 (900)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS
T ss_pred HHHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Confidence 367889999999999999999999999999999999999999999875
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=95.01 E-value=0.0043 Score=49.02 Aligned_cols=41 Identities=27% Similarity=0.394 Sum_probs=35.8
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
++.+|+.+|.|++|.|+.+|++.++..+|... +.++++.+|
T Consensus 77 ~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~----~~~~~~~~D 117 (134)
T 1jfj_A 77 LKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEK----VAEQVMKAD 117 (134)
T ss_dssp HHHHHHHHCCSSSSEEEHHHHHHHHTTTTCHH----HHHHHHHHH
T ss_pred HHHHHHHHCCCCCCccCHHHHHHHHHHhCHHH----HHHHHHHhC
Confidence 77899999999999999999999999887643 888888776
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=94.94 E-value=0.013 Score=49.74 Aligned_cols=49 Identities=20% Similarity=0.298 Sum_probs=39.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh----C--CCCC------HHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL----G--SKLS------ETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----~--~~~~------~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.|++|.|+.+|+..++..+ | ..++ ++++.++|+.+|.
T Consensus 98 ~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 158 (193)
T 1bjf_A 98 EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDT 158 (193)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCT
T ss_pred HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCC
Confidence 3567789999999999999999999999874 5 2333 4568999998873
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=94.84 E-value=0.0097 Score=52.33 Aligned_cols=48 Identities=19% Similarity=0.330 Sum_probs=42.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..+|+.+|.|++|.|+.+|+..++..++...++++++.+|+.+|.
T Consensus 89 ~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~ 136 (224)
T 1s1e_A 89 TYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDI 136 (224)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCHHHHHHHHHHHHcC
Confidence 456778999999999999999999999998877788999999998873
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=94.83 E-value=0.0084 Score=50.89 Aligned_cols=47 Identities=15% Similarity=0.245 Sum_probs=42.3
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+..+|..+|.|++|.|+.+|+..++..++...+++++..+++.+|.
T Consensus 64 ~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~ 110 (190)
T 1g8i_A 64 FATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDL 110 (190)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHHHHhhcC
Confidence 47789999999999999999999999998877789999999998873
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=94.83 E-value=0.01 Score=53.42 Aligned_cols=48 Identities=23% Similarity=0.351 Sum_probs=43.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..+|..+|.|++|.|+.+|+..++..++...+++++..+|+.+|.
T Consensus 129 ~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~ 176 (256)
T 2jul_A 129 TYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDI 176 (256)
T ss_dssp HHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccChHHHHHHHHHHhCC
Confidence 456789999999999999999999999998888889999999998874
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=93.88 E-value=0.028 Score=57.26 Aligned_cols=47 Identities=15% Similarity=0.145 Sum_probs=41.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh-CCC-CCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL-GSK-LSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-~~~-~~~~e~~~~~~~~d~ 447 (447)
++++++|+.||.+ +|+|+.+||+.+|... |.. ++++++++||+++|.
T Consensus 80 ~el~~aF~~fD~~-~G~Is~~EL~~fL~~~qge~~ls~ee~~~ii~~~d~ 128 (624)
T 1djx_A 80 AEIDRAFEEAAGS-AETLSVERLVTFLQHQQREEEAGPALALSLIERYEP 128 (624)
T ss_dssp HHHHHHHHHHHTT-SSSEEHHHHHHHHHHTSCCSSCSHHHHHHHHHHHCC
T ss_pred HHHHHHHHHhcCC-CCeecHHHHHHHHHHHhCCCCCCHHHHHHHHHHhCC
Confidence 4688999999985 9999999999999975 776 899999999999873
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=93.47 E-value=0.01 Score=51.44 Aligned_cols=50 Identities=20% Similarity=0.340 Sum_probs=38.5
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++++++.+++++|..+|.|++|.|+.+||..++ .+|..++.++ +++.+|
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~~~~~~---l~~~~d 71 (208)
T 2ct9_A 22 GFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAINPLGDR---IINAFF 71 (208)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTSTTHHH---HHHTTS
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCcHHH---HHHHHc
Confidence 3467778889999999999999999999999864 6777665543 444444
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=93.46 E-value=0.02 Score=46.48 Aligned_cols=47 Identities=17% Similarity=0.359 Sum_probs=38.4
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCC-CCHHHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSK-LSETEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~-~~~~e~~~~~~~~d~ 447 (447)
.+..+|..+|.+++|.|+.+|+..++..+... ...+++..+++.+|.
T Consensus 39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~ 86 (155)
T 3ll8_B 39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDM 86 (155)
T ss_dssp THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCC
Confidence 56678999999999999999999999887643 457788888888773
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 447 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-93 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-87 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-86 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-85 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-85 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-82 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-82 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-79 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-79 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-77 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-77 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-77 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-77 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-75 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-73 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-70 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-70 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-70 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-70 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-69 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-65 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-65 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-65 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-64 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-64 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-63 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-63 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-62 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-61 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-61 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-61 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-61 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-59 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-59 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-57 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-56 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-43 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 4e-13 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 0.004 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 2e-12 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 2e-09 | |
| d1s6ia_ | 182 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 5e-09 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 4e-08 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 1e-07 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 2e-04 | |
| d1qv0a_ | 189 | a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr | 2e-07 | |
| d1avsa_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 5e-07 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 5e-07 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 0.002 | |
| d1wrka1 | 82 | a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens) | 7e-07 | |
| d1jbaa_ | 189 | a.39.1.5 (A:) Guanylate cyclase activating protein | 1e-06 | |
| d2scpa_ | 174 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 1e-06 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 2e-06 | |
| d2opoa1 | 81 | a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che | 3e-06 | |
| d2sasa_ | 185 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 3e-06 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 5e-06 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 6e-06 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 0.004 | |
| d1uhka1 | 187 | a.39.1.5 (A:3-189) Calcium-regulated photoprotein | 8e-06 | |
| d1bjfa_ | 181 | a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId | 9e-06 | |
| d1df0a1 | 186 | a.39.1.8 (A:515-700) Calpain large subunit, C-term | 9e-06 | |
| d2zfda1 | 183 | a.39.1.5 (A:32-214) Calcineurin B-like protein 2 { | 1e-05 | |
| d1rroa_ | 108 | a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) | 1e-05 | |
| d1wdcb_ | 142 | a.39.1.5 (B:) Myosin Essential Chain {Bay scallop | 2e-05 | |
| d1m45a_ | 146 | a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye | 2e-05 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 2e-05 | |
| d1wdcc_ | 152 | a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop | 2e-05 | |
| d1auib_ | 165 | a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch | 2e-05 | |
| d1qx2a_ | 76 | a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax | 3e-05 | |
| d1nyaa_ | 176 | a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth | 3e-05 | |
| d1pvaa_ | 109 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 3e-05 | |
| d1y1xa_ | 182 | a.39.1.8 (A:) Programmed cell death 6 protein-like | 4e-05 | |
| d1jfja_ | 134 | a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histoly | 4e-05 | |
| d1snla_ | 99 | a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo | 4e-05 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 4e-05 | |
| d1alva_ | 173 | a.39.1.8 (A:) Calpain small (regulatory) subunit ( | 5e-05 | |
| d5pala_ | 109 | a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis | 6e-05 | |
| d1g8ia_ | 187 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 6e-05 | |
| d1fi5a_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), | 7e-05 | |
| d1jc2a_ | 75 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 7e-05 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 8e-05 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 1e-04 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 0.004 | |
| d1cb1a_ | 78 | a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [Tax | 2e-04 | |
| d1tiza_ | 67 | a.39.1.5 (A:) Calmodulin-related protein T21P5.17 | 2e-04 | |
| d1rwya_ | 109 | a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta | 2e-04 | |
| d2hf5a1 | 33 | a.39.1.5 (A:81-113) Troponin C {Human (Homo sapien | 3e-04 | |
| d2pvba_ | 107 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 3e-04 | |
| d1juoa_ | 172 | a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: | 5e-04 | |
| d1hqva_ | 181 | a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous | 6e-04 | |
| d1s6ca_ | 178 | a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera | 8e-04 | |
| d1xo5a_ | 180 | a.39.1.5 (A:) Calcium- and integrin-binding protei | 0.001 | |
| d1qxpa2 | 188 | a.39.1.8 (A:515-702) Calpain large subunit, C-term | 0.001 | |
| d2fcea1 | 61 | a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [ | 0.001 | |
| d1wlza1 | 83 | a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {H | 0.002 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 281 bits (720), Expect = 5e-93
Identities = 122/299 (40%), Positives = 173/299 (57%), Gaps = 5/299 (1%)
Query: 87 KPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQ 146
K EDIR Y LG G F L + T A K I K+ L K+ ++ EI
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS--MENEIA 59
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
++ + NIV YE ++L+M+L SGGELFD+I+ +G YTE+ A+ L +++
Sbjct: 60 VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAP 266
V + H +G++HRDLKPEN L + D + + +DFGLS D G V G+ YVAP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
Query: 267 EVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325
EVL + Y K +D WS GVI YILL G PPF+ E + +F+ ILK +F+S W ISD
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKK 384
SAKD +R ++ +DP+KR T + L+HPW+ G A DK I +V ++K+ A +K K+
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (682), Expect = 3e-87
Identities = 83/306 (27%), Positives = 158/306 (51%), Gaps = 12/306 (3%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+++ + Y + ++LGRG+FGI + C E S+ +Y K + + D+ +K+EI I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVV 208
+NI+ ++E + + ++ E SG ++F++I E+ + + +
Sbjct: 57 IAR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV 268
H + H D++PEN + + +K +FG + + G +R + + Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 269 LRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327
+ D+WS G ++Y+LLSG+ PF AET + I + I+ F+ E + IS A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMAL 387
D V ++L+++ K R+T++E L+HPW+++ E + + V+ +K R + L K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE----RVSTKVIRTLKHRRYYHTLIKKDL 290
Query: 388 KVIAEA 393
++ A
Sbjct: 291 NMVVSA 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 265 bits (678), Expect = 5e-86
Identities = 89/331 (26%), Positives = 158/331 (47%), Gaps = 28/331 (8%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
+ +Y + +ELG G FG+ + C E +TG + K I D+ +K EI IM
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQ 82
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVH 209
L ++ A+ED+ + L++E SGGELFD+I A+ + +E R +
Sbjct: 83 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL 269
H H ++H D+KPEN + K +K DFGL+ ++ ++ + +A + APE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 270 RRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328
R G D+W+ GV+ Y+LLSG+ PF E + + + +F+ + + +S AK
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGGE---------------------ASDKPIGS 367
D ++ +L ++P+KR+T + LEHPW++ +D P
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQ 320
Query: 368 AVLSRMKQFRAMNKLKKMALKVIAEALSEEE 398
+ R+ F ++ K + ++ +E
Sbjct: 321 PAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 264 bits (675), Expect = 1e-85
Identities = 97/301 (32%), Positives = 151/301 (50%), Gaps = 9/301 (2%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+ + Y + +ELG G FG+ + TE +TGN++A K ++ ++ D+E +++EIQ M
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMS 78
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVV 208
L +V A+ED + ++ E SGGELF+K+ + +E A R + +
Sbjct: 79 VLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV 268
H H +H DLKPEN + + K LK DFGL+ +D + + G+A + APEV
Sbjct: 138 CHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 269 LR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327
+ G D+WS GV+ YILLSG+ PF E + + + + + IS+
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKMAL 387
KD +RK+L+ DP R+T + LEHPW+ G SR + R K K A
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS--QIPSSRYTKIRDSIKTKYDAW 314
Query: 388 K 388
Sbjct: 315 P 315
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 259 bits (663), Expect = 6e-85
Identities = 97/274 (35%), Positives = 146/274 (53%), Gaps = 16/274 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVN------KQDREDIKREIQIMQ 149
Y + LGRG + C T YA K I + ++ RE +E+ I++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
+SG NI++ + YE LV +L GELFD + + +EK + RA++ V+
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL 269
H + ++HRDLKPEN LL + +K TDFG S +D G+ R++ G+ Y+APE++
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDM---NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 270 -------RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL 322
YGKE+D+WS GVI+Y LL+G PPFW + + I+ G F S W
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
SD+ KDLV + L+ P+KR T+ E L HP+ ++
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (645), Expect = 2e-82
Identities = 81/262 (30%), Positives = 135/262 (51%), Gaps = 10/262 (3%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ +G+ LG+G+FG YL E + A K + K +L ++RE++I HL
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 66
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
NI+ G + D V+L++E G ++ ++ + E+ A + N + +CH
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYG 274
V+HRD+KPEN LL + LK DFG SV + + G+ Y+ PE++ R +
Sbjct: 127 VIHRDIKPENLLLGSAG---ELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHD 182
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
+++D+WS GV+ Y L G PPF A T + + I + F +++ A+DL+ ++
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF----VTEGARDLISRL 238
Query: 335 LIQDPKKRITSAEVLEHPWMRE 356
L +P +R EVLEHPW+
Sbjct: 239 LKHNPSQRPMLREVLEHPWITA 260
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (645), Expect = 4e-82
Identities = 105/272 (38%), Positives = 164/272 (60%), Gaps = 6/272 (2%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD---REDIKREIQ 146
E++ +Y G+ELG GQF + C E STG YA K I KR+ + + REDI+RE+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 147 IMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVN 206
I++ + N++ YE++ V L++EL +GGELFD + + TE+ A + I+N
Sbjct: 66 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 207 VVHHCHFMGVMHRDLKPENFLLSNKDGGAM-LKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
V++ H + + H DLKPEN +L +++ +K DFGL+ ID G +++I G+ +VA
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 266 PEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324
PE++ G E D+WS GVI YILLSG PF +T++ + +FE E + S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
AKD +R++L++DPKKR+T + L+HPW++
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 246 bits (630), Expect = 2e-79
Identities = 72/312 (23%), Positives = 135/312 (43%), Gaps = 18/312 (5%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
+D + ++ +E+G G FG Y + A K + + + +DI +E++ +Q
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
L N +++RG Y + LVME C G + + E AA+ + +
Sbjct: 71 KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVL 269
+ H ++HRD+K N LLS ++K DFG + + + VG+ Y++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAPANSF---VGTPYWMAPEVI 183
Query: 270 RRS----YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325
Y ++DVWS G+ L PP + I + + + S+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSE 241
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLKKM 385
++ V L + P+ R TS +L+H ++ + ++ R K A+ +L +
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL---RERPPTVIMDLIQRTKD--AVRELDNL 296
Query: 386 ALKVIAEALSEE 397
+ + + L +E
Sbjct: 297 QYRKMKKILFQE 308
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 9e-79
Identities = 96/320 (30%), Positives = 157/320 (49%), Gaps = 19/320 (5%)
Query: 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHL 151
I + + LG G G T +A K + QD +RE+++
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 61
Query: 152 SGQQNIVEFRGAYED----RQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIV 205
S +IV YE+ R+ + +VME GGELF +I +G +TE+ A+ + ++I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVA 265
+ + H + + HRD+KPEN L ++K A+LK TDFG + + YYVA
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181
Query: 266 PEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETE----KGIFDAILKGGVDFESEPW 320
PEVL Y K D+WS GVI+YILL G PPF++ G+ I G +F + W
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMN 380
+S+ K L+R +L +P +R+T E + HPW+ + + P+ ++ + + + R +
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 301
Query: 381 KLKKMALKVIAEALSEEEIK 400
++M + + E+IK
Sbjct: 302 VKEEMTSALATMRVDYEQIK 321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 4e-77
Identities = 78/278 (28%), Positives = 136/278 (48%), Gaps = 11/278 (3%)
Query: 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIM 148
+ D ++ YT +++G+G G Y + +TG A + + L + +E I EI +M
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM 71
Query: 149 QHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVV 208
+ NIV + +Y + +VME +GG L D ++ + E AA+CR + +
Sbjct: 72 RENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 129
Query: 209 HHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID-EGKVYRDIVGSAYYVAPE 267
H V+HRD+K +N LL +K TDFG I E +VG+ Y++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDG---SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 268 VLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326
V+ ++YG ++D+WS G++ ++ G PP+ E I G E + +S
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAI 245
Query: 327 AKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364
+D + + L D +KR ++ E+L+H +++ S
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 5e-77
Identities = 81/267 (30%), Positives = 136/267 (50%), Gaps = 12/267 (4%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ L + LG G +G L T + A K + ++ E+IK+EI I + L+ +
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-HE 63
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
N+V+F G + +L +E CSGGELFD+I E A ++ V + H +G
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG---KVYRDIVGSAYYVAPEVLRRS 272
+ HRD+KPEN LL +D LK +DFGL+ ++ + G+ YVAPE+L+R
Sbjct: 124 ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 273 --YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330
+ + +DVWS G++L +L+G P+ ++ + K + PW I + L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKIDSAPLAL 239
Query: 331 VRKMLIQDPKKRITSAEVLEHPWMREG 357
+ K+L+++P RIT ++ + W +
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 7e-77
Identities = 78/283 (27%), Positives = 134/283 (47%), Gaps = 19/283 (6%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
+ F+ + ELG G FG Y T A K I + ++++ ED EI I+
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 65
Query: 151 LSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKII-AQGHYTEKAAAALCRAIVNVVH 209
NIV+ A+ ++ +++E C+GG + ++ + TE +C+ ++ ++
Sbjct: 66 CD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD-IVGSAYYVAPEV 268
+ H ++HRDLK N L DG +K DFG+S RD +G+ Y++APEV
Sbjct: 125 YLHDNKIIHRDLKAGNILF-TLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181
Query: 269 L------RRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL 322
+ R Y + DVWS G+ L + PP + I K ++P
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SR 240
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
S + KD ++K L ++ R T++++L+HP++ S+KPI
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT---VDSNKPI 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 9e-77
Identities = 84/271 (30%), Positives = 129/271 (47%), Gaps = 18/271 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ GK LG G F L E +T YA K + KR ++ + + RE +M L
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 68
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
V+ ++D + ++ + GEL I G + E IV+ + + H G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI---DEGKVYRDIVGSAYYVAPEVLR-R 271
++HRDLKPEN LL+ ++ TDFG + + + VG+A YV+PE+L +
Sbjct: 129 IIHRDLKPENILLNEDM---HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
S K D+W+ G I+Y L++G+PPF A E IF I+K DF + A+DLV
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK----FFPKARDLV 241
Query: 332 RKMLIQDPKKRITSAE------VLEHPWMRE 356
K+L+ D KR+ E + HP+
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 6e-75
Identities = 60/267 (22%), Positives = 116/267 (43%), Gaps = 12/267 (4%)
Query: 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQ 154
F E+GRG F Y + T A + RKL K +R+ K E ++++ L
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-H 67
Query: 155 QNIVEFRGAYED----RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHH 210
NIV F ++E ++ + LV EL + G L + K + CR I+ +
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 211 CHFMG--VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEV 268
H ++HRDLK +N ++ G +K D GL+ + ++G+ ++APE+
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATL-KRASFAKAVIGTPEFMAPEM 184
Query: 269 LRRSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328
Y + +DV++ G+ + + + P+ + GV + + K
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVAIPEVK 243
Query: 329 DLVRKMLIQDPKKRITSAEVLEHPWMR 355
+++ + Q+ +R + ++L H + +
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (586), Expect = 9e-73
Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 10/264 (3%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ L K LG+G FG +L T +A K++ K ++ D E E +++
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
+ ++ ++++ VME +GG+L I + + A I+ + H G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIVGSAYYVAPEVLR-RSY 273
+++RDLK +N L D +K DFG+ G+ Y+APE+L + Y
Sbjct: 124 IVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333
+D WS GV+LY +L G PF + E+ +F +I + + AKDL+ K
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLVK 236
Query: 334 MLIQDPKKRITSA-EVLEHPWMRE 356
+ +++P+KR+ ++ +HP RE
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 4e-71
Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 21/271 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y + +G G +G S G K L + + +++ + E+ +++ L
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWK-ELDYGSMTEAEKQMLVSEVNLLRELK-HP 63
Query: 156 NIVEFRGAYEDR--QSVHLVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVH 209
NIV + DR ++++VME C GG+L I + + E+ + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 210 HCHFMG-----VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY-RDIVGSAYY 263
CH V+HRDLKP N L K +K DFGL+ ++ + + VG+ YY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPYY 180
Query: 264 VAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL 322
++PE + R SY ++ D+WS G +LY L + +PPF A ++K + I +G +
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY-- 238
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
SD +++ +ML R + E+LE+P
Sbjct: 239 -SDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-70
Identities = 67/303 (22%), Positives = 119/303 (39%), Gaps = 49/303 (16%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ ELG G G+ + + +G A K I + R I RE+Q++ +
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM- 214
IV F GA+ + + ME GG L + G E+ + A++ + +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSY 273
+MHRD+KP N L++++ +K DFG+S + + VG+ Y++PE L+ Y
Sbjct: 125 KIMHRDVKPSNILVNSRG---EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTHY 180
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETEK---GIFDAILKGGVDFESE------------ 318
+ D+WS G+ L + G P K +F ++G
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 319 -------------------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPW 353
P + S +D V K LI++P +R +++ H +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 354 MRE 356
++
Sbjct: 301 IKR 303
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 3e-70
Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 23/276 (8%)
Query: 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDRED---IKRE 144
PLE Y +G LG G FG Y S A K + K ++ + + + + E
Sbjct: 1 PLES---QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 57
Query: 145 IQIMQHLSGQ-QNIVEFRGAYEDRQSVHLVMELCSGG-ELFDKIIAQGHYTEKAAAALCR 202
+ +++ +S ++ +E S L++E +LFD I +G E+ A +
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 203 AIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAY 262
++ V HCH GV+HRD+K EN L+ G LK DFG + + Y D G+
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALLKDTV-YTDFDGTRV 174
Query: 263 YVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW 320
Y PE +R R +G+ VWS G++LY ++ G PF + E I++G V F
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR-- 226
Query: 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
+S + L+R L P R T E+ HPWM++
Sbjct: 227 --VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 222 bits (567), Expect = 4e-70
Identities = 73/267 (27%), Positives = 130/267 (48%), Gaps = 16/267 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ + + LG G FG +L G YA K + K +V + E E ++ ++
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 64
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
I+ G ++D Q + ++M+ GGELF + + A + + + H
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYG 274
+++RDLKPEN LL D +K TDFG + ++ + V + G+ Y+APEV+ + Y
Sbjct: 125 IIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYN 179
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
K ID WS G+++Y +L+G PF+ ++ IL + F ++ KDL+ ++
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----FNEDVKDLLSRL 235
Query: 335 LIQDPKKRI-----TSAEVLEHPWMRE 356
+ +D +R+ + +V HPW +E
Sbjct: 236 ITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 221 bits (564), Expect = 5e-70
Identities = 62/266 (23%), Positives = 109/266 (40%), Gaps = 7/266 (2%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y LG+ LG G +L + A K + + +RE Q L+
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HP 67
Query: 156 NIVEFRGAYEDRQS----VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
IV E ++VME G L D + +G T K A + ++
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFG-LSVFIDEGKVYRDIVGSAYYVAPEVLR 270
H G++HRD+KP N ++S + ++ ++ + ++G+A Y++PE R
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 271 -RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329
S DV+S G +LY +L+G PPF ++ + ++ S +S
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247
Query: 330 LVRKMLIQDPKKRITSAEVLEHPWMR 355
+V K L ++P+ R +A + +R
Sbjct: 248 VVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 221 bits (565), Expect = 4e-69
Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 14/270 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+++ + +GRG FG Y C + TG YA K + K+++ KQ E ++ +S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 156 --NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
IV A+ + +++L +GG+L + G ++E I+ + H H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRR-- 271
V++RDLKP N LL D ++ +D GL+ + K + VG+ Y+APEVL++
Sbjct: 126 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGV 181
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331
+Y D +S G +L+ LL G PF K I + + E S + L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLL 240
Query: 332 RKMLIQDPKKRITS-----AEVLEHPWMRE 356
+L +D +R+ EV E P+ R
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-65
Identities = 60/266 (22%), Positives = 109/266 (40%), Gaps = 19/266 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
T+G+ +G G FG Y + A K +L Q + K E+ +++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGD---VAVK-MLNVTAPTPQQLQAFKNEVGVLRKTR-HV 64
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKI-IAQGHYTEKAAAALCRAIVNVVHHCHFM 214
NI+ F G Y + +V + C G L+ + I + + + R + + H
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR- 270
++HRDLK N L +K DFGL+ + + GS ++APEV+R
Sbjct: 124 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 271 ---RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE--SEPWLLISD 325
Y + DV++ G++LY L++G P+ + ++ G S+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEH 351
+ K L+ + L + +R ++L
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-65
Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 15/268 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ K LG+G FG L E +TG YA K + K ++ K + E +++Q+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HP 65
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
+ + A++ + VME +GGELF + + +TE+ A IV+ + + H
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI-DEGKVYRDIVGSAYYVAPEVLRRS-Y 273
V++RD+K EN +L +K TDFGL +G + G+ Y+APEVL + Y
Sbjct: 126 VVYRDIKLENLMLDKDG---HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 274 GKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRK 333
G+ +D W GV++Y ++ G PF+ + + +F+ IL + F +S AK L+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAG 238
Query: 334 MLIQDPKKRITSA-----EVLEHPWMRE 356
+L +DPK+R+ EV+EH +
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-65
Identities = 86/342 (25%), Positives = 131/342 (38%), Gaps = 48/342 (14%)
Query: 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQH 150
D+ YT +G G +G+ +N A K I ++ + REI+I+
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLR 62
Query: 151 LSGQQNIVEFRGA-----YEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIV 205
+NI+ E + V+LV L K++ H + I+
Sbjct: 63 FR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGAD--LYKLLKTQHLSNDHICYFLYQIL 119
Query: 206 NVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD----IVGSA 261
+ + H V+HRDLKP N LL+ LK DFGL+ D + V +
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLNTTC---DLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 262 YYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP 319
+Y APE++ S Y K ID+WS G IL +LS P F + + IL E
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 320 WLL---------------------------ISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
A DL+ KML +P KRI + L HP
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296
Query: 353 WMREGGEASDKPIGSAVLSRMKQFRAMNK--LKKMALKVIAE 392
++ + + SD+PI A + + K LK++ + A
Sbjct: 297 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-64
Identities = 87/275 (31%), Positives = 146/275 (53%), Gaps = 17/275 (6%)
Query: 96 YTLGKELGRGQFGITYLC---TENSTGNSYACKSILKRKLVNK-QDREDIKREIQIMQHL 151
+ L K LG G +G +L + + TG YA K + K +V K + E + E Q+++H+
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHC 211
+V A++ +HL+++ +GGELF + + +TE IV + H
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID--EGKVYRDIVGSAYYVAPEVL 269
H +G+++RD+K EN LL + +G +L TDFGLS E + D G+ Y+AP+++
Sbjct: 146 HKLGIIYRDIKLENILL-DSNGHVVL--TDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 270 R---RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326
R + K +D WS GV++Y LL+G PF + EK I + + E +S
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 327 AKDLVRKMLIQDPKKRITSA-----EVLEHPWMRE 356
AKDL++++L++DPKKR+ E+ EH + ++
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 5e-64
Identities = 70/286 (24%), Positives = 109/286 (38%), Gaps = 33/286 (11%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD--REDIKREIQIMQHLSGQQNI 157
LG GQF Y + +T A K I +D REI+++Q LS NI
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62
Query: 158 VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVM 217
+ A+ + ++ LV + T A + + + H ++
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 218 HRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KVYRDIVGSAYYVAPEVLR--RSYG 274
HRDLKP N LL +LK DFGL+ + Y V + +Y APE+L R YG
Sbjct: 123 HRDLKPNNLLLDENG---VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL------------- 321
+D+W+ G IL LL VP +++ I + E W
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 322 -----------LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
D DL++ + + +P RIT+ + L+ +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 3e-63
Identities = 75/310 (24%), Positives = 121/310 (39%), Gaps = 48/310 (15%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y ++G+G FG + TG A K +L + REI+I+Q L +
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HE 69
Query: 156 NIVEFRGAYEDRQS--------VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNV 207
N+V + S ++LV + C +T + + ++N
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK-----VYRDIVGSAY 262
+++ H ++HRD+K N L+ +DG +LK DFGL+ K Y + V + +
Sbjct: 130 LYYIHRNKILHRDMKAANVLI-TRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 263 YVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW 320
Y PE+L R YG ID+W AG I+ + + P TE+ I + E W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 321 ----------------------------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHP 352
+ A DL+ K+L+ DP +RI S + L H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 353 WMREGGEASD 362
+ SD
Sbjct: 307 FFWSDPMPSD 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-63
Identities = 73/337 (21%), Positives = 135/337 (40%), Gaps = 45/337 (13%)
Query: 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
+ K ++R Y + +G G +G + TG A K L R ++ + RE
Sbjct: 9 VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-KLYRPFQSELFAKRAYRE 67
Query: 145 IQIMQHLSGQQNIVEFRGAYEDRQS------VHLVMELCSGGELFDKIIAQGHYTEKAAA 198
+++++H+ +N++ + ++ +LVM G K++ E
Sbjct: 68 LRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQ 124
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258
L ++ + + H G++HRDLKP N + + LK DFGL+ D V
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYV 179
Query: 259 GSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE 316
+ +Y APEV+ Y + +D+WS G I+ +++G F I+K
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 317 SEPWLLI---------------------------SDSAKDLVRKMLIQDPKKRITSAEVL 349
+E + S A +L+ KML+ D ++R+T+ E L
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
Query: 350 EHPWMREGGEASDKPIGSAVLSRMKQF-RAMNKLKKM 385
HP+ + D+P R +++ K++
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 202 bits (514), Expect = 4e-62
Identities = 74/299 (24%), Positives = 128/299 (42%), Gaps = 49/299 (16%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y L ++LGRG++ + + K + ++ IKREI+I+++L G
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKIL------KPVKKKKIKREIKILENLRGGP 90
Query: 156 NIVEFRGAYEDRQS--VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF 213
NI+ +D S LV E + + T+ I+ + +CH
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS 147
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR--R 271
MG+MHRD+KP N ++ ++ L+ D+GL+ F G+ Y V S Y+ PE+L +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 272 SYGKEIDVWSAGVILYILLSGVPPFWAETE--------------KGIFDAILKGGVD--- 314
Y +D+WS G +L ++ PF+ + + ++D I K ++
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 315 -----------------FESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
SE L+S A D + K+L D + R+T+ E +EHP+
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 2e-61
Identities = 63/293 (21%), Positives = 113/293 (38%), Gaps = 35/293 (11%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y E+G G +G + + G + ++ + + RE+ +++HL +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 156 --NIVEFRGAYEDRQS-----VHLVMELCSGGEL-FDKIIAQGHYTEKAAAALCRAIVNV 207
N+V ++ + LV E + + + + + ++
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPE 267
+ H V+HRDLKP+N L+++ +K DFGL+ +V + +Y APE
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 268 VLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL---- 322
VL +S Y +D+WS G I + P F ++ IL E W
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 323 -------------------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
I + KDL+ K L +P KRI++ L HP+ ++
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 197 bits (502), Expect = 7e-61
Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 34/289 (11%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y +++G G +G+ Y +N+ G ++A K I K ++ REI I++ L
Sbjct: 4 YHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HS 60
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
NIV+ ++ + LV E + +G A + ++N + +CH
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GKVYRDIVGSAYYVAPEVLRRS-- 272
V+HRDLKP+N L++ + LK DFGL+ + Y + + +Y AP+VL S
Sbjct: 121 VLHRDLKPQNLLINREG---ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 273 YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLI--------- 323
Y ID+WS G I +++G P F +E I + S+ W +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 324 ----------------SDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
+S DL+ KML DP +RIT+ + LEH + +E
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 8e-61
Identities = 66/290 (22%), Positives = 114/290 (39%), Gaps = 34/290 (11%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y +++G G +G + T A K ++ ++ REI +++ L +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALK-RVRLDDDDEGVPSSALREICLLKELKHK- 61
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
NIV + + LV E C G + + ++ + CH
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRRS-- 272
V+HRDLKP+N L++ LK +FGL+ F + Y V + +Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRNG---ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 273 YGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFDAILKGGVDFESEPWLL--------- 322
Y ID+WSAG I L + P F I + E W
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 323 ----------------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
++ + +DL++ +L +P +RI++ E L+HP+ +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 9e-61
Identities = 84/344 (24%), Positives = 126/344 (36%), Gaps = 53/344 (15%)
Query: 69 KSSATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSIL 128
K + P Q P+ +P E YT K +G G FG+ Y +G A K +
Sbjct: 2 KVTTVVATPGQGPD----RPQEV---SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV- 53
Query: 129 KRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAY------EDRQSVHLVMELCSGG-- 180
QD+ RE+QIM+ L NIV R + +D ++LV++
Sbjct: 54 ------LQDKRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 106
Query: 181 -ELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239
A+ + + + H G+ HRD+KP+N LL A+LK
Sbjct: 107 RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD--TAVLKL 164
Query: 240 TDFGLSVFIDEGKVYRDIVGSAYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFW 297
DFG + + G+ + S YY APE++ + Y IDVWSAG +L LL G P F
Sbjct: 165 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224
Query: 298 AETEKGIFDAILKGGVDFESEPWL-------------------------LISDSAKDLVR 332
++ I+K E A L
Sbjct: 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS 284
Query: 333 KMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQF 376
++L P R+T E H + E + + K + F
Sbjct: 285 RLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 328
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (497), Expect = 3e-59
Identities = 79/267 (29%), Positives = 136/267 (50%), Gaps = 16/267 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ K LG G FG L +GN YA K + K+K+V + E E +I+Q ++
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FP 101
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
+V+ +++D ++++VME +GGE+F + G ++E A IV + H +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYG 274
+++RDLKPEN L+ + ++ TDFG + + + G+ +APE++ + Y
Sbjct: 162 LIYRDLKPENLLIDQQG---YIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYN 216
Query: 275 KEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKM 334
K +D W+ GV++Y + +G PPF+A+ I++ I+ G V F S S KDL+R +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNL 272
Query: 335 LIQDPKKRITSA-----EVLEHPWMRE 356
L D KR + ++ H W
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 7e-59
Identities = 72/314 (22%), Positives = 126/314 (40%), Gaps = 40/314 (12%)
Query: 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
L K + ++ + Y +G G +G + TG A K L R + + RE
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-KLSRPFQSIIHAKRTYRE 67
Query: 145 IQIMQHLSGQQNIVEFRGAYEDRQSV----HLVMELCSGGELFDKIIAQGHYTEKAAAAL 200
+++++H+ +N++ + +S+ + + G + I+ T+ L
Sbjct: 68 LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
I+ + + H ++HRDLKP N + LK DFGL+ D V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLARHTD--DEMTGYVAT 181
Query: 261 AYYVAPEVLRRS--YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE 318
+Y APE++ Y + +D+WS G I+ LL+G F IL+ +E
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 319 PWLLI---------------------------SDSAKDLVRKMLIQDPKKRITSAEVLEH 351
I + A DL+ KML+ D KRIT+A+ L H
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 352 PWMREGGEASDKPI 365
+ + + D+P+
Sbjct: 302 AYFAQYHDPDDEPV 315
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-58
Identities = 65/290 (22%), Positives = 116/290 (40%), Gaps = 34/290 (11%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+ +++G G +G+ Y TG A K ++ + REI +++ L+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALK-KIRLDTETEGVPSTAIREISLLKELN-HP 61
Query: 156 NIVEFRGAYEDRQSVHLVMELCS-GGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFM 214
NIV+ ++LV E + F A + ++ + CH
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLS-VFIDEGKVYRDIVGSAYYVAPEVLRRS- 272
V+HRDLKP+N L++ + +K DFGL+ F + Y V + +Y APE+L
Sbjct: 122 RVLHRDLKPQNLLINTEG---AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 273 -YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL--------- 322
Y +D+WS G I +++ F ++E I + + W
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 323 ----------------ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356
+ + + L+ +ML DP KRI++ L HP+ ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-57
Identities = 60/274 (21%), Positives = 102/274 (37%), Gaps = 24/274 (8%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
+G G FG G ++ +K D D E++++ L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKI----------------IAQGHYTEKAAAA 199
NI+ GA E R ++L +E G L D + + +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 200 LCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVG 259
+ + + +HRDL N L+ + K DFGLS +
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRL 188
Query: 260 SAYYVAPEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFES 317
++A E L S Y DVWS GV+L+ ++S G P+ T +++ + +G +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRL 245
Query: 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
E L D DL+R+ + P +R + A++L
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 4e-57
Identities = 68/273 (24%), Positives = 103/273 (37%), Gaps = 21/273 (7%)
Query: 93 RQFYTLG-KELGRGQFGITYLCT--ENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQ 149
R+ TL KELG G FG + A K ILK + + ++++ E +MQ
Sbjct: 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPALKDELLAEANVMQ 63
Query: 150 HLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVH 209
L IV G E +S LVME+ G L + H +K L + +
Sbjct: 64 QLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121
Query: 210 HCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD----IVGSAYYVA 265
+ +HRDL N LL + K +DFGLS + + Y + A
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 266 PEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323
PE + + + DVWS GV+++ S G P+ + + KG
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGC 235
Query: 324 SDSAKDLVRKMLIQDPKKRITSAEV---LEHPW 353
DL+ D + R A V L + +
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-57
Identities = 58/287 (20%), Positives = 105/287 (36%), Gaps = 36/287 (12%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL---VNKQDREDIKREIQIMQHLS 152
GK LG G FG T + + + L + +RE + E+++M L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH--------------------- 191
+NIV GA ++L+ E C G+L + + ++
Sbjct: 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 192 --YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249
T + + + F +HRDL N L+ + DFGL+ I
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV-THGKVVKI--CDFGLARDIM 215
Query: 250 EGK---VYRDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304
V + ++APE L Y + DVWS G++L+ + S GV P+
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
F +++ G + + ++ +++ D +KR + +
Sbjct: 276 FYKLIQNGFKMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-57
Identities = 57/266 (21%), Positives = 101/266 (37%), Gaps = 17/266 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNS---YACKSILKRKLVNKQDREDIKREIQIMQHLS 152
L ++LG G FG+ ++ A K + L + +D RE+ M L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHC 211
+N++ G + +V EL G L D++ QGH+ + + + +
Sbjct: 70 -HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 212 HFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY----RDIVGSAYYVAPE 267
+HRDL N LL+ +D ++K DFGL + + + + APE
Sbjct: 128 ESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 268 VLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISD 325
L+ R++ D W GV L+ + + G P+ I I K G
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED--CPQ 242
Query: 326 SAKDLVRKMLIQDPKKRITSAEVLEH 351
+++ + P+ R T + +
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 9e-57
Identities = 52/278 (18%), Positives = 98/278 (35%), Gaps = 21/278 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y LG+++G G FG YL T+ + G A K K + E +I + + G
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGV 63
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
I R + +VMEL ++ K L +++ + + H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 216 VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY--------RDIVGSAYYVAPE 267
+HRD+KP+NFL+ G ++ DFGL+ + + + +++ G+A Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 268 VLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL---- 322
+ D+ S G +L G P+ + S P +
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEV---LEHPWMREG 357
+ + + + + + R+G
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-56
Identities = 54/261 (20%), Positives = 109/261 (41%), Gaps = 17/261 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
T KELG GQFG+ A K I + ++ E ++M +LS +
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLS-HE 59
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKII-AQGHYTEKAAAALCRAIVNVVHHCHFM 214
+V+ G ++ + ++ E + G L + + + + + +C+ + + +
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR--DIVGSAYYVAPEVLRRS 272
+HRDL N L+ + ++K +DFGLS ++ + + + PEVL S
Sbjct: 120 QFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 273 -YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330
+ + D+W+ GV+++ + S G P+ T + I +G L S+ +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTI 233
Query: 331 VRKMLIQDPKKRITSAEVLEH 351
+ + +R T +L +
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 3e-56
Identities = 74/326 (22%), Positives = 130/326 (39%), Gaps = 53/326 (16%)
Query: 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
+G + + Y K +G G GI + + A K L R N+ + RE
Sbjct: 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRE 66
Query: 145 IQIMQHLSGQQNIVEFRGAY------EDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAA 198
+ +M+ ++ +NI+ + E+ Q V+LVMEL Q + +
Sbjct: 67 LVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMS 122
Query: 199 ALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIV 258
L ++ + H H G++HRDLKP N ++ + LK DFGL+ + V
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC---TLKILDFGLARTAGTSFMMTPYV 179
Query: 259 GSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG------ 311
+ YY APEV+ Y + +D+WS G I+ ++ F ++ +++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 312 --------------------------------GVDFESEPWLLISDSAKDLVRKMLIQDP 339
+SE L + A+DL+ KML+ DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 340 KKRITSAEVLEHPWMREGGEASDKPI 365
KRI+ + L+HP++ + ++
Sbjct: 300 AKRISVDDALQHPYINVWYDPAEVEA 325
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (471), Expect = 4e-56
Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 17/272 (6%)
Query: 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILK-RKLVNKQDREDIKREIQIM 148
E + + +G G+FG G +I + ++ R D E IM
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 149 QHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNV 207
N++ G V ++ E G L + G +T + R I
Sbjct: 82 GQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 208 VHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVY------RDIVGSA 261
+ + M +HRDL N L+ + + K +DFGLS F+++
Sbjct: 141 MKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 262 YYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEP 319
+ APE ++ R + DVWS G++++ ++S G P+W T + + +AI + D+ P
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPP 254
Query: 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
+ + L+ +D R +++
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-55
Identities = 56/261 (21%), Positives = 106/261 (40%), Gaps = 21/261 (8%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
L + +G+G+FG L GN A K + N + E +M L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY--RGNKVAVK-----CIKNDATAQAFLAEASVMTQLR-HS 60
Query: 156 NIVEFRGA-YEDRQSVHLVMELCSGGELFDKIIAQGH--YTEKAAAALCRAIVNVVHHCH 212
N+V+ G E++ +++V E + G L D + ++G + + +
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-R 271
+HRDL N L+S + + K +DFGL+ + + APE LR +
Sbjct: 121 GNNFVHRDLAARNVLVSEDN---VAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK 175
Query: 272 SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330
+ + DVWS G++L+ + S G P+ K + + KG ++ + + ++
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVYEV 232
Query: 331 VRKMLIQDPKKRITSAEVLEH 351
++ D R + ++ E
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-55
Identities = 61/261 (23%), Positives = 109/261 (41%), Gaps = 17/261 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
T +E+G GQFG+ +L + A K+I + ED E ++M LS
Sbjct: 7 LTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIRE----GAMSEEDFIEEAEVMMKLS-HP 60
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH-YTEKAAAALCRAIVNVVHHCHFM 214
+V+ G ++ + LV E G L D + Q + + +C + + +
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 215 GVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--IVGSAYYVAPEVLRRS 272
V+HRDL N L+ ++K +DFG++ F+ + + + +PEV S
Sbjct: 121 CVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 273 -YGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330
Y + DVWS GV+++ + S G P+ + + + I G F L S +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQI 234
Query: 331 VRKMLIQDPKKRITSAEVLEH 351
+ + P+ R + +L
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQ 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-54
Identities = 65/267 (24%), Positives = 97/267 (36%), Gaps = 22/267 (8%)
Query: 100 KELGRGQFGITYLCTENSTGNS--YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNI 157
ELG G FG A K + ++ K D E++ RE QIM L I
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NPYI 71
Query: 158 VEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGV 216
V G + +++ LVME+ GG L ++ + A L + + +
Sbjct: 72 VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 217 MHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD----IVGSAYYVAPEVLR-R 271
+HRDL N LL N+ K +DFGLS + Y + APE + R
Sbjct: 131 VHRDLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 272 SYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330
+ DVWS GV ++ LS G P+ + I +G E L
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECPPECPPELYAL 244
Query: 331 VRKMLIQDPKKRITSAEV---LEHPWM 354
+ I + R V + +
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-54
Identities = 63/265 (23%), Positives = 106/265 (40%), Gaps = 14/265 (5%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILK-RKLVNKQDREDIKREIQIMQHL 151
R+ LG+ +G GQFG + S N +I + + RE +E M+
Sbjct: 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65
Query: 152 SGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHH 210
+IV+ G + V ++MELC+ GEL + + + + + +
Sbjct: 66 D-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR--DIVGSAYYVAPEV 268
+HRD+ N L+S+ D +K DFGLS ++++ Y+ ++APE
Sbjct: 124 LESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 269 LR-RSYGKEIDVWSAGVILY-ILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326
+ R + DVW GV ++ IL+ GV PF + I G +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMPPNCPPT 237
Query: 327 AKDLVRKMLIQDPKKRITSAEVLEH 351
L+ K DP +R E+
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 6e-54
Identities = 58/270 (21%), Positives = 111/270 (41%), Gaps = 21/270 (7%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
R+ L +LG+G FG ++ T N T A K++ E +E Q+M+ L
Sbjct: 16 RESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP----GTMSPEAFLQEAQVMKKLR 70
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHH 210
+ +V+ + +++V E S G L D + + + + I + + +
Sbjct: 71 -HEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--IVGSAYYVAPEV 268
M +HRDL+ N L+ + K DFGL+ I++ + + APE
Sbjct: 129 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 269 LR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326
+ + DVWS G++L L + G P+ + + D + +G + +S
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 242
Query: 327 AKDLVRKMLIQDPKKRITSAEVLE--HPWM 354
DL+ + ++P++R T + +
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-52
Identities = 54/264 (20%), Positives = 99/264 (37%), Gaps = 19/264 (7%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS 152
R+ L + LG GQFG ++ N A KS+ + + E +M+ L
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQ 66
Query: 153 GQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHH 210
Q +V ++++ E G L D + T + I +
Sbjct: 67 -HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 211 CHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD--IVGSAYYVAPEV 268
+HRDL+ N L+S+ K DFGL+ I++ + + APE
Sbjct: 125 IEERNYIHRDLRAANILVSDTL---SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 269 LR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326
+ ++ + DVWS G++L +++ G P+ T + + +G + +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEE 238
Query: 327 AKDLVRKMLIQDPKKRITSAEVLE 350
L+R + P+ R T +
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-51
Identities = 54/264 (20%), Positives = 98/264 (37%), Gaps = 16/264 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILK--RKLVNKQDREDIKREIQIMQHLSG 153
+ K LG G FG Y G +K R+ + + ++I E +M +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCH 212
++ G +V L+ +L G L D + + + C I +++
Sbjct: 70 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD---IVGSAYYVAPEVL 269
++HRDL N L+ +K TDFGL+ + + ++A E +
Sbjct: 129 DRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 270 R-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327
R Y + DVWS GV ++ L++ G P+ I + KG + +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQPPICTIDV 242
Query: 328 KDLVRKMLIQDPKKRITSAEVLEH 351
++ K + D R E++
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-51
Identities = 62/286 (21%), Positives = 106/286 (37%), Gaps = 35/286 (12%)
Query: 93 RQFYTLGKELGRGQFGITYLCT-----ENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
R + GK LG G FG T ++ + A K + + +RE + E+++
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKV 79
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH---------------- 191
+ +L NIV GA ++ E C G+L + + +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 192 --YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249
+ + + + +HRDL N LL++ + K DFGL+ I
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR---ITKICDFGLARDIK 196
Query: 250 EGKVYR---DIVGSAYYVAPEVLRRSY-GKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304
Y + ++APE + E DVWS G+ L+ L S G P+
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350
F ++K G S D+++ DP KR T ++++
Sbjct: 257 FYKMIKEGFRMLSPEH--APAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (435), Expect = 7e-51
Identities = 51/260 (19%), Positives = 103/260 (39%), Gaps = 15/260 (5%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
T+ +LG GQ+G Y + A K++ + + + E+ +E +M+ +
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HP 73
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY--TEKAAAALCRAIVNVVHHCHF 213
N+V+ G +++ E + G L D + + + I + + +
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI--DEGKVYRDIVGSAYYVAPEVLRR 271
+HRDL N L+ ++K DFGLS + D + + APE L
Sbjct: 134 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 272 S-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDL 330
+ + + DVW+ GV+L+ + + + + +L+ E + +L
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG--CPEKVYEL 248
Query: 331 VRKMLIQDPKKRITSAEVLE 350
+R +P R + AE+ +
Sbjct: 249 MRACWQWNPSDRPSFAEIHQ 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 8e-50
Identities = 55/296 (18%), Positives = 107/296 (36%), Gaps = 43/296 (14%)
Query: 89 LEDIRQFYTLGKELGRGQFGITYLCT-----ENSTGNSYACKSILKRKLVNKQDREDIKR 143
LE R +++G G FG + A K + ++ + + D +R
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQR 65
Query: 144 EIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHY----------- 192
E +M NIV+ G + + L+ E + G+L + + + +
Sbjct: 66 EAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 193 -------------TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKA 239
+ + R + + + +HRDL N L+ ++K
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKI 181
Query: 240 TDFGLSVFIDEGKVYR---DIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLS-GVP 294
DFGLS I Y+ + ++ PE + + Y E DVW+ GV+L+ + S G+
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 295 PFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350
P++ + + + G + E +L+R + P R + +
Sbjct: 242 PYYGMAHEEVIYYVRDGNILACPENC---PLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-49
Identities = 56/284 (19%), Positives = 108/284 (38%), Gaps = 30/284 (10%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNS-------YACKSILKRKLVNKQDREDIKREI 145
R LGK LG G FG L A K + + ++D D+ E+
Sbjct: 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEM 69
Query: 146 QIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKI----------------IAQ 189
++M+ + +NI+ GA +++++E S G L + + +
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 190 GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249
+ K + + + + +HRDL N L++ + + ID
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 250 EGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDA 307
K + ++APE L R Y + DVWS GV+L+ + + G P+ + +F
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 308 ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
+ +G + ++ ++R P +R T +++E
Sbjct: 250 LKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 167 bits (423), Expect = 4e-49
Identities = 47/286 (16%), Positives = 97/286 (33%), Gaps = 22/286 (7%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ 155
Y +G+ +G G FG+ + T A K +R D ++ E + + L+G
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 61
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
I ++ LV++L + ++ K A + ++ V H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 216 VMHRDLKPENFLLSNKD--GGAMLKATDFGLSVFIDEG--------KVYRDIVGSAYYVA 265
+++RD+KP+NFL+ + M+ DFG+ F + + +++ G+A Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 266 PEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLL-- 322
R + D+ + G + L G P+ + G +S P
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 323 --ISDSAKDLVRKMLIQDPKKRITSAEVLE--HPWMREGGEASDKP 364
+ + + + D+
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 8e-48
Identities = 56/264 (21%), Positives = 106/264 (40%), Gaps = 16/264 (6%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILK--RKLVNKQDREDIKREIQIMQHLSG 153
T K +G G+FG Y ++ +K + ++ R D E IM S
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS- 67
Query: 154 QQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCH 212
NI+ G + + ++ E G L + + G ++ + R I + +
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 213 FMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR----DIVGSAYYVAPEV 268
M +HRDL N L+ + + K +DFGLS +++ + APE
Sbjct: 128 NMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 269 LR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326
+ R + DVWS G++++ +++ G P+W + + AI G F + +
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSA 241
Query: 327 AKDLVRKMLIQDPKKRITSAEVLE 350
L+ + Q+ +R A+++
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-46
Identities = 59/290 (20%), Positives = 122/290 (42%), Gaps = 35/290 (12%)
Query: 93 RQFYTLGKELGRGQFGITYLCT-----ENSTGNSYACKSILKRKLVNKQDREDIKREIQI 147
R+ T+ +ELG+G FG+ Y ++ A K++ + + ++R + E +
Sbjct: 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASV 76
Query: 148 MQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGH----------YTEKAA 197
M+ + ++V G Q ++MEL + G+L + + +
Sbjct: 77 MKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 198 AALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYR-- 255
+ I + + + + +HRDL N ++ +K DFG++ I E YR
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 256 -DIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGV-PPFWAETEKGIFDAILKGG 312
+ +++PE L+ + DVWS GV+L+ + + P+ + + + +++GG
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252
Query: 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE------HPWMRE 356
+ + + D +L+R +PK R + E++ P RE
Sbjct: 253 LLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-46
Identities = 66/293 (22%), Positives = 116/293 (39%), Gaps = 24/293 (8%)
Query: 71 SATSTRPVQKPETVLGKPLEDIRQFYTLGKELGRGQFGITYLCT---ENSTGNSYACKSI 127
SA + VQ + V+ P I F + +GRG FG Y T + A KS+
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHF---NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63
Query: 128 LKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGA-YEDRQSVHLVMELCSGGELFDKI 186
++ + + E IM+ S N++ G S +V+ G+L + I
Sbjct: 64 --NRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 187 IAQGH-YTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245
+ H T K + + +HRDL N +L D +K DFGL+
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLA 177
Query: 246 VFIDEGKVYRD-----IVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWA 298
+ + + ++A E L+ + + + DVWS GV+L+ L++ G PP+
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237
Query: 299 ETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
I +L+G + E D +++ K + R + +E++
Sbjct: 238 VNTFDITVYLLQGRRLLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-44
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 30/284 (10%)
Query: 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKL---VNKQDREDIKREIQIMQ 149
R LGK LGRG FG + C+++ + L + + E++I+
Sbjct: 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 71
Query: 150 HLSGQQNIVEFRGA-YEDRQSVHLVMELCSGGELFDKI----------------IAQGHY 192
H+ N+V GA + + +++E C G L + + +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 193 TEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252
T + + + +HRDL N LLS K+ ++K DFGL+ I +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 188
Query: 253 VY---RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGV-PPFWAETEKGIFDA 307
Y D ++APE + R Y + DVWS GV+L+ + S P+ F
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 308 ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351
LK G + + + + +P +R T +E++EH
Sbjct: 249 RLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-43
Identities = 55/300 (18%), Positives = 98/300 (32%), Gaps = 51/300 (17%)
Query: 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHL 151
I + L + +G+G+FG + G A K R+ + + EI L
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML 54
Query: 152 SGQQNIVEFRGAYEDRQS----VHLVMELCSGGELFDKIIAQGHYTEKA-------AAAL 200
+NI+ F A + LV + G LFD + E A+ L
Sbjct: 55 R-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRD---- 256
+ +V + HRDLK +N L+ D GL+V D D
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 257 -IVGSAYYVAPEVLRRS-------YGKEIDVWSAGVILYILLSGVPPFWAETEKG----- 303
VG+ Y+APEVL S K D+++ G++ + + +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 304 ----------IFDAILKGGVDFESEPWLL---ISDSAKDLVRKMLIQDPKKRITSAEVLE 350
+ + + + ++R+ + R+T+ + +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 3e-43
Identities = 57/343 (16%), Positives = 119/343 (34%), Gaps = 68/343 (19%)
Query: 85 LGKPLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE 144
G+P +D R Y L ++LG G F +L + A K + +K E + E
Sbjct: 6 KGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDE 59
Query: 145 IQIMQHLS----------GQQNIVEFRGAYEDRQSVHLVMEL-----CSGGELFDKIIAQ 189
I+++Q ++ G +I++ + + + + + K
Sbjct: 60 IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH 119
Query: 190 GHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAML-KATDFGLSVF 247
+ + ++ + + H G++H D+KPEN L+ D L + L
Sbjct: 120 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179
Query: 248 IDEGKVYRDIVGSAYYVAPEVLRRS-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFD 306
+ Y + + + Y +PEVL + +G D+WS +++ L++G F +
Sbjct: 180 CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
Query: 307 AI--------------------------------------------LKGGVDFESEPWLL 322
L+ + + +
Sbjct: 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 299
Query: 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPI 365
+ D + ML DP+KR + ++ HPW+++ + +
Sbjct: 300 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 4e-22
Identities = 39/209 (18%), Positives = 68/209 (32%), Gaps = 35/209 (16%)
Query: 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQD---------------RED 140
+GK +G G+ + C + K K+
Sbjct: 2 DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 141 IKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAAL 200
+ E + +Q L G + + + ++MEL E + +
Sbjct: 61 ARNEFRALQKLQGL-AVPKVYAWEGN----AVLMELIDAKE-------LYRVRVENPDEV 108
Query: 201 CRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKVYRDIVGS 260
I+ V + G++H DL N L+S + + DF SV + E +R+I+
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGEEG-WREILER 163
Query: 261 AYYVAPEVLRRSYGKEIDVWSAGVILYIL 289
R+Y E D+ S I IL
Sbjct: 164 DVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 67.7 bits (164), Expect = 4e-13
Identities = 19/87 (21%), Positives = 36/87 (41%)
Query: 359 EASDKPIGSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTIT 418
D L+ + + + L+ LSEE+ L+ +F + SG +
Sbjct: 81 ARGDAAAEKQRLASLLKDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFS 140
Query: 419 YEELKTGLARLGSKLSETEVKQLMDAV 445
+++LK LA+ + E +K+L V
Sbjct: 141 FQDLKQVLAKYADTIPEGPLKKLFVMV 167
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 36.9 bits (84), Expect = 0.004
Identities = 10/42 (23%), Positives = 20/42 (47%), Gaps = 1/42 (2%)
Query: 405 MFANMDTDKSGTITYEELKTGLARLG-SKLSETEVKQLMDAV 445
++A D DKSG ++ EE++ L + + + + V
Sbjct: 258 LYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVV 299
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 60.7 bits (147), Expect = 2e-12
Identities = 37/58 (63%), Positives = 46/58 (79%)
Query: 388 KVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
K +AE LSEEEI GLK +F +DTD SGTIT++ELK GL R+GS+L E+E+K LMDA
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.9 bits (124), Expect = 2e-09
Identities = 22/55 (40%), Positives = 31/55 (56%)
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ L+EE+I K FA D D +G+I+ EL T + LG SE EV LM+ +
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 53.5 bits (127), Expect = 5e-09
Identities = 30/45 (66%), Positives = 36/45 (80%)
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSE 435
AE LSEEEI GLK +F +DTD SGTIT++ELK GL R+GS+L E
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELME 45
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 48.1 bits (114), Expect = 4e-08
Identities = 20/52 (38%), Positives = 31/52 (59%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
L+EE+I K F+ D D GTIT +EL T + LG +E E++ +++ V
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 53
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 48.7 bits (115), Expect = 1e-07
Identities = 22/55 (40%), Positives = 31/55 (56%)
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ L+EE+I K FA D D +G+I+ EL T + LG SE EV LM+ +
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 39.1 bits (90), Expect = 2e-04
Identities = 24/116 (20%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 333 KMLIQDPKKRITSAEVLEHPWMREGGEASDKPI---GSAVLSRMKQFRAMNKLKKMALKV 389
+ +D I+S+E L G S+ + + + ++ + +
Sbjct: 17 ALFDKDNNGSISSSE-LATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQ 75
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ SE+E+ +F D + G I+ ELK L +G KL++ EV ++ V
Sbjct: 76 LKSNDSEQELLEAFKVF---DKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREV 128
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Score = 48.9 bits (115), Expect = 2e-07
Identities = 14/61 (22%), Positives = 29/61 (47%), Gaps = 5/61 (8%)
Query: 387 LKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLAR-----LGSKLSETEVKQL 441
+K+ + + IK K MF +D + +G IT +E+ + + L + +T+ Q+
Sbjct: 1 VKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQV 60
Query: 442 M 442
Sbjct: 61 C 61
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 45.0 bits (106), Expect = 5e-07
Identities = 18/52 (34%), Positives = 27/52 (51%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
LSEE I K F D D G I+ +EL T + LG ++ E+ +++ V
Sbjct: 8 LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEV 59
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 44.4 bits (105), Expect = 5e-07
Identities = 14/51 (27%), Positives = 26/51 (50%), Gaps = 4/51 (7%)
Query: 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSK-LSETEVKQLMDAV 445
EEE + F D + G I ++E K + ++G + L++ EV++ M
Sbjct: 1 EEE---ILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEA 48
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 34.4 bits (79), Expect = 0.002
Identities = 11/47 (23%), Positives = 19/47 (40%), Gaps = 3/47 (6%)
Query: 382 LKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLAR 428
K + KV E L++ E++ D D +G I E + +
Sbjct: 24 FKFIMQKVGEEPLTDAEVE---EAMKEADEDGNGVIDIPEFMDLIKK 67
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 44.6 bits (105), Expect = 7e-07
Identities = 16/59 (27%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 388 KVIAEALSEEEIKGLKTMFANMDTD-KSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
K E L+EE+ K F + G+I+ +EL + LG + E+++++D V
Sbjct: 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEV 61
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.8 bits (110), Expect = 1e-06
Identities = 9/55 (16%), Positives = 20/55 (36%), Gaps = 1/55 (1%)
Query: 392 EALSEEEIKGLKTMFANMDTD-KSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
A+ + L+ + + SGT+ E K ++ + V+ + A
Sbjct: 13 GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAF 67
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Score = 46.2 bits (108), Expect = 1e-06
Identities = 11/48 (22%), Positives = 21/48 (43%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
S+ ++ +KT F +D DK G IT + ++ R + +
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKV 48
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 45.3 bits (106), Expect = 2e-06
Identities = 14/56 (25%), Positives = 27/56 (48%), Gaps = 1/56 (1%)
Query: 388 KVIAEALSEEEIKGLKTMFANMDTD-KSGTITYEELKTGLARLGSKLSETEVKQLM 442
K E L+EE+ K F + G+I+ +EL + LG + E+++++
Sbjct: 2 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMI 57
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Score = 43.0 bits (101), Expect = 3e-06
Identities = 13/51 (25%), Positives = 26/51 (50%), Gaps = 1/51 (1%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ ++I + +F DT+ G I+ EL L L ++ EV+++M +
Sbjct: 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTL-GSVTPDEVRRMMAEI 50
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 45.0 bits (105), Expect = 3e-06
Identities = 7/52 (13%), Positives = 18/52 (34%), Gaps = 1/52 (1%)
Query: 393 ALSEEEIKGLKTMFANM-DTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
L++ + + +K F D + G+I + + + R +
Sbjct: 1 GLNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYK 52
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 44.1 bits (103), Expect = 5e-06
Identities = 22/54 (40%), Positives = 32/54 (59%)
Query: 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
E L+EE+I K FA D D GTIT +EL T + LG +E E++ +++ V
Sbjct: 1 EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 54
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 41.8 bits (98), Expect = 6e-06
Identities = 18/54 (33%), Positives = 28/54 (51%), Gaps = 3/54 (5%)
Query: 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
E S EE + F D D SGTIT ++L+ LG L+E E+++++
Sbjct: 4 ERDSREE---ILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEA 54
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 34.1 bits (78), Expect = 0.004
Identities = 11/45 (24%), Positives = 20/45 (44%), Gaps = 3/45 (6%)
Query: 384 KMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLAR 428
+ K + E L+EEE++ M A D + I +E + +
Sbjct: 32 RRVAKELGENLTEEELQ---EMIAEADRNDDNEIDEDEFIRIMKK 73
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Score = 44.2 bits (103), Expect = 8e-06
Identities = 9/47 (19%), Positives = 19/47 (40%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQ 440
+ I K MF +D + +G I+ +E+ + + +Q
Sbjct: 6 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQ 52
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Score = 44.0 bits (103), Expect = 9e-06
Identities = 12/64 (18%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 381 KLKKMALKVIAEA--LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEV 438
KL+ ++ + E+ +E EI+ F + SG ++ EE K ++
Sbjct: 3 KLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASKF 60
Query: 439 KQLM 442
+ +
Sbjct: 61 AEHV 64
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Score = 44.0 bits (103), Expect = 9e-06
Identities = 16/71 (22%), Positives = 32/71 (45%), Gaps = 10/71 (14%)
Query: 384 KMALKVIAEALSEEEIK-GLKTMFANMDTDKSGTITYEELKTGLARLGSK--------LS 434
++ + +EE+I G + +FA + + I+ EL+T L R+ +K S
Sbjct: 1 EIEANIEEIEANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFS 59
Query: 435 ETEVKQLMDAV 445
K ++D +
Sbjct: 60 IETCKIMVDML 70
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 43.4 bits (101), Expect = 1e-05
Identities = 13/54 (24%), Positives = 21/54 (38%), Gaps = 3/54 (5%)
Query: 394 LSEEEIKGLKTMFANMDTD--KSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
S EI+ L +F + + G I EE + L + K S ++ D
Sbjct: 11 FSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESL-FADRVFDLF 63
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.9 bits (98), Expect = 1e-05
Identities = 20/56 (35%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAV 445
LS+ +K +F +D D+SG + +ELK L + +L+E+E K LMDA
Sbjct: 34 GLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAA 89
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 42.3 bits (98), Expect = 2e-05
Identities = 12/49 (24%), Positives = 29/49 (59%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
L +++I+ +K F+ +D D+ G ++ E++K +LG + E+ ++
Sbjct: 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAML 49
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.4 bits (98), Expect = 2e-05
Identities = 9/44 (20%), Positives = 18/44 (40%)
Query: 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+ K +F D G I + L L +G + V+ +++
Sbjct: 2 RANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIIN 45
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 44.4 bits (104), Expect = 2e-05
Identities = 17/137 (12%), Positives = 42/137 (30%), Gaps = 4/137 (2%)
Query: 100 KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ----DREDIKREIQIMQHLSGQQ 155
+E+G G + + + K + V + + + E +
Sbjct: 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91
Query: 156 NIVEFRGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG 215
+ R Y D + VME S ++ K + +G + + + + +
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 216 VMHRDLKPENFLLSNKD 232
+ + K +N +
Sbjct: 152 LEPKVKKQLVKQFTNPE 168
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 42.3 bits (98), Expect = 2e-05
Identities = 13/51 (25%), Positives = 21/51 (41%), Gaps = 2/51 (3%)
Query: 394 LSEEEIKGLKTMFANMDT--DKSGTITYEELKTGLARLGSKLSETEVKQLM 442
LS++EI LK +F D + G + +L LG +V +
Sbjct: 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVG 51
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 2e-05
Identities = 14/50 (28%), Positives = 21/50 (42%), Gaps = 1/50 (2%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
+EIK L F +D D SG+++ EE + L V + D
Sbjct: 10 FDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLP-ELQQNPLVQRVIDIFD 58
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.9 bits (93), Expect = 3e-05
Identities = 17/53 (32%), Positives = 27/53 (50%), Gaps = 3/53 (5%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSK--LSETEVKQLMDAV 445
S EEIKG +FA + D I+ EELK + LG + + ++++ V
Sbjct: 3 SPEEIKGAFEVFAAKEGD-PNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEV 54
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Score = 42.3 bits (98), Expect = 3e-05
Identities = 11/55 (20%), Positives = 21/55 (38%), Gaps = 7/55 (12%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL----GSKLSETEVKQLMD 443
A++ + LK F D D +G + + + + G EV+ L +
Sbjct: 3 AIASDR---LKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKN 54
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 41.0 bits (96), Expect = 3e-05
Identities = 24/75 (32%), Positives = 33/75 (44%), Gaps = 15/75 (20%)
Query: 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL---G 430
K+F A+ LK M S + +K +F +D D SG I EELK L G
Sbjct: 27 KKFFALVGLKAM---------SAND---VKKVFKAIDADASGFIEEEELKFVLKSFAADG 74
Query: 431 SKLSETEVKQLMDAV 445
L++ E K + A
Sbjct: 75 RDLTDAETKAFLKAA 89
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Score = 42.0 bits (97), Expect = 4e-05
Identities = 15/50 (30%), Positives = 23/50 (46%)
Query: 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
A + + L F +DTD SG I+ EL L+ G S ++L+
Sbjct: 11 ARHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLL 60
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} Length = 134 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Score = 41.3 bits (95), Expect = 4e-05
Identities = 8/40 (20%), Positives = 23/40 (57%)
Query: 405 MFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444
+F +D + G ++YEE+K +++ + +E ++ + +
Sbjct: 5 LFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKS 44
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (93), Expect = 4e-05
Identities = 9/49 (18%), Positives = 20/49 (40%), Gaps = 1/49 (2%)
Query: 392 EALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQ 440
+ L KT F D + G + +EL+ + K+ + + ++
Sbjct: 9 DGLDPNRFN-PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEE 56
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 4e-05
Identities = 10/44 (22%), Positives = 16/44 (36%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
K F D G I Y + + LG + EV +++
Sbjct: 2 FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNP 45
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Score = 41.4 bits (96), Expect = 5e-05
Identities = 7/47 (14%), Positives = 20/47 (42%), Gaps = 1/47 (2%)
Query: 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443
EE++ + +FA + ++ EL L ++ ++ + +
Sbjct: 1 EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGI 46
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Score = 39.9 bits (93), Expect = 6e-05
Identities = 23/75 (30%), Positives = 35/75 (46%), Gaps = 15/75 (20%)
Query: 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARL---G 430
K+F + LK ++ + +K +F +D D+SG I EELK L G
Sbjct: 27 KRFFHLVGLKGK---------TDAQ---VKEVFEILDKDQSGFIEEEELKGVLKGFSAHG 74
Query: 431 SKLSETEVKQLMDAV 445
L++TE K L+ A
Sbjct: 75 RDLNDTETKALLAAG 89
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (96), Expect = 6e-05
Identities = 9/64 (14%), Positives = 22/64 (34%), Gaps = 4/64 (6%)
Query: 381 KLKKMALKVIAEA--LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEV 438
KLK ++ + +E+E++ F + SG + + + T+
Sbjct: 4 KLKPEVVEELTRKTYFTEKEVQQWYKGF--IKDCPSGQLDAAGFQKIYKQFFPFGDPTKF 61
Query: 439 KQLM 442
+
Sbjct: 62 ATFV 65
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Score = 39.2 bits (91), Expect = 7e-05
Identities = 18/59 (30%), Positives = 30/59 (50%), Gaps = 3/59 (5%)
Query: 387 LKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+K ++ +EEE L +F D + G I EELK L G ++E ++++LM
Sbjct: 5 MKDDSKGKTEEE---LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDG 60
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 38.8 bits (90), Expect = 7e-05
Identities = 18/55 (32%), Positives = 24/55 (43%), Gaps = 3/55 (5%)
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
A+ SEEE L F D + G I EEL L G + E +++ LM
Sbjct: 3 AKGKSEEE---LANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDS 54
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 40.7 bits (94), Expect = 8e-05
Identities = 20/68 (29%), Positives = 31/68 (45%), Gaps = 4/68 (5%)
Query: 378 AMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETE 437
+M + A LSEE I K F D D G I+ +EL T + LG ++ E
Sbjct: 2 SMTDQQAEARAF----LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEE 57
Query: 438 VKQLMDAV 445
+ +++ V
Sbjct: 58 LDAIIEEV 65
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 1e-04
Identities = 15/50 (30%), Positives = 29/50 (58%)
Query: 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
EE+ + ++ F D D +GTI +ELK + LG + + E+K+++ +
Sbjct: 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEI 51
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.3 bits (80), Expect = 0.004
Identities = 24/116 (20%), Positives = 43/116 (37%), Gaps = 7/116 (6%)
Query: 333 KMLIQDPKKRITSAEVLEHPWM---REGGEASDKPIGSAVLSRMKQFRAMNKLKKMALKV 389
+ D I E+ E K I + + L M K+
Sbjct: 13 DLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKM 72
Query: 390 IAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
+ EE +K F D D++G I+++ LK LG L++ E+++++D
Sbjct: 73 SEKDTKEEILK----AFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEA 124
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} Length = 78 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Score = 37.9 bits (88), Expect = 2e-04
Identities = 9/55 (16%), Positives = 19/55 (34%), Gaps = 4/55 (7%)
Query: 395 SEEEIKGLKTMFANMDT--DKSGTITYEELKTGLARLGSKL--SETEVKQLMDAV 445
+++ LK++F ++ EELK + L + L +
Sbjct: 2 AQKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQEL 56
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 37.2 bits (86), Expect = 2e-04
Identities = 6/44 (13%), Positives = 19/44 (43%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
K +F D +K G ++ +E + ++ ++ + + +
Sbjct: 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Score = 38.0 bits (88), Expect = 2e-04
Identities = 22/76 (28%), Positives = 31/76 (40%), Gaps = 4/76 (5%)
Query: 373 MKQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS- 431
+ F A + L ++ +K +F +D DKSG I +EL + L S
Sbjct: 15 IGAFTAADSFDHKKF-FQMVGLKKKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSD 73
Query: 432 --KLSETEVKQLMDAV 445
LS E K LM A
Sbjct: 74 ARDLSAKETKTLMAAG 89
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 33 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 35.7 bits (83), Expect = 3e-04
Identities = 14/36 (38%), Positives = 19/36 (52%), Gaps = 3/36 (8%)
Query: 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLG 430
SEEEI+ F D D +G I+ EL+ + LG
Sbjct: 1 SEEEIR---EAFRVFDKDGNGYISAAELRHVMTNLG 33
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 37.6 bits (87), Expect = 3e-04
Identities = 20/75 (26%), Positives = 29/75 (38%), Gaps = 15/75 (20%)
Query: 374 KQFRAMNKLKKMALKVIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS-- 431
K+F A L S ++ +K F +D DKSG I +ELK L
Sbjct: 26 KEFFAKVGLASK---------SLDD---VKKAFYVIDQDKSGFIEEDELKLFLQNFSPSA 73
Query: 432 -KLSETEVKQLMDAV 445
L++ E K +
Sbjct: 74 RALTDAETKAFLADG 88
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} Length = 172 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 5e-04
Identities = 9/57 (15%), Positives = 20/57 (35%), Gaps = 6/57 (10%)
Query: 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLG-----SKLSETEVKQLMDAV 445
+ L FA + + G I +EL+ L + G + + ++ +
Sbjct: 1 FPGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSML 56
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 38.5 bits (88), Expect = 6e-04
Identities = 12/53 (22%), Positives = 25/53 (47%), Gaps = 1/53 (1%)
Query: 391 AEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLG-SKLSETEVKQLM 442
A + + L +F +D D+SG I+ EL+ L+ + + V+ ++
Sbjct: 10 AAGAALPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSII 62
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.3 bits (88), Expect = 8e-04
Identities = 11/64 (17%), Positives = 23/64 (35%), Gaps = 1/64 (1%)
Query: 366 GSAVLSRMKQFRAMNKLKKMALKVIAEALSEEEIKG-LKTMFANMDTDKSGTITYEELKT 424
+++ + + + M K L E+ + + F MD +K G +T +E
Sbjct: 100 KDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLE 159
Query: 425 GLAR 428
Sbjct: 160 SCQE 163
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} Length = 180 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (87), Expect = 0.001
Identities = 12/51 (23%), Positives = 21/51 (41%), Gaps = 1/51 (1%)
Query: 379 MNKLKKMALKVIAEALSEEEIKGL-KTMFANMDTDKSGTITYEELKTGLAR 428
+ + + LS E+K L + D D+ GTI E + ++R
Sbjct: 118 SRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISR 168
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 19/63 (30%), Positives = 32/63 (50%), Gaps = 10/63 (15%)
Query: 392 EALSEEEI-KGLKTMFANMDTDKSGTITYEELKTGLARLGSK--------LSETEVKQLM 442
+ LSEEEI KT+F+ + D I+ +EL+T L R+ SK S + ++
Sbjct: 11 KVLSEEEIDDNFKTLFSKLAGD-DMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMV 69
Query: 443 DAV 445
+ +
Sbjct: 70 NLM 72
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Score = 34.6 bits (79), Expect = 0.001
Identities = 13/44 (29%), Positives = 23/44 (52%)
Query: 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445
F D + +G ++ +L+ L LG KL++ EV +L+ V
Sbjct: 3 FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGV 46
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.1 bits (80), Expect = 0.002
Identities = 12/47 (25%), Positives = 20/47 (42%)
Query: 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLM 442
+ F N DT K+ TI+ EE + R L++ + +L
Sbjct: 16 TSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLW 62
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 447 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.8 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.76 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.75 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.75 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 98.64 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 98.63 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.61 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.6 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.46 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.46 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 98.44 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 98.44 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 98.42 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 98.34 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.23 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 98.16 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 98.14 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.02 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 97.99 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 97.99 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 97.88 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 97.87 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 97.86 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 97.85 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 97.82 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 97.81 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.8 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 97.75 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 97.73 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.72 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.72 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 97.68 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 97.65 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 97.64 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 97.63 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 97.63 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 97.62 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 97.6 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 97.57 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 97.57 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 97.54 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 97.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.54 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 97.51 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.5 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 97.49 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 97.47 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.47 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 97.43 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 97.42 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 97.42 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 97.31 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 97.29 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 97.27 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 97.27 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 97.26 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 97.24 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 97.23 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 97.23 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 97.2 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 97.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.05 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 97.04 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 96.99 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 96.97 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 96.9 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 96.89 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 96.81 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 96.77 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 96.74 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 96.67 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 96.58 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 96.47 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 96.47 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 96.4 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 96.23 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 96.13 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 96.08 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 95.97 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.91 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 95.79 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 95.78 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 95.7 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 95.63 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 95.5 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 95.5 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 95.4 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 95.39 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 95.31 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 94.89 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 94.25 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 94.21 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 93.91 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 93.9 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 93.86 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 93.77 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 93.75 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 93.75 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 93.75 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 93.65 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 93.6 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 93.03 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 92.92 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 92.84 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 92.75 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 92.59 | |
| d1j7qa_ | 86 | Calcium vector protein {Amphioxus (Branchiostoma l | 92.32 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 91.76 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 91.51 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 91.28 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 91.15 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 90.95 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 90.95 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 90.66 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 90.6 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 90.08 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 90.07 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 90.02 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 89.54 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 89.24 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 89.22 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 88.98 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 88.56 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 88.33 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 88.29 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 88.14 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 87.88 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 87.82 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 87.31 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 87.21 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 87.16 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 87.09 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 86.82 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 86.6 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 86.5 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 86.44 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 86.44 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 86.31 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 86.11 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 85.66 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 85.57 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 84.65 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 84.5 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 84.48 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 84.18 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 84.05 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 83.77 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 82.42 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 81.5 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 81.17 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 80.66 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 80.4 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 80.1 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-66 Score=484.36 Aligned_cols=291 Identities=41% Similarity=0.693 Sum_probs=235.7
Q ss_pred ccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC
Q 013201 89 LEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ 168 (447)
Q Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 168 (447)
.+++.+.|++.+.||+|+||+||+|+++.+++.||||++.+.... .....+.+|+.+|++++ ||||+++++++.+++
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYESGG 80 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 457888899999999999999999999999999999999765432 23456889999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 169 SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.+|||||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++...
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999999999999889999999999999999999999999999999999999976666678999999999987
Q ss_pred cCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.........+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+....++...+.++...++.+.+..+|+++
T Consensus 161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 77666677899999999999874 58999999999999999999999999999999999999998888777777899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHHHHHHhhhh
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQFRAMNKLK 383 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 383 (447)
++||.+||++||++|||++|+|+||||+.... ........+..+++++....+++
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 295 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA-LDKNIHQSVSEQIKKNFAKSKWK 295 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC-CCCCCHHHHHHHHHHHSCCCTTT
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc-cccccchhHHHHHHHHHHHhhhh
Confidence 99999999999999999999999999986432 23344444445555544433443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-64 Score=462.55 Aligned_cols=255 Identities=31% Similarity=0.616 Sum_probs=232.0
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+++.+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence 45999999999999999999999999999999997765544556778899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~---~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC---CCCEeecccceeeecCCCc-
Confidence 999999999999999899999999999999999999999999999999999999954 4569999999998765543
Q ss_pred eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..+.+....++. .+|+++++||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHH
Confidence 456789999999999975 5899999999999999999999999999999999999888766553 47999999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+||+.||++|||++|+|+||||+..
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCCc
Confidence 9999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-63 Score=463.46 Aligned_cols=267 Identities=39% Similarity=0.708 Sum_probs=241.9
Q ss_pred cccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh---hhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 90 EDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK---QDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
+++.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++ |||||++++++.+
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence 3467789999999999999999999999999999999977654332 24678999999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCC-CCceEEecCCCc
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDG-GAMLKATDFGLS 245 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~-~~~vkl~Dfg~a 245 (447)
.+.+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999999999999899999999999999999999999999999999999999965542 346999999999
Q ss_pred eeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.............||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+.+..+..+...++...+..+|
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 98877766677899999999999874 58999999999999999999999999999999999999988777666566789
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+++++||.+||+.||++|||++|+|+||||+..
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-63 Score=459.00 Aligned_cols=258 Identities=31% Similarity=0.518 Sum_probs=218.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|++++ ||||+++++++.+++.+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeEE
Confidence 3569999999999999999999999999999999876532 223457889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||+|.......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~---~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE---RDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TCCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECC---CCCEEEccchhheeeccCC
Confidence 9999999999999988888999999999999999999999999999999999999954 4469999999998764332
Q ss_pred ---ceeecCCcccccccccccc-c-CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 253 ---VYRDIVGSAYYVAPEVLRR-S-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 253 ---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.....+||+.|||||++.+ . ++.++|||||||++|||++|+.||.................. ...++..+|+++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~ 236 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDSAP 236 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGSCHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccCCHHH
Confidence 2345789999999999864 3 467899999999999999999999876554333333333222 233456789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
++||.+||+.||++|||++|+|+||||++.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-63 Score=459.45 Aligned_cols=256 Identities=33% Similarity=0.547 Sum_probs=228.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++ ||||+++++++.+++.+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence 45999999999999999999999999999999997765544556678999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC--
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-- 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-- 251 (447)
||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~---~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC---CCceEEecccccceecccCCc
Confidence 99999999999999999999999999999999999999999999999999999994 4456999999999876532
Q ss_pred -CceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 -KVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+++..+.++...++. .+++++++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 239 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARD 239 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHHH
Confidence 2334578999999999986 45899999999999999999999999999999999999988776653 47999999
Q ss_pred HHHHhcccCCCCCCCHHH------HhcCCCccCC
Q 013201 330 LVRKMLIQDPKKRITSAE------VLEHPWMREG 357 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~------~l~h~~~~~~ 357 (447)
||.+||+.||++|||++| +++||||++.
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 999999999999999987 5889999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-62 Score=467.95 Aligned_cols=263 Identities=35% Similarity=0.642 Sum_probs=239.3
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+-++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+.+.+|+.+|++++ |||||++++++.+++.+|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 446799999999999999999999999999999998653 3445678899999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+ .++.+||+|||++..+..
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheeccc
Confidence 99999999999999864 4579999999999999999999999999999999999999643 235799999999998887
Q ss_pred CCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
........||+.|||||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..+......++...+..+|+++++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777778899999999999874 5899999999999999999999999999999999999998888777777789999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
||.+||+.||++|||++|+|+||||+....
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999999999999999999987643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-62 Score=455.72 Aligned_cols=257 Identities=29% Similarity=0.482 Sum_probs=224.9
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|++++ ||||+++++++.+++.+|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence 34579999999999999999999999999999999875532 34577899999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~---~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TCCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC---CCcEeeccchhheeeccc
Confidence 99999999999987655 57999999999999999999999999999999999999954 446999999999877543
Q ss_pred -CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 252 -KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+....+..+....... ...+..+|+++++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIFRD 248 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSSGGGSCHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-CCCcccCCHHHHH
Confidence 34456789999999999874 58999999999999999999999999988877777666543321 2223468999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
||.+||+.||++|||++|+|+||||+..
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.4e-62 Score=450.18 Aligned_cols=262 Identities=37% Similarity=0.664 Sum_probs=238.7
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh------hhHHHHHHHHHHHHhccCCCCeeEEEEEEEe
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK------QDREDIKREIQIMQHLSGQQNIVEFRGAYED 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 166 (447)
.++|++.+.||+|+||+||+|++..+|+.||||++.+...... ...+.+.+|+.+++++..||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4679999999999999999999999999999999977654321 2235688999999999889999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
++.+|||||||+||+|.++|..++.+++..++.++.||+.||+|||++||+||||||+|||++ .+..+||+|||++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---CCCCeEEccchhee
Confidence 999999999999999999999999999999999999999999999999999999999999994 44579999999999
Q ss_pred eccCCCceeecCCcccccccccccc-------cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLRR-------SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEP 319 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 319 (447)
.+.........+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+..+...++.+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8877666667899999999998742 368899999999999999999999999999999999999988888777
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+..+|+++++||.+||++||++|||++|+|+||||++.
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 77899999999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.5e-62 Score=466.08 Aligned_cols=263 Identities=32% Similarity=0.626 Sum_probs=238.5
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.+.|++.+.||+|+||+||+|+++.+|+.||||++.+.. ......+.+|+.+|++++ |||||+++++|.+++.+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 3456999999999999999999999999999999986542 344567889999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
||||||+||+|.+++...+ ++++.+++.|+.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|.....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecCC
Confidence 9999999999998876654 69999999999999999999999999999999999999642 335799999999999887
Q ss_pred CCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKD 329 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 329 (447)
........||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.+..+++..+..+...++...+..+|+++++
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777778899999999999874 5899999999999999999999999999999999999999888777777789999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 330 LVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 330 li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
||.+||+.||.+|||++|+|+||||+....
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 999999999999999999999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-61 Score=447.30 Aligned_cols=254 Identities=23% Similarity=0.425 Sum_probs=219.5
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----CCeE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----RQSV 170 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~ 170 (447)
.|++.+.||+|+||+||+|++..+++.||+|.+..... .....+.+.+|+++|++++ |||||++++++++ +..+
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEE
Confidence 45888899999999999999999999999999876543 4456778999999999998 9999999999875 4568
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--cEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMG--VMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
|||||||+||+|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +..+||+|||++...
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~--~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST--TSCEEECCTTGGGGC
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC--CCCEEEeecCcceec
Confidence 999999999999999999899999999999999999999999999 9999999999999532 346999999999764
Q ss_pred cCCCceeecCCcccccccccccccCCCCCcchhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCCCCCCccccCChHH
Q 013201 249 DEGKVYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAETE-KGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
.. ......+||+.|||||++.+.|+.++|||||||++|||++|+.||.+... ..+...+..+... ......+++++
T Consensus 166 ~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~ 242 (270)
T d1t4ha_ 166 RA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEV 242 (270)
T ss_dssp CT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHHH
T ss_pred cC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccCCHHH
Confidence 43 33456799999999999998899999999999999999999999987654 4455555444322 12223578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
++||.+||++||++|||++|+|+||||+
T Consensus 243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-61 Score=460.05 Aligned_cols=256 Identities=31% Similarity=0.536 Sum_probs=233.2
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|++++ ||||+++++++.+.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence 35999999999999999999999999999999998765544556788899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC-CC
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE-GK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~ 252 (447)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~---~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec---CCCCEEEeecccccccccCCc
Confidence 99999999999999999999999999999999999999999999999999999994 445799999999987543 34
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
.....+||+.|+|||++. ..|+.++|||||||++|||++|.+||.+.+..+++..+..+...++. .+|+++++||
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli 236 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHH
Confidence 455679999999999986 55999999999999999999999999999999999999998776654 4899999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 332 RKMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
.+||++||.+|++ ++|+++||||++.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HhhccCCchhhcccccccHHHHHcCcccccC
Confidence 9999999999994 9999999999763
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-62 Score=458.04 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=228.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
..+.|++.+.||+|+||+||+|++..+++.||||++.+.........+.+.+|+.+|++++ |||||++++++.+++.+|
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEE
Confidence 4456999999999999999999999999999999997765555556678999999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 172 LVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||||.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~---~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET---TTEEEECCCTTCBSSSSB
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC---CCCEEEeecccccccCCC
Confidence 99999999999888888889999999999999999999999999999999999999954 457999999999876543
Q ss_pred CceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHH
Q 013201 252 KVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSA 327 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 327 (447)
...+||+.|||||++. +.|+.++|||||||++|||++|..||.+.+..+.+..+..+....... ..+|+++
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~ 243 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--GHWSEYF 243 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC--TTSCHHH
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCCCHHH
Confidence 3568999999999984 348999999999999999999999999998888888887765443322 3579999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 328 KDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 328 ~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
++||.+||+.||++|||++|+|+||||.+.
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-61 Score=452.37 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=225.2
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||+||+|+++.+++.||+|++.+. .....+.+.+|+.+|++++ |||||++++++.+++.+||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEE
Confidence 45699999999999999999999999999999998654 2344567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|......
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~---~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL---DGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC---CCCEEEEechhhhccCCC
Confidence 99999999999987764 56999999999999999999999999999999999999954 456999999999765432
Q ss_pred -CceeecCCccccccccccc------ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 252 -KVYRDIVGSAYYVAPEVLR------RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
......+||+.|+|||++. ..|+.++|||||||++|+|+||..||.+.+..+.+..+.++...... ....+|
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~s 242 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWS 242 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGGGSC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-ccccCC
Confidence 2234578999999999973 34889999999999999999999999999888888888887543322 234689
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+++++||.+||+.||++|||++|+|+||||+..
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-61 Score=457.30 Aligned_cols=262 Identities=29% Similarity=0.589 Sum_probs=238.6
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
++.++|++++.||+|+||+||+|+++.+++.||+|++.+. ..+...+.+|+.+|++++ ||||+++++++++++.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC----cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 4567899999999999999999999999999999998653 234456889999999998 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|||||||+||+|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +...+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhccc
Confidence 99999999999999998765 69999999999999999999999999999999999999653 34579999999999887
Q ss_pred CCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 250 EGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.........||+.|+|||.+. ..|+.++|||||||++|+|++|..||.+.+..+++..|.++...++...+..+|++++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 776677789999999999886 4589999999999999999999999999999999999999988887777778999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCccCCC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEHPWMREGG 358 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h~~~~~~~ 358 (447)
+||.+||..||++|||++|+|+||||++..
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 999999999999999999999999998653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.7e-61 Score=451.80 Aligned_cols=254 Identities=28% Similarity=0.573 Sum_probs=231.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++ ||||+++++++.+++.+|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence 35999999999999999999999999999999997665444556788999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
||||.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~---~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc---CCCCEEEecCccceEeccc--
Confidence 99999999999999999999999999999999999999999999999999999994 4457999999999887553
Q ss_pred eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..+..+...++. .++++++++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence 345789999999999875 5899999999999999999999999999999999999988765543 47999999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
+||..||.+|+ |++++|+||||++.
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 99999999996 99999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-61 Score=443.73 Aligned_cols=253 Identities=27% Similarity=0.494 Sum_probs=211.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQSVH 171 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 171 (447)
+.|++.+.||+|+||+||+|+++.+|+.||+|.+.+... .....+.+.+|+.+|++++ |||||++++++.+ .+.+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence 459999999999999999999999999999999876543 4455678999999999997 9999999999865 46689
Q ss_pred EEEeccCCCchHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC-----cEeecCCCCceEeecCCCCCceEEecC
Q 013201 172 LVMELCSGGELFDKIIA----QGHYTEKAAAALCRAIVNVVHHCHFMG-----VMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qil~~l~~lH~~~-----ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
||||||+||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~---~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG---KQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT---TSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC---CCcEEEeec
Confidence 99999999999998864 457999999999999999999999976 999999999999944 456999999
Q ss_pred CCceeccCCC-ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Q 013201 243 GLSVFIDEGK-VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 243 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 320 (447)
|+++...... .....+||+.|||||++. ..|+.++|||||||++|||+||..||.+.+..++...+..+......
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~--- 235 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP--- 235 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC---
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence 9998765543 335678999999999986 45899999999999999999999999999999999998887654322
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWM 354 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~ 354 (447)
..+|+++++||.+||+.||++|||++|+|+|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 2579999999999999999999999999999996
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-60 Score=454.11 Aligned_cols=265 Identities=34% Similarity=0.589 Sum_probs=226.0
Q ss_pred cccceeec-ceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe----
Q 013201 92 IRQFYTLG-KELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED---- 166 (447)
Q Consensus 92 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---- 166 (447)
+-+.|.+. +.||+|+||+||+|++..+++.||||++.+. ..+.+|+.++.++.+|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 44568876 5699999999999999999999999988532 4577899998777669999999999976
Q ss_pred CCeEEEEEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
+..+|||||||+||+|.+++.+. ..+++.+++.|+.||+.||.|||++||+||||||+|||++..+....+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 46789999999999999999875 3699999999999999999999999999999999999998766677899999999
Q ss_pred ceeccCCCceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHH----HHhCCCCCCCCc
Q 013201 245 SVFIDEGKVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDA----ILKGGVDFESEP 319 (447)
Q Consensus 245 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~----i~~~~~~~~~~~ 319 (447)
++...........+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.+....... +..+...++.+.
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 998877666677899999999999875 599999999999999999999999987765444433 334455666666
Q ss_pred cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCc
Q 013201 320 WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKP 364 (447)
Q Consensus 320 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~ 364 (447)
+..+|+++++||.+||+.||++|||+.|+|+||||++.......+
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~ 285 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence 678999999999999999999999999999999998765544433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-60 Score=453.58 Aligned_cols=254 Identities=31% Similarity=0.560 Sum_probs=230.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++ ||||+++++++.+...+|+|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence 45999999999999999999999999999999997665444455678899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCCc
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGKV 253 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 253 (447)
|||+.||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.+...
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~---~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC---CCCEEeeeceeeeecccc--
Confidence 999999999999999999999999999999999999999999999999999999944 457999999999887653
Q ss_pred eeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHH
Q 013201 254 YRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVR 332 (447)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 332 (447)
....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+...++..+..+...++. .+++++.+||.
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHH
Confidence 345689999999999874 5899999999999999999999999999999999999988765543 48999999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 333 KMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 333 ~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
+||+.||.+|+ |++++++||||+..
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCC
Confidence 99999999995 99999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-60 Score=453.95 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=215.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. .......+.+|+.+|++++ |||||+++++|.+++.+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence 467999999999999999999999999999999986542 3445678899999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|....+.
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~---~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT---TCCEEECCCCCCHHHHHH
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC---CCCEEEeeCCCccccCCC
Confidence 99999999999999999999999999999999999999997 59999999999999944 456999999999876443
Q ss_pred CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHH-----------------------
Q 013201 252 KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDA----------------------- 307 (447)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~----------------------- 307 (447)
...+.+||+.|+|||++.+ .|+.++||||+||++|||++|+.||.+.+.......
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 2345799999999999874 699999999999999999999999987654321110
Q ss_pred -------------------HHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 308 -------------------ILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 308 -------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+... ..+..+...+|.++++||.+||..||++|||++|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000 00111112368899999999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=445.06 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=227.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++++.||+|+||+||+|+++.+++.||||++.+.........+.+.+|+.++.+..+||||+++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 35999999999999999999999999999999997655444455667778888776433499999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-C
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-K 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 252 (447)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++...... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~---~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec---CCCceeccccchhhhcccccc
Confidence 99999999999999999999999999999999999999999999999999999994 4457999999999865443 3
Q ss_pred ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHH
Q 013201 253 VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAKDLV 331 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 331 (447)
.....+||+.|+|||++. +.|+.++|||||||++|+|++|+.||.+.+..+++..+..+...++. .+|+++++||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli 234 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLL 234 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHH
Confidence 344578999999999987 46999999999999999999999999999999999999888665543 4799999999
Q ss_pred HHhcccCCCCCCCHH-HHhcCCCccCC
Q 013201 332 RKMLIQDPKKRITSA-EVLEHPWMREG 357 (447)
Q Consensus 332 ~~~L~~dp~~R~t~~-~~l~h~~~~~~ 357 (447)
.+||+.||++|||+. ++++||||++.
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHhcccCCCCCcCHHHHHHhCchhccC
Confidence 999999999999995 89999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-59 Score=449.68 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=215.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHH---HHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKRE---IQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E---~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+.|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+| +.+++.+. |||||++++++.+.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEECCEE
Confidence 359999999999999999999999999999999976544333333444444 56666665 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||||+||+|.++|.+...+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+|.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~---~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---SSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc---CCCcEEEeeeceeeecCC
Confidence 99999999999999999999999999999999999999999999999999999999994 445799999999987765
Q ss_pred CCceeecCCccccccccccc-c-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLR-R-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ....+||+.|+|||++. + .|+.++|||||||+||||+||..||.+.......... +.........+..+|++++
T Consensus 160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCCCCCSSSCHHHH
T ss_pred Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCCCCCCCCCHHHH
Confidence 43 34568999999999985 3 4899999999999999999999999876543322222 2222222222336899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCCCccCC
Q 013201 329 DLVRKMLIQDPKKRIT-----SAEVLEHPWMREG 357 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t-----~~~~l~h~~~~~~ 357 (447)
+||.+||++||++||| ++|+++||||++.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999999999 7999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-59 Score=437.66 Aligned_cols=260 Identities=26% Similarity=0.366 Sum_probs=215.1
Q ss_pred ecceeccccCeEEEEEEECCCCCEEEEEEeeccccCCh--hhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEEEe
Q 013201 98 LGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNK--QDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLVME 175 (447)
Q Consensus 98 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 175 (447)
..+.||+|+||+||+|+++.+|+.||||++.+...... .....+.+|+.+|++++ |||||++++++.+++.+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence 45789999999999999999999999999865433221 12356889999999998 9999999999999999999999
Q ss_pred ccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC-Cce
Q 013201 176 LCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG-KVY 254 (447)
Q Consensus 176 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~ 254 (447)
||.|+++..++.....+++..++.+++||+.||+|||++||+||||||+|||++ ....+||+|||++...... ...
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---CCCccccccCccccccCCCcccc
Confidence 999888776666667799999999999999999999999999999999999994 4457999999999876543 233
Q ss_pred eecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC---------------
Q 013201 255 RDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES--------------- 317 (447)
Q Consensus 255 ~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------- 317 (447)
...+||+.|+|||++. ..|+.++|||||||++|||++|.+||.+.+..+.+..+.+.......
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 4568999999999875 34899999999999999999999999999988888777642111100
Q ss_pred -----Cc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCC
Q 013201 318 -----EP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEAS 361 (447)
Q Consensus 318 -----~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~ 361 (447)
.+ ...+++++++||.+||+.||++|||++|+|+||||++.+.+.
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 00 124688999999999999999999999999999999865543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=428.47 Aligned_cols=253 Identities=31% Similarity=0.554 Sum_probs=217.3
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChh---hHHHHHHHHHHHHhcc-CCCCeeEEEEEEEeC
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQ---DREDIKREIQIMQHLS-GQQNIVEFRGAYEDR 167 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~---~~~~~~~E~~~l~~l~-~h~~iv~~~~~~~~~ 167 (447)
+.++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+|+++. .||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 346799999999999999999999999999999999765543322 2234678999999986 489999999999999
Q ss_pred CeEEEEEeccCC-CchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 168 QSVHLVMELCSG-GELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 168 ~~~~lv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
+.+|+||||+.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~--~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC--CeEEECccccce
Confidence 999999999976 67888888888999999999999999999999999999999999999996443 469999999998
Q ss_pred eccCCCceeecCCcccccccccccc-c-CCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 247 FIDEGKVYRDIVGSAYYVAPEVLRR-S-YGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
..... .....+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+. ..+.++...++. .+|
T Consensus 160 ~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~----~~s 228 (273)
T d1xwsa_ 160 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ----RVS 228 (273)
T ss_dssp ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSS----CCC
T ss_pred ecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCC----CCC
Confidence 75543 3456789999999999863 3 567899999999999999999999753 245555554443 489
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
+++++||.+||+.||++|||++|+|+||||++.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.8e-58 Score=424.73 Aligned_cols=261 Identities=26% Similarity=0.358 Sum_probs=220.7
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-- 168 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 168 (447)
.+.++|++.+.||+|+||+||+|++..+|+.||||++.+....+......+.+|+.+|++++ ||||+++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence 35677999999999999999999999999999999997766656666778999999999997 999999999987643
Q ss_pred --eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 169 --SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 169 --~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
.+|||||||+|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||.+.
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~---~~~l~d~~~~~ 159 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIAR 159 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS---CEEECCCTTCE
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc---cceeehhhhhh
Confidence 4899999999999999999999999999999999999999999999999999999999996544 59999999987
Q ss_pred eccCC----CceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Q 013201 247 FIDEG----KVYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWL 321 (447)
Q Consensus 247 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 321 (447)
..... ......+||+.|+|||++.+ .++.++|||||||++|+|+||.+||.+.+..+....+.......+...+.
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 65432 23345689999999999874 58999999999999999999999999999988888888877666555556
Q ss_pred cCChHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 013201 322 LISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMR 355 (447)
Q Consensus 322 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~ 355 (447)
.+|+++.+||.+||++||.+||+..+.|.|+|++
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 7899999999999999999999555555566653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-57 Score=423.04 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=214.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++.+.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+|++++ |||||++++++.+++.+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence 46999999999999999999999999999999986543 22334578899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 174 MELCSGGELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
||||.++ +.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++ .+..+||+|||+|......
T Consensus 80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~---~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTHHHHHCCC
T ss_pred EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec---ccCcceeccCCcceeccCC
Confidence 9999764 4444433 35699999999999999999999999999999999999994 4446999999999876543
Q ss_pred -CceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC----------
Q 013201 252 -KVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE---------- 318 (447)
Q Consensus 252 -~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 318 (447)
.......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 3344568999999999865 346889999999999999999999999988877776665421111000
Q ss_pred ---------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 319 ---------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 319 ---------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
....+|+++++||.+||..||++|||++|+|+||||++...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 012468899999999999999999999999999999876443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=421.69 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=215.2
Q ss_pred ccceeecceeccccCeEEEEEEECCC-CCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc--CCCCeeEEEEEEEe---
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENST-GNSYACKSILKRKLVNKQDREDIKREIQIMQHLS--GQQNIVEFRGAYED--- 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~~iv~~~~~~~~--- 166 (447)
.++|++.+.||+|+||+||+|++..+ ++.||||++...... ......+.+|+.+|+.|. +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46799999999999999999999765 667999998654332 222345668888888774 49999999999853
Q ss_pred --CCeEEEEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCC
Q 013201 167 --RQSVHLVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFG 243 (447)
Q Consensus 167 --~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg 243 (447)
...+|++||||.++.+...... ...+++..++.++.||+.||+|||++||+||||||+|||++ ....+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~---~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc---CCCCeeecchh
Confidence 3578999999988776544433 45699999999999999999999999999999999999994 44569999999
Q ss_pred CceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC------
Q 013201 244 LSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE------ 316 (447)
Q Consensus 244 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------ 316 (447)
++.............||+.|+|||++. ..|+.++||||+||++|||++|..||.+.+..+.+..+........
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 998766655666789999999999885 5699999999999999999999999999988888777654211000
Q ss_pred -----------------CCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 317 -----------------SEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 317 -----------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
......+++++++||.+||++||++|||++|+|+||||++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 0011246899999999999999999999999999999987643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4e-56 Score=416.02 Aligned_cols=257 Identities=30% Similarity=0.452 Sum_probs=214.3
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++.+.||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+|++++ ||||+++++++.+.+..|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence 46999999999999999999986 789999999865432 3334578899999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK- 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 252 (447)
|||+.++.+..+....+.+++..+..++.||+.||.|||+.||+||||||+|||++. +..+||+|||++.......
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~---~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TSCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC---CCCEEecccccceecccCcc
Confidence 999988777776666788999999999999999999999999999999999999944 4569999999998765432
Q ss_pred ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC------------
Q 013201 253 VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESE------------ 318 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------ 318 (447)
......|++.|+|||.+. ..++.++|||||||++|||++|+.||.+.+..+.+..+.+........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 234457999999999985 347999999999999999999999999988877777665421110000
Q ss_pred -------------ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccC
Q 013201 319 -------------PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMRE 356 (447)
Q Consensus 319 -------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~ 356 (447)
....++++++|||++||++||++|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 01246889999999999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-56 Score=413.19 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=209.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||+||+|+++.+++.||||++.+. ....+++.+|+.+|++++ |||||++++++.+++.+||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc----cchHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEE
Confidence 35699999999999999999999999999999988543 234578999999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~---~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE---NHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG---GGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECC---CCcEEEccccceeecCC
Confidence 99999999999999764 46899999999999999999999999999999999999944 45799999999987655
Q ss_pred CCce--eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCC-CCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKVY--RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.... ....||+.|+|||++. +.|+.++|||||||++|||++|..||. +.+...+...+..+ ...+.+ ..++++
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~ 244 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERP--EGCPEK 244 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHH
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCCCCC--ccchHH
Confidence 4322 2346889999999876 569999999999999999999766655 44555555554443 333322 358999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+++||.+||+.||++|||++++++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=422.86 Aligned_cols=252 Identities=24% Similarity=0.411 Sum_probs=212.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCCC-----EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGN-----SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.+.|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++.+|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3579999999999999999999876554 68999875432 2334567889999999996699999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCC
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG-----------------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPE 224 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~ 224 (447)
+.+|||||||+||+|.++|.... .+++..++.|+.||+.||.|||++||+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999997642 4789999999999999999999999999999999
Q ss_pred ceEeecCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCC
Q 013201 225 NFLLSNKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAE 299 (447)
Q Consensus 225 Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~ 299 (447)
|||++. +..+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+.
T Consensus 194 Nill~~---~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLVTH---GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEEET---TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cccccc---CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999954 45799999999987654332 22456899999999886 669999999999999999998 89999987
Q ss_pred CHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 300 TEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 300 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
.....+..+......++.+ ..+|+++++||.+||+.||++|||++||++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7766677777766555443 3579999999999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=412.21 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=203.9
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++++.||+|+||+||+|+.+ ..||||++.... ......+.+.+|+.+|++++ |||||++++++. .+.++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccEEEE
Confidence 456999999999999999999754 369999886543 33456788999999999997 999999999875 456899
Q ss_pred EEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++. +..+||+|||+|......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~---~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE---DLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET---TSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC---CCCEEEccccceeecccc
Confidence 99999999999999765 56999999999999999999999999999999999999954 457999999999876432
Q ss_pred ---CceeecCCccccccccccc----ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHH-HhCCCCCCC-Ccccc
Q 013201 252 ---KVYRDIVGSAYYVAPEVLR----RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAI-LKGGVDFES-EPWLL 322 (447)
Q Consensus 252 ---~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i-~~~~~~~~~-~~~~~ 322 (447)
.......||+.|||||++. +.|+.++|||||||+||||+||+.||.+.+....+..+ .++...... .....
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2334578999999999985 24789999999999999999999999987665544444 443322211 12335
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+++++.+||.+||+.||++|||++|++++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 78999999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-55 Score=413.29 Aligned_cols=250 Identities=22% Similarity=0.384 Sum_probs=203.3
Q ss_pred ccceeecceeccccCeEEEEEEECCCCC---EEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGN---SYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
.+.|++.+.||+|+||+||+|+++.+++ .||||.+... ......+.+.+|+.+|++++ |||||++++++.+.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence 3569999999999999999999987765 5788876432 23455678999999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+|+|||||+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 99999999999999988874 469999999999999999999999999999999999999 45567999999999876
Q ss_pred cCCCce------eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Q 013201 249 DEGKVY------RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPW 320 (447)
Q Consensus 249 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 320 (447)
...... ....||+.|||||++. +.++.++|||||||++|||+| |..||.+.+..+++..+..+... + ..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-~--~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-P--PP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-C--CC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CC
Confidence 543221 2246899999999986 569999999999999999998 89999999998888888776432 2 22
Q ss_pred ccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 321 LLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 321 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..+++++.+||.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3589999999999999999999999999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=408.91 Aligned_cols=250 Identities=25% Similarity=0.315 Sum_probs=208.0
Q ss_pred eeec-ceeccccCeEEEEEEEC--CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 96 YTLG-KELGRGQFGITYLCTEN--STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 96 y~~~-~~lg~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
+.+. +.||+|+||+||+|.+. .+++.||||++.... .+....+.+.+|+.+|++++ |||||++++++.++ .+||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~l 84 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWML 84 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEE
Confidence 3443 47999999999999865 346789999885433 34445678999999999997 99999999999654 5789
Q ss_pred EEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 173 VMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
|||||++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~---~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET---TEEEECCCTTCEECCTTC
T ss_pred EEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc---Ccccccchhhhhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999554 469999999998765443
Q ss_pred ce----eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 253 VY----RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 253 ~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.. ....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..++...+.++... +.+ ..+|++
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-~~p--~~~~~~ 238 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GCP--AGCPRE 238 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CCC--TTCCHH
T ss_pred cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC-CCC--cccCHH
Confidence 22 2357999999999986 558999999999999999998 89999999988888888776432 222 358999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHh---cCCCc
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVL---EHPWM 354 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l---~h~~~ 354 (447)
+++||.+||+.||++|||+++++ +|+|+
T Consensus 239 ~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 99999999999999999999984 55554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-55 Score=418.65 Aligned_cols=255 Identities=29% Similarity=0.402 Sum_probs=211.8
Q ss_pred ceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe------CC
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED------RQ 168 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------~~ 168 (447)
.|+..++||+|+||+||+|++..+|+.||||++.+... ...+|+.+|++++ ||||++++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence 49999999999999999999999999999999865432 2247999999997 9999999999853 34
Q ss_pred eEEEEEeccCCCchHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 169 SVHLVMELCSGGELFDK---IIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 169 ~~~lv~e~~~g~~L~~~---l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
++|||||||+++.+... ......+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||++
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~--~~~kl~DFG~a 170 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFGSA 170 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT--CCEEECCCTTC
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC--CceeEecccch
Confidence 58999999976543322 23456799999999999999999999999999999999999996443 36999999999
Q ss_pred eeccCCCceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKG------------ 311 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------ 311 (447)
............+||+.|+|||.+. ..|+.++||||+||++|||++|..||...+..+.+..+.+.
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 9887766667789999999999864 35899999999999999999999999998887777666431
Q ss_pred -----CCCCCC--------CccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 312 -----GVDFES--------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 312 -----~~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
...++. .....+++++.+||.+||.+||++|||+.|+|+||||++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000110 012246899999999999999999999999999999987543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-55 Score=415.01 Aligned_cols=263 Identities=27% Similarity=0.409 Sum_probs=214.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe------
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED------ 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~------ 166 (447)
-++|++.+.||+|+||+||+|++..+|+.||||++.+... ......++.+|+.+|++++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence 3669999999999999999999999999999999866543 2344567889999999997 9999999998854
Q ss_pred --CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCC
Q 013201 167 --RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGL 244 (447)
Q Consensus 167 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~ 244 (447)
++.+|+|||||.++.+.........+++..++.+++||+.||.|||++||+||||||+|||++. +..+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~---~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecC---CCcEEeeecce
Confidence 4568999999988776655555677999999999999999999999999999999999999954 45699999999
Q ss_pred ceeccCCC-----ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC
Q 013201 245 SVFIDEGK-----VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFES 317 (447)
Q Consensus 245 a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 317 (447)
+....... .....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+.......+.+....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98665322 223468999999999875 35899999999999999999999999998887777666543222111
Q ss_pred Ccc----------------------------ccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCC
Q 013201 318 EPW----------------------------LLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEA 360 (447)
Q Consensus 318 ~~~----------------------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~ 360 (447)
..+ ...+++++|||.+||++||++|||++|+|+||||+..+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p 314 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 314 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence 110 0137788999999999999999999999999999975443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=407.48 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=212.9
Q ss_pred cceeecce-eccccCeEEEEEEECCC--CCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKE-LGRGQFGITYLCTENST--GNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~-lg~G~~g~Vy~~~~~~~--~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+.|.+.+. ||+|+||+||+|.++.+ +..||||++.+. ......+.+.+|+.+|++++ |||||++++++.++ .+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-eE
Confidence 45788874 99999999999987643 457999988543 34556788999999999997 99999999998754 58
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
|||||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~---~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR---HYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET---TEEEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC---Cceeeccchhhhccc
Confidence 8999999999999987654 569999999999999999999999999999999999999654 469999999998776
Q ss_pred CCCce----eecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 250 EGKVY----RDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 250 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
..... ....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..++...+.++... +.+ ..+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~-~~p--~~~ 237 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-ECP--PEC 237 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-CCC--TTC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CCC--CcC
Confidence 54322 2357899999999986 568999999999999999998 99999998888888888776532 222 358
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHH---hcCCCcc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEV---LEHPWMR 355 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~---l~h~~~~ 355 (447)
|+++.+||.+||+.||++|||+.+| |+|+|+.
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999988 5677764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=422.60 Aligned_cols=263 Identities=25% Similarity=0.431 Sum_probs=213.5
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
...++.++|++.+.||+|+||+||+|+++.+|+.||||++.+. .......+.+.+|+.+|++++ |||||+++++|...
T Consensus 12 ~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD 89 (346)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC
T ss_pred ceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh-hcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccC
Confidence 3345788999999999999999999999999999999998653 334556678899999999997 99999999999765
Q ss_pred C------eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEec
Q 013201 168 Q------SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATD 241 (447)
Q Consensus 168 ~------~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~D 241 (447)
+ .+||||||| |.+|..++ +.+.+++..++.++.||+.||.|||++||+||||||+|||++ .+..+||+|
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~---~~~~~kl~D 164 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILD 164 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECC
T ss_pred ccccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc---ccccccccc
Confidence 4 579999999 55666554 556899999999999999999999999999999999999994 445699999
Q ss_pred CCCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----
Q 013201 242 FGLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVD----- 314 (447)
Q Consensus 242 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~----- 314 (447)
||++...... ....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+....+..+......
T Consensus 165 fg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 165 FGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 9999876543 346789999999998753 4789999999999999999999999988877666554432111
Q ss_pred ------------------CCCCc----cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCC
Q 013201 315 ------------------FESEP----WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGE 359 (447)
Q Consensus 315 ------------------~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~ 359 (447)
..... ...+++++.+||.+||..||++|||++|+|+||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 11111 1246899999999999999999999999999999987543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=403.95 Aligned_cols=246 Identities=24% Similarity=0.408 Sum_probs=202.7
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||+||+|++. +++.||||++.+. ....+++.+|+.++++++ ||||+++++++.+++.+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG----AMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS----SSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC----cCcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence 35999999999999999999986 5678999988543 234567999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++ .+..+||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---GGGCEEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---CCCCeEecccchheeccCCC
Confidence 9999999999998765 4589999999999999999999999999999999999994 44579999999998765433
Q ss_pred c--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 253 V--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 253 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
. .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||...+..+++..+..+...... ..+++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---TTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---cccCHHHH
Confidence 2 23467999999999987 569999999999999999999 57777777887888888776433222 25789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+||.+||+.||++|||++|+++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.5e-55 Score=414.67 Aligned_cols=254 Identities=28% Similarity=0.499 Sum_probs=213.1
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe--CCeE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED--RQSV 170 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~ 170 (447)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. ..+++.+|+.+|+++.+||||+++++++.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 35699999999999999999999999999999998532 346788999999999879999999999974 4569
Q ss_pred EEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 171 HLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
++|||||.+++|... .+.+++..++.+++||+.||.|||++||+||||||+|||++.++ ..+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~--~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC--CeeeecccccceeccC
Confidence 999999999999765 35799999999999999999999999999999999999997544 3599999999998877
Q ss_pred CCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHH-HHHHHHHh-------------CCCC
Q 013201 251 GKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEK-GIFDAILK-------------GGVD 314 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~-------------~~~~ 314 (447)
.......+||+.|+|||++.+ .++.++||||+||++|+|++|..||...... .....+.+ ....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 766777899999999998753 4899999999999999999999999765432 22222111 0000
Q ss_pred --------------------CCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 315 --------------------FESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 315 --------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
........++++++|||++||.+||++|||++|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 1111223578999999999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=405.47 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=211.7
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++.+.||+|+||+||+|+++ +++.||||++... ....+.+.+|+.+|++++ |||||++++++.+ +.+||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT----SSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC----cCCHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEE
Confidence 467999999999999999999986 5788999988543 234567999999999997 9999999998754 56789
Q ss_pred EEeccCCCchHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQ--GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.+..+||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccC
Confidence 99999999999876543 359999999999999999999999999999999999999 4556799999999998765
Q ss_pred CCc--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GKV--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
... .....||+.|+|||++. +.++.++|||||||++|||+|| .+||...+..+++..+..+..... + ..++++
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~-p--~~~~~~ 238 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-P--DNCPEE 238 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-C--TTCCHH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-c--ccChHH
Confidence 432 23457899999999986 5689999999999999999995 556667777777777776543222 2 358999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc--CCCccC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE--HPWMRE 356 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~--h~~~~~ 356 (447)
+.+||.+||+.||++|||++++++ |+||..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999999987 778753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=418.26 Aligned_cols=261 Identities=32% Similarity=0.536 Sum_probs=217.2
Q ss_pred cceeecceeccccCeEEEEEEEC---CCCCEEEEEEeeccccC-ChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTEN---STGNSYACKSILKRKLV-NKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
++|++++.||+|+||+||+|++. .+|+.||||++.+.... +....+.+.+|+.+|+++++||||+++++++++...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 55999999999999999999974 46899999998654432 223356678999999999967999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 170 VHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
+++|||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~---~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecC---CCCEEEeeccchhhhc
Confidence 9999999999999999999999999999999999999999999999999999999999954 4569999999998764
Q ss_pred CC--CceeecCCcccccccccccc---cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 250 EG--KVYRDIVGSAYYVAPEVLRR---SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 250 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.. .......|++.|+|||.+.+ .++.++|||||||+||+|++|..||.+.........+.+.......+....+|
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 33 23345789999999999853 47889999999999999999999998765544433333322111222223589
Q ss_pred hHHHHHHHHhcccCCCCCC-----CHHHHhcCCCccCC
Q 013201 325 DSAKDLVRKMLIQDPKKRI-----TSAEVLEHPWMREG 357 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~-----t~~~~l~h~~~~~~ 357 (447)
+++++||.+||++||.+|| |++|+|+||||++.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 9999999999999999999 58999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=398.56 Aligned_cols=246 Identities=22% Similarity=0.368 Sum_probs=215.1
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
+.|++.+.||+|+||+||+|+++ +++.||||++.+.. ...+.+.+|+.++++++ ||||+++++++.+++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc----CCHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence 35899999999999999999985 68899999986543 23567999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC
Q 013201 174 MELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 252 (447)
||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.+..+||+|||++.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence 999999999998765 4569999999999999999999999999999999999999 445579999999998765433
Q ss_pred c--eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 253 V--YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 253 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
. .....||+.|+|||++. ..++.++|||||||++|||+| |+.||.+.+..++...+..+.... .+ ..+++++.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-~p--~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RP--HLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-CC--TTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC-Cc--ccccHHHH
Confidence 2 23467999999999986 568999999999999999998 899999999999888888764332 22 35789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+||.+||+.||++|||++++++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=414.11 Aligned_cols=264 Identities=29% Similarity=0.416 Sum_probs=212.3
Q ss_pred ccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCC--
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQ-- 168 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 168 (447)
++..+|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|++|+ ||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccc
Confidence 45677999999999999999999999999999999986432 3455678899999999997 999999999987543
Q ss_pred ---eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 169 ---SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 169 ---~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
.+||++ |+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 82 ~~~~~~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---~~~~~kl~DfG~a 156 (345)
T d1pmea_ 82 QMKDVYLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLA 156 (345)
T ss_dssp TCCCEEEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTC
T ss_pred ccceEEEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---CCCCEEEcccCce
Confidence 355555 5568999999865 4799999999999999999999999999999999999995 4457999999999
Q ss_pred eeccCCC----ceeecCCccccccccccc--ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC------
Q 013201 246 VFIDEGK----VYRDIVGSAYYVAPEVLR--RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGV------ 313 (447)
Q Consensus 246 ~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------ 313 (447)
....... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.............
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 8654332 234568999999999975 3478999999999999999999999988876655544432100
Q ss_pred -----------------CCCCC----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCC
Q 013201 314 -----------------DFESE----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASD 362 (447)
Q Consensus 314 -----------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~ 362 (447)
..... .+..+++++++||.+||++||++|||++|+|+||||++.....+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~ 306 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence 00001 12356889999999999999999999999999999997655433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=400.12 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=218.6
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
++|++.+.||+|+||+||+|++..+++.||||++.... .......++.+|+.+|++++ ||||+++++++.+...+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence 46999999999999999999999999999999986543 34456788999999999997 99999999999999999999
Q ss_pred EeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCCC-
Q 013201 174 MELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEGK- 252 (447)
Q Consensus 174 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 252 (447)
+|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++. ...+||+|||.+.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~---~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TCCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc---CCceeeeecchhhcccCCCc
Confidence 999999999888888889999999999999999999999999999999999999954 4469999999998765433
Q ss_pred ceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCC-CCCHHHHHHHHHhCCCCC--------------
Q 013201 253 VYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFW-AETEKGIFDAILKGGVDF-------------- 315 (447)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~-------------- 315 (447)
......+++.|+|||++.. .++.++|||||||++|||++|..||. +.+..+.+..+.......
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 3334578889999998763 37899999999999999999998865 445555555543311100
Q ss_pred -----------CCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 316 -----------ESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 316 -----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
.......+++.+.+||.+||+.||++|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 001112468899999999999999999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=413.50 Aligned_cols=268 Identities=24% Similarity=0.383 Sum_probs=217.5
Q ss_pred CccccccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 88 PLEDIRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
....+.++|++.+.||+|+||+||+|++..+|+.||||++.+.. .+....+.+.+|+.+|++++ ||||+++++++...
T Consensus 12 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 89 (348)
T ss_dssp SEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred ccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeec
Confidence 34456678999999999999999999999999999999986543 34455677899999999997 99999999998633
Q ss_pred -----CeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecC
Q 013201 168 -----QSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDF 242 (447)
Q Consensus 168 -----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Df 242 (447)
...++||+|+.||+|.+++. .+++++..++.++.||+.||.|||++||+||||||+|||++. ++.+|++||
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~---~~~~kl~df 165 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILDF 165 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEECCC
T ss_pred cccccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc---ccccccccc
Confidence 33455667777999998874 457999999999999999999999999999999999999954 456999999
Q ss_pred CCceeccCCCceeecCCcccccccccccc--cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----
Q 013201 243 GLSVFIDEGKVYRDIVGSAYYVAPEVLRR--SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGGVDFE---- 316 (447)
Q Consensus 243 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~---- 316 (447)
|++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.+......
T Consensus 166 g~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 166 GLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp ----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred chhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 99976543 3345689999999998653 478999999999999999999999999888777776654322111
Q ss_pred -------------------CC----ccccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCC
Q 013201 317 -------------------SE----PWLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDK 363 (447)
Q Consensus 317 -------------------~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~ 363 (447)
.. .+..++++++|||.+||..||++|||++|+|+||||++.......
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~ 313 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC
Confidence 01 113478999999999999999999999999999999986554443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=410.18 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=203.0
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-----
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED----- 166 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----- 166 (447)
+.++|++.+.||+|+||+||+|++..+|+.||||++.+.. .......++.+|+.+|++++ ||||++++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccc
Confidence 4477999999999999999999999999999999986543 34556678899999999997 9999999999953
Q ss_pred -CCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCc
Q 013201 167 -RQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLS 245 (447)
Q Consensus 167 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a 245 (447)
...+|+|||||.++ +.+.+ ...+++..++.+++||+.||.|||++||+||||||+|||++. +..+|++|||++
T Consensus 93 ~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~---~~~~kl~df~~~ 166 (355)
T d2b1pa1 93 EFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLA 166 (355)
T ss_dssp TCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCCCC-
T ss_pred cCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccc---ccceeeechhhh
Confidence 47899999999765 44444 457999999999999999999999999999999999999954 446999999999
Q ss_pred eeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------------
Q 013201 246 VFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILKGG------------ 312 (447)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~------------ 312 (447)
............+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 8877766667789999999999986 458999999999999999999999999887766655543211
Q ss_pred ----------CCCCCCc----------------cccCChHHHHHHHHhcccCCCCCCCHHHHhcCCCccCC
Q 013201 313 ----------VDFESEP----------------WLLISDSAKDLVRKMLIQDPKKRITSAEVLEHPWMREG 357 (447)
Q Consensus 313 ----------~~~~~~~----------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~ 357 (447)
....... ....++++++||++||..||++|||++|+|+||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 1111000 11246789999999999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=394.21 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=207.3
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 172 (447)
.+.|++++.||+|+||+||+|+++.+ +.||||++... ....+.+.+|+.+|++++ |||||++++++.+ +.+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~----~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG----TMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT----SSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc----cCCHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEE
Confidence 35699999999999999999998755 57999998543 234578999999999998 9999999999854 56789
Q ss_pred EEeccCCCchHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIA--QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||++|+|..++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhccC
Confidence 9999999999888754 35699999999999999999999999999999999999994 445799999999987654
Q ss_pred CC--ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhCCCCCCCCccccCChH
Q 013201 251 GK--VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFDAILKGGVDFESEPWLLISDS 326 (447)
Q Consensus 251 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 326 (447)
.. ......||+.|+|||++. +.++.++|||||||++|||++| .+||......+++..+.++... +. ...++++
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-~~--~~~~~~~ 242 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PC--PPECPES 242 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CC--CTTSCHH
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CC--CcccCHH
Confidence 33 223467999999999986 5689999999999999999995 5556666777778777765432 22 2358999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc--CCCccCCC
Q 013201 327 AKDLVRKMLIQDPKKRITSAEVLE--HPWMREGG 358 (447)
Q Consensus 327 ~~~li~~~L~~dp~~R~t~~~~l~--h~~~~~~~ 358 (447)
+++||.+||+.||++||++++|++ ++||....
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999999999999999987 88997653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-53 Score=393.06 Aligned_cols=248 Identities=22% Similarity=0.379 Sum_probs=201.5
Q ss_pred cceeecceeccccCeEEEEEEECCCC----CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTG----NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+.|++.++||+|+||.||+|.++.++ ..||||.+... ........+.+|+.+|++++ |||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence 34999999999999999999987654 46999988543 23445567899999999997 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
.++|||||.++++.+.+... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence 99999999999999887765 569999999999999999999999999999999999999 45567999999999876
Q ss_pred cCCC----ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhCCCCCCCCcccc
Q 013201 249 DEGK----VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFDAILKGGVDFESEPWLL 322 (447)
Q Consensus 249 ~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 322 (447)
.... ......||+.|+|||++. +.++.++|||||||++|||++| .+||......+++..+..+.. .+.+ ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~~~--~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LPTP--MD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CCCC--TT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-CCCc--hh
Confidence 5432 122357899999999986 5699999999999999999995 555666677777777766533 2222 35
Q ss_pred CChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 323 ISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 323 ~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+++++.+||.+||+.||++|||+.||++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 7899999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=393.95 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=201.8
Q ss_pred ccceeecceeccccCeEEEEEEECCCC---CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCe
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTG---NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQS 169 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 169 (447)
+++|++++.||+|+||.||+|++..++ ..||||.+.. .......+.+.+|+.+|++++ ||||+++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~--~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT--TTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc--ccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence 467999999999999999999987654 4678887643 234555678999999999997 999999999986 467
Q ss_pred EEEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceec
Q 013201 170 VHLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFI 248 (447)
Q Consensus 170 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~ 248 (447)
+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+ ..+||+|||+++..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~---~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN---DCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET---TEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC---CcEEEccchhheec
Confidence 89999999999999987664 469999999999999999999999999999999999999654 46999999999876
Q ss_pred cCCC--ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 249 DEGK--VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 249 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.... ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+.+..+++..+..+.... .+..+|
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence 5432 223467899999999986 569999999999999999998 899999999988888888765332 223689
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+++.+||.+||+.||++|||+.||++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=401.87 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=208.8
Q ss_pred cceeecceeccccCeEEEEEEECCCCCE--EEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNS--YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.|++++.||+|+||+||+|+++.++.. ||||.+.. .......+.+.+|+++|+++.+|||||++++++.+++.+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC--C------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECc--ccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 4599999999999999999999988875 56666532 2234456779999999999966999999999999999999
Q ss_pred EEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCC
Q 013201 172 LVMELCSGGELFDKIIAQ----------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGA 235 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~ 235 (447)
+|||||+||+|.++|... ..+++..+..++.||+.||.|||+++|+||||||+|||++. +.
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~---~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE---NY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG---GG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC---CC
Confidence 999999999999998754 56899999999999999999999999999999999999954 45
Q ss_pred ceEEecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCC-CCCCCCCHHHHHHHHHhCCC
Q 013201 236 MLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGV-PPFWAETEKGIFDAILKGGV 313 (447)
Q Consensus 236 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~~~ 313 (447)
.+||+|||+++............||+.|+|||.+. +.|+.++|||||||++|||++|. +||.+.+..+++..+.++..
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 69999999998765544444567999999999986 56899999999999999999965 67888888888888776533
Q ss_pred CCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 314 DFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 314 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
++ ....+++++++||.+||+.||++|||+++|++|
T Consensus 245 -~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 -LE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -CC--CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22 223579999999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=391.23 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=203.4
Q ss_pred cceeecceeccccCeEEEEEEECCC-C--CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENST-G--NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
+.|++.+.||+|+||.||+|++..+ + ..||||++.+.........+.+.+|+.+|++++ ||||+++++++.+ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cch
Confidence 4599999999999999999986533 3 368999887666555566678999999999997 9999999999976 467
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
++|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~---~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET---TEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc---cceeeccchhhhhcc
Confidence 8999999999999877654 569999999999999999999999999999999999999654 469999999999875
Q ss_pred CCCc----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Q 013201 250 EGKV----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLI 323 (447)
Q Consensus 250 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 323 (447)
.... .....|+..|+|||++. ..++.++|||||||++|||+| |..||.+.+..+....+.+....++.+ ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--EDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC--TTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc--ccc
Confidence 5432 22346888999999986 458999999999999999998 899999999999999998876655433 368
Q ss_pred ChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 324 SDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 324 s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
|+++++||.+||..||++|||+++|++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=397.40 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=199.4
Q ss_pred ccceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED- 166 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 166 (447)
.+.|++++.||+|+||.||+|++.. +++.||||++.... .....+.+.+|+.++.++.+|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 4679999999999999999999754 34689999885432 344556788899999999889999999998765
Q ss_pred CCeEEEEEeccCCCchHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeec
Q 013201 167 RQSVHLVMELCSGGELFDKIIAQ----------------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSN 230 (447)
Q Consensus 167 ~~~~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~ 230 (447)
+..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~- 168 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 168 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC-
Confidence 45689999999999999999754 2488999999999999999999999999999999999994
Q ss_pred CCCCCceEEecCCCceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhC-CCCCCCCCHHHHH
Q 013201 231 KDGGAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIF 305 (447)
Q Consensus 231 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~ 305 (447)
.++.+||+|||+|+...... ......||+.|+|||++. +.++.++|||||||++|||+|| .+||.+....+.+
T Consensus 169 --~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 169 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp --GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred --CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 44579999999998654332 223468999999999986 5589999999999999999986 5678776555444
Q ss_pred HHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 306 DAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 306 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
..+......+..+ ..+++++++||.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCC--ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444333333322 2579999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=396.63 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=202.9
Q ss_pred ceeecceeccccCeEEEEEEECCCCCE----EEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeE
Q 013201 95 FYTLGKELGRGQFGITYLCTENSTGNS----YACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSV 170 (447)
Q Consensus 95 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 170 (447)
.|++.+.||+|+||+||+|++..+|+. ||+|.+... ......+.+.+|+.+|++++ |||||++++++.++ ..
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-Ce
Confidence 499999999999999999999888874 666665432 23345678999999999997 99999999999765 56
Q ss_pred EEEEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceecc
Q 013201 171 HLVMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFID 249 (447)
Q Consensus 171 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~ 249 (447)
++++||+.+|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~---~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET---TEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC---CCeEeeccccceecc
Confidence 7888999999999888764 569999999999999999999999999999999999999544 479999999998765
Q ss_pred CCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCC
Q 013201 250 EGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 250 ~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+.+..++...+..+... +.+ ..++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~~p--~~~~ 239 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQP--PICT 239 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-CCC--TTBC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CCC--cccC
Confidence 4332 23357899999999876 568999999999999999998 89999988888887777776432 222 2578
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+++.+||.+||+.||.+|||+.|+++|
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-52 Score=392.59 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=213.7
Q ss_pred ccccceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 91 DIRQFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
..++.|++.+.||+|+||+||+|+++. ++..||||++.... .....+++.+|+.+|++++ ||||+++++++.
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~ 86 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCA 86 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeec
Confidence 345679999999999999999999753 56789999885432 3445678999999999997 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecC
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQG------------------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDL 221 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~------------------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dl 221 (447)
+.+..++||||+++|+|.+++.... .+++..+..|+.||+.||+|||+++||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999986532 3788999999999999999999999999999
Q ss_pred CCCceEeecCCCCCceEEecCCCceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCC-CCC
Q 013201 222 KPENFLLSNKDGGAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGV-PPF 296 (447)
Q Consensus 222 kp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~-~pf 296 (447)
||+|||++ .+..+||+|||+++...+.. ......||+.|+|||++. ..|+.++|||||||++|||++|. +||
T Consensus 167 Kp~NILld---~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 167 ATRNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SGGGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cccceEEC---CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999994 45579999999998654332 233567999999999987 46999999999999999999985 789
Q ss_pred CCCCHHHHHHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 297 WAETEKGIFDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 297 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
.+.+..++...+.++..... ...+++++.+||.+||+.||++|||+.||++
T Consensus 244 ~~~~~~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999998888764322 2357999999999999999999999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=389.83 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=209.0
Q ss_pred ccceeecceeccccCeEEEEEEECCCC-------CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEE
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTG-------NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYE 165 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 165 (447)
.+.|++++.||+|+||.||+|++..++ ..||||++.+.. .......+.+|+..+.++.+|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 467999999999999999999976554 379999885432 34456788899999999966999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 166 DRQSVHLVMELCSGGELFDKIIAQG----------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 166 ~~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
+++.+|+|||||.+|+|.++|.... .+++..++.++.||+.||+|||+++||||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 9999999999999999999997543 489999999999999999999999999999999999994
Q ss_pred cCCCCCceEEecCCCceeccCCC---ceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGK---VYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 304 (447)
. +..+||+|||++....... ......||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+.+...+
T Consensus 170 ~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 170 E---DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp T---TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred C---CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 4 4569999999998765432 233468999999999886 679999999999999999998 7999998888888
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+..+..+. .++.+ ..+++++.+||.+||+.||++|||+.||++
T Consensus 247 ~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGH-RMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTC-CCCCC--SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCC-CCCCC--ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 87776653 33332 358999999999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=383.57 Aligned_cols=242 Identities=23% Similarity=0.335 Sum_probs=199.5
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-CCeEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED-RQSVHL 172 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~l 172 (447)
+.|++++.||+|+||.||+|+++ |..||||++.+. ...+.+.+|++++++++ ||||+++++++.+ .+.+||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEE
Confidence 45999999999999999999985 778999988542 34577899999999997 9999999998854 567899
Q ss_pred EEeccCCCchHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 173 VMELCSGGELFDKIIAQG--HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
|||||++|+|.++|.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec---CCCCEeecccccceecCC
Confidence 999999999999997653 489999999999999999999999999999999999994 455799999999987654
Q ss_pred CCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccccCChHHH
Q 013201 251 GKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGIFDAILKGGVDFESEPWLLISDSAK 328 (447)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 328 (447)
.. ....+|+.|+|||++. +.++.++|||||||++|||+| |.+||...+..++...+..+... +.+ ..++++++
T Consensus 156 ~~--~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~-~~~--~~~~~~~~ 230 (262)
T d1byga_ 156 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DAP--DGCPPAVY 230 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-CCC--TTCCHHHH
T ss_pred CC--ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CCC--ccCCHHHH
Confidence 32 3457899999999885 569999999999999999998 79999988888888887665332 222 24789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 013201 329 DLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 329 ~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+||.+||..||.+|||+.+++++
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=389.48 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=212.5
Q ss_pred ccceeecceeccccCeEEEEEEEC-----CCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTEN-----STGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.+.|++++.||+|+||.||+|++. .+++.||||++.+.. .......+.+|+.+++++.+|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 467999999999999999999863 456789999986532 3456678999999999997799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEee
Q 013201 168 QSVHLVMELCSGGELFDKIIAQG------------------HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLS 229 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~ 229 (447)
+.+|||||||++|+|.+++.+.. .+++..+..++.||+.||.|||++|||||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999997643 488999999999999999999999999999999999995
Q ss_pred cCCCCCceEEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhh-CCCCCCCCCHHHH
Q 013201 230 NKDGGAMLKATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLS-GVPPFWAETEKGI 304 (447)
Q Consensus 230 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 304 (447)
. ...+||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|||+| |.+||.+....+.
T Consensus 180 ~---~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 180 H---GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp T---TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred c---cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 4 44799999999987654332 23367899999999986 568999999999999999998 6666767666666
Q ss_pred HHHHHhCCCCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc
Q 013201 305 FDAILKGGVDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE 350 (447)
Q Consensus 305 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 350 (447)
+..+.+.......+ ..+++++.+||.+||+.||++|||+++|++
T Consensus 257 ~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66655554443333 247899999999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-51 Score=388.01 Aligned_cols=260 Identities=20% Similarity=0.255 Sum_probs=207.6
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.++|++++.||+|+||.||+|++..+|+.||||++..... .+.+.+|+++++.+.+|++|+.+..++.+.+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 34679999999999999999999999999999998765322 2357889999999987777888888889999999
Q ss_pred EEEeccCCCchHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccC
Q 013201 172 LVMELCSGGELFDKIIA-QGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDE 250 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 250 (447)
+|||||. ++|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+.+..+||+|||+|+....
T Consensus 80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999995 566555544 56799999999999999999999999999999999999997666667899999999987654
Q ss_pred CC--------ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCCHHHHHHHHH---hCCCCCCC-
Q 013201 251 GK--------VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAIL---KGGVDFES- 317 (447)
Q Consensus 251 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~---~~~~~~~~- 317 (447)
.. ......||+.|+|||++.+ .++.++|||||||++|||+||..||...........+. ......+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 32 2234689999999999875 58999999999999999999999998765443332221 11111111
Q ss_pred CccccCChHHHHHHHHhcccCCCCCCCHHH---HhcCCCccCC
Q 013201 318 EPWLLISDSAKDLVRKMLIQDPKKRITSAE---VLEHPWMREG 357 (447)
Q Consensus 318 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~---~l~h~~~~~~ 357 (447)
.....+|+++.+||.+||+.||++||++++ +|+|+|.+..
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 112357899999999999999999999874 5778776554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=384.54 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=217.2
Q ss_pred ccceeecceeccccCeEEEEEEECC-----CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeC
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENS-----TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDR 167 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 167 (447)
.+.|++++.||+|+||+||+|.++. ++..||||++.+. ........+.+|+.+++++. ||||+++++++..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecC
Confidence 4679999999999999999998853 3578999988543 24455667899999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCce
Q 013201 168 QSVHLVMELCSGGELFDKIIAQ----------GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAML 237 (447)
Q Consensus 168 ~~~~lv~e~~~g~~L~~~l~~~----------~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~v 237 (447)
...++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +.+.++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 9999999999999999988653 236889999999999999999999999999999999999 555679
Q ss_pred EEecCCCceeccCCCc---eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhC-CCCCCCCCHHHHHHHHHhCC
Q 013201 238 KATDFGLSVFIDEGKV---YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSG-VPPFWAETEKGIFDAILKGG 312 (447)
Q Consensus 238 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~ 312 (447)
||+|||+++....... .....||+.|+|||.+. +.++.++|||||||++|||+|| .+||.+.+..+.+..+.++.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999987654332 22346899999999986 5588999999999999999998 58898889999998888765
Q ss_pred CCCCCCccccCChHHHHHHHHhcccCCCCCCCHHHHhc------CCCccC
Q 013201 313 VDFESEPWLLISDSAKDLVRKMLIQDPKKRITSAEVLE------HPWMRE 356 (447)
Q Consensus 313 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~------h~~~~~ 356 (447)
..... ..+++.+.+||.+||+.||++|||+.++++ +|+|++
T Consensus 253 ~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 253 LLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred CCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 43222 257899999999999999999999999987 566553
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=378.64 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=201.2
Q ss_pred eecceeccccCeEEEEEEECCCC---CEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEe-CCeEEE
Q 013201 97 TLGKELGRGQFGITYLCTENSTG---NSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYED-RQSVHL 172 (447)
Q Consensus 97 ~~~~~lg~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~l 172 (447)
.+.++||+|+||+||+|++..++ ..||||++.+ ..+....+++.+|+++|++++ ||||+++++++.+ ++.+++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence 34688999999999999987654 3689998853 335666788999999999997 9999999999765 578999
Q ss_pred EEeccCCCchHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEecCCCceeccCC
Q 013201 173 VMELCSGGELFDKIIAQ-GHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKATDFGLSVFIDEG 251 (447)
Q Consensus 173 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 251 (447)
|||||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+ +++..+||+|||+++.....
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccc
Confidence 99999999999988754 347788999999999999999999999999999999999 45567999999999876543
Q ss_pred Cc-----eeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCC-CHHHHHHHHHhCCCCCCCCccccCC
Q 013201 252 KV-----YRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAE-TEKGIFDAILKGGVDFESEPWLLIS 324 (447)
Q Consensus 252 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s 324 (447)
.. .....||+.|+|||.+. +.++.++||||||+++|||+||..||... +..+....+..+... ..+ ..++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-~~p--~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-LQP--EYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-CCC--TTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CCc--ccCc
Confidence 22 22357899999999876 56999999999999999999977777654 444555666666433 222 2578
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
+++.+||.+||+.||++||++.|+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.1e-49 Score=368.22 Aligned_cols=252 Identities=19% Similarity=0.272 Sum_probs=205.8
Q ss_pred cccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 92 IRQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
+.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.+.+|+||+.+++++......|
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 4567999999999999999999999999999999875432 22356789999999987899999999999999999
Q ss_pred EEEeccCCCchHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCC--CCCceEEecCCCceec
Q 013201 172 LVMELCSGGELFDKIIAQG-HYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKD--GGAMLKATDFGLSVFI 248 (447)
Q Consensus 172 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~~~vkl~Dfg~a~~~ 248 (447)
+||||| +++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++... ....+||+|||+|+..
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 679999887754 699999999999999999999999999999999999996532 2457999999999876
Q ss_pred cCCC--------ceeecCCcccccccccccc-cCCCCCcchhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCC
Q 013201 249 DEGK--------VYRDIVGSAYYVAPEVLRR-SYGKEIDVWSAGVILYILLSGVPPFWAET---EKGIFDAILKGGVDFE 316 (447)
Q Consensus 249 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~ 316 (447)
.... .....+||+.|||||++.+ .++.++|||||||++|||+||..||.+.. .......+.......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 4321 2335689999999999875 59999999999999999999999997543 3333333322211111
Q ss_pred C-CccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 013201 317 S-EPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 317 ~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
. .....+|+++.+++..|+..+|++||+++.+.
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 1 11124789999999999999999999987764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=369.02 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=190.4
Q ss_pred ccceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHH--HHHHHHHhccCCCCeeEEEEEEEeCC--
Q 013201 93 RQFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIK--REIQIMQHLSGQQNIVEFRGAYEDRQ-- 168 (447)
Q Consensus 93 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~--~E~~~l~~l~~h~~iv~~~~~~~~~~-- 168 (447)
.+.|.+.+.||+|+||.||+|++ +|+.||||++... ...... .|+..+.+++ ||||+++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT 72 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCc
Confidence 45699999999999999999986 5889999988432 223333 4555555676 999999999997654
Q ss_pred --eEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--------cCcEeecCCCCceEeecCCCCCceE
Q 013201 169 --SVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHF--------MGVMHRDLKPENFLLSNKDGGAMLK 238 (447)
Q Consensus 169 --~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~--------~~ivH~Dlkp~Nill~~~~~~~~vk 238 (447)
.+|+|||||++|+|.++|.+. .+++.....++.|++.||.|+|. +||+||||||+|||+ +.++.+|
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~K 148 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC 148 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeE
Confidence 689999999999999999764 68999999999999999999996 599999999999999 4455799
Q ss_pred EecCCCceeccCCCc-----eeecCCccccccccccccc-------CCCCCcchhHHHHHHHHhhCCCCCCCC-------
Q 013201 239 ATDFGLSVFIDEGKV-----YRDIVGSAYYVAPEVLRRS-------YGKEIDVWSAGVILYILLSGVPPFWAE------- 299 (447)
Q Consensus 239 l~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~elltg~~pf~~~------- 299 (447)
|+|||++........ ....+||+.|+|||++.+. ++.++|||||||+||||+||..||...
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 999999987654332 2346899999999998643 567899999999999999998876321
Q ss_pred --------CHHHHHHHHHhCCCCCCCCccc---cCChHHHHHHHHhcccCCCCCCCHHHHhcC
Q 013201 300 --------TEKGIFDAILKGGVDFESEPWL---LISDSAKDLVRKMLIQDPKKRITSAEVLEH 351 (447)
Q Consensus 300 --------~~~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 351 (447)
........+.........+... .....+.+|+.+||+.||++|||+.||+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2233333333333322221111 123458899999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-45 Score=356.93 Aligned_cols=259 Identities=24% Similarity=0.425 Sum_probs=196.9
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhcc----------CCCCeeEEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLS----------GQQNIVEFRGA 163 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~~iv~~~~~ 163 (447)
++|++++.||+|+||+||+|++..+|+.||||++.+. ....+.+.+|+.+++.+. +|+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 4599999999999999999999999999999998643 233467788999998875 25789999988
Q ss_pred EEe--CCeEEEEEeccCCCchHHHH-H--HcCCCCHHHHHHHHHHHHHHHHHHHh-cCcEeecCCCCceEeecCCCC---
Q 013201 164 YED--RQSVHLVMELCSGGELFDKI-I--AQGHYTEKAAAALCRAIVNVVHHCHF-MGVMHRDLKPENFLLSNKDGG--- 234 (447)
Q Consensus 164 ~~~--~~~~~lv~e~~~g~~L~~~l-~--~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~--- 234 (447)
+.. ....+++|+++..+...... . ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 46677777776554433222 2 24568999999999999999999998 899999999999999755432
Q ss_pred CceEEecCCCceeccCCCceeecCCccccccccccc-ccCCCCCcchhHHHHHHHHhhCCCCCCCCCHH------HHHHH
Q 013201 235 AMLKATDFGLSVFIDEGKVYRDIVGSAYYVAPEVLR-RSYGKEIDVWSAGVILYILLSGVPPFWAETEK------GIFDA 307 (447)
Q Consensus 235 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~ 307 (447)
..+||+|||.+...... ....+||+.|+|||++. ..++.++||||+||++++|++|+.||...... ..+..
T Consensus 169 ~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred ceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 34899999999865442 34568999999999876 56899999999999999999999999654321 11111
Q ss_pred HHh--CC--------------------C--CCCC--------------CccccCChHHHHHHHHhcccCCCCCCCHHHHh
Q 013201 308 ILK--GG--------------------V--DFES--------------EPWLLISDSAKDLVRKMLIQDPKKRITSAEVL 349 (447)
Q Consensus 308 i~~--~~--------------------~--~~~~--------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 349 (447)
... +. . .... ......+++++|||.+||.+||.+|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 110 00 0 0000 00112467899999999999999999999999
Q ss_pred cCCCccCCC
Q 013201 350 EHPWMREGG 358 (447)
Q Consensus 350 ~h~~~~~~~ 358 (447)
+||||++..
T Consensus 327 ~Hp~f~~~~ 335 (362)
T d1q8ya_ 327 NHPWLKDTL 335 (362)
T ss_dssp TCGGGTTCT
T ss_pred cCcccCCCC
Confidence 999999653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=5.5e-27 Score=203.99 Aligned_cols=166 Identities=20% Similarity=0.206 Sum_probs=123.1
Q ss_pred eeecceeccccCeEEEEEEECCCCCEEEEEEeeccccC-----C----------hhhHHHHHHHHHHHHhccCCCCeeEE
Q 013201 96 YTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-----N----------KQDREDIKREIQIMQHLSGQQNIVEF 160 (447)
Q Consensus 96 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-----~----------~~~~~~~~~E~~~l~~l~~h~~iv~~ 160 (447)
|.+++.||+|+||+||+|++. +|+.||||++...... . ........+|...+.++. |.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence 568999999999999999985 6899999986432111 0 011233457888999997 8899988
Q ss_pred EEEEEeCCeEEEEEeccCCCchHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCcEeecCCCCceEeecCCCCCceEEe
Q 013201 161 RGAYEDRQSVHLVMELCSGGELFDKIIAQGHYTEKAAAALCRAIVNVVHHCHFMGVMHRDLKPENFLLSNKDGGAMLKAT 240 (447)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH~Dlkp~Nill~~~~~~~~vkl~ 240 (447)
+++. . .++||||+++..+.+ +++..+..++.|++.+|.|||++||+||||||+|||++.+ .++|+
T Consensus 80 ~~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~----~~~li 144 (191)
T d1zara2 80 YAWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE----GIWII 144 (191)
T ss_dssp EEEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT----EEEEC
T ss_pred EEec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC----CEEEE
Confidence 7653 2 269999998866532 4556678899999999999999999999999999999643 38999
Q ss_pred cCCCceeccCCCceeecCCcccccc------cccccccCCCCCcchhHHHH
Q 013201 241 DFGLSVFIDEGKVYRDIVGSAYYVA------PEVLRRSYGKEIDVWSAGVI 285 (447)
Q Consensus 241 Dfg~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwslG~i 285 (447)
|||+|........ ..|.. .+.+.+.|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 9999977643321 11221 12345678999999998543
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.80 E-value=2.1e-09 Score=77.37 Aligned_cols=60 Identities=27% Similarity=0.399 Sum_probs=54.7
Q ss_pred HHHHhhhhHHHhhhhcceeeeecCCC-CcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 388 KVIAEALSEEEIKGLKTMFANMDTDK-SGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 388 ~~i~~~~~~~~~~~l~~~F~~~D~~~-~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
....+.+++++.++++++|..||.++ +|+|+..||+.+|+.+|..++++|+++|++++|.
T Consensus 3 k~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~ 63 (82)
T d1wrka1 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDE 63 (82)
T ss_dssp HHHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCT
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 34556788899999999999999996 7999999999999999999999999999999984
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.76 E-value=1.5e-09 Score=77.33 Aligned_cols=55 Identities=40% Similarity=0.603 Sum_probs=51.8
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++++++.+++++|..||.|++|+|+.+||+.+|+.+|..++++++.+|++++|.
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~ 57 (77)
T d1f54a_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDV 57 (77)
T ss_dssp CCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4577888999999999999999999999999999999999999999999999884
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.75 E-value=2.8e-09 Score=76.66 Aligned_cols=55 Identities=33% Similarity=0.466 Sum_probs=51.7
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++++++.+++++|..||.|++|+|+.+||+.+|+.+|..+++.|+++|+.++|.
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~ 61 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDE 61 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 4578888999999999999999999999999999999999999999999999874
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.75 E-value=9.9e-10 Score=80.22 Aligned_cols=59 Identities=63% Similarity=0.923 Sum_probs=54.5
Q ss_pred HHHhhhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 389 VIAEALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 389 ~i~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.|++.++++++.+++++|..||.|++|+|+.+||+.+|+.+|..++++|++++++++|.
T Consensus 12 ~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~ 70 (87)
T d1s6ja_ 12 HMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70 (87)
T ss_dssp HSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCT
T ss_pred HHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCC
Confidence 45567778888899999999999999999999999999999999999999999999984
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=3.2e-08 Score=88.26 Aligned_cols=87 Identities=16% Similarity=0.076 Sum_probs=63.0
Q ss_pred cceeecceeccccCeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEEEE
Q 013201 94 QFYTLGKELGRGQFGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVHLV 173 (447)
Q Consensus 94 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 173 (447)
..|+..+..+-++.+.||+.. .+++.+++|+....... ....+.+|..+++.+..+--+++++.+..+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 446666665555567899875 45777888876543222 2335678999998887555578889888999999999
Q ss_pred EeccCCCchHHH
Q 013201 174 MELCSGGELFDK 185 (447)
Q Consensus 174 ~e~~~g~~L~~~ 185 (447)
|++++|.++.+.
T Consensus 89 ~~~l~G~~~~~~ 100 (263)
T d1j7la_ 89 MSEADGVLCSEE 100 (263)
T ss_dssp EECCSSEEHHHH
T ss_pred EEeccccccccc
Confidence 999998777543
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=98.64 E-value=4.5e-09 Score=73.96 Aligned_cols=54 Identities=37% Similarity=0.576 Sum_probs=50.9
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++++.+++++|+.||.+++|+|+.+||+.+|+.+|..++++++.++++.+|.
T Consensus 2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~ 55 (73)
T d2pq3a1 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 55 (73)
T ss_dssp CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 457788999999999999999999999999999999999999999999999884
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=98.63 E-value=7.4e-09 Score=74.36 Aligned_cols=51 Identities=27% Similarity=0.534 Sum_probs=47.8
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++++++++|+.||.|++|+|+.+||+.+|+.+| .++++||+++++++|.
T Consensus 2 ~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~ 52 (81)
T d2opoa1 2 PQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDT 52 (81)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCC
Confidence 56788999999999999999999999999999999 6899999999999984
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.61 E-value=8.1e-09 Score=69.70 Aligned_cols=48 Identities=27% Similarity=0.555 Sum_probs=45.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++++|+.||.+++|+|+.+||+.+|+.+|..++++++++|++.+|.
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~ 48 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEV 48 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCC
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCC
Confidence 367889999999999999999999999999999999999999999874
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.60 E-value=1.3e-08 Score=69.71 Aligned_cols=48 Identities=29% Similarity=0.553 Sum_probs=45.6
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++++|+.||.+++|+|+.+||+.+++.+|..++++|+++|++++|.
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~ 50 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 50 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCT
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCC
Confidence 468999999999999999999999999999999999999999999874
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.55 E-value=1.8e-08 Score=71.07 Aligned_cols=48 Identities=27% Similarity=0.385 Sum_probs=45.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++++++|+.||.+++|+|+.+||+.+|+.+|..++++++++|++++|.
T Consensus 9 eel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~ 56 (75)
T d1jc2a_ 9 EELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDK 56 (75)
T ss_dssp HHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCC
Confidence 578899999999999999999999999999999999999999999984
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.46 E-value=2.5e-07 Score=87.44 Aligned_cols=82 Identities=13% Similarity=0.118 Sum_probs=52.1
Q ss_pred cceeccccCeEEEEEEECCCCCEEEEEEeeccccC-C---hhhHHHHHHHHHHHHhccCC--CCeeEEEEEEEeCCeEEE
Q 013201 99 GKELGRGQFGITYLCTENSTGNSYACKSILKRKLV-N---KQDREDIKREIQIMQHLSGQ--QNIVEFRGAYEDRQSVHL 172 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~---~~~~~~~~~E~~~l~~l~~h--~~iv~~~~~~~~~~~~~l 172 (447)
.+.||.|....||++.+..+++.+++|.-...... . .....+...|.+.|+.+..+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45689999999999988777889999965432111 1 12334566788888877543 346666654 4555678
Q ss_pred EEeccCCCch
Q 013201 173 VMELCSGGEL 182 (447)
Q Consensus 173 v~e~~~g~~L 182 (447)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977544
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.46 E-value=9.5e-09 Score=58.42 Aligned_cols=31 Identities=29% Similarity=0.530 Sum_probs=29.0
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
++++++|+.||.|++|+|+.+||+.+|+.||
T Consensus 3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG 33 (33)
T d2hf5a1 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33 (33)
T ss_dssp HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 4789999999999999999999999999886
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=98.44 E-value=4.3e-08 Score=70.21 Aligned_cols=48 Identities=29% Similarity=0.475 Sum_probs=45.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++|+++|..||.+++|+|+.+||+.+|+.+|..++++|++++++++|.
T Consensus 15 e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~ 62 (81)
T d1fi5a_ 15 EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDK 62 (81)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCC
Confidence 468899999999999999999999999999999999999999999884
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.44 E-value=4.9e-08 Score=69.26 Aligned_cols=51 Identities=27% Similarity=0.469 Sum_probs=47.2
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+..++++++|+.||.|++|+|+.+||+.+|+.+|..++.+++.++++++|.
T Consensus 6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~ 56 (77)
T d1oqpa_ 6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADR 56 (77)
T ss_dssp SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCC
T ss_pred cHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 344678999999999999999999999999999999999999999999884
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.42 E-value=6.4e-08 Score=66.53 Aligned_cols=47 Identities=13% Similarity=0.454 Sum_probs=44.3
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++++|+.||.|++|+|+.+||+.+++.+|..+++++++++++.+|.
T Consensus 2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~ 48 (67)
T d1tiza_ 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDV 48 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCC
T ss_pred hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCC
Confidence 35789999999999999999999999999999999999999999884
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.34 E-value=4.9e-08 Score=67.26 Aligned_cols=48 Identities=23% Similarity=0.479 Sum_probs=44.6
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCC-CCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSK-LSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~-~~~~e~~~~~~~~d~ 447 (447)
++++++|+.||.+++|+|+.+||+.+|+.+|.. ++++|++.|++.+|.
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~ 50 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADE 50 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCC
Confidence 468899999999999999999999999999985 799999999999984
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.23 E-value=1.3e-06 Score=76.94 Aligned_cols=75 Identities=11% Similarity=0.086 Sum_probs=52.6
Q ss_pred eeccccC-eEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCC-CeeEEEEEEEeCCeEEEEEeccC
Q 013201 101 ELGRGQF-GITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQ-NIVEFRGAYEDRQSVHLVMELCS 178 (447)
Q Consensus 101 ~lg~G~~-g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-~iv~~~~~~~~~~~~~lv~e~~~ 178 (447)
.+..|.. +.||+... .++..+++|...... ...+..|+..++.|..+. .+++++.+..+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 3444443 67898874 456678888653322 234678888888776432 26778888888899999999998
Q ss_pred CCch
Q 013201 179 GGEL 182 (447)
Q Consensus 179 g~~L 182 (447)
|.++
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 8665
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=98.16 E-value=4.5e-07 Score=68.64 Aligned_cols=48 Identities=40% Similarity=0.511 Sum_probs=44.2
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
++++++|+.||.|++|+|+.+||+.+|+.+ |..++++|+++|++++|.
T Consensus 41 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~ 91 (109)
T d5pala_ 41 AQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDS 91 (109)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCC
Confidence 568899999999999999999999999887 678999999999999884
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.14 E-value=9.6e-07 Score=63.34 Aligned_cols=50 Identities=24% Similarity=0.370 Sum_probs=46.2
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
....++++|..+|.+++|+|+.+||+.+|..+|..++++|++.+++.+|.
T Consensus 18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~ 67 (83)
T d1wlza1 18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPV 67 (83)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCB
T ss_pred HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhcccc
Confidence 34568889999999999999999999999999999999999999998873
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.02 E-value=8.1e-07 Score=67.21 Aligned_cols=48 Identities=35% Similarity=0.533 Sum_probs=43.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh---CCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL---GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---~~~~~~~e~~~~~~~~d~ 447 (447)
..++++|+.||.|++|+|+.+||+.+|+.+ |..++++|+++|++++|.
T Consensus 41 ~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~ 91 (109)
T d1pvaa_ 41 NDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADK 91 (109)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCC
Confidence 457789999999999999999999999987 668999999999999884
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=97.99 E-value=1.8e-06 Score=68.84 Aligned_cols=48 Identities=17% Similarity=0.356 Sum_probs=45.3
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.+.++++|+.||.+++|+|+.+||+.+|..+|..++++|++++++++|
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d 122 (142)
T d1wdcb_ 75 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAP 122 (142)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCC
T ss_pred hhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhC
Confidence 356888999999999999999999999999999999999999999887
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=97.99 E-value=1.4e-06 Score=69.47 Aligned_cols=52 Identities=21% Similarity=0.472 Sum_probs=48.3
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+++++++++++|..||.+++|.|+.+||..+|+.+|..++++|+.+++++.+
T Consensus 2 ~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~~~~ 53 (142)
T d1wdcb_ 2 PQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEAP 53 (142)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHTTSS
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHHhcc
Confidence 5678899999999999999999999999999999999999999999987643
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.88 E-value=1.5e-06 Score=65.68 Aligned_cols=51 Identities=35% Similarity=0.475 Sum_probs=45.1
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHhC---CCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLG---SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~---~~~~~~e~~~~~~~~d~ 447 (447)
...++++++|+.||.|++|+|+.+||+.+++.++ ..++++++++|++.+|.
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~ 91 (108)
T d1rroa_ 38 MSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADN 91 (108)
T ss_dssp SCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCC
T ss_pred CCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCC
Confidence 3445788999999999999999999999999874 56899999999999984
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=97.87 E-value=2e-06 Score=64.78 Aligned_cols=50 Identities=30% Similarity=0.408 Sum_probs=44.8
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhC---CCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLG---SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~---~~~~~~e~~~~~~~~d~ 447 (447)
..++++++|+.||.+++|+|+.+|++.+++.++ ..++++++++|++++|.
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~ 90 (107)
T d2pvba_ 38 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDK 90 (107)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCT
T ss_pred CHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCC
Confidence 345688999999999999999999999999985 46899999999999884
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.86 E-value=3.4e-06 Score=67.06 Aligned_cols=49 Identities=33% Similarity=0.485 Sum_probs=45.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.++++|+.+|.+++|+|+.+||+.+|..+|..++++|++++++.+|.
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~ 123 (140)
T d1ggwa_ 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV 123 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCC
Confidence 3568899999999999999999999999999999999999999999873
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=2.9e-05 Score=63.19 Aligned_cols=47 Identities=28% Similarity=0.467 Sum_probs=43.9
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+.++++|+.||.|++|+|+.+||+.++..+|..++++++++|++.+|
T Consensus 70 ~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d 116 (165)
T d1k94a_ 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYS 116 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHC
T ss_pred chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcC
Confidence 35677999999999999999999999999999999999999999876
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=97.82 E-value=4.5e-06 Score=67.33 Aligned_cols=49 Identities=24% Similarity=0.468 Sum_probs=45.6
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+++++|+.||.+++|+|+.+||+.+|..+|..++++|++++++.+|.
T Consensus 81 ~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~ 129 (152)
T d1wdcc_ 81 FADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDL 129 (152)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTC
T ss_pred HHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhcc
Confidence 4568899999999999999999999999999999999999999998873
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=97.81 E-value=4.6e-06 Score=62.97 Aligned_cols=50 Identities=36% Similarity=0.424 Sum_probs=44.3
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhC---CCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLG---SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~---~~~~~~e~~~~~~~~d~ 447 (447)
...+++.+|+.||.|++|+|+.+||+.+|+.++ ..+++.++++|++++|.
T Consensus 39 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~ 91 (109)
T d1rwya_ 39 SADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDK 91 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCT
T ss_pred CHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCC
Confidence 345678899999999999999999999999985 46899999999999984
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.80 E-value=3.8e-06 Score=45.27 Aligned_cols=31 Identities=32% Similarity=0.407 Sum_probs=27.6
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
++|.+.|+.||+|+||+|..+||..+++.-|
T Consensus 4 eELae~FRifDkNaDGyiD~eEl~~ilr~tG 34 (34)
T d1ctda_ 4 EELANAFRIFDKNADGYIDIEELGEILRATG 34 (34)
T ss_dssp HHHHHHHHTTCCSSSSCBCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCcccccHHHHHHHHHhcC
Confidence 5788899999999999999999999988643
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.75 E-value=4e-06 Score=66.96 Aligned_cols=48 Identities=19% Similarity=0.281 Sum_probs=44.3
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++++++|..||.|++|+|+.+||..+|+.+|..++..|+.+++.+++
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~ 50 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPS 50 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHh
Confidence 467899999999999999999999999999999999999999987654
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=97.73 E-value=8.2e-06 Score=65.10 Aligned_cols=54 Identities=39% Similarity=0.588 Sum_probs=50.2
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++++++++++++|..+|.+++|+|+.+|+..++..+|..+++.++..+++.+|
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d 55 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVD 55 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcC
Confidence 356778889999999999999999999999999999999999999999999876
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.72 E-value=7.8e-06 Score=66.10 Aligned_cols=56 Identities=27% Similarity=0.428 Sum_probs=51.0
Q ss_pred HhhhhHHHhhhhcceeeeecCCC-CcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 391 AEALSEEEIKGLKTMFANMDTDK-SGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 391 ~~~~~~~~~~~l~~~F~~~D~~~-~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.+.+++++.++++++|..||.++ +|.|+.+||+.+|+.+|..+++.++.+++..++
T Consensus 5 ~~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~ 61 (156)
T d1dtla_ 5 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD 61 (156)
T ss_dssp GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC
T ss_pred HHHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhh
Confidence 45677888999999999999995 899999999999999999999999999988765
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.72 E-value=6.4e-06 Score=67.09 Aligned_cols=54 Identities=33% Similarity=0.492 Sum_probs=50.7
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++.+++.+++++|..+|.+++|+|+.+||+.++..++..+++.++.+++..+|
T Consensus 13 ~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d 66 (162)
T d1topa_ 13 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVD 66 (162)
T ss_dssp HSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheec
Confidence 457788899999999999999999999999999999999999999999999886
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.68 E-value=9.8e-06 Score=59.41 Aligned_cols=51 Identities=20% Similarity=0.273 Sum_probs=45.4
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.++.+.++++|+.+|.|++|+|+.+|++.++...| ++.+++.++++.+|.
T Consensus 5 t~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~ 55 (95)
T d1c07a_ 5 SPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDT 55 (95)
T ss_dssp CSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCT
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCC
Confidence 456677888999999999999999999999999876 589999999999884
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.65 E-value=1.3e-05 Score=58.32 Aligned_cols=52 Identities=15% Similarity=0.218 Sum_probs=46.6
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++.++.+.++++|..+|.|++|+|+.+|++.++...| ++.+++.++++.+|.
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~ 54 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDF 54 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCT
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCC
Confidence 3567778899999999999999999999999999986 589999999999884
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.64 E-value=1e-05 Score=64.62 Aligned_cols=54 Identities=41% Similarity=0.595 Sum_probs=49.5
Q ss_pred hhhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 393 ALSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 393 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++++++.+++++|+.+|.|++|+|+.+||+.++..+|..+++.++..++...+
T Consensus 3 ~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~ 56 (146)
T d1lkja_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEID 56 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHC
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhc
Confidence 457888999999999999999999999999999999999999999998887654
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.63 E-value=4.3e-06 Score=58.61 Aligned_cols=49 Identities=22% Similarity=0.357 Sum_probs=40.8
Q ss_pred hhhhcceeeeecCC--CCcccCHHHHHHHHHHhCCCCC--HHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTD--KSGTITYEELKTGLARLGSKLS--ETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~--~~g~i~~~el~~~l~~l~~~~~--~~e~~~~~~~~d~ 447 (447)
.++++++|+.||.+ ++|+|+.+||+.+|+.+|..++ +.||++|++++|.
T Consensus 4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~ 56 (76)
T d1qx2a_ 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDK 56 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCT
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhc
Confidence 35688999999764 4699999999999999987664 5689999999884
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.63 E-value=1.2e-05 Score=64.16 Aligned_cols=48 Identities=33% Similarity=0.505 Sum_probs=45.0
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.+.++.+|+.+|.+++|+|+.+||+.++..+|..++++++++|++++|
T Consensus 82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d 129 (146)
T d1lkja_ 82 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS 129 (146)
T ss_dssp HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc
Confidence 356888999999999999999999999999999999999999999876
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.62 E-value=1.6e-05 Score=63.41 Aligned_cols=49 Identities=22% Similarity=0.287 Sum_probs=45.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.++++|+.||.+++|+|+.+|++.+|+.+|..++++|++++++.+|.
T Consensus 76 ~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~ 124 (145)
T d2mysb_ 76 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPP 124 (145)
T ss_pred HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 3568889999999999999999999999999999999999999998874
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.60 E-value=1.2e-05 Score=64.24 Aligned_cols=49 Identities=27% Similarity=0.540 Sum_probs=45.6
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.+.++|+.+|.+++|.|+.+||+.+|..+|..++++|++++++.+|.
T Consensus 80 ~~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~ 128 (146)
T d1m45a_ 80 TEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEV 128 (146)
T ss_dssp THHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCC
Confidence 3568889999999999999999999999999999999999999999874
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.57 E-value=1.1e-05 Score=63.95 Aligned_cols=47 Identities=17% Similarity=0.237 Sum_probs=42.9
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
..+++++|..||.+++|.|+.+||..+|+.+|.+++++++.++....
T Consensus 4 ~~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~~~~~~ 50 (140)
T d1ggwa_ 4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIESTL 50 (140)
T ss_dssp CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHTTS
T ss_pred HHHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhhhhccc
Confidence 46789999999999999999999999999999999999999886543
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.57 E-value=1.4e-05 Score=63.25 Aligned_cols=51 Identities=29% Similarity=0.541 Sum_probs=47.7
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+++.++++++|..+|.+++|+|+.+||..+++.+|..+++.++..++..+|
T Consensus 2 ~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d 52 (141)
T d2obha1 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEID 52 (141)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhc
Confidence 467789999999999999999999999999999999999999999998876
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.54 E-value=1.2e-05 Score=64.10 Aligned_cols=45 Identities=22% Similarity=0.346 Sum_probs=41.6
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
.++++|..+|.+++|+|+.+||..+|+.+|..++.+|+++++...
T Consensus 3 ~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~ 47 (146)
T d1m45a_ 3 ANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINAD 47 (146)
T ss_dssp CCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC-
T ss_pred HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccc
Confidence 478999999999999999999999999999999999999998753
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=97.54 E-value=6.4e-05 Score=59.63 Aligned_cols=50 Identities=30% Similarity=0.494 Sum_probs=46.3
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+.++.+|+.+|.|++|+|+.+|++.++..+|..+++++++++++.+|.
T Consensus 80 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~ 129 (146)
T d1exra_ 80 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADI 129 (146)
T ss_dssp HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCC
Confidence 34578899999999999999999999999999999999999999999873
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.54 E-value=0.00017 Score=67.50 Aligned_cols=75 Identities=15% Similarity=0.179 Sum_probs=51.2
Q ss_pred cceeccccCeEEEEEEECC-------CCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCeeEEEEEEEeCCeEE
Q 013201 99 GKELGRGQFGITYLCTENS-------TGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNIVEFRGAYEDRQSVH 171 (447)
Q Consensus 99 ~~~lg~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 171 (447)
.+.|+-|-.-.+|++.... ....|.+++.- . . ...-...+|..+++.+..+.-.+++++++.+ +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-P---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 3678888889999988653 23556666542 1 1 1223456899999998866556788887743 5
Q ss_pred EEEeccCCCch
Q 013201 172 LVMELCSGGEL 182 (447)
Q Consensus 172 lv~e~~~g~~L 182 (447)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987544
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=6.8e-06 Score=65.03 Aligned_cols=46 Identities=22% Similarity=0.338 Sum_probs=42.2
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+++++|..||.+++|.|+.+||+.+|+.+|..+++.|+.+++..++
T Consensus 1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~ 46 (139)
T d1w7jb1 1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPK 46 (139)
T ss_dssp CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCC
T ss_pred CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHh
Confidence 4788999999999999999999999999999999999999876543
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.50 E-value=1.4e-05 Score=64.58 Aligned_cols=49 Identities=29% Similarity=0.447 Sum_probs=43.8
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.+.++++|+.+|.+++|+|+.+|++.++..+|..++++|++++++++|.
T Consensus 90 ~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~ 138 (156)
T d1dtla_ 90 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDK 138 (156)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCC
Confidence 4567889999999999999999999999999999999999999999873
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.49 E-value=3.4e-05 Score=61.32 Aligned_cols=47 Identities=32% Similarity=0.487 Sum_probs=43.4
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHh
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~ 444 (447)
....++++|+.+|.+++|+|+.+||+.+|..+|..++++|+++|++.
T Consensus 79 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~ 125 (145)
T d2mysc_ 79 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG 125 (145)
T ss_pred hHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh
Confidence 34568899999999999999999999999999999999999999975
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=97.47 E-value=3.5e-05 Score=56.09 Aligned_cols=51 Identities=18% Similarity=0.201 Sum_probs=43.3
Q ss_pred HHhhhhcceeeee-cCCCC-cccCHHHHHHHHHHhCC-----CCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANM-DTDKS-GTITYEELKTGLARLGS-----KLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~-D~~~~-g~i~~~el~~~l~~l~~-----~~~~~e~~~~~~~~d~ 447 (447)
..++.+.++|.++ |.||+ |+|+.+||+++|+.++. ..+++++++||+++|.
T Consensus 6 ~~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~ 63 (93)
T d1zfsa1 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDE 63 (93)
T ss_dssp HHHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcC
Confidence 3467888999988 78875 99999999999999763 4579999999999984
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.47 E-value=8.7e-05 Score=60.01 Aligned_cols=50 Identities=26% Similarity=0.375 Sum_probs=45.7
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
....++++|+.+|.|++|+|+.+|++.++...|...++++++.+|+.+|.
T Consensus 94 ~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~ 143 (162)
T d1topa_ 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDK 143 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCT
T ss_pred cHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCC
Confidence 34567789999999999999999999999999999999999999999874
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=97.43 E-value=7.8e-05 Score=61.80 Aligned_cols=48 Identities=23% Similarity=0.279 Sum_probs=44.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..+|+.+|.|++|+|+.+||+.+|+.+|..+++++++++++.+|.
T Consensus 105 ~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~ 152 (187)
T d1uhka1 105 IWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDI 152 (187)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCC
Confidence 456789999999999999999999999999999999999999999874
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=97.42 E-value=2e-05 Score=65.49 Aligned_cols=49 Identities=29% Similarity=0.427 Sum_probs=45.8
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+.++|+++|..+|.|++|+|+.+||..+|+.+|..+++++++++++.+|
T Consensus 16 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d 64 (182)
T d1y1xa_ 16 DNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYD 64 (182)
T ss_dssp TTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHC
T ss_pred cHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhcccc
Confidence 3467999999999999999999999999999999999999999999876
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=97.42 E-value=1.3e-05 Score=64.48 Aligned_cols=48 Identities=25% Similarity=0.326 Sum_probs=43.0
Q ss_pred hHHHhhhhcceeeeec--CCCCcccCHHHHHHHHHHhCCCCCHHHHHHHH
Q 013201 395 SEEEIKGLKTMFANMD--TDKSGTITYEELKTGLARLGSKLSETEVKQLM 442 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D--~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~ 442 (447)
+++++++++++|..|| .+++|.|+.+||+.+|+.+|..++++|+.+++
T Consensus 2 s~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~ 51 (152)
T d1wdcc_ 2 SQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVG 51 (152)
T ss_dssp CHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTT
T ss_pred CHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhh
Confidence 4678888999999999 48899999999999999999999999998764
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.31 E-value=6e-05 Score=59.82 Aligned_cols=51 Identities=24% Similarity=0.511 Sum_probs=42.4
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCC-CCHHHHHHHHHh
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSK-LSETEVKQLMDA 444 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~-~~~~e~~~~~~~ 444 (447)
++++++++++++|..+|.+++|+|+.+||..+|+.+|.. .+.++++.+++.
T Consensus 1 f~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~ 52 (145)
T d2mysb_ 1 FDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKE 52 (145)
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHHHHHHHHh
Confidence 356788999999999999999999999999999999965 455555655554
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.29 E-value=4.9e-05 Score=59.80 Aligned_cols=48 Identities=25% Similarity=0.405 Sum_probs=41.8
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHh
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~ 444 (447)
...+.++++|+.+|.+++|+|+.+||+.+|..+|..++++|++.|++.
T Consensus 74 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~ 121 (139)
T d1w7jb1 74 GTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG 121 (139)
T ss_dssp ----CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT
T ss_pred cHHHHHHHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh
Confidence 344678899999999999999999999999999999999999998864
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.27 E-value=0.00022 Score=55.90 Aligned_cols=49 Identities=24% Similarity=0.505 Sum_probs=45.9
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|..+|.+++|.|+..+|+.++..+|..++++++.++++.+|.
T Consensus 78 ~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~ 126 (141)
T d2obha1 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADR 126 (141)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCC
Confidence 4567899999999999999999999999999999999999999999874
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.27 E-value=1.3e-05 Score=56.31 Aligned_cols=50 Identities=16% Similarity=0.232 Sum_probs=40.6
Q ss_pred HhhhhcceeeeecC-C-CCcccCHHHHHHHHHHh--CCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDT-D-KSGTITYEELKTGLARL--GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~-~-~~g~i~~~el~~~l~~l--~~~~~~~e~~~~~~~~d~ 447 (447)
..++|+.+|..||. + +.|+|+.+||+.+|+.+ +...+++++++||+++|.
T Consensus 5 ~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~ 58 (78)
T d1cb1a_ 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDK 58 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCC
T ss_pred hHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcC
Confidence 45678899999975 3 45899999999999987 445678889999999884
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=97.26 E-value=0.00011 Score=53.11 Aligned_cols=51 Identities=22% Similarity=0.375 Sum_probs=42.3
Q ss_pred HHhhhhcceeeee-cCCCCc-ccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANM-DTDKSG-TITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~-D~~~~g-~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
..++.+.++|.++ |.||+| +|+.+||+++|+. ++...+++++++||+++|.
T Consensus 6 ~~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~ 63 (93)
T d3c1va1 6 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDS 63 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcC
Confidence 3457788999998 566655 7999999999987 4567899999999999984
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.24 E-value=5.5e-05 Score=55.15 Aligned_cols=51 Identities=14% Similarity=0.232 Sum_probs=44.0
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
++.++...++++|..+| +++|+|+.+|++.+|...| ++.++++.+++.+|.
T Consensus 4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~ 54 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDI 54 (95)
T ss_dssp SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCT
T ss_pred CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcC
Confidence 35667778899999999 8999999999999998876 578999999999884
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=97.23 E-value=0.00015 Score=60.07 Aligned_cols=48 Identities=25% Similarity=0.251 Sum_probs=40.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..+|..+|.|++|+|+.+|++.++..+|..+++++++.||+.+|.
T Consensus 107 ~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~ 154 (189)
T d1qv0a_ 107 EWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDL 154 (189)
T ss_dssp HHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCC
Confidence 345678999999999999999999999999999999999999999984
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=97.23 E-value=5.6e-05 Score=55.42 Aligned_cols=51 Identities=14% Similarity=0.216 Sum_probs=41.8
Q ss_pred HHhhhhcceeeee-cCCCC-cccCHHHHHHHHHHhCC--CCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANM-DTDKS-GTITYEELKTGLARLGS--KLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~-D~~~~-g~i~~~el~~~l~~l~~--~~~~~e~~~~~~~~d~ 447 (447)
..+..+.++|..| |.+|+ |+|+.+||+.+|+.++. ..+.++++++|+++|.
T Consensus 11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~ 65 (98)
T d1yuta1 11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDV 65 (98)
T ss_dssp HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcC
Confidence 4467788999988 67775 99999999999998653 3577789999999984
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=97.20 E-value=3.2e-05 Score=56.05 Aligned_cols=50 Identities=16% Similarity=0.296 Sum_probs=42.5
Q ss_pred HHhhhhcceeeeecCCCCcccCHHHHHHHHHHh-----CCCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMDTDKSGTITYEELKTGLARL-----GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-----~~~~~~~e~~~~~~~~d~ 447 (447)
..++.+..+|..+|.| +|+|+.+||+++|..+ +...++.+++++|+++|.
T Consensus 6 ~~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~ 60 (92)
T d1a4pa_ 6 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQ 60 (92)
T ss_dssp HHHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhC
Confidence 3567889999999987 8999999999999874 345578899999999984
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=97.15 E-value=7.7e-05 Score=58.04 Aligned_cols=45 Identities=18% Similarity=0.443 Sum_probs=40.8
Q ss_pred cceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 403 KTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 403 ~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
.++|+.+|.|++|.|+.+||..++..+|...++++++.+++.+|.
T Consensus 3 e~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~ 47 (134)
T d1jfja_ 3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDA 47 (134)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCS
T ss_pred HHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhh
Confidence 358999999999999999999999999999999999999998873
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.05 E-value=0.0012 Score=59.59 Aligned_cols=69 Identities=12% Similarity=0.100 Sum_probs=45.5
Q ss_pred CeEEEEEEECCCCCEEEEEEeeccccCChhhHHHHHHHHHHHHhccCCCCe--eEEE-----EEEEeCCeEEEEEeccCC
Q 013201 107 FGITYLCTENSTGNSYACKSILKRKLVNKQDREDIKREIQIMQHLSGQQNI--VEFR-----GAYEDRQSVHLVMELCSG 179 (447)
Q Consensus 107 ~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i--v~~~-----~~~~~~~~~~lv~e~~~g 179 (447)
--.||+++. .+|..|++|+..... ...+++..|...+..|..+ +| +..+ ..+...+..+.+++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 357999875 478889999865432 2356788899998888622 22 1111 123457788999999976
Q ss_pred Cc
Q 013201 180 GE 181 (447)
Q Consensus 180 ~~ 181 (447)
..
T Consensus 109 ~~ 110 (325)
T d1zyla1 109 RQ 110 (325)
T ss_dssp EE
T ss_pred cC
Confidence 43
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=97.04 E-value=0.00019 Score=51.85 Aligned_cols=50 Identities=14% Similarity=0.231 Sum_probs=42.1
Q ss_pred HHhhhhcceeeee-cCCCCc-ccCHHHHHHHHHHhC-----CCCCHHHHHHHHHhhC
Q 013201 397 EEIKGLKTMFANM-DTDKSG-TITYEELKTGLARLG-----SKLSETEVKQLMDAVS 446 (447)
Q Consensus 397 ~~~~~l~~~F~~~-D~~~~g-~i~~~el~~~l~~l~-----~~~~~~e~~~~~~~~d 446 (447)
..+..+..+|.++ |.+|+| +|+.+||+++|+..+ ...++.++++||+++|
T Consensus 6 ~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD 62 (93)
T d1ksoa_ 6 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLD 62 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHc
Confidence 4556788899987 999999 599999999998853 3457999999999987
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=96.99 E-value=0.00022 Score=58.79 Aligned_cols=48 Identities=21% Similarity=0.353 Sum_probs=43.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+.++|..+|.+++|+|+.+||+.++..+|..+++++++.+++.+|.
T Consensus 84 ~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~ 131 (182)
T d1y1xa_ 84 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDR 131 (182)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCT
T ss_pred cccccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhccc
Confidence 345678999999999999999999999999999999999999999873
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=96.97 E-value=0.00011 Score=52.59 Aligned_cols=49 Identities=29% Similarity=0.492 Sum_probs=39.5
Q ss_pred Hhhhhcceeeee-cCCCCc-ccCHHHHHHHHHH---hCCCCCHHHHHHHHHhhC
Q 013201 398 EIKGLKTMFANM-DTDKSG-TITYEELKTGLAR---LGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 398 ~~~~l~~~F~~~-D~~~~g-~i~~~el~~~l~~---l~~~~~~~e~~~~~~~~d 446 (447)
.+..+.++|.++ |++|+| +|+..||+.+++. ++...+++++++||+++|
T Consensus 7 ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD 60 (89)
T d1k8ua_ 7 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLD 60 (89)
T ss_dssp HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhc
Confidence 456677888887 888888 6999999999887 456678888999998887
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.90 E-value=0.00035 Score=56.98 Aligned_cols=45 Identities=33% Similarity=0.546 Sum_probs=42.1
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
...+|+.+|.+++|.|+.+|++.+|..+|..+++++++++++++|
T Consensus 79 ~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d 123 (172)
T d1juoa_ 79 WRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYS 123 (172)
T ss_dssp HHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTC
T ss_pred hhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHH
Confidence 456799999999999999999999999999999999999999876
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=96.89 E-value=0.00028 Score=58.45 Aligned_cols=45 Identities=24% Similarity=0.391 Sum_probs=40.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~ 444 (447)
..++.+|+.+|.|++|+|+..||+.+|..+|..++++.++.|++.
T Consensus 93 ~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~ 137 (188)
T d1qxpa2 93 RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR 137 (188)
T ss_dssp HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHH
Confidence 456789999999999999999999999999999998888887765
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=96.81 E-value=0.00017 Score=65.21 Aligned_cols=52 Identities=29% Similarity=0.475 Sum_probs=47.8
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..++...++++|..+|.|++|.|+.+||+.+|..+|..+++++++.++..+|
T Consensus 117 ~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d 168 (321)
T d1ij5a_ 117 SEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVE 168 (321)
T ss_dssp CHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHh
Confidence 4566778899999999999999999999999999999999999999998876
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.77 E-value=0.0018 Score=53.08 Aligned_cols=46 Identities=30% Similarity=0.461 Sum_probs=42.6
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++.+|+.+|.+++|.|+.+||++++...|..+++++++++++++|
T Consensus 87 ~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d 132 (181)
T d1hqva_ 87 DWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFD 132 (181)
T ss_dssp HHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHC
T ss_pred ccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhC
Confidence 4667899999999999999999999999999999999999999886
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=96.74 E-value=0.00047 Score=55.99 Aligned_cols=47 Identities=23% Similarity=0.343 Sum_probs=42.1
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|..+|.|++|.|+.+|++.+++.+| +++++++++++.+|.
T Consensus 101 ~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~~~~~~~~f~~~D~ 147 (176)
T d1nyaa_ 101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDT 147 (176)
T ss_dssp HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--CcHHHHHHHHHHHCC
Confidence 34567899999999999999999999999987 489999999999884
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.67 E-value=5.9e-05 Score=56.60 Aligned_cols=50 Identities=20% Similarity=0.189 Sum_probs=36.6
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+.++.+.++++|..+|.|++|+|+.+|++.+|.+.| ++.+++.++++.+|
T Consensus 17 t~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D 66 (110)
T d1iq3a_ 17 TEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSD 66 (110)
T ss_dssp SSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHC
T ss_pred CHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhc
Confidence 445566677788888888888888888888776654 46667777777766
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=96.58 E-value=0.00015 Score=51.68 Aligned_cols=48 Identities=6% Similarity=0.094 Sum_probs=28.7
Q ss_pred hhhhcceeeee-cCCCCcc-cCHHHHHHHHHH-hCCCCCHHHHHHHHHhhC
Q 013201 399 IKGLKTMFANM-DTDKSGT-ITYEELKTGLAR-LGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~-D~~~~g~-i~~~el~~~l~~-l~~~~~~~e~~~~~~~~d 446 (447)
+..+.++|.++ |.+|+|. ++.+||+.++.. +|..+++++|+++++++|
T Consensus 9 i~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D 59 (87)
T d1xk4a1 9 LNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELD 59 (87)
T ss_dssp HHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHC
T ss_pred HHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhC
Confidence 34555666665 5666664 366666666654 555555566666666665
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.47 E-value=0.00047 Score=50.45 Aligned_cols=46 Identities=22% Similarity=0.257 Sum_probs=36.0
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCC----------------CHHHHHHHHHhhCC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKL----------------SETEVKQLMDAVSI 447 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~----------------~~~e~~~~~~~~d~ 447 (447)
++.+|..+|.|++|+|+.+||..+++.++..+ .+..++.+++++|.
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~ 79 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDT 79 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCS
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCC
Confidence 67799999999999999999999998753211 14456778888873
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.47 E-value=0.0004 Score=57.16 Aligned_cols=49 Identities=22% Similarity=0.322 Sum_probs=42.6
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCC-CCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSK-LSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~-~~~~e~~~~~~~~d~ 447 (447)
.+.|.++|..+|.|++|+|+.+||+.+|+.++.. .+.++++.+++.+|.
T Consensus 18 ~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~ 67 (181)
T d1hqva_ 18 QSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDR 67 (181)
T ss_dssp HHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhcccc
Confidence 3568889999999999999999999999988754 689999999988763
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.40 E-value=0.0007 Score=49.44 Aligned_cols=45 Identities=11% Similarity=0.234 Sum_probs=38.0
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...++|+.+|.+++|+|+.+|++.+++..| ++++++.++++.+|.
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~ 56 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADT 56 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcC
Confidence 455789999999999999999999998765 588999999988874
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=96.23 E-value=0.0021 Score=45.33 Aligned_cols=51 Identities=16% Similarity=0.262 Sum_probs=40.3
Q ss_pred HHhhhhcceeeeec-CCCCc-ccCHHHHHHHHHHhC-----CCCCHHHHHHHHHhhCC
Q 013201 397 EEIKGLKTMFANMD-TDKSG-TITYEELKTGLARLG-----SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 397 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~l~-----~~~~~~e~~~~~~~~d~ 447 (447)
..+..+.++|.+++ .+|++ +|+.+||+++|+... ...+++.|+++|+++|.
T Consensus 5 ~ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~ 62 (87)
T d1e8aa_ 5 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDA 62 (87)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcC
Confidence 34567888999885 56554 799999999998843 34578999999999984
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=96.13 E-value=0.00035 Score=57.47 Aligned_cols=46 Identities=17% Similarity=0.335 Sum_probs=40.0
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..+|+.+|.|++|+|+.+|++.+++.+| +++++++.+++.+|.
T Consensus 105 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~--l~~~~~~~~f~~~D~ 150 (185)
T d2sasa_ 105 NRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITD 150 (185)
T ss_dssp HHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHT
T ss_pred HHHHHHHHHHccCCCccCCHHHHHHHHHHcC--CCHHHHHHHHHHcCC
Confidence 3467899999999999999999999999876 477889999998873
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=96.08 E-value=0.00033 Score=51.35 Aligned_cols=51 Identities=18% Similarity=0.191 Sum_probs=41.1
Q ss_pred HHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCC-------CCCHHHHHHHHHhhCC
Q 013201 396 EEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGS-------KLSETEVKQLMDAVSI 447 (447)
Q Consensus 396 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~-------~~~~~e~~~~~~~~d~ 447 (447)
+..+..+.++|..+| +++|.|+.+||+++|+..+. ..++++|++||+++|.
T Consensus 6 E~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~ 63 (100)
T d1psra_ 6 ERSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDK 63 (100)
T ss_dssp HHHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCT
T ss_pred HHHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcC
Confidence 445677888898887 78999999999999998753 2356778999999884
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=95.97 E-value=0.0016 Score=52.66 Aligned_cols=47 Identities=23% Similarity=0.296 Sum_probs=40.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...+..+|+.+|.|++|.|+.+|++.+++.+|. +.+++..+++.+|.
T Consensus 93 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~--~~~~~~~~f~~~D~ 139 (174)
T d2scpa_ 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGL--DKTMAPASFDAIDT 139 (174)
T ss_dssp HTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CGGGHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCccccCCHHHHHHHHHHHhh--hhHHHHHHHhhcCC
Confidence 345778999999999999999999999998875 67889999998874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.91 E-value=0.0072 Score=53.93 Aligned_cols=30 Identities=27% Similarity=0.445 Sum_probs=24.5
Q ss_pred cCcEeecCCCCceEeecCCCCCceEEecCCCce
Q 013201 214 MGVMHRDLKPENFLLSNKDGGAMLKATDFGLSV 246 (447)
Q Consensus 214 ~~ivH~Dlkp~Nill~~~~~~~~vkl~Dfg~a~ 246 (447)
.|+||+|+.++||+++. +...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~---~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLG---DELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEET---TEEEEECCCTTCE
T ss_pred cccccCCcchhhhhccc---ccceeEecccccc
Confidence 57999999999999954 3346789999874
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.79 E-value=0.00085 Score=54.09 Aligned_cols=34 Identities=32% Similarity=0.506 Sum_probs=20.2
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHH
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLA 427 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~ 427 (447)
++++++.+++++|..+|.|++|.|+.+||+.++.
T Consensus 10 ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~ 43 (165)
T d1auib_ 10 FDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPE 43 (165)
T ss_dssp CCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhh
Confidence 4555556666666666666666666666655443
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.78 E-value=0.0014 Score=53.69 Aligned_cols=48 Identities=27% Similarity=0.369 Sum_probs=37.3
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh-----CCCCCHHHHHH----HHHhhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL-----GSKLSETEVKQ----LMDAVS 446 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-----~~~~~~~e~~~----~~~~~d 446 (447)
.++++.+|+.+|.|++|+|+.+|+..+++.+ +..++++++++ +++++|
T Consensus 94 ~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D 150 (180)
T d1xo5a_ 94 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESD 150 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHC
T ss_pred HHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhC
Confidence 3567889999999999999999999999987 34566666544 566666
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=95.70 E-value=0.0023 Score=51.83 Aligned_cols=44 Identities=25% Similarity=0.404 Sum_probs=37.2
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHh
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDA 444 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~ 444 (447)
.++.+|+.||.+++|.|+.+|++.+|...|..+++++++.+++.
T Consensus 78 ~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~~~ 121 (173)
T d1alva_ 78 KWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRR 121 (173)
T ss_dssp HHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhhcc
Confidence 45678889999999999999999999999998888888777653
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.63 E-value=0.003 Score=51.86 Aligned_cols=49 Identities=20% Similarity=0.236 Sum_probs=39.1
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhC------------CCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLG------------SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~------------~~~~~~e~~~~~~~~d~ 447 (447)
.+.++.+|+.+|.|++|.|+.+|+..+++.+. ....++.++.+|+++|.
T Consensus 95 ~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~ 155 (187)
T d1g8ia_ 95 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDK 155 (187)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCS
T ss_pred hhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCC
Confidence 35678899999999999999999999987642 12335678889999874
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.50 E-value=0.0033 Score=51.19 Aligned_cols=50 Identities=18% Similarity=0.207 Sum_probs=41.8
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhC------------CCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLG------------SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~------------~~~~~~e~~~~~~~~d~ 447 (447)
..+.++.+|+.+|.|++|+|+.+|+..++..+. ....++.++.+|+++|.
T Consensus 93 ~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~ 154 (181)
T d1bjfa_ 93 LEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDT 154 (181)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCT
T ss_pred hHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCC
Confidence 345678899999999999999999999998752 24567889999999884
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=95.50 E-value=0.0019 Score=53.18 Aligned_cols=44 Identities=23% Similarity=0.416 Sum_probs=37.1
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMD 443 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~ 443 (447)
..++.+|+.+|.|++|+|+.+||+.+|+.+|..+++++++.+++
T Consensus 91 ~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~~~~~ 134 (186)
T d1df0a1 91 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVA 134 (186)
T ss_dssp HHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHHHHHH
T ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHHHHHH
Confidence 45678999999999999999999999999999888776655443
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.40 E-value=0.0027 Score=52.22 Aligned_cols=117 Identities=17% Similarity=0.176 Sum_probs=63.1
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcCCCccCCCCCCCCcccHHHHHHHHH-HHHHhh--hh-HHHHHHHHhhhhHHHhh
Q 013201 325 DSAKDLVRKMLIQDPKKRITSAEVLEHPWMREGGEASDKPIGSAVLSRMKQ-FRAMNK--LK-KMALKVIAEALSEEEIK 400 (447)
Q Consensus 325 ~~~~~li~~~L~~dp~~R~t~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~k-~~~~~~i~~~~~~~~~~ 400 (447)
.+++.+.++-...+|+-+.+..|..+. |...... .....+..+-+ +...+. +- .-.+..+..........
T Consensus 21 ~ei~~~~~~F~~~~~~G~i~~~Ef~~~--l~~~~~~----~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~ 94 (189)
T d1jbaa_ 21 AQLQEWYKKFLEECPSGTLFMHEFKRF--FKVPDNE----EATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEH 94 (189)
T ss_dssp HHHHHHHHHHHSSSTTCCEEHHHHHHH--HHCCSSS----TTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTH
T ss_pred HHHHHHHHHhcccCCCCeeeHHHHHHH--HHHcCCC----ccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHH
Confidence 356666666667778888888875332 2221111 11222222211 111110 00 01111122111222334
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhC----------------CCC-CHHHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLG----------------SKL-SETEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~----------------~~~-~~~e~~~~~~~~d~ 447 (447)
.++.+|+.+|.|++|.|+.+|+..++..+. ... .++.++++++++|.
T Consensus 95 ~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~ 158 (189)
T d1jbaa_ 95 KLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDE 158 (189)
T ss_dssp HHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCC
T ss_pred HHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCC
Confidence 677899999999999999999998876541 112 25566889998874
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=95.39 E-value=0.0031 Score=51.70 Aligned_cols=51 Identities=27% Similarity=0.343 Sum_probs=40.9
Q ss_pred hHHHhhhhcceeeeecCCCCcccCHHHHHHH-----HHHhCCCCCHHHHHHHHHhh
Q 013201 395 SEEEIKGLKTMFANMDTDKSGTITYEELKTG-----LARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 395 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~-----l~~l~~~~~~~e~~~~~~~~ 445 (447)
..+.++.++++|..||.|++|.|+.+||... ++.+|...++.++.+++.++
T Consensus 9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 64 (189)
T d1qv0a_ 9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEA 64 (189)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHH
Confidence 3456678899999999999999999999764 45678888888877766554
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=95.31 E-value=0.0015 Score=53.58 Aligned_cols=46 Identities=24% Similarity=0.517 Sum_probs=39.6
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+.++.+|..+|.+++|+|+.++|+.++..+| +++++++.|++.+|.
T Consensus 82 e~l~~aF~~~D~d~~G~i~~~el~~~l~~~g--l~~~ev~~~f~~~D~ 127 (182)
T d1s6ia_ 82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQ 127 (182)
T ss_dssp CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCS
T ss_pred HHHHHHHHHHhhcCCCccchhhhhhhhhhcC--ccHHHHHHHHHHhhc
Confidence 4677889999999999999999999998887 588899999998874
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=94.89 E-value=0.0049 Score=50.65 Aligned_cols=49 Identities=24% Similarity=0.307 Sum_probs=39.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCC------------CCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGS------------KLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~------------~~~~~e~~~~~~~~d~ 447 (447)
.+.++.+|+.+|.|++|.|+.+|+..++..+.. ...++.++++|+++|.
T Consensus 98 ~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~ 158 (190)
T d1fpwa_ 98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDK 158 (190)
T ss_dssp THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCC
Confidence 356788999999999999999999999987632 1125778899999884
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.25 E-value=0.0097 Score=48.69 Aligned_cols=48 Identities=21% Similarity=0.227 Sum_probs=41.2
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+..+|+.+|.|++|.|+..|+..++..+.....++.++.+++.+|.
T Consensus 58 ~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~F~~~D~ 105 (189)
T d1jbaa_ 58 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDK 105 (189)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCS
T ss_pred HHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHhhhcc
Confidence 456789999999999999999999999988777778888888888773
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=94.21 E-value=0.014 Score=47.86 Aligned_cols=46 Identities=22% Similarity=0.343 Sum_probs=41.9
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
...+|..+|.+++|.|+.+|+..++..++....++.++.+++.+|.
T Consensus 65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~ 110 (190)
T d1fpwa_ 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDL 110 (190)
T ss_dssp HHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCS
T ss_pred HHHHHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhcc
Confidence 3568999999999999999999999999988889999999998874
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=93.91 E-value=0.011 Score=45.01 Aligned_cols=42 Identities=29% Similarity=0.453 Sum_probs=31.2
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
.++.+|+.+|.+++|+|+.+|++.++..++. +++.++|+++|
T Consensus 76 ~~~~~F~~~D~~~~g~i~~~el~~~~~~~~~----~~~~~~~~~~D 117 (134)
T d1jfja_ 76 GLKVLYKLMDVDGDGKLTKEEVTSFFKKHGI----EKVAEQVMKAD 117 (134)
T ss_dssp HHHHHHHHHCCSSSSEEEHHHHHHHHTTTTC----HHHHHHHHHHH
T ss_pred cccccccccccccCCcccHHHHHHHHHhcCc----HHHHHHHHHHC
Confidence 3456788888888888888888888776653 56777777765
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=93.90 E-value=0.0074 Score=53.76 Aligned_cols=48 Identities=23% Similarity=0.329 Sum_probs=42.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCC-CCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGS-KLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~-~~~~~e~~~~~~~~d~ 447 (447)
..+..+|..+|.|++|+|+.+||+.++..+|. .++.+++..|++.+|.
T Consensus 253 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~ 301 (321)
T d1ij5a_ 253 LVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDV 301 (321)
T ss_dssp HHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTT
T ss_pred hHHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCC
Confidence 34556899999999999999999999999997 4889999999999874
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=93.86 E-value=0.0066 Score=49.65 Aligned_cols=47 Identities=26% Similarity=0.369 Sum_probs=39.9
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCC--------CCCHHHHHHHHHhhCC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGS--------KLSETEVKQLMDAVSI 447 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~--------~~~~~e~~~~~~~~d~ 447 (447)
+.++++|..+| +++|.|+.+||..+|..+|. .++.+++..++..+|.
T Consensus 18 ~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~ 72 (186)
T d1df0a1 18 DGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDE 72 (186)
T ss_dssp HHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcC
Confidence 45889999998 99999999999999998753 3578889999988773
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.77 E-value=0.017 Score=46.40 Aligned_cols=47 Identities=15% Similarity=0.222 Sum_probs=28.1
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCC----------CCHHHHHHHHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSK----------LSETEVKQLMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~----------~~~~e~~~~~~~~d 446 (447)
.++..+|..+|.|++|.|+.+||...|...... .+.+.++++|+.++
T Consensus 78 ~ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~ 134 (170)
T d2zkmx1 78 PEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYE 134 (170)
T ss_dssp HHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHc
Confidence 457789999999999999999999999986543 46778888887764
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=93.75 E-value=0.0075 Score=40.08 Aligned_cols=30 Identities=17% Similarity=0.529 Sum_probs=26.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
+++.++|..+|.|++|.|+.+|+..+|.++
T Consensus 37 ~~i~~~~~~~D~d~dg~I~~~EF~~~m~~~ 66 (67)
T d1tiza_ 37 EDIVKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 456788999999999999999999998763
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.75 E-value=0.0079 Score=48.04 Aligned_cols=49 Identities=27% Similarity=0.320 Sum_probs=39.2
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh-CCCCC----HHHHHHHHHhhC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL-GSKLS----ETEVKQLMDAVS 446 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-~~~~~----~~e~~~~~~~~d 446 (447)
....++.+|+.+|.|++|+|+.+|+..+++.. +..++ ++.++.+++++|
T Consensus 83 ~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D 136 (165)
T d1auib_ 83 KEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINAD 136 (165)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcC
Confidence 44568899999999999999999999999774 55554 555667777776
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.75 E-value=0.024 Score=46.74 Aligned_cols=49 Identities=20% Similarity=0.225 Sum_probs=38.4
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCC--------------HHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLS--------------ETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~--------------~~e~~~~~~~~d~ 447 (447)
.+.++.+|+.+|.|++|.|+.+|+..+++.+....+ ++.++.+|+++|.
T Consensus 98 ~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~ 160 (201)
T d1omra_ 98 NQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGK 160 (201)
T ss_dssp GGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCC
Confidence 356788999999999999999999999987643222 3456778888874
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=93.65 E-value=0.019 Score=46.55 Aligned_cols=47 Identities=19% Similarity=0.307 Sum_probs=36.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHH----hCCCCCHHHHHH----HHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLAR----LGSKLSETEVKQ----LMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~----l~~~~~~~e~~~----~~~~~d 446 (447)
..++.+|+.+|.|++|.|+.+|++.++.. .|...++.++++ +++++|
T Consensus 91 ~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D 145 (183)
T d2zfda1 91 DKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEAD 145 (183)
T ss_dssp HHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhC
Confidence 45777899999999999999999988765 366677766555 455565
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=93.60 E-value=0.012 Score=41.88 Aligned_cols=33 Identities=12% Similarity=0.399 Sum_probs=28.6
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
..+.+.++|..+|.|+||.|+.+|+..++..+.
T Consensus 50 ~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l~ 82 (93)
T d3c1va1 50 DEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA 82 (93)
T ss_dssp SHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Confidence 345678899999999999999999999888763
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=93.03 E-value=0.025 Score=39.01 Aligned_cols=30 Identities=27% Similarity=0.443 Sum_probs=26.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.++.++|..+|.|++|.|+.+|+..+++..
T Consensus 41 ~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~ 70 (81)
T d2opoa1 41 DEVRRMMAEIDTDGDGFISFDEFTDFARAN 70 (81)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHHC
Confidence 356788999999999999999999988764
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=92.92 E-value=0.058 Score=37.80 Aligned_cols=50 Identities=16% Similarity=0.253 Sum_probs=38.4
Q ss_pred Hhhhhcceeeeec-CCCC-cccCHHHHHHHHHH-h----CCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMD-TDKS-GTITYEELKTGLAR-L----GSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-l----~~~~~~~e~~~~~~~~d~ 447 (447)
.+..+.++|.++. .+|+ ++++.+||+++|+. + +...+.+.++++|+.+|.
T Consensus 7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~ 63 (90)
T d3cr5x1 7 AVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDS 63 (90)
T ss_dssp HHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcC
Confidence 4456778888875 4555 58999999999987 3 334467889999999884
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=92.84 E-value=0.0054 Score=50.35 Aligned_cols=52 Identities=33% Similarity=0.460 Sum_probs=30.9
Q ss_pred hHHHh-hhhcceeeeecCCCCcccCHHHHHHHHHHhCCC--------CCHHHHHHHHHhhCC
Q 013201 395 SEEEI-KGLKTMFANMDTDKSGTITYEELKTGLARLGSK--------LSETEVKQLMDAVSI 447 (447)
Q Consensus 395 ~~~~~-~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~--------~~~~e~~~~~~~~d~ 447 (447)
+++++ +.++++|..+| +++|.|+..||.++|..+|.. ++.++++.|+..+|.
T Consensus 14 s~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~ 74 (188)
T d1qxpa2 14 SEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDR 74 (188)
T ss_dssp -------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcC
Confidence 34444 45899999999 558999999999998776543 467889999998873
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=92.75 E-value=0.042 Score=39.54 Aligned_cols=33 Identities=18% Similarity=0.326 Sum_probs=28.7
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
....+.++|+.+|.|+||.|+.+|+..++..+.
T Consensus 50 ~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~ 82 (100)
T d1psra_ 50 GTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIA 82 (100)
T ss_dssp TCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence 345688999999999999999999999888763
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=92.59 E-value=0.024 Score=40.19 Aligned_cols=31 Identities=13% Similarity=0.338 Sum_probs=27.2
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
...+.++|..+|.|+||.|+.+|+..++..+
T Consensus 48 ~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 78 (92)
T d1a4pa_ 48 PLAVDKIMKDLDQCRDGKVGFQSFFSLIAGL 78 (92)
T ss_dssp TTHHHHHHHHHCTTSSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcHHHHHHHHHHH
Confidence 3467888999999999999999999888765
|
| >d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=92.32 E-value=0.064 Score=33.94 Aligned_cols=52 Identities=19% Similarity=0.310 Sum_probs=46.0
Q ss_pred hhHHHhhhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhh
Q 013201 394 LSEEEIKGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAV 445 (447)
Q Consensus 394 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~ 445 (447)
+..++.++-..+|..||.+..+--...+-..+|..||...+..|-+.+|+++
T Consensus 8 lgpeekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkea 59 (86)
T d1j7qa_ 8 LGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEA 59 (86)
T ss_dssp CSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHH
T ss_pred cCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHh
Confidence 3455667778899999999999999999999999999999999999999875
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=91.76 E-value=0.023 Score=38.66 Aligned_cols=30 Identities=20% Similarity=0.504 Sum_probs=26.9
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.++.++|..+|.|++|.|+.+|+..+|..+
T Consensus 45 ~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~ 74 (76)
T d1qx2a_ 45 STLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp CSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence 357789999999999999999999998875
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=91.51 E-value=0.02 Score=40.74 Aligned_cols=33 Identities=21% Similarity=0.268 Sum_probs=28.4
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
....+.++++.+|.|+||.|+.+|+..++..+.
T Consensus 50 ~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~ 82 (93)
T d1ksoa_ 50 RECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC 82 (93)
T ss_dssp CHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 345678899999999999999999999888763
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=91.28 E-value=0.016 Score=38.54 Aligned_cols=29 Identities=17% Similarity=0.298 Sum_probs=25.2
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
+++..+|+.+|.|++|.|+.+|+..+|.+
T Consensus 39 ~e~~~~~~~~D~d~dG~i~~~EF~~~m~r 67 (68)
T d1c7va_ 39 AEVEEAMKEADEDGNGVIDIPEFMDLIKK 67 (68)
T ss_dssp HHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 45677899999999999999999998863
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=91.15 E-value=0.054 Score=43.69 Aligned_cols=47 Identities=15% Similarity=0.279 Sum_probs=38.1
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHhCCC-CCHHHHHHHHHhhCC
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARLGSK-LSETEVKQLMDAVSI 447 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~-~~~~e~~~~~~~~d~ 447 (447)
....+|..+|.+++|.|+.+|+..++..+-.. ..++.++.+++.+|.
T Consensus 55 ~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~ 102 (183)
T d2zfda1 55 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDL 102 (183)
T ss_dssp HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhccccc
Confidence 34688999999999999999999999887544 346678888888773
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=90.95 E-value=0.025 Score=40.24 Aligned_cols=32 Identities=16% Similarity=0.403 Sum_probs=27.7
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
...+.++|+.+|.|+||.|+.+|+..++..+.
T Consensus 51 ~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~ 82 (93)
T d1zfsa1 51 ADAVDKIMKELDENGDGEVDFQEFVVLVAALT 82 (93)
T ss_dssp HHHHHHHHHHHTTTCCSEECSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence 35677899999999999999999999987763
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=90.95 E-value=0.045 Score=37.16 Aligned_cols=30 Identities=20% Similarity=0.316 Sum_probs=26.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.++.++|+.+|.|++|.|+.+|+.++|+.-
T Consensus 45 ~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~ 74 (77)
T d1oqpa_ 45 EELQEMIAEADRNDDNEIDEDEFIRIMKKT 74 (77)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHcc
Confidence 356678999999999999999999999864
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=90.66 E-value=0.099 Score=41.73 Aligned_cols=49 Identities=18% Similarity=0.219 Sum_probs=36.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhC------------CCCCHHHHHHHHHhhCC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLG------------SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~------------~~~~~~e~~~~~~~~d~ 447 (447)
...++.+|+.+|.+++|.|+.+|+...+..+. ....++.++.+++++|.
T Consensus 86 ~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~ 146 (178)
T d1s6ca_ 86 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDK 146 (178)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCC
Confidence 34677899999999999999999988776531 12235567788888874
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=90.60 E-value=0.033 Score=45.83 Aligned_cols=46 Identities=13% Similarity=0.315 Sum_probs=39.2
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
+..+|+.+|.+++|.|+.+|+..++..+.....++.++.+++.+|.
T Consensus 65 ~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~ 110 (201)
T d1omra_ 65 AQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDV 110 (201)
T ss_dssp HHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGGGSHHHHHHHHCT
T ss_pred HHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHHHHcc
Confidence 4568999999999999999999999888777777788888887763
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=90.08 E-value=0.039 Score=37.64 Aligned_cols=31 Identities=19% Similarity=0.598 Sum_probs=27.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
+++.+++..+|.|+||.|+.+|+..++..+.
T Consensus 47 ~~v~~~~~~~D~d~dG~Idf~EF~~l~~~la 77 (78)
T d1cb1a_ 47 RTLDDLFQELDKNGDGEVSFEEFQVLVKKIS 77 (78)
T ss_dssp CCSSHHHHHTCCCSSSSEEHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcCcHHHHHHHHHHHh
Confidence 4578899999999999999999999988763
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=90.07 E-value=0.05 Score=37.96 Aligned_cols=32 Identities=13% Similarity=0.339 Sum_probs=27.8
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
....+.++++.+|.|+||.|+.+|+..++..+
T Consensus 49 ~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l 80 (87)
T d1e8aa_ 49 DKAVIDEIFQGLDANQDEQVDFQEFISLVAIA 80 (87)
T ss_dssp SHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence 34568889999999999999999999888765
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.02 E-value=0.039 Score=39.61 Aligned_cols=28 Identities=25% Similarity=0.351 Sum_probs=24.8
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
.+..+|..+|.|+||.|+.+|+..++++
T Consensus 69 ~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 69 MREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp HHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred HHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 4667999999999999999999988764
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=89.54 E-value=0.043 Score=37.08 Aligned_cols=30 Identities=13% Similarity=0.449 Sum_probs=25.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.++.++|+.+|.+++|.|+++|+..+|+.+
T Consensus 45 ~e~~~~~~~~D~d~dg~I~~~EF~~~m~~~ 74 (75)
T d1jc2a_ 45 EDIEDLMKDSDKNNDGRIDFDEFLKMMEGV 74 (75)
T ss_dssp HHHHHHHHHHCSSSCSEECHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence 346678899999999999999999988754
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=89.24 E-value=0.067 Score=36.82 Aligned_cols=29 Identities=31% Similarity=0.590 Sum_probs=25.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
.++.++|+.+|.|++|.|+.+|+..+|..
T Consensus 52 ~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 52 EELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 45777899999999999999999998864
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=89.22 E-value=0.14 Score=35.61 Aligned_cols=30 Identities=20% Similarity=0.533 Sum_probs=26.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
+++.++++.+|.|+||.|+++|+..++..+
T Consensus 49 ~~v~~i~~~~D~n~DG~IdF~EF~~l~~~l 78 (87)
T d1xk4a1 49 KGADVWFKELDINTDGAVNFQEFLILVIKM 78 (87)
T ss_dssp TCHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 457788999999999999999999998875
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=88.98 E-value=0.062 Score=43.01 Aligned_cols=45 Identities=18% Similarity=0.351 Sum_probs=37.5
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+..+|+.+|.+++|.|+.+|+..++..+.....++.++.+++.+|
T Consensus 53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~~~~~~~f~~~D 97 (178)
T d1s6ca_ 53 AHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYD 97 (178)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHHhccchHHHHHHHHHhhc
Confidence 356899999999999999999999987766666778888887776
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=88.56 E-value=0.056 Score=39.53 Aligned_cols=28 Identities=25% Similarity=0.367 Sum_probs=24.0
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
++.++|+.+|.|+||.|+.+|+..+|.+
T Consensus 81 ev~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d1pvaa_ 81 ETKAFLKAADKDGDGKIGIDEFETLVHE 108 (109)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred HHHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence 4566788899999999999999998763
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=88.33 E-value=0.047 Score=39.93 Aligned_cols=28 Identities=21% Similarity=0.355 Sum_probs=24.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLA 427 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~ 427 (447)
+++.++|+.+|.|+||.|+.+|+..+|+
T Consensus 80 ~~~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (108)
T d1rroa_ 80 SETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp HHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 4567789999999999999999999875
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=88.29 E-value=0.063 Score=39.24 Aligned_cols=29 Identities=28% Similarity=0.401 Sum_probs=25.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
+++.++|+.+|.|++|.|+.+|+..+|.+
T Consensus 80 ~e~~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d5pala_ 80 TETKALLAAGDSDHDGKIGADEFAKMVAQ 108 (109)
T ss_dssp HHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence 34678899999999999999999998864
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=88.14 E-value=0.062 Score=39.13 Aligned_cols=28 Identities=25% Similarity=0.360 Sum_probs=24.7
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLA 427 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~ 427 (447)
++++++|+.+|.|++|.|+.+|+..+|+
T Consensus 79 ~~~~~l~~~~D~d~dG~I~~~EF~~~m~ 106 (107)
T d2pvba_ 79 AETKAFLADGDKDGDGMIGVDEFAAMIK 106 (107)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 4567789999999999999999998876
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=87.88 E-value=0.04 Score=37.91 Aligned_cols=29 Identities=17% Similarity=0.415 Sum_probs=24.9
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
.++..+|..+|.|++|+|+.+|+..+|+.
T Consensus 51 ~ev~~~~~~~D~d~dg~I~~~EF~~~m~~ 79 (81)
T d1fi5a_ 51 DDIEELMKDGDKNNDGRIDYDEFLEFMKG 79 (81)
T ss_dssp HHHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred HHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence 34667899999999999999999998764
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=87.82 E-value=0.14 Score=36.07 Aligned_cols=50 Identities=22% Similarity=0.315 Sum_probs=34.7
Q ss_pred Hhhhhcceeeeec-CCCC-cccCHHHHHHHHHH-hC----CCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMD-TDKS-GTITYEELKTGLAR-LG----SKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-l~----~~~~~~e~~~~~~~~d~ 447 (447)
.+..+..+|.++. .+|+ ++++.+||++++.. +. ...+...|+++|+.+|.
T Consensus 7 ai~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~ 63 (94)
T d1j55a_ 7 AMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDA 63 (94)
T ss_dssp HHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcC
Confidence 3456677888875 4454 58999999999987 33 23356779999999884
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=87.31 E-value=0.082 Score=36.20 Aligned_cols=29 Identities=34% Similarity=0.590 Sum_probs=25.1
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
.++.++|..+|.|++|.|+.+|+..+|..
T Consensus 50 ~e~~~~~~~~D~d~~g~I~~~eF~~~m~~ 78 (81)
T d1avsa_ 50 EELDAIIEEVDEDGSGTIDFEEFLVMMVR 78 (81)
T ss_dssp HHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 34677899999999999999999988864
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=87.21 E-value=0.079 Score=35.42 Aligned_cols=29 Identities=38% Similarity=0.595 Sum_probs=25.2
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
+++.++|+.+|.|++|.|+.+|+..+|..
T Consensus 44 ~~~~~~~~~~D~d~~g~I~f~eF~~~m~~ 72 (73)
T d2pq3a1 44 AELQDMINEVDADGNGTIDFPEFLTMMAR 72 (73)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 45678899999999999999999988764
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=87.16 E-value=0.08 Score=37.30 Aligned_cols=30 Identities=23% Similarity=0.372 Sum_probs=25.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.++.++|+.+|.|++|+|+.+|+..+|+.+
T Consensus 43 ~~l~~i~~~~D~d~dG~l~~~EF~~a~~li 72 (92)
T d1fi6a_ 43 LELSHIWELSDFDKDGALTLDEFCAAFHLV 72 (92)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeecHHHHHHHHHHH
Confidence 357789999999999999999998777644
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=87.09 E-value=0.057 Score=35.24 Aligned_cols=27 Identities=26% Similarity=0.501 Sum_probs=23.2
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGL 426 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l 426 (447)
.++..+|..+|.|++|.|+.+|+..+|
T Consensus 39 ~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 39 EEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 456778999999999999999998764
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=86.82 E-value=0.82 Score=35.80 Aligned_cols=39 Identities=18% Similarity=0.395 Sum_probs=28.5
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..+.|..+|.|++|.|+.+|+..++..+ +.+.++++.+|
T Consensus 114 ~~~~~~~~d~d~~G~i~~~EF~~~~~~~------~~~~~~f~~~D 152 (173)
T d1alva_ 114 LYSMIIRRYSDEGGNMDFDNFISCLVRL------DAMFRAFKSLD 152 (173)
T ss_dssp HHHHHHHHHTCSSSCBCHHHHHHHHHHH------HHHHHHHHHHS
T ss_pred HHHHhhccccCCCCeEeHHHHHHHHHHH------HHHHHHHHHhC
Confidence 3456667788999999999998888654 45666666665
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=86.60 E-value=0.12 Score=41.23 Aligned_cols=45 Identities=20% Similarity=0.313 Sum_probs=36.7
Q ss_pred hcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 402 LKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 402 l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
..++|+.+|.+++|.|+.+|+..++..+-....++.+..+++.+|
T Consensus 61 ~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~~~~f~~~D 105 (181)
T d1bjfa_ 61 AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYD 105 (181)
T ss_dssp HHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHHHHHHHHhc
Confidence 457888999999999999999888888766666777888888776
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=86.50 E-value=0.11 Score=37.14 Aligned_cols=30 Identities=13% Similarity=0.318 Sum_probs=26.6
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
..+.++|..+|.|+||.|+.+|+..++..+
T Consensus 54 ~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l 83 (98)
T d1yuta1 54 GSLDEKMKSLDVNQDSELKFNEYWRLIGEL 83 (98)
T ss_dssp SCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 457789999999999999999999988765
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.44 E-value=0.21 Score=39.29 Aligned_cols=41 Identities=24% Similarity=0.352 Sum_probs=29.8
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVS 446 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d 446 (447)
+.++.++..+|.|++|.|+.+|+..++..+ +++.++++.+|
T Consensus 40 ~~~~~li~~~D~~~~G~i~~~EF~~l~~~~------~~~~~~F~~fD 80 (165)
T d1k94a_ 40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENFMTVD 80 (165)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHhhcc------chhHHHHHHhC
Confidence 345667778899999999999999887653 34455555444
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=86.44 E-value=0.082 Score=38.58 Aligned_cols=28 Identities=39% Similarity=0.430 Sum_probs=24.5
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
++..+|+.+|.|++|+|+.+|+..+|..
T Consensus 81 e~~~~~~~~D~d~dG~i~~~EF~~~m~~ 108 (109)
T d1rwya_ 81 ETKTLMAAGDKDGDGKIGVEEFSTLVAE 108 (109)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 4567899999999999999999998863
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.31 E-value=0.11 Score=41.92 Aligned_cols=45 Identities=16% Similarity=0.303 Sum_probs=37.8
Q ss_pred cceeeeecCCCCcccCHHHHHHHHHHhCCCCCHHHHHHHHHhhCC
Q 013201 403 KTMFANMDTDKSGTITYEELKTGLARLGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 403 ~~~F~~~D~~~~g~i~~~el~~~l~~l~~~~~~~e~~~~~~~~d~ 447 (447)
..+|+.+|.+++|.|+.+|+..++..+.....++.++.+++.+|.
T Consensus 63 ~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e~l~~~F~~~D~ 107 (187)
T d1g8ia_ 63 TFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDL 107 (187)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCT
T ss_pred HHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhhhHHHHHHHHhc
Confidence 458999999999999999999999887655567778888888773
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.11 E-value=0.053 Score=38.53 Aligned_cols=29 Identities=14% Similarity=0.274 Sum_probs=24.8
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
..+.++|+.+|.|++|+|+.+|+..+|..
T Consensus 44 ~~l~~i~~~~D~d~dG~l~~~EF~~am~L 72 (95)
T d1c07a_ 44 TLLAHIWSLCDTKDCGKLSKDQFALAFHL 72 (95)
T ss_dssp HHHHHHHHHHCTTCSSSEETTTHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence 34667899999999999999999887754
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=85.66 E-value=0.13 Score=36.28 Aligned_cols=50 Identities=14% Similarity=0.210 Sum_probs=38.2
Q ss_pred Hhhhhcceeeeec-CCCC-cccCHHHHHHHHHH-----hCCCCCHHHHHHHHHhhCC
Q 013201 398 EIKGLKTMFANMD-TDKS-GTITYEELKTGLAR-----LGSKLSETEVKQLMDAVSI 447 (447)
Q Consensus 398 ~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-----l~~~~~~~e~~~~~~~~d~ 447 (447)
.+..+..+|.++. .+|+ ++++.+||+++|.. ++..-+.+.++++|+.+|.
T Consensus 7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~ 63 (95)
T d1qlsa_ 7 CIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDL 63 (95)
T ss_dssp HHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcC
Confidence 3456677888775 4565 68999999999976 4444578889999999884
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=85.57 E-value=0.094 Score=37.49 Aligned_cols=30 Identities=23% Similarity=0.287 Sum_probs=26.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.++.++|+..|.|++|.|+.+|+..+|+.+
T Consensus 45 ~~L~~i~~~~D~d~dG~L~~~EF~~am~Li 74 (99)
T d1qjta_ 45 LILGKIWDLADTDGKGVLSKQEFFVALRLV 74 (99)
T ss_dssp HHHHHHHHHHCCSSSSSCCSHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCccCHHHHHHHHHHH
Confidence 357789999999999999999999888754
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=84.65 E-value=0.095 Score=35.40 Aligned_cols=29 Identities=17% Similarity=0.394 Sum_probs=25.0
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLAR 428 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 428 (447)
.++.++|..+|.+++|.|+.+|+..+|.+
T Consensus 46 ~e~~~~~~~~D~~~~g~I~~~eF~~~m~~ 74 (77)
T d1f54a_ 46 AEVNDLMNEIDVDGNHQIEFSEFLALMSR 74 (77)
T ss_dssp HHHHHHHHTTCCSSCCEEEHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 45678899999999999999999987743
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.50 E-value=0.13 Score=36.41 Aligned_cols=30 Identities=17% Similarity=0.278 Sum_probs=25.5
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
..+..+|...|.|++|+|+++|+..++..+
T Consensus 43 ~~L~~Iw~~~D~~~dG~l~~~EF~~a~~Li 72 (95)
T d2jxca1 43 DILGRVWELSDIDHDGMLDRDEFAVAMFLV 72 (95)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCeEcHHHHHHHHHHH
Confidence 357789999999999999999998777643
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=84.48 E-value=0.1 Score=36.49 Aligned_cols=30 Identities=20% Similarity=0.414 Sum_probs=26.9
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
..+.++++.+|.|+||.|+.+|+..++..+
T Consensus 50 ~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~l 79 (89)
T d1k8ua_ 50 AEIARLMEDLDRNKDQEVNFQEYVTFLGAL 79 (89)
T ss_dssp HHHHHHHHHHHHTTTCEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence 567889999999999999999999988765
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=84.18 E-value=0.2 Score=31.94 Aligned_cols=25 Identities=16% Similarity=0.485 Sum_probs=21.4
Q ss_pred hhhcceeeeecCCCCcccCHHHHHH
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKT 424 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~ 424 (447)
.++..+|+.+|.|++|.|+.+|+.+
T Consensus 37 ~ei~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 37 AEVDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcEeHHHhcC
Confidence 4566789999999999999999853
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=84.05 E-value=0.12 Score=36.39 Aligned_cols=32 Identities=22% Similarity=0.394 Sum_probs=27.5
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
...+.++|+.+|.|+||.|+.+|+..++..+.
T Consensus 51 ~~~vd~im~~LD~n~Dg~vdF~EF~~li~~la 82 (95)
T d1qlsa_ 51 PGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLA 82 (95)
T ss_dssp THHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence 35578899999999999999999998887763
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=83.77 E-value=0.14 Score=35.69 Aligned_cols=31 Identities=16% Similarity=0.349 Sum_probs=26.9
Q ss_pred hhhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 399 IKGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 399 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
...+.++|+.+|.|+||.|+.+|+..++..+
T Consensus 51 ~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (90)
T d3cr5x1 51 QEVVDKVMETLDSDGDGECDFQEFMAFVAMI 81 (90)
T ss_dssp HHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 3457789999999999999999998888765
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.42 E-value=0.16 Score=37.06 Aligned_cols=29 Identities=21% Similarity=0.329 Sum_probs=25.0
Q ss_pred hhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 401 GLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 401 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.|.++|...|.|++|+|+++|+..+|+.+
T Consensus 57 ~L~~Iw~l~D~d~dG~l~~~EF~~am~Li 85 (110)
T d1iq3a_ 57 ELSYIWELSDADCDGALTLPEFCAAFHLI 85 (110)
T ss_dssp CHHHHHHHHCSSSCSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCeECHHHHHHHHHHH
Confidence 46678889999999999999999888754
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.50 E-value=0.43 Score=37.94 Aligned_cols=45 Identities=7% Similarity=0.186 Sum_probs=35.7
Q ss_pred cceeeeecCC-CCcccCHHHHHHHHHHhCCC-CCHHHHHHHHHhhCC
Q 013201 403 KTMFANMDTD-KSGTITYEELKTGLARLGSK-LSETEVKQLMDAVSI 447 (447)
Q Consensus 403 ~~~F~~~D~~-~~g~i~~~el~~~l~~l~~~-~~~~e~~~~~~~~d~ 447 (447)
.++|+.||.+ ++|.|+.+|+..++..+... ..++.++.+++-+|.
T Consensus 60 ~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~ 106 (180)
T d1xo5a_ 60 ERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDF 106 (180)
T ss_dssp HHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCT
T ss_pred HHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccC
Confidence 4588899987 79999999999999887543 456678888887763
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=81.17 E-value=0.25 Score=34.71 Aligned_cols=32 Identities=9% Similarity=0.354 Sum_probs=26.6
Q ss_pred HhhhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 398 EIKGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 398 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
....+.++++.+|.|+||.|+.+|+..++..+
T Consensus 50 d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (94)
T d1j55a_ 50 DKDAVDKLLKDLDANGDAQVDFSEFIVFVAAI 81 (94)
T ss_dssp --CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 34567889999999999999999999888765
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=80.66 E-value=0.25 Score=38.87 Aligned_cols=30 Identities=20% Similarity=0.324 Sum_probs=26.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
.++..+|..+|.|++|.|+.+|+..++...
T Consensus 128 ~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~f 157 (174)
T d2scpa_ 128 TMAPASFDAIDTNNDGLLSLEEFVIAGSDF 157 (174)
T ss_dssp GGHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCcEeHHHHHHHHHHH
Confidence 346678999999999999999999998875
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=80.40 E-value=0.37 Score=32.90 Aligned_cols=30 Identities=27% Similarity=0.517 Sum_probs=25.8
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHh
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARL 429 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 429 (447)
..+.++|..+|.|+||.|+.+|+..++..|
T Consensus 54 ~~vd~~m~~LD~n~Dg~vdF~EF~~li~~L 83 (83)
T d1xk4c1 54 KVIEHIMEDLDTNADKQLSFEEFIMLMARL 83 (83)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHhhC
Confidence 457789999999999999999998877653
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=80.10 E-value=0.14 Score=40.28 Aligned_cols=31 Identities=23% Similarity=0.411 Sum_probs=27.3
Q ss_pred hhhcceeeeecCCCCcccCHHHHHHHHHHhC
Q 013201 400 KGLKTMFANMDTDKSGTITYEELKTGLARLG 430 (447)
Q Consensus 400 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l~ 430 (447)
.++..+|..+|.|++|.|+.+|+..+++.+.
T Consensus 136 ~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~ 166 (176)
T d1nyaa_ 136 AEAAEAFNQVDTNGNGELSLDELLTAVRDFH 166 (176)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHSCCS
T ss_pred HHHHHHHHHHCCCCCCcEeHHHHHHHHHHHh
Confidence 4567889999999999999999999998754
|